<SEC-DOCUMENT>0001144204-11-025256.txt : 20110620
<SEC-HEADER>0001144204-11-025256.hdr.sgml : 20110620

<ACCEPTANCE-DATETIME>20110502100445

<PRIVATE-TO-PUBLIC>

ACCESSION NUMBER:		0001144204-11-025256

CONFORMED SUBMISSION TYPE:	S-1/A

PUBLIC DOCUMENT COUNT:		11

FILED AS OF DATE:		20110502

DATE AS OF CHANGE:		20110505


FILER:


	COMPANY DATA:	

		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC

		CENTRAL INDEX KEY:			0000720154

		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]

		IRS NUMBER:				351345024

		STATE OF INCORPORATION:			IN

		FISCAL YEAR END:			0930



	FILING VALUES:

		FORM TYPE:		S-1/A

		SEC ACT:		1933 Act

		SEC FILE NUMBER:	333-172508

		FILM NUMBER:		11798444



	BUSINESS ADDRESS:	

		STREET 1:		2701 KENT AVE

		CITY:			WEST LAFAYETT

		STATE:			IN

		ZIP:			47906-1382

		BUSINESS PHONE:		3174634527



	MAIL ADDRESS:	

		STREET 1:		2701 KENT AVENUE

		CITY:			WEST LAFAYETTE

		STATE:			IN

		ZIP:			47906-1382



</SEC-HEADER>

<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>v220305_s1a.htm
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">As filed with the Securities and Exchange Commission on May 2, 2011</font> </div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registration No. 333-172508</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED STATES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WASHINGTON, D.C. 20549</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment No. 3 to</font> </div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form S-1</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(Exact name of registrant as specified in its charter)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Indiana</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8731</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="32%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35-1345024</font></div>
</td>
</tr><tr>
<td valign="bottom" width="32%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(State&#160;or&#160;other&#160;jurisdiction&#160;of</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">incorporation&#160;or&#160;organization)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="32%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(Primary&#160;Standard&#160;Industrial</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Classification&#160;Code&#160;Number)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="32%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">(I.R.S.&#160;Employer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">Identification&#160;Number)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701 Kent Avenue</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West Lafayette, Indiana 47906</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Phone: (765) 463-4527</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Michael R. Cox</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Vice President-Finance, Chief Financial and Administrative Officer and Treasurer</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701 Kent Avenue</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West Lafayette, Indiana 47906</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Phone: (765) 463-4527</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Please send copies of all communications to:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stephen J. Hackman, Esq.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ice Miller LLP</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">One American Square, Suite 2900</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indianapolis, Indiana 46282-0200</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Phone: (317) 236-2289</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Approximate date of commencement of proposed sale to the public:</font> As soon as practicable after this Registration Statement becomes effective.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box:&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">x</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">&#168;</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this Form is to be a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">&#168;</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If this Form is a post-effective amendment pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Wingdings">&#168;</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant is a large accelerated filed, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 9pt; FONT-FAMILY: Times New Roman">Large accelerated filer&#160;<font style="DISPLAY: inline;" face="Wingdings">o </font>Accelerated filer <font style="DISPLAY: inline;" face="Wingdings">o </font>Non-accelerated filer <font style="DISPLAY: inline;" face="Wingdings">o</font> (Do not check if a smaller reporting company)&#160;&#160;&#160;&#160;&#160;Smaller reporting company <font style="DISPLAY: inline;" face="Wingdings">x</font></font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CALCULATION OF REGISTRATION FEE</font></div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="88%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title&#160;of&#160;Each&#160;Class&#160;of&#160;Securities&#160;to&#160;be&#160;Registered</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" colspan="2" nowrap valign="bottom" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proposed</font> </div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Maximum</font> </div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aggregate</font> </div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Offering&#160;Price(1)</font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" colspan="2" nowrap valign="bottom" width="13%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount&#160;of</font> </div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Registration&#160;Fee</font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6% Series A convertible preferred shares</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares issuable upon conversion of 6% Series A convertible preferred shares(2)</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares issuable in lieu of cash payment of dividends on the 6% Series A convertible preferred shares</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrants to purchase common shares(2)</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares issuable upon exercise of warrants</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,900,000</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">685</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font> </td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the shares being registered hereunder include such indeterminate number of common shares as may be issuable with respect to the shares being registered hereunder as a result of share splits, share dividends, anti-dilution provisions, or similar transactions. No additional registration fee is being paid for these shares.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2)</font> </div>
</td>
<td>
<div align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">No additional consideration is payable upon conversion of the Convertible Preferred Shares or upon issuance of the warrants.</font> </div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font> </div>
</td>
<td>
<div align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Previously paid.</font> </div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to Section 8(a), may determine.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell securities, and it is not soliciting an offer to buy these securities, in any state where the offer or sale is not permitted.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PRELIMINARY PROSPECTUS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Subject to Completion, Dated May 2, 2011</font> </div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><img src="logo.jpg"></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5,000 6% Series A Convertible Preferred Shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(and _____ Common Shares underlying the 6% Series A Convertible Preferred Shares)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_____ Warrants</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(and _____ Common Shares underlying the Warrants)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">We are offering up to 5,000 6% Series A convertible preferred shares (the &#8220;Series A preferred shares&#8221;) and warrants to purchase up to _____ common shares to purchasers in this offering. We are also offering up to _____ of our common shares issuable upon conversion of the Series A preferred shares and _____ of our common shares issuable upon exercise of the warrants. The Series A preferred shares and warrants will be sold in units for a purchase price equal to $1,000 per unit. Each unit will consist of (1) one Series A preferred share which is convertible into ___ of our common shares at a conversion price of $_.__ per common share, (2) one Class A Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit, exercisable at any time after the closing date at an exercise price of $_.__ per common share and (3) one Class B Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit, exercisable at any time after the closing date at an exercise price of $_.__ per common share. The conversion price of the Series A preferred shares and the exercise prices for the warrants will depend upon market conditions and will be determined by our Board of Directors after consulting with the placement agent for this offering.&#160;&#160;The conversion price of the Series A preferred shares and the exercise price of the Warrants are expected to be between $2.00 and $2.50.</font> </div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Until May__, 2014, the Series A preferred shares will have a stated dividend rate of 6% per annum, payable quarterly in cash or, at our election and subject to certain conditions described in this prospectus, in our common shares, which are also being offered by this prospectus.&#160;&#160;Thereafter, each holder of Series A preferred shares will be entitled to receive dividends equal, on an as-if-converted to common shares basis, to and in the same form as dividends actually paid on common shares when, as, and if such dividends are paid on common shares. The Company has never paid dividends on its common shares and does not intend to do so for the foreseeable future.<font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;</font>The conversion of the Series A preferred shares and the exercise of the warrants are subject to certain ownership limitations described in this prospectus.&#160;&#160;If certain conditions described in the prospectus are met, we may, at our option, redeem the Series A preferred shares for cash or require the holders to convert the Series A preferred shares into common shares.&#160;&#160;For a more detailed description of the Series A preferred shares, the warrants, and our common shares, see the section entitled &#8220;Description of Securities&#8221; beginning on page 12 of this prospectus.</font> </div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Our common shares are quoted on the NASDAQ Capital Market under the symbol &#8220;BASI.&#8221; The last reported sale price of our common shares on April 29, 2011 was $2.59 per share.&#160;&#160;There is no established public trading market for the Series A preferred shares or the warrants being sold in this offering and we do not expect such a market to develop.</font> </div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">We have retained Ladenburg Thalmann &amp; Co. Inc. (the &#8220;Placement Agent&#8221;) to act as our exclusive Placement Agent in connection with this offering and to use its &#8220;best efforts&#8221; to solicit offers to purchase the units. We intend to enter into a Placement Agency Agreement with the Placement Agent, relating to the units offered by this prospectus.&#160;&#160;The Placement Agent is not purchasing or selling any of our units pursuant to this prospectus, nor are we requiring any minimum purchase or sale of any specific number of units. Because there is no minimum offering amount required as a condition to the closing of this offering, the actual public offering amount, Placement Agent fees and proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth below. See &#8220;Plan of Distribution&#8221; beginning on page 17 of this prospectus for more information regarding this arrangement.</font> </div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Investing in our securities involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page 6 of this prospectus for more information.</font> </div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Per&#160;Unit</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Total</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Public offering price</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Placement Agent fees (1)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds, before expenses, to us (2)</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1) For the purpose of estimating the Placement Agent&#8217;s fees, we have assumed that they will receive their maximum commission on all sales made in the offering.&#160; The Placement Agent will also be entitled to reimbursement of expenses up to a maximum of 1.2% of the gross proceeds raised in the offering, but in no event more than $60,000.<a name="page4"><!--efplaceholder--></a></font> </div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2) We estimate total expenses of this offering, excluding the Placement Agent&#8217;s fees and expenses, will be approximately $250,000.&#160;&#160;For information concerning our obligation to reimburse the Placement Agent for certain of its expenses see &#8220;Plan of Distribution&#8221; beginning on page 17 of this prospectus.</font> </div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This offering expires on the earlier of (i) the date upon which all of the units being offered have been sold, or (ii) _____, 2011.&#160; We expect that delivery of the units being offered pursuant to this prospectus will be made to purchasers on or about ______, 2011.&#160; In either event, the offering may be closed without further notice to you.&#160; </font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus or the prospectus to which it relates is truthful or complete. Any representation to the contrary is a criminal offense.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 12pt">L</font>ADENBURG <font style="DISPLAY: inline; FONT-SIZE: 12pt">T</font>HALMANN <font style="DISPLAY: inline; FONT-SIZE: 12pt">&amp; C</font>O<font style="DISPLAY: inline; FONT-SIZE: 12pt">. I</font>NC<font style="DISPLAY: inline; FONT-SIZE: 12pt">.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The date of this prospectus is ______, 2011.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><img src="pg5.jpg"></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Table of Contents</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prospectus Summary</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Offering</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Risk Factors</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Use of Proceeds</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Determination of Offering Price</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dilution</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dividend Policy</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capitalization</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Description of Securities</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Market for Registrant&#8217;s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Plan of Distribution</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Business</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Properties</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Management</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Executive and Director Compensation</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">42</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Material U.S. Federal Income Tax Considerations</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Legal Proceedings</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Legal Matters</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46</font></div>
</td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Experts</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="92%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Index to Financial Statements</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-1</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">You should rely only on the information contained in this prospectus. We have not, and the Placement Agent&#160;has&#160;not, authorized anyone to provide you with information different from that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it.&#160; We are offering to sell, and seeking offers to buy, units only in jurisdictions where offers and sales are permitted. You should assume that the information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of units. Our business, financial condition, results of operations, and prospects may have changed since that date.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Some of the industry and market data contained in this prospectus are based on independent industry publications or other publicly available information that we believe are reliable as of their respective dates, while other information is based on our internal sources.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Cautionary Note Regarding Forward-Looking Statements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This prospectus contains forward-looking statements that are based on current expectations, estimates, forecasts and projections regarding management&#8217;s beliefs and assumptions about the industry in which we operate. Such statements include, in particular, statements about our plans, strategies and prospects under the headings &#8220;Prospectus Summary,&#8221; &#8220;Risk Factors,&#8221; &#8220;Use of Proceeds,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Business.&#8221; When used in this prospectus, the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and similar expressions identify forward-looking statements.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause actual outcomes and results to differ materially from what is expressed or forecasted in such forward-looking statements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except as required by applicable law, we assume no obligation to update any forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prospectus Summary</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This summary highlights information about our Company and this offering contained elsewhere in this prospectus and is qualified in its entirety by the more detailed information and financial statements included elsewhere in this prospectus. You should read this entire prospectus carefully, including &#8220;Risk Factors&#8221;, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and related notes included elsewhere in this prospectus, before making an investment decision. In this prospectus, unless otherwise specified or the context otherwise requires, the terms &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, &#8220;the Company&#8221;, or &#8220;ours&#8221; refer to Bioanalytical Systems, Inc. and its consolidated subsidiaries.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">About Bioanalytical Systems, Inc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc., a corporation organized in Indiana in 1974, provides contract drug development services and research equipment to many leading global pharmaceutical, medical research and biotechnology companies and institutions. We offer an efficient, variable-cost alternative to our clients' internal product development programs. Outsourcing development work to reduce overhead and speed drug approvals through the Food and Drug Administration ("FDA") is an established alternative to in-house development among pharmaceutical companies. We derive our revenues from sales of our research services and drug development tools, both of which are focused on determining drug safety and efficacy.&#160; The Company has been involved in the research of drugs to treat numerous therapeutic areas since its formation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We support the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates.&#160; We believe our scientists<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>have the skills in analytical instrumentation development, chemistry, computer software development, physiology, medicine, analytical chemistry and toxicology to make the services and products we provide increasingly valuable to our current and potential clients. Our principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic neuroscience research from small start-up biotechnology companies to many of the largest global pharmaceutical companies.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our services and products are marketed globally to pharmaceutical, medical research and biotech companies and institutions engaged in drug research and development. The research services industry is highly fragmented among many niche vendors led by a small number of larger companies; the latter offer an ever-growing portfolio of start-to-finish pharmaceutical development services. Our products are also marketed to academic and governmental institutions. Our services and products may have distinctly different clients (often separate divisions in a single large pharmaceutical company) and requirements. We believe that clients are facing increased pressure to outsource facets of their research and development activities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We operate in two business segments &#8211; contract research services and research products, both of which address the bioanalytical, preclinical, and clinical research needs of drug developers. Both segments arose out of our expertise in a number of core technologies designed to quantify trace chemicals in complex matrices.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The following is a description of the services provided by our contract research services segment:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Product Characterization, Method Development and Validation</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>Analytical methods, primarily performed in West Lafayette, Indiana, determine potency, purity, chemical composition, structure and physical properties of a compound. Methods are validated to ensure that data generated are accurate, precise, reproducible and reliable and are used consistently throughout the drug development process and in later product support.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Bioanalytical Testing</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We analyze specimens from preclinical and clinical trials to measure drug and metabolite concentrations in complex biological matrices. Bioanalysis is performed at our facilities in Indiana, Oregon and the United Kingdom (&#8220;UK&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Stability Testing</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We test stability of drug substances and formulated drug products and maintain secure storage facilities in West Lafayette, Indiana to establish and confirm product purity, potency and shelf life. We have multiple International Conference on Harmonization validated controlled-climate GMP (Good Manufacturing Practices) systems in place, and the testing capability to complete most stability programs.</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">In Vivo Pharmacology</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We provide preclinical <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo </font>sampling services for the continuous monitoring of chemical changes in life, in particular, how a drug enters, travels through, and is metabolized in living systems. Most services are performed in customized facilities in Evansville, Indiana using our robotic Culex&#174; APS (Automated Pharmacology System) system.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Preclinical and Pathology Services</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We provide pharmacokinetic and safety testing in studies ranging from acute safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity studies in our Evansville, Indiana site. Depending on protocol, multiple tissues may be collected to monitor pathological changes.&#160;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our products business is focused on expediting preclinical screening of developmental drugs. We compete in small niches of the multibillion dollar analytical instrument industry. The products business targets unique niches in life science research. We design, develop, manufacture and market state-of-the-art <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling systems and accessories (including disposables, training and systems qualification), physiology monitoring tools and liquid chromatography and electrochemistry instruments platforms. We offer three (3) principal product lines:&#160; Analytical Products, In vivo Sampling Products and Vetronics&#8217; Products.&#160; The following is a brief description of the products offered:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Analytical Products:</font>&#160; The analytical products consist of our liquid chromatographic and electrochemical instruments with associated accessories.&#160; The critical component of these products is the Epsilon<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">&#174; </font>electrochemical platform.&#160; This incorporates all the hardware capabilities needed for most electrochemical experiments but can be modified through software development.&#160; The market is principally academic institutions and industrial research companies.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">In Vivo Sampling Products:&#160; </font>The <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling products consist of the <font style="DISPLAY: inline; FONT-STYLE: italic">Culex&#174;</font> family of automated <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling and dosing instruments.&#160; These are used by pharmaceutical researchers to dose animals and collect biological samples (blood, bile, urine, microdialysate, feces or any bio-fluid) from the animals.&#160; Since dosing and sample collections are automated, animals are not manually handled, reducing stress on the animals and producing more representative pharmacological data.&#160; Behavior and other physiological parameters can also be monitored simultaneously.&#160; Compared to manual methods, the Culex&#174; products offer significant reduction in test model use and comparable reduction in labor.&#160; The line also includes miniaturized <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling devices sold to drug developers and medical research centers to assist in the study of&#160; a number of medical conditions including stroke, depression, Alzheimer&#8217;s and Parkinson&#8217;s diseases, diabetes and osteoporosis.</font></div></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Vetronics&#8217; Products:&#160; </font>The Vetronics&#8217; products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram) and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Growth Strategy</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We believe that the development of innovative new drugs is going through an evolution, evidenced by the significant reduction of expenditures on research and development at several major international pharmaceutical companies, accompanied by increases in outsourcing and investments in smaller start-up companies that are performing the early development work on new compounds.&#160; Many of these companies are funded by either venture capital or pharmaceutical investment, or both, and generally do not build internal staffs that possess the extensive scientific and regulatory capabilities to perform the various activities necessary to progress a drug candidate to the filing of an Investigative New Drug (&#8220;IND&#8221;) application with the FDA.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">While continuing to maintain and develop our relationships with large pharmaceutical companies, we intend to aggressively promote our services to developing businesses, which will require us to expand our existing capabilities to provide services early in the drug development process, and to consult with clients on regulatory strategy and compliance leading to their filings.&#160; We have recently launched our Enhanced Drug Discovery services as part of this strategy, utilizing our proprietary Culex<font style="DISPLAY: inline; FONT-STYLE: italic">&#174;</font> technology to provide early experiments in our laboratories that previously would have been conducted in the sponsor&#8217;s facilities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We will employ the following key strategies, among others, to achieve our growth goals:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Expand our CRO business.</font>&#160; We will grow our CRO business through increased investment in our people and facilities, and by expanding our network of relationships for new and existing CRO services as follows:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Gaining new clients for our existing CRO services from competitors or from internal client functions;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Focusing on new markets, such as start-ups, biotechs and generics, for our services;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Expanding Culex<font style="DISPLAY: inline; FONT-STYLE: italic">&#174; </font>automated <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling and dosing instrument capabilities into the discovery phase of research;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Partnering with Phase I clinical units;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Evaluating and expanding our capabilities in biologics, and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">-</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investigating acquisition candidates that add services we do not currently offer to our markets, or that bring innovation to existing CRO offerings.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Expand our portfolio of commercially viable, innovative products.</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>We intend to expand our portfolio of value-added products using innovative technologies that are desired in the market.&#160; We will utilize our own research and development efforts and existing client relationships to identify and prioritize opportunities that allow us to respond rapidly to the market and shorten the time to market for new products.</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Challenges in Executing our Growth Strategy</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We face several challenges to the successful implementation of our growth strategy. In addition, our business is subject to numerous risks, which we highlight in the section entitled "Risk Factors" immediately following this prospectus summary.&#160; For example, our ability to grow by expanding our CRO business requires that we take business from competitors, identify new clients, expand our scientific capabilities and broaden our geographic presence. Our inability to do any of these could prevent us from successfully implementing our growth strategy. In addition, the success of our business model depends on our ability to correctly identify market needs for new technologies. If we are not successful in identifying market needs or in developing new products to meet those needs, we may not be successful in expanding our products portfolio. We believe that sustained growth at a higher rate will require that we attract additional scientific and business talent. If we are unable to accomplish this, it may negatively impact our ability to grow.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Where You Can Find More Information</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our common shares are quoted on the NASDAQ Capital Market under the symbol &#8220;BASI.&#8221;.&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our executive offices are located at 2701 Kent Avenue, West Lafayette, Indiana 47906, and our telephone number is 765.463.4527.&#160; We make available on our website, <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.BASInc.com</font>, our annual reports, quarterly reports, and proxy statements, as well as up- to- date investor presentations.&#160;The information on our website is not incorporated by reference into this prospectus, and you should not consider it part of this prospectus.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have filed a registration statement on Form S-1 (Registration No. 333-172508) with the SEC under the Securities Act with respect to the securities offered by this prospectus. This prospectus, which is a part of such registration statement, does not include all of the information contained in the registration statement and its exhibits. For further information regarding us and our securities, you should consult the registration statement and its exhibits.&#160; The registration statement and its exhibits, as well as our other reports filed with the SEC, can be inspected and copied at the SEC&#8217;s public reference room at 100&#160;F Street, N.E., Washington,&#160;D.C. 20549. The public may obtain information about the operation of the public reference room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains a web site at http://<font style="DISPLAY: inline; FONT-STYLE: italic">www.sec.gov </font>which contains the Form&#160;S-1 and other reports, proxy and information statements and information regarding issuers that file electronically with the SEC.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Statements contained in this prospectus concerning the provisions of any documents are summaries of those documents, and we refer you to the documents filed with the SEC for more information. The registration statement and any of its amendments, including exhibits filed as a part of the registration statement or an amendment to the registration statement, are available for inspection and copying as described above.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="92%" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The Offering</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Our common shares are traded on the NASDAQ Capital Market under the symbol &#8220;BASI&#8221;. On April 29, 2011, the last sale price of our common shares as reported on the NASDAQ Capital Market was $2.59 per share.</font></font> </div>
</div>
</div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issuer</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bioanalytical Systems, Inc.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Units</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Each unit consists of (1) one Series A convertible preferred share which is convertible into ___ common shares; (2) one Class A Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit; and (3) one Class B Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unit Price</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$1,000 per unit.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Series A Preferred Shares</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Each unit includes one Series A preferred share.&#160; Each Series A preferred share is convertible at the option of the holder into ___ of our common shares, has a stated value and liquidation preference of $1,000 per share, and is redeemable at the option of the Company so long as certain conditions described in this prospectus are met.&#160; The Company also has the right to require the holders to convert the Series A preferred shares in certain circumstances described in this prospectus.&#160; Until May __, 2014, the Series A preferred shares will have a stated dividend rate of 6% per annum, payable quarterly in cash or, subject to certain conditions, in common shares or a combination of cash and common shares, at our election.&#160; After May __, 2014, the Series A preferred shares will participate in any dividends payable upon our common shares on an "as converted" basis.&#160; The Series A preferred shares will not have voting rights, except as may be provided by Indiana law.&#160; See the section entitled "Description of Series A Preferred Shares" beginning on page 13 of this prospectus.</font> </div></td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> &#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dividends and Make-Whole Payment</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Until May__, 2014, each holder of the Series A preferred shares is entitled to receive dividends at the rate of 6% per annum of the stated value for each preferred share held by such holder payable quarterly on January 1, April 1, July 1 and October 1, beginning on the first such date after the original issue date, and on each conversion date.&#160;&#160;Except in limited circumstances (including a failure to meet the Equity Conditions), we can elect to pay the dividends in cash or in duly authorized, validly issued, fully paid and non-assessable common shares, or a combination thereof.&#160;&#160;If the Equity Conditions are not met, we must pay the dividends in cash.&#160;&#160;If the Equity Conditions have been met and we choose to pay the dividends in common shares, the common shares used to pay the dividends will be valued at 90% of the average volume weighted average price of our common shares for the 20 consecutive trading days ending on the trading day immediately prior to the applicable dividend payment date.&#160;&#160;From and after May __, 2014, each holder of Series A preferred shares will be entitled to receive dividends equal, on an as-if-converted to common shares basis, to and in the same form as dividends actually paid on common shares when, as, and if such dividends are paid on common shares.&#160; We have never paid dividends on our common shares and we do not intend to do so for the foreseeable future.</font></font> </div></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> &#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In the event a holder converts his, her or its Series A preferred shares prior to May __, 2014, we must also pay to the holder in cash, or at our option, subject to satisfaction of the Equity Conditions, in common shares valued as described above, or a combination of cash and common shares, with respect to the Series A preferred shares so converted, an amount equal to $180 per $1,000 of the stated value of the Series A preferred shares, less the amount of any dividends paid in cash or in common shares on such Series A preferred shares on or before the date of conversion.&#160;&#160;</font></font> </div>
</div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prohibition on Down Round Financings</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For a period of 3 years from the closing of the offering, without the prior written consent of the subscribers in this offering, the Company shall not be permitted to consummate a financing below the Conversion Price.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Conversion Price of Series A preferred shares</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$_.__ per share, subject to adjustment as described in this prospectus.&#160; See the section entitled "Description of Series A Preferred Shares" beginning on page 13 of this prospectus.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares underlying Series A preferred shares</font></div>
</td>
<td align="left" valign="top" width="2%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Based on the conversion price of $_.__ per share, each Series A preferred share is convertible into ___ of our common shares and all 5,000 Series A preferred shares offered hereby would be converted into ___ of our common shares.<a name="page11"><!--efplaceholder--></a></font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Class A Warrant terms</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Each unit includes a Class A Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit, which equals 50% of the common shares underlying each Series A preferred share.&#160; Class A Warrants will entitle the holder to purchase common shares for an exercise price equal to $_.__ per share, subject to adjustment as described in this prospectus.&#160; Class A Warrants are exercisable immediately after the date of issuance and expire five years after the date of issuance.&#160; See the section entitled "Description of Warrants" beginning on page 14 of this prospectus.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Class B Warrant terms</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Each unit includes a Class B Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit, which equals 50% of the common shares underlying each Series A preferred share.&#160; Class B Warrants will entitle the holder to purchase common shares for an exercise price equal to $_.__ per share, subject to adjustment as described in this prospectus.&#160; Class B Warrants are exercisable immediately after the date of issuance and expire one year after the date of issuance.&#160; See the section entitled "Description of Warrants" beginning on page 14 of this prospectus.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares outstanding before this offering</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Approximately 4,915,318 shares.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares to be outstanding after this offering including common shares underlying Series A Preferred Shares included in Units</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Approximately _____ shares, excluding shares issuable upon exercise of the warrants.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Use of Proceeds</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assuming all units are sold, we estimate that the net proceeds to us from this offering will be approximately $__ million.&#160; We intend to use the net proceeds from this offering for the purchase of laboratory equipment, working capital and general corporate purposes. See "Use of Proceeds."</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Limitations on Exercise or Conversion</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notwithstanding anything herein to the contrary, the Company will not permit the conversion of the preferred shares or exercise of the warrants of any holder, if after such conversion or exercise such holder would beneficially own more than 4.99% (or 9.99% as elected by the holder pursuant to the terms of the Series A preferred shares or the warrants, as applicable) of the common shares then outstanding.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liquidation Preference:</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In the event of any liquidation or winding up of the Company, the holders of the Preferred Stock shall be entitled to receive, prior and in preference to the holders of Common Stock and any series of preferred stock ranked junior to the Preferred Stock, an amount (the &#8220;Liquidation Amount&#8221;) equal to the original purchase price per share of Preferred Stock then held by such holders, plus all accrued but unpaid dividends.</font> </div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> &#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Risk Factors</font></div>
</td>
<td align="left" valign="top" width="2%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">You should carefully read and consider the information set forth under "Risk Factors," together with all of the other information set forth in this prospectus, before deciding to invest in the units offered by this prospectus.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The number of common shares outstanding before and after the offering is based on 4,915,318 shares outstanding as of April 29, 2011 and excludes:</font> </div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160; &#160; &#160; &#160; &#160; &#160;691,500 common shares issuable upon exercise of options with a weighted average exercise price of $2.64 per share;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160; &#160; &#160; &#160; &#160; &#160;1,000 common shares reserved for future grants and awards under our equity incentive plans; and</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;&#160; &#160; &#160; &#160; &#160; &#160;_____ common shares issuable upon exercise of warrants to be issued in connection with this offering.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Risk Factors</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">You should carefully consider the risks described below before making an investment decision. You should also refer to the other information in this prospectus, including our financial statements and the related notes thereto. The risks and uncertainties described below are not the only risks and uncertainties we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. If any of the following risks actually occur, our business, results of operations and financial condition could suffer. In that event the trading price of our common shares could decline, and you may lose all or part of your investment in the units. The risks discussed below also include forward-looking statements and our actual results may differ substantially from those discussed in these forward-looking statements.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Risks Related to Our Business</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We have experienced periods of losses on our operating activities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our overall strategy includes increasing revenue and reducing/controlling operating expenses.&#160; We have concentrated our efforts in ongoing, Company-wide efficiency activities intended to increase productivity and reduce costs including personnel reductions, reduction or elimination of non-personnel expenses and realigning and streamlining operations.&#160; Despite these efforts, we experienced a net loss in fiscal years 2004, 2005, 2006, 2008, 2009 and 2010.&#160; Further, our net revenues in 2009 and 2010 when compared to the immediately preceding fiscal year, declined approximately 23.8% and 9.5% respectively.&#160; Demand for our services and products may continue to be subject to substantial year-to-year fluctuations as a consequence of industry cyclicality, as well as global economic uncertainty and other factors, and such fluctuations may have a material adverse effect on our financial condition or results of operation.&#160; We cannot assure that our efforts will result in any increased profitability, or if our efforts result in profit, that profits will continue, for any meaningful period of time.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We have limited ability to obtain additional financing.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Substantially all of our assets are encumbered as security for our existing indebtedness.&#160; It could be difficult to raise additional debt without additional collateral for security.&#160; There is also a limited market for our common shares, which could make it difficult to issue additional equity.&#160; It could therefore be difficult to raise additional cash if our revolving line of credit and operations do not generate sufficient cash to fund our operations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Noncompliance with debt covenants contained in our credit agreements could adversely affect our ability to borrow under our credit agreements and could ultimately render a substantial portion of our outstanding indebtedness immediately due and payable</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain of the Company&#8217;s credit agreements contain certain affirmative and negative covenants including compliance with certain financial ratios. A breach of any of these covenants or our inability to comply with any required financial ratios could result in a default under one or more credit agreements, unless we are able to obtain the necessary waivers or amendments to the credit agreements. Upon the occurrence of an event of default that is not waived, and subject to any appropriate cure periods, the lenders under the affected credit agreements could elect to exercise any of their available remedies, which may include the right to not lend any additional amounts to us or, in certain instances, to declare all outstanding borrowings, together with accrued interest and other fees, to be immediately due and payable. If we are unable to repay the borrowings with respect to such credit facility when due the lenders could be permitted to proceed against their collateral. The election to exercise any such remedy could have a material adverse effect on our business and financial condition.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Unfavorable general economic conditions may materially adversely affect our business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unfavorable global economic conditions, including the recent recession in the United States and the recent financial crisis affecting the banking system and financial markets, could negatively affect our business. While it is difficult for us to predict the impact of general economic conditions on our business, these conditions could reduce customer demand for some of our services, which could cause our revenue to decline. Also, our customers, particularly smaller biotechnology companies which are especially reliant on the credit and capital markets, may not be able to obtain adequate access to credit or equity funding, which could affect their ability to make timely payments to us. Moreover, we rely on credit facilities to provide working capital to support our operations.&#160; We regularly evaluate alternative financing sources.&#160; Further changes in the commercial credit market or in the financial stability of our creditors may impact the ability of our creditors to provide additional financing. In addition, the financial condition of our credit facility providers, which is beyond our control, may adversely change. Any decrease in our access to borrowings under our credit facility, tightening of lending standards and other changes to our sources of liquidity could adversely impact our ability to obtain the financing we need to continue operating the business in our current manner.&#160; For these reasons, among others, if the economic conditions stagnate or decline, our operating results and financial condition could be adversely affected.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">A reduction in research and development budgets at pharmaceutical and biotechnology companies may adversely affect our business.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our customers include researchers at pharmaceutical and biotechnology companies. Our ability to continue to grow and win new business is dependent in large part upon the ability and willingness of the pharmaceutical and biotechnology industries to continue to spend on research and development and to outsource the products and services we provide. Fluctuations in the research and development budgets of these researchers and their organizations could have a significant effect on the demand for our products and services. Research and development budgets fluctuate due to changes in available resources, mergers of pharmaceutical and biotechnology companies, spending priorities and institutional budgetary policies. Our business could be adversely affected by any significant decrease in life sciences research and development expenditures by pharmaceutical and biotechnology companies. Similarly, economic factors and industry trends that affect our clients in these industries also affect our business.<a name="Page13"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our future success depends on our ability to keep pace with rapid technological changes that could make our services and products less competitive or obsolete.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The biotechnology, pharmaceutical and medical device industries generally, and contract research services more specifically, are subject to increasingly rapid technological changes. Our competitors or others might develop technologies, services or products that are more effective or commercially attractive than our current or future technologies, services or products, or that render our technologies, services or products less competitive or obsolete. If competitors introduce superior technologies, services or products and we cannot make enhancements to ours to remain competitive, our competitive position, and in turn our business, revenues and financial condition, would be materially and adversely affected.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We operate in a highly competitive industry.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Contract Research Organization (&#8220;CRO&#8221;) services industry is highly competitive. We often compete for business not only with other, often larger and better capitalized, CRO companies, but also with internal discovery and development departments within our clients, some of which are large pharmaceutical and biotechnology companies with greater resources than we have. If we do not compete successfully, our business will suffer. The industry is highly fragmented, with numerous smaller specialized companies and a handful of full-service companies with global capabilities much larger than ours. Increased competition might lead to price and other forms of competition that might adversely affect our operating results. As a result of competitive pressures, our industry experienced consolidation in recent years. This trend is likely to produce more competition among the larger companies for both clients and acquisition candidates. In addition, there are few barriers to entry for smaller specialized companies considering entering the industry. Because of their size and focus, these companies might compete effectively against larger companies such as us, which could have a material adverse impact on our business.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The loss of our key personnel could adversely affect our business.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our success depends to a significant extent upon the efforts of our senior management team and other key personnel. The loss of the services of such personnel could adversely affect our business.&#160; Also, because of the nature of our business, our success is dependent upon our ability to attract, train, manage and retain technologically qualified personnel.&#160; There is substantial competition for qualified personnel, and an inability to recruit or retain qualified personnel may impact our ability to grow our business and compete effectively in our industry.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Any failure by us to comply with existing regulations could harm our reputation and operating results.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any failure on our part to comply with existing regulations could result in the termination of ongoing research or the disqualification of data for submission to regulatory authorities. For example, if we were to fail to properly monitor compliance with study protocols, the data collected could be disqualified.&#160; If this were to happen, we could be contractually required to repeat a study at no further cost to the customer, but at substantial cost to us.&#160; This would harm our reputation, our prospects for future work and our operating results. Furthermore, the issuance of a notice from the FDA based on a finding of a material violation by us of good clinical practice, good laboratory practice or good manufacturing practice requirements could materially and adversely affect our business and financial performance.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our business uses biological and hazardous materials, which could injure people or violate laws, resulting in liability that could adversely impact our financial condition and business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our activities involve the controlled use of potentially harmful biological materials, as well as hazardous materials, chemicals and various radioactive compounds. We cannot completely eliminate the risk of accidental contamination or injury from the use, storage, handling or disposal of these materials. In the event of contamination or injury, we could be held liable for damages that result, and any liability could exceed our insurance coverage and ability to pay. Any contamination or injury could also damage our reputation, which is critical to getting new business. In addition, we are subject to federal, state and local laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. The cost of compliance with these laws and regulations is significant and if changes are made to impose additional requirements, these costs could increase and have an adverse impact on our financial condition and results of operations.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The majority of our customers&#8217; contracts can be terminated upon short notice.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Most of our contracts for CRO services are terminable by the client upon 30 to 90 days&#8217; notice. Clients terminate or delay their contracts for a variety of reasons, including but not limited to:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">products being tested fail to satisfy safety requirements;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">products have undesired clinical results;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the client decides to forego a particular study;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">inability to enroll enough patients in the study;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">inability to recruit enough investigators;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">production problems cause shortages of the drug; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">actions by regulatory authorities.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Although our contracts frequently entitle us to receive the costs of winding down the terminated projects, as well as all fees earned by us up to the time of termination, including a termination fee in some contracts, the loss, reduction in scope or delay of a large contract or the loss or delay of multiple contracts could materially adversely affect our business.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page14"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We may bear financial risk if we under-price our contracts or overrun cost estimates.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Since some of our contracts are structured as fixed price or fee-for-service, we bear the financial risk if we initially under-price our contracts or otherwise overrun our cost estimates. Such under pricing or significant cost overruns could have a material adverse effect on our business, results of operations, financial condition, and cash flows.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our Products business depends on our intellectual property.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Products business is dependent, in part, on our ability to obtain patents in various jurisdictions on our current and future technologies and products, to defend our patents and protect our trade secrets and to operate without infringing on the proprietary rights of others. There can be no assurance that our patents will not be challenged by third parties or that, if challenged, those patents will be held valid. In addition, there can be no assurance that any technologies or products developed by us will not be challenged by third parties owning patent rights and, if challenged, will be held not to infringe on those patent rights. The expense involved in any patent litigation can be significant. We also rely on unpatented proprietary technology, and there can be no assurance that others will not independently develop or obtain similar products or technologies.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We might incur substantial expense to develop products that are never successfully developed and commercialized.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have incurred and expect to continue to incur substantial research and development and other expenses in connection with our products business. The potential products to which we devote resources might never be successfully developed or commercialized by us for numerous reasons, including:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">inability to develop products that address our customers&#8217; needs;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">competitive products with superior performance;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">patent conflicts or unenforceable intellectual property rights;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">demand for the particular product; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">other factors that could make the product uneconomical.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Incurring significant expenses for a potential product that is not successfully developed and/or commercialized could have a material adverse effect on our business, financial condition, prospects and share price.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Providing CRO services creates a risk of liability for which we may not be fully indemnified or insured.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In certain circumstances, we seek to manage our liability risk through contractual provisions with clients, requiring us to be indemnified by the clients or covered by the clients' product liability insurance policies.&#160; Contractual indemnifications generally do not protect us against liability arising from certain of our own actions, such as negligence or intentional misconduct. We could be materially and adversely affected if we were required to pay damages or bear the costs of defending any claim which is not covered by a contractual indemnification provision or in the event that a party who must indemnify us does not fulfill its indemnification obligations or which is beyond the level of our insurance coverage.&#160; Furthermore, we could be held liable for errors&#160;and omissions in connection with the services we perform.&#160; There can be no assurance that our insurance coverage will be adequate, or that insurance coverage will continue to be available on acceptable terms, or that we can obtain indemnification arrangements or otherwise be able to limit our liability risk.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We may not be able to successfully expand our business through acquisitions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We occasionally review acquisition candidates and acquisitions which we have already made.&#160; We have faced substantial problems integrating acquisitions in the past, and if as a part of our growth strategy we decide to undertake an acquisition, we may not be able to successfully integrate it in order to realize the full benefit of such acquisition.&#160; Factors which may affect our ability to grow successfully through acquisitions include:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">inability to obtain financing due to our financial condition and recent performance;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">difficulties and expenses in connection with integrating the acquired companies and achieving the expected benefits;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">diversion of management&#8217;s attention from current operations;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the possibility that we may be adversely affected by risk factors facing the acquired companies;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">acquisitions could be dilutive to earnings, or in the event of acquisitions made through the issuance of our common shares to the shareholders of the acquired company, dilutive to the percentage of ownership of our existing shareholders;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">potential losses resulting from undiscovered liabilities of acquired companies not covered by the indemnification we may obtain from the seller; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">loss of key employees of the acquired companies.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Changes in government regulation or in practices relating to the pharmaceutical industry could change the need for the services we provide.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Governmental agencies throughout the world, but particularly in the United States, strictly regulate the drug development process. Our business involves helping pharmaceutical and biotechnology companies comply with the regulatory drug approval process. Changes in regulation, such as a relaxation in regulatory requirements or the introduction of simplified drug approval procedures, or an increase in regulatory requirements that we have difficulty satisfying, or that make our services less competitive, could substantially change the demand for our services. Also, if the government increases efforts to contain drug costs and pharmaceutical and biotechnology company profits from new drugs, our customers may spend less, or reduce their growth in spending on research and development.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page15"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Privacy regulations could increase our costs or limit our services.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The US Department of Health and Human Services has issued regulations under the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;). These regulations demand greater patient privacy and confidentiality. Some state governments are considering more stringent regulations. These regulations might require us to increase our investment in security or limit the services we offer. We could be found legally liable if we fail to meet existing or proposed regulation on privacy and security of health information.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We may be affected by health care reform.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In March&#160;2010, the United States Congress enacted health care reform legislation intended over time to expand health insurance coverage and impose health industry cost containment measures.&#160; This legislation may significantly impact the pharmaceutical and biotechnology industries.&#160; In addition, the U.S. Congress, various state legislatures and European and Asian governments may consider various types of health care reform in order to control growing health care costs. We are presently uncertain as to the effects of the recently enacted legislation on our business and are unable to predict what legislative proposals will be adopted in the future, if any.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Implementation of health care reform legislation may have certain benefits but also may contain costs that could limit the profits that can be made from the development of new drugs. This could adversely affect research and development expenditures by pharmaceutical and biotechnology companies, which could in turn decrease the business opportunities available to us both in the United States and abroad. In addition, new laws or regulations may create a risk of liability, increase our costs or limit our service offerings.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We rely on air transportation to serve our customers.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our laboratories and certain of our other businesses are heavily reliant on air travel for transport of samples and other material, products and people. A significant disruption to the air travel system, or our access to it, could have a material adverse effect on our business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Risks Related to Share Ownership</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">There is no public market for the Series A preferred shares or warrants to purchase common shares to be sold in this offering.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There is no established public trading market for the Series A preferred shares and warrants being sold in this offering, and we do not expect a market to develop.&#160; In addition, we do not intend to apply for listing the Series A preferred shares or warrants on any securities exchange. Without an active market, the liquidity of these securities will be limited.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">As a new investor, you will incur substantial dilution as a result of this offering and future equity issuances, and as result, our share price could decline.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Series A conversion price is substantially higher than the net tangible book value per share of our outstanding common shares. On a pro forma basis, after giving effect to the sale of 5,000 Series A preferred shares in this offering and assuming the conversion of all the Series A preferred shares sold in the offering (and excluding common shares issuable upon exercise of warrants), our net tangible book value as of December 31, 2010 would have been $____, or $_.__ per share. This represents an immediate increase in net tangible book value of $_.__ per share to existing shareholders and an immediate dilution in net tangible book value of $_.__ per common share purchased, without giving effect to the potential exercise of warrants offered by this prospectus. In addition to this offering, subject to market conditions and other factors, it is likely that we will pursue additional capital to finance our operations and the development, manufacture and marketing of other products under development and new product opportunities. Accordingly, we may conduct future offerings of equity or debt securities. The exercise of outstanding options and warrants and future equity issuances, including future public offerings or future private placements of equity securities and any additional shares issued in connection with acquisitions, may result in dilution to investors. In addition, the market price of our common shares could fall as a result of resales of any of these common shares due to an increased number of shares available for sale in the market.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Our share price could be volatile and our trading volume may fluctuate substantially.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The price of our common shares has been and may in the future continue to be extremely volatile, with the sale price fluctuating from a low of $0.60 to a high of $9.39 since December 31, 2005. Many factors could have a significant impact on the future price of our common shares, including:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">our inability to raise additional capital to fund our operations, whether through the issuance of equity securities or debt;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">our failure to successfully implement our business objectives;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">compliance with ongoing regulatory requirements;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">market acceptance of our products;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">technological innovations, new commercial products or drug discovery efforts and preclinical and clinical activities by us or our competitors;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">changes in government regulations;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">general economic conditions and other external factors;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">actual or anticipated fluctuations in our quarterly financial and operating results;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the degree of trading liquidity in our common shares; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">our ability to meet the minimum standards required for remaining listed on the NASDAQ Capital Market.</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page16"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Although we currently meet the listing requirements for the NASDAQ Capital Market, our common shares could be de-listed from the NASDAQ Capital Market and determined to be a &#8220;penny stock&#8221;.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The National Association of Securities Dealers, Inc. has certain standards for the continued listing of a security on the NASDAQ Capital Market.&#160; These standards require, among other things, that a listed issuer have either (i)&#160;listed securities with a market value of at least $1.0 million and (ii)&#160;a bid price of at least $1.00 per share, and either (i) minimum shareholders&#8217; equity of $2.5&#160;million, (ii)&#160;net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the three most recently completed fiscal years, or (iii) market value of the listed securities of at least $35.0 million.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If we are unsuccessful in maintaining our NASDAQ listing, then we may pursue listing and trading of our common shares on the Over-The-Counter Bulletin Board or another securities exchange or association with different listing standards than NASDAQ. We anticipate the change in listings may result in a reduction in some or all of the following, each of which could have a material adverse effect on our shareholders:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 10.8pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the liquidity of our common shares;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 10.8pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the market price of our common shares;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 10.8pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">our ability to obtain financing for the continuation of our operations;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 10.8pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the number of institutional and other investors that will consider investing in our common shares;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 10.8pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the number of market makers in our common shares;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 10.8pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the availability of information concerning the trading prices and volume of our common shares; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 10.8pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#8226;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the number of broker-dealers willing to execute trades in our common shares.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Furthermore, if our common shares were removed from listing with the NASDAQ Capital Market and we are unsuccessful in listing our common shares on another national securities exchange, the shares may be subject to the so-called &#8220;penny stock&#8221; rules.&#160; The SEC has adopted regulations that define a penny stock to be any equity security that has a market price per share of less than $5.00, subject to certain exceptions, such as any securities listed on a national securities exchange.&#160; For any transaction involving a penny stock, unless exempt, the rules impose additional sales practice requirements on broker-dealers, subject to certain exceptions.&#160; If our common shares were delisted and determined to be a penny stock, a broker-dealer may find it more difficult to trade our common shares and an investor may find it more difficult to acquire or dispose of our common shares on the secondary market.&#160; Investors in penny stocks should be prepared for the possibility that they may lose their whole investment.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">We have never paid cash dividends and do not intend to do so.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have never declared or paid cash dividends on our common shares. We currently plan to retain any earnings to finance the growth of our business rather than to pay cash dividends. Payments of any cash dividends in the future will depend on our financial condition, results of operations and capital requirements, as well as other factors deemed relevant by our board of directors.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Proceeds</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Assuming all units are sold, we estimate that the net proceeds to us from this offering will be approximately $_._ million. However, the offering does not specify any minimum sale of any specific number of units as a result of which the net proceeds actually received by us may be considerably less than this estimate.&#160; We intend to use up to $___ of the net proceeds from this offering to purchase laboratory equipment in the ordinary course of business and the remainder for working capital and general corporate purposes.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><a name="toc42166_6"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Determination of Offering Price</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Some of the factors considered in determining the offering price of the units were the history and prospects of our Company and comparable companies, similar prior offerings of comparable companies, our management, our capital structure, and currently prevailing general conditions in equity securities markets, including current market valuations of publicly traded companies considered comparable to our company.&#160; We cannot assure you, however, that the price at which the units, Series A preferred shares, common shares or warrants will sell in the public market after this offering will not be lower than the current offering price or that an active trading market in our units, Series A preferred shares, common shares or warrants will develop and continue after this offering. The conversion price of the Series A preferred shares and the exercise prices for the warrants will depend upon market conditions and will be determined by our Board of Directors after consulting with our Placement Agent for this offering.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Dilution</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our net tangible book value as of December 31, 2010 was $ 9,460,879 or $1.92 per common share. Net tangible book value per share represents total tangible assets less total liabilities, divided by the number of common shares outstanding. After giving effect to the sale of 5,000 Series A preferred shares in this offering and assuming the conversion of all the Series A preferred shares sold in the offering (and excluding common shares issuable upon exercise of warrants), our net tangible book value as of December 31, 2010 would have been $____, or $_.__ per share. This represents an immediate increase in net tangible book value of $_.__ per share to existing shareholders and an immediate dilution in net tangible book value of $_.__ per share to investors in this offering. The following table illustrates this calculation.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><a name="Page17"><!--EFPlaceholder--></a><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="85%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Series A conversion price</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net tangible book value per share as of December 31, 2010</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Increase per share attributable to this offering</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">As adjusted tangible book value per share after this offering</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dilution per share to new investors in this offering</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The number of common shares outstanding used for existing shareholders in the table and calculations above is based on 4,915,318 shares outstanding as of December 31, 2010 and excludes:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">689,500 common shares issuable upon the exercise of options outstanding at December 31, 2010 with a weighted average exercise price of $2.63 per share; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3,000 common shares reserved for future grants and awards under our equity incentive plans as of December 31, 2010.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Policy</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">We have not declared or paid cash dividends on our common shares and do not anticipate paying any cash dividends on our common shares in the foreseeable future. We expect to retain future earnings, if any, to fund the development and growth of our business. Our board of directors will determine future dividends on our common shares, if any.&#160;&#160;The Series A preferred shares included in this offering have a stated dividend rate of 6% per annum as described in the section &#8220;Description of Securities&#8221;.</font> </div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Capitalization</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets forth our capitalization as of December 31, 2010:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on an actual basis; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on a pro forma basis to reflect the sale of 5,000 Series A preferred shares in this offering and assuming the conversion of all the Series A preferred shares sold in the offering (and excluding common shares issuable upon exercise of warrants), after deducting the Placement Agent&#8217;s fees and other estimated offering related expenses payable by us.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The offering does not specify any minimum purchase or sale of any specific number of units. As a result, our actual total capitalization following completion of the offering may be significantly less than the &#8220;Pro forma&#8221; total capitalization reflected in the below table.</font> </div>

&#160;<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">You should read the information in this table together with &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and the accompanying notes included elsewhere in this prospectus.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="70%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td colspan="6" nowrap valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Unaudited)</font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr>
<td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td colspan="6" nowrap valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December&#160;31,&#160;2010</font></font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr>
<td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Actual</font></font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Pro&#160;forma</font></font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr>
<td align="left" valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,238</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Senior Debt</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,460</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage Debt</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,628</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders' equity:</font> </div>
</td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Preferred shares, 1,000,000 shares authorized, none issued and outstanding at December 31, 2010</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares, no par value, 19,000,000 shares authorized, 4,915,318 issued and outstanding as of December 31, 2010</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,191</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Additional paid-in capital</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,412</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated deficit</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3,671</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated other comprehensive income</font> </div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">84</font></font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 63pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total shareholders' equity</font> </div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">11,016</font></font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">-</font></font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 81pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total capitalization</font> </div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">20,104</font></font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">-</font></font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The number of common shares outstanding used for existing shareholders in the table and calculations above is based on 4,915,318 shares outstanding as of December 31, 2010 and excludes:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">689,500 common shares issuable upon the exercise of options outstanding at December 31, 2010 with a weighted average exercise price of $2.63 per share; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3,000 common shares reserved for future grants and awards under our equity incentive plans as of December 31, 2010.</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><a name="Page18"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Description of Securities</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">This prospectus relates to the sale of units.&#160; Each unit includes (1) one Series A preferred share, (2) one Class A Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit and (3) one Class B Warrant to purchase 0.5 of our common shares for every common share underlying the preferred share included in such unit.&#160; The terms of the Series A preferred shares are described below under the caption &#8220;Description of Series A Preferred Shares.&#8221;&#160; The terms of the Class A Warrants and the Class B Warrants are described below under the caption &#8220;Description of Warrants.&#8221;</font> </div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Authorized Capital</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We currently have authority to issue 19,000,000 common shares and 1,000,000 preferred shares. In connection with the offering, we anticipate authorizing 5,000 Series A preferred shares. As of December 31, 2010, we had 4,915,318 common shares issued and outstanding and no preferred shares issued and outstanding.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Description of Common Shares</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Voting Rights</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each outstanding common share is entitled to one vote on all matters submitted to a vote of shareholders. There is no cumulative voting.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Dividend and Liquidation Rights</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The holders of outstanding common shares are entitled to receive dividends out of assets legally available for the payment of dividends at the times and in the amounts as our board of directors may from time to time determine. The common shares are neither redeemable nor convertible. Holders of our common shares have no preemptive or subscription rights to purchase any of our securities. Upon our liquidation, dissolution or winding up, the holders of our common shares are entitled to receive, pro rata, our assets which are legally available for distribution, after payment of all debts and other liabilities and subject to the prior rights of any holders of preferred shares then outstanding.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have never paid any cash dividends on our common shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Transfer Agent and Registrar</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The transfer agent and registrar for our common shares is Computershare Ltd.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Equity Compensation Plans</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have one stock-based compensation plan, the 2008 Stock Option Plan that replaced the 1997 Outside Director Stock Option Plan and the 1997 Employee Stock Option Plan, together referred to herein as the &#8220;Stock Plans.&#8221; As of December 31, 2010, 689,500 options to purchase our common shares were issued and outstanding under the Stock Plans with a weighted-average price of $2.63, and 3,000 of our common shares were reserved for future issuance under the 2008 Stock Option Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Description of Series A Preferred Shares</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Second Amended and Restated Articles of Incorporation authorize 1,000,000 preferred shares. Our board of directors is authorized, without further shareholder action, to establish various series of preferred shares from time to time and to determine the rights, preferences and privileges of any unissued series including, among other matters, any dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms, the number of shares constituting any such series, and the description thereof and to issue any such shares. Although there is no current intent to do so, our board of directors may, without shareholder approval, issue an additional class or series of preferred shares with voting and conversion rights which could adversely affect the voting power of the holders of the common shares or the Series A preferred shares, except as prohibited by the certificate of designation of preferences, rights and limitations of Series A preferred shares. As of the date of this prospectus, there were no preferred shares designated or outstanding.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with the completion of this offering, we expect our Board of Directors to adopt resolutions which would authorize 5,000 shares of a new class of shares designated 6% Series A Convertible Preferred Shares (the &#8220;Series A preferred shares&#8221;). The material terms and provisions of the Series A preferred shares are summarized below. For the complete terms of the Series A preferred shares, you should refer to the form certificate of designation of preferences, rights and limitations of 6% Series A convertible preferred shares which is filed as an exhibit to the registration statement of which this prospectus is a part.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Voting Rights</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Except as required by law, holders of the Series A preferred shares will not have rights to vote on any matters, questions or proceedings, including the election of directors. However, as long as any Series A preferred shares are outstanding, we will not, without the affirmative vote of the holders of 50.1% or more of the then outstanding Series A preferred shares, (1) alter or change adversely the powers, preferences or rights given to the Series A preferred shares or alter or amend the certificate of designation, (2) authorize or create any class of shares ranking as to dividends, redemption or distribution of assets upon liquidation senior to, or otherwise pari passu with, the Series A preferred shares, (3) amend our articles of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series A preferred shares, (4) increase the number of authorized Series A preferred shares, or (5) enter into any agreement with respect to any of the foregoing.<a name="Page19"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Indiana Law</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding certain protections in the certificate of designation for holders of Series A preferred shares, Indiana law also provides holders of preferred shares with certain rights. The holders of the outstanding Series A preferred shares will be entitled to vote as a class upon a proposed amendment to the articles of incorporation if the amendment would:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">increase or decrease the aggregate number of authorized shares of the class;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">effect an exchange or reclassification of all or part of the shares of the class into shares of another class;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">effect an exchange or reclassification, or create the right of exchange, of all or part of the shares of another class into shares of the class;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">change the designation, rights, preferences, or limitations of all or part of the shares of the class;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">change the shares of all or part of the class into a different number of shares of the same class;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">create a new class of shares having rights or preferences with respect to distributions or to dissolution that are prior, superior, or substantially equal to the shares of the class;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">increase the rights, preferences, or number of authorized shares of any class that, after giving effect to the amendment, have rights or preferences with respect to distributions or to dissolution that are prior, superior, or substantially equal to the shares of the class;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">limit or deny an existing preemptive right of all or part of the shares of the class; or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">cancel or otherwise affect rights to distributions or dividends that have accumulated but not yet been declared on all or part of the shares of the class.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Redemption</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">We will have the right to redeem the Series A preferred shares for a cash payment equal to 120% of the stated value of the Series A preferred shares, if the volume weighted average price of our common shares for each of any period of 20 consecutive trading days beginning after the original issue date exceeds 200% of the then effective conversion price.&#160;&#160;If the optional redemption occurs prior to the three year anniversary of the original issue date, our right to redeem the Series A preferred shares will be subject to the following conditions, referred to as "Equity Conditions": (a) the Company must have timely honored all previously requested or required conversions, if any, (b) the Company must have paid all liquidated damages and other amounts owing to the applicable holder in respect of Series A preferred shares, (c)(i) there must be an effective registration statement pursuant to which the Company may issue conversion shares (and, as applicable, common shares issued in satisfaction of any required make-whole payment (described below) and in lieu of cash payment of dividends) or (ii) with respect to conversions that occur after May__, 2014, all of the conversion shares may be issued to the holder pursuant to Section 3(a)(9) of the Securities Act of 1933, as amended, and immediately resold without restriction, (d) the Company's common shares must be trading on a "trading market" (as defined in the Certificate of Designation) and all of the common shares issuable pursuant to the terms of the Series A preferred shares and the warrants must be listed or quoted for trading on such trading market (and the Company must believe, in good faith, that trading of the common shares on a trading market will continue uninterrupted for the foreseeable future), (e) there must be a sufficient number of authorized, but unissued and otherwise unreserved, common shares for the issuance of all of the common shares then issuable pursuant to this offering, (f) the issuance of the shares in question to the applicable holder would not violate the beneficial ownership limitations described below, (g) there must not have been a public announcement of a pending or proposed "fundamental transaction" (as defined in the Certificate of Designation) or change of control transaction that has not been consummated, (h) the applicable shareholder must not be in possession of any information provided by the Company that constitutes, or may constitute, material non-public information, and (i) the average daily trading volume for a period of 20 consecutive trading days prior to the applicable date in question must exceed 20,000 shares per trading day (subject to adjustment for forward and reverse share splits, dividends, and the like); provided that clause (g) will not apply after the three-year anniversary of the original issue date of the Series A preferred shares.&#160;&#160;Holders of Series A preferred shares will receive 20 trading days prior notice of any redemption and will have the ability to convert the Series A preferred shares into common shares during this notice period, subject to the limitation on conversion described below.&#160;&#160;There are no restrictions on the repurchase or redemption of shares by the Company while there is any arrearage in the payment of dividends or sinking fund installments.</font> </div></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Conversion</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to certain ownership limitations as described below, the Series A preferred shares are convertible at any time at the option of the holder into our common shares at a conversion ratio determined by dividing the stated value of the Series A preferred shares (or $1,000) by a conversion price of $_.__ per share. Accordingly, each Series A preferred share is convertible into ___ common shares. The conversion price is subject to adjustment in the case of share splits, share dividends, combinations of shares and similar recapitalization transactions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the volume weighted average price for 20 trading days during any consecutive 30 trading day period beginning after the original issue date (a "Threshold Period"), exceeds 200% of the then effective conversion price, the Company may deliver a written notice to all holders of Series A preferred shares requiring each holder to convert all or part of such holder's Series A preferred shares plus all accrued but unpaid dividends thereon and all liquidated damages and other amounts due in respect of the Series A preferred shares, into common shares at the then current conversion ratio.&#160; The Company may not deliver a forced conversion notice, and such notice shall not be effective if delivered, unless all of the Equity Conditions have been met on each of at least 20 trading days during the applicable Threshold Period and through the trading day after the date that conversion shares issuable pursuant to a forced conversion are actually delivered to the holders pursuant to a forced conversion notice.&#160; Any forced conversion notice shall be applied ratably to all of the holders of Series A preferred shares based on each holder's initial purchases of Series A preferred shares, provided that any voluntary conversions by a holder shall be applied against such holder's pro rata allocation, thereby decreasing the aggregate amount forcibly converted if less than all of the Series A preferred shares are forcibly converted.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page20"><!--EFPlaceholder--></a>Subject to limited exceptions, a holder of Series A preferred shares will not have the right to convert, and the Company will not have the right to force such holder to convert, any portion of its Series A preferred shares if the holder, together with its affiliates, would beneficially own in excess of 4.99% (or 9.99% as elected by the holder pursuant to the terms of the certificate of designation) of the number of our common shares outstanding immediately after giving effect to its conversion.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Dividends and Make-Whole Payments</font> </div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Until May__, 2014, each holder of the Series A preferred shares is entitled to receive dividends at the rate of 6% per annum of the stated value for each preferred share held by such holder payable quarterly on January 1, April 1, July 1 and October 1, beginning on the first such date after the original issue date, and on each conversion date.&#160; Except in limited circumstances (including a failure to meet the Equity Conditions), we can elect to pay the dividends in cash or in duly authorized, validly issued, fully paid and non-assessable common shares, or a combination thereof.&#160; If the Equity Conditions are not met, we must pay the dividends in cash.&#160; If the Equity Conditions have been met and we choose to pay the dividends in common shares, the common shares used to pay the dividends will be valued at 90% of the average volume weighted average price for the 20 consecutive trading days ending on the trading day immediately prior to the applicable dividend payment date.&#160; From and after May __, 2014, each holder of Series A preferred shares will be entitled to receive dividends equal, on an as-if-converted to common shares basis, to and in the same form as dividends actually paid on common shares when, as, and if such dividends are paid on common shares.&#160; <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have never paid dividends on our common shares and we do not intend to do so for the foreseeable future.</font></font> </div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">In the event a holder converts his, her or its Series A preferred shares prior to May __, 2014, we must also pay to the holder in cash, or at our option, subject to satisfaction of the Equity Conditions, in common shares valued as described above, or a combination of cash and common shares, with respect to the Series A preferred shares so converted, an amount equal to $180 per $1,000 of the stated value of the Series A preferred shares, less the amount of any dividends paid in cash or in common shares on such Series A preferred shares on or before the date of conversion.</font> </div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Liquidation</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Series A preferred shares would rank, with respect to rights upon liquidation, winding-up or dissolution, (1) senior to common shares, (2) senior to any series of preferred shares ranked junior to the Series A preferred shares, and (3) junior to all existing and future indebtedness of the Company.&#160; Further, upon any liquidation, dissolution or winding up of the Company after payment or provision for payment of debts and other liabilities of the Company, and before any distribution or payment is made to the holders of any junior securities, the holders of Series A preferred shares shall first be entitled to be paid out of the assets of the Company available for distribution to its shareholders an amount equal to $1,000 per share, after which any remaining assets of the Company shall be distributed among the holders of the other classes or series of shares in accordance with the Company&#8217;s articles of incorporation.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Description of Warrants</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The material terms and provisions of the warrants being offered pursuant to this prospectus are summarized below. However, this summary of some provisions of the warrants is not complete. For the complete terms of the warrants, you should refer to the form of the warrants filed as exhibits to the registration statement of which this prospectus is a part.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Each unit includes one Class A Warrant to purchase 0.5 common shares for every common share underlying the preferred share included in such unit and one Class B Warrant to purchase 0.5 common shares for every common share underlying the preferred share included in such unit. Class A Warrants will entitle the holder to purchase common shares for an exercise price equal to $_.__ per share. Subject to certain limitations as described below the Class A Warrants are exercisable at the option of the holder beginning immediately after the date of issuance and will expire and entitle the holder to a cashless exercise on the fifth anniversary following the date of issuance.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Class B Warrants will entitle the holder to purchase common shares for an exercise price equal to $_.__ per share. Subject to certain limitations as described below, the Class B Warrants are exercisable at the option of the holder immediately after the date of issuance and will expire and entitle the holder to a cashless exercise one year following the date of issuance.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subject to limited exceptions, a holder of warrants will not have the right to exercise any portion of its warrants if the holder, together with its affiliates, would beneficially own in excess of 4.99% (or 9.99% as elected by the holder pursuant to the terms of the warrant) of the number of our common shares outstanding immediately after giving effect to such exercise.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The exercise price and the number of shares issuable upon exercise of the warrants is subject to appropriate adjustment in the event of recapitalization events, share dividends, share splits, share combinations, reclassifications, reorganizations or similar events affecting our common shares, and also upon any distributions of assets, including cash, shares or other property to our shareholders. The warrant holders must pay the exercise price in cash upon exercise of the warrants unless such holders are utilizing the cashless exercise provisions of the warrants. After the close of business on the applicable expiration date, unexercised warrants will become void.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, in the event we consummate a merger or consolidation with or into another person or other reorganization event in which our common shares are converted or exchanged for securities, cash or other property, or we sell, lease, license or otherwise dispose of all or substantially all of our assets or we or another person acquire 50% or more of our outstanding common shares, then following such event, the holders of the warrants will be entitled to receive upon exercise of the warrants the same kind and amount of securities, cash or property which the holders would have received had they exercised the warrants immediately prior to such fundamental transaction. Any successor to us or surviving entity shall assume the obligations under the warrants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon a holder&#8217;s exercise of a warrant, we will issue the common shares issuable upon exercise of the warrant within three business days following our receipt of notice of exercise and payment of the exercise price, subject to surrender of the warrant.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page21"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prior to the exercise of any warrants to purchase common shares, holders of the warrants will not have any of the rights of holders of the common shares purchasable upon exercise, including the right to vote or to receive any payments of dividends on the common shares purchasable upon exercise.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain Provisions of the Indiana Business Corporation Law</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As an Indiana corporation, we are governed by the Indiana Business Corporation Law, or IBCL. Under specified circumstances, the following provisions of the IBCL may delay, prevent or make more difficult unsolicited acquisitions or changes of control of us. These provisions also may have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions which shareholders may otherwise deem to be in their best interest.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Control Share Acquisitions</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under Chapter 42 of the IBCL, an acquiring person or group who makes a &#8220;control share acquisition&#8221; in an &#8220;issuing public corporation&#8221; may not exercise voting rights on any &#8220;control shares&#8221; unless these voting rights are conferred by a majority vote of the disinterested shareholders of the issuing public corporation at a special meeting of those shareholders held upon the request and at the expense of the acquiring person. If control shares acquired in a control share acquisition are accorded full voting rights and the acquiring person has acquired control shares with a majority or more of all voting power, all shareholders of the issuing public corporation have dissenters&#8217; rights to receive the fair value of their shares pursuant to Chapter 44 of the IBCL.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the IBCL, &#8220;control shares&#8221; are shares acquired by a person that, when added to all other shares of the issuing public corporation owned by that person or in respect to which that person may exercise or direct the exercise of voting power, would otherwise entitle that person to exercise voting power of the issuing public corporation in the election of directors within any of the following ranges:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">one-fifth or more but less than one-third;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">one-third or more but less than a majority; or</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a majority or more.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A &#8220;control share acquisition&#8221; means, subject to specified exceptions, the acquisition, directly or indirectly, by any person of ownership of, or the power to direct the exercise of voting power with respect to, issued and outstanding control shares. For the purposes of determining whether an acquisition constitutes a control share acquisition, shares acquired within 90 days or under a plan to make a control share acquisition are considered to have been acquired in the same acquisition.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An &#8220;issuing public corporation&#8221; means a corporation which has (i)&#160;100 or more shareholders, (ii)&#160;its principal place of business or its principal office in Indiana, or that owns or controls assets within Indiana having a fair market value of greater than $1,000,000, and (iii)&#160;(A)&#160;more than 10% of its shareholders resident in Indiana, (B)&#160;more than 10% of its shares owned of record or owned beneficially by Indiana residents, or (C)&#160;1,000 shareholders resident in Indiana.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The provisions described above do not apply if, before a control share acquisition is made, the corporation&#8217;s articles of incorporation or bylaws, including a bylaw adopted by the corporation&#8217;s board of directors, provide that they do not apply. Our second amended and restated articles of incorporation and our second amended and restated bylaws do not exclude us from Chapter 42.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Certain Business Combinations</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chapter 43 of the IBCL restricts the ability of a &#8220;resident domestic corporation&#8221; to engage in any combinations with an &#8220;interested shareholder&#8221; for five years after the date the interested shareholder became such, unless the combination or the purchase of shares by the interested shareholder on the interested shareholder&#8217;s date of acquiring shares is approved by the board of directors of the resident domestic corporation before that date. If the combination was not previously approved, then the interested shareholder may effect a combination after the five-year period only if that shareholder receives approval from a majority of the disinterested shareholders or the offer meets specified &#8220;fair price&#8221; criteria.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For purposes of the above provisions, &#8220;resident domestic corporation&#8221; means an Indiana corporation that has 100 or more shareholders. &#8220;Interested shareholder&#8221; means any person, other than the resident domestic corporation or its subsidiaries, who is (1)&#160;the beneficial owner, directly or indirectly, of 10% or more of the voting power of the outstanding voting shares of the resident domestic corporation or (2)&#160;an affiliate or associate of the resident domestic corporation, which at any time within the five-year period immediately before the date in question, was the beneficial owner, directly or indirectly, of 10% or more of the voting power of the then outstanding shares of the resident domestic corporation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The definition of &#8220;beneficial owner&#8221; for purposes of Chapter 43 means a person who, directly or indirectly, owns the subject shares, has the right to acquire or vote the subject shares (excluding voting rights under revocable proxies made in accordance with federal law), has any agreement, arrangement or understanding for the purpose of acquiring, holding or voting or disposing of the subject shares, or holds any &#8220;derivative instrument&#8221; that includes the opportunity, directly or indirectly, to profit or share in any profit derived from any increase in the value of the subject shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The above provisions do not apply to corporations that elect not to be subject to Chapter 43 in an amendment to their articles of incorporation approved by a majority of the disinterested shareholders. That amendment, however, cannot become effective until 18 months after its passage and would apply only to share acquisitions occurring after its effective date. Our second amended and restated articles of incorporation do not exclude us from Chapter 43.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Directors&#8217; Duties and Liability</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under Chapter 35 of the IBCL, directors are required to discharge their duties:<a name="Page22"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in good faith;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">with the care an ordinarily prudent person in a like position would exercise under similar circumstances; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">in a manner the directors reasonably believe to be in the best interest of the corporation.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under the IBCL, a director is not liable for any action taken as a director, or any failure to act, regardless of the nature of the alleged breach of duty (including breaches of the duty of care, the duty of loyalty, and the duty of good faith) unless the director has breached or failed to perform the duties of the director&#8217;s office and the action or failure to act constitutes willful misconduct or recklessness. This exculpation from liability under the IBCL does not affect the liability of directors for violations of the federal securities laws.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Consideration of Effects on Other Constituents</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chapter 35 of the IBCL also provides that a board of directors, in discharging its duties, may consider, in its discretion, both the long-term and short-term best interests of the corporation, taking into account, and weighing as the directors deem appropriate, the effects of an action on the corporation&#8217;s shareholders, employees, suppliers and customers and the communities in which offices or other facilities of the corporation are located and any other factors the directors consider pertinent. Directors are not required to consider the effects of a proposed corporate action on any particular corporate constituent group or interest as a dominant or controlling factor. If a determination is made with the approval of a majority of the disinterested directors of the board of directors, that determination is conclusively presumed to be valid unless it can be demonstrated that the determination was not made in good faith after reasonable investigation.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chapter 35 specifically provides that specified judicial decisions in Delaware and other jurisdictions, which might be looked upon for guidance in interpreting Indiana law, including decisions that propose a higher or different degree of scrutiny in response to a proposed acquisition of the corporation, are inconsistent with the proper application of the business judgment rule under that section.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Mandatory Classified Board of Directors&#160; </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Under Section&#160;23-1-33-6(c) of the IBCL, a corporation with a class of voting shares registered with the SEC under Section&#160;12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), must have a classified board of directors unless the corporation adopts a bylaw expressly electing not to be governed by this provision by the later of July&#160;31, 2009 or 30 days after the corporation&#8217;s voting shares are registered under Section&#160;12 of the Exchange Act. In accordance with the law and our second amended and restated bylaws, the Board of Directors is divided into three classes: Class I, Class II and Class III, each class having a staggered term of three years. Each year the term of office of one Class expires.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Indemnification</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chapter 37 of the IBCL authorizes every Indiana corporation to indemnify its officers and directors under certain circumstances against liability incurred in connection with proceedings to which the officers or directors are made a party by reason of their relationship to the corporation. Officers and directors may be indemnified where they have acted in good faith, which means, in the case of official action, they reasonably believed the conduct was in the corporation&#8217;s best interests, and in all other cases, they reasonably believed the action taken was not against the best interests of the corporation, and in the case of criminal proceedings they had reasonable cause to believe the action was lawful or there was no reasonable cause to believe the action was unlawful. Chapter 37 of the IBCL also requires every Indiana corporation to indemnify any of its officers or directors (unless limited by the articles of incorporation of the corporation) who were wholly successful, on the merits or otherwise, in the defense of any such proceeding against reasonable expenses incurred in connection with the proceeding. A corporation may also, under certain circumstances, pay for or reimburse the reasonable expenses incurred by an officer or director who is a party to a proceeding in advance of final disposition of the proceeding. Chapter 37of the IBCL states that the indemnification provided for therein is not exclusive of any other rights to which a person may be entitled under the articles of incorporation, bylaws or resolutions of the board of directors or shareholders.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our second amended and restated articles of incorporation and second amended and restated bylaws provide for indemnification, to the fullest extent permitted by the IBCL, of our directors, officers and employees against liability and reasonable expenses that may be incurred by them in connection with proceedings in which they are made a party by reason of their relationship to the company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling the registrant pursuant to the foregoing provisions, the registrant has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is therefore unenforceable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Market for Registrant&#8217;s Common Equity and Related Shareholder Matters</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Market Information</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets forth the quarterly high and low sales price per share of our common shares for the last two fiscal years and for the first,&#160; &#160;second and third quarters of fiscal 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="75%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="70%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">High</font></font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Low</font></font> </div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fiscal Year Ended September 30, 2009</font> </div>
</td>
<td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="right" colspan="2" nowrap valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="right" colspan="2" nowrap valign="bottom" width="13%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.13</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.00</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Second Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.82</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.60</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Third Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.81</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.70</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fourth Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.15</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.60</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fiscal Year Ended September 30, 2010</font> </div>
</td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.42</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.81</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Second Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.42</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.65</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Third Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.50</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.74</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fourth Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.22</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.77</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fiscal Year Ended September 30, 2011</font> </div>
</td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.98</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.84</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Second Quarter</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.00</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.74</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Third Quarter (through April 29, 2011)</font> </div>
</td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.89</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.00</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shareholders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Our transfer agent is Computershare Ltd.&#160;&#160;On April 29, 2011, the last reported sale price of our common shares on The NASDAQ Capital Market was $2.59 per share.&#160;&#160;On February 28, 2011, there were approximately 2,700 holders of record of our common shares.</font> </div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Plan of Distribution</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ladenburg Thalmann &amp; Co. Inc., which we refer to herein as the Placement Agent, has agreed to act as our exclusive Placement Agent in connection with this offering subject to the terms and conditions of the Placement Agency Agreement dated ______, 2011. The Placement Agent is not purchasing or selling any units offered by this prospectus nor is it required to arrange the purchase or sale of any specific number or dollar amount of units, but has agreed to use its best efforts to arrange for the sale of all of the units offered hereby. Therefore, we will enter into a purchase agreement directly with investors in connection with this offering and we may not sell the entire amount of units offered pursuant to this prospectus. There can be no assurance that we will sell the entire amount of units pursuant to this prospectus.</font> </div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Confirmations and definitive prospectuses will be delivered, or otherwise made available, to all purchasers who agree to purchase units, informing the purchasers of the closing date as to such units.&#160; Purchasers will also be informed of the date and manner in which they must transmit the purchase price for their units.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On such closing date, the following will occur:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">we will receive funds in the amount of the aggregate purchase price of the units being sold by us on such closing date;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">we will deliver Series A preferred shares and the warrants being sold on such closing date; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">we will pay the Placement Agent, a Placement Agent fee in accordance with the terms of our Placement Agency Agreement.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">We have agreed to pay the Placement Agent a Placement Agent&#8217;s cash fee equal to 8.25% of the gross proceeds of the offering.&#160;&#160;The maximum aggregate gross proceeds of the offering is $5,000,000.&#160;&#160;The additional $900,000 of securities being registered pursuant to this prospectus are for common shares issuable in lieu of cash dividend and make-whole payments on the preferred shares, as described in the section titled &#8220;Description of Series A Preferred Shares &#8211; Dividends and Make-Whole Payments.&#8221;&#160;&#160;We will receive no proceeds from the issuance of such common shares and the Placement Agent shall receive no commission on such issuance.&#160;&#160;Subject to compliance with FINRA Rule 5110(f)(2)(D), we have also agreed to reimburse the Placement Agent&#8217;s expenses up to a maximum of 1.2% of the gross proceeds raised in the offering, but in no event more than $60,000</font> </div></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table shows the per unit and total Placement Agent&#8217;s fees we will pay to the Placement Agent in connection with the sale of the shares and warrants offered pursuant to this prospectus assuming the purchase of all of the units offered hereby.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Per unit Placement Agent&#8217;s fees</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Maximum offering total</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Because there is no minimum offering amount required as a condition to the closing in this offering, the actual total offering commissions, if any, are not presently determinable and may be substantially less than the maximum amount set forth above.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our obligations to issue and sell units to the purchasers is subject to the conditions set forth in the securities purchase agreement, which may be waived by us at our discretion. A purchaser&#8217;s obligation to purchase units is subject to the conditions set forth in the securities purchase agreement as well, which may be waived by the purchaser.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have agreed to indemnify the Placement Agent against certain liabilities, including liabilities under the Securities Act of 1933, as amended or the Securities Act. We may also be required to contribute to payments the Placement Agent may be required to make in respect of such liabilities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are offering pursuant to this prospectus up to&#160;5,000 of our units, but there can be no assurance that the offering will be fully subscribed. Accordingly, we may sell substantially less than&#160;5,000 of our units, in which case our net proceeds would be substantially reduced and the total Placement Agent fees may be substantially less than the maximum total set forth above.&#160; The conversion price of the Series A preferred shares and the exercise prices for the warrants will depend upon market conditions and will be determined by our Board of Directors after consulting with our Placement Agent for this offering.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">We estimate the total offering expenses of this offering that will be payable by us, excluding the Placement Agent&#8217;s fees and expenses, will be approximately $250,000, which includes our registration, legal, accounting and printing costs and various other fees.</font> </div>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page24"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">The foregoing does not purport to be a complete statement of the terms and conditions of the Placement Agency Agreement and the securities purchase agreement.&#160; A copy of the form of securities purchase agreement with the investors is included as an exhibit to the registration statement of which this prospectus forms a part. See &#8220;Where You Can Find More Information&#8221; on page 3 of this prospectus.</font> </div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Placement Agent may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by it and any profit realized on the resale of the units sold by it while acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act. As an underwriter, the Placement Agent would be required to comply with the Securities Act and the Exchange Act, including, without limitation, Rule 415(a)(4) under the Securities Act and Rule 10b-5 and Regulation M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of common shares and warrants by the Placement Agent acting as principal. Under these rules and regulations, the Placement Agent:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">may not engage in any stabilization activity in connection with our securities; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities, other than as permitted under the Exchange Act, until it has completed its participation in the distribution.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following discussion and analysis should be read in conjunction with our Consolidated Financial Statements and related Notes included elsewhere in this prospectus. Some of the information contained in this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this prospectus may contain forward-looking statements based on management&#8217;s current expectations and projections about future events. There can be no assurance that actual results, outcomes or business conditions will not differ materially from those expected or projected in such forward-looking statements as a result of various factors, including, among others, trends in the demand for our products and services, trends in the industries that consume our products and services, global economic conditions, especially as they impact our markets, our ability to develop new products and services and other potential risks and uncertainties discussed in the Risk Factors section of this prospectus. The dollar amounts included in this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations are in thousands unless otherwise indicated.&#160; References to fiscal years refer to the Company&#8217;s fiscal year which ends on September 30.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Business Overview</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We provide contract drug development services and research equipment to many leading global pharmaceutical, medical research and biotechnology companies and institutions that advance the drug discovery and development process. We offer an efficient, variable-cost alternative to our clients' internal product development programs. Outsourcing development work to reduce overhead and speed drug approvals through the Food and Drug Administration ("FDA") is an established alternative to in-house development among pharmaceutical companies. We derive our revenues from sales of our research services and drug development tools, both of which are focused on determining drug safety and efficacy.&#160; Since our formation in 1974, our products and services have been utilized in the research of drugs to treat central nervous system disorders, diabetes, osteoporosis and other diseases.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We support the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates. We believe our scientists have the skills in analytical instrumentation development, chemistry, computer software development, physiology, medicine, analytical chemistry and toxicology to make the services and products we provide increasingly valuable to our current and potential clients. Our principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic neuroscience research at many of the small start-up biotechnology companies and the largest global pharmaceutical companies.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our business is largely dependent on the level of pharmaceutical and biotechnology companies' efforts in new drug discovery and approval. Our services segment is a direct beneficiary of these efforts, through outsourcing of research work by these companies. Our products segment is an indirect beneficiary of these efforts, as increased drug development leads to capital expansion, providing opportunities to sell the equipment we produce and the consumable supplies we provide that support our products.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Developments within the industries we serve have a direct, and sometimes material, impact on our operations. Currently, many large pharmaceutical companies have major "block-buster" drugs that are nearing the end of their patent protections. This puts significant pressure on these companies both to develop new drugs with large market appeal, and to re-evaluate their cost structures and the time-to-market of their products. Contract research organizations ("CROs") have benefited from these developments, as the pharmaceutical industry has turned to out-sourcing to both reduce fixed costs and to increase the speed of research and data development necessary for new drug applications.&#160; The number of significant drugs that have reached or are nearing the end of their patent protection has also benefited the generic drug industry. Generic drug companies provide a significant source of new business for CROs as they develop, test and manufacture their generic compounds.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A significant portion of innovation in the pharmaceutical industry is now being driven by biotech and small, venture capital funded, drug development companies. Many of these companies are "single-molecule" entities, whose success depends on one innovative compound. While several of the biotech companies have reached the status of major pharmaceuticals, the industry is still characterized by smaller entities. These developmental companies generally do not have the resources to perform much of the research within their organizations, and are therefore dependent on the CRO industry for both their research and for guidance in preparing their FDA submissions. These companies have provided significant new opportunities for the CRO industry, including us. They do, however, provide challenges in selling, as they frequently have only one product in development, which causes CROs to be unable to develop a flow of projects from a single company. These companies may expend all their available funds and cease operations prior to fully developing a product. Additionally, the funding of these companies is subject to investment market fluctuations, which changes as the risk profiles and appetite of investors change.<a name="Page25"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research services are capital intensive. The investment in equipment and facilities to serve our markets is substantial and continuing. While our physical facilities are adequate to meet market needs for the near term, rapid changes in automation, precision, speed and technologies necessitate a constant investment in equipment and software to meet market demands. We are also impacted by the heightened regulatory environment and the need to improve our business infrastructure to support our increasingly diverse operations, which will necessitate additional capital investment. Our ability to generate capital to reinvest in our capabilities, both through operations and financial transactions, is critical to our success. While we are currently committed to fully utilizing recent additions to capacity, sustained growth will require additional investment in future periods.&#160; Our financial position could limit our ability to make such investments.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In fiscal 2009, there were several announcements of large mergers in the pharmaceutical industry. Pfizer Inc. and Eli Lilly and Co. have both announced significant acquisitions.&#160; Also, Merck and Roche announced mergers with Schering-Plough and Genentech, respectively. We believe that such merger and consolidation activity reduced the demand and increased competition for CRO services and was a distraction for the research and development arms of these companies as they awaited finalization of new drug development portfolios.&#160; With the closing of these major mergers, the pharmaceutical industry can now return to focusing on driving drugs and therapies through the development pipeline. We believe that as larger pharmaceutical companies become leaner and more efficient, generally focusing on their core competencies of fundamental research and development and commercialization, they will also continue to be conservative in their staffing and further reduce their in-house expertise. This should lead to reinvigoration of outsourcing as they assess their key internal priorities.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our primary market, the CRO market, is experiencing serious economic pressures.&#160; Pharmaceutical development companies have delayed the initiation of CRO studies and reduced their total spending for CRO services.&#160; The combination of reduced customer demand, cost containment initiatives pursued by our customers and excess capacity within our industry generally, resulted in significant pricing pressure in fiscal 2010. This resulted in a significant negative impact on our revenues for fiscal 2010 as compared to our prior fiscal year.&#160; In response, we have taken a number of steps to better support our customers in today's challenging environment, identify new strategies to enhance client satisfaction, improve operating efficiencies and generally strengthen our business model.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Patient Protection and Affordable Care Act</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In March 2010, the Patient Protection and Affordable Care Act (the &#8220;Act&#8221;) was enacted by the U.S. Congress and signed into law by the President.&#160; The purpose of the legislation is to extend medical insurance coverage to a higher percentage of U.S. citizens.&#160; Many of the provisions in the Act have delayed effective dates over the next decade, and will require extensive regulatory guidance.&#160; Companies in our principal client industry, pharmaceuticals, will be required under the Act to provide additional discounts on medicines provided under Medicare and Medicaid to assist in the funding of the program; however, government estimates are that over 31 million additional citizens will eventually be covered by medical insurance as a result of the Act, which should expand the markets for their products.&#160; It is premature to accurately predict the impacts these and other competing forces will have on our basic client market, drug development.&#160; Additionally, the Act does not directly impact spiraling health care costs in the U.S., which could lead to additional legislation impacting our target markets in the future.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We maintain an optional health benefits package for all of our full-time employees, which is largely paid by our contributions with employees paying a portion of the cost, generally less than 20% of the total.&#160; Based on our current understanding of the Act, we do not anticipate significant changes to our programs or of their costs to the Company or our employees as a result of the Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have experienced increases in the costs of our health benefit programs in excess of inflation rates, and expect those trends to continue.&#160; We are exploring options in plan funding, delivery of benefits and employee wellness in our continuing effort to obtain maximum benefit for our health care expenditures, while maintaining quality programs for our employees.&#160; We do not expect these efforts to have a material financial impact on the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Critical Accounting Policies and Significant Judgments and Estimates</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our management&#8217;s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and judgments, including those related to stock-based compensation and asset impairment and significant judgments and estimates. We base our estimates on historical experience and on various other factors that are believed to be appropriate under the circumstances, the results of which form the basis for making judgments and estimates. Actual results may differ from these estimates under different assumptions or conditions.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Revenue Recognition</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The majority of our service contracts involve the processing of bioanalytical samples for pharmaceutical companies. These contracts generally provide for a fixed fee for each assay method developed or sample processed and revenue is recognized under the specific performance method of accounting. Under the specific performance method, revenue and related direct costs are recognized when services are performed. Other service contracts generally consist of preclinical studies for pharmaceutical companies. Service revenue is recognized based on the ratio of direct costs incurred to total estimated direct costs under the proportional performance method of accounting. Losses on contracts are provided in the period in which the loss becomes determinable. Revisions in profit estimates are reflected on a cumulative basis in the period in which such revisions become known. The establishment of contract prices and total contract costs involves estimates made by the Company at the inception of the contract period. These estimates could change during the term of the contract which could impact the revenue and costs reported in the consolidated financial statements. Projected losses on contracts are provided for in their entirety when known. Revisions to estimates have not been material. Service contract fees received upon acceptance are deferred and classified within customer advances, until earned. Unbilled revenues represent revenues earned under contracts in advance of billings.<a name="Page26"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Product revenue from sales of equipment not requiring installation, testing or training is recognized upon shipment to customers. One product includes internally developed software and requires installation, testing and training, which occur concurrently. Revenue from these sales is recognized upon completion of the installation, testing and training when the services are bundled with the equipment sale.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Long-Lived Assets, Including Goodwill</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Long-lived assets, such as property and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Goodwill is tested annually for impairment, and more frequently if events and circumstances indicate that the asset might be impaired, using a two-step process.&#160; In the first step, we compare the fair value of each reporting unit, as computed primarily by present value cash flow calculations, to its book carrying value, including goodwill. We do not believe that market value is indicative of the true fair value of the Company mainly due to average daily trading volumes of less than 1%.&#160; If the fair value exceeds the carrying value, no further work is required and no impairment loss is recognized. If the carrying value exceeds the fair value, the goodwill of the reporting unit is potentially impaired and we would then complete step 2 in order to measure the impairment loss. In step 2, the implied fair value is compared to the carrying amount of the goodwill. If the implied fair value of goodwill is less than the carrying value of goodwill, we would recognize an impairment loss equal to the difference. The implied fair value is calculated by allocating the fair value of the reporting unit (as determined in step 1) to all of its assets and liabilities (including unrecognized intangible assets) and any excess in fair value that is not assigned to the assets and liabilities is the implied fair value of goodwill.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The discount rate and sales growth rates are the two material assumptions utilized in our calculations of the present value cash flows used to estimate the fair value of the reporting units when performing the annual goodwill impairment test. We utilize a cash flow approach in estimating the fair value of the reporting units, where the discount rate reflects a weighted average cost of capital rate. The cash flow model used to derive fair value is sensitive to the discount rate and sales growth assumptions used. Due to fiscal year 2009 operating losses and lowered expectations for the near future, we performed an impairment test for our UK reporting unit as of June 30, 2009.&#160; As a result of this test, we recorded a $472 impairment loss equal to the total value of the UK goodwill in fiscal 2009.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Considerable management judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows. Assumptions used in our impairment evaluations, such as forecasted sales growth rates and our cost of capital or discount rate, are based on the best available market information. Changes in these estimates or a continued decline in general economic conditions could change our conclusion regarding an impairment of goodwill and potentially result in a non-cash impairment loss in a future period.&#160; The assumptions used in our impairment testing could be adversely affected by certain of the risks discussed in &#8220;Risk Factors&#8221; in this report.&#160; At September 30, 2010, remaining recorded goodwill was $1,383, and the net balance of other intangible assets was $84.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Stock-Based Compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We recognize the cost resulting from all stock-based payment transactions in our financial statements using a fair-value-based method.&#160; We measure compensation cost for all stock-based awards based on estimated fair values and recognize compensation over the vesting period for awards. We recognized stock-based compensation related to stock options of $226 and $570 during the fiscal years ended September 30, 2010 and 2009, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use the binomial option valuation model to determine the grant date fair value. The determination of fair value is affected by our share price as well as assumptions regarding subjective and complex variables such as expected employee exercise behavior and our expected share price volatility over the term of the award. Generally, our assumptions are based on historical information and judgment is required to determine if historical trends may be indicators of future outcomes. We estimated the following key assumptions for the binomial valuation calculation:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 25.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Risk-free interest rate.</font> The risk-free interest rate is based on U.S.&#160;Treasury yields in effect at the time of grant for the expected term of the option.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 25.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Expected volatility.</font> We use our historical share price volatility on our common shares for our expected volatility assumption.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 25.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Expected term.</font> The expected term represents the weighted-average period the stock options are expected to remain outstanding. The expected term is determined based on historical exercise behavior, post-vesting termination patterns, options outstanding and future expected exercise behavior.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 25.2pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Expected dividends.</font> We assumed that we will pay no dividends.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employee stock-based compensation expense recognized in fiscal 2010 and 2009 was calculated based on awards ultimately expected to vest and has been reduced for estimated forfeitures. Forfeitures are revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates and an adjustment will be recognized at that time.<a name="Page27"><!--EFPlaceholder--></a></font></div>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Changes to our underlying share price, our assumptions used in the binomial option valuation calculation and our forfeiture rate as well as future grants of equity could significantly impact compensation expense recognized in future periods.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Inventories</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories are stated at the lower of cost or market using the first-in, first-out (FIFO) cost method of accounting.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Income Tax Accounting</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use the asset and liability method of accounting for income taxes.&#160; We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We recognize the effect on deferred tax assets and liabilities of a change in tax rates in income in the period that includes the enactment date.&#160; We record valuation allowances based on a determination of the expected realization of tax assets.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We recognize the tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. We measure the amount of the accrual for which an exposure exists as the largest amount of benefit determined on a cumulative probability basis that we believe is more likely than not to be realized upon ultimate settlement of the position.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We record interest and penalties accrued in relation to uncertain income tax positions as a component of income tax expense.&#160; Any changes in the accrued liability for uncertain tax positions would impact our effective tax rate. Over the next twelve months we do not anticipate resolution to the carrying value of our reserve.&#160; Interest and penalties are included in the reserve.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of September 30, 2010 and 2009, we had a $30 and $473 liability for uncertain income tax positions, respectively.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We file income tax returns in the U.S., several U.S. states, and the foreign jurisdiction of the United Kingdom.&#160; We remain subject to examination by taxing authorities in the jurisdictions in which we have filed returns for years after 2006.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In April 2010, we settled state tax litigation relating to our fiscal tax years 2003 through 2006 by agreeing to pay $35 and foregoing a refund claim for $63.&#160; Because we had previously recorded a $443 liability for this uncertain tax position, we recognized a net tax benefit of $345 in our second fiscal quarter ended March 31, 2010.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have an accumulated net deficit in our UK subsidiary. Consequently, United States deferred tax assets on such earnings have not been recorded.&#160; Also, a valuation allowance was established in fiscal 2009 against the U.S. deferred income tax balance.&#160; We had previously recorded a valuation allowance on the UK subsidiary deferred income tax balance.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Results of Operations</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Three Months ended December 31, 2010 compared to three months ended December 31, 2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Service and Product Revenues</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Revenues for the fiscal quarter ended December 31, 2010 increased 26.9% to $8,090 compared to $6,377 for the same period last year.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our Service revenue increased 27.7% to $6,143 in the first quarter of fiscal 2011 compared to $4,811 for the comparable prior year period primarily as a result of higher bioanalytical analysis and toxicology revenues.&#160; Volumes of studies and number of samples to assay continued to increase, though pricing still lagged pre-recession levels.&#160; An increase in proposal opportunities and in new orders accepted in calendar 2010 has led to an increase in our bioanalytical analysis and toxicology revenues in the first quarter of fiscal 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three&#160;Months&#160;Ended</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December&#160;31,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Change</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">%</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bioanalytical analysis</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,797</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,630</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,167</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44.4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Toxicology</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,953</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,563</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">390</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other laboratory services</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">393</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">618</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(225</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-36.4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales in our Products segment increased 24.3% to $1,947 in the first quarter of fiscal 2011 from $1,566 for the same period in the prior year.&#160; The majority of the increase stems from sales of our Culex automated <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling systems.&#160; &#160;Though we continue to experience sluggish demand for higher-priced capital assets, a few customers have begun to release capital funds for larger projects.&#160; Sales of our analytical products also increased in the first quarter of fiscal 2011 over the comparable period in fiscal 2010 as these sales are less dependent on capital investment cycles.<a name="Page28"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">21</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three&#160;Months&#160;Ended</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December&#160;31,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Change</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">%</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Culex<font style="DISPLAY: inline; FONT-FAMILY: times new roman">&#174;</font>, in-vivo sampling systems</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,087</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">705</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">382</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Analytical instruments</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">697</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">626</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11.3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other instruments</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">163</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">235</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(72</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-30.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Cost of Revenues</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cost of revenues for the first quarter of fiscal 2011 was $5,374 or 66.4% of revenue, compared to $5,181, or 81.2% of revenue for the comparable prior year period.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cost of Service revenue as a percentage of Service revenue decreased to 76.0% in the first quarter of fiscal 2011 from 95.0% in the comparable period last year.&#160; The principal cause of this decrease was the increase in revenues, which led to higher absorption of the fixed costs in our Service segment.&#160; A significant portion of our costs of productive capacity in the Service segment are fixed.&#160; &#160;Thus, increases in revenues lead to decreases in costs as a percentage of revenue.&#160; Also, a reduction of our work force in January 2010 and other cost containment measures contributed to the decline in the cost of Service revenue.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cost of Product revenue as a percentage of Product revenue in the first quarter of fiscal 2011 decreased to 36.3% from 39.0% in the comparable prior year period.&#160; &#160;This decrease is mainly due to a change in the mix of products sold in the fiscal 2011 period.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Operating Expenses</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Selling expenses for the three months ended December 31, 2010 decreased 12.7% to $685 from $785 for the comparable period last year.&#160; This decrease was primarily driven by a decrease in salary expense resulting from the reduction in work force in January 2010 and other departures and reduced marketing expenditures.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research and development expenses for the first quarter of fiscal 2011 decreased 34.5% over the comparable period last year to $112 from $171.&#160; The decrease was partially due to a decrease in salaries from the reduction in work force in January 2010, as well as reduced spending on temporary labor, operating supplies and consulting services.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">General and administrative expenses for the first quarter of fiscal 2011 decreased 7.1% to $1,381 from $1,487 for the comparable prior year period.&#160; A decline in salaries and hourly wages from the January 2010 reduction in force and strict controls on other variable expenses contributed to the reduction in expenses in the 2011 fiscal quarter.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Income (Expense)</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other expense for the first quarter of fiscal 2011 decreased to $228 from $241 for the same quarter of the prior year. The primary reasons for the decrease are the mark to market adjustments to the interest rate swaps slightly offset by increased interest expense from our new line of credit agreement and from capital leases that were not in place in the first quarter of fiscal 2010.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Income Taxes</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our effective tax rate for the quarters ended December 31, 2010 and 2009 was 0.0%.&#160; We continue to maintain a full valuation allowance on our U.S. and UK subsidiary deferred income tax balances.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Fiscal years ended September 30, 2010 and 2009</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Service and Product Revenues</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Overall, our Service and Product revenues continued to be negatively impacted by the U.S. and European economic recession.&#160; Revenues for the year ended September 30, 2010 declined 9.5% to $28,781 compared to $31,784 for the year ended September 30, 2009.&#160; A substantial portion of the decline was in the first half of fiscal 2010.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In fiscal 2010, our Service revenue declined 9.5% to $21,864 compared to $24,158 for the prior fiscal year primarily as a result of lower bioanalytical analysis, pharmaceutical analysis and toxicology revenues.&#160; Our bioanalytical analysis revenues for fiscal 2010 decreased $904 (a 6.6% decline from fiscal 2009), mainly due to study delays in existing projects by clients and price declines.&#160; While new orders and samples continued to increase, pricing still lagged pre-recession levels.&#160; &#160; Our Oregon facility experienced the majority of the decline in bioanalytical analysis revenues, or $1,049. Likewise, the decrease in toxicology revenues in fiscal 2010 of $411, or 5.2%, from the prior fiscal year is mainly due to study delays and cancellations.&#160; Further, other laboratory services declined from fiscal 2009 to fiscal 2010 by $979, or 38.8%, due in part to customers bringing these services in house.<a name="Page29"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">22</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fiscal&#160;Year&#160;Ended</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September&#160;30,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Change</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">%</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bioanalytical analysis</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,779</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,683</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(904</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-6.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Toxicology</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,543</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,954</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(411</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-5.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other laboratory services</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,542</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,521</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(979</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-38.8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In fiscal 2010, sales in our Products segment decreased 9.3% from $7,626 to $6,917 when compared to the prior fiscal year.&#160; The majority of that decrease stems from lower grant revenue in fiscal 2010 as a grant funded by the NIH expired in January 2010.&#160; Also contributing to the decline in Products revenues in fiscal 2010 were lower sales of our Culex automated <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling systems, which declined 3.5% from $3,263 to $3,150, when compared to the prior fiscal year, and a decline in the sales of our mature analytical instruments, which declined $186 or 5.7% from the prior fiscal year.&#160; Though we continue to experience sluggish demand for higher priced capital assets as customers reduce spending as part of their overall cost savings initiatives, a few customers have begun to release capital funds for larger projects.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="85%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fiscal&#160;Year&#160;Ended</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September&#160;30,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Change</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">%</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Culex, in-vivo sampling systems</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,150</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,263</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-3.5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Analytical instruments</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,070</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,256</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(186</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-5.7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Although our revenues for fiscal 2010 were less than fiscal 2009, our revenues increased 16% in the second half of fiscal 2010 from the first half of fiscal 2010.&#160; This increase is the result of increased proposal opportunities and acceptance rates for our Service segment revenues in fiscal 2010, as well as slightly increased capital spending by Products segment customers in the second half of fiscal 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Cost of Revenue</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cost of revenue for the fiscal year ended September 30, 2010 was $21,448 or 74.5% of revenue compared to $24,180, or 76.1% of revenue for the comparable prior year period.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cost of Service revenue as a percentage of Service revenue decreased to 85.0% in fiscal 2010 from 86.8% in fiscal 2009.&#160; The principal cause of this decrease was a reduction of our work force in January 2010 and other cost containment measures.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cost of Product revenue as a percentage of Product revenue in fiscal 2010 decreased to 41.6% from 42.2% in fiscal 2009.&#160; This decrease is mainly due to headcount and other expense reductions, as well as a reduction in the cost of obsolete and slow moving inventory in fiscal 2010 compared to the cost recognized in the prior fiscal year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Operating Expenses</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Selling expenses for the year ended September 30, 2010 decreased by 19.1% to $2,665 from $3,296 for the year ended September 30, 2009.&#160; &#160;This decrease was primarily driven by a decrease in salary expense resulting from the reduction in work force and other departures, lower commissions due to the decline in sales and reduced spending on marketing.&#160; The reduction in marketing expenditures is related to the initial costs of our branding and marketing campaign in fiscal 2009.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research and development expenses for the year ended September 30, 2010 decreased 28.3% to $546 from $762 for the year ended September 30, 2009. The decrease was partially due to a decrease in salaries from the reduction in work force as well as reduced spending on temporary labor, operating supplies and consulting services.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">General and administrative expenses for fiscal 2010 decreased 20.3% to $6,119 from $7,674 for the prior fiscal year.&#160; The decrease is mainly due to the following:&#160; 1) severance expenses for former employees recorded in fiscal 2009 exceeded those recorded in fiscal 2010; 2) a decline in stock-based compensation expense as grants became fully vested; and 3) company-wide efforts at cost containment.&#160; This decline was after incurring $216 in fiscal 2010 for lease settlement costs.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Income/Expense</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other income (expense), net, was $(1,027) for the year ended September 30, 2010 as compared to $(1,060) for the year ended September 30, 2009. The primary reason for the decrease is a $103 non-cash charge on our interest rate swaps in fiscal 2009, slightly offset by increased interest expense from our new line of credit agreement in fiscal 2010.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Income Taxes</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our effective tax rate for continuing operations for the year ended September 30, 2010 was (11.0%) compared to (3.5%) for the prior fiscal year.&#160; In fiscal 2009, a valuation allowance was recorded against the entire U.S. deferred income tax balance, adjusting the rate from (36.4%) to (3.5%) due to the uncertainty of the benefit realization.&#160; The benefit in fiscal 2010 is the result of resolving an uncertain state tax liability for less than the recorded amount.&#160; No net benefits have been provided on taxable losses in fiscal 2010.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">23</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Liquidity and Capital Resources</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Comparative Cash Flow Analysis</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font>Three Months ended December 31, 2010 compared to three months ended December 31, 2009</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Since inception, our principal sources of cash have been cash flow generated from operations and funds received from bank borrowings and other financings.&#160; At December 31, 2010, we had cash and cash equivalents of $1,238, compared to $1,422 at September 30, 2010.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Net cash provided by operating activities was $737 for the three months ended December 31, 2010 compared to $242 for the three months ended December 31, 2009.&#160; The increase in cash provided by operating activities in the current fiscal year partially results from our operating income versus an operating loss in the prior year period.&#160; Other contributing factors to our cash from operations in the first quarter of fiscal 2011 were $530 of depreciation and amortization, net collections on accounts receivable of $128 and an increase in customer advances of $136 as our new accepted quotes improved.&#160; Included in operating activities for the first quarter of fiscal 2010 are non-cash charges of $607 for depreciation and amortization and a reduction in accounts receivable of $1,437.&#160; The impact on operating cash flow of other changes in working capital was not material.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We anticipate that this impact on our cash flow from operations will continue through fiscal 2011.&#160; We have seen increased order activity in the calendar year 2010, which we expect will translate into earned revenues in future quarters of fiscal 2011.&#160; Selling, general and administrative expenses and other operating expenses declined approximately 11.0% in the first quarter of fiscal 2011 from the comparable prior year period due to the reduction in work force in January 2010 and cost containment initiatives.&#160; We expect the reduced spending levels to continue and that our efforts to reduce costs will positively impact the remainder of fiscal 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investing activities used $311 in the first quarter of fiscal 2011 due to capital expenditures as compared to $57 in the first three months of fiscal 2010. Our principal investment was a mandated waste-water treatment facility at one of our sites, with selected investments for laboratory equipment replacements and upgrades in all of our facilities, as well as general building and information technology infrastructure expenditures at all sites.&#160; Although we may consider strategic acquisition opportunities, we do not intend to aggressively pursue additional acquisitions until we fully utilize existing capacity.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financing activities used $603 in the first three months of fiscal 2011 as compared to $509 used for the first three months of fiscal 2010. The main use of cash in the first quarter of fiscal 2011 was for long-term debt and capital lease payments of $868, offset slightly by net borrowings on our line of credit of $265.&#160; In the first quarter of fiscal 2010, we had long-term debt and capital lease payments of $319, as well as net payments on our line of credit of $190.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font>Fiscal year ended September 30, 2010 compared to fiscal year ended September 30, 2009</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At September 30, 2010, we had cash and cash equivalents of $1,422 compared to $870 at September 30, 2009.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Net cash provided by continuing operating activities was $2,441 for the year ended September 30, 2010, compared to $1,999 for the year ended September 30, 2009. The increase in cash provided by operating activities in fiscal 2010 partially results from a decrease in our operating loss.&#160; Other contributing factors to our cash from operations in fiscal 2010 were $2,323 of depreciation and amortization, net collections on accounts receivable of $650, an increase in customer advances of $1,719 as we booked new business and the recording of a $216 long-term liability in settlement of a contingent lease liability on our former Baltimore facility.&#160; Included in operating activities for fiscal 2009 are non-cash charges of $2,645 for depreciation and amortization, $103 recorded to reflect the fair value of our interest rate swaps and $472 for impairment of goodwill for our UK operations.&#160; The impact on operating cash flow of other changes in working capital was not material.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In January 2010, we completed a reduction in work force, through both attrition and terminations, which impacted all areas of operations and reduced our annual compensation expense by approximately 10%.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investing activities used $450 in fiscal 2010, primarily for capital expenditures.&#160; Our principal investments were for laboratory equipment replacements and upgrades in all of our facilities as well as general building and information technology infrastructure expenditures at all sites.&#160; The 46% reduction in capital spending from fiscal 2009 is a result of our efforts to contain cash commitments throughout the organization, funding only necessary expenditures.&#160; We intend to increase capital expenditures, particularly for laboratory equipment, in fiscal 2011 when financing becomes available to fund our purchases.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financing activities used $1,458 in fiscal 2010 as compared to $1,476 used for fiscal 2009. The main use of cash in fiscal 2010 was for long term debt and capital lease payments of $1,325, as well as net payments on our line of credit of $564.&#160; We also conducted a sale and leaseback of some of our unencumbered laboratory equipment in fiscal 2010, which netted $431 in cash.&#160; In fiscal 2009, our net payments on our line of credit were $264 with long term debt and capital lease payments of $1,212.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During fiscal 2009, cash provided by operating activities for discontinued operations of $588 was mainly due to the collection of outstanding receivables.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Capital Resources</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Property and equipment spending totaled $311, $450 and $834 in the three months ended December 31, 2010, the year ended September 30, 2010 and the year ended September 30, 2009, respectively. The decrease in spending in fiscal 2010 is the result of cash savings initiatives, funding only necessary expenditures. Capital investments for the purchase of additional laboratory equipment are driven by anticipated increases in research services, and by the replacement or upgrading of our equipment. Although we may consider strategic acquisition opportunities, we do not intend to aggressively pursue additional acquisitions until we fully utilize existing capacity.<a name="Page31"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">24</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have notes payable to Regions Bank (&#8220;Regions&#8221;) aggregating approximately $7,500 as of December 31, 2010 and a $3,000 line of credit with Entrepreneur Growth Capital LLC (&#8220;EGC&#8221;), which is subject to qualifying collateral that may substantially reduce or eliminate our borrowing capacity at any time. The Regions notes payable include three outstanding mortgages on our facilities in West Lafayette and Evansville, Indiana, which total $6,901 at December 31, 2010.&#160; Two of the mortgages mature in November 2012 with an interest rate fixed at 7.1%, while the other matured in February 2011 with an interest rate of 6.1%.&#160; In addition to the mortgages, we also have a note payable with Regions, which matured December 18, 2010.&#160; Interest on this term loan was equal to 6.1%. Monthly payments were $9 plus interest. The notes payable are collateralized by real estate at our West Lafayette and Evansville, Indiana locations.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On November 29, 2010, we executed amendments on two loans with Regions.&#160; Regions agreed to accept a $500 principal payment on the note payable with $1.1 million of principal maturing on December 18, 2010 and a $500 principal payment on one mortgage with $1.3 million of principal maturing on February 11, 2011.&#160; The principal payments were made on December 17, 2010 and February 11, 2011, respectively.&#160; Thereafter, on February 22, 2011, the unpaid principal on the note payable and the mortgage was incorporated into a replacement note maturing on November 1, 2012.&#160; The replacement note bears interest at LIBOR plus 300 basis points (minimum of 4.5%) with monthly principal amortization.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have interest rate swap agreements with respect to the note payable and mortgage mentioned in the above paragraph to fix the interest rate at 6.1%.&#160; We entered into the derivative transactions to hedge interest rate risk of this debt obligation and not to speculate on interest rates.&#160; The notional values of the swaps as of December 31, 2010, September 30, 2010 and 2009 were $1,309, $2,442 and $2,701, respectively.&#160; One swap matured on December 18, 2010.&#160; The fair value of the swaps was determined with a level two analysis.&#160; As a result of recent declines in short term interest rates, the swaps had a negative fair value of $10 at December 31, 2010, $31 at September 30, 2010 and $103 at September 30, 2009, with the decline in the liability being recorded in our consolidated financial statements as a reduction in interest expense in the current fiscal year and the increase in liability recorded as an increase in interest expense in the prior fiscal year.&#160; The terms of the interest rate swaps match the scheduled principal outstanding under the loans.&#160; We do not intend to prepay the loans, and expect the swaps to expire under their terms in fiscal 2011 without payment by us.&#160; Upon expiration of the swaps, the net fair value recorded in the consolidated financial statements is expected to be zero.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As part of the amendment, Regions also agreed to amend the loan covenants for the related debt to be more favorable to us.&#160; Provided we comply with the revised covenant ratios, the amendment removes limitations on the Company&#8217;s purchase of fixed assets.&#160; &#160;The covenants, which are common to such agreements, include maintenance of certain financial ratios including a fixed charge coverage of 1.25 to 1.0 and total liabilities to tangible net worth of no greater than 2.1 to 1.0. &#160;At September 30, 2010 and December 31, 2010, we were in compliance with these ratios and based on projections for fiscal 2011, we expect to be in compliance with our covenants throughout fiscal 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Regions loan agreements both contain cross-default provisions with each other and with the revolving line of credit with EGC described below.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Revolving Line of Credit</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 13, 2010, we entered into a new $3,000 revolving line of credit agreement (&#8220;Credit Agreement&#8221;), with EGC, which we use for working capital and other purposes. The Credit Agreement was amended on December 23, 2010.&#160; References to the Credit Agreement refer to the Credit Agreement as so amended.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrowings under the Credit Agreement bear interest at an annual rate equal to the prime rate plus five percent (5%), with minimum monthly interest payments of $15 per month.&#160; The Credit Agreement also carries an annual facilities fee of 2% and a 0.2% collateral monitoring fee.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrowings under the Credit Agreement are secured by a blanket lien on our personal property, including certain eligible accounts receivable, inventory, and intellectual property assets, a second mortgage on our West Lafayette and Evansville real estate and all common shares of our U.S. subsidiaries and 65% of the common shares of our non-United States subsidiary. Borrowings are calculated based on 75% of eligible accounts receivable.&#160; Under the Credit Agreement, the Company has agreed to restrict advances to subsidiaries, limit additional indebtedness and capital expenditures and comply with certain financial covenants outlined in the Credit Agreement. The term of the Credit Agreement terminates January 31, 2013.&#160; If we terminate the Credit Agreement and prepay the outstanding balance prior to the expiration of the term, then we are subject to an early termination fee equal to the minimum interest charges of $15 for each of the months remaining until expiration.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The covenants in the Credit Agreement require that we maintain a minimum tangible net worth of $8,500. The Credit Agreement also contains cross-default provisions with the Regions loans and any future EGC loans.&#160; At September 30, 2010, we were not in compliance with the minimum tangible net worth covenant requirement.&#160; The December amendment waived all non-compliances with this covenant through the date of the amendment.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Based on our current business activities and cash on hand, we expect to borrow on our revolving credit facility in fiscal 2011 to finance working capital.&#160; To conserve cash, we instituted a freeze on non-essential capital expenditures.&#160; As of December 31, 2010, we had $2,120 of total borrowing capacity with the line of credit, of which $1,460 was outstanding, and $1,238 of cash on hand.&#160; We had an increase in our total borrowing capacity of $346, from $1,774 to $2,120, from the fiscal year ended September 30, 2010 primarily as a result of higher revenues.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Based on our expected revenues, the availability on our line of credit, and the impact of the cost reductions we have implemented, we believe that we will have the liquidity required to meet our fiscal 2011 operations and debt obligations.&#160;&#160;&#160;Should operations materially fail to meet our expectations for fiscal 2011, we may not be able to comply with all of our debt covenants, requiring that we obtain a waiver at that time.&#160;&#160;If that situation arises, we will be required to negotiate with our lending bank again to obtain loan modifications or waivers as described above.&#160;&#160;We cannot predict whether our lenders will provide those waivers, if required, what the terms of any such waivers might be or what impact any such waivers will have on our liquidity, financial condition or results of operations.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">25</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">New Accounting Pronouncements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page32"><!--EFPlaceholder--></a>In August 2008, the SEC announced that it will issue for comment a proposed roadmap regarding the potential use by U.S. issuers of financial statements prepared in accordance with IFRS (International Financial Reporting Standards). IFRS is a comprehensive series of accounting standards published by the IASB (International Accounting Standards Board). Under the proposed roadmap, we could be required to prepare financial statements in accordance with IFRS. The SEC has indicated it will make a determination in 2011 regarding mandatory adoption of IFRS, at which time our required adoptive date will be determined.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In October&#160;2009, the FASB issued an Accounting Standards Update on the accounting for revenue recognition to specifically address how to determine whether an arrangement involving multiple deliverables contains more than one unit of accounting.&#160; This guidance is applicable to revenue arrangements entered into or materially modified during our next fiscal year that begins October 1, 2010.&#160; This update has not impacted revenue in the periods presented, and we do not expect a material change from the methods we have historically used to report revenues.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Business</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Overview</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc., a corporation organized in Indiana in 1974, provides contract drug development services and research equipment to many leading global pharmaceutical, medical research and biotechnology companies and institutions. We offer an efficient, variable-cost alternative to our clients' internal product development programs. Outsourcing development work to reduce overhead and speed drug approvals through the Food and Drug Administration ("FDA") is an established alternative to in-house development among pharmaceutical companies. We derive our revenues from sales of our research services and drug development tools, both of which are focused on determining drug safety and efficacy.&#160;&#160;The Company has been involved in the research of drugs to treat numerous therapeutic areas since its formation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We support the preclinical and clinical development needs of researchers and clinicians for small molecule and large biomolecule drug candidates.&#160;&#160;We believe our scientists<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>have the skills in analytical instrumentation development, chemistry, computer software development, physiology, medicine, analytical chemistry and toxicology to make the services and products we provide increasingly valuable to our current and potential clients. Our principal clients are scientists engaged in analytical chemistry, drug safety evaluation, clinical trials, drug metabolism studies, pharmacokinetics and basic neuroscience research from small start-up biotechnology companies to many of the largest global pharmaceutical companies.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Changing Nature of the Pharmaceutical Industry</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our services and products are marketed globally to pharmaceutical, medical research and biotech companies and institutions engaged in drug research and development. The research services industry is highly fragmented among many niche vendors led by a small number of larger companies; the latter offer an ever-growing portfolio of start-to-finish pharmaceutical development services. Our products are also marketed to academic and governmental institutions. Our services and products may have distinctly different clients (often separate divisions in a single large pharmaceutical company) and requirements. We believe that clients are facing increased pressure to outsource facets of their research and development activities<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>and that the following factors will increase client outsourcing:</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Accelerated Drug Development</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clients continue to demand faster, more efficient, more selective development of an increasing pool of drug candidates. Consequently, our clients require fast, high-quality service in order to make well-informed decisions to quickly exclude poor candidates and speed development of successful ones. The need for additional development capacity to exploit more opportunities, accelerate development, extend market exclusivity and increase profitability drives the demand for outsourced services.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Cost Containment</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pharmaceutical companies continue to push for more efficient operations through outsourcing to optimize profitability as development costs climb, staff costs increase, generic competition challenges previously secure profit generators, political and social pressures to reduce health care costs escalate, and shareholder expectations mount.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Patent Expiration</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As exclusivity ends with patent expiry, drug companies defend their proprietary positions against generic competition with various patent extension strategies. Both the drug company creating these extensions and the generic competitors should provide additional opportunities for us.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Alliances</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Strategic alliances allow pharmaceutical companies to share research know-how and to develop and market new drugs faster in more diverse, global markets. We believe that such alliances will lead to a greater number of potential drugs in testing, many under study by small companies lacking broad technical resources. Those small companies can add shareholder value by further developing new products through outsourcing, reducing risk for potential allies.&#160; Clients seek realistic business partnerships with their service provider in an effort to ensure that costs are controlled as their development programs progress.&#160;&#160;We have long-standing business relationships with many pharmaceutical companies and continue to offer flexible services and adapt to our client&#8217;s requirements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Mergers and Acquisitions</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Consolidation in the pharmaceutical industry is commonplace. As firms blend personnel, resources and business activities, we believe they will continue to streamline operations and minimize staffing, which may lead to more outsourcing. Consolidation may result in a disruption in the progress of drug development programs as merging companies rationalize their respective drug development pipelines.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">26</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Biotechnology Industry and Virtual Drug Company Growth</font><a name="Page33"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The biotechnology industry continues to grow and has introduced many new developmental drugs. Many biotechnology drug developers do not have in-house resources to conduct development. Many new companies choose only to carry a product to a developed stage sufficient to attract a partner who will manufacture and market the drug. Efficient use of limited funds motivates smaller firms to seek outside service providers rather than build expensive infrastructure.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Unique Technical Expertise</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The increasing complexity of new drugs requires highly specialized, innovative, solution-driven research not available in all client labs. We believe that this need for unique technical expertise will increasingly lead to outsourcing of research activity.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Data Management and Quality Expertise</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our clients and the FDA require more data, greater access to that data, consistent and auditable management of that data, and greater security and control of that data. We have made significant investments in software throughout our contract services groups to optimize efficiency and ensure compliance with FDA regulations and market expectations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Globalization of the Marketplace</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Foreign firms rely on independent development companies with experience in the U.S. to provide integrated services through all phases of product development and to assist in preparing complex regulatory submissions. Domestic drug firms are broadening product availability globally, demanding local regulatory approval. We believe that domestic service providers with global reach, established regulatory expertise, and a broad range of integrated development services will benefit from this trend.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The Company's Role in the Drug Development Process</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">After a new drug candidate is identified and carried through preliminary screening, the development process for new drugs has three distinct phases.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">preclinical phase</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>includes safety testing to prepare an Investigational New Drug ("IND") for submission to the FDA. The IND must be accepted by the FDA before the drug can be tested in humans. Once a pharmacologically active molecule is fully analyzed to confirm its integrity, the initial dosage form for clinical trials is created. An analytical chemistry method is developed to enable reliable quantification. Stability and purity of the formulation are also determined.&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clients work with our preclinical services group to establish pharmacokinetics (PK), pharmacodynamics (PD) and safety testing of the new drug. These safety studies range from dose ranging studies, that involve acute safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity and reproductive toxicity studies. Dose level confirmation is provided by our pharmaceutical analysis group.&#160;&#160;Bioanalyses of blood sampled under these protocols by our bioanalytical services group provide pharmacokinetic and metabolism data that is used with the safety and toxicity information to determine the exposure required to demonstrate toxicity.&#160;&#160;A no effect level is then established for the drug and sets the basis for future dose levels in further safety testing and clinical phase I studies.&#160;&#160;Upon successful completion of preclinical safety studies, an IND submission is prepared and provided to the FDA for review prior to human clinical trials.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Many of our products are designed for use in discovery and preclinical development. The Culex&#174; family of robotic automated dose delivery and blood and other biofluids sampling and physiological parameters measurement systems enable researchers to quickly and cost effectively determine PK/PD profiles of drugs in large and small animal models.&#160;&#160;The Culex system allows experiments on freely moving conscious animals from early research for therapeutic target validation to lead optimization of compounds.&#160;&#160;Using the Culex system, researchers are able to automatically dose and sample in-vivo to develop pharmacokinetic and pharmacodynamic profiles of drugs during early screening in rodents and other animals quickly and cost effectively. Our bioanalytical services group utilizes our depth of expertise in liquid chromatography with detection by mass spectrometry as a mainstay of our bioanalytical laboratories to support research, preclinical and clinical programs.&#160;&#160;We also offer bioanalytical services that utilize electrochemistry, spectrophotometric (UV/Vis or fluorescence) and Corona Discharge detection as options. We have invested heavily in robotics and mass spectrometry systems in previous years.&#160;&#160;Application of this technology allows us to rapidly develop and validate methods for new compounds and obtain information suitable for regulatory submission.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">clinical phase</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>further explores the safety and efficacy of the substance in humans. The sponsor conducts Phase I human clinical trials in a limited number of healthy individuals to determine safety and tolerability. Bioanalytical assays determine the availability and metabolism of the active ingredient following administration. Expertise in method development and validation is critical, particularly for new chemical entities.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exhaustive safety, tolerability and dosing regimens are established in sick humans in Phase II trials. Phase III clinical trials verify efficacy and safety. After successful completion of Phase III trials, the sponsor of the new drug submits a New Drug Application ("NDA") or Product License Application ("PLA") to the FDA requesting that the product be approved for marketing. Early manufacturing demonstrates production of the substance in accordance with FDA Good Manufacturing Practices ("GMP") guidelines. Data are compiled in an NDA, or for biotechnology products a PLA, for submission to the FDA requesting approval to market the drug or product. Our bioanalytical work per study grows rapidly from Phase I through Phase III. The number of samples per patient declines as the number of patients grows in later studies. Phase II and III studies take several years, supported by well-proven, consistently applied analytical methods. It is unusual for a sponsor to change laboratories unless there are problems in the quality or timely delivery of results.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our services include evaluation of bioequivalence and bioavailability to monitor the rate and extent to which a drug is available in the body and to demonstrate that the availability is consistent between formulations.&#160;&#160;We additionally offer support in clinical sample development, release and stability of clinical samples including comparators.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Post-approval phase </font>follows FDA approval of the NDA or PLA. This includes production and continued analytical and clinical monitoring of the drug. The post-approval phase also includes development and regulatory approval of product modifications and line extensions, including improved dosage forms. The drug manufacturer must comply with quality assurance and quality control requirements throughout production and must continue analytical and stability studies of the drug during commercial production to continue to validate production processes and confirm product shelf life. Samples from each manufactured batch must be tested prior to release of the batch for distribution to the public.&#160;<a name="Page34"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">27</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We also provide services in all areas during the post-approval phase, concentrating on bioequivalence studies of new formulations, line extensions, new disease indications and drug interaction studies.&#160; Our ability to offer quick sample analysis has provided increased business opportunities for release testing.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The increases in our services offerings as a result of both acquisition and internal development have resulted in our ability to provide a broader range of services to our clients, often using combined services of several disciplines to address client needs.&#160; Our ability to solve client problems by combining our knowledge base, services and products has been a factor in our selection by major pharmaceutical companies to assist in several preclinical through the post-approval phases.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Company Services and Products</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Overview</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We operate in two business segments &#8211; contract research services and research products, both of which address the bioanalytical, preclinical, and clinical research needs of drug developers. Both segments arose out of our expertise in a number of core technologies designed to quantify trace chemicals in complex matrices. We evaluate performance and allocate resources based on these segments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Services</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The contract research services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The following is a description of the services provided by our contract research services segment:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Product Characterization, Method Development and Validation</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>Analytical methods, primarily performed in West Lafayette, Indiana, determine potency, purity, chemical composition, structure and physical properties of a compound. Methods are validated to ensure that data generated are accurate, precise, reproducible and reliable and are used consistently throughout the drug development process and in later product support.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Bioanalytical Testing</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We analyze specimens from preclinical and clinical trials to measure drug and metabolite concentrations in complex biological matrices. Bioanalysis is performed at our facilities in Indiana, Oregon and the United Kingdom.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Stability Testing</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We test stability of drug substances and formulated drug products and maintain secure storage facilities in West Lafayette, Indiana to establish and confirm product purity, potency and shelf life. We have multiple International Conference on Harmonization validated controlled-climate GMP systems in place, and the testing capability to complete most stability programs.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">In Vivo Pharmacology</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We provide preclinical <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo </font>sampling services for the continuous monitoring of chemical changes in life, in particular, how a drug enters, travels through, and is metabolized in living systems. Most services are performed in customized facilities in Evansville, Indiana using our robotic Culex&#174; APS (Automated Pharmacology System) system.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Preclinical and Pathology Services</font><font style="DISPLAY: inline; FONT-STYLE: italic">: </font>We provide pharmacokinetic and safety testing in studies ranging from acute safety monitoring of drugs and medical devices to chronic, multi-year oncogenicity studies in our Evansville, Indiana site. Depending on protocol, multiple tissues may be collected to monitor pathological changes.&#160;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Products</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our products business is focused on expediting preclinical screening of developmental drugs. We compete in small niches of the multibillion dollar analytical instrument industry. The products business targets unique niches in life science research. We design, develop, manufacture and market state-of-the-art <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling systems and accessories (including disposables, training and systems qualification), physiology monitoring tools and liquid chromatography and electrochemistry instruments platforms. We offer three (3) principal product lines:&#160; Analytical Products, In Vivo Sampling Products and Vetronics&#8217; Products.&#160; The following is a brief description of the products offered:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Analytical Products:</font>&#160; The analytical products consist of our liquid chromatographic and electrochemical instruments with associated accessories.&#160; The critical component of these products is the Epsilon<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">&#174; </font>electrochemical platform.&#160; This incorporates all the hardware capabilities needed for most electrochemical experiments but can be modified through software development.&#160; The market is principally academic institutions and industrial research companies.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">In Vivo Sampling Products:&#160; </font>The <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling products consist of the <font style="DISPLAY: inline; FONT-STYLE: italic">Culex&#174;</font> family of automated <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling and dosing instruments.&#160; These are used by pharmaceutical researchers to dose animals and collect biological samples (blood, bile, urine, microdialysate, feces or any bio-fluid) from the animals.&#160; Since dosing and sample collections are automated, animals are not manually handled, reducing stress on the animals and producing more representative pharmacological data.&#160; Behavior and other physiological parameters can also be monitored simultaneously.&#160; Compared to manual methods, the Culex&#174; products offer significant reduction in test model use and comparable reduction in labor.&#160; The line also includes miniaturized <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling devices sold to drug developers and medical research centers to assist in the study of&#160; a number of medical conditions including stroke, depression, Alzheimer&#8217;s and Parkinson&#8217;s diseases, diabetes and osteoporosis.</font></div></td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">28</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page35"><!--EFPlaceholder--></a><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">Vetronics&#8217; Products:&#160; </font>The Vetronics&#8217; products consist of instruments and related software to monitor and diagnose cardiac function (electro-cardiogram) and measure other vital physiological parameters primarily in cats and dogs in veterinary clinics.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Clients</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Over the past five years, we have regularly provided our services and/or products to most of the top 25 pharmaceutical companies in the world, as ranked by the number of research and development projects.&#160; Approximately 11% of our revenues are generated from customers outside of North America.&#160; We balance our business development effort between large pharmaceutical developers and smaller drug development companies.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pfizer, Inc. is our largest client, accounting for approximately 7.0% of our total revenues in fiscal 2010 and 2009. Pfizer, Inc. accounted for 4.7% and 3.2% of total trade accounts receivable at September 30, 2010 and 2009, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There can be no assurance that our business will not continue to be dependent on continued relationships with Pfizer, Inc. or other clients, or that annual results will not be dependent on a few large projects. In addition, there can be no assurance that significant clients in any one period will continue to be significant clients in other periods. In any given year, there is a possibility that a single pharmaceutical company may account for 5% or more of our total revenue. Since we do not have long-term contracts with our clients, the importance of a single client may vary dramatically from year to year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales and Marketing</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our current sales and marketing efforts target both the top 200 global pharmaceutical companies and smaller companies. We recognize that our growth and customer satisfaction depend upon our ability to continually improve and create new client relationships.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our products and services are sold directly to the client. We currently have 10 employees on our sales and marketing staff.&#160; Sales, marketing and technical support is based in the corporate headquarters located in West Lafayette, Indiana.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have a network of 11&#160;established distributors covering Japan, the Pacific Basin, South America, the Middle East, India, South Africa and Eastern Europe. All of our distributor relationships are managed from the corporate headquarters in West Lafayette, Indiana.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Contractual Arrangements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our service contracts typically establish an estimated fee to be paid for identified services. In most cases, some percentage of the contract costs is paid in advance. While we are performing a contract, clients often adjust the scope of services to be provided based on interim project results. Fees are adjusted accordingly. Generally, our fee-for-service contracts are terminable by the client upon written notice of 30 days or less for a variety of reasons, including the client's decision to forego a particular study, the failure of product prototypes to satisfy safety requirements, and unexpected or undesired results of product testing. Cancellation or delay of ongoing contracts may result in fluctuations in our quarterly and annual results. We are generally able to recover at least our invested costs when contracts are terminated.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our products business offers annual service agreements on most product lines.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Backlog</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The contracts pursuant to which we provide our services are terminable upon written notice of 30 days or less.&#160; We maintain projections based on bids and contracts to optimize asset utilization. We have increased the use of sales forecasts in manufacturing our products, with the result that we rarely have a significant backlog for Products. For Services, backlog generally includes work to be performed under signed agreements (i.e.,&#160;contracts and letters of intent). Once work under a signed agreement begins, net revenues are recognized over the life of the project.&#160; Some of our studies and projects are performed over an extended period of time, which may exceed several years. We maintain an order backlog to track anticipated net revenues yet to be earned for work that has not been performed.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="page_ca16501_1_6"><!--EFPlaceholder--></a>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Although backlog can provide meaningful information to our management with respect to a particular study, we believe that our backlog for Services as of any date is not necessarily a meaningful indicator of our future results for a variety of reasons. Studies vary in duration; the scope of studies may change, which may either increase or decrease their value; and studies may be terminated, or delayed at any time by the client or regulatory authorities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Competition</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Services</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We compete with in-house research, development, quality control and other support service departments of pharmaceutical and biotechnology companies. There are also full-service Contract Research Organizations ("CROs") that compete in this industry. Several of our competitors have significantly greater financial resources than we do. The largest CRO competitors offering similar research services include:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Covance, Inc.;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pharmaceutical Product Development, Inc.;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Charles River Laboratories, Inc.;</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">29</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Parexel; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MDS Health Group Ltd.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CROs generally compete on the basis of:</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">regulatory compliance record;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">reputation for on-time quality performance</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">quality system;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">previous experience;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">medical and scientific expertise in specific therapeutic areas;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">scientist-to-scientist relationships;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">quality of contract research;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">financial viability;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">database management;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">statistical and regulatory services;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ability to recruit investigators;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ability to integrate information technology with systems to optimize research efficiency;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">quality of facilities;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">an international presence with strategically located facilities; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">price.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Products</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Founded as a provider of instrumentation and products utilized in life and physical sciences research laboratories, we continue to serve these product niches today.&#160; Though many global analytical instruments competitors exist, we have an extensive, long standing network of customers who are repeat buyers and recommend our products.&#160; In contrast, there are few competitors for our <font style="DISPLAY: inline; FONT-STYLE: italic">in vivo</font> sampling products.&#160; The primary markets are large and small pharmaceutical researchers.&#160; Our differentiators are high quality, flexibility to meet customers&#8217; specific needs and superior technical support and service.&#160; We provide equipment that enables our customers to attain premium scientific laboratory information on a reasonable operating investment.&#160; As customers&#8217; needs constantly change, we continually invest in the refinement of our products and in new product opportunities that meet our operating objectives.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Government Regulation</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are subject to various regulatory requirements designed to ensure the quality and integrity of our data and products. These regulations are promulgated primarily under the Federal Food, Drug and Cosmetic Act, and include Good Laboratory Practice ("GLP"), Good Manufacturing Practice ("GMP"), and Good Clinical Practice ("GCP") guidelines administered by the FDA. The standards of GLP, GMP, and GCP are required by the FDA and by similar regulatory authorities around the world. These guidelines demand rigorous attention to employee training; detailed documentation; equipment validation; careful tracking of changes and routine auditing of compliance. Noncompliance with these standards could result in disqualification of project data collected by the Company. Material violation of GLP, GMP, or GCP guidelines could result in regulatory sanctions and, in severe cases, could also result in a discontinuance of selected operations.&#160; Since October 2004, we have been audited, on a routine basis, by the FDA and UK&#8217;s MHRA fifteen times. The FDA has visited five times in West Lafayette, and twice each at the UK, Oregon, and Evansville locations. MHRA has visited the UK facility four times. Of the eleven FDA audits, five were without findings.&#160; Where the FDA had findings, which have not been significant to our operations, we have taken actions to address the findings.&#160; The UK facility was found to be compliant with GLP and GCP.&#160;</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have not experienced any significant problems to date in complying with the regulations of such agencies and do not believe that any existing or proposed regulations will require material capital expenditures or changes in our method of operation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Analytical Services</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Laboratories that provide information included in INDs, NDAs and PLAs must conform to regulatory requirements that are designed to ensure the quality and integrity of the testing process. Most of our contract research services are subject to government standards for laboratory practices that are embodied in guidelines for GLP. The FDA and other regulatory authorities require that test results submitted to such authorities be based on studies conducted in accordance with GLP. These guidelines are set out to help the researcher perform work in compliance with a pre-established plan and standardized procedures. These guidelines include but are not restricted to:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font>&#160; &#160; &#160;Resources &#8211; organization, personnel, facilities and equipment</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font>&#160; &#160; &#160;Rules &#8211; protocols and written procedures</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font>&#160; &#160; &#160;Characterization &#8211; test items and test systems</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font>&#160; &#160; &#160;Documentation &#8211; raw data, final report and archives</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font>&#160; &#160; &#160;Quality assurance unit &#8211; formalized internal audit function</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We must also maintain reports for each study for specified periods for auditing by the study sponsor and by the FDA or similar regulatory authorities in other parts of the world. Noncompliance with GLP can result in the disqualification of data collected during the preclinical trial.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">30</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Preclinical Services</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><a name="Page37"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our animal research facilities are subject to a variety of federal and state laws and regulations, including The Animal Welfare Act and the rules and regulations enforced by the United States Department of Agriculture ("USDA") and the National Institutes of Health ("NIH"). These regulations establish the standards for the humane treatment, care and handling of animals by dealers and research facilities. Our animal research facilities maintain detailed standard operating procedures and other documentation necessary to comply with applicable regulations for the humane treatment of the animals in our custody. Besides being licensed by the USDA as a research facility, we are also accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International ("AAALAC") and have registered assurance with the NIH.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 35pt"></font>Quality Assurance and Information Technology</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To assure compliance with applicable regulations, we have established quality assurance programs at our facilities that audit test data, train personnel and review procedures and regularly inspect facilities. In addition, FDA regulations and guidelines serve as a basis for our Standard Operating Procedures (&#8220;SOPs&#8221;) where applicable. On an ongoing basis, we endeavor to standardize SOPs across all relevant operations. In addition, we have both developed and purchased software to ensure compliant documentation, handling and reporting of all laboratory-generated study data. In fiscal 2004, we purchased similar 21 CFR Part 11 (FDA guidelines on electronic records and electronic signatures that define the criteria under which electronic records and electronic signatures are considered to be trustworthy, reliable and equivalent to paper records) compliant software for our preclinical research group.&#160; At the end of fiscal 2010, the majority of our laboratory operations in the U.S. were fully in compliance with 21 CFR Part 11, in our analytical, bioanalytical, toxicology, lab information management, and document management systems. Systems compliant with 21 CFR Part 11 were formally validated and released for use in regulated studies.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We manage our business systems through the use of an Enterprise Resource Planning ("ERP") system. We are continually refining and adjusting our ERP system to improve efficiency, provide better management tools and address changes in our business.&#160; These changes are appropriately documented and tested before implementation.&#160; We also test these systems in connection with management&#8217;s annual review of our internal control systems.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Controlled, Hazardous, and Environmentally Threatening Substances</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Some of our development and testing activities are subject to the Controlled Substances Act administered by the Drug Enforcement Agency ("DEA"), which strictly regulates all narcotic and habit-forming substances. We maintain restricted-access facilities and heightened control procedures for projects involving such substances due to the level of security and other controls required by the DEA. In addition, we are subject to other federal and state regulations concerning such matters as occupational safety and health and protection of the environment.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our U.S. laboratories are subject to licensing and regulation under federal, state and local laws relating to hazard communication and employee right-to-know regulations, the handling and disposal of medical specimens and hazardous waste, as well as the safety and health of laboratory employees. All of our laboratories are subject to applicable federal and state laws and regulations relating to the storage and disposal of all laboratory specimens, including the regulations of the Environmental Protection Agency, the Department of Transportation, the National Fire Protection Agency and the Resource Conservation and Recovery Act. Although we believe that we are currently in compliance in all material respects with such federal, state and local laws, failure to comply could subject us to denial of the right to conduct business, fines, criminal penalties and other enforcement actions.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The regulations of the U.S. Department of Transportation, the U.S. Public Health Service and the U.S. Postal Service apply to the surface and air transportation of laboratory specimens. Our laboratories also comply with the International Air Transport Association regulations which govern international shipments of laboratory specimens. Furthermore, when materials are sent to a foreign country, the transportation of such materials becomes subject to the laws, rules and regulations of such foreign country.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Safety</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to comprehensive regulation of safety in the workplace, the Occupational Safety and Health Administration has established extensive requirements relating to workplace safety for health care employers whose workers may be exposed to blood-borne pathogens such as HIV and the hepatitis B virus. These regulations, among other things, require work practice controls, protective clothing and equipment, training, medical follow-up, vaccinations and other measures designed to minimize exposure to chemicals, and transmission of blood-borne and airborne pathogens. Furthermore, relevant employees receive initial and periodic training focusing on compliance with applicable hazardous materials regulations and health and safety guidelines.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>HIPAA</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The U.S. Department of Health and Human Services has promulgated final regulations under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") that govern the disclosure of confidential medical information in the United States. We have had a global privacy policy in place since January 2001 and believe that we are in compliance with the current European Union and HIPAA requirements. We continue to monitor our compliance with these regulations, and we intend to take appropriate steps to ensure compliance as these and other privacy regulations are revised or come into effect.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Product Liability and Insurance</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We maintain product liability and professional errors and omissions liability insurance, providing approximately $3.0 million in coverage on a claims-made basis. Additionally, in certain circumstances, we seek to manage our liability risk through contractual provisions with clients requiring us to be indemnified by the client or covered by the client&#8217;s product liability insurance policies. Also, in certain types of engagements, we seek to limit our contractual liability to clients to the amount of fees received. The contractual arrangements are subject to negotiation with clients, and the terms and scope of such indemnification, liability limitation and insurance coverage vary by client and project.<a name="Page38"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">31</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research and Development</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In fiscal 2010 and 2009, we spent $546,000 and $762,000, respectively, on research and development. Separate from our contract research services business, we maintain applications research and development to enhance our products business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Expenditures cover hardware and software engineering costs, laboratory supplies, labor, prototype development and laboratory demonstrations of new products and applications for those products.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intellectual Property</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We believe that our patents, trademarks, copyrights and other proprietary rights are important to our business and, accordingly, we actively seek protection for those rights both in the United States and abroad. Where we deem it to be an appropriate course of action, we will vigorously prosecute patent infringements. We do not believe, however, that the loss of any one of our patents, trademarks, copyrights or other proprietary rights would be material to our consolidated revenues or earnings.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We currently hold three federally registered trademarks, as well as one copyright registration for software. We also have two pending patents, one on the Dried Blood Spot (DBS) sampling card for the Culex Automated Blood Sampling Instrumentation and the second for the No Blood Waste technology also for the Culex instrument. The former (DBS) reduces the cost of bio-sample collection, shipment and storage and the latter is important for precisely sampling of bio-fluids of very small volume from animals such as mice. We also generate client value through continuing client support, hardware and software upgrades, system reliability and accuracy. In addition to these formal intellectual property rights, we rely on trade secrets, unpatented know-how and continuing applications research which we seek to protect through means of reasonable business procedures, such as confidentiality agreements. We believe that the greatest value that we generate for our clients comes from these trade secrets, know-how and applications research.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Environmental Compliance</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are subject to certain requirements and potential liabilities under foreign, national, regional and municipal environmental laws, ordinances and regulations.&#160; We may generate certain wastes that may be deemed hazardous or toxic under applicable environmental laws, and we from time to time have incurred, and in the future may incur, costs relating to compliance with environmental laws.&#160; Although we may incur remediation and other environmental-related costs during the ordinary course of operations, management anticipates that such costs will not have a material adverse effect on our operations or financial condition.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Raw Materials</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There are no specialized raw materials that are particularly essential to our business.&#160; We have a variety of alternative suppliers for our essential components.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Employees</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At September 30, 2010, we had 233 full-time employees and 15 part-time employees. All employees enter into confidentiality agreements intended to protect our proprietary information. We believe that our relations with our employees are good. None of our employees are represented by a labor union. Our performance depends on our ability to attract and retain qualified professional, scientific and technical staff. The level of competition among employers for skilled personnel is high. We believe that our employee benefit plans enhance employee morale, professional commitment and work productivity and provide an incentive for employees to remain with the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investor Information</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We file various reports with, or furnish them to, the Securities and Exchange Commission (the &#8220;SEC&#8221;), including our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to such reports.&#160; These reports are available free of charge upon written request or by visiting <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.BASInc.com/invest</font>.&#160; The information on our website is not part of this prospectus.&#160; Other media inquiries and requests for reports or investor&#8217;s kits should be directed to:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Corporate Communications Director, Corporate Center</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>2701 Kent Avenue, West Lafayette, IN&#160; 47906&#160; &#160;USA</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inquiries from shareholders, security analysts, portfolio managers, registered representatives and other interested parties should be directed to:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>BASi Investor Relations, NASDAQ:&#160; BASi</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Phone 765-463-4527, Fax 765-497-1102,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">basi@BASInc.com</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.BASInc.com</font></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">32</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Properties</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We operate in the following locations, all of which we own, except as otherwise indicated:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Our principal executive offices</font> are located at 2701 Kent Avenue, West Lafayette, Indiana 47906, and constitute multiple buildings with approximately 117,000 square feet of operations, manufacturing, and administrative space. Both the services segment and the products segment conduct operations at this facility. The buildings have been financed by mortgages.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">BAS Evansville Inc</font>., is in Evansville, Indiana. We<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>occupy 10 buildings with roughly 92,000 square feet of operating and administrative space on 52 acres. Most of this site is engaged in preclinical toxicology testing of developmental drugs in animal models. A recent addition was financed by a mortgage.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Bioanalytical Systems, Ltd.</font> is in Warwickshire, UK.&#160; This facility contains our contract services and instruments operations for laboratories, sales and technical support services in the U.K.&#160; During fiscal 2008, we moved into a newly constructed laboratory space in the same office park as the previous leased space.&#160; Our space of approximately 8,000 square feet is leased and is specifically designed for laboratory use and will allow us to potentially double capacity over the previous space.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">BASi Northwest Laboratory </font>is in McMinnville, Oregon, approximately 40 miles from Portland. We lease roughly 8,600 square feet of laboratory and administrative space, principally used for bioanalytical services.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We believe that our facilities are adequate for our operations and that suitable additional space will be available if and when needed.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Management</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Executive Officers</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table illustrates information concerning the persons who serve as our executive officers. Except as indicated in the following paragraphs, the principal occupations of these persons have not changed in the past three years.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Name</font></font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Age</font></font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="54%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Position</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Anthony S. Chilton, Ph.D.</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="54%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President, Chief Executive Officer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Michael R. Cox</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">63</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="54%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vice President, Finance; Chief Financial and Administrative Officer; Treasurer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alberto Hidalgo</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="54%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vice President, Business Development and Marketing</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Craig S. Bruntlett, Ph.D.</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61</font></div>
</td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="54%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Senior Vice President, Instruments Division</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lina L. Reeves-Kerner</font></div>
</td>
<td align="left" valign="top" width="4%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">59</font></div>
</td>
<td align="left" valign="top" width="4%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></div>
</td>
<td align="left" valign="top" width="54%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Senior Vice President, Human Resources</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Anthony S. Chilton, Ph.D.</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>was named as the Chief Executive Officer, effective May 13, 2010.&#160; Dr. Chilton had previously served as Chief Operating Officer since December 1, 2008 and interim President since January 27, 2010.&#160; Dr. Chilton has over 30 years of experience as a scientist and executive in leading life sciences companies in England, Canada and the United States.&#160; For the two years prior to joining the Company, Dr. Chilton was in charge of early development programs at Atherogenics, Inc., a private pharmaceutical company,&#160; of Alpharetta, Ga.&#160; In the two years prior to that, Dr. Chilton provided consulting and advisory services to various pharmaceutical companies.&#160; Prior to that, he was Vice President of the Biopharmaceutical Development Division of Cardinal Health Inc., a major supplier of distribution and scientific services to pharmaceutical companies, which he joined through a predecessor company in 1998 that was acquired by Cardinal in 2002. Previously, Dr. Chilton spent three years with life sciences companies in Canada, prior to which he held positions in his native United Kingdom.&#160; Dr. Chilton received his bachelor&#8217;s degree in Chemistry from the University of East Anglia in 1981, and his Ph.D. in Analytical Chemistry from the University of Hertfordshire in 1993.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Michael R. Cox</font> has been Vice President, Finance, Chief Financial Officer and Treasurer since April 2004. In October 2007, he assumed the additional duties of Chief Administrative Officer.&#160; He was Vice President, Finance and CFO of Integrity Pharmaceutical Corporation, a private specialty pharmaceutical company, from October 2003 until its acquisition and merger in March 2004. Prior to that he was Senior Vice President, Finance of Intergen Company, a private biotech manufacturing and research products company, from 1997 until its acquisition in 2001, and continued with the acquirer, Serologicals Corporation, also a manufacturing and research products company, on special projects until joining Integrity. Prior to that, Mr. Cox held various executive positions in two environmental services firms and an investment firm. He was a partner in Touche Ross &amp; Co., an international CPA firm, where he began his career after obtaining a BS in business administration from the University of North Carolina.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Alberto Hidalgo</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>was hired as the Vice President of Business Development and Marketing, effective August 18, 2010.&#160; Mr. Hidalgo has over 15 years of senior-level sales experience in both domestic and international markets. From 2009 to 2010, he was Director of Financial Investigations for the Indiana Gaming Commission, the state agency that assesses casino applications.&#160; During that time period, he also consulted independently with companies to develop and implement new sales and marketing strategies. From 2005 to 2009, he served as Area Director of Sales with Covance Central Laboratory Services, a large Contract Research Organization.&#160; For more than ten years prior to that, he held various positions at Eli Lilly and Company, a major pharmaceutical company, including Director of Sales, for Eli Lilly Export, Puerto Rico.<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Mr. Hidalgo has a bachelor of science in chemical engineering from Rutgers University, and an MBA from the University of Michigan.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">33</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page40"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Craig S. Bruntlett, Ph.D.</font> has been Senior Vice President of the Instruments Division since September 2005. From 1999 to 2005, he was Senior Vice President of International Sales.&#160; From 1992 to 1999 he was Vice President, Electrochemical Products. From 1980 to 1990, Dr. Bruntlett was Director of New Products Development for the Company. Dr. Bruntlett has a Bachelor of Arts degree in Chemistry and Mathematics from St. Cloud State University in Minnesota and a Ph.D. in Chemistry from Purdue University.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Lina L. Reeves-Kerner</font> has been Vice President, Human Resources since 1995 and is responsible for the administrative support functions of the Company, including shareholder relations, human resources and community relations. From 1980 to 1990, Ms. Reeves-Kerner served as an Administrative Assistant with the Company. Ms. Reeves-Kerner has a Bachelor of Science degree in Business Administration from Indiana Wesleyan University.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following information concerns the persons who serve as the non-employee directors of the Company. Each of such directors is &#8220;independent&#8221; as such term is defined in the listing standards of The NASDAQ Stock Market and the applicable rules of the SEC.&#160; Except as indicated in the following paragraphs, the principal occupations of these persons have not changed in the past five years.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Name</font></font></div>
</td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Age</font></font></div>
</td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Position</font></font></div>
</td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="45%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Board&#160;Committees</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">John B. Landis, Ph.D.</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">58</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Chairman</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Compensation; Nominating</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Larry S. Boulet</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Audit</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David W. Crabb, M.D.</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">57</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Audit; Compensation; Nominating</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David L. Omachinski</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">58</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Audit</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="26%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">A. Charlene Sullivan, Ph.D.</font></div>
</td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></div>
</td>
<td align="left" valign="top" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61</font></div>
</td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></div>
</td>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font></div>
</td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Audit</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">John B. Landis, Ph.D.</font> was elected as a director of the Company on November 12, 2009 and elected as the Chairman of the Board on February 11, 2010.&#160; Dr. Landis retired from his position as Senior Vice President, Pharmaceutical Sciences of Schering-Plough, a major pharmaceutical company, in October 2008 and is currently an Adjunct Professor at Purdue University's Department of Chemistry.&#160; Prior to joining Schering-Plough in 2003, Dr. Landis served as Senior Vice President, Preclinical Development at Pharmacia Corporation, a pharmaceutical company, from 1997 to 2003.&#160; Prior to that, Dr. Landis held various positions with The Upjohn Company, a pharmaceutical company, and its subsidiaries.&#160; Dr. Landis also serves on the boards of the Metabolic Solutions Development Company, a private therapeutic development company, and on the Science Advisory Board of the Southwest Michigan Venture Capital Fund.&#160; Dr. Landis received his Bachelor of Science in Chemistry from Kent State University, his Masters in Analytical Chemistry from Purdue University and his Ph.D. in Analytical Chemistry from Purdue University.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Larry S. Boulet</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>has served as a director of the Company since May 2007.&#160; Mr. Boulet was a Senior Audit Partner with PricewaterhouseCoopers (PwC), an international CPA firm, and a National Financial Services Industry Specialist.&#160; For the last five years of his career with PwC, Mr. Boulet served as Partner-in-charge of the Indianapolis office&#8217;s Private Client Group.&#160; Prior to serving on our Board, he served on the Board of Directors of Century Realty Trust, an Indiana based, real estate investment trust.&#160; He also served as Audit Committee Chairman until the Trust&#8217;s sale and liquidation in 2007.&#160; Currently, Mr. Boulet also serves on the Indiana State University Foundation Board of Directors, where he is a past Chairman of the Board.&#160; He holds a Bachelor of Science degree in Accounting from Indiana State University.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">David W. Crabb, M.D.</font> has served as a director of the Company since February, 2004. He has been Chairman of the Indiana University Department of Medicine since 2001. He has been a member of the faculty of the Departments of Medicine and Biochemistry and Molecular Biology since 1983.&#160; He served as Vice Chairman for Research for the department and as an Assistant Dean for Research from 1993 to 2000. Dr. Crabb is the Director of the Indiana Alcohol Research Center, serves on several editorial boards and is a member of the Boards of Directors of Polymer Technology Systems, Inc., The Regenstrief Institute, and the Health and Hospital Corporation of Marion County. He was a recipient of a NIH Merit award and numerous other research and teaching awards.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">David L. Omachinski</font> was elected as a director of the Company on October 8, 2009.&#160; Mr. Omachinski is currently an executive management consultant.&#160; From 1993 to 2005, he served in various executive management positions with Oshkosh B'Gosh, Inc., a publicly-held children&#8217;s clothing manufacturer, including President, Chief Operating Officer, Chief Financial Officer, Vice President of Finance and Treasurer.&#160; Mr. Omachinski also previously held various executive roles with Schumaker, Romenesko &amp; Associates, S.C., a Wisconsin-based, full service, regional accounting firm. Mr. Omachinski also&#160;serves&#160;on the board of Anchor Bancorp Wisconsin, Inc., a publicly traded savings and loan holding company ("Anchor Bancorp"), since&#160;2002,&#160;and&#160;its wholly owned subsidiary, AnchorBank, FSB (the "Bank"),&#160;since 1999, the University of Wisconsin-Oshkosh Foundation since 2003, and Chamco, Inc. (a non-profit regional development organization) since 2002.&#160; Mr. Omachinski received his Bachelor of Business Administration from the University of Wisconsin-Oshkosh and is a certified public accountant.&#160; Mr. Omachinski is the Chairman of the Board of Directors and Chair of the Audit Committee of Anchor Bancorp.&#160; On June 26, 2009, Anchor Bancorp&#160;and the&#160;Bank each consented to the issuance of an Order to Cease and Desist (together, the "Orders") by the Office of Thrift Supervision (the "OTS"). The Orders&#160;require&#160;Anchor Bancorp and its directors, officers and employees to cease and desist from engaging in any unsafe and unsound&#160;practices that resulted in the operation of Anchor Bancorp&#160;with insufficient liquidity and earnings and an inadequate level of capital for its risk profile or the Bank operating at a loss, with a large volume of adversely classified assets, or with an inadequate level of capital for the kind and quality of assets held.&#160; The Orders require Anchor Bancorp and the Bank to notify, and in some cases receive permission from, the OTS prior to making certain payments, incurring indebtedness, entering into certain contractual arrangements or changing its management or directors.&#160; Further, the Orders require each of Anchor Bancorp and the Bank to submit financial plans to the OTS within a prescribed period of time.&#160; Finally, the Bank must meet and maintain certain core capital and total risk-based capital ratios.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">34</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page41"><!--EFPlaceholder--></a><font style="DISPLAY: inline; FONT-STYLE: italic">A. Charlene Sullivan, Ph.D.</font> was elected as a director of the Company in January 2010.&#160; Dr. Sullivan is an Associate Professor of Management at the School of Management and the Krannert Graduate School of Management at Purdue University since 1984 and has been a faculty member at Purdue since 1978.&#160; Throughout her career at Purdue, Dr. Sullivan has taught undergraduate and graduate classes on corporate finance, financial institutions and markets and financial and managerial accounting and has received numerous awards and honors from the university.&#160; Since 2000, Dr. Sullivan also has served as the Management Faculty Advisor for the Technical Assistance Program at Purdue, which consults with small businesses in Indiana.&#160; In addition, Dr. Sullivan has served as a financial analyst for the Indiana Gaming Commission since 1995 and as a risk management consultant for Edgar Dunn &amp; Company (a strategy and consulting firm) since 1994.&#160; Dr. Sullivan has served on the boards of directors of several private financial institutions and not-for-profit organizations, including the Federal Reserve Bank of Chicago from 1990 until 1996 and the Purdue Employees Federal Credit Union from 1997 until April 2009.&#160; She currently serves on the board of directors of the Greater Lafayette Community Foundation and on the Asset-Liability Committee for the Purdue Employees Federal Credit Union.&#160; Dr. Sullivan earned a B.S. degree in Home Economics from the University of Kentucky and a M.S. and Ph.D. in Management from Purdue University.</font></div></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Committees of the Board of Directors</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board of Directors has established an Audit Committee, a Compensation Committee and a Nominating/Corporate Governance Committee. The Audit Committee is responsible for recommending and approving the Company&#8217;s independent auditors, reviewing, in connection with the independent auditors, the audit plan, the adequacy of internal controls, the audit report and management letter and undertaking such other incidental functions as the board may authorize.&#160; Audit Committee members are not employees of BASi and, in the opinion of the Board of Directors, are &#8220;independent&#8221; (as defined by Rule 4200(a)(15) of the NASD listing standards and Item 7(d)(3)(iv) of Schedule 14A). Larry S. Boulet, David W. Crabb, David Omachinski and A. Charlene Sullivan are the members of the Audit Committee. The Board of Directors has determined that each of Mr. Boulet and Mr. Omachinski is an audit committee financial expert (as defined by Item 401(h) of Regulation S-K).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Compensation Committee is responsible for making recommendations to the Board of Directors with respect to compensation arrangements for the executive officers, policies relating to salaries and job descriptions, insurance programs, benefit programs, including retirement plans, and administration of the 2008 Stock Option Plan.&#160; The Board of Directors has adopted a written charter for the Compensation Committee and for the Audit Committee, which are available on the Company&#8217;s website at <font style="DISPLAY: inline; FONT-STYLE: italic">www.BASInc.com</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Nominating / Corporate Governance Committee is responsible for receiving and reviewing recommendations for nominations to the Board of Directors and recommending individuals as nominees for election to the Board of Directors. Nominating Committee members are not employees of BASi and, in the opinion of the Board of Directors, are &#8220;independent&#8221; (as defined by rule 4200 (a)(15) of the NASD listing standards and Item 7(d)(3)(iv) of Schedule 14A). The Board of Directors has adopted a written charter for the Nominating Committee, which is available on the Company&#8217;s website at <font style="DISPLAY: inline; FONT-STYLE: italic">www.BASInc.com</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board of Directors will consider for nomination as directors persons recommended by shareholders. Such recommendations must be made to the Board of Directors or to an individual director in writing and delivered to Bioanalytical Systems, Inc., Attention: Corporate Secretary, 2701 Kent Avenue, West Lafayette, Indiana 47906, not less than 90 days nor more than 120 days prior to the anniversary date of the prior year&#8217;s annual shareholders meeting. The Secretary will forward all such communications to the addressee.&#160; Nominations must set forth, with respect to the person nominated, such person&#8217;s name, age, business address and residence address, principal occupation or employment, class and number of shares of BASi which are owned beneficially or of record by the person, and any other information relating to the person that would be required to be </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.&#160; The shareholder making this proposal must state his, her or its name and record address, the class and number of shares of BASi which he, she or it owns beneficially or of record, a description of all arrangements or understandings between such shareholder and each proposed nominee and any other person or persons (including their names) pursuant to which the nomination(s) are to be made by such shareholder, a representation that such shareholder intends to appear in person or by proxy at the meeting to nominate the persons named in its notice, and any other information relating to such shareholder that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.&#160; Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee and to serve as a director if elected.&#160; The Chair of the Nominating/Corporate Governance Committee or his or her designee shall have the authority to determine whether a nomination is properly made.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There is no fixed process for identifying and evaluating potential candidates to be nominees for directors, and there is no fixed set of qualifications that must be satisfied before a candidate will be considered. Rather, the Nominating Committee has the flexibility to consider such factors as it deems appropriate. These factors may include education, diversity, experience with business and other organizations comparable with BASi, the interplay of the candidate&#8217;s experience with that of other members of the Board of Directors, and the extent to which the candidate would be a desirable addition to the Board of Directors and to any of the committees of the Board of Directors. The Nominating Committee will evaluate nominees for directors submitted by shareholders in the same manner in which it evaluates other director nominees.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="FIS_STOCKHOLDER_PROPOSALS"><!--EFPlaceholder--></a>Family Relationships</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There&#160;are no family relationships among the directors and executive officers of BASi.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain Relationships and Transactions</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board reviews transactions with related parties, but has no formal policies in place with respect to such review or the approval of such transactions. There were no transactions with related parties in fiscal 2010 or fiscal 2011 through the date of this prospectus.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">35</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Executive and Director Compensation</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Executive Officer Compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page42"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Compensation Committee and Compensation Methodology</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the 2010 fiscal year, the Compensation Committee of the Board was responsible for administering the compensation and benefit programs for BASi's team members, including the executive officers. Historically, the Compensation Committee annually reviewed and evaluated cash compensation and stock option award recommendations along with the rationale for such recommendations, as well as summary information regarding the aggregate compensation, provided to BASi's executive officers. The Compensation Committee examined these recommendations in relation to BASi's overall objectives and made compensation recommendations to the Board for final approval. The Compensation Committee also historically sent to the Board for approval its recommendations on compensation for the Chairman of the Board and the President and Chief Executive Officer, who do not participate in the decisions of the Board as to their compensation packages. Neither the Chairman of the Board nor the President and Chief Executive Officer was a member of the Compensation Committee during the 2010 fiscal year.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi has not hired a compensation consultant to review its compensation practices. The compensation of BASi's executives who were employees as of September 30, 2007 was frozen by the Compensation Committee at the 2008 compensation level through fiscal 2010 as part of the effort to return the Company to profitability, except for the amended employment agreement with Dr. Chilton as discussed below.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi's executive compensation practices are also affected by the highly competitive nature of the biotechnology industry and the location of BASi's executive offices in West Lafayette, Indiana. The fact that West Lafayette, Indiana is a small city in a predominantly rural area can present challenges to attracting executive talent from other industries and parts of the country. However, the favorable cost of living in this area and the small number of competitive employers in this market, enable the Company to pay generally lower salaries for comparable positions than others in its industry. The Company has also recruited a number of key employees from Purdue University, particularly for scientific and technical responsibilities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Compensation Committee, in collaboration with management, is in the process of reviewing the compensation structure of the Company in order to provide the proper incentives and necessary retention of key employees, including the named executive officers, to achieve financial success and an appropriate return to shareholders. These efforts will be ongoing in the current fiscal year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company intends to develop compensation packages for BASi's executive officers that meet each of the following three criteria: (1)&#160;compensation levels competitive with companies of similar size and performance to BASi; (2)&#160;performance-based "at risk" pay that is based on both short- and long-term goals; and (3)&#160;shareholder-aligned incentives that are structured to create alignment between the shareholders and executives with respect to short- and long-term objectives.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Fiscal 2010 Summary Compensation Table</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following narrative, tables and footnotes describe the "total compensation" earned during BASi's 2010 fiscal year by each person who served as the chief executive officer of BASi at any time during fiscal 2010 and the next two most highly compensated executive officers of BASi who earned more than $100,000 in fiscal 2010.&#160; We call these people our named executive officers, or NEOs. The total compensation presented below does not reflect the actual compensation received by BASi's NEOs or the target compensation of BASi's NEOs during its 2010 fiscal year because there was no value realized by BASi's NEOs during its 2010 fiscal year from long-term incentives (exercise of options).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The individual components of the total compensation calculation reflected in the Summary Compensation Table are broken out below:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Salary.</font> Base salary earned during BASi's 2010 fiscal year. The terms of the Employment Agreements governed the base salary for Dr. Chilton and Mr. Cox.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Bonus.</font> The amounts presented as bonuses for Dr. Chilton below represent a sign on bonus paid in two equal installments per the employment agreement in fiscal 2009 and an accrued cash bonus of 2% of EBITDA per the amended employment agreement in fiscal 2010.&#160; No other bonuses were paid or accrued in fiscal 2009 or 2010.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Option Awards</font><font style="DISPLAY: inline; FONT-STYLE: italic">.</font> The awards disclosed under the heading "Option Awards" consist of the aggregate grant date fair value of the stock option awards granted in fiscal 2010 in accordance with FASB ASC 718. The grant date fair value of the option awards may vary from the actual amount ultimately realized by the NEO based on a number of factors. The factors include BASi's actual operating performance, common share price fluctuations, differences from the valuation assumptions used, the restricted nature of shares acquired under non-qualified stock option grants, the limited liquidity in the trading of the Company&#8217;s shares and the timing of exercise or applicable vesting.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Company Contributions to 401(k)</font><font style="DISPLAY: inline; FONT-STYLE: italic">.&#160; </font>Amounts paid by the Company on behalf of the NEO for matching contributions to a Company qualified 401(k) plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">All Other Compensation</font><font style="DISPLAY: inline; FONT-STYLE: italic">.</font> The amounts included under the All Other Compensation are described in the footnotes to the table.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="26" nowrap valign="bottom" width="99%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SUMMARY&#160;COMPENSATION&#160;TABLE</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Name&#160;and&#160;principal&#160;position</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Year</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Salary&#160;($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Bonus&#160;($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Option&#160;Awards</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(1)&#160;($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Company</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Contributions&#160;to</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">401(k)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">All&#160;Other</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Compensation</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Total&#160;($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Richard M. Shepperd,</font></font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="30%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">President &amp; Chief</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">285,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">3,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">9,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(3)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">297,010</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="30%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Executive Officer (2)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">90,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">130,036</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(4)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">220,036</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Anthony S. Chilton, Ph.D.,</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="30%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">President, Chief Executive</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">195,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">10,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(7)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">79,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(9)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">284,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="30%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Officer; Director (5)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">227,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(6)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">32,403</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(8)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">121,100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(10)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">28,667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(11)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">409,370</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="30%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Michael R. Cox, Vice</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="30%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">President, Finance and</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">165,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">1,900</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">166,900</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="30%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Chief Financial Officer (12)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">165,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">22,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(13)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">187,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">36</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160; Aggregate grant date fair value of the stock option awards granted in fiscal years 2010 and 2009 in accordance with FASB ASC Topic 718.&#160; There were three stock option grants to an NEO in fiscal 2010 and three grants to an NEO in fiscal 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2) On January 27, 2010, Mr. Shepperd retired as President of the Company and retired as Chief Executive Officer and as a director of the Company on February 12, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3) Housing allowance of $1,000 per month per amended employment agreement with Mr. Shepperd executed on January 12, 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4) Retirement payment approved by the Board of Directors upon Mr. Shepperd&#8217;s retirement of $120,000 plus a housing allowance of $1,000 per month per amended employment agreement with Mr. Shepperd executed on January 12, 2009, plus vacation payout of $5,536 for vacation accrued up to his retirement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5) Dr. Chilton was hired on December 1, 2008, during fiscal 2009.&#160; On January 27, 2010, Dr. Chilton was elected as the interim President of the Company.&#160; On May 13, 2010, Dr. Chilton was elected as President and Chief Executive Officer of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(6) Per amendment to the employment agreement executed on February 1, 2010, Dr. Chilton&#8217;s base salary was increased to $19,105 per month for the months in which he served as the Interim President of the Company.&#160; His base salary was increased again to $21,188 per month when, on May 13, 2010, he was elected as the President and Chief Executive Officer of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(7)&#160; Sign-on bonus in two installments of $5,000 each, paid on March 15, 2009 and July 15, 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(8)&#160; EBITDA bonus per amended employment agreement accrued in fiscal 2010, paid in fiscal 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(9)&#160; Grant date fair value of new grant on December 1, 2008 for 30,000 options on common shares, vesting in equal installments beginning December 1, 2009 and each successive year through December 1, 2011.&#160; As of January 31, 2011, 20,000 option shares have vested and are exercisable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(10)&#160; Grant date fair value of two new grants in fiscal 2010.&#160; The first grant was on February 1, 2010 for 25,000 options on common shares, vesting evenly beginning January 31, 2011 and each successive year through January 1, 2013.&#160; The second grant was on May 12, 2010 for 125,000 options on common shares, vesting evenly beginning on January 31, 2011 and each successive year through January 31, 2013.&#160; As of January 31, 2011, 50,000 option shares have vested and are exercisable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(11)&#160; $600 monthly car allowance and reimbursement of reasonable living and travel expenses per amended employment agreement with Dr. Chilton signed on February 1, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(12)&#160; Effective October 4, 2007, Mr. Cox also assumed the responsibilities of Chief Administrative Officer. In April, 2010, as discussed above, Mr. Cox entered into a new employment agreement and was awarded additional stock option grants.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(13)&#160; Grant date fair value of new grant on April 15, 2010 for 20,000 options on common shares, vesting in equal installments beginning April 15, 2011 and each successive year through April 15, 2013.&#160; As of January 31, 2011, no shares have vested and are exercisable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Outstanding Equity Awards at Fiscal Year-End Table</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi has awarded stock options to members of its senior management and other BASi team members. The terms of these awards typically provide for vesting over a defined period of time. Option awards generally have a four-part vesting schedule in which the first of the four installments vests on the second anniversary of the grant date. Each subsequent one-fourth installment thereafter vests on the anniversary of the grant date for the next three years: however, the Compensation Committee and the Board has to ability to alter, and occasionally does alter, the vesting schedule to meet specific objectives. The options expire if not exercised within ten years from the date of grant.&#160; The following table shows the equity awards granted to BASi's NEOs that were outstanding as of the end of BASi's 2010 fiscal year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="15" nowrap valign="bottom" width="98%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">OUTSTANDING&#160;EQUITY&#160;AWARDS&#160;AT&#160;FISCAL&#160;2010&#160;YEAR-END</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td colspan="15" nowrap valign="bottom" width="98%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">OPTION&#160;AWARDS</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Number&#160;of&#160;Securities&#160;Underlying</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Unexercised&#160;Options</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Name</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(#)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Exercisable</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(#)</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Unexercisable</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Option&#160;Exercise</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Price&#160;($)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Option&#160;Expiration&#160;Date</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Richard M. Shepperd (1)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Anthony S. Chilton, Ph.D.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.53</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">November 30, 2018</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.79</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">January 31, 2020</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">125,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.99</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 11, 2020</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Michael R. Cox</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.58</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.60</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">November 5, 2017</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(6)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 14, 2020</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">37</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr. Shepperd&#8217;s options were forfeited upon retirement.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options on 10,000 shares vested on December 1, 2010 and 10,000 shares vest on December 1, 2011.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options on 8,334 shares vested on January 31, 2011, 8,333 shares vest on January 31, 2012 and 8,333 shares vest on January 31, 2013.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options on 41,666 shares vested on January 31, 2011, 41,667 shares vest on January 31, 2012 and 41,667 shares vest on January 31, 2013.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options on 10,000 shares vested on November 5, 2010.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(6)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Options on 6,667 shares vest on April 15, 2011, 6,667 shares vest on April 15, 2012 and 6,666 shares vest on April 15, 2013.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Fiscal 2010 Option Exercises</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">There were no options exercised by NEOs in fiscal 2010.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Employment Agreements and Post-Termination Payments</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi has Employment Agreements with Dr. Chilton and Mr. Cox and had an Employment Agreement with Richard M. Shepperd, our former President and Chief Executive Officer.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><a name="eolPage26"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Employment Agreement with Anthony S. Chilton</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On February 1, 2010, BASi and Dr. Chilton entered into an Amended and Restated Employment Agreement. Under the amended Employment Agreement, the Company extended the term of Dr. Chilton's employment until January 31, 2013. The amended Employment Agreement provides that, during any period Dr. Chilton serves as Interim President of the Company, (a) his base salary will be increased to $19,105 per month, and (b) he will receive a cash bonus equal to two percent (2%) of the consolidated earnings before interest expense, income tax expense, depreciation expense and amortization expense of the Company for that period ("EBITDA Bonus"). In addition to reimbursement of business expenses in accordance with the Company&#8217;s standard reimbursement policies, Dr. Chilton will be entitled to reimbursement for reasonable living expenses in the Lafayette, Indiana area during the term of his employment, and reasonable travel expenses for travel to and from his residence in Alpharetta, Georgia. The Company has also agreed to provide Dr. Chilton a $600 monthly car allowance and certain other benefits consistent with other executive level employees.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On May 13, 2010, Dr. Chilton was elected as President and Chief Executive Officer of the Company.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Employment Agreement provides that if Dr. Chilton becomes the Company's President and Chief Executive Officer, then (i) his base salary will increase to $21,188.33 per month, (ii) he will receive a grant of options to purchase an additional 125,000 common shares of the Company on the date he is elected to those positions and grants of additional options to purchase 25,000 common shares on the first and second anniversaries of the date of the Employment Agreement, (iii) he will continue to earn the EBITDA Bonus, and (iv) he will be elected to the Company's Board of Directors. All of the options will be granted at an exercise price that is equal to the fair market value of the common shares on the date of grant. The options granted on the date of Dr. Chilton's election would vest in three equal installments on January 31, 2011, 2012 and 2013. The options granted in 2011 would vest in two equal installments on January 31, 2012 and 2013 and the options granted in 2012 would vest on January 31, 2013.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;According to the Employment Agreement, if Dr. Chilton's employment is terminated without Cause (as defined in the Employment Agreement) or he resigns for "Good Reason" (as defined in the Employment Agreement), then the Company shall (a) pay Dr. Chilton (i) his current salary through the termination date or resignation date; (ii) all vacation accrued as of the date of resignation or termination, and (iii) all bonuses earned but not paid as of the date of termination or resignation; and (b) pay Dr. Chilton as compensation for loss of office twelve (12) months base salary at the then current salary, provided that such payments shall cease if Dr. Chilton becomes employed during such period.&#160; If Dr. Chilton is terminated for Cause or resigns without Good Reason, the Company will pay Dr. Chilton (x) his earned but unpaid then-current base salary through the date of termination or resignation (y) all vacation accrued as of the date of termination or resignation and (z) all bonuses earned but not paid as of the date of termination or resignation.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Agreement provides that Dr. Chilton could be entitled to severance benefits following the termination of his employment, as is further described below under the heading, &#8220;Change-in Control Agreements.&#8221;</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">38</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Employment Agreement with Michael R. Cox</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page45"><!--EFPlaceholder--></a>On November 6, 2007 BASi entered into an Employment Agreement with Mr. Cox to serve as Vice President, Finance and Administration and Chief Financial Officer of BASi. Pursuant to the terms of the agreement between BASi and Mr. Cox, the agreement has an initial term that ends on December 30, 2010, but this employment term can be extended for successive one year periods unless either BASi or Mr. Cox gives the other party written notice at least 90 days before the end of the term. Mr. Cox will receive a base salary of $165,000 per year in the first year, which may be increased by the Company in the future. Mr. Cox is also eligible for any bonus plans adopted by the Company at the discretion of the Compensation Committee of the Board of Directors.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Agreement provides that Mr. Cox could be entitled to severance benefits following the termination of his employment, as is further described below under the heading, &#8220;Change-in Control Agreements.&#8221; If he is terminated by BASi without "cause", or if Mr. Cox terminates his employment for "good reason" he would be entitled to the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr. Cox&#8217;s base salary, payable monthly for 12 months following termination;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All vacation accrued as of the date of termination;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All bonus amounts earned buy not paid as of the date of termination; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">All salary earned but not paid through the date of termination.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, the non-solicitation provision of Mr. Cox's employment contract will not apply in the event of termination without cause or resignation with good reason.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On April 15, 2010, BASi entered into an Amendment to the Employment Agreement with Mr. Cox.&#160; The Amendment revised the definition of a "Change of Control" to exclude the filing of a Form 13-D with the Securities and Exchange Commission as a triggering event.&#160; The Amendment further stipulates that no event constituting a Change of Control from the filing of Form 13-D prior to the date of the Amendment has occurred or will be asserted.&#160; &#160;Additionally, the term of Mr. Cox's employment was extended until December 30, 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Employment Agreement with Richard M. Shepperd</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 12, 2009, BASi entered into an Amendment to Employment Agreement with Mr. Shepperd.&#160;The Amendment reduced Mr. Shepperd's base salary from $35,000 per month to $20,000 per month.&#160; Partially offsetting this, the Amendment provided for a new housing allowance of $1,000 per month, for a total of $12,000 in calendar 2009.&#160; The Amendment also contemplated that, if a "Change in Control" (as defined in the employment contract) occurs prior to the end of the term of the Agreement, Mr. Shepperd will receive a bonus payment of $201,600.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The agreement provided that Mr. Shepperd could be entitled to certain severance benefits following termination of employment.&#160; If he was terminated by BASi without "cause", or if Mr. Shepperd terminated his employment for "good reason," he would have been entitled to the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr. Shepperd's base salary through December 31, 2009, to be paid monthly;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all vacation accrued as of the date of termination;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all bonus amounts earned but not paid as of the date of termination; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">all salary earned but not paid through the date of termination.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, the non-solicitation provisions of Mr. Shepperd&#8217;s employment contract would not have applied in the event of termination without cause or resignation with good reason.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The agreement further provided that if Mr. Shepperd's employment ended for any reason other than termination without cause or resignation with &#8220;good reason,&#8221; Mr. Shepperd would have received his earned but unpaid salary through the date of termination, all bonus amounts earned but not paid as of the date of termination and all vacation accrued through the date of such termination.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 27, 2010, Mr. Shepperd retired as President of the Company and retired as Chief Executive Officer and as a director of the Company on February 12, 2010.&#160; In connection with Mr. Shepperd's retirement from the Company, the Board of Directors approved a retirement payment to Mr. Shepperd of $120,000, payable in twelve equal monthly installments commencing March 1, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Change-in-Control Agreements</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dr. Chilton&#8217;s and Mr. Cox's Employment Agreements contain a change in control feature. Under these Employment Agreements, if Dr. Chilton or Mr. Cox is &#8220;involuntarily terminated&#8221; for any reason following a change in control, Dr. Chilton or Mr. Cox would receive an amount equal to his monthly base salary for the 12 months prior to termination payable for at least 2 years.&#160; Each would also be eligible for any special bonus program and be eligible to participate in Company sponsored benefits, savings and retirement plans, practices, policies and programs, with the employee contribution paid by the employee.&#160;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="eolPage27"><!--EFPlaceholder--></a><a name="FIS_COMPENSATION_COMMITTEE"><!--EFPlaceholder--></a>&#8220;Involuntarily terminated&#8221; is defined in the Employment Agreements as resulting from a &#8220;change in control&#8221; of the Company, and due to either (1) the elimination or diminution of the Employee&#8217;s position, authority, duties and responsibilities&#160;relative to the most significant of those held, exercised and assigned at any time during the six month period immediately preceding a &#8220;change in control&#8221;; or (2) a change in location requiring the Employee&#8217;s services to be performed at a location other than the location where the Employee was employed immediately preceding a &#8220;change in control,&#8221; other than any office which is the headquarters of the Company and is less than 35 miles from such location.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A "change in control" is defined as (1) approval by shareholders of the Company of (a) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which shares of the Company would be converted into cash, securities or other property, other than a consolidation or merger of the Company in which holders of its common shares immediately prior to the consolidation or merger have substantially the same proportionate ownership of voting common shares of the surviving corporation immediately after the consolidation or merger as immediately before, or (b) a sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all the assets of the Company; (2) a change in the majority of members of the Board of Directors of the Company within a twenty-four (24) month period unless the election, or nomination for election by the Company shareholders, of each new director was approved by a vote of two-thirds (2/3) of the directors then still in office who were in office at the beginning of the twenty-four (24) month period; or (3) the Company combines with another company and is the surviving corporation but, immediately after the combination, the shareholders of the Company immediately prior to the combination do not hold, directly or indirectly, more than fifty percent (50%) of the voting common shares of the combined company (there being excluded from the number of shares held by such shareholders, but not from the voting common shares of the combined company, any shares received by affiliates (as defined in the rules of the SEC) of such other company in exchange for shares of such other company).<a name="Page46"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">39</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-Employee Director Compensation and Benefits</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Non-Employee Director Compensation and Benefits</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi's compensation package for non-employee directors is generally comprised of cash (annual retainers and board and committee meeting fees) and stock option awards. The annual pay package is designed to attract and retain highly-qualified, independent professionals to represent BASi's shareholders and reflect BASi's position in the industry. With the 2008 Stock Option Plan, BASi intended to better align director and shareholder interests through the use of stock option awards to directors. Actual annual pay varies among directors based on Board committee memberships, committee chair responsibilities and meetings attended. BASi has not adopted guidelines with respect to non-employee director ownership of common shares. Directors who are employees, if any, receive no additional compensation for their service on the Board.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Compensation for non-employee directors during the 2010 fiscal year consisted of the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="96%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="85%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Type&#160;of&#160;Compensation</font></font></div>
</td>
<td align="left" valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Amount&#160;($)</font></font></div>
</td>
<td align="left" valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Annual retainer for Board membership</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,300</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Annual retainer for director serving as Chair of the Audit Committee</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Annual retainer for director serving as Chair of the Compensation Committee</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Annual retainer for director serving as Chair of the Nominating Committee</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">500</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Meeting fee for Board meeting, in person</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Meeting fee for Board meeting, by phone</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">500</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Committee meetings, non-Board meeting days, in person</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">500</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Committee meetings, non-Board meeting days, by phone</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">250</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="85%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Daily fee for consultation with management</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,000</font></div>
</td>
<td align="left" valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For meetings of the standing Board committees held in conjunction with a meeting of the Board, no additional fees are paid.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Option Awards</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The amounts disclosed under the heading "Option Awards" in the table below consist of the aggregate grant date fair value of the stock option awards granted in fiscal 2010 in accordance with FASB ASC Topic 718.&#160; The grant date fair value of the option awards may vary from the actual amount ultimately realized based on a number of factors. The factors include BASi's actual operating performance, Common Share price fluctuations, differences from the valuation assumptions used, the limited liquidity in the trading of the Company&#8217;s shares and the timing of exercise or applicable vesting.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Business Expenses</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The directors are reimbursed for their business expenses related to their attendance at BASi meetings, including room, meals and transportation to and from Board and committee meetings. <font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font> Directors are also encouraged to attend educational programs related to Board issues and corporate governance, which are reimbursed by the Company.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">40</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Non-Employee Directors' Compensation Table</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table shows information regarding the compensation of BASi's non-employee directors for the 2010 fiscal year.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;<a name="FIS_UNIDENTIFIED_TABLE_3"><!--EFPlaceholder--></a></font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="16" nowrap valign="bottom" width="99%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">DIRECTOR&#160;COMPENSATION&#160;FOR&#160;FISCAL&#160;2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Name&#160;(4)</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Fees&#160;paid&#160;in</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">cash&#160;($)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Option</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Awards&#160;</font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1)&#160;($)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">All&#160;Other</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Compensation</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">($)(3)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Total&#160;($)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Larry S. Boulet</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,450</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23,695</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David W. Crabb</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Leslie B. Daniels (2)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,504</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,449</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">John B. Landis</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,675</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">227</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14,392</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David L. Omachinski</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,975</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">560</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15,025</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">A. Charlene Sullivan</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,925</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stock option awards granted to non-employee directors on August 16, 2010 with an exercise price of $1.01 per share and grant date fair value of $.849 per share.&#160; Assumptions used in the calculation of the grant date fair value are included in Note 8 in the Notes to Consolidated Financial Statements included elsewhere in this prospectus.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr. Daniels resigned as a director on October 5, 2010.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Reimbursement for travel expenses associated with Board meetings.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total options outstanding for each director at fiscal year end 2010 are as follows:&#160; 10,000 outstanding options for each of Dr. Landis, Mr. Omachinski and Dr. Sullivan; 15,000 outstanding options for each of Mr. Boulet and Mr. Daniels.&#160; Mr. Daniels&#8217; options were subsequently forfeited upon his resignation on October 5, 2010.</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">41</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Principal Shareholders Table</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table shows, as of February 28, 2011, the number of common shares owned by our directors, executive officers named in the Summary Compensation Table below, our current directors and executive officers as a group, and beneficial owners known to us to hold more than 5% of our outstanding common shares. We believe that each individual or entity named has sole investment and voting power with respect to the securities indicated as beneficially owned by such individual, subject to community property laws, where applicable, unless otherwise noted.&#160; As of February 28, 2011, there were 4,915,318&#160;common shares outstanding.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">NAME</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Jointly</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares&#160;/</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Owned</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beneficially</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Peter T. Kissinger (1)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">427,547</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">595,910</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">252,310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,275,767</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Candice B. Kissinger (1)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">252,310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">595,910</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">427,547</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,275,767</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Thomas A. Harenburg (2)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">276,767</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">276,767</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Michael R. Cox (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">87,667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">87,667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Anthony S. Chilton (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">70,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">70,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David L. Omachinski (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Larry S. Boulet (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(6)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David W. Crabb (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,300</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,300</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">John B. Landis (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">A. Charlene Sullivan (3)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="35%" style="TEXT-ALIGN: left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11 Executive Officers and Directors as a group</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">223,886</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">223,886</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">* Less than 0.1%</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1) Dr. and Mrs. Kissinger&#8217;s shares owned beneficially include the shares owned individually by the other spouse and 1,354 shares jointly owned with their children, as set forth in their Schedule 13D filings under the Exchange Act. The address for the Kissingers is 111 Lorene Place, West Lafayette, Indiana 47906.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2) Mr. Harenburg&#8217;s shares owned beneficially include 155,307 shares over which he has sole voting and investment power and 121,460 shares over which he has shared voting and investment power, as set forth in his 13D filings under the Exchange Act.&#160; Mr. Harenburg&#8217;s address is 206 N. Main St., Oshkosh, WI&#160; 54901.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3) Addresses are in care of BASi at 2701 Kent Avenue, West Lafayette, Indiana 47906.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4) Shares owned include 86,667 exercisable stock options.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5) Shares owned include 70,000 exercisable stock options.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(6) Shares owned include 2,500 exercisable stock options.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Equity Compensation Plan</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BASi maintains stock option plans that allow for the granting of options to certain key employees and directors of BASi. The following table gives information about equity awards under the stock option plans of BASi as of December 31, 2010:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Plan&#160;Category</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number&#160;of&#160;Securities&#160;to&#160;be</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Issued&#160;upon&#160;Exercise&#160;of</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding&#160;Options</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted&#160;Average&#160;Exercise</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Price&#160;of&#160;Outstanding</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number&#160;of&#160;Securities&#160;Remaining</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Available&#160;for&#160;Future&#160;Issuance&#160;under</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">the&#160;Equity&#160;Compensation&#160;Plan</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Excluding&#160;Securities&#160;Reflected&#160;in</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First&#160;Column)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="37%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity compensation plans approved by security holders</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">664,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.56</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="37%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity compensation plans not approved by security holders <font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">(1)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">25,000</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="18%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.58</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#160;&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="37%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="37%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">689,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.63</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="18%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">42</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1) Includes option to purchase 25,000 shares at $4.58 granted to Michael R. Cox on April&#160;1, 2004.&#160; This grant is fully vested and expires after 10 years.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For additional information regarding BASi&#8217;s stock option plans, please see Note 8 in the Notes to Consolidated Financial Statements included elsewhere in this prospectus.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Material U.S. Federal Income Tax Considerations</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This is a general summary of the material U.S. federal income tax consequences of the acquisition, ownership and disposition of our units, comprised of convertible preferred shares and warrants, which we refer to collectively as our securities, purchased pursuant to this offering. This discussion assumes that public shareholders will hold our securities as capital assets within the meaning of Section 1221 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). This discussion does not address all aspects of U.S. federal taxation that may be relevant to a public shareholder in light of such public shareholder&#8217;s particular circumstances. In addition, this discussion does not address: (1) U.S. gift or estate tax laws except to the limited extent set forth below, (2) state, local or foreign tax consequences, (3) the special tax rules that may apply to certain public shareholders, including without limitation banks, insurance companies, financial institutions, broker-dealers, taxpayers that have elected mark-to-market accounting, taxpayers subject to the alternative minimum tax provisions of the Code, tax-exempt entities, regulated investment companies, real estate investment trusts, taxpayers whose functional currency is not the U.S. dollar, or U.S. expatriates or former long-term residents of the United States, or (4) the special tax rules that may apply to a public shareholder that acquires, holds, or disposes of our securities as part of a straddle, hedge, wash sale, constructive sale or conversion transaction or other integrated investment. Additionally, this discussion does not consider the tax treatment of partnerships (including entities treated as partnerships for U.S. federal tax purposes) or other pass-through entities or persons who hold our securities through such entities. The tax treatment of a partnership and each partner thereof generally will depend upon the status and activities of the partnership and such partner. Thus, partnerships, other pass-through entities and persons holding our securities through such entities should consult their own tax advisors.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This discussion is based on current provisions of the Code, U.S. Treasury regulations promulgated under the Code, judicial opinions, and published rulings and procedures of the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), all as in effect on the date of this prospectus and all of which are subject to change, possibly with retroactive effect. We have not sought, and will not seek, any ruling from the IRS or any opinion of counsel with respect to the tax consequences discussed below, and there can be no assurance that the IRS will not take a position contrary to the tax consequences discussed below or that any position taken by the IRS would not be sustained.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As used in this &#8220;Material U.S. Federal Income Tax Considerations&#8221; section only, the term &#8220;U.S. Person&#8221; means a person that is, for U.S. federal income tax purposes: (1) an individual citizen or resident of the United States, (2) a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or of any state thereof or the District of Columbia, (3) an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (4) a trust if (A) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. Persons have the authority to control all substantial decisions of the trust, or (B) it has in effect a valid election to be treated as a U.S. Person. As used in this discussion, the term &#8220;U.S. holder&#8221; means a beneficial owner of our securities that is a U.S. Person and the term &#8220;non-U.S. holder&#8221; means a beneficial owner of our securities (other than an entity that is treated as a partnership or other pass-through entity for U.S. federal income tax purposes) that is not a U.S. Person. Each prospective investor is urged to consult its own tax advisors with respect to the U.S. federal, state, local and foreign tax consequences to such investor of the acquisition, ownership and disposition of our securities.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">General</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">There is no authority addressing the treatment, for U.S. federal income tax purposes, of securities with terms substantially the same as the units, and, therefore, that treatment is not entirely clear. Each unit should be treated for U.S. federal income tax purposes as an investment unit consisting of one Series A preferred share which is convertible into our common shares at a conversion price of $_.__, one Class A Warrant to acquire ___ of our common shares, and one Class B Warrant to acquire ___ of our common shares. Each holder of a unit must allocate the purchase price paid by such holder for such unit among the Series A preferred shares, the Class A Warrant and the Class B Warrant based on their respective relative fair market values. A holder&#8217;s initial tax basis in the Series A preferred shares and each warrant included in each unit should equal the portion of the purchase price of the unit allocated thereto.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The foregoing treatment of the Series A preferred shares and warrants and a holder&#8217;s purchase price allocation are not binding on the IRS or the courts. Because there are no authorities that directly address instruments that are similar to the units, no assurance can be given that the IRS or the courts will agree with the characterization described above or the discussion below. Accordingly, each prospective investor is urged to consult its own tax advisors regarding the U.S. federal, state, local and any foreign tax consequences of an investment in a unit (including alternative characterizations of a unit). Unless otherwise stated, the following discussions are based on the assumption that the characterization of the Series A preferred shares and warrants described above is accepted for U.S. federal tax purposes.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">43</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S. Holders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Taxation of Distributions</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page50"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If we pay distributions to U.S. holders of our common shares or Series A preferred shares, such distributions generally will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the U.S. holder&#8217;s adjusted tax basis in our common shares or Series A preferred shares. Any remaining excess will be treated as gain realized on the sale or other disposition of the common shares or Series A preferred shares and will be treated as described under &#8220;U.S. Holders&#8212;Gain or Loss on Sale, Exchange or Other Taxable Disposition of Common Shares or Convertible Preferred Shares&#8221; below.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dividends paid to a U.S. holder that is a taxable corporation generally will qualify for the dividends received deduction if the requisite holding period is satisfied. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment interest deduction limitations), and provided certain holding period requirements are met and the U.S. holder refrains from making certain elections, dividends paid to a non-corporate U.S. holder generally will constitute &#8220;qualified dividends&#8221; that will be subject to tax at the maximum tax rate accorded to net capital gains (currently 15 percent) for tax years beginning before January 1, 2013, after which the rate applicable to dividends is currently scheduled to return to the tax rate generally applicable to ordinary income.&#160; Also starting in 2013, the distinction between ordinary and qualified dividends will disappear, and all dividends will be subject to the ordinary income tax rates.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Conversion of Convertible Preferred Shares into Common Shares</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. holder who converts Series A preferred shares into our common shares generally will not recognize gain or loss, except that the fair market value of any common shares attributable to dividend arrearages may be treated as a deemed distribution if not previously recognized, taxable as described above under &#8220;&#8212;U.S. Holders&#8212;Taxation of Distributions&#8221;. The adjusted tax basis of the common shares (excluding any common shares treated as a deemed distribution) will equal the tax basis of the Series A preferred shares exchanged and the holding period of the common shares received (excluding any common shares treated as a deemed distribution) will include the holding period of the Series A preferred shares. The tax basis of any common shares treated as a deemed distribution will equal its fair market value on the date of the conversion, and the U.S. holder will begin a new holding period for such common shares.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Gain or Loss on Sale, Exchange or Other Taxable Disposition of Common Shares or Convertible Preferred Shares</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In general, a U.S. holder must treat any gain or loss recognized upon a sale, exchange or other taxable disposition of our common shares or Series A preferred shares as capital gain or loss (other than a conversion of Convertible Preferred Shares into our common shares, which will be treated as described above in &#8220;&#8212;U.S. Holders&#8212;Conversion of Convertible Preferred Shares into Common Shares&#8221;). Any such capital gain or loss will be long-term capital gain or loss if the U.S. holder&#8217;s holding period for the disposition of common shares or Series A preferred shares exceeds one year. In general, a U.S. holder will recognize gain or loss in an amount equal to the difference between (1) the sum of the amount of cash and the fair market value of any property received in such disposition (or, if the Series A preferred share is held as part of a unit at the time of the disposition, the portion of the amount realized on such disposition that is allocated to the Series A preferred shares based upon the then fair market values of the Series A preferred shares and the warrants included in the unit) and (2) the U.S. holder&#8217;s adjusted tax basis in the disposition of common shares or Series A preferred shares. A U.S. holder&#8217;s adjusted tax basis in its common shares or Series A preferred shares generally will equal the U.S. holder&#8217;s acquisition cost (that is, as discussed above, the portion of the purchase price of a unit allocated to a Series A preferred share) plus any deemed distributions as described above less any prior distributions treated as a return of capital, as described above. Long-term capital gain realized by a non-corporate U.S. holder generally will be subject to a maximum rate of 15 percent for tax years beginning before January 1, 2013, after which the maximum long-term capital gains rate is scheduled to increase to 20 percent. The deduction of capital losses is subject to various limitations.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Exercise of a Warrant</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A U.S. holder will not be required to recognize taxable gain or loss upon exercise of a warrant. The U.S. holder&#8217;s tax basis in the common shares received upon exercise of the warrant generally will be an amount equal to the sum of the U.S. holder&#8217;s initial investment in the warrant (i.e., the portion of the U.S. holder&#8217;s purchase price for a unit that is allocated to the warrant, as described above) and the exercise price. The U.S. holder&#8217;s holding period in our common shares received upon exercise of the warrant will begin on the date following the date of exercise and will not include the period during which the U.S. holder held the warrant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Sale, Exchange, Redemption or Expiration of a Warrant</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon a sale, exchange (other than by exercise), redemption, or expiration of a warrant, a U.S. holder will be required to recognize gain or loss in an amount equal to the difference between (1) the amount realized upon such disposition or expiration (or, if the warrant is held as part of a unit at the time of the disposition of the unit, the portion of the amount realized on such disposition that is allocated to the warrant based on the then fair market values of the warrants and the Series A preferred shares included in the unit) and (2) the U.S. holder&#8217;s tax basis in<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>the warrant (that is, as discussed above, the portion of the U.S. holder&#8217;s purchase price for a unit that is allocated to the warrant). Such gain or loss generally would be treated as long-term capital gain or loss if the warrant was held by the U.S. holder for more than one year at the time of such disposition or expiration. The deductibility of capital losses is subject to various limitations.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">44</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-U.S. Holders</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Taxation of Distributions</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page51"><!--EFPlaceholder--></a>In general, any distributions we make to a non-U.S. holder of our common shares or Series A preferred shares, to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), generally will constitute dividends for U.S. federal income tax purposes and, provided such dividends are not effectively connected with the non-U.S. holder&#8217;s conduct of a trade or business within the United States, we generally will be required to withhold tax from the gross amount of the dividend at a rate of 30 percent, unless such non-U.S. holder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper certification of its eligibility for such reduced rate (usually on an IRS Form W-8BEN). Any distribution not constituting a dividend will be treated first as reducing (but not below zero) the non-U.S. holder&#8217;s adjusted tax basis in our convertible preferred shares or common shares and, to the extent such distribution exceeds the non-U.S. holder&#8217;s adjusted tax basis, as gain realized from the sale or other disposition of the convertible preferred shares or common shares, which will be treated as described under &#8220;Non-U.S. Holders&#8212;Gain on Sale, Exchange or Other Taxable Disposition of Common Shares, Series A Preferred Shares and Warrants&#8221; below. In addition, if we determine that we are likely to be classified as a &#8220;U.S. real property holding corporation&#8221; (see &#8220;Non-U.S. Holders&#8212;Gain on Sale, Exchange or Other Taxable Disposition of Common Shares, Series A Preferred Shares and Warrants&#8221; below), we will withhold 10 percent of any distribution that exceeds our current and accumulated earnings and profits, which withheld amount may be claimed by the non-U.S. holder as a credit against the non-U.S. holder&#8217;s U.S. federal income tax liability.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dividends we pay to a non-U.S. holder that are effectively connected with such non-U.S. holder&#8217;s conduct of a trade or business within the United States (and, if certain income tax treaties apply, are attributable to a United States permanent establishment or fixed base maintained by the non-U.S. holder) generally will not be subject to U.S. withholding tax, provided such non-U.S. holder complies with certain certification and disclosure requirements (usually by providing an IRS Form W-8ECI). Instead, such dividends generally will be subject to U.S. federal income tax, net of certain deductions, at the same graduated individual or corporate rates applicable to U.S. Persons. If the ultimate holder (ignoring intervening pass through entities) is a non-U.S. corporation or transparent entity or vehicle ultimately owned by a corporation, dividends that are effectively connected income may also be subject to a &#8220;branch profits tax&#8221; at a rate of 30 percent (or such lower rate as may be specified by an applicable income tax treaty) when ultimately remitted from the permanent establishment or fixed base to the non-U.S. holder.&#160;&#160;A corporation for this purpose means any entity treated as or electing to be treated as a corporation under U.S. tax law.</font><br></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Conversion of Series A Preferred Shares into Common Shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Non-U.S. holders generally will not recognize any gain or loss for U.S. federal income tax purposes upon the conversion of Series A preferred shares into our common shares, except that the fair market value of any common shares attributable to dividend arrearages may be treated as a deemed distribution if not previously recognized, taxable as described above under &#8220;&#8212;Non-U.S. Holders&#8212;Taxation of Distributions.&#8221;</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Gain on Sale, Exchange or Other Taxable Disposition of Common Shares, Series A Preferred Shares and Warrants</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A non-U.S. holder generally will not be subject to U.S. federal income or withholding tax in respect of gain recognized on a sale, exchange or other disposition of our common shares, Series A preferred shares or warrants<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>(including an expiration or redemption of our warrants), in each case without regard to whether those securities were held as part of a unit, unless:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the gain is effectively connected with the conduct of a trade or business by the non-U.S. holder within the United States (and, under certain income tax treaties, is attributable to a United States permanent establishment or fixed base maintained by the non-U.S. holder);</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">we are or have been a &#8220;U.S. real property holding corporation&#8221; for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the non-U.S. holder&#8217;s holding period for the security disposed of, and, generally, in the case where our common shares or Series A preferred shares, as applicable, are regularly traded on an established securities market, the non-U.S. holder has owned, directly or indirectly or constructively, more than 5 percent of our common shares, or 5 percent of our Series A preferred shares, as applicable, at any time within the shorter of the five-year period ending on the date of disposition or such non-U.S. holder&#8217;s holding period for such securities disposed of. There can be no assurance that our common shares or our Series A preferred shares will be treated as regularly traded on an established securities market for this purpose.</font></div></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unless an applicable treaty provides otherwise, gain described in the first and third bullet points above will be subject to tax at generally applicable U.S. federal income tax rates. Any gains described in the first bullet point above of a non-U.S. holder that is a foreign corporation may also be subject to an additional 30 percent &#8220;branch profits tax&#8221;. Gain described in the second bullet point above (which may be offset by U.S. source capital losses) will be subject to a flat 30 percent U.S. federal income tax. The gross proceeds from transactions that generate gains described in the third bullet point above generally will be subject to a 10 percent withholding tax, which withheld amount may be claimed by the non-U.S. holder as a credit against the non-U.S. holder&#8217;s U.S. federal income tax liability. Non-U.S. holders should consult any income tax treaties applicable to them, as those treaties may provide for different rules.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We currently are not a U.S. real property holding corporation. However, we can provide no assurance that we will not become a U.S. real property holding corporation in the future. We will be classified as a U.S. real property holding corporation if the fair market value of our &#8220;U.S. real property interests&#8221; equals or exceeds 50 percent of the sum of the fair market value of our worldwide real property interests plus our other assets used or held for use in a trade or business, as determined for U.S. federal income tax purposes. Each non-U.S. holder should consult its own tax advisors as to whether the shares or warrants will be treated as &#8220;U.S. real property interests&#8221; and the tax consequences resulting from such treatment.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Exercise of a Warrant</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The U.S. federal income tax treatment of a non-U.S. holder&#8217;s exercise of a warrant generally will correspond to the U.S. federal income tax treatment of the exercise of a warrant by a U.S. holder, as described under &#8220;U.S. Holders&#8212;Exercise of a Warrant&#8221; above.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">45</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Legislation Relating to Foreign Accounts</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="Page52"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Legislation has been recently enacted that imposes significant certification, information reporting and other requirements, and in certain cases, withholding taxes, on certain types of payments made to &#8220;foreign financial institutions&#8221; and certain other non-U.S. entities. The legislation is generally effective for payments made after December 31, 2012. The failure to comply with the certification, information reporting and other specified requirements in the legislation would result in withholding tax being imposed on payments of dividends and sales proceeds to foreign intermediaries and certain non-U.S. holders. Non-U.S. holders should consult their own tax advisers regarding the application of this legislation to them.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Federal Estate Tax</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Common shares, Series A preferred shares or warrants owned or treated as owned by an individual who is not a U.S. citizen or resident (as specifically defined for U.S. federal estate tax purposes) at the time of his or her death will be included in the individual&#8217;s gross estate for U.S. federal estate tax purposes, unless there is no federal estate tax in existence at such time or an applicable estate tax treaty provides otherwise, and therefore may be subject to U.S. federal estate tax.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Information Reporting and Backup Withholding</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We must report annually to the U.S. Internal Revenue Service and to each U.S. holder and to each non-U.S. holder the amount of dividends paid to that holder and the amount of tax withheld with respect to those dividends. Copies of the information returns reporting those dividends and the amount of tax withheld may also be made available to the tax authorities in the country in which a non-U.S. Holder is a resident under the provisions of an applicable income tax treaty.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Backup withholding, currently imposed at a rate of 28 %, may apply to dividends paid by us.&#160;&#160;If you are a U.S. holder, backup withholding will apply if you fail to provide an accurate taxpayer identification number or certification of exempt status or fail to report all interest and dividends required to be shown on your federal income tax returns. Certain U.S. Holders (including, among others, corporations) are not subject to backup withholding. If you are a non-U.S. Holder, backup withholding will apply to dividend payments if you fail to provide us with the required certification that you are not a United States person.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Payments of the proceeds from a disposition (including a redemption) effected outside the United States by or through a non-US. broker generally will not be subject to information reporting or backup withholding. However, information reporting, but generally not backup withholding, will apply to such a payment if the broker has certain connections with the United States unless the broker has documentary evidence in its records that the beneficial owner of the disposed shares is a non-U.S. Holder and either specified conditions are met or an exemption is otherwise established. Backup withholding and information reporting will apply to dispositions made by or through a U.S. office of any broker (U.S. or foreign).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Backup withholding is not an additional tax. Any amounts withheld from a payment to you that result in an overpayment of taxes generally will be refunded, or credited against your U.S. federal income tax liability, if any, provided that the required information is timely furnished to the U.S. Internal Revenue Service.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S. Holders and non-U.S. Holders should consult their own tax advisors regarding application of backup withholding in their particular circumstance and the availability of, and procedure for obtaining, an exemption from backup withholding under current U.S. Treasury regulations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Legal Proceedings</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of the date hereof, we do not have any material pending legal proceedings.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Legal Matters</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The validity of the common shares offered hereby and certain other legal matters will be passed upon for us by Ice Miller LLP, Indianapolis, Indiana.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Experts</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements of Bioanalytical Systems, Inc. at September 30, 2010 and 2009, and for each of the years ended September 30, 2010 and 2009, appearing in this Prospectus have been so included in reliance on the report of Crowe Horwath LLP, independent registered public accounting firm, given on the authority of said firm as experts in accounting and auditing.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">46</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Index to Financial Statements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems Inc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Annual Financial Statements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="94%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Page</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated Balance Sheets as of September 30, 2010 and 2009</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-2</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated Statements of Operations for the Years Ended September 30, 2010 and 2009</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-3</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated Statements of Shareholders&#8217; Equity and Comprehensive Loss for the Years Ended September 30, 2010 and 2009</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-4</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consolidated Statements of Cash Flows for the Years Ended September 30, 2010 and 2009</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-5</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes to Consolidated Financial Statements</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-6</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Report of Independent Registered Public Accounting Firm</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-21</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Unaudited Interim Financial Statements</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Condensed Consolidated Balance Sheets as of December 31, 2010 and September 30, 2010</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-22</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Condensed Consolidated Statements of Operations for the Three Months Ended December 31, 2010 and 2009</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-23</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Condensed Consolidated Statements of Cash Flows for the Three Months Ended December 31, 2010 and 2009</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-24</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="94%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notes to Condensed Consolidated Financial Statements</font></div>
</td>
<td valign="top" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">F-25</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-1</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONSOLIDATED BALANCE SHEETS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In thousands)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">As of September 30,</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,422</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">870</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts receivable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trade</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,670</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,996</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unbilled revenues and other</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,298</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,684</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,847</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Refundable income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">544</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prepaid expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">555</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">622</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current assets</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,634</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,563</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Property and equipment, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,439</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,282</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deferred income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Goodwill</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intangible assets, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">84</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">114</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Debt issue costs</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">123</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">145</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">80</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">86</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">29,743</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">32,585</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liabilities and shareholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,911</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,848</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Customer advances</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,582</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,863</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income tax accruals</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">473</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revolving line of credit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,759</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair value of interest rate swaps</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">103</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current portion of capital lease obligation</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">524</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">650</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current portion of long-term debt</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,855</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">524</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current liabilities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,976</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,482</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capital lease obligation, less current portion</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">623</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">792</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long-term debt, less current portion</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,477</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,191</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders&#8217; equity:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Preferred Shares:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Authorized 1,000 shares; none issued and outstanding</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares, no par value:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Authorized 19,000 shares; issued and outstanding 4,915 at September 30, 2010 and 2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,191</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,191</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Additional paid-in capital</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,357</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,131</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated deficit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3,981</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,290</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated other comprehensive income</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">100</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">88</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total shareholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">10,667</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">13,120</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total liabilities and shareholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">29,743</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">32,585</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In thousands, except per share amounts)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">For the Years Ended</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">September 30,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,864</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product revenue</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">6,917</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">7,626</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,781</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost of service revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,574</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,959</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost of product revenue</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2,874</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">3,221</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total cost of revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,448</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24,180</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross profit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,604</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating expenses:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Selling</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,665</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,296</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">546</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">762</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">General and administrative</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,119</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,674</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Impairment loss</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">472</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total operating expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,330</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest income</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest expense</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,028</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,063</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other income</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss before income tax benefit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3,024</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,660</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income tax benefit</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(333</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(197</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(2,691</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(5,463</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net loss per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1.11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net loss per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1.11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted common shares outstanding:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY AND COMPREHENSIVE LOSS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In thousands)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Common&#160;shares</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Additional</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">paid-in-</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Accumulated</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Accumulated</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">other</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">comprehensive</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Total</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">shareholders'</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Number</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Amount</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">capital</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">deficit</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Income&#160;(loss)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">equity</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Balance at October 1, 2008</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">1,191</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">12,561</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">4,173</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">17,795</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Comprehensive loss:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Net loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(5,463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(5,463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Other comprehensive income (loss):</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Foreign currency translation adjustments</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">218</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">218</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Total comprehensive loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(5,245</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Stock compensation</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">570</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">570</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Balance at September 30, 2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">1,191</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">13,131</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(1,290</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">13,120</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Comprehensive loss:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Net loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(2,691</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(2,691</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Other comprehensive income (loss):</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Foreign currency translation adjustments</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">12</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Total comprehensive loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(2,679</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Stock compensation</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">226</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">226</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">Balance at September 30, 2010</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">1,191</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">13,357</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">(3,981</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">100</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: times new roman">10,667</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The accompanying notes are an integral part of the consolidated financial statements.</font></div>
</div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In thousands)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Years Ended September 30,</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating activities:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,691</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,463 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Adjustments to reconcile net loss to net cash provided by operating activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Depreciation and amortization</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,323</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,645</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Impairment loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">472</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee stock compensation expense</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision for doubtful accounts</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liability incurred on settlement of lease</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">216</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Gain) loss on interest rate swaps</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(72 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">103</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Gain) loss on sale of property and equipment</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deferred income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">160</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes in operating assets and liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts receivable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">650</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,680</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">174</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">338</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Refundable income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">529</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">739</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prepaid expenses and other assets</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">90</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(86 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(212 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(709 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">52</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Customer advances</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,719</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,169 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash provided by operating activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2,441</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,999</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Investing activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capital expenditures</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(450 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(834 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash used by investing activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(450 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(834 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financing activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments of long-term debt</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(599 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(491 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments on revolving line of credit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(28,948 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19,052 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Borrowings on revolving line of credit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,384</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18,788</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from sale and leaseback</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">431</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments on capital lease obligations</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(726 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(721 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash used by financing activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,458 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,476 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash flow of discontinued operations:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash provided by operating activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">588</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash provided by discontinued operations</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">588</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of exchange rate changes</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">19</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">258</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: -54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net increase in cash and cash equivalents</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">552</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">535</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents at beginning of year</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">870</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">335</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents at end of year</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,422</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">870</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">&#160;</font><br>
&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="A001"><!--EFPlaceholder--></a>BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Amounts in thousands unless otherwise listed)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;&#160;DESCRIPTION OF THE BUSINESS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc. and its subsidiaries (the &#8220;Company&#8221; or &#8220;BASi&#8221; or &#8220;we&#8221;) engage in research services and other services related to pharmaceutical development. We also manufacture scientific instruments for medical research, which we sell with related software for use in industrial, governmental and academic laboratories. We conduct our businesses through our research facilities in Indiana, Oregon, and the United Kingdom and our manufacturing facility in Indiana. Our customers are located throughout the world.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A002"><!--EFPlaceholder--></a><a name="A003"><!--EFPlaceholder--></a>(a)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Principles of Consolidation</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant inter-company accounts and transactions have been eliminated.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A004"><!--EFPlaceholder--></a>(b)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Revenue Recognition</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The majority of our service contracts involve the development of analytical methods and the processing of bioanalytical samples for pharmaceutical companies and generally provide for a fixed fee for each sample processed. Revenue is recognized under the specific performance method of accounting and the related direct costs are recognized when services are performed. Our research service contracts generally consist of preclinical studies, and revenue is recognized based on the ratio of direct costs incurred to total estimated direct costs under the proportional performance method of accounting. Losses on both types of contracts are provided in the period in which the loss becomes determinable. Revisions in profit estimates, if any, are reflected on a cumulative basis in the period in which such revisions become known. The establishment of contract prices and total contract costs involves estimates we make at the inception of the contract. These estimates could change during the term of the contract and impact the revenue and costs reported in the consolidated financial statements. Revisions to estimates have generally not been material. Research service contract fees received upon acceptance are deferred until earned, and classified within customer advances. Unbilled revenues represent revenues earned under contracts in advance of billings.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Product revenue from sales of equipment not requiring installation, testing or training is recognized upon shipment to customers. One product includes internally developed software and requires installation, testing and training, which occur concurrently. Revenue from these sales is recognized upon completion of the installation, testing and training when the services are bundled with the equipment sale.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A005"><!--EFPlaceholder--></a>(c)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Cash Equivalents</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We consider all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A006"><!--EFPlaceholder--></a>(d)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financial Instruments</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our credit risk consists principally of trade accounts receivable. We perform periodic credit evaluations of our customers&#8217; financial conditions and generally do not require collateral on trade accounts receivable. We account for trade receivables based on the amounts billed to customers. Past due receivables are determined based on contractual terms. We do not accrue interest on any of our trade receivables.&#160;&#160;The allowance for doubtful accounts is determined by management based on our historical losses, specific customer circumstances, and general economic conditions.&#160;&#160;Periodically, management reviews accounts receivable and adjusts the allowance based on current circumstances and charges off uncollectible receivables when all attempts to collect have failed.&#160;&#160;Our allowance for doubtful accounts was $165 and $110 at September 30, 2010 and 2009, respectively.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A summary of activity in our allowance for doubtful accounts is as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Opening balance</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">110</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">83</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Charged to expense, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">61</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts written off</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(6</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(12</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ending balance</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">165</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">110</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A007"><!--EFPlaceholder--></a>(e)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Inventories</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories are stated at the lower of cost or market using the first-in, first-out (FIFO) cost method of accounting.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="Page59"><!--EFPlaceholder--></a><a name="A008"><!--EFPlaceholder--></a><a name="A009"><!--EFPlaceholder--></a>(f)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Property and Equipment</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We record property and equipment at cost, including interest capitalized during the period of construction of major facilities. We compute depreciation, including amortization on capital leases, using the straight-line method over the estimated useful lives of the assets, which we estimate to be: buildings and improvements, 34 to 40 years; machinery and equipment, 5 to 10 years, and office furniture and fixtures, 10 years. Depreciation expense was $2,287 in fiscal 2010 and $2,609 in fiscal 2009. Expenditures for maintenance and repairs are expensed as incurred.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Property and equipment, net, as of September 30, 2010 and 2009 consisted of the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Land and improvements</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">488</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Buildings and improvements</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,296</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,298</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Machinery and equipment</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,652</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,462</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Office furniture and fixtures</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">952</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">972</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Construction in progress</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">109</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">40</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43,497</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43,262</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less:&#160;&#160;accumulated depreciation</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(24,058</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(21,980</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net property and equipment</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,439</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,282</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(g)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Long-Lived Assets including Goodwill</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Long-lived assets, such as property and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized of the amount by which the carrying amount of the asset exceeds the fair value of the asset.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We carry goodwill at cost. Other intangible assets with definite lives are stated at cost and are amortized on a straight-line basis over their estimated useful lives. All intangible assets acquired that are obtained through contractual or legal right, or are capable of being separately sold, transferred, licensed, rented, or exchanged, are recognized as an asset apart from goodwill. Goodwill is not amortized.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Goodwill is tested annually for impairment, and more frequently if events and circumstances indicate that the asset might be impaired, using a two-step process.&#160;&#160;In the first step, we compare the fair value of each reporting unit, as computed primarily by present value cash flow calculations, to its book carrying value, including goodwill. We do not believe that market value is indicative of the true fair value of the Company mainly due to average daily trading volumes of less than 1%.&#160;&#160;If the fair value exceeds the carrying value, no further work is required and no impairment loss is recognized. If the carrying value exceeds the fair value, the goodwill of the reporting unit is potentially impaired and we would then complete step 2 in order to measure the impairment loss. In step 2, the implied fair value is compared to the carrying amount of the goodwill. If the implied fair value of goodwill is less than the carrying value of goodwill, we would recognize an impairment loss equal to the difference. The implied fair value is calculated by allocating the fair value of the reporting unit (as determined in step 1) to all of its assets and liabilities (including unrecognized intangible assets) and any excess in fair value that is not assigned to the assets and liabilities is the implied fair value of goodwill.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The discount rate and sales growth rates are the two material assumptions utilized in our calculations of the present value cash flows used to estimate the fair value of the reporting units when performing the annual goodwill impairment test. Our reporting units with goodwill at September 30, 2010 are Vetronics, Oregon and Evansville, based on the discrete financial information available which is reviewed by management.&#160;&#160;We utilize a cash flow approach in estimating the fair value of the reporting units, where the discount rate reflects a weighted average cost of capital rate. The cash flow model used to derive fair value is sensitive to the discount rate and sales growth assumptions used. Due to fiscal year 2009 operating losses and lowered expectations for the near future, we performed an impairment test for our UK reporting unit as of June 30, 2009.&#160;&#160;As a result of this test, we recorded a $472 impairment loss equal to the total value of the UK goodwill in fiscal 2009.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>We performed our annual impairment test for all other reporting units mentioned above at September 30, 2010.&#160;&#160;Using a discount rate of 22% and a revenue growth rate of 0%, the fair values of our Vetronics, Oregon and Evansville reporting units is greater than the carrying values by approximately $2,500.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Considerable management judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows. Assumptions used in our impairment evaluations, such as forecasted sales growth rates and our cost of capital or discount rate, are based on the best available market information. Changes in these estimates or a continued decline in general economic conditions could change our conclusion regarding an impairment of goodwill and potentially result in a non-cash impairment loss in a future period.&#160;&#160;The assumptions used in our impairment testing could be adversely affected by certain of the risks discussed in &#8220;Risk Factors&#8221; in Item 1A of this report.&#160;&#160;There have been no significant events since the timing of our impairment tests that would have triggered additional impairment testing.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At September 30, 2010, remaining recorded goodwill was $1,383, and the net balance of other intangible assets was $84.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A summary of activity in our goodwill account is as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Opening balance</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,855</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">UK impairment charge</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(472</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ending balance</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,383</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,383</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The components of intangible assets subject to amortization are as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September&#160;30,&#160;2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Weighted&#160;average</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">life&#160;(years)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Gross&#160;Carrying</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Amount</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Accumulated</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Amortization</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">FDA compliant facility</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">302</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">218</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September&#160;30,&#160;2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Weighted&#160;average</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">life&#160;(years)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Gross&#160;Carrying</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Amount</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Accumulated</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Amortization</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">FDA compliant facility</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">302</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">188</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amortization expense for intangible assets for fiscal years ended September&#160;30, 2010 and 2009 was $30.&#160;&#160;The following table provides information regarding estimated amortization expense for the next five fiscal years:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2013</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2014</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2015</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A011"><!--EFPlaceholder--></a>(h)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Advertising Expense</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We expense advertising costs as incurred. Advertising expense was $180 and $219 for the years ended September 30, 2010 and 2009, respectively.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A012"><!--EFPlaceholder--></a>(i)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Shares-Based Compensation</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have a stock-based employee compensation plan and a stock-based employee and outside director compensation plan, which are described more fully in Note 8.&#160;&#160;All options granted under these plans have an exercise price equal to the market value of the underlying common shares on the date of grant.&#160;&#160;We expense the estimated fair value of stock options over the vesting periods of the grants.&#160;&#160;Our policy is to recognize expense for awards subject to graded vesting using the straight-line attribution method, reduced for estimated forfeitures. Forfeitures are revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates and an adjustment is recognized at that time.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use a binomial option-pricing model as our method of valuation for share-based awards, requiring us to make certain assumptions about the future, which are more fully described in Note 8.&#160;&#160;Shares-based compensation expense for employee stock options for the years ended September 30, 2010 and 2009 was $226 and $570, respectively.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(j)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Income Taxes</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.&#160;&#160;We record valuation allowances based on a determination of the expected realization of tax assets.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We may recognize the tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. The amount of the accrual for which an exposure exists is measured as the largest amount of benefit determined on a cumulative probability basis that we believe is more likely than not to be realized upon ultimate settlement of the position.<a name="Page61"><!--EFPlaceholder--></a></font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>We record interest and penalties accrued in relation to uncertain income tax positions as a component of income tax expense.&#160;&#160;Any changes in the liability for uncertain tax positions would impact our effective tax rate. We do not expect the total amount of unrecognized tax benefits to significantly change in the next twelve months.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(k)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">New Accounting Pronouncements</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In August 2008, the SEC announced that it will issue for comment a proposed roadmap regarding the potential use by U.S. issuers of financial statements prepared in accordance with IFRS (International Financial Reporting Standards). IFRS is a comprehensive series of accounting standards published by the IASB (International Accounting Standards Board). Under the proposed roadmap, we could be required to prepare financial statements in accordance with IFRS beginning in fiscal 2014. The SEC has indicated it will make a determination in 2011 regarding mandatory adoption of IFRS.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In October&#160;2009, the FASB issued an Accounting Standards Update on the accounting for revenue recognition to specifically address how to determine whether an arrangement involving multiple deliverables contains more than one unit of accounting.&#160; This guidance is applicable to revenue arrangements entered into or materially modified during our next fiscal year that begins October 1, 2010.&#160; The guidance may be applied either prospectively from the beginning of the fiscal year for new or materially modified arrangements or retrospectively.&#160; We are currently reviewing this authoritative guidance to determine the potential impact, if any, that it may have on our consolidated financial statements.</font><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(l)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Fair Value</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The provisions of the Fair Value Measurements and Disclosure Topic defines fair value, establishes a consistent framework for measuring fair value and provides the disclosure requirements about fair value measurements. This Topic also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company&#8217;s judgment about the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the inputs as follows:</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 13.7pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 1 &#8211; Valuations based on quoted prices for identical assets or liabilities in active markets that the Company has the ability to access.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 13.7pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 2 &#8211; Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 13.7pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 3 &#8211; Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The carrying amounts for cash and cash equivalents, accounts receivable, inventories, prepaid expenses and other assets, accounts payable and other accruals approximate their fair values because of their nature and respective duration.&#160;&#160;The fair value of the revolving credit facility and certain long-term debt is equal to their carrying values due to the variable nature of their interest rates.&#160;&#160;Our long-term fixed rate debt was adjusted to a market rate on June 30, 2010, which approximates market rates for similar debt instruments at September 30, 2010. See Note 6 for further discussion of the fair value of our interest rate swap.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A015"><!--EFPlaceholder--></a>(m)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Use of Estimates</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates as part of the issuance of these consolidated financial statements include but are not limited to the determination of fair values, allowance for doubtful accounts, inventory obsolescence, deferred tax valuations, depreciation, impairment charges and shares compensation.&#160;&#160;Our actual results could differ from those estimates.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(n)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Research and Development</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In fiscal 2010 and 2009, we spent $546 and $762, respectively, on research and development. Separate from our contract research services business, we maintain applications research and development to enhance our products business.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(o)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Comprehensive Loss</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>We report comprehensive income (loss) in the consolidated statement of shareholders&#8217; equity and comprehensive loss.&#160;&#160;Other comprehensive income (loss) represents changes in shareholders&#8217; equity and is comprised of foreign currency translation adjustments.&#160;&#160;At September 30, 2010 and 2009, accumulated other comprehensive income consisted of foreign currency translation adjustments of $100 and $88, respectively.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="Page62"><!--EFPlaceholder--></a>(p)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Foreign Currency</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>For our subsidiary outside of the United States that operates in a local currency environment, income and expense items are translated to United States dollars at the monthly average rates of exchange prevailing during the year, assets and liabilities are translated at year-end exchange rates and equity accounts are translated at historical exchange rates. Translation adjustments are accumulated in a separate component of shareholders' equity in the consolidated balance sheets and are included in the determination of comprehensive income (loss) in the consolidated statements of shareholders' equity. Transaction gains and losses are included in the determination of net income (loss) in the consolidated statements of operations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.&#160;&#160;LOSS PER SHARE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We compute basic loss per share using the weighted average number of common shares outstanding.&#160;&#160;We compute diluted loss per share using the weighted average number of common and potential common shares outstanding. Potential common shares include the dilutive effect of shares issuable upon exercise of options to purchase common shares.&#160;&#160;At September 30, 2010 and 2009, we had 705 and 620 shares, respectively, issuable upon exercise of stock options that are not included in our outstanding share calculation as they are anti-dilutive.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="A016"><!--EFPlaceholder--></a>The following table reconciles our computation of basic net loss per share to diluted net loss per share:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Years Ended</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September 30,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net loss per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss applicable to common shareholders</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,691</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5,463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net loss per share</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(0.55</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1.11</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net loss per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net loss applicable to common shareholders</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(2,691</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(5,463</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dilutive stock options/shares</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net loss per share</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(0.55</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1.11</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="A019"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.&#160;&#160;INVENTORIES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories at September&#160;30 consisted of the following:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Raw materials</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,732</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Work in progress</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">283</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">131</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Finished goods</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">218</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">271</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,035</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,134</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Obsolescence reserve</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(362</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(287</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,673</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,847</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-10</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.&#160;&#160;LEASE ARRANGEMENTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The total amount of equipment capitalized under capital lease obligations as of September 30, 2010 and 2009 was $4,334 and $3,884, respectively. Accumulated amortization on capital leases at September 30, 2010 and 2009 was $2,736 and $1,981, respectively. Amortization of assets acquired through capital leases is included in depreciation expense.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During fiscal years 2010 and 2009, we did not acquire any new equipment through capital lease arrangements. On February 1, 2010, we conducted a sale and leaseback of some of our unencumbered laboratory equipment with a term of 36 months and a monthly payment of $19.&#160;&#160;This accounts for the increase in equipment capitalized under capital leases.&#160;&#160;Future minimum lease payments on capital leases at September 30, 2010 are as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Principal</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Interest</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Total</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">524</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">177</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">701</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">476</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">565</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2013</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">147</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">159</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2014</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,147</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">278</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,425</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>We lease office space and equipment under noncancelable operating leases that terminate at various dates through 2013. The UK building lease expires in 2023 but includes an opt out provision after 7 years. Certain of these leases contain renewal options. Total rental expense under these leases was $439 and $485 in fiscal 2010 and 2009, respectively.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Future minimum lease payments for the following fiscal years under operating leases at September 30, 2010 are as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">435</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">430</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2013</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">416</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2014</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">413</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2015</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">340</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After 2015</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2,579</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="88%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,613</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-11</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.&#160;&#160;DEBT ARRANGEMENTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Long-term debt consisted of the following at September 30:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage note payable to a bank, payable in monthly principal and interest installments of $40. Interest is fixed at 7.1% through June 30, 2010, and thereafter fixed at 4.1%.&#160;&#160;Collateralized by underlying property.&#160;&#160;Due November, 2012.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,896</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,117</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage note payable to a bank, payable in monthly principal and interest installments of $19. The interest rate is 6.1%. Collateralized by underlying property. Due February, 2011.&#160;&#160;(a)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,346</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,489</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage note payable to a bank, payable in monthly principal and interest installments of $17. Interest is fixed at 7.1% through June 30, 2010, and thereafter fixed at 4.1%.&#160;&#160;Collateralized by underlying property.&#160;&#160;Due November, 2012.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,809</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,897</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Note payable to a bank, payable in monthly principal installments of $9 plus interest.&#160;&#160;The interest rate is 6.1%. Collateralized by West Lafayette and Evansville properties. Due December, 2010.&#160;&#160;(a)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,095</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,212</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Note payable to Algo Holdings, payable in monthly installments of $10.&#160;&#160;There is no interest on this note if paid within terms.&#160;&#160;Due May 1, 2012.&#160;&#160;See Note 11.</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">185</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,332</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,715</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less current portion</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,855</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">524</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,477</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,191</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes our principal payment obligations for the years ending September&#160;30:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,855</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">888</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2013</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">5,589</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="88%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">8,332</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Cash interest payments of $1,067 and $917 were made in 2010 and 2009, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Mortgages and note payable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a) On November 29, 2010, we executed an amendment to the loans with Regions.&#160;&#160;Regions agreed to accept a $500 principal payment on the note payable with $1.1 million of principal maturing on December 18, 2010 and a $500 principal payment on one mortgage with $1.3 million of principal maturing on February 11, 2011.&#160;&#160;The principal payments are to be made on or before December 18, 2010 and February 11, 2011, respectively.&#160;&#160;Thereafter, the unpaid principal on the note payable and the mortgage will then be incorporated into a replacement note maturing on November 1, 2012.&#160;&#160;The replacement note will bear interest at a monthly LIBOR plus 300 basis points (minimum of 4.5%) with monthly principal amortization.&#160;&#160;On December 17, 2010, we made the $500 principal payment on the $1.1 million note.&#160;&#160;Since we have made the first payment and expect to have the financial capacity to make the additional $500 payment in February 2011, we have classified this debt, to the extent of the amount of debt that will be reset to a due date past September 30, 2011, as non-current.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We entered into interest rate swap agreements with respect to the above loans noted by (a) to fix the interest rate at 6.1%.&#160;&#160;We entered into these derivative transactions to hedge interest rate risk of the related debt obligation and not to speculate on interest rates. The notional values of the swaps as of September 30, 2010 and 2009 were $2,442 and $2,701, respectively. The fair value of the swaps was determined with a level two analysis.&#160;&#160;As a result of recent declines in short term interest rates, the swaps had a negative fair value of $31 at September 30, 2010 and $103 at September 30, 2009, with the decline in the liability being recorded in our consolidated financial statements as a reduction in interest expense in the current fiscal year and the increase in liability recorded as an increase in interest expense in the prior fiscal year.&#160;&#160;The terms of the interest rate swaps match the scheduled principal outstanding under the loans.&#160;&#160;We do not intend to prepay the loans, and expect the swaps to expire under their terms in fiscal 2011 without payment by us.&#160;&#160;Upon expiration of the swaps, the net fair value recorded in the consolidated financial statements is expected to be zero.<a name="Page65"><!--EFPlaceholder--></a></font></div>
<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-12</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As part of the amendment, Regions also agreed to amend the loan covenants for the related debt to be more favorable to us beginning with our fiscal quarter ending December 31, 2010.&#160;&#160;Regions requires us to maintain certain ratios including a fixed charge coverage ratio and total liabilities to tangible net worth ratio.&#160;&#160;The fixed charge coverage ratio calculation has been adjusted with an ending ratio required of not less than 1.25 to 1.00.&#160;&#160;Also, the total liabilities to tangible net worth ratio has been adjusted to not greater than 2.10 to 1.00.&#160;&#160;Provided we comply with the revised covenant ratios, the amendment removes limitations on the Company&#8217;s purchase of fixed assets. Based on projections for fiscal 2011, we expect to be in compliance with the adjusted covenants.&#160;&#160;The first compliance test under the amendment will be on the balance sheet and trailing twelve months at March 31, 2011</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Regions loans contain both cross-default provisions with each other and with the revolving line of credit with Entrepreneur Growth Capital described below.&#160;&#160;At September 30, 2010, we were in compliance with Region&#8217;s covenant ratios.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A022"><!--EFPlaceholder--></a>Revolving Line of Credit</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="A023"><!--EFPlaceholder--></a>Through January 15, 2010, we had a revolving line of credit with PNC Bank, which we used for working capital and other purposes. Borrowings under this line were collateralized by substantially all assets related to our operations, other than the real estate securing the Regions loans, all common shares of our United States subsidiaries and 65% of the common shares of our non-United States subsidiaries.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 13, 2010, we entered into a new $3,000 revolving line of credit agreement (&#8220;Credit Agreement&#8221;) with Entrepreneur Growth Capital LLC (&#8220;EGC&#8221;) to replace the PNC Bank line of credit that expired on January 15, 2010.&#160;&#160;The initial term of the Credit Agreement was set to expire on January 31, 2011.&#160;&#160;If we prepay prior to the expiration of the initial term (or any renewal term), then we are subject to an early termination fee equal to the minimum interest charges of $15 for each of the months remaining until expiration.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrowings bear interest at an annual rate equal to Citibank&#8217;s Prime Rate plus five percent (5%), or 8.25% as of September 30, 2010, with minimum monthly interest of $15.&#160;&#160;Interest is paid monthly.&#160;&#160;The line of credit also carries an annual facilities fee of 2% and a 0.2% collateral monitoring fee.&#160;&#160;Borrowings under the Credit Agreement are secured by a blanket lien on our personal property, including certain eligible accounts receivable, inventory, and intellectual property assets, and a second mortgage on our West Lafayette and Evansville real estate. Borrowings are calculated based on 75% of eligible accounts receivable.&#160;&#160;Under the Credit Agreement, the Company has agreed to restrict advances to subsidiaries, limit additional indebtedness and capital expenditures and comply with certain financial covenants outlined in the Credit Agreement.&#160;&#160;At September 30, 2010, we had available borrowings of $1.8 million on this line.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The covenants in the Credit Agreement required that we maintain a minimum tangible net worth of $9,000.&#160;&#160;The Credit Agreement also contains cross-default provisions with the Regions loans and any future EGC loans. At September 30, 2010, we were not in compliance with the minimum tangible net worth covenant requirement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 23, 2010, we negotiated an amendment to this Credit Agreement.&#160;&#160;As part of the amendment, the maturity date was extended to January 31, 2013.&#160;&#160;The Amendment reduced the minimum tangible net worth covenant requirement to $8,500 and waived all non-compliances with this covenant through the date of the Amendment.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="A024"><!--EFPlaceholder--></a>7.&#160;&#160;INCOME TAXES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Significant components of our deferred tax assets and liabilities as of September&#160;30 are as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long-term deferred tax assets:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tax over book depreciation</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(709</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(842</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lower tax basis on assets of acquired company</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(448</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(418</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Domestic net operating loss carryforward</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,396</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,440</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares compensation expense</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">416</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">363</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign net operating loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,592</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,293</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign tax credit carryover</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">119</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">119</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">AMT credit carryover</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">13</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">13</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total long-term deferred tax assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">3,379</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,968</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current deferred tax assets: &#160; &#160;</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventory pricing</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">232</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">186</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued compensation and vacation</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">283</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">240</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued expenses and other &#8211; net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign net operating loss</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-STYLE: normal">(1</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: normal; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current deferred tax assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">550</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">425</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Valuation allowance for deferred tax assets &#160; &#160;</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(3,929</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(2,381</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net deferred tax assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">12</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-13</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Significant components of the provision (benefit) for income taxes are as follows as of the year ended September 30:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Federal</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(345</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">State</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(345</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Current</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(345</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(357</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deferred: &#160; &#160;</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Federal</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">118</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">State</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">12</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total deferred</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">12</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">160</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(333</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(197</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The effective income tax rate on continuing operations varied from the statutory federal income tax rate as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Statutory federal income tax rate</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(34.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(34.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Increases (decreases):</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nondeductible expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">State income taxes, net of federal tax benefit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5.4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Nontaxable foreign (gains) losses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Uncertain tax positions</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(15.6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Valuation allowance</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33.3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32.9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(2.5</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(2.1</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(11.0</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)%</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(3.5</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)%</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><a name="A025"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have not provided any U.S. income taxes benefit on the accumulated losses of our UK subsidiary. In fiscal 2010 and 2009, our foreign operations generated losses before income taxes of $993 and $2,293, respectively.&#160;&#160;We have foreign net operating loss carryforwards of $4,975&#160;that have an indefinite life under current UK tax law.&#160;&#160;Payments made in fiscal 2010 and 2009 for income taxes amounted to $3 and $1, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Realization of deferred tax assets associated with the net operating loss carryforward and credit carryforward is dependent upon generating sufficient taxable income prior to their expiration.&#160;&#160;We have a valuation allowance for the deferred tax asset related to the foreign net operating losses.&#160;&#160;In fiscal 2009, a valuation allowance of $1,088 was established for our domestic operations to reflect our estimate of the temporary deductible differences that may expire prior to their utilization.&#160;&#160;The valuation allowance in fiscal 2010 was $2,337 for our domestic operations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>At September 30, 2010, we had domestic net operating loss carryforwards of approximately $4,691 for federal and $9,420 for state, which expire from September 30, 2028 through 2030.&#160;&#160;Also, we have a foreign tax credit carryforward of approximately $119, which expires on September 30, 2016.&#160;&#160;Further, we have an alternative minimum tax credit carryforward of approximately $13 available to offset future federal income taxes.&#160;&#160;This credit has an unlimited expiration.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We may recognize the tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon regulatory examination based on the technical merits of the position. The amount of the benefit for which an exposure exists is measured as the largest amount of benefit determined on a cumulative probability basis that we believe is more likely than not to be realized upon ultimate settlement of the position. At September 30, 2010, a $30 liability remained for other uncertain income tax positions.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A reconciliation of the total amounts of unrecognized tax liability at September 30, 2009 and 2010 is as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beginning of year balance, October 1, 2008</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">473</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes during the year</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">End of year balance, September 30, 2009</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">473</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes during the year</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(443</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">End of year balance, September 30, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-14</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><a name="Page67"><!--EFPlaceholder--></a>&#160;<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As noted in the table above, we had a reduction of $443 in our gross uncertain tax positions during fiscal 2010.&#160;&#160;This was a result of the settlement of our state tax litigation.&#160;&#160;We paid approximately $98 and released the remaining $345 of unrecognized tax benefits associated with our state tax litigation.&#160;&#160;We file income tax returns in the U.S., several U.S. States, and the foreign jurisdiction of the United Kingdom.&#160;&#160;We remain subject to examination by taxing authorities in the jurisdictions in which we have filed returns for years after 2006.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.&#160;&#160;STOCK-BASED COMPENSATION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Summary of Stock Option Plans and Activity</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In March 2008, our shareholders approved the 2008 Stock Option Plan (the &#8220;Plan&#8221;) to replace the 1997 Outside Director Stock Option Plan and the 1997 Employee Stock Option Plan.&#160;&#160;Future common shares will be granted from the 2008 Stock Option Plan.&#160;&#160;The purpose of the Plan is to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees.&#160;&#160;The Compensation Committee shall administer the Plan and approve the particular officers, directors or employees eligible for grants.&#160;&#160;Under the Plan, employees are granted the option to purchase our common shares at fair market value on the date of the grant.&#160;&#160;Generally, options granted vest and become exercisable in four equal installments commencing one year from date of grant and expire upon the earlier of the employee&#8217;s termination of employment with us, or ten years from the date of grant.&#160;&#160;This plan terminates in fiscal 2018.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The maximum number of common shares that may be granted under the Plan is 500 shares.&#160;&#160;At September 30, 2010, 3 shares remain available for grants under the Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The weighted-average assumptions used to compute the fair value of options granted for the fiscal years ended September 30 were as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Risk-free interest rate</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.85</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dividend yield</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="top" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Volatility of the expected market price of the Company's common shares</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">55.00%- </font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">96.00</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">55.00%-</font></div>

<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">77.00</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expected life of the options (years)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A summary of our stock option activity and related information for the years ended September 30, 2010 and 2009, respectively, is as follows (in thousands except for share prices):</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted-Average</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted-Average</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Remaining</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aggregate</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted-Average</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Grant&#160;Date&#160;Fair</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contractual&#160;Life</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intrinsic</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(shares)</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Exercise&#160;Price</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Value</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(Years)</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Value</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding - October 1, 2008</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">754</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.00</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercised</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">60</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.07</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.73</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Terminated</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(194</font></font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.74</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding - September 30, 2009</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">620</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.97</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.36</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.4</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding - October 1, 2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">620</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.97</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercised</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">432</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Terminated</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(347</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.58</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding&#160;- September 30, 2010</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">705</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.66</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.82</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercisable at September 30, 2010</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.22</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.36</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.9</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-15</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A summary of non-vested options for the year ended September 30, 2010 is as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted-Average</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number of</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Grant Date Fair</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-vested options at October 1, 2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">299</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">432</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vested</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Forfeited</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(53</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.02</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-vested options at September 30, 2010</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">520</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.27</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No options were exercised in fiscal years 2010 and 2009.&#160;&#160;&#160;As of September 30, 2010, our total unrecognized compensation cost related to non-vested stock options was $441 and is expected to be recognized over a weighted-average service period of 1.99&#160;years.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes outstanding and exercisable options as of September&#160;30, 2010 (in thousands except per share amounts):</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Range&#160;of&#160;Exercise&#160;Prices</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Shares&#160;Outstanding</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Weighted-</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Average</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Remaining</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Contractual</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Life&#160;(Years)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Weighted-</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Average Exercise</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Price</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Shares</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Exercisable</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Weighted-&#160;Average</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Exercise&#160;</font></font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Price</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.79 - 2.80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">432</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9 .69</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1 .06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.81 - 4.59</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">114</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4 .70</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4 .28</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">94</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.44</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.60 - 8.79</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">159</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6 .70</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5 .85</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="14%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">91</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.03</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><a name="A026"><!--EFPlaceholder--></a><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.&#160;&#160;RETIREMENT PLAN</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have a&#160;401(k) Retirement Plan (the &#8220;Plan&#8221;) covering all employees over twenty-one years of age with at least one year of service. Under the terms of the Plan, we contribute 1% of each participant&#8217;s total wages to the Plan and match 22% of the first 10% of the employee contribution. The Plan also includes provisions for various contributions which may be instituted at the discretion of the Board of Directors. The contribution made by the participant may not exceed 30% of the participant&#8217;s annual wages. We made no discretionary contributions under the plan in 2010 and 2009. Contribution expense was $43 and $296 in fiscal 2010 and 2009, respectively<a name="A027"><!--EFPlaceholder--></a>.&#160;&#160;The decrease in contribution expense in fiscal 2010 occurred because we suspended our match of the employee contribution as part of our cost reduction efforts.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.&#160;&#160;SEGMENT INFORMATION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We operate in two principal segments &#8211; research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions. We evaluate performance and allocate resources based on these segments. Certain of our assets are not directly attributable to the Services or Products segments. These assets are grouped into the Corporate segment and include cash and cash equivalents, deferred income taxes, refundable income taxes, debt issue costs and certain other assets. We do not allocate such items to the principal segments because they are not used to evaluate their financial position. The accounting policies of these segments are the same as those described in the summary of significant accounting policies.</font></div>
<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-16</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><a name="A028"><!--EFPlaceholder--></a><font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Operating Segments</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Years&#160;Ended&#160;September&#160;30,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenue:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21,864</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">6,917</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">7,626</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,781</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31,784</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating loss:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2,350</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3,884</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">353</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(716</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,997</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporate Expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,027</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,060</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss before income taxes</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(3,024</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(5,660</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Years Ended</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September 30,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Identifiable assets:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,309</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,102</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,406</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,046</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporate</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">5,028</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">5,437</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">29,743</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">32,585</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Goodwill, net:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,009</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,009</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">374</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">374</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,383</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,383</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intangible assets, net:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">84</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">114</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">84</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">114</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Depreciation and amortization:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,108</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,377</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">215</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">268</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2,323</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2,645</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capital Expenditures:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">698</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">67</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">136</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">450</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">834</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-17</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">(b)</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Geographic Information</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Years Ended&#160;September 30,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales to External Customers:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">North America</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,578</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28,656</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pacific Rim</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">661</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Europe</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,215</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">208</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">252</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">28,781</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">31,784</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long-lived Assets:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">North America</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,650</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22,472</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Europe</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">459</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">550</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">21,109</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">23,022</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">(c)</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Major Customers</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="A030"><!--EFPlaceholder--></a>In 2010 and 2009, Pfizer accounted for approximately 7.0% and 7.0%, respectively, of our total revenues and 4.7% and 3.2% of total trade accounts receivable, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11.&#160;&#160;SETTLEMENT OF CONTINGENT LIABILITY</font><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In June of 2008 as part of selling our Baltimore Clinical Pharmacology Research Unit, we subleased the building space it occupied to the purchaser of the assets.&#160;&#160;We remained contingently liable for the rent payments of $800 per year through 2015 in the event the sublessor did not perform.&#160;&#160;In 2009, the purchaser ceased operations in Baltimore and sought to renegotiate the terms of its sublease.&#160;&#160;In March of 2010, a settlement was reached with the landlord of the building which canceled the sublessor&#8217;s and our obligations under the lease in exchange for a cash payment from the sublessor.&#160;&#160;We agreed to contribute $250 to the settlement, payable in twenty-five monthly installments of $10 without interest.&#160;&#160;We recorded the discounted liability of $216 in March 2010 and recognized the related expense in general and administrative expenses<font style="DISPLAY: inline; FONT-WEIGHT: bold">.&#160;&#160;</font>At September 30, 2010, the balance of this liability was $185.</font></div>
<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-18</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12.&#160;&#160;CONSOLIDATED QUARTERLY FINANCIAL DATA (UNAUDITED)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following is a summary of the unaudited quarterly results of operations for fiscal years 2010 and 2009 (in thousands except per share amounts).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="90%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">First</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Quarter</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Second</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Quarter</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Third</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Quarter</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Fourth</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Quarter</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,377</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,935</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,064</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,405</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross Profit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,196</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,485</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,671</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,981</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net income (loss)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,488</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,212</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">288</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(279</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net income (loss) per share</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net income (loss) per share</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,076</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,066</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,521</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross Profit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,047</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">872</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,135</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,550</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,584</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,831</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(632</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,416</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net loss per share</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.32</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.29</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net loss per share</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.32</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.29</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13.&#160;&#160;&#160;SUBSEQUENT EVENTS</font><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On November 29, 2010, Regions agreed to accept a $500 principal payment on a note with $1.1 million of principal maturing on December 18, 2010 and a $500 principal payment on another note with $1.3 million of principal maturing on February 11, 2011.&#160;&#160;Thereafter, the unpaid principal on the notes will then be incorporated into a replacement note maturing on November 1, 2012.&#160;&#160;On December 17, 2010, we made the $500 principal payment on the $1.1 million note. On December 15, 2010, EGC agreed to provide back-up financing up to $300 towards the second $500 principal payment on the $1.3 million note.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 23, 2010, we negotiated an amendment to our line of credit agreement with EGC, extending the maturity date until January 31, 2013 and reducing the minimum tangible net worth covenant requirement. See Note 6 for additional information.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">No additional matters were identified that would materially impact our consolidated financial statements or require disclosure.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14.&#160;&#160;RISKS AND UNCERTAINTIES</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our long-term strategic objective is to maximize the Company&#8217;s intrinsic value per share.&#160;&#160;&#160;However, in the second quarter of fiscal 2009, in response to cancellations and delays of projects by our customers, we began to operate the business in a manner designed to place more emphasis on cash flow generation.&#160;&#160;Thus, our short-term tactical objective is to maximize free cash flow from operating activities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The overall economic downturn first began to negatively affect our operating results in fiscal 2009 and continued to negatively impact revenues in fiscal 2010.&#160;&#160;Revenues for fiscal 2010 declined approximately 9.5% or $3 million from our prior fiscal year due to study delays and cancellations initiated by the sponsors as well as price declines for accepted work.&#160; The lower sales volume and a decrease in our operating expenses created a net loss of $2.7 million, which is a 51% improvement from the prior fiscal year&#8217;s net loss of $5.5 million.&#160;&#160;We experienced a 16% increase in revenue in the second half versus the first half of fiscal 2010 as the volume of bookings improved and products customers increased capital spending.&#160;&#160;&#160;To improve cash flow and reduce our break-even level, we implemented additional cost reductions starting in the second quarter of fiscal 2010.&#160;&#160;One such control was a reduction in work force, through both attrition and terminations, impacting all areas of operations.&#160;&#160;This reduced our annual compensation expense and is expected to save us approximately $2.4 million annually.&#160;&#160;These and other cost control measures resulted in the reduction of operating expenses, excluding goodwill impairment, by approximately 20% ($2.4 million) in fiscal 2010 compared to the prior fiscal year.&#160;&#160;In addition, we reduced our capital expenditures by 46% ($400) in fiscal 2010.</font></div>
<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-19</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page72"><!--EFPlaceholder--></a>In fiscal 2011, we will continue to monitor and address the impact that the challenging economy is having on our company and industry.&#160;&#160;&#160;In fiscal 2011, we expect to see slow but continued improvement in the volume of new bookings, but little improvement in pricing.&#160;&#160;We also expect improved gross profit margins due to the cost controls implemented.&#160;&#160;If current economic factors and industry trends for the CRO industry continue or deteriorate in fiscal 2011, our results of operations could be adversely affected.&#160;&#160;We have renegotiated our note payable and one mortgage, which were set to expire in December 2010 and February 2011, respectively, to extend the maturity dates to November 2012.&#160;&#160;We will continue to assess the need for additional cost controls such as freezing non-essential capital expenditures and current wage rates, reducing employee costs through personnel reductions either by attrition or reduction in workforce, reducing non-essential expenses, and monitoring our operations for efficiencies to further reduce our break-even point.&#160;&#160;We have debt and lease obligations of approximately $3.0 million in fiscal 2011.&#160;&#160;Based on our expectation of a small increase in revenue, the availability on our line of credit, and the impact of the cost reductions implemented, we project that we will have the liquidity required to meet our fiscal 2011 operations and debt obligations.</font></div>
<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-20</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To the Board of Directors</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems Inc.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have audited the consolidated balance sheets of Bioanalytical Systems, Inc. as of September 30, 2010 and 2009, and the related consolidated statements of operations, shareholders' equity and comprehensive loss and cash flows for the years then ended.&#160;&#160;These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.&#160;&#160;The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.&#160;&#160;Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting.&#160;&#160;Accordingly, we express no such opinion.&#160;&#160;An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Bioanalytical Systems, Inc as of September 30, 2010 and 2009, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">/s/ Crowe Horwath LLP</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indianapolis, Indiana</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">January 12, 2011</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-21</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In thousands)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December 31,</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September 30,</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Unaudited)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assets</font></font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,238</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,422</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts receivable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trade</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,704</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,670</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unbilled revenues and other</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,133</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,298</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,618</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Refundable income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prepaid expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">496</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">555</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current assets</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,205</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,634</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Property and equipment, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,233</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19,439</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Goodwill</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,383</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intangible assets, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">76</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">84</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Debt issue costs</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">96</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">123</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">67</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">80</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">29,060</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">29,743</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liabilities and shareholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,535</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,911</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,688</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,848</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Customer advances</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,718</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,582</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income tax accruals</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revolving line of credit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,460</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair value of interest rate swaps</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current portion of capital lease obligation</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">470</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">524</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current portion of long-term debt</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,376</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,855</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current liabilities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,279</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11,976</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capital lease obligation, less current portion</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">513</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">623</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long-term debt, less current portion</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,252</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,477</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders&#8217; equity:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Preferred Shares:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Authorized 1,000 shares; none issued and outstanding</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares, no par value:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Authorized 19,000 shares; issued and outstanding 4,915 at </font>December 31, 2010 and September 30, 2010</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,191</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,191</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Additional paid-in capital</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,412</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13,357</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated deficit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3,671</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3,981</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated other comprehensive income</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">84</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">100</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total shareholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">11,016</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">10,667</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total liabilities and shareholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">29,060</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">29,743</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The accompanying notes are an integral part of the condensed consolidated financial statements.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-22</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In thousands, except per share amounts)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Unaudited)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,143</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,811</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product revenue</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,947</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,566</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,090</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,377</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost of service revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,668</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost of product revenue</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">706</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">611</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total cost of revenue</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,374</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,181</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross profit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,716</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,196</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating expenses:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Selling</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">685</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">785</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">112</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">171</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">General and administrative</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,381</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,487</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total operating expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,178</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,443</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating income (loss)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">538</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,247</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest expense</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(235</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(241</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other income</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">7</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income (loss) before income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,488</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income taxes</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net income (loss)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">310</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1,488</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net income (loss) per share</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net income (loss) per share</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(0.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted common shares outstanding:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,981</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The accompanying notes are an integral part of the condensed consolidated financial statements.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-23</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(In thousands)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Unaudited)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Three Months Ended December 31,</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating activities:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net income (loss)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,488 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Depreciation and amortization</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">530</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee stock compensation expense</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision for doubtful accounts</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gain on interest rate swaps</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(21 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss on sale of property and equipment</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deferred income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(8 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes in operating assets and liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts receivable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,437</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">55</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(160 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Refundable income taxes</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#8212;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prepaid expenses and other assets</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">85</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(376 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">53</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accrued expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(160 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(526 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Customer advances</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">136</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">53</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash provided by operating activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">737</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">242</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Investing activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Capital expenditures</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(311 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(57 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash used by investing activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(311 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(57 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financing activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments of long-term debt</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(704 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(128 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments on revolving line of credit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7,752 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7,334 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Borrowings on revolving line of credit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,017</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,144</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Payments on capital lease obligations</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(164 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(191 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash used by financing activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(603 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(509 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of exchange rate changes</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(22 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 54pt; TEXT-INDENT: -54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net decrease in cash and cash equivalents</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(184 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(346 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents at beginning of period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,422</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">870</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents at end of period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,238</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">524</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">The accompanying notes are an integral part of the condensed consolidated financial statements.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-24</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Amounts in thousands unless otherwise indicated)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Unaudited)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DESCRIPTION OF THE BUSINESS AND BASIS OF PRESENTATION</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc. and its subsidiaries (&#8220;We,&#8221; the &#8220;Company&#8221; or &#8220;BASi&#8221;) engage in contract laboratory research services and other services related to pharmaceutical development. We also manufacture scientific instruments for life sciences research, which we sell with related software for use in industrial, governmental and academic laboratories. Our customers are located throughout the world.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have prepared the accompanying unaudited interim condensed<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles (&#8220;GAAP&#8221;), and therefore should be read in conjunction with our audited consolidated financial statements, and the notes thereto, for the year ended September 30, 2010.&#160;&#160;In the opinion of management, the condensed consolidated financial statements for the three months ended December 31, 2010 and 2009 include all adjustments which are necessary for a fair presentation of the results of the interim periods and of our financial position at December 31, 2010. The results of operations for the three months ended December 31, 2010 are not necessarily indicative of the results for the year ending September&#160;30, 2011.</font></div></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">STOCK-BASED COMPENSATION</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The 2008 Stock Option Plan (&#8220;the Plan&#8221;) is used to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees and aligning their interests with those of our shareholders.&#160;&#160;The Plan is described more fully in Note 8 in the Notes to the Consolidated Financial Statements in our Form 10-K for the year ended September 30, 2010.&#160;&#160;All options granted under the plan had an exercise price equal to the market value of the underlying common shares on the date of grant.&#160;&#160;We expense the estimated fair value of stock options over the vesting periods of the grants.&#160;&#160;We recognize expense for awards subject to graded vesting using the straight-line attribution method, reduced for estimated forfeitures. Forfeitures are revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates and an adjustment is recognized at that time.&#160;&#160;The assumptions used are detailed in Note 8 to the Consolidated Financial Statements in our Form 10-K for the year ended September 30, 2010.&#160;&#160;Stock based compensation expense for the three months ended December 31, 2010 and 2009 was $54 and $89 with no tax benefits, respectively.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>A summary of our stock option activity for the three months ended December 31, 2010 is as follows (in thousands except for share prices):</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="center">
<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted-</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted-</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average&#160;Grant</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Options</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average&#160;Exercise</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date&#160;Fair</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(shares)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Price</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Value</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding - October 1, 2010</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">705</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.66</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.82</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercised</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Terminated</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(15</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.73</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.33</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding - December 31, 2010</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">690</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.63</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.81</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INCOME (LOSS) PER SHARE</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We compute basic income (loss) per share using the weighted average number of common shares outstanding.&#160;&#160;We compute diluted income (loss) per share using the weighted average number of common and potential common shares outstanding. Potential common shares include the dilutive effect of shares issuable upon exercise of options to purchase common shares.&#160;&#160;Shares issuable upon exercise of options were excluded from the computation of income (loss) per share for the quarter ended December 31, 2009, as they are anti-dilutive.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-25</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table reconciles our computation of basic income (loss) per share to diluted income (loss) per share:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Three Months Ended</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December 31,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net income (loss) per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net income (loss) applicable to common shareholders</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,488</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic net income (loss) per share</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">0.06</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(0.30</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net income (loss) per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net income (loss) applicable to common shareholders</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">310</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1,488</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,915</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Dilutive stock options/shares</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">66</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">&#8212;</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 4px; MARGIN-LEFT: 9pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,981</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">4,915</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted net income (loss) per share</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">0.06</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(0.30</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INVENTORIES</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Inventories consisted of the following:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December 31,</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">September 30,</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Raw materials</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,417</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Work in progress</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">300</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">283</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Finished goods</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">263</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">218</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,035</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Obsolescence reserve</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(362</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(362</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,618</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,673</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SEGMENT INFORMATION</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions.&#160;&#160;Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2010.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-26</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" nowrap valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Three Months Ended</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December 31,</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Revenue:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,143</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,811</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,947</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">1,566</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">8,090</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">6,377</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating income (loss):</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">228</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,193</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">310</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(54</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">538</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1,247</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INCOME TAXES</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use the asset and liability method of accounting for income taxes.&#160; We recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. We measure deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We recognize the effect on deferred tax assets and liabilities of a change in tax rates in income in the period that includes the enactment date.&#160;&#160;We record valuation allowances based on a determination of the expected realization of tax assets.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We recognize the tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. We measure the amount of the accrual for which an exposure exists as the largest amount of benefit determined on a cumulative probability basis that we believe is more likely than not to be realized upon ultimate settlement of the position.&#160;&#160;At December 31, 2010 and September 30, 2010, we had a $30 liability for other uncertain income tax positions.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We record interest and penalties related to income tax matters as a component of income tax expense.&#160;&#160;Over the next twelve months we do not expect the total amount of unrecognized tax benefits to change significantly.&#160; Interest and penalties are included in the reserve.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We file income tax returns in the U.S., several U.S. States, and the United Kingdom.&#160;&#160;We remain subject to examination by taxing authorities in the jurisdictions in which we have filed returns for years after 2006.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have an accumulated net deficit in our UK subsidiary. Therefore, we continue to maintain a full valuation allowance on the UK subsidiary deferred income tax balance. Also, a valuation allowance was established in fiscal 2009 against the US deferred income tax balance.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DEBT</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Mortgages and note payable</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have notes payable to Regions aggregating approximately $7,500. Regions notes payable include three outstanding mortgages on our facilities in West Lafayette and Evansville, Indiana, which total $6,901.&#160;&#160;Two of the mortgages mature in November 2012 with an interest rate fixed at 7.1%, while the other matures in February 2011 with an interest rate of 6.1%.&#160;&#160;In addition to the mortgages, we also have a note payable with Regions, which matured on December 18, 2010.&#160;&#160;The annual interest rate on this term loan is equal to 6.1%. Monthly payments are $9 plus interest. The notes payable are collateralized by real estate at our West Lafayette and Evansville, Indiana locations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On November 29, 2010, we executed amendments on two loans with Regions (&#8220;Regions&#8221;).&#160;&#160;Regions agreed to accept a $500 principal payment on a note payable with $1.1 million of principal maturing on December 18, 2010 and a $500 principal payment on one mortgage with $1.3 million of principal maturing on February 11, 2011.&#160;&#160;The principal payments are to be made on or before December 18, 2010 and February 11, 2011, respectively.&#160;&#160;Thereafter, the unpaid principal on the note payable and the mortgage will be incorporated into a replacement note maturing on November 1, 2012.&#160;&#160;The replacement note will bear interest at a monthly LIBOR plus 300 basis points (minimum of 4.5%) with monthly principal amortization.&#160;&#160;On December 17, 2010, we made the $500 principal payment on the $1.1 million note.&#160;&#160;Since we have made the first payment and expect to have the financial capacity to make the additional $500 payment in February 2011, we have classified this debt, to the extent of the amount of debt that will be reset to a due date past September 30, 2011, as non-current.</font></div>
<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-27</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page80"><!--EFPlaceholder--></a>As part of the amendment, Regions also agreed to amend the loan covenants for the related debt to be more favorable to us.&#160;&#160;Provided we comply with the revised covenant ratios, the amendment removes limitations on the Company&#8217;s purchase of fixed assets.&#160;&#160;&#160;The covenants, which are common to such agreements, include maintenance of certain financial ratios including a fixed charge coverage of 1.25 to 1.0 and total liabilities to tangible net worth of no greater than 2.1 to 1.0. &#160;At December 31, 2010 we were in compliance with these ratios and based on projections for fiscal 2011, we expect to be in compliance with our covenants throughout fiscal 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Regions loans contain both cross-default provisions with each other and with the revolving line of credit with Entrepreneur Growth Capital described below.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Revolving Line of Credit</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 13, 2010, we entered into a new $3,000 revolving line of credit agreement (&#8220;Credit Agreement&#8221;) with Entrepreneur Growth Capital LLC (&#8220;EGC&#8221;), which we use for working capital and other purposes, to replace the PNC Bank line of credit that expired on January 15, 2010.&#160;&#160;The initial term of the Credit Agreement was set to expire on January 31, 2011.&#160;&#160;If we prepay prior to the expiration of the initial term (or any renewal term), then we are subject to an early termination fee equal to the minimum interest charges of $15 for each of the months remaining until expiration.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Borrowings bear interest at an annual rate equal to Citibank&#8217;s Prime Rate plus five percent (5%), or 8.25% as of December 31, 2010, with minimum monthly interest of $15.&#160;&#160;Interest is paid monthly.&#160;&#160;The line of credit also carries an annual facilities fee of 2% and a 0.2% collateral monitoring fee.&#160;&#160;Borrowings under the Credit Agreement are secured by a blanket lien on our personal property, including certain eligible accounts receivable, inventory, and intellectual property assets, a second mortgage on our West Lafayette and Evansville real estate and all common shares of our U.S. subsidiaries and 65% of the common shares of our non-United States subsidiary. Borrowings are calculated based on 75% of eligible accounts receivable.&#160;&#160;Under the Credit Agreement, the Company has agreed to restrict advances to subsidiaries, limit additional indebtedness and capital expenditures and comply with certain financial covenants outlined in the Credit Agreement.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 23, 2010, we negotiated an amendment to this Credit Agreement.&#160;&#160;As part of the amendment, the maturity date was extended to January 31, 2013.&#160;&#160;The Amendment reduced the minimum tangible net worth covenant requirement from $9,000 to $8,500 and waived all non-compliances with this covenant through the date of the Amendment. The Credit Agreement also contains cross-default provisions with the Regions loans and any future EGC loans. At December 31, 2010, we were in compliance with the minimum tangible net worth covenant requirement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At December 31, 2010, we had available borrowings of $2,120 on this line, of which $1,460 was outstanding.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FAIR VALUE OF FINANCIAL INSTRUMENTS</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The carrying amounts for cash and cash equivalents, accounts receivable, inventories, prepaid expenses and other assets, accounts payable and other accruals approximate their fair values because of their nature and respective duration.&#160;&#160;The fair value of the revolving credit facility and certain long-term debt is equal to their carrying values due to the variable nature of their interest rates.&#160;&#160;Our long-term fixed rate debt was adjusted to market rate on June 30, 2010, which we believe approximates market rates for similar debt instruments at December 31, 2010.</font><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">COMPREHENSIVE INCOME (LOSS)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Total comprehensive income (loss) is comprised of the total net income (loss) as well as the change in foreign currency translation. The table below presents comprehensive income (loss) for the three months ended December 31, 2010 and 2009, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="MARGIN-LEFT: 36pt; TEXT-ALIGN: left">
<table cellpadding="0" cellspacing="0" width="70%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-ALIGN: left; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December 31, 2010</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">December 31, 2009</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr style="TEXT-ALIGN: left;">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" nowrap valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net income (loss) as reported</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">310</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,488</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign currency translation adjustments</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(16</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(18</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr bgcolor="#ccffcc">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Comprehensive income (loss)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">294</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">(1,506</font></font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NEW ACCOUNTING PRONOUNCEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In August 2008, the SEC announced that it will issue for comment a proposed roadmap regarding the potential use by U.S. issuers of financial statements prepared in accordance with IFRS (International Financial Reporting Standards). IFRS is a comprehensive series of accounting standards published by the IASB (International Accounting Standards Board). Under the proposed roadmap, we could be required to prepare financial statements in accordance with IFRS beginning in fiscal 2014. The SEC has indicated it will make a determination in 2011 regarding mandatory adoption of IFRS.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>In October&#160;2009, the FASB issued an Accounting Standards Update on the accounting for revenue recognition to specifically address how to determine whether an arrangement involving multiple deliverables contains more than one unit of accounting.&#160; This guidance was effective for revenue arrangements entered into or materially modified beginning October 1, 2010.&#160;This update has not impacted revenue in the periods presented, and we do not expect a material change from the methods in which we have historically reported revenues.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">F-28</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><img src="logo1.jpg"></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5,000 6% Series A Convertible Preferred Shares</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(and _____ Common Shares underlying the 6% Series A Convertible Preferred Shares)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_____ Warrants</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(and _____ Common Shares underlying the Warrants)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div>
<hr style="COLOR: black" align="center" noshade size="1" width="20%">
</div>

&#160;<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Prospectus</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<hr style="COLOR: black" align="center" noshade size="1" width="20%">
<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PART II</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INFORMATION NOT REQUIRED IN PROSPECTUS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 13. Other Expenses of Issuance and Distribution</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table sets forth the expenses (estimated except for the registration fee) expected to be incurred in connection with this offering.</font><br>
&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">SEC Registration Fee</font> </div>
</td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">685</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Legal Fees and Expenses</font> </div>
</td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">150,000</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounting Fees and Expenses</font> </div>
</td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50,000</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Printing Expenses</font> </div>
</td>
<td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20,000</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="#ccffcc">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Miscellaneous</font> </div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29,315</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">250,000</font> </td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div>&#160;</div>

<div>
<hr style="COLOR: black" align="left" noshade size="1" width="20%">
</div>

<div>
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt; TEXT-ALIGN: left">
<div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*&#160;</font></div>
</td>
<td align="left">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">To be completed by amendment.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 14. Indemnification of Directors and Officers</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indiana Business Corporation Law</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chapter 37 of the Indiana Business Corporation Law, as amended (the "IBCL"), authorizes every Indiana corporation to indemnify its officers and directors under certain circumstances against liability incurred in connection with proceedings to which the officers or directors are made a party by reason of their relationship to the corporation. Officers and directors may be indemnified where they have acted in good faith, which means, in the case of official action, they reasonably believed the conduct was in the corporation&#8217;s best interests, and in all other cases, they reasonably believed the action taken was not against the best interests of the corporation, and in the case of criminal proceedings they had reasonable cause to believe the action was lawful or there was no reasonable cause to believe the action was unlawful. Chapter 37 of the IBCL also requires every Indiana corporation to indemnify any of its officers or directors (unless limited by the articles of incorporation of the corporation) who were wholly successful, on the merits or otherwise, in the defense of any such proceeding against reasonable expenses incurred in connection with the proceeding. A corporation may also, under certain circumstances, pay for or reimburse the reasonable expenses incurred by an officer or director who is a party to a proceeding in advance of final disposition of the proceeding. Chapter 37of the IBCL states that the indemnification provided for therein is not exclusive of any other rights to which a person may be entitled under the articles of incorporation, bylaws or resolutions of the board of directors or shareholders.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our second amended and restated articles of incorporation and second amended and restated bylaws provide for indemnification, to the fullest extent permitted by the IBCL, of our directors, officers and employees against liability and reasonable expenses that may be incurred by them in connection with proceedings in which they are made a party by reason of their relationship to the company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Directors&#8217; and Officers&#8217; Liability Insurance</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We maintain directors&#8217; and officers&#8217; liability insurance policies, which insure against liabilities that directors or officers may incur in such capacities. These insurance policies may be sufficiently broad to permit indemnification of our directors and officers for liabilities, including reimbursement of expenses incurred, arising under the Securities Act or otherwise.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 15. Recent Sales of Unregistered Securities</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">None.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 16. Exhibits and Financial Statement Schedules.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">See Exhibit Index</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.</font></div>
</td>
</tr></table>
</div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item 17. Undertakings</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The undersigned registrant hereby undertakes:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i. To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii. To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iii. To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5) Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(6) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i. Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii. Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iii. The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iv. Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(7) For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(8) For the purposes of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(9) That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of West Lafayette, State of Indiana, on May 2, 2011.</font> </div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><br>
&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">BIOANALYTICAL SYSTEMS, INC.</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="47%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="top" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:&#160;</font></div>
</td>
<td align="left" valign="top" width="47%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ Michael R. Cox</font></font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Michael R. Cox</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vice President-Finance, Chief Financial and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Administrative Officer and Treasurer</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">KNOWN ALL BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Anthony S. Chilton, Ph.D. and Michael R. Cox, and each of them singly, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to sign any registration statement for the same offering covered by this Registration Statement that is to be effective upon filing pursuant to Rule&#160;462(b) promulgated under the Securities Act, and all post-effective amendments thereto, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their, his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</font><br>
&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Signature</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Title</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Date</font></font> </div>
</td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ Anthony S. Chilton, Ph.D.*</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Anthony S. Chilton, Ph.D.</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">President and Chief Executive Officer (principal</font> </div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">executive officer)</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font> </div>
</td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td align="left" valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ Michael R. Cox</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Vice President-Finance, Chief Financial and</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Michael R. Cox</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Administrative Officer and Treasurer (principal</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">financial and accounting officer)</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td align="left" valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ John B. Landis, Ph.D.*</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">John B. Landis, Ph.D.</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td align="left" valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ Larry S. Boulet*</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Larry S. Boulet</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td align="left" valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ David W. Crabb, M.D.*</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David W. Crabb, M.D.</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td align="left" valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ David L. Omachinski*</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">David L. Omachinski</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td valign="top" width="35%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
</tr><tr>
<td align="left" valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">/s/ A. Charlene Sullivan, Ph.D.*</font></font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Director</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">A. Charlene Sullivan, Ph.D.</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="43%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td valign="top" width="18%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> &#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*By:&#160;&#160;/s/ Michael R. Cox</font></div>
</td>
<td valign="top" width="65%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="35%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Michael R. Cox, Attorney-in-fact</font></div>
</td>
<td valign="top" width="65%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT INDEX</font><br>
&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exhibit&#160;No.</font></div>
</div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Description</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; &#160;1.1&#8224; </font></div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form of Placement Agency Agreement</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;3.1</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Second Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to Form 10-Q for the quarter ended December 31, 1997, SEC file number 000-23357).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;3.2</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to Form 10-K for the fiscal year ended September 30, 2009).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;4.1</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Specimen Certificate for Common Shares (incorporated by reference to Exhibit 4.1 to Registration Statement on form S-1, Registration No. 333-36429).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; &#160;4.2&#8224; </font></div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form of Warrant</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;4.3&#8224;</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form of Certificate of Designation of Preferences, Rights, and Limitations of Convertible Preferred Shares</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;&#160;5.1&#8224;</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Opinion of Ice Miller LLP</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.1</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loan Agreement between Bioanalytical Systems, Inc. and Regions Bank dated December 18, 2007 (incorporated by reference to Exhibit 10.7 of Form 10-K for the fiscal year ended September 30, 2007).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.2</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form of Grant of non-qualified stock options dated April 1, 2004 to Michael R. Cox (incorporated by reference to Exhibit 10.3 to Form 10-Q for the fiscal quarter ended March 31, 2004, SEC file number 000-23357).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.3</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Agreement for Lease, by and among Bioanalytical Systems, Inc., Bioanalytical Systems Limited, Abbey (Deer) Park Management Limited and Pettifer Estates Limited, dated October 11, 2007 (incorporated by reference to Exhibit 10.1 to Form 8-K filed October 17, 2007).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.4</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form of Lease, by and among Bioanalytical Systems, Inc., Bioanalytical Systems Limited and Pettifer Estates Limited (incorporated by reference to Exhibit 10.2 to Form 8-K filed October 17, 2007).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.5</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employment Agreement between Michael R. Cox and Bioanalytical Systems, Inc., dated November 6, 2007 (incorporated by reference to Exhibit 10.1 to Form 8-K filed November 13, 2007).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.6</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee Incentive Stock Option Agreement between Michael R. Cox and Bioanalytical Systems, Inc., dated November 6, 2007 (incorporated by reference to Exhibit 10.2 to Form 8-K filed November 13, 2007).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.7</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bioanalytical Systems, Inc. 2008 Director and Employee Stock Option Plan (incorporated by reference to Appendix A to the Revised Definitive Proxy Statement filed February 5, 2008, SEC File No. 000-23357).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.8</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form of Bioanalytical Systems, Inc. 2008 Employee Incentive Stock Option Agreement (*) (incorporated by reference to Exhibit 10.31 to Form 10-K for the fiscal year ended September 30, 2008).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.9</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employment Agreement between Anthony S. Chilton and Bioanalytical Systems, Inc., dated December 1, 2008 (incorporated by reference to Exhibit 10.1 to Form 8-K filed November 14, 2008).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.10</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee Incentive Stock Option Agreement between Anthony S. Chilton and Bioanalytical Systems, Inc., dated December 1, 2008 (incorporated by reference to Exhibit 10.36 to Form 10-K for the fiscal year ended September 30, 2008).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.11</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Temporary amendment to Loan Covenant between Bioanalytical Systems, Inc. and Regions Bank, dated May 18, 2009 (incorporated by reference to Exhibit 10.3 to Form 10-Q for the fiscal quarter ended March 31, 2009).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.12</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Third amendment to Loan Agreement between Bioanalytical Systems, Inc. and Regions Bank, dated January 13, 2010 (incorporated by reference to Exhibit 10.34 to Form 10-K for the fiscal year ended September 30, 2009).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.13</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loan and Security Agreement by and between Bioanalytical Systems, Inc., and Entrepreneur Growth Capital LLC, executed January 13, 2010 (incorporated by reference to Exhibit 10.35 to Form 10-K for the fiscal year ended September 30, 2009).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.14</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Master Lease Agreement, by Bioanalytical Systems, Inc. and Forum Financial Services, dated January 22, 2010 (incorporated by reference to Exhibit 10.5 to Form 10-Q for the fiscal quarter ended December 31, 2009).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.15</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amended and Restated Employment Agreement between Anthony S. Chilton and Bioanalytical Systems, Inc., dated February 1, 2010 (incorporated by reference to Exhibit 10.6 to Form 10-Q for the fiscal quarter ended December 31, 2009).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.16</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee Incentive Stock Option Agreement between Anthony S. Chilton and Bioanalytical Systems, Inc., dated February 1, 2010 (incorporated by reference to Exhibit 10.7 to Form 10-Q for the fiscal quarter ended December 31, 2009).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.17</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment to Employment Agreement between Michael R. Cox and Bioanalytical Systems Inc., dated April 15, 2010 (incorporated by reference to Exhibit 10.1 to Form 10-Q for the fiscal quarter ended June 30, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.18</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee Incentive Stock Option Agreement between Michael R. Cox and Bioanalytical Systems Inc. dated April 15, 2010 (incorporated by reference to Exhibit 10.2 to Form 10-Q for the fiscal quarter ended June 30, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.19</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Promissory Note between Bioanalytical Systems, Inc. and Algorithme Holding Inc. dated April 30, 2010 (incorporated by reference to Exhibit 10.1 to Form 8-K filed May 3, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.20</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employee Incentive Stock Option Agreement between Anthony S. Chilton and Bioanalytical Systems, Inc., dated May 12, 2010 (incorporated by reference to Exhibit 10.5 to Form 10-Q for the fiscal quarter ended June 30, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.21</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment to Loan and Security Agreement between Bioanalytical Systems, Inc., and Entrepreneur Growth Capital LLC, dated May 13, 2010 (incorporated by reference to Exhibit 10.9 to Form 10-Q for the fiscal quarter ended March 31, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.22</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Employment Agreement between Alberto F. Hidalgo and Bioanalytical Systems Inc., dated August 18, 2010 (incorporated by reference to Exhibit 10.22 to Form 10-K for the fiscal year ended September 30, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.23</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Non-Qualified Employee Stock Option Agreement between Alberto F. Hidalgo and Bioanalytical Systems Inc., dated August 18, 2010 (incorporated by reference to Exhibit 10.23 to Form 10-K for the fiscal year ended September 30, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.24</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fourth Amendment to Loan Agreement between Bioanalytical Systems, Inc. and Regions Bank, executed November 29, 2010 (incorporated by reference to Exhibit 10.1 for Form 8-K filed December 2, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.25</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment to Loan and Security Agreement between Bioanalytical Systems, Inc., and Entrepreneur Growth Capital LLC, dated December 23, 2010 (incorporated by reference to Exhibit 10.1 to Form 8-K filed December 30, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.26</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amendment to the Fourth Amendment to Loan Agreement between Bioanalytical Systems, Inc. and Regions Bank, as amended on December 29, 2010 (incorporated by reference to Exhibit 10.1 for Form 8-K filed January 5, 2011).</font></div>
</td>
</tr></table>

<div>&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E-1</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.27&#8224;</font> </div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font> </td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form of Securities Purchase Agreement</font> </div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.28</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fifth Amendment to Loan Agreement between Bioanalytical Systems, Inc. and Regions Bank on February 22, 2011 (incorporated by reference to Exhibit 10.1 for Form 8-K filed February 24, 2011).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21.1</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Subsidiaries of Bioanalytical Systems, Inc. (incorporated by reference to Exhibit 21.1 to Form 10-K for the fiscal year ended September 30, 2010).</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.1&#8224;</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent of Crowe Horwath LLP</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23.2&#8224;</font> </font></div>
</td>
<td valign="top" width="2%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consent of Ice Miller LLP (included in Exhibit 5.1)</font> </font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24.1</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="86%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Powers of Attorney (see signature page)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<hr style="COLOR: black" align="left" noshade size="1" width="20%">
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#8224;</font>&#160;&#160;&#160;&#160;Filed herewith.</font> </div>

<div><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">E-2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`*0"Z`P$1``(1`0,1`?_$`*\```$$`P$!`0``````
M```````&!P@)!`4*`@,+`0$``04!`0$`````````````"`,%!@<)`0($$```
M!@$$`0(#`PD)`0`````!`@,$!08'`!$2"!,A"3$B%#,5%D$R8K(C-747.$)2
M)#2T53:V-W<1``$"!0,#`@,#!PP#`0````$"`P`1!`4&(1(',4$((A-1,A1A
M<2/P0C-S%18W@9&AP='A\6*SM"5U<D0F%__:``P#`0`"$0,1`#\`[J,IYHQ;
MA.#+8LHW6$I\8J<4F@R;@?K)!8H;BA&QJ!5I"06#\I44S[;^NVL8RG,\7PJA
M_:.45K%'3$R3O/J6?@A`FM9^Q(,9GA7'N:<BW(VG"[=45]8D35[:?0@?%QQ4
MD('VJ4)]HC]2_<)ZAWN42AHC,$4P?KK%;MBV>*GJH@Y6.;B1-%Y88N/9F,<?
MA\X`.M?V;R"XCOM4*.DO#3;ZE23[R'6`HGH`IU"$Z_?&TLA\5N>,:HC<*ZP/
MNTR4[E&G<9J5)`ZDH8<6H2^Z)E-735\V0>,G*#QHY2(NV=-5DW#9PBH4#)K(
M+I&.DJD<H[@8HB`A\-;C:=:?;2\RI*V5`$*2000>A!&A![$1']YAZF>53U"%
M-OH40I*@4J21U!!D01W!$X\J/6:+ELR5=MDGCPBZC1HHND1RZ3:@F+D[9`Q@
M57(W!4HJ"4!`G(-]MPU4BE&3I"$O;I"W1L29U2ZU$VJ7(I^ZIBSJU-NH@!#F
M,*4FE7K&'U`G`I2D.B0@[[B<NVK7=ZB[TU)[MFIFJJK!^1QXL`B1Z+#3VO0`
M%(&NJA%ZL5+8JRN#.0UC]#0$?I6J<5*@9CJV7V/3*9)"B=)!)G%2^2/=FDL3
M7>PX\O/6*9BK36'OT4JR)E2'=I%.9,BZ"S=TWJ!T7#9TW4*HF<H[&(8!U$_(
M_*^IQ2]U&/7S&7FKI3+VK3]<VH=)@A0IR"%`@@CJ#$Y<1\'*/.<<I<KQO,J=
M^RUC>]M9MKJ3*9!"DJJ@4J2H%*@>A!B3V,^V&:\S42%R-B_JV2Q5>::&,@N]
MSA5H!X22:J'0DHT6<G6"*"#-T02%6$2D5#Y@``ULW&>5LTS.Q,Y'C&+BHM;R
M-"JY,-*WI)"T;5L@^E0D%:!742C368<'\=\?9+48EF6:&DO-.L3"+/4OH+:@
M%-N;VZ@CUI,R@3*>AF89&]>Y[)89MQ*?G3J[D'',@<GU")V]N@;*D^8`<4SO
MHEPE&Q4=*H$5#B(I.!`!^(AZ;X5??)NIPV["T9SB]PMU01,2?:>"D]-S9"$(
M6)Z>E?WQL7&O#:DY!L1OW&N:6J[4H.TA5*]3E"Y3"'4EQQQI1&LE-_<#$T.O
MG:W#'9F->N\96%5:4B4TU9JK330T598A)80*DX<L#G53<,U#_*"[=19'E\O(
M!]-;EX^Y5PWDNF6[C-035-`%QAQ.QYL'H2B9!23IN25)GI.<1\Y4X1Y!X>K&
MV,QI4IHGR0U4LJ]RG=(ZI2L`%*@-=BTI5+64HD<<Y$R&44,4B9"F.<YS`4A"
M%`3&,8QA`"E*`;B(^@!K8Q(2"I1`2!J8U(E*E*"4@E1,@!U)^`BE?*ON],*5
ME*S4^IXQ8VZH5J>/"#:C6-9HO*@Q6!O*O6+1-@LD"*2Q5"I;F'GPW^`AJ%^4
M^73%ERBIM%IMB*NT4U06_?\`>*2YM,EJ2D)(D#,)UUE/O'0["?`^IR+"Z._7
MR\N4%^K*4/?3>P%);WC<TA:BL&9&TJT],Y=08M^H=UK^1Z96;Y57A7]>MD,Q
MFXIR42B86SU$JGA7*4Q@2=M5!,DLGONFJ0Q1]0'4N[%>K?D=FIK[:EARWU;*
M7$*_RJ$Y'X*29I4.R@0=1$#,FQVZ8CD%9C-[;+5UH:A;+B?\R#*8G*:5"2D*
M_.201H89_LAVBQ=U>J2%ER(^=JO94Z[:LU:'0^KG[&]0(4RB+)`3$20;(>0H
MJKK&(DF`_$QMBCB'(_)^+\86E-RR%:R\Z2&6&QN=>4.H2.@`F-RE$`?:9",]
MXCX8S3F:^*L^*-H33L`*J*ET[6&$*)D5JU*E&1VH2"I7V"9#>5?(O<;(\"PM
MM>Q)A[&\/,MD)"(A\EW.T3-F4CG1"K-5Y!"I0R+&/4<-S`8$S*&4)R`#%#6/
MVO(N8<CH&[M;[39[;2/)"VVZRH?<>*%":2L,-A*"1K(F8[B,JO.)\`XE<W;'
M=;[?[O7TZU(==M])3M4X<29*"#5.E:PE0E,`),M##`9_[G=J.M<*=_D+K15Y
M%@Y4!G'9`J5VDI:B)/U3B5NE+MCQ*,Y&^;^P1P+<51`0(8=8!GW,O*?&]$7\
M@QJE<84=J*MBI6Y2A1Z!P>V'43[!>S=V,;2XN\?.%.7K@*;%<PK6JE`WN4-3
M1MM5I0!-1:4'2RY+N4;]NFX1/^R9+:4[$4AE:=8KKM8>EIVV0CHLHG65$8U)
MZ=FT\HB(`993@!C;\2_,.^VM^W+)6;/B+F5UR%*:9H@^M"-2?0%;4S^TRF>@
MU,1=M&'OW_.VL(MKB4O/W$TR''-`/Q"@*5+X`3('4Z#K%2.%_=QF\@Y?K=+M
M&)(J)J-QG6T'%/H&7D']CBU)!7Q,7$@BY3!E)%*80\I4"I&^(EWVVU$O#?+6
MNR#+Z:RW2T--6BL?#2%-.+4\@K,DE8(VK_S!(3]D3IY!\%+=BV!U>0V6^OOW
MZ@IE/.H>:0AAP($UI;*3O;/7:5E0^,7>ZFW'..#2$&D(-(0:0@TA',;[M3.[
M(=H".K$LZ5J3RFP"F/B*&.9FU8I,TF]A2;`(BDFNI8DESJ`&QA`P"/IMKF9Y
M8LWI')X=N!6;2NC:-).>U*0D!T#L"7@LGOJ.T=CO!E_'7.&2S:4H3?6[@^*X
MB6]2RLJ8*NY`8*`GMH0-9PHNI7M?S.=:/$Y/R;;W5'J-C0%W6X.'8(/+%+QW
MD,FG)/5GIP:Q31UP$R1>"BQB^IBE`0WN/$WC%69U9&<GR6L70VBI3N9:;0%/
M.(G(+45>E"5?FB141J0(M/.?F7;^-,C?PW#J!%ROM(K;4/.K*&&G)`EM`0-S
MBDSDHS2D'0$D&+%Z7U^[`]+&WWAAR[2^?L0-3'<6+#%K*BQML:Q#<R\CC>7*
MLJR-(M&Z0?X$Y4DW8_*4O+B(2(LV`<@<,-?48=6NW_$$DEZW/R2^A/==&Y,I
MWI`_1D`+Z`3D8B=D/*7%OD,]]+G]N8Q?/5@)8NU,2NE<7^:BO:D%AM2C^F!4
M6QJ52F"^>9,-5KMUC&GWZK25NQ;E.#8'M6&,D$:R56O&/I]VB0XM)2,<`F=:
M'DU$"-Y-BX350<(>H`;8HC(FPWIB]VIB[TR'D4U2T%A#S:FW$@]EH4`4J'^!
M(UB*&2V"IQN^55AK'*=VKI'E-EQAU+S2BD_,VX@E*DGJ#U[$`S$,%[>WN`H=
MFPLV&<JI1E;[(XJ</XFUQ[$Z:$->FT*]7C7-LJR!E#"GS.W!1VS*8XMA/R#]
MF/RW=UK9)2?D,6)MS=Z3\PBT/5&*L<D7N)?UC9E_B$!_UF(UR8\AOXPWC]8U
M_HMQW2\4OX`X_P#JG_\`<.Q=M[=MVIM)Z:XW>7.VUJI-'4K;$VKJRSL7!-W*
MB4PY453;K2;IJFL=,@[F`HB(!ZCJ:OCQ>[-9.&[:]>:NFI&ENOA*GG4-`D.$
MD`K4D$CO*.=/E=CN09'Y`W>GQ^AK*Y]#%,5)IV7'E)!:2`5!M*B`3H)]8@9[
MG&>L==AIG'F*\)`.3['5).4DY6?J+-68;E%VV!D2OQ#IHBJ:6*L?9=8[<3H`
M*9-C&$?ET3Y,YYCO(59;L7PK_D[A2.K6MUA)<`W#;[3:D@ER?S**)IT3J3TD
MUX<\999Q5;[KFO(O_#6FN9;;;8JEAI1VJWE]U*B`U(>A`7)9W*T`&KM>V)TW
MS#B^]2>;<G1;BD1[JIO*[7ZL^5(6?EOO9VP=K2,JP2,<8QBU38%!-)807444
MW$A0)N;+?&7AW,,8OKN:Y,TJAIUTBFFF%$>ZY[BDJ*UI$]B4A(DE7J),Y`#7
M!O,CG_`<SQIGCK#GDW*J17(??J4`^PU[25I#;2S+W%J*SN4B:$I$MRBK2:O>
MK,%AJ5&@,.8T.*N8,_2Q:#4TFYQ%U#Q<@`HSUE.0@B9-)BR,<"&,'`P\@WW#
M6Z.<\ON%IL=/AV-&>7W]WZ5@#YFT+T=>^P)23(G0Z]Q$>/&K`K5?<DJL_P`P
M&W`L78^MJ2H>EUQ&K-/,]2M8!(&H$NQBJSO_`-%(K!>,<7Y$QXQ\D=6X*)I6
M4%6X**'>SB@G4:W1R8_S"$A(KJ-E3"`F'FCOZ%U%CGW@REP;&+7D6/(G3TS#
M=-6D3.YPZIJ3_P":R4*/75$^D37\7O)6MY*S&\XIE;DJNKJ7:NW!4AL9$@JD
M3+3T-@.)`TT<EUAU/:1[-"U=RO6JV/C"@],[LN,UESAP0<)IF6L=:(8YMP!P
MF0'K8A0V`Q'`B.Y@#65>)G)?M/.\;75?X:]SU&3V($WF1]X_$0!W#GQ$83YT
M\.^^PQR_8VA[K833W`)&I23)BH,A^:3[3A)Z%KLDQM/>!PID*?DZ#F2"CI&<
MI5;K+NK6-*/34<GK;I666D&\NY;($\J<>](Y\1EP`WC.3YQ*42[_`*O+W"\@
MKZJ@S&A;<?LM-3*8>"`5%E1<*PX0-0A0.TJUD1J0)1^/P*Y$Q6UT5TX_N3K5
M-D576)J6"LA(J$AH-J:2I1D5H*=P1IN2?2"=T,_UM]V.YXZAH2E9DJW\P*W#
MM&T6QM,&NFQM[1DV*"*`2+9R<8V:!J@4"@8HMU1*4`'D/KK#^./*Z]8[1L67
M,:7]H6UE`0E]HA-0E*=!O!]#FT:3&U6G<QGO+O@[CV67"IR'`*W]EW>H<4XN
MF>!72J6K57MJ2/<9W*F9'>D$F4AI%QF.>PG6?MY4Y.KP5A@;8SG8U5M8,>6=
M`L=/_1J"`*I/(%\8JRX)&`IO,U,L1,W$04`P!M,+'.0>-.7;2[:Z&H8JV7VR
M':1X;'=IZA32I$RT.Y!4`9'<#$!,MXKYAX'OC-ZN5+4T-13/!3%=3GW&-XZ%
M#R-$SU&UP)*A,%)$X4N9<XXBP17TX[(S.P)5D\&")TXVB6:S5]*&`#QH,I*2
M813R#:@=-(2"@Y7*H*>PB7B8!&YYCF^(X);Q39$BH%L+$B$4KSS0;U1M6M*%
M-"8$MJU`D:D2(,6?C_C?.^3+J:O$W*55X%3,%RMIZ=\NZ.;VVUN)>5(F>]M!
M`5H#,$"M;"&9O;2_G]2V^&\/SB&2[C:6T/7IQ>MR*4!#2DF*O!]'M9>P.F,.
M!-C;';-"&)O\NVHVX3F7C7^_U$WAUG?3DE95!MITLK#3:USDI"7'5);EKJAL
M$=HE[R-Q]Y@?_E]Q=S^_TRL0H*)3K[*:ALONMMRFA:FF$K=GIHXZ0>\XNNU-
M..=L&D(-(0:0@TA!I"(L]L^J]-[58Y4JDZ8L39XD5WU)MJ:7D<P,HJ0A5$UB
M%V,YB9$J12.4OB(`!B_,4-]6\L<66?E3'3:JXAFZ,S53/@3+2R-01^<VN0"T
M_<1J(W5P;S7D'">6B^6T%^S/[45=*3)+S8)D0?S76YDMJ^,P=#H@.I^39*`@
MX;K#F5D>F9LH,&:*9-S_`+.)R)5XTITF=OHLJ0/I9)(K,"_4HD'S-5`^8OQV
ML7$^3U%NHV.,\Q;^CS6WL[$I/Z.L91\K],OY5C;+>D>I!ZB,FYSPRDNU?4\Q
M<?N_7\=W6H]Q:D_IJ"H<D5TM8W\S:MT_;61L<'0_%E<DV_M%T0<6"X-8>V]N
MNL#^3DIY]'G?@YSMAE22=*/7B39\=!1.]T1%54YD@5(1RR`0()RI@`CO=(;=
MT^5S^@Q&HE3>O5'](B`^?/?VJK^D2L-UUQ3<X^\2C-PR;VC)0P3"/JZRQ3)"
M_:PT'+3BLP^;E,)DBJK-TR*@`G*<`$HU$4IG-9$HIJJ!+TC6*0>F]PRBQ[@X
M7M6/UI*5R-*Y-9+'!`JKA>;+./5#61*133,7S1[QHX5,X*803XAZ[``:_2X$
M^V0>DHH(*MX(ZSC]`75JBX1R1>XE_6-F7^(0'_68C7)CR&_C#>/UC7^BW'=+
MQ2_@#C_ZI_\`W#L79^W?1:1>.G&-&]UIU6MZ#&4MQV2-GK\3/)LCKS#A-=1H
M25:.BMCK$``,8G$3`'KJ:GCS8K)?.';:W>J.EK&T.U!2'FFW0DEP@E.]*MI(
MZD2G'.ORMR7(\;Y_O#N.U];0..,TH6:=]UDK"6DD!1;4G<`=0#.4)7O%TAP2
MMA>^92HU5B,8WO'E=?VQC+U1,T(SDD8-`SU>)>QK(R3(RKU%(R:"A"$436,4
M=Q#TU:^;^$L%7AE?E%CI6;9?;?3J?2XQ^&E8:&XMJ0F29J`(00`0HC6+UXX>
M1W):.0K9A>2UK]YQJZU:*9;52?>6V7CL#J'%@K`02%+224J0")"*D>IW=G.^
M(\B4Z&-;YV[T>=GX:"EZ=:)!Y.)?1RL@V9&7@G#U59[&R34%N2()G!(Y@X&(
M(".HE\4\U9UB.0T=&:Q^ML;]0VTY3OK4Z-JUA,VBHE2%B<TR,CT(D8G3SAXZ
M\9YWBE?<!04UNR2FI77FJNG0AD[VT*7)Y*`$.-JE)14-P'J"@1%W]5P3D:Z=
MC,UY^M4NUB9>,C#XWZ\NG\,>395*$,W27D;*$(Y=MTWCU5VJ*1P$Y"**D,<H
M@!M3<M>"Y%>N1;UGUT>2U6--?1VE2F]Z6&Y`K>]M2@%**B0=0"H%0,C'.2]\
MEXGCO$V.\7V6G6_0//"OOB4.AM=4]N*6Z?WDI44H"0%#0E*2$D3$;*Y]:>R>
M0JI/4FX=J(B:K5EC7$3,1R^#*N4KEHZ()%`(H2=!1!8OYQ%""!R&`!*("&OT
MWKC7DG(;2_9+QE++UMJ6BVX@VQC5*A(ZAV8/<$:@ZB/Q8]S!Q#BM\ILCL&%/
MT]WHWDNM+%XJ/2I)F)@LR([$&8(T(E'-WDFC7_J9GQ_71>K,[7C6SM)6MSZ*
M9VZ4JR;KIOX*;03!0P"TE&?`54N9R@)CI&$=C:YQY)8[_P`49XNW[U(NMMJ4
MK9=`D%I!"FG`)_*M,MR9D:J029&.N&(Y)B_./&+5U#:7+)>*-3=0P2%%I:@4
M/,DR'J;5/:J0)DE8`F(ZN>N.:Z]V/PQ5LC1Q&IOOR.,QLT*;BN6+GFI1:3D0
MY24`>:1'`&X<@XJHF*;U`==5>.<UM_(^&4N14X3^.WM>;Z['4^EUL@]ISE,:
MI(/0QQ%Y:X[NO$G(-;B=65CZ9[?3NB:?<95ZF74D="4RG(S2H$=1$>LW>VOU
MHS$9Y)L:XKC*U.O(H,[0O#'-57)QW\K^O*$4A70;_$")HFVWV,`^NM?9MXW<
M:Y@5U+%.;9=53/NTLD))/=31!;5_($G[9QM3CGR\Y@P$-T=55IO-D1(>S6S<
M4$CLA\$.I_E4H?9+2*'>S?5+*_2J[UN5_$0O(N0>+/*+D6M*.(EV20C#)+':
MNFX*F<Q,NT(J0_$#J)*E$1(8P`8`@ER9Q7E?"][IJHU&^E<654M6R2VH+1(D
M*$]S;B9@RF4D="9&.F?#O-V$>0^.5=%])[=:TV$UE!4!+J2AR8"DJEM=:5(B
M<DJ2?F2)@F^/KWEJV9UZ(2EYR"@5>QN<>9,AI%\HW(FG._AYA-Q2$T9$0\?E
M?D:`=40*!!6`PE#;;4[N/LLNV<\%.WS($A5Q5;ZQM:B)!WVDN(#DNDU;9JTE
MNG+2.9G*F#6/C3R98QO%E%-I1=;>ZV@*)+/OK9<+,^LD%1"9DG9('6<<\'2?
M^JSK?_\`3:Q^JMKGIPK_`!4QS_LV?ZXZL>1/\$LM_P"FJ/ZH[']=B(X"0:0@
MTA!I"#2$&D(-(1A+1L<Y>,Y!PP9+OX\%@8/EFJ"KQD#D@)N`:.3D,LV!=,.)
M^!B\@]!WU1734[CR*AQM"GVY[5%(*DST.TD3$QH9$3[Q^ANKJV6'*5IUQ-*[
M+>@*(2O:9IW)!DK:=1,&1Z1F&*!@$I@`Q3`)3%,`"!@$-A`0'T$!#5:/SQ`_
M,_MG]+<[33BS73#$-'V=XL==_/TMV_IKZ165-S56D48)=K&OW"IO4RJK<ZP_
MWM54O.(T!TBFIIM6I&L*_KMT+ZL=6Y%>>Q#C"/B[4X24;GN$T\?6.S)M5@$J
MC5E)2R[@8M!0@\3E:D1\A?0_+7BW5N:*.D>I;0CY1K$E[D:\$AS#C]&K+3XJ
ME`@6]>50B"H"4W,YS0R*[PZH&X[%```0W]0U9;R;X*/_`.?32JKY_P#L%8;E
M\?PP5$_9I]\7_'TXVJO'[TJK4VS;K]*&E.D]@/=(0!*>NOW12AF#VN>P>:\D
MVK*%MR_BM*>MC\KQVWC*_94&#5-%!)HS9M4S'.<4FK1`B8&,(G/QY&]1'4+,
MO\7^0<UR.JR>[7>UBOJW-R@AIX)2``E*4B<Y)2`)G4RF=8Z)8%YG\5\=XC18
M98K#>U6RA:V)4X_3J6HDE2UJ,@)J42J0T$Y#2)Z88P5G_K[@>AXJQ[:,42<]
M`R5@<6.6M49:CQ3MI).SNV!(="-70=)+HG4$%16$2B'YNM[X9@N?\?X)08KC
M]5:G:]AQTO./H?V*2M6Y`;""%`B?JW:?"(R<@\E<6\I<F7/-LJHKXS;*IEA+
M#5,Y3!Q*FTA*RZ7`4D$#T[=1WAJ<^=9.Z?8Z&-2[=G/$E-H3E1%63@*34;2"
MDL*"A54TY1](2(NWB!%2`8$@.DEN`<BGUBN>\9\T<C41LUWOEIH["H@K:IF'
MYN2,P%J6O<H3UVS2F?4&,VXPYB\>>)+@,AL6-WVX9.@$-OU=332:W"1+:$-[
M4*(T*B%*D="F/76KVO\`$N#K+%7VVSTCE"Z0BZ;Z%^\6;>,K,)(I;"D^;0Z)
MW"C]XU4#FBHX5$$S#N!.0%,'UQMXQ8GA%R:OUV?<NEY84%-[TA#+:QT4&Q,J
M4DZI*SH==LP"/GE[S,SGDBSOXQ8Z5FRX_4I*'O;6IRH>;/5"G2$A"%#1:4)!
M4--TB0;.M2:B'$8SPSLC1R9@FBL]*@J+1)RH9%NHY`@BB1=4A%#II&4V`Q@*
M80#\@ZIO%T-*+`27MIV@F0)EH"1,@3ZZ16IPPI]":DJ33E0W%(!4$SU(!(!,
MN@)'WQ3OVWZ-]D>V%YAKE*R6%Z8%?@QK[%M%N+/(/GC/ZYR^(I*R*\8@*YTU
M')@3(4@$3`1V$=]0^Y9X.Y'Y6OC-YJW;+1?3L>TD(+ZU*3N*IK64"<BHR`$A
MK\8GUP7Y(\1<'XU48_0M9#</JJGWUJ<33H0E>Q*)-MAQ6T$)&XDDJTZ2A6=0
MND_8;KLCD&K2^2ZP-+OD2*R#BJN9I*=JMVCT^,+9H@CQJ1F?D`%2>)G]%D$R
MD^`CJ[<1\*<A<>)N%KJ[G2_L:O9F"P7`ZQ4H'X3S84G:>R7`?F2`/C%BYX\B
M>*>5UVJ]4%GK/WAMC\BFI2T6:FD6?QJ=TH45CNII0^1:BKL(DY`P'>Z*CDV$
MM?\`KG:'+</$6:=U&[Q+QVF0!*1=XTCI/Z$'2@`!C^(J9.7P*`:V90T'.M+3
MABKK\=JG4Z>XJGJ6U*'8J2A>W<>IV@"?01IVYW3QGKJLU-#:\LHF5:^TFJHW
M4))U(0IQO?M'0;BHRZF&@O/1B^]C;1!3_:K-2=F@:RJHI"XYQ?7#5"KH"Y\7
MUAEI"4>RTTNNZ(W(114QA.)0$">,!VUB-\X.OW(MS8K^4[T*FAIB2W243/T[
M(W2W36M3CA*@`"HF<NFV,\QOR3QCB6S5-LX3QU5'<ZP`.U]Q?%54*VSV20VA
MIH)25$I2!*<BK>1.)+9'QID)KC'^4N`&V,*;6%:B[J!#VAM8'`0D>[9K1IRQ
M4;#@5)TI]"J/[1=;D*HB8W(?CLC(\:R%K&?W2P!%LH[6:15/-\.GVT*24'8A
MO11VGJI4]VIG&G\1R_%7LQ_?KE%=YN%Y37IJB*93"?>6E0<'N..S*1O'RH3+
M:`!**HL9>U!G?%-^I61:YE[%ZTW19Z/L$2B_@K,JS6=1QA%-)VF0Q3&14*(E
M-L(#Z[AJ*N,^*>=XK?J+(K==[6JMH7T.MA;3Q25(Z!0GT/>)OYCYO\99MC%Q
MQ2[6&])MURIEL.E#U.%A+G4I)&A'43B\JIFMYX9`;RE7$;#S.#DM56DEX<4P
M`OC,@>621>@8P\MRF`=@V]1U.&TF[FC2;X*=-PGK[!66Y=I;P%?'K'-N^"PI
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M;([OR_Q@N<](T<_DSL9,,U(&`QC8(>.?9=C\6-73UC8$[A%4B'E7"4[EN0LS
M=XG&.(V<A(919D=!,#$5>MP5$PG4`GNU`UGVG_=`E7P[Q\E,Z=IW$;.3</U_
M40:$NWX8J]6G6<P-M-78AQ-JR]RL+Y*00AOH9.&8-A9D;B*@/W'@V6((*Z;4
M=">T-RNLN\:.4SAVW^YX&:3PTZ9+QN%9Z[W&M-*C+NUYK(<G*GC:CC^#D%9X
MBD6[BX=0)"1$X'X*IBGY`*/I[M;Z`]X37\.T-';Y[L!D*T$KU<<6"V5K'Q,,
M4&35J3FS-'++*MW/%W7(U^=6J(FVKM5MBFLLVXL_*"J2I)D6RB)C&YF]`2D3
M/4S_`)NW\\?)*B9#M+\OY(GKB2ZY-NDC=G-LIAZ/7H*<F:S5XB<822-GF"P$
MP_C4+8ZF#.%(9Y"6N/;(O6I&Z/D;D6XJ'.8!U24$CH9F*B23U$1;IUDS6TQI
M.77)--S+:^P#6PW.RL<>5]1W`5&.9UJ47_"]2CG+1<T$M69Z'(B(JB"KF34$
MX&XF``"H0G=($;(^1NE,SW1E2V=^YL728659]?HNPVA57([F38,XR;8-UXB&
M^[XJ@J-6"MB=OHR0L=CD]Q065654B&JKL2M_LR^;6YRGII#<Y+IK"B_GQVC:
MWB4CW'7QQ)TJ):7!^C)1D?+MY:Q%J=.BGK>-BQ>2!V3%_;;JZ<L8L5RF*JW;
MBH<I-R&4;6Y==8;ESZ:1]Z/F?M+,OJM&W##K&N?B&'G;P]F&M;M+R-@(9FZ*
ME%XTE459=%1#)#AL(K&=@H:-4``*0G(?04H[&`4LF1'Y?VPF:WE7M8_/69>V
MXHLKDC2H92RS(P,'"NZHX%]&B]B<9X2<JN9=^SDK#-L7!9!R=8!2(X)PW`2I
M\O=K?8]P/[3'DU]3]_\`=&F>=A.[3.L%D4^N,;*RYW%N<)),HJP(IKQ31*M1
MM4Y1B]@,^:O7]JFW11*<XG<P\:H^\;;F5'0(;GJ=(;G/A$ZOO2Z?[2P_X)]Z
M?9N_^:?[3]O_`)#]'[7]+5+3^F*FL+O7D>P:0@TA!I"#2$&D(-(0:0@TA!I"
M#2$&D(-(0:0C73'[IE/X<^_TRNO1UCP](C!TN_\`#8O^-2OZC/7V[\\?*/EB
66&J<?<&D(-(0:0@TA!I"#2$&D(__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`/P#U`P$1``(1`0,1`?_$`,<```("`P`#`0``````
M```````("0H%!@<!`P0"`0`!`P4!`0``````````````!P@)`0,$!08""A``
M``8!`P,#`@,$!@<)`````0(#!`4&!P`1""$2$S$4"4$B42,5876U%C)"M#4V
M=G$S)#07-QF!="75)E:6MC@1``(`!0,"!`($!@L/!0$```$"`!$#!`4A$@8Q
M!T%1$PAA(G$R%!6!H4*R<S61L5)B(S.S-'06&(*2HD.#D],D5+0E=38W"?#!
M4Y07./_:``P#`0`"$0,1`#\`NG<CN8>'.,S-N2[RYWUED$A6BZE#`+R7=$*8
MP>1T5`BX1;<W8;M5<`0AC%V`1'26=QN\'#^VE%5S=8ODJ@FE"G\U1AYM('8.
MLF>0)T$+9VE[!\_[PUV;CE`4\12:52YJ_+24^2[BOJ-J)JA)`,SI"0UWYD,/
M2<H#2?QC=JQ&^02C+JR$;+D`G>!?)[&,;J.Q#L^[;;?Z>ND1Q_O$XA<W7I7^
M,O;6VG_&%TJ:3Z[4!;XPXW*^P'GMG9>OC,SCKR\E_%!*E(SETWU&"]=)_AB3
M#$N;\7YQ@"6/&=MC;&Q$A%'#5)4J$Q'E4_U?ZI"KB23C14'<"^9(G<(#MOMI
MRW$^;\7YQ8#(\9NZ5S0D"5!E42?3?3,G2?AN43AGW.NW',^V^4.(YA8UK2YF
M0K$;J3RZ^G56=.I+QV,9:3CK&NKCAXQ@34,,N:OA+1@SQ&"<H>$!^U&7)&*K
M*MDI$T;Y?>%8*.$3IE6$GC$Y#%`=P$-$C*?A!&3T00:((2GD5A/.DU&VBWX<
MY*9'I4ZFU?2;.INAJCFGE]L@HX2C8Y,]6"3:"N<O8!UW:A2[@(]`$=(MW$X5
MSF\MKK,<.Y)D;*_"LZT&]!K?0$A$'H;UGTFU0@:3AQ':?N+VUQ]W98#G_$,1
MD<:72F]ROVE;KYB%-2H1<^FVT:D)24G4"*\#GG7S(:.G317D!=?*T<N&JNR%
M:$/*V6.@IL(0(@(=Z8[:CVJ=].\5*JU)L_>;D8J=*/4$@_XKX1*S1]M/8"O1
M2NG%L=L=%8:W'1@"/\=Y&)+N*R_+WEEC)O:8KE39Z0[JK]Y7YDRT3"/E9]TX
M<*R3:0.9.&\:7M62Q&X%``W`F_[=.3[6/W=[K\97*6O*;FRK6KM2J32FQJL2
M75S*G(;5(3\$,_[UT^P_8[F+X6]X39Y&A>TDKTI5:R"@JJ*;()UIG<X+SUZR
MC,YMP[\E6*JW(W.I\GYS)\;#IJ/7\'%0T.SG$6*(;J*I-EHHZLL?<0_*;$%3
M;<=M@'6;S7A_N2XKC:F9Q7)Z^3MZ(+-22G36J%'4@%":A_>H)^,:_MSS[VA<
MVR]+CV<X;;8:[KD(E:I5JO1+GH"PJ`4A^^J,%\)S,)GCGY5^25->IDM8P%]C
M16`'J<TQ<I2A4@.'D*R78OH]NBMV@(`*B9P`?4-(UQWW4=R,/6`RGV>_MI_,
M*BD/+QVE60`_2##@N6>R7M%G[<MA/M6,O-OR&DZFG.6A=71V(\Y,/A$\/&#E
M)0>45)&SU+RQLO'*>ULE7?*$-)0KP"D,`F$I2`Z9KE4`4UB`*8CN7<3%-L^O
MMCW0P/<_"_>>*G2NZ9VUJ#'YZ;:?1N4ST8:=1.8,1G=Y>R_)^S'(ON;.;:UC
M5&ZWN$!].JNOT[7$C-"=P$FE(B&9TID([$0_RI<F9?&54K&*Z-/*1%NMCDTS
M+/&!DSNV5>8)JMU&:VX*D;'?N'R*A`.4!.5+<O3?31O=-W+N^,XJUXM@ZYHY
M:[;U*C)(LM)005/7:6+*1,:@::0^_P!D_9ZPYCF[WFO)+45\%8H*5)7!"O7<
MA@PZ;@BHRF1D"TCK$:?#+F+D*A9]IBE^NLC,TJQO4:Q/I3"K8K&-0EW39N$Z
MJ=-%`Q1B4^\X?=MUZ@.FV]F^\/(<#SVR;/7M2MA;EQ1JBH5VH*C*/5,@/XL3
M/67PAW_N![!<4Y-VPR*<8QU&WY%:4S<4#2#;ZC4E9O1`);^-,ATGY$1:A34(
MJF15,P&34(50A@]#$.4#%,'[!`=2E*P=0RZJ1,1"FZLC%&$F!D?I$<GSAF6I
M8%QO8<E7%<2QD$W(9)DB<H/I1ZX72:M6#%(0,=595=<O<)2F\9-SF^THB')\
MWYCB>!\<N.29AO\`5J"Z*/K.Q(544=222)R!D)DZ`QW';CM_G>YW+K7B&`6=
MY<N9N0=E-%!9G<]```93(W&2C4@1$%A:U\D/D:MUREGV09'$6$:M(MF[BNU=
M)LF]>"]!48QDB[?HRA5Y,D>FH+EP4!;@J!@`I>XI=-$X9E>X_N*R]Y=U\A4Q
M'";6HH-&@%#-NGL4,X>;[`=[CY-TY`3`A^?<+"=I/:7@L?8VV*I9[N->TF9:
M]P6*)LEZCE4-.5,N5%-#\^V4R9$PT[[XM\)JD5=1]ZRRPL(H>-.?"?A%'9E`
M*/W.2#7/`H14^PG`I"B/TVTJ5?VO<*935M[[+4\AMD*OJTRT_C_`R,SUD!"*
M6WO0[B(RT+O&8.KB@TS0]"L%`_>GUY@@=)D_&<1C\RL5\P^-M>?1\OE:QW3"
ML\@K'$EF0,RMD!<$]N,3/($9B]9*'!4A2+&%))8Q^U,1,4=-F[Q\6[P=M\?4
MM[O*W%[PNX4H*B[0!,2].J-NY3J`&.U6)DNH,/&]O_->P?=S*TKJPP=IC^XE
MLPJ&D^\L=IW>K1)?8X$B2@W,@$VD"(L%X!$384Q<)A$PC2:_N)A$1$?T]'J(
MCN(CJ0#@!)X5BR>OV*E^8(BS[H`#N)F@-!]XU_SS%</Y&<\Y'NV?[=2)"7=Q
M]2I+M.-A:^V$6[<IDTP35D5!'=<ZSTZ7DW[^W8W0-MM1S^XKG?(\WS^[PEQ6
M>GB+)PE.D-!H)%SXDM*?66O2);/:;VRXEQSM=8<DM:%.KG<C3-2M7;YF,S,4
MQ^2`D]LI3TU,._\`$?G#(-K+>,761^YG*Y7&L;(P3IT03JPHK`\*LP\Y`(3P
MN@3()`.`F_+'8?72W>TKF_(,J+[C&2J-7QULJ/2+=:<]TUF/!I"4]=.L-Q]]
M7;?BN$^[>:8BDEME[MZE.LJF0K2VD/M,S-9F9&GS=(F[T]F(Y8-$$&B"#1!!
MH@@T00:((I4YVR59,M96N-XM3ERXE9*561\;@QNUFV8@1DBV;)#L1L@)6_?V
M$`I>XXFVW$1U"YSKD>1Y9RJ\S>59FNJE4C7\D+)0`/`?+.0TF2>ICZ'^VG$,
M1P;A&/XWA$1;*C0!FLOG9YN68]6;YI3))D`.@C6\?8UO65+"UJN/ZU)6:<>'
M`B31@F0"$Z;B=P[<'19M2`'U44(`^@=1#6MP'&\YRG()BL!;5+J^<Z*H_;8R
M51])$;;E/+^-<*Q3YKE%Y1L\;3&K.3,_!54%V/P53$A-,X?\\>,\@PRC08)P
M1W'$"0EXB$GXE8BC5L!55&TS%KO_`&<J7;<``A%S!L/;Z]7!X;M#WV[:7%/E
M&`H,*U,;ZE.E5IF8&I%1"^U_P!SUE#5^0]^O;-W@M:O"^472&A5.RE5K4:H(
M9M`U*HJ;Z7QF4!TGTB;GBCRPJ_)&L*I+(&JV3JX1%M=J+()+,GT>\[!*=XP1
M="*KB,6624*7<153[!\A2@)1,]CM5W6Q?<?%E74VO)K8`7-JX*LC?NE#:E"0
M9?E"7S`3$XY^]_8_-=HLR'IL+WAMV2UG>(0Z.D]$<KHM0`J3^29C:3(R6_GM
MQYR.RDF/,KCA/S,3G##T,5S+5O\`57BM>R)0HA9T^FJW)Q#I1S'`5*,=O%2>
M))-7R=2&\G;I8:3K_%O]4P@M13]=?K"&(X7\OJ-S!Q0RND`<D5;XD0B<@TIP
M!TI*L6)M^4[2,BH8XJL'1R^5`Y3GV34*53M4W*'BI3--I'IX1ZIN'$_&'`U;
MCW&"L_\`AR=_=,A_95=8&5_5M?\`0M^T8V>%_6]K^G3\X11]G/[]G?WW,?Q)
MSJ$B]_GM?]-4_/,?1UCOU;;?T:E_)K%B_P"'S_D3=O\`/!?X:GJ1+VA?]#7O
M]-'YD1-^_7_N7CO^6G^4,2TN?'[9QY=O%X%?)W?T?'XS=_=^SMWWT["KM])M
MWU=IG]$H8U1W>LFR>_<)?3/2*5&="02>9\I$K`-@KA+Q/EA`9;^T"-!X?VP-
MM]A\/9Z?LU"YS<6*\QRBXS;]W"^J^GM^KLW:2^$?1!VW;)-V_P`*V9W_`'L<
M;1];?];U-HW;OC/K$J?PU05D&]Y:L1$G*55&MPL8HY/W^R>2R3]XL9HCZD%T
MV2<)J']![#!U'TTZ?V<6.2.=RV14,,5]FIH6_):H'8[1^^`()^!AD_\`Y`<E
MB/ZLX+$LR-F_ME:H%$MZTBB#<?':Q5E'Q!B?J8E64%$R<U)*@A'Q+!W)/5C"
M``FU9(*.%S]1`-P33'8/J.G[WEU1L;2K>W)VV]&FSL?)5!)_$(B^L+*XR5]1
MQUHNZZKU5IH/-G8*!^R8K[5G$#SY"[]RDS1*+.30\1%R%2Q&MW&;H@Z:.B&K
M4LFD'80ZJ4'&*)K$,!B"HMN8HF`!!@&,XC6]P>?Y1S.Z9OL=&D]"P.H&Y6'H
MU`-)D4D(8'2;:@G42F9CGMO[5N,<+[>V2H+^O62YR8T8[64BXIDZD`UJBLA$
MCM70@3!AR?,GL4^=1[]NLRD&#@[9VV5`4UVKE$VRB2@`.Y%$S>OX:9[7H5[6
MLUO<*4N$8AE.A4CJ#\1#^[:XM[VV2ZM66I:U5#*PU5E/0CS!BV+\?F>?^.W'
MN`>R+D5[73EC5*T"JH4R[A\S;MG:3XI1,*AFZS9Z0@'$``3IF#Z:E;[`<\_K
MUV_H5KAMV5LSZ%:9U+*`P;SD58`'S!B#SW2]LO\`\T[IW5O:)MP>07[3;R&B
MH[,I3RW!D)(\F!\85OYD!FPPUC+V0G"''(2P2X(BKW#_`.GI(6WN@`/%[0%P
M+MN._D$NDN]XIO?ZG8ST9_8_O`^I*?\`\3RW>&V<O[J4+5[`1CCW`S/VB7V_
M[J7TIRE_'T]VWQW2GT_)G$;7`KF>EQ7L<_#VF.>2N/+JJR7EP8=BLA$23$ID
M6D@T27702]N""RH*E`VYA,`]HB&X-P[#]Y4[6Y&XM,I3>KQ^]*FILD7INNBL
MH)`E(MN$]9SD8=S[F_;X_>O$VM_A:M.ARO'!Q2WS"5:;ZLC%0QW;@NTD:2E,
M#0V6L79HQEF6`9V/'5NBK$P>(E5!)!849!#<A#F(YC714'Z(D[]A$R8%$?01
MU)/Q?F?&>96"9'CMW2N*#B<@9.-)ZHTF$OHE$0/-.WO,>WV4J8GEEA7M+FFT
MID3IMJ1-:BS0SET#3\Q&5R;CBJY;HUCQ]<X]*2K]ECG$>\14#<R)EDCD0>MS
M`)13=LE3`HD8!`2G*`ZR^3<<Q?+,'<\?S-,5,?<TRC`^$QHP\F4ZJ?`B,'AW
M+LWP7DMIRKCU4T<K9UE=".AD02C>:N/E8>()C.52MQ]/K4'5HKR?IL!&-(IE
MY3"=3VS)$J*7>81$3&["=>NLW$XVWP^-H8NUG]FMZ2HL^LE$A.-=G,O=9_,7
M.:O9?:[JLU5Y:#<Y),OA,PEW)?X^L.<E;$E<)5W,4JV"DDWD9VL$:&6ED4"$
M20*]:2!5V/D33(`=Y4P./U$1TC/<KV_\.[DY$9BZ>M99:0#U:(6=0``#<KS6
M8`E,+/XPX3L_[IN?]H,2V`LJ=OD<'N+4Z-P6`I$DEMC(0\B3.18@>`CK?&GC
M)B[C-67];Q^0SZ0D5T%[#87ZB:TS**H%5*U!V"1Q1;)I>502D3*F4>X>G0-N
ML[:]L^+]M,94QO'QON*C`U:K$&HY$]NZ6B@3,@`!K'#=X.\?,^\68I9?E!%*
MUI*5H4$!%*F#+=MF)L3)9EBQT&NNK+:4J$?@T00:((-$$&B"#1!!H@BIE\A.
M"%\&\@)X&C0Z51NB"-FK"A2F%--L9(K!XS44[2D%R608+J;!O]A@'43_`+@N
M"U.#\_KBDI&(O5%:@?`"6UE)\]ZL?H(B<CVK]RZ7<GM=:FNX.=QS&WN!XEI[
MT<#]SL=%GY@Q-W\:F$*YC#CW`6M!JV6N&1".)>P3!2D45.U*^<IQC!!82`JB
MV28I(BHF`]AEB]VVX;Z>U[;>$8[C';ZWRJ*IR^1!J5:G4[=[!$!ZA0H68Z%A
M.(YO=_W&RW,NZEU@ZCNN!Q)6E0I:@!MBFHY$Y%BY;:QU"&72'K7NM2:VMA1G
M-BB4+A*1;Z:CJXJ\2)+/(F-69-W[]NT$044;-5I)`IS!Z"J7\=.'D93\(:?,
M3EXPKV5>(\3:,KT_-^,K`IBS)</.M%[/,PK$AF]P@5';=6593K)%PR3D%G"*
M9RF%43^<#]I^@:1SE7:6TRG*[/F_&K@XKDM&NIK5*:B5Q2+`NM505#D@$'=/
M=.1AP'">^M[AN$7_`&XYC:KF^'W%LPMZ59SNM:P5A3>BY5R@4D$;9;)376&_
M.DF+,R+X4G"0MC)/#+)D*@NF*0E<"JD;N3*DJ7?N*.Y0`=O32PJ&"@,9L!J>
MDSYRA`G*LY*#:A)D)SD/`3\9><4D\6<IW7$#Y`<C6^ANSKXXE\Q7&`N<`D]5
M)%R<')W!\D],`D_)3")D0(NF/:($3;@0-@ZAM&3U*(!^M*->&V5"1TG%URNV
M"(M<!"V>`>)2,'88MA-1#]`P'1>QLDV3>,G21BB(&37;K%,`@/H.M:1(R/6,
M[KK'KL_^')W]TR']E5UK\K^K:_Z%OVC&SPOZWM?TZ?G"*/LY_?L[^^YC^).=
M0D7O\]K_`*:I^>8^CK'?JVV_HU+^36)YOC8NEDQ_Q-R=::E1)S),\PO+0&50
MKI`/*21EVC=$XH@(@`$0(<3F'Z%*.GW>V_,Y+`=J<GE,38U\E?T[Y=MO2U=Y
MJ`9?0#,_`1&5[N^/8CE/?+#X7.Y.VQ&,JXUM]U7,J=.3,1/XDB0^)C5N4O-7
MF2ZI<O`L>.UPP=#NF?AF+<]%V[ERLW27YI&:J31J,0<#%'M624,<2[AL&^M5
MW1[T=XZN&K6%'CMY@[-TE4KMN:IM8:A2%7TSY,K$RG&[[+>WCV_T>04,G<\K
ML.27Z5)TK5-JTMZG0L"S>J/-&4"<NLHC2X_4?C7<)MLGG'*]FH9"+D,]:A7F
M)8=T0Z@>0A[$I/M7K/8`'O.#8PE`=]ATVS@&$[;9B]5>;96YL%W#<OI+Z;3.
MH]8U0R^,R$,H=_W2Y)W>P..=^W&#L\FQ4[&]=S560T/H"BR-X2!J`'I%IGCI
M7,(U7&<3#X"6K[NBD.HLG(P3AN\&5?'*F5>0E'R1"*OY%1,A"&55W/V$*7?8
MH`$HW;K'<)Q7&:5GP%K=\$"2'I$-O;2;NPD6<B0+-K(`=`(A8[L9;N-F^85[
M_N>MTG)"`#3K*R^F@GM2FA)"4P22%7298]2857Y+,V.,?880QK6G(EO.99:.
MIT2FW4,5XR9O7J9U7QBIB"H-7:C06@B&_540TEGN3YK4X_PU>-XUO^.9FJEO
M3`/S*K,)MIKM8KZ9/[Z%L]H';JERGN"W+\PD^-\?H5+JJ6'RNZ(0$F=-RAA5
M`_>PQ7$O"C#`6"*10"H)HRI(IO*V8#$(54;#,(D?2Z"AQ`%%4FKU=1-/NVV(
M&VP>FE#[3\*M^`\%LL`%"W0I!ZWGZM0!J@)ZD*Q($_"$H[Y]Q+KNAW+R/*"Q
M:R-9J5OUEZ%(E*3`=`60*S2ZD]3$!7R>8&3Q/GE>Y0K0Z-7RL1[8DC@0"MT[
M(1T*D^V0*3\M-!('K<2%#;;N]`TPKW-\$7BG.VS-DA&+RH:J#X"MNG54>``W
M)(?&)/O9OW-;G';)>/Y"H&S6$*4"/RC;E94&:>I8[*DS\.L?/\96?B8?SRVJ
MLT]%O4LHE:5QYY5-TF\X!W"==,@D<Q4B*OI5ZDDH<!`PD`/7;;5OVT<^7B'/
M%Q=Z^W$93;1:9T%7449`Z`M495)ZR\XN^\3M>W/>V3YK'4]^=PNZNDAJU&2F
MN"0)D)31F4=)^76+'&;\-5+/..+!CBXMQ/&S38`;O4@+[R+?H*IN6;]FIT.0
MZ3A$O<!3%\B>Y!'8PZD6YOP[$\\XY<<<S"SMJZZ,/K(P(*LI^!`GTF)CH8B7
M[<=P,[VQY=:\MP#2N[=_F0_5J(05=''0@J3*8.UI,!,15;Y)<-LP<;)MVG88
M1U-TT7*Q(F\1+=9>)=M]^]L5Z;Q)@SDCMA`RJ(>0I#@8`.8``1BS[C]G>7]M
M[UUR%%J^&W$4[E`338=5W:#:\NJB8!F)F4XFM[1]_P#@7=W'4WQ5PEMR#8/5
MLZK`55;HVP3.^GNF%8[21(E1.07^B9#O&,)Q.QT&SS52F4S)BH[A)!W&J.B)
M&[RMWWM%D#.FPF_I)G$2CK@<%R#-\9OAD<!=5K2\!$VINR%@/!MI&Y?,'2%1
MY+Q7CG,L:<3RBSM[['D&2UD6H%)_*3<#M;R8:Q.%Q2^5@+%+1%#Y#,F,8[D%
MVS!CD&+*DVCU'3@X()A.1P@W0C&Q#=HBL118QA,.Y>@;O=[5>ZG[PNZ.![@H
ME*K4946[200L3(>JF@0#3Y@6)F=-(CA[W>R3[JL:_)NU52I6H4E9WL:DV<*H
MW'T:GS&HQU^0J@$AKKI*[E:N9`O]29$Q+E%#'D@J8)`LV2M,K4A,L%F9_;,T
M_<R#$(]-150BON$Q.;8NW;UTZKE6-S^?Q*#B>47'W!._U!16N*BE=%$W78"2
M#O$SI*6L,BX1E^+<7SM1N<X5LM:J-GHFX>V-)PPW.=J/O(`*[&VB9G/2*V/)
MS.',;$V4[1BNZYNM:$K!BT7%U4;#,PS9U&RK<'T6Y(#1TW\1W#%4ACD`!`AA
M$`$0#?4;_<SFW>'B?*;KBV:S=VMU0VF="M4IADJ#<A&UA(E2"1X'29B7;LYV
MX[`\XX59<VX[QRQ:RN=PVW5"E59:E)ME13N5IA7!`,YD:D#I$@_P_7FZWA#D
M&ZNENLEM<M'V-P:N+',OYE9N"[:Y"N""C]=<Z0+"D43;"'=VAOZ:<#[0LYFL
MVG(*N9N[F[J(]GM-:HU0B:W$Y%B93D)^<H:Q[]>-<=XY4XK1X]86=C1>G?[E
MH4DI!MK6LIA``93,I])F)I]//B/*#1!!H@@T00:((-$$&B"%:Y;\9JYR?Q<^
MJ,D";2R1@+25,G!33,K%S)2D'Q]QQ+VMI)-+VZH]P;)J".DM[M=L\=W.XN^)
MN))DJ4WMZLA-*GE\`X&QM>A,+3V+[Q9;LUS2GG;2;XBM*G=T9F52EKK(=6ID
M[UTU90(6+X\<L2-;AI7BAEA,U;RIBIY)(Q3&7$[1U:*^YD7$@F^C2NP2,[30
M3?D\)4@/WM0!0!$H;Z3/V]<LN<=95>U7*P;;E.*=PBU/E:M29RX9-TMP`<;0
MLYH-PTA9/=9P>TR^0H=[^#D7?"LW3IFJ]*3+;UUIJA2IMGM)*'>6E*H2IU,H
MWOFQPP<9W+`9<Q!.+8\Y,8R5-)4&[,%$V_ZF*:)`+`3:IC(F]HJHW2\:GD*"
M0`8!`W<`E=)3J;?E;5##+G3=J-&$)1BSYH:K0%G^,.:M!M>+LKTL1B;$]@*_
M,S;&9D6GY)WJ$`DP]_$MW9TS&+WKK@/X_75UK8GYJ1FICP*X&CB1A>N:WS<5
M.W4.P8WXM14X=>U1:T1(9&LK%_`KQ;"02%"30C:^Z;-W?O%&ISIIKBN)2B<#
M=@["`^J=L0P9_"/#UYB216P<K+.E7#ETLHX<N5%EW+A4W<LNNN8RBRRI_P"L
MHJH<3&'ZB.LR,:+SWQ4V2Q6?A!A]U9%UUW,:Q=5^.,N10ADX*#,DPAD2`H(B
M9))BD4"B'00]-:NN`*IE&?2)-,3A][/_`(<G?W3(?V576KROZMK_`*%OVC&W
MPOZWM?TZ?G"*/LY_?L[^^YC^).=0D7O\]K_IJGYYCZ.L=^K;;^C4OY-8L7_#
MY_R)NW^>"_PU/4B7M"_Z&O?Z:/S(B;]^O_<O'?\`+3_*&);%44ETSI+))JIJ
M%,10BA2G*<A@$#%,4P"`@(#IV3HE12K@%2)$&&,I4J4F#TV*N#,$&4C%:/Y3
M^.M4PWDBI7FEQ[.$A,HI38.(5BFFDW0G(`6+B4?)I$V[`?%FTN@AZI^H_2-?
MW2=N\5P[D=IG,+32A9905)TU``%6EM+L!^^]1?V(F`]E?=C-]P.(WW&^0U:E
MSD<*U';6<DLU&OO6FA)Z[/1;^^Z0L'#KD3=\!9BJ;N`DE1K5EL,)!6Z!6.H>
M/D8J3D$H]=P=`AR;O(])V99`W4"JD*(@/II,>S_</-\!YA:5;"H?NVYN*=*O
M2).QT=@A,OW2!BRGP8#0PLG?WM1QSNAP&^H92BOWO9VE:M:U@!OIU::%PH)'
MU7*A7'BI(F(FBF\1S^<?D/B;?9SED<;8HHD+9JVR<-SJ,SJ2L4R,G$N!,H*8
M.R2TW[\NP`(`0/M_K:>;>\2R'-_<+2R^3/J<;Q5C3K45(FLW12*9UEN]2IZH
M^CIXQ'OCN=8OMO[4Z^!PP]'EV<R=:WKNK2>5.H\ZJZ3VFE1]$]1J=?".GY-X
M>9OO]YL5MC^6=VJ$?+OUUX^MPL8=..B&'E4%FS2[I8?(=!`Q2F.`%`XEW`I?
M373<F[/\WS^<N,M;\LO;2WK5"4HTT(2FLSM4?PFI`D"=)]9".,X?W][<\7XW
M:8*ZX-C;ZZH4@'N*M0%ZKR&YS_!:`M,@:R!E,]85+D)\<^69;&=FGICD;;\I
MR%.A):?@JM-PZBX2+UDT.Z!@S.225.@X?'0*4#`0_7;[1]-)5W!]NO++KC5S
M?WG(KO*7%G1>K2H5*9.]E6>U?G,F:0`,C]$+;VK]V7!['F%GC+#B5AA;6_N:
M="M<T:H'IH[!=[@TP"J`DD3&GB(@4:/'\/(-G[!=1E*13U)TS<IB)5F<@P<%
M506(/02JMG*("'X"73#Z5:O9W"UZ#%+JDX92.JNAF"/B&$XDXKV]M?VKVMTH
MJ65>F5=3T9'63`_!E)'T&+A'#_-[+/>!Z5<R+(C-(QY8:RLTU04692T4HJQ_
MVD!$3D6?-6Z;G8P`.RNX=-AU+YVAYO0Y[P2RS(9?MJT_3K*#,K40E?F\BR@/
MK^ZB!/OUVXN.V/<S(\>96^[VJ^K;L1(/2J`/\O@0C,U/2>J^<,F_8,I1HX82
M+5!ZR=)&1<-G"9545DCAL<BA#`(&*8-*17MZ%U1:A<(KT7$BI$P1Y&$AM;JY
MLJZW5H[4[A#-64R((Z$&(M^1WQ:8CR8B_L&*3!C*XG!5<C%FW05J<@MVF/XU
M(Q/V:S9PX5VW6\YBEW_H::_W&]KO$N2I4R'%/^&9@S.U0#0<^10;2I)_*W$#
MRAZ/:7WI\ZX>]+%<W'WQ@!)=[L1<H.DQ4.X,JC\G8"?W45YLL8INN%KQ,8]O
M\2I$V"(.'>00,9J^:*B8$)".<B4I'K%<2F`JJ>Y.\IB[[E'4?'*^*YKAF;K<
M?S](T;^B>G@RGHZ'HRG63"8F")Z1*IP?F_'NX7&[?E7%ZXKXNN-#IN1A]9*B
MS)1UF"5:1D092(BPW\3F69^_X(FZK8WJSY;'5G5A(9=<QU%30CMDSEB$55,(
ME$R#V24(4`VV(`?AJ0CVH\KO\]P6OBLBYJ/CKHTZ9,R?395J2)^#.0/A*(J?
M?%P;&<8[EVV<Q--:=/+68K55$@/65WI$@?%*:DGSG$4GRC?_`+1R)_EO'7_U
M".TU7W0?]YLC_1K3_=TA[GLP_P#YZQ7],O\`_>GAW/A6_P!QY%?]_P`9?V6Z
MZ6OV7?Q'(OTEE^;<PW7_`,AW\XXG^BR'YUI$Z&GR1&O!H@@T00:((-$$&B"#
M1!!H@A7L_<6:=G22J5K&3E*3D&E2C9]"W:M&00EC,TS_`.TP[[SHN&[I@Y(8
M=^Y,5"B``!@+N&DPY]VNP_.;FTROJU;+D%E55J=S1D*FT=:;3!#(?B"1(2,H
M6;M?WIS_`&VM+[">C1R/%<C19*UI<3-+>1\M5-I5E=3Y,`9F8)UAG$4S)(I)
M'5.N=-,A#+*]@**F*4`%10$RD(!SB&X[``;^@:4U%*H%8EB!*9ZGXF6FL(Y4
M8/49U4*I),A.0^`G,R'Q,1]<WOCKQ!S-@O>2:84[*$6U7)7[]%(D!P900$Z#
M&=;F362?Q9UQ_,$$P<=HB!3@.VU^G6:GT^K%AZ:OKXQ6(S1\2G,G$<\Z8L*$
M7(M<!821UKJ;^+,A($$>@C#*R2DRS$@=!%9(@"/4.FLY+BFPZR,8IHN#*6D;
M9QI^(;E)F2X1I+]5#8NQ\U?HFL$_8'4>=TLU1.15Q',(AN^&4.N\1`2%5\)D
MBB/40U1[A%Z:M%5HL3KTBXUC''-9Q)0*EC>G,P8UNFP,77XI'H*AFL6R19)+
M.#``>1RL1`#*&_K&$1UKB2QF>L9@``D.D>_(L_"UBCVF;L$FSB8IA!R:[IZ^
M73013(FR74,`&4,7O4$I![2%W,8>@`(ZT?([^SQF#NKV_JI2M:=!RS,0``%)
M\>I\@-3X1T?$L7D,SR2RQV+HU*][5N:85$!8DEP/#H-=2=!U)BDC+J$6F)A9
M(P'26EI-9(X>ATE7SA1,X?L,0P#J%*[97NZSKJIJN1]!8D1]%MBC4["A3<2=
M:%,$>1"*"/V8L4_$.\9Q^`;PZ?NVS)LG>2`=P[72;($[HY,"]ZRQB)EW$=@W
M'4B'M(K4;?@5]5KNJ4A?"98@`?(/$R$1/^^ZWKW7=#&T;9'J5CC3)5!9C_"'
MH`"8E(D\AT&&9+2,K=JG'L6Y#'6=.[%$-T2`4HF$!45>%*)A*4=@#J/TTZ"Y
MY#@;.BUQ=7MI3H*)EFK4P/V2T,OL^*<GR%PMI8XZ^JW+F05:%5B?#H%/[/01
M6?\`DEY2UGD/DBOPE(<^_I>-TI5O'S!DU4"R<K+';I2JZ!'":*@-/%&(=@B4
M-]QZ_A&I[C^Z.-[A<CM[+"-ZF%QP<)4D1O>I(.0"`=LD66GG$P?M%[+9CM3Q
M&ZR'(T]+D.7:FU2E,'TZ=(,:2DJ2-TZC[I'RCF?"7B_>,^9;I[]K$/F=`K4[
M%6.QVARU41BE&<.]3D`C6+E4$R2#F249^WV0%04A4`Q^TO77-=E.V.;Y]RVS
MKTJ+I@+:NE:M7((3;38/L4F0<N5V?+/;NF9#6.P]Q7>7C?;#@M_:UZ].IRB\
MMJE"A;*P-0-50T_4=1,HM,/O^?;NVR69TBV+&0,1#G<+1S)%NN[(S3=."@(K
M."Q[)O'-`4.81'9%FT3(`!L'V[[;[CJ5VVL+2S+-;H%=PH8^)V*$69^"J!^#
MSB#R]R=]D%5+NHSTD+E5\%WNU1I#XLS'\/E&8UEQ@1X,4IBB4P`8I@$#%,`"
M40'U`0'H(#JA`(D>D5!*F8T(BGWS8QK`8JY'Y#K%7=-EH(\D$FP;-ETUQC"/
M$R"K'N#)&-V+IN"G.)1V,!3ATU$+WIXU8<5[C9'&8QD:Q-3>JJ0=FX":&70@
MS,O(B)ZO;MR_*<V[28K,YE'7)"CZ;LP(]0H3)UGU4K(3&DP8;WXGL]FHV4Y?
M#\NZ(G"9+15=0HKJ@FW:6N-8F7!5<Z@@4J#B,C12`H"43*&#;J.E<]J7/#@^
M4UN(7;`662!:G,R"UT6<R3X%$VRTF2(0?WP=L1R7A5#GMBA.2P[!:VT39K:H
M\I`#Q6I4W$F<E!\(G(J')+&%ALEFHLQ8HRH7RH23B.FJU97J$,Y.0CE5!C)1
MJLB9NA(,I=NF#A$$3J'*D<._8=]/@Q'<CC&0R5S@KRXI6F=LZA2I1K,*9T)"
MNA>0=:@`==I)"D3B-[/=HN98K$6?);"TK7_&;^BM2C<6Z&JH)4%Z=04PS(])
MB:;E@H+`[=)1U9U>Z0Q0.Y>W*JLVR8;J.'5AB&Z!`ZCN=55X1,H;!]1UU57.
MX2@AJ5[RU2F.I:K3`'X2THXBCQKD=S4%&WQ][4K'HJT*K$_0`I)BMW\C.5*K
MR2SQ7*UA2/<7B0KD2V@7DK`1[QVI)RJKV0-^GH^-#N69,P<D/[@`%'[S??L4
M=HXO<5RG%=R.=VV-X73:^N+:B*3/21F+N6?Y1(:JNX'?]74ZZ&4N/M-X5F^T
M7;*[R_<2JF-M;NNU9*==U44Z81!O,VT=]I'IZ/H/EU$YB^`7'&1XX8-0A[)V
M$M]PDU;;9VY13,1@Z<-D&+-D50ACA^5%LD!.'<(`H)O3T!X78/MU<]N>#K9Y
M*0R]Y5->L-)*Q4*JS$^B*L]>LX8)[H>[5IW;[D-?XB9P-A1%K;MK-U5F=GD9
M=:COMT$UEUB"CY-I..EN9.17<6_9R+4L'1&9G+%RBZ0!TRJS%L\;BJ@<Z?F:
MN$S$4+ON0X"`["&F,^YBYM[OO%D:MK42I2%"U6:D,-RT%#"8)$U.A'@=#$E7
MLZL[NQ]O^)H7M*I1K&YO7VNI5MKW#LK2(!DRD%3T(,QI#K_"[,1;9;/D*X?-
MD9:46Q^\CF"BI"N7C:.;VPCY9ND(@=4C4SQ+O$`';O#2T^S*\M:3Y^RJ5%6[
MJFT9%)&Y@@K[B!X[=PGY3AN__D*L+VM2XQD:5)VL:*WJ5'`)5&J-;%`QZ`ML
M:4^LC$\>GVQ&9!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@A2<N<-
ML99KEY&4O,UD!ZWDCF,O`MK[<&-;`#"(B0L`SG6\1V_=M_J?3II)N6]G.,\U
MNZEUG:V0>G4.M);JX6C_`)I:HI_X,+IP7W`<P[=V%&RXW;XNG5HCY:S65J]Q
M]/KO1:K_`(<<,_Z4_$__`-OS_P#\HL?_`)QKA_[*_:C_`&>X_P`_6_TD*3_;
M;[W_`.U6O_UZ'^BCN-;X689J>([+A:!;6"-IUJE&LO*`TLD\WDQ>,SHG2,A*
M)299%N7=$`$I%2@(=!#KKM\=V7X;BN)7/#+%;BGA[JJM1]M:J'W+*4G#[QT\
M&$)OEO<-W!SG.[/N'DWM:V?LJ+4J>ZA1:GM8$'=3-/TV.ID2I(CD[[XRN.$H
MW,TDPO<DT.("=K(7^Z/6QQ#<`$R#FP*I&$`'ZAKE*_MG[<7-,T;D7]2D?R7N
MKAA^P:I$=Q;>\3NU9U17L_NRC7'1DLK1&'T,M`'\<;#3_C;XD4]R@^;8Y4E'
M[<Y3E6F;%8I)N;L,!B%/&O)5>/.0!#J`ICO]=];#$>W#M+AZJW%+'&K<*9SJ
M5:SC^\9RDOP1JL_[NN^F?HM;5LL*-JPE*E0H4V^D5$IJX/T-IX0ZE?K=>J<6
MA"UB#B*]$-@_(C(2.9Q3!(1``,8C1BB@@4YNT-Q`NX_72T8_&X_%6RV6,H4;
M>T7HE-%11_<J`/Q0WC*Y?*YR\;(YFYKW=^_UJE:H]1S]+.6:0\!/2,WK-C70
M:((Y5EG&`Y4@4H`;=9Z@D54RBSVJR+R+?KD,!0\0NV+MFY3*`!T$IP'KKE>6
M<8_K58"P-W=6:`S+4'9'/PW*RD?@,=MP;F8X3DSDQ865^Y4`)<TTJ("/':ZN
MI_"(0R1^)_`LN]<R<M8KM*23U45GDA)3$F_?.UA``%5R\=RJSAPH(%`.XYA'
M8`TA%Q[4^!W==KF[N+VK<N9L[U'9F/FS-4))^),.;M?>_P!S;"W2SL;3'4;2
MF)*E.E31%'DJK2"J/@`!'VUWXK,#U:>A[)"SEM9RL'),Y1@Y1D'J9TW#)PFX
M3#N))`(IJ"GVG+Z&((@("`B&KV/]K/!,7?T<C9U[M+JA45U(=@05((_+Z&4B
M/$:'2,?*^]?N9FL9<8G(6UC4LKFB]-U*(05=2I_Q?43F#U!`(UCNV9N#6!\Z
MW-'(5XAI$]P*Q:LG$U$S$M"N'96;=!LW55"*?,B@JDB@!2B'4`$0#7=<R['\
M$YUF5Y!G*-0Y<(JFI3J/3+;0`"=C+J`)"$S[?>Y'N9VTX\W%>-W%(8$U&=:5
M6E2JJN]BS`>HCZ$F9\XY_P#]-/C:YV2F$+Y-1YA_/C7^1[VHU<E]!(J7^8QW
M*("(?CL.M!_9L[;U/DNUOZUOXHUY=%6^G^&CJ?[7_=RC_"6#8RWNA]6HEA9A
ME^(_U>&9Q;QTPMAANFCCK'T!!+)"(IR8LR/YH@"7L$I9N0!S*@02B.Y?-MU'
M\=*7Q?MUPOAB!..X^WH..C[0U0?Y1YO^#="/<T[L]P^X-4U.696ZN:9ZT]Q2
MB?\`(IMIS^.V-CRAC&)RM7RUR9E[-#LP<><R]6L4U6GZFZ9DQ2.^@G\<[,B8
MINI1/V_LUL>4<8M.56`QUY6N:-'=.="M4HL=)2+4G1I?"<HU/"^97W",J<MC
MZ%G<7&W:%N:%&X0:SF$K)46?QE.$F=?%CQ9?.%GCV(M#UVY4.LX=N[?:7+IP
MLH83J*KN%YI19950YA$QC"(B([B.D6J^USM;7J&M7HW3UF,RS7%=F)/4DFH2
M2?$DPXFC[U.]-M26A;5[.G00`*JVMLJJ!H`JBB``!H`!(1F*W\:/'6G2B,U5
M/YYK<L@/Y<A!WRXQ3OMW*84SKL9]!11$PE#N(81*;;J&LO'>VOMWA[E;W%?;
MK:[7H]*ZN$;Z)K5!(^!TC`R_O`[KY^R;'9O[MN[%NJ5K*UJ+](#T&`(GH1J/
M`P^5?ADJ]"QL(@Y>O$8UJ1JFZD73A\^7*3?91T[=*K.'"H[]3'.8P_CI=L?9
MIC[*G94V=TI*%#.Q9C+Q9F))/Q))ALV5R#Y7(ULC42G3>LY8K35403\%50%4
M?``",QK,C7P:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"/!
M@$2B`#VB("`"'J`B'J'^C1!$3M"S/G.S9"Y,89?7PD;+X[R4L[2OTA&BWAL?
M89:O90C.3E4S2':[EY5FV6,W`RJ)78M#[G*!=]9!50JM+K^,Q9!8DCR_:ADJ
M+S:PC.5K($B$O:C1^):"7(<Y8YR#1CVMLHY'DI$ENU04&5=!,P3Z;@WK1)83
M)E%RU43W^P1U;-)@1TU,>Q44CZ!&06YQ8-1BI.9,O:18PE<J]HFCEA$!-$1M
MRDH*/KY)`/U(`;O'Q+&T=%3$?]T5\@"/H)Z3?"#U%COF/,EP>4:T\M%5:RY(
M]"2F(IL,PQ!@=^O$.EF9G;,I5G(+1KQ1'O05W#R)&`VP;[:\%=ID8]`@B8A&
ML(<BKC>LH9`K61[LGC2[8LLUE?VS&]F@DXY@\Q&W724AK#`NE)-/W;=!LQ>>
M64%NGW`)1$O3;5UD`4%1,'Q^,6U9B9'J(Z3=N9E$<4ULYILG/U^;M5MK='H\
MO,U%"18S$Q9YYA7XZ0C&!IEL65B!?R!2F5!0H@!3#VCMJ@IF>LM(J7$O+6-_
M?\L<35N_,\0RLZ\G+ZT]S$V-6`C45XJ)L\52%KV_AI90'Q314J\KK4SM!L)3
MB*:A/NV'?5/3;;N\(KO`,CUC\X]Y@8>R?/(5JI+V)Y++TBQW\J"L2BD!8*J2
MT9"3)5#%?JB60;R,LBF"6VPCO]P;=0TV43/G`'!Z1QV*YNPF2ZIC&1IS.QT.
M1S!DMA5L=K6BKHR1;#67JQ"L+&HT&2:`RCY=NZ24!0AE_"'IW[[ZJ:14F>LA
M%-\P/`DQP',?*>V6S(&3XF(M>0,/UO$MDQ[0:=8F58.[9R^=7D^W<2E;NL:G
M/12,Q`S,9,PR!(]54Q2D<&/L;R=NO:H`!H"3^U'EG,])B7[<2"L<^U)M<JOB
MAXM+6+(#QC&-K(XK\.FK#UV;7KJ4^HC93E?=U?6?,CE<)(B"NR;A,-Q[M]6=
MID6\(N!A/;XQRO/F>[I$YMQ)QJQ,5BSO61V<E;;%;Y%B2;8T>@P2Z4?(R1X,
MRC<)*0=2<@T213.NW+VJ&/W_`&@4WI4!0NW011F.X*.IC(W+*R?&!=_(Y2O<
MW?HVSH1+;']$KU>+*Y"DI6.(Y"T+QC1:9*I*-CJ/68`F!B@B)@#<>[0%]0R4
M2@)V?6,>^Q\W<$5=M4G\G*3@QMTQY8LFP\HUBT%H\*S5F+Z0E_>.!D$P;R"2
M$<J!4@`P&.`!W!ZZ!28_@,H/46/FL?.?`U569MIF0L3=U(TR,OC%J$.@9PZK
M\M*#%-5$4QD2B=SY@\AB>@(_=W#Z:!28]/.`NHC,W'F5A.DVG'5.DI&:?3F2
M4HM:-;PT:@_)`HS4!_,T8K;3>_1-"$>0WYQ![5-R]?3KH%)B"?`0%U'7QCX;
M/S0Q/6Z9DR_%8W&6J>,(N0EY6Q1L(BO!3#.-,8CA:O202'CD40$"CW[$#8Y1
M^N@4V)`TF8"X`)UD(Q$1R<"UY`QC5Q.]QP_5I,]D/*%0M<`DJXBZV$<X7AQ=
M3BC]J>"4:FBW"IQ%NH"I!`![=M]&R0)ZB>D&Z9'AI'KCN?&`I)K>GB2]N0;T
M2+:6%<[J!01_F:K/+&2H)6RG?^*&_6ZX%G\K$SG\H`<-EB;;DZGI-I\8/46,
M@CSFP2O'R4FF[LWM8JRPE4=B,,@!PE[!BVP9@CTTR_J0@=$:9671SFW`2K@4
MFP@;N`])OQ?^\H/464__`%YPXFK<>X-$$&B"#1!!H@@T00:((-$$&B"#1!'Y
M.`F*8I3=IA*(`8/ZHB`@!O\`L'1!$?53X_84@XSEZPLV=6MF)EAI-#G%Z\NM
M51=XW8R;:>3D2R#@.T*>Q8-W;D4?U$-D03.)A'M-M=+N=LATZ?&+>U9-,]>L
M:O%<;N,R%(R]7`S_`![E[=:I5%[M:&^1:0$A4\/Q4T"L-%,C@F=O`T&1DF3T
MH+NB*(K.G#GM5WW*6N]YC3I\/&*;4D9&,'!<7^)\53<EL0Y$Q\I2Y>ZXKFLC
M*O<GT-Q",WU?;4E/'<187R2:2$8>6"+AS-$EE$A=@LEX@'RDW"[S&FLC**;$
MD==/&)!LC5RK6['-FK4W/&K%8F(P6CZ?B91A#*12`K(G(Z:RCE-5BS.58A``
MQRB7KM]=6@2#,=8NF1$O"%`R#@/!\S)932S#G"-1R%:\`6>@3;^1N=5KL[5L
M6.XQVULMR(RD!*[CRIMW/D=2:X"R2\13"!0`=[JLXEM'RS_''@JNNXZRC+2O
M'_$YG/&-6V9XDU@QI8G4ICE*3NE0:?\`$&9=-(QM'QS0%6"86%LR4:(*)(,P
M%7R*"(&^XNU-[?-(=8-JZ:](PV/>/."J^^Y"#4<\J2[Z^*SH7\$KW3I5[3"/
MXX0G"R'MFQEX19K'&4V,Y[!1;[=VY0$1&=SMF.D`4:R/6-9QIQMXPQ8W0^*\
M^L7'\P8/JU$;IUG)%*E4:[0Z]%5J.?W)H$>1PHDI8EXMLY>/S']HHLX$0*'>
M4`]%ZFFX:3\O&*!4'CX1X<8TPKB4W%.ZU?(EUR:SQY67%4PU3ZC:*W:/YOJL
MNVK1)2TPT3"0SM[<(F*;1#$5%H[<B97)!$Y?(7>@+-N!`$^L$E&T@SETC1\2
MX'Q]8L58\>YHS%"UB\LN1+C(EWBJYD"H(-'><'CBI(U>D3:[P\C[BRQY(B&5
M0C>XCT5G1``@^0@#5F()V#27XHHJC;\QUG^.&_P[B.AT[*^;[A3<K2-IDK?=
MHR3R!3BV6OS+6M7%O1JU#HM)9@P:?J$-)N*XP9NBMUSIJ"DL10"]AR[VV9BH
M!'01[50&)!\8^?*>*\6W'/6-KBGDIM2\_P!3JTZG5H)C9H%K,V6B.Y!D,XE(
MU-R4\]-5M&8]H*BS?QIIN`2*8^X@`U5F"$2FDX"%+`S^:.-96XV8?GYBN%RG
MR(D(V^)0&:&Z#R<O=3AIY>EWYS4%KT6"9239-9*-I9X=D1HX!-4D:5ULN8XJ
M$'7I78`[5TT\(\E5/4ZZQK^3N/7#ZW,$1DLUTZIP3_#D35:.DQR128^-AL7P
M+^T/K1.U95ZNJFM&65E*.F\J^*95J*#;;=/L,.@-4'0&<X"J2Z^$>K*'&;C'
M8Y>94N/(9I!RLA7L1>4'F2*-&2+#'=7L=4<4-H@F]1*9"MSUSB6PMUA)XGCM
MUXDSF,<I="NXZ#S\(J56<R==(Z)7L"X%C\]Y=N\5FLKN_6JMUQE>*B2]4]W)
MP$='41M`Q;I]#%;'D89D_KI2O>Y0B8*B)52&!/H-"[[`):0;5W$SUC34.,>!
M$.*%-QC(<C9!UA*)DJI)PE^7R+22P\A`PC!ZWC89M:Q9!`O8F79NP.KL8_G\
M1#%,``.]2[>H6`^;Z(IM39*?RQO-@P%@=Q>^0DU;<VO?Y@R!@9"F9)B)*_5!
MDXI>&U6%M:1UC7:+,TGE=B&Y9*35;23K9H)T5!$3`F8`IO:0TT!T^F*[5W$D
M]1^*.5,N-7$AG7;)&26?:_(&D$\93-QE7>2Z*55''59M595HE<5.`D3C:+.6
M^$;[&5#M?23M4J2O<J4A:[ZDP9>?A%"J2U,?6AQIXK$H\G$I<@(XT.YY&0>4
MGLF&2Z*:/0M#+^87L7C(7!4_$E#NJ0_>-`CS']XHQ1$Q3]A#CJN^I/IKMET_
)'!M2772<?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>pg5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg5.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@#B@*R`P$1``(1`0,1`?_$`14````&`P$!`0``````
M```````%!@<("0,$"@(!"P$``04!`0$!`0````````````(#!`4&`0<("0H0
M``$#`P,"!`,$!08&#`,"+P$"`P01!08`$@<A$S%!(@A1%`EA,B,5<8%",Q:1
MH5(D-!>QP6(U&`K1<D-38]0E53:6-SB"5&0F5O#A\9*B<T351E<H&;+"@V65
MQ69VMB='H\-TM,1%=89G=UC2XK/3A)2%I;76>"E9$0`!`P($`P0&!P0%"00$
M!Q$!``(#$00A,1(%05$&87$B$X&1H3(4!['!T4)2(Q7PX3,(\6)R4Q:"DK+2
M0W,D-%2BLS4V8X-$%\*3=+34)455=3<)XJ/#9*2EU4;3&+76)__:``P#`0`"
M$0,1`#\`[^-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"
M$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"
M$-"$-"$-"%\5]T_H.CCZ5T9KB^^I$SW/>W[A#U/_`)JK*:"M2?X*Q@=*?9K]
M%ODU*UGROV0&O_)?_IYU\W]7?^:+W_>#_1"@E(BG<"D&I'4$$D4_V=>@K.K`
M8Y":4(7]O0'KU\?LT(6#LDT)'7<!X'I]I^S0A9!'4>@-3\`"="%[3%6#ZTG[
M-M3^NHT(69,?ILHL!1J=PH!3KX_JT(6R(]0`*D@^0)]/Z-"%F^5"-JD).XUJ
M:&M:4]0_7IZ*01UJA>3'!)]+AZD]01_@&N1O#'%QR*0V0.=I"^?+?Y"_Y#_L
M:EZQHU\$XM@,JW`>5`:T-.E$[?TT&FOB&\BA>RP2?2>GD.I.G&2"2M."%E#*
M>G150*_^C_ETM0I(BWQ&E*K-0_`_R'0F4*'X'^0Z$+Z$$BO30A>PCS\@.O7Q
M/Z*UT(02BG4T^RA'^"M1^O0A>@WNJ0DGXTJ?\&A"]!M8/@JE.@VGI]M?'0A?
M=B_Z*O\`TT_[&A"]F.H4^%12A'\I!-:#0A?0RHDUH*'H?&OV]#TT(7E31W%(
M!*2>AH:`'XG[-"%Z[)!2*]#7K0T%!Y_IT(7P-$J(KTI7=UIY=/TZ$+UV#\4G
M["*C0A>BR*"G0^?F-"$A,VFW2S,Q)T-F=/MZT2XMZMT!F*X^]$<;W_,Q')"V
MW8]PB[*M%LN!?5*FZ'>GS/YHOWF/8G/VA\VET3FN+=/A-.TBH.6'-:+IR.R-
MZR:\TDM>*`UIZ:8JNCGRYPLDE1X,2YVD7M]+2[-?FG?R&->4LID."SY4ILM2
M;7?U-K4A+<@!2I"!M^\A1_-#J:\EN9@V^G=-N,;0QS7`AX#2?\FF)IC5>\6#
M&2ZFQ-;%&:N&.!KW<<%#.\9-<Y%EBQKA=K7-DN+7"$QR4\RF,$I2XTU+5\L6
M7F(HH:.)05+!(>J-8MEE"ZY,Y:0WD<U*?&YE*\4FHN)7Y,*X)FRW[0\PQ#N\
M9Q[N28[DV+<%M/S79RHS#=M+3L=L-)J`H/`+JD;M+N)H3,UX#7@&E#]*=;;N
M<,P,/V"UX>-63)6+A&R:YS8%_E54=F.7"XR[NF.V5(ERGH[X2J*Z]N;5V$+6
M24[!7=K0[.8KK=?+N0UD/ET::BC>_CGV*#<F:.)VEI#Q]J;?(N%<LD2[Q>+*
MXJ1&MI85\]`7*_.93:V$R4340ERE3Z.172D]Y*.V/0KIU-B^Y%K=.L7G6_4[
M2YONT`J,\4Y;WES+&*X-&&.:,L$YJS[B^3#QZ]6&/F>+QD3F[,)-Q9L<]I4K
MY9M4EQN09T=3T!+*F$ID->E#JQOH3K?;'UO>06C+.7RY(C$^,5X!X`/KHH=_
MLEH]WGP.?'=%X-12AI_2G&L^7LYM<7H\'$(L2,Y!=<M2C_6$,RG2TPTQ&>:<
M:C*WMR0\LBJ&RVIRB4`#7B]ZS])OO/AD<=4Q!!]T-<3Z<,**W;JN`(FXOH*D
M_2EC=;*Q.N%OQR,Y,+N,6]^5D9AK3&B.NST.R[=;D?,1WY#Z;8Q#?[Y62EY9
M*-H2"$W?3.QOO[Q\K8721/J\T(&%:<2._N3UW)\)&QH(+FUQ&7'[:)O[MCV'
MS<<B7FVVQN^7*1=_FNTS/@R[I%L<Z>\P]-G.6Z4ZD1T,QE;/PJA'<00@!*M7
M&\;-!LF]1W#"#9W)TECLB1CGE6M`H]D]MYMY9,";B,5(X@5P2AMEKQN!;9GY
M+;9"8LIY<1V:A=TN5OC.M_+JEHC1ULLK0\'F@4%8?9):44)44G41NW;G//-%
M;0>67'42V0L`K]UU`:D>Q19)8HFZI'`'@*&I[DI'K3<<5;MF66ZWX_>''9+<
M-#MQMDR5<YB)Q[D&V6.W1PRF-;504N/2)1V[D)&Y&T=:S<-C@:UFTB</OKEV
M(8'$@#WP7.`!QX\<U:VLMV^,O?&1;L:,21C48*0LA]N)%?BNV'\FCR$Q1?XS
MTU*5L276'9:)4"7'7)2I];*_QTFJE-I23T!2?.=TV:\V?<_@9365N()QH!E4
MCL2IKIES:C0"*5S4>,HM%JF,W:19%,-OJ6S$+BGV4)G!I*?E&GPTI2(WRS;B
M5-.(HVX4]0-2MO\`-%P/-()[%5E,M;;/%D.O1Y?<7(C(2_&F=UUM4UMA,EEW
MY%0C(0[<1%(9>9[GKC#=4E(&KA[M#"_@"/:5/LHC<0NMVD![6DX\>P+[:U?F
M4*'>9D]E+=R%SQ:_1VOPE2[?9YJ;LU-=E,LA*6&H3/RVY#:UJ<4HD@)KI!FT
MS.@::",`@G\3O>]?!5S*Z!7`T6E\E9_Z<;_/5?\`/O\`]EO^9_WG^;O_`"K^
MS_9IZM]RX52U^SUKT=:%#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#
M0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#
M0A#0A#0A#0A#0A#0A?%?=/Z#HX^E=&:XT/J--A7O6]P2]O\`[%5G!(-*4PS%
MP.GG77Z'_)__`/!CLG_R+_\`3SKYNZN_\T7O^\'^B%!U;-2"10@_9UIY&G6F
MO1W.:W-9Y:RXY43Z`?A0BGZJD'3`D\=2?"N+!V4TKLZ?&G3^73OFLYKJ])3M
M!"0`#X_JT>:SFA9NR`0"2$FE"34[CY?HTHN#14Y(60,I!J23]AUT$$5&2%F0
MVGJ0*=*5'ZM"%Z"#45Z#]6A)<]K?>7KMBI\?YO\`8UU,L!8XN=@TH;16O4_^
MDTK4[3IK@D.D=J.DFB^I;W&B14^/EX?#KY:2N"1U<2:+)V%5J$_SII\-/PO:
MRNI2?-CY_2O0:77[OZZCP_ETN24:?`<:HU,D\.:S=@?TC_(-=CD:0&D^-<=&
MTM.D#4O26D@U)K]A'33A>UIH<U#<QS31V:]I:2:"FY1\STK_`(M*25[^7Z@;
M!4@D=1Y&A\_B-"%]^6_X,?RC_9T(7M#!!IMVI_2"?L\]"%D2Q4#<2#YCH="%
M][`\U?R#_#7ST(0[`\U?R#I_/UT(7TQMM"5?>ZBGP\J_;H0OG83_`$E5_F_D
MT(7KY4[=U3M^/3]'A6NA"R!H*_922!4TZ"@/VTT(7P-)4:!`).A"^AA*@2$`
M@%0Z&E"DT->OQ_ET(13>;1^8VY]G8ROH'4I?B?/(/;!JD1DR8JW"H>06#\.N
MJ_<=LM-SMS!=1-E:#4`BN(-<D_:O?#,'Q.T.KG6GM."A'R_Q#C66_-29MPQ)
MFX!E3;S,NS7RVS760IMMQ'9G7!A,QN.SN`;4\\KU*("Z`'X=^<7RVZ9M/B=[
M;N#(+N234V(@QN:1C3Q`59V#/&B]:Z8WK<9#\&Z`&`"H>'`XGN)Y*(-UXH9Q
M^U_E5LCV6XQU,OVEZ4U:)#DRSJ[S<F!=9L1M:WYUJ"7?EYJFD+06G75%H*;0
MO7R3N[)K*\\N*<36A:"U[:TK]X'E0TI5>GVDL5Q'^:UNMJU,G3;96%62UQ#'
MD3[?OCSFVER#"EMB>%Q+E;U-%#DJQK=#A)2LI;?+J=WW0:2$^3<%]Q[K1JIG
M7']Z;GP%1P.";F+-;MD2=(A2;U:KN[+B/+N&))AOL/NS([;D&*HHB-2K6U-V
M%*N[5&_TJ`W!6M>RP@N[1^^6,38KMA`.HZFO<*>$,!K2G92J1%>1SSBTNJ^6
MXT<[(Y9U[$GK;R#E$++.UFC*&<>>M\>UOM6JV_)6PWUMP/1GIR6;;NB/N,U6
M\X\K:7=E2>H"XKBWOB^=SFV^Y.:&Z7^&-M<"65IC3MQI@I#]HNK9NIA$UJ#@
M]N-1GB,ZCCAR6/DSC2RYW:;A>[$B#=R)*)"7(CL=5QA+G%J7*B.QG6&$/.+2
M\M12VVX3MW530D1#<MVZX#/.;(6X$-!``&3LJ$N[,<,4W+&][6O:/":T6AP9
M;19H]RM-TAK<R*&+`UB3\F0B`TBQSY3\&[PUO//E4F;)`2VDM(IVHZ&ZU=4-
M5^[W7Q[V/#0V*A#@,CC@3VT3]G)'&TC*:A&6-$4J-_4B=.MC[T>5:5X0A/S#
M[[(GHE/7==P5="Z5R([#&*PGFW4N*WE]U1J`X!J3M>Y3V$;G,DD;K9(UP::%
MPT`1BO+5ERXJO>T/<&38L!R./&JV(TC'HJ5R;==?RVUS+0C&F42;D;4F9$A.
M3)F3*A0VT2I28L6$M`0X@!QVH`"5/*5KT+=_A-_V2TM;*K=QMX&NJXUHX"KJ
M'\1(.-4UM\S[+=I;F1NNUD(`:,R*`5[NS-*IB^XQ8[6W:V?D[_+MMNG157`-
MRK=!LBY\0O17H4N5*EJO%Y5#:2&U=IE85)6M+W0UR.S[G>2M+KMY@:\U<=7O
MGM[OK5KN`M;>Y:+1H>XG*F7KYI88RW`R:9;<NR&VWJ7:L9APX$!<:.;>W*NM
MS)MS:H3<BXMS)L=R-`[086ATE,@+!4E*J[/8=^Z>N.I`[<VS26,%J(HFM-'&
M1KM4DKS3$/KH:*U#0*J-N5E>0[,R2-[?B72E\A?C1M26MH,R,FTRXIVD6/\`
M)D3I[F,?U>\J5,D&*42ID>-;9"OZP(3%QE!24-.%3:G%-R`2$[$C:T</\R-N
M&V=1-9`P16LL9>P:@<'`.I4$XXY9]B9V^9]W8MN)"7XEI)SJ#2G=R3!9+8[:
MIB:R[#?=;20]:7K<EB,N5$F)^<=:E//NLH?9C.56PIIU>]1.PU`0<;;85>/?
MJI#O*;@X#U*.\=J^0\KCRK8;E>K.;L>VEI:3'B2WF2AB67I#L>-%=D15K:"J
MI<*CMVDU!T#HA/:%DC0QXQ-./)-VLACN6:20XF@6WE<]5BMT>&Q9[I;)R)SR
M(K$92F[E'?GPYL%7YBVA':3$6AIM"U*"!O0DU"::K;*V?,]SI-+CJJ2^AJ&F
MOLX+EW#)%,X$4J[V56S^3XK_`.=&[?\`0^GW$?\`2C_GK^T?VO\`R?#2?U"[
M_OF?Q]/NGW.662=U6W9[O+BOV:->HJV0T(0T(0T(0T(0T(0T(0T(0T(0T(0T
M(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T
M(0T(0T(0T(0T(0T(0T(0T(0T(0T(7Q7@?T:X30$\0NC-<;_U%V"KWI^X`@&A
MRBS5'6I/\&XSX=/+7Z'?)UP/RPV:I%6V[V^ALTI]=7&J^;NKO_,][_O!]`4'
M2RL#PK7IZ:D^?V:]#F((%%G2L):-:`&OP/C_`"`:80O';-*':1\#X?R4T(7W
MM5H$I%?A3_!05T50OG:-0*5Z@4'4_P"#II3GN<*%"R=LD[2#4>`'CX=:TUT2
MN`H$+(&EDTH1TKZ@1_BT^Q^H5<15=68,)H-U:^=#T_P:<!'!)<QK\U[#24FH
M!Z].O70'#@4.:'#2<EE#)()V4IY$&I_1TZZ[4I'DL[5Z^74*4VBH^W_8T5)3
M+V:74:#1>D,>.X!1_9I6H\:_#74C2[D5F$:A!"5^(ZGP_P`%=<3^G0W4SWEE
M+"CN!`Z#R'C7^CTZG2@XM-1FAKY"X`C#N7T12D=-O7KZJUZ_^#KI>YQU'-<F
M!+L!P7U+2C0^D$^`-0?AX4TOSWIG0>168L#:"D`*Z;CUI7]KR\2=.NDHRH(U
M)%,5\+)KT(`^!)K_`(-*8\%M7$50OJ6#^T*_"E:?X-(DD+7`-I1`"RJ:2HU(
M/ZNFG=3>87%D#70`;?`>/C^OIKH<#@"A>NT:5H*>%:=/Y::[4H7TM=!X#IT!
M\_M3T\-"%Y[?^U_]#]6N%U,RA>@V20/$?`=?Y!370>*%][)!ZHVUZ"@\23^O
MJ="%]+%!T2JOVIH!^@CJ=<+@,RA?`U4D`$CQ('C7[0!KJ%D$<BFWTU!I0=$]
M/,%)`T5(]TD'F,UQS0X4<*A-CR!A3]^MJ5L)9GS([W<+$\]R(ZBG;6E++Z9+
M200/`H<IX@>6O/\`K/HJRZFM3%,QDKG`@AX:[@1A45!QSJK_`&7>IMNN`&$M
MCJ,![IY^GFJ^>8\%RC#HD_,[9$;#UO"UHM+-P=2Y`E(+;S5QA/H6N=%1'[`[
M8)#:5CHE/2OYU];=`3?+R1]G>1O=;W'B!HZD;W.<`*T\(I3PE>P[5O$.Y1UB
M<!)A@"*FO(*"+G,5M?:FJN;=P8?DSWWWXL=E3BDNWF,F+*A6]#;3;++$F1'3
M(;4V``Z=CB0E`6?)9K)OQC"SWNW):C4YUMJ?[X2/A9M?;C+>NUDB(2JZR7)K
M4/8ZH-B+(<B!J1&F,M(4XA+`2D-I55:#TJ4C5S;;=<M(CMG/<UIK1IKVDX<O
MH4-DL;H@9M-#GZ\$X&+<=S[=:3E5OR"!+F9$RB7\B[*BVV!;F;HHH<EAJXNW
M">J:[(;!96N%'8"*API04I.[DV_HZYV261YN;S<F,]UT#XPQQP%)*4-#EVJ?
M%-O5K,UQ,$-@6@@B1K@>]M<SDGW;0U:("[6["M"Y5T@R$O)9ALM6]XI3V7W.
MV%J8CSUP7W$I=84E)0X.H20H>'21RV4S@_51N#@[WC3OQKS4R6<S.\Q^D5Y8
M#T)@;9CEW-SNELD*;%N91<[1"DO5=97)N39?AAI_O)7`D]]".V6G1L*7`-P`
MU/-S;R1@,P=0'$J.QL8=5IQ[TF++8)K/>8O=69LINVNQH,VXNERZ2+;8[9">
M==HI3+T2UEJ2\MSU!8<!*545N;FF#8VM&+#G3/V9)$K68N^\F/SZ[SI5V=E7
M9%IAL7*+-MD*2TTE+9MEU>3<9D>WQB6E&9":98*I""$J2Y1Q)#@"='MD_DP4
MM'.T5J:FI&0I7@.Q,LE<P4`&?$(VX?M]XN]]N.-P[E;DSU0#?+?;[Q?&;#+N
M5M891,C1+1,?(BOWA!:V1$A24K)#:BCR;WF>V@C\Z:/4<<!DWT#)6D#?->R>
MK=9SK2G[E/BX8Y=L)NN.V2]JB6U,QJV7%<^7.8?AKO\`$+<I,2XNQ;C)4RK(
M&T+4Q*VG<HH0A82%TS^U;X('NOK9FN5E:#AZ>[DG;RUDE86N>W1JX)9WG(Q<
MKI#58X<QCYR(+A$3)NPE*_)VHUPM\JD-U^2N'<WID18D-/D*4VPE;9.X++V^
M[A^HEMW)JD(`<&EVLL-,0VF6/#ADH3&>1$8!314'#FHZW.YF^3)UP%T?LEV:
M*8SD6[Q8\2RS5N.O!*PIU!M<(J<.X(2@)4I6_K4DM6L;/+#G$5=B!7$=X3;F
M,DQ.*93)H$9VX,P[A\Y'=<<]<N))<A-3'@^AWY*2_'4["6J&XE(4EYI"5"JV
MR"#JYBFDDK&Q@>7"F=`.]1`=+VR#WFFH3J6.,G*AAMV<`@R;:[,M5]94TV5N
M*&Q;`EOLS)3,MI26:.42PI2`76FTTKK)WTDE@9(7.I*7X4.`QQ"OIY!NC(YI
M*#RV@&F%32E4^/\``F&?^=.X??[O_2IK^W_T/[#_`)A^W]]]FJK]0D_$W]N*
MC_!P=OK_`'+]8W7OZEH:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$
M(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$
M(:$(:$(:$(:$(:$+X30'7'>Z>Y=&:X^/J'L@^\[GQ2@#7)[014`]#AV-?;K]
M`_E`:_+/:?[,W_?/7S?U>VG4UV>;Q]`4'WHP%-M$CXD>/3PZ5/37HZSBUELJ
MJ*>K:.BN@I7Q`J0?#0NM;J-%@2RE1H$`GQ_]"IT)SRNU9!'(-0@`_I'^SH1Y
M7:O*6JJ.U(W=:^`\_P!/QUQ)<S2*U641^J5$4)KN/3T].GGUKKJ"RC-55D["
M?-1/Z.G_`*`T)M9A'W`$-CQ-.HZCI0^/GI;'Z."ZOJ6$*\`-P5U'P2/.I-/'
M7&/TFJ%L!A((J2?'IMZ>'F1X:<\_L1594QQY@$$UKTZ`_KT>>>2*K((Z`:@=
M1Y@>'^QKOG]B*E9`@"E>O7S_`$4_DUSSSR1594L%5#Z-OQ_V`0#_`"TT><>2
M[5>A')50BB>M"0/#RZ5\#H\\\ERJR)B;ON]:?8D4_E.G&/UUP1BO2H2R/$?^
M%2GZ.A)T,DU.TT4:2/3XJ\5C^5)2"=Q2*D$`4'VFE>GZ=/)E?!&Z$@F@Z'H.
MGZJZ$8KV(Q255&Z@J0:=!\?'0NK.F,WZ3MZ%-:CR)ITIXG2F.T.JN+T&*@@H
M``Z@5'4_RZ=\\\D40[)*2"D=*!*>GAT\Z]*:///)%%Y,4%/W4[JUH"0/LZTZ
MG^0:0^36*40`O2(X'4I"2/#P)Z^/6NE-FH`*9(HLS;&X^I(41U`-.E"**K7Q
MUWSSR11?7(]""JJ0:T":5%*>=?#3;WZ^RB`*+XF)10H/44A1'3PKX5KYZ<\\
M\ERBS_+$D'92E>@4*&H\Q7K32F2ZG::(HM2;:S+8<:4EM1+;B4AVG9JI*@"Z
M$!2RE-?V>NF[NV-Q#(QNG6Z-P&KW:D$>*A!ISH1AQ2XS1[?[0[>/+CW**^4Q
MK<XS=,?E)A75R1%?95$B77\PA.;QM3(4T_)C72$&"?%)51!K10KKY:^8>P[9
MNUL\?JCK6\8'"6W,HEM)&-H"TQN:'1D_=<'DMQS7H^U75W::7&!YB=D\-TD4
M[!GZU4'S7Q(S"OZ[@U97+2TB7(CPKB;A`7$NT9(=7):;N5MD2HE8SXW-Q);:
M9);4I*'*>D?*>[]+7MI+IBM[=MG[T9BF;*QX'`/'B!IDVG>5Z1:W4+R#*]WD
MN%#4>)M:>(BON@X5KQ34X%8E7*^,VB]NQH3%M<DR[S*=MH+ELA%\NA,!4QV0
MJLIIHR"@;2HK70(HM0OND-LVS>;^!L+Y(XVN(FH=#FFA%-6-,:<,1@H>YQR6
M`<UX:Z,^ZX'!PX%6$X+@D3/\;O>/VE;EB.-SP[)=B7)YU#T",VE3[=P=EF/:
MUQ(ER;E0F6TM..*90DAU.Q>O<Y^C(>H=JEVB(:+>V`#Y"ZM6C%KC(`VAK7PT
M-*5KBLL-XDLKLRW!+FN:`QN8)QJT#F.!XE1HY$M,_&)+D2WWF/<6D/M*3(AO
MJ6B*I*74BW+*)&U7RBZ`K0ON(5U"OO`_(/6'24?36]263WON+,G4)`-6>>-<
M>];RTN_C+..70Y@Y.P=PS'!,[9^0FS=)%FSEL&S9%*AL3G814S*[[#+S4.?'
M<CH6VVY$N#C;S@0D+=8"DGJ37(3[>=%8FT!.!XT[0I%O)6;13/!8+IR"N]Q9
MMG0]'B*4A5L8E!AV*M,>"EU,IV>XA3+S3:T)4R\I2$!?D0":,PV,K96ES2YH
M.0S*>N&ADSFYY?0F`R>1-N<VW3F4MR;DRPN6^N9%9:M-J;1';M]L@VN+&<V-
M.NJ:2JH(3O*:U(Z::SMS'$]K@&A],!C2G/M[$ED6MI)-%(_@!^T0[>W9+C<,
M<N,Z5%D29F&Y/;&K3=&E;GE(5AE^DE%IE)DIC.%2$W%#Z_O-,[A4T?4<<SG:
MO$QN.AV;:\=8Y945I'9R"V9Y=79J4>21K=>K`+@COW6W6ZQ?*V^'D<2;;+I;
M;="DFXB'WVF0A^5#?2M;#RF%*<`2`4T).*MG/BDT,<,3XJ9./$CL/!=Q?6)P
MH1]28W^-7%6RVQ9EP9?7$-RM<2ZOP'V[C!B24]VSV>YO16`VB.A?<##E%)>0
MI:PI*JMZT!MW5!8VD6&/TJL?-FV@25M>2R;_`&V=&GN_,&,PQ\V)\5]5G2A$
MELS7Y,U#2E-MH8<;>0@J6@D>0(H]"SRI1*#4C@DLET"E,U]R;&;XMEG(;?C,
MAV,Q**75V&4E:2&&XSJ)["8TM(B.-LN!:FMM%)KN3XJ%HZ^?/,9IB&/(^Z`!
MZEV2/RP#6M2DY@G(CUCN<JTVR1?ES')*HS5HR"+'EP5/+!75N,I"5-LM4=*A
MO]*%;Z4--5^X[,;R(SN<QK3C4&KCZ,,^/)3+.6(?DM-7G%.W_>Q</^:(?^:?
MF/\`,U^_>?TOWG_1G_YU_DZRWZ.W\9]ZF7[U/7Z[FO?UU#0A#0A#0A#0A#0A
M#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A
M#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A?#X'2)/</<@9KD,^H2
MQO\`>/ST4@*)R>T5!J?#$<:\`!77Z!_)_P#_``:[9_9E_P"]>OF[JTG_`!/>
M?[P?0%"-;9/B"*^9!^'E77I*I6,TFI7CLFE:)(Z`GH/YO'KIH2-+]`K5`80_
M5P6#Y9(\$G](_P#2:'S-8ZAK5.(?+I_HJ_G_`-C2?B&<C^WI0OGRR?@H?JK7
M[-*9*UYH*H68-4`H!X>?C_@TZN$@"IR7L,D>*>AZ#H?'R\M<2?"YM0%Z#1`Z
MI/3["!_@UU1EZ2RH4VH/A2O2M":^9!.A"V&XY":J2H#RZ$4\:UJ-"ZLHB[B*
M`I\R55`(^`-#UT(6<1U`4!33])_G].A"R(BDU)2"*&FT$]>GCZ="%F0RI*0D
MHZBO@D^9)^&A"RAI2B`4T^U0\OYZ:$+.&&QX`C]!T(7WL(/@D_JK_+H0OHC)
MI4"@IX5/^"FGV2AK0#6J2YM6D#->!$13[M/CX]?M/3J=/->'"HR3/DNYA>S&
M_P!T(I]G0[J`]"/$:XR0/.%4AS"S->TLJ(JE(_4#T^SH-`D!=IQJFT/E5!14
M6^I_\(`_8$DTTXNH?*K)"MI]-12G0U^SQ_FTVZ0,-"N+$8OJH0:GKY^9_1XZ
M<75[$8H!]/3_`"@?\8T(7H,JK0)ZTKT!K3^3PT(0+*NE1XF@!%/@/$^.A"!:
M6.I%/*M#_AIH0OH:402*=/'Q_P!CIH0FLY&S"1BY@Q5P+JW$F@%=[CL."WQG
M5N=IJ,Y/0AYJ&^I1ZA]`:4A70D]1DNH^J6;//%M\T=P&S#"5L>J-I/!QKGV'
M#F0%;[5MS+MSI009&C%H]Z@X\L>&*KKY+=MS^20Y-P9C/OF2Z\BX)Q^TJ%SC
MEI[NJEJ*FXRI;B'CMD,%;2U;:]M=0?B;YL7$.T[F_<(C;W+99!YE8A1PXCPR
M4J.S!>O[(7S6C(,F@8`Y^E-1F&38-9+.Y$38,I6[>HS3,9_&2M46;,478\=1
ML4AY5KN?<+M-BHQ(4%-I4GH1CXNH>C[US(K?:Z7U:-$3Z4-*8`N`&*G/@O(#
MYLLS#&.8X<L`H791=,LQ6ZP3)Q&_XU>$L2)-HF0[1\O9[C%:?=+D')8*"_$L
MJX#H>2\8ZVG4N/`*;0DDFMMK'>NG-S?>/$UJ^8`4(:YKJN!:UU":.)IEPXJS
M;N-GN%L+&Y\I["WP'$.8[C3"A%*YE3*]MW-;<NZ2I#]GDL7R18V&<]L\H/"-
M<)$*^75],QB$EA]`AHM-U['<31"E,DCUH77Z,Z:^9EAM,,YW"`?'F(,D@=BY
M[P,7-8PDD$$4<1IPS%"L-?\`3KW3,:US3%&\EAQP:<JX>\#6O91)CF=JV9%>
M[B6[9'L]O=;D_DRKA._+F8#\64C?#:6EEM!D)W4+96C<E)555-?*O7?6-GNN
M\37%E'Y37.($?WHJ=GNG5PQ.2WVV6,AM&MUL<X<:G[%`_*V'T+1#N%AF/J:E
MOCY!R1VOQG$.AOY9U+`6XMXD%)2HI4GP!KN.3@?YF<KGDMK0@8=N')=D#V!S
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M'KE9LJ@W6\R;8VW>FI%L9N*WHI8N33TYY2'$-W&"VJ/,M+Z6=X4V5;T=4J`U
MD([A\XDMG`-D:X'*F%>'8GXS'JK+71V9I-Y7B:<GL7YKCMW"8\VW.2)CUM";
M=<$0ID9Y`CRT1W$]R"[)W)?9JEM2%G;N)`%CMMVRVFT3UH/4>ZJ'EK7ZH!@,
MJ_6F)9C7806S;Y0:OMEC-QTVZ,U*<45MN.1(,F,^.PN69!4N&I&Y2]JP5)W@
MJU;RN:3J>/\`@W8DC@>7UIM]MYC?.BIKXCB3V=B5EAY2Y+@3U,VR`Y&;C(;F
MW6,IDQ'A+::CQC"E1I(=2[/B6YP[0E2P\VI1*.A(;GM;0Q^(DQ<:9]E/3FFG
M-?*P$C2:Y'-./)Q2P\CN6B9,M+N$9'!?M4DR4,.Q(60VR'/[#[<P22NWO?-,
M.K2.VM"D!H)6D@U5`O-[^'D8^T8QL9A:QX&)+J4+C7`&O));;1L(>W^)^U4Z
M/Y!#_P">6O[3_!7WI7]B_P![^Y^\^W[G^5K/Z7\_OZ\U9>>SD<J+]:O7OJ?0
MT(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0
MT(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0UP@
M$4.2%R-_4";2?>+SLHG;7)K2#]I_A''?\(U][_*.1P^7.V`'#3+_`-ZY?.75
ML3QU->.(P+Q3U!0J=CJ411(5Y4!%!^@FFO1?-?S5!XUKF.=I)3M'Q!'3J/MT
MC40=0/B76ZJXK$ID@>FI-?`T'3]>N$EQJ<TM>.TY_1_G3_LZXA#M*/["J_&O
MII\/A7]>NASFG#`H61MA1JI231-.GC6M1X`DZ5YLG,H.(H<ELEA9V^D4H#2H
MJD]?+IX#71*_FFR",&^ZLB6NJMQH!]T]#7QKTZZ?CESUE-$+Z&>O11\?@--&
M1]<#@NT6V&W*^'\Z?]G2F2.U#4<$460LD^"NM*FHZ?:`0*5T22G5X3@NAI(J
MOI:!``)!'G3Q_3I/F/YE<H%F0FG0?I_P"NEQR'5XS@N$+,$>!/AUK]GP\]/>
M;'S7=+J5X+T$I_34]/'^31YK.:30KV&224A-2*5%?B*CS^&CS6<T4*RML`]3
MT)\`.M1T^WST>:SG["NAI.`^SZ5M?+>HT0:&E`K_`!*-*ZZ)&$T!Q06D&A7W
MY8?M-]/L4`?Y>NE&71A6BXO28J55W)`^'AX_;0^&DB=K<G41Y>OA59DQ4(21
MTJ36J3T`Z>(.NMF#G>$^)<,(&)"^B,#6A/05/AX:=\Q_-)T,Y!`QMM*GHKJF
MB?+[3X5TDN<[$H\MG(+Q\J@G<:5ZTZ>H4/0].A%-*\Q_-'ELY+,F(>BJ;AXT
M.WX4^/QT"1_-)>P:3I&*\"*DE7IJJA]0-"!_+U`.CS'\TQY<G+Z%X,9)!!-0
M?&H!UWS7\T>5)R7DQ4D4)J!Y=-2/,9S24$Q4)ZIJ"?'P(Z>'0^&CS&<URJ;#
MEZ*&,0G3W'[@RU#2%R5Q!$=99AK"VY+TB)(:6F6TAMTJ4D+35*=OF*>5?-FP
M^,Z>DNC=7-M;QMTO,-34.!%7-XM;F:4PKBM/TQ,'7HMM$3W`@@.K7'+'`=U3
MWJE'E"R7"+)E7G`[XG);=9Y;LY&.Q4W!U3*GRKNOQ(LIN0TRA)<ZQ7G$.MT&
MWH-?GCN-G=&SEVJQW:/=;1CWN`T%LD8XFIXMX5->0*]HMB&O:YT(A</>H:UY
M5H2DC9[[+R1IAI4V!!==A27UB\,!EQ$ELJ5)3:UM@E*&D+"UJ:0Z0L`'K51\
M\A,FVRBY:]Q>,`:XUY]^"L@TO)#0"/J]*6#C+V9VB:+])N]DAP4._+9!:[I*
MNUPN-Q=;;MJGA;&[VTXJ?(C[(ZG`ESN,IV*0=NMK:?,"=]M\)-KFN`#D<:D'
M%Q?05`Y'E3%,C;`Z2N0/`#[$W3,V/QQ9KANNS=]F6M[M6^'-;..3HMNEK+O9
M1<!`:N5VN;3R2M2'70IQIW8@T"=]E:];P7VQ-V_<H'RWT0I#/&6M+`#45>"'
MDU)!!)%$W-8W$4P;$]K832H<#4XX^L)S7K"O)\3<S>1=Y]Z<3;X-SNELO"$O
MW!+3,9F:[;R8>]J_`QZ;G%)[G800NJTD#R/==WEFOO)E&JX))X8DYXTI[5;P
ML;;C3`-([%'AJ-B]P=E1K=9I#$"+E]@RR#=TOQ776(%V?>BMQ';>WW#&;9>0
M$E+@#>YL>FJM.1RRV;?/<\D/:0!](]%$@")SJ``N6+/5,N6.'!D1V'F[BS'L
M=N4/E6Q#?BWJZJ:_"=84P")LI)2HH!#C(\^NH>U3OCNI)8SH<,3Q`PPKGV9)
M;70-<&/IHXI0<7W_`!RPO72#`:DPVXB/R-ACY9:8CK,=B/#::9N+,=]#*KB^
M%=GYI52%[04#IJPO+'<K^V%VYGF/;BYS>!)S->-*9#DF?.A87`&@KAFB^X)>
M;N\.;C;2(AAO.2_R@A$5=K+B3(;4U#6\M-QM\EMLMO,!:FMBU)].ULJ@NC(C
M?;W#=1%""<R?1R37F/SJ4:WH0W[*XXQ&?;QT7"US'/EWG0[9)TMR7>7K:WL;
M_%E,OJE=ADD.+"]J-Z?NP8&E]^U\Q(+G:2?H!_;TIS3<^7YN/EUI5:V$7&VS
M;Q&5`N62V>ZL1X+4U6/XU-R*,J(ADR!=Y)CW&,A,QQ$G8ZV4GO&GWTUU)NH+
MAKM+RQT.LZ:^]GPI[%*M@V0M;,[2PG%W(<\$57WBN^Y9=5N/2+$;W\N^Y;W(
M,O\`*,EN"H[RWNY)QVU-&=*NH80.RTV4N*55*45)U91;@;.(%M<L>/H29#)%
M-6V<=(P!''UI?X9QGBS;^+VO)6[VWEDZZ)N$)Z'=A:<DF1W(J83$MJ7/BEEY
M;T8!EV-*:>DL/*63W*.)U27VY7T;'W%MH8"`-+JEH[:"I5Q:W&W3.#MS8[M+
M?>/U)Q\BC\?M6-+6,7#(%VF9#NK2T979XD&[VF\PVUM6RU7"YQ?F(CI>?B);
M4^$MNI6AI9&TDZIK-^X.=3<&P^)X),=0W.N1Q47>!M8D$FSF40\1)[RC3_'0
M^,G_`#7^8?NE?]+O_$?N_P!O_P#0IJ\\J7D??_['V>U4OF2<ROV"M>[J^0T(
M0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(
M0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0UPY(7
M)1[_`)'_`+6%SI1)5NR6TD]*T(Q''/Y-?>/RF-/EUME/PR_]Z]>!]6,:_J&Y
MU?B'T!0U4@'HH`4\:5`!\P3X=->@ZSP6:DC#0--5A4U6FW;0_$UK^CH=&MR:
MTGD5A4R"2DA(VC>=M1X?X^NNAY)Q1I/)>$QTJ(I45%.IZ?'QI]FG*HTNY%?0
MTJNQ="`L%!2"$@>`!/[5/CI(-3BG9(PT`MK5;"6*'J4T\Z'K]GD//2DS0\BL
MI804^)`\.G4^'ZM"-)Y%?1'04D`_>`!J144Z?#IHU)'E@\UF$8`>M!Z=1Y]!
MYU'CILR.73$!G5>TL))H*U/B3TKTJ*CK32M9TUXH\KL-%LMQ]O0FH-?`FM>G
MV#0'5%3FNZ:8+[\JK=]T[?\`PMWA^BGCI/F.2=#5G3%2H;0G;^T2:BIZ#QH>
MITX'(T-61,0)!`VT/E4G^2HT52J84X+T(I)Z!)_16O\`[CHU).@(Q@V>5<I*
M8MOBO2Y"@5!II)6=J*;E*`%=J0>NFYKFWMHR^=P!X5('TI^"T?<2")@.H^H=
MZE+@/!>/?D3N2YO,D)4RVX^W:6]C,=<8I2EEU3B27Y#R7"26TG:`.OPUYUNW
M7$YN1;;0S0`:.<?%6F!I3@5Z5L_0MDRV=<;J\OETU#1X6XBHS&)].*C/GM_X
M[QG(8]F<O$.R2+VJY/X_"N<A<9N5"M38>GOMO2#\NVIAH[BE:TJ\D@GIJZ9U
M=8;:Z&+?+F*&>2,O:9#0.H:4)X>I9J^Z<DD>[]-A<YQD#0`["E,32E1CQ31N
M\Z<)PQON7(MAB14J2V].6W='(D=!6$=U^0S;UM--!74K40E(ZD@==1C\S^BY
MYOA8+^VEOG'2UH\P`._M:*$>E(@Z+WIS29(2#7\0"E*YQP[&L\>\?.,S6YS#
M4R$F.D*CKB/MI=86MTJ&_O-J"AMZ$$4KJS;U);R77E-H(^94F3I1\-J)O$7'
MEC]21L^R_*.>EI24I0DK*_)PI!4E-*@BIIJ[L[^.9QT^_4T[EG[W;WV[`X^[
M05[T7F(0%$`&@Z@'[">HH-6`N']BJS&T!8.TNA&P^5/2:>)K7I\*:5YS^Q-T
M02R22"GR\`GK_.-.1R%Q\5%PA91'/05(K7I3H*?TC^S_`"'0)"9-)II13!`Q
MZ&E*UIZAX>(-:T^(T[J;S"XOJHB0FM`JOB!T)\//SI^K1J;S"%C$=-15"J5Z
MT3UIYTZ:-;>837DM[4/E4D*)3MIXU!J1Y4!I4C]6NAPYA'DL[409':&[E:)D
M60H"*&EN+3\M\PI3:$DEL-]MTJ)\B**IX$:K]VC;+9.8XD-H:@4-13[P(-1Z
M%)MG&W>'1DAU<^/K587+?!@O%Z'Y')-ER22S(6J;CUFD6R882FUHCIN%LA(6
MW=92SU4MR,I0"NBPDU/Q+UUT;O6Z[B^?;;=MK>@NH(8P/B14:6:&"K3P+S@*
MXT7K=AN=O"UD+G$Q:`:N(K7CBHB9%P7S+@C[LP69JXO-PD1'9UK4RR^W:.ZP
MY)-PA,MID6=BZ;$MK9;*@\*T0*T/S_N_0/5]I<_#W=E*UYQT`%Q!_M@4-,J+
M86U_MCX]4<P?-Q:.`YIH9F39)!O\:#>4W"SIE+C_`#-DMK=PB6YB)'D.)=-T
M?^1>123#6XZRT'>XO85J2FG3,MV>X@E?!/$["H>`"7##+#BK**0N`EA=I)R/
M)*/^\OBW*KDJU,75B(MIQZ,;1D-M^;;N4EEY;BYMJN3,::[;WG%`-K;=VH6O
MU%VG1.Q?M/3#^E/,MIY;:_C;_#+'>)W/70#'+3F*5XJLDN-QDO=$[#(*#Q5I
MA7VI9(OJ</0_#:BN"UN@N?U5]F<I:)*B[,C=I>V8W'DL.[G8BA194KM.5<4%
M>//9+<D9"4>O%6:9<L16,QS61B[C+K.7VF+:[2_;PU%@-R)5WL5Q@R+@F:O<
MA,&0SV)S2TI[:OQ4FI4#*EE#;:$3@EC*Z@/>S]./H2&0:WZ(2!,[`5RKGBDQ
MFCL^4PQ9+BI<>\V=J_O3[8[VHJT"WY,I4Z([-*7$)F1%W1.QY8'[H]"?5IW:
MV1MG?(*Z7GCW8#OIP4:8$2%IS&![QG[4RLBUY#$4VQ:KU.MMT%P4U,F1'9CH
MEK;0JY1DMO14!^4I]N4-H<JE&U/A6FMI9;A)"XMQ\IS,@/":?7Z5'<UA-7'%
M*R=<4SK=(:GR)ZY"P%LWLH5'N3-T[;C<TEV:ZSWX5P2-Q21VZ>@@UKJKOY+>
M6],L`!<Y@+AP!QR`R3A#@`2#1%=IYGR3&4W#%'[19;K%N`A75:[BR%"XJMT:
M4B"N`KOQF(LMA$IPA`=4`X%)!&\T<@VR.2%TLP`#\`1A2N7I5C:7#OX#M/ED
M5](1-<_</FF9FW81AMFOD)A:(:E63$K)^-<+K<Y/X$%UF"TI4.(IYXCNEMY]
M9HBJ?%,J/IR.SM7WUS(/)8]H))!`%/I0-;S0CQDY`?4CO!8V6V?.;49\^X0[
MDF5<53UV&TRKZ,4O+#(^7&51XSLR[/H8!")@:^8>BI`4&DJ3TA;C#:-MM;&Z
M8CD211W:.03,CGL=I'I_;@IX9G:D7G#;;?I[4>/E32X%UES;7NE-1Y9BE#UT
MA,.L?,J5=4Q$25.=Q+JUDI6VAQJJ\+!6.ZT#QQ.%,<0I4C&-`TFJ:R]W]F66
MVI?SK+=Z;C2(T@/)G*D7%3?R4V<W\R"U-C7!30`V;5MK=2A7@=/?">/RH:U;
MSY#ZTR6ZQH**_P"&+S_SI!_SQ\C_`&=_]W_0_<_VW_R'^T?;J=\0/P/RTY'/
MU9)'PW8Y?KKZ]N5JAH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH
M0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH
M0AH0AH0AH0AH0AKCA4$(7)[[]F-WN[YS72E<DM/JZ'PQ/'16E1XTU]S_`"GF
MI\O=N;3(2_\`>.7@W5.'4-S_`&A]`4-W8Z4@B@H>@53SI\*^6M^Q^@US6?6H
M8W4"M1\:#I^JNG//[$+Q\NJM=OV4]-/T^-:Z//[$+Y\LNA\.I\.E1^CK3^<:
M//[%U>!&4>J:D5/CM\?AXC1Y_9[457M,90W5\>E!TZ_'KNZ4T[K\&M"V40U$
M!23TK7P'B/TJTUY_8N'$46P8ZB!N0#2M3TJ?T!.N>=3@D,;H[5E0R1U50>6T
M"HIT\?"FNF;L77MUBBS%G>2OIM33H$I%!2GCY^&CSNQ=:-+0WDLR8_A^&*=.
MM1Y_971YM3DFY&:CJKP68M$$U/3I0@#KTZ]`>E-.@53<;-=5E2Q0;B=P(IX4
MH33KXZ;;)J<6TR39SHO260"$E-?BJGV$]:$TZ:=IA5.>7X-=5D#"1U%`:T%#
MZOL/@1333WZ32B&,U8UXI38W<7K!+1+82''0E;8#@2:)<Z+%?#:?UTU6[C:Q
M[C&(Y,*5[<U<6&X3;?(9(@TDTK4<DX;_`"1D4F(J`EP(C*"J(!&].].U92L=
M`5)-"?AJ@CZ6LXY!(T^(&N7[UHYNJKQ\&E[:M-..'T*OCW`<68_S3R_QM@66
M2LDB6I.&YID2I6*7^7C5[BRXLB&Q$<8NT(*=2V5ND+13:L4!'AK#]6]+;3U;
MUY9;1NK7_"Q;9)(-+J>(.XJ5MF]WUAL-QN=KH$YN6L.H:O"14@'"B5^&^T;@
M7%;?+@3\1FYV)SQ=>?Y`R&ZY"^E)0TW\N@(>A1?EAVM^TM$[UJ))KTN-O^5/
M1NVEKH;8/E;)J#I"YQ&`%!1PH./'%0).L=TG-9:$TIAAAZE-ZS79UNSJ@AR/
M%@P(S,&#$"1M:889#49EL.;@EIAI"4II\!JZGVR-ERV-C=1![OM5E:[I(^R.
MMVG#O2`D-NR7"Y(D..=31&X[>OG0^D?JZ:UD#(X6-HRCPT!8V\=)+KU.JPNK
MEVK65'2CH$U"O`GQ)IX:G,=6CE3N9XM"QF(I7@-M/]J:_P#J0T^9*<$A\`8<
MZKR(BE#HJH!(^ZD&OF"=U=<\WL3?ECFOHB*2H5ZUK1-!UZ?'=Y:4U^HTHN.9
M057H1JBG;Z>'B`?U5.G$VOOROP;'ZU#_`!?[&A"\&-U"4IH111J0:CPI7IT.
MA"R"*=Z24A(%:^"@:CIXD'H?LUUKM+M2%]7$2JJ"A*D+3M7Y`I5T4D]0:$>.
MEE^IX<<EPU#33-,GGV+29+4AJUX]:[<M;2_EKPZM]YU!H"X68]N5\V)"2*)0
MA3:5'S6>AP75PW*1A;9>1:2.J&S5=YG]AC6M-=7$ZA2@P*T>U/9&QKKLZV#[
MIPKZ<5$*\<,Y=:66WK]F-T$.=<E7&+:K]WV(D^5O92U,FP&IWS#)[BPAF.@(
MDO[]I0"21X1O?RXZ@AM&OEO'SW\IU!KG.PJ<:`.!)H</H6MM=XMP\EK&-`;P
MSIRJDQ,X'D6BW3I61WVS6MVYM"X?-7NP,P[Y/F(91&2YCE@-RFWQ#3D-(:)[
M*791"0K<B@T1?+/;]AM9+C=IF16SF@M:8SYCZTKI!>2?%GB<*E(&_.N91%9L
M>9"<:NHQOLY9=J:RX<8V:SP&OF;7;+U?)0CQX"I-OM[]RC[.\X_>[S#BHEL?
MG,%N8MMDL+2FWM.+6M`<4-8'J?;+NXFAV^S9;:91I'ET>`TU#7O;A1SB:''P
M@`XK1[1NEM;Q22$O<6'Q:SQ.!TG\(X>E1VY'P!S&(<^RA<=2[(6F2(+Z9,R(
MUVG%_*!3R%R9H2HH%=K:MM24T/3YPZCZ;O-@WE]E?-:R:,YM.H.[CV+117K9
MF"2,5C.1JH/R)E^LUWBRG7HCD"?\XF\LI$E3:$H5(:8NMR@NG^KR;,XON(6H
M'MNH*37TUB?#VU*O%"?:>2<MWZ;AKZ5\2*WKQ=$R.U^:,7F0],@OW-$_MLFX
M6*X1'$RWU(:+RD/+>BC824EM`2Y4431/DQQ5=(S1'3#'.0F@_P"R4Y>0>3^;
M6NHUIWI%.R<ARZ="GR),5=PN%VN,.):"U)M4N*VT40D21,BE!2P\W'2E6]24
M-NK%>JAK1QSC;+00$M.C#%N=17GAFJ\1RS>-@P"<BXH=M&-6VSQ;+(3=;:\6
MXS]ON\F9.DN7>*4QV9!<<>0\Q(E17&2A:%,]Q*2`FM=43;F.>4R.+0RF)#:4
M[\<5,DF\R)L=/=362K3<;M"1,5:9<6],7M[&9(%U@/3;;<I[7>;GO-PD0HP?
MEL=Y+D=T)VLI4NOAJR;.+21L<4@EC>W4TD8&@J12I]WFF6G2X'D401K+%PYY
M^^0;_E%CG?P4S+"HDQR++E/WZL"-&84R65H1<5;"ION+1V620M>Z@F_'R[C&
MV-S&B%SP7,X$MP!HIHNWF4/C\,G`YT/-:]CSW(\0,2[/6N;&9:@SWK;>G&K8
MN=O;[)D2(+DV$^RJ*^^5!5*I6>E`1N#%SM%G=M\MDA>*XLI@#V8X#T)5#4N>
M:N<:DJ7_`!+[K+9D3+=AY*E6=E^<'8]E=M$)=JMZ;>^F.M]5Z<<=BH=EM/%2
MV5)0VE;I4$J14$Y?=^E7VDKKC:]8@8*T)J#]BZC[D*RNVAE@V:;=9%E<:<?M
M\M,T7""NKI5`N=O@7*CL=;#A_'+3B@\G<%`G:K55MVJ23S),)!6H[>*0][HF
MZVX%([^+<A_\=E^&[_.5V_S[_P">/^S_`-A^S]]_PNKI,_&7'-?L-:]65TAH
M0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH
M0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0N4
MWWY-C_2WYN*JT7DEJ(I\$XICOCT\:C7VK\KR1T#M].4O_>N7BG5#!^O7!(&)
M;_HA1`<933T@&G4UZ]!7PZ>==;RKN967\B3L6HMI*O&J?@0/Y>GG73QD!CTX
MZDN.%S75=0A8>T-PH13I4?M?::Z::XAP-31==$3)J%-*^]KU?Y'7I4U^SR^.
MI/GL[421%U--`O081X`']77^;7?/9VI'D/[%[#0&WTFJ:^*:'K\1UUWXAM*8
MT1Y#^Q;264[>O0_9T'V>6N>>SM7/(?V+TED4`J0KXCK_`#=-'GL[4>0_L69#
M6T=/CXGQ/AH\]G:CR']B]AL=:T'AX4_GZ://9VH\A_8L@:)Z`*_F%/Y:://9
MVH^'?V+,F(M:D)34J6H(0!52E+4:)2A-*K4H]`!U)Z#KKC[ID<9E>2(FYN)`
M`[R2%UMN\O#&TUG+]J*:W$/L%Y[Y6CQ+L]:H7'V-2D]QF]YVMZW/26AM_%AV
M!EMR\O-J2:I4ZW'0H>"M>/=7?/3HCIASK6*66\OQ]VW+:5XZGN.`!P-`5K]M
MZ`W?<*/FTP0'&I]XCL%.(4T+;]*"P_+(1>.<+B;DIM*G4V;!8R8"5&J2$*GW
MYQ]]L*!H:I)'EKR*?^::XTN:S:6B+F9CKI_:I2OH[%JV?+&T#0/B'^H)$Y;]
M*3,8D=^1Q_RIBN3/,MK=3;<DL\_%9CU`>VVF5&E7Z*VMPB@+B6T>=1J^V;^9
M_9+UX9NFWW4#@::F3-?0<R'-:*9UQ4*]^6[XF?\``3_FTR<,#ZJJOSDSA'E#
MAB[MV7DS"[OB[S[Q9M\^0TF78KRH>H_DN0P52;/<U;>I;;>[R1]Y`U[[TYUM
MTMU7;B?9;R*1Q^X3I>*Y5:>?"A*PVX]/[IM9/QC-+1Q%2#Z:)OD,*0%5`'J)
MZ]"!T\21Y:TX>TDM9J+A_5(]I`'M[E3"K_"TZCR%5'Z8E4CW36-LT4FV\)7M
M\IJ2$F?E4)@*Z>!4`/U#6`C>)/FA,VA#H=HCK7_TDK@*9\L<EHW`Q=*,#L-5
M[)[(VTKW<%(,-?8G_P!#]6O0EFQFMAF,_(6&V6RXH_L@CR\2:D>&H<EU;14=
M(:$\:*VAAGG=Y<0)*#L5QE92XDA2#18'6BA3I4"AH3IP7,;FAS:D%,OM9H9'
M>93`D46-QD@^*5``$'J.IKU%/,4TZ)!HU"M%&?"2ZK:+'L/E0?HZ:3\0WM2?
MAW'.B`20!3PK3IY?'[-.U/--NBT"IHLH0FH/4T\]N[R^'3_#I]LH`&=5%,3B
M3E19"V5`*VUZ_#KY^(/EI7G#M23"0*X+VEDJZ@)'Z13_`!:YYX[5'>W52B^"
M(2*]`*D;C2I(-"D>!I4?HUSSV]JZYNH4"]_+J\P@_8:T_F`UWSQVIORW+[\L
MKQ*$4\B3^L4H:UI\=`F!-,4XUM!0KP(:%.M.+2A2FM_;62H%!6!N4D?="C2E
M?$"OQ.G#B078D9=G=R3F.2*I4.$P\U?Y%O6N8TR84%DLA;X[LA1"D)0E9:>?
M`J"2%(;^TTU!E8T'XF=H=.S".@K@<237(U"X6ZB`2X-KP*AG[DF;?$<=7D=R
ME,7A^,9UNEQ_2K'DQ6EN18D"*`M4QSNG<I;E6'E$H]"@"?GWYR7NW_#P_JUU
MY.Z:@Z(DD-9B!I!XFE:@@9DK<]/LNY`?AF`VXXNIB.W/BH[8GR/C$=UB/DT*
MQ+3)9$-RZXT^PX^JPN,.*OMXM\5Y+$]F1:93B9\JVJ0)[:V#M#S00M>3V#<-
MK;:/DG9$+[26EP<,8Z>&5N5:$DNXT'%6EW%,6EEO&2RM75%*\P/J3.<KNV=M
MJ[-ON-S;K*D.2+'?[3)$M%X;C,)<9><>"G4S+/<H3>^"^BG;#K*5@=%:^:OF
M'N%SN&XL+P)7L<]OFL-1(WPT/#Z.*U.UVYC@#8VO$9`(:1@VO`'B>?+!5A<D
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M<<:4Y2#%EK=6XTK:$(6""%4,GSF10QW-S@Z*W$0`_$7''NI2IS4B0_E`TH#D
M:8&F=$I\GM.'18]XOF00XD9YR/;K?:F+E,M\%"[=:K='L5D@QHZ$&4^XK:\\
MHM)0&72D$CU$0;&XNKC_`(:"K@RK@0<L:^(_0!7!,`$^[FF=P;")>;NW1J(W
M>4,MVR:Z+VY'3^7R9+"H[D&TVZ"V[TMK5G="TA`"%)!24JWDC1[CN3MM,=\=
M(>'`D#E2F/;52X@YH.NH->*7=_X5L-DNB'+@ZLQ&K;B[+4AR/_5HTE-E:E7I
M;CK\UI<*3/N,PO)HO<$,BE"`=5]OU/<3PLMP/&'/K7+QOJWOH,^7!.XIZ^#(
MF,+PBQ/7"[0X]FOKTUO'X%U3=KED%PFW">\W%DVY@S)UN8;EQXJ4EQY;980@
MD@E81JMWF2[;.^!C&B5E"XM%!B>8`4F&!SG"M*$<4\'\)X5_YV<G_M&__,*O
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MTW?H]/7S-*UKKAG(.DNQ3/ER<E]3'`()-1\*'K_/I7F/YH\N3DMA+(2:A%#^
MG_T>N>8_FG(XS7QC!>^V3Y$?J)_])KH?(<`4ET;M5`,%[[8\QY>'7QKI;?.)
M[/1DELC&FA'B7I#!)!VE(->IKT\?(D:=\QG,)ORW\EE["@KS*0`2=M>M?`@$
MTKH\QG-'EOY+/VFZ#T?S'RTUYA\S/P)YL;:#4,4I,8QB^Y??K7C..6B9>[]?
M);4"U6N"V79,N6^?0E('1MM"4J4MQ5$-H25*(2"=5^[;O8[-92[IN,K8MOA;
M5[B0,,<!Q)/``'%2K:QEO9VVUHS7.[(?;V*^SVJ>RG#N&H]JRS,8<+,.3G^V
M\+C*:;F8_B>^.XZ[$QB,ZE34B:PI.Q=R=2%E=>R$I^]\*?,OYU;MUE>2;5MA
M?;],@D-TFCI!^)Y&/=2F97LG3_2MELT#99@V3<3B7$5#3^%O=W54]4M;924M
M$$J9D+<<65*4M96PFJE+)*@$B@'0`#I37B'F/::`Y<<SZ\_:M20#XOZ/L6PW
MM,IVOB&6*@IJ""])J0FE2.@\/#4ACVO:&N/B/!!%,N:#`WR)"R.B$,(]))*:
MI=(.U0"D`@^0J=*\IC27-'BHDOT4QS5:GU2N7N/GO9][@N%+'G5@N'.=ZQ:T
M0\;X\M5V:DYRFZ2\GQV<Q(;ML-:IMJDMVD.26WW>R4M#<E5"*ZGI3<X=EW&&
M\GG%N`[/413+@VOM33]IOMQ@,=O;OE8X<JU]:XB>4^8>6O;=>;%CW)N:\EXO
M=K]:EWNVPTW*ZWL&WM3'K>7900],,=?S,=2=BAU`KU&OI#:OF:S<M4ECN=S)
M`VH)#B6@C"@#AZL%AMQZ.NMKE$>YVL<;G8AOWJ<,CZTF;?[P;C;;W:N3'>4)
M3#]VL5RQ*/?K[:`\[+BV^YPYCMJ=C2K2[\NU'>JO>I"2JM-Y\-2]NZQO(NHY
M]SBNR97VL4>MX%2&R.=I/AX5K]:C7&R64VWLM#%^6'EU`34..&K/.@'9V)X;
M3]02YJ*/_EJ<9W&M/P[C"M<-9K6@66W[:L$T/PUMX?F-O9'AGMGBOWL#W9#!
M4QZ5VMN!9*#^W:GDQWWQY1='*6Z#QOD2PVIU?Y-=)8?+22`XZ41;M.#;2=W5
M6T)23UU+=\S+F+&^CLFM.7BS/',I,72D9=6%\^H<J)90O?MA%GGLCE(XE@]B
M2HF[7\Y:[<%6ID_AHDN62-`EW22A<M;;1V).PK!40`=+V_YN[/<7S;.X\M@)
M(U"I%1RI7`\%'N^D[^-CIF%\N.#<*X\3EEQ3QV7WF^T+($H-J]Q_$BU.4(9F
MY0Q:70"*]47=$$@_8::WT76/3<@#&7T..&-1CQ&("S7Z1N;&ETD+\">67K3K
MV?E?B#(4I58.5>-+UOH4)MF<XQ*6H'PHVW="NI^%-3XMZV><%T5W;$`T_B,'
MTD*.ZUN6X.C>/04MH[L6<D+A3X4U!ZI,*3%E(()`JDQW5A5>FK".]AD-(YHR
M?[;?M4=\9^^UU.X_8C)$.0A/[AZE*E7;6`?M\/AIYLLKSICJX]@J#W$"A]"8
M?&W31@.KT_6AVEA801170GSH"?'K3PTZ)@UA$E0_',$?2!ZU&+'5TD8E9>WZ
M5`'<L4ITI3KU\Z>&HXGKD]OK"[\([\/M'VKV&@$^KJ?CX>/Z#3IKHF><`3ZD
MV(030-Q7I+((Z#<1XGP_QZ<CD=J&H^%*^&/X5Z^7/F@?J-?]C4GS(P:@A'PQ
M_"O#C:&6W'G0&VF4+==<4:);;;25+6HUZ)2D$G[-=-RT`DN%`*GN71;DNTAO
MB*(8.6X_<;B;;"N,>2\P^Y&E%IP+;COB$W<HH4XBJ"B;")<;5NZBE-5=OOUI
M<W;K)LC/.'#Z.SVI<VVSQ1B1H)U?1Q]2C=[G8.*2+9)9RIN0(TMD,PPFUHNC
M4H/)"2TRC;!6\L/Q_P!TF45U'W2FHUY5\W[38MWVGRK_`%2D5H!'KTNPRT@'
M`?U@K[ILW4+P^(N:VN/+U%4K9&7[!*E1\.GVO(FT+3/<MDF3.@R;2;1*D/.,
M.N.]]#;]O:(7LE;D-[@A+B=VOACJ';+VW.BRO'7%C$TZ3$',=&,:QN:XU(:,
M2<<#0+U>TO(1$/,BTR5]?];BOK?(T^]VZV8W>;<W"N5L?=F6!QB+%EP&XLU@
M(;1'@6^.\MN.G8%;XJ5,G84+37UC!W3YY&1RR2N>PB@Q(H!V8>T*UMKED32R
M@<VM>XG/UJ)G)5ILV,7"R0X<Y3B;PAI5TE6V4ZN3$EOS@IYUYB1%6TE0$W:'
M/!3:VU!=2JEAM9NYS6:I8.[+T*#<,807`9FO%,KF^*97B\A^3%E3VDR(GS-H
MN-L?#D%^QM(;[3RWX+P$9M];H2YN<[F]90=RB!K4M-M'(V-]`PG+%0XB^VG$
MT1TN!K7^FJ;]VW*MORM[;7`4P%J5*##LJ2ANYEMSYF&JW%(693Q47!MVCT+K
M3I5S4^0E@QIEW*QW"'SXA<AWCP]/%&4[+WX1GVZ7:EP6G0P]!?<A.1WE,KC-
M['D(4H,L(^7VEM)*BD*V'HLD0V67P[/B`08^6&/[>A06?F.TQXN4B\6S/(XL
M#`L/M$"PPF</Q>YPH$FWP940WV\YI,7D$IW*LA<6+?\`FZ@E##:=RQV&THH@
M-FM-N,#=QB+W#10Y?6K6^\-M;60PDC#G4YZL?8E]_!%NY%M[TB^6*Y/WNT0E
MV^1"NYBQ7F2XM`N-H5;#`90PY\L`Y;U,@M/):2=X<(4JJCENMJ#!$2VWU@BE
M/$1[?0<%&B9IH\CQA&W%6),6^UQW;;(G&XX?:,DCMKA-(C+FVA_)9L#YJ1'6
M"F5V$7`/NH0%O)4V1M2@@)9WN]M[PN#CRH,<>WUJ3223Q9T1'FD6T9#:LDAM
MWV8ZE^X)CVN&S&8[R&93#EH:G-KDI=83$3&?"G%A*E-^G:*D:BV4SFRQN$1#
M2T5_M`UYICS&$9A,WC15A,!B?<F+F^QBLA^WV:SL,W!VZ-N0TP;/:X.-VV6N
M%#=BW1V4MLR%LJI*>=4RA55DZV=TMPYPA<UDDK:R$BN6)K0''E3BI=M<&-A>
M_$\!V)\/[WN6?_9:83^[W_\`2E']J_\`._X_]*O^%_LG^1JG_P`/;?\`WDV6
MO(^O+W5)^/'X%^N_KV1"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&
MA"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&
MA"&A"&A"&A"&A"&A"&A"Y:_?*@*]V'-8/BK(K7X>-$XM8*4Z:^OOEO(8^B+$
M"F(D_P"\<O)]]B#]YG)K[P^@*(3S*`=HZ?`]/$^`-!X5UL:A5K(PW%M5J+:6
MFFY-0?,=1^FGCU_1IUL[@*"F"2Z!I.HUQ_;DL(;%0?5T/_I?+23(2[5A5<\A
MG,K,&JD"@!/A5/0^/GY>'PTOXAW8N?#L[5E0VE0J"KQIY>/G3IY:/B'=G[>E
M-1QAQH:T3&\D6G(LEY`PK$K%G=_P5J5B&;WN=-L*&)#DSY"XXM$BL2(LE:&%
M!"IRREP$.(%0D@*57";];WV^;['M-K>7-I;?#.D?Y-"2YKP!@0:CU=_!7MEY
M%G8R73XFS$3-;I=B""TDY4R*67'/'5RP@7ARZ<@YGGTN]*A..KRJ3'5;;8J`
ME]H"P6YA"ORL3FWDF2GNN!Q;:5=#75YL&T3;!!)"^[N;I\A!+IJ`@#(`#(<\
MZJ)>7,=ZSP0,@:.#<_:3FG0#(IUKT\:>`_E!.M!\0>Q5.E9D-E/I`/6O4CJ*
MT'C3[-<^(=V?MZ4Y'&'.H:Y++L4"KH/32M*]>GETZTTMDQ<ZAT@8^H"O-`A<
M^3RXZEQ."L3^FWF_$6/<D9@UE618W&S7(X&-8=QM%E4F7BXWJ_7"X(N-ML@8
M9D%IU]N.PE]1*$A"D[E!-=?*?\Q._P"V;G96.W[7?Q3O\U^N*-W$4]ZA-:9X
MX8+U+H79;Z-L]S-;2!K:>-S2`!0UQ(%.&2OL1!DNN-!*/0RL*5Z2E(26G6@D
M"E*@KJ0#T'EX:^5Q8W+L10K<ES!F<TV7(',_"/$J')G*7-'%W';3#+FY&89S
MC./N;0H*JU'NERB2W%`)ZI0A5=/Q;7=R.I2N'#'Z*IETU!4X!0=S[ZP_TY./
M.^D\]HSNXI3VS$XUQ#,\S"RP5*2AJ[6^R(QX`J<-#\Z`?C3KJZM.EMRG:71Q
M/+J>$C(]X-#[4V^Z:QNMSF@#/'ZL5!SD/_6*^![.J0SQ1[=^5<X=#93'N.:W
MC%>/K<XXDD(4Y'B2,TO(9\Z%E"Z=.FM#!T)N\C6F5@:XG$$@U'H^U13N%LX@
MAX+>8X>M1#;]P%T]XF573GO)L7MN"W#,;,[,&,8Y<9UUAVIK'(Z<?A!%SF1(
M,FX2'H]O2Z\M3*4)<6H)2$@4\(Z^$NS[ZZSA\(#P"`213L7TS\L;>&^Z<CD)
M=I?#(^I`U`M<ZF8R(]?-<Z_U9YJG.;L"8[Q=7&XHA.*4C>$TEY)?E*"2NJR5
M%NI)K4D]=>T_+'_P23^WZUX[\R1KWF+76ICJ?4%`R[H"N,N-6'RLJ=5E4T;O
M,+NRV$[J$;TA+('7SUO_`#GQ%[F4J7AOH(&*\^\EG:F,R()A/1DLJ)^80ZXM
M+E%(';=&W:%5(%%G^;4^UI*PND%75[5%G@9K!QR32Y'=)<>,R[$D/0UOS8\9
MQR,XY'6N.I/==:6MIQ*UMN%L;DDE)IU'33XBB'!KO[0#O5J!HEVL;8W&G$(I
MA2WG+=D2RXZ0;"X=RB3N^9S*V(!%20?N^?EI%NUD6YQ:6MQ=7+ZA044F7^&>
MY$[KBMCAZ$[%#XCP--:YXC<]SBQNLN.-/J.'K%%F"TZBX5S7DON-M[P`7`D$
M42$JJ*>8`(H=<;AF&'O8WZ@$H2/&9KW@?8E3'RJ_VQ"'8-YO-O6"K:J#=I\-
M:2$**=JH\AK:33I2AUP-`]VH[G.^U(;@:T!]`^Q+FR>X[GO'.VJQ\S\J6GLL
M=QM,'/\`)VDI4=U"E'YD4`#;X4U*9>7K!1EQ<M:T84ED`%,J#50439MK61U9
M(8W5.-1GZE+[!O?%[MX%FM$IGW!\D2'GH;2E?FMW8O"%*VE1!3=X<Y*^B?`^
M.H#NMNK+63RXMPN"UIPU.U^@ZJU'85+DV'9W&IMV`D=J>RS_`%*/>+;@-W)\
M&[)1XHO6$89+WD4J%.-66*^H%/GOKJ?!\T.MH`0V[::\XHS_`/!4.3I?9I2"
M8J4Y)TK3]6/W.VY*3=K3Q7D*$J05&5BMRMCK@'0_B6G((S=2#4[4?R:N(/G#
MU0QU9H[>5M,M+ACS]\?L5'/1VW2X,=(#WM_U4YUK^LER*QL%[X2P&8@'\5RU
MY+DEK6:&AV)F-W9"33PJ3JQC^=FXLHV>P@)&9$I;7T4-.ZI427HB(5++B@X`
MXGTIUK7]97%0`<BX%R"/78HJL>=6R8`%4!*6KA8H)(^'KU80?.V(D?$;>^FK
M'0\.%*\R!CZ%%/1$S@71W$>FG$)Y[?\`4FXZSC%;A<[=BO(.,M2D&#'EF#8[
MS,LMT0Z!W942/<VTS(?:4VZK95P)J$I.X4H]X_F"V)DLEE\-=V\YC=Y;BWS&
M\*Z@"WLI0\U'9T==1SM>^1KXA6NG`CUJ)&2>ZN9B^22I.-RVK=:+W<;=(NK"
M(*G7$,F.B2EII+'>DQ8*5R'%,-#:8[`2T7`E6T>(,^:T\>^-O]M>X;:]P=0U
MS&!KCAC6@6C.PLELQJS8"!EB#S4B<8]WN#\B1)[=ZNC$/:J,[:%3!#98D/R+
M@_WH$M4^)<&76W&I`2TA962[5!3]W7LFT?.'9KFWD&YO\BC@YA-`)#@/$2'4
M&?"JS\FR7<7E^0/RQP;@3Z?W*-_+V-<1YW*O6:6+/F&\JD0Y3,)6++L3T%]]
MMAUHL7)+3-G;;6'$'=1@[T)HJNO+.L;?9[_<9=TVVY@CNYFE](W`LH:T&(%"
M>(6AVZ2^A'P\]LXMSU',!0+CRI^`W"%9YSUV89FAR5;QM;$7<D$O3([3<AU,
M!]T)KNM[D=0*AN2H^'A>X;7,7B230'NK72?I%5=0NB=7RJ^E);-Y2,DE&Z7:
M;<KA=VEE5MN+\E,6Z(<277)A4RAW\SEI65_>=#!:/Z5:[:"YM!2@+.XU3KFA
MXH4W657[/';6F,]\Q?L?==>=MK3;,&=*:9CK3%DL-*^8?68B9"D[(Q*0'E'H
M335K$Z*X<SS262@Y\!GF/WKC;"6<AD5"79"M"B!7'N;7^S_EMYLM\;:F6V)<
MK+-_*'8RD1"XI:E(D6M*&GGH7S2F4HE)=6@K`2H``!`W6TAD+HG!X;@:X"O+
M%6;-MW&W(DN('&W`I0$>NB3]LQ2:G)[)C692YZ&9<B&8M[;/S,K\OCK2F0J5
M8ISOI?MT",EE:35.\IJM(3MT\98[FV=+8AC9"/$P5.GEB#QQ3HVY@F9.T$6U
M3_:^CZE*#B;$\/=R:X_E[D3(479;/Y9$<3)1+N(=BMEBX8R52(3,IER&JKC$
MQMGY4_AID!Q*5*RVX7%S(UKZ4=&0*-!H:88YJ#(&/+WXFCR!7.E</8I`W:':
MH-EMT&+%NI=A..Q8]Y>;F+D1[4MQ:/RFX!U;/:3;BAI46H,AI+2?%*4J-1/=
M2W5QYDE`</",`*"F`[?I4=QHTD<E%Z#E]TQS(KG:+[(?-HG)N$R)-A&*S!,R
M3#8BR)251451)3&*^YM"$N'\1)W$DVPVT26WG1XO[4TQSGBI);W)+7&Z0$71
MF="D?,LSF=C<!!7';1)3'D6^*AQI*E!"'6W&WE^6YJ@I7I81VKA'Y4S0&<",
M"HJV,H:C9?B2[?<64VFXNQ9%NAWB-+DH2F7_`%Q;9>45([L9U1:DL[R%+,92
M0K<@Z=L9'[?(!"=1+QB[$TKB,*8%.LE=4,-*9*O#YQ__`)MA_NOR3^SS/'_G
MK]__`)Q_RM>B>0/QGW/,X9_AR]WL]JM?*BY^T+]TG4U/H:$(:$(:$(:$(:$(
M:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(
M:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+X?#0BM,5RZ>^5Z/&]U
M7-#C\B/%2O);4VEV0ZTTDN'%;"H(2IU205J2#1(-30Z^KN@YHHNB;#S',8-,
MF+CI'\1W$KS7?+<NW:9PU&NG)I/W0HB!V')"E1I464`H-%V,^U(2AR@*FE%I
M:TH<VJ%0:$`CXZT[+R*05C+7CFUP</6%`9;R0XO&!6)2"@T/ZCX5%:5_E&G/
MB!R1(W6W2L:$D`@=:54?T?\`HM<^('),?#GFM@-[@B@I4'<?'KY:[\0*9(^'
M/->^R:@E22*CH!0G]0_PZY\0.2/ASS32RVN]S[CZ$I%(?#^3.;2H^HS\SQQH
M*%/`@1#K/"<?XOR_^S'?]ZU30VFW"+B93BGG+)`%#7J!2G@/C6OEK0_$#DH7
MPYYK,E"4I*:5KX_;_*>E-.QO\RM!2B/ASS60#H*`T\/T4I\3]NG*(^'/-?5(
MJA=?Z"R1^A)/Q^S4#=7F+:KIXS%M+_H.4NP@(OH"#_MF?Z048^<^2LZX&XRM
M7*W%F02L/S^Q7;%YN+Y#$BP)KMHNLS.;+9$3H42ZQ;A;'GT6^<\E/<9<0"=V
MW<!3\K>F)'3]3SF7W(Y)33M)/%?<W6\$5IT9#Y0QD8ROJQ]:@4W[VO=USOB$
M>[<K^Y7F;+%W.Z9.R[#?Y"R"U6-R)!R6[6V$RFPV*=:[*&T0HJ$FC`"NI/CK
MZAVOI[;&[?$\Q-=*]@+BX5SR7R_=WLPN'!II'P')-[`LT^\S')$&T7&]SNO<
MD1+?+N\Q2R>G<?99DR%*4KS*CUUH((=NM3K<(6`"E6TKW*,1-,--93QH[W?1
M]25LCBGD=3`F2,1N=HBJ&_YK(W+?C#`20**[F23+4"#]E=(FO[-CRV,N(&5`
M3[5SX"Z>,FAIXEP'L6DGC=UILNW7.N,K33JJ.<O1?YHKY&-AD')=J_L*DZ:;
MN+=8+(Y"*C@D.VUS6DODC!IS"M.]ORDXQQ;C@M<N#?H[N.S8<>>VS<X4!],Z
M?+*Y;3$Z-#N`VK64A+J&5*4FM*'K\@?,2W^.ZFN'@Z=,Y/.N/H7UST#>"UZ<
M@);JUVX&=*5"HT^JA*[WN&LT=+VY4/C/'&EJ6G:*O7;(WU)0DJ*D(;*J#J?T
MG7K?RS=IZ<K_`.E=]*\:^9<X'4A%/]DWZ%"C-9QMV$\51T1TN%S'+K)(2L!:
M"]?9J@H!*2%;AU\/'7HD;//+B,*"J\_^(%,O:F!OER,Z0WO8V%EE:/4L$U+J
M%'[J4@>'GUU/M&:8W"N9^I-2/\PUI1-/D[KS,>WI"VPM5S:2G]I2=S2QN-4A
M-0.M:=-.QQ>62:UJG(,SW+6MCSKEHOFYYQ:%VNSMJ;4I11N>RR.K[A)2DJ2S
M3H!6FB)NO<XP.1^A+G=HB+NQ:CL6,`HAIKHC<HI2$;:^/W:&H)_EUK9&Z':>
MP?0LNV25U=)I'4X+"^Q%0E;BFUK2`*!+KH-5$"HHL5H3I"4SQR"/F%]>;0&U
M44^=PV@%XE-:="=R55`/6GV:$IKM!JM=</8V^\)#].TX0"&E4"&5*"#5O[M1
MXBGCI#_</<G6S4<,.*?S'&TIL-G2"X1\C&.W:%=5M@J4=A](KYDZR$W\4JXD
M=J(.6`2B`(2@U]&VBJ4))(Z^)W;?M&FDVO1"4*9->@64GJ%`=*I'F1XG0A`I
M4:*578HD]4(*B*]*5*B*?`>&A"VXYC(=09SCK<=`"MS:=R_2I)0D)6E2:$^-
M013RTQ<O+(Z"M75`IP)P70*FBDGA^71T%F;`N5NM]Q<:1;'K0Q:[9;HMU[2E
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MEC:XER.T`^VXVK?7JORH1TU4W'E^>[0=2J7QF,#&M44HXRO5QM#+EZ2RT&7B
MJ);Y2)^)W>0TMMI\J<;<G6AN1%=4X%!3:PI8!/Z4-W&""32?%AF,0.PGGV(?
M%H;KKFFN<P?D;$;T9K,+'[WCUQ>,9R/<)5Q:#D;NMJ;MC5V9AO0X[S!`:;D+
M6\X6ZIW@KH9_ZKM=Y#Y+RYEQ&,VC,Y^+GFD-H#XJT[,#Z"E+!MF46>ZW*4S?
M5X%*N#"G&%Y%.7E4>1(CI2Y"-A:@VV._8TP&D;.^X&]Z5`CIU,62XV^0Z;B+
MSB,FM865'-U:U/,\E)9+>.%63RAHR%5M6:-8KDS,LV=Y_*OEP=%[_++BHS'H
M5E3*M\F7>6(L^8_.3%6ZAIED-J6Z7WCM(&T#46:ZNH9&/L(6P6;2=8&9&%,,
M*\4Z+R\N,'OR[$FHN,O0)3@NMQC(OF`[;3CSLJ6NQ-3[?VX;!MS4Z2A++@NJ
M)BOD5+#C6QO8E("J:D?$"4QFV#C!.2#09.YD?3R4)]=9KG5/E:,IL+-F8D7?
M++K$A3TJDVQ]["IKKB&6&D4AS+A%>;1-MX>47DO[*,)4I`!;`VTEQ83LD>'Q
MM+P3B'@^RGL2:$X#$I-Y?A]^2?S+'UVB5:;F(:518SBXK5QE"*_)0N+:IS2'
MX$>26SL4=HJL@%05J;;7C(8Q',-+OI34D3W&K_"5'NW6*_/R+A)86[:(L"["
M:B,^4FZVV*^V$STE0:4)D.(](0IQ@54F+^(GU()U>27=J`/,\03$D>@`UXHV
MLULR)Q*6YLA*50)*[;(,I:T*EQWU./\`SC,9UV.XZ$N1>X@`E9254!!H89GM
M"[5$/'6J92!_N;D?"U?V7^*/W<O]S_1^Y_9O\C][_D:O/U]G]T?X>GWO;DC!
M?M8:V2T:&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&
MA"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&
MA"&A"^'PT+A%<%R3_4PM-KR#W7Y)8;U;XEUM5TYEQ]$^W3V42(<MB'Q;,GEM
M]E?I6@+C)5]A%=>_]/-%STULUA<#7:22S%S.8:XDU/*G#(E8^[<\7UTYI(&@
M<>(%%'3'<,Q;";>Y:<1QRRXU;Y$IR?(A66"Q`9D37@VV[-?[2=STHM-)3O65
M**4A-:`4]!B@L[-GP^WQ^7`.WZE5/8X`:\0C<CUFI7M'2M2?AU'E7I3]&GF/
MHZKJT2&L#C0`57U1^7`4ZXVA*U):&]="M3B@E*$#Q4I:J``5ZD#S%4OGC$H!
M-!A3M2Q"27``>$5/<MHD)%2/#PI7IY>`\=.2/U'PU3=&\@LS:%.&B`H@=5;0
M31(\3T!I2OGI,DHTC--,C<TDEIIW)K&(CKO/=T4A)(A\,VH5KU'YAG$]=:BF
MS=^7'].J*TE8_JF=V)T6+!W5<*@=_%69M'FP9)0:?,/T)W6Z)%-VZAZ]=U#Y
MBOV:T3I6D855=)$X2<*+[4_^ETF.716I*71O)944-36B1U\:`>'C7I2FG1,3
MC4@#,DT`',FN28\IY."+9M[LL5MUN3=K4PZM#C+;+UQA-.NNN(4AMMIM;V]Q
MQ:U`)`!)5T\=4'4^ZVUCL=XZ6>)CC:R::R-QJPY#57V*SV6QN+G=;>/RY-/G
MLK1I_$"H<^\L75K@!`FV^2B#!Y`XI@QUS8RVXJ&9'(5EF.L.*<#2EI<,=6^I
M-4@@$:_-3HSR#OC(FN#I)&R2.YTU4-?6*+[,ZZ9='I\>8TM9$]C*'+%M6X>@
MU5=7#G*N32>,,5FVV!A6-":S=Y*FL6P+$+2EGN7^ZT#<D6B1/0LI2"H]\J4H
MDDU).OJC;[,"PB!\R3"F#R*9=OJ7S+=S2"<UC:3V`?8EU=>1<VN4=N)<LXR>
M0P10Q7,BN;<.E*@"&U+;B@$>0134W1;#[K?4*^E0C)=.XOIRJ:?2DNBQWF\+
M#D"R7B[NJ)47(-JGW)Q6[KN*X\=]2MU?UZ#+:Q-U%\;:<.(7!%/)S+CPXI:6
MSB+E.9'4['X\R]ME12H/3+',M3&WJ-YD75N#'2V/B5`:0S<[4.`$@S7'[?,Y
MI+X\*'.E5<#P=;<.QGBKCNT9##DIO,;&8B+O#$AV;'3<:OO2V@Y$D.07D(6K
MQ:6XW7SU\0=:2[O-U5?RQRTB^)?3PT]G!?;W1D?3]MTK81F,F7X9E:FO#GQ5
M!7U6KIB<WW52!;[<Y&@1N-\"CI8^64E7>4S<Y#R@DK4XVE:GZ^(U[I\L;:ZC
MZ3:R4@S&0NK7A7]L%X#\TI+6?J^<V[:1-CC`%*4P4(.3(EH:L7%[<H$-N80T
MN,BKH6$NS775;BWU%5.CQZ]->B6SGN:1$?&,ZKSAX9&T.<!0]B86;%QPNN)0
M\6UJ00$]UX`G;4DJ6DFOZSX:E-N+J(4<`36N":\R+E[$U^86^"M-G9MSBY,E
M5T2IY&]*@W&;9)+E5A``3YGRU*@NGO)\T4'!-1/#*ZJK:QS`\@N>'WV[VV+\
MZEM=A@N1HROF)C;D23*O3^YAA*U;5Q1N2!4DI^)&G+:\@;NT8=7%I&7&B?>!
M);OD'N-&*^O8C<;79KG/O-EN:7%0[$Y:"8LY+"WKXZZXPM2D12EY;4**Z5-;
M@I#H2%=.AOV7L4]P6-<:@T->Q4K[5\<0>X-TNQ'I2&F-K;;6A2%M^`(=0MI0
MHI-11:4T-?LZ:G.DC;]X>M1A&ZM12JP/+0&5$N)-"*A+B=Z!6E0D^KH3U^S2
MZM.3FGTI(:X\*=ZPEW<W*"5A2!%<0#NK7TJ"J]:>.DR4T'$9)Z&)QD%:44A;
M&AM-GM::KK\E'2`GKT[::>`Z>.LA**RD<:JWD<'.JW*B/$H6=B4^`(W;@22B
MA\".E>FD/C>RE16O)(7Q`034J-3X*4FI!()&X?L;5=/'2%Q>''0D*2%^L=10
M]`-OJ\ZA53TT(7E6UY9)62D#<M)J4&AH4^((^/Z=&&!H"0NBM:#-2EX:PJ')
ML4R]2'G%.1XOYDQ#C-N=UYA$AQA"W'7W$E@M2$!3;D?:"H4+@5KSSJ7>:3_#
M4\3J\/#A3-/^5-S]J?X7Z%=K/DL2,T_)B28I$AEZ+$D/6^8W\B$S7'S/DRWI
M`C3`E6WU]IQS>3Y>>OCEC(D8=)U<#3#T<$W&6M<2_P"U12R/AIS)LBM3MHL5
M\5?KG;GC`:M,BX0I\E2%R6XLI,2VQ)$>3W'MVU3PWJ30>'AH+6^D9"0Y[2TC
M`$"OI<4XUDUP]S86N+?8GDL'M,]U-BL=QNR>&N18=N$4/F[3+%>)")R(H=DQ
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M`X8<#R]"<`8YNH`4/8E):6,6OKALB8,*\RYAD2[Q9K4JT.M1VHXW2Y&1RRRS
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M+Y29!#W;;.XBFIE&VNB9%/$T'6"7BFHO.(%.+>>*88WR\`2:<3FIGX+;<PM5
MG7DMVD(O$9^W.?.6EV,V$14/*D.7&5)O\6.ZI-PA24I:3$6'6`4E94#5.L=N
M$L=P]\430V1AH'TX<J?6I#)&AM'XE+N'CT&1)=D/1&I+$^TBX78.B.U,V/07
M1&>?CQT@)EQT/E&]`*'VU;_O`@T<D[8QJE<[4/=&8)[5'H#FD0]:78;\^R%0
MGHLMOA3[6EY!+CEV4MR+;!)?"5R)3LA!9;6M0]3:G3TZC3T,Q(;<NP:^N7--
M@QE^@#'N6CV[=_XK#_S;^5?VIC_IA_OOW/#_`"?N_;J9YSN4GJ/[42]+>0]2
M_7^U[4K-#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#
M0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#
M0A#0A#0A<F?U$5E7O9N$>B5`\FS99!-/['PU(34$5J4JE#Q^.O?>EI&G:=G9
M4:VMNB!R-"LK<Q?\3<%X]YN':F*6HUHEHTZ>"@H?RZWC9M61Q5>6!^!%5@6L
ME*AL(I2I-.G4>.E&0@5)P0(0TU`Q4*?>Y:.:+_QW;(G!MTOUMS1LW]T?P_,9
M@3)K;L:UP[=%^8<D,+;V7F1'?;4W5:7F4^`K7*=0W<\=S:R1%WPS'@O(`PJX
M`9YU.`'$J?:60E$CB6AY8<#@,N/8M+V.\M<\\C8=EUIY]QZY6S*,&G6*U1[U
M=;";%.OGS<.8N<F4EM"(-SE0W(K:E2&$(![P"@5=3-V/<[V[BE=?`M+9*-U-
MTDM[10#U*)/91P$`U+B,>7HXT[U.9+CR:.(>70T"]M4^GQ-:'RU?%Q.:/,?^
MP":>TN*D<X\@`..I#7&7'D912XH!0E7[,I5#NJ1^YK04ZZH+.1HZ@OG@C4V*
M%O<""2/712'/>^S:WAYA^A.BF2U&*JNKJBJ5M;=QK0K&T4`45(0:=17PU=NN
M`UFNHI]:B"`2/TD>+ZD3W'+&X4EMAM"I&VIE--H;,E#!;2ZF8A#K["51DHKZ
M@2%&H\A6AN.I1:R@.8'0`$O((U-IR!(K[5;6_3[;F-U)-%Q4!@():ZO,@&B3
MUPRW#L[QRYQ;5+9NS;!MCLV,]%D(0R'I0<C%[OM)8=0]V%%)0I:5;33IKS+Y
MI]5VFZ?+R\FV2:5CHYHV/-2QXU.H144P(Y%;/HSI6[L.K;>WW>.-]O)%([P^
M)A#6$@US!#@/H29ML&):W(LNW0;8U)CR&92%,0HNUMUI;2VPDENA(4D=-?$-
M[=7=QK\V61X)(J7DFF69-<L%]"6\%O9O:^W@C$HTG!C:UP-:T]*:;WSY;=Y_
M"-LC760F9$=Y5XR6[`?BM-1I'RM^5-5&?5%3'E+96VPH*2EQ"@"2"#0ZLNA=
MKAAWLS0L(N1`X5J31A(U&A-,Z8YIGYC;Y>W^P`W#AY3IFEPTM%7M:=.0'"N&
M2A3PCD4)OB;`ID#`.,[3\Y88\I,>+AL6XL1_G5O2RB.,GDY"ZE%7MU5K6JM3
M7KKZBL+<BQC\Q[CGD2/HHOFF:>LI?&*-/IJG,=Y(R:VM.2V;I&LS<9EYY9Q_
M'\?LKC3;0J>RFPV>')JA"#0(JH^0)U)\F'C_`*7[U#CN9G2%I/AQX?N1,SRM
MDF6Q%O)SG,YT6A:7&N-^R..MM:1N2E^VSI3+D?>A27&PMM-4*20*'2V1V]0'
M!FGMHD2.N#(2-5.P+7%KN]S>)8MEVNBQ&>5^#`G7!2:MNBHV-/'J>G3QKI%T
M^QMVM?6)IU#DF717,SM`$CI"#0`NQH%9WQA!,'`<&B/M/0Y43&[6Q)C2HRF%
ML250]ZVW8[^QUE]"U5*"`I)'77R-U%,)=_OG-(+#<O([E]==/1MCV"Q8:A_P
MK*C&N6"YXOJ:S%/^[#+6W`750\6P&/O2I12K;C$=^I4I(-:O#I0:]O\`EZUW
M^'6DY>+Z5XCUZYQZLN6DX>7']"C%S0&FF>+X;KBBICC>SN=4[>K\A9.]215-
M>WT^.MAMNGS7:O=6.NOX+%'A;*I4I;+"F@\O<&4]!O4I"=C851(0MQ0H"?VC
MXC5J][6'\JFGU_2H/%?;W@B^Y:IWS+NW\Q7")=;[;C7YCCLN[05OM$52ET,!
M.[H*J(I4:A2;C$YAHT:QE13C:@_U.]2:XGP/(L*B7^.\Y$>LU^;LB3+0ZT@M
M.,6NZ*<6&WOQ$(<2ADN%0W=I?I%`%&DDO8WW#'-PE:,3R*E-MJ6CV$5!IZ0G
M,S6$\VU;;'ZHL6PQ;4"E50)$YZ>P[)4H(%/F`\^E@!5>V&BD'QK-MY6NJYCO
MS#B<55W,<FG10Z&C#L3?WBWE4187W%!3D8?^GRF!UKXU!U90/?I.)586EIQ"
M3&16B)\B^Z]$BNA54@N1&%D*WHJKU-DUJKXZEVU6O)!.7-.^9K:X2$5`P[TR
M]_L%L^2RN2Y;+<%-8[=)D=:;;#;[:A"6A#C3C;*5)=:>0DU'4$U\3J:V5[34
M'%1;9[C,&GM^A%UL8:5:(+6QHER'&;7VU*971TL-G\5HH4%!*CX&HTR1%Y@+
MO>JK&0EK'.&8!2B?QV$@MK9<N;!+HV]N[W%:>B55VI<D+1X)^&I8,;<J*I^+
MG_%CW+";0>ZE*+G=`A2'"4F0PZ0:H">KT5RJ?4?&M=-""W<<!CWE'Q<_/V?N
M6%5GE%PH3>)B4-A-`N/;'5>HJK3=!%?#^;3+X&-J:>$+OQ\@&D@]],%@AA]K
MYI#\DREM2Y$5+O899*FF@VI"EH04M[P72%4'6G0:A2Z`[2SEVJX8YITN::Y*
M9G#.+97_``U`EPU_GF/W*:[%=M;#42YSH4IZ0W%;=Q]:%&6Q+=$GMRXQ0I':
M5N]-0H>5]4NLWW#K-S"R\YNKI->)Y=E%9-:7>Z*I:M6:Y<2\F6>/G.+NWJWS
M[M9KD]8X]X5&LV286_)4MQ%QO-CF?FD)B9`V=OY-9<4`4%:'$FF9+&EH:ZA`
MY*&P"-Y?(PO8/NY5[%<[[4>9;'@IXTX/Q2R6^)?$Y*]R(_D4&W1#>&W9V-.P
M[':<CO3KL2Y-/XS)N\-=I<;N#S$2XN#O1E.]QS57<V[WB00NK3[HS6EVN_@B
M<RW%&N(/KH2,_0%(/W`<$V[);!P/RKG]]E<E6++<?L+S3+D._P!XMV)36[8)
MN2P46*??X>/7R;!N%UDM.[6/ETM);?65?,-]R#$Z6R=XB6R'GCAZ:JVFMWW`
M;/(XM&D`XT%:G@,,D@LE]@^&97'?3QMA6&L?.XS=[2F#&NPRG/;O-5'@W*T7
M"Q(P["I%DP&3<+5=%5D?+S5.)92P9*GQZ;:&YD>*W+C0^[AZ\O0FCML;Z"%P
M->2HD]R?M%S#A*7&F/P8Z5W"WV^^W;';M%N\2[89;[@J7*M%ON\29&$7(GW(
M,=+_`,PVEUATNH6DM*#@1/;.TM+:MQ;08+-;GMQM7U;Q.([4VDS*;$W:K#;5
M8_;K5*BRI[TVY1YTNY7"Z"2U&9A_,QR\X(TY,:*M^&XPE*6%R=J5'MI5JMBC
MD;Y@<\.#![U,._VJ"RZB:!"YM)&9Y^+CAP6M<;_@V..BVXU9HK-]<:<0_:GW
M9OYFJ#',21*DIN4UYZ!$N"]X):6=J5K55T]*N-L9[DUD=JAIF`*5]"EPWL#:
MD-H[O*:ZZ7YG()5ON.--7"X,-/SX<>X?ERDQ&[F\XR)46SL*FL-%]#S[)?F*
M#;;B45*B.AL?@&VM&W?\>@)!J*`Y&@PQ337!V16SF[L%C";LF*;BTB/(87>8
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MF-<C4/LP(Z4.MT51Q:Q&="#L[J65E=4KSMU;F5GFN\#`<N2B)C^2K@YB&2WU
M%P:^5ESK#%:B&6XTR_;I`NGR;K4]&Q2VA;TN++;A%"L4\SJ;96QF@A`KY;7.
M->&6'K42420R@N!:78CM'-,-_"+G_.2O\R_F/^<(G]M_\=^_^Y_RO#[=:'X^
M;^[^[I]T9<_WI/FR<_H7Z\K?NHX;=KLO=UZ4!KCEZ'C_`/LFO<G=)=1#_P!G
M([RW_6"D,WNP?@''U+8'N=XA(!%[N="`>N.WD>/QK$`&FO\`#.^`T,!KWM_U
MDO\`6+#\161/N9XE6:)O-S)\?^CUX'^&*-'^&M[I7R#ZV_:C]8L/Q'U++_I)
M<4D5%WN7_P``;M_Q;26]-[V[*$GTC[4?J]C^(^I?#[E.*!_]F+E^JP78_P#U
MMH;TWO9-/)/K'VH_5['\1]2\_P"DKQ1_SO<_^K]V_P"+Z6.E]]=@V`U[V_ZR
M/U>Q_$?4@?<MQ..IN]S_`.K]W_XMH/2^^MP=":][?]9'ZO8_B/J6+_2;XC'C
M>;H/TX[>!_ABZ!TMOS_<@]K?]8(_6+#\10_TG.(O^>[E_P!7[O\`\6TK_"?4
M7]Q[6_ZZ/UBP_$5\_P!)WB'_`)[N7_5Z\_XX@&N?X3ZB_N/:W_71^KV'XBA_
MI.\1?\]7+_J_=_\`BVN_X3ZB_N/:W_71^KV'XBA_I.\1?\]7+_J_=_\`BVC_
M``GU'_<>UO\`KH_6+#\10_TG>(O^>KE_U?N__%M'^$^H_P"X]K?]='ZQ8?B*
M'^D[Q%_SU<O^K]W_`.+:/\)]1_W'M;_KH_6+#\10_P!)WB+_`)ZN7_5^[_\`
M%M'^$^H_[CVM_P!='ZQ8?B*'^D[Q%_SU<O\`J_=_^+:/\)]1_P!Q[6_ZZ/UB
MP_$4/])WB+_GJY?]7[O_`,6T?X3ZC_N/:W_71^L6'XBA_I.\1?\`/5R_ZOW?
M_BVC_"?4?]Q[6_ZZ/UBP_$4/])WB+_GJY?\`5^[_`/%M'^$^H_[CVM_UT?K%
MA^(H?Z3O$7_/5R_ZOW?_`(MH_P`)]1_W'M;_`*Z/UBP_$4/])WB+_GJY?]7[
MO_Q;1_A/J/\`N/:W_71^L6'XBA_I.\1?\]7+_J_=_P#BVC_"?4?]Q[6_ZZ/U
MBP_$4/\`2=XB_P">KE_U?N__`!;1_A/J/^X]K?\`71^L6'XBA_I.\1?\]7+_
M`*OW?_BVC_"?4?\`<>UO^NC]8L/Q%#_2=XB_YZN7_5^[_P#%M'^$^H_[CVM_
MUT?K%A^(H?Z3O$7_`#U<O^K]W_XMH_PGU'_<>UO^NC]8L/Q%#_2=XB_YZN7_
M`%?N_P#Q;1_A/J/^X]K?]='ZQ8?B*'^D[Q%_SU<O^K]W_P"+:/\`"?4?]Q[6
M_P"NC]8L/Q%#_2=XB_YZN7_5^[_\6T?X3ZC_`+CVM_UT?K%A^(H?Z3O$7_/5
MR_ZOW?\`XMH_PGU'_<>UO^NC]8L/Q%#_`$G>(O\`GJY?]7[O_P`6T?X3ZC_N
M/:W_`%T?K%A^(KX?<]Q"!4WNY_JQZ\'^812=='2745<;<GN+?]8H_6+#\16B
M[[L.%F02Y?;JFAI_T:OA-?T"'UTX.D.HG&@M7^MOVI+MZV]C2YSCI'8BQ[WC
M<$QS1W(KND_9BM_/_P!94II]O0_5+Q5EH^G>W[5'_P`2;3^,^I:3GO6X`:.U
M>1WH?:,1R(CPKXB"1H_P+U7_`-(_UM_UD?XDV@Y2'U+6/OA]O(J/XFO=0:?]
M$,C_`.(:='0/5A_]D<.][`/:Y<=U-L[14R'U+&KWS^W9%=V37L$"I_\`,ADG
M3^2WZ[_[O>L3BVT&G_>Q_P"LF7=7;`W!TU'<J&JU3[\?;B"1_$]]Z>-,,R;R
M^'_)_72O_=WUE_TC?_C8_P#62?\`&&P?WKO\TK"OW\^VI%-V57[J"1_YBLIK
MT_\`X;IW_P!VW6G_`$?_`.=B_P!=*_Q?T[_U#?4?L6LOZ@OMC;.U>67\'X_P
M5E-/A_S9I?\`[L.NB*BR;3_?1?ZZ/\7=/?\`4-]1^Q:+OU%O:RS]_+\@I0J]
M.#98J@'CU%KIKO\`[K^N_P#H17LEB/LUXIE_6G3K#3SP2.`:5RG>[;W,8;E_
MU!>3;W!O\F5@LC-)]SL<J7;I414%,[BG&K,%_ETQA,Y*I-P;=2I!2D>"QXJK
M)V#>I.G=Z;L>_,=%+9ZP14$@R-Q&!(P'M5BZ`;A;-W.U.JWD%6]HXX=Z061>
MX_";=(@Q;/=T7!R1<HD5^0_%<CQFV'72A]UE1<*UK;!'I*:]?CK93=5[<7,;
M;R!U3C2N`4-NW3M]*Q/>XG%[???RR\2VX[,@)$-#+:WWY"M[QW%$<.U4E#?6
MI`!Z?&D=_5UI;70@N'Z6NK0FN7"J?.VSAFH4JM_*\GL&6BS-P[ZS$A3([*W9
MK3[+,R`T;_CLM2RW+2D-NF/#<K4':GK\#IC?;O;M]B%DZY<RS?'@]ITEA8[7
MJ!SJ'9^Q*MVR6DE7,$AXMQH>STHTXVN%OQ;'GF;AR=<L]C_/.KMMUR>Z,R[A
M!M:`68\(R5DR9K3?:43(61W%"M!TK8;'N%C9;:R.?<?B14@%Y+BT#"E3SS46
M\C$DOF-B,5>&8]&:<UO+\><#/;N<%1D1A,80W,C=QZ.I2T!YMI3B'"G>VH>%
M04GIT.M1^L6H%6RQ/[!_2HHMI'X,!KVIDK+GN/P^<.45R9*NW*QSBNU1I"&R
MID/,1\RD.-+6D4!#DH>!Z^5>NLS;;U8,WJ^<2:O,(/+!AR/>K`6,C;5I<<`=
M7I."=&\WN"^[$ARWTHCO3DI40MQM*RY'<#3?=BJ#RJE&^B3N-/L5I[<-T#0U
MKR`PD=U.VF/?12;&V<]SJ-U-T_Y7HX5Y)H6LA@*S6=;(UUN-MMQ97\^^N`U+
MQ^VDQVEM-E,]E#MI5)2`IDH0KN);*31%%C#VNZOFWZ2V<]T=@Z-U9'-8Z)GH
M<TN%>];F[V^WCV"*>)H==,>VC`][)/\`LD`^HT1;<<JF1L7O+-BER(SC$5-R
M9N]FQB$NR7)Z(Q(E-N/1ILX,1(B6HR4N*;[A2E:4)JI*JU_4UO8;]L<FR7!I
M9OD:]Q91NHL-0<J8_05%V^YN=HGDW6U;KNFQ.P>7'2UPTD"A!KCZPF;Q;E'D
M"]Y5CMME7AAJ%-O5OB2V(MBMK04R_+::D-*D]AYQ(4V2-Z5)4/$$:\9WGH[8
M;#:;F^MQ_P`1'$Y[149C&E,UH=DZLWJ^WBULW$_"22,:<#4--`<>Q/YSG8+9
ME0XGQJ],-3[3<^8+`N=;GC(5'F,VG'<KO"6WQ'>CNJ9<<@I"PAQ!*20%#Q'D
M>TW$]C//<0N(D;$`*\GZ7'U$8>U>K[[:Q7K;>WG'Y3I*EO/1J:/6#C[%"'+<
M]B<;Y5D>$XQB?'EAQC#KC'Q_'X3.%Q+HB'$9[Z(K"E7YV^2'E%E"0%+*ONU)
MJ>OT?TO+=;GL\4]U*\NIV4'=@O`^H8;7;=WEMK2)@C![3]:^,<S9R%[K;-QF
M`$I4D+M?'O'T)04%`J"7&\52X:*\Z^/GK0_`6IS;4]Y5"+AS#JCHUW,?O1`O
MF;E!U<EYO/K^TA^4^M1M<F/:6CVU",AI(L\>$C:P&-HIX>&CX"T_![2E_&W/
M]Y[`G9X!S[D+(^7\5@WC.\YND);=X>>B2<OR)QEP1[+.<0%M*N8;4$+2D@?$
M#6%^84,-KTU/+`-,A#0#4U&.8QS6LZ'+[WJ:&*X<3'I-10<CV*SJ-;B[L(ER
M%%P,J<6YW77"M047E/O/)4XI7J.XDJ4KQZUU\V2.=+*97FKR`#VTXGM/%?1T
M438HQ%&/`T4'8.`[@N9/ZD;B#[NN3&F5.?U2%A\0E9.Y18PJR!((Z4-7#77T
M?T#ATI"_(N+_`&'!?./7$SW]5W1(&484:^<YJUY+8H2-Q_)L+QFWNBHZK5"3
M-<(/B2$R`/#6MVV)KBYQ/-92Z?XO)'NM^M,(\F0VZAQ"U,K2D+0XE12I*DC<
MEP'P"TJ34>==6OP[","5%&!JIB\=/V;D7&1/982K(+?*L-ERB,RI1?>6])DP
M;?DZ$)CO+4B,9KIV[@-F]!%`DJRMW'+:2:2!I*N8Q\1$'.P/8G\MC<)G"I\I
M,55PFVV^0,<D6^$@+9N-SQV$[;PZP\XW(:;7,B.I,QPEM#;3*MQ"JH&??,([
MKQ^X:DJU\DR69DM\=!`->:2V5XY:>Q:VKM#9E9#>(]DN]^M\=N));M1=FR92
M(LN<E*V6W7W)9<0EO<X`I==A*5"9#N,,!+FXU'%5<ENZ0$/PD(]"9++K99F%
M+1'MZ)"?S&$'W69JX3;95/94XAA49]86VT3L'0`[:@TIJP@WIE#@,^U5\VV2
MDCN2%OJ&S9Y*X4*4D,`K4ZYD-P2UV_F8[:0TTN;ND#<L`D)Z#QU,AZBL@36N
M29_2YBM'C_C>X9_8N753KW<(:L9XOO&000U(<F1Y#IOV/6A%LDMNJ"Q'D+O`
M)4E1*0V>AKTA;AUC%:7=K#"SS&32%KLZT`)P.5>^JG6FSR3/='5K7-#:$_UB
M`:JR2T_20SE5OCID<PX[&4&F-CT;';DX6E)2RM*D(==6WN04_M@I/7IKS^7Y
MQ6NLEEL2\$CC2H)'/L7I,7RGOY&-<Z>/Q`$CO3D0_I)WY:6S<>>X3J-P65Q<
M(;&P[2D@H7)94:=SRH.E=-?^^>3_`*0>W[5/C^3,L@.JZA9WBJ4<7Z35A0I#
ML[FRZ2G`%)6S#Q&+'J!UWC?.<6%51X!)!!)\M17_`#FO7"@M&#'M^U.?^YV+
M_J&^S[$H6/I4<9M*<7*Y2RQX[$%0:M=K;40/,)[;NU)*_$G[:Z;/SAW-PI%;
M#7PS^U`^4%B3HGN2&\:`?8CJW?2GX##2').<\AR/F7G7G0I-NCJ2^Z4DA`0R
MK:BB1U)'\FH4_P`V]^<2"QC"1Q!J.W-6<7RKVEE&BY=2O(?ZJEK[7_IRX1;>
M6,'PWC/-,WM5UR'('F(<V=>(C;$2;^53G8TM3YMMT$)IQR.$/$-+!0JA!&JL
M]6WO4NXLCN-'Q#A0&A'K3&^_+_;-GVN3<6S2/$>=-/M\*A+[VO;GD?MPSG(.
M,>25WJW1G[PW<KXJ'_#5TQX9#+=E6G^(+*W:94I6-.&VN]Y2&Y#K;JTH*FFU
M.-E%B-PB#S&_-IIZ1@O'+^`VH$C#6-U*5SQQ449%RR.Q-6&]PDMW*18Y,%J8
MQ%=??5-MUL<;F7&+</F76I,ZV7%3:7SMD!)"54VGJ$0W%;HZ0-#S]2K(W.,P
M</>KP4F<.]Z-[RBT8E[?KOD3_P##^//7C,[4F5D3]BAOQ1B';AV"1!DQXSC5
M[M;8+#DN4[VI$./$+)<0V";%]EY[3+0&@^A:&&\FF`@E.F,8FF=/2NB[V9\I
M<5X-],?'^7\?OEML&1WG)[C_`'DIM^107\PL\'Y;^#)L*U,S2_<H-I9Q*1+N
MS"MO=3&:^68+:GB4-DOAL1'$2TOS.%1W5RS5S9RESP\`&!H!;7(XUJ3V$##U
MJ`6?\;V+W/YAGN%W#(;5E656I#F27IR[25NY]=+.;S;;18$8C=(B9*<WFY%`
MO5L0'HC25MVUEQQ!!(0F)0AIS+@..92+BV%^XMK0XG#)49\[<,W7B7(7)]SQ
M9J;(9N]QMUKFV]B*6H,=BXGLV?*+46F\BB6NP.-C:]/+<N2TENB"A=4EL]UY
M%Y3AIIG3,]]:K+WD,=N\-E&9Q/'T*#>0XU(NT>)-LD?N7^,WVIC"'S);,28N
M0_=%V^0M"FY;(HYWDN(<6RUL2%B@&M?T\/*N?S6ZK8#B,:_M10)(G1''W3B.
MY*C&K==XL<6ZVP[:FV6]J5'M$9,&1<:-L[I+2T0W50W%3;A+>2MSYI-$-LA`
M!!<*-#/;V=U`-0/F%^HDTKAD.X%<8\L/A`2AS7'V%8);;1;#24N^Q)UVG/+<
ME294MQ<EZ7<T2E,.IFN-/Q35\)VL!P;=E0!42EC99'@-!=@?0IC34!(&:W@-
MQ9BOY*[*L=J<B,2&\R:AS;B+,_;,C9;M5RNJ(DA1DW.;)MCR&$!6Z0VI&]:&
MU)(K(6WVJ9D#BZ'4`&X8@@$^U+9&)7B-QHUV"W(V=S8-PB6B\Y+$<Q\1&6L.
MN5EE,LV&^.R%%J<XBU3D1E6TS0T%N.E1K0[B2-P@R[?&YY="0\MQD!S8.0[4
M2-<3I:7!K<,/K[4YC*@TB+%:>M#]U<CK_+S;7GHEQ`CQ?FFI;3]MDVYY2(\A
M0<"'&'3V2%4(/2`;6-Y#G5(!RX>E0I8Q'0XU[4T^;81G.8PVKMF%XD3YLNUS
M.S=HTI]VXECYE"H4$,O1V*1&-_<6\XE(6O=L0M5";6RO[6V<(O+:1VUHD_#2
M2T\W^'P/$#L3)_W+\C?\]VSP_*/[%-_S9_X[^Z_??^H_;K1?%V/]VSW:KGP,
M/XCZPOT]XT$)>3O30$A500:%'6I``%-HU]52Y!>?L9I-4:J;2D@;00?`[10C
MXFG33"=6/JVH$$_"H36E:@UKY4T(7PN==H57]7_HM"%]!<)!-*5\OT^8-2-"
M%OH:2XD!/WZ#XFGGX5IX#7*IX0EPK5!4-0'J/2OP/C_+HJN^0>:P*CD&FW</
MT=#^HDZZD/864[5B5&)K5'3QZ)`I^L4.E,=I-4VL"HR/'U#[$]:_RDZ[J\>I
M"Q*CFOIW4_RAUK^K0YU7:D+R6'$BIV_H!ZG]'32_-')<HL>U0-"DC2FR:C1%
M%\TXN(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$)
M,W:/2JJE6X44*=*D$BA'AX?SZEP3`%K*)+_=(2!GQUN[]@(HF@00:BBC45U<
MP7`#*4XJOEC+^/!))^&LJ.])]/0$5-!\?AUKJ5')YA.%**!%&6$FM47.Q>A`
M2E:0:4V#=6M/"E33XZ>:[2:J(X^(]Z3\F(M"Z)J4]:$^(^Q7PI34V.5ND5P"
M8?"7.+JHJ>@%P[A4$$@CXFM2H5'AIX2P_B"1Y!YHM?MSE">F[]H#J2*>%"#3
M]6I\-Y!4XA-OC\OC6J3$ZWFBZCU`J(22KK0U(%/#5@V2-X\)J4VD9/A[DK-*
MJ2`"344!K44KX_SZEPRT+64XJ'<QU8Z2O!4#>ZZ^JL/N0S]^&X\\^B[O[6FT
MA*4%K&+,E:5K(WJ9V+JK:=WZ.IU\(_,FYDM.O]SF9[HF;A_DA?0W2O\`Y:L_
M]V?I416N7;L)ZT,LI7$9N292OF'5LJ"F75LI;#A(K3NJJD54HE*E5I742TOY
MX(62$UQ5G&PO-`4LI7)C-^OHO<<KBN18C,6,R*?+-EAG:ZGNE;OS!!1N*P-W
MJ/AUK&O=TGN;[XEOA`8&T[N*?T^5`YAQ)(3CM\H_F=J9?<F'?#=#H^ZA%1(M
M;?:*>A!*2#M'4?KUV.Y,M'/'B)7&#\D]Q7Q/**4V:8MNXE/??8A>DN!;JNZA
M?:3L7XA$ENJ3^RKX:LXAKA=&.)45>W^1KHJ2A,>[M.NP(R4+CI>==<:CQUJ9
M4#MJ$-MBIVD@UJ.I.H$M_=AA\IVDA3(H&:P),05MVOE*7$R3(7DW4)C72#BK
MKI94VIYURVMWAIB7&4HCM26!-5125$MK5X$^#,&^;A''IA/OFKASQ_8J3/96
M[`6D$J4&(<@75['6[E<[TL)LTM-TM^^1%-QG-O.$,0$QWENK<4N&ATES_<4;
M5!23TUL7;N]NU"[FE9J8\`8T(!(U8<4S86+YMP$$#:M<T^SAZ?8G-Q&ZV?(+
MYE0A7:(XEUUJXA%\FS;:A]NSQUK?DH(FQG[A<FE1T!"I;2FVH^Y0<V&ND;%<
M&\FN7V4T,DV#@R7PM-*X$DT5]O%Q#"RWMKBWD802TN&)!-/=-$]MKPN&U@V/
MS\KBVXW-5W;R5$2+.C3;19)<Y4]T,6N9"8B)G151;A4I67F"XI1;&TZA_,Z"
M2UZ%AU.$6Y37+2=#@0&:7DBHX5HG>CKJ*]Z@FB/CMXX2-3FF@\3:'OX)3V^(
MT''NTF-\NW<9C<5YMEAM:[>W/=1`EO-M]PQYKT((4ZVEQ:&W24[B`*_+ES>R
M/:YDLLO"IKW+U^V@`:TQQQMEH:4&(S^I-O=598_EO$J<K=L<AYOF._"TBPQ9
M4:.FTVOCG-0RJ8);KRW)KKBRI>RB4GH-2)!;?#2BWU&,QMKJ-23C518OBW74
M0O7:I?,<!P\-!0*.GNT&&</0F,T;X[PN^WJ^S+S-O]ZR-[-'I<EB"Q(GA!CP
M,TM5J:6AM2FD%,5("0*@J)4?0?EYNM[N!.UND<RS@:"`.1!K]"P/7FU65@YU
M^UM;B1U*\E&NY\W6^T6>\W5OC+BY$>PV^V7%YMNT7Q^2&K@RW)"'$2\LDAI2
M&7005GU#PZ:]9;;A@<_S)::3A5>8?%4-#%$3W)N<+]S%HO*K;;HV$\4147"[
MS[?#`P>&5(4B)&NG;"9TF>EYUZ5.VJ(4255ZFAK`@:'R-B$DH)=2NKM3K9=3
M=9CAI0\#P!5O7`MLQ^[X!AV>,XOA5MOMPA7$NW*Q8;8;5.!3<[G:W4-S(45$
MJ.%MQ]B]BT[AT-16OAG6N\[@=XNMF,CCML4M`UV)K0<>2]WZ,V/;CM-KO(C:
MW<GQ8N&`I4\%*F#(V;0$M.%4=""'4J*3M2CHV012HH3UZ:P:]$8\-*Y7OJ#2
MW)GN^YGW*"%-WZRP]A!44]C%L=8#95M2FM!\!7[?'7TKT?\`^5;9OX0[TU7S
M-U;+YO4MP0*4)'M*C7S3)2YR)?F?2$Q&+1!(KU*H]H@M$$CH/T?9K4;<-5LQ
MO,GZ2LE+_$*9B1N<<;2K<AI=$+4L$A(JKUT30J2D&OQ--6E1`-)QJF\L5)?A
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M+7RL;]MX!)60$(H`D]5#K3IH2V/UBJ5EQMR+#`9FW&X0;E/4]`9193;1(BEL
MW&(\4O*$EI*4$MT(4`%`4">M=55=0+>84Z*,L)->"F-8[+.8]I^2\BVK`..[
M=)R[)[#QY?,D@6ZXQ<@-FN7(.'QC!B.(R.1'+:9;+1*5P$HINJX336/#S_BE
MMEYKRR"W?*&\*Z"2*?0KJ..5VWM=H8#).QA=3'2'C3^]7VLJ6M:FSVR&I!1V
MZ(2YO"5;S1)22V"D>)-*^6O(FCRWTS(<?](E?1Q/F/UY:J'V`?4E(C<VDI2M
ME7<"'4LH2=J/4$A57R-JRWU`*B/LU)^('(IROE8'&J+I4=52\F0U4@[234*0
M30AU`H#M\*`^.FY)0\4`08CS6J]!26(Z/F6UJ>WJ0K>XVM*DELJ"=J:J1L\`
M>AKI3)PUH;0X)`;XM*VX[#K8:W.,KV%"6@XI:'4)"B4N"K>ZB2.NTD>&NFX!
M!%#B$L1D&M4M,.R2_8+D]KS7$KJS;K_CTE4RV3S"CW(17WV7XCBE09\25#D)
M4T\L;5MK%.OCI-K<26=PVZB_BLR35]96^XVSK*[!=:O]X#`GN/!5]^]:RY1R
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M>6T7`_-&9YIN/<;ED!M=5;?DC#$>5N3L9O-OR2'F.58O=+"EB%CK\*^/P[C8
M+?;H,1B%9DRT.I=AP4/$!M)HD%FA)#:5:J+P/C?\3&:#+T%=%U?6_C;X6TH.
M[@G1R;E6_P"9-*@Y9E<N]W#(;'\Q`O$^;%_,WF++`A6>$J8)#8C3+BU%A+AA
MYQMYQ]:$%PKZ$<LIWPR?$'%Y_H39NW2.US>^<RM#-N(,:QMS&[U8<A8RNY,6
MB1/DJQ-J<J1:KYO9BSH$EY-LB/JDR514J<HTI"4J430`UT5O=RSP2W+)O)N8
MQX:N`U=E/I/)3Q\.&ADP\R)PKAA0IK,RL&88(+/>83QN2<I,:Z1;%=+'_"\R
M.F/"DO2Y4=F0\W"=9ER8CCB$LK[;Z%J0H!6X&M@Z@?<ASII&.E:X@EAUUIS%
M!1/W>W-M='PY:]SVU..FGKS1?9(6699>&F;GCZ+:TY&[B\@3#2)$;=;T_)P9
M4&JS$0RN9O2I`0TZE7<)"MQ22WEN]O@=JD)J1D>U5$,9=<%IP.*))6"0[-9[
MU(N%E9N]E>DQT/VR[S'9`L3S;L@9')^0A]IJ;,CW!E+K9"BR&*D(ZFK#-Q$3
MQ'$TB0G$US4IS=)TI;W+#+/?K?`QV`\AFVL3+;(O:(\3M_.P6K?=.P(3Z@EZ
MUP5/26EI2K>V[T+B#0DP8]RG9<2R9U&GVU3C9BV%T(>&U-<4LL,L&'X]CLP/
MVXW$O96S"@9->(:'[PXIZWR5R5JEAZ.[$BMSH[K*5.+W.J0'`"$FK5U=/GD\
MV+P$\![H[AS5G#/`+5K9FM<T'`OQ=7M*<;*;;C-SQ-<-QM*+W`N*H\%,*2[$
M6NX-I$R5%BS'DR;D\Q)8D)6C>%LI=9%`H)]4>.6Y#P9:F/\`:B:NIX7@.904
M%`!ZL$P'Y'G7_/E]_MOY[_:8W^:?_$OW7^=OM_\`G.K?]49^`^[3,*C\CMXU
M7Z$+D`!02$=OP]5:*H>A_50Z^US<,.9*P/E/1@U9UJ0*D$)\%%->AZ^)U!==
MZ)"6U..7!3&P'2,!DMAW'TA"J)*J':5#U)!/P^)!.DB\U.#G5`[%QUH'`NK1
MU,N"3S\)3*5[DJ)2H)`/2O7Q"?,4U8131S`EE:!0W,<SWEA92V00JH4#6@`I
M0>/E\3HE:]P`9G5=C+0:NY(T8C@+2I!22L$J3X;?2:?9U^S4-SI&G22:CM4H
M$$5&2.$QT[=J@"*5Z@$U_6GRUS6_F?6EAA<*A8S!:)Z(W'^<_J``T:W\SZT&
M$G,!8'H%15'3H!LVU\S4FFC6_F?6N.BTBI`6N+>/,)_1M"2/TU!\=2&3-#0'
M5JD:6\@M1R&LD@-$"M`H)`\":=:4ZZ7Y\?:FGQEQJVE*+`8?C6OII7J//X>G
M7?/C[4CRGK!\NL$[:4J:=?+^33H=Q"YY3^2UUL`*.ZA5YUH3X?$CX:5K=S*#
M$X"IR6$L(\DC]:E>/Z`::[K=S*;6/Y4?TC_+_P#FZYJ=S*%B+"DF@4%?'Q%#
M^O2V/H?$31<7DMK`)*30=:CP_ETYYC$46.HT>8Q%$*C1YC$47W2P:BJXAKJ$
M-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%B<:0Z*+%0?$=**\/O=.M*:`2,1FA$L
MFRH>6M2=@!ZI'AZO(5\0*:<$CP1XC3O22UIX!$<G'75+"4H!W5\"JE`!6I\/
M/4P7=/=<[VJ,;5LF!\-.2+I6/IBLJ==;1O-4I'B?(UKXZ7#>RODTO)T43$EA
M&QNIF)[4B7[*M2EE":A9/4J433RZ@T)U:QW,>@-<['DH?PDGF:J#0OC5@6H'
MN)2D`4W557PZ>/GISSH?V"=-N:9!%$RQO?=*`?V@NA"AM/3J/'IH$T8R5>;=
MYS`2,N-K[96M":]5%2@"37]I)!\"KPU:V4S1(#4TTJ-+&-.EH&I-O=XIVJ4!
MT%:CI]NTD4\_/6BM9V$M))S^M096'26'.BYK?=O9HC_N-YVE_FOR:TY/%BR%
MH9<>,5<O&\0#*$%&T,2'$,E**D5#I54I2L#X;^:&D=>[D'TH96FG^2."]^Z2
MC>[8;6,TKH.9PS5=V7W"XP7H[4%#,%<&2VAQLN..*<+;Z79#DDK*7)$@MT!4
M?0L=*]2-9ZVG:ZV;B2*JVG#HW:*%IY\#Z>*-[U>)26)EPMVQX&XMPHSSD5S8
M)"F4J,=`93L2XXAI02FH*32I-3J5:VPN+@->0&&IS[$W)*T14-2<$X7']S>R
M2UVJZ/.)B=O*V+8BW,&.I;Y:N^.-;&V6`_\`UJ2ZRM`2I!"5GU)/AI=VX6;S
M`RA:!74.U+M0Z1[#_L]6(/?R4E)&61K2TZU/P?*`F.8SK4A>/V!;#ZY/S3BG
M0Y*L#.U+(A)JLJH"XV-WAJJ?/.YGF12.#!@?$1C]:OW1V[<"QOJ";^]YA9W3
M<)UOQJ[Q'V74-,2IULM5L:FK=?+A>8<MX[4N.HHJK>A:>G@.FH3II0/>=ZRA
MIMW.#6Z=7#)-:K*;?!R%UMT&.Z8EJDL/?+QW66GI;MR[$+97M-M//`GP!H`D
M;3T#^F9[6&"NJG#--!\;)I(YR/>XY>M+&%R5!M]W$5Q#JIK:8P#+7<^5:=D(
MBMHCE'<2`TAMQ14$`^K:#NT?IE[.09VS!M1@:\,C3ZT_'<0PO$L+FAXRH0/1
MW%/E:\GD76!$N$RWO3H"MD$`S2U#9F,%MUA+,9N8W+C-MJH&PI;K>X]$]1JN
MFM[N*]#6>:YA!KG3N/>KN3J!UU:"VD9$1S-*@]E?J1QB//"<+R>XV_(TWJXH
MN..2&X-@;D2)`CH3<HB?G>S+N;C;21%94ID))<VTH!6@3O0O+^R9:23N\MKP
M0USS08$8`X!&UWEIMAD:0T/>TUH!0X@XD?6I-\,>\K"LEY'POB-VTY6J\93,
M?M\"9)CPY-K4_:D29$G^N_F0GH90W$4I;A85WG%[>FTUQ%]L,T6WR7I+#;L(
M!%!B:C(\<\UIMFZJ@N-PBVPM=\00?%4\CC]2E-?I"',]X8[CZGU)SCD>:2HJ
M3536!WM&UMM(11#:IYI7PJ-4L%!9S<J!:1VH7MLY_![R>XC#VHD]Q/#_`!_S
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M<7(S;TF1,<[LY<:&J4XN3)6HD,H`)KKPK=;]^Z;C-N4HI+.[4X<`<J#LP7T!
MLUA'M6V1;=$XNBA;0$YGBEVPJ>D]MF0QXVY`*FZK+;ZWN\E?1(`[;8H0`:UU
M7G)6`F97BN5'WJ.F=[Q.;=SH=+G)*8AW!2P>Q'M,<4--R04-CQ&OISI=H'3-
MO04\'_P0OF7JFKNHKG3^.OM*CES`XIWDC,E)+0*+L^FJR0=S*?ET[A7P"61U
MUH-O_P"49SQ^DK.W!!F);EA]";9R.2'CZ%!)3T25`;E`*]*MY-!N/Z=37$G,
MUP3">/BZ\NR\FM3@FSOX@M4"99DLMQ`MNXVO)@FQ6U3DJ.\RX](M$J2\%M*`
M<=8>]"P4DC*[V!\'Y.EOE$X^C$8=IS6BV-[#*WQN9,WB*@X]J?;F[-K7#N]G
MC6>]26HT.U2HKZY,&Z6ZV7"[X=CD&V2+TJ4[%=^?:8N<A]26T)]4AU8=4@@)
M%)9,:V$P!K&R:V>[3%TC=5#3@`5=7T=O/(Z1\I\S002XFC:4H03Q/%1?MF<7
M'*,YBMK8=-AHF3$CN+ALRRPBVE;#Q6ZRQL#O=*DI7NJDCU>&K6XM616&I]1<
M`N]AYK/R36EQN3_@SJM_,PPH*8<$[M\R!-GLIEVVPRF7HTEIYMQQZW+"GF6G
MEH4\@3-RT^BO6GV4U20Q.N':=3@[O*L9/)A;J(`;V!1FRKF'+.V4ICPFE&3&
M6%+B,ND%MT+0#LENJ4"4?'6EAV"T).IYR5(V_N'DAH'K4[_;3[H+IEO%=LX'
MS:-*_AV\\B\92H%PM.&RTQ(MYF<TX?)GNWG)&75QX4'\GA.H:"T^J1M0DE1&
MO/.H-@BLMUFWBR83=-M9VGQ8D>6X-(;Q^K-;;8[UMS\-:77\'XF*N-![XX_M
M56D?4H]W^?>UOE#CS'N&A8+A:\HPJYWZ]*R#''KZ\F\-9%+MC'RBP_`?C,*A
ML`J2=P*C4'RUA_EST]:]4[1+=[Q$]EVR;RQ0TK4$U/;IQKS7J?S+ZF/3&[QV
MFPO!M'0AYU"M#4-H#Q!=PX*#/'/U6O<QE^=X-C5Y@<>1;1?\IQFQW&4KCZ2T
M^W%N%ZMMNEN-O_FJDLK:BR5E*R"4D`FHUL]V^7&Q[=M5Q=P"1US'$Y[`78$L
M%2">`HL-MGS#WZ]W6WM[@QB)\K6.HW@\TKWUHNI>7C7'#<A-;Y%7U<:2IR6Q
MM[8=6A"Z=@(6M00.O3KKYA=NF]-\3X2YIR`93VKZLAVW8:T<\:J8_F<>*K.^
MI_[C<F]GW$_'F=<*M8OD.09'G\[&[E%R*V.W^$Q:6;"_<PXRS!D09$>69B$I
M*]Q26^E`>NO3OEKL;.JKN>VWD/:&1![-/A()-*.YKR_YH;NSI&"VN-E+?-F>
M00?&TM`P(/`]B@M["_J0\X>YKW3\<<,\H6;C3'<+RN%D4J\W6RXO/LUUC?E&
M'WC(8K$2YS[M*C1D/3H+:%;FUJ4DD#U$$;+KGHC:NG>G'[E8"5]XR1K0"XT\
M1I4]RQO1/6FZ]2;_`![3?F(6<C'$T`8X:17!_:I)>^GWL95[7O<MCO$F$R,.
M=P2^<76W+)-[O-F>R"X,7^=<KM%;BHE0;E`C-V]UN"W5*D*6@DG=UH('0?1=
MIU/L0W/<=;;GS"TAKJ``?353?F+UA?=,=1';-J\MUD(F$:F@FI&-3Q[TL/:'
MRM_IP\A6[%,MGVK&HRL6B9!)E6"SM6R1#NKU^QZS1(3S\N8]V'I*[JX\AM+B
M20TG[P.H_6'3\725O`W;W/DEEO(H\:X!SJG'N%.U472]Y=?,*>\@WA[(X;6R
MGF\(IXHV$COP)([0B'Z@WLDQ[BSF;*L;3<)%ZL$K/LKQF/=[3C]Q>+LBQ!*?
MF,IQJRR;M`MSS"1Z+@W\FM4A:DU\4A.WW\SKJXMX:ZHI7#Q8?>X++;ATG/M^
MVVFZO?YMC=1L<`T5,=6@^,\:GB>)50MYQ!?&<F?:<5R%J\+!?8NMFN=D=@WD
M0YC<H2FG4/39C+2:2%#O`LM.!:4+1N2'5:F21D@#+IGBTU#FN]0P[5D+R2&)
MA;9DF3(@X#O6Y-9=D8Y;)42RWJTS;5!8C1VGHK[S3$55.]!#_;6GY=[>V$I/
MX2@4E%"E)U")U>\0?2L\Z-S*`\4S-QD2V;A:Y$F_3K':(S;D.-#-O#]IA[G'
M7YC$-;3C;R6I'=4[LJDH6[4BJB53X8]4.AX#G5J.."0)S)^67&@YG#!'..YE
M9(][;QB6Y#GVFYS%HM,E<F/,@.R7UI:$JV2VU[&($J4R5D%25,]]23YZ[);E
ML9TLR'`)/FQ-?1^(KCA5/'/SZQ0+LX[;X";2^VP[;+PQ!<D=R5)+00N6I3<Y
M\,RY';)<3Z?W:MJ4!0&H<EJZ2!D@:WS#B"<Z?5B%,%Q"YOAR[D70K5:<O<M[
MEQ>N1MQ??ELW1UI;TJVSE-S`EQA=R6XBZ6E"F1W8ZJN);!2G=0D-.O+B%Y91
MH=6IHDNCGE8U[R7-R%3DG8NC[V/L6^8Q(A/R+9$>;N93WA;L@QJ8#$EVV`&G
M%%UY$28[L2L!32TIV=*'50PUN3(?>))/I.*XYX:VC,)!R]N*;^VKN=H:;8ND
M4.6R<J9;;$)460MJ]]J6CY*:W(2I4-,N%:YR5/IZJ=8!/J*=NK&>&24&>'W*
M#L.&>":UR$U+CZUK+9?A&VRH,N.^PXS=;.N<SWV42IEH>B2XR7&HR0HVR3;5
M%33H!"JD@U2=0G2QR7+VQU&7"G"A]J223FLN592XSCMO$27+8CMH85$BNEEP
MLK#LR4RE^4X2R$OR5!`?!2T=P0K:I=3.AM#(2'F@`2S)(1I+C0=JT[+G'RMV
M;O$`6FXS)<:8F1;G9,IQ05<4*2^\\R#%DMEEY'=954(;6FBAL44B=-;AUOY(
M.0&/<ELN9&.Q:"`G(_O%D?\`,$?PI_8(_P"\_P![_P#5O^5^]_X351Y$7XWY
MTXI[XUWX&K]#[\A`:"W6PO\`:``":$`FAIYC7V-\9+^(>H+*^1V%8EP2"#M[
M;=!44HKKT!%?$'II)F><:KM-.')#Y=O9LI^T%`^'2AJ*"G4Z!*^HJ<$9X%)^
M9`2ZI:SO'JJ01UH.@`/B`*ZG17#XP1$<"F)86NI051,]9E)62E.T)&Z@(IX^
M)J:]3J>+IWXA[%',`&8*\M,.)*DD4)(\.M*5K7]6F)):@N!&I.QM&H-X(Z9B
M*72J5$$;JFHZ=.G2GQU',K^:E!H:*!&:(:=A&VAH-I\T^-?O&G72?B#^(>Q=
MH%C7;0L`[E5H/('IXTZ:/B#^(+A:UV!6!5NVD)`W'S)(37H#]E=28Y&E@)(J
MF_+;P"U'8"TFJTBA\.FX#J:`GJ*C2M;.87?+;R6J[#\`I&X_8"H#P_5UUW6S
MF$A\=/="P&$*]4>(\`*C])IX*T\)I*8'!-Z7<BM)=N2%$`K2.G2E:=!\377?
M.DYKA8XBA!HL3D`A-4"JN@IX5'F2:^.NB>3B<$V86C,+3%N/[2*?H54_X=2O
M,9S"YY3%K.PRA5`E2?'Q!-17H?UZ/,9S"/*CY+`J(KH3X>70C7?,9S"9?&0[
MPC!82P02-A/V]>O\^E!S79&J3Y;^16)46OBW0#KT33^4BAUU'EOY%8C'1\5"
MGD.O^&NEB1PP&2013/-8/EU^1_1T(_\`2:[YCURB\]EP`DTZ>04"?Y-+8^H\
M1Q11>2E0\0=+UMYKB\Z-;>:$*Z-3>:$-*0AH0AH0AH0AH0AH0AH0AH0AH0M&
M=%$I"14@I/@/"ATIKBTU;FN$`BA1.JR)VJVMI42#2M4_R$'[=*8\^:'DXU2?
M+:44.VI3:RDI<\Z4H>E2/+4_X@?B"/*8L;MM`:4LH(0HI%%"HZ?I]0KKHG+O
M=(3#K:,4T@^U-O>H*$NU2!MIZO+P%:`#J=7<$M&M+2->E4]Q$QE2!C5-/>H%
M5J26Q1=2=H)^P5(/4$:O=OG+B&R$9X*MEC:6%^3J9JB/WP73B#A/,^2;QD'&
M<O.LCY#L=ZOIF0,OO-DO]JS!M"+?BUQM[#\YRP_E=IM48,JCEJ.TL..+4I3I
M%?E_J-MK-\R=Q<\1O<V5N!H?NCFO<MFGLSTY:1:"#Y1J:D5-3B,53!9L`Y8Y
MC<QR\X.[BV&6AK((ASF/E_*/%-M>FP$R6)+[MHQK+,EMN0S2RE2@2AQIIY:M
MNY.VJ:_J^ZV*X>RY@M'QW!;XA""65[`,`?0D[7:[F8RPRME8,M9HX=X1G>?:
M9[Q95Y",(O/$<^U..QY,)J-R'QE\VW/=:0Z\E5NCY!>FOFH+JU-AY+JDO)%?
M2%;!@3<[9$PR/BN0\#[P>T5_;)6IM+Z$8#7(<10`AO8G;NWMN]W]BQZ+'LN,
M2I.4QVV5LW.VR\14T@LK?(4EZ#:I$)*`4(*2&UK!4DA8(!%19[A#.\FZULAJ
M10M=JIV5&/8G8V;@P"1T;J@UR'!'\B+R-;\)O9S[#L]PO*XD/&(JKG(S>'D-
MCE/1933>1)5!3`;>B-OPVG'&&PA/XKVT$)2`.;M+:0M9\()W6[LR]I;XN`'>
M%(EO_P#A7MD;*R_)&CPC33C4\#50RE<H\@/9Y;+#ALI^9.O%[9Q2Q8U*";C;
M\CEY!"BPV;2PW)>;1;GE+G-=E;(45S'!M77<1;6GP<5JZXF`)#"3CD!B2>P!
M9ZUDOI;AK&:G/)R`4H8>(\D</>X;`^,N1>.8-GY'R!T62^8KF%Z@VFT8C<K)
MC4ZY0[G/O#K[]N[]L^6ENN1B5.O>D(4%[2=7T[?V&S6IZHDB%P`PB,>\`YPT
MAQ;D[/"H..*GWNU;EO-R-BBU,O)7`$4HX$8BO>13MR57=IO$N7E9N5X@RY4R
MZY)D4^'?/F7_`)&5</GTOR76N\L-R8=G3&<#(94I*7'!NW#IK=7%S:W3'3PE
M@:\CD2T.`PQY$FBK'P.@&@ZM4(+2:FA+#0NY4J.[`I573GRW7A6&QH>',69&
M/0I35UA6!VX6]&17"8$I;E7)MJY/2)2&>VA24@I7OW&I"J""&;7:PR1S2TEE
M(HXM;A2OVH\G=IQ6%M0#0\#7D`,2ID<*93:K?*N]WS+'LLD\<WN+#E7CCNZ7
M&Y9)E-ZC&*TLQ<>=BQ7KA@W?R-+0@*E3F6W(BTLR*^AP0M[Z;MKK:Q?12V\=
MX\#RP8]6OM#6\.9R&2D;)N<K+OX7=(W.LVGQO-6AIY5%#7L*E1QKR/P]C>>X
MIS'BOMKS'&+I:I<FX6ZVW/(EW+.[^_=(LFUH-FQV$[*C0VG#(%/FMX4T%%"`
M`5IS<WRXWC<=A<-XN[6&"1P$<44;O-.1U4=AF,:X*]L>K]@V_>H[BSBFD;&2
MUSW`AH%#2AXC&E4\>7?4,QW'<IQ&[9+Q@YC$O!IN8_F.-7_E/#;7DTIS+K4R
MS'DBV.1BF%&A-`=5+*G@L%`V^K6*/R=WJ!KHO,_+DR)`&#<:GEJR^A;9WS'V
M^2XBE9"XLCU%U,R",*=WM6'D3ZIO#60XF+%CZY<"_P!^M<V-,BPTLY7/:F.%
M+<&T6,VE"8;URN3U#WW`&V$#HE2R-NEZ+^4=AMDWZGOI?=[CYGY%LT$M.=2X
MMQ(&&>:INL/F#>[C9&QV9C+:RD:-<TA`.G[P`=A4]F(5<F6V7&6L>Q*^OYW?
ML&RF[92W)S'#SBV.R9-OM<A;UP3!Q&VVRRO9-<+\ZV@[UW`(W%A2_P`-*D:]
M/W/9MWM2Y^X6MI")V$1PU`?F*>'->5VUY:73#\#(Y]/#KI5@IF:IV?:W=\5]
MK6=2^=LWFY%D>5KC9XPK$H5G2U%1BE_C6_\`*;A<;LR%3;=D[<Q,A+\-R&EM
MEM316\%EX-YCKGY?'<-D@^(N+>WE>06P,#G299''2.?*G:MWT!U!:6N[/FE@
MG-M&RCY2YK6#M:*!SN[ZE.I[ZJ)_,8%KL/`MPRRZOQKA(R6UVCD1,1_!W($U
MJ*_!R"[7##6\;$X&0E0^4E3&-G@X24@^2;5\EMTWF9S+*5Q8S$DMX?9VKT3=
M?FIM&TPEQ:XQDX.=AZ*<4>Y-]6SC#'EV):>/F7+K.:=5?K3(Y%@K9L$BUN)3
M%CLWE&,,0;J[-B3.Y1*4J96VI*@4[5E=[\DMVAE+&7#0.X%/0?-/IN:%DK63
M%I8"33CQ50&=<J<=\P\^91R5*E75MO-LY.0/8M9I$.5<8#EWN<2-!BIN;Z/E
M9C<*6XTI]08&]E"PD)-"/2;+IK=-IV'R]43F014SQK0`D^I><7][T]N.XR7+
MKB\;<2N)`\D4I4D-RRQI5)_D_';1>R[EV'LY3=;R_G.=8WFUOE6_O0HEPLDR
M`_;+E8)$)C<[:+I'N;C&UXEU#\-1W$+"4N65M>L@C;,PAI%06@N#JXXG@.U4
MMY%:UU6;GO/WJ@`#N/$IHUVF[-%9EVV9%62H]M]I;:VTA2:)4%!LU"1UZ5ZZ
M?E;,UVEK3ZE$-O.UNLL=I3Z^WK"LER'*[O=;;AF4WZQX].P&3DURL>-7J^P[
M%9X^4L3;K<+Q(MD&4BWP6(0"G'7=J$]*GJ-9G?FS,A,8:0]L;S2F((TT^DJ;
M8V\S2^4M<`S,T.![:)P>:9Z,OPS%;K;6KS"L^"8UR?BDV9>;;.#]ZR#+,^DY
M#$AX_%90]<;XM&/L*>D/I92RD`E2J4)G=/\`1V[!MU>R,\J!US&YCG5-0(P*
M`'/'`\BD[IN<#XA!$YID-">-:9J(F#7FU0K\VZL278S,6;W7E6JY)&U<=26S
M14>E.YN2#7JH4\M7.[;+--'6%T6@\W4).1P[>"@6,XCD,KM((Y4%:)QK[>%Y
M!9[HSC$"[W7Y9D/2WHUHNLJ%;TNQ):`9\]J$8S#:%!0*UK2E&TU/35)!TKND
M5PRC8P'-J*N.(JK"7>()('-.+P<D[?`OLLB<OW'`;!G,;D:#?N0GV9L=S'TV
M^W6K%L:7%F70WJ].7JR3')K4>PPW+@X4N1D!@;`K?4CT6UZ6ABM!>[G<MBD(
M]P4.','-9L;A<B<LMHM0(XHPXZLE_P"*+5=K?9>+LR_AYC)L5R>!/R6[VEI%
MSC\>9_;\M:=<6REA4*#*+"7W0Z@+7&2I#1+E"<MNW3O1M[,^\DO;@:8GL<V.
M@=5[2V@+L,SWJ\VW=MUB\N5ENQQ;*QP!.!TN!KZ*56M[XN=H_NDO5FY#R5NU
MXE-X]:A\>/VS$ENWB`XJ^+NF41[Q(E7E=N4TC>TXP4-N+)VI4*@FE;TCT5LG
M3]@ZUL+B8P3.UCS=)<UX!;XB,*$8!7_5O5&Y;]<_%W%O&QS6!E&G)H.HG#.I
M%?8HG<&XU/B<S<1MRF>Y!D\@82];KC&!<M]P:=S#'F$JCO?=[H!*5LKHXDGJ
M/`FOZOB^'V:Z:W'3`^KN!:1I<>ZF%4STY*VXW6U<P'7Y[/2X'4WVCTKM9R3D
MG`\=NLNVY!EMBL-Q:C.W?Y&YW&+!=-M5+<97.+$F6VIUGNI*/2DE-#T(U\J#
M;KV:W;+:12OA)H"T%PRYBO!?4TNY6-I(8[F6&.XIB'%H./8>U4^?6DN#&2<+
M\#67&);5QN-]Y+O;T#Y&>SW)2_X7;$<HD-24([#R9%4[R$G]-!KT[Y41R07=
MY/,US&-B`<YP(``/$GZ5YK\T;B&ZM+2*![9)M1.EI!-*'@,@JW_I@XADS7O$
MXZO]X0^Q;+9;<M#K<^4M2E$XE?[2A\,N*6V6F;FSV`L^+KC>VH576UZ^N&NV
M"6&-NO4YE:8]WT@K%=#1!F^1RSU91KP#6F8Q">OZJ\&YW_W/65W&W%2?E..<
M/M!1"N#BHJ7Y$[('Y+DL,G>ER*6QOW`;016HU6_+6[BM>G/*FH'ATKB,B*$4
M)7?F-/%)U&71O#HA$T`UKB!B*]G%3,^D3:HC'N<L%G#5M_JMOQJ,Z+7F<V<E
M^?(Y`PN++?N&.O2)`MDN4\PHN.[J$@I'0[=5W78?+%87%*N?>1$FF'O8>Q6/
MR_#&NW)T)-/@I<0>;*'V$JY[WM8OFN7<_<UL6BSIE0KGR=GC+TQ5_-FML-!R
M^?%^8G.A:%O5=VH"!XI%2D4Z^;7TSXMSN)2"#YSR:#/$X8!:&XV[>MQVFQ%N
M&FU^&C95S]+0V@'CQX<SV+F)YVM>88;SCG>(1';$U)Q*_JC7&[F5,N-INQ>@
MQ928\%;ZI3TB2@2DM!M37=4/6V@H-=;FP@BEL8KFX<\R2LP8!BVN`!X@KR3=
M;62RW"6TEH71OH2,CQJ#Q"S3,FRZ/"D*1;GDVIQ):7"^49C?.+CN/PZ/%:%S
ME(9<94H`M]I(0E0\01%.TPMJ'/`TFAQR/:JFXBD%!I-4U63X''NKZIQ>=+]Q
MA-J?L*-D93LNJ5-0V;@KOPF;LPA:E)7U0VN@41]P28+B>%X$)!IAD#@JYT$9
MK4&O>4R-PXV7:G_DWY##<F0ATMV>3(5'O"I'?):D-2F%/V]F7W5`[0Y1R@<2
MG8!2_BW!PD#"!WT%,1ZDN*VC<\,H37M*\6K+[A9\AAV_+K?*1',%R+-^9CF2
MZXRI+JTWE,-#L=+TAKNU?^\E=54!56K-Q:A\6NV-".&?;DD%KK>X+)06P<*_
M:I*X7E7:C!J!#L$)5Q4W%G+>B7..8JVF65MPHK0:>"W)IZH+;BDH02HT*T@Y
MN2,.>3(/'Q5C!(YS=!/@;DG@5EB)T-NS2;?%4N,V+A#G6Y+JUP'(;9<F.O1]
MJ-L9M8))*5H10AP!)!U!-LYKR]IKCD%'>QY<:`YE,1F&;WC&+TTN3!1-ML?Y
M>0EJ,^^U#E4VN,/Q(Z-[<"4V[U#[-%-!=4D#TZN=NCDEC,`.E]#0G@5"EE="
M\UR'#BB#+.28UIC,3&WTW&R7Y#E_QV8V'94BPA<J2'+->`TS':^<MJWY$=:V
MV]BT+!H4T(4=D=--K:=,P%/[7&H">F#V1MF:?RW"I[#R*+<;Y&*VY4"(J+=+
M,RTQ<%-727'<6/S)AI+3<22E<PJ2ZTWM+*!184=U:4$H;==6SCYK34\*)J*Z
MCE)`%*<TD<AS0VF9;7[=5A%OFLS9=KHVNX;2ZTKY2!-[9=4SM4%!*NKFP(6%
MHZB7#:&6-XD!#Z&E4ETKZFAPJGT_OPP;_GF#_P!'?G?W$W^T_P#-GW?[1_[[
MO_4M9W])W#D[^)RX)/G/7Z?QMH*2@%(!KX^H=13I6IKUU]1><>03546OX^'%
M5/4$`>FI!`\*BE!J4V0EH-.";,0)K58OX;;KT3L\*5K3QZFI]7AI7F%<\D<T
M1S;`X2XGS\T^(()&W:?#P&ELG<S(!=\IO,H@E6IX)+:DJK4).T&H'4UJ?'PT
M_P"<ZN049PU8+61:@D#<"HCQ10A1Z^!\STUWSCR"2&`&JWE05)V!#:TH](H`
M2`37R_1KAF)%*!.+.J&4@J/I``KZ:;J"G3_'IE<6ONV^A(VD$IW$`U%0.M/*
M@Z:$(!A5?52A\2/]@Z=;*6BE$+TJ*BG2A-?$CI3X4IX_;KOG'D%VI6#Y*GW0
M%?8E(!_4//1YSN015:[L%-00W4TZ[4].IZ@BE"K[=2H[M[CIH%RBTEP$IW*2
MV=QI]XG<F@Z$#XZ>\\\@NT6JN`I2>FT*)K4BA'Q!Z5KH\\\@D.C#N*UOD""4
MJ`41_1_17H*==.1R%]:I!A'-:SD18-"W0>2J#H*]`3Y'3JYY0YK5=AH(_$2#
M6H!%*@T^--"X8P!5:A@-5/I5_P"GZ=CE,8H`"FE@7;Z#HJH/0@TZ?I^(TOXA
MW((6'\M2?$)(^`H"?T$"HT?$NY!-&($UJM-<-1Z=M2:'Q"0.GVFGAJ1&\O;J
M.!7/);S6%<+:DJZ$BGC3S('PTNJ/(',K7["NM`!Y5!`UU1U@7&"35202:]:`
MG]?3[="XL"HR3]T$=:UK_-0ZZ#0U0O'RQ_I4_2*_X#ISS3R7*+&65`T!!IY^
M&EL>7&A11>5-K2"2DT'GY?RZ4XZ15<6,:&.U"JZONE+B&A"&A"&A"&A"&A"&
MA"\[4GJ4I)_0-"$0WEP(3LH`E**]/(`5Z`:D6^92'N+<DV-T:2H+W`?=W@T!
MI44%*_9J\MLQW*GF:)'.!XN*;N?$2HNEO>H@*`420!0&E0.@2%:LXY?+<W@`
MX8\JE02!')IS`YKG%]XWR;ON7Y4BW14HHBY!`0A8MK3[:&QC]D6>U,E1WMB5
M&I*6R`#7IXZ^$/F=?L@^86ZEDCP\7):"#0T:*#+FO5]AB#]G@+B?=-!RQ4;$
MV3%9Q+7?LDH5"2J;'MRW4A1*@E9<C)1X'K0'PUY_!NNX`DMGF;A]U[@K80,X
MDGV?0@_Q?B\[J+1BT[<W3U6R`%JW>JJ5&(T6SM'D0#\=3?UW>@*,O+D#_>$_
M2NFWC(P+@>QQ1:>%L.*BE6(6?=M\&&DL$)/@L".ZXZ!U\0DC^73HZDWUD1:;
MF9QH<2ZOLI0I/PPXO>?\HKS)X;PYEI]#-@>MQEPWH[BH5RG,N=ERGXK04VHL
MN(4`I*Z>FE/`G4:XZHWF\C9!=2!\##73I`J>TC'U)YC`P4;6G::I!XS[7\+Q
MKDK!^1(DS,9#^'YUC&<-6=Z59G[==)N+W^!DC4)V2JRLS[?;Y;MN"'5LJ31*
MUJH236<>HK@VK[7RX]#XW-)J:@.%"1VC@I]I((KALS&@.8:]_>I!>Z^"][G>
M9<_YGEN1L,GYU)D2(]BLZ7+N[C[LU"HX59KY<(!D1WV65*[;Z&VGFU$$*U;;
M?U:^TL+?;S$[R86TJ/O4%`37#]Z<OM=_=378JR>9M!I)&@\'-.=6G$5PYJO:
MY>TO+6\KPVZ+N=CR*S8%B-NQ&QV53:(#D@6U-VDRW9X<EQXJOS*X71YUZB@5
M!2DUW$*UHX.M+">W='>1R^:\@:LM(&66&";A8ZUF;</`<YCFNTN%6G30T(XA
MQ!+N=2G<_A#D6Y9A8?R[@7B_CGC;$+'"MZ;=C#-KA9/E5U8C-H7=\GN#<V[P
MK@Q*E+<)+"8BDH"$=OHI:HD^_;'"6R:WRRC)KB=)YUIBM[;_`#%NW/EMI8;6
MSBN)-9F@MJOBP`HQ[<6`^WT)ON?L-]PV2Y[\CQGC-WQ#C]YFUQHTFP9.Q1EE
MZJ[M=;]%:D6VYN36.YTCL=YH-M("5N*W*.BVSYBVMRR)MU=,MP&%NF0>X:B@
M9V$8XJ@WK=ME8_\`^K7-N97--)3$]GF<]>KPZJ\A4XE-;PUQ?RYQ]STQ=,@M
MV?7J!!MMZ:MF8.VRZS(/SETM+L=M<M`?FD50\MA9JI(4L5IU(LY^I-LNG$17
MC)Y&_>)('H`66;="ZMBQ[61SC,-:*$UXU5@'N7SC@/FZ^8+9.?;=<EQN+,/>
MG7[)+9AV.8_REEOR-G04Q;KF\:T8^]EKBK5;V8EM:O#KBXK;;32?PT5/;/J:
MQVP"2<ONI2^@#7&C0<B>P<5M]DZ6MNH-ON99[RWAG@C#HV2>'614N%6XU-/#
MVYJ%W!6=\-6^?=<APKAZVAFUYTRU;YU^M4%67HPAZT-%V`U*$:ZQHTUZ07WG
M[F@=N.WVT*H"5:LCU!,Q\LTTLL$^DN9Y3RV@&7?7^A09;AFVW,<6W06MS;'2
M'BY@9+XCF!7W0.S/CD%ZRCG>7F7.W(F-8Y)N_$/'=JO&32[(U;F<*R&1;;+9
MVT1[59X^46:S6J->[O=I3W;^=4\W':0JJZU-*9D5[NDL;[^Z?-@2#J)?1WBQ
M]'M6B=UWL5E8/M[?:[:+<`^@'D,8PG$8%HU4KD,J9Y)K/<%DN(X/?L?LS\W(
MN5[M<<9M&53[M&Y)OUJC0+MDC!?<L,ZVR,%M<IZZQHJ6N\MA3L1Y*T]MQ::T
ML]M;L%Q!YUG).US:@.>XDO():=(/(U'H6:W??=XNY#%?Q0"!H%&L:&AH(!X8
MG.N*963S7G>12(&!8OA2[2]>;C&@JQN!(O=TR'(\AN<UMN,ZY+?4W<9=UN*W
M&V$)*5A54A(!IK9;?U))MMFVQMR!`*ZL*%]13$Y^@+!7.SV=Y/\`$35,O#D!
MF!3)/S9_:KR)<L9N')6:C!L6PUJ8_:+Y<V7,RS"#B]TDK;^8M-REXC;Y6+6B
M^C>V$Q7KK\R-R1MZZ:_Q!;PL%&1!W$N+B3[>"T-GT3N^YA@@D_X?A32**2'M
MC]D<OEV3DV9\'XQGWN`M_%DVV3<VO-IQ->+X3@LF\.3+A;)%U?N&72;E<U2U
M6R2J$R4(9[C`4YN%$G/;AUYMUI#+M]_\.TSM.C275(KCF:5Y*3-T%=02^>ZY
MK+$,6BE<,#7N4:^9<RR3%<@F8EFB,AA1+7,D16(4$-=FX(BSRU<&;3<$W!3<
M>3M>+JGBG8%BB4U6E2+R;>[NZVN#;[<.AL6Q@!Q:,0<3J.=*\L5"Z=V?;(KQ
M^Y//Q-PV7QLU'4S#.F7*G!1TEXC=<AM[D:VX3G:[PY=RJ([.CI;C.6!X..,O
MS94EII]ZY..*0`NI:*0JJB5:O-JL]TO9&0V=I+)`&^)[0#4^GL4*\DVNPGEG
MOKJ*.Y=)6,.)JUG*@PSJI,\&WGE/CJZ8A;[5(M7#URL,M]RYYO9LOG6_+LRL
M4N8U+NV$WVQV2[FUY+;KM#8[)9GL_+MMI"RK<FBGNI.CKV>VEO9;26!HC-2Z
MFG$M'>HFQ]1OVJ_;+MU]')=3/+:!H=@]I#@`X4K3`$XA*W/_`'-X_>)<2WJN
MMNBPHEND@3K6Q'N;OYA#LKRH(3;K:]U5=9[3<=2MRD,!U3E"E)!]+O88MLVR
M.%EK\0Z-HHXX`@@5(IF.5<5@6Q[GN%PZ:0B!FLTSP!.1[5&VRPN;N3)LR-$O
M[-@PZ%(B.W"\R2P,>BHF,_-LM1$,PDJNTUIMY24QV4EQ#I4%E("E#'V;CO$Q
M9:Q6]JR(U+Y(VD@\2'9U'#DKF9MOL]N);IQEF&((/O'@*=F2D%9+VUQ-895@
MQY[-[]"RN,Y;,B=>N$BTQ,RML=M]4QA&.6?Y:!\FU'D.=M+A?VAPE3AJ=66]
M6>P1^"X)EN6`>,85KCA3@JF&YOKZ?4(S'&<17,J3EJ]^7OKC89F6%7#F_E/&
M<6?X%FWG&\>QI_'IUA9X\39W[7!Q;+95UC-7)JWOVXICJ;@K6XEM93MZFF-N
M;N.]BC=&*P,DT"O$`5J?W+1[?=2PW33'0$@]O!0>LO/')#H>&197;/F6H"9*
M(]RL;=ULMU[K33HA]VWK3(0XM*Z>"Z'Q%1J8=DBN]/EQ,C#J5('MQXJ,-YNV
M/X'&G'ZE)?#.0[=F,6):[MA#5OE7FW(N9;ML%N\V&6VQ)F0D/R)+$5:[--;<
MC.K3'N"67DL+0M)*'$E6-W79[R%[Y;(R3Q-<6T``<*9U`%*<E>VVXQRN\NX<
M`:9G+'GV(\ESK;8C'NC)F,RXST:5`A,MKA;'K>A+D-]V:Y'2U!,/Y=LM*0>X
MC8D`HH-:7IOI2":VDEZE+GVTL?@@;&YYD_JO(]T=V:J-TW>[@QVL:7,-0\<^
M!;3ZTUO-G*=PY!A-S8-XR7/>7[J\B):4IO?\6WJS66`EF3<'+A:%VVZJCV2W
M-/.)+WS#&YU?I0H!:@.?8[+,;/:[&SL[5C20#"T`G*E<R>Q)9/=[J/B=REEE
MNR!5Q<0:9TH,,T;<5\81[CDUM<O3-^N>8X_?;--G.91,C3;1.$B/'=M;/Y4P
M6;?:;<YW7T+9`W*&U1*U-5UX[UINDUI"]K_+$<\1%6-#13.N'UK1VUX*%['/
M$S<*$DCEQ[.2=_-;8Q@D639E_/MM0I>46"!=K&ZEBY/67YV4J"H2+:Z`XZU.
MCQ"6D+`710J"H:Q&T7C=PN'37-'0/8UQ:<@6#AZN*E3W-S"6LBD<T@$U&?C&
M(]'!$,;!T7VWY#=),AR3>K);GN^_-=FK6B#:;<LVYXR'72Z`WL2S)=6%A:W4
M4I4DQ8=P\G>X;.0-;9234;3`DN/NGA0J+#$9FR22.<7M:34FM:=_U)N_;-[@
MW_:EDO(G(ECR"5"Y0DXC;[U:<ACR[>94E"<QM\^Q6J$\]8+Q;+1D;`B-STR7
MV5H4RWV@@K5O'K.Z=/6>Y75I=7-FRXL(KJC&$D-!BTGS':36H-6TRH>:E]+[
MV^VBNX/BA;7$T#Q4XU!\.D5XFM?0DMS5]4CW&<N/7%B_9+-2G(;K*NN37%RX
MR$9+?9,B>[<I`>N,134*([(N;RG'7$1]ZU$U/51.BO>GNGA+(Z(V\9))`#00
MVN)`U#'.F*C-O]T+0V6ZF(#0,Z5T@`8#`5H,E;G["_:=R#]13CB7R%A&4L<?
M0K7=Y4.6<G;R'*+C=&;'"MK%P18DQ7(=LCMO7>6M(;3(+X"B]+`9ZCSW]-V-
MUS+&99*Q4<[1$YS=)-`:C"N!J."TAZ8WJ:RAW(>0(+UY:PNE!D,M!X?*]\-Q
M;1Y\-2>137<[<;9%QID=UQF`]#RF%;;B+*Q>7NY-N5ZN-O1'_.7F+C?K=:'T
M+A.7$MEI49MB,$%*$A`;!IMN?TU>V-T^S.ED$S@]TC'L+JG"FK/(UIDHG5?3
M'4G3,\,6Z"-LLD>&F1LGNTK[N6?'-,%>[$TM4=+UC>LZPMQI1M]Z;1/?8"$M
M.+E3VWX?:>25#MI0P@*I^U]X4;MDN&`WD#2ZT.1[\0>ZGI5!$PO-'9T]J9?+
ML-:AJ8G.P<@=:#*EVJV72SR)MPFN.OK;;1NA6Z2S<H3JVRM#KKJ5-D@`$:@,
MU->&O+2X'AE[?;VIYT6@:VDU"9"5BCSCLDR(>2NO1I2F1%?M%YDW2W2)'=$:
M!*EI:=M:H\BH+J7U)<V)JA1VFD]D_EB@I1=A'Q-8)L>->/<DS;>0,MX[)QBX
ML/3;1'N[2XZ_FI*T1C$=6W'6ZFWJM[<I<1#CBF4.+4`.I2$[#I]]C:7\1N&.
M<UPX`"B-$D?\(`DYU3]X3-R:[RQ/F1Y3\:X2VID23&EVUA]<!Z2^J6K8HJ2J
M;*824E)<[B0G[I"TUH[LV\=(8AX^)[LT]&X>49)L*&F"7F783;LRL]TEXU=4
M6Z>PM!.+W*68[[J&U,MJ^5#L-QE$B$MU*GMB([BP%%O<BI#5M<"SD\V84B<<
M"JR\CCD>Y["=-%":]R<JQF-)Q.^6M2X#\=\LO!P7.'1??2N<LI+JF93N\I*B
MVTO:*%)/76IMS;7&FY@E`H*$.YYX)EEP64J`6`4H<CVK5QZZV6!#@Q(T.*S)
M<4TVN;)N#2C.>82VEMV1$5!F&.KO.]M(7_N:BE*@FH#DL4[7F6:IU?4GW0QW
M`U67\/FE,Y:K1(6D9-#1#6XZ6U/P'KG%[<1K=\HF//DR)B.RPFA#)82A((VE
M(TV=?W`"Y,20^6W',(B[>"?\]7__`#A^4_YQLW]D_P#'OO\`[O\`X3][_DZ3
M6Z_"WUIA?KYH84E?1)`(`ZA73J.I)\M>S,E$F`"DW'NCO6R&B:U">AZ;DUK]
MHUU[M#=2CL:7NTA9S'10U:(%.OI(Z>=2".FFOB!R3OPYYA$DN#N<4IM`IT`W
M#TII\*^(.G&/#\DV^,QY\4GG[2Z\E8Z;CYBG@#X5'6AU-;/&W(U47R36M46"
MT+96%+0E8Z^D^73P!/QKJ1YC'LP(U'@CR9*Y>'FLQBA5`60!T`IU(/A7I\!I
M%:"J=8W2VA6-VUIZ$@J2:TZ>'A6E:[JZ0QX?EP2EJ+M.[TD)`/@D4%?@?#QT
M_K"*+R;&4^*:$UZD@'^6GEKNL(H@;-4@J`H`!0%/@/.E#56CS`BB]*MK:4@-
M@BE?V*J/7R--'F!(>PNR6K\BE))2#N)-2L'I4]>G@-'F!(\D\UK+MZDU2$I*
MA^T=M>O7^:N@/J:(\H\UJNP6TT'BL]5$DTKUJ``?"NEIMS=.!6F[;^B2`5$D
M]5`$"GP4.@TY&_16J2L!@K/0=%_`]$_;U/CISSAR*[5::[>4DIV#=3I1/I!(
MZ$*UWSQR*%J+@;`0M"=ZO4%I4`1UZ^/C74F"<:3@<T4JM9=M"NM5!7@:]:#[
M-IH3I[SQR*Y18'+<0-J#N5\2-M#45J:TJ1H\\<DT8B36H6FN$L*"5#KT\*TZ
M_;X:ZV8.-*+GDGF%KO0P/O(W4\Z$@=1XGPZZ>7/*/-:YA"E"WY>"02.OPITK
MH271Z15::H"05`;@*_`U3]@^/Z]+C=H=J2%@=@K_`-S`I2A2!M^-3UZ:?^('
M(H6J;<OS0`/]L3_,%$G7?B6\BFI&%]*+5<B$>D)*5>/4*\.OVG3KY`QNHA(\
M@\PL1B*(J?`>=%4_ETIKM30[FN>2[F%KEGR+9(^U)(_GKI20]A8:%83%'4E!
M'Q]*DC^0$`:6Q^FM4A8U1T>(W?H'7]9K4Z&N`=J0L787Y=?U4_G/33GFCDN4
M6,MK2:%)/Z/5_.//2VN#A5<7@U'BDC](II'FCD5VB&G!B*KB&NH0T(25NL<N
M$U2:'<!T("2GJDD_"AT[%((ZD\4E[=02(G155*BFH31*O'U*'3<C^D*_#5K%
M)J`%."K)8BVKB>*24N&I"1NVFI])ZT/3J-OVC5G#[@59+_$/[<%S>^\BU9@Y
M[G>8Y$678D6LW^#\NQ<8CKLB.@8U9@I:%LM+<&]P'H#3]!U\"_,^*.3K_<R\
M5/FC_1"]?Z<C+]DMSA[I^E1A7!E%L/3\>A7`!*0IV&XIITN(`"%ICO!V00.O
M3IKSV:VDD`#,356\D98*U14X_C"T..*9N-LDE!"M@D.)"ZE`*5Q9+2F=@32B
M@*_`Z[Y=Q$RK6G4$G3$!J:#YG-;$)EU:TJL>2O[R4[>[+2M8`&TI=3,0TY3K
M6E2-,.NKAIT2"G-<%2:--"E$W<<_@J97WK?=VDJ342F'("5-T-5J>C[FE`TK
MT5]T?HUSXAO(IUPO6TH0>X+R<YN:2\)>,.L)5W%+>MK@G(=(&TI0CH^1Z`>I
MJ/AI39V...`2Q<')S'#OHMI.3XJX@)?>FP9FU*W&I,61"6%5Z%#E-JP:FGAM
M_G$@:"*ZQ1*^(;R*4,5<>YAARV7**""I3>Z2S)71OTA1:<4A#9*#Z=RG#\-<
M-`:`U"6V>-V!-#7);9M:R5"2JU34JVH0#`;0M;B"#M9>;2D$DU!4%)VGXZ$]
MDM=[&6@>^Q#GL*6XL+:@37`VDG:"$[YC@[04*UV]?/QU&,[:TH4U(PO;I&&*
M^2+&^V"6I\@;C2DYAIX!Q2@I.QSM1=R$4-22:U'4Z/B&C@4Q\,#@_%JQ2+>I
MID"=#M]W2%J*U,+>BK:.P4;4A0EQDI((4#2GCT.GHYYJ5C-&UXIM\%NQU`'5
MYU29ND;%'6.W<L;F=A#9;>I'M\N*&2%)#7X46))+*0:>D'>#2GAJ<S<;V.NB
M1S:\OWI&D_WLWK"12.,>);HZA[^&\;3\NVZVU\T_>K$.Q)*B^VB'\XN$M3Y7
M^(K;ZS3=X=)\?4N]1&L<Q:0*5&=%&,+B<Z]Z3&1>UOB;*9ENN<W$Y:;C!@&)
M;IMDS0ER#$:G&<B.6)#KK"FQ(*EME2#T6H`@'5E9=;[]9R:_,;(1^+ZT/M[T
MQ$-TF*G/'U+?P+VZX5QSREC7-%@BY`[GV)Y!9\HQF[7Z-$OENMUVLBV7X3;U
MG,9VSW*&'&BIQN9'>;>*B%53T$R?K[>+E_F3!H<!3PX!.V$EU8DCRFO!Y@U_
MH6WS#@_)/)^&7W!+?S@]@^.Y+GU[Y.R'&+)BD3&L;RC,[Q=W+L[=\KLN/-PK
M5<UVZ0\4PDK80B,VAM"!M0FBK?K>;%M\QTD1I@TCZU<NZDW&&)C+:WBA=Q<P
M4=Z*JP_Z1_(O&7L=X/\`=A@/+F93\FSGGR[8-,L=TQG%;C,MBX>,6W,(,A$M
MS>RFWT%\8HD,D%061Y'51N>ZVVZ[I:W4;7100''50FGH5OLO5-G%!<2;G*[X
MB1I:!I)->W[0JD<^]O<S*\[O7*%Y;M=R<Q:]7B]8K@,R)<G).929L\7.W2XU
MTM\MB';&(<IIM3D>3L[^S;N2#U]CM>O.E)KVUAO97.VUD6IQ`I1[3A@5B]3K
M>PNY[;RVWDSZ!QK4-/.G'EV*.TZ]>X:+<LNS#+>";I?\CO\`:I<6W6J^8ZN]
M8FS;;C;[G$NUP7#M=P)MEYM`,=^VM!35'ZJV.$!.O8K/YJ]*;Q%):V.X2V\S
MV!OAHPX<:G"E,%C8MK<VZ9=S,CG<U^HAP.D_O3*\&8#D.5\DSKIEEDN&*6RP
M6B\7N8)./S+5;][L*9;T-+?EMLRH-MC*?*WG$J6L%(2*;]R8W4G7M=LCL(+Q
MS[-KF`G4"]^DUS&%!FM18[/')=FZ,3(@\O<T-'A::?7D%:WQ[@WL5PO@R[\T
MW3,3>QB[$BWS>*\.MKE@RT7],]3UMD/2[_C=GDOXZNS*90\\W=7)0D%UQ+>T
M(0;.7JV]O["62PD@FN?+TQOD/@8XBC2YH\1IV!55M96\5Y&[<V2"'75[6D!S
MF_>#:X"O:JN.3^3[SR;G.62.`FN0&>/&9DVY6BQY3>;8N]6.S.O.*M=BG7*S
M,PHEZN3+:*=U*4ET%/H!W'42#JC<K:UBC\JW??QM!F+`=+CF2VN./:N3V%G/
M=2"+S!:%Y\H$^-C2?""1A4=BCN[(O.0):F&.7TO$JWW"X%Y]J4RLID)*94U)
M2XT^@IKM'34D]3VEP`]\#!+][O2F;7Y0I'-)0HP99OKSS0E2@V@NQP[NND<)
M6PA6TM25F<MPQ:'U(H1M\O+5==]5L\O4QC6/::@M%?6I$>R1L)-1EVJZIKC_
M`-JLVR\2VCC>=CV-7_'_`&U73^]^_1HF&99.S3W%QTY=>$1+?:\LY#M5PMUI
MO4"3:[?'NL=J(Q:4H+ZHBU(6M>&FZ_W%SI67;G.CU^$AIP`.%?W*V'3\!;')
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M,%<W8NKZ."Z+!]<'Z1V9J1/`V79+;\O98-YM\IN[SX35QAOY'!1?)4=A"PB;
M:+A.D2&9<B`E1`BJ7O<2:(0JJAK`==&#<]M+HHG1EC*,TC`CFX9\T];6SH"X
MN=JJ?3Z5-O/I<ZR7@-Y.Y*BLW&*D"8XP$Q;O;U16_P`MN$%AU:THES&-Z524
M*4VJB7$FJ2->)6E'L^'C-7,;2N6(]JD.F:QU"*IG+GR=-8N.4VZU7]]C&\RC
M"$UMAO//W!4Q"V%]V0T]VW#%KWMG0CL)(]--6MM!-+<PW449-Q:5>TD@"HI3
M/N4354RG@]A`[$R6["[UR1:V;U;'F\)O'Y;BSTBP_+&\PKA,B1;>U^6Q))=0
M_,9075-H>V[W5[:)""->IVFY;B.G6P,>&7C9#(ZO$.J2!Z2K;IL6%I=O^(8'
M!\)8"6M=0DMQ`=A7#O4\[G],/,K7(E1N.+=;\JQ'(K?#;-ZS&_X["RJUIDNO
MMW-<B"S&:B27(\.43$##K!4XR$NE(45:@6G5!:US+P&2>A`%,*T.:N9>GY;B
M1H@<'6PR)HTD=PP'H5PGMSY4]S?LHX$QCBKAKBFR<G'CR%...,9U)P:TJO*I
M$Z7<76)TFSO7T"YNKDE#;G9/="4)<4/OB/'U+=-:+>Z+1$,@QI]:N&;7<V[`
M&,JUHK[P]-%%OG7,O=![DD9)R3.X?@PK[)=SJX6^W)R:1<;?#NM[R*Y7J]-6
M>V6RSM(MZEY-(%L[*"ON1[>'%.!*@$5D>Y6;;H63W$;?K<\@M/OFF/*BJ+C9
MY+IING@Z.`-:J%>!X![@X4MA;^%Y2[:4VN*W=(6:6.]6C(&<E:25W*Z6&%9\
M7N,VXL.,#M*4ZZVWW5(#;A`52RN[K8K9W_"NFFG(K7S'%@)S\+L!V4RX*LCV
MZZ<TOTD,!IBGNL46_?QG8;-<^+N29EH@A5QR++;'%O15;9CT0[;<43[##O#E
MQ;?0TI2"3&0TDJ)JNFL??Q6#@;^[!=<NPPP\.5.].1;?N'FA@'Y->2+^3IJ,
M7R:XQ,5A9E;(TRU-+:ON:6<1E-VZX@"='M]K=0J(\AAQE2$RI%%J()';JI.L
MN1`YY<6NH#X<<@H]S#*V6A::A1&O.!8]&GM.W>R(FL39J!,OB[4)4U4J>-R)
M-L=N:V2E+S+:JH;#B)`'57W5"XMMSGTO;S`^M1DN9=[P;,D-PKI&MO9ML<Q8
M>38A9)&*LOOOMA"&\KM450MKDUY-#W0R%(<Z[ZBIK'LN8W&:&1QDK4@G"GWJ
M?4HDL\CP8W'P`_0C.'P9+A65";AF34N;,OT.ZX^JZ6YZ39WL%E-)9<ER,H8D
M(F0K_:[FVIE"7F>P65*JM`&W1#OC9YPV)KOA6L(<.)?S'8%)BMH'VAD)'G\!
MQ(Y]P4;^8./+W8YK0;64Q^ZAEVDZ%<(DB4P_^&(=ZB_-"='DL5VA6UQ0(H7$
M)*M:6TNXHXO'AJQ53=,+'@',A,-<&(;O=?S-ENUL390;<F6N)"CKN+2`TKY%
M\Q6^X[%?D-='6D-J64@D@`:M()'@GX=[Y#3$'AW)-O</MB2SB*(AC67%"^7+
M7D>708?:?FMV:%>DT9?*4J;9A]JV7'YE/9JV0\L*!2$570D33=7FC3Y49/,@
MU*DZS)XSF<4;?(XQ_P"?"=X;?[7B_P#;?_.]_P!'O\Y_^4?NO\K3?GWG]U%Z
MBC%?L.)8J.IH?LH=>H!Q;E7T+FD.P-/2O0:4A1"D`BOBJE?#X'[=!>YV!K1'
MEM::@"OH6=)`/7_TGVZXA?%MH=2L"E54J2!Y?'I7RUT.<W(T7"UKLQ58?E17
M]JOQ!`'\@T-);BW`KFAG(+&Y";4/6`2?,`5\JT/B-.1R%KPXDI7W=/W>2U?R
MY%>B!X^:CX?J\]23<`M(U&M.U)T,Y!91;`?OI*4C[M55K7QV^7CJ()91DX^M
M'ELY!8565*C5)W&OVU`K_BTZRYE8:DEW>C0SD%@-K<0LI[:A_E%7II2H)\_#
M2_C9>2/+9R"^KMX0CJDDDCU`]!4?=.CXV3(A'ELY!::K<:&FVH_R>A_73I^O
M3GQ(_$4U+%6F@+2=B[#0H2?B:"E>H(K33\<F-7$THH[6N<[2,UIFVM+)(;*O
MB13X>8IT\-/^:RN:[I=JT?>6NY;6Q7HHJ\`FO5(KX"G@!I7F#.JZ8''$@+35
M:-P-2E7P!KT/Z:5-=!E`S*:TLY!:JK1L)!(ZU-`%*`Z^'@1TTXU_$Y(T-Y!:
M#MH4GP!77H20JM*>72HTO6U)+!3`8K5=MBP@D!`(I0U-0*@4(IU.NB6F1(37
MEOY+25;:)ZHK6HW('0^/ATZ$?'7?-/,H\MZPJM8`)2DJ41T'B17H:@^8TK6[
MF5PL<!4K27;:DD-'<13UUHFE>OZM*;(X.!)-$A:RX3HJD)"CX=!5(I3QZ5\-
M2?B/ZQ7<%HJM]%46!N_HH)'C]E*:/B/ZQ7"`<"M9RW(!*J*W']GQ^%>FG(IP
M7XN-%S2SD%@5;S3T]NIZ=:^'7RH!74KS8^:YH'(+4,#;4&BE#^B/#]5.NN><
MSFC0.06JY%4#0MT^!`'VT%:>/V:4;@$4)-$SY3ZK`N(@4WI'6OI(H?*NX4H=
M.-D=3PDT7/+>M14!HDT2>I-.OA\.FN^9)S*X8B<2`M5RWTZ!0(-?$#RIXT^.
MGXI:5UDIO0SD%@5;U`5"4+^Q(ZT^/4:=\^/G[$:&<@M14-:J41MI6M`!_P"G
M?#1Y\?-,.B<7'2,%B7"4E-:`]?\`)\]*%PS($I/E/Y+7^77Y"GZ"!IS!'E/Y
M+`IE-34"M37HGQKU\OCKNHY`E<=&YHJ<EA5'2?N@C[:UK^HZ4UYKB<$A>#&Z
M5W`?&O\`Z*NGC(SFN46!4>I-4I6"*>'4]/#J*Z;8^A\111%$RT!RJTH4D$^%
M#T)/E0>>I45R&NJYQI3M23&UWO`%(R7CCBRI6T[0*JW`DJ)_2*C4UFXN:0&G
M\JN:BOLH7/\`,-.Y<S_O0C3(ONFYLCM*[2V<EMZTR&IC25QV1BEA4M"VVG0^
MQL3ZU%8J1X"E=?&/S&ABEZXW%Y=2LK?3X5Z%L\LEGMD,.D5H3[<%&9-U0@?+
MNW&)(;6FB69`"BX\E8*F]\=G<X^L>L4"ZI(Z$D5P@@?%C&XDGM5B;YQS8U%*
M+=;9KX6LI5VW?NL/@Q$MJ6`XY\NE+"0TH+%"0HFAZ$U`"VX(H34=Z?;<VQ:"
M[!W'!;TFR6'[B[9%*E%2$&.[\N=K3:BMU:1UW+%2#2AI0[3TU#ELY'OU%H/J
M1YEFXZB\M/<?L6L<>993OAW^7;WU`-_*.+*A4J*4);2'DN.,.%'2@(*A3QZ:
M9=8@'\P:3V*5#*S2?)D+AZ1]*TU1,F[J$@6F[>I02AA4=,LK&WNK<;"F9"@#
MX_'Q\JZA,@.HB1M6IMOFM/B`>.TA?7[BRPCMW"SS(JJAM:4MJ2PX%^#@;DE3
M@J$DFBB%:;?"X$D-HU&N&OB`#NP+3+.#3'E../Q8TE+`2H!J3:'"M2@"*1%!
MP>H`A2R-U/#KIFEQK`9J#5T6]O,1("`ZO)'+-C=9(>MMXGI;57Y9$9]FY*43
M152VI!>0DH'4%0-/Z.I!EFAP(U5[4J6&1A`8_5Z5X_B#,+27$!FWSFD]M#I<
M2Y$?1TJE&PF0A:EGQ2?O*/0:4+B&0Z7,#3SHF=$_,^M:B^4I(<K=X,^.@.%!
M4TD.1PCH-A<424D%(*AT5U\J4TJEK374ZN5,$P^ZD8XQ.!H.*.&\TQB<XT](
MDQ&@MI+>]WN-NJ((5VD+Z*7MW_>%/"E3IZ/21X*43T4L3FU?B:\0CW\PLL[M
M?+3VG7%U0T&WD(_!3T"BE_<HA&ZI%`*@5^&NRP3&FBGK3FJ#D/4C1,"/VG%!
MUHEP$(66HSBTK![2E-H)+8!%2!U`TS&V0.\9P[T:H.0]2R+MML`<'9LH2L(;
M4F1"&QY26^KBBT`$@@$4`J"?*O1Q]2TAOO*,\,\PO8*'@B@V:VJ"6OEK:@DI
M066'I<1YVI44#MA2`V.WUJH^&N1!X;X\U+A<XQDN)JLAM$.,XAQIJ^,T66=T
M"[*E.$NFE%-%*TI#2*]`"FG377O:SWE$+W',DHLD1VD]/S22T4E%1=H#;C#2
MRHH4'7$(96XH[A4#K\:>2@:XKE36O%:ZF)R&ENLIL,Q.T*)4AZ&L@BJ@0&U]
M`37S33K77#-X]))U+A@!826C035>0+PQ^(;6[(7L"EFVSFG4,O4"ZG<1N!KX
M)->FA[1)[XJDAC&BC0`$7S93\Q%+Y;UH6XD`)GVX.[$K4DA#;FQQ2D%*1NV@
M4KY'3[+FXC;ICD>!R!*?:]Y&CS'-:.22<G%<)DNR%KMMH"Y2D,SVEM2(L*Y)
M7ZA'N5L=E1H5R:60?2^RX`>H%3JPCWZ_MH]+))&M')Q4*>W\U_F/<Z1XRU'A
MZ4+9P[Q@RM;UOP##;>[-2!*>LJD6H+-'%%S;;G4+WM*>4H`"J=]1J7;=;]0V
MSM-I<O8PX9NJ>],_#D&H:*I,CVH>W6W12@\.VB:.X^O\PFW/(I<A<B4\7E`+
M=O</NA*WR0`.B>AJ=2_\9]0U+OB!4YYXJ5#'(`?RVNQXT25F^U;@U:9,1''V
M*VUV5&?92\K&KK)?B;T+;#L=;>8$]U@*!"MM=Z?"NGX.NMU8_5YI=3,"K:]_
M,);KR4X/A8T=E/J3-7#V.8[&QA=OQCD-RZ95\PI,:9FN.RXC";>\C88;D['9
M2+E*;#2=J4NH4L)4HJ<*0$ZN8?F.WS/S(7"3C0X5XT4:5T;FE^FCCV)K;7[`
MLDN]ZO;V99QAT*%:;*W+L*K!/N-R?R:YQID7MXQ<8]X#+N.QI=O[X^:*W`AS
M8`G:I6VQAZXLI6^)OEM<<<"3WX)VTFM(V.,KG!]#0:2<>"RR?:[GEPQ*?C]T
MXZ5%R#(<L+)O=MFV*\6VV6N9=4Q[?.7^7RGY3$:Q6U33M`!VX[*DTJ2%7PZH
MV"XM:BZ+9XL6M+7`./(DC+V(AG9).V(U$9&)IB.Y.'>?IM<<VER2@^ZRVL1F
MF'1!7<>*LK2\M\)68YDN1IKC"(I<(W[!O":T%::@1]9LU$V\3`_CXVG#N!5Y
M\'M=?^9'K1[%]EWMSQ2S7/(+%S!.Y0OEL9MR_DI5G3:+?`FH2'7KC';=$5V0
MRP^BI9<*U=DU()2K5!U!U;NDS6L@HQA&):X`_3Q4.ZAM[=NMC]3.'&J-58VW
MD^%R;9<94D06C<$V1<IR1*DX_(*FG#9),F275M06P\9$=55I2D@*';576--U
M2Y;=QCQDC4WAVGO*JWM,AULQ:HD3XUTP^*N#<`E]J,[N:4IMH+?=;4&HSD,.
MI:2AV(VG<X>B4MA-:BE=1`^)S3,XXOX<AR]*CJ4?M$N/M]QDY`GD2V6"?G4:
M]63,;#<\@LLN7=($'Y*7\T+0MIE]A$J'<HS+G=#0<_%-#J[BNI[AE(\&TIG3
M`845K8/MFC\T#S.ZJMNQ#W$<,C&+$9G(4*%+7;65R8[[%^6ZR^K<MYAQ0MNT
MN,+5M5U\=2H=IW*=K?(A>Z-V1%*'TU6FBO[".$.D-*#$Z3S2HB^XKA1V5&BQ
M.1HJY,F0TRPVF+D04\^ZXEMAM*C!*07'5`>7Z0-2?\/[TP%WD/`&/#[4ZS>=
MM+:,F%*Y4/V),X!SEQ?:,1LMNG\@QH=U81.<N<142^N*C7*7=KA,F,GM6Y;)
M4W(D*22@E)/4$UKI#=CW6X;KCA+P>5#Z\4X_>[.)H9+*YK3D"'?8EJ.>.)7W
MNTG/XH6^XAM26[;D#+CZET24N/+MJ$MME72O3I6J@--'I[=::1:O]0^U(=O=
M@(Z&7\NO(T^A"5SAQ(ED0[=E$!80LQU_*V'(FV0LJ4H/%Q%I#BF-J3NV>MU7
M[0!ZP)^DMUG=J?`\-Y&E![:+K-YM7`>6]Y;S#74^A(#*KGP+E$%8>G1L@=<8
M=9GKNMOR)#ZN\AP*B0U/6QV1%C.-5W!L*=4`:%*>A@2]*S0NT3,#7$5Q(^U1
M[F\M9&^"I?7\)^Q0SS_`V+E.8=QZT7B8N<Y(,&'#L[,J-%B-O..6\1"I2W8$
M9E`*4*5^,7"%**$ZH9MM=;R&)F,@SQP]>151*(3*3&WP<,%'Y7'EYQV?+ELR
MEQ&VEH<FQ8[JY,Q:8[>UR(AD-+MKB]LA*GW:?>0E`*@G4>[@!@T4&JH5;/;N
MH2UHS2M0]>Y%BBVPWKYVUN(EW-%NGP6&OR=R:L47'<;#4*&](#38W(4E)"AU
MJ*:J-#(9-;FC4,^U03K8[$^("GH.8[DU5Y4YC"76;I=VW[0](;,BZ.Q#)DU*
MAV82X*92([2$205MN[TLH/K0I(JE5O:R,NHRYS1X33+TI)`>:OQ/:HJ<O!,C
M*'<;L^0VB\6Z9'9>@W=A0M%O=EKBE^8Q.E2Q&=CW.*VX$#;VTJ=(3525I6K6
M[1$&6YNLA3TGL/8DW%E^;^0:M=A3)-J,/=CQV%1'+GNG2S%0H0910L*3';D(
MEPU.?@2DB4VHIEEIMULA3;B0HUG&^=J<Z4!D8`=Z\@.=>25%;7S)=(B>_A0"
MH[^X<T:_W*0?_/1:_P#?/\Z6OQ_YN^_X_P#ON^__`,+J-_B9O_3/SI_#=E^+
M+VJS^!O_`.ZCRK[[/MS[,U^M#[D>2\BPFQV?',2M,QZ_YJN6Q_$+C@B63'++
M"[#=WD2)B%JF.7N2U+2W"89:4=RE.+6VE%3[!8,#GDO]VGUK.7KW"7RP?"%$
M['N2.5\:99;B7V_NQFBD=G\WCWR,H)H*F+?6VW%`^)`K^G5BZ&![=)R45DCV
M.U`XJ7G#'+L_-7)]FRAYMN_M!$JVM(L<VVN38#;:OGW'5H0[;=\9PH'1:*[N
M@.JR\@BA`,?$\ZJPM9GRN<'D4`4A4K2H"A%3Y5%?Y-0E*!!R6^TZ.B#3::]:
M]0?M\@*:$+;1$;6`0NM16@(-/Y#H)`%3DNYY+0EKB0E,"5,BQ/FG.S&^;D,,
M&2\`5%N/W'$=US:*[4U5376@O;J8*M[$ASV,=I>0'<B<5NMLJ;!*D)6"`02F
MJ:4K4*%10@Z*'DE5"VD(:4FNP(%:4'0$]/\`#72:C+BE!KCD"ML0V'$=6T@J
MKUH/C3_!KJZT#51V`1?+MJAU8)4``2FGG4UH17P'EKFH#,BJ)`T.HW)%*HRV
MU*J"2:5)216@^%.GCH!!R*2`3EBM9Z$M?@*@GJ"=JMQ/D/-/73PF>!2H2&Q`
M.JT'4LC5G6:42O</`U30]3X?&FN.E>X4)P1Y0UZJ'6LBK'2JG$*\:U4G=X_;
M2@ZZ:QYGUIS0ZF(*UEVBA-$I*?Z2D@J/3^4Z6Q[F9'UXICR8^U:CMGIU":$F
MNX!(`J?#K2FGQ>RL&.([D>2Q:CEG!JK94TIT"33IT-`>NG67X+?$TU1Y+%H.
M6=("BE"5+KU244ZD]>I\*:6+]E<04U)'I/@!R6FY9R:G8$*H>B5)'ET^TUU*
M%S`[W<.\IO0_D5I+LZCU4G=3P!VU_5X:<$[#@US4ES#3Q`T6DJTA.X@@K*2/
M4FA\#2A^-=*\WM"0(014`T1>]:B!52>O](;:^7C2I-=/,U."X8F<*K1=M0-5
M5433[!3IXFM!0:*CFN>6U::[6L#HTVLG]J@5\/&FNM?I-015-%K@<`:(O5;@
MDT4!U\*5(!/A3RW:<\]W,+FEW(K6<MR`:I25.&O4C:00!XG[1KOFO1I=R*UU
MPEA)HE2E'IM`\`?%532M#I<<A)\1%%Q:9A[#0MT4/,I]7A\0#Y:DB>@H"*(H
M%JNP$A5-NRHKMHD@DD^K["3KOQ!YA<H%K.6VM55-?VO$GR`VTZ'3L<S75U.'
MK";,3%K+@*V^D>K_`"JC_#0:>UMYCUH\MJU##74@CU]*I\`#3H*^&C6WF%QT
M8#<*U6N_%`HA20?`]:D>8\_\.@/;7,53.EW(K67`!Z%HBG4!-:?JVU'73_GR
M(TNY%:BK>*]"K]'04^PD^8UWSY.Q<=&7"C@:+7=@*Z@=0KH!Z@?#K4D4'71Y
M\G8F_)8,P5K_`):KS20/B%;C_(#IZ.74*O(!JCRF+55&/@$E)\ZDJ_1U'33N
MMO,>M'E,6(Q%'J?`=*T5HULYCUJ.6.J:`TJL*X_[)1N%/@3XZ=9)D`1I7/+)
M]X&BY)O?_D$=CWF^Y&"XRTS^3W^RH+Z&I+YD)DXCBY;C!"UA#<K8XM(4FJ#6
ME!0Z^2_F"0[K2_I_>-_T0M?;&L#1P`HHEVO*VY$!LQ1;^['0IR,]-2U'[32#
M("U!QLJ6FA8.U8JHH`*:U!UF1'`1J!P[T^MAB_1G.XN-\TX\GTS&V'UNL(+*
MF%N(2`27-SBBI+*:]0DD]0-1WM()('A15K35X)'8LR+]&714.)=W@PU(;D+6
MB1$2OY=AMYTJ7+C+:4AM-4O>@IW]!UZZX&N.(!H@RQ%ITM=JI@L,:YQFV_G'
M47B/VUJ!*K;+EQT--(=E(>;#+)::#1**HWA;>^BD@5.D21`D:P4F+S7@U!SX
M(P<F(0HLNQ'6):G)<A\+;>92XVQOF5;?0.U;T+"J)""H.FGW:H!4&UP:T'T)
M9#QG6BWHMZ7)MKZ6VI4KKW%J&T-,[15#33+JUJ4Y)D2D@+VJZ';6ITES&N!:
MX!2(G2$@'W*<D7*3;G4-I?L4AZ;W>X>RVZAJ0VTION.*+D902XTM[M]OKZZ?
M=)!TV8(J8C!/&-I=JQKWKPQ:W$)6Y`BS&'TK6IU#"U2&D)=HKO!,9YE2V0RD
ME(\J@541349]G9N][_20^66*GEUQ]*^7--W2R\V\(R$J?*$*F2Y`3'6'6V&G
MVXZX^XM`.`FIHE0H5=::<-A;R`-#3Z$CXJZ_9J$6=`;E?+SU6EM0A/SFG^]\
MNA9;944)>"]FU<A210?>(/G34-^WQ->6AKL.TI]EPX@!VG7W+?4[:IFTF%$E
M.M'MOQG9+"&UI*U)2VRYVU(>.T;0@44%==1I-L<YVJ/4T4R7'N).H@=V2UI[
M>/=I;T*S-.,K;W28\>;;3)W=QMI*&.TMM;Z`Z=J`D`J`)K0$Z[^GW'XG)'Q,
M7WX]/<ZJ*7+5;));;<?N%N84DOMH6&T]@;RWW.\N0V$*);)&P+4$C27VUW2D
M%'OY'#!=\V!PH=;!SI7T46U(LLA+#LF#DSH9[J$N%R:VMY+CJWVV@B'(=20X
MD15+-.FTCKZA5HP;JT5=&W2,Z&I]7%)UQ_==4<S@?4MR"]FK*&7&GXMP90MU
MO<^VI$I""$E8=7'+J6G%%NIH5$4IT%=-EURPT<T@]H2VSZ!0$4*RJRG)(RJ/
MX^E2GD^I5N*Y3I\4N2-A`<44M4W$J'Q`\CUK7O\`XP('#"B2"#EBO0Y%CH4(
M]S;GQ>\7.RB1&#BO2C\4*[B0II!W#<1NV`@Z>%`*#)`<":`XH_M>5V:;O:;,
M":7%=A27'VX[[+2E;0ZXXMU"UI!;-"">A-:T.N:&:M9S3K91A&X@,2HWXX\(
MRD1'&G%QRFJ9+J]_4M]QU:ZLMM%8K1L)IMJ=-RO>T^#*B=I;?B'K6X_;X[J7
M/^5%QT;Z".8+CZG5+:*D*0HD;"LIJ"I744(2?.-)<3`#33U);HHFYX>E9(]H
M:0TRVHVVX-%I*CVEH8<;)%#\R]M'X@`402/3\#4:8=<3N%'9=R7';PN<-7N]
MZ^#%[3,0B.S9I`4IV@DQBGMJ2VE*MI4%-..*-#O22*U!KU.EQO\`"'G-=?;1
M:Z,!IWK0_);;'6I$&?=X#84E,A!;6X5.'<XL!:BXA*F5F@*%>H`=.NE.GA<?
MS:D\*&GT(T-A\)PKS10+=.#JXL+(''2X"&5R8T)U!'=;W(=:<<3L?2M()2.E
M/MT_`0'&II@FG,\O&,8GTK6>M&4*:+KK]E?=92"4A@Q'UM&FY"PP&PDK(!`\
MTGHK3;GZ9"\<TTXRN&DMP[ECD6;(FV6)CN/VV/'D%/I@N)=><H05]P!;QKN;
M%%*/I)%:C23.7'WDWH=^'V+1+*E.)=_*KC"7'0IU+4;LRTJ2HJ]96TE"0YT(
M"E)2%42*T&C4>./?BDF(Z@_2=0"(G;BZI:*NW*`EY5"[+:G,//MH4LAQ8:4T
MAFJT'I4[Z5\.NIK0R/Q-\)/+!($$3LF-)[D9.K9N\/\`*Y-W0H2FE-?UTN_+
MK3OHX)D>2TA:%.)/:*VEK*D*4:U%=1IKA\;_`#22X-.''L5E!"PQ>01X'#U<
M13EBHE79.0V#)GX"X[KUHN34Y+$-,I$9NW3X4D(BVYI]UQJ.RY\N4N,I6DK6
M%&J>VL$7UF^&YA\QOO\`*O)076TEL'1/(+L2*<CD$R&<,PYE]7%4U($B,E#T
MUJ\EFV7!FWNL?A*;0LI@JE1GSZ5-**5LFE%``'4V_P#`:J]K3YK6OP84F<*S
MB^\?Y]%GVR<AY)L-_P`9M"W&$-"2_?HZ6K<(]P?8D-IBN2$+9.XMAH]!]TC5
M@ULWPNF,Z7ZO9BE!Q8XEBL=X3]TEP@8E!LLN69KU[`$%)C0V+NJZI=F2;BRI
M\)D,-+DJ65I(03L;('W#JDO+B\UZ+=]'M]XXX]V/T*_V[=FVL8\UH=(!X:4%
M.\_:G2=Y5D7!IF^6SDF]PDL2+>_*BRIS,E#*I2@VXP$)@L,4_$2$DH6AI2#0
M=3J`[=-QMSHD&MV==;F^RJE2[]+(ZH`#:?C'V+1@9ES':UB+BG)]H1"M#<)J
M+:;S9K3.;0RLAI$-QQ;7S#S##*DI2L;5[R#4UIJUBZCF$#1=!Q=P\9=WY'!-
MQ[X8OX5&UY4^M/\`X7SCEZ0Q$Y'L=G<2IQIA>08RV%QE+<25@NVUQUYYHJ1U
M!0HI7Y(2332F[Y:2&DA>P<ZN/HS4FSWRV%7S`,?4XL:-1]0.?%/O'Y%P"6%?
M+Y!`2L)!"G[==6!5RHH%.6QMLE-#4;NE#^G4G]4VKRZF9Q=R-?HJK,;AM]PV
MI()=Q=0'TC"B,(-VQBY*^;8OUGG/#<TV@3V`I2U$(6XEO>"2L("4)VC:`0.M
M=/P;C:2,_)E:&U_LX]Q*YKL*T#HZ]X62]V!=WAK#;3ORZFG5/H99CN?-)*%;
M@IZBBY7<0D$D(W$T)`HJ;2Z,EN+QZ2GQ:-?@P-!"BG?>.L=Q:.IW(X\J<YD$
MUUYR5#CLU:75+YM_R7S34M-ODN,!*7&DK*BD(!*BD)I+W4RVUL`,M1@33O5%
M=VWE:F2`EQ=6HR&.2BY?95KNH>A8[(MDJSO%U$DMMW&-<KBZRU(85:U1'OEW
M&9K0W_=HO:E(IN^]GB^9TXJT`U&`Q'KXJAFCB$I!S[U$SD]V[6I^)9\<COR$
M6^,N1LN+=PE-O1IJ9(>?A-J6M49P%L[#)>:6LN$A"=II:V$[3+HE<T-KCP4=
M\1/\($MIPQ45%QI4NS=EN3;[7!:G,W*4TM3$_?<WDN=N:UW&)FZ*0Q7LJ;>"
MU))(K2FO$PA!:T5#L*#%5S))XW:F5U#GBO6)<6S.05Y!>;9(MT5=M=C.WB^1
M`]`WK98C@?DUF$IUZ8T'GVURW24[B@JV@"FD27<<$0,C0YC7>[2IJ<!7G3V*
MRAGO7QNN1,YM#0M!H<<,.Q([^#<%_IK^]V_&]?YV_P#'OW']I_R_N_\`":5^
MJ7W-ON_A^[RR3&N7\;LZY\>:_5^]SJ_F9?'[#:*`KON]2B`$`JME.@!*B2GP
MZ:]MMAH9Y8R"J[[^/Z%'N+!D!-`TA2`JBBVXDD'S(0[VSX=>E=2%#4@.#H>W
M+Y#BTN)I8YH&]&T#>_&'I5U2JH'D3J%??PQWJPL`"YP/%OU*6"&0@@@DTKXT
M\Q35>IC&!F2S`[>M:`"I-:``=22?```=="6HR\\>[;C/@K%[ID-]RG&;-"M#
M2Q/R?)+HS;\9M+NU9#/S"G$N7FY+*:-Q8V];B_2*GTZ>;":>9,/R.*@SW;`7
M1,-)0N2#WY?6QNG*<F7BO!4^[PH+%QBO3>6\D<5:;C.:MDM$M$+"<:0MO^'K
M$^ZT.X])*9#K8/X3=2HNMO;>V&B'O'>HOPT]S^<[%O'T*,7#_P!=;W8X)=85
MFA9C.S.,U_:7'E%V!':34J+\F0XEMPJV4"4[B:^>NQ[B^7&9C'$9</H0+9K?
MX1<T<<:_2K8.)_\`6.KNU\M%Y-X]A3VP$)?D0DAIP*`!<5N8*55^TG2Q\'-X
M:Z3G@G&27[#48A6;\2?74]H/(*&&,@N%QPR<[M3MEE#D<*.W]I="$U5X[CKC
MK)I:3%*SL#L/71.?'O9A-%(2,R!AZ%9!QY[P_;;R<PR[B?+.)S"^A"D-2+E'
MC.E2_P#<]JUJ!5^O4.2QGK4EKO[./H[T_%>6\HJ=3,:4(Q4B8%PM=V:0]:YL
M"Y,J3O2Y"DQY2-I`(5N:4NE0?/4;3)#[['-K^+ZE90&(U\MU5LJC57U!J.H!
M"105\!TZ>.N><>2<;$&NU<UG1';!2$)IUZ?^E.N^<<J!'EC7KKBLYC*/[)5]
M@H?UTIKGFGD$Y1:3D8.`!2*$>%>E"1YCQIKOG'DF/AQS6M^7I!)60I/]&G3K
MX>(\M<\X\@CX<<UY5;V%"FVA'4;:)J?@2!X:4V4DTHCX<<RL*K:@B@!'V[SI
MY,R,T&E5J.6U*3U*2?@:G]=2.OZ]";6FY:]Q^XE?CT/B.M?33J!I3':':DII
M`.(J%H.VFM2$*W#QK4D``]0`*TT\;AU*`4*X^CJ@"@(6DJU5'5.Y7[*=JDD_
M&G3KKC+F9@H'*/\`#CF47.6@T(2FB?$G:344-1X5U+CNW/-"`N^0WF46+LO4
MJ'A_X1IY=4^.G/BF5T#WTA\(:TN1:]::#;VUJ-:]`H&AK]@%-2(WZAJ4=%Z[
M.CK^$O=_E;J5^VFGM90M1RTJ0*`#<37;U50&O7]1&CS"F_*'-:2[4XFI-*GS
M*33I\32@T>8CRAS6J[;#MW4255\012AKY'[=+::BJ28@!FM,VTHH=AJ:T4`5
M()'PZ?;KJ96JY;5(.X(5U/4BM.IJ10@4&GA,:9+M5JN6VM2EO>3_`)7W:`>`
MZ5KKOG'DBJU%6\^38)\*D>D?Y/7IOT"<@UH$56H8"4G:IM6[S3Y^'2@\0:'4
MMET7U\(%%RBTEP-JU4:<!))%02*$GR(TYYYY!%%@7;UD"B6ZFM:U!3X4\?CH
M\\\@D&(.-25K*@K2#1&]8-/3X#XCKT)T[&\O%3ABD&$#BM9<1W<:M*KT_9KY
M#STXCRAS6!V(B@#B:D_L_=IU\#]HT)HBAHM,P&_(*!\CN'0_HT_'*0`RF%4D
MY+C7^I-:KD??/[AG8AD-QVLMLZK@\5-]KY'^",724]NCA?:=4Z04I*55%#1-
M=?*G7?\`YQW#_>-_T0M%;?P@H4PX,.*],5=KA8D*1<Z)1'2AU*[:77$_E$6"
MM$AKYE\.U3M2L-EJO4@ZRC?#&(^`-5(2EM%WAK?@FV7.TVMV&Y&1!9C-QS+<
MD*<[S1EIV/1YJX13M0TA!K6JDBI&G3*2SRZ)<;0]VE;[<2[RGF?DY2;O'+C"
M6G&GGHQB-)DAWO/LR8VU*'7=J>TG<HE"2H*4"-=9<Q1#0\^)/_#\&G%'CK&5
MQX?:;D,,1E/2(4=*+U\T8$I^3N?#<13R>T\AMIMQV2$E*EN!)Z;Z)?,R;%E:
M!<I+;8/`J4638V9*BB)<;CND.(;2I"(\9^?/[4M2FOG7MK]6G7(ZS*;!0H`4
M1Z5T(QYC-0GI(WRMHP5.:P)<O;J;C/<OR4S8_P"6[7+=&2U:TIEE]H)H%K,3
MNN10VAM*5(4XYY!":\<2XEW$I36N8T-=[P1LRYDUQ:C0X]XAVJ2MT2YT@&8[
M$$942?\`,(?F1),^9;)TR0VVI2`TM#F\DA`I1)%11*647Z_R94%J>TZN+<&&
M'KA'Q]OY=<=28W:CN,35K_J+0>=0&4;0ET=*!1J8_P`,WF5Q;S;)1;W9#SMQ
MGHD,-!R(B%(#<00YMPB_E$::4A3\21%:1)50HZLD*4G;U;=._)N%$(A6[):N
M$=Q*;;>&Y28D%ZWQV7''$O;"XY<F93Q65OLF0&RDI[8</4D^+PFC$5:DS437
ME@2:ZXKS/0J.[$"+7.AN!D-S%1V2Y<F&4+EJ*(7:>"G7'(X/I30(WGN)`I54
M<A>*TXKDDI:[0!@?K6T]C0;A2'F$2([3*&G6808242ICZ(BMBD56ZR([;I*S
M5?<(30!5#IPIB6,1TH:U11,L=P8D,NR)H<D%<>.N.5AU;W]42B2M#;L?M]P/
M)0PETNH2-J@H$U3H.C[K0'<UQTI<W31;42V9`6(\FUV)NXS8)=WM-NT7%91-
MI#AW.0\TB+"JP[M:61527/4>B0&?/B\SRB?S$VMBW2\OM\]278K]O=+DU]+L
M:8WW'/F&RV6U(2B.IEY;._8XE6U2E(&XGH52QQ^7YK@"ZM$+5DW:]-O0EV^X
MJ;:<BKBH0[=6W)FQ#"EN?@/!]3"&CM6XIS80Y1"0KKI#;>,>^-7>EQO,=<*U
M69-YFRU]J3<G+A*=BI*A+5;77VB^\\TINYLMT;4I#\,J04J22C82`*G2O(A_
M"$-?I?JHO@5(E,)"++&$]+Z@ZU,@0FC.4N*OL-PE18Y;D-)3$[BD*6?4H`#<
MI53R8?PA<<[4[4C^,]&DLQ(R$LP)YEAIV3%+Z&7G6I`2MIN,IQ:&VH@64;45
M+B@:IZ@!F1L3#0,&2<CCUBM<BMX/W0"0^AI2%-NI=894I3L1#S3K1<3+;<=#
MS82V0=J`6]BP`LI"B8GEQ?A"!<2?>.KO1\U*E6]ONK["0MM,IE%%2GUQ3)?6
MWWVV4O+9[4>(H^)V(4GP\=1WL#_RV,!-5SSYN#B`M&#DDB[1A=(W?2UND,LM
MAF2RY*=$A#2YJ5MN-I*E-/`E/HZH("5)(U(=:LB'E.:*T^E`N)P:ZBC.7>YD
MIE;KDEU3#$),UMG\8M1RAQ$>0AU8:*:PTOH<6^2E*DCQ!50,_"0<DMUT]V+L
M47B^6Y4)UV:U%;:82A6]P[$J*NRM3SJVRE;O;4Z14@^M"A^R3IKX%OXCZD]^
MH/\`PCUK);LGQ":&V_ZI%N2G416W'9CLON?O0%[0EZ"XF,L*%:E5!U35)`1)
MMS_++B3Y:[\>_P#"/64:-Y!;(B9*X$Q]?R,M<>2XN01N2I)K(9C]K=*AOJ"D
MI<4D"J0.H*=1FV+-0\1S7?U!@P=0/Y+6;R`D_-,W5+:WY#;)84XEH2FW'W$;
MDIDR>R8K:TA:E!6UH*!`(`.I#[5K*>(IR*\=("2T9HU3>X\6Y.QVUMW`%3J)
MJ&A!>1'<CNN;E;C\NM:6PFJ3ZMR3YU&A[`]H%4\;F`X0@:^*SKNMIEN[?DY4
MYM4;OM!R`I*FFV]JD$%SO-I2\L=M/J`-0?"M4M@:#4XCDDF=Q%!@4T.><;X?
MEJ8ZI+EWB71`VL2X2WU[G8[P==5,AK1$=>6ALU"D+HVR"`H#:=2H)!;DEC10
MC),EQ<:N-2HM\E\:-6IXOFT)"D22TA;.176?!9B*'<^8+5WCBXQ52GW4N4,J
MC04`0M(.M)!N#66[?,%*C@FI(Q)2I48<AM*'Y+2`_*@1;,M4RUORW5W>-'?0
M0\F$IAM*6U1Y<A))=2`E:EU4FFY>K]ET[3@!0A0C@:)%VW+[ECN37#&F(*XW
M<F0KNB.PZ(:HJJ-72+.4^ZM*4S8]T0:!NG]54\RK<5`B2RPADMA,ZH!%*\==
M<NZB`I$8)RQ8[K.<:@,3(-LO;[DBX]F7+>7'?CDSUQH:.VM341R?LW*">@4Y
MNIZ1JHOML\ENJ8?F'+N.10!4I[XV>PV+G'F2%M`/0VF;U#0PVJ\-%Q:3%O[I
M!=<;CVE;C++[9#:D%0HE0IJE_39U)^'',IT<'R6'=<E3;(UQ=^4NEM?>8[#K
M_;?N5IN+D*Y,=MD)+CD9/;6VG:=S*ZIH`=1[FQDBCU28-JELA##J!3O3\CCV
M5@1VK@_O7(=^<+RV&#%0`A*.ZD[EA2^X[N4`$IH*@$=8'D5P;[R=UVXP>XAW
M<O,;*YKJ%1W1;G4-$MQVI3;*G70@46X[-8V(W):"E4":[0>JM<-I=\,&HK&[
M&,DA*N#FDZ*(QA4A@-SW8LJ)>KG:4O(C"K2DNI?;C=Q10DJ_9"1UIU(=9YD-
M3"]S:YXU^E-S2.8!H+P3_6*:OE3-)V6-LVX9'=I[[20^B+=[S\S'FMH1VB(L
MUMZ7*@;Y(46G4.`E(H4A121(:VYD-)C^6>/--NNFENECG>;_`&B>]1UFY2WC
MUU789;5P:+OS2_EY3:I,MR*AA*$SK9+#"$K>5(64E8*']R2%4K777VTX!=%E
MP*CEQ<[4XU<DU<K)<+@5&R9#>+F9LCOAR-!ASKLDMLH;/=F2W9#<]MK;M2UL
M0L+)14U4=<:\Q-TRQMU\ZG'M2F22,P8Z@2&R'&Y600A'78(3"#W$3&92VL>D
MK*E!2F7H,5RAED-K<;884E+9<'5:>@?M+@02^82X'OK]*D7.C2-+0W'@F1FV
M*59>\J$56R(U(71B9<)4>,N?VDI:2T[:RRCOH*&=C@`HK[R'">E]%>0S.#B'
M/XD#.@Q)]"BM):PLYFJ2_P#`;G_GT=_S7\S_`)WB_P#3?_>?[-^X_P`G[^K3
M]1B_Z=^5<O\`9_B[^S)<JOU8/<,EQ-UP-D-%PN"]%2BK8E">Y"]2E*ZCP^!U
M[8H-Q_S)[DT\&+(&S<P7$IJ"67&U]`F@K4MD===3:D+PC;P_DLU2D.-=NQR0
M`ILI!(E1:;:]"KKY'3,\K8V@.!.K!3K8:V$#,8J0&13+5B]JD7B]7%JW08]/
MQ'QZW5GJEF,T/Q),ASP2A`))/PZZAIRK1[Q`7/E]1'ZSO&7`4:^X#AK[&:<@
M,H>8&&6BXH;B6E_:4MR.2<CAEQ%K;22%?E,52Y:D_O>V"%ZDON(F##Q=RJ"]
MTI+:$4Y_N7)=R!R][LOJ%\C)FS9=WRH"4XBVMH8>MO'F$Q75A*H^-V-I1B(6
MA!`,A17)=VU<=6=1F&XO'N8WPPUX_N3NF"./60?-IFI6CZ4"(''D&5G$RXWC
M)\BEK8F2D+`$-E$8*"(S2@MMM`6L^`H=.?I[6BCS63LR[%QMW(T:6>X4R5[^
MG@JUMH;L;EVMHCMAM+C#KS84$#:E:TIHVM2J=24U.HS[9\=*D8I'FCD4SMZ]
MH/*MB#AMMP5.2E2B@2HW[((.PK:+!KTZ5!)TPX7C15I!1YP[4V-RXVYAQY97
M-QIV6VV11<-Q23Z3]Y*'DHJJG^4-=%R]HI(QQ>,Z)0E#O#BOELY*Y`PM]IUF
M3F.-R6E`[V5SVT)4D^986M%!XZ=9<_>H6X\4X0TX')2_XH^IM[G^,GHXQWF/
M(0VQMI#ESW7DI":!*%-O+W`E(\*`ZL8;]QK5[4QY#&_PC3G56C<0?ZPS[F<5
M3&CYG"L^:16=B7%2@E#ZD#U$I*@:JVJI72"^%Y.N-H!-:C/V\TY&^_A=J9,3
MA2AR"M'XD_UC7A"^JB1^3<"N&.R%[$/2[<\IQI"J)!44JWII6IZ`"FDNM()&
MZV2.:3DTTHI#=SNHR!(TN<,R,CW55GG%'U7?9)RPF.FV\M6NRS'P@?*7I:8R
MD*</I27*CKUZ]-,_I\YQBH\=A^U/C>83_P`P'-?W</0ISXMR?QGF[")&(YSB
M]_;=2%H-NO4)Y6U2=R5%LNI70C[-1Y;:YAIYL;FU[C]"FLO;*3W91AV$?2ER
M8@6`JC:@1T4D5"J]:@CHJNHP>2[26D43X>QWND%8%1`*@;ZTZ%(W"OVUTXE+
M!\FK_*-?BDC_``:*E"QJC$`D`']!Z_R5KH7*!8"PJAW)('QH1_/32F.TNJ44
M"P%E'@`3T\C73OFCM27-J".)"QKBI5X-C[2H$D^%-=\YO(ICR'<PM55O:4:D
M)!^*:C1YP[4?#GF%J/6Q)J$IW4\%*2?#IX[:@Z<!J*I#HBUM25H.VD_MMBA%
M`12FXUH*$@5TJKABTXII%SEJV5HWT'WE*0=OE2A`II;+BY;F044"T7K.A72@
MZD*J-OG7[=.-N9#_`!,1V)N1A>*#-:B[,`.B2:UZA*54_2!4]=.-NM!U-KJ"
M9\AW,+079D#P2A1K0BFTUZUZ:?%_K/Y@.I!@DK@*CFM%=G`Z!%%'PIMJ#T^/
M74CSF<,>Y'P[CQ"TG;-MK5-%$_M!/F?&E:Z4V1CC1IQ31%%HNVD`U"$DGP4`
M`10`5VZ=!H4APJV@6@JT)W$!O<>JC0)Z&IKTW>(TO6$SY1YA:3EMW5`!)\E@
MI%>GF":]-'F#M7?)=S"UC;0#0I2M5/Z(5^LE/6NNM?4T7/*/,+15;5I`JA))
MKU!J?TUTI<,9`JM0VW[U-H65$]32@)Z@D&A.GHY`P4-<TA:CD10200:D$*`!
M.P4\:_HTOSQVH6@N*P!Z@G[37:H_;^LZ=AG;KR*YG@B*7L30I51*02H]:)_2
MJE*_9XZG!VINH)LR-C=B,EQQ_4AG9N?>KS];;-C$.Z1+CE49MB9(E0H;D=IW
M"L71&>B.HE)E%]3Q(4A0!H*;34;OFOK:*W?U=?&4T(D;_HA:7;2';=$[F#]*
M@Y=_XV198DJX8W96V`D[NX\B!+>^=<?#K+*ID5QKM..1U+*4*25@*"#U*=9.
MMO*0TU<.SAVGL4I[A&*GBM=$:Y+NEFNLFT16`8\Q*5/+F+I%<@V]5P^7,:%6
M"TMR*6T*::*ZA143M]3<KXQ6)F0.![DP^5KFD`40G9K=(;;XMT!]]E^7(5=G
ME/SXZ[I$#;*(\AN4\Y%<7%86UVP$C8ZML%":`C4=MC',X2O-#SY4XKL<H8VA
M!JLMGR6ZW3\T7;\1@3;.+&JX0Y.X/)C(;7-MY=88=29")+4A;BG$/.)4I"B`
MDE(4);66]MX1(75QQ73.T\"MBWW++KW:G6KC"M<&X,LI;M_S<IP,SUI2&Q'A
M%]:)\E^:A*U%#A2ALA"%JKMHR^,L&HTQ3<4GEDDUQ1A:Y5_GVJ*IQF)!NKDE
MY4YM$9M7S$)DI?0T)TQQTV]L--'>T@%30W[1NVZ:HQV#ZZ4]\0WD460\KO3R
M&%NVNV,WZW`J4S$G,VX*;EJ0RV[.>D)<CVYN/#(6`V.TZNAH5*H7&P@1DQ^Z
M*YYH^(;R*4-TN;Q3&:O>1SE76.Y&;N$&S3D&);6;B`%S93I00_*>=:4@J+^Y
M10:(24Z::XNS!'>G(Y!)6E<%LR69MY"1#=GQY;3[CJ'8\Z(PH.75M;#T&,A*
ME1HD>4A:0&^V=BT%1]6\Z=C>UCJD5P3$LH<-(!J"M\H8M%O;M3*W@\VRX_(=
M=>8=6]L>V%,RX=P(9-R5("0$%&U"PNA2.D2:(R2N>T@`E=U-\BE?%19T7&ZO
M,S6VK,Q%D2$#Y-$E,!;S;<8;E_+QRZ^KY::7E!2`ZJJ4UH*'2V,+6%IS3+6@
MMU%P!6A)D,I9#R';EW7EOLMO&[18<1A<.,-A$<!!D.%X$)V*4EQ.RI4!0)BC
M,=:T-4A9X$9R4X]+<GW*%*J8"4O7%EEU#[BF77'GQ-,E_?-9*RTVE`V+6A1(
M"*!<C"]ND'%+<P!M0X%&H4EL]QK+KS<&HZV8]T2XQ$C)EH;6U%>D2KEV.T^U
M:1*2H.**>YZDA%`-($8#-)CB<ZF9K5/M+#%H)`=1>&(T^;"DRWK[)N*W;DVE
M$V2RPXW,@EMHIA-,K?BO00TY&#BEJ]0J$;:D:3J$?@+6MK^'+VIORVU]YJ(U
MPK5-98C7=E4!TLNB7(M\)N.Q!AS7%.L*FNN/;4RU*80VHC>=^XBGCI<<996I
M!JI)^&?A*:@+Y%Q^R,2%RVFF(BG&8BF(8MCB7+=:U2;@ZZVY<W+@'I,9Z`&D
M':31M*E*VC:D.J.Z&W!K&0'=Z\NNXZS`GQ8TF':XR)(D)2ZW+,,B,IEM7Y>\
MEAQQB48\B13TT<4HJZ5&F9);EM61^ZF7#2:5!6-N!9PB,Z^Y$BQ65RKLJ0F6
MZ0Y#>+C$3\O^:?6ZW-=D,N!>U'I6.IZA6D,EO&@AP]BYW+-,9M+)=4Q>X2%M
ML?,(MRBXD=MEA+22\U%;:*%(4@.>)4^XC:M52K3+(S(2`N(H2PQ$DK@3KQ#N
M$9;[,9N3#D(BPGI8252GFY#3"D2UI9D(4VI*]A"2G<16KHAE8=3"-2ZE!*D3
M8,'YN.J-*M\1IAB6N-=G$-MRDR):V(;*FNZI$-U+)>E+;2E"CN)I1(TVX2.?
MID(+SZD^R81MH!X@E$'KC<;E;S<'"_$M*E--6N"_'=A*AMQHTDIFQY`4A:0C
M:55![E?N^E)''L,9`*7\27?Q!CV+"P_:6'KZ7KG,9G+8DOQF94:U.(C*#JEL
M6]J0ZB$6TO,A:PI7<<_#2D*!%--&NIKF@FAX)]C+6OY9`/:D7<,8Q.09!5%N
M<B@BJDW#\&&\W=U,M$HBI85587)F*.Y+15Z"I1'@)$KKAS2__9G[O'L]2@R`
M>80,<4JGK3'^6D29\QZ2W\DF2T6(:HT21;H[R$QWWI<MUE4F@B.(2E`4%I0K
M<:*VZC^/BQP2I8(XW4D%9*5K]")9V(XHU=D1OG%7>%-CNQRA5QF-6U*&&G/Z
MZ1'041BU*?+13O[*2C<$TJ"_%(U@-15-)?P+)Q];V(TA`BR7V(C4IM4NX?,/
M%^;;D+ALOH+0"7/F&2-J%+"`N@.ZIU`,<I)(:<U9&*W8`Z(U><T!=;+*2\U$
MDE^<TJ-!@6>U7+_E"5<'N_%8@+CR!#&Y*G%!+?[2%`J6#2@(I*X@@=J2BMV]
M-M/.1RQ-[EE6@"2MV,^W+<+C:7T1(A=D4@*<'967UK#E03M2$@=\EW,)M\H8
M=)!JL<Z)CERMUQAR6E,[+J\09=LARWG(D=$1$AEYR-_4Y:7)SP;0IE7:0VA9
M^`#L+3'*'NQ:$GXAO(I+7;@[!,BA.0'K*N$J3)?M%K4$%"K?)D]R6N.VIJ:I
MHN=I/H;D5;0G<DJ'5.E_'WL9,D6.G$CLK13(7P@DS,#VEM*'GS4*N2_;SAEF
M8ER+;F+ME7:DR(L"=?;(T\[<7&VI#:[3.?B3E[(<A25-!PE32DJ)])"=::SW
MB]:]K)FET+Z5I]WCC5*9'9&(M<!&>`X'N_>HH@NX=.N-IG079]@R*(A^X7V'
M+D62'!80HKC)B.QG9$M1F.1`9+17L<_#%4]"-.7Q;EHN0\1NAJ&AV9)%"12H
MP!5=\(V%Q\L@L)JG&L?(`N,5VY0(A3E$:X6N9=K45_/)O4>TJCQ/S%,E4=+Z
M'#"^7=F(H:!*BO<H:@26$T+M+I"]O`G+T)JXG;08%.2GD639[Y;[QCPN$=RW
MS&,B@J7&2NUB!<)-PCHC2[JE1990W"N#T8]U*&WTMH&X+2--.M`]I;(06D)F
M.=VK\OWNU2CA<CRL[LBX:F8,:Y,N0I<)F(I"PV\RIE2I6_LE28"2L$I!<4XV
M=KG12=V6N;9EA=.,AK"6:<,QQXJ5YNJ/2\>,A+W"<[N]R:7`R"V0XL^(X/F4
M1(J3'46(L@&004H4PTXPI0:=I11;2%T]6H5W$S6TPGP%OVKL,C6>$CBG!=R"
M4VA^W,-VUZY,=HE###,L3K7-<B]E;*2R\S*&Z*D*7T"-XJ1TU'AXJTN.'>H^
M\B6]B;$N\S\MF8].BS(L=R]VVUN;$ME492WF8Z5,!.QA1JA%75)4DJ)%*7<+
MF,:':@<,E521%M7U%*IA;I!Y2N&/F+&AXYG,&-/1-@/IAW.#*[`05NQXTAV(
M\\\EH`*;+X+@`VI44FHE,-E(\>=6IS";T/(U4.CGP1)C<+DN+<XCF5P)>-0[
M2['9_*H,=^WQLA4^^A2FI4>W!N.W%:;;6MV0'^K+1)2JAJ_<,LQ"8[6-K@<2
M7<#V44JWB@D83*:.!P3U95E]TAL0+);+8F[RG5!Z7?$0VHEFQZ&^7G(W=AH3
MV;>AX(+3347?)DD[5+"B:9Z"!MQ"Z60$-:*@',]@79&&0"E$W%WP:6`S,+C3
M3/S`7;&H\9V0ZB3+<2_,N$:!VUN'\*1M;5N_JZ-Q)31*RXR=C6C2'##]@H[X
MG,;J)"U/[K#_`.+G][\K_F^P_P!G_I^'W_\`@_WG_E&E?%#^LF5^F/[CUJ;R
M'`F4M$UC7I:U@A+;:>]#`WD_M$CH!7IKZ>:]KO=4*8ATY>WW:)J[1(7Z4K:4
M%$;MK;C3J""0JE0M*R2/\G2DVEP><^/^";??\NSB[Q;>U#QR7*;8F26+>A+3
M3C+RY=RG2E(BVBTL-ME3DAT@4%$!:B$ZBW#2XU--(4AEPR%A%?'RY]BY/_J5
M?7`SGF>Z7+C7V[W>XVG'7W95GD9Y:6Y4>^7IE[\%=HXUMRMLNQVV1X.71U/Y
MC+2:H["*$UD]UY1&@5JD`-OO$\%FG#OJH"^USZ='(?/%PAYGS")M@Q*3($]N
MPONN?F%U4XOOJ>O$IVKKSKQ-5)ZE1))J3J5!9.<\&7PL_;DE2OB#:=JZ2^$/
M;)@?%-B@6O%,:@6]IAEMH/.1FV5$MI`"@PEL/NJ(3XJ*`?MU:T;$2R'W/550
MG![LO=3Z9-@46YL6J.\IQU460IZB%*81ZD`!/89HV4';X*"C3Q.D.D:#XCBD
M^6_DF&NO"_=*RA54FM&WHK#H-.G1QI+#E"#\=-E\+O>1Y3^2;VY<$%]"M]L@
M/@E7[M+K"^@\TK;D#J?MT!\+<6X>A=\I_)-9>_;=`E(*G[`Z"5$%+3,:2#4>
M(2VON'T_Y(.N%\%<:5[DC%IY%,;DWM,QF=W4O6N.V5U2/FH1CT\*`E]E`W$?
M;H\N&5I(:#Z%W6[F5'/+/8#B=W#BS8HJRO=5;3;2B.IH4E"54\/LU"&WM=D`
MWN1K?S49LK^G>N(IU5FDW2W$$J2&)+Q:/3T_A'<G=7XBFD?`W.0D=3O1K?S*
MCQDOM`Y?QOO+M4U=R0/4AN8PD+])51/=0&%>(UPV]S&W41J(YD8I]DU&@$FJ
M8B;AGN(L4]]AK"93"(X#ANW?<2PLBM4L(96EUUY`ZT*J"O4Z9\R0'Q@M/(?N
M2C,WB4YN`>XSW#\2R0]$SSDFQ2FE-J4M*YL6#'#8^XPW&4\WVJ_TUJ5J2Z\:
MW-Q]122(9<'`&G8K'>&?KD>\WC14=AGE)&40XY2%0,@3\PI:4FA;5N)750'6
MNGA<V\@`>T4IG1<:R2(ZXGNKRY!6O</?ZRSDC/R<?EOBBU7=JC:)$^PR.PZH
M!(WN!O<GJ:D^)TLVUE)&9&EX?3"AP]2=;>;C&X4TNC'`YGTJTGB3Z\GLEY%^
M58R&[W?`9KZFT+1=V"Y':4N@)4YM11(K\=1#:MX/^G[%+;NG_41N#N&D@8=J
ML<X\]WGMDY499>P?F7`[MWTH4W'5>8<24=Z=P!9?6D@D>5=#K2X;FTGNQ^A2
M6[C9NR>!W@CZ0I#Q7X5Q:1)M\R),96*H=@R&)3:@14*"F%K%"#J*26NTN:X$
M<P?L4MLD3P"Q[#4<PLBHJ:'I4T)H0GQ_7I/F-U:<:]Q2_4M944JIZ=O^U*17
M^?3B%C5#V]5=`32I"3_@J="%KKC*!(20H&E".E*?8:>.NASAD5P@'`Y+$N.H
M"JDDCP\-PK0].A.NZW\TGRV<@L'9'FV/T$#_``'1K=S*/+9R"Q*BHIU`H>E*
M)\_+3XD9Q*:DBJ/`,:K4<M[1V[4?&M"$_"G37?,9S37DR<E@5;$D]-R>E/O)
M/Z_CKGF,YI09,!09+5=M:>J:I)/B255'A3J$]=+8^E?+-$VYCF>]Q6B[:Z))
M(H$^*@2HTK\`"1I326'4PD.37ELSH$6NQ$@I`05@UZJ%0*4\#2@TYY\P^\[U
MH$4;L#@$7/P4=?2`HG=THD4)/PK4Z=9>2L%""X]I1Y,33X<1VK45`HDD!`%/
M`BJA^L5&I$5XUU?,\/+BFI(ZTT!%+D'U*J0H$FH0"%`U/V=0-2&W,1-&G%,!
MCR:`8HK?MP%:#HD5Z;`34#SK4:>#R14'!<<VATN1#(B*3O*&U$[SUW5\].-=
MAXCBH[XR3X1@B5]EX[U```I_:2L]0GS`32G32P0<DVYCF^\$FIH?0200NM:)
M#9`"@:[>OATU+88\`WWDV\T;AFDK)2XL$]L)W&H#A)&[K05\>FIT3AI#![U?
MK49U34E<<?U%+TBW^^GG^"W)FO7=O+L?G)8CQWG&8;$?$L66LR7NU)9C,260
M4H'H2M9/2OWOF;KJ,R]6WKVBK=8_T5H+:;RK=D8)#0,`H43[NG(42HUP3#F1
ME*;3'D2FDG8_"6X]#!6RZDMQX2WG`%-_?6@[`.FLM:!K2X-%*C%2BYSLS4(D
MG7.SP93Z529S=W<;:(ND>=/993(D-L++Q^84FMOE45'00:NN550`@GCK=SB6
MCPMK@4R96`T)Q6M(EV-$*5*3<7?D[?%B1'.Y<U1Y5S<C3ENLLK1WUAFWPQ+#
MBE@`J'WNA2D28HBR/RR=1^U=+@6%S3P66RY7%MN.1(P=7N6MJ1.F*?*FD,NI
M:4ZVB*(S;;KBDI*FP0HTW*3U*M#K6(>^P*,TS/\`=)P[5JNBVWA^U-W"7=)<
M>(9L]R9`G)<$F=.7+1"WSU126BT\WM"2=J%I*D)2!4N/:YC0=`</0D>9(,R4
M<"Y0<>C11!DN2$Q@EX)D.R)6R.H_,0+<&UNM"XM(;?V.!84"5J6JI!U#=&]S
MB0T`'@I#9F:1J/B1%:Y>*MIEWE;MI>O$*WQUJ9[1;6VEE0<<M[)=[CP+3J4N
M$=7%[$@T%`$UDC=HQ"49F4-#BC1ZZVZ2W*EJ+,.._;H3\!U;"T,AY<,3)4Z8
M\'#24VTI2&T+2:/.$`$I)T2:Q377Z4F&<M!JXXK7F\C6I4I%IC.OJF+<:D2Y
M9:>2Q)-Q;_$B-I825%5N6M`0D$U=>*Z#U@N?"SG'3AWA=<_6*1GQ+1D9!8Y`
M9EH?E(D37>\2T\W)4[;HR9$5S<II':96.C1H:.%5"1Y)^'EU::8]Z07,`_\`
M2^U&SV1Q;!%EQ[@7X5U1<(,!!>260BUR(SDA^ZQE.%Y<IAQ!0PR`E/[Q6X^!
M*C8S'QU+:<*IDDDU)Q2@%[65/&;+C0F(#D!`2EAL(>;%OWI968JT*95U0DNJ
M4E1)2I(-1I4<5*ZPNF1_,I,3,DD0$H9;BO\`SQNSQG.2G3&DQT!,2KBT%:Y"
MITUQ3)2A14E*"%'J::XR+QDN'A2=1&(.*T;OF,W"G6;2VS\XQ=4VBXNOPFG9
MS"''F5I9B0XZ%K:EMH<J5()*G5+!--X`DFU<Z+6QH]87*DFI66%R3<YEL<AI
M6Y2,4R;@F0L,//44XLKE/*="BL.`%:#X=M-020K5?+#H>!(WQ^M=P6A=<J5"
M@J;?<0U<I<KN074IEM_F#O?=0AF#&:*F5I**5;`*6QTV@$DRH8'.)U`%<13_
M`!1/2(D5$Z%$3/<4VRRE;C\H0&XR'9<^YB1_5K?5#<A6RI(0>B-I35+8B)#J
M'AQ0:41/+3F$E-B-OFR$,FYL%#ZT2%E#2VOFUN28D9MLKAMQT(0@D)2I*%I`
M)3038/*:'!],L$H/<!0$T6Y;\WR9^;)@O6^ZSXDJ*A,B4PL-2/F43VX,=QI"
MFFY$*;'=2XZVE:Z+99"UT-1ISRXI1JU!O8N^8_F4M8=YN:OD7ND]P//,NAST
M.I2V4H;:A1'TACL--*5M+E274[B">A@B&)ONM`7/,?S*-C>;G\R\\TB!'7`B
MH%>PIS[WRI1;XCJ8SBD-MANBFTFH:*NH&XGCXP6^`"J/,?S*VY>2KB28;S2E
M+,5]9DJ#Z'HLAPEY?96TXH?-*8=V,[EI#:$56L'I6.;<UU:15=\Q_,K58RR8
MF0^V[<PR]%=8;BO-.L%Z4PW,4M*F5LAUY'X8""[NZG:GH54UPVY=[S04>8[F
M5KNYK<;E>7W+@RXNXMO_`)FJ/\LZNW_)-+:EJ$5;M8@8CMI2I2BL+475)\B!
MUMN6GPM`*X':<BO:,XO#STAF':'/EF"B(XX&MC:%37&9$N>RIK<C<AMYMLA2
MAN<D5":(KJ2V-H`J!J1YC^91Y-R#(1*0W<9,=#,5+34B8EAB6'6FE,L0VN\>
MVDMS'%4>[6Y'JJJM--21.)\(\-$LSROQ>XERSB]W5V7*MS-O9+<D]^.T&VTQ
MVD)"WOEE*_'[S(?:*B"4C:H_83&?:,^\=*3YC^96G(O%QC7%J^7(J6E"'%R6
M4Q$T?B%O\9EN0''D+0=JD!Q22EU:54&T=)CX_"`P8KK9I&FH<05L(R&X1@Y*
MD-MW!J-*2[`<1';>0X\Z]#=F+8DK6NMN3#8]380H%T5/2HU%<S55CC1+^(G_
M`!N647V\2IL(1@Q#MKEH$V9.,`".T[(=?*8@0P2RMN8ME2T[4^I#8(1U`T@0
M1L%,'=J299'&KG&J,G;S<+?*7;2IU#\>WJ?B*#P<5<$/L%\2([*D%YAN.6EJ
M422*)!!TIMNUP\+1@N>8_F5CM-^N\^US(UT1'AQU+#A5(;,>8Y(0Z_#B3:!<
M5]Y3D<.$J4JA*PLI)H0U<V3(CK8XM8X4-/H5G:3![-#C63-)C(\>CWJ`I+$R
MXV^[+;2XP;=(:9#C:G$MH:DQG[3.D,MOH6I>Y4ELJ%54^,:.[NH9=+=3HN)/
M'OXIUWE2/#7`%PR[$P-\P*\6UV>ZU$D7B=^5RTW=)G6R8J=;E0WUO/KD1[;%
M:>:2H-N*,G>4!'HJ%TU/9>%SVN<:.:<!^W/)/MB\!+0`W%0OS3&+M:U1D09@
ML-U:8<DWB[,L3[>W=6T1U2+=&,P0U0GW=B@F,6NCAZJ*54IN=MN];'?%,#HQ
M32#0TSK3V*L+0X8XK2Q+-;[:Y"+=D-IE)L+@$-<AY]<AMN1*C/QITD+>==:E
M/3!)`[*"E/<VA+7WJNW%M`^,NMY!YF=`1ZEP-:#5HH5(VQWMRP3L:?8F17K<
MVHL627%^9MT!<5*6T(CR&TMF(JX1D(#+K2PAUAX@I`;=4E&,OH)+J"0R,!E`
MYC#$<<DI.W,SA-HN*G$-RF$2XCET5+75+OR[[C,>8EL5(*8[9<.PN;5"I`37
MK0PVYD827$%II1&1JG"LF3PG[U(>D+1=719&[?&9B7%4(3[N(:'&4-.!:DS&
M@HE;K04/2M5%5*!IH,="*R8`Y*U9=1B)SY`'ZAX:\UI9??[HJRR(\J;$CJ[[
M3XMPASK@MQY,-)A%J(I]*U-IC.):=<2O;W&0K<I)3NG6C'22T9B:%,N<PMU/
M'A*1-KR6VW=.Y-TN<I^&N)'?MZ7I:ES)0$EB6I`=?<8=3:NRH44W5I*2*)(Z
M3'6I+J.;1_/D@O\`R"&'P4*.H$Z;+N+`9L\[N/PWVHBVGU,0GE27VHZ^XET)
MDNEU+'X@6VAM%3N*30D\M]N-`<350.*+8U@GSKW!L]WG7&/*G7NVWRXP&9(B
M,14NJD16>['".[VE0^XHK*4!LJ;-`GJ55,<.K3J:?=["K![VM%2G5OL==BG7
M6=.@*O=HAS5QF#;FY*6U1H;CZ6H;8!=*6IDLH,MPT[B2-Q"4I(JB7.=XR&NX
MU(`]949KB^4M)JS'!$OYEB/_`#K;_P#-?=_M-M_LW_,W]G_LW_#?S:33L_;[
M.W)/^7'R"_12]V]Q3`NV%O,I6H,VB\.N*^ZE%9L1*=RE4Z*(I37U%;YGN51<
MLC9)2+%O?55Y9SS-=,0LERFPT26Y+$*6IE3'R[ZN\EA?92VDK6DGN4IN24_I
M\-2":`GL4=<EOO(]QWO`]RN<-X%?;/+L.)OWA3$#%[==I$J%<)K"B&;UELYQ
MB'(O]P0E&YMM24Q8_@TVG[QI)3-,\N-=60PP[,$['%$2)'>\#SY=BF?[,?8#
M8<5EVS,<[:1?LMDM,2'),YM,EN"XH;U,P65@LQ$)!I4!1)ZG5C%9M8P&6A<4
M[++I(T45]&#XK;+3&B,0HJ1V@EI-$E:PG^BE5*A/V``?9J4"W@1@JQSG/S1C
MDG,_&F#]^#=,C8FW>(V77<<QB/(R;(&4)]),JVV9$E5L0"FA<F+CM)_:6!UT
MB:40PF=W\-N9X>M/PM?.`RW!DDRHT%QKW"JB'?/J3<-6'*6K5?I6'8Y!!4B*
MK(\]2Y=9#K;G;=$M.'8WF.,6):$JJ&95U[Y/124&NLO-U=TVV?R9KR!LE0*>
M)W_::"T'L)PXK9Q?+[K62W^+.W3^2X>$"GH<0:.H>0'<G/QGWI\"Y<6VK7D%
MAGKZA`QO/N.\D<=K3]W`_B6V7HE/F/E-U>E*]-3H]VV>?"VNHGTS\313EQ53
M=;!OEF`VZLKF-PS)8^A_[."=^'RWQ;-8^9=NURM#1ZER^XQD-OC@5ZE4PVQV
MWE'^4'BG[=36N:\5801V8JD>]D9TR$-=R.'TH_M][X[R`[+)E^(71Q9([,2^
MVIV03TZ?+_-"0D@]*%.NNH':78.Y)#6,FK(PZAS!JCN1AD9Y!<5$2MEP#UTW
M(5U\4J%4D>GXZ<8][11F55UL+'5TU-.22L[B^T225NVZ+X5*^PE"_&M=Z:+'
M4GST?$.)+01J&8Y=ZX(XR*C)(^?PW:WE.+0EUI*B1M#BG$BOP3([J/'3D<I<
MZCB**.6D&E#1-U=^`HTE*TA+#QZD"3":(H37J8JV>M/LTZXL<-)(H>U&EW(I
MJ;W[9X;T>IM$)]2WGC^$O80G\.@"7FT@E7F"H>'\B0R$"F![T:7<BF&RKV@X
M_/"TR\>6`JH56"AYNJJ]-T93]!]O37'1P/S#4IA<#X0HO9A[`<)N@<VV>`VX
MH**CVPPNOQJXE"R:_#4>2WA`JRI=7FN^:]1FRGZ=+T)+CM@F72`"2`([CJF^
MHZ`)45(`^VFF!:3EVIAH.11YK^Q,+D/M`YAQM:E6R<+@AH=&YD19)2/^%:[=
M-W\NN217H<-.FE.20YQ<:N37R;3SSQQ(,AJR7YE3"BKYK'I<YMT%"J[FTQUH
M-21T!54:&S7<>(+V^M.`LEPE:T@98)Z>,?J8^]CB!Z,YBN=<G6=B.YM;;R2;
M.^02&E$GN,R6Y+Q;J/':=P^.GQ<N</S'5Y@TS2C%!]VC3S!H5:MPK_K&WNTQ
M9$*+GL7!^0VF@A$I,MM<.8N@`4E,CMH<4L@=2I`ZZ:\RU=(&.:-1.82FOGA(
M,3QY8QH34JU7B7_62.$;]\K&Y8XGR+%9#JD(?N%@FM7.$DJ("EAI82Y0=32F
MB:&W80/,+:CE52X]TF:/&QK_`$Z:*T#BCZL?L2Y=$=NS<UV7'Y\C8$V[+0NS
MOI6OP;+COX5:]/'34EG=-`+*$J2S<8R?&"`IWXSGV#9K&;FX?F.,Y-%="5-N
MV6]0)X4%`%/H8?4X*CXC399(QM9`13,TH%,CN(9*!CFEQX5%?5FE2I@)^\E:
M03YU`K]E=(U-YA.U"QJ8!IMZ?&M3KM0<EUOB]W'N6)41*C6B0?\`)%-=0L"X
MM*@!7V*`)&A"PJB*\55^%2%#0A851U"M$UIY@^/ZO'2FO+<DA[&OS6%;!4*+
M3Z:^8/\`C&E>:_L2/(9VHN=MR'%UW$@#PITJ?'P\B`-=;*XNH:41Y+.U85VA
ME73:/_3>O\NG]0YA,R1Z31H-%A79V"V4T2:`TH.IK]HZZ*CF$WI=R**WK""E
M10WZJ41T'ZB>M=*;)H.H$52R9"*%N'<BI>,NT!4*@5J#UJ/LU(;>2@4%*=R8
M="''4X%%TC'%#_<B37H`FO2OPZ:[^H/8:/%>X)'DL[43O8RYMIV/%*J$!*:>
M74$@C4D;@P9`I)MHW9U]:34_%%*#FQ"0OP*5$#[`?Z/CYZE,W&%M'4.JBAS6
M;VM+ABVN0S23E8K)*:J"0BA`H!XT-3MIJ=#>%])64&*A/@?H/A=6G(KA]^J!
MB7R?O8]W\Q=ZNL6Z*S_%IEKA1TL1+:8,?C_%(H7<+DM;Q2TJYNE8:0E*@AHJ
M<`WLU^?^JW:^H[IW$O'T*TA:QT0UX$#FJWF6+M+_`#06V*XVXTY%=#\1*HS,
MJ1)29;DV;<+BEU;C5Q4\8S2TMQF4MCHE0%-4ATF%KL`\G&B=CEJ:.(`28NJ;
MJX_+@7=<.)%E-,RUR(49UP_,1&?EDM('?3V+;*ENLI7Z5'<S0=L@`<+&EE6X
MO4>3%Y(YI6N0[:N,\EV%+$YB=*7/AH2VP_#4IGYMQ3/?/R[<./*EH2R\4I4T
MA"B`D!(5"=+(''RL:<L5(B+?+TN/-$UQN4U4FS7.W6R4A=W?D1ID-IM=SV?(
M)=9D7IV:XAU<>;)0TCNA04DETMU/4KGMTR1ATA\=.Y)<X181G`^E:M@:N"9+
M2+C'NY4BUW*0TPZVN(U(3+:A36TM2$N_*F3`)<8:66FT1UJ*C4^!*YC@-)!]
M*;C:UQ\>26LVQY0VY`9M"HD-2HR;<_?[I+!*X,>%;2),)B%,84RX;\=NU*VR
M2WM!(J-1BX1?Q`7:LJ<.^B<?''I\&+N](M&%K7(M*7[HY=I$BTS=[/RR$1)%
MP2Z)5PNRRAI3[LY#C\9H,L_OW&:DE*E5Z+B.FD,=4\2"F=#N11[D]BER+_:X
MX8;:9G1[U-8;3"<FS(T5SYYZ5(4Z'TM2G)#Q26@X4]ON%"2"D:?B#<=5%S0_
MD?4M>TXO>X+3ZF'V%-)EV"ZVY<V0'+L)2+@\AV`U;DN*8==2FCC:EK4VI!'[
M=3KKKB)PI'[RF,C:W$5JC=['Y3=Q:D.*B-J@%=CFP=LA2OG60N>IF1-:2\RA
M"8;:@>TA;:/`DJ3TBR7`;4M:?,''@AT3''4:HA<L-[N#YRB=,CN"Y7.?!,6X
M.'Y>U%,4.LR1<&UKB/J,PK93&0A(#K==Q!Z/273648X>)S?I2'11`=M.:.7\
M?F]N+:+@MS^MM3W(REO-O);GICP5F6NC[@9E2G9#K26RH%I*`E`K339(\ISF
MXO&2B(SMM@B!"[O=+BM#\*;,5&@M)#T=F.J"AY#79WO>EQ1;4I+:5A:U`J5N
M172'N<&`M][!2'1LT@LQ<L%P:9L[[TQTMSKG+8NTVU+<<8C*M]!)9C0VH;KB
MH\2+"$D+6ZZ2HJ6FA)/1<9DTA^/U)@@@Z>*V6<<A-VZ1/[\NY1V)PB*A5+"Y
MP,PO=^*%-L-IB1G$([KK@4E86D=4@@.&0G,`GN0:C/!:5\A8Y*FJ>G-+6IQ,
MY:VOG$2$6IB-;EH3)`96T&V;JN&X&U-42AQ*>NW=7C&SN_@4KQPJBAI7@B2V
M9#9FK5C[WRL.X6F1W7$1R\[)>@R)49RW,P'8[A<4MT)0VX%5)#&P@D4`X6OK
MXAXN*`"<DJQDCMK;<@)EQ+8P9W;@H:C-R7Y"V;>^&GU-@.)::"7$%MLD.E#J
M:@!05KE"GF6LSR'5`:2CR-%F(C7=$O\`,8$B+.<1VP\EMF[RFFHJ7$0XL1QY
M]Z(RZIP/A+BPI!J%*%%::<(WFNK$<BGS:B/!YJ5@O]PA6Z+;XTGMQ+@T],N]
MR,DL2UNW%]25Q4J9C@PVH`#9<92"2&2L'U)!U)C:UQ.I0]+N(*3ST[OPH4BX
MK;2^\B&&&K>EV!;TI;BM;E2&6]LIAV*A+DD@)27''D[J)*J(<!J+1F/V">=$
M!'J;75@C)F*S\J"94IR-'3<;M(=<1\N_'6_#2FWBV/!MQ"8\DM!+BZ[OP2KH
ME>DES1F0$-B!CU$'6O<6+:9=]:97<''5W*,Z[<"VEAF'#83';;2MAWMK2@1%
MN.]URK9<4Z@"I-#T`D5&2CD$9X(I8O4!N9+VOEQZS2Q;@U,B.[74%E,9+4-R
M(HLJ);<>65(*V4K"!3TD:*85X)6EW(H]M\23<GTO*>D6EYN#(<>MB'7@R8C3
MJ+>TB&X'$%IY7RJ-ZGTJ4'G:I)`H.`UQ&2-#^1]2T+2I11%M%PN0B-IN`6XS
M=KG+5/D+>?9F.-)+266(-L0RBJDA12G:5&O33,CY&NHWW>Y<I3!V!1NN_P!B
MMROFK:\]*D2YSBE6YB3":3&B..P84AR)(2VXP@,=PJW%.[L**J[B:@8Z05E!
M'+@N@.^Z"4EYUTGW^)(;B*8D-2>]:9,'K%D-Q(Z9+34Y$C>EA<=#.U"1N3LW
MJVI/0:=!:<`<4Y%`Z4D>[AQ1S\[-A,V^!<`S(%D>9M2A$E1GK<U(>+34JZL;
M'&.W&4E-&^Z-A<`Z^LZARD!YKE5#HW,<69T1FEB[-7$Q65.-2Y9<E0PC?(AH
M$1"6(,S<PAM"7PD**@3M2TJI\J]9Y!;5SA7O"2&N)`H:50G2+C9K@MQ;[LF_
M-PW2Y%:<;=7!:G1I<23#<C?+%R5#84@]L5\"IRNTG4MK`P5;[I2Y8]--`*P.
M75$%Q5NF)C/$MR7D?*M2G@Z^9413C4=UI*Y2&H\:64I4\JGX>U%-M--R.JVC
M:.->]=BC>'5<'`4[E[4E#\L_+.2G+?%3#DK;>>2])FI<+<=-K5<4%"F4NMJ<
M_IJ2VH54$I`$5_C;H<!CV4*E2$Q,8Z+%_'BLULO]K,64W<%?*MN.&&S"$%NX
M&/'GQW5L/NE+_=?0VPVII#0*2I)WE0*D@0WPD.\`)9S_`'I/GO>/&:/]7L15
M/QVQ.RFWKG;'I`:L>YB>_#$"RQI*HZ7&EFW/3),=QP(HK:HB@20>IZ3X[I\+
M=#'^'OJN1B5U=0/J2)R+CRR2F;?>2A0CW&2EI2$-Q;?'DPHY7(E(3'1;BAIY
MQ1[0D$)<<W@I("?40[G<.D+&1-8:'Q#$GT=N:<T/Y%,%DUN1"FN6ZTQN^PB4
MF`Q##LA4=W:HJ/ST=`;B2T,.DI;N*`R\TE7B%).Z7'(X1$.R=G7]L%&>^4.(
M:*CN6_\`/S,WN%SMN.1'[O=HN,7"6J*V(C=J8M6.P'QDQNTY^3&*%QPM#C9"
M27DIKM7YD-G!%&9B':0=6>=,5,M;>6[B(;A*.>5*)WH>-R\8Q.RI1`C7%JW"
M9)8F3+K;@N3>(L12W4,-O&'+FIC-`M)6"E"*A0"4HKK-/D^.OB]^ID3\6@-)
MH#P/(CBD`G0&?=":/+>4+)C]P-CY"NV+J_,5MW6;:H1N5QE_*RD,2;:N1(M*
M'F9$^&R2EMC<B,TI(4HJ5UUH]OV2[O1KVTAVEU*N.FA[0<QS3S'&0^6[W:?0
MHN-9I88MQ;:7<+B[!;N-VNT2?"4M$E4:Y/[H[+D0/J3'E/.,$OI4^[Z:J]*R
M=;"7;9)(27M#9@VA':!2H[\PI3(VFD9]Q2GPW-H<PL"$;<F?'?4\NYQKA&CL
M72V.NH;MLA*'7V)<VY)2$LMM*W5:<(*BI&[5!/MCFD:VN)IPJH4C"'D-!H"M
MV9(M=]+-S?SF:J[I>2R;VW<!;)EHE%.QE$V3(66I;,:-'+26_P`4T7TV$=(\
M<%ZQOENMW-8,LW)]C))ZAS20.03A3H_+5TMT=5FOZEM6U,9AB[OO,1;W=8C3
M;?=?ARDW=Z(Z&G%ELH4WV5L#U!*TDA,5A:!SI[R,FAR=E4]AY<.2EBQ(8'1A
MPE[:I-_DG,?_`(]<?[5\]^YQ'][_`$?\_?>_R?#3U=IY#E[PRY=W8N?!W?9Z
ME^A1SYSAA_*EXR"U8A>(EYD\;,MV/(TQ)L=Y^U72[=F[1XMVCM+4;8^]"V.-
MLND/*0H**4I4FONL#HG.I&:D"CNQW)9MPKXF8PG(\RJY>0+@_-COQWF9!;6E
M0=VA+B=M*)ZMK<(\>AI31)(35E%P!5P<EM<=89D^+WS)[A;K0[/O,M$!A]IQ
MZ;<GV(BGW6[=;V&'9LQYML[B&T$)\20-,B6%AK(ZA&/8E"*XE(9:L,DI/NC/
MT<R>"F9@&79A=;/!N^(X3"L&.RH["H69\I7B-8;3*:=`+<JWXO97[CE5TCK;
M4%(4H1`H:#N-M]QS7_V<:=ZD&RGAH;P&)O&N8[".:/\`)KK"O=KFVC)>;LCD
M7)[<VPWBMAMUKPJ$HIH5-V2'D,._9"V%$I"+HEY"DBI34TU537MSY;F6Q$4C
M@1JIJIZ#3Z4NSM[6&X$MPWSX0?=KIKWD5^A53^X^T<>8Y;'T9%[V\;C04R5M
MQ,+RBQS<9M")**[PG%,(;=B,!@K`<<$!2JJJ2I6O/-VZ4WG<VF2ZW)YBY#P8
M5X@$KV#9/F?TMTW'Y5OL<;9]-06DRDD"N)+!I]JK<RM<&\0;4^S*8N,1*I#L
M&;$3(;A2VJL;9,5F6RW.1'DIVK;#B$.;%#<`:@>(WNJVNY;:*0.;&\MJ,:D9
MU[5]=V`BW&QAOM&DR1,<&\JM!`]%:)N'[;8Y<UMFYW1BQQ&0Y,FW=RP7G)&H
M#$8))=<M^.Q+A?'4(4:$M-+2DD%5$@J&CZ6VR3==P9:B1XD<TN%,,N"\XZ_W
MS;NG+`[BYC)'M=0AV3:]F-?8GEP_(O;U;2RG#??/><$R-A*$J1=,'SO$8"I%
M%;E1IV+YA-O;47K1(?MR'!2I'6FMK<]'[S;$26E[-!XLG%[F]WAJ0?0O'H_F
MQL-U^5NVVBXB.5&QBAX$!S6BE/ZRDSC^?\]@,_P;[Y>$>1HA0GY6'F.>]UQU
M@`AI?R7,>`1FE*4I)33Y@]?VO$Z=:SKVR&NSOC(&>Z''P'O:YH=3/`G-+;O/
MR>W#4[<MO=#*,W-CH6][HW.!]#4]V+\S>_\`L"%OV;!L!Y!A(/<+_'MVQE3T
M@4(*F4\-\B6U\J4JE/ZL23^SIQO4_P`P[0:+FVM[APQUB/40.0((Q&8PXIUG
M2OR=W=O_`-6[A-9\:NE,;:_V7-J>_(Y)TH7U(?=CQ\6F>1?;]RU98H0A2Y27
M\F<BI3U2O8>0L&R=EWU(-/ZXFHKU\]2XOF)O,8UWVUS:>+J$'TX*-/\`*#8;
ML^?M?4,,K7Y->6D#NH1GQ3FXW]9?&:MQ<ILF1V][_=#>,-L5R*#50V..8WF>
M,2`M(3ZJ033^CJSA^9NQ8-O(YX9"*XMP]:I+KY)=4-9YFWSV<[*TP?0TYX`J
M2.*_54]O-_0PFXWC&X4AX`I1-?R_%7%E0!\+QA]PM::?#Y_;_E&A.KBQZZZ7
MO30738W'@]KA3O=32.^JSE]\K.O+!X#K'SH3]Z)[7?\`9P=[%(C%_>7[=LP"
M$6W(8SSZ25/M6R_X9?\`M%>P5$>W9,;JJA!%#%2H4\-7]ONVTW3==M=6SV`T
MJ)6#'E1Q!/H"RMUT]U!8R%FX65Q$VG]V]U?\T$>U.VSR/Q/=&DK1E$2*V\`4
M&ZVJ\VIHD@``R9]M9AU_0Z1J7&YKZZ7,=_9-?6J=L0B;5Q(D.;7-<QS>_4![
M$9M0<*OR`U:[SC=X4I0HU!N]KFN'=T">PS(=<%?T:>8?+=JIBFC$":U13<.(
MK*Z5%5J2R:54XTV6"HGJ:K8#9-3Y]=/>>>2XZ(`$UR2"NG`EFEA>U"T$@E.[
M:^":>&V0TX:`GXC7/B#R]J9JFCO_`+8;7+W*^2M[Y54*#D0-U!J:U:4H`GQ^
M[KM?/P.%$)B\M]G-DG//AW'(SJ2%>ILL+50I^\IMUIFGV#<3KOPL/$8HHHKY
MK]/?#[B'73CAC$E?XGR2D[`?!0<90L$`GXTT?"P\&T****V2_3NEPW%.X[=+
ME"KN*41Y:U(!J:5:>"@!7RIII]F'D'4?4N43!9%[2^<,5"EVR6FZ(:*PE$R.
MMIPD&E`XPEO44MN3_#<24XYY>*%)S'<^]YW#=P[^**S;&U00E3<ZR9=<8\=2
MTDG:U#:<*E%/0D*``T$SQMUN=4C@1@G`R)L>LMJ[L-/:IW\2?6]^H7PX6(E_
MY#GWZ#&+:$6[,;!(N4?8W7<AV:\IQQ[<*>H!)&EL+)6ZY6M+^S!.Q/>T!T1+
M6@Y'Q>TJU#A[_6;LA0(T3E[A?'+\#VTOW#$KJJV3/(+<^2E*"`:=:?'2)([<
M4J2SV_2I!W&ZC]X@UY"BM`XJ^OW[$.0C&8RFY9AQ?.>2@.)O]G^=M[;BO&LV
MWK6`@'SVZ3\/([",M_RC3!.,W9M?S6.I_5Q^Q67<9^[_`-K7,3#;W'//''&0
MK=""B(G(H,.>"XD*2E<.:ZP^E76E*'KJ.YMPQQ:6:J?AQKW*2R_MWD`&E>>:
MD6P&YC0>BNL3(ZQN0_$>;DL+3Y%+K2E(5^HZ9?,YAHYI:>1P*F->UXU,Q"^E
MB@J6B!\2E0&EQR>97A1*6%3"%?8.G2GF#6NG4+&J,@CXD>`H!_L:$+$J*".C
M:@?CW`1_)TZ:$+65%":CIN'D0*?'J170A851E^/I_0D_[(2-"%C6PH#U))'6
MGIKUI\173C9*"E$ES=0(6#M)`^X/U@?X^NE><>29^''-8%1D4)4013KZ1X4_
MV-/U34D>BF*+GK2R\:@)(4"15(%"HU!K6O2OPT)M)ZZV=IEL$@$D5'G7RH:]
M*:>AE>Q[0#X:Y)$GN'N7Y\GU<KA(C_4;]UMO>A2),1O-[0RRR]),9/<7QYA<
MI$]II,M*'[='?A(H0@*#R!50.T:\CZBAU;Y<NKF\?0H"KYL^67>-C%RE,/-Q
M9<=%OBAMY3<LR$R';C+E/;6MSKY2M@K`!=<4OMA)2FE*-[`P`US7$8QL^LZ[
M+;K)DL]3LJ3%2N,W;ELS-EPD28C[S%SDK7'BHE30B.YV5%YM+JU(![A5MCN%
MU_LVT[>S]ZZB([L@AW1J?,:A?(MRG5),1/9F,K0W>(B;H]^(AMJ.T\PAU**O
M`-JVT#?5+'.CG+0P!S@!2O/CZ4Z(M4>NJV<<SI$"R6:[P6'B9DH0&1>H<EAC
M*[8NXFVW')7H+C<5Q=MGO/EJ(EHAPN1VE)[:D%0F"W>/X@H4U1'J+@'Q>'$/
MPK(K'[1\_*CKCMR7F+CW0RS9$J515SF(8F(<=C)5O<;"W$BC=!'%M)"=3Q@4
M[)'H:#5:UPO<F-&@3!;[C)V35Q9MJ=C5CF5!MTEEJ;WUI)E1#-[9HR=H==2*
M;DDE;0TN\1HU-L=H=J62R9A='V&9`C&!9(3;B6Y,];4.Y1FTO+6EQIM]I##<
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MLPY#EIF)>?;8+KCNUML.*0A2%(&X@^LDZ0R3RZX9J/\`"R/_`(>*1D:XOVEM
MEIB!-3*O%TM@CHD,$N2FW&`U=_D]B!MWQDL/$*Z@FGI:--31D"DZ/(\>9R2R
M@OMHGOMWBULNMW1H2K;&;APY$A#+4-#REP0XV`Q\PV$-K[@*"%T0`H&J=+]5
M=1T<E)8]CXP2T:^:14C)47(K$:="@.1L?5*G0[J%%FW3F`6%L1BTF-#4X9+J
MVZJ2"EQM2O`G2DU)%YAK6F"PR;@+M9EVJZ0(]R<5)CMQ'TL):?>BI9ES$D[4
MM_+0F#+2TX=W;*$*%`14J#GM]PT1Y(\ML=?=6%FS765/:9A67\FC0VH)GS?D
MFDPW9C=G+B6S%VK84&8I"&W&VQ1ULIWC:I29!>0W4<5QD6AU:HJMMQ@R(3EF
M^6<F7Z#=8=R%UG]N.J"R?EFGUPG1#2X[&7+=5(#M:MI6K:2H$:9GU-B$S15S
MN'L4IIU%C<M)JG@N$]RXW]MG#I3MQM5D>7'$M^<RNWR[>Q#;+S[2WWF;BS(D
MK2ZA(0FJ&]G4J(2*=C'M),@H2:T4F1D,QUP/U14P-,^?M1QCMMQMVYW_`#.[
M7275JX1KD+>]&1;T2([LQ34")"MBXEP;?$*&IQ]`;*#\NVX0=U-=NIIWM'DC
M&N.*;M]%3K;J20ORH1NC]T5=)T;'GH)O=LMK#%OM\Z!<'NY&N$UFX,M-"7.G
MSH;2-D@*<6"Y4"B=2;25TL?B%)6X.//D/0F'TUFF`JLUPOT*1:0B,TY;F);G
M<GU2)MUF_E[$@QX<=]UM24P`ZI!`0H!'J)"BE(#KH0Y^MV7))3/.8S(1/O%Q
MRB7<?S=7YHB)$A1D/1(#4F,6+9\\J4IYVZ.-W*X!T+9`0'`0:I1Z)SIVD-:U
MH``YYIQKK=H_.IJX=R.Y\^]-V.TQX\RY)M]K4V\GY&$EV9.MYLGS[5RANS'T
M&WRUSWY!DN#:-[.TU---,&H.9S"071$?ENJ4=6A%Q;M:9]S4_;9ZI#S%NN+C
MCCT95MFMS%IES5OMA32FF5J=8<5M?<KZ4J(2H16NT/\`(I@,*]RXMP0['EEG
MMT-B9\XZQ-?B7>YOOR(/=>N+;9BO+:,<NON,*>[("`X$@H51.[=HDETNTT4A
MD+)(_$/$:BJU7,8M&+7!.2W!IY^5>;A&L[:+*K:1'L$GL&.RS\JITQEQ8:W'
MG3VG$)4&PDE)IU]X7M:W3[HYI,=F(Q343Z$KC<+2W?6T!^U6XNP;DS;HCW;+
MD[YP3'X$%TQFS"5,;:6VAQPAH,.-A:E`#49CS&[52J<\A@]YQJ<L,SR6"'F,
M.UP#'L]O"G'Y_P`I*;DPX[BILR[#YMVU,Q8S3LU^`HJW[2%(^7:[B5*)&[LL
M0DC,E:527N#&>2Y@$HP)66[2I]VAMVBVWJTP[H];E,NR&8)E-N!(D=N.PI;C
MC<=#B'64[DE6SM^HU&T%M;0Z`7C405'HB*VS)UOCOM0Y2I*;:J$^S<DM.-.M
ME^0PTJ'.?4GN]^+(60VLN)0_16T)2I(U-`(.?@X#DNK,J>N1"::8ODK?$A.L
MO25*1)EW5J5(:ELR.U!D)4F9*E+5M0ZH>H(*R!33$<4K'ESQ1I3TDT;VAK35
MP2Y3&,&VL?+MP&)%OB-K"KB9$-I2FTQW)ZU0G>],[33;JVW=B74JW)0*;1IB
M7^(4POL&QVVY60/7*V)DW)Z39%`+EF`B-;I8E3(\EV+%C-]Y?]0<`2A5:@ET
MD;JL/#Z'2X@4R2VE@]YH)",KK`CG<9-UE29?Y<&R'XG;B0$MHA-PXC-L/:9:
M0V7NV7?2VE)<</J42(%4[\2>7M2*O%BDO6EB7)@]Y^5)A-1$MRG'?F>R^Y-G
MKC24OAJ)#A1XP;4&]R5.*V;E+W!,RQ/Y_P#DGZDB2[+&5T^U)2Z6:%<(\=-K
MC1+O%N=O3$1(BMH#:+H]%9?DW&46REN5#1(WI92*'MI5W0$I32?-*!5CL&\U
M'B-6`_MFDM8L`LV*3GKVW#7*NK*&V&Q;U[')'S#*F9<B!+B('R+*GG`E#PW+
M'0!1"5;H]S?N?$((3X*9I^*:2%^IAP(R1KFN-2K_`(TRY$N$]A>/0+C!"N_^
M9..H"7BZA2R_$E7$K22&PX&P)/;Z#>5:-JEACN*S8@Y)I,U;.)&Y4&,G)+6W
M,LCD=BWI@/QV9TJ/(0B9/DOVF<YMFH?A6]2:N.%*&W5+`*2"G6A^.?"7-MO`
MTN)S3C':':@D#DO`>*1[Q=;BS`=9M$>Z*C-ICSW5MOR)T"WS;+&+J&([\U]3
MLAP2%)"4IJFO@5:L(M\OHK?3J;05Q(!*<^(/()07SV^8[:)T3&K4](7>)F-B
M[C'[I=7H\:X72W%I<7MH=?2V\ZT4[DE1-6W%`T%%B&.I;YS/->6&'S=!=I&!
MH"KFRLG;@',MQ(V9K-7C;I8>YW+T)&W*WVRTPK2MM#LZ$])<@MIF//SK4].E
M_F4*Y14QYKSS+;A;"7'%(2'6'D%2:[D;I<-S/*2-1%%7&2X@\1&FN&:>ZPQ^
M/)%NL,Z`XB%?&("(]UA3(REHBJM,<K3%CON+7MB3W`DM/K264I4I"AUJ*:]%
MV"\GQ-+J>LYJ5YS?+#W2.U$946S_`'FVS_Q5C_-'Y=X3?[9_XQ^__P`[_P#"
M?N=5_P"CS<SE7+V)'Q3/[TY<E^@'[@,.XAXY7DO]U.&X'BDG)6)%]SM6`6:Q
M6C\XRE4UMC\TRLV1IE$O(%1DA)<DUD%N@)I37T)"V"`DLK4K,4Q#!Q/H58F:
M9$YM?4IN4``0D=M94:`U/H"@1IN1XJ7\*JR9$<(\-05-OO<GOSY^%.EU\;;C
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M6NM+\K+^YO;Z1EQ+)(T.K1W=WK`_/G8=KVVTCNK&"*!]*>",,KF<2":CT*Z.
M#]&SV+YG'X]=G<)2[1-S+*N1H>17'&L]S6W39MMLLO,EV5IKYJ]W&+&5`5#C
M`+2T%+2T`K=N57V9EE#*XDYFOUKY@DN+J1CJ$!Y&'?P]'-<ZW*N/0,*S?*\,
ML276[-A^6YEB]F1(<^9D-6NP9!*L]K:D22E/SLA,*&D.+(!6L%0%337R-NEN
MV#=[R)F1N7GUT7Z2],W$EUT[873@=4EI$3RJ&@'Z%8!]%#&9.2?48XVB,L,*
M<8P3EF8D+2RI+B?X/DQ5)Z@-$J3(H00?T^6O1OE6]HZHBK]R%Y/HIDO'_GG&
M'](R-;34;EGUKLSS+V,<.<D0G4\@<-<29>\ZVK>WE'&N$WUY970FKMRL<E?7
MX[JZ^E'WML_-@(K][`>Q?'#K:88>]3O5<%V^B9[)L\7F#V1^TOBMI;&;9'`M
M\S'[3=,)DQH,4PQ'A0GL'N]@[,6.\MPH0$@)4LT'730_2)G4EAC+CGBFC\3&
M:,U!X[Z*'O)_^K]^T>)<<5CXC9>7>,SDF4*L<Z1B/,.5O-1H/Y#?KN56Z+ER
MLF8BR4RK4T$KZT1O33U5#4NU;9,_5"TL9E0?3WI;9[LM_-()[<?I20D?0EOF
M%(<_N?\`J!>[#CMY%"U%F2L:R:W((2=B7D0FL2?>2CI_NE2!U.FI>F[(T$3Y
M&CCD:^LI^'<;B'(T[L$U=K^EI[\[Q;;)?(_ONXURVT7NWP9DFT<Q>W>)G,N'
M"FL(><B+EW2[WYFYO(2L`[NRE1\QJKFZ,M)L'N8\$XA\8<*=V&/+%6T'5F\V
MS@^&:9CFY:)'-/KQPYX*N_WE8/</:9SG:.'<UPKV\\SW&5QS8,XFY;;.$GN)
MA\Y>KA=X+ULCV[CS,K0XB/'1:]P=6[O<+A!2FG7QWY@[?MG2UXRTM+6UF,K-
M1+F%E!E@0XXU[*+Z$^4VX=1=91W%U?;A>Q6UN\-+6O#M6%<:M%1SQ!5?%QCK
M6IUUN"F,U)=?<1%9"NU%"U*4F-$^9<=>4VV@E*>XI2U`=5*/77E\+K>6LLS6
MM<'5`&0`QHO>/*O&,$8\;`*5=6I[3@4O\=AY9BEOLF5/O>Z#"\4NC7?@YAQ]
MPYRA>\9D,MRW(S\BT9789T/&[HU%=C+0XEM]M2'T*:6$E-=>G[3TIO%U!'ND
M%W<-CF;72VI`'#,KPCJWYC[-M6[W.R7>U6LUQ;N#2XYDN:#Q%:4/K3S6_P!R
M2;1+9:L/O\C(>7M[%FYYXMSBT264)<*"F2F]X]R6AE0*?42\GKX&FKLV75^W
MNTV]Z2S\,@Q[\CDLG_B?Y;7[0Z_VSR)CB7LH1CF`"X9\%)3$O=C[EX0C.XCS
M=[8,_9"PB/\`P_S#:L/F2T)`%!:Y.1<7NI<62"4*C5232FEC=.N[7%S+>:!N
M)\'C<.0=4=U:8)J2U^3FY,<+2XO+2X:*@NU:`>8`#FD<ZNISHI,6+WS^].SL
MM3+]P;DF4VYLT5-P2^6+.[<XV17>ER)9,X=<2JG0B;Z@1UU)AZRWZ(:;G:P]
MQ-:UR'+-,GH3I"^:#MV^VXE_]*UF7I<#Z@1VI?P/JJRK8M3/(W#6>XFMI0;E
MF\X%*82UXI6#+9OMI4E:#X_U+]6I+/F#M\4ICN[2ZB'-K"X>FA)")?D]NSF&
MXVJ]VNYM^!$C(WN[*`D%/#C_`-3SVWY`4IFRF[0M:4*=$]V]VQQK=2F\7?%H
MMM!KY?.$?;YZLX.N>EYSI=>,C?\`A>'`^D4P*S]S\I>OH1YHL?,AYLDC=APP
M#J^Q/MCONL]N&8;&[9F-M4Z^FM$R[)<``16I:L]XN,P"M/%D'[-7-OONSW#6
MRVUU!(PG#\QH)-<@UQ!KZ,>"R]WTGU+8.+;ZQNH@.)C<YO\`G-!'?7+BEV;[
MP]D2$AK*,<>[@3M$SNP*DFB0#=8\-!)\NNKP7+'4T!SR1DT:O]&H"H96/MW%
MMP#'3\?AKW5S6G)XJPR_(4;?^63`34FUS&'P`02HE,.0M`_21KOG`8EI'J^H
MKA:6FCBW5R#FD^H$IO,@]L^/2V>L8(W..FCT=AP*!#8`-4(7T)^(K_/KK96/
M=I`Q7*^I,#E7LRQJY;TNV>URPLJ]1C%%*@FA4`]T.G',:YI;P(1BHM9M].?$
M;DE]Q&,MM.$JH[$0RKH?`I*%-O=*^.HGP$)S)0HB9G]-R[,[OX=R3(K$&BIP
M-H4M3:@BIV#YMMQ"$*'0D&OPUT6;&8LS[4N-VAVKL3%R?:'SK@DL3[!>KA<'
MXBBY'D&X7*/(!02I)0N#)9:"J#I5!ZC3;H9HG&5A&'>G#*S.F*>OCWW@_42]
MN#L<XKR-RO;(D*I$-F_2+W;3L(-%6Z[=YM2*_LC3$D]P3XVA[:8X<.2!K<=3
M"6A6!\7?ZRO[N.-UQ('+V.8?R#%2I*'$W_'IV-WA[M]%A,VUI4RIW8":E!!.
MHQ\B;.,QTY<5.CN98J^-SZ_B`%%:/PU_K.WM9S`QHG+'%>>8!(7L$BZV,-Y)
M9&E4&\I2MN',*$D^53]FE,MXR[P.H:<5)BO)'NH6EV&0_?16K<.?5?\`I]<Z
M,M_P?[CL&MEP-`NRY?+.*71LK-!N:NH::70CR7XZ0ZVE;)K!#F]A3IO(FFDH
M+*9UX>JJG!CF=8'F49$S$,VQ3*([M%-.V#(+5=4+0JNTCY.4ZNOZM<<]S#0M
M<GXYX)6ZHG@MJE24+'BD]?#H:?RTUUC]7`CO3@(.1JO!('B0/TZ6NK5JVH$(
M"R1^L#]-"="%HNN?>12GBE15TZ@TI30N98HN><;%0:`$4VI"C04\3X^.E,:Y
M^13/GL/`K24XW5/;4KJ*T(.U0\J+\M/,8YKJDX)N25KFT`Q11-<0]Z5HZ@I(
M4I15^KR'73JCN%6D+\\#ZOL27>OJ>^[2U6]S\D+W(.-E%X=6XN)*-OXWP9N<
MPZZCN*A,1^^VF@20MQT@>JFO)][DC;O%P)'`'4,Z\E&\A_8JY[/A[\-H0(\U
MAM%Q<*XTZ[25!IX6YI]N:&V]@5&=ESVR5O-)2HL%)W)\=4[[AK7-;I<2XTP1
MY#^Q::,-L$.U6N"S'C*F31<9,I46XQY<A+,*:EYX1F%*?:AQ7"^E45Q24OJ4
ML*.ZI(:EO]-8P]K2#2AKA3G@@6X<:2>XE'#4FS6'(V(^,.JG7"$]:H<=?<5=
M4WFZR$(B264):>+L:5W'%KW;4B.DJJI1-8#IVN?YLCP2.(KP]">$;6,+&9(F
MG0415X'<9+LRWPORYZU-(>B*><9M]EN3-K;*D-)W-PYJI241U``G>%[@4*5J
M5%<,G!,;M0'>HCV.81J7A]#L*/<K;,2F)<;UDRX^/7`N?-N0;2RN.F2]-FQE
M)0]<65IWH2`_^$2G:HU(6V6.4'0_46BI&/UJ5(TO:`$LLF;8^5QN!&D/NH4I
MAR/;X2DQ$1@T^^E$F4V0EQN,[(80XM0(<6M52H]*5KI0YYS#:YIS1Y;6AU*D
M(LO[";<+DK(*7"6_>9K.-B0PQ,M]SES5*CB;+9B*>5-<BJ?;!0A+:@H!*:*%
M1/,['D:&DBE*T2C5C-?W2:8(H=MUMAS,9N;TAM#-@N3R1/M<)QBYB[;8D.WP
M7A)1*A/M*<F./NQTE;R6ZI<HH%1)9&"-T3C1Q:7>@9Y=ZXE!C^9.2;]<Y%U<
MN5S7<(3L6WIF]V0NWQDRT(6+="CLO_-W>:W(7W`$!N*R5I2`HAQ+=3*P!H(P
M!J4_`?&>5$<7,73);C(_,;W.%QO;[,DWJ]SW+HGYIF<Z8UPFP&MTYBV6^&E"
M$,..=M##HVH"-HTJWN(K-SC<#4SV?:E/B<YQ?4!J2F.\>7Z&572?.?R%0C7.
M0)TV"VQ;XL1E<Q*9<MIEPHN-NDS76H[3:NRK::*%=VEW.YV$T>F(!KN0!Q3)
M&EPJ:^U.M!MMH:=QA5WG?.L?E`:RBXP8?S*;2B>[/M,N[0K9&84[,3<Y4=EJ
M(E+85)0IS:I38)U&;)'`P/G\(?E4<LT^/S)0]F#6UKZ4W4MJ'#RB7$G*R"9(
MN=Z;3$N<JUQ'D!N6\ZT]$^8BRH3K+JF).U]S:=Q24(3M22F9#2=FMGNI@/H]
MVMIICRIFO$BR3F;-<K=!D6N7D5DD38T1^5(?85&@-MMPVG-UM>>>D-IF,.G^
ML/"*@-*<4E.TDN!_B\@-)=E7AS33B!$T?AS]9^U$.+EB!&@AF%9I'Y6ZF=)R
M$0&7I\],U+KVRU(?E3F'@IJ-(2VA9;&TI6V":E29(Y&8%IR3]M*R3P`'4G/9
MM[DNT"XKC-HB2/F%0+EVVV'(MT=>N4B2XRQ'D,3`U<FMS;BDA3;;;1("@5:A
M1/<RNIKDJ9U:8$'M2<O>7=V68S;SJY<N)`:BSH[,1JUN-13\K+O<=*GENI;)
M?=)5VT[VD*W[MYIWRI'8UP[U$;(USM(S6A<%RXQARK050YT>XR;+>K7'9=F)
MN#MPD+G0NXXJ.`&H]Q=4K<E)[3;0`4.AT]$7FL5'$MX\.>"D18R`98I66QN+
M$E2D#)8\U;3%MGORVK8F'`DST&7<3;GHTAI+KD%J/-4K:UL*G%DFI3N#4X>7
M#PG)6+8V@4#F>A)7(;HJ4V+FE;,J7$D622[:T2TKI&9CW67.ML=AI^(Y&5)@
MN.*[ZU%S:D!-.@)!")7Z)0X5R3#WM9B>*R8/:G\ILV+W5NXO3;,Y(NX>@N,,
M2(,>=;6/S:2A*B76I)<AF.ZPMT=L'TD*/<*NWGE1W'P\;AK8T5`KQ_;%--@?
M(_4TBF:\SIUAD7B'!5&:V,NW)JTVB.J;'9M$Y$R.Z9=P5`0B).CWZ4A=%MJ+
M+`_#2!0*2U(R2-VEU:4K7@ERSQOJ&@UI3TI5QX2HS03";B1H,I$M)N$NX.K+
M\&Z.I_,XF/R'$S%LQ(T9;"C)2C:T0M2DDI*@@$NQ95P[*_6DVX:6FHQJF\E7
MI<Z<_),U^U6D3;U9DVMN))GW..51X;469`?>28SBI4E3@0A+9;#2@M6PK&IY
M.F0QGW@$U-'27S!3211?;I'>R+)(,"2J7!AL1%6Y%K2IU,60J.TAZW3XC;H[
MS=6V5=Y0#B`TA:6E*J*]PSXIFIK32:<^"4MKM=E<B2)T>%)0S<)T&<\M;CC,
MJVQ2(EO=>%J1VE+$SYA"EOLE(9[:J)*"HCAH`2>`2JE&N3VENU3B84R.&ODD
M1$3(LUA;[$V?+2_-4XJ4W'2M[Y*$MQP%*E*9>=`(4NI9^(A&>'H14]J*X>+P
M)-^D-,R;2])M<^$(US<V2($-A#4N->8EU:1*3&,J=:Y;R]O;=4CNANI7LIQU
MQ#&-4H+6\R$IC2\T!Q"5RL>CQ),"Y0I-M@H8=O"UO!<67\M)1#<@RVHJ7/F$
M*??MD?M,-A%=CJ=P3I'QUJ11AU'D`N.J'$'$H@C,V8R_[1$?=EP[PZN3VWVV
M&V][;4]A=L0WMBN(D.+*5_B*94*HHE)(0Y[I3J8UP:DHR7D6/SH5S6%-VQIJ
MW(NJ$MK';ND-MZY2H[4)QE(:DO*0R]1E((;[554&T:323DY-R,<ZE#DD[:&G
M8]J_B%;2XL*+=9#UN3(?BIB3$T4>QW&=\ER#\K%.Q"3O<0`L#[P$[S(]0A#P
M7Z:TQ^M-MA>(=&&NM5KW:Z/38UNM,Z4S#8$"X(7<U]Z3<)T)2WYL9Y9=D]X)
M?=?2A**(6II/B*&D>9FG5*\@,7/)D'$+>AW&]0G(MR@3&UICXW$NZP[(<44N
MM3C%3N3'060GL%9#94O<PM2T`)*M1FR1.%6N!]!^Q=$+QQ1Y*N=LDVMF_-7M
MR9)EO-QGI#P4\F-$;2A\,+8B)273=)\ED*]*BIHFB:((TEM7Y,.'8G7R!F=<
M4B7KI=W^['FSVI46=$,.5*89=<LXCR$M/2+,'-S4>,_$*D4*0$EU;I7ZB4B0
M(X;3\]U<</6NN<&MU')*1^P*A0IELCNJB/P6%FU[F56V,NW.S%6]B:\MA#34
M7L6ON/K';*GMQ"-OFVVXADG&FIJ<J=GJ7`X:-7!.!9X.-P;',N,PIO4\VY$M
MR,Q)[MN%MC/RDVVW-/%Y4GO/N!IE;+6TJ2VL`D5)JY(WNF+@TAH/[U+:1$`'
M8DXA$=P9MKED+Z$Q7)D:J[P1)D,VN7,(9"K?)9],=;!0IVFY-"I@E5`-Q?MY
M(Y9WOCRH.&7[=B><]K,2,T3P+>J;&BR)MM=>:[D9V"EJ2EV'(N=PDNM/&0OM
MAUJW-193CJFD$N.*(.^A2E,R6]MZBW:ZLIY=F:<C+0=1&!'TK3=MK=PCP9@B
M1NW;+G<X<*5(671?9=O:^5>N[\N-N)8BNA?957<^$):4@MME*I0(#?(?6KA]
M*@$OB?5M"\&HY<TV>7VW+<S,MUQMV1&NSIM-H0ZN(XJWVR"'7C/;0F67%M7"
M=O[+G]$[]J@#M9LH8;'0R5PTYD8FN.>7+FK^XWFYO&'3X30`<.'9VJ)MPQ._
MXW%:C/QY<AZ2[.N3ML3+3&A3[Q%FI:0X)DEZ0ZAJ&PE.Q/<:<6I2%;ANZ[!E
MU%,\RBC82-(K0'2,?\ZJIS=R/PD:7`<DE9')>7V=J/=;A9G8ERM<E#$<L.EQ
MEN"VS)0M+JE]R1'7&D.)2TH$)<2XH*2JAW3(+6QN*LM9@`<ZXNKV<*>E19*O
M[,:XK)_I$1/_`#GJ^_N^[;O\Z_\`CO\`FS]Y_P"3?V?3?^'Y/^J.=?0I7FQ\
MN'(+])/WO7N\VF\P+0F/8T/7#$%3Y"K?9W('S)3>RSW9BV#';>DJ*D@*74TZ
M?9KT]S'MS&"IY1IO`&X1C%5%9'D,V:9C2X+P^6=6VI:6I"D.;`6W5)[2)"DE
M*P?O;:TZ:B2>8*U]RJM(B'2U&6*K!]U\,W>7A[I+[01/N7;4&^]W%)8944H9
MD*AO]S8Y^RE?3RZ:\M^8\+;BUB@I5[C[.*]T^35W';[E<B1HT:!4]M,$\_"U
MX8LOLPYB@*[ZV[[+Y!;;E?@(_%1BN+H98<C%\2TM)[9/<"2BI_3J%TU'':_+
M3=I*U?))+I/,&@;Z\5:=83&Z^<FQ13#!D,)`Y5)H4VOTZ)#%H]^W!.225;8N
M/,97+DOMALNMHDV&?!"FV"ZA^5M6^G<EI*UI156W:E1%-\GWM.X2`'&OU*S_
M`)C'/&T0>9DXU';FNFG%^:<3B)XZCQKO\X_8KYG/SZV(LKY1J1<OSF2T$32R
M8ZBJ/."CX=#\>FOH"%P8YA=[FH5[JXKX]D:[RRT'2^@QY'"BXZ.;FW;CR=F\
M]N8D*GYQG5S2$IW!:)F37%X-A-=QHAZH50D^/0Z^-]PNF3;I<O:=3S<2'O&L
M@>P47Z9;+:R6/3EA:LD+*6T0H.UC>PYU*L6^BY'NUB]\N/WN)NG2K;Q?R6ME
M+#K,4!,F):XW<#LD(:"V4/=0HDJ3YC7I'RC<9NJRU[`'?#/I[%X__,!;/LNB
M&R`_F/O(Q7LQP7:#;><LRC-(3(L<N66VTI2\@6:4X4@]$U:NB5D5'AMU])RV
M=N8P/+EKAQ'VKXT^)<QYTN(-2DW9N8+Q(:OK\F+?X8E99DLW:FS3UM(<=N2T
M*2?E&I*$K;[("A4T.N6]E:@'6S'A7/V&BX^XE(+M1JDUDW)3$VZ8>9LQQQB'
MD4B<M$F%<(BTD8YD44*!EQ&QZ%2QNIY'RH=2`88/"/#ZU'+Y'XDDK;<S##92
M'G'+BS4H6H@S(P-`%=`%.)56@T\)=0+@<!FFT3X;,QG^#L7CQ9<%DL8[9VG8
MSJVDNAU%MBI4"G<KKO2:^==*U&E00?2$+DU^M]$BO>]RVOL#;MX+P-I"V'`E
M)6N\Y2HJ(-$G[W@>AKTU\W?.6;_Z^MF5_P#9C]*^P/Y<(]/36X2N'B-XT`]F
MD8*H:9$E.MA+;@"`E:?4X5)W]-R10M44-U1Y#RUXZYT+01)353M7T*]D[S2(
M<*<,UVP_3#@1\9^G)[<KW?;Q9,;L[&&Y%=+C=+O=3;X<)N3G.62''Y4AXHCM
M)54D%1Z^'B=?8W1$WD])69<ZC?*'T+\[_F=I;U_NDLF;IFBO/2P`^HKC\^MM
MSQ:.9?>!=U8'EEMR3C5%I0SC5RC0EMVNY3;6I6+WZ5!$N.U(?!F8VII#VW\3
MME:#L4DF'O<XFOG30NK&&@`]O%9"U)H3+SPKRX*M&P\:8[=L<XIE72YVFS.9
M3D&5Q)MPNZF+9:;5;+0[&6]<+G(0\U(0P\EE331``*BD[@HA)B11/FC!-<>*
M?>\GP@G0.%</5DKB_8?]/./S-89?(]O=LE[PW!,ZN6/O2;==.6<@CY?,:CVF
MY?E45?'&78O=DV5N)+"5W%K<6WE*`W;-6FW[(RX<7R>-@-/KYIF6^DAD;@TD
M#,AIH/4G6][TG)/;C[EI''7$N19YQIA;7%G%]Y5AMHY.Y)O5IMV372T2U9`Y
M#?RN]S;O*BRI;(<'S9*TCTJ%:Z\B^:%W<;5OC+2P>88C`"YK30%U>/'VKZ=^
M2'3VV;WT[-N.YPLDO1>.:QY!KH`P``(%!VA,3[6_;QF/NSYOM'#.)Y3BV)Y#
M?[%E^2-Y!GELR&]X\TO'+<Y>):;G&QJ\62^./7(C8VXT^E#;BZJ2M-4G(=#[
M9;]3=0?!W='N#7DDC$4%17*J]#^9NY;KT-TB=PV63R[@3L94`>$.-=.7X585
M>?I*^[_#)QQ]?'WLBYI2_`>NS-T9Y,YQXGNR+?$?:AO,IDW!3L03''7@[M=^
M90$!9*Q2FO:9?E?LKXPP-CKQIX33L=F#R(Q"^<[;YT=;0%SGW9<'BFAT37M'
M?4BM>.":H>R3W78E,N;43V>\V0W+0_'ASYWMX]VO%N66Q$B3;X5W9_+(.51K
M+=KDT_;KFPXA27Z!2]E=R5`53?EB^VFU[?-=Q`9:+ASOI+?K5I%\Z[^X:(MT
MV_;+AG$OMV-KZM7U=RPN8![EN.,&O/+%_7[L^*N.L>MT:Z73).5..N-<Q@08
M$^=#@0)4EZ#R?,OK\=^5-90%L6\K(6%%(%:)O-AZIV6V?N+MRE9!&*O+FMD%
M.[#CQ%5(LNKNBNI+Z#;;GIRU=?7,H8TQRN8\N=E0@-'=7!)-WWN\V\>Q8TRP
M\QX]R#;RV\M]N=8\QPKY%#7:4)%P$^XV>RL-O)*J*;6\V@MDKV@@G*V_S!WM
MM_#:VT\-WYCM('DZ'%QP:-5<"3Z%Z3=?)[I"7;I]QNK6[VUD+"\DSM>`UN+B
M6BM:"N%:\@4]G''U(^:,G2EIK'N/LR>_#)@6ODGCAJY.MKW@)8@W*2W<I#M1
MU0B2MP#KU'76S9U;U1"&NNMLU,U8N$H;A7'P8XCM.*\H?T3T%(^ECOS(R<A-
M&7-QR.L`4!XU'A4BH'OVR&$A7\>^WSDJVQFTH6_-LV(7.\PD(()*D7"S3KK%
M<0$^*DH_V-2X?F#;NG\F^LKR%OXFC#ZZ^A1Y?E5).QT^T[MMETT<!/HS]'TH
MYMWU!/;-=5EB]O3\9>(6'$7R%)MKJ!T]*T7:!:FT*"A2G<\=6\76_33I/+?.
MZ,TSD:X#UEHQ5;=?*[K.V@UQ6HG8#FQS"[T#74CN&*<>U\T^U_.4!=NS/&?6
MFJ?F!$4OKX*#D-V:.A\?5T.KF#>MFO&5M[F&1IY.!)[AF?0LG>=.[_8?\Y97
M48[8G^V@P1E+XZXDRADOVZ^8_+:=`2DMW6&FI-:'Y>6L*403X%(U9M#=&J,5
M8>0K]%:*HJ]C_*=5C^3O#_I430Y9[.L*R!A]2+5;I:%(KO,)ATT4K<2EUDI"
MMQ\QY'3<C+=M/-TCO*6TS.<6,JYPSIC3OHJP?=9[.,1XWMUFR.VX;9)\NZWY
M=G4S)^:;;2Q\A*F+<9,9Z.MI_N1TBIW"E>FJ^XC##I+2*X]E.]=CU/Q)JSL/
M'T*`]PXL@QG"XW8LEM2J?N[%DCBHB%"M/ZK)A@J4"/-T:;:9&-#FX-">IA3@
MO5GO7)O'`=F8/S#R?ATEE:GVPPNY6]+-`E2&A-L<]Q\@#SI7099#B3BC`=@5
MD/&_O*^KYQ#`M%PQ'W`95>;6J%#GQ(%TGR,B8EPI,=J2R'6LC$M5'67`2%4/
M7KUUTMN'M#FLUM/=^Y#+@Q^XXBJE[AOUYOJU8S.BVO(^',(Y.=)"&8BL)>-W
MFH2:%R.SBSR9CJETH0&BH?KTLEM/S(PSM[?0GQ<S_B-%)ZP?ZS+RSALP6CG7
MV52[/<8NP7-BT7#*\:ND=2O'?;<BM$E;:3U*=]`0-)U09_44H7<S36I-.'-2
M=PK_`%GOV27E:(V>\=\PX%+*DA_LQ+1DK#&XCUJ##]OE%(/EVZZ-4'[`KOZA
M+^!3+P?ZYWTSN0T1_EO<`UB<B2``SG&*Y!8]BECTI=?3#F1D"O2I733L?EU.
MF@]GTILW#GY-TJ86%>\GVE<F(9.">Y+AG)%/I2I$:#R#CK$I6X^E/R=PGPY6
M[[-FEAI<:#-.MGB.!/B[BGVA7BU79E#UJN,&Z,+"5(>MDV)<6E!0JDAV&^^@
M@C[=*,;P*GZ0E^;'S48L\]E'LXY'S'(<_P"0_;'P]F>=98YW,HR[(L*@SL@O
MKHC1887<[B]^-)5\K"9;ZG[C21Y#5<_9K"XD=-)`QTCCB3F3ZT>;'S39W[V/
M?3TL,42KW[8/;S:HEO9N"Q(N.%69AB''E1UIN)1W5)2RS(8JEP)`WI)'6IU`
MGVOIZQ:9KF*&)C035Q(RQ.92:NE`\BIJ5'OB_@#Z4W,MUR:%@7MH]O$U6*7*
M)`=EKP.S1$377(Z)*)%OHYW$Q([S1:_$"#W&_#P&JK8[[HKJ*27].BA>V)U'
M.=][&@<T&AH>'8D/;<QNT/#@Y/I_[;Z]ADEZ.M'M,X`?<B2(Q;VX):G%1G8_
MX32ZBNQYE&Y"2?4D$T\]:O\`0=D,9:VVBT$'A^]<8Z3S6M>3B0I3K^F#]/"2
M8KLCV9^WIY<5H-QB[QMC[GR[:CO+;6^*K8C<:T'365_1]K::-@8!W*U=!"[-
MH*^M?2^^G>PII3/LR]O+2F%J<8+?&N/I[#B]@4XR!%`:<4&T@E-#0`:[^E;<
M01Y+*'L2O+CY!:O_`+:R^G)\RW,_T*?;F);2T+1*'&6.B0%M&K:B\(G<44'J
M*DT.N,VG;8Z%D+!3L06,=2H&&2SN_2[^G8\TPP[[,/;PXS%?9E1FE<:X^41Y
M,=*T,/L)^5HT\REU02I-"G<:>.G';;8.SB9ZD%C"-)&"P+^EE].5QF-'7[*_
M;JIF')^<B-GC3'RB-+^87+^98'ROX3YDN*<*DT)4HD^.N,VVPCKHB8*BAPX>
ME'ELY!?'/I8_3D=ELSU^ROV[&;&:<88ECC6P(D--/%PNH;=1&2M(=+RMW7K7
MKKAVO;R*&%E%UK&M-6BBVT_2^^G>E3BT^S/V]!;Q275CC:P;W-A:*`I7RNXA
M)810>`V#X#37Z+M5=1@95=<`YNEV+2ML?3-^GX&#&'L]X!$97R]8_P#=W8NP
M?E!($8=GY;M[6?FG"D4H"LGQ.N_HVU?W$?J2!#$T4`%%HM?2[^G:S)8F->S'
MV\HDQ>Q\LZ.-[!5CY9@QHW:28Q0CY=@[&Z#T`]*:6[:MN>`U\+"!E49);6M;
M[HHME/TQ_I[H^8V>SKV_I^<7#<E4XZL0^8<MY>5!<>_J_P"(N(9#A;)J4;U4
MI4ZXS:=MC&ED+`$.`<*.Q"UC]+OZ=A3-2?9A[>-MR:2Q/`XUQ\?.,):6P&9-
M(H+S)9<4DH55)"C4=3IQNW6+3J;$P$)!BC(H0*+0'TIOIM)V@>R'VV@(D-RD
M`<78V$ID,M]EIU*?DZ!;37I3_1'0>.EFQM'9QM0R*.,U8`"C3_VV#]/':VC_
M`$-/;V4MMN-(!XWL!HT[&$-UNORM2AR*`VH'H4"AZ:;_`$RP_NF)Q_YGOXT6
M`?2W^G0D1TCV6^W4)B1A#BI'&6.TCQ0*".R/E*-M`&FT=*:1^D[:?]BQ-""(
M&H:*K91],3Z>;3L5YKV:^WMMV$YWHKC?&V/(4R[Z/Q$%,4>H=M-":TH-+9MM
MA'[D315*\MAX!:*?I8_3C25*3[*?;F"OM;C_`'8X[4EC:&E?V3HI`0*$=>FN
MG;K$FIB;5<\J/D%N,_3!^GC'#08]F?MX:#`BAK9QICH*/DHZHD2A^4J?EXJB
MVBO@CIX`:3^E[?4'RF5"66AWO!;4/Z9WT^[>DH@>SGV]PVRAQ';B\:8XPV$/
M-N,NH2AJ&E*4.-/*20``0HC29-IVV5VN2%A=AC3EDE-);[N"TV_I?_3P9`2U
M[-/;VV`EI("..+"G:ACM]E":1O2VWVDT2.GI'32QMM@,HF8=B;\MG(+ZQ],#
MZ>$9M+,?V:>WMIE"MR&D\;V#MH552MR$&,4H)*S6E*UZZZ=NL7&IB9ZEUK6M
M]W!8D_2Y^G4@E2?9=[=4J(VDCC+'0:;X[G0B)T.^(T:CK^&GX#31VC;2[686
M:CW_`&KI:'"AR6XKZ97T^%N0W5^SGV_+=M[?:@NKXXL"W8C1?5)[;#BHI6VW
M\PHKH#3<2==_2-M_N6>W[4$`MTGW5Y3],?Z>J"2GV;>WM*E$DJ'&N/;JE)22
M%?*5!*5$&GC70=HVTBAA93T_:D^6SD%IS/I;_3IN*5(G^R[V[RT+>$A29'&N
M/NI+Z4):2[1<4@.!I(37QV]/#78]JVZ($1PL`/8CRX^06PS],'Z>,<`,>S+V
M\-`.+=HCC/'4_BN*0IQPTB=5K4VDDGJ2!H=M6W/%'PL([ET-:TU`Q68?3)^G
MR%]P>SK@`+V=NO\`=U8OW>XKV4^6IM*CU^.D#9MK!J((Z]RX6,)J0*K6:^E]
M].YAU3S/LQ]O#3JE/+4MOC3'D**I"%MO_=B"@>0ZH*'@=QKIP;7M[100LIW(
M\MG(+"?I:?3F5\ON]E7MR/RD=V)&KQAC9[$9_?WF6A\G1#;G<54#QJ==_3+#
M^Z9ZD>7'R"VF/IA_3SBQU18_LV]OC49:U.&.GCBP=G>HI4I26S&*$%:D`F@%
M3XZ2[:MN>=3H6:NY'ELY!8W/I>_3M>6'7?9A[=G'$_=4OC+'%%(':Z(W0SL3
M1A'04'I&DG:-L(H8641Y;.07MSZ87T\775O+]F?MY+C@`<4.-<>1O"65QTI4
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M8*_DLQ2RQIS&2V%?3,^GTM.Q7LY]OA25K=*?[ML>`+CJ5H<6H"(`I2TNJ!)\
M0HZX[9MJ=G!'ZEUS0[WA59HGTU/8#`;0U"]H'`45IL`(;9XZL#:$;:;=B4Q0
M$D4Z$==(=L6T/(+K>,D=BZ,,`L:/IG?3];C-PV_9[P`B*TV\TU'3QS80RVB0
M5E]*&Q&VI[Q<5NIU54UTO]%VO5J\AFKT_:DEC2:D"JU/_;8'T\"VEK_0S]O/
M;0D(;3_=KCU&T`$!+?\`5:MBBCX4\3\=+_2=M'^Q9ZET`-]W!8O_`&US].KN
M*=_T+O;J7%(4VI1XRQTU0XL..)(,0I(6M(*NG4@5\!I+]GVR1H8^%A:,AC]J
M&M#35HHDY<?I%?3"NSW?N7L/]L$QT$FKW$V+%)*E!2B6Q!#9JH5ZC3\5C:0,
MT11M:WL7"QA-2!5%W_MG/Z5O_P#S_P#:KX[O^Q_$_O?TO[!X_;IWX>#\(7/+
M9R"YP_<C]3S@'G++H5ZL]OS##H-IQY^Q*CWRVP%/OJ;N_P`\W+>-ON*F(G<;
M(!:"E[5`]3Y7SMQ:\4+2J)Q,DAD(\2A._P"Z#A&2[-"\WMS;S[S[B4.*'<2E
M<AQQ(=2PXZ6SM/F?'3;I]8X`%3XB]H!`QHHF\ZY?BF;HQR1C626:YMV5=[FR
M4$.*<WR($9B.RRAUA7>??6FB`%)'Q.L/U?MMUN'DR6U"&->2.=.%>97J/RYW
M[:=GN9CNDGERRN92H(:`,ZFF'?P1]@6;8S;_`&H9/BTB_P!ICY%.N>8NHL#D
MIF-=GA,LUEC1>W"6"I7S"8;@1MJ5;#\-4&WV\]I\M+V&Z88I27D-)Q(QQIG3
MMR6NW?<+#=OG+M%U930S6PAMVAT;M0!H:AQ(`KV>M1XXSYG7[?.4,0Y47:S=
M#:8]SLR8S`9=>0C*K3?+*N9&;E*0AV5`;?[H22-Q3TUG?E*!#<W$S/?:,*Y<
M%IOYC@UVVV$7.O?DY2(/U$>3\`P+D2SLV'\^FX]D+&+6")9VYLF\28>08Y-Q
MF*Y=+=&M\]Y#/Y98:L7%"TJ$K:LMK2DI7[7+>RL@>X::M8YPPX@$\^:^0C"Y
M\D3*.(>X5H.U12RM]RXW.)<9:74O7!MR9(*U'<F5*<[T@22M"27TN.&I-1NJ
M"!KX_N"UEY)(TBI>[VN)^M?J#9O;^GV]FYIPAB`-/_1MI4JT_P"B=)AVGWF/
MS)Z$RHK'#W(22Q-9+S0=E2<?920GN&BBI70"FO6?DNX2]7DN(PMW^W^A>%_S
M'0R6G0T0)J77L?;E5=9:,HA-J6Y$MEN2D]`GY%U!Z=:U-*?#7U,71N%*CUKX
MD=74>]$%ASA3,&>A-O83W;YD+I2EHIV[[Q,-%&I!VI`_0.FN:8ZUK[5W4ZE*
M8(ON^5.3;CC_`$4@-W";(HEP$4_*)K'0]0!1[H*?X=))`D8UH!:XFO'(88\%
MP/<!1;EPNEN>ARU.QWWTIA2%)W)C*0I26'%&I6VKTDZD&(.A>*4-!DDI/6I-
MB%ELJ#!MZEBTVP+#]MB*)4(3`4L+7'WDE7B:]=,,@B8`0T!U,^*0]S@*MS7+
MY]7Y$21[ND*BLQ@PUQ3@T;8RWVFAMF9`\JC8!]16[U%::^7/G;*^+J6(-IX;
M9A'^6X@_1@OMG^6NU;+T7<RR!P+[Y]>`\#&TIZ\55VN)%50+:844`(4E-&@2
M1N2FB5IJ"#Y]3KQ:2XD=BZE:<E]&1VS&N&FN:6/./O\`O<`GB/!_9@_&PJW<
M28/#MEYPXWHY'C'\46!-B-UO<%-^L>36"1>+A9;U<IKFQ3Q960B-V%OA!/UE
MTO>33=*V<+B`WRN&!Q"_-_YD#5UQN>`/_%.46+O$XMS;$>/[)"XOR/*^7<DP
M*5`QC"<+R;*8B)=G:S?D.^JR;&[A=X^6!2+7$L\PW.-)9^85%=9,<K"BAO0-
MLOB&!D52Z@[5BW!@D:VH#"WV\E*[@?VA6;GNZ^W;VU"S9!@$?D;`.1<ID97)
MS3&<_LKZK=GSK%NN4!M>+8U(N,M:)@[*F'86ZVH<:>CK*`%.QP&$-@=0.[<,
MTB73'4YM"LCPWWS>V#Z1_%4?A.7D\_W"7VX9[R=%MK_&;EIN5S@W/%!8K#<E
M9;:HURB6.)8/SZ(J-#$.8[*:^6DH(42%)M;>\-@TPG27.-</5P3`MS>#S&`@
M##']ZK?Y%YYR+W>9'!]PF37&T7*YYY8&FPY`QB7AEOML#'[_`)%8K99X-AEW
M?(I33=KBV]+)>=FON2G$J=41OVCYD^:-[+)U/JD(+O)&'I7V_P#R];<+?H,W
M!\3C>/'9@/MP4]OI'1(5J]Y=MO5U=,>%;.*^4I"I#.Q3C9_*(Q6XE"U[EM,Q
M4N.+IX(032@Z/?)Z9K.K9)'8_DO.'=3U51_,*3_@`O<*.=N,0/#)HR13]7SZ
MC3_(N5\>VKV7<OV=L<6WO),3SC*8_(/'42UY7<,ILT>:]8H4*\7\V^ZP+1&@
M-+WN)4M3SJNV$A!4KZ.W*_;.&,MM0D8ZI/`]B^(V6[Y&^8*:%8O](7W#WO..
M%_[M>4\P>R#EL/W;/'<JG7ZVW^-EMJFSG;,\U`NMI=DVL-8LFQ-1F&6W27&/
M6E*4MK.INT7A,;Q-4NU"GJ3<D4@(\N@':GA^H)>K`S["N5\8EW6W(G7/%\/Q
MZ'!$@.RWKBF^XY<.P8B*O)"8D)QTJ6`C8@^HZJ.NI@SI2\Q;4Q\2.:U_RR+I
M>O=J:YM:7L9R/`X^Q<P%MO5JX]NMGSV^0G+Q8\'NUORVYV1AQIE^X0,=E,W.
M1`9?D1WHD9R;'C%L+<:=;2554E0J-?*_2TK!U%M[WBO_`!4>'^4ONKYBQ2'H
MO>"[3Y)LYOH-%9O]+?(?;/[C^._<?RW[R>&?;O&XYQ*]X_&M>;\G8AB[..O,
MRYU_DW,VV[S;9"3'N,*,N"Q(1$><DNO+"E]7$)U];[08)Q,Z5C?+;EJ',FN:
M_.1S``&M!]T?Z(5#7-.5Q+)[@/<!_<G(E<>81AV0Y2K#&\`R'*,=M[N-0\PM
M]ML<UAF/=VU($FUSFW&U`-J#9`(KJCN7E]R]IIY;3X<!0#C16;!IA:*D8</#
M_HT]JD-Q;R_S'/Q?Y^Y\BY9?6I[*Y,9&17)_)VVX3V]OY8IOYNV]!"#YE0K7
M=X:\(ZZW6^M>H#;6[@R#RG$^%IK05QJ"*5[CVKZ]^2&P[7N/2#-UNH_,W$73
MV:G22%VAI`\(UYX]H[%,^%]/CW3KPWC+.L$C<'<F2.5(MGNUFPO(\9R5MB#;
M;U:%7=J)><BM>0L=F5!8>::D/%N*T'G*ASTDGU;;^A=HO-ML[GR6_$2P-<XU
M+22YM23I(IV4HO%.H_FGU;;=1WD5K>S,MXKE[6,HTM:UIT@`.:[@.-4_#GL8
MY5XZQG%LUY*N?#O&5COV/Q+O-C\?<F\[V6[X_/+-K$^RR;-=&LRMEQGVI^YE
M"OD%2D+2PXM*"CKJ2?EW:VH,D%S/;/S&F5XQX8DD8\E7.^;V[2#1N5I97?-T
MD+1AVEH!'>%#^V>XG,HEC1*P//N6;/+;>0$P\HR/&<PMBF6WE-N+1<&\;L%S
M"5H3N:/:54*&ZFO(;WK;>=GNI+?:[RXTM>6.U:7XLY5;@,?2OHS9OE?M/4.U
M0;CN^WV,<=Q&'TA<\.`<`1Q!![P?0B'._>#R3=+5;[5R9=,:R"U19AE0%WV-
M>&%LS5-+9[BI-DEK<#JXZUBI9"0/MUH-AZ_ZGWAWP;?(DD&)\S4W+#,5Q-<!
M19+K/Y6_+KI*T&X7S[VWL97AK!$6OHX@FKFEM2,#C5>;9RSQ]?(<=:Y7%K[S
MQ[?R,+EQJPW1#N\H++EOS7&K:V76U#J$R5I%:;JUIMSU!U%;M\J:PMY6G)T<
MYJ?\DM^DA>3NV7Y<S-)L]ZG:1_>P:6>D@D@=P.*,7(F)W]MUEG'+[+0ZRIT*
MQF^<9YVG:!M-8^/YO^8K"?AV`20::6SJ2X8VM]MUXQ_)@;(-/.M1CGA]J8_P
M;M=SX=NWO;97G@YSH\.]PS4_8/NZX+QZQ8Y9\VX^Y`Q40[5;K.U,O.(S68\Y
MRUP(T5:V%JAK:<6I*`LH0M90#U/@3+M_F#TU"WR[LW5L!EYL=-7,"A.(PK7F
MI;?D[UC/$9[%MI/#0:3','>DB@(!X<\5)GB[ZJ_&O#EN:M?#4O@+%4/@"X7O
M)>.LN8S2XJ(_>7')F\T:DR"2>C:&V([:?N-C2CUGL%Q^;8WD!:74(E#FCUBN
M/915Y^7O5MH#'>[;=EX!Q88R#3D-5:?L4M,L]YN#^[(*<S2T^V;EC-K;8KPY
M8YGY2FZ3;#;X<)^Y7:X3WLBFKF2K+:VXH?<8*UI2@*VT*MVM#8;MM-Z2QD]N
M^734!AJ#V@FAIS)"S6X[%OVUAK[^RN((WNTL+VDZCRP%`>0J25"V[>WO@/.7
M9$NWW#CZ4N6XZ\MFSFTQX33LBCJV8D/O*5&AH57LME:@VB@!/CJQCDLIQ6%\
M3P?PN:?H*K)8+Z%VF:&1CN3F.:?40$T.0_3]XHO>]<*'9JJW*2J"\RVM0/G_
M`%:2H@_JKKHLH,G-U=ZC&<MP=04S3)7OZ:5C:)=L[]Z@J45N(6Q=YXV*ZA*D
MAQ:@D=!Z10:X8(7C0TY<CEV)9NG.90::<Q]M4IN+_9;SK9,UQFTXM[B^6\`M
ML_(;+;'Y=@OLP2(D*==(D*0N*E$]EHOM1G5%&X%`4!4$::-FYIUL<=(X$KC7
MO-"?<Y\%TQY1C?%WLE#%LA^[[WM\XY-"6["7:,LYOM8MC5VC/*:98N=IM&`L
MJ8M[B67%O$N.4;`":[P=>/\`7_SDV;H*T>V/1>[Q72(&D!S7?UC7`#C4!::T
MV?XO2]@?Y1&?#T')55^X'WB9E[@L\O,>6Y><:N;09@S8\&/)19UPK6XMMDS&
M5+:82T!*=(5]\UI0CU'X\ZM^9G4/5C7WFYRLCC=E'%(XZ>W$`"HPXK4VNU6T
M.&DC3CC_`$**[O/V0<0W6W8AB(N*;K=5+E7VZPI"(3KSL$,OM-VYF0"[.M\%
MR44N+9*O4A6_>H*UFNG[[J%NO<[.\DMK6K6@`D&H/$<CS7;Z.!\C6AK3AF,U
M=E],KWL9IFCT3B#D>R."4]+NMUM&1RY;MPOM[>E3"\ZU-=5VXD>';$QWU[U%
M`*"$BJ@HG[-^47S`W;<8STYO49\^-A>R8FNIKL:''U+-7^WTG;<1Y5&'<NIA
MHU;;/Q0@_P`J1KU>I+G<JI)6375Q#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0
MA#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0
MA#0A#0A#0A#0A#0A#0A#0A#0A#0A?GYY]>+W;;!/?+DF5"2S4RX<A,V$E;:0
MFCCC3RPPOU5VN!"_#[-6SV:!6M536[:Q^;SX*JS+$L2A=5&P6:<E^[7ETJN%
M@MEQ6HO7:2\:NR8CSA&]9(&[I7ITU4SNT.<[M5S"W4&M[%%+D:#9DV>Z+_A3
M%6%H86YWFL9M4)P;?`I=8ALE*P!T-1JEW6YE%H2QVEH!]':M%L5E!-ND,%PT
M2QR.&!RP/IK50QXILEQ_C>WR7KC<DQ8UR[X;,^4B/^$ZM2.ZTE[M+``I0I(I
MTUYWU!NT\VU.C#RXEI83_5.8]*]NZ-V"V@ZB$XCB:8WAS!HR//-7=^W2!`OV
M8WANY08US8BXG!D*3*89F-H?-Z2IN6$.I4GNI4H[5)H0*^7337RK%);H=@^D
M*/\`S`R&:*P<<"TD=^#CZ%8Y;;>TVU/#3DEE"D_.2$QY<AA+KI3*(4XEE\%5
M>X:U'ZM>O73=5K*W_P!$_P#T2OFZV=IN&.Y/'TJIK+NW)O:U]QS8M4G<E3>[
MN+5,>5Z0JB'&Q]Y5:$T^.OC^^\N.[>QSO'J/TE?I=MKI9HHPUOA$49K7_P!&
MU6A?1O8MD?W8WQ^=':FQF^'<KJU(;#J.XN[XPAM00XEQ)4VHJ]1%=>M?))FK
MJ6=]::+4GOJX-^NJ\"_F<DT=&6>&=_\`_HW+J.3,PV@6;/$[A`&T40$4KZAV
M>RH$UU]6/M&D:(6^,+XB9-&6`,-74&'H1+C4_&$P7BY:WB7;C>TE<>XW",@-
MF[S0@)#3X!"6P!U\:==-?"$8.-'<J+KI*BE%%#W->[_VE>V%^+<.8>6;=ARK
M:VFX7.Q1WKIE.3VNV7B1`L]MO$['K&+A>8-KDW*Z1V@ZXTE*N\E0J@DAB6>*
MT=Y4AQ(KRS_H37!5=QOKN>WG)^4,?P+#^/L^=Q?,'WK:QR3DW)=AQ:TV]A2_
ME6[M<,84U=7A;Y'S#+C38D?-+0\D+90JJ=1OB[/G)_G_`+DD:_OMTJ.'U"OK
MMV[A_-;3Q#[8H5MY-;MF.AOD'+WLMR3&A8\I;==@2L.LHM-OM\I<NQ&,I$I]
M2R`\0A`&PDP[O=BUPC@=K9SKEV?O3MO'),"YXTM'IJH%91[A\B]U=JXZYKS.
M,Y;+_DN&/Q),%W()^3+;C8_G.:6"+OO-VCQIK]&(*0$J22V/2"J@)^<OFG*;
MK>Q/+B?AV-'9I<37TU7V]_+RYMOT<Z-TF!O974I_4;AFD>&FT!327F.KE4[E
M;B:"C@-%%*5*)\STZD:\DECU@FM,"OHJWN87$>+[RK_]SM\XFD\LY%:\JMO,
M$VYV6WXDP\,?S?$OR:.MS#<?F2U6.P7C!I#MHARB_N>2)SG<=W*4JJNGU7TQ
M'HZ=L<?_`&5B_-KK_P#\\;O_`/+I%.OVG\T>S#AAO$\[RZ[<J8IS19_;BQ']
MOF83+?;,F3C.0WG)^0H,:X?P_9;C;<<NEV8^><<29C3<?<TA174J!V&VW7P[
MW`&A+3CV\O2L)<0:VYT\0*C%R?REAC6#<2+N',G(5ERRPQ\Z2S>V>*+*B6JV
M3N4>05*B1G<5Y397;FHM\7<"@1U&J)&TI0E*&VZZY=+<8O\`#*">WNY)?E>8
MS.E0H\<H6KBN[83PM<(W-$9J0_CN:S$3;YQYGD.1/;F\LYC\Z#^3+O\`\KND
MQ7$**PXI125@G<--6[7Q2ZWNU'U*4TTTCDK!^!+-;[3PIQ;#AWV%DL-.*2G&
M;[;(5VMT66A[-,QD(+<.^VZTW1!9#P0KN1T#<@E)4DA1^<_FA_YM=_N&_2ON
MCY!-CB^746MU`Z\N#_V\E\YSN&28[Q;D]WP[-;?@M]0_:(L+)+GF#V"L,L7.
M=^672$G(HCL5^.]/@REH[/=0E])4E1VU!=^5#G1]3N<PT+;=[>\$ZC]GM4+^
M8EK).A(]/CA_4&5/(Z`JPW^-,G7Q2R$91QS>9<SEF3.>DQ>5^.U,..MX=#5Z
MY$_(8>YUQV550JETA>Y0H0=?2GQ#1@UM!W_N7Q$`UHHT4"L+]G%[YN]MO,/M
M/SS'#-NF/VRW0I.3X?A_(&$):OME1FG)3M[2])MN8+8DQ)$2<UW(R$O-R4-"
MI"TA.EQ7WDR!^K3V<U&N(Y'N!8*BB67*N6<X<V>_KD;D7/,6R6UV.-.Y#LD)
MU+DV3B]NPZSP95GQ6TH=+[C2+>AMM+K2'/27Y"BD!1J<?UQ<2/Z=NY'FHT##
MTK=?*J+_`/Z#MN/^U/\`HI=\G0Y</CG.Y]D:EMWB!BMZD6P6=B1*N1N#4!U4
M54*+&0MV3*0\`4(2DJ6>@U\]]'2:NJ-O%/\`VJ/Z5]P?,!FKH;=F_P#ZC+_H
MJ%*?>)[F8OMYM_'&;%%YQ)B_WZQ6FW9QQ;9;TU8V6[79KTB99T9):5Q['<'I
MUR>#\U+"Y+Z%K2M2B:Z^JW2R-;0'PC5AZ2OSJ$5*8Y!O^B$093R;\OD/.Z'\
M7P60_%M"?FY$O%+6PF2K^.<+AJ+YM7Y0\MM1<\BGP!'6FH\4GF5PR2G,U*7G
M$DUK(.,\0OS%MM5F;NMA84(-I9G-6N+MDRV!V&YLV;+;0\4;U;G5`*4=M!1.
MOGKY@R:^II64RCT_YV%?1R7W'\C+6.'H6UE9[PNIO]-BZ@?9[[HN#(_%G`&-
MYM[AN/<4S!G$I.)C%\EN%OMSD54&Z6O$[5$?>A2E1D3I4^UN,QFWG&)"VV7E
MN-#9NU]+;!N5N_9+1@<&S"W8*9Y-I]55\5]6QZ>J]Q97_P!LE_TB55C]4[+,
M>Y(?Q_CW*/<%&Y`QW`.0(.0V2SXEQ)#@LX2O(;=>&8N'Y$]>IEKE7R^-16(Z
M?S5M2XC;$J.L(<5(*T3KF<2LT2'S(P*CAC[52"U,K*!V)P5>;%G3&2$LMI=B
MH+S2%%((4T%JVK`Z[U+!2?`>GQKKXTOKBFXW6'_M,G'M7Z@;'8W$.SVK*5_X
M>+_NF)NN1<?CW)NTQY-QM%E;>N92';HBZN1I22PM!C-&UVZXO(>65;DA24(]
M)]0-`=I\O9FNWJ0OP`H?8O$?YA1Y'3=J<R;S1_FL<:^FN27/%?MKO><YM-OC
M65\9V;';!DN8(N,N3?UV:0ZAR/$7;V+8W,M*'ES8Z&775AL-;`H$$DA)]A\R
M.>SD?&^CQ_K+XV\KC57:>R_'>>+CQMR9;<NBX3G?&%NX7YDND?-,P2U<<\L[
M-VQ6]0EQK5=UV.X&\P3=(L!QSYB:CY-3SNTBH2;_`&R>:&![9M+K?RG&I&.K
M2<CZDJVMVOW"!CJ4=-&,1S>`J!+5:&XMH@PD++K<.&PE+9D)(]+*:;4N+`0H
MI`!-1TIKY<NYY)IY'RO<[\UWO&M%^C&V6$=E:L@MXX6R-A!\)IJIPRPIZ5=S
M[,/8QPAFS6<?WA6R_9ZQ<\5Q&Z8V[.-ZPJUXS)GO79=PGQY]LN5HES)85'92
MXQ+C$-,OQUMJ6ES>OW#Y>]-[8('S7;&S^:QKF@C!E0">=:DYX+Y/^;'6&\3W
M%O#`XVLD3Y6N,4F+J.H*@-&5,<<5.F1[1/:=Q/E.1W9F0_;F\;7/Q_.(MTS"
M#=8N/<:99Q_)GWAV<[-MCUY1$F6F-*69!?6E+*5A84$TUZ1^B=/VSW75M"UM
MR(RUU,*-/#TKR.3JKJ*2%L#[RX>QCP]M7U+7C(MJ"`?05R/<SYY-Q0M)QRRX
M$TQ*Y$>QRT72'8TVA3MJEW:YP;*OYFP/VHR$J@ML+!"27/O$5-1XELT5GN>^
MW.VN8/@H"2VA<'#'*K7##CDOI3K6]W;I[H^SWJVG<_=)XXRYTK8WUU,#LM/"
MM/15$EGYZY)B6=F:U8K#*2RJ6P'K5G'*UGN`,?(ACD.7+83EUQM<9JZ+2MY@
MH;ZAI14UM%=;*38+-C2YCYXR&D^"5XK3@=1<O%X_F+O<SPR^AL9ZYZH&#B!P
M`Y\:J>W%>79+FF&YAE$KW!WSA5.!QL<E.VK(+[D6>.9B+\[*8>BX[&;L;\J'
M(LRX@6YO#Z7&W:^@(-:OIFZW7=?B(H+Z[@9"^@\3'X5H!BP'(9XK>=>Q;#TK
M#9B?:K&YDO&ZR0UT5"!4X!SLSPP`4GLLR'FSVRWKV_YI?.6[[R7B/(R^,,ZC
MIQT8[>7?X<RFY/S+9!N$&_6O"9JI-X399,0JC!]$9T>M74$WF[7^[=.[>-QO
M;XRV+'@OU1C7I!J[Q`@8<,%C]G'2_4LTEE:;/%#N8MWR!PE?I`8#BUIP)%,1
MS3Q>X?W%93E')F;Y9CF-2++;,FEMWV!9.0+S9TY;CPO"RZ];I)M<I+5RF-H<
M=+:6V`"TR2%*'J/Y\=7MVGK'K"_W[;_B##=7#GUKJ%2>&5!5/V<T]M9PP1:6
MM;&#0NI35C3+&G-0'S+E7(L_N&-X]B.<VR!>KRY#MEWNMZENV;&F/GW7HS:)
M\Q3#3EJM]N;477I!*HZ64*H-_I.UZ2Z-M9;N*+>6L9$7#1J=I:2#B''N57N.
MY7+QJMG5<[`]@4K\E]G&$,R(69<?>\CVM\K9,ZU;+%`X<M689WBL#'WGV$O2
M;K!Y+OUD9=R6[(N!6Z([L:*ES>`A3I`0KZ3W'Y>[+="-FT2[8V=[070A[3KX
MD!W#OH>Y4K+JYC/C<=7%2G]C'!L[,?<5AG'F9WJZ!R[QK3R+=1A<[(;CC#46
MVW:9;)F+YGF+%QL]]B0KIV$MVN6U&GPY3Y2B4D%?;T_LG2FW;?N3;1NJ.]:-
M1:UU=-,0TG#4WLH,$EU],Z8,)\)("[MVA1IL4":(2`D=`D;11(^Q(Z:]1:-+
M0.2EK)KJ$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$
M-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$
M-"$-"$-"%^<3>LV<MS%QDVE4MZ0]+;W(;:4EB5%4S$;>B7-I]IQM<"0E)2XR
M\ESN#H&E:G^;&[)[3Z55Q1OBA#'BA!45)$2/,A2'7&>TIZX75T-QX\@QV0[<
MI;@8:44J);:"MJ14D`"NJ^=NNH;3-6L#@S23E3ZE%[F6T1F\5R%UO<E:8<@@
MK96*#<@`A*TI!-3^O6=WII9MDX)Q%/H6IZ:(GWVU8TZ?%GRQ2CXH<P9/&Z^0
M6/9?Q)=+?97&8,[+I_*G+3;DE-M$>!<YK^-M\DQ)2KI,N,A#BG8R6XR0I2$-
M`"J?/YQ%-LQOO@-5JPT=(7D"O:%[%#$^'JB+:_U>2*^D]V,1MK0Y8UJ1VE./
M:O>?9,`R]$+$?:YPG:4W'&)"[C/BWOEZ0^ZB`B=.B1=ETY`NC*=ST7U+2E*O
M4>IH-77R]EM)67$EK;06[=63`ZI[W.)J/1FL?\Y[?<MMGM+>_O;B\C<TN:9-
M(H<1D`.[,X(SRWZFN:62XW"SQ.&.,+8F-:,==>G)NN:N/%[(HTE1C,L2KI+;
M4F(&ZI4-Q/6HZ5UM=SD?!;RO!Q,;J?YI7B^VW8EW*"$-&CXB-N(YO"0=[O3E
MQ3%G*0@.NPTR74I_#3M>6MU/9WFJAO7Y@:^5+@1.F<YHK4G/.M?2OTFM9IXK
M>%D=`T1,![Z"J77"WN_SKVA9-<N5L%QRWY)=#8&<6E6>>XTS\[!O=W@U2)2V
M)C41YI<$+*MNY212H)UZO\GI)(M^N'QO$;1;$N-!B-0`]I^M>"_S(7(EZ5L8
MYXP\F_PQH/X;E+YW_6#.4W;5(8O7MA7:EN1W67;[CW),:`[%[J5MIG157+C6
M_P`*$^R%`H*RZ@.)\#X:^D)+RZ;&3\0QQ:,>%:<B,U\5NM[(M`$5'$C[Q283
M]>-_`)J`[@?-US>8L%F?,"X\WX%>K,Z[<+(U+3=7[?+X&AI=N5U=N`E.[7$,
M*D46EM"*H-?%OUW4/H"SMS7?A(624.H`<`2:>DYJK?/_`'-^U3G#(N?N3^6\
M']YN19AR\,05G^1#F;@KYIQ=DRBRR;.S9T1>#[3;XD.'^3QXR&>UVDQ6]B0%
M>K5;-<3W4IEGIK.&'+@I+?)8*-%1VA,]C&4>Q.)EF+2K';?>O;1:[_:IMLM]
MPN_`.0/(5'DP5.L?F*+5CQ^7E]D(4&VDN;#0!1&DN:YF:<:YLG#+FG:Y.SGV
M3Y/9LKM<RZ>Z*SL9;R3G&>W)Q/#/M:OF5P;L_E<U$B&QG?Y_9\W-ICNK++49
M%Q1'4PFJVMQ)+D<_D1MMG-:8WU<#05PYGTI+&QAY+"ZO+@I7\*S_`&AS.'^/
M[)9\Q]RP-BQ:\,69^\<:\50_S`R\QS*ZQU7!N!RA*$8)N,U;:^T75=E(6D%9
M*1XO\P&[*[>!/?R3"<1:6L:T%M*<3J&->PKZN^33NH']*"#:X;8VGQ<I<Y[G
M->?"VM*-.%.U$@>BH;4J0X6V]G<63ZRNIVDM'_?2!^DCR'GY!(&T#&8@`CVG
M-?25L`P"C-#01A6IR%3CVU4!N7L;X2S?EW++AE'-.78-<KC,M$>Y6^+PBYF4
M&S&U8[9X12;O#SZTR+FPN-$2X:1V3^)LH:5/U%L,K6['9YT%NUOI"_/#K>9D
MW5NYO;7&_DS6_F?%'M;RJ+Q\IKWC2K(]AW&=BQ9YN]^V#E)EN:8UWR6Y?/H>
MM%_O`9CR574@-'<M.PFI!&K/XR('[U1^W-90@'N2=S+B+V]7?%.+;8CWQ<=V
MF3CV+7ZW//WO@CW)ENXO3>1\SR3YN*NV<=W1QII+=X0RO>`KN-*(JDI45BZ8
M\:L48!>;AP'P;DELX-LKOO>]OWR=BL5SL]UAR,6]T%CF783N5,WR-[\EFN>W
M6[LPUNV^])CI>D-T1)2H]M:`DJEVLT3W>70ZB>2ZVE:JU+A/C3B=_B;$(F$^
MY#@Q-ELUAD1HMO7D',5VF(0N]WVYQHB+[=^!\/=N[[K<X)2\Y!A;E^E24@;S
MX!\Q+&UN=^DFCN8&3!O\.0N#Z=@#2/:OLCY+[K=V_1<5J;*[GB%S)1\3&NC\
M;M5:E[3@,\%%WW96=O(^&;ECJ,IQ3&I%RR3&78]QS"\.6:S;8,MR:ZT]<(T.
M>IN8^ANC:"BBU5J?#47Y95M]^>Z1IHVW<TX<2[4#_FX5]"F_/]E>BX8*@.=?
M--/_`%8./:H(6_VXW:\<56VTPN:?;"FXL<G7Z]OQ[ISYBE@<$"3B.-V^,XE.
M0IM?<#DAAT!'B-H/@=?1$%U`8M9[>55\6R1^4[0XU-.&2=6]>VS*)4'B6/;^
M4?:]*3CN%8[:;L\U[J>$;:6I+&6Y1<)\5A-PRZ&_,;#5S0K<@;%FJ024D:A"
MDEP9:CR^1^Q-@G@GVX-]N6>Q/=)E.<+OO!TBS7:Z\LKMEPB>Y?V_W*1/_.)5
MR-F0W;(_(R[FE3[;J?2IM/:KZPDCI4=4Q&XZ>NHHRS46#-P:,_ZQ'VK=_+.X
MM[3K>QN+@T8UY.#7.)P.0:#[:#M4P?<;AV=8UQ;F-L6_8F[Q?<3O+%B>L&=8
M9=G!(+28[-;WC62SH%G>+[H#:I3\95*J!V@G7A'3UE)M_4]CYN@Z9VN.DAP`
M;B<<J\J8=J^M>LMUM]WZ!W>2S\T,%G("7,>RA.&9%%5_9>+/=[<>-+9;<;NV
M<S+E'S;(YTN':>:<=,AFV2<=Q2/`4I+7(57H[TR+)"`"=JT*)2FH)^ES(UX+
MAD*_23]:^$"--&$@D-`-/[(3WWGC/WEMW3G"?%Q_E>Z,7"/VK&XU?H62LS@K
MD'&)"?RYAN_702J6V*XH!"54:"B>E=(9)&[+!<4V^)N*^<5\68?<<QP#-OS>
M/C3*\BER\;?97%7$+[CRYS<6*F-&3$BI2%]$@)34_$_/W7VV7\_4-Q+!&YT6
M!U#(!OB/;D.2^W/DSU%8V_2&W;9(]GQ0GD)%#0A[FEN-,<L:Y)I...9O<D&,
MVB0<=1%C6_/(MKPQNW<$O7J[OV@,97(9N4:1C=JMUYN[,HVZ.%R?FNVDKWNK
M&ZI^ANEX[9^WP^9IIY+>`K[H*^,.LY+B/J2_F$#Y2Z]EI2E#60BM:UPS]"7W
M(W-ONQO]_P`K9SO@U[(V++E>/V&R76X<5<@)7^3,1<ODN/PT"<[&W=R(@]V`
M\A*G5MJ<2H&FI/Q#9V3EI'Y0.`S(IA0#,J//9/MI;<"0.\[2>6DUQ:<LN:4,
M['<@LT9Q^\8_>[,RDEI;UVLESMD=3IW;6X[\Z,RWW5A)*6Z[B`2*T.OC?<;>
MXCOKJ20.:TSO/B#FX$]H'I7Z<[1N^W2V5O:1SL==-AC!:UP<:B-GX:CVHFL>
M-\=YE=8]BSR75<PJ7A-K:D.1W+MDD1*IQBA2&EK*6[6Q(>5]R@16O@#Z5\J+
M..^W"YCEX,K7CFT?6OGS^9.ZGM]EL@\`M??2$>AG'M1[R#R/P7PQ>,@QES)7
M\2N]NDNY%?+?,R-B:+9_$D1F(Q/2S<L"N2(K4I;S:VU-/$+6H)65"@'LUUM\
M%FPM9Z/WKY6VZ*WW/&=QC+.(&'[U)3B7DDV/CZV7B7R3:<)P*>ZBS_*Y-=HD
M>Q9M;'[-!N]QC2(TAB!CQ3=X`C/.(,,#TH]!J`%6@+[<L)\))&.(%1R3U_M[
M;&Z9Y,GFL#6NKD<S@,,#A@>U/);^4!:<AS#C+`\P]OU^D8Q(NK%UQ67BU@R"
M\PLAL$2=<<A"K(V^#;RPRX6PPO>6FDIWE?0ZJ[S:9;6UEE@_3W,B87T-L/$`
M*FIU&AY<UI]AWFRO+ZWMKM^[MNIK@1APNG4:)#3#GZL."9*Z?41NO!V#8?ET
MR#`M\_D#([AQW9[3CN)LMVEN?C\:T9#?KA+=3?8@^558;E;F(C*%)=WA:%DL
MMI&H?26]7.[6CKR)K(VMD,=`-(J`#@!]VA%/4I?S3Z/BZ.W>/:P]T[Y8Q*)'
MN+G!I)%"3F2<SQS4).!O<CF?N.Y_]P7,&7\J7NX9+>_I_>XF^/Q8F/3L?L]E
M8@6^?8[)+MUO9R>Z,LBQP-K;:?[0LA2N[N5K<6KGO;*Z4@$L-3PP"\P$!86.
M=2CG`#TFF*C9S*PN'8<!>&5*QEUS/\/#MU5%NCWSY5(>6[$=9M4:;)2JXT*J
MK1M"D@$@]=>+=!SLDZPOY&`^2:XTPS7UE\X(M/RSVY[]+1KM&@FF-&4-*5-"
M1Z>*;?`.4<@'Y=;[AGN(Y/8W[9!D-X_=+7D_RK,^=R;D5MB2VGKG@<N:),2(
MGML[W^BFQNH`E8]AN;RW@@DDD:2WR7C`#,C!?,>T[>[<-P9%&TDC'#^TW-*/
MF21(L\6`J'=,4M[BL>R];L?+&6U(GIBVQMUM4=QZVS?EVVGTI[I0ME9"@`3U
MIYA\NWDF]()Q>/I*][^?=F(QM$;F'1Y3L13#PC`K)QIGV4Y/R58860S,%O*,
M51=V["Q8C&7+MMKM&4V=IBS0HC"DJC6M*W7"X@,*JM>Y1*UDJG_,QP'2$SI7
M$0EVD^D?0O-_ES;/CWN2:.G@L[@BN8!C+0/\['/MS3I<@YZ_,R;-)&86G(G+
M[>)*+;`1(MK+\RV1'HLEU3T)Z5<8TB&DK:;[<MU+C99*PL(H1KYWV/9HY+&#
MX'RM`<7'AQRP;[%GGF=SGR2BH8`TTQII%">ZJ9V^WY>+&S+PV[7"'E$N:PY<
M[=!>7+5*BW!"%0[)#C0&$-O%E^4:-L)5W'BJ@45`G;6.U.W(Z+Z$.B'N<*'G
MER2'>3"-3"ZIYH_X(O5_OO.O$,2ZWFY+CL\K8NQ,M;\=;;<29$OT$KAR8+3;
M;L=^,$A>UP(*5D[T]-:[8MJLK'?K2*"!HD\T5.9&!K2H5=/(&^/&FH?2K`/:
M1]1+,,7O4&\W"^Y@W>1?HD27DF-0\->R%YENX`1>_=L[;EQ(+#/[U9W)(=4/
M3NVJTCI>VW39>L9Q)-YEA=MJ&O)+F''W7&IQY5`6@@VINY;?+>L+8_@PQ[OQ
MO#G4``ID#@37`+]02`LN083BB5*7$CK43XE2V4*)/VDG7L:A+;T(0T(0T(0T
M(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T
M(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(7Y>#]R:M
MZ)D>XR&42&X[19A!);FJ6YN;`B17K5"D.N."A`!1N3UJ?/!VLFY27),;)&PT
MP(II)Y.KC3N5Q<MLW6@U:?.KV\O4E'C2V7L9AE\E*U&:O:XGU)*YLA1"TI2?
M70T/7H=;>'7Y+?,IKTBM,J]BI@*"@R4<N?H\-6"Y4K<LJ;MCCP"$]=Z9#%-Q
M(0`D5^W59OD;';5<%PK@/H6GZ1`._P!L#E7ZUXXSE"'[.;\TT$A,R3>A-<6U
M5P+_`(G@(;2I20FI#`13J:)IK'O+7_+N8N]W6W1CR?X^_P`.=?0O1]#9/G)`
MYX!<8R:_V8ZM]1Y9\5%EQH)R-J8"7";0]&K2A3\S&O2`D513U=/CICY;M+(K
MAI%/%AW*)\^)'OEV_P`PUD\K[4QW,<Q-GRS*?F6G7&8^7<76MOT[@A#UFR9Y
MQ24@H4X-S5/$4V_#6[WB"1]I(YCJCRG8<O"5X9L0B_6K5II0W,=?\X*>TY:6
MH<(N*4ICY9D5;<:``0IWHE2P:5*:^?A0#7RH1^<6G/6?I7Z2`N\D&/W0P>P)
MML\A62[<;YNF\*NL:$E[$$(E6J6VF:IV1>I`2R%O-.MI"DM*W)":[:4Z:W72
M\]QM@N+BT#1*6M:0[W2TG(\?>IE0KYL_F'O"_IW;XR_Q_J&7_JW=BA^C%L-N
M%N18F+SG'Y<%K?:0],M(C?,MMO'<#\BZX%A"-H\B3X5UM1U'OL0<9X8*4IX2
M:@U&.?#%?()NB]S6`4(<,4X7+''F"L9FB(\O*F7T8EQH7HT./:9#K[)XYQ13
M+0>4EM7<**_=2#O4:#P&K:?J3=8WFWA@8XT`#@"<P#P^M/SWOER.#FUIQ2KL
M/`5I>P'/+M)PWDZ#:7DX<Y';FQ8-M$AIN_J?*8LBXQ^ZO8EH%U120$J](ZZF
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M7,Q/'@$II=T*V'4-AR0L-+1O<`:#.U*TJV_AJVHW>)^S]>LO#`QC3J;Q7M9N
MV2$%CP?V[DP_,7MCB*R^?D]]Q?D3'C?HV/7F)>8-VM\NVWABY8_:76)\2UM6
MV7+CQ'V"5H#JD%2.M3KW:P/6%OML$D%FUVWNA:6%P->\T]"_,CK+=W#JW=`V
MFDWTE,1P-#ZB*)K,TX/Q>1<K!:H%PSN?-E<?8P(\.);6[A<WTUGRA*^3M\)4
MAV3L:J\@)H$'J!XA%UO>[PSBTBM6279:'.#0ZK>)50S<GN`%,:=B<F7[34W*
MW8);Q@/-%VDN8<^$_E.,N.2'0C(\GEK0ZTBS2)")O:25K2`E09"21XZF-N>L
MIK9DMM8Q@&N8-<#Q%4I]]+I):T5X8C[5NWKVH62R7'C5N9B7)4":FWOHM,"X
MVM$>>N;&RS)'E1EQ'X463*DDO(W-AM1#:VS3J*RHW=<B9LD5B-(9CIRKVU.?
M<B7<V1AK74!(QQ">C$./'>,;=;,3$"]6==MLMO#EOR&&85[BJ?8,L(N,=;$1
M49U8E%0';3Z".FO(>MW7+]WU7\?E[AH'F-HW`G$=M2.W)?=7R#DFN/EY:30N
M<YPEF.!(^]IK3`98)/<JXO:,MQI^)D-AO.06N%/M\PVRV=]M]R0VMUIE3SK#
M;SZ8+9<.\I"14I]7D>]+_JAE<W:&N?=B+4X-;J.BNFI`!.>'/FL__,=+):]+
MVSS4,-\!GF?+%5'S(>#^/1@5GN*,=S#"57+*[H]"1)0Y*C28<"WX\;@IA-PC
M1YDIEY+H;:=0ZI++FX^K[HW/ZWOFVVS77L6J5[BT:F/:0:T&%![0OC3]2=P%
M?2C*5P/QW-?Q*';\?S5SO6;&Y,6>@N35):EW"84,2SVT,E25J*BO:"H$@@@"
MELS<.H9O+D;9N?$6XEK'GUZ1@D_J9&8IZ4^%CX/L5LRJZY!:\+NF/)QNX7**
MF0,<OD"&T_*G&WO"ZW6\R97S<ZXI`D-)"OOJ66TI;4$H9WV\O+K:)XYMMEM8
M0VIDD)<W#@`]HH2>52O3?E#+\5\P+"%LF.IV`XX=GUIZ;IC]JR>&[C=_;AR+
M%-8D?GT6;+<M4%ZU18KD^>B1<&W&C%1\M&55T%)2?,:\\Z+>+G?+;5$V25\G
MAB+M`<<:-#AE7APJOJWYLON[?Y?[H^W>\0"T=B":'$`5!S](4>.2/;UP%8;;
MBB96`7V-(N$S(;A9)]ASI-TL$IB6Y$7;I#K\:-?%OV]<!YAM2F9(7O:7N2%J
M4D>Y[IOUKM\Q\^QFMV/=@TN#P"<*!P.55^?5I<WH9JD<XX]F(H$A\OX.XKM&
M-Y?/QJW/RLMCW5MAF.Y<6?R9,5N^0DJ>09-OAR3<BZ"5-E98"4$`DFFJF7J/
M:=.N6*5C1V_O5C!N31,?/;^7H-/[7#)26P2TP<5L@MEK^5BP]K#X8AO35Q.[
M(A1'GUM.25OS%(E25J6K<LT4HA(":`>-=5SW-_O,MWJ,,!(Q)(&BE#0`TJ1A
MB%][?)B>&3H6TK&P-KJ!TM)SIG0N3?*XMXV897E&,3,P:NS.4V]Z_29V?V=R
M%%=F&[.2UVZ+%L"'S'31XF(\I"EI*$]]-%*5[5TWO>VWS(X=OCNG2!@::`:1
M1M,SPPPH5\,;_>M_6KLOD>&MNY:4K4?F.YC]@G#GX%:8<"X3\:Y6Y5;?M3[\
M-B+-RM%G:<=N:'K;(;:-MODJ1LBH4XI!2DKJVDG;UKL&[.RVB>_3,-8+B:M&
M6/XJX9X)I^].W2[A@TM!9I`<!S/$$4)/%+J/D^7S<5M=LON4Y+>X<2-$<:8O
M-[O%S82XPR4-NENX3GV^^A"E46$[@%'KUU\B[H;N;<+EL[I'L\]]-3B<*X4J
M?VXK].-H%I!M<#((XFSB-FIS6-!=^6RE2&A:N%W!;O(6(=IU2%)ND@?,L.O,
MNM4M%U4M#:FY+33G=1Z5)6EWIU"0?4/4/E#$^/=+G0RI,=.X5;BOG'^92XDG
MV?;BUVI@O9:_YH3;^[U#T+DC)920I#,WC_&E"2%K<^;6QF-AB$/MDEM799>"
M!M`50T434:]9ZFD?`]L,8KPU<_1[,E\[])AKYI^+6TI_0II0[(NZ>U_%RC.;
MA@#JL\C-&ZVZSQ[PZM"\2PAE<1R,^M*$L/E8;)(60'B0*I&E[3&'LT/&8^I*
MZKNW03LD+M(TM&7:<*43^V/$[K:N5N=[Y<9RI:3E/N&D6UQRR1+:(]M_(+>Y
M"AH>0VU(GM07`\$O*WI<+B_4-H26[VV^'VF\<#5WPS_H7>G+GXKJG;8R*,^+
M82.9J*>I5Z9E@,CD/ASA)B/E-WQY^+S5RZ^V;-@5GS;YUB-QWQ8Y(+J[J\#8
MW&D-*2VZVV\%K>&\!"21BOEG!"-@D=-(X!UR7>$5-"QHKES!'/!>H?S!7;O\
M7P!U7O%B`!W2.2T]OF'W['LWY]M4>^R;I:O]##F)BRW.7PSPY9EK@W&WVPV]
M"8MKQ2P9!=51)<I8>@RV4VR4O<%!T%*U>CV[XHG2",2N86GQ/`TY'W1GZPO%
M;<1/@@EN)@'N>-3"#X/'09#C@<SFF>DXQ<N?X5EQ'(\[P+C^1BD)_,F[[,X]
MPV/^>7>P0DHC6EN-;\;89DW>2ZYW(S"@"IU&UHA?0^1]"SMEZ@OX;V5L4/ED
MM)``KJ/$#.G-?27SC@BVCH7;'6;2^225A<*EU:-!!HXD"E3E1,CCW$N3XT&?
MF;[P-,MMNL;JK7>)?`,>-.GR;;?Y]QM49;;F*-OQ9,Z0\\ZCO.DH>*RZ0""?
M0KQUC=6<AM[AKR(W>$5.K#+)?/O3]]#:[C&9P]SY)8V#2:8.=XB<NQ&'*'S_
M`"6BRW%VT<909F.6*[1_D1QNZAB[F]QXK4PR9=G#5NC)[C:4J#Y15"U%"NA!
MQ'0$8?\`%->^*W)<`,3J=0GG4=Z]E^>$S;"XV@POEEA-O(7N>0?S-60IS;2G
M9VH_Q.`_AN?66Z,8G[?S.NI>AJFVG"<F@NMNWAR)<ITV0\C)(Y@M0[ZE*71V
MVU;F3VZIJ!I>L-MFGV7].`@N9);I@`=5PH1F0TM!'958;Y=;B^^Z@N2!Y,8V
MR:@YN`-/25)NW^RG(.<\AS>WX'G/%MSS>%;+WDN0.V"]<@OP$V6$JW2EXU#G
M7VTW.'$NLMYR+V&USD1RA]6U8;2M0R.V=`R07_\`PTT+[4#^$&&-K#Q`Q)([
M2>Q*FM'V/3CKF8.;>7CW,!U,+2VN9`)<#7#(*JCD[%,LXLND2^Y#>%XUDS61
MSXEHB6>3<;1?;1<;2J-,$]I4F#:U18S*WMK4F,\M!=02TLIV.*MAMM]:R1^!
MGD!WBT@U`[*K(_$B<::4IS3T^V.)R3=N>\?O$WC[,Y=I<YM;O4K,V,:RR5;;
MF5R+@I=VN61+M[MM>9!0AQ3PD[G5+*G%*W#4J.P=#U):7D(>(O,J:CA3CPJH
M\OYL9$?BTN%:8\5'+@2>W:LFA6R7%==1?;]:VFX=^C;OEI!NC+FV7:[K&FPG
MW'.P4J1+C/(.X;@*:KMPAD;NEO?.):Z$D.'^4:$_V5<V6X3VL,UNV-KHYVM;
M4U#F@&I%,,"<0:>FB_:,M`*;3:TJZ*%NA`CIT(C-`^%!XZW[':F`\P%Q&.E(
M0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(
M0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(
M7YI.2X5`Q"'?HIAI8F-$%R1/6F1.1N;:2$_-O@O);2FFU((2/(:8%O#'&&#`
M53$6NIUDT[408U+C-8S"09#5=DK;1U!Z?.2%"OJ\>O\`)33HTM;0$4[T^,30
M8E1YYAL]US*SW3$<=7`D7N^M?*VV--N<2W,27TO-O?+_`#DUUN(AYUMI00E2
MD[U>D&IU5[S1VV3QL<WS'$`5(S(P5[TW=QV.]PSW6IL+:FM#@>W]@LMGQ?*,
M.]N&1\>7^W?)WG'U7:+<69*4N1D3I.;6V8C\5I:E(`C.I20:*"O(BA.0DA;'
MT&ZSD<-37NKB.*]!LMSMMQ^9T&Z[>[7!Y9`J"*'3I-?0:A1`:R1W&[C`?-GL
M-W-R=@V\QK[#DS0P:7=:3#<A3K>\S(<2:*4%&J32FHWRX>9(KASL"'44CYX1
M>=<;>36IA-*+YR9"P[(I=YN&3\7&2U,Y!QE#4[%LLRNSRC)LMJO#+$M`F/9#
M``C*E*2MH,)2O<:^1UH]^WN6QAFA9$2-#A4X\,Z#%>#[(P'J&U8/=^*9_I!/
M5,"5-0P&]R&P6E)<HDMI#CJOQ02`Y4=04CIX`:^99GS->7/`U.\6':5^EENT
M&-C<Q0?0$NL-P:!R%BV=V9^T_G"8#N%W)5L8RJU8>7WF+M<$M+7>+K9+Y'40
ME52QV0I6ZH6FE#Z)T)MEWNOQ$<+'RN+&DM!HXT.H4)K3$4-0OG+^8:TM)[#;
MXY)&Q@7I/>0PHEF^V9AUIPCB>ZAON_AB-[A,19:`;]260S"XX+?96H=5%)6?
M,ZW;>FMW\PF:RN0UQQ\0.G&M::>"^2QLUO4/%RSFFYYF]R_&7#'+N2XA-X<S
M8WJW67C*-)NC/(5I^3<-LP3%7?EV6).`)=>AI4TF.Z^A1^80THH*$K*=>N]/
M10[7;AHBB,SV^,N&-1WD4R"B7&WA\KFM<75.8R/<G\X$]W6`\BX)R'+N6,V6
MUG$7;5<Y`S3E3Y%$F/<[M='H\"'+O6-6N$)C:(1,.$VEUUT?AI*P@'6LM[[7
M)IDDB8T#(M^NM**)-8.CMG0@.<7D98\<.&"EU[5\7MGNPRRU9'@ENQ?#K!'O
ME@N%TD9[<KZBUSH<6:(Z;EA=FBXZW<)4F0A@I:DN(9MLAT?A/I(43'W"<0M\
MZU?&7G/2VG=5(CVXM>'SL='(UP+345J/0K6V/I6>W[(N0(=QG\IW>PY3?+XU
M;(<VSV:%BV,2[_=ENM)MK[5HE%AQ;TY@LAZ4$A]XC<KU:KHKJYD=&`\LA94E
M@`TNKGJJ">/`A6$D+;U[S?$S.D`!+J5`&0%`/K3,<R_2DXHL6;W?%Q[AW;)D
M6,MM6&9C3N(W&^R8<X2'KM-$^XH;:MPFOKO"W>VT\MML[4;A0T\RZB^75ANU
MS)N0GGB:02`R(.8*YXU!./<O:.A/FJ>BMI;T]#:0S1M>YP!D+""X8ZL"*4&%
M/7P44N6OIG91BN/.7CB/D&+R](90\ZYBQPK(<8O\]KLN.!NSREM73$[G(Z$(
MCN3(;[R_0REUP[#@-S^5VZVML;K;I?B0,:%FAP`[*GA_0O7.G/GIT_NU^VPW
M2#X*0N'YFO7'V`X`@D]M*45,'/WNRN&+<JY+9(6(XW!N&.8_B?'EP7.R?D6S
M2)K.'8Y!M*DY%9;7E%HML>[PI+:VU;64*3VTI6$J2=>Y;-N6X1[+:VK7EK!:
MLK@*UY&H^I?*_56V;1<=0WD\48/F7,SC0U&,KLCR])3\CF7*./>/^/.:+EPC
MQ[<X/+/'F,0[#D2,ROF/W<6RP1TOWUR-=_XLO5^:M\RX!32%?*DOR(R$+44'
M>(]K;LLKJ3='$?%/)%<-5#V'GQP53<6-H`R!S1Y9:,.X)W,&]TUM3_`/\%\,
M3+E>K[QS`O,"1%RW-V)EEML_)\P2MNXNW*_R;61(4'^ZJ9Z75.J22L)2D6EK
M>S7%SJ#SHKAEC[%`N=OV^W:USFAH/.OT<5(>3[R?;WBV*XE?,]X#S6TL7BZ/
MV^Q3GLUME[A1)SMYNUKBW''W;7^?YG"E37@XVQ<$P6/F15*7'$)2M=P^^,(I
M*]P'H^Q(M-JM=RN&VM@UDUR[)M'`XX#$G*J0=UX:Y>YHR^\Y'Q'P7FZL/=0P
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MV_R+)C7#%VQQK$;_`)#:[U98ADY,S;\CM6.7V19+5*;6E;-MF(N#KY1L<+;;
MR%>]7%Y:[A'YHA,I;D:@XCG6I_;!?)?Z-\.1&"&1'B<NWO46<B]YG.?'MUQ^
MSY_[#N.\7.-NV5ZZPN4^).1L.M!@0;EOGL6VZ&_V/M6^W.+"HTE4^3M*AN02
MK;J/%?7K&D-:^(<@2/\`1I[4Z-KLV?F7)9-$.68[!C]2Z@^$,*]L7O9X`L-[
MN/';W"D2_6NP+RS%V+A>K7*Q^\N,.WO'Y!GS)-K:O.-W@R#=K#=F&VHUU@J6
MD5=:E(;D7>T6?5&UR[?N5Q6)S<B34=HU$X\\%-V3>)>DMV@WK:FM9=L=@:$C
MN.(P](56'NG]E.:>W.Z,7GA?->)?<:TS>)$>RV6!F?'YFSYK&^9)Q7*,5O\`
M?I<1`EV)+R)B'3(:[(6JI%=GC0^7MQTIU+:;QMY\[8X902<W-(X$"E1PR]*^
MC+OYP;;UET/?[#O41M]]EA#1I]R4$CQ-!KIYT)*BI!XK]Q,#%4Y=R)[?6L3D
MOY8[`M6#<70</NN-*:R7^%(EE-LQO%&LUGH6[,3(6@M*3&;6AQ2NRA0UMMTM
M+?>W4E#A'KJTC`TK45J#]2^<FPB!NES`\@8@9&G#T@+S>3SK$R1=B5[,^3+I
M9KV_+GS+E\LN+;FH*KS$$1VXW*#Q)?(UJ>1)<4ZXA*''0PVM2JI`W5AZ8VR%
MX=./-Y:B"/91)\UA_@V0:./[%%6)+B9UR-C]BSGVI^]7CF#E?(V*X*O(++:[
M%E6/1E7N[6C'D9!)MEUXHX]O4/&H<5\27)")"@VRVI5">AJ]RZ-VC<7>9,'E
MH()`(I0<L/K7IW3?S2ZAZ;M(MNVZ!K((6D-+@XXYC51PJ*\!0T5MW)OL%]K#
M%ES"S2LAYEQN;C&<)P8K@9+;,8SRXW/%7[TRG,[3AS^,*MF38G/L[_?)C=F2
MMJ4RZ7%IIMV>V[?86=HSX75'`0*-%!EPRJL9U1;3;=U!/MT\3)IW@3>:W%KA
M(`\D`5R<XBE<*8XJCGWY87R[[,^1+);,M.6X[B.?HN.<\:7R?(R'#IG*6-RB
M8+T2[6^\S;PQ;LAQ1RXAV:Q&2PUME19#/=CR4*&CL[?;]RN!;W1>R-S'#77B
M!@*4S5+;OD@>)XXHM(/$$98YUP]6"4UVNW"HX,P[E#&N:X.87ZX*L$?-.+?X
M2R/$[C@S=R8>%Q!S.\-2\#O,BTS6@GM"9'5.:6EQ@E56QYCNWR>VYLLE\V](
M@+B[Q.:#4\L`OH;;OG[O?POELVN!QC:-3A*XMH`&@X-\(PQ)XE;]]PR^P;+Q
MYR-[=N7<%SINXY`W$SS`7VY]@R7%XK#3RA+R"X27V;#<+6&7"KMP'GI*'=I4
MG::HM^B.C[/IQLES8745S%*:.>^1K6M_JZ@,\,NQ>?\`S(^8E[US%!%=60M6
M02.<&L<7N)>*$D:?=PJ#PKQJGBX_D^WKFKE9-IYECV;CJW"R1(,N\)]QF(S2
MIQJ^QY3#R,=FP(C1AO-VY3GJAN/*<:+&Y&Y+FO6&=,VF\P^;/%;R11M)\R*X
M:7D"I)`TD&G+"H%!BO'V[I>6%P8K)KV7#W!K*@BKW4#0:@8$D"N0K4JQ'$;E
M[-\KQ3DKA6T0X?,5ZDV+\UX:Q7C_``7,Y4^;R5`D6Z[VR\0T8P]!G7VV2,6L
MXD,PY45DMHC(6?G6ZK<P<]UM-KX[*5\K?=;IC?YCA6FKRG!M&UPU%U<":9+T
M>XZ4ZG;OQV#J(6EM?B-I#IKF-T()C$FD2Q:PYU3@*`5(!-:KQPM[<YN91N9?
MX:Y!N]JE7V_\JNY)#Y9MMQL4B1FO)%JA-L7&VM6_'[2PS:+1\LL/QU6^,N,^
M^XEL+316J3>=SMA#-8QFIDMR,ZT)&(^P'%,],;5<V^[6^XRGQVMRTN;^+2?%
MI/\`2DN/I/\`N4F\98#B>+\YX79[AC.5\DW:\L8?R)'L=JRJSYQC^%62%%N+
MM\Q:5(<<AC&WU*:VMA(=`JK<=N`Z<OKOIG9VVEE$91(XD^+0!3F2UV./+%>F
M=;W\'5O4$NZMC$-N8F1L#_$:-))/ARJ3ZEJ\>_23]P7$V.\BVZXW5R[77E/C
M/-N'<:N5DY6L4R4J\YA;\=19DPIBK8?RE\*QR4\F4ZCL1WGUJ*#O2E.ML^IK
MJX@E=/:N+F0.=1KP<<@-5`/8%YWN&U-MY8G1Z7-<\$X<B,AGP[5!#W&?2Z^I
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MRXL;FF5O2H4Q`*DM&I2JS=!TU<Q&.*W;K<*U:"*G.OI*F2MO[NYC._SW4MG%
MX2T`/+1EX1ACVU]"CG>[5[Y&[N,BP;B/FO,L626[FTC),9D-/-WE*V'<BM;^
M.W6%)EI8MU\"T1U(;0\8Q`W$*<JO;]N%O;MA,9-'Z@,<,<*$J+J9:SO.W.DC
MB-0'.&E^D\",1C[5=[[1>:?JBOHL/`^8>U:ZY9BO,''.3R77C?K!QUBW&4.\
M6N4XQ)R?-WK3)Q_&;DM;`:EVV7',UY*TQD@I<JG0:WOC\B&UTS<"*>WM46TM
MK(71DO7S_"%M"6#4X.K6H)=1M>/A*47NF]G7/7.O%=AXSR=?M^XVRW`&%?PA
M:<"SF4Y@UD6+>CY0SK'C6$9H_<[W+O`D&1)=O#VUN4HL%@`L)S]ZWJUMPPQ0
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MMH,'UR5UNO5FR]5WD`#K:TW:UA:PM:US72M:*#55Q#G$<0!W+],"W@I@PTJ&
MU28D9*DFE4J2R@*2:=*@BFM#`#Y;:_A'K`Q2#FMO3RXAH0AH0AH0AH0AH0AH
M0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH
M0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0N1O+^'O9[QC=+!8\U
MBX98+CE<[\GL4>]729*?N=W0TVMFUNIF2)#[3[[+@#:G2&RKTE040#Y`ZZN7
MBCY93_E+8!L+<1&T_P!K$)Q+1[8?;]D5N<>Q;&\0F04/2K<N?846R0U#G1'5
M-3(C;Z$/,-2XCP4A:'$;D+!"AIOXB6M/B)#_`%:J1Y37-!:R-I/$-H?750WY
MM]LF1<8WBX6[!LJM.2+S^S2'<<M.9XEBD<83/@R$0F%6F[V.T0WIBKA-N#7J
MDH7VPUU*@=:38H0ZUN[IWYDH:-(?B`X#`]F*S^ZLN63".%QUR-.D=H'UE4@\
M[<&>]#BR3=8'+2.1H$=Y\NR;C'QV-?<#EK2\@M.MR[1$FXXEC<T%-M504BA4
M$D4UY/==3=76T,K98(7V0D-*-UDX\`%3V]_U!L;_`(IS9/-X4"BQC5^O&,6N
M\K>L>`YG<9DQ4A4C,,*CW"/"G-*=^3,<Q(<5=E5!7((I%>0%]2KX:<VCKJ_V
MY[G-ACBUD.<T\3SR%,."T&Z]=V_4-M;P;S',V\@9H:\'W0<\*9>E.-#G<;Y7
M8XMHR;BZ9;;W*DL7:5>.*^6\WPEEV_(C=KONV?(!F5N3;I,ETJ7%3V&W?`!)
MI302_,<WS7QW4+2Y[2`X$`BH[BIFQ;?T=+>V]U;[I-;OAD:XLE8WRW$&I`.#
MJ<C4X\T2*L5PGNW+Y"7;C^20D+GP/SJV)D1RMTHWMPERTR9%7%5*4(6H)2I7
MI2E1&%$<,GC'B=7`]J^JXOF'TVPGRKV'Q,``U#.E$L,"O^,8>SD-NRM>4H&0
M?D:RO"[QA\:ZMRK1)FO*C.LY/9,E8$&2B611#"7@XV"%4)KL.CNI9NEKR641
MO,LS`T$<-+@ZIP/<O+OF=+TEUCM]M'#N<$=U:2N?('-+BXEND!FDX\23PPPQ
M3H6'FGV_6:U/0I&-<E99("WTJN5_Y4P)$QM:=RW8[RL;XM9CQTQTUH2V5!2=
MIJ>@]#?\W+^,O?):OHXG'S!Q-?P+P-W3G2-M)HEW2.04R9"\FO<7##TIO<V_
MT6,XR6\9UE7!N1Y#>\N38X$M^?S&[._#L=HB6:U_(0F.*WEVJ/\`(Q4J<<;+
M:5K42H^`34Q_--\KW'X=_FCF=0_T<5-AV+HZ0!IW*<1G@('4_P!-.5Q/QU[!
M<?1!'-_"L?'^);KG&!*DV^]<KYK>XE_S=J^3%X/CD^.C'H,:/8KN_)F?/DMK
M81&15\ML@DZGIKJJZW^ZDDFB++6-H[`3W4[L4QNFS=.6MO&W9KN>:]<\U!86
M`-%#6I<:\<%:'QUPKPQB_)C^:VOE/GVUP$28\G'L?D7'A"Z6ZR.,QXK/RENN
M;F!6PN6UM5KCJ0@-A>QL("MI4-;R.[C?74--%E[FQ+I#)J&/8ID<-8QQ98;G
M'8RCG7G[/V$SL8N2GKNSQ'$7!=M-SD2@Y(DXKCMOJJZ27$EQXI]!1^'M)5I]
MD[`'%V#=)Q3#;%A(,CB6@C+`XD#/'FI)<5Y![:?J/YERQS5CO*4_B#+K5E[>
M,Y1A-LNF*<A!YR([=,2L^17,=['KA@M_R:%AJGI=GF+?[9*'D/*#I":38^I1
MN<$GPS-1AD+2S!Q./H&.?<O1_F=\K)OE_?637RW-S#?6L<K9"SR&-<]@=I;Y
MKZSM;6ADAU>*H+004XEQ]C>%6_((H@^^/,\7C-M,H:QG',7X-1<9DEA3A>:,
MK))N77%UYQE(3V&6`ML(*O$U$^3>K66Y9;13VPNGX"-DD9=7M;KK4<5YZS:7
M:2]\5TYC:%SG,.D`F@\1PSR5)OU#>,L-M7/J;#[<)_#.57-KC:RWOE[(>=,;
MX'Q'+L@RF]9)?8$K+Y%QS7`;';\@9NC3++4Q<`O(9<CAU\(^9:4[YYUQN>Z6
M6Z-M]ND<VD8+AI-"3Q#JXUY<%M]KL;>+88+^^L&7'GS2AOF/T%C6'32C23ZZ
M*KOW'<Y\F89B?%F%<6HXFS/,[!CN:3,HN.'VSB;*<5QBU6)AF^ABQ,-6-NPQ
MH]OL4IO^KV]IA(D`MJ;=4%#5CLDDNY6-O/?$NN1JUT-#A[E>Q5-Q<B-THBM8
M60.H&APUF.F8:["H/#VU5,<OG?E)^\9%?WKVY)N.6(4+NZ7G(7<;=$A78BB)
M;84.V14"<Y1F(AEA*E;FVT>&MB)`&^8QH:!D!E@LY+9Q3T\[Q:35O84<<;<U
M9S`RR#.DMP;G,L>.3;!B]JNU_#&.P+7(A.V[Y=A=YBW1N/*2F<K:^510T^H+
M2X'"G0)7W((G.J+*G[U*M&_!2MEM_#.UP(</>!!J,>5<PK`L?^I'[K\2L4;C
M_&[19[:#>57"<_:<=P_)91:DH@&28-\%RE.2T):BAS:IK:AU:SXDT:CGCVBP
MT22MCL8SB]Q:*$X>)SG-%%<[\Z7?M]GW::U<W<)Z.DCB%6ZSC(]K`,Y'^*G#
M*I3@<;>XSE[W#<NY#$Y3L^?VV^-88_(QFT\%8O;Y.?Y,U;;C`2R;KC\>Y0Y,
M&SO69Y^;-GE+Z2[':2$$*!3ANN8[3>=MM]SM;IOQ#)',\R!P(-,"TEI(J.)K
MBI6P2[QLCIMNV\3,8_\`,=',S%I.-0UPI0\!3!;EW]Q7./M^O5]R:Z/9GQCA
MN+P_SZ?A?,..OQL@Y6@NWVVV15IL5QO4"'=;1=H5CDKEM-P7'`J:E/<)9!J=
M#W<]C9OM'2/DJXNUN-3GD>[@HVY?'[K<?%;HT5:T@`-#03PH```I7<>?5LQ^
M2B/;T\KX//M\@H9%NS2:]CJ'EK2*,26+\S?;85EM5%)<*4D^>MN[=Y1[AU!5
M`L(OOMH5,S@'ZI^*\3\FW1BU>UWBWD;BO(\<Q/)/<EE^&R^/(,>RXX[D\W$<
M0F2L<8L,FU<FBQSK@Y(D,N+BJ@0WRIHEQQ=4NN75:UF!)HAM@W_:&H5XO('O
MI]D7%6+M9!;N(^+,'S6<NWM0+;F''R.,6(\ZXSPRIE_+L0PN\MPUR(D2:J,H
M+6F4Y'VDH25+3)==EH\IS]3AA1<DLHFL+F"CE0K[S,ZQ_D+,+)R?[$^$.1L\
MMMRO&:(YILG"$N9?..<2O2KC'NN*WW&(4JY(>C7S+K(^7+_;;8T(<:[)6\VV
M`ZI2\QO33(]LL4SHY:BHK@1R]/%6FTQ`-<WRR_`X@T^U0G8]U?.N-)<=S;A'
MW5\9(AN.M[\HXUY#?B2A&2HN+9N6/6J\06V6E)`4'%MK2#U2-5FF]_''_G*P
M\F!O\5CV\J"JU./_`*I'-'#L?#<;Y+YL9Y%NG*%D<RZVOV>QX_B=_P"%;HS<
M41Y?&U^7<[YAT:[XE>+1+2&E7Q\7.#/A%39+3[J3:7!<R)I@<TR85KAPYJ%;
M1.DF\;:!N()YUP]BE)BOUA3RSEMWPKBKC/G#-,VLTUR3E$3$,7@76S1KY=)(
M3-N=OKF.36DLW":DN!4-YYI:BI;:4@TU!N[9EW:L%YBQKP\_F$`D94#:.%#0
MY\,<%+G-Y/+4EAD#=`.FATC&E:^U-C[I./O?3]1$\;8/FWLQS^'P]PER)#OU
MKR+(\FPW'LSSBU'%W[#(BV.WS4XK>(%LGN=I<TO7%Z1MCLI0D;`$3[#=I[66
M5US=23L>`(VE@K&!]VHIJ!X5%>9*0_:Y)8:"-HH:DEU,>ZBK>G?2A^IK;<HN
M=ZQ3VZ9-8HD_+I4>W1+KD'&[_P"38>;E\S8KQ>+O9LK>BSYEO;"4O--QG)&]
MON)"PNFI-W?0;FT,N(Y'L'9S3VWS[GM4-Q#MTK8F7,88^A8=0#@['4#R(]*D
M]G'T9OJ*<FK1D%\Y"X?&1O28LF??,OSDLW:["<TTF\R+WMQK\R;D1PPRU%3W
M72L->M2`0$QK,,M(C:V,#A;G-A%&]].?;VE1KX2RN$\TX#P[-IQIRP_H3^2O
MHI<^WQ%HO]T]QG$:N28\NV?F7(-QF9W_`!T]C]IM3]MC8I&N%BB9#:D6=,A3
M;Z@I+Q6EA+8`*0O5QME[N^UEK]OA$<8^[P^CGBH-Y!MU^W3=RE[QZ_77ZDI,
M<^FWR/PE\IR5[B_?%C;<N+>+6);^*8IF:XV06FVN.+3BD%K\VP_)EKN=O0AJ
M0XV^X^AM*MBFTJ)%E?;EU/NK-19$,*8YX*MCCV+9CJ>YPAS]VOHJG@]IG)$#
MVP6C+\:QB_YISI(RO-(##/)'+MSMN#RTVJ)`>,7&+3BMN;ODRW66QJ#[RI3C
MDER4\LJ<V':TFGBZ1M+@>?.7,F=BX#`ZN))[?8I;.LG1N(VYG_#\-0^C!66X
ME[B,UO>0\:8S/X[L4N1RE"S"XXZU8.2\7"#!P2V)NM[<NKF06?'(T-1A/492
MI]2W'"0H)`)#\?25O$_4V5YPR.(^E,NZPN'Q&1T+!XJ8&A]=$[\KE^T7)6%8
MS:..9MGY!;>@YC;V\L,R)8LIQF3(D08$R%?\,S+(K'/@J5+(<?A2&I3BF!M:
M9]=9L6R6,(=`6U<_!QY^A,2;_-<QB>NF5N+!6ND]ZV^1/=7G'`>2QXG+'&<3
M'\#N^*6FXXQR-CF8<E7'$,BS%^Z2&+SAMJOB[_<85LFV*SMHFJ9FLQIJT+H&
M"E._2QTWM)/\-1G]0;DV/S9'ZC5:Z_='P_SGB[-D;Y6Y3XERJ[/B);KK9>=S
M$QY]V24LQHLF?=L5?=MKDAW;V&98C1'%K*52T$IK+CV#;;602>3$X5RTJ.=_
MO+@4+WM<,@#2O8FJYX]O?+..\0YY=N#;GFGN%SBU6"^MSK/<,YO5FYKQ*Y"U
M.?+38^"3WU6[,6[=,'>5\HM,A]"C_4]HJ9)B:'49$R.,'`@<.`1'>7WO%\CG
M$>Z3S^Q5F\9^]+!;4JVW6,,;A9U:H]GCY%"R&P<?Y5OR*UPTQ,AM=\+EM:RR
MVJ7-,AMX1IT>0R7%)`KZ3:@E\:A&:\#]#P=!./I3HV+G+VV^[!68<C\,9C8>
M&N9D,VO#KK@/)<.X/\/91?L,>N/Y<FTWZ7CHS/!9,P71Q!DNLW-GJVB2U&IW
M-=CAETDL&IJ?`C/ON#2B7#/<9[^>.[S<[5[A/8/F_)7MUDOV.?C;N!P6N49.
M'28SK[]VG6O../\`(LMO5MQ><2AU,(I4@(6H%AM([1;:_5AJDB/.A%>Q+=:R
M/'Y>)2RP'W^<,9E>,MXFF\S-6&9E-SB3^-O;GR3Q%&Q3->$KC&B_,S4X-=FN
M3;[D]KN+K<9<VC\%II92H".$*"$OSM;-;Z))&\,0<^US>)[?2FOA+B'Q::@\
M\2/[)X#L5D4_FSVHF^\8<1^YN=R+DW+;L&*XQR/<+]A>-9UG%KBQ^[;97($6
M9C.%R)<".T4=N0N&V''@A/=4\LI<L-IW_<]BV^:QVV_MWV<[2)+:7413FUE"
M`YW`UQ46?9[+<9&.N8"+UKAIE:0'-%>.&(](74'"2$18X"BL=AFBE$$D!M-#
M4>GJ/ATUYBXU)K08G);G(!O(46UI*$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$
M-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$-"$
M-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%^34.:YL^YPN3N1N6+AD4R#/[MH5-Y;
MM^8W2ZW.S-2$V_)7,)7\ID;4A#TE;;<F8I8&X!+6T)6/EW>F_,)EGY>V^4Z:
M1U"6PEI`SK5Q/LH5L&-L@?-EU1R'`^(D>CM4BO;-]1;+>".2L4P_".2N,K=@
M&8W*9?\`,[ODZ\[S"W8V[>5ROF8U^8EOW.YM7-VX,"5(^00$-&1N!4DJ2%6N
MW=<Q0LNI)YW2:16-\4894C'Q`:L.&-2<T_'>V\;_`"A%JMSF\N([J=A*E[;/
MJHR\^R^S99RTK#;E'PR4Y:#;^-;3=(K;T2WY1'GS;I%-PDR3>4WN'!;=C*2E
MD-MJHI((-/1^DG;K#M]Y^LR#S)8R&Q@4H0"`2>W-5]Z6SW\,ULTB)AQQKZBK
M4H'U;?9O?[)'DR[/R4^JXEI,O'F<(%V:85,(;$.2X_.BQ7WR[N2=@4A120":
M'45EM*P?E-P_J_N5RR:,@B2OI_>H:\L9=]-+E+(V[TKV>^X"?>5.I7)C\=V\
MX'!FON;I'<NEJM5W<M\AY\DJWML'NJ50J-1J#N?3VTW$^J^C#+KGJTU']D8=
MM557>S[.^9SW1R%VG`AQ()[>Q1;D6;AS-L9S+&<"^E]RNUE9GW2TX->^0<FY
M1O-D@,3#(C(RV=;DKB1KC(BNAJ2W%"FVW$GU>D;33#IC9(YO,8*T/XRJQ^R1
MW,0A=9C3A1Q.`IR-,*I18KQ9EMOBXE!G?2SXQOCV'N-F<Y.AY-&F\A-1;(Q'
M"K\WD]SLYL3D2ZN&:@00HD%"%`(!*K.UVBQA)<R@CIE74:^I3H^GK-CF$1Q@
M-(\)H:X\Z<5)+BS`O=Q#Y3G9/9?91[7[#C5XMDQN/@\O&^-;"[8W8R&%M*3F
MU]RFUW!^:@)2`94KLOA:@$$A`%A:;;'<RB.(.:_FX:1ZU+FM9]MU7L$;7L&4
M;`*]VJ@*?"_8E[ZU-L/6GVV>QK$&WID*YM3[=$Q21<%,1;C%2^U=EVVWYFRN
M=,A]]09]/K"0I9%#JPN-LBM9/*D:U[J<M0]O%)D%Y>Q-DBC9$_4"=;16E,1C
M59+AC?U*)=\BW&Q9#[0>.[8BXPYZ[%;>.5.(;M[<=QI%O#S>&2?F`>\'9+CB
M0EYQ"4A`%0>6]DVCQY3:.R%`/;3!<GLKMY:]DL0(S`:!ZJ#%0(^H1[2/J0^X
MSV^7'#,BRO"^?5X1>WLZP6R\?V/',1O$G)5B3'4EDR$8ZM3$2TS)#*&W4!(0
MA*1M416_V8OV^4LT-9;2"CJ'53D1]:1NEEYUFU^H&9IS`T_0H?6[W%<Z\#8Q
MC5K]P'L:]Q^%7BQVJUQ+SEN!7>)>(TVXVVWQXUSO!LTD11#>E.;W76DRW$)4
MNB5`:U,5U$VNMU?:LP;>0YMJE18O=##]R=[RODCA#F;F+"![1N#\VYPS/CG+
M["UB:L_F6V[V"(QC6?0KE*DV[*\(%C-R8>9CO/OL2)C3R>VI*5:GQR":K6.J
M*5SX)+H2P5<T`=RL1QSZUWL*B8CA$&5G?%-EN/SED;D#!L%G8IE;4J[N1&6Y
M&?7'$L2#.1L8TH!<V5/9ENLI2ZI)6I:DK:MGVML'16\,+0_WO#I#N>K30^D8
MI_<+W=-XDCDW"[N9YHH_+C,LCY/+9^!NMQTL_JB@[$\63?4=]BO'^)7?GMO*
M>('+7CEPB7"=F>#8E<\DRJ)<[],7";NL9G&N,H.4(<E3+@I+\I/:[7>)6M(4
M3K.VO1?05CNWZG9[58LWAQUF4AY(<>(J:@X*5-?]026GDON'&TTZ2T5TD=K:
MTX\EEX^R/VP?5`XMLG(UYPA.>\1V7)\JB<9LWS$LOQ)F3<T(L\/.,E:@/W6)
M=Y<&;*MT*,9$MQ:''(1VH04*)=ZB=^H3-\QP)97(\U,V6P@M[:CH]3#D":4Q
MJ:#M.?/-:6=_2A]J&?8ZY9K%C^1<630Q<(2[WQ7<OR.["#>('Y=<(\UV]LY'
M%FL3(CB@M+[:5&H*5IV@ZJ[)\MG)J8?!2E*_5DK2ZM8)X?++6M;4<!PX55?6
M=?ZNIA(8#7&7NCY2L?;04Q+?R)A^#9O;6$(+:66'IS36/SE)#0.[:FM0`E)K
M468WZYB>&:1Y8YC!5#MBMW.U-=X^02`QOZ*WN^X=XW]P&&X<YP/SJ[S9AD3#
M;#/7*'%=QQU,"=-<$^[Q+["N=O=;=_,4R4(B2.ZEZ,BH_:1.M]]B?)YDYP`I
M1HJ/J3$FR7#"-+13MP*9+@'Z&/OCXORQC(LJXYXNFRX[,N`N=C_N5R_#;BW%
MD@LS4Q+Q@U@EK09T5SM*2*M$"NT^&JW>8;;?+(V.Z6PGMRX'0]H<TX\000>R
MH4BRBELIS<1STF(]X2$.P[1BK-/IK_2I]P'M2YYY(Y_Y^Y&LF=7G*<)G8#A=
MJCY;=;_<L=L%VR"%=)JKSE606Z/(GR;?:+8S`9^7:::6E;RU)`7L$<[99,M(
MMOVVV;!9QN<=#&!C17D&@"O,TJE_'SMN)+R\N/,G)IJ>\N=3EJ-33L5UDS`L
M.O#*HV1M8K<6TN_AQ;PS9KTU'_"##A2P\)BZ=D4`*!Z>G33]OM-ZP#X:)^@\
M0*5YU7';K;/'YKXBT>GZLTRN:>T+V:\@QW(^9\&<*94"E;<J3+XNM7=<;=26
MWEMR+98XRFU`=4^JB236I)U+_2]Q9@6EM>9HH[MSVSA1_<T%1RO'TD_IPS+9
MD<"V<07GC^WY3$3!R-GB#+,VX\CWR"02W#N$2'?C#<B`J)VJ923N4D'8HIU8
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M]85/]A'SJ&6)UO;:BLML,$N+CLA!="C1:U*):TV?]VS_`#0I?P^\_P#5'VJ1
MF)<P<6Y1;7LCY+XLSZ%9V9L87>]6O+N/<ZCQUR=C#4FXVC*<,E78PI*U=L..
M4;K5!4*=)(M+:;PR-:&YY!1'R[G$TN)=A^!P!_[0(4TN,>/_`&Y\@0Y-RXF;
MO3!A);1)FKP/A*S_`""I(4MEU;-HM-GO+C+X02AY*4I<"3M4?'23;6[/`&,+
M1V#[$_:ON[F,2"9VJF+335Z7"F/:`$Y%XX,Y$$)F5BMY@Y_""75NVFU2Y=AR
MR$A)<`,?'+PI$>](`;^Y!F*?)/H84-28!;1@#0T8_A"<D;=`^-[B:?B)3!R[
M8ZIQYB8VXU-C2784Z)*;EL2X<IGTNM3&7VFWH<IM1HIIU*5I\QJXC=$:^73T
M*)0C,$+Y^1N%0$9Q+12I*4UCJ*``GJE3Z*.*W5ZU%!IQ)H!P6(6*Y$TV6L47
M2JILF/5(K4H)AK9WD)KM*DC[=&NGA!QY(TLK4@`\USZ_64Y5Y0QGFWVL\589
MQ_?<J%VL>;9;BL;&)`8F9+FDJ4G';A8ID]]+EOB6FPXW#^<<=2VZZT)/<5M0
M-1+FX$+@YQ.K"@KCZN29NX#?V;]O:!IDH=7X:&N!X$\:<%2IEWNAYYP[D21B
M^7XA9L/NUDM['S>%\BO-2AWW'Y#`NUKR:!&@RG7.UNCJ!4D-E"@H;JZ<;N,T
MA)`"I3L\MN`)7G2<L2:<\$L;;[V<KM]VM&0/X$Z+[86)L6VW#"N4)"X+;%S2
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MOMNX8Q"\<[W+)[#QIPO!QS`X_/>)\N\@\BYC%DRUC^';9F;V(6*%G[CO=66H
M+LJ%VH[*6V&EAL-H2ATT<;=1=5O(8JVC874I[U$I+'[6_HE?4EPJ[\K85@_"
M//[F1S9,3)>7+1E6=6#FN)D@9+KK.996B\VWD2T9>E+B5#\YC(>6%I40INA$
M<7#2\%CCIY?N2B#K\MP)=SX>M41?4,^B#B7MRO&+3O91[K.5\`RK)79*6_;_
M`,KHR'DR??[5$*Y=[O\`@')&*V2=9X7Y/'4A;[>21F(_8;4XF=W/0KMU>WL$
M!DM'/:\<"*@^U/Q6]NYWES-K)PH*BG>J0('NQ]TWM`]Q./XEC?)-QYM?C2X%
M\QZQPFKTY(RR&Z'Y%LL]_LF&S,6F7@72"AN2XU!E-K[*A1XG<E+%OO\`=S6A
M%Y5Y`PJT`@\\U)EM(!0,>=1-,"?:K6>'??+R;[RN7+-=^7/;>SQOEN`8;F*+
M3DU]CWR:E%YDV*ZPY%[BGD&%=,JL&RUOR+<F'&NST933Y6J.IY"71FKOJFRM
MKIMI2-LSXG/KJ!=5K2[+MICBG)+:XBC`<'!@(Q-<1S4>>#/8)>N3T1\/O_N0
MY,O&&L-88C,\,BWB+E>/W2YXO<VKU:+E:;].8K9K#"N)WLM-I;?7L+:J(4:^
M)N^=M]'</A9`TR.D+"XFE&UT@@<Z+9['TO#NS3-/*61L:20T#`#&I-10%?J0
MVM)1;H+1I^%#BMU%:'8PA-17R-->X1NU,!XT%>^@/UK,?:1ZC@C#2T(:$(:$
M(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$
M(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+B,L'T
M[/:!;T)B.<$8G>GC*7+#MR%\E%M911M26%SE(!8:5L0:)VCP.O-!:7?WKB1W
M>`WZ`%Z%IM'X>6!WX_22GDQ/V9^TC$XR+>W[<>.'6F7>\E]%@MGYC&==4IU#
MJ%7%BXMS`EQ9*4/4!-:J&I$6WQ!P?<22%O$!SL^ZJ;<=&,0%1E@#["GQL7MN
MX@B!*\'XYXS*EN?,KA1./<5LUZ^8;04MO%KY#Y>XO)22D&.\^NA.U-`:/?!V
MK'%T(>0>))KZJI(F=F]GCYT``]`P]B<2RHN&%L3(%C[.,-2I3"I\*PPX]L?D
M/,(+;#S[$5#-'(Z4E.Y0\?$Z?AK;`B+`$X\?IJDR-CN*&3$CT?11&[[K]SW/
MW1"YI4AIN1<+\HW-UUML'MI3WTR"2@GT]3MZTU&,=O.XEP:]_,XGUE28VNAC
M+*4;3"O-:,=J+#<_"*FVR0G9'B);0E`Z-A#6R(E""?"B30#KJ3':,=1H8P-Y
MT:HIN7!E'//F#,8Y]V25D.\W=MI38FI5$<4D*B3F8LF*TVG<:_+S6UQ6]Q&Z
MJ!6M#6M-.NA9%X`&'N:/L4<N?*?,S/V(UABW2R7G+0II2`D*DVF8ZX%("B4J
M%IDO/H.RG0)=:%#4A1TC2SDE:KG_`&=/22/HS1FU8'9E%Q9PD$I6\N)/C3+4
M\E+:0X7-[Z%Q'25^A"$2.XI0Z)IH;&T^%H)/<2H[G-<_S'N\>7O&GJK1:,B#
M"0%M2I<-I8(JW+D-0E@N"J4E<UUJJ*?`D>6GV6]P^C&,<6G+!+-Q:Q1ZW/:'
M@<3DM!X6-2J3KS8T[1LVIN<)V@/7T(BE\*2D#QV'J/UZ?;ME\X5;"\A1SNEJ
MYNETS2RM:#^A$EP8Q.2TIE>219D;M;'8[D"=<8ZAW$/+95&>MCEN=;>>0DE)
M1M5M]0.I$>R;B^NJ%C>]Q^U,2;MM@IH,G^:%&[ESVC^SWFNR2K1RGP_9\FB7
M6&85PFXQ%NG'5]F0W'TR)L27><0O&+39T28I*`MF4W(C*[:*M52DB9#LV[0.
MUQO:TD4PQP/"AJH=QO&WRLT"-[L>(IZ<**'B/H]_3#M:MS?MON<M!=W,IEYG
M?9"4LU!0RZ])OLA:@E/0DD*41Y:D-V+<'-U.G'=0?8H0W"Q::B`U[W?:G!L/
MTT_IVXRP7+9[2L-?2D;J7J?.NJWE;ZAM]I]+[:6"0*I!-1XG2V=/U=KFF>),
ML`#@ENWMS6^5;P-\HXG43FIE87B>!\:6J!C?'O&N$X59(49#-NM]@8G-V^!'
M#A=,1AF.]$C-,`K45(0G::DGJ3HBZ7M(WN?J>]SOQ$CU8KDO4%ZQH8=+6C+3
M0^NH3I'+KT]&<C`6=#147EJ%O;?":IV&JYKDI:R`!_E4I^N2-@M&XENH=Y^U
M1)-YO)6Z72>'/(?8L+%^OD@4-];B@TJN-$MC2BV`0&V4B.C<E!^RM/+4J+9]
MN:T$Q#5VD_151';A?D^!YT]@'V+1N63W5:5)_.;I(;2A*"A,Y])=53;0-H".
MV%$``)JD`:EQV=I$*1Q,`[@N?$74OBF>\N':1]")F;@]'2\N5(DJ`352%O*6
M[55`$)2M2U*\?O4(.G_*C_"/4F)7.:`037O*SL2(\@E3<9YSP2=P6CMJ\-J6
M6W*!:O,UZZ!&QIJ&MKW!=8&M`D.)IQQ]AP6_L0E("H\EGMJ+K@*''"D^"B2-
M]?#Q/PTYJ=32#1O9A]"698R*'33N'V+T]`[ZVY3;P#9;`:1VP%+7N!VA"5AQ
M6T*Z]25?#RTG3Z>_'Z4D.B'NZ1W8+,8;:T*4VXYO"D*4UN24$E("`%)VD`*\
ME`U.N$AOO&@27O)'Y>)54/N;]V5CQOFZY\;W_&KAD6%X/(QR7.&./VVYNB[2
M(2)=WF!+K"4V[)+0F8Y&C*6ZX&%;OPTJ4LZ3("YGA5!N=[(V0V[FGRBP>EP.
M..:B[R7S9[<.6+FJ5CN89AQ=\I<+@C&D9):GKR8UEDRU+B6O(5QX\>#/D---
MHK)97&H[O*1M534*6W,K=#ACP["HFV[['8/>6>Z^@T\:C+M45<AP/EVX9I!R
M/CODSV\<BO1XMPC8_BTO,;OBUXNMN1;W5R9"V7F9"6+@B;*;0XXAY;++2U$A
M1`28'Z7+^+V+6Q=26SXM;VOJ,](KZZHQ@<A^Y?$'T,9QP'REBMO"FQ*NV$W/
M'^9<,*@ZVGODV*6UD;,9).\J,1:TI'5/31+`YK?S6G2I3-TLI:MC<T&G/@I#
M>WSZ@]HL/-=KP&Q9U;U9I/G2;.XU98\V4];KE'4EE4/)<;+,=4FS2)#89DQT
MGN,NE#S6QQ)4>-&36J/+2UI>VSAH.)`QSP_:BO6QWWL6JW69FY\@7*P8[(A.
M&+<XB6LE>N;-P:;#K2[/;[5;;S<;Y!G(*78ST5I9+:AN2E:5H2IT4NDT!R5C
M%>6L\?FZFA_?Q[EZRGW>V#FY3$?`^!?=+R5EK%NA,1N4..^`\GA1++NDN-P8
M.9O<H_W71.1,6DH2=\>(IRZP6JNQGVB=JTV@N8-5`YM:<$ATD<_O$&B?K"\&
MR9[#K7E/*O#F>\93Y:'1+LN27VT3&&`T@)1=9;^(+F2+!;[BLJ6S'N:H<QI*
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MC^W%+_@7V"^]WCKA3W^#-N`<RQ&\H]O6.PL<LLRY6!-ZSB:WRMC%ZO-JX\MT
M&Z_,Y9>8=CLSTAR/$0ITMA*4A2EH2JP@OA)$^5[@&`8=BK;C;G1/CA#2)'FG
M>HE^S[VCL\U\U73%^?\`C3G+'+-;+:R6X:.*<VDWA$^<Y-2X^N&QCLL//1Y"
M6E%*0ISM;W`AQ#;FR.ZY-P^L+PZ@X*;#87,#=+F$U-<0%H7''_<G[8>8LDLG
M#.!\M7C'\%RMBYX%=KCP]R!?(D1^$^);#L-A-@EQ68I<;;4]$45--OA;:VP0
MM&I$4L]3K)51?].LEO!<QL_,!P+01[!@5;!PIRS]2WF=5ZR[+_;G<;SB4K$Y
M6/8Y:\<P[C[C*Z6K*+[(<EY)ES6`W:TV-V\2)3DS9"+R87R#33;+<E;3+3*8
MS]R+"6U+2#2JL;;9;QK/,DC<7<.X]B:'!N!/JE<8<J99GG%GL/Y%MF(YAQQC
M6$9M9LBN>&X)C%RN6-/H>M4N!<K;=&HV:S[+"<7&:F2F'[C,C.J7*4I2-^JK
M=-ZM;:V\RXGDA><G,87GTM#37N%"580;3=RSMA;`7//`X5';B#12GXA]O7U`
M\GY;P++N6>+.2^-N-K9.8G9OB^/\K6.]1N0+$XI#KM@>@S[G/8QJP3(C:X\P
MQ(H?+"EJ!2337GV\?,,VMMY6VLO+RXYF&6-OT9]RU&W]'2^;KOG1PQG@#5WJ
M)*L<R3VW^T&'.DW9GV?<%X5<)[$I+TZU<-V"]SX8;"5(6M\VV?+[<=1!4XV6
M4C;0`^&O']XZNZROY*R-NXF?A8V1I].D`T6]99]&[9;ZYRU\_P"*@/LR]BBM
MFF.P(=VM;_"7#,/#6+4;W&N]XQ[C.;8&,D9G1HT.((]JCV*-WW7&^XI3Z@O8
MI22@UJ!D6]1[]971NOAKV6X:'-!<R5YHX4/O`X8KSSJO>[7<AY%C`?*90`@>
M]0YI'1<?Y,M3L"!;K/G>-6I5P@/S(C\"]6]*V7YB5R4N-F(%?*(VJ).U523U
MK4ZS+)][N=SC>;6Z:7S,SB>`*N']6BPLE_?N;I8Z1EMQ`J,.-2,2.PX+]!NU
M<G\:OVV$\QR'@K[*XD8H=8R['WF5T90DE#K=P4A8J*5!.OT/@<PQ!S2""`?8
M%-#7.:"`<0C'^\GCK_S_`&%_]:;'_P`>TOS(_P`3?6$:'\CZEY/)7'(I7/\`
M"17PKE5B%?T5G]='F1_B'K"-#^1]2WXF;8;/;4]!RW&)K*%EM;L2_6J0VAP)
M2HH4XS+6E*PE0)!-:$:[K9S'K2<LT5-<I\8R&6Y#'(V!O,.[^T^UE^/N,N]L
M[7.VZBX%"]BNAH30^.N&2,9N`](7&D/):S%P-#3&A&8/;V+X>5.,$FBN1\"2
M?&AS#'@:?H-QT>9'^(>L)1:YN8(0_O5XO_\`9D8%_P!<,>_]>.CS(_Q#UA`:
MXX@&B']ZG%]*_P!Y&!4\*_QACU*_"OYCH\R/\0]:X01@<%\_O6XN_P#9DX#_
M`-<<>_\`7CH\R/\`$/6%T`G(+,CD[C5Q24-\A8.M2ONI1EE@4I70GTA-P)/0
M5UT/8<B/6N+PYREQDRYV7N1<$:>V=SM.9=CZ'-E=N_8JX!6S<:5I2NC4T8DB
MB[0TK3!>/[UN+O\`V9&`_P#7#'O_`%XZYYD?XF^L+B\GECBQ/57)?'Z1\3F6
M.C_#<M'F1_B;ZPND$9A>3RYQ0`2>3N/0!XDYIC8`_2?S+1YL8Q+FT[PN+S_>
M]Q-X?WH<=U_^/7&O_7GKGG1?B;ZPA#^][B>M/[S^.Z_#^-<:K_\`U/2@]AR(
M]:%]_O=XG/AR?QX?_NUQO_UYZ3YL7XF^L(0/+O%`\>3^/!^G-,;'_P`,M*#V
M.]T@^E"\'F'B,>/*?'(_3F^,C_X9Z[45I457"YHS(61/+?%*S1')O'JR:`!.
M:8VHFOAT%R/CKJYK9S'K6T.3N-B*CD+!R/B,LL-.OAU^?\]*TNY%*J$/[SN-
MO_9A8/\`];+#_P`?T%C@*D&BY4+RKE'C-/17(F"I/^5EU@'^&X:`UQR!1J',
M+RGE/C%94$<C8&HHH%A.7X^HI*JE.X"X';4#I71I=R*"0`"30%8G.6N*FG>P
M[R9Q\V\&N^67,SQQ#H8W;.]VU7(+[6_INI2O31H?R/J76^(Z6XN[$'.6^*6A
M5WDWCYL#Q+F9XX@=*UZJN0'2FN:7#,%%#2O!>4<N\3N':CD_CQ:@2G:C-<;4
M=R0E1307,FH2L$CX$?'7`0XT;B0N%S6FCB`5LCE#C0@$<B8*0?`C+;`0?T'\
MPUW2>10'-.1"\GE/C$&AY&P,$>(.7X^#_)^8UUW2Z@-#0KFME=-1JY57D\K<
M7`T/)&`@_`YACP/\GYCKA!:*N%`@N:!4D42PMMSMMXA1[E:+A"NENEH[D6X6
MZ4Q-A2FZE/<CRXRW6'T;@15*B*@C7.-#F$I;VA"&A"&A"&A"&A"&A"&A"&A"
M&A"&A"&A"Y3X&7X>$J#N30)DAP@+;AL7MP=.OJ^6@MJ<6E(\5+/3IK,_I&X_
MA'M6I_6K#F5MN9SAD=LM,7"]O[@M#BH%N;;<2CR*_G+A#6KKX%0)Z>`U*BV"
M]DIJ+6`\3DHLO4-G'72'.(.0S*^M\@8TA`;:M^0W'>M*D+<>B04*.RGX@WW)
M2!N'4)!^SQZ2F].7`(#IHM/'-,?XC:]OAA>&'B4</<U1V8XM\BTQKBHI_JWS
MLQZ7.C)%/PV)P@1I;0H@)H7%`)%``-/GIP<)-7=^]1SOTD?\%K".-:_:B[^\
M>_S`RN!;K)'0'$[V'VKC.<VK'1)<D7%#+2P/@DZECIK;OOZG#T#Z`H[]\O'B
MA#0/3]JW#R1>4[F79=G#K82*Q;7&+[CU*AE#LQN4WT^PC3XV#;&MTAAH.TID
M[ON'!]!RH,%Z.7W]QS>S<Y3#J4A:T@0FP`HFH+K4="!2A`-.E>FI,6UV,3-#
M&"BC2WMY,_6^1VJE%Y.5WV3ZY%XN"]Z`W5,Z92NP$&JG&VTT3YI'GTTY\!9_
M@";^(N?[QR+&KJZXIP_.J0E15O67GI3I4?2I2G'W%U/\U>OEJ6P!GNAN5,A]
MB;\!Q(]I^U;+#<)9+*7&Y+JO4I+B$N.[J^I`<[?;0NO4BNE:C6IIIY4%$UY<
M8=K`\7>5O0H,=E]W:W/=(Z(;<6@H2[3:4)0EUME0'6@23H)!R``2T=)>[$?N
MO2$(2$+)A",A.P`#HXXM"TA1`\*ZXA:HFI0@*0XQ&^96.VRI3E'4;:]P.-MN
M`;E>7I\-"%LM37ZI2XMEPI*E,E*$NU-`37HM(37S50@>`&A"-F5O%A?=6PK\
M%8[B'@A#86-P_85UH"12O70A8XMN7(++KB5J2X%[77Y!2TP!1)[FQY+BB=U:
M)2$TZ?8!)>P/S1Z[CH6D;41W$H"=R@ZE,EVI)HV"05IZ&@KX>>NU3#X@UNH%
M9F[.^&@ZA##KG5"D$(*8J`?2%=2E#A2>AW'=IDR'S-&%$[%[@"UW<>DR!WG'
M&6`E0_";0"I>Q6XJ*FA2C@5UZCH*_#1(\L-$YBOCUF0\E+J"J0U')[1;"E!+
MB1N6O84I6`V"%=:^53IY0Y'N=2N"^Q51K:G<DO@=H*DRW7&%+-%"B$T(::H=
MJ?CU)T&@Q.2Z9"YNB@1U#@7::ZAF#:+Y<7I"CL-NMS\CT`A)4I<5A;73N&I(
M!(`U%FOK>`D2.`H*DUR3D<!D:"VM3V)7G$,A:2E2K,_;'%E"#^>N6RRG8TI2
M5++=VF0U&B:*!2BJAX`ZKI-^L&$!CP\=E?K4F/:;V458!0=A7M&%.J51S(L6
MMSBBCLN+FW"<Z!1/<*&K5;RU7N#;3NE-*TU!?U):/%""K.#IZ^J:TR7(-[F_
M9;S!S?\`44YGX^OV2Y9P'ADJXC.\!D8^[(19,SN68W6]W"1FMSG8Y=#%A-WZ
M%C5U-L-P<97(EPVX@2VZ^7`J._CNG:K9QT\:\#R"B/VGX:1[;UHUN)TUS<.;
M>SO4)['.S6RY5R1Q)?+W?)]_XJR!<&+D698#<L8RO(\6D/S(MGD9CAE\5!OF
M/7^.Y;W$O(6L/4VDK=_>+N+:5_E@''%9'=K"UM+ECG"D$@.(S!",E9CD48IB
M2;58+J['E+=9=MMR_*K@TZ\@(<<:BWZ(LH<6A(2JD](/A74J1[FTH%7^3`]A
M9%*6`YU^JB<+'?<3F^)%HQKIG./M-KIVID>==+8@4'J<=MJLCM8;J*5)1T\*
M:9<_4*.:#ZTF+;IH3K9,UY(R"6`]P.-9U=X-ZRS'\/S/(K,F0+-D%LE&Q9=8
MG'7$.NR8-QM<D3(<IQ]A'K+*5FE#TJ-.".-S:T`*[(+P`L>X^5WJ;''/U$,*
MX;G6>Q<B\]3L-4^U$3;QG4NS9+`V.,H5M8O5K?LV4LLL*<[;F^,^$N`I*B0=
M<,30*U3;(+@T?'$^1H^]R]7)6,<,\_\`MBM63P>5K!"Q*W7Z_-E#/)7%V1W=
M&/7LN*[ZG[S9X%PCX_<'R%J<4F5;Q(2"L^JIJQBI\-\YD@CE<0'?MQ5S\GDO
MFW#;5#OAKE&)SK7%O5OR7$YL3+K//M-PC%^--0;7)N33T5^,25;5=**"DI((
M$)K-;R'*\>^\C8)*U8:98J,MT]__`+=;/>WK?D-ZM^*9)&>2)#&*+D/)1)N"
MDL-2[YB=K;N2;0EUX%2IBFHS2$A1<5M"B&KK;[>=E7$APXBBE[9O9M)7!]0*
M^//Q=_+T*6\2XN7JW1+W`$:9;KO!CW!N:F-#E,2(LMEN0Q+C3$H<:!?9<2I)
M1M"@:T.LI/&V&4L!.D+T!CM<;9!DX5"\H4VZ5!Z/&C)C"K@29$<RT@#:%EAT
MD*)/[(1UK4:&RVC,ZD=JD11ROJ(C2F:T"S`6RZXMR,A'^YM&:$_+J.ZGS!=9
M(D(-?O;DJ`K731());[I7'FXIIE#0WVJ-7+L1MO/>%F+?,9<_,<B$635A"6T
MEZ[6I.UN0TXXJ1'[;9\`D4)I6NK".1D6U3S2>ZS`]QQ]:H-P)_4+7PEWY@P&
M9SR3M9$BVP928MKNT*>I+&V:FV27BEA:P'(XD-BFTD%12`5`4-.M=1NE]UVO
M=99F;?,)70BKZ9-X:3VK6B":V8/B(]+G>)NK.B(43980E+<R6$"@V_,.@"A/
M@D*Z4IX:U">BFE?&'DXGL'V),WUPN)477'5KZ]2I2NE`!]XFN@-`\30`[G_2
MF7>\>]._`>6YPO$`<%(N:6Q:4JKN3\U8LB:WI%>AK"H3YG0X:OXF(&6`%.XC
M(JBTM=U"V,CWH'&M36H]B0R5$[:O/%P@[E;CX=#]FHTA#"`"\_Y3E=NA8W`U
M)[24C,K38WKA$=N%YM\*4J`P%,2YS4=X-HE34M.*2ZI)#;G6BA\"-0I8F2/U
MDOJ?ZQ5>9[*SE?!=$,>1QJ1Z$8XRO#X2DO2,LL#;8HM6Z]0BH[2D!*4?,=UQ
M:E*HE*14FG3771S1QZ@YWEC+Q%,3;M:0@1VLH>=.`T_NX)&<RM6B?D$%ZV7.
M',0YC<=@F+=+;<$(=^<NC:FWY$*X/,-OAM:5EO<I0"A75=+)(9*$N(/;50[:
MXAO[&9DTPC):\4TXY'LXJ./%5BA+XXQ511"4AJ"&.\$`(*FUN)2C<I":*6!X
M$`G4&W?(PNC:34'/B?JPR%%+VED7P,=7,>#$QU1A0NK48]R<`V&&4[D)M]$D
MDI/9%*T^'6H/@/M.GG17#!J>XT4WXF7(.'J"+I=@C+2I"68JU)4E2D-I;6MK
M<#L*D`E386FM*@5ITTS\.Q[J4J\\R<?:FI)':2]H&OG3M4Q/;';F$81D<7L-
M@#+BH!*$G][9K:@FE#51V>/C3H-7%G%Y4&DBF)/-9[?`&NU$U+F@'(9UY*"/
M%>'(N^`86PS;G9:V;GFT3=$MSK[319OW9'S*D1UMQ4$HHDK(2:'S!U#W2%DI
M9K!P!YCDHG1P,$E\^&M?C'=OW1S6HOB'+GW%DXL6$A:DUFO6F*`=QJG:]+;^
M(ZD:KA#'D&^T_:KAUK<%Y<YH-2<P>)7ASAK)&VW'I$"SPVF6W'%DSXCZNVRV
M7%G9%1*ZD(-/B>E>NE-@8\T#<>TG[4"RN-7B;1N.5>54U./.V#)DR%6<)EB*
M&2^IVWO12@2$N*:%'FFTJ44MGH*D>?B-==`V,T</%G@3]JJ;26&^F=IJ&L<6
MGO']*7,?%HZ@$_*LCTU![*.IJ*#JD]377"T2?Q*NIV_8KMEK%)6@I3DE3CF+
M,Q+M!D_*HJR^KUH91TJTM!'5/@0NE-2;>)K7U95IIG4_6GFV=N:@C(+4RVPQ
M)>?,-)C,U<Q6:X4=AO=^#>(*34;3Z:K-:>?CI<Q>:Q.)+%7Q-:^Y=$1^6&5]
MM$3S,3BI2I`AL@C;U^70/43T'W?N]=0S#$W('UG[5-;;0%M2W%(VY8S%2.W\
MLU2I45=AL!)-?(I]0K\?#2M4GXBJ^>!M!B4AY>/QPK^Q,**J41VT[*5`)K05
M!`\#UUUL40.IS:GM)^U5Q%"0M1O'&5.+_JK%.A(4PD)14GT@T'7RH?'3@$`(
M/EMJ.T_:DHXBXHRL](<=)V@`]A!-/+Q!ZD^.G?-=7\L:&\A7ZT!*%C!X=`/D
M60DGJ`R@@=:&A*=34\^WN6CP@56]_`=OVD*A-5/2A9000?MV]#33GFO`H,"E
MM@%!J)UTQ6!SC^V*22JWQR`.H[#7GT'3:-VGF.<YE23JYIF2Q>:R"N@!%;N`
M6Q*R&X$=(\"HL(30T\!1!IM/AYZ4)Y(<!XJ\U&%NWM6`X:VTD".N1'%0-K3T
MA":"O]%8&AEQ,\TU%2!M<+<9&4'>?M7I&/7F.3\M<IP*0K:%J#WI\31+S;@!
M`\]3F;A>L`:)#I'"@*KW[/\`FE\1ICABLPB9<S57ST:1N`2$/VYA9'DD@M]A
M=:TK0^&IL6X79BHYU0:\`FSMUTV0#62*A%S%YR9AHR7[/99/?6_(4#&?:5M)
M+<8DJ<>*0F&RVD"A'GXZDVUQ@:M:?6G[YMW'/\.UK2QC10XXUQYK-:^9LGQ-
M]\P<4B(4^TMI];#%CGAZ.ZH]Z,X+W8I9#3I43MKM!-10]=6[MQB?02"M.S[%
M14NFGS9:EK#6@<YIQPS:0>.62?+&/J`<M6*+$@FS6)TPD?)I3<.-<`GM]N(%
M1@'%0+=!D+;=CT4H$E1W?$ZFP_I]Q`YSVT>!^V:B;GMKXYBRPNKMK7,:YM9"
MZE2*BCJ@C/-$^$YC<KWGN?<VKX_P_+K]>KO-NB\6NN"?GN+OKO\`:;3&F$X:
MPYO"(;!W-("R&%("C6FL[93V3;X-G&FW>YPKQ%%8.VR_W)E#-)\5"UCJB@+A
MR.%$49CS)BKZ9+%WX]X:PVYNK9B0[?9<,N6*7-;SG5<AR.]?>^5CNI0TA+>Y
MUQ8(H$T5HGP[(:>3.TCC4?8JNX-W#(67KY@/NUIZ<@.Q)R^\;\F<<27<VYD>
MQK$^,\O0S>,,>:M%PE7K%K<VXQ!FQ\PM=JB7*YPRN?*28[3C`?+5%4*"%:R6
MSOWC]7W"+?'POVL/!LVQ@A[F`>+74D:JTI0`4X*JVYO5S-\O=PWB[AFZ2=H^
M'9%$#-:-&#A)IH7-=F<\1VI/<,7K$^1VKRURKE>,>VB_PLAFVZR8WRC#R&]R
MLHQI@H3;\SBW?"L8N5DLL*\.!Q"(<QY$YE3*NXV`03=;%N<.X0"6YM'QELI;
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M"X^L42@IVAILI4L`4ZTH3UJ/#0A&2@F*@2&GU*<4VE*4N%:5)03T6VRL*!J!
MXUKH0MII,N6&BQWWUDA&\N-@$J^\%M;PM0ITH10>6A"4+5I+B2J0UMWFA2RK
MY5**#Q(4Z`4(`(Z`:$+`E,."ZE!,<T6K<W5Q3M#78MQYO<?NFE`:4_F$+:BR
M5=Q:6([6U9W=CO*0HHK3TBH!I3]KP/CH0E':TSI;DK:RU$884-[4A03W04UZ
MO-+-$[^M:U\O#0A;+S3#B2VZM@DDEP,%2]P'0-NDJ*P?$5"@:?#0A:(9CMN%
MH@,-[TT;D)712:$J!0V"$"G6O51'C70A*2):$RHW>8>;#`30H9;W-]2DI6IT
MC>A)IU)53].N.-`7+J'R#G<5_7&6PI"DH3'>)<E*W@K;;C_B.';M`50&OZ.F
MD-?J&K`#M("YX_NM)"4]KPO,[HMA<#%\CN,84V/(MEV?;I5.U;DTLQX[8(-!
MN(J/(`:8DOK:&GF/;CR(*4;6:XPA:XD9X$)?6?C#/!(4@QH-K;*R#^<WZTH"
M$J)"TM1(TA^YE8!-4J9`-:5U7S;[MM"P/)<#R*EP[%N5=18`TCF$HXO'LJ(^
M\WD&3Q(.W>V(<.V7JYN%=`A)?$R+9(K:5"FT)=HOP\!UANWF(`NA:XBF!R]B
M>=L\P:6R.:U_+/VA*VU\>XNDU%YR>]!*PX4M)M=@C;:E3C<=E;%\?4PXJ@(2
MH*-.AZ:@R]0W8-(FMTT^\*GT*XCV`/C:9)75I]W`([_AW#X#Z`G&&ENM)IVK
ME=+K<EG>OO*6M"9<*W533JDM)K4?"FJV3=;]X]^BGQ['MC23()'CM(P6Y&:M
M$595!LMDL^]PN*=MV.VU*EJ>ZAQ]]J)W>XA(JKUK-:=3J!/<[C(#21[ZGW>'
M[!36V5C&`(H8Z@9D5]:VS=Y3G?ARI:IJ'4EJ*+B)+B&T.?<=BAQQ"T*0D]*+
M'Z*:(PXMU/-7?M]"#;_@TM;R&2(W+6P$QFHS4AIWUB?,=5'EMN-%5-T.&OL*
M:=32A27U)/D1J3$+=X/G8'@FW173?X)P27O&+/O">6I]O"66U/1A<&$P%2=B
MMZD,MH5/2T^DD@!;P"O*OAJ%(S6*`\4^);JH;(TFI53GN\]DG-W(&3V/F/C*
M;QNJX"TQ\0NN+<C,9/$Q;*[=:;O/R+&%N9#@<S\^L&28Q=KI-^4=,=^._$N$
MEA]EQ*D%$NPE%FQ['#47G@HVZ6C[S2UA#7L%"#]JYY.5?I!?4UE\D9)R*_EF
M`NY1.M=EL45G&L[RR:];\:PZUV^PXM9&9.36V+=)[-DQ^V1XK*I:G'.TWU-2
M=6T6\^20P&@KV+.7&Q.G`BN`'-&(HH_9+PC]4/B%"F,JXEL_*%HAC:\B\8G9
M,L2MI*:^FX6](NS(*$FA2ZE2:ZG_`*[_`%E63]+VQ(U"0'LP3-W#GR]XH^F-
MRK[3,FPB<@;)-TX_R/)[`I:]H)=19\E:OMNW`_L(4A"OAJTCWBU>?$=.'-5,
MW2LC&UCD?6OWL0OD/W"^W.]/(<<RK-,7N#+P>^1SK#H4EQI?6B&<@LS[O:57
MIO,=)Z=::D&]MY&U:X4*KYMGW")CFAFI@PJ#G7C3-9?:S[>,3]VWN$O=^R[)
M,'N.+W#DN5:;G:[[R+#P7*+EQ];+'<9(N.#NRV53;U!M3[=K9F1;6I5Q9:N#
MDL1I"&R$5%U?&.73&[P:1ES6GV^S=!9QQ.():,?L2V;XGNOM9Y@<X%Q/ERQ\
MCW3(K3?QG&#\=V_DDP>)^6L8C1;_``8#?\<XMBLJ_P`&_P"'W%FX-2K>)49U
M"J?,*4D$S[&X+J5=KUY<*+/]1V,3(6W3FX"5N">F+S9]43V_X&S?N-^3KY%Q
MJY.W2W1<9Q/*LIMN0,JDL2F9H5A,QE_\J-RB1E[74J2'!M25!;C04[,POJVO
M%,V,UC;QUA?*UCG8C4,"4TG#W&GU'O=KF?YBJW7R!#S>[.F_Y!EDB]7S+,@C
M0KB\S<[C&Q24Y=9JY`D6IQE%PF0XT9IYH!4A"03J'+Y=N*S/:VHPKQ6AMK;S
MM1MVND<ZGBKW9K]`[$1;L2P_'+$Q+8QBSVC';+8&6)=TBQFV6[1:8<)$9Q]]
MQM$U3;<?U.IW]Q55=:UUYYN._;;!(Z266,`&A\0X9E>C0;7=F",%K@[2/ND^
MU:TGEO%8T0*1<W+XW&:JR+9$C.1^TEU;*7?S:X(8[T=3B%)!0'D;J=*ZPFX?
M-#9;,DVC3.P9FF'HY+16726ZNIYX;'KRX_0D)E'.CS!;+=HQG%H79>E&Z7%U
M$\R[<RZN,](?2&#9-GX[:J(2'@D]!3=K`[M\S=\OP8]O:V&`FN'O`<ZA:&QZ
M3L+;4^]>Z245[!W446\^SRQ95E>'3+KR+8PBP3W)+;T-V$XEE:GHS49M$.W.
MN083<E2FZ%(()3ZANU.V;K&*WZ1W*VWJ]$EU,_P!WO.P`S.&&7H6<WO;;,;Y
MMTMDYD<,1)>2X9`E?+;[C^.+2]<6[8U.O#;3K+=PN-N6U(CI?:1VD//;W0B*
MB0FI3X?=('0#6H^0]_9FQW00R-D<)X<&GM)4+JSJ;;;B]@;:%TK@XAVD>[AG
MVA;+WN[XIC;S,F+A);0''5RY=NC(0A7W3W)$EELU^PGPU[T;VU^Z\%8[_$</
M]S+ZOW),Q_>9[?<BNZ+!;,]L<B\NJ646]%WM2G=R%I2L!0F=HKW+``"JJ)II
M3;J%YH"ECJ*S^\V1O>%-/C[.;'EO%640K2N:N18,APA^>),-<9AO\Q9SIF.(
MSRT!+ZU)`[FPE(!3\:Z=.F1ITG`J/;7L5UOK+B&OE^2YN/:L#14K:%)K51!)
M`J`*>JH'0'Q\=0WQZ"!7-:9.9C6"X]E-H:N%TL%DNLA$J9!$B?;84M]+#:FG
M4L!UYEQWMH5(44I!VC<:#KJ/<MT.T<0LMN]TV&Y+"TDI66?A_`WKP&W,(QI;
M4*$T5(78K9V5/7%Z0UW'!\N-ZX[$!8'G^+^C454[]TN(VET1I085*AW[R.7?
M8W[:>0\"Q+G+D[B;@^_9CABK]C]@OS$NUO9#:HV0W*UR+S$:M=O?:>[<MLL*
M4HA=44\*'3C(Y#1X`T5SJ/H43;M_!AGAO(KF9QQ!B87M!`PJX'UX8*NFQ>];
MVO<3Y?QAP-S-D-PP^-D7'<G/1R1>+4XCB.TV%W*K_8;*O*,NCSVY6-K3<[4L
MF1)CMPF4/)#CP4M*3`@;JD^)!\))PXX&BM[3>;.';X;"YA+M%HQ^HBI%:X:,
MU/O@;*O93[A,IFX]Q1SAQ#S%=;9C\G()V/<7<IMWV\1;8S-A6]5XEQ['?WI;
M-K9E3VVE.[=H==0DD%0U/=&]@JX4!48[O8R"EB)!)F:MTX>GM4/N=LHY^XFY
MOS_#>"L*X'R/!;8Y;(33O,F7<PV_-%2VHRIS\,W2PQ,@@2K?%3<*1EK;0M39
MZU`"C&,MN2?.872-R-1A[%R"?=72&6VNHHHZXAS2[UT(5@OT_LOY2S7`<]D<
MMX1QS@]\@9S:8]LB<:9IDF:6FZ6Y^QQW53IK^48WC<^V242FUH#"4OH+8"NY
M4D"7$YCX28QI;C@H.X-NG2?$W<L<TM`*L:6B@R%#7$*L:?[L>:N"/SG#<(]L
M,+E>R6V^Y7)8S+^_+"\+?D3)>5WEV;;G\)R.V-SFDVQQL-H=3.V2!520D=`S
M=/9,V-I.G2#GQK1=LF7MKJDMY;9HDH2)7R,.%<M&>>-<ELXU[X.:+SC5WRC*
MN%)=MO$43)36`X:O$;]>3%C.20VIC)[EGIQ:6MV(VV^4_A.H'<;"%+2G==]/
M;-MW4&[VFV37;+"WGG#'W#P3'$T@U?)0@AG/T*+<;YO]M"YFGS[QN+=)T@\@
M"ZI_<FMOWOC]P%VQF]M6SVZ<Z0,T3,,.Q8[DT7AC&,3NUO<2T)\B;G+<B_3;
M.ZRRZXAE'Y:^'GVP@N())3[)NWR8^6VS=;P]/[CUKMTVPS[>Z;XRT:^9@D:0
M/+#*XN)(J20`*X8)FVZDZHO;41OMM,VO4XND&G'`UTT=@.1S7CB;G[$,`LT&
M!RKPE[F<!SI^-`DYE:,;XDRCFS#K<3O=MSEBY*P6$U8+_&>LTMIYQUF(TEIU
MPM*!+2E'PSJ+;-NV[>IK#;KT7MA$_2R;R_+\QH.!#1E7MQ6@M7WUBSSOTR5S
M7'WHWZF&OWR7FM.)'(*R*/<\!N:&(N'8UR==;K(93,CI>;L%R2J"`AUR0Y;(
M$*!<XJDLN>I)*BTM0"M5CK9@_AX*VMMWO6D_EQM']H,^G-*!B&\VTXZ_BN8V
MS8RZ3)N.+SXD2*`V27I$HA;++"`"2X>@&E16Y\P&HP4EUS&&ESXI(W.'O&FF
MIY$'&O!-Y(>MIS^UR'3,EMC#;\T\8%NF7!Y+J+Q87-ZV(;+CJ8Z$@E2RG:C]
M>G[@:W.`XJ)%-'%(V1QK&UA%?36M/8E.U;+=D,)RYV9WYV&EQ4=;B6GFU-R4
MH;=+3C3J4J0H-/)/A]T@^>J]["QU,RK**:*X;KA)+*TRHFVO=B<25U94A5:^
M&U7B1U305T@AX]X$!1IX":8\TWLNU$=%,[O5Z?$T&T5!4>@577%$EB=&S4,3
M5>8=HWJ2GMC8D*H#17W?"HIMKU\M=:W4X`9E)BA?,0'-(82EQ:L86YLJT2!0
M@[:T42"*FE334Z*,L%*YE2OTV'M3C6_$730*;"MP2```"*BI(``J-P\/B=3(
MXY&5UBE41QF,DU6Z]BZ4+2VLM;D@D(W)2M(H?%%=_5(KX>&G(H&OE\>+<<$D
MR6;75REX]_%$4W'2"X2T@A)(21N!'3[U:G[H-=2C;`8,H&IMP\SQQEI'>`4G
M'[(M)-$%/6N\$FJ?#U4"O/PUSX<\PFJ.!H\`5[0?H17$;MUUN=VLD<J7/L;L
M1FXMJ96EIM4^(B6Q1U20AZK#H/I)VGQZZA,C+"35+@N;:ZGFMB"3`_2>T\PE
M:SAZE$?@&B3M-$GKTIUIXI'F-2H1XPILEK#Y6J,4=@LKF'J3Z@UMIY``C[P`
MITJ":ZL6Q%S-=5%^&)P)J#P3;SL>,:`E#C/;7'0Y'<1T6:L.N1U;20"?4U4Z
M>M\CWIG=6-CO-`:6T:W/C@FQ5CS<Z[PXRU!AJ5-B1'7Z-58:DRFF77?Q5--[
MFVW-U5*2D;>I`J=6\8C?;NGD-`P5'>LGIDAE:][<"ZBC%P1RVGF7DWGS"&>-
M<IQ.U<19+9;?:,NO;L:3:\Z8NS$R(](M4N*VAEUV))LRW%AO\,M/(I4@DQ]J
MO([]DNHZY(Y":\JBE$O<89I[QCF--!"/I5C_``?`1"8RB.DN1NWD"6]Z%%"R
MB/:[33U((Z)4`>GGJLN`'2EIQ!P/<K6RU!X+A0FC:?6F]YOP6TY'D&/9,PH+
M?@W:V6FX4!6^Q&,QN5"E5`)!8=6L$@BNY-.NH,+YA*ZWA<`![K4G=(HY8BUP
M)+3ZAQ=W!:4V#:;<9MVMZ;GW53XSR)$ER514]N[PWN^J'*4%.M%Z-6G;6BJ5
M"O4@OLDO6RM=)@&G]RS;[>W=&YC6,#B,'`4.>9[$U^8VYO)\#C"YPGY67MY/
MD]SNMXE?++;DV1^):6K9$:1'<*([K,^,^XXGMH2=Z351W45:%S3*Y^+JU]:>
M+I)(-$WCN0\:2.#:`:>_C5=2GTY8PB>R/VZQ@``S@ZT`#P_S]>3TJ3TZZ2!3
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M<>2E?I%^T_F-#.\C+G3DE`UPY!MLI#=US.XL/I4I;S4##)D:0&E(5U;7?9]J
M?8;'],QB2/`>6HEQU.Z@^'MJ\_&`I0V)\C`_XAFGAI;7UT2I@8)QY"2IUNWY
M3>RP/Q'KA=X=KBR"JJE%_P"3MRWD@*`]'=W']/741^_7LK:-I&:UY^A38-CM
MFN\1=(:95IZ4HV+)B4=+3L3!\<BI[KA+MV1)OJFI"J!+B%W:XO,E[:>M&`$C
MS\M5\NZ[F]Q:Z8^6>0(]15@S9-MP\)$W(NJ*]J43<J9`06XDQJSM)*Z_DL.)
M:#M(`&U-H:BDH01]\J.X_P`NH[IYI<7N>>&)*4;"WMSH#68XY!>''+@IIQ4J
M[/W(A1=W*ERN^>XHE(*7WGEJ<J1M`(TP-`R"D-MW1_PR23S*PMS6`Z$1G4-2
M75;%50\E6_TDMK=JOME-`5?:-.`Z!J!HD:'/.DBOT)7,7R>AQ;SWR5Y6]&,1
M3MZ@)O!$9(`4MLW#N2(JQ0I:V[.OAH,CCA4FJ#;T%:"@0^?@/Q8D2!%^3G-N
MH5+GP9R9"NT31+*;2^PV6I+:*&H=2DTITK72</O)3!*X>$X!;`M/S\J1$M-X
MB/I+*GDW"Y!&/./E'5Y@-7*86'Y2B*4#B@K]G15J4)WQ8W(HTY4Q^A$*7(GR
MSA?C29*F@XG>W&?995(6KM;4O.MKB/%L'JD4`KXZ2U\X=@`&XX@XT_>I1EM=
M`<QSO,(RH45OSY"B&6T]AOO)"-RF7=J8J%=#4IH1X5"Z>6E@4%%#?/)KTL`\
MOFO.Y:&PM"WVU]ADN*4$.AI3CA(6T5.*:VK*OA72'-!X!.13%@-25@1'W;U2
MI$E3F^0"6H^T!9]24]%MI*MOQ*O'RTH@D841'.\&KBX\LRLJXLM\A;:4.!3C
M);[X9>4"H;.XVVRI*VE;B*%()!TC(J00)O?QKCC]=5LW1BXO2K?,N;[-Z=8:
M[#T:^L1KML2P-A:>;N9DE3/;5Z`I-4D@BAZZ1&QOGE\@JV@IA5-S-:R'RHM+
M7@UPP^A)A_!,/N:)8FXE&G.3E`,MP5JM#4-Q1*F5QV40Y4<-I/38KTE/@3X:
M28`Y[B\D-X42O-)C:(FM<0,:A,]F7M4X<S.W3/XQQRV*6MM;+<.?AL*XQ)+2
M`"XRU*D.+6S(0YU!+03M\"-<=%0?EN<7=M4ETE?XK&AO9105Y(^BC[1.3+9.
MNC^`8I;W9`(0]9!'M]Q0\[5*2]:XC[3S8?6=R2V#M\54&ACKN,@AQ('#5@HS
M[:RE)(PE/9]:KSG?0.Y5X6OZLU]L/*&.8XS.BW>-^0\F8KDKS,=RZVNX6-5^
MP+-[`V[>L%S&+:+M*C-W"%5X,OJ!"QTU/MKBY<2+EA%M3WL\>()X#Z%`ELH(
M7_DNK.<-/*N1HHA\M_0W^I-R3?\`#;WD',O"N+1L#Q^%A>%7"!FF7VV^PK'$
M:=9AMW'*,EL=NRC*KQ^7T:^8D*D/?),ML-T9:0@0[WK+9]D&KS8VMX^(.]0'
MU(CZ9W/=OR98_.#2,-.`]81_BGT._<R7VXG)WOIRN\6>&AM,V-@%RS*X1TR%
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M=3W8+-K8GPXJHUQDLKDV^<ZAEB*[,A13*<7*4A"XZ"E+BAO25(`$6XW2RL@6
MSS-:WE54]]U'MNW-\Q\[1)']VN/J48\E]UMJF0;E;+-A%WDL+*H3,K*G`9$B
M.E<>0Q(DOVR2\EQA#B5I4RI2$+2:$4J-96^ZV?:POCM+4ECL!(33/(CL.=%@
M=P^8;YB[X.&NH'$G#'B!]"B%-CW[)+A.N`9BVU$EYYPS9SD.*Z"\\I]QJ#W"
M'W!4!:4HH=O4UH3KR^\W7<KMY;<O<YI[30#D`O-;@WU_*Z>=SO'GXCERS44O
M=#D-SQ%.-V['LVD8\NZ6V_SKC'89BO.9"NU.6.,5PV'PIIYR''F+<*]ZE*!-
M$D54GZX_E6M!+MN]/82W3-!EACI>\G_-8[U`<4]:W!VUICH2]V-<\,J5Y*NF
MT9^P_/NENR+)K@,HC5CRFI[]JA6UN[+6\68\&:A3<=UA;?;4ITM.-(W`$!)H
M?J460'\'$]N"GOW64,$CXVAI.%!7UT15FS<:!-B2+[E;TZU.M-%N\62V6]3*
M[A/9AW"UL,M02ED)G1E()<2VA#)K4$^DO1VH:_4#X^(X)EUU!*VK8G.D.--6
M':K!/;I[\.=/;U:+C%XTY`C9MQZM6-HF\=93\A?(<Z2U+?8CFV0F9(O-J>8D
MS410ZU.AI4Y*05(=2"=2F274`?0#RZ88_4H,5T&W39XF%CP<!^_D5=)P%]4W
MASD6)'@\MV/(."\E:4W'N$[)VOGN.D2W"6@I.7Q`%6QGYJC1$YAMIMSH7U#K
MJ9%>PST9(*24Y8>M:2UW@E^B[:QL1XBA*L?O/N!R;B7!XO(N,V&T<@\6H3.G
M7-VW2$GYR:]#0['-NR^%^9VV(TY#;0Z@*8<#A3M"AW-/_IK+FTEG;)^8T`BI
MSQQ'J7C_`%KU;?P?,O;>E;6$/VB\MM;IVX^6[^O3APQXHXSSW/V7*<7OEBQ#
M,K5@=]R6QV,Q,KLN90U7W&)$&XMW%QUN*MN+W';C;YRHWI<:].]8U7/L]S>W
M7:02.><J,U`@\AE16=W=],2Z]NOMWLV^5*1*=0;IQH&EYHT$',5P57'N#C/V
MUEWE"^<XPN1LSL-N=AVNXYO=$3[C%@)4N4NT0;PO(9=UM5O=DK+JF8^ULK45
M%))KIFXV/J&)OQ<UO("X8U`:&@<:5P[U"/6?R[V$>5LV^V/Q;B6G3<,#G$X4
M&EU75.5,U6?[B.-.)LYY6X%Y&Y,Q;E#.TXMPZW?K'$X\2RFS1KC9N9,VNRKK
MEDZ>Z(<_'69$I(D1W$N=R(AP_>4"*N6]^'D@LXF.=*7XT;4#G4Y"JVO3\S9G
MR;E1MPQVW-#7ZQ74VH-.-:G#FK*/;Y[6K7A'N<R+W?<`\TX)QUEON'MT*WWG
M$U<=8I>K<QC^7R<4E3[/;PB?9GE2Y-SL3,B.\6$;''.K*R.OHEWNED;#X&YV
M.Y%S'%X9Q)0$_B<!F!VU6<9=;5=7'P[NH;<O#JOB8`7U_NVZQ0=[>*?/W4<(
M\T6K*KC=+7G%XR>_ST6_(LGN\;!83K,@7%V;8XL&-;(<%34148VIKU-@J`6/
M30UUYX?/+=6FLA]2MKK;62,T[?(]K2,-1!>?[0&!/;PS4V/8%CF16+C&_KRN
MW7Z)>[EE$!V5(O\`"EVQRX,PH#K+;L2#*BPVF&4]PU#::5/75E9^9\-^:-+Z
MG!-7,3;>R9#0B0`5!-23Q/<4G>'^/\4N/%N:WRYV<R;O#Y-Y;C(>7,N?9;3"
MS&ZMQ:0VY;<)3B&'`#N;-:U/QU'FB,E*`&BN=HG=%<1,`!8X8@XCU*`]\3';
MPO.,@6U'=N]MY-RFQLW#\OAJDILD*Z]N';UM-1NW)$6,YL22A3BDT!)H-3]M
M9!)%I+0:'B%'O]++5]RUC3*V0XD"H&.1^Q1&Q+W+\79YF][P7$LSQS(L^Q,2
MYC]D_(D]UM^(ZRN5*A/R[0U#N*8<]UDON1EK[2U)42.BM7,-NR1WP[?`)#0Z
M<*UIRYD"O-8N7>98+*1\<4@<(W.!#1XJ`FH+O"1AB3PJLSON;Y/1'X>XKN>*
MV9$V[1\PO$FQW3#[5"NHLMHND2)<X-HOUHM[5X3(;"7Q"83.6E\1T(6$NJ2Z
M)MYTB8K*2Y+P!"1JJVKA7+'.GT9K$[;\QKFXW/;-OFDF#K\R!A/DO92(:G-8
M!7W14FG/#%,9[\<J]Y^=9[PAQK[2[[G>"VGD/))=\M/+/&UZR7CG'H&)S;7;
M(6,6SD[D2Q8VBWV-+%RE7$R8@=>96B)$?<2'7$MC.VS8(W.:XEQ%,Q4<<BO6
MO@/U61MS=.9)9@5:YP>&@.S]WN%:Y+W[>N$?JNX9SWQ8OF+Z@=SR_B:!EMIF
M<B\?N\H\AY_%S'%D+4+ABRG+QA=I@2#>VEA!*G4-H!-5'S67U-`QH',44NUV
M?8_.,L9=%.`1X#,01_E'30T5C7N.SCE;C>\\%9#Q#FMRP:]3^?\`AO$\LN-N
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M.&8Q[<D_'.QLS1+=3-!X:FX]X?\`4DC8/K3>_*7\^Y=/[AIC=NEHB2G)O$[[
M(;6X6T=QY-LRBW&."MY()/@JOD-=M-AL[R4ATD,9Q-'.:T^@'@I;S,'C1=7)
M#ZEH$<1P'H]J=BU?6]]UMHFO1KK@WM4ORXB0MUQJTYY!B/M_=_!N%MSF5%=6
MHFI0WO57RIKLO3]I',^..6`Z..MO*N!3+I=P:[2VZN-/)S(QZZ#53NQ3NX]_
MK`O.413;3WM@]MV02$K([<++N4\?==0G<M2D+N<:5$\!X=TJ)\`=<AV)EQ*(
M87QEQQKJ%/7D@WFZ01DBX9I[8]13K6+_`%C7,C>)&/WOV(XE*N4&,)4M&.<Y
MW=A+<9.T%X.3,(N*%)"EBM%&@\?CI1V"\N)76\&J22,^*CA3O!J`1VA<CFZB
M='YHN;.1G]>(MIVC30GTJ<[OU!L8E>VIOW\Y;[>K^JPR$IAS>$K3F=NFWV&Z
MWECG&S,UC,)]EML%_L28XN7JBMT95VPJHW:@,VZX;>NL7-=YS!B!B1ZO:FQ=
MWTEL;\?"/FU:"TM(8:8%PIXJG@<^:BZ?KM^U.[**YGM:]P%E>)4DKMF><<7;
M;5.Y:@#FUI6O;6M-@IYTU..UEGB<\D#/'%,MN)YCK=9Q5Y-DP/<78CTY(RQ_
MZW7LXO/S"F>/O==`;AG9*2QAE@OZ([@;#ICK=@\@2SO+1"@/,$'S&G&;1-=M
M+[=LI:W.C3W\`DS[@;(:I;/0T_\`ZPW[0I\W?W#\->W>R<D\U\R9#>K?@DB?
MQT[$?B6&1D&7R&LML5J5:F6<4L@-PGJMB+G'$U3"%B*CUNDUJJGM('SRF-K=
M3NXGCV`J)M6XFTW.]ECC\Z1TC2&U`!#Q48DT)IPS"3=B^L[]+I_:BX>X"^6-
M_P#H7WAGEFW%.Z@*G%-XK*17R-#TU(FVVYAF+':6NP.9&>0RS[%HO\1E@\L6
M-R\M!K0:CAGQ3IPOJE_3#R!JMO\`>#QS#*D;ME^L'(MC%:U"2[=,+C-))_VV
MGQ:74+=$E:T_K4])I1(/4\.#IK*ZCH-0HPUYBH!]B);I[U_8M?8TJ?8_=Y[?
M9L-V:6X[[O(-LM:')<J,)+T,?F_R!$EI25.%LT4$.`]=2+6WF<"(QJ/($5]M
M%+W#<;"\AAO7&9FKPN+HW"A.0.!X)O1SGP5E?<MV"\O<=\@7:ZK5;85JP'-<
M:RV[I>N#+L9B<_;[5=)<F+:XTAQ'?E.([+.]&[[P!C;[NUCL.S3;ANI=%9L:
M*G234D@"C6U)Q]E5G1?6<TXMF.:Z3S-)!!!&>(!'M4),`G9/[0N=IT_E/E2Y
M\AX[GN2WGCZ]\?X?&@7.UX[DR9UMN.%.VN;-LUHNU[C6"QY$8[[ZOEG7I#Q'
MJ91ZL;L6\MVR_P#-82^RO*:=-34D5!+<QWD*VW0P6T`N+4ZI[>3RY6$^\"TN
M:6GLSH.5.*M?Q7(IE\M2W.-[G%?>S#)+K<8%QMR8-T0Y9K?:HKDEIGO2X<53
MB'60T[1P.-.-K01N20-;(9))'-(`EH3ARX>E5MI>Q3PB8R`5.&H:*'\./$))
M9-%Y@Q:/,N&1IL"K8^75..FR9"Q<)2V5=Z('EQKA=[<RXJ5';*G%;&T]**!H
M#!D@FMW-G=X7NK0\5!NW7$6N>1Q\NF-'`FG'`$X<T6,,YU+D.P$R;(A96T\M
M(8N,MLR%!$DKI*[BR$K>)3UHFM``.FI[?,EPJ3A7$KL=L^8"KQHH"*-TGLQ3
MMV3@;E.ZV:ZWMC,,:CP8T9M]<-6(.R%K`7]UPJN;+*TDK5M_#Z'QKI#(K@S%
MC7-TG[M,<N:N+;:X9&M8Y]'4./'"IS]"Z+O8Y$N4'VG<)0[Q(B2KE&Q5]F7(
M@VYNT1''$7R[`%FVLO2&H@"*`I2M0*@3YZZ10T*Z""/":MYJ5VN(0T(0T(0T
M(0T(0T(0T(0T(0T(0T(0T(7&BS<&XR0S&BPVS4(2NJFQ6A2%/J:V[5T)*7!N
MH:5^R_J#Q5>X%N+L%J1`A4Q7;>C,ND!)[2"F0M2JG:Y^\(6X/VJ46*5ZZ*CF
M/6D@@F@S2ZMV)YA>BPFT8SD]P^9<+"6[38ILDNU07:!9:9BL@)020I93YBFF
M)[NVMFETSV-PXE.LBEE=IC:YSNP)Z;3P[R"N,EF99XUC4E/164Y/8K1VVU*"
ME..1G[@9)(``ZME8IT4!J`-^VT?Q"3_9Q]:F1[9=/!U-<WO"4$#B!2&UHOG)
M>%04K4"U#QZ/D63/JH34K<;A0(#BMGBI+X`\U*&HTO4<%/RX7--<S5/1;1-*
M2W4!1*N)Q3@RD,H?ROD*<Q%=2^^W9[1C&/1Y"`H58?D3$93.6PY3=1L-U'[:
M?#5=+U)=$$01,["2I\6PP"AFF=V@`>Q*R'A/'\?N;,:F3$E*FP[D5ZODD/+.
MX(6IJSKQ]HJ32BF^FW]E1&H,N^[J]IHYK#3(`'VTK53V;'MU*ZJCM)!]2-XZ
M;7C7;C8]A^$P&B3W%VW%8$V0[XK5VY5\3=I*GE%)W("]X\5#K74;XB\N8VF2
M=S7CF2%R6SL;6GD0Z]6>;J4[\DMH^=W=4<-MH?B17`&PQ'E.6UO<$CT"!`8B
MQU(ZGHV"!YJ335:;><N)\TY\U:-?9AHI"T&G`46NE42:ZKOMH8J0HR#(E.37
M%5"W`VGM*0!T'W=J`.I4H5TH,#1XPUQ'$@8I^%["\>7X1P%<D8N(2MU*H90Z
ME("E=]N:\M:@`4%I:U(;"FSUJD(2GI2M*Z6PMIX:`=F"3=1RR/K1SFZ>]'[5
M]N4EQ]%R9CY*Y(A)B;\GC3;D_`#7[I5LF2;HV^TI@$T(7LZ_=^(98V^\X!1Q
M%(YH:QE&CD*>NBWF<:M-T-IB6&?<;?.=0\U.7E"K3:+)W2`I?RUR^8[B&7/B
M\A*@?VCIQMQ#(=$(:7]KJ!#8IK<^;+JT94:*G'L2:D6^3"=EQY+;78BN*C..
MM2&)=MWHJ2IJ?",F(ZPI0JE222K3K99!1HT^C$>OBFR(G3>8[4!_6P/I'!:;
M:X\U2$`L-!A1W/)"]R^M0M;B4%79!'H14J(ZT'AKDFL^)^`RK1*=Y>L"(UPY
MU61!##J5[Y@;%0E;BFUH"*G>\''&W74]U2JIK2GV:;\G20-0<3R1\8?P.6Y(
M=<C%+ZY+*T@"K45H%]#)'H0\?W06Z?O!*MPKI$;(=+M3"V8.S)/IPK1/LED<
M:R/;Y9X4`(Y8YX+<113)4ME$:GXE6G)#N]TT4EE)6CL,J2>I2"H@^!\=<(-<
M$[0.&&+2O:9;2?P%/(7N3M;4X^ZEY,ET5+@._P!?;H:5`_P:*..:3X(\,JK,
MMN6^AAQB2^^4K1$/X:2TY'112W.VA2BA"E)I4T_ETK2%&\U_'Z$:*O%U5#7;
MW)]W9B2W5J?M\9^2FV2$L@)278T62XR[N5^RI()/E7P;\UNHL!%1P4EMOK:'
MEI)(JO5P7:YL>VQW;/;+:(K*GGID)$F!-EH<(#H=[LLLK6I&XE19)W="HCII
M8+G$`9I#[735^J@`R/[<5EFP,9>F,1L?E+7">;B-/G(Y$*'&AOA84-\J(^XE
M]L`#:2VT*T!&GQ!(<SI[U%:X@8L+CV56^JWNP)BX#<>+)0'%53:'H]U0XVXU
MO[B9$!Z>E?IZT"DE`Z;1J&6ZORI*N(QU#`'LP4R.X@BB$Y86.<::3GWXHK^;
MAJ:#168[7;=C!PK3U6TM6U#H#2.RM0'45"OLUT`-%.`2=3IG5I^4<4&BBJ%1
MXL9A"@EX*8=<==[2:"2KN.*;:"UI'VG[-/-DD$=&^YW+AMHB[40:]Y6RVV7Y
M;C=-S!(#:%,-O2A&=`*24T<#B4KH1UZ#RTV7L#=;R`WF<$2AT(!;@UWM6:XV
MFQ6A(EY#,L=E0['?6AR^R!:Y&V/5YV0B&T\7G6^V/60RFG0&M1JAW/J;9]O<
M?,E:-(K0$$GT*?;V%U?^&VCUD"O$#UIK[SREC%G;B1\>C2,HD/?.EI2U2[+;
M0(Y']5BA3KUQGR`%I7M0TV=J@M*R.FO.=T^;,$0<W:H#))EXSI'HYJ^L>DI7
M'S+MX9_5&)'8.:8G)^6>0LG%WM3S]NP_'6K>W*FV:VMW2WSD)*XBGGK]=);E
MW=W(0ZIM6[HT&R[L.\)5YMNG7'4V[D_$3&&$BFB,T;3M(XGBM9;;!M=A)KB:
M)):>\X8]U#R2",BXVN)$N%TBNHE72U,`7AB>J2W^81P@I1<+PII*%/W*3)JA
M]V1Z07"A'BTG+!LMQ)4R.,AYG5Z@:JUC_)<#'X7=B5;GS#$0EZ*N,[W'&47F
M:T)_Y3/F6\NM1[4\W%@Q771&;2W'6EM5&=N]!K4OBSFA(DF]WT#%&H&KB1A4
MGLYE1SY/Y_Q;CN+-*[K%OV4LORORZ&P4VAZ8W+MS"G;M/>ML>8Q-2^NH6\W(
M:;;>4:ME9W")N>\66VPODNI(_.</"VH!![@L?OW5=AMELYT3XYY",&AW;EAZ
MU7[.YISO(;1)M;^1FWVUYU]YZ'$F-HWH><$D1IKSB%RI*`LJ4"A2"5*Z@]"G
MRK<NN]PFB=9Q-;HUDAQH#3L^I>4WW5NZ[@TQ^:8H36C6GVUS]J2K6/7P,?G.
M07^+'MDE:$M,ML6^9.D[D(<::C*0N5+#K3Q2=RCN25$D^&LS)>R7$3W/K4C"
MN->Y9CR7.<7W$H+CQ=B3Z3FL3+3%LCI>+Z;:V[*=#2ISBG+B^\Y53[FYQ"!'
M0ZXV:H:*0:5J-1OBK^5@#BX1-`&DCEQ'8K6,1P@/%,O1]BT+C>!U=D2H\U:U
MCME4A`4I/<;055#@0DL!U-5$A5!MZU(*!;[A([S*-$!X\:=R0^25SB6#P=@5
M3WU&\C9LUYX8GLO,JFQ8><+CFUR5-.`.3<:9+CZ@5I0I]I2TT`5N:73IUU]G
M?RIET>V[XP.#OSX?_F]TG(HIY6ZJ@"O$!5662^6R[W*7<;C/DVP/..F.6`H2
M02]L_&?!-6@EA)74DU%>N[7U@06#\O-3A#&UH8!X0AD6;K<M-ML$=R6XB,'E
M1_FW5+CQV6VVWRAMM"E*"4OS7"*U50_:1IQK0/%]Y=;:ACM<7A>>)RQ[\$46
M3D/+L5E-W6U3OZU`AOL",XM+B51'V0RE)C="M49R,RI)-%)<0DCXZ6D/M`YA
MB%#(1F.U3`P?W9W2?8G9>1-6Z[3+>\];,E@2F$=K),:N:9A"$L,H2VS<[2[*
M64N)"@5)030C7'M;*W0[W3Z/H5)=[=/`\"I%16BECQ7S!D6%QWF?;]S3)MMO
MO3,FPC`YT@S[5<F;VE;<)IJQWU,J!:KFJ*MVWIDH;;#CC#14XDKIJ%*VYMG:
M(G5AX4Q_I3$EE:74C;F:"EZT4K2AT\!W)^VOJ4^Z^WX:]A>3FQP70OY>5R+9
M<6EP\^MJ[0]%:<$"<U*>LK3,MN*ZRY2"\E*5.@`#8H+M-SFAD:^Z+I86R-K&
M7%H+:X@4(QIE15^_=.#>-KDV_;IH[*XD::/,#'`2G)SO"2X5YU'-%O,/N4]P
MEVPFUW/).8LH@P<BL27F8;"656>,;;'NMXVY4K^'Y28DK((;'RZ7RYVW_P`)
MNK;BJGVH-Z.W7IJ7<X(962M)`82XNJ<J5-2!S7RE/MGS2L^N+;I>^FVVZVT`
M!\K8(8VNI0'P>6*N/`9N)KB%)SA'D[F/$N0)5GN'\,KRVRIPLN3+G&OC%K3+
MB1/S"+#HBZ0YT;'PG)%LEME;:7FVPH%145'Y_P!RCT7LT%JYX\R-VFHII-:4
M[_:OLC987-MHH8-,=NQ@!`:`-0SRYGADNJ;Z<DE=_P#;+:,ZNB;2O(,WRF_W
MF^1;5%<;M%GN4(0[+(@V$3Y%PN3-O?5;OF2'7U*#SRR``1J^V#;+C8MAM-HF
MO+B\FCB.N21[BYQ<:T-3D`:*@ZDL[2/=G31P0ZG`&OEMP/,88'M"G"Y)=;&Y
M+KB$J4:;5J0!OZ$G:0%`A--3Y(FM95K1553#.YU*O]!(*2ET<+LAA3Q4O8L)
M2M2C2FZM!4G4)]=)KG1/P,D;,2\N-6\23]*@'QE<HELXTY8MKBF][?+'+Q:2
M[0K+;E_<?2$UW4%5GQ\=5<KW,II6PL(WM='/0AK1GP%55#DTV1>,#YHQJ'+;
MCW"=G.=HAR&_0B-.G,1E1W]A4LMAEQ]"U$F@H5>&I&W"=KB6`^73EQJHMQ<1
MSV;X*>(N/IS7/E[0L`SIGW.X%:;Y:K[:;_QU(GS^05R84Z/97HK5@O&/)L4Z
M\AE*+K)::NC$>,%.I;EJ?=+)4([:C?V]R896/;0W#'!P!PQ&(KW4K19:YL8W
MV+[6Y!^&DC<PAY)&EU6N`KE4$XC$9C%7D\C\)X_P;<,&Y@LUFX\D8[PBS%B7
MG".,;]<[[,B87R!FD>/D>4W>+/RO*\DN.3XI<5MSY-L84S*5`#Q/1*JLW^Z;
MONUQ/<W,FCSR!(UN#7!N6`H!Z**BLNFND]DBL;#9[6)TEB"80"X^6UW\0A]=
M1<X5U$DU``."G"JRXKA^5Y#@^/)L#_'%TRB^W;C%-OEQ)-MM5OF1(62W#'8I
M?>DI?M*OF7YUO4HK6VUO:42E#6VM<2Q@9'D%Z!8S1-8+>V>!%(26-K4-YX'`
MUPP.7!//9+/!8M+ZC;;,A]N`_(2ZFWV]+C2.T^62EU$<*0_YFA!%!2FGCX1X
ML,%I8K=PKYS:49W8_MP47N1'+Q,M[LBPJ<,JTQ)<I24S&K?WHH=B&2@R7+=<
MTA!:14@M$D"@(KI5K);PNDDEA$U<JY-]/!9'J2&YO=N^%LKR>QN1)J+XVM<7
M"E*4D!:#3F$EXC%ZB6)5UC9*^F&FV/7$-`6AH$HBKDI:-+,4)<*TA!-"-WEY
M:D.OK.1FAUI%I[''UK.VW3F_Q0L-OO5VZ("N,=KCSK2.M.'-<X_OE-\O',O+
M&8W;$,DLMK=R=NT?F5WL=Q:M;[]H@,X\S,AWE=JM]N?1>W;3WF-IHM*@D%1!
M.EME@TB*%N@#UG[4\^WN;:X^*OA4"FIQ;X7`Y4X#CEFJH<<9!:Y%0`HM-R[/
M(4G<D_OW[4G<4=112WC^BNK'<+:WS>T5#&8\<1CCGCR6ADN2_P"'\MU!I?@,
M*##!9/REMRA*01T(H`-M*@J^)\/#56QEO&"&Z<>>*DMFC8T.F=7O.)2IMMFC
ME/4$()))*?2I?CXBAI2H-#_/J2V,-HT5:#RP^A5%S=S2N,;,(:\OK67$K?&B
M<F7-*&4J2]B&2IH0`G:RXTA050B@+*U5ZDTZ'QU<W=B/A+636"YT;ZFN>EY`
M]GK3V[R&';&.+M(J1G1=`UQC,(^C)\V6MK7YDT@H6V@@*1[@)(Z(VG<*)\*D
M'58QCW7!+2[S`*5:2#0=HX<^:B6<==A#FUUF4\>U11]AOMZXFY[M?)+V4<70
M^1LPPS-N/%PH$V\76V6I&&Y7&O$&]*<MMNN-LB7*7;I\),@-O*<[J!L"#TJJ
M5D[BY@J!3$\NU8OJ3JGJ'86VK=GBBFB=<L8]I:]TFEY\3FD>'P]HH.*N*L'L
M3]E5FBQD6+$<1QJX72';I=YMC=CC1U*NYB);=9HWD#;\QJ,'PTE>Q*E#[R00
M--1C?;:W?^DWDL;:U<&R/;7#,@9X<5?WW5O29<(=]CF-U[NET+'%I^\T$XY\
M$EN6?;<OW-3+QQ0WG]WQ"/`O-PCQL^;QN9>7H<?&K)B$B'#3;F+E;E(9FQX;
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MG&9EOLT1]$A[%I=R2ET**]P20?'4#<.I-PW")D=S%;`&0"OP\330YT(:"/0M
M+L>WPL$]O;OGT&(R!OFO(+V#`T)-:`G#)/I[0Y42[<P<46!%IPVV1!QSD2Y]
MPMUJ>BW*[_*V^]M.+NTV"J2_<I;Z8J%*24!"U-@^DI!UWK:>UN.F8+9EI#"X
MP4+F``DAP/BIGSQ6-FM)0]\SY)I7"4/&L9"F+J\0!VT5HOO'QG"+3<&[98OR
MQMERY\A?)M"U7F(0Q(X8QJ2N5+6U':<80RXIQU"$K4[WD=4'=U\FZ>:R3J%F
MHB2,,I7AJ#33TUHMK<AC=NE=(UHC==6YU$"I!96M<\4_&/8);N:?91Q[Q$<F
MM&(66_X_Q!DUGO$!C(W+5;[E(AQ;7?K;&1A]QLE\BOS\WPBYR7'#(2A$J:XE
MY*DT2?1K8QP7CY9K4W+ZXMU%F'80:5Y5P7F5UO%EM]NX[J\1PS3!@<&-D+'N
M>6D.810`C30T[0IH^USV+<R>U?$,]<BMY]S(UDN&W3'XT&#/S#)[9:)2LA9O
MC<N"9M[R]3[JDN".I#2FW4H(!4/NZ?WJ[VW</A8H;-UD&N(>72B1U#3$`&@I
M3&OH5G#8/;!-N&S^5=1B"1K6@-9YCC2@-*8CA3FK3,>]N',EEGS)3G'O(G(S
M4>8AK\[QC!'(IN7=8:FI;:MRYC$""BV,241%%<E/<4P5J]:E`5-])9;>0(3+
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METR;(G7&TI(6RXS,NL>W./[E4[?9VGX>0SDFY[A,`))7$#N"TUKM5BQSB&<.
M)*7%JR*XPDMBQVJQV?\`^T.+8Y8PZT$@*:1-C047%EYD"J3W"%4'7QI`<][W
MDN<ZI[2I;K*TB\8C!(2YQ?)"NXM2,XLUWS:S+0XG\ON.772T#YUM>UE[YMEF
M2&Y#*R04I:VK3]U0/70UL8=KD;K=PJ3A[5UKG:1#`&LJ>`Y\ZI199@MLMJ8E
M]L]TQ&=%NKKLM-EL]ZDWBZ8Y'*4K0S=W'X-N[;[*%;"Z4*.Y'K3UW%;G!Y\+
M0.Y,_FM>YDL;F4.!-*.[6]@39?,Q%+3L[DMY+@0V4I0B,UM2M7XZ4;TL+<;4
M`E9W(6>NWKKKY2\4-*+C8PTU"75JC]M+SLE]Z$XVB@;[CC3KK1)(0H-*7\K7
MH*N`M*\0D:;`>]VAE-2EMBCTZI"0*+P7%N/%"(S4AT`I4.Z7GT-56D)>"UJ4
MX"A0ZFL?>/NC77,<TT?@Y16O8^I9[H-/4CA*I"=OS<9U`4V%[W:CT4`_";4%
M[Q4@$@EA)'[-=<2E\3<%-;G76&V4/>E"E2)#B%A!W`J2G=N<(5X!2VTJ\TC7
M4/\`!)H&5*K5=O+J=J@XME(HI1<W]E3M04I6M275A1"O2$;DI`]2DC3[8VAG
MF'$TR0"__9^_P2PMCK\YEQ0F-CQ^80J6S)#(H=BG6XZ7EMD_T$T'0A2P-0)[
MJ)DP:10T&`RS4ZWM[R5FHG&J-(5OE+*C)N(0=B]R$QE*6A`-$//NO.-MLM;?
M!.TU(^^>AUVYN`VE(=6?N_O4AT#3X/-$<HS!R[*+'\Z_'4ZC\PF/M(KU:AHH
MXD)VAV3W:-ENIZ)!VDCQ-:ZD-MI7-#FL#:@'MQ5?YCV.(+M0!I^]'4+)<T;M
M3ULMUWFLVJY(49=N=4$-2D!2?ZQ)A+0([38V@`TV_P"40==U10#\PGS6YC@A
MUO+.-8`H4<ERRW46<"QQ\-D!98F7M^=<KI!G':I(N#]I>C3;A"2R:$K:<6@`
M]$@'2A<V]Q'H<2,>"8^'N;5^M@!-.*\7+';I\W,A6N=&RZ)""7/GL=;G2K;+
MZJ[?<+L.*ME*:&N[T#XG2WMA8YKX27$'BE">ZGB:^ZH.5,$F(Z)JEN4:F-".
MYL,<0G$*<?)ZU[32&DL-'K4K2*^-=,.=J<7<24P9"#E@C",AEAM<N<E]!;WB
M*A>V.93RZ!1=:6L%10KH%;54&DZL:#)3XI*0![LA5>&DHDAR3V)$B.R0B*ZS
M\FR%O.$=ULR@PZIQ:3]TA**4TYI!%2]C>PYGN3+YFRG4QCW`<12BQ=]:GGBR
M.S'CAN-ODK9#REN.4=4AIMMUQQT)5X^D$CP&D)",D*A,NR%01)>5VVXJ7>V\
M7:D&HHK:D4-?#I7Q&NF%P&LM`;SXXKOQ,;?"7N!'<M]E84W)<?::<=9#3+3S
M[[;>\$A6U22JA64FA"J#IXZ;/A."EQ/#V!]=0[>*V%L+<;F*:MR04JCT2S(:
M"DJ.P*0E;X^YLZ@)K]GQTV_6\U+W)VH^Z`.Y?8$:_-3'',=FW2WSX4Q@[;5W
M1-2TZE)4"XPZEQ0600:>DT(TF2:.$`O>UE?Q))8R04<`0L]SR^S8Q<G)G(^4
MXS*E+>6#:KY*>>G/CTLE]Z+C[SEU:?;=6$*4X$-MDC=Y:SFY=:;#LY/Q4T;Y
MA]T<?Z,U+CV?<;VW/P43Q&*#5PSX)$7WF3!(O?\`X?LEQD-):D.-N7N=*M5A
M@+<8;=;BSU1#)EI2KOH4$R9+"PV25``=?/MR^;<3B7[;$#$<`<:`_NXJ[L^D
MY]/DW<@#Z5(XD'AZ4UDKF;*[P\ZBUW%5MM@CHCNVBU,P8$:$&Y*&5RS>K?*9
MFN)D,.*4TS(D/.)>;HXE"!Z_/MUZPWK=9PWXES6$'!N%,5I;'8;*WC+)(@<J
M5Q^E-&B^6B\7*6[=,B?O4J5,@RMT"=%D0BF4N1<6G;A<V9CLZ(DL17`^PTXM
MDN%`]"7*G*WD+C*#).979GQ&O<>Q7<;6Q1^4P#2.P#Z$:*0Q:7+G.>MT-R3:
M5,.NJAR&(T:2U+BH;:9;4VN/$@1RZZVF6XD@4*$]P[4G3+0/+>Y@H&G`?O/K
M3)?%$\OF<&Q#,GAWJ/\`R'[G<!P.>8J%KE2H_P`XM!M=^:#\YQB+%$5]AI^W
MS!#AQE/.)HY*0EQ+;A6BBTJUG]UZJV':@8S.)[S3@R/@3D#7MSHLUN75VVV(
M+0\2/[/VS4/<Y]WN8Y%#M[>.VK$[1#W,,?,M.V^5)?N$1'X=QDAUE-LA2'UC
MHJ(RG;O7\>F%O.O[^0!L#?AWC,YD^ODO/[WKK=I0Z.U;Y,9R<<7'^A-@_P`J
M\@93:S;+IR)=7(#KCLJXQX\D6]B.MY*HZVTOAEM$:(XTDA:6U)0E!H0=4LN]
M;U=L,9N)"'8G&F"SLV_;S<QF*YN'NB/#+Z$U;2\:G%,A-PM,YE$B2U,4Q(5*
MBLF,XGOMO2`7T2)24+)>;V[J`@'<0DUD-D73M9>2F(U\!D<2T\<./K5*&&A:
M7.<TY5QIW(TD+BW&.Q(A1X#Z$()CNMVU3FUE*0Y0%Q*`REQK[O@6ST54]"F6
M>&$NB>`YV-#S[1V)<=B^0:V5+05@A7N/;XJ$[$I=2ESMM0U,?,E:E5<+4A<=
M):"E]5+ZH2$].H(T]:WCHH&N)#8^.`)]JF"",'Q8CM11=<JL4OMI7'51V4VR
MW'2E9E,E,5:%(,WN(`V5J%A*0"JO7QU(FW&*6/3$`34&O,?O1&\%^AS06CZD
M13;?!<4W(8M$),=HA;;PG,=]#NYAQ*B7U2'`X%MI<W("2-H!56FHC;J75GX>
M2Y)<Q,<6-P?RX*I3ZDK$U5_X82J$QW68&</1HT9U;BEEJ7C1>#H0VTVZE954
M;=OI/6M!K[/_`)4(P[;-]?7$W$/_`,VN5-M'F2,DYU^I5:KM[K-6WEL-/1T2
MA,0P>C+,ET3$*6H`A*@7@$J3N)2/LU]7QO+QCR4I>OE5/(AMI9;3%:;E)>F%
M2G'4)GLT;4TX%(2HM%)(H/5UKY:>KP3AD);I6O&AN&;;G&J.(4VEN6L[V6EN
M1*?O2"4"._&2A1*A4!1/7J!UHU.`YI&(RP*.+-C<2X1KX;2M]-Q0S)4BW-I0
MEUD,3&^RXE#QWK;?AJ<4I).X*9"03N&G)(9`1Y5".U=K7&0:CVHQB_Q5BUPA
MW:T3G(LUU3;S4F*IX[7V&DN-NH<=HIM;G<VKV@>H=*$Z8<P/P*Z^"WNGETS!
MEP)"N/\`IZXMR![D\AA<?Y*1^7VB*XA%SFB(S:HLJZR5B.Y<;K*BW!<-J4XL
M,I*2E,@NI"EIK155\.9KDQ-SJ?8EPV,(E!!#6M-<<A3$=JZ:O=#],R/S!PIA
MMKRR]QN&+;@V$9'B"Y7$=WM4&W<G2,IQ^-;K4,LLR6W47HJ^3"FG$O+4V7GG
ME*207$7<=K=,TS!SA&P8M!P-.)',*EW*#I_<;L7UT637T1)8X`"CA[N6)TG)
M4P<=7;(XG(N'Y5FL&'8K5>\!XNG7YV=;8'SC60-XWC]PFQKDP[:Q*CR)D=32
M4-J)CE?W5[5*",]?1"'=B-9=45QIQX)%CJL(Q\2*6SY<",Z'-7V>U[E[W!XK
MQ3<\/X?QB7G<7&[I<[ME-VQSBU.:0,-GW9YIH0+S<<IYDXBML%<=BVN!<:-;
M41FGNI>4HJW:5]P^.*-[6%^IE33@JO<=I.X3OGCEGBC:^@),;:C_`"@1ZEH^
MX+WI>XO`)&.P<GOW(/#,V\VIZ=!M[G$7MT,G(#;G4Q[K,MC-^Y4SN7\BP^4C
MMM_B`.>)%-55S>W,3PZ.K2[&AQHHL73<`I(_\VF9$\0<X\Z4IZD.,/J,\DW7
M%G1<\)/+MQBS&!&OTF_\*<5W':L/"3#O%DB<B)8$F/\`AE+B8,/TDDH4/5KL
M5W-,S5*U[W8BHI3]@I+-I@8\,C<(FU]US@\]^IHI3LX*8'M(XPXRYZQ;(KGF
MN:7##L_R3,LRR.7Q'9\UP%^\66Q7"X-N1YCC]JD92W>&)BG5J2^PX$MM;4K0
ME8)+;X'S`%C7-I^).W.ZNVYAM7-_+/WC6AIQ"D/;OIF^U2#*GRY!S^>JZ7!Z
M[342N2TML.S7TLI6YVH5NA*9%&$^E*@GI0UZZ3%#>VC:,-:GBJ23>'R"@B8!
M7,52Y:]@/L\2I<B=A"YBG%J<>=N/)65['73]YU:&,CBL-J2#0!*4]*CPT>;N
MFJM?!RI]>::?N<SPT:&U;WE%A^GG[`+)<V,PC<$\?2\B@0Y4"(_(S#+)K+L:
M>ZI^3%GVY[,EVN7`<>)6Z'F'`H53X&FF7FY@@+R?S'$X)ZWOY72A[A&W2#C3
M,$4(/91$4#V4^R:VM61B#PCP3;&,7=<D8\S$_+8C5E6_'?AN&WMM7E`82N+*
M<:I0I"%J33KJH^(W$#W'.[OWIYMQ9M<7QN97AI^[Z^:;+W%\=\58%B-SS7%K
MKB]J@VZVO1;QC5AOL"X/K<<2N/;KK;[1'N$VXK4X_(2S+2T@H2@H>HD)<.K6
MSEO"SRKB-VG/4[Z%?;=OML6NMI'%S])()SKR[E2AR5E#*,9-W_+;]>7TY%C)
M;M&-7>W1+O'0NZ,QG+E(9G9'C4>ZV:TI=#\V&J4GYEE!3L</I-K:%\@?`!B<
M%GMZW*VM;%UW="2C'&HC8Z1U*?=8WQ./8$X>-S+%)XV8;5=F$7")C)M,B/<&
M(,:[&<Q9_EG`AMR3M=6I::I6FJ5U!K4G29X76SPQ_*J<Z?W:QW7:H[BV;=-8
M*MI+"Z%U<\&OJ2,<#EPX)`\KQ,"]P&#R<-R[Y1ZS7[&(6+7;%IDFMREPH\-E
M*;E`=<0AF!<[7(:3)B.GU-2&$*\1M+D5Q:EVK5B%H)9KZX>QQAE<QC:%I:*'
MD<LPN43)O9QSGQOR1SOQW;>-.1<[M-CO<.VX]F6.8'E4^QY=:XTRPS8EVM<^
M):WHDK?;R%/I9<6AJ0AU`51&K7<MSL9"Z-KO&&Q\N`2[K9]Q>V,Q6S]36$\,
MCB4:_P"@U[S6L:>RL^TSW(_PPU`=NJ\@:X2Y*D6?Y!MLJ5,%Q:QUR(8J$#<I
M840D"I(`.J<7$#SI:?$532V5U/&"UA$C<FG.O)1W;CO-U:>0XRII*V5-.(6A
MQN0V5(=;<2H`H<0I)"DD!22.O44U;Q2F4-K0::!0I8S&X1N:YKZ8AW/L[%I8
M2P[+Y%>5%;?DO/X;G">U&;<D;U-M-LE`0VEQ2:DD&@Z*^!UIY6>9MEF\UJ62
M_P#>%)O&-=9&"4ZF`U%>Q=9GLRX2Q'FSZ<W$O%O)UJNLS$\EN&:KOEJ@W"=C
MMP6JQ<G97>K:/S"+MF14IG6]I9":=Q`H:A6LW=EUO-1F9JKG8;>";:QYK=<9
M>\Z>'LQP4E^!O:KQ'PI9WW^*K!*QV-)DW"%=/G[[<\EDN&RWKY^*VA^^.2RA
M;$Z.T\T113;P4:T(2*S4[SS<`GSR!Q-!088?:GX]FL#"^:*("1P/`OI3D,Z]
MV*@Q[B/9'F\OEZ]<O8K?[-*LN=7Q5_N<6\6I,R7%N<N8U+N5O"3"F18ZENL%
M4)]#;2FT'97<@%7HYZQV=^R?!WMI=,N1'H,D1TZAG6G$KYAZB^1'4SNM9NJ-
MKOV2V%Q=:PV:&1V@N&+0*TIR5F?T]V,<@Y!RGAMEB3F<EL2<2F959Y]O<>D0
MV7#/&.W!$%+R'Y,6[K=E($U:&6G'8;J$A105#S2VD+&'R/X)&#C[P/T+Z!VV
MWMMNF?93'3.&#4T`%M*]O:HT<[?3IX;]T''[G'>5R\ZL,/%\MS>5C=^Q6\6]
M,R/=+Y'M,@7*^Q7;7-M^1M0GXK+C<=)CI+6]M+B=^\=L-WN]NFEB:XF&5P+J
MXU+34$<JD8J_VFWVN.9[Y8QI<2`YM`X:L,!D1SJN.?W)^U7EKV[^Y2[<(<GV
M61#N\K+K6FRY-&@2%XYEN,9/>41['FEADOI99DVN>TX2MI;B7(\AIR.Z4N-J
M.M(VXCDK=2$^774>P<?4K3=8[>P8`W3(P1@U!X4R[U;=[;/HJ<K9O;;IS?C^
M42[W@?'CN36_+)UOXUNJ[3=<@>D6VP2\%M5WEY"FVRKK;$9"M4YY2.Q%[7;_
M`!''6V]-;W>0B,-V8F:Z91P#\`33B1P43:]R%X7LBBDCI"]@(I7QM(X\0,0N
MD?DOBWAG%N&,F_OLY+QO@/)KKQ;.N?'W$G&'#.,69&;VF[/NVW"LNNMYRM.0
MY)'9OV1VR4B4U'DV>';XD984A#SJ$JS%[=..BUN"6W`;D"2"3F,>WDDPW4XM
M397LAGAT%H?I:!B-.8&=/151H]X/LJN'$K6`\^9=QE%RS%,HY8L;?&V)VJ)D
MF37K/K#D/&MG1DD>X\?1+3>;M!QAC';)-D3+A(AOL08KF]U3'H68,-I/9SLO
MV-(+#72W[W[54JYNV.VZ2WM\9721/%:>'RP&T`Y%M24:X-P+G&'<AY\^,+XD
MQUEZ]V2-&QBR<]\=1N.X-JM5NCI%HQ0O7Z-<9$./+GEMY;2(D94AEY*0\ALN
MO746\W0E=<4TO<<B5F-QV"#=+B1UY+;F![6O!`-&TJ:D<P14JR7AOV/<+YKQ
M7CTOEOF/!^*\]%RN+V53)'N3<Y#ON21TOMJ8FR+?'SJR<?XFW,<11,6/#F+:
MBM,CO!>[4:[L+6ZD^*>_1-)B?$:'N%59[39V^V6@L[F&*X#22'!M00>(J$]%
M[]NGM>X!XTSG(<#]SF.9?D%CLU\RBT87"R'AB^Y'F5]@VSNV_&+4YDDZ8A$N
M\2(K45I;A[;/<[BZ^HE4-K#!5[)&N.G*M?K5K;W\;IA$Q@9JPJ#D.ZA&')0&
MX3E_4"QZ[VO/.6/<I[0G_P`REP;P>),6Y5]L=BQ:SVUIUFXG$9]S7Q[DV22G
M'X8,*5*CRXSJ25.)>"D@ZCLE.H2O+0SC^8SN]RFK]JJ%/%N49$[+QPM23@YK
M]-*D8D>#ZJKIZX$39AP_@1Q]C`HMI<L;3T>+Q=*<G\>Q77WGGIL;$Y[WXD^U
M1YZW4)?*4=Y84O8C=M%XPL+:QFK"F'/>]VJ0ZG<^:=[2TE#0A#0A#0A#0A#0
MA#0A#0A#0A#0A#0A<L;#DQ);80U%:2'.XZSV/FW7]B`4RX9)Z/-!7J[;8ZJK
M6M*XT.@=[WB[EN7BYEP@;I(YD)4PI=5=N9=W2\VE#H3&8C1XDIM!V@%]IJ1V
M9K:@*DIW?#S`CO>0XAK'::X9)UC'T#9*:Z8]Z-^W*GLLR_G52H3BRRD-J>DS
M4)2:"//16,XI)%:.J305J1YE<,A<X@@@MQ35Q`11U10X)VL-S7*L"1*:Q6?=
M[:+C%CMW6)"5&1+?B$KWA]3[;S,QM(44A:6]R$U&X]1INDP>YT4CF!QX)Q_E
MEC6OB$I:,SP3L1\!M/(22[Q;C5X@R;/%5*R!.09+BZ7'E/)[BG+8AEJW`(=<
M"D%)04J](_#5TU*^&^+&BV%)!B:D99*&Z9UH-=RX&,X"@/[9)F)%QLS+CEL:
MM[JYC*W6RXRXEA<24RM2'NT[5P-R([I(6E9<03]VNHPM[F&;3(YNAIR_>I3;
MNV?$',:[41G^Y88T>.H_YX]!4[O")DT)2^7*%*4,M,I7(0>M"@-=?NTU).K,
M`D*/(YCW:J@'EQ6=A:H;_:1-FSA'!*XLQ4IE,=:QN$AQMK?VVR$_L$H->HUQ
M-+<4F6XAHQDQG"X0H!2E-.-I=/J4EI(/:0Y7JMD5)I7KJ8R9AP.&":E,[FT/
MB%>&:UY5NE1E-K^7N*D.E3D=;$1:HVY2=SHC/K#94\H$I6M(2X`>N[3D<D3B
MXZAX4V62Q%CBQQ#DH+2MZ"AF3,M<6&AC<E%Q2'%LL.E)Z/AAZ,P_+=!J5D)<
M-?!1U62L9YE1*14UH,E86TDC"92QU*46*4^RY*:EJ8"W$JWIEMEUOO-'[OSB
MFU1VJ455`>HOTTW*KIQ1:N=(YY!%>:5L=,)^)W7&IXCE:2B&\\RG\Q=2HGNN
M%:&2A"%#IO#2A3[U*58K<DT#FT]*L-%HUFIX(P]96PVDI0Z^8+\*`D5E.ASM
MEP[@IMIAS:JK230%12%"H(60--:+DRU<YNFN.:6R2#R"2QS'`85(Q[E\-R02
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M3.\]K+AITN(`<,C]8]*TQ#"6VXS_`,W&9BLJ>2B'<0Y(96X%*2E]E;*6G$*)
MJI*4[@/.FJ^2:9K@(HV/;QKFK+R+4_??&>0(Q128%Q8CL-"2ZL++CQ0XY'VJ
M;4=R4NM%+C3SA"@4CU*`'EXZ?<8*>#P]ZBNAO!_&`(X41[%Q>;.CMF0MF3&6
MKOK*FS'8HV"LF4\XXF.PVS0$$J50C5==[E;V@_-<T,IGJ'#L3T%C<7`)8TU'
M!%MZR7%+(W*%]S3'(K,=UY3Z(,H9#+6[$2RE;!>A)%G9EE#R2&GI:75'[J3U
M`R5[\P>G;848_P`QY-*<!WUX*UL]GW"9XB:P@?BX)!CERQ(MDNYV7'KO<;4F
M6M=SFW11<(CQ0EER7&L5M^3:+49P?C!U]Q":!7J%*X&_^:UYJ?!9PQB*N#Q[
MP[`KUG2+WC_B7NU<-.`]-4@,AY$SR98[@W<IUQM41"W&XT&`F/9HS\6X_*N@
M_(65Y<&7*AASMK>+ZOEVP%.`%6XX:\ZAWF^+GS32ASA0FN8Y!7MEM-E:`!L;
M`X<1F?6DLB-!828=UMC^/1`Z3,D/,-3FKTTN,Z&FRXY.^>EAU^4YW%J1L7)V
M@DH&[5`R&5TP,C2^/5B:BI''TD*Z,T;?X)H_@*'Z<DWLVXV[&WVK5)F+M"+:
MIV)^9O,1PS!??;0FWMA4Z*U(9N2426D*;>*VV211*O6O43=;W:=CD?-=$B&9
M[1'3A3)I[:\<E6WF]Q6`!O'AK3V?6D]=>6\8Q^3%B*NEE@_F32G8<M:ORN?.
M><+D:]722TT1&8?+K+)2\P*+2T%*W.=O5=/N^WV[/BKF0,9)BWC4#/)$N];=
M`X-ED:T$`@DY@\NY,AGON<XO<CV>Y"V3<KR+'+A,5$9`8CQXRGK?+ANKBR9S
M#B6&BDE(4ILN.AS=4+)4<[==?;/:Q.?;_F39`$>U9F\Z[VQL9%CJDN*TPH*=
MN/!0\S[G_/>0H3EICR&\<M$MF4V_!L>P.O-)D*2B6_<6N_*=>#2FT/%QUU2M
MB0@)ZC60W?K+=-\L&VD0%NZM2YF#G#MKQ/'L7GV[=5;GN.J-QT,X@?>_M)@6
M[(XHI=?#8;>=V*$X.&5*)0DA8BO,J>6I]1]*71L*3ZD@]=><QQ2/F+:ELH-:
MG.O/O6:>8W._+!%>?-*.';'@A*8S%O9;(!^;3'><=*6Z;6FF%-(CI"BF@[9H
M">@J-6<47ER"5U#)]YW%W>ID%NZAQ"]E:'`H/K=O3CA<95!>0VQ$0FJ2I#K+
M;)[JSL-%.FB33X4TJ>5T3M+,''%2/(/,(O7-MD0!Y;2H[/><2Q!;#1[2EGN*
M5V4M-J6TVXFNU#?;J>J@>NF(VON9'/FU!@S</J4>9WDM+CC1>8-^@)1,7$D3
M)"U-*$AHID+:7&;"7G&FV83SC@8:=-4I*E!1'AHECC;(&1.<YIXNQ*A#<7M<
M/+!#:K3M-NO.4!Y^W09;BY:W*0@IBW2#;Z;G7RB6EV3%0II/3T*?<":C;XZF
M6^WOED\L-+Z\N'?WIF[?/<R:Z5'9P2:N%I=M$:>;D].3;DQ$2V)L-,>Z,O0G
MI'RZTEUEP.H8:6%U6G<I+B?N@=0-L+N.8MT',CVJ0VW=I&/!)B/=[)##R1&2
MXJ-N6S5B:9DA3A4I=%NDH2A"""WU65JJ*&G6_M]H<QOGW#=.G''CW)F6S=4O
MJ*>E55?4>R20NZ</V_>Q%=#.;*=#RV4/QV%O8^TT%.-NN)*7`HE2-V\;!7KK
M[,_E<$;=OWCRQ0-N(CZ[:Y"L=JC,57G$559*)5O09+%U?>=7L*4&.ZE(=C'M
M;'7%-E2B\E7[*B#0#<*=-?4-,%92M=$`0"ZO):LJ_MQ'?DH<AR:U'>4I:=HV
M+!D=UL)6VE*JM4`!J!TH.AT^^0&,-`Q3@B<6:NRJ-HDR[V(N2)+*N]VD76(\
MM*5LR8TAA>Q"@I);7%[(3W&_Z!ITJ1IE1XB;C4R/PN'$K*SF,"(^JX6VWB+,
M?@R(4M#;[[[2FI392RX!M0HKBNK%%FI!"?MUVB!9SG^(\$^E:]MN-VD/[&9B
MJN/I4EE3A5W%@K+BV_34*H$IK6I5U!\1KE%)\EW,*\'Z:7/F78O=;SC[<F'!
MMN-6J9=A>)%J5)=8Q6__`-4N(>EH:[:W+7<XT61%0LU0\PG8D*KJ&Z33(1&X
M"2O]*?G@=':&1Y+6:<Q^V15W7`ETP'WJ\BPL$M>3YACG*DJ`_D\BZY)R!<9$
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MDG(4RWK=E_&C=P-M?D08_8?8,IUEE]'86E^]GNK5EFV>`O;$^(/:*:7@%NH`
MAV1IF"D6L?Q;S):P0^2T\`:#T)M\7YDG<?YG`S*Q<;8%)N$*/=&';=D$;(KW
MCUT1<D+;F)O=I<R".F<MM]MN0RX@M*:DM(6#U6E>4AW9[7^=&P"-P]W[>T\5
M9L%Q;MI!IBE.=!A3L[4[][]__+M]8=M[_&O`$>WS8KL5UF#QO)968\AM4=P,
MR7<@=F07"R=H6PXVM)%00=23O<KON-;_`&>*:N8[R[C\JXGUQ?A>QKP?\[$>
MA,YCO.>;P9D:W1HMGCVZ5*C_`#,0.Y!53;[R6)!9<>OKCK3JV5U*J*!4!4&F
MD.W^^;3',T4?]+M'?EB-D=N![K!05YT/I1W<N2LM<=WI>:;2V"II!?NY0I!\
M4J"[GM=25>2OB-2'[GN!;36WU)O].L]?D^6W1E7[WV)*/<F9557<:MJRM1"5
M);N'<+?<-$*2N[+:4DCQ)!])'7KKC-PNPW\P@OKP0_;[.(Z&1,(_K9^Q:DKD
M#)G([303:TI;4Z?[&K<X'5"G=*Y*PXA`\J`@TZZ>9?WDOON&"(]OMY*T8QE.
M7%86.1,J;=;4AFQEWME`6JU,J6D&H)[A=6>@%""::X+^[K2-P#D,MX8G58QC
M3E49I4VOE#-6EAP(QQ:DD[.YCMH5M/0*6G<VXH@)ZD5ZU\].?%W3L7N&I,N<
M62ZVX.!3RX?S[RE`D1C!<PDT]*D2^.<.N%4$@[C\Y:)&T@]1T\?/1\7<#&H(
M4R*\OM!#)7L;V*RCA#W)<C7_`"W!<2F,\9W*'?)3PO@7P]QBPM"6\?N<UEEB
M1'Q=+R)!?AMK4L*)H"#4J)U1#>)7[B&"*+$]JN[9UW/$QC;NZ!QXA6CV?GZX
M8Q;(-N9XWXFG/(CE;UQDX1;HLR2I3[R4]YNU&!`24,I2CT,IW`5/4G5ZW<O*
M>7-ABU]R=.U7DS"YUW*`#2O'[$<V[W=YOCBI2+#A_'UG:FK1(D1[=:KI"A.R
M$IV&2J%%O+4-N4XD`..(;2MQ*4[B=HHZ-[F;BV*,'LJH;NG2Y^M]Q(XG.N95
M=W+OMP]F/-W(F2\J\G^R;VX91GV:2Q<<JR--MY"L;M[N88:CJN=PAXSR%9K0
MNY2VV@9#Z8R79#E5NJ6X5**3O$IJ=+6G^KDEGI]A/\0GO57M@]K/L`]M'/W.
M?*%S]MENY0A6?C_-\D1Q+>\KR0<=XKC#MVMU]NMMP^)*D7G(%9'96K1&9CO2
M)2V1%N2FB%.)+FMW8=97\5K!;/:UT7EC3^)O.AH1CQ6)WS9A=73[:"0LN(FE
MP\+7M?V$'*G8G<5[F+CFGLZQ+W(^TWVJV3CS")*9TC$^#L,O\ZZ3;(8.1WC&
M,H!AQ+1$CW"+.NL:3.<=9E-+<<>0H!/J0;^>[Z9^'^.W`7DETX8BA8VKL_&,
MZ<.:JMJ_QJ[:C%9MLX+>,2%CM)#R\=V`U\DJ^=_>GP1POCF.WJUXCR=*@Y[D
M'%V)LV[+N0,)PNUXCF/)"[.+JO)KW'LMR/:LCU\!DI#)6M5LN!*FRA#9@6%Y
MTG)^2Z.1K034@DEP/!SG8T^@8*7<W?5,5LZ:UEB;*V`%^L.+2[2-5=/#GQ2?
MY9YKYUXQN+,"S\6\4<BVX(?AW*W6KD9WD*Q_F;JXUQB25W.V3L/DR;';8$UM
MA<A4)ILW",XJM`MENHN8Y/B'?#1N-K7P]@2A>W][;11V\T1N'#\RE6L8>?BX
M*.V*_4!Y.XVXSY:R3F;VB\3<*QLT<BX0QR)PGG>17ZXXRX]%E1K-=,DN=HN!
MRS)7(][NB%,1+?<[*F"JJPZM3BD*DM.T1%\6F1KRW#PD@GEAEWE5M\W>;NSD
MOA-;W5@UAUAD;8W@4P+7#,UX%4&7CGWDV/Q)(N*/<M[B9'*C]P;GRD-\]Y/:
M+%`LB?ZH7';"PLR+]?KLZ@I6REZ#^6-LT49/<';B&4,BTQ!VL98%?.EKOFY_
MJ;[6:2Y=$'N#"&D`#&E3QIV%)7'[YG7)S$&9R3R%G')%@9'Y2[:,SYVN$-;T
MJY]YVU-0HF1WN[W&0EN_18\C9&@/-K>;0EQ316EP*AEJ'>?2KA0@G2[U$?TJ
MMGZCW^62:&&::2W8[0ZF!H<#ZEV$+YGM?&^5>U5KCWF3B=S!/:W!Q3`[3POQ
M]S)F%FL-_2S&E0KIR-R7+M^+W-[/Q;GYDV[7*#)6TJ5=2M0=)=(,&6X>W<9)
M8'!UOY8:._M[LE]@P1V=KTIMUO"&G=&-9(=375<*#CP/?@F$]TW,."^[?W6<
M<W_EK.>";[QCA/%[;CG,A5D;4:1E<')I%SMO'TK`[9A$*==\;?EANY.FX6R;
M#+DKM(6*/%6%DV??[G;?+O=UC=OS9WEETV!K"R%S@[RVQCPZ\`"_,BO-/2[C
M:0M@>YKWV183*P#Q"II2IPS2&]]ON-YEYG]S^+7H>YD2<,XHP'DCCC%./\=Q
M>^XXSGN.\BQ;+C7)5_$VSV6%C2+-+8LS#3D"Y%F4Y#(2PWU*=2MUWJ_U_"0X
MM;0%X%&X`5-!E7ZU9Q[?M4D$=Z!,;R-Q='5C@TAPI0.RP!SR)448L*%(0S(B
M,MID)W-%"VDG?MZ`A`1T1Z3Y@=-4;Y-3P_&O'O4EIJ*NC97MS_;DE/#6J.P\
MUVX[3;A0A3XCM`H=.W8T`VA%4J6!4GJ?"NB6024SP2DL+8U<T$+0AMQ("U$@
M-;6PDA!("@%=Q:E&O4II_,A3ADCE2)D%Z+-6&0"VMTN*)<;29#1;'<*U$E20
M@I`'1)ZC4B*8%KFT-6`U[4Y)"9(V/J*-Q79)]/)T/>RSV].`J(5@YIO^\`+W
M=P$J\*J32A_1KTW9W:]LA=S8%EKQP?=/>,BY3-U9*,AH0AH0AH0AH0AH0AH0
MAH0AH0AH0AH0N523<TOL,)ESE!H%;L-R,II<A"^E(RY:6`ZL+H1N2D;@`DUH
M-8YEH^/'R]/HHMM=7%O<,#=;A0UR*-+<]:WXB1%MMS*?O3`^XRX\V[N"UN)D
M)`6T@D5&T;J=?'II1AN6.'G/:(#E08]F*:9<Q>61;AYE;A4G#MP*6T`/R$D%
M,*"%*"VEI6'!):VI]#S`4IQYU"!U*S]M/$::>UK7DL).&?-28Y'RQ@RYUR1C
M,FNQDQF&[NTVGLNI?6X"Y<8`4>XA86B.JD1>T#;2IZ=2.H7%&YX);3TT34\[
MH2`"X5'"JQQKO/@,LQ57-R4RG:LLF$&F'$*(>6F.E[<N0V2:K2H=0>E-2Y(?
M#X`T'O`4,/DC):\ET68<<37ES4G[)<,>YE$'$(MEXQXUGVB%W9%]4Y=[2Q>D
MM-CYAIP.(7%>=H0Z6G"%I'W'"*ITD1RN_+#65YU%4RY\4#O.;YCR[$@GPM[F
MIG[W#59+Y.MUPNUHF?EKJVQ(MLY-TC.LM+11Z!(C=9D!P+!)Z+0311!J-+(-
MO%24@5[>:"77/YK&$#++DO2;[9`V(HE1YKBPA3$N(\M3**J<:+<-;?<6[(Z#
M\%Q)!_1X0U,PT-'WJ8K=BSNQ'_JLAR.E16LMK8#+I?<;ZID@--/0E=-W0!%:
MFE3KH89/"!5`)&2V%SWW252)CA>0`7%MM-H2IM1"@$QPH(<)02.\V"L4J1H;
M`TO\L@-)S0^ZF:/=JUN16]%1*?JT@N+CO(`,9;RY"&TA)"EOI)9%S`H%#>%+
M'E\==?9V[7>)U7#L78[VX(P;1M<<?6M0RF&WVQ1F(VE26FE=UM)F.**DB.%N
M=I]ME924EAY*TCIM5IZ`!U:BJ=F>Q]-.061J2U\RXT2TL[4B6GN&*]`:6!T9
M);[T6J14T4MIP>(\]+EACC;KB<`^O$$A0A+<EU)&`QC+$>@HSGRD--QF`W,A
MK9(%M8[TC9)0:*,@AP^I*4KW!R.:TJ-A\-1-5'U.ESAV4!]"E.\V=@=*2&]^
M7<LL7Y6&"_(:GRF&SW77GVZQE/FBOPEGY%B2IMU5"@%MVM*`]==,DCCX1I[!
M@NP"*.3\PES*<<481+LVXXG?;X[B75..2)Z6/F51XM4(0AX27&0PL-D_O5)4
M!4;R0#ITV=W%^=YCO,/W-6'TT3PFC`,0]QV9HMXV5,QQ4R/<685O6HQHJ4NR
M4=QPJ2CN]E3+NU8K2KBU(^"PDZB07$VE[I8A4..8[>'/ZU%%K#(_RQ/05PH<
M4:Q<>OEJ(F,S?EK/#8+K]RNCC-NMA65J01(=NVU,?93<G:N4E0(*0@E-6;C>
MMELX1<W\L48QJ,"X4_JC%/LVV]CN/)M]3P2,0:UP6Q<>=\'MM@CXG<Y=AS*7
M-9=GL7#&,=5<);(0XI+<=.5(3:XRY$I5$,]U$E*@A2J%"=8?=?FKL>VM)MVL
ME=]W[H([:\5=V/26Y;A-KE#F`84)`KZ"F2O'.\R"AURPXW9<?N+S<(RX^2W!
MN[W6&P90AAZ1$6E<:1'CRGT;TQFD+"%E:3N3M/E6]?-3=;RHM@V%W$#@.8IQ
M[ELMNZ-M;9S1-K>XYT-/63FFDB<DW_DN?;;E>IE[R21&F7/M-8^F[6^WVQF+
M-B1X$63CRC-@3I,)GNOF0B.VETMA*.VE5',-=;EO&ZD/=<.D#AJ(Q!KGQY+0
MLVNQL928@QD;200ZA)//4M$S+6_+NJ)T15M<EPIU[8MDI$):WH4Z1(CRVA%-
MV7&E2E-QMR'4IAAU:PI24M=TZJC\4:M>78X$$J69(HF?ET#78#3Q*V9CM@>F
M6R_6R/#<2J"S;Y]ONTNY,-R+7%DA+[$BQS&93DEZ=#*%B."V$.`]O>"A.EPL
M+&D&@]*8UO=^620TYNXCL6O;VY-FNXF37OR^&RMRWK:5,DVYMBURHZ)87=,8
MEJFPTW![YM@,H.U:&@0`AUDHU?V+7WMPV"9V#<&^$MU<:DGCP4*\D%M&=.G7
MWIFLSYAQ7%<FE7F^N/SKE%:=9L.46MR)=9;D:\SXZE6.YPI17&5&CM[4/,N!
M#(%`E525Z<N7[)83N,L\<;FU.JN-3@6GL]BHINHK.UMP;F1QD+0"P5PID01S
MX]B@'R=S-<<L$ZSVO%[*BRN3D25_F-O9MR2]#+3"I4FX6]=MN=W^79;2XQ'2
MXF.E]14K<E*1KROJ'J[9;@/LQY,@%:5`([\5@-ZZF=N;#;.BTP#(&AK_`$IO
MI][GY:[;HLJ\*NDJV58MD!$`1S%C3EF3(3'?:7(9?::=6@%3KCCZTI'J&V@Q
MK]SCO0QC7:Q&"&L&+:'V<%F+AS]PT^>ZGEB@!/#L1"[C-_L>^3--%J=2II?Y
MQ`CO%`6%K2S$C_.REQ^VH[5I]":47ZC0U%^V&SE$C61X\!0T/H45EO'$=3#4
M]R-F;?;S$<;;?4N/*24J?1.?8=:0.XIYBWF#V4-)2.I2:!1%:5.F[*]'FND=
M&'ZC4DCW<."Z6-.)`JB^!&QV,IQN.RJ5(=*VC=#\^999922E$V0^M3[H6.F\
M>FJMM*4`A/>V64S-:`:TRY)Z-L`'B:-5>2,Y>2P2IB+=);VYMER+"M[CBOR[
ML,)([,:.VTTPI:4`)&Y*B34DT\83GWID<0P:.&(2WW3(/=:#7L1!=,CQ1"'7
MG+A,9D!MM3J#$<;04@(+;09[#;<A]WP2E`'I)ZC4N';9IW-N97$5-*5P4>3<
M;<CPN.JO(I$RLWM4Z2;>W%N<:`%18R9+D8!AQV7WE.MI:8C-AD':WN;W+/0G
MK3I>7FUM@MPR%P+9!XL<!W*M?=,ED+*N(/,&B]N25F$N%:X5V:D5?E!YP1H[
M8#80(:4%#94Q%`WK4M2D$D@^-0*>."+088QJF#JU(X=Z4V#5BT"B0.1/7J\1
MXT1J[7^Q&8PJ+)<M$MV.^F,F4EQYLSD*9W092?4IKHI(0!75YM,]W;2O?;-8
M?#CJ%<>%*J5`QS*ZL$5_D-N84[:V)-UO[D@*=0M&23XS45O:M3JX*0^MF3+!
M:"24@E204J)KTOMOOXX6?$7U'.:ZI!%<>-!WY*5&6AU7Y([CV"V-K$:RVU34
MMA#@CW)Z0N.4++"RWVTO;U/R0I2JK;"5-)/0].E9-ODE\XE[2V-SC1HR`KA0
M)YXB=&2*9*J'ZGT./%F\-J4PMN6_;\Y475K>5W5QUXNVVV9#S2%R%-[E554[
ME$'SU]A_RN-<S;=X+L`^>$#_`.)G9_I/:/Z"G[)C!&10>]]BJA*U&([)6YL>
MB2XL55:A9$AJ0%O$`[%]HL%)K2M0=?47>IZ%M<+"I*UG=WXRVFEG<@A:`I84
MM`"DUV@F@\B=+86AWB]U!Q2^9?G7.+:6'GEB,KL6^,24]EEEY*D-J!5Z4-M+
M?)\*T-/#77L)_,9[BB:6Q2U:`!QHL5^L<"T71AJ,M3;$R#%=?:6M`="G_P`.
M=%<4*;$HEH<"#XA"4GRZMU3_`)K.:\1B_&2UN<2'XSZ`AA904,D*V]]=*+(_
M#3N%>JJ^&GFP2N<&M%7%'FL70E[)>,9Q]I/-W(<J,8\VYX]\DQW&PR7HMOG8
MA=YRM[KC8^4:5W=@2=I47`>M!K-WK'6^[OB=X7",&@]I[UI]VV]LOR^EOQ6K
M7M)=Q#0X5`XT`X)D?;SFK6'>^+`;]8;I&?ND;+YD:5:FU+[4B%-M4U,RTS_E
MI$9_Y&=&!2M*76P4>"DFBA*8^>WDCUM!#B"#WKQC9V6P8Y[!JUM)!H:D'*O[
MU,+W"^Z#D'BW.,VSF!'LEZLBKDU!=Q>?AH7:19;R(;4R$S=D.&4RW8?G9#S;
MP??#2V"LASU5;@OX)-R,9($F6"U&QB87QMV`MAGB>QQI2E!J)]`39VODS)_<
M+A7&7)MR2Y8X$FWVK,L<QA&*6&_HP[(X)DP;?=+'D#N+1IC]RAHAAUB2[O4T
M7/0E.T:KKZ_^&NWLMOXK31U!3,4..1J,.Y0&PPV=RZ(3R&4BE*.RKZEK\SYW
M>H2^!IE]Y/R*1DV0KP?#+[:;W=X%DA7K#K%R!FTA"%VI=I7^=2V&KD&FV(IC
M20V05N%/I-8ZY==NE8\$-%OGG0_;]2T.VO8RW=!#43&0ZL*:AVGBGNG6*0TY
M.=89#JDN+74MC>MO>E2J57UJ%?`:S,<;VL9H<2V@2WR,=4NQ<B_\C[JT+[7@
MID&C*5!)4I2Z>!1X=*5_PZDC%X9Q/J4=*.T6);<Z+N;W$3&%"C2*T#XW[-Z5
M;J)`H*4/3IKKASX*-$]Q>0:\4JY3;9WDM+4EEU22A2/Q`H*VIH.@-.@-!32_
MB+@>$-!"[)%*VLU/"DY(:6IP4:*-U"`!0#:H[CU\5)\?&@\:GPU*MI'2@AU`
M_P"I-!KY!KQ]*U9$)Q6U*3LW=5$IK4;D>=*5I^FFG]>GC1):\C*H6(0J4`0=
MJ5E0`3MJ2?O;C]XU->IKYUTB.[K)I>`!S46-SS(0XFF*-845Y#A*P`D'IN3Z
M@%>`-17:`D]1Y_9I]\@8^KG4:$\6@XEI/;0HREY$FT,_+PG@JX+<V-G:#VU%
M(*G%]`5(2E0(\JD>9TEUW;Z31XK0H`TC!K@.XJQ?V;L_,YOQ&YZGI$B[2T.]
M5*(<.-7]*BKQJI2O'RUE+.5K]U'BR%3Z,U?6\D3K</MW`Z1CIX*R3-<^L^/\
MHVSC.=%ND.?.P.7G`ODAAB-B\.!;KU$LYM$R\O2&VF\@G2+D'68@25JCMJ<)
M"=M=89&RM,C'QF.O`4/K4^WOJGR`"8R-1<0:U'#VHODYCC;84I[([`U0DI#U
MZM:"4JJ*$F6*@I\-)H-.JK=/>GFWENX5U4[Q3Z4EI'(F%MA5<SQ<D&FT7VV.
M>=>J$R5$T&D$BE<V\^'K2A=6]<7@'D<#ZE"K.)%LN^5<AR8\3';I"R:1\BB[
M(NF1-S+A9G6F'9<)FZ69I+MMMDF5&1O;B2-KZJJ4$^H*UEN^`P1N&FK6`=H*
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MNJ?:QQAXNN$U4K=4GQ-=:N'9]E`,C+.W-`1[C>/H53^B6A9IA/#!M!@._L4[
M?9/Q?SM[N^1XN%<189B]_P`NQ2T2,W?M\*R3H#";+C]]L<9V8[&L4Z*D+:EW
M)EI)4$LA+G5)Z:U75=MT%TC\O(MTW+;!<7=Z)80Y@:W0\L-'95JT8]XP5"WI
MW;VWIAMX;9LDAJ[\L:C3,EU/4K".?N%.4Y/(^)V2W66Z8WE7'_.%@RR]VV_J
M5:D+MN.WN[0,IMC#D>T($F0F1>&`VRM2F'-[6X^I*M?G7;7;87/B)>T!IP))
M(<234GB:4Q7L%U'.-G@FE&D@!AY"GNU.0J%)>'P=F%S6W&3;)T%Z0RL1E7`%
MJ,LMO=M2>Y&QN2VLMO)4A:158`J$D4)#J`J34]AK]"IW&=CC"3[V!%<#WIM.
M6FN5>,?=MA.%Y]@O(V'1N1\*RG)+:N\Y"\G$<NL0F0+P_=48W;4)A2YUDG36
M=BY9/84^AQM*=H4JL<?#/B,795QS'!6KF7EO':S%C7QNUM;1P<?!@[`'"E4^
M%NE1&UNLJ2$,)H>[M;'19(2&:)VE>[H`*T\]16&/3I=[_!.FGXM1/;6G9Z$L
M8,6TR&FWBK<VH*46R6R%;G$**BD!.XMH2JGGI(ADXCVIR,L%=:,BY;$R$]IS
MLJ[0*C3NH!W-E?<;;HH*+!Z@$`D^9.AT;FBKLD^U[78-2K7'AW%<&'#6A;K[
M(4T76QV0RR'U=MO;1S<44/JJ0"*_'26`U(;F0?H3CG.&EE3XB*>M=A_T_P"+
M\E[-^`HI5O[.&.(W[=F[_ER[G=M!.VM=>I[,TMVN`'/1]96:OV:+R1E*4<IA
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M4XOTOH;VNTAE?P(&WP'2FEOC<T`D.'K4=DS)'%L0\0]*/79T<.,R+@(ZGG6R
M@/--N-0WQO24L/NE#"3+(!"!_)7PTT'!KO"?%WJ2RVB<1)(,\^2>BS\B0,@Q
M.+QR,+P,MSI"8K67WV.QC5VMSBWA\N_+OD=2`E4=TT^86ISN)H'$K%=3HI9)
M&"WTM<"<RT$BO;FH=XR"&3S`YS6``T#J`T[.U$?(O'-SXDE6^-?HN)R47*(9
M$;^'[BBY071O"W.\O\&?%N;`6%)<4RAIT&K:C2H<ELI&4HX8J/'N-K*#1CA1
M-G'D*D-293*Y,=MMS:9\@(FU<:6HIBSDO!I\1Z4`)5U2317[6F`'0G5K:>'!
M2@[7@UCAVFM$>6X?,I#JA'4ZPV'$QA(;#4*H4EY<)0#W?96@@[2JHZ`4K33#
MFSR/U:@6G@!BI#6Q-:'/(!&=2E`P8TAKY4/M1&$U6Z\ZZ4HDD@BJ&%_C-.U/
M78?U>6E".88:74[0N.-N[)S=7>BE#Z`IZ.U;GDO(&UE]::K`*@DNOID,=B3!
M<21U"]P^-:T?B#XY6MU-+7<J<$RY[`-):6N;FXY'NJE!!@Q4LU7':5'0VJCB
M$D!UQ)]+4>4TF0QO"P4[%D@I](&G)G!U8VFK@<N-$RQ[G&OW.?[TM;?%+<%+
M2=BI<CMK+0W%F(4I`;<?A[VODW$@[5N--D`D&@U6OFCC)>2*-SQ5HQL?E!C\
M)",N/J6I=!'LZHO\13H%IL[[K;:1>IT*.].FO*[:4!M*]M[C.$A*4ED/=S;M
MW$T%1?=3[)M\?F7,S0_\(()[^?8G8=INKB:D;'^73D<T2O<F8)9A<'68=XN@
MMP1\P[&CKQBT6]AUQ<1F2ZN>E5X5`DO.)9#C<8QRZ>BMH4I.$W7YHPP_\K$7
M<JGZ.:O;;I.1X;\0]S:YT;^U$D'>8+[=H<I-EM'\(-I>?A6E%DM<*YWB6X7A
M$8FC++G(NZ&XP65O*0S;T/[!M46ZDIP-Q\PMVW<NCBD<S/!N`%."O&=,;;92
M"5[&EW,G.O&G;]::W(HST_-8$Z[Y1%N;4E*DW-!EN9!&E1[:^RM45J0@&[6R
M;&NCS*TM!"EM.L*2H%5-N)EGO+^\/Q$I?,\XM/O$##+/):.-C+>`&-C6TP&`
MS.7I15`[606ZXMV:5>1(==DQU-/(A1DN,0G77\@=M#T-3T:9`B*><:9,=45;
MY;0$J23W-5,]E+?,<RV:'.:Z@`%30?8I1NF6LC?,_C$8_P!";FQ6%5\2S:(S
MS+JX\*!>K3)R28TAB?(>F2F+DVY=&KPZY=&X@A2EM1F&GM[Y0@E2D.;$VVPS
M'3<7,@$CA45-`0,30<<%.GW2DCH8XS1PI4#+MK1;C><W.1:HJ[-!MR.SLB29
M-IO,MF5,F,IN\95NQ]5OM8EQ[K'!)?[NV$TZO<M:Z$*5?2,$<9L]1:YQK0D.
M;3(`#$CA7B%%BMHM+Y+@5>#C4X8Y$CZ%BA?F%L>AY0BU0H4M,9QF_P`5_OO7
M-#,ER;*F*N&2WBU/R94EEAAMF<^RPX@J<*TJ2A:=D:6>]:/->TM`%*/PJ3D:
MG&@XE<E-HU@C>]C*U<TU``#?>PR->"97..=L,Q$RV6;S&SR\0Y3K=E;MLJXO
M6UN-L$N&P6Y$A^#'=6XX79$@-*6\=HV-THC,=0]8[1!J_3]3KEC15E:@$9G5
MR)6(W7K;9]N8^.V)GO&FE!@#WD*)F5\[99>([DM$J)92Y/7/?1$7%=E1E+=E
M+#=QESR\9K"_FUG:KN4VA1ZU)\\W#KKJ2^C:V&K'-<34.I@11>9[GUC>WS`'
M:(S7,$8BF29>ZYS*^4BM1+D3&_"(;A%4]U]3BELI1V'$!-010+KM2?AUUE9F
M;U>Z6W;RUCL:EY)Y\<UG#>RR/$FNKAV_4DQ<+M.BL(;:DS7Y#R]ZV;E&:7$C
M1=I[[OR\0.H9<"*`U7114GT@]1:G9-LM[$37$K73.KX10]U3VI+[BZ?("!5O
M8$J+<[*4PEV:'G8R6VT119VX=M>[BRIM^22&2L+9;<!2I*@X$I())U)LK]MH
M`R)K*C*@%?3S0\R'WJCV+4+KBFX["&W;4RAP)4_.E]L+AK#NV1*=8>>ERG)6
MZ@"G$A(Z[>FH,F\-DG'Q;&MJ?PAM4[%*2ZCB*47Q-TC6YF1#9:5)AK+26>Y(
M9>;6IT>HI2X4J#(+>X)-%#KUH*F5-N-I'^5;`'5G0U/[D_K9S"3,N1&C-1D#
MOJW2"5/R3*?(<954)3&86C<%*55/<_#24';7IKD%K).TNB!;B<#GWJ/-/Y9(
M:1DB>]W*4\S'D%26$EML074+;,E3Y;[KSCEO:0I+2`!M*DJ"-I44TZ#5O:;7
M!(TNGD8-#"XC4`33[H[3P"KW7,SP"ZE.Y:$B-&:4F4M")$B1%;0S-=G*MRD.
M1RZL;S-;+J4//;0"PG:`0>YTZ0F3:08"=+#B`<Z<.U-QAKW>+BA<)LR`OL)C
MS9JXT9*H?R<EN9;HUQ?0'EOJE`J>0R=R4O52KMJ2"D462+&RM;>\9Y$KR&-R
M-<1Q]*==YD9T-&`[%MV_+78P+3EINL_\PM[9;>3&`C,)><+1EEY3C2F6II=2
MG:X0II)20D;DZO[2VVJW<9WL>^W:-).+34=JD6LLNO3)@RG*B2=\O5MN4Y5M
M>FIG?+!)<MD%N$%1@V6EORYB5[''$LR5(;<+;A4MM``ITK!N'0,_XBU&BT=D
M3C[4Y=W#H@TQD8U[44S'I$6QPI5@9C+MJ'ER)L),!<EN"B$.ZX_&3WD(:2X`
MX0-RBI8Z!7DU#:MW0TFPFKX0TX&G$D<>Q(?<3!@+::L."-TSKA>7V65SH$5B
MX);F*B=YYJ8IT)[:2AYU"NT2D@!*5I)2Y5+>\$ZLGV5O;V[G::RL&-/L4.2:
M9Q(<<U4O]4=$J%=^$FGWQ)8:A9R&5..M29=')./AP2BR*-O-@!::@4'6@I0?
M6/\`+#<&XV[=RX:=$T.G"G^RF=Z?&U@]('%:#82'1RL><A5O?]:JAWM[);6Y
MPEQ]+RUN+2ELAE#C@J@@EQ2^Z0/#J137T^KM?7'6Q1PD*CE"'-@2X7`EULJ]
M2C5*%A)V]#X5KH0EC"D!QJ6T!VMT:$8#3+86RN6P6$OQ2Z@U9"HP*TN>!4@)
MZ$@AQCB:1GW2FW-C)\7O+W='WG)$*=+4F87DQD);<<*0ZA;+B)*=VTJ2?Q*)
M(!]0-:DZF1GRFZ69'GBD!C#DEABF/.Y'<$LRTE=>TTMU"-REI84WVF5'<4J7
M\N@^'J7V^M2=6EHZ"V@-Y+0``YG,TJ`$H6[I7MBA!\QS@.>97:1[/.,V+/PO
MB''.2PFH3-ZQ)VWW>WNQF5!A%_MSB9(DL*:+"E,B<DE*DDI4C^D*CR"_WX7N
MXRW)+6SD.'`8#A1?25ITLV;HUVROQ:^-S7#B#3`GB*%5>R^#^%/:OSA>.=LP
MS%F;*A)O43%\5O(MD=J-<Y#,JSKN%N:$I5RR1YB,V^8XVM#<DASTE3B=49II
M-JBF<-6EHK0>KT\E\BF`[')+M[8RZ2)SFCMH<,?K1[RC[Z$*P^X6CD[V;R&N
M$)Z(:7,@SNQIQ-F598[K[7SK4]>/JE9`F(F*$#L.]R9(-&PHFJ<[#M5+X2@G
MSLR:X&N(IPP&!6K@O-R@VL7DT4/FXMBCP:?&VCG%V9`R[%&6']8'BNVKL-GX
M[]HW'V-VW'[59L2QMA_DR[P(;]O@,)@QKA>XS7&;T-JXW`_UF:KONEMY:@AQ
M24(.KP;,QH>YLCS(XU]RN*I9/B7R_$SQL8X#.M:]@'UI5Y/S`Y]2GWQ<+XWP
MKP+'Y`D<<V.U6SB_BKB"`U:[_><UF1+'D69\C\F9U8;(NWW7"++?X#K;3UT=
MMB$L.A7>:4M8-;):S6ME+!#&7ND=4U%"22!_DCL4NWNY7.,TC6Z?N_=#0>#C
MQ/*N973);_HS^\&<%.S+'@MK6ZELE-QSRT.NI*VTI="A;5W)D+21ZJ$CITKJ
MDCZ=WAS!Y38M'#QC#^A+-SM8!K*\O[&\4M+5]#WW-*4/G,AXAAH<;&[?E%[?
MVJ!\Q%Q-P5"32J2>NGV=-;SH+)!$0?ZP!3'QFWC[[_\`-"6]L^A7S2XXQ(N'
M*W%5N6R\'`B,<LG`#<*4/\/0MRD``#J/#QT['TM?$T?-&!3L2G;G84P8\^BG
MM2MC?0=RQUY3ERY]Q"*JM%)@X?D,U*D*+BC5<B]P`I0*_(:?_P`)W7&YC`[!
M7ZDT[>K)K=(8:]I2GA_05MQ36X^X]E+A621"XQ6I`0:^D?,9L%$^HU.E,Z59
M&_S)+H^;V-H*=R8.]6A-='M/V)61OH-<:51^9>X;*9"1]]N)@=DA5)`KM5(R
M":!U'2J333DG35O,?S+EV')H2'[S9N/BC;A_7T_8E?#^AA[<8J=UWYAY-DMM
MI*EN,LX=;@$(3557';3/V)"`22?T^6G(NG]M#PUTSS0\J>VJ:EW>R+*!D;#S
MUU^M<!O+GNGY8M_*7(]KP7-W8V%6K.\PM>'LOV'&G7E8I`R&Y0<>>DOJM15)
ME.6AEE:UUHMQ1(Z4&M[;[#MHMFM=$)!3WB,3W_0LQ-?W,LY,#WZ2<`#]%$VA
M]TO/7<[C^;E3I04-E>.8HHD=%)ZFS'IT\-*_0=G_`+AB;?>7GE82O$M:9E*J
MV>]SW/VA5O5:N5KM9I=NDIF6^58X%HL4Z#*2AQLO0[G8XENGQR4.*2=KJ=R2
M0:@D::'36R";SQ;L\RA'K[$F2;<C$(IKF9[.'BR]5$8-^_3W9IR$Y1-YIRJ]
M7T.-J7<+[<)M^3)#326&42X5WE38,QI,=L(2'6UT0*#4EFR[5''Y;8&:>Y)<
M;^%[2R>0QZ>#C6O[9I>L_4V]X*5N.2,]QN>KM`(:E8%B*@@%844(,:V1G`L#
MRK0>5.NE_HVU2,,$D$?E.%#A3`]JF27^[AC'P2-+ZY.:''`\0G^QCZX/U%\>
M;:CV7EC&X3349F,U%:XXQ1,=+*=C:2Y':@M(>!1Z*KW`#J>O75;MO1VP[),V
M2Q;*\"OADE=*S$_A=A]BE[QU=N6YL%I*+:*X(!+VQ-8ZHPP(R&&7-)7_`-NL
M>Z>3/1+N5FX)E.(C28WRB>'<>M,=]3S@=^:EL8\JULN3$.?<=Z.H02*T535O
M?[#MMU1QBTFOW"6_0H%ENN\6,<D<ET+EDKM7YD;7%IXEIIA7*BQ*^J/[BER`
MZC$N&TIW!2F(V+9!&8Z$BB3_`!6EP57Y(6.O2GP;&T;6R,1L8\/`I4N*Y+NU
M\YN;<^#0D[;/J'<DV]NY,,<4<3(7<I#TF<M*<[CKD+?8:BRDCN9:^IAM]IA(
M6E`VD)K2JB3';T_MP\88^@/XC11OU&\?X'Z=)_JA*BZ_4FR;)W,.=R#@;C6\
M+P6_6W)K%(@Y+R#:7V[I;&'(S#DQ;5[<;GLJ2OU-K2JM.E/'2)>G]KFD9+(Q
MVMAPHXCV<5'O/)OG0/O6:WVTOF1TPHX88T]X=A47^<>7>&O<7R9>>6.3_;M(
M>RN_QK/$N`Q7FC,\>MB8]AM<:SV]N/`DV:[]E:(41M*E*<7N4"376VV/?MPV
M?;66%J1Y#,&@M#B.\G%6\F\W4[VFY\IU&T&H.:/1HQ)[TQDUGVG1W4LO>W[D
MMBI*@(7N$>"D-GJE)5-XQGI*DI%1JP/76^Q:FMEB:TG$&-M5*AOV/PC@B,N1
MTNES_P`H:?7Z%+WV?^];A+V.Y1DO*W$?MXSN^9?<L-N>%&%G_-MLNV,HM][N
MUENS[R8UIXLL=T3,3)L320KO*3L4H;23TF=1_,2]ZJV*VZ>W$1?`6TA>PBC7
M%Y%#6F-.23;VH;>>;,!Y[144=AXN9_:B>;W&_6A=YBC/8_*X0&.9)=,==B+E
MV#,)]R5"O\]QM8<MMN6N-<5PBPEM!0T^RZIQIM:4(+:!KQ'<.G[&4OG$AB(/
M>#VXK46%_O4MJ(;F%CK(U!8:8BN!'&M.*C=8O:M]3'W:<F7"3[3[;[M,_3DE
MHCY7)'(&29GQ-=S='VU_GL>V3LRR+$L1OL*.XV'8RX$I5(BDU0G8K2`;2V`C
M:QCY>;1F/0FG_"&/S-Q;)"]QT@"I'90\UTH^Q'Z"/U.\B5Q/FWOA]W%FX@M?
M&>(95@MAXSQIU'.7(UUXZSN;%N61X'G68W&;#QVV0YLF$P%.Q+G>9:&HS+2'
M6DMC4&YL;2:-[G-:P2T)<!4CMP]JK_BH;=K8;(O>R-[G,J['QD:L>%:9<%;8
MGZ%''K"MP]Q-\4A*4I0F3@5K<""`*CU96002*]:D'53_`(<MVG&[KQ%&C#L4
M\;Q`X`MM@T<?'2IXGTHT1]$/"VT)1']PL\E``JOC^$M7IH!U;RT`53T/V:<_
M0X?^J_[(39WRSR=&`[L>3Z^2^#Z)6-L'N1_<0IDI1M!<XZ:)30)]2EC,PM5`
MGSZ`_HT.V"!X\5UA_9"6-[M&>+21Z3]BVK9]&VQ6ZX1YCGN1BS>VT^WV'N/&
MFU*#P4@K0Y_&CB]Z0:5(/A3PTC_#]JS\SXL`#B0$O_$%J=+RWW3AB?L5RG!'
M&K7#W$>#\9,W=N_M8=:56IN\-1/D&YZ#,E2P\F'\S,^7Z2=NWNKZI\=;2SCC
MBM611$N8T4!(I7M4.YE=/,Z9V;\4[>I*80T(0T(0T(0T(0T(0T(0T(0T(0T(
M0T(7)7#N,N:&)Z%/=L;F+E&FLMN05!)JZI#;*@ZY(0I*=JB2%I)2!U!UBG-8
MW%HH5Z(P^?$'G#%&9C)MJ8^^,]^735*+#BI0=;8??JMIIF+WD)BQ7=Q"%%02
M@C;T!&GV7#P`UH:"!2M!50W[?$7&1SGFIRJ0$J+1'@2VE?-,`3.U5R-#DIA(
M6PG=L#\A!<4X%IH2`:)4?'3<DI)U2'AB<L.Y(;9PL=4!SB/=!<:`_P!*65FC
M6]F*M]FU6>%#<;=;=,EUPNQ5,`[W$K6^Y)*DG[QZ>KJGQU!FF%1Y+C3BIL<9
M(_/8*\%N6[Y"/)[4*093RVT%I];:V4S6D[G7&6I"T,N+*-Y.Y2J`$FOCIR2>
M6-H=<^X3AWH9:`$F$>)+%#K3L=32F(TU';:4Y8FG$S4LN%Y*P\IU*GF$+01N
MH.AI445J)A,^K'4!XI]HT>%XJ1F%ME4&?!:C3E-12YN^3DJ;^5$<5(^7++;2
M4N**!U-0%GJ*'3D7Q=M/JC)<S#/!-7,5I.S3)X7#ECW)3X'>>/L<F2W<HP-C
M.W5-=IJW2I]RMRX[K;A+<KOH+BY,=P4]"DU%!M(U<-N9#[^*J7[;%)322WT)
M;9)Q;E3>,N<F(Q!J!A<EQ,EB2B]0<A<MUND.K+;$IB,Z]*1;HY4&E.N*+C1/
MX@30G3D6WS31.FI1(DW."*5L`:\<*N%!@F<$Z))D--0V'TH:0"U`:(>1;QN6
MAR5'*:N/QE?T>H^`'W=1?+N&-U$4`XIUTEN]^!J3P1K9V;A.DIB-,.2G!(2%
M*A1E*%R3M4D/=AU(7;Y+!H%4"DJIU^QJ6=L$7G7,S615ICG_`$)^**)XJ&C5
M7@C2Y"%9HYE<E93:+"TT\XJ(Q>+PAJY1H+:FH[KB(<5=$.I??2@J*NSN*014
M:R>X]:;/M#P\R,D(Y'Z591;)?;L3!%&]H&9<.?):;V?X)9T/P[`Y'RMN*N.[
M?D(R!#!3"?2B0F8W:K?W/FU.Q74K0/PPLD!2T&HU@-W^:S[EA-KB[50!N=,>
M/J6CV[HF9D7Y[Z-:?O``53?WCE_D$3K2BQWBVX[956N:]*Q=E%KM,AEB6Y&D
MV`76[-S1.M$]N(A<=QMV>AB0H=S>0M*!YUN?66YW9)MIGL<W%S3]?L6GM-CL
M;<N9=,8^1^#7#GV)KA<57=^[76]7*=CCS\Y[NOKD,P[L!<WK;^56^)<##OJI
M+TY$50(#BW0RZ5HHL(*<K-N5[=M+))"ZY)K5V#:<J\ZU]:O8K:"`@QL%`*+=
MO69BW3("E&,AM-WE1H,M(F0+D+1:8SL"5-FVB;9?_-A\D\CYG<AU2&7`@`%2
M65:5+.!$R2=Q\621!"):@DBBV',UO,QJVSKA=[9"3;"TFS6^!.;;1DTVXK7'
MAV][Y5#<..J=<'MY>?"G74[MS2AO=2Y'KNV"261AT$:0W`T&5:9]J-`@!;&U
M_EDXZ@"#W',=E$U^8<BWG#7WG$VJTVPQ_P`T,J':IUQ4R^E<-N5.D2V8/Y,X
M7V&R&@IQ\-R'V"7'2FH3/@+7W3KJXH7MC+23X<*9U&5%4;C=VT%O\./`W6'9
MU(IW\T:S^8\78X[C3X";1;&GH2(R(-P1&CO,NR$1+B'I;C"U1K3;)3Z"RIYB
M0Q);<"6UK;"TNJ@17[;>-CXIX@:.H:Y"IP[>\J-<[CMT+#=W#BZ-U,>6%*?6
MH_7WW&8=%?-PRJY2LAOL:SF(A%F_+U1))==<DP)L6\?+SKC!>LTM];07&<;=
M:VH4%T<=2N#==1;5M[77U[,V:3$-ID!3*G`=JS]SUWM-LT6ML^L;37'/'F>*
M8C-/=IEUTMMMM^,3FL46S$4P[-(3=)L]PL-H?D-3NP'V%N/J=%5K><_%70^H
MC7F>Z=:MN"(K",PPN%=6=:8@U.5>0P6,W7KV^O"8K%WE%KCX@22X#*H.&"BQ
MEO)F>9=LF7+,KZE(5-1,FJF3W7I2'%H&U*>^I4)DH2$AM.ZC8`-.NL+=;_N%
M^[RI97O)-*ZB*]A&6&2S%UO&Z7KVR32O,[014&@-<J@88)),3KFT4IM;$53D
MF.?F9<DNSDJ#:F74H#<9UEP/54E6XC[M4]2>D".WM+;7\6]S'R-ISJ.>/T*L
M<R[<2YS07',US7V1%M>60.ZI$B%<DOL&0K;-CMK3%WI*BIY(>+,@$50X*':-
M*CNC8ZI*@8<0"DV]O`^/S9B<2C.WXNQ#<=D0IL.#^#M<=A1WI$UMP]M:HBFE
M/%A/;"JI5M`(7T\-)@W>*YC<Z6A=7`\N[L4^.*W;0M:"U&/SEJ84\RIJ0Y\P
M>XIU3*FWG9(6IL*:2MM]W:E":MIKM2K;4=#KK[ALK`UGN5K5<?*&R:&M`;AQ
M7V-<X+,HS'?F;9`<90$&23,D#LI2`V7`IL,O2$J-.XE156M"HZ5;NC8_6\D$
M<$W<9A:-YO34YHR"W-CM)<4L-54S%V+HRHSG/4824.5&_<4]0I:J$U?AV6]W
M:[!M(C+&,<,3WJ/5OWCB<NTHCL6165%AF?\`*";P(C[GSDVW.0)<%'R\M2&V
M(SV^0L*BOI6AU39"E4)5X`ZU'^'9;.5D5Q;OMR[WBX?Q.-6URX9*/<.DB`C(
MTR'/L16G+LBR=U0B6-3T22\(L7M(:?:6E%P2PT'GTJ;<;<$6BU&BW$!6W;J;
M(VUM)J.D8UND5!SIQ("1%`96T>XU)I5',JQB'8FKO>4K8<L[R6Y<:.XTZY'>
M:<^6=@M+?4A^0)#VT(W==JQ4*VDJJ&L-W=N&WM?-">(&7*O>G3$`3#7!G%$4
M:XXR+A*#DPWHIE,P)JOF&KVW95*7$D(,];2UJASHOI2MI=26%DE(H*S+FQN]
MOH-PMG,+\6.=]YO%<;:W`<'`5`*7N_'X<I,Z5</S>2[%>F/,LL.F.P%PV67D
MH8908:NP\\K:V74I)4FBNE=0K:?R[DAK*M<<AGEP4AYD<\^$"3DFV7D>7S;C
M;[9"&0PDO6Q+<>=/M3+EL^6@S8W;AP&$//RWER(CFX./*5V@E-*5H=!+':2[
M:9YM8EUEH:33@*&G>:'U).BY/W!3O6S,:F&\K>EVQN/+9><A)G)@H@R&TR([
M3I<ENOK99#117<@TW!7H%0-5,=F_0&7DA;:-<#0#EWI3=(P>`X=J3;]W3!<E
M,KEKN#A=;4]#;;#$"(E8=4^^AI+#/?CI*PD;CZ0=WB0=6D5];P$_#-!-:@]F
M*C.G()``I5$#DNX9&F?$:96S'0L,.35P6$OJ[_>0E3/<3VRF260V**%`:@B@
M.HL$US`XO:[7(XDX]IR3-?-DY554GU(VF84[B)9D3GYDF'ERGV)[+C*H#;3N
M/):2V2M:9"G5*5N)]5$T/QU]E?RU^<[;]R=/349X,A3FM'M$`8#)7$%5H0VT
M*D,LRE%IJKP4Y]Y2@6PL);0@E2EEV@'D#\`-?3"NT<V]P)6V'DH6AP%0%$DI
M4D!`#R0E84E(KT%/,UT(1]\S&2MENVAR0^X"\XTPT%;5-DD%AMI"G%,M`DJ4
MH)!J1X>*X6ZIFCF0CX&\N3JM8G/YG[H'?V)P[!QSF6;RXILED6\B,TA;+LAM
MQJ&PRE#22Z4L(E2%$`I)"4FBE#XC5C(P1D"M57R73+1YBE'Y@S5HOL!]J\B\
M\O6%SD1:G;%:'A=W[?\`D5WCP)TVW.MW*-"?N=VC6QE3KKZ&RM"$+4IA"DJ`
M2HG5%O)E\C0UY$;B13EAFMI\OKFUO=Y8^2)SFM%=+\`:98KIML5R:29T3'9-
ML<O,="51W[S*4Q!;6ZZ&6D]QIZ#&B!Q][U.27T-H%:'5+L'2.S[E<ROW")]Q
M/'&2VA+221A@,\5Z]U'U?N5C`WX-T3;=[BQX'O-X>D\ZJ%_N@X+X9R]/&\ZZ
M8I%RVX62Q1[A'G7JV1I4-=RY$M4M_)QC4V#.N$";;GUVYME)3*D)<;47%AKP
MU=]66.[[/9V;+JV?:PR-\%?=D#>TXU:OFK<9X-TW>6:"0R%CJR&@%&MS-!R"
M,/;][9^`K]DF'XCFG$V'9?BT?9!:Q?)8#]]QR'$*W7##@V6Z295NBQ6_F%@)
M;;0"">@K08IMW.V025)(3K;W]0W9H:`+,-`:WAAF>\YJWK%O:I]++B^;".9>
MU+VZXZ)"'7X:X?MZQ3+9+J(JVT27$,KLDT,[5K0`MR@"CT"NHU(EN)9&_GRO
M#>P\4C=3?P$1V["7DX4%?0:\.U6#<=<H>VC@T/#V[<%X1@L"Z0X@FWK$^/<2
MP*3D49"1(A?F#..6NU2ID9DN!3:)0"6U&J6D'KKC'AC@]I<X]KCCZ%5?HG4%
MZ`^Z>QE<:8@M[".)3C2?>]?%@"-86&:UIN4@GH>M:K4*^'@=36[A.P:6T`0.
MEKRH$ES&'51/(]YV<+)#-MA(KU"E4H*T/4)!ZZ5^I7"D_P"$+C_JV_MZ46O^
M[CDB1U:^3:"JJVA)(`)IU5L'6OAIDWL_-=9T=:DG7/*[Z*^M$;_N;Y8D[@BY
M--J4JC?;CJ6*5%.I*2"JO\VD_&S\RGO\&[;Q?(3WHEE>X3EA>_N9`XR/B&]B
M4GPJ%&@I7[::;?<3R&NHA2(^D]CC9IE+M52<2DK-]PF:H5_RCR,S#(!2H/W>
MVQ4UIU*@\\GJK]('32?-F_$4D=.],,_C/CQR\93$\V^Z]S%>)>6,E<Y<M[DK
M'N-,]O,>'#RJUNRGIELQ&\2HC##466MY;KLME"4@#<2?#2[&2XN+Z&WSU2`=
MW:F[_:^G[>QEFAB!D9&2W$D$\/6OSA9DZY,/*#T@.K6=SCJR4J6\Y1;H6M2@
M5N;C55//7JU9+?P.U$-PH%D;&!KK=DKVALIJ:#AB?J7A-VN!2%!I9J$[5%)V
MJH"!2O55!Y]?MU+<RY:`70R`$5&'!-R6$(DJ^4-<<:'/T+'^<RD*!4TY5)!H
MH4'Q\?`)ZDGX5TMD=P^M6@*0;$#-Q]2^*O[J%54PJGI"DHH>E#M56@H`#TUU
MD<I?20!K.:/@!^(^I8QD8:ZIC.)Z*_9KT-`H#J:$_P`VDO;*UQT@&/FNLLM+
MP6$EW`+;8S#:%!;+E*4V'H%I!J$T\``HUK]FG(XP\:JXA1Y-E?*\O>,?0MS^
M,HU4J+4@55N]1VE)/C4FFX=*"I_PZZ)IQ_$8`.]-OVJ9@KS6P,UA@U/S/2E$
MN;0*A>\D`GHDJ_7IDFKJ]J;_`$V9>OXUAN.N.*0^"=_XF].Y(7T54$TWI_FT
MX)2(]%!1=;M-XYPTM_+/%>VLV@MNH<6'NWZ2THA)/X-=J4`DT24J/Z^OCINB
M4_:9V&B^?QE%6X"ON@%)J$%(66U*)"DT)0%;?#Q_174?XN(L='&3YKA0=Z0S
M;[V&5OF-'E.-".8Y5X>A3UL'*/TR6H=L?R'@+W"7^["+"1=`OGRV18LJ8AE*
M9+S$&W8=99$>.Z]N"6_FJ@$5)\=9:XL.K)'N$.Y-9&3@TPFH'(O/A-.=<5MK
M>]Z=LK?RI=ME\T`5=Y@TU[!4NH>&'>G63[S_`*3G&2[?!?\`IW9OE*78Z+@3
MEF:+RQ,E1D+2@OM7;DIF*_M#'2K&VGEJ$[;NHFO`N;YCW#.C0*CE@58V5ST[
M.PS,L7ESL,7$`<.62G/Q)_K"GL+X-##O$/TY97&\UCME5QP+#?;A8[VZ^#1$
M@W^XV+(+T'DGP/?/Q.NG;[U[@7R.<P?=YI,T%@7>Z8QP`<3]BE1(_P!;,Q65
M%;+?"7NA:25E*8O]Z'`[+8;53MK<=/#T]T*"OV05;13U:[^C7T@TN>T,_JFI
M](/!4GP]LTFC21VN<X>HE(6X_P"M80'G$D^WOG.<AM!4RB\<]<>I:+M`:&-;
M.%(;24$FA\?\>G6[+<M;1TH(Y<?4G0VW`TF&)S.3@2#WBJQ#_6LKT8NZU^T^
MY.K96$5O/-0"E(/JHTNTX%#0FJ/$E(%?`>>N_HLW:FG26D4@TVEK44-=%#]*
MQSO];(Y$LT5Z3!]GEAEK;;2X&[ASK?T`DTW@EK!GU"J/NFE2?LTR_:C!3S"<
M>[@N5^,G_@QX\L*>S%)1O_7!,ZJD3?8U824A*OZO[A<D(*O`[@_QZKN)/F%=
M-(^!93WCZE:R6'FM#"`X"F%`/:E/"_UQ.Y-AM`]C,2`R%)4Z[%YE1<91*3^(
M$+E8-;U!*B#1*E4^-=(_3KIKO-B?$UE<#Y32X?Y1./?3)<;M-I3\VW:3Q.HC
MV47:)].[W1)]ZOLK]OGNH1C,G#$<V82K+D8M+G,7*19$_G5VM/R;DZ*RPQ)-
M;9O"DH34+\`:ZN[9CF1`.=J=7/)4DS6-D+8VZ6CA6JFCI]-(:$(:$(:$(:$(
M:$(:$(:$(:$(:$(:$+AA=]\OMT3<+>_#Y(E!ML!N<9&*91V?E5DK<$8)M"]L
MIIX)(.PC;45\-/?^[KJ[_I3ZPK<=9;9_?-'>"CJ)[Y/:VR\KO\@NI:>#ZW7F
M\4S!QY"U#]D+LZ4=M0-$I2``?(:Y_P"[OJW+X9M>7F,U?YH-?L77]6;'(RAG
M&L]A2AC>_/VJ.16VY7)+Z#&75E",1RL.2$4';[_;L!:2=H`6D+ZZ8D^7W5H=
M0VCO6$J+JKI\-TNN6A]<J'Z:(P/OW]IO89E-<E/B>A"4(A+Q3,GH*6RO\1"P
MNTJ2"`HD.)*304(Z]$?^[_JS_I'>L);^K=HB(#+AE#WK)$]]GM*:?8<=Y=4P
MU(?67/DL'S:4;<DI/[COX^AP,J</W4N$)/6E*Z6>@>IZ4;:`'MFB_P!91O\`
M$6VO(+[F/2#7"OV(^9^H/[3HKZXXY@GHBM!"$W*/@'(*Y4UH$$H>#=A"6R`/
M$!0!ZCX#@Z!ZJ#Z_"1N'+S8S[`:^I2W]2[(YI`N&U/>MX?42]F3#0=<Y3NKS
MA6YW;>_Q[GZ6)"%FG=^8_AQ*5.DIW`*Z$?#3W^!^KQ@RST,Y:A3MQ*C'?-A=
MXG7`U^E'$'ZD/L?8D*3+Y<=^75&#33C6"9^V^PK;N##JG<;.]L.#HI*4J36A
M*AJIGZ"ZTCN1+%;1EAK4>='_`*RENZHZ:-N(9[@!_#`HQA?4?]C$)@?G'/5\
MO=B9E.R!BEEQ3D6,],6K<NC2IV.1[)#D.+2D+<6E9(U/N.F/F%#!_P`-MS'/
M.&,\-*4S]Y53=SZ8F>*7VD@UJUCW'U`=N:T9?U2?9H;Y'C8[>&;/B;<<N.2[
MACN?9!>G)O9DJ2A3*;;;V&6$O=M*BKYCO[E`-M(2E2O/]SZ%^<]Y*1;[;"R$
MG!S;B*H[JNIZUJ;/?N@K>/5/=7$L_(POTGV5R[$C<@^J1P;)M$V);>3V9B7G
M##38X^!YACULG0BH.BX3WX=H$EJ;\RE.Y"`/P`0*J))\YW7Y+?/"_N#YML3`
M6X4N(<\?ZRUEIUY\M(81YCRR1IK_``)2<.7A2*N?OD]J\U^Y36N=<KM2YEE9
MA-VVTX?DMRA(D%Q]<^2[-O>,_F,(R1<'VV66-P:9*5%PN(HY46O\N_SE;,!<
MVA=`?>_/AP];E8O^:70-Q&?A9GF<9%\,H`KW!:UM^H)[?W;C*G3.0K'CRFE2
M(@=M.$99<Y-WLL@/H99E3IN-LW.Y+B)DNH6B4*/,.^"'02XX[^7;YL0N=+:[
M4'S8Z?\`B(>>9\67<HS/FAT0XZ'7K]8S_(FI7C]WGDMFT^^?VJQ[1D$5_DZ)
M<&[O;9##=EO7'F?-VYB<W<+?*A/VI]/YP]"IM>2HO,$=NI;,=2]HKO\`^V[Y
MO4+CL[G3G'&>"C3_`%2)/I"'?-+H0/96]?X#C^1+[/"D2CWE>VEN';&'>3HE
MZA6!-L59(F2X=F$V^0),F._$N)BW2'C2(CK5H;7Z/F?FFG&E%(;W#<IR+^6S
MYS2#3+M+1#7+XB"M>?O9+MQ\UNCW1UL;J0R5S,$M.[*M4FF_>QQ,1-@GF5#,
MQE</9>UX)>DVJXQG(\A!8@PUV>5=(2K>VXTEPN.(;?4%MEKMD+5.9_+K\UFN
M+9=L:YG`B>&GM<JU_P`RNG'@4NGC_P!3+_JIF\B]Y7'][:<B-YA(BI=G39\^
M>]B-]0_*E2TI"YD=B'<W(L>X=Q9'=2AO>RV`34]:R3Y`_.:-SQ;[%)7$-/GV
MU#R/\6M/0JW=/FIM-Q#Y-M<U>V@'A(RPK^[--?,]Y!OEEF8^<H>2R^X78;,F
MUSYT\/,!;;+[SZ8"N\5!2BDO$[`X?,JKC)_Y9_YG]Q,L,.RCX9X(U?%6S</[
M3Y6M%.;B!VK`[AU[)=QF*6Y94UJ0#6G94<DV#O-%H5_5)V62)++%2Q";@7%N
M`T'&E)6'VF1N=<W*IM24;1Y_#*S_`,IO\QK'Z7[/&YPY[AMQ]5+H_:J`]16C
MA26X>_OX)(KSK$7HDJ&G(G8HD+2H/IAW8+#:5)*V$++;[H+PZ$J.R@'GU+C?
MY4?YB'>_L<0';>VG_P#54!^Y;7+@^3#N*-(G(7']ICI;MUS=D2"XVX%W&-='
MV65=M:%+2E48[U)!^[3;0]/.E?<?RB?S"RRB0['&&`$?\[9`>C5.T>U/?J6W
M1L!;(-(IP*,&>5,+"P[)O;[B6J;&VXER1W0IT+6V0N*6D@E5`=O1">G7IIMO
M\H/\PE01L4=.R]LC[6SN'M4F'=]NT@&2F/(HW;YKQ)@J^5O3L'N,H#AB6Z8D
M)4`DEH%<-Q;B=P5ZJ@FH\*:A'^3;^8%TCG3[)&23A_Q]B,/\NX:?54*PCWC;
M&`AT[3Z"MF%RUQEW5.R;P^ATI3N>-HG.)<5TW%P%E#[A2DJ230@D@TZ#3L7\
MFOS_`!(TNV&K:\+NU=3M($IP2?U[:\M?L7B1SAAG==1%NLB'`=`2ZPS`FEUP
ML-*0VKO*AK4$NJ7YA5-IZ`$:LI/Y0/GM#7RMB:6GWA\99@U[`9JC'.JB'?-M
M=(0)*8\BM1'+&!W!^(N3E#\!P)V+>-DN+R(94MHK?:#+(<<66T*\:U40-H`T
MK:?Y.OGB9'?%;0RWC<31SKF!PQY:'NQ"=;NFV.]^8`'L*T4<H<5)D3/F7KO-
M,A,A!N#RKDVR`C?\J[$BMQDNH<*DI^\$[:^/6@?C_D[^>>WO#7[*RZ8":.^*
MM6BA/#S)F$]N:X_<]IC_`(4M:]Z2-[Y4QR>U(C_F4V:V\XZPI#S=P:^8MCZ&
M$2(,]]$4+DQ9@BCN@>JCA3U!UI++^6K^8#:VZ;+9'P-Y_$6WJPE/[!0+J_M)
MWAT4@/9B%OVS->&K?!MS(=8B_)&3+<MUFM5T@0C*D,EAU+U6"76Y*5=6^K:J
M;E]=);_+-_,7=37%U)MY\3-(!N(":F@P\=/:G[;>MOCTQR/\;<\*I3HY>XLN
MUKN5ON]UE0U/1(S$-Q$*XH99==>8:E_+(B1FGHO9AH.UP+2NM:5(`U1Q_P`J
M'SZM+EDXV<R3`#4XSV],_P#>*3)O6VN=5LE!3D4VT^^<.9&A^)E&2WUZ'^8_
MF+P@2[S%DW5,8NHB0W'%!YZ+N;V%3F^NY-:4])UVV_R]_/G:IS=V^PQNN`TA
MNJ>WH*\P)$Y#O.UBNJ4#T%*BP\E</X9%<CXI;(\6)<)S=RNL-LW!Z9<YZ&&@
MN9=)LFWK<GS75)`WE8%4>(%`:7=/Y9OYANH)Q<;OMY$K1X:7$&D<@/'EGP4I
MF\;6\T$S:]Q^Q$SW+&),W1-SAQUJ>>VL=I"I[<>*WWN[(<#:66XRGG%5VO!M
MQ8KU'2NH0_E2^>(@T3[9&Y^O47?$0U(R_%^Y,OWS;&/+3)4CL*THG-EJ8NB7
M&S;T-NK<D2$KAW*<ZTZ'`$U+Y?43(;*@XV%I0L$5J0")<O\`+-\XV0"!NU-#
MQCC<0GU>)*;O>WO%6OQ[BE[<>=+/<[:;8[<XZ[<IAU34)6/O-*:G%=N1^8O/
M)8"Q(<@L%LA)"2^WO54+Z2XOY<OG/<V;K:[V(:Z"A=<0`=N4A*;?N\4L18\X
MG)(09K8KG-AQK?*9CN/;X_RS\>Y+9DR):7(Z65NIC!8#8>])-$UZU'AK%;A_
M+I\V^FMMNMYWK:'1[7;,=(YXFA=I:TYT:\NIZ%$ADCGE;"UPU.-,4Y=C@0H5
MKMDQ5_9CSH\F5!$)Q^0R`XE9:CJ<"MS8+"D%7J]12XD@4)IY"U[IB'#Q-=DX
M9?;AD>U6D#2QP8\4<"1[54;]3B$F+,X?#ZD/RWF,W6_(1*^8[S:9]C[;BT@%
M+974FB%*'4CQ%!]G_P`LC]>V[NWBV2W'J9*_Z(R.\A:.S_AFG-5@12EJ2`E1
M6HI`!;`6YW*!2T@BFPH\`:@]*Z^H_/9G0^Q2Z*4_"/MRSCF`S[NU:+VWBMO2
MRJ=)MEO7*FW!;ZRU$M4!UQ3$%DNEE96\^ZVRAMM1.XBAR>_]26>SN^'<YIO9
M!5K3EWX<0O0.A.A]QZJN0V4%D#GZ0['W2>[(A7D(N%F^G)Q-QOAO!_"V$99S
MKR]-M,G-L[Y%AR<ABPHMQ@/W1S$K?(MKEHD*9L=I92Y)"'&&CW4*4E2G$TR<
M1,]B[?\`=KESKR-QT-K1KAP!RX+[$-M!T(;+ICI>QMJ%FJ>0@DGBXFHR[O2H
M$^]5GDG`,IM_)&.7>ZX-9N47?SB9CF*),''\8F28D1%SMU@(:6NWVJ;-C+?1
M'WGSIN2D4U'3/4[]WG-J\,9#&VM!Q_>OD'YG])V%IU%-O-G;NCCN9*.Y<S3E
MC[$\GTV>6LJE<NP,<S2]W7-,=O"+K+N+]X=>G7&T?*V=YUF?9[T&')UH<#Q"
M74J[L-X+*5LE12I-EO6\/@M1,]C7L:[(]O),_+_:;5NX$0-,;GDFK.7(U^I=
M`G&-NQN].9R]:\AO-O?CVN'.LM]CS+?->B38^0L0I%J<:;=A-(?=A3OF6G'5
M(;`C*32M"-+TAU5M,#6S7]J?)9(S72E7-!%2W'Z5<]5='[KN%W'!93.+]#G#
MD'-:2-7I"^^Y?)K%D65XU!QUN0S`Q?%+'95HG,ICW!N;#@(CRQ<&VUNLKN*J
M_C/(4M+JJJ2M:5`G1_/;J7:MXO\`;;/:':K&&SP`QH9'>9S^Z,#[%\N;)MG4
M&QW&XP;LZ1EY/<G4#D6@Y?Y0R]JTN!G?EL_Q<E0!_,$`*!`VA5"237I6@_37
M7@K3601\2%L-E>&7[0>(3Y>ZBZ9A><GLEMQ.\P['\G&:3+N,J!^8J=@-9%99
M=PA,-B7%2Q)D0FG$!P]Q&UT^DJ"2.GDIV\Z_U#4U[FAM,L\<%*.S1.49EFLS
ML:Y81$@+M=O^46;/>ITGY7Y)@LKDJ-YB-*?[)!5M2$[JTZ=`YHDTUC(#N%5=
M"*\\H1L>UQH,3F>]'3-@Y!6I)DY[:8NY(0E$'#H*54K4J0JX7&=U4?\`)US3
M.#63Q.[/WIV.TN-%9I=+N0(I[4<Q<$S6<L!&=YK-4M5$BUV/'&DU/0A(B8Y(
M=%*]!N)U):XNS!'>FG@1TU3N%>Y*6-PMF#H(?F<PS6U$D+7+O-M94E1Z$+M]
MNMK:$^/0$::,+TUYFV<9F$]C@X^D#VK,.`5$$W")?5CJL_GO)4V&10@'>BXY
M9$Z'X%(I\-.&![H]#VGRR,ZC[:I!N-K!S+AV@T*U3PAA,51,Z!@:E#U%,[*H
M%Y=)*O%2&[C=W5D=:BA/V:;;;-:-+'`#M2Q?;6T:6PZG'(@.*WV.*N,X96I2
M>-(JD?>#&.W*<YN)*B4N1\36E0-/$.$UTZR-K<WM]OV)<,CY"0RWE-/Q,#?]
M*E?0H,_4^NN'\<>PKW(W*U7"VM3KOA]LPNW-V_')=O2_)S/*K#876D3)+<);
M:E6R9(/[I1*00:>.K?8+75NL;F/:=)U'/(4^U4/4%S/'MDH="^-IPJ=-.[`K
MA3LN+O\`)G(?%'&;(+RN0.9L`Q4-H`6ZM-[R&':G!2A"MC$U2B#Z?37XZ^C^
MAK"&ZZDL&2QM>&W3'.#QJC<&NUZ7#B#2A7E_76_Q=(]`;SU.#HCL-CNY03P<
MR![@?7EVT78O>OI/^T:[S6[9;\;N%I_+@[':,9MF4Y,HZ0W*=,R`B$F0I(ZH
MC%IL=/2.A'Z*P=2;:P/?>]/]/W(>:Z)+<M9&"/=C+75#>.-2"31?S';3_/S_
M`#`L>;F:ZN+FT>2YI\X,('W6@`$T`IB<:D\L43=_HP^W*6E28DBXL/N+2TEM
M=LCE27%H#A0`QD%IW;0L5-.I/AXZ:9O?04C2+SH[9/(:*GRY)F8#G1KJ]F7?
MBO1=H_\`QCGSK@FCMW2ODN9'!H:;@OIVUEMG-:#V4[:X+P[]"3AQ;9>C9I)A
M*4J.@IDXY>:)<?(0TRXIK*'T;RH[4@).Y0H*ZHCU%\F[IVEW24#9*&ACOGU`
M&=&R0.:,.RHYCC[59_SR?/BT@=<W<5_Y`<T.<88I8P7Y:2"TD<G4`(QTBM$F
MKA]`C"I:756WDO'EI2?49#5[AT+H!`45VR[)2%)/QIYZ@R3_`,O]TP17_36X
M1UKXF74+R?[32V)I'`#2,.W%:BT_GL^;+V><"'!C@"'V+Z$D5Q-:4[4A+M_J
M]LIYMQ=LSG&'G$I](:OJFAM%.J$2\';0DU\]WAJM?MW\M4P,;]GWB&*N8$#_
M`$T;+5;6R_GT^:<#!,^.P>QK:ELENYK>\GV#%-%>_P#5_.4H^]NWW>US"W^U
M"O.-+40000XF:FV$4!KT`U'=T+_+'>2-?'<[S;!WX[:OH\#G*^A__&)]4`D7
MNW[9X*$ACYF'TG20>X)KKS]!;W!L(!A0GY(#>Y'9=QB7U`I39&RQMP@C[*ZB
MS_)7^7:ZU/L]_FCD<[#S+*2@!YNH<>WBM+9?_C&/.HZYVF'6`*:)W@EO'WF@
M9<TT=X^B%[H+;W%#%[V\U2H$?%[E-"54KU_+KO<=VXCJ3X?#5=+_`"W?)NX:
MUMCU5MIE#J_F.D@(XXL,=`.VN.:VNW?_`(Q'IA[6B^VB:-AS+;@'TYT32W[Z
M1?N:M@)5B-_!`*0%XUE4=":"OJ<=L#R*5\@?#35S_*7TO=$2;?U3LOE@<+Q@
MKCR(JM3MW_XP3Y;32TO+.Y\BN)\X5'M"9J\_39]REI46W\:0P-IWB6[.AI!K
M0;1,M$7;4=14GQU!G_DSWR>0R[9NFTS-(PTW<?B[!QKWK36W\^7R?>0;R2^C
MC.`)A!Q]#N29?E'VL<H^WU6'W/E*RMV2WYU!N,_$9KUP@_E]VC6F1$CW"0)*
M708T=A4YH;GTM=5]*C7SK\ROE;NGRWW'X'<I`Z8.+7!KP]NH9^(8'O&"]R^5
M/SVZ$^=45[-T'<NNX]OE$5Q6,L,<CA70:\1Q]BBMR`S-O=Z9D6V*Y-;8@M1U
MF(_'?0VM#T@J+13()<"TJ!](ZD=!KQZYA+YM0ID%[?M+FVS"9C0DG#O2,CVF
MY-*J[:KJ%)!W%4&8$5!2?WG:VU2#U%=,_#OYA3+J6&>/0UP!KQ6T9R6C1\EH
M`"H<';*3_2V.!*B$TZZ?<]L8Q59\/*31GB/[<T$W*"2?ZZPKR31;?6M"0055
M!_1J,U[?-UG`=J/AK@8N;1O>$KK1.8<@2*/("D2FU-K)IO!8=;4A-3M!2:&I
M_1IU\[*$-QPX+C(7OE\NAI0$GL6G<)L(1W4*F1B:%.PO-A85Y5'<6H@>8IJ(
M<<U8?"!G\(^M-/<`T5E;;[1!57[QZ$`U`%//RU#?&Y@J<E;MP`'&B+2XD'>'
M`2/((7U/A6FWQTEH+CI!2P?H7Z_?^K[FOT9OI^G_`.\D?_DSRO4Q@HVBR<QK
M*X]JN-TI-(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+\<)'NQPU!"9^/Y1`/6J7
M8,?TD>-=LH$BNO88^M+5QI)#,T=Y6-&QS/PK7TA'$;W3<7/T[\J\10?]\MBU
MI'7S++CE::FMZRVES`US)&FF=#7UTJDOZ>N]/A\NG935ZZT[T=L>X_B:17_S
M3!E`\$OVZY-$'RW$Q5>(_2-.-ZMV,T:Y^DD_>#J_1ZD@;1N48T,87-_R4<L<
MY\52`G9FME054H'77&/'PJ7F6QJ0WJ'8G93M_P"U]B;?M%_]Z$GU(Y9Y0X]E
M!*FLOQQPJZ4_.(237KTHMU!\!J<-YVJ?P-GA=3'[J2[;[Y@JZ)U.Y'#.7XQ(
M3NCWZRO)Z`=J[P5UKX!(0^>OV:4+[;":-DBKW@)AT%PWWF.%.Q9TWBVK)+%R
M9*CTJU+!ZFM/4TX0`:_'3@N+(XA[".^OUI.B3D?4LB;PZ5)99EO;A0K6I94D
M#KT!=JFAIX]=.MEM3[IC]07"9(\""*]G[D=MRE+2"XZV\/$]QI@IJ4]!ZT$]
M*_HTXV*-Q\+03W!(=*0/$2!ZO;@ON]ISH68*TC[P,2.D4/Q*$H^'GI)MXWG1
MIHX]G[EP.KB"XCO*&R-NW&'%Z)IZ0XV*&M#5MY`KKHV\#B?4?L7?/+#IU.'K
M7I*(H_\`6=0_VDF2G_"XK73:@-+3)X3F/V"4Y[W>\YQ])7H-->/]:3_1"9(-
M/,5[C*]PU&^">XZ6OP7`YP.!->\KZ&DDFDB6@#[H(BNT^-/P$?SZ4+:=H\O7
M4<L/II]:D-?'2KR=?I7U+1HK^NN=3T#D-M=/A]U]'AIMUM(#0MQ3<C@7#02&
M]Y6!3+_E*8JKH"Y#>2`?(I4A]8/V]-/""Y#0P#PC+)/:H>9]96O\M(4XD2ID
M1,2I+JF&YBY:]I]+;#18#86OP]2J#QZZ(XFZ_P#B7:(QQH#CP&`)Q29)&%E&
MTKW(Q0ZVRTIB$A4-E9JZI1[DF3]KSJ3T)^`H-3FW+1&60M`812H%#]JC85U<
M5Y2$TZ4-/A\?M^!TPWP^[Q2M3E[\-!:QWO-8?\EOV+FHH`]>O7[-+T%K:AK0
M.P-'T"J69)"W23@AKNESAJ(:>TAI/M%4"1X;I!\*'AH:'D>``#L`'T42*H:3
MH\P%NEM#G@T?0`G/.EYH5^W2!;1QMPCC#1_5;]B3K>#JKBA77`Q@-0UH/8`/
M8,%QSW.-78E>%+3122%%5*C:GI\1N)H!6GQUSRF5J`0>PD?00NMD>SW31:2F
MG75$NN=M'IVM-U!`\RM77<===;1@5<QM.X(<][Q1QJ%M!"4)_#Z)H.GCX=/$
M_;H\N,4\(P[`N->YONFB^&AZ=%#]%-!8W20&M]0^Q+$TE<\%KK2RGJXE`\ZE
M(ITI6O2FH#H@SWFM'H"D.EB=[Q!]"T^TAXE,9I+ZO&NP!OJ3^UT)`/PT@0QR
M^'0#Z*+@DA;E3U+*FU.$I5(<+8-?P624IIMHH%06214ZX[;H:%[@*<DMLS2:
M`X]W[D8,QV6!M:;2D>`Z`D#ITK3XZKKF`,?2%H#*=G:G?,>!0'!9%)))(-*^
M/359+'J`T`>B@38`6_9DTN]L"D+>!G1@&V]P<6HNI"4ME%5I43X%/4:\S^;@
M<?EAOK>6W25[L%,L&.=?0^6,1(/4GLN<BZ,.18KUNCL,/RGD)N#9,TH?:=;0
MS)D-OBKBD+*"LJHNJ>M3U/Y$6T+)[5CF/HX1MJ!A3!;:1LKY"_C7-5A?4;?G
M3)'$+\Z&J,'(.7"(ZM3J%25!S'@\^XA96`2O^B$@^)ZUU]<_RQ1&"QWFKM0,
ML&/?%<,_TG-'I5OM^H0N\S/5]2BY[?>'I'*?)N/8.F@5<I[3;ZEK`8#=!)E/
M2WT]P1[?$BMJ>6KJIQ""@4*P1]&;YN,6U6+[F@ULX?0M9TWM3M]O6V\0JRH)
M.5&UQSHNE'D>YX7P7Q9QUQ?@42/#L\2&S`5([:D3KQ>+M&6B[Y!=2C:J1(>#
MA0C_`')EI7;0$H%-?.>Z22[G?NN:$DN+S7[N-32O+L7VIT-;V>W-@M+4-:T/
M8!04J!A7TH_S?,,(O'N:]D?'F>8@,@L>:0>2+]=9JYK4&/;KDFUV")`4^5I4
MU(6A-J35+BJJ;(2@>HG5WN]O<R[,RZ9<`0MD:!'S!&)[UM.H9FW'5+-H,;_B
M/A))&N!%,/N]QX@IQOJ9\5X;D7MAS:1;([;Z<<C?/6!V.PQLC/P0XS$CL=H(
M65.E6T[`=K22H]`3I/2-W-:[M%&W)[Z.Q&(ID>SBO'/F1MD=STY+*\#4WW>Q
MU>"JH^E4[;\9Y/\`SB<4?,2#'M#:G0K<4W:%&@)9W?NJF2$J4E?I_%`'7J?1
MNH[HO88::6$X`<5Y-\MWQ66Z.-TT4X5QH/Z5T1RABN+.7#,+>["QD+MX>O%]
MA2&;?!5%:D(4_+G.%34%M$"A4ZMP@):"PNJ2=6NR[=N$G3[KB!Q%V\M:PG&@
M)`=[.:]?9)MAW9OQ(:(6@N<,L*5&)^A,%D&=8ER6,>R_$KE%O=LNMI<"KW!C
MJBP[PMNX2T1+E'0IEE;S<B,KTN;4A:`DTT[U-M5MMDUNUERVZN1"-9%?"7#+
MT=B^5_FK>[5?]5R_H[`RW:T%S1E6F?:3FESQ0\8F;8XX@T_Y11NH!4[$'Q\*
M^`_EUF13S`!_$X+S_:GM;N#`3C1/)RE=%S,M/<)V);FMCT@;DN&.JOB34=O]
M1T"1[B0Y@;3N3U\9S?$2$D\<>%589QQF4\8+AKK3-B"AC-F;[R<9QY;[ACPF
MF.XX_(MDE:W5=H$JW=3J5'-(0(R(]'.GB]:T\<$5Q;M=(Z8AS031P`3D_P`?
MY04;6KY+BI(I2&U#MY%#0[?RZ)%!Z=`?'3XD<!1I-$H;7M[FU<"?[52?7R6B
M[EF0R`OOY)D#VX`4=O-U4`*]=R/FRA7^+7'/<[WC5#-OLH_<B:*]_P!J)7Y:
MW]RGY#\A2B2LNN+>6LD=0I3ZB:'].DI\PPD4T,_S1]BU:M`$(9;0?(I0E/3J
M12@'A72=+:ZJ8I0C8!0-%.Y?>\$=2*`)V@#S)/CX=#KCF,<:N`)2Q@*"E.Y:
MYD&I03T"J4Z_<(J%>!ZU\M<\F,<`FVM9PKZS]95+WUT<T9L7M`QG%D/E$G.N
M9<;06TK"%.0<3L60WR0I04H5:1-7$J:$!13K7])6S#<NE#1J:TBO::4'L69Z
MH<TP6]M7^(_%O.E<USD?35P7^\OZC/L\Q<-)?3#Y/E9O+[H7V6XV#V:;DXD/
M%(64MMO6P&H22#KZD^6D<;+Z&><>.&.:7*M2W2T-/=JP7R/_`#>;C/8_RZ=4
M164K8)KJT;9M<<F^<=+_`%M)]2_0/QWBR#<66P[?G8LI^4MN,TNS7)V/L;H6
MW&GG!$2=Z5^*J@$$`FAU]`[AUI>6Q+C:ZF!E20]H]!%5_,YTU_+OL>ZV[`[>
M)HKV20M%;<O:0,BVM,A@!E@F!R*\9_;,MR2R6*)^:VNQ7.5;A-_([V]%GO0E
M_*W#8N!*EK'R<M57$E*4L)<9&Y5::V>W#8)[."YOWRQ7<T+9-(>P!H?BT>*A
M=5M#AV\E)W?H@;5!)8PAMS9VT_DF2-KM;S'[SY8V@B(FN%'5.*\0N1\XM[33
M,RQV\H;>;4I$J??X`D*1533KC%PM+JTEIQ!*"%)[9/I%"-+'3&QW4U8;J8'2
M<HX3CQ]V4DBA':>.-58?K+K+;VV+&-CA>]E'%UQ4TKH%'M#0>VM`E-9N>LJM
MO>CQ;`S&:4X'$)@WVV.*;>*BTEWM3(4%+ZU';0N"O0#5+==";5/JEDO&%H_%
M!*W+GI#B*<2*\UL=H^8VX;;HLHS,'!U=0EC+J\PUSJ$\`#P2W:]QSLRVIM^4
M6*\S5NN(,AR''QA!<;;<:D-!Q"+P7T_=!Z%&_P"%#UH?_=ZV&0W5C/:5^[J=
M,T>C6P#G6JTUS\WKG=K>/9-S-Z^%^$T8BMY)7MK4'\MQ.GL'$(NB\L8XTF1W
M+!?VRM;SK*Y\+*'4MN272\Y1V/,O*TD*%00=J0HA*4@#3_\`@_<26R%UN'?U
M)86UIE7%N2I-QZZVFQ+[*`2LA(P,]JX$<Z.:UU?J&2VFN:,1BL1T/[PI"@TZ
M_)>O*'VF2ISN..KNEF;=>(JDA(42`2.FT;IAZ0WV.GY)=&X5&@MDKQ'N//K6
M-FWS8;ECKB2Y:ZZ#L&>)FH$XD%S0`!R)KP2OB\F\=7);)C999`E2?6E5R,96
M_I]_OK8IZA3PVZAR].;S$S5<6MQKKAX''Z!2G>HDF[;;)?,$+H_A=-"-;:UI
MGGGR1I&R;&I3:FXN2VM[O.'TMWN(XIO<H^H)3(5X'IJ))MLD<A;);N:YN8\L
MCV445MT/AS;1.<9)7TH75('!PIZD>,MM3(SC#<LNA*B-R'42*5`'@LN-=?T:
MC.>R)X<6D=X+?L2K6.9\3H8Y7LE8ZE0\DCNQ*X]_]8QR=IWGKAKC^(H!.(<)
MSKQ-HTPTX].SG/;\=SI9;05E4#&8]"K]D=#37AWS;G;)-$:F@``%2:8#OIFO
MW6__`!:FSG:_DI<WTCI7WUWNT[G2.I61K/""XT!-,A7'CDN:5:4`T%%"@!!(
MKU(W>/4"HUX;(0YU0OT7)+C5V:\*=6R*M.O,KZ;5-.N-JZ$$U*"FNDKE`O8N
M5U;](N$](/J"?G'R*?&G<V_S#22UKA0BH3CP^GBK1;4>\7`NM)4\B0I3C;59
M4.#.-'%I!3_7(D@E2AY^7D=,31,\LX!*!C#*CW_2D;.QMV3/FN,D-(+SSI;;
MHAI&U7J(9;*4(4D?``4U#TAK:-P5C%>11EK&`8T!/>DT]:UM$J+B:5(K2M2!
M1/Q/73%)^WUJU`B=D`BQ;1:-#3J/(FGGTZT^&FG.<<'%.47D`^.D@T-1FD^8
MP&A/-?L!_P"KZ&OT9?I^G_[R:O\`Y-<LU.9[N/;]*RDA!>2,E<?I20AH0AH0
MAH0AH0AH0AH0AH0AH0AH0AH0OREGI%AD;N_BL5VH-0Y-B/`"GW@F3;O$?IUZ
MP76[L(XP#VA9%VIV!<[T%$+^/\=SB1+P2VO_`!)MF,R2NM>@"H[2DC7!Y+35
M[&EO8$\)IFM#0XT`1#*XNX4GE1?XWM&XIJM0QJU)*@#X[HLE"J#SI2ND/;ML
MAJ^`%W.F*[\5<C*1X'84GY/`/`,D%;N"1(X7U"H\*[1:^5"(LY:`!7RH-(;8
M[/)B^*E/0EMO;MN`D?Z2DO,]L7M[D`E-LE0=RJ?@W3(HU!_1H^'P*4\.HTD;
M1L(QCB<T]A(3C=PO1CK)2>D^T;@QY(^4OE[@J5U13(&5;2?%7]<MY7U\/'IK
MAV7:GUIJ##_62/CKK5J<=781@?0H-\XX59N+L_D8QBM]G76VM6>V3UR7I[#[
M[<J;\RJ1$6]!#;:2REI)`*0L!77Q&LI>@VMP8+61S8J<ZXE7%J[S(?,FC;JJ
M?NTP4A\-]KF09%B&-Y3;>5[];G;[9H-V^3+$IQN(N:REXL(=9O++CB&Z@5VB
MH%2!J^BVN1S0Z*\<&EH))!SXT59/?QB4L\H4&7A2F/MHYL@!/Y7S7*(`J@2$
MWUM-#Y*'S<P4Z?`ZD&UW:,5AOGN=E3+!#KBR>*21-<.T(YL_M[]X$WYH8SGL
M?(/DTMKE!CYMX,H=4I+!?3(LCJ4)>6V0G<>I!III]UO5HW7)=@4YN%3[5R..
MSF=2.)VGDT&@]F".?[C_`']0!N:LT&[I!-*L05*</B``N%$413_!KD?4N\1-
MTB[C+>1(Q]J=?MUG(<8I:]Q^Q9$8'[^HB%][AYNZ;`*JCPX9WI!]()9N[1Z4
M_HUKKKNL-VB_AB`UYN!^M--V2U/O^8WT$U]BVF;9[W8Y"97MJO4ROJ)B1)"?
M+J"6YDA`^`TY%UYN,;JR11$4X$?:C_#T'"1]/[)1Y%C^[A)2F9[5<X6>G2+N
M14D5(VNH4?Y]/M^8<GF#7`-7&CA3Z4?X:#L635Y`MI[4HHL?W(*),OVK\L-A
M)V++$*,^*]"=M7FR:?X=31\PK,BMQ$X/[#4434G3=P'4:11'\:S\[224.^W#
MF*%440ZYC;<@)4>M.VS.2H_I\!]NG?\`WAV+_<8X'M"CR=/7K::"$I8&%\L.
MA(D<,<M,.*ZK7)Q&0O:KP"#V''`*?;X:FLZXZ?<!5[A(1C5II7C^Y-_X?W'[
MH#G<LO:E,SQGRBZC<>,<_:/DE_&9S)/GX*33IYZD1]7]/R$5ETD]F"8=M&YQ
MNTF"M.(<M]'$G**T%:>/<LH*U!M#R5`CQ])HHG]&I7^)NGO^I'L^U<_2MS_Z
M<_YW[E[_`+H.5-VW^[O+2>GA:'U#K3S'3SZZ/\3=/?\`4CV?:N?I6Y_].?\`
M._<M@<,<KGJ./<H`\?\`-CO^"O33K>J.GG>`W+:>C[5T;3N)]V)Q?^''Z>Q`
M\,\K*)V\=Y:F@K15J>'Q\_`^&G1U+TZ!H%RVG>/M7?T?<@/%$YIY4)]JS#A'
MEQ0!1QYE1\ZBV+)Z_#U:4WJ#8![MTQO?3[5S])OOP._S2O7]QW+JC3^[S+"K
MX"UN*Z5/6NX#45O4.S@^"[C)]'VH.T;D/=B<X]Q;](7D\'<P5*4<;YBI0^%F
M=(\O,*/32CU'M+O";N/U#[5T;/NA]Z!S6\\_91>#P=S&*;N,LR5UZ)39I-3T
MK^RE72FD?KNS_P#5,]GVH_1MP_`[_-*!X0YEI5'%N:&E`4BQSE*IY'TM'H/M
MIH_7=J'N3QN](%/:N_HVX?W;O\TK4>X6YH;5ZN)L[)(`_#L,\]%'QVJCA5?L
MT\WJ#;7^%\L6G^VW[4W)M&Y-'AC?7^R5Y_N:YC".O$W(?05J,7N2OMZ;&373
M3M]VO409HPWGJ!^M*;L^XEH)C?7^R5A/#7,JRA+7%&?IWTJX_BMX0E-0*>CY
M4K4:_HUS]=VS)D\;NTN`]E4'9]P`KY;\/ZI69'`_+*E[YG'.>/J\"V<6O`;2
M4D;0E(B#P^)%>FEMW+;I1^;<0X9>-H^M,?`7_P#<3?YCOL1H.&N4F@$M\:9N
MA('4?PK>0:^?5,'J=2?U7;"*>?;_`.>W[4?I]_\`W$W^8[[%B5P[RJY_\S3/
M32OW<4O?2OQ_J7V:B2[MMX)!GA+.Q[?M2X["_$@K!-_F.^Q>5<-\LDA0XQSY
M0":43B=\K45H?[%X:JKK=+)S_P`J6/33\33]:F&RO.,,M/[+OL24R+#\LQ!<
M-K*\:ON-.W!ER1`:OUJG6IR:PRYVG7XJ)K#)D,MN^E2DU`5T/741DT,@K&]K
MAV$'Z$S)#+$:2M<TGF"/I1;8W6V;U:7G:]MJY0W%D="`E]'J2=JJ*'D:&AUY
MI\VVRR?+/?FP^^=OEX5PP4S;"X;A#IXO"=H71ZX94S(;5'9M$)R9'GRI:9#<
M>8ZF,X4RF'&&2A]:RH(6%`$J`6"2BFOR/BL76^RN>YP^)>UH:T$5`H*U%:CB
M:^A>BBW;4BAKJ/TJLWZC,^Y3I7$#LIM$:(8^<&)&WJ6^&VY=@CI>>&P-I+S*
M$[0DT*0%4Z]?JW^62*.':]X#)?-=YEN7&E-)Q\/;S4R&/RVEM".]:7T_6I;/
M(MLN+;+BFV+5=HT5:(]$N/F=#=N+:74#U2%0%K70FO::4!KV'K@^?$V.0T96
MN!I7E7L7JGR\:?/=.P>ZT`$#"I.(5GON?9O:K*<J4T'7;,W#<M\51(+B(*DN
M.-$IZH4^@"IH:&FO-;8"28VLM/,E:0TC`8Y57T1LFZBREBE<*-CD:34?=!QS
M^E3IX=M?#_.G%F&YKEN+?Q5=\9<LURQB6Q-=AW#''X,8!UTO-.>J%<GWVT2F
M%)6%K0@I(4-0-VMYY+80GS&Z7#F!5N%>Y>^;W:V\#8NI&:2R>'2QV?A<,0#S
M*2OOXS&WXO[;;Q87G5+E26&8%(I4MQ'S"E)E-;U;7&4K2XG<H=5-^G[M0;'I
M6R$6Z1:B2X>+/(KYU^8NY0-V1]L/=J3VJC'V[<D+PR\&^(4(C.]Y#20M*&8L
MU3L-<>2&QM2^EA$<[T%22"O<""*:]1W:`R2`PT/?BOGG:MP^%<+BOYO9]85U
MKGN<LV:>V>]W!VRP,K>8.-1)=CF(1,8EMNY):Y$AJ2PMM[N&)%:DI`4A0W(2
MIP;"5:N_BGVW2S8X]3)->)&'?3L4CJ?=[O>;&.**0LN-1Q;X<!S^I.5Q]E%B
MS3&+9D&-J:_*YC:DM-H;:;$+Y9195#*(ZEQV2PI!1M0=J2*=*4UC0T:S+5Q+
MAQ-1WA>)W<-S:W3Q<$NE(Q)XC@GWX]7VLMQ\[@@B?'`4#0;EE2:`GIN/GI30
M!('#WQDFK-S67C'5&OZD[_([:A?(CJBD*4_*:+B4U73Y=U9"%;:@GM@^.D3/
M<P5&=58WY<;W7Q(H>Y32XLG%7'^(U25?\C,)"J':$H?>;`/0*30#IT/AIZ#4
M[2X\0M7:@?#,#<M(3EM2JGT[M@!`)2=OWJ]2:5534HU`[4_D?$LWS2O"GB.B
MJ>!Z4%!6M=(87'WETN8[W`1WKPF0I*MP2:GI2I(\C4&@K3]&AA<74=DDNJ!A
MFLR7U;224UZ^@@@^->I`.W2G5`\.:!EBO)>57<"/NT(H:#KU\:5(^.FM<G+V
M)+B=0`]U82H)Z@U!)ZFE2>I(`J?#KIUA<ZNI<=1GNKFW_P!8%S)#COMSP-ET
M=R-:N0LWELFFU/YA-QW'+>ZNGAN%IEA/7XZ]#Z,@:Z!TSJU<\5Y88!87J)IE
MWNT<XFK6.PX#E4**O^KY<>G._J2'("PF3&XI]MO(^0.5:#Z(TO+)UOQ"*OJT
MZ$OKCY$LH)0H@CP(Z:^H^C?^$M)[C`.=%!$WF"'N>>1\0IJYBB^'OYV[UC_E
M(S97:7QWNY#S`YH<WRV-=]T@A]#2M016E<EWD8]C%C:D1"VI]DQRY(2P;,W%
M;2Z@%<DF6Q`AH-6VPD%7WDI!ZD];R_O;F=C@\`ZC35JYX4TDDK\O.F.E-GVX
MQBT.B*%KB&"!K12E2:L8QO#B*IO>`;:[-P1B^[(BOXJS'-,@N"9#2'I$B#=[
MY.D1FF5'P"4=LFE1M`KK3]=W,3.H'6`+A\+9VT3=)\-6PLU'M\503V463^6N
MT.N=D?NENR)T5WNEU)-J;J+V:Z,`[J'UJ1+6+VMQ:%FVQ:`I4G\)`-4BB*E(
M'W4F@^%-8!]Y,`6N>[T$A>SVW2^W2R-D^$M]%12L;33E@0LC^#8G(3W)5BMB
M]I+BC+A1G4]-Q4IT.LN'92I/Q'CI@[MN3!2*>84RH]WLQ*O!T/TUYU9+&U=+
M6IUQL(/''`8*(<ODC@NY&6<G]MG(-L1%D.H>FO<6Q'XZWD2G(:P'[-.=W.HV
M!:@%**6U)/B"!Z-:V77-NYOZ5OD+FE@-&WC0!AJ((?CAD<*$X9KS'=V_*:<2
MVN\]-R.@9)0R0VSBPD<0YI:[/D[`>E$KE^]D4H*7<+;(Q:4HEM2)=GS:R2F%
M=SY9*$"(T]N6MT42$UJ**'0@FSCNOG*QIE@D-Q:M%:DP/PI4^_V<J'FLO/TY
M_+M=.#+FVN;2ZF-#3XV`=E7,=0]Q-`MMC#_9]D8"[-R=,MJE.-H;4,UN,`EZ
M0@*90AK(6VTAPMKJ!XJ&F/\`%'S,M)/^+VV*:HK4V['4IGC&:Y\<JIB7Y3?(
M'<'".QWN^AE:*`?%N>T5P:`V=Q:=/&OB&:S'VY\07Y)9Q?F=NY#:E*XCE^Q#
M(MJ2G>ISUMN.FH6D@`BH-=2;?YH=3VKG?&[2ULE3XF_$1N'<*Z01P]JA;G_+
M7T?<0A^R=23.H/&R1MLX`#,EPH2TYX9#),#S[Q-;N-5X]'8EVJXB\F9)#MOL
M4:VJ:CP66(X0ZZQ*DLOAUR1O("4>JIZB@'I?RQZON.I;FY?.Z1@@%*22A]2<
M>(&67-?,_P`YOEU'\MC906=V+B>X?KUQMTEC`=/`G,XUR3"1VUMI*67U,J]1
M4IEQ3-4I34)HVI)!3\=>M216;C5S(S_DM/T@KP$[E=PO+1/(QSWU)#J4[^07
M)7]7#*QE7O-Y%MCLJ0ZC%,;X]PEIQ3KC[S;UOPVUW>8TDR%+">W=+X_N2#3<
M5=.O7\\?GK=6KNN+R"W:!;,#00``-5>%``"<\L0OZF_Y"=AFV/\`E>Z:^(/_
M`!5S;NG>7>\[S"'#/'+'M&*ITOMS;M#X;0V9":T)*TARFVI\!MK7RZ]3XZ\'
MDN+=CJ!KJ+[/CM9I8_,8/#C[$_G$GM[Y3YJPJ9G>%6FU.V>#>+A92W/O$>#.
MD2K;"C3999CK2XKLI$I"`H@!3M0#T.N"1D@U,!`[5%\Z%ER+.6HG(KRH.WEZ
M4WG)7'N:<1YODO'/(F.W#',VQ"ZNV;([&X&9JK7<(Z$JD179<)YZ,Z\QO`4&
MU+2/Z500$^9'72'-U<JA6MU:.:X!CFEE!Q2#B7FV(>0?G6P0XD;O4D([;B5+
M*BI'2E*?ITW-(S01J%>](982:QY@_+[%YE9-:ZK4F4MQYUQ16II"U>@[OO;0
M*5KJ%K;S"4ZR<V8&/W*C-).3=HSFX-H=61N_8VUJ>GF:>&FI92VF@A6S'LCK
MY@.*)7)8<-4LJK]WJ2?B:=$^/744G%(%SYATL:X'M!6%2'7`"$D#KM3U"OT$
MT`TIC"YPJ#I7"'$DD8X_0OV!O]7SK_[9D^GY7Q_N25_\FF6?SZG``#!9P@@T
M.:N0UU<0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(7Y6J;2I0&QM:A6OI[IIX]?2
M\LTK]FO7_([2LC585V<]=X=I4U&R0H)-?`@M+T>0.:*K47;@GTK;73PZA%03
MY'<PGX:;<W2_17-=X+'^7M`I&UM-*[1L;W4\_NE'7]8TYY`YIM\FG@L'R":@
MDI4=U-NZE.OC1N01TT>0.:1YQY+`Y;TJ2:HW#:!7:X3]Y5>E5_'270#2<>"4
MR74\"G$*F;FQ7>Y=Y'4LA*D93.:HE(IL80TPDT"$4*4-I\17].O/+IVJ=W8:
M+71?PAW*S_@^S1GN)./JI"W',9@++J0@=PN(4NI4IU*P4@TUN=OCUV,=32@6
M=N?^8<G,M-A[/SBEEVKDV044>=.U)4E(0*/T2*('0=-6$=J)'4U4PY*%YV-*
M*57MOM*#>I[4AM,B,Y>\?6MB6#(:6&[)F:Q5J0IUOTJ&X=/$?'6,ZMC$#XXZ
MZJK2;`[4V5W[<%/5C'+.Z6E?E-G0E2@VEQZ!`91W34(;0IQI(6XKR`ZG6,?)
M;PL#YY&,!-`#F3PP[5IH;>><$PL>^@)(:*D`9D]@1TG$H2/OV.U)(IZORR&2
M?*I(C^=>FE$4PXJ/6N(1/>Y.`XK\M_$\S"\<5+J(GYVJT6WYK;][Y<RT-)>4
M/,)J1J%=[EME@0=PGCMHW$!AE.G6>('IRYJUL=BWS=6O=M%K+=MBIYGE#5H!
MQJ>[BA:IW'5^GJM=FN6#72ZMH+J[;#=L;]P#:4DESY)%990$==VRE--P;OM-
MW=&SL[J"2Y#=6@.\6GF!^V"5=;#N]E:_'74$S+/5IU&-]-7(NII]->Q&KW\%
MP;S;\;E'$X^172-(F6RQN-6I%TN$2&%?-2XL);8=?9C[#O4`:4/PT^Z_V^.\
MCVZ69HW&459%]YP'&G+`BO8H[-MOI-MDW:."9VWPN#7R!M6-)I@7<Z&M.1"U
M[M<N/L?>^6O3^+VV5\L9IBOQH)DL0@I2/GGX[+#CL6$5I([S@0U4'U=#IF;=
M]IM:LO+ED=R,2VCG:!Q+](.GLKGCR4K;MAW;<X_/M;=[[?66M=5K0\\`S41J
M/,#+!8TY%QGV\;=3=L)[.9/N1L4="K3V\DD-**'&K.LMA,]:5BE6Z@J(`))%
M>-WK97OATW<`ANC2`N.DRD9Z0>'+BE?X;WYK;KS;.?594,^D:A&'9:CE7GP2
MV:Q^SA1I9[4H_;;H73_TYDZLWLT.+>(-%5"(&/S`>%5N)Q^S4!_*;2E7_P!K
M(/2OC]U@^.D)I;3=BM%`19K2`:`J%N@BM.A)'8!\1KM%)^''-;0L5G*:)L]J
MKX%0MD'<>E#T$?S&B@2V0Z':JK,+%9ZT_)[0:B@_Y,@CJ3T_W#2FG2X.Y)UP
MU`CFMUO'[*FA59[0KH*I_*X)`-/,F/2M=*D?YAK2B8^''-;35@L1&_\`)+0#
MU!'Y5!VD`@D?V;4J.$1FH*=DC\P`$Y+?;Q['QM7^1V?KU"?RF%\*>'RY5TT"
M(!^OBE-;I:!R6ZC&K"I0I8K,:=?\U0.G6A\6.AH=.I2W/X8L/<2$6.RJZ'K^
M40*I`IT)5&`\=%$5*W6\5L2E&E@L@'15/RNWD[AM%:_+]$DBOQKHH$+<3B^/
MB@78[$DGPI:H&X_$"L?K3_'HH$+:1AUE<2%"PV98)Z*3:H`Z`]-U8_CHH$57
MT8A8&]K:\=L84>M56F#3U*)K7Y<$TKHH$5*/&,(Q3;ZL=LJ_0KJJU0*%=#2G
M]7`!"O#X:6Q@>:)X1UQJF/Y?SOC#AS%KOD%UL^.W6ZQ-D:U8C".,P[M=KK*;
M==@194FY.1X>/VU2&E.O3YJFX[$=*E^M6Q"^.\IKC&#63E1<,4@-?]GS1/P'
MR[Q=SM$G,8[C!5><<MMI=RZ2UQ_DT'`&KQ/01*M6(9QE&+8[#S-$&0E:>]':
M05H3W0@(4#IR.*M"<,4U)05`-<%`+ZB$=B+E_'L&(PU&C,Q<\7'CL(2TRRAS
M(XB"AII(2EI.YDD@`#=U\=:?IV,/M7\/S"L5U.?^)B_W84'^-L>R;*^0\*Q;
M"['+R;,<ARFRV3%\<@,HD3;Y?[E/9AVRU1&%A2'9$R4ZE"`01N(U2_,>RN[_
M`*!WJQL`77DEA(U@XN<:4`[2JC:WLCW&%SS0>8%83<O8)]0:\N/M)]EW/ED+
MBU,=R-A3[[?;CJ3&2-Q6ALH<0R'=P%5J/0T/3\N9/E/\QPT2':[QU&-J`WDT
M<,"5O[B\&IYBQ-<#4*F[ZM'MQ]P'"-ZX`M?.'$N;<5R,FM^?IQ@9K:ORK^(A
M:Y6*"Y/V].]0<7;U7&.AT`>D.(\:]/HK^7WI??NE-KW<]1VLUH)IH"T2-TDT
MJ#05-1AG53MI<Z[!$AQ!^I2$^E#P^B7C>77F^VIW?!O,219I2DI"69BH@C26
MU5_$2M"FDJVJ%"VZKR5JYZVW#XK>6FTE)M!$,.!7TC\N]@:-I$Y)95VK+GPS
M5@O.7&B;E8+E'3'6]1IY"FRG::K;W.!7I(""``33QZ:R[IPQS9JZ"!0'.A.1
M6]O(1#2*M6F@/<H]^T^PY/@%UG0+I.FP,1CJ?DQ[,Y^#%D@2$3@VHG\0M,RJ
M+2@;17H:TZ6-Y>NG:(FC4:#'B33%:YG5]_'MC=COI`;!O\.HQ;V!0U^HI[@1
MEE^&$V^4O\M;2EUUZ&^P$+>=4I182`74J&]H;RH?=00?'6PZ,VT"4W<WO@T`
M]'/]R^=>O^I673W6K'>$85]/)5A6K*9<&.S'0^E2&E`-$$]MQIP+"FG5)+:D
ME25TK6I/@?(^AQ69J?.'AX+RSS7CW312OX9Y?N-EBWRVB4(<&XN1)K<!:C\N
M]\HRM$AIQ+B4EQQWYM.VB@H*`6.H&HG4%C<R[<V"%Q9#2N&-:_8N0W3_`#]$
MI\%2%<1[1,QM&4\<.R;&RU!C)O$E^1`0U\L(LN>"N>VIC:EMF293*E.I31)<
M)(`!&L1;NEA8VWEQ<W"OT*FZH@<V5LT1+HB!CEWJ<F%J0K(K*Z!M";C&3T'B
M.X$A1`!.XUZZFM%)1)Q"H]MCC-VV1XJ6I\>36E,R;>[1*@)^T#P"4N0I?WC0
MD=?Y=-7&+1WJ=N8\J;6,:J5/$<DKXVQ)9I^'!E-JH:C\&Y3D4\*U%*]>NIT&
M$3>Y:3;G_P#"1/I]P)QDNE(J:J3X@5(`\Z^'PTX3Q4Q[M;JK:,NE-SA)('5*
M=H!('CYTZ]-)C=K3;CI6XE\$!1('C3Q)\:$_=I2HTWYO8E468+J-P/0BM?T?
MJ\M.M-0"N$5P7JJ]E?%)-*]/,5_3X:4N`4%%B*`0:$@GS^%//^37:I/E]JY"
MOKFYFB^^[YO&VG`ZQ@G%&"6)U((+;<Z[*N^83!L2HA+I9OS.X=.HZC7J71\(
M.U-?7^(\#NJ\-^NJPF\312;TXM/CB9ES4WO]6&P1R7GGO?Y7::41;+7P]Q3%
M>*!W=LU^_P"275MA9!0"E=@CJ4G8LDD4`\=?4.TQ,M]J!=[S[J0`\_*:UH//
M&N-,J+\W/YXMQDDBV39('8-9+(]H`)(<\5=0AS:@"@!:X''#B.O7)YMDQ_!\
MQO#+3ZY]GQ6_3H<B7;#"[*HUK?)0V^Q$BQE]V0K=4U*E$T)\!-VF"6\Z@L[5
M]/AY+J)CJ$G`NQ.->`[E\)[S/LFV=);EN$#)9+V.Q>^-\L38@'`:0&F-L;2*
MG/23V\LO$-E.*\<\=VAUJ3W#CD)Y]0BE:4R'(49:PZXA`4TH5Z`]5=?AI?4]
MZW<.HK^Y93R_/>!_9#R`!ZDS\N-JEZ?Z*VBQN&R&>6#S7.#<`Z0ZCJY9T!XX
MIXH\Z&E.XOI&PFH(*35)((HH`@[DTIK+2-<[(8+UFSN8&LJ7"H=]"]72:U^6
M37TK1ZXJPV`L%1+B>VB@%>I*QIN*(F41C,G-6-Y=1/MGSA[!5N5<>`R1E#C0
MMO8[,934=+:TH2R&]CRDE*UK)IN==W$E70U)K741VL'S*GS#49\%>0QVDU;5
MT<;[>.,$>$#/GSYU6.=8;$\RXJ7;8SS0!JVMA+]=]$D!*PK=4#PT17-U"-,;
MW!H[3]J1/LVPN:^6>U@-:#%@.9IQ20N7#G&%X21<\(QB>E9W*$FQ6IT+-*`E
M2HG=!IT!"@0//5E!U%OMNW_A[N>-U,"UY!`Y<13O!5%=?+SHJZ+F7&WVTD9=
M4U8*$UK7"A&.5"FFOOLC]K62279UQX8P[YZ0H*?FQ(DFW375)2$!2YEOE1I*
ME[4@`E70`#R&MCMOSC^9VT1"VLMZO!:-&$9+',%34^%['#$XGFH\GRJZ'N(@
MR.T=$>&B5[1ZJG#L2!G?3J]O+BNY8XO(6)+V@(.-<GYO#;;H2H=MB5>9K``)
M\-NW[-:"/^8+K^@9?G;+R(&M)["T?C_:$0</00J;</D?TW?O+R)P:4%7!X`_
MRP?I2/NGTX[3("6,7YVYFLV]:$-L76X8[E48%PI0:B]61U]P"OFY4_'5M#_,
M1>L>^?<-BV65Q8:F-MQ;DX?^AF:!Z!AG19&Z_E<Z<W0^1;"$R2.:VCH&9%PK
MB'`FG*N*_.O]]-U?N7NU]QTIV_/Y2(G,7(5I9R"3$B09-ZB6+(YN/09ZX4%M
MJ%#7)@VQI6QL!"/!/AKYF^9=TS>>H[G=61-MFS"-XB:Y[VQ^&FD/D+GN`KF\
MEQXDK]KOE#T]:]-?+S:NF[:GEV<#(PX``49&&X`8`8<U6ME3Q=N"AX$!1V5K
M]VB02J@%337D=VRDA;V+V:",QV(#3XG$BO+M3AX+DE[QJ)8)]JG2HJH4UF[(
MB)DOI@R),.ZJDH1+C,NMH?8=<C)2XDT*T=*C4J-FB%H[%1W38YIY#*T$/9I=
MS/;7,=RE/RW[NI_,.977D#/>'.-)^3WZ2Y+NUPM$O+K&B9,<[BC)D1A>K@U(
M<*UU.^M0D))H!J-<11A_G,%''!,6EJ(I*ASB`,B:J"4VT;MBH:4[BZ5NAUR@
M*2"5!/I\U>`\M070.>XEF+CP6CCOF$B.GC14+5.;4HB,V=ZB`.^T*!1'A4T/
M4?IU'=&]CPQXHY.E^IX=1:C[1BNEMYMQMQ0"MJ-IJ#YU!(/ZM=ECT4[4/?KH
MMR!$ENA2XD%U\`@[W`D!)/\`1)6G<HT^VFEBV>1^7B[DN-D9$=4AH,D;)9NS
M:>MH4L)J5`"I/Q--Q5T\Z:D-CG8`'-HT<4XRYAD?I:?$:_0OUX_]7\W'Z-?L
M`WMEE7]R9JV004'^,\KZ4-"-*6<G),KB<ZJXG0FD-"$-"$-"$-"$-"$-"$-"
M$-"$-"$-"%^6P>R"=\=VH&ZI2VK^3NVD_P`@(.O9UCG.#14K66ZQX=I77J*1
MV`JGVK2RQH7'FK*K54XT*U6I/F`6T@`'J*TD@Z`*D#BD-D`;0UJL/X*ZJ#Q!
M!\02G[.A#YIJ;!&8I`]U"T+CW!R\D))]#@H/,*<4K^7MKUQD1:XN-*%-K5<0
MVM%5*"CZB%!'J-#X_N3N\//RU'D'YI[#7U8I32&O!.552'S,WLY;Y+"D*03E
M]V]*C7T]X]=O3;N!'2FO,K^AO97#(O)"V5N[7""%;5P<TE/$?'10#TQ.SDC?
M0"L5!Z_BBG4^8&M[M$9DL64I@%F+_P#Y@T3HPF5J0\02$_,R/2=RNI76M25F
MFKR"%WG398%OT*&I/>VUH'()@5N)%VM"@2"G=ML&:$]"`?YM8;K=M#$#2H_>
MM1T][DH[/L3R<Y\32>2\QX98O-VN=MXY1=[I9LE<@R%1A#N4UM,RS2"Z0IJ(
M[>7HX@(DK2KM+4E*?4M(/S1UWTS-U!U+M8O9)8^G@V1LA82WQU!;B,JTIJQI
M6H!7T?\`++K&'IKI+?&V%M;S=3`PR1>:`ZK/$UX:#[VGWBW`$8$ID?<3[FN.
M_;WPSD\BV<J3(_*7$^0V9SCWB;-;B\.3G+O'GF%=,-S*UB07<JX[R/%G7W8M
MR<0ZPW&=0\U)4ZRSM]%VK;I-JM_@?.=/:L_AND%9FC^[?)7\QK?N.(!SKFO.
M=XW&UWBX&XMM8[6_DKYK8C^0X\)(XR/RW.QUM!(RIDG']UN3VWD'@C@O-[='
M>:M6=93@N4VZ/+323$AY!C#MU89>JD4>9:GAM9``*DUIX:\R^=#0^RVEK@"#
MNH!KQ%68=R]9^0KW-O\`>7Q.+:;2\X?B\>-,B>]9>8V$V[W"<,YAR5$1AF-V
MV7^68OD6-NMWV5?+PU/:D-Q,GDI:MLNS6P!]NJ&V97X2W!N`*BF%U;#;V7S"
MVO=>I8V6.W@/$#K;%LAC^[-7014D#`.]2G]'ON;WY8;YM/34SK[=*">:*Y)#
MXHZ:C+!36TAI831Q;5)7GAN_VVYXY[BX=GRAG(L5S)J8M+UFGHL<7C+N(MMB
MMJ[D4_)M2IBFW7Y**!07=5-J-4"E/UL^_P!MO[7K:VBD-]!=:BZGA%N0T#N-
M=1IEQ5UT':[7=65_\LIYH'[9<VNF.0O8V5UZ:R2RAI(!)+A&`*C0T8`X)=96
M_P`M<?Y;?.?>+;?!Y+XTY+LV-WW(,7<[GYW;8-OLK;45^VK;"I)C1HBUJ_!#
MZ$*4L.LFF\:'=SU7TYN%SUCT_&V^Z4W)K)GQX$M&FCQZ,Z5H,UF]HAZ.W_;+
M;H7JJ=^T]9;8Z2&*48,D=JJPFAKRQ+:E8IN>8/D=\]KTNQ\;XQ<,;RW(+C_"
MDBXO7*/>\$ND:XL&_LQ[?"VVF26;DZ%M$K<9#C06$B@UV7>MCW#=.G'V=G!-
M;WDA=$YQ<)(#4A["T#30$$`@DT`3,'3'4&T;1U8V\W2[BO;>&-MPQC6NANF#
M2YGB)#P'M-7'2"#E53U0S0U4-WG1-3UKY]//7L>9+N;B?6<EX*]I<72-/@J:
M#D.0[!D%L!HGP30D#TTJ4T->@%>OQ\?#0G+?W3WK8884"HE-*))%>@!J.I!`
MK^K75(6XRR*40$UIZCU\13Q-/B="%LICBOK`-?`#SZT^`)T\R,T\S[H^I",6
M&*4`%?Z(`H$C;X&IH3_/I9;YV+,*<T+:1'VBFRB>I]()H3T)Z5\CJ2NK;1')
M(JD*2*]/$CH:=-=0M]N*4J0`$$'U"J5#H>H53Q`!'GH0C1,=)%.M30D@T'2A
MIT'@::$+=1')H1M6:TH``1]IZ^`UUK2XT"%\:C./2T';1+:O63Y4K45&X441
M_-KCJ,!+R`UH))[A5`%7!O$D#UFB;]O.KO>^7KMQ78)4>Q0,0Q*!D^27QRWM
MW*Z39E\D!FUV>T,2U?(1HK#)[LB0XVXLDA"4IZJUE&;[/?\`5<_3-G(V&"UM
MA-)*,9'EV36`X$-)%:TXK<GIRTVSHVWZIW**2:ZO;I\,,50(V!@J7O<,6EP!
MTT#L:8+;_CB7CMSN>.9LIVZWJWV')LYB7*QVF-#@/818I+##9DL.7(]J_)+F
MUQH>AQ?J24IZ!3NHG;?YUINNN:[M[-UT7,`QA#M(&)'C''"G:DS=.1[PV#<]
MEK!8S7#+4,ED+B)B!4BC<&&HQJ7&F2/+!R;9LJ=>M-GA7Z//1A=CSE;LF%!;
M0U8\H;E&S%I1FR6TW1Y,-TEI:2ELI]1H1J;9;_;7\SX8&2ZH[%ETZM,(Y`XM
M&?O4::C+*A*K]TZ;OMMMHYYWQ%DEY-;MH377;T#SB!X:F@X\P$P$:#[=',=O
M')3W%JWH.?7'&+CF.<3[9$F9!/=EF19;)DN6WQJ]O7VV1K6VE3:W2MH0VG`0
M@-D4SNX=0].[GM3;_<()7[:\QMU@_P`/S7:6EYC),8!&)?3A2H*TUCTOU'M&
M]R;3M=W"-ZA,O@:2TRF`5>(G2Q^,D5(T!U0"#0IV^*N*\<Q2YW#(,;E\C,6^
M\6]I+%ARK)KA=K"RP[)4ZS,MD"<_,?8D+:82I"E.DI8>'FH@6?3O3&W[)<27
MUA)?-,N'DOE\#3J][[]0YM"*'%I&2K>L>I]RWVSALMQCVUTT&+9;>#RIS48M
MDEP+M)J'`L'B!HJQ?J/-@<@X(VE/I_)\V=*@.NY><3FE55]A8\=>K=/,<^V?
MI_O"O$NJ6%ES%7^["9[Z?K.WWW^S@CJG_25X>J.I)/\`&MJ/P\-6&Z1N9MLY
M-/X95!8D&[8.)<OTRJ#X#^37F!`.!Q6NJN4;_61_:U:?<7R/[*+C>9*6X6#V
MOF??"<::<8G)O=RXQ+C;V]*BV-MLVA0\-Q\#0Z\M^8W4-SLCK2RML&7&LNIR
M8`?7C@O7?E;L`W8WEV^A;"(V]M7DTX=F*KQX1XQQGBZU"QV:$[$:3'8:4XNK
MKJPA16RAQ1*RMN/UI4J('@=>*!KIYG3..J8@5<2:D<!3(+Z;V/;A:01QL(S]
M"=ZZVV#<I!C3;<'FW6B:.LIJHE04X%`G:I!1ZT]`H`'QZ4=#'1G4_%N7K6IF
MM&R-)ETZ1CZ1DJA_?_S;#XI<%IL_:CNK3)8<_+REMP/I9':60WZDH*E5VT43
MU(-1K5[!LGZA=AKJZ217.E%XWUSOOPDIB<:N;3W>[ADN=3.<UEY;=YUTER'G
M7IO>6IPG[E%*4Z6TT"4!I*4]*`DJ)^.O<]MMFV+&QD`L8*"F:^?+Z\=?7+Y3
M4"O[TWJ9\A7:8*BUV5%Q"A6BMBU%(JG=O4L;:5\AY:LK=I?,T#*JBDE/]QY)
MD29D:*XZAE6V4EN9(.V*S6,7%)EE56VTL,M[RLU5M50`U316^6IE@/X00"!W
M\%&#W1RZP0"#Q701[1<"O^'X1^8WL342K\S`FF"\4.L0T_(L4##S+20\@&B5
M*-%+?WJ(ZU/F^Z1,B<V)N#JC"AKBHV];D^YTPLR;2IX>A3JPZ2XQ?K,HNE`3
M<8WI%!XO-TZDBE"K].HD;'L!#\U36L@9?0O-=+75/:I0\K1%IC1G0#M5.B*"
MRD+`[C+R**!I4;EZ1/@T=ZNMV89)"X<!523X&L5VNW%5IF1FVOD($J[0I4N1
M+BQV67?S60I#97(>;6I2A(10;3U4`/AJQL;2>X8'18FF7%6EG?VUKM[&3'%S
M13L3P6+%%Y"\8EOOMH==:$I;B6E7"0EM,1Y#+J%R$6],1+B'7$I[?<W$JJ`0
M"=60VRZKI>`UQX%.#=+9PU,U.'8$=?P5\O;IMP?N8<7'ANRHC46WR'42GD1?
MFW&'''7&G(S3"/07G&TMK=HE!4?$GVV:UA,TQ8&CMQ*0-R=(\,@8^IY@?:4C
MT@_[HM"!XE2EI;"4>)]2RE(U2&GW"''D/WJUC<7N\LX24K0X+%*O=FMS2ES;
ME"8:;`WJ=D-J2E*JD;E(*DA(ZGQT@2,U:7.#7<:\$MWEL!U/8'#A5-3?/<CP
M-C(=%[Y8P>"ZT2ER,O(K4J0@I!-/E4RR^5#X!)5Y4KH=?6<!\N21NLX^M0Y;
MVRB.F25@?2M,4P]_^HA[:;,XIF%DEWR1T*+:!8L:R"6T\[MW[425VUF$:#S[
MM.FDR;G;QMU>(@N`PIQ]*@2[[M\)'F$BO8N1[W]\KP^<?=OR[R#;FI<2U9'E
M[+%JC7!#;4MBUV:TVG'H3,EM#BVT2$L6T*4@$[2HU.OHKHN)Q98PAN+ZD888
M-U?5ZU@)IF7-W->,-(WNPKFNES_5L,*OME]DW(_(-EDVV#-Y;]RV<3R;I&=<
M<N-BP?'\:L<=;#K,EE1;:N%UDI`+3B`L*J02G7T98QVT.U6[;YKW?DE[2TC!
MTCW$:J_V14C'E5?DU_.ENF\[C\W;?:MJN;=L%M81!S'1DNP<7O#795+9!F.^
MBZ+N;HT"/P_?HUO':?R25CN/A9:;CR'57_(+?#?"T,H;ZEE]RGQ^)\=2.BGR
MOZLMIKC&*VCFEXD`LC<1GV@47R_\TVV-A\M[QMH/'<O@@#:!I+I'AIJ!@!G6
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MH%MH/@1(]KI7%X<!B*9`889A;$EUA]AMA*T/)?4VDT-4J17<2:>JE!X_;IL-
M-=1&"ESS6[XQ#'(USG.'/(&O)&M44V)(](`\1Y?'[=,4.95F7,?5C2-2\)7Y
MT4`.O6E"/L-:&NE$8T3#7EOB<"*<%E0Z%=0HC:0*$BAKT/GY#2',TYJ1%<M?
M4@TH>*)<IRAK$\:R3*I'1C%,=R#)WU+]*.SCUFG7ATJ4?2`&X9\>FFGQ!S='
MXR&_YQHM#L#C?;]:6T6#_.!QRPQX=R_(HY/R1_)\ORO)):U+D9#?+Q>I)K5?
MS-XN,FY2%.'I59=D'IX=?+61ZO(DW*<L/A\PT[A_0OTWZ;C\G:H2:4$;<NT!
M1-R%]Q=P>/0>K;T%/O"H_FUYW*X.>2ME'X(P799I=8ZHJL=M15)_#D5)!])$
MR2=M3X]*'ITZZM(WM;"VJIIVG67<"M:ZR)"),>.VZ$MKC275I*&U[EM`4]2T
M*4@4^'7467S2/RJ:J\586T,<S"]WN`>FJ+E?/)2`'(Y53H2DT/@>M&QX`ZB.
M;*#5XQXD9*3%;6DL9E:3AZUX"Y950MM*(&ZB0#^CJ74>/PII!QQ*[Y%N,274
M_;M6;MNO)25VYA\IZG>1T-?&H=)2:#R.EMC,F5,.:0'6T?N.SYHQ1-?8:2E%
MMVH3T*62I*"KQ*@.V:$_#^?4B,3AWYFG13AFHQ##]]M*KTF\*!H[`?3\:;]P
M%#Y=JG\^NNF:"6FJ=9;ZAJ:]@]?V+]<?Z`[H>^CG[!70A387PL2$+KN2/XRR
MH=:@'K2NHKR'.)&2JYJ>8:8JX'24VAH0AH0AH0AH0AH0AH0AH0AH0AH0AH0O
MRT5H"0.XTH`&M2PVW4_"ORS?EY:]Y^&'X5AR7'-:V]&\@$)%3U`344_0\G2!
M"PNTAOB15Q%"<%YJD^)%?C4]?A4F2KI^K2Q;`&NG%)HOA[*NA4DJ'^6LA/ZJ
M+`K33GEOY+JUUI25C:$J2*$GU?'KXL@TT>6_DA:JVT]LI*$D`*"4A*">I/Q;
MW&NF98'`:@WQ5'M.*%25S.A*^6^2RA2AMRZ[)VK]1JA3:350Z4W#RUY1N+=&
MX2M=@T2'#L6OL_\`EPK<^%6`CBCC@;FU(&(V11H5$#=";411*^OCKTG9XC^G
ML<P8$+.7_P#S!3D0D49=511'S,A5`%*_W0T(3VE>0\-6T.H27!:*N!!ISH%%
M:USW:6XE32XAP2_<=Y)&.6HA6^-=E66X0)BYL80742,9RUU494I?8:;N$1;H
M0ZRJBTJ/F""?,NJ=PAW)L<D1'F-]YO%I!(XY^BJU6R126X>)AI+LNWU*9;5W
MLBXRXCUVQR3%="4NQI-SM+S#H"T.`+:<D+0NCB4D5'1201UUBGQLDC+9`#&2
M*@]F(P[%H(IY8)!)"YS9`"`17C@?6.:;'E;A/VY\Z3K-<N7<#XRSZZ8Z4"TW
M.^JMR[G%8#A?$!R?%GQ94RU+=)4J*^MV,22=G4U57M'K"76<?B1SR#QSQSR=
M&QNV9#D;4&R8C,AW"Q6.Q7RQ6JV194%E$>*5,-M..*8CQD!E#25I:0T*)2/$
M9WJ'I3:>J?)?NLUPWX>421LC+0T/'WC7C@*X^A:[I7K+>>C6W7Z3#`]]W&(W
MND!U".AU-%,*&JS7OC/CG+\DL639CE$C+I6+3%SL>M=WR2SMX_:Y*W&WA)3:
M;8Q;VI3[;K#>U3RG#1M-:^;%YT9LVZWT>Y;R^:[FMGUB;)+5@<0*O$8`'`5!
M.)%4_9=>;]M>U7&S[-%;6=M>^&=T<1\UT9!!C,A<<""1@,`:);YO;L8SS%KW
MB%UR.%%MF11%P+HNWW.R&4Y"=IWF6ES4S6V2N@HL([B*520>NK??=K@W_:W[
M1=R/9;3@-<YFG4&C+/APPQ51L&[3=.[M#O=C'&^\M'%\8D:2-;L":T)KWX<D
MBL7XTQ;$<8A8A8N4,FAV*!`D6UF)_%&-K<$.1)DR"AF2_;'783R!+6VEQ@M+
M#02":I"M56U=(66U;<-JAW"_%F&%E-32"UPH6T(R(5ON/65QNFZ'>;K;[$[J
M7A^O2[2'M-0[G@5I2>$>,'IO',RW7]VPQ^*E*>PFVV:^6)$"!(?=0_-ER_G6
M)LFZ2;B\V%/K><65$FE"2=1;GH/8S<V%W;2RPG:Q_P`.R,@`<ZUXNQ+NTE6#
M/F'OGP.Y6=PV&:3=A_Q#WAQ)/"F&#6#!HPP`3[MW&U40/S:T>JHW"YP*U'^2
M))/76R-,,1D.*\]HX/T@'R\*X9\_:MQ,^U)*3^;6GHGK_P`I017RJ29``-=)
M+V--"0GAI;[H(]!6XU,M:P2;M:@4C<0;C"!H#U`/?(J1_)J1*8J#00E5';ZB
MMU$NU;04W:U`$`]+C`)\/,B1U\=.1B%P`PU42B"&ZB#3N*VVYUJW>BYVLJ-:
MI3/AJ/I\1T?--.UC'Y=1W570UQ%0#3N*VT28'B;C;P#U!-PA@#QH"D/$DG2F
MM8W!M!Z5W0_D?4C5J1;MJ-MSMR7"HT0)L,TIU!KWZ$DZ`]CLB/6C0_D?4C,/
M6TK257*`:#I2=#2.H-:_BFFNU',>L(T/Y'U+<;>@J*0B?!)H*5FQ:[:;@`KN
M>8'37"]@-"17O""QX%:&G<C!LPU)/];A[U!)!,V/Z:&A*AW#XU^.G&OB;_$+
M<4T7CM]1^Q;[+L922/FX9_9325&H32FZH<KTTECJC6P^&M*_TKKG-;2M<33(
MHP2J)3I(B;U4%!(CU&T>-$N'R'CH)=4X$UY"H-<\14'T)=*.H"/,!RJ*U[JU
M]BCEG%H=<Y$7E5BMR+9E%L@-6-&36/D6PV%^^6-<9J:NU9'8KYCU[@2TQ)96
MIE2DE:&PDI4/NISE]T]9W6[C?(77-MNOEEDDD8H)&4P:ZHI1M*G`=ZU-AU-N
M-GLIZ?N(8;K:!)YD;)0X^4\^\YM*'Q#M(15*M5PR>Y"3,AJM4I5AN^"7BY+Y
M/L=RN5VQG(Y+[U[$BN.N1V'XDEEE;7RR&EI"EH;(2D:3)TM97[WRRS73IWV;
M[5[F%I+XI"#I=V`BHR.*?MNL+K;86V\5M;.MFWD=RQCFOI'+']YM.+L*UPP"
MR6BPWNQN)O-N@CYM6-XW@\]J'R/BS<2=8</9D-V81W9>+!;"T/7$B5NHY(#@
MH`D$:(NEK.UGFN+6XF:Z:WC@(!&$<32QH/90GUE*O.K[B[M8(+RVAE9#<33"
MH=[\[M4A&6)P![EKXW97[7C#.'JQ="\=1`B1?R67R!@LF'>;3;*H9LF7.0,>
MBRY<N:Q<'70K<XV\N,VVM814*+3I2R@L';7)-(^PD86OC\(;(*.`#J4U:=6%
M3A3G1.W77=_<[D-YCC:S=_,\QDH!+X7U#B6EP(&LM\=!BUSAQ3^<1Q+A`M$;
M%%0Y:K;CL=N#;;K<LTLF3SW&0ZH1+1(5;8$!YM$2&!VG'DJ5VTA!)*:ZO-HV
MV/9[&.P=*^9L8`:YQJ0T`!K:\F@4%<5G]TW5VZ[A+N\\,5O>SDND;&"(];L7
M.8#D'9D?BJJC_J)OL2N1L"D1UER-*Q;+9$=:D*1W&U\F9:R5!"P%!*E1CM53
MU)`(Z4UNNEV.?:2.9BWS"O,>JG/=?,QK'Y8HFG^G\E2???[.NG3_`$EN'R!T
M^Z<VM0K^H:E[L)!MUQJ]WRRJ6PI\6S\5<.]?I@:\P6M'8J'_`*S$)<F^^W]U
MN.M];%JY%)HUN2EM4K$`M:E5W*V)Z[$@J/CY:\(^<S)VS;?=!KOA6"9KG4.D
M.<&Z03D":857TC_+_)!)^IV+BUUR_P`AS8\W.#2[40W,@5QHJ?X-F`0PMAY]
M24--IKO;6M;:T$IZ)VN;"I0(%:_9KRV&\D:3J8OHYEL(Z:&@4R'$(ISR7_#=
MH7<_GMH2T5%"4;5R5-I``"EIHX5H<VT`J`:$>.KJW8+O3^'"O>H.[W;H(P*U
M``J/I*Y1/J*\J*S#E26RT^>W;B8R>XI*BAQDJ!JHU"5AJB2@FA\?'J?;.C]N
MBBMO.)%:&G;0KY3ZRW22\W!X95U'XGD.'L59<M<A#*W2:=XM/M)*0%J"E+"0
MC[J2=S:DJ(\=;5K'.]T8+$T`)/$K.PIU'GX4;VI151]-6=H!J5)W`'SU8QP/
M:/-C%.U<Q3^\.8QD^<.S;9CT9F3<K9!ERQ&=>AP6W75]D*0[)EJ;;>4D-!-'
M%I2D&B>I56/O6XP;;M_Q-ZX-!(&-34U[%`NAFP^\<?K2HF<9>Y#!7WKE:+!R
M/#DEU#PE8A=KBZQL6XDJ=0K&KJ]Z&VSN24CR'EK'C?-IOQK\V/2.>%*<:D!0
MF"V+-3@/:G&Q?W'^\GCY;<]')O,EHBVLI<*<AF.WB-'+*DJHN-ET:Y[0TL`T
M*0:Z>IMTTHB!BDE(P#2'8=[20/2A\<(+9(P,L"K,N`/JN9U%P2^8S[E[?DO+
MDTS[1=\7S?'D8XQD<%F=+C?.V'((#*;1;+C`A-/%<9;0;DLK"FE!;2FU-U%Y
M90F1T;'@8&@RQ]*<NI9/AFEY/FEU#S(H<%T#^Q[WC0.2^(L@MO&^`W:[6NS9
M0]#OD_-!"Q\1+C=X8G1F(42/<[E(F-QT-)49(2@-N[=H52H5L\MP+<_#M:[3
MAJ)%/3BI-HVUEM&W#JAC':"X9APS%#[32G)''-/N]]TW%<;(;OC_`!EQS`Q6
MQIM47\^O^7O+N<E=Q1;U(9AX7.^5OJWX<JX)0M24T4E)<2>UJMW/=^H+)KW2
M1P_#TIKU-PKV:JX=RL7V\1VYUZRXM77#'C3'61LA%<21HT$#^T"56GFGOQ]R
M=Q;?G2\XQ'#(5:.+CV.*WVFQN(;^>RV\W5A*6^A%4`IZ4'EK*S[AU!?0&&U<
M'5Y`D'TT(]JAQWD[CJ\+7#+2/IJH<9M[ZI"G9#F9>[)ZE%)7!L>;1HP"P?6A
M,#`667=Q3\174B+8^H;Y@?Y<K``,*@#OS4:<W=V_S)M3W\^ST)2<#R,*]SML
MR+)K3E^8Y?9;/>A8';Q,;O,UEZ\-08UQD1$?QBZR_.2S$N#"@6QM"ED*->FM
M+MG1-W<VSCN,KHI*>``UKC][-5US-\&VDE7%W`U\/8OC4O@>6J5;,)YPXT=O
ML63(@.VR]S[);$1IT1]R*_%E,0;V[<"['>;4EQ(8310Z?'5W;_+B9M2ZX:82
M.(JX]Q^CM5=)?:)`',PH#SP2(R3C/W'R(STS`LP]L$J.QW7@_-;Y-EOH9;;[
MBW4OQVIEM62R@TK1`/4FFK6SZ!V]NF.02NJ:D$C,9<4\[<;,!U*,.@TP)QX<
M%3=R!=S,OV17F0XT\YNO5S>6D`-K>"9<K<GU$)#CJ`0*]`0/'7NW33FV4S9(
MVUAM(7$C\/@I7M./"JI8(G26T391B^3$]I=AEV5"_0'^B!Q?,X[^ES[0VV;2
MXY*R'&LDY&N!=%&WW<YS3(;JEN2PB2RZXARU"*>J7$J.TT\]>R[B&V\WP4SZ
M2Q1QQD?A<&`GL\+BX>M?D1\];F\W+YN;IN4$3IF,O'!N+2S3&&Q>72NJG@KW
M\59-RQ%:N,CB>PQ[<S#E9!R7`<D,M-KCE</%K9<[Q5:764[FV7V&C0`IJ>A(
MZF7TJYMNW=K]SM0AVYP;7\<K@P#TBN)Y+Y^^9]K^IQ]/[##$UL]]N[2]C6D>
M"!NMY->#:CZJJ0<$`*E?<!2\&E!"]_5M"0%*\FU%-"4^5=8R;$`#]JKV6RC#
M#(YHTMU!N=:EHIJ](H$8@`J2%`$;TFGZ#4>'PTP00%8Q!KY&M<*BJ),H@F[*
MM=L:N-PM+@<D7`S[4XEN8T(:6PD#>AQ"DK#Q000>BJCK0AVT>8=<VEKP:-TN
MRQ2>H["/<I+7;1-<V@\<ID@(:_P@::U[:T646.[!*WH.435M.[5,M7")$F)0
MG;M6DEV,'?5^D$:;DN(9#1\0:X9Z20G+79]S@89[+<Y)(W>ZV:)CP`!3$T!S
MQ^M:BF,J96$@6"Y(.XD/17[>XH``*"'&9+H/2G[``J=.4LG#%TK#W@J*6]3Z
MVL#-MN"VIQ:Z%SN>D@NJ>=:#DOJY-_*%[\5*U!='/R^],?B)3N4VIL3&H(4$
MGP&_SZ^>FPRW!.FXKV.CI[03]"5KW:2-OG;<0227:)P?[-`=/HQJ%X<OLJ&\
MTN1:\GCLJ)2\IZWIGQFT[14[[<],)2D]2:#X>)&GH[7S@=,D#G<`#I=Z=5!W
M*'<;W/MURTW%OND5H6T)?#YT0/\`:B+W`<:TP7M.9V%2TMF\VUMTT"6II=M3
MJE&O0HN"8YZ`'Q`ZC0[;[G^ZD=_9&K_1JG&=5;7DZZM&_P"\U1'_`/.!JB=]
M1#E9/&_L1]VN<P7F5/P.!^0+7!E1I;;S:)V5VE6'0%)<94H;S,R!&VG6NDV<
M#1N$'FAP:V4/-6D8,\1KAP`JO5/EG<#=>L[&&#RY6.DS;(QPPX@AU#AR7Y9.
M2NA"G5`]%**0H#=]W<`:&E:@?JIKR[>G.DED>::M3B:$&E2>2_5"RC9%;1PP
M?P]+:=N7-1VN[BG);Y*>G=Z*J.M`12GB-><RO<)]-<*K4AM&M:[D$X6-)+EC
M@[?44_,!7E0_-/&G6FM'$UIA;544Y/FD<`5JW8?\HQ/_`*4F5_64I/F/CJ#<
MES9]#,.Q65BX-M7EV5%O/Q4*2-JF=Z*+*05`BB:>I`4XH"AZ4Z:<)<(]$O`8
M_L%'B.AM6856)IG:4J4E)W`E*RI24FE#Z0IOU=?MTAK(G"K0*)Q\CPRKSX#@
MC%:%':2P0"FH*5,T-16O523TKYZ6U@;[HHHOY'[57D(+8`<;>5T"@$I;.Y1\
M%5"U?HII29<PMQ.2]J*312DK2>H4GL+)/0"BMJ"!TTVYL>)<!1=$;PWS`\Z>
M2_6X^@7U^CM[!^A'_P`I;P(*3_TQRKR(!&H;])<=/NIM6_:2A#0A#0A#0A#0
MA#0A#0A#0A#0A#0A#0A?E[+,4))VL)H"1Z8C8!`)'I:O+!'7X#7T3I=R*PZT
M"6UDA*`03U*%NT^/0HN[P'\^GF-U'2YM!SIBA8EL!0J$+-.A`5+(%*UZ#O@J
M_E!T[\.SM0M93+2?4M@].M%MK&[_`-.@;M'D,[4+2+3(\6P*FG0-=?A5/RZ.
MGVZ/(C[48#$K04PRE("D;=U0/N;3UIU*5((`KJ+-%0EI!T@IM[J,U-IP^E4>
M\KJ"^4N2B%A8&:Y`G>CJ@TF.)&U53N"=M#]NO%=T<7;C.3_>$+;6C0(&`<0/
M:K?.%@K^ZCCO\$HIA]B(2W4@5A(J0=BR*TK^O7J>Q!WZ7%@<EE[TGXM[>`*?
M/CZS?GN3X]:E(3LGY#':?W;2D1D2^_,6O>UTVQ6EUZZEW!\J"\T>\X`=O#+M
M2;3&Z8#[I=CW*R-GYS),5Y'-QN4Q(B61^1;9"']C]HD*B71QB=!<4A;<>1#+
M*5)44F@%"*5&O,^H;.UC9&6L:'4Q/$GM*U=C(Z5Q#J4:2`FK]U2<EXVR##DX
ME?)EHM\W!+3-N+$4,%J5/E7:^14SW!)0ZH2GV[?M604A6T4'B3.Z-VFQO+B7
MXJ(/+6BE>W[%&W>[N;5P\A[FB@P&7''O43/[V.2:J_\`-?=>M-Q*80(^'A']
M.O0?\-;-_P!,SU*B_5-P.4[_`%KX.5^2":)S*\']"89'Z>L(]-'^&MFXVS/4
MC]4W#^_D]:]_WM<DC_V,;H*_\#;Q7]8@=-<_PULO_3,]2/U2_P#[]_K7Q7+/
M)I(IF-S(^"D6\4/F1_4P"2/MT?X:V;_IF>I,2;QN37`-G?3O7E7+?)"?',+H
ML_!+=M)_6!$--=_PULW_`$S/4G_U3<.$\GK7A7+?)>PJ3F%W!!`H6K:?YA"/
M0:Y_AK9?^F9ZDPW=]R,A:9WZ<>*S*Y=Y/3MV9C<A4TJ8UK/3[2;<331_AK9?
M^F9ZE(&Y[APGD]:^GEWE$4(S">33KOC6L5/V'\O'2ND.Z7V5QJ;=M>Y<.YW]
M<9Y/6O*^7^4/23F=S))HK;&MNT)^)!ATI\=*_P`-[)_T[/4C]4W`Y3R>M>QR
M_P`GI4E0S.Y$#K0QK8KJ/`A/Y>44'VZX[IK9'"GP[!W)P[KN1;H,TE.]9_[Y
MN54IHWF<ZH\2J#9CT\^OY76FF3TGL1=J\D576[ON;103R4[U[1S;RV@@IS*5
M4"E?R^Q^%*$&MJZU&E?X6V/^Y"[^L;I_?O\`6L@YPY;22LYG))IT";;8"*CP
MZ?E.TUIJ/#TMLNHU@"Y^M[EEY[_6LHYUY86CU9>]4@%219<;K7H?`68G4@=+
M;(<!"$R-\W;S-)F?HYU7P\]<O-FC>8.4V!/6P8LOS\]UB-?#27=)[&3J,`JN
M2;_NK'T;,XA??](3F-H5_BY)('0.8QB"@?L(./T4--3]+;-5OY`HN?XDW?\`
MO?8H&2OJ">ZE/N-5QRUR';4XL,WCV00?[ON-E.?)&.RIQGYDXDJ34J*O5OWC
MXZPMAL]K=]6,VMX>;4RZ2T',4KR6BO=YO(MF-XQS6S^436G&M.?[%6#,^X;F
M$)W'*("UD>HJPS!E@?:D*QKT^&O<3\M>CJXV0K_:>/8"`L*WK#?RP!T^%/PM
MKZZ:O:MW_2.YD11(R6U'H"*81@I^RO7&O'7/_=MT<,?@A7^T_P#UD?XMWO\`
MOT#[D>8]P)R*T$IKXX+@1\?TXS73$_RYZ0-/^#!SR<X?Z)"D0]6;UCJF]?\`
M2M=7N;YC3N!OV/E-:$*X_P"/R%`>`-<9%=5\G1'3D>'DT]*>;U/O5:B4E:_^
ME+S(A0+5YQK=0@E?'7'RB0=OC_YF^OAY^6H;NC]A+BT0X=_[E+9U-O``>9<>
MY/CQM[PHMCQ#-Y'+-A9S/(),W'K=AB+#C6!XTFT1I3BVKS/E2&\:<8D.)6^T
M$(<:<))-"GQUY9U?8V^TW,3+-NEKS0@X^G@M-LN^3WL,OQCM4C<CWX4]";?W
MAY%:,GR3B.3CJ7&+"."L3D6Z"\TPT8#MRR/,9<YA/80$T4[M)%2`:TH#36CZ
M-A8=I,F-3*Y4_5,[Q?-8VFD1A:7L"%/?5[.QTZ>Y7A\5_1FMJ\]2>H(0W:KA
MPK7057;?C>1'CJ"_2U'^,_X=>0+7C)48_6)DR8E_X`?8"MB;9R(75!.Y`VR<
M0*"Z""DH223\:Z]?^6W2VR=8;+NVS;];LN+*00MH0*M+B\:FFATN'`^Q>-?,
M?K7J;H#JC9>I.E+J6TW.#SG:F$T>&@49(/O,-3489YJH^UW2WRG1L2EF:ZC<
M\VI(#*RMM*!);=2`30@'KZT^!Z'7R'\X/DAOGRPF=?V@??=*N?1LX!!B)_V<
M@IB17W\`[@OT$^0?\QG3?S>VYFT[CIL>N(V5?$<?.&/C8:X`TP9B6YE,#[I;
M\SCO'&2N/A:V68C[L-]DDN-I_`=>*5BGXK:4K6E(HI6WH>M->;;"'><V)I:7
MEU,>(XX+U3JZX++%\C"`ZGTKBGYORM_),\R*7*E+F/OR)`6MU/5T]U0;='2J
M"13::5`Z$Z^BMMM66L#&<QCZ5\E7MQ))<2%U#4E-FAYIR'%[#='(Q4PZAS]^
MZD*2ZZY4E24@AS;05``\:ZN6-:T>')0"4:(91VDMH07*[E]M:AN#KB"&:J24
M?AH*D=3TJ/TZM&EK8PP$:4QYKNQ6E>R/#>,H6,7?+^0^1',"EW><S;X,1K";
MWE[_`.414]M5R6FWO0HK?<E;DA#CNX)05;**!.&ZOLH]Y=%;NN!!''7`M)U'
MG48*CO\`=H89_$*Z00:=RE5R+FG%^+7*-;N,\RNG)4%-H8DN9!<<47@-O8N2
M'I3*[7)L[MSO]W$=#;+;H>CMN`AS;L!2K7GMQTS86+PYUVUY?081DGZQZQ14
MYN&3GS(M3&<*XZNRF8';DJP9\B*_C'-!N%WNST[*+W?KM:K/94WLVRTW>8)3
MLB,J1=F&Y;D9Q]UNIW(JEOJT*:VSHG,O[5L`C;$&AI=1HU#F:4IZ5<PS-ET,
M+FT`QH1AW\E%JUS>4+(4)MDZ]A-4E,9]GYZ.0"%)5\M*8DI4FJ1TVZNWVMK/
M+K<UKG"O:.7!377M@1XR"WO"L0]NGN^]T>&V.XX?%Q'+<SQF[SW+Q<<>QILX
MG$OMVC168MHF7.7%B)VR+)Z^RMIM>X.E*D^"A2W/3MOI\NTF=!;'WVC"ISS[
MTPZ\LG#RV2Z65]T-)QY]I[5**S9#[\N<)J+3:/;9D&&V:^+1&NF;0K3D&:9E
M;X#RV$OR8-PR)D6ER5\JVII"GV'4A*N@&U-*F79=CMGAMY,9GM!-'8M(/`Y?
MN3\0ED\%NUSVG^J1]7M3Q\U?1KYNYFNN(W+"+QR/?'$6YB)=;ES$S@N/+MT)
M49$HQ(%JQQBS-=+J\[N<*%K((!'2NI]EONR[4`V)K&LX!E*#Z4]^F;^X:;"U
MU//%S@`.7)*[!_\`5RN19RX*\GY9LD!DADSH4*WS)LEI92.\VT8S#32THH0G
M\3U>9&N2=96C6:&,>\:JTK3TY*:[I[J-K0Z2>UA`H26%SG=HH0!Z0<PGIE<8
M0_IXX+RKQ1C$=V^8OQE9\[S:\<ASMT,S\P-@;E.POD%+?6%L7*/#@LCNK"PW
MU*553K8;7,;W;67>AS'.=@TUJ&]OVK#[B^Y.Z/LI3YD48]\#,X9G+T+ECE.J
M=49$LB1)D*[\IY8#CC\EU2G'G%J5]Y2G%DG].M0RNAH[%.<Q@+6X$4"4>#&4
M,IL#<*3+A!5R8==$67(B!UB.HRY"74L+;"FRRP:@U"D]"*=-/-UL>'`>()G<
M&L9:N;&`:\>([D>9:X]/9O,=E0[US[%HC]02I^ZW"+#';0A-"0V\L].FO3/E
M_M#MZW<6`!UW$K&$#BUP\5.T-J>RE2J+<;QNU[.+Q]/+BB?(ZO\`48YP[L0*
M\POU6_:%@43B[VM>W7C>*UV&<'X1XPQQ39]*A*MF&V=B<I::"BES4N*5\23K
M=[[*9MXNI<#6YDRRP<0/8OQUO=V.\[S=[L31\T\DG^>XN/H%5\Y*?NUUYLXP
MLEBN$*WW2TXOF.0,R[C#7<($-4MRV6\2),1IZ.M87$8D(20M)JKQZ&M_LC8+
M;HW<KR=CI(9KBWBHUP:XANIQHXUR)%<"O&.M9-TW3YH;#M&V7+;>^@M+B</D
M9KC:'4;5S`6UP:>(JG#6>1XJG'$,8=D<=PJ<#L)ZY6"7(0LIVJ(<%PC)53_+
M/0=-9XC9I#H+KB!W(M;)3TU;^]:J,?,.V+GTVG<K.M6NBDDMY'$YES':VMX4
M#7.XU6PUE=\BE";IA.3QU(/K59YELOK8"MROW:'F9;B`*UHW44H/MCFPBDJ(
MKJ`\M;7,]N(JK%O46[6.E]]LVY-EJ*NM9K>Z:VN>IM62#U&E,2M^!D`R"ZJ=
MCM75MB'#3&=%RMCUIE)7*>[CC?;E%LNM%N.**2%H5U'B#J//`;.#3)H+W/\`
MN.UMPRQP]/:K6PWIV^;V9(VW+(+>V:"+B,PR!SW&H(.#J`"FDG@2G4C-A##2
M$_<"!M`ZD`CP)'3I]FJ9Y&HGBO2K>$16[(VUT4^E:ZD*^800:]IM?1(W!1<4
MCQ/B`-FG*@MQXJ(X.CNJ,!JP&G'/FMU/@.E.G7RTT<U-972*X&BQN**:TZ5Z
M$]?,=?LT"-CB'$8@I$EQ+"-,1+>T$_16GL1=)99>`[K;+B0#5+K3+B%>?J#B
M%`ZDL+F^Z7`]CB/H(5/=^7**S,A>..N.-X)[=33[*#L5''U^\AL^!?3=Y+3"
MM\"'=.0<[XNX^1+BQ&(TI49_)!F-P:"HR6BIMR%AQ"AUJ-64-].V.9\\CW0,
MM9S0FHJ8RP9XXER]1_E[Z6V*[^9\.Z16-G%?L;[\4+(:UJ:$1-:SA6E*\5^=
M/DSRTMO.*I0E5$TZI*17R50CKKPV_8Z!QTDXY\AAP7Z@V+26^/WVD#!1]D.*
M4^\HT.Y:^GD*D^`KT--8ESG.DU'.JT<IH`1F&IU,6I^1PC0U1\P/(`UDO?$@
M&@.M-:N<Z!I<J"<#77B<U]ND3YFXQB%/MJ3%=VEIMI;:AW1N2YN4E0/4>'EJ
M/,T.NB[DI<#Q\*148FBRN0Y"&U24?+*=H$K<>94A2T)]6U7:4\"A)^(/7RT3
MDO:3Q*X`&MIP"+D/S(SC;K<:('$!124OO"B2-JQ21&*!N!(`'0:B-E?&-(7'
M%KVB,D4!69J=,<=9:,0`.JVU3)8<"!3Q"`M+A344\*ZD0R.DKJX)#H6"(O%=
M0(1TM#J30H4>GB*``^.WU$4('EIY1S(YS:'):STM3-$?*2#5*4EQME2PH#[M
M5("ZG465[ZEM/"I#0#&`<J+];;Z`ZRY]'3V#+.[KPLKHI*DJ%,RRH44E8"@1
M2G4:CJ,\`.(&2N`T)*&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"_,%^8F*H$/OJ
M0?$B<\XDI)H0`+Z_U^VE#KZA\KM6#?)H%:+RM$L*!(DK"JG:KOJ!_P#49)--
M'E=J6'5`*+W8R^JELNDTKZXI))IY[[0:]/MT>5VH)H">2+EQR3T;`W=2GM(;
M4#X@5^3:!-!71Y/:F/B.Q:BF$A0J&TD4(KM2G]9!1I^S@_/!N&TCY_6D/GUM
M+:9A:;\=1='8IMW)VU<!WF@J*%U-1O\`TZA7UN]^Y2B)U;0O-#V4^U=#=-JU
MM<J?2J+^32U*Y'Y'>9J$JSC)J`I`-47)]"DT!*:;TGP)UX%N9T[G<\:3.]B]
M#LHZV['$Y`*X;AUI2N+^.R4=M2\/Q\@;?`&VL4_W&AH:^>O:>GH]>SPOYA8^
M]_YV3O4K_;Y:?FLPESG$;T62S7F<EP(2D(ES'6[1'J>VE15_R@M73^CJ#NC_
M`"'N&;9)`6GF`""?04K;V^=J?E0'V*?V'0TKQ/D]80E:$V)`*2*=P&WWC<@$
MA02#3X']!UA>K(J0M=7A]86@VIU07=J07OWB&/>+`VM!JW@V)A*@`%$+R+,#
MX)4F@KY?S:O>@16X_P`DIGJ6/RBT9U8#[2JV^T0C<3X=0DIZC]8)3_+KU7X?
MM]BQ<<NBN%5Y[2B12I416FV@I^D)/6NN&W//V(;)I<747PM.5I3]0IU_0HIZ
M_P`NCR.U<<_4XN7PMJ3U4-OZ5(_P!1.@P=J35?-A!*E)`)Z>)`Z#R3N\::;9
M'KKC1.,D\OA6J^=*]2!X^1/3]`]/\ND$4-.2234UYKY2@3T)2K<`I2156T`G
MJI->E?L\-<3K9=+=-%]V@T*>M!UHG;0_"II7].A(>_6:TR7P]4T)&TU'W@0?
MLI7[=,>1VKL;_+)-*U7P``4Z@>'@`?U$UZ:/)[5),E&:Z(;1^R2?.J_`?J*#
M31Y/:F_B.SVH=1T)!KY)V_SJVI`UWR>U'Q'8O0J14>9VT\#4^5/'^;7/([5&
M7TI6!4IH!]@TIL6DUJG3)6/11!2:$`'<2`?NJ`H?C4?'3CAJ!',)I8G`"DU'
M5-1T!`!%"0.@\!IF8T:QGX0N*IY`+GO/4#L57DQ1!3U2`F$%;A7]I.WK]NO.
M^EFZ_F/$,OS_`*BM#O./30_W?UJW!IH!M(\:I%?*OG\=?3<D.G4ZO$_2O,B<
M:+(&R"#MZ@4\1X?#QU'(J*(!H:K&Z@J(VIZ]=U/T"G\PU#DCT4QK52F/UUPI
M1)V63W%I\`"#3[3K)[C)JGTTR5S!P[EK,^MVGB/&GV`=?Y]0X_?"?D]PK!>"
MD69W<HH!NMF0%`%755YMJ$B@ZT)H#]FO%OF-_P`];_VOM6DZ<_A/[S]`3M<K
M*6Y&XJ?4M:TN<46AIL*%`V(.6YK;U-H_R0N*3]A--7'1G_@H_P!XY-]0?\RS
M_=A.E[!$#_3K]GM%5_\`:E.(%'IX'^-;7Z?'5KOXU;-<C_T14;;9JWT+:??"
M_2S'3^?_``Z\.`H%M52K]6^#,EW#A%<4!*&H.=AYU8W-@*?Q<I;4.IJO:2*@
M@[=?0_R*_@[GWV_^D]?.WSU$AN=MT-J-%Q]#51@^VY"?6"2WLWNL.)"06W0'
M"G:4DD=%]!^HZ]HWK9K'?]MFVG<XVRV4\;F.:X5%'"E:?B&;3P.*\*V3>-RZ
M>WBVWS:)Y;>_M96R,=&[34@UTNYM/WAQ"C;[L[PN]\+Y`PMH?/QX,XN`NJ:2
M^H1G%MJ4L!9"B6A16T_K`(U^8?S%^5U]\J>L1;10N=TU<.!MY?>H*^ZY_!U,
M".)7ZX?+[YUV/SF^7K+^=\3.K+6K+N$#2:@4$@'%KB"1A@#F5Q39Q(,C*+PL
MJ.]N;*9421W/0\L;'"@ALE/GM`2?AKT"*.MNQ]?N#Z%Y_)_%</ZQ^E$<.3V1
M4$D*%%G[W4)(IM\:4Z&E/Y=/P>Z>](*6,*XE3T1+R$=MM7100$FBDT2T]N)W
M5W=*$_9UT^HSV:6%]<EU+_2IX$Q[W6<%79NS06IF38)>7K?/ML&-$FF/;G(<
M29`>_)C_`,HIA*5O29)<V*6@H!"@1K+;Q<S0R^8^`OM&UJ0?0,**L&S07L3Y
M_.CC>_GF"[GBK"V_IH0KU(#L^[V^WL)0J*];\?Q-Y]\!MYPI4X[*N2$?-$GJ
M-I":?'68=U5MY&FVA+W#/PXCTJ7#T)=!A?-<,9$Z/2'>BE<UN*^EA[8</C/3
M<]ODZ+#D%R5.DY)DF+83%DN+*E.K=*X$22G=O-2)&X?'4*3J:Y!'PL(TG/7S
M[,$J/H3I^W;_`,9>$2GB'TK]*+&^-/I1\2J2;K?.%+M.CMEI3(N-YY1N9+:=
MJB(D(Y)$[H'P2G[!YZAW74&ZO8`^YM[<5SJ!7L5I9[%T78-I!'<2NR.HU'>$
M<->^;V&\7QOE..>+,MR/ME10<6XHL^(PW'`@FHN61.V=="E'0]I1IY?'.7?4
MMC"7"^W35)Q$9U8^@BBN(Y+&!H%E8AP:/"2*5'::)K<S^L,+6T6\$]MD5AO=
M2-(SK.V5J;H/0IVW8O;`$"AJ0'P>GCK/.ZOV2<UA?=7$@-*AII3MSRXJ5;R[
MY<`N@CABI7$XF@X4P4*^3OK.>[E1<9Q2!Q3@<=Q+BVUV3#UWN6SU-"U*R>5<
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MC#"'"KN:<#CALKO[LT!(3;;%>IRBNFU)7%^0;->E"79P`^T^>EQ2/9.P/.K/
MT*!>,\J*F>MP;W53M<#XC_>9[A."<#0P7DYGS7Q]9'&4A*E*:DWZ/'<0`04%
M'<E-$CS`U]$?)F&6'?7[FYN%O;S3#LT1EM?^TO+/G-N`V?Y<[S>5\;-NE:TY
M8ENGZ"2OU>K6RU%BMQF&TH8C-(CL-HZ(0PPV&6D)\@E+:!3424ZGEQ-=1KZ\
M5^06V$AA-*G01W^&E?K4?K>^N[>Y7.9*DA36*\>6"S)=<.R,RN<N;<76UJ`Z
M%P7%!5X=`/'6VNF,M_ESMT=`R2XOYY",R0-,;?0"QR\OB>_</G1N#V.U_`[0
M&DG!K0YK3GS.JE%)2.SMCLM@[4I0E00!0)"OV1U!H*>.L"YP\YYX_P!*]FMK
M?R[6.$'\L-U`<J\%L,E0E/+!KM:90.IZ!.X_$CQ.FWM!8*\U-M;F=MW*&N-`
MQOL";2X9+?6LARB*SA-WOMIC-P4/7NV76VL.QW&X$=Y4%B#)?8FN2`)F\*00
MD@D;@H4-E\%8FWMVONXXKJ0.(8YKL@2-1<,*8>U9.XZ@WENX;@?TJXO+"%T?
MYD<C`X58TEC&$5)))XA;[7*5ECI9:N2[[C:C3T7RQS$,BNVB5RXS4B,E`"NI
MW@UI\=(=L5T[QP^7,P#-CV^JA(-?0I\'7]A`&17@O["HRGA<13^TS4*#UI66
M_+[+<G#^4WRS7!14$'L7*,'%&J2AOL%7=;60L>(&J^6PN8FUGAE:T9^$T%>W
M(K26O4=A<S:-NO;2XE?D1,QA?V-8\A]>\!*07(I(2]&?1Z5E3@HM%6Q55"/%
M)'4'P.HOP^H:F.']*OV[F&'1<QR-<`:FE14<B,QVC!>/S%AU-:["24T75!%!
MXT4$U!!Z>1UWRBQVGBHQW.UN&UJ6BM,1B.VBP+<"T[10C=7<#7R(_D.G&LKW
MJNGE!:6-Q83@5RY_ZT'R`Y:?;Y[:^.67J)R[E3,\OFL(*JK:P?$[?982E@4J
MDR,U<V_`I.BXD;!M5Z\BKC&Q@[WDN_\`@KZI_E7VOXG<[N]=A21NAV="QND^
ML$]U5PO93*'RSH!5N2VKTA(`"J*I3J?+7CV[.,#7->,3[%^@-D!Y[0,J'Z$Q
MBE;U5H05$5'B=Q^/PZZP[FZ)0*\5=C-.WBB5?DD9*QTWR``:4H)+O7]>M3#_
M``&E4,_\5W>CA:2J<P`:!+"R?.H+J13]>FGQZ!6J=A@_X7/[R-BFC531*1T`
MV@[B1U'3KX:;XI3QIBTK26RV>A0@CQH4_:?L/73,D6MU:T34<>KQ5XK5=0TA
M;-$)2KN)V]*&M?$=/Z.NQQZ*BM4\]^BF%:HRV[J)4:^-*CP!/Q\]27,TBJC,
M;YCJ9+'+B-.;@4@]L!(5X4Z)'P)%2-1Y?X94AXTQ%N:_6A^@:T&?H\>PAM/@
MGA;I^O,,I5Y_IU!416^:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+\OU%ZCJ'
M5OU*)3N^9F+%/`>E?S.W]>OK9GEOP:6KS6I.97KY^$:`,H6?VNK:R5#S`<LS
MA_GKKI:W*@1J=S*P+E0J'\%.WP`2B,2%?H_*V:?IKI8BJ*@!%7<RM7YE@E02
M"@%*Q0ADT])ZD)[2DT\>E-=\GL"YBL*I++B$U6X!T`H37P(\I@Z?KTXUE,Z4
M7:+"2C>*+!&Y/A52P*CQ`D.5TU+"7-(91!)]%1]*HQR&P+N?(7(;<B=%@,C/
MLK:5->5N[@5>920J-&02]-=3YI0?+J1KY7Z@<(=TNGO=0>>[O7J.VQR30,9%
M75I&/`*RS`<Z<M>"XY:H$:*B+8,=M]N5-NC:FW97Y;';C*>^6*FRSN4FNTJ5
M0$"IT[+\W[RPMV[?86T99&P`.)H7'F1P^M.?X,;<R.FN92Y[CPP`]2=;`O=9
M<^-W[FRQ9,8O3=^_+FG''ESX3J&[>Y*?+<=UE]Q"$+5)"G"I)!4A/Z#7N^:U
M_=RQ/N;:/\EI:`#@02"2>VJ2>DHXAX2:=A*G3Q-[U\#DV#+K3D&+Y)99>1VY
M,&#<K/\`+Y';&I@C3&4_,H9^7FM-=R36H:<V)'7KHW3K:SWP,\R/R)!G0X'O
MQP3]ML]Q;!T;&ZF<.:D;[N^0.-\MNMFS_&+Q:N0<.=Q3%;*38`U<'(UQ3<<D
MDEJ?$FKC+@38R5_BM.)0Z@D="#76KZ=N+R_:^RV,.FNRP$!AQ%,ZD$8*!O;[
M9LK72N:&A@!KS!.&(4*E9;QA(([N*71DDDJ_\SSIZGX_)O.@^'D?T:NYK+YB
MMI\/!..>)/TE9XS;*W^(0T=H"Q*O/#SOK<M\^*0:5<L61,@>=*B.M%.NF'W'
MS'MVU#Y]0PIH!I[5($>PRT!\MU<<'&OT!85/\)/!6Z[&+U2H]QV\Q""KP3_6
M(Z4BGP/0::'4?7EKC*V1TK<ZLS]&2:=8;&7$L`'(ZCAZ%X5#X7?&UG,H#2Z@
M4.0QVE>?[,I"=<?UWUA&0V:*KNUA&'<`E-VK:G"HD"^#%N/92D&)F4=Q(&X;
M+U:'NOP"%*234?:=28_F)U%'7S+6T<.%8GC_`.$DR;-MK@-,H]:]JXXL#_JB
M94EU*C7:#;GQ6OQ:D=#]FI!^:&X@4DM(^V@.?9AEZ2DCIZ!WNN>!SP/UK,YQ
M2ES:8]]872IJJ(VJI('B4.KJF@T_'\T3HI+9M!XN#B'#M&!`*0_8BT:&SD"G
M%HK]:UU\571`);ND):!TI\O)03UZ=$UITU(C^9=J\5=;R''BX.]H#:=U$R-@
M><Y`_P!E/4BYSC.^('HDV]8/047)0"?MWI(`U(MOF)LLQ(DMIP`.7_Y2;DV"
M<#\HMKVG]RT%\?9`V2D)M[GG42Z=!UJ-Z21TZ_HU)'S!Z=+M),K3RTC#LKJ2
MG;+>&,,!96@XG[%JG`\D0@_U!E8-3N3+8*JT/@E0KJ4SKCIUXU><6M[1EWXJ
M*_9MP:[2&:AS&2U58;D35#^5R5#S".RL?R)-3X^6GV=9=,ORNXO:D_I&X_W3
ME@..WQM)4NT3@`?)A:SX^-$%0`U8Q]1[$TU-S%3O3#]MW%N<$GJ_>M-RW3VR
M`[;YR=Q(&]E\))`K3H/+]&IT.^;+.X,BN(2\Y5('M-![4U\)=`T<QP*U9$5P
M=%L/H``-5-+I7KT)V$:?=-;2XLEB+#A@]I^@D)MT,S#0L=7N1>XDAD4W=0HJ
M24J&TI<*:$*2*5IKERZT+8VP/:2`:XA(+7-]X$=X53=D"W_>@H$H4K^\VXJZ
MJKZ$1GU5ZDGTI%-><](->[YBQ/H[29Z#`FN!Y5^Q7F_?^6:5II90_2K?`*``
M4/0?=Z@]/*FOJ.2.0.=J8ZM3FTCCVBGM7E_F,`\1X=JV$,U()(^(2/'^7_T6
MFM/,4*4U[7BK34+$\ULJ:G]H@4ZFHZU/2@%?MZ:AWP`A)`%:*5;FK]/$I%2#
MN<52OC3KXFA-?Y]8*9I?6F=5?PX&AY+[%;"G#2NZA_1^OI746%I=.6C-IQ]2
M[(UU2ZOA6*^L_P#(R5T"JWRR-%&TD';>K6HJZ$'T[Z_92NO&?F"TMW>W8[E]
M96PZ8%+5[SD7$>F@3K<BH<<Q3B*2HU3_``ME5L"BDC<+=R'E$FB55-2A-T'2
MG0G5IT=_X:X</,*B;_XI891[KX:CT$M^D)U/8.D?Z<_L]ITI[E.("2/'IFMI
MI_*?'5QOO_@US_NBJ[;/_$(?]X%^E7KPU;U5#?5&X,G<LRN)KUC.22L1S;%;
M9FT>QWJ,T9;#D:ZO8\[-MMWM;LEJV7VTR5V]LKART[%E(4T]&?2AX>[_`"7O
M'6D6XG[I=;U_SG+Y_P#G3%.^^VUT<FB(1W&IE*^:*-.DG[E,]0Q.62HRR'&,
MJM*I3.8V/\KNMME?E4B1!;E-6"X/=EMQN9#1<-USL[<XK)88DJ>H4D-R)%-Y
M^AX9&W%/+(Q7SI>,=,XR1@MC'/#Z%'+D7!(N58_>,?E]]=JOEOE6Q<R.H&1!
M5(:6AJ2TM02A,J(5E;9ZI64[2"DJ&JKJSHK9>M=FDV/>&5D/\-P`_*D&+9!V
MM.-/O<5-Z9ZKZ@Z!W]F^[$]VDM:Z1NHZ9(\/,C=_:&`.)'!<5GN&X;S/@3E_
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M$YMYI,R+,9"EMS&Q,2I02L%)5M6W4`*&.WV[D\LLKIB-.SUJ)-=0,B+X"VN%
M"`#7T%2WY(]W_OJS*),N.4^XGD,V-,?YAVV1\BGV7NQD@-%(@V<1&&T5)IT'
M05^W6'=+9LN&QBOGN%10"F',_N4>2_FFMSKD>XT/8/57!,UP_D5^S[&+M?,S
MN]QRR]1\SR:U*G7N2_<Y8BP931@MAR0IQ2PRPZ`/,^9.K-T,$=S=6<53Y88Z
MKOZS233/BK#9[B#_`!`+6[;KBDA%,`ZA].2D=:0TF."PAMA.P!:6&D,C?T"@
M$I2`*D$=.G2FOF;K3S([SRG.-`ZM*FB]:EM&L8-+6#T#[%BE;^PZJ@JT2X%`
MG>.G5-":DEM1\O+6+A#1+4`5-:]O>C0?*\L<DWF1'N,J44T5107UW'<DJIU(
MZU0>E0>GAK4;*YQG,$6H$\L!CW>U0)89?-HTTK3BHWYPILE+*4G<4)4!56Y&
MZII0`C=0^`IT/AKZ#Z/A\AA;(!5T=,.9YK-]3-<W:Y628D>E*7VC8*G+?<O@
M##T<28MCG/YE=310!C8Q;%W&$%5!VH_-T14GI7U:W6S1A[VAQ]UU1RJ%YI;^
M?<6#(30-:P@T.-">"7'U9,OC-YOQ+Q=;5N_+XUC5[S*Z,NO.OG\TRRXH@0%+
M4ZXMQ3K<.R/J!)-$/T'3IKT?SQ([$4<>627MMI%9LUPN<YKW4.HU-<U47XFJ
MNE?$CX>=-.`D'L5PG/P)"FK9F4])2D-VVUVMHJ%5J-QG+EK2GH14M6@G]&I;
M7M?EF%"NF%\\0&6/U*Q7Z/.$/<@?4_\`9WC881)BVW.;WR%<T%O>EN'@%E?R
M=A82:I`%QL3(-?$*^.O>^@-RN;+9KUC!X9;`EY.8#Y&,:`>W[P^E?/'\S4]M
M:_+"_CU$R3OBBISU.JX?YK2OTR&61L3L!""1Z1T6-QJ*CRZG29)`R,DCW6G+
MLSI]2_,"UL2-`9A&2.PXG`'UX]BKWM'N`PC`N5N;(^2(O)DW_,7(:+K:VVGV
M[?&LD:/94`I=4$N(68)4:*&TBA!KKW6]^7?5&^],[)=;;&UUI%9AVBN),CG/
M[]7BQPH,#7-?,%G\T.D>F.K^HH]X=<-N[NZ\LR,+:!L=!0-=]WPY@BN5,`I)
MX][C^*<C';@9M:V74E"51[LS(MCZ`I5*J<"'XI"4]20NG37F>Y=%]3[4ZEY8
M7`YD-J,Z+V79_F7TKO3`VSW2U,?W0\^6['UCV]R>.R7VVW=I4BW3(=S97M=$
MBU3H<]E38&[<7([ZNE-9:ZBFBTB1I8ZM*.!!H1W<UO-IW"W>_7$1,VNHN86N
M;1M":FM:4["BK$EIELSKDTVXI%RRZ_R>\ARB5-,/_EK`6@$;VPW!`">H%`?'
M4G<8?+E9`34,MF`@XXEH)]%3ZU5]*73KZVEW-L=63[G<N#P2/!J+&$CCITD4
MR&%$O2A"P4J;0M*AU2M`4#]B@00=50&DX+;'QMT/`<SD<1ZDCI6'XI?TNFX6
M&RR70XXA3J(*&GFP5>@ID-T=#A2!504//P\-6(W&_MV^7%-((SPU$@^C)9Q_
M2O2VZDWMUMU@;K41K$-'`CB'`U]JTT\<6>*V$VBYY38%!`0C\HR.X]EL"IJ(
MER<N$0[BHDC90_`:!N]T3^>R"<?UV#+ABVA]J6>D=FABT[?+?V<P&#K>=[6]
MNIDIE:3W4'((N_A7.K<IURW9Q#NS)]7RV5V)#[BE`_LW&S/P'6RE!*?W1KI\
M7FVW+2V[M"QW`PR:0.]K@:C_`"E3OZ;ZHLF:]OWP7%N`3Y=_;B;G@)('1/%>
M>8X(L?N?(%L*A,Q&!=FDGTR,9R=QET(2*]+?>VHRDN+5442XH$?RZD-@V=^E
MC9S&:9/BK_VFNQ';14,][UW;5+MKMKF%@]^VOGM<>/AAN6^$=@D./%<8W^LQ
M<M/93[@.!./51KW;DX/PY,O\NU7=MIF0S=,YS.[!3B!'?<9>:5;<8CT<"CNI
MT\]9_JZ..RV=T#'QR.GEJUT9);2,`&I-"#XL!3)?H]_)I\5>=#3;S=VUY;/E
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M<P4([:5X)G+!&<C6B.R\@5<#CI"^VM0W27R`E2-VQ-1Y'J/'5-;5AB#)FD'M
M`6XD)<\R`'0[(\^Y&@2>Z@CP#90""-QW+KT^SIJ+.\22ZF^ZD@D"E31&"*I0
M@@UH\4^!(-1UZU%"FFHT@+FD-S4QF+!7DL96WOV]Q`WC<"M0Z;O$]#NHG[/+
M1$PM9XW"O>NTP("T7V:.,U.XH>4=Z3Z%';U*3UJ@[>GV:6H_E2'-;B5G[QI0
M5/\`)U_Q]=#ZNEU#W*)P2QCABL[@*MY5TJ`H[0:4/6@)/17I^W3?F,+_`"SF
MNO(,1(RHOUFOH(G=]'OV%$?^R8(_DS'*1_BU%EPD*BE6\Z;7$-"$-"$-"$-"
M$-"$-"$-"$-"$-"$-"%^-\Q[MLG_`-WQF$YM%?PKU+200#ZMST)\#KK9MZYW
M4>[YO^;_`/DJH_PW#^/Z?L1JU[OKF!1[%5;AU]%[:4*$?LE=G-=28_F#O37`
M'S7-'#0/]6JZ>F(J:M>'I1@S[Q&B2'<6N0VIW51-M[I\:==T>,=21\R]T8X-
M<'#L(`/J(JF7=-5/Y;\$<Q/>+8=Z/F;#?$-U"75I;@/#:L$&J6[BTL"E1T&I
MD7S1N8Y0)F$L/,!</2\C<W(Q8]X&$K(2ZS>XR"20IVT%92D=`A:HMR7N-!XT
M%3J3'\T9:G7$=*:DZ:DIX'XU6#(O>#B\2P3Y./MOW"^D"+:H4N'<(31FOA0:
MD27GFU-EB+T<6D*W%(IYZ>F^9LC[9S;:(?%%ITUY_0DQ]-2F1OF2>"N*B?@E
MO9R>YS\@FKC2)KLR3*?6\T@KE7*0XJ5,?2D+2PTW\PZ2D`?:=?.G4>ZWMQ<N
M=,/^)DHYVGF:YKUG;K6*"!K86T`%#]>:E!9K*7'$IE2W7VI*`A"GGB$[D)W+
M2PE)0I1;'D!MI\=9F.(:BYP\1HK/PLRP1G=./G;JXEAZ&IA*VT_)U<"7'D)Z
MD..-%"^ZJ@(W=::>#6MQ"``#49HPQG#+K8Y[7R\Z;:IL9WN1G42%_+.K[B=M
M6U!ULN.&A4%#H-19H!+J:_!IXU3L<CV/#HS1X/(*P3C.;;,^LSN/WG_D?)0P
MVHS(Z.P+R[&0M#<B3&;/8EOL`DUZ$I)VA.K+I'K/>.@=[9N-M6:T=5KV$T&G
MC0C&M*TQI6BUMSTMLGS`VE]A)IMMX:WPR``5IS`PSSPJG8M/MAS>[0F9\+),
M$#,BHV.W&[-R&E(.U33S7Y$ZE#R.E4@J%#T)'77UQMGS;Z9O+1EU:BX<U[03
MJ)P=Q;WCBOF[=.B-VV>_DVZZ,8FB<1X@?$W@X5PH>STHR/M+Y$50?Q)QZ:FG
M^>;JJI'E08V"#UT^SYI=..D(<RZ.?`45>>F+[\4*S)]HO)-`/XDX]^`0;Q="
M/Y\?2!_+IT_,[I<^]%<_YK5S_"]]^.+UE>U>SGDMS[U\XW7UKZKY<R:T`ZUL
ME/#RTC_WD])G_835[6,/U)0Z:W!HHV2(#O*UG/93R&XDJ,_BYP*-!NO$P!73
MPHO'U4K\/VM1[CKWIB4"L5:?U6_8EMZ:W-_NR1GTE8O]!;/'_4H\4;A45_.7
M6Z=.M"G'#UU&/5W0SQXH'ZSG5HI7T>Q+_0MW:*><P4[2O2?8AR.`$,N\<,K3
MT4J/F,Z.=IIM`+5G;(IU^&H\G4G0CVFML#4<BG6[#O1;X964[UM->Q+F-/\`
M9KUBS*?NCY;DR^L5K57W4QD$G]6H#MV^7\F+[=[2/PU^U/,V;J",4;,P#T?8
MMUKV/\_`D,9E96B!U_\`EJW%0`H4_P#K1%=2>GE34+XSY>OP?'=-']7]Y2CM
MO4;,?,C=ZOL1Q;_8U[HI:EIMN9V1]3:`ZM"<_MLHH;*@VE:A*L;A(W&E?T5\
M=-M9T#=DLA=>Y_A;AV8A/ML=^H*NCJMY_P!D'O`AME]W+,49:2I"2N;D6)O)
MW.*"6T;G+&RI2W"0`!UKJ/<[=T<P&DERUA&!<UOV+OPF]C`AA/,$_45B'L]]
MWR`GM9+Q:_Z:GYJ[X]7QH-Q;=B]#TKT'34%FW]*$>"[E:/\`<M?]E$?"[U^!
MOK/VK='M#]Y+22HCA>6DJ"07,FA1PH]"M(+5[!%4GX=-5\EGL)]R^=G_`'!_
MUE+,&ZN%"UGK/VKV/:7[Q45#F+<+S:UVAGDJ-$WBM!L+C[^TZ:=9;<]FB.Z:
MX<*MI7O:0:=V*#;[D!BQE.S/VKPCVL>\'N-MR.*^-)4=0_&>@\S8R-G4`_U>
M<PT5DH)-`>OQU"DMHX#Y<4QI2M&DM%>X4"=99W+FZGQX]P2O?]FG.;S-V+>&
M8X\^+JAVS,-YMC24?E5;1WD+6+V@)6&TRNAH11/2M-,M^+'NND_SC]J?ALWT
M-8P>\`I/O>RGE=NZ.O(]N.,3)#%PDO0KXSDO$B[C)0M;I3.2[)OS%R2XXA5*
MK7W"/'2K:ZO;6Z^,M+B6&[!KK:YP-<N:9.WS&-T!BK$[`@@$4]/U(Q5[/.8R
MJCO![Z?&GRV2\?N*J:5VF/E]``>FK^#JGJ^WH^+<[MP;D"\N!KS#J@^FJAOZ
M?@>"UULT@]@^U8T^ROE]X%2>&+RV-]%%J_XN5I\^G:RAU/7XZLXOF%U_%1L5
M\=%<G-CK_H**[I';Y#XK05[R/H<L#WL>Y>D5/]TN5)\>K=ZL"C2E"`D7I8\!
MTZZG'YE]>AI:^:)X/XHVNIW:=-/:AO1>VL.HPN#A^&OUE$3_`-/OF!U22QQ;
MGVY1HGM2;)*ZJZI1M1,4HJZ_;J.SYA=5%U'QVWM&*Y_@^`$D&;U#[5H'Z>?/
M;;CA8XOY*04[=NZSVY]/^5]R4G=10^.IUKU]O\,KGW%K'WC(X<$E_2$1:0#/
M7N":[DKV0>Z#'K)(E1N#N4I]DLKD7)+U>&\6?=8M]LM,^+<[O-DHAN2'41+=
M:X*W75@$);2I1Z`ZR.][Q?[[>MO+B/068`#+`DU]-:*;9;--M]NZ*)LA%2[&
ME:T_<M'),"EY7Q=PA*A26+>6[-R$DLS6)"7'G',_G[WT%(!+:@Q0&A'35AL/
M5-OL=N^VOHGO+GEP(Y'AZ%#W/:'7_DB#PMCCIZS4C'M)/I3I^QOBN^6KWM^T
MF<Y-MSS$/W$<2RG>W\RE:D,YC:W%;`MC:5$"G4^.K/<NL;"]V^:WBC>'R1D"
MO;W<576NSOM;ELI=J<UV7+M]"_19UYVM&J1_K`<W9-PL[PQ<L8M#UYER[5R#
M)<ALK*5.(@/8H`D4_:4))H?(5^.O??DC9B];N,1/WK?#_*>OF[^8'=7;2S;[
MB)ADE#+C`#&FEJH4M_U.L:S=Z=B7,&#.6EB7"?MRI0?8$AH*-$1U!]L%%5G>
M@KJE+@!Z:^BXMBGMY&_I[V$`^*IR'!?+,'S'V*[MW0WL5Q#*1@:"OI!1S8\\
MX^Y/MS+'$V21<INL)CM7/#KR]'MF<OQXJ%EQ]NV2ULJN<A*&TU^67(2OJ0NI
MVFQCB=#J=?'1XJ!U"16O"E<^"LK;>[?<[$S;-*R41`!S#34X#.H-#7G3"JJ,
M^J/[7(W.?$[G(F&P'/[TN'X]RO*;8];W85\O&$+0J=E&,/1'6T27'K:EDW.`
M2"%+:?;1U?KKQ[YU=!G>=I_Q-MY#[RT%)`*8QTQI3LS)%5['\@OF,WIWJ3_#
METXMZ?W0Z:.HTV]R#J8[$`>7)7RW&IQ%>U<TE@PC(+X&S98[DV<O:]'MC$=Y
MV7-8V**W882VXW([93ZFP0YM(4!0$CY&#`P8"G[E]QRW\4;@!1P(_;[1S5MW
MTT.`,AY/SPV>^\=9+=+9)A29:;X;5?[2<:D155M]ZL]UBI92].:FLJ0INH;>
M0L^L=L4;FN7.9I:ZH.:J[VWCNY@^%WA)P(-:]E/M5C'N*X>QS"_<EFBOX<AP
M+K)A8_+??;B)9ER)<NUQW9DJ:>](=5)6]7<MU:GB>JC4G7D'4&X7,E_)9"0E
MC7'PT&`KAP^M5C8"R22*8>-I]A.&`P49^;+'&C6.Z?+-)VIQB4\LI(Z[#(_9
M2*#P'VZIK4.=>QAWO-</44B8Z0V./.HJ.RJ8#VREMS#<QC>(C\EY".HW!*7H
M-GD);34D^+A/3S.M&+C1U'-$\:F264+B.9TFI4^&86W5%M)IK$^.@/;7)2MM
M45YMEWPWI:+R=R?2$@K50@?9Y"AKKYRZZ(=N8</X>M>ZL>Z2V:]^+M2+Y+;@
M<D#H`XTHFB?*E44\?O"M3TZ?KUF&6T4=+@N_+/JQP[TD`DT&::>_.J$9T4*2
MRZX%TV@[=P\10A.Y*J@TUN-BM8K>\#6D/:YH(/:>"1)&`2YPHX!1QRIW>LA!
M4M==I-=IW`[-R55%:CP/3QU[KL<)AB?(6THRH/:%A^K7']-?3WW>U3=^G+B8
M=S+E#-Y*-J[79+/BMK7Z2I;]YD+N]VV#HI2H\6TQ@K:"$AX5\1K9=,1ZXO,F
M%79U_H7F-G-IV^(!WYSJU[<56%[W<[_O!]T7+-U;D?-0[+?D8;;'0O>CY+$8
MK%F6$$>FB[E'D+-.A*R?/6[C:W2'4\2N8(P(6@BA!KZ>:BGX$^8Z=?LZ5-/L
MTZG75TDMQ=0T[TZ>,$1L'NKVXI,_(66MI2-RD6VWFBP2?`.7,@C3T!_-#?NG
M-0W3&2Z9AI:QHKWG-7U?ZM9@+.6_4?O^8.-)#'$WMSRNX)E+2$I1=<SO5GQ]
MH!2CM[RX-S?`_:(!`Z:]_P"GW,9T]<AHJ2V"+`')NI[V^@Z"?1BOCG^;O<H+
M3IO:]N$K8GWFX2/HYP%1"QP`\6>+Z]J[_GEM1(CTA9"4QV77UN=2`EE"G5*-
M*]`E-=0VO=(YK,:O>&@<ZN`IZ5\/2AEI:R3OH3'$]Y(QII:75PJ,*5]"YZ+I
M.7=;Q>[NX>X[=KO<KDM9-3NGSI$M1Z@=%E[IT&OTIVNU.W[5:[>:TA@C9R]U
MH'LR7Y"[[=.O][N[E]'%US(2<#74XNK4<ZU12AH!>\I&\&H50$]>AH?V>G3I
MJQF+'MT9MY''Z57Z_*IY!T]V"4MCNM_A3H:+5=[E#<5-CH;4Q+?2$+>?0E-`
M5J2!O-?(5UE-[Z?Z>NK*::^LX'EL;C72`<!7-M#GBKC;.JM_L)FQ;?>W$;W.
M#0`\TQ(&1PR5Y''Z[6UC>--6N1#NA:LK1N$F%/8E/(FNE+[R7X["U$NKDR'"
MLD)*5`^->GP-N;WOOIB\.8#(0`01X1@*$C*@7ZG]*6EK!LU@VTT3-99,+G-D
M!!>\:G5`=F237#-.");1J"H(6`?0OT*Z="**`'WNGGJL<QS?$`2.S'Z%HQ<Q
M.)!HQP-*'#Z5ZBJ:*"ADHHE1WH00=BU$DU`\"H]=$]0:N2[,Q.@+(2"X..H`
MY%9R?'_8TT,<DX2:TQ6BX4`KHKU'<KIT-3X)/QU+B:X`5"K+F1E78\$4RW0`
MI/3HV5*\*J-*^-/32FI<3<=7$+/;C*SR",,OVQ7YUWU\>03G'U).;XS;X=B8
M)!P#CJ&4N=Q+7\.X397YS"#56Q0O=TEEQ/DLGH#K(=8S-;!;V['#S0QSBWEK
M<2#EQ`%.Q?J;_+5M#+#Y8V3G`ZGM)Q)-:FI.)XE.%]"ZRX?>7?=<C,<8BY1;
MV[;Q"I,>2(Q*'&YO(!*V_F4@A2DN_L.-G<A)-:4"^@;[>K:VGDVN=]K*'`$@
MTK0\:+2_,_:^E]Y;!9]3[='?V$<3W%CF!YKY@:UPU=A]7:BGZR4K&N.9_"EE
MX^QF-%Q?,,>S!&5X]<'Y2$W&^8S<\95!NBE?/WIAQ"6;BH)H&TU!.T5.I?S,
MW+K'<=MMOU/<IYVNU#0':6T&50`VO;7/BHORGZ1^7>PV]S>]);5%8R2/&JL;
M<"#]UQU%M>(:0#Q5%D^<F[)8>:M$"QM"+VDQ;<M12M29$A2I3RE--=R4ZM5%
M$)2D)2D`=->/L@?"P"1Q<\CBO:`X.)(/[?4M9E([;=>AH`"?TGK]IU&<UPQ*
M>CT$^/*BVTE(:`5N(*E'<D[5).T=1]H*M-/U:3I]Y2''3'5BUF(C;CKZI-QE
ML)3'<<94EIJ4''D[=K"T/=$)<J34']6FFP.?^8]U'`Y=R9;-*/NEPKFM'\5+
MC7==9<1W*@?*L-.A10JGXK24D^(Z4U(3_F,YHQZ)2?3T(Z_X:_;H7#`QGB+@
M05[D;T((;4VLU%=VY!I0GQ2H=36E?MU#D;)YA<T'-*<T-&EV#5^LU]`T*3]'
MCV$!82%?W+=0E2E`$YAE)Z*6I2C^LG3;M6KQ>\H;Z:CIR5OFDI*&A"&A"&A"
M&A"&A"&A"&A"&A"&A"&A"_*7?]LOMG<K2USHQ60%!,3*8X1^C9.?`IKZ_D^6
M_P`OY!3X-PIRED^MR\S_`,1[P/\`;.1#(]J7MQ>]*)%R85U"=DW)&.G7_?HS
MJ?#XUU"?\I?EZXF0-FC<<<)),.RM:)YG56\MI^;4=J3\CV@\!N*7V,END?<0
M$A-[=%`/N[C*M2N@/VZCO^3_`$5(ZL,LHY$FI![W-)2O\5;F3J<6$]H/U%$;
MWLLX?<)3$SR\MK-:(_-K2]4>.X]RV(40"/"M=-.^2O3#L[N;UM_U$^WK'<FC
MW83WAW^LB=_V-X`]N5#Y+GM[CX..V%XGRZ&K!(^%!758_P"1^S.PCW"5IKP#
M7^B@#:=]>RB>CZUOG'Q6PIZ?M5>_,.+V?CODO(<(M-Z=OT#&OEX)NCC;"`Y<
MY$9B3.:0B,XMLA@/):*JFNP^&O#>KMEAV#>)]KL9'2QV^!>X`$G#(#+/+&BW
M&TWTEU;LNY6!KR`=)X5]*,,(D2)B$,M2%6\--)3&9;.TNJW`EQ8%-RCMJ:T"
M1Y>)UYO?Q-C:7YO/-;Z&8OB!HT5'!2\PZZ1D2X;;OXK$5@)=D.NE4@;D!)=K
M4(45%!I2@'35!2B67%RD_:'E.=MU^,PA"2MQ)7M#_8>2VE+JW&U':O:K>4GJ
M/"HTDI;23@4KFK+`;+GS#2NW(E"2PUM#CB4M)/=>45J7VPBO7KT)H#I,@'ED
MJ9'&*!^-4\>.6UII,::RU215/:E;5*D()V!92$=5J24[DUH5`T%-5=S;LF;5
MY(I]2U>P.EC>'1$M>78$>A2PA<K,\68;.RC*[=>KG;4.P(ZVK)"COS%RY#H8
M:EI9DS83#<=S<$J5OJ5E*0"3JPZ/W6.SGFV^<G2X:F=^-1]"D_-3:IYMGMM]
ME'Y[7Z'$"@+74SXUPPQHC?B+W'8'GF>6+`K!@F?8S<\_R*0AJYWFQV]JU/7B
M3$=??FW!Z#?I[S6]N"D+*4':"DE(3UUO(+EDD@#:ZSG]:\7-NRM!6BGJUQK=
MP5!4^V@].BVY@/B:_P"YGRU;.C)<6Q8E(^$DU:O]E[4:L\:W4D$7"U^HJVDI
MET-.AZ=FI4/']&D^5*W!XQ.5,DKX=N6-5LN\+RY$Z!=W'K0]<K=&GPX$O;<$
M.QHER,8SVDI`2PM$@Q&RHJ2I0VBA'77/(N?ZGK3L5LZI\L^M'L?BB_JIMG6M
M92`2`B90`BGJ/9(*J_#1HD/A;37VY+IVZ0^*HQ1LCBC(2`$S;60JHJ1-'\M8
MI)'Z-'D77]1.MLYFC2TM7N=PK<[S;9EHN#]FEV^X150YT82KM'^9C.T#C0=B
MQV)+86$^*%I4/CIZ.!VD^<1JKP*5\)<=B.V^+KVTIMI4ZR-ETAMI#CTY*E*0
MWZ&6D_*T<7L17XT'736EW(KGPL_]7]O2D-S%>,I]O_%')?*,.)9+U<,)P2\9
M5&M,ER8F%=F[')@&5:WWVT,2+<ZM,E*TO)2Z`$GTZ&7,M@'2PMUO)R/;ZDW-
M%-!&9'4HH$>RSZB]_P#?+GC_`!S'PK",<:MT--[?79+]<KI=UR6);,6)%=BR
MVXXAPGY$BJGE!=0@I":]0\=QGO(AY[`QV.''Z5$@D?-/Y.'8K2<TPV;@6)Y+
MFV1OP46+$;)/OUZ<B*E2I;=OMK1>?$6.(C;;[NT42E2D`DU)`U%>WB7%H[Z*
MQ?;OBA,DGO`X<E#2P^ZK@"ZW&XWV!=\C5=&X,>TW)F1;[B5Q;;"N#IBK_)4S
MWX;*5SIZA\VVT''0I*5+*0@:;CN89G%L9!([4U&W6:*PF-Q3E#C,>2/R[LR&
M6GV5&8^DEE]I+K54*@;DJ4A8*ATH>FG31PH#0]AQ3[;.9SN`848L<49,L>@6
MJB:J"43W2H;17Q7"ZBGZ]288FZ02275XI;K6X8=+:%M%XN?#&07:!\C*,9I@
MO0WRN#?IUME)<ARV9S*3+@LL2$LN/1TAQ`5L=;)0H%*B-.36\DY!C)%.13;8
M+AHPTH[3Q7E*U52FV*41TK/])J?NI(BTK7P&CX=@SJI#[:X:VHTU6XQQ9E25
M"K%K4HD4!N210D'R7'3M-#YZ>:-(H,@E-M9RT$Z<5O(XHRI!J8UM77R3<6EH
MI7P)+*>HIU'PUW$BB5\'/V+%;.&<G@,R$`&6)5RGW1;EVR!J:Y'5<'R^J''<
M?;_JULA_=CLUV,M]$]-->2X9N>N&TF&9;3O2C3Q]DUF^7N<JWQ%QF)$):RW/
M8>`5\XTEI90R%+4P'""HI"E4Z@'2RYS2W0TO.H98>E=-I.T%QI0"JKFRCZLO
M'^(9-E^+7#AO*YLO$,AOF.W*7:LNQ1Z._*L=QDVV2]";==9EH;??C$MI<;;<
MI0*37IJTDN+^.,SBT<ZW:,7:@<,L@L\_>[1DYB<'8&B>3@_ZC-AYLFHLEGX/
MY/Q0WF=_"*+OE<['X%H2_?F!;'%L75B8Y&<=C&>E1C%:)+U2&D+5JO=O3R-+
MK8MJ..&:L;*]M+QU`7!OUJB/W_8[=L;]T6;8SD-_O5^NV.V?"8DB;,O%R?;B
MR+CB%GO]RM]I"I"?D[/%NUV?##20GT^L^M:CKTWIW9-LN]M9)=Q-D=S*\WZ@
MNKNWW)\;97E@R!X>JB+/8(9+7OF]GJ6KC>4-J]R/$`6S^<W5;#J%9I:@IMUE
MR6MMQM0^\D@@^?32=YV3:[;;;B:"!K)&,)!"B[?NM[)=QPR.U1.<!0_MFOTI
M]>0+5JG?ZHG"64\L95P=/QV?%98Q^TY_$N4"8$]J8W=Y.+%MP$A1"HY@GP!K
MN\M>]?)B\9:VFYUP>7V]#QP<_!?.GSQMIY]RVPL<1$(IZC"F3<34*FWDCV?\
M3QR+7?<<LV57Q2"N9-^4;'8EJ"M[4/:=RV65`]34J(/AKW"+=YY"1$X@C->!
M7O2VT2UN/AXWSG,N&?JHHQ7WVOX($(@VO#GK%DMO*)6+Y!9%/6N3&=:W*3$<
M?0E+0"U#TJ6%``]:4U=6.YW;)0Z>1SH2TC2:4Q]'!9J^Z3VUT)N+2,V]\P:@
MZ,T.&8H:@@\?I1Q:(_*T6QB"^C&>58%E6Y"N.!9U%^1S*U_+.@J:M&1,I3(2
MCY5Q%&PXVEP5`JDC4O587+O)E)@M96EKR?$QX=G49X))BW^6`7#(8;^WC:*L
M%63,<,0=0<`>8H*^E5[K^FKBMQR&V7?V]\G/\%W&'E"<BD<;<MX[%RR#C,IZ
M[+GR#@666]E$Q,:.B2M$>'=(<EIQE"6W)02`H?.75/R/OV3RWW3]W%/"]Q(8
M1B*GAE@OIKI+YWVM\8K;J6-\$K&-9(\8NJT4:#G4@85`5^/M_P"'G>),+M<"
M5DMRSBZ)CLQ'LFFPL>@15L,5++4!G'(<6$U'2X:@5<=<%"M1-2?!]PZ?W+:7
MF/<H7QGGP^A?3O3>\=.[E`+K9)&/CY./B](K]2IW]_,?Y'W49"I14GY[&\5F
M$T&VCMN`HD@;B!0_S?#7BO448CWJ4,;FT&M.U+N")+^5[J`N-#V4."@-S`P9
M5BF*`0O=BEX2"`"`6VI=-Q\5>(\!JDMR67S",RYJARPM$M03P40O:U)0;;R1
M!6E(+'(GS"]U"$&5C=E6`:4V54T34?K\-7-Y)%%O+9,?BY-OCH/N^&H[ZXXX
MJ9';B3<;25U=3&DCOJ%-B,4)CT0E?<6VPDD`U"J*71(\!51'Z=>!]:2-N+D1
MNT@AU<,\BO9(;EK[5K8P=5>/<DC<W7O65;O4G<D*HD;BD*44GP%.M3XU.LO9
M6S9O$USC&PX@TIZ%,@J2UQXIE\FDK2F45*0"\V=W1(H[2@!<30JKU`41_)KU
M78K8S/9(&MH*=^"5<12N<7-IHI_2HS9#+)64&CA[A]2:*5XT^ZD`5!Z#Q'B=
M>N1'X>Q<6?>:0:\BO-.KIW"V+!0@55OGLLPRWQ>`K3=DQ;'<;SD%^R3+(;DU
M$>0FW3V718;(V^\AB3+@.)1CR'7"A)>2APD(-`#LNE6-M]ECC>:SN)<2>5<@
MO/;>T=&Q@D-&,&'/''%5`<B?3S]X-GN-QO;G'\'D%=VN%PNTR?Q[E5DR!R1+
MGRGIDYX6J>_9<A5ND/*41\F3U\*]-:EMP`W0T$O'9@K:.YB)$7WO8H?9?QYR
M!Q_)=AYW@F987)9.UQO*<8O5B2E5:>EZXPH[#@)\"E2@?(G3\;RYM74!4II%
M:U"7&.663=<9QJ%%>;2W+=NUT?><H8T:.[</D3(<+8W*&V"F@K52B$CQU*MP
M73-(Q"J9IHX9)'OSPHK8/IX>Y:![#LXSW*<?QF-R1%Y1A8K;,E9G7<66]6VV
MXY(FR&ACDH0UI8^8D3>XXE84266J*`"MWOO0W5VW[+:.V[<6%KY92\O/B&(#
M<@<J`&F/%?%O\SGR'C_F&VZRL=PW"YVV^VYTLD+V-U#S'T#=0`J6T`]UP//-
M=(O#7UI_;IE\!W',UR++N*G+@U*@+C97`GSK8F'+;,8,NY#"7=BL+8>55XM1
M]IIU'CKU6./IK>)67&SR6\]S&YKZ"C7!S?%[KBW&H&`K6J_.K=?Y4_YG>@V3
M6VS[G'N^RO@>USHWF-_EN!:X&*0/(.DD4#J\0I,XCQWPGS/:VKSPKR?9KY'?
M0WLAV#*,>RMV&O\`W-$^TMSF+\P"CKZZJIU\*G7IUG\V]WV]P@W:*.2-M:N>
M'QN))R#@"P\AAV+Y+ZB_EWZSZ>D<-PVN]M8J#W&B2-HR['9BIQ.=>Q%EU]M_
M(5O[JK:[8\B9;2I85!GB)((!-$J8F?U<.T'W0^2=;BP^;'3UP6B^CGMB<ZC4
M!WTQ_P"RO+;WY=[C;E_D3PR.CS;QKVG(>E-Y,Q+)L?46K]C]WM:E%14N3">3
M'(2*^F4E"HBD!`KT6>FM?:]0;+NK2ZPN8I6\J@''^J<?8L%>;%N=F7Q74,C0
MYI\3<0/2`?6OL*_WJU/HD6J\7&&MH)"'(DQY-$U!"00LA(!^%#J'?=,;#NC"
MR_M8G@U^Z&G.N;:<5S9NKNJ-BF;^G7MS%D*:W4P%,B4\E@]SO+]@998_B+\Y
MB,J0/E[RTU/4M"23VC(EHDNA*JCP*:;>FO/-U^2?25VUSK7S;>4_UCI&?`4K
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M#@01@<%LS+K#WQFGU&,J0MKT2&EM.)0ZLM^O>``*U'7STJ&(N8YS<:`Y%0=R
MW*T;)#:SN\N:9X%'-(P)`S-*FN"_+4]^?(:^4_=O[D>0U23*_BOFODR\1W3X
M+A.Y?=6[;MH5$I;M[;24]?`"FO.>LC_]:F+C"R.,][&_O-5^TWRQV[]'Z$VV
MV:/%Y`KR_I5QW^KKX_&R)?O-:E(!^7L?#+B>GI0')^?`D*H:5I0C5)LVZ7&W
MO>8G:6ZBM-N&SG>=PCCE#0/@W4I_O!G7BF5^O:RBR<E^WZTPD"B<1Y#D'8$U
M1W;]C;`6GTCU4C'QZ]=7O4.[7&[;5;N<09HY'`U_#7[,E&V?9V;.9;5M?$:G
MZ13ZU0NTLJ984I.Q79&Y)IT5WGMWA0&I\_/6%N<QW+0PY%8')C;#[445*UMJ
M6D$`HVI6`=I`Z+%?/RU62O=YICIX0K*.!KHO,-=5:+.)+:]K:7`2*FB2#U5Y
M*\Z@)UW0W1JXIM[G#\O[JW5+B)CQU)?4I]WO!]DH"4Q]BPED!955WOH]7@*#
MIUTVN,>X#3]U:CG:4ZP`I'12BKQJ2$$`D>H"FN5/FM81@4/:T>X:K9<2*J;W
M)/IW;FU`IH!N]*OB/#P\>FG6M:7$')+C<9"&GAC@O@47GDMI"?6I+2`H@=5*
M"6]Q4=J:D]2>FDN`#B!DNSRN<\@T7ZT_T&V'(OTA/8C&=V=V/PZZRYL6EQ`6
MUF>5(6$.()0M(4GH0:'5?+_$*C*W+3:$-"$-"$-"$-"$-"$-"$-"$-"$-"$-
M"%^9NO*+"N%$CCB7'!*8DNNR[C_$E\#TZ,MEAMN&MANYQX\=##C:W`ML!Q2G
M*$T`U]_OVVX8*D+QY]_M[QBVGI_<DO<Y5MG%"H.*+M+JBL*$.^O265%QTEI*
M$S;@ZIIIAM02.I4JE5$G26;9<RO#(M9E<:`%U&U/#[$RZ\VYK2[36@KG^Y;&
M2XXU:+=8;DW\\@W3&)&0OQ>_"=0E^-=[S:%VQ'<W2$.G\I#N\N%![E`:#51>
M?%6E_+92@"2%FHBM>%=-59106DL,4S1X)*>BOTI.26K9&G/PS'O;ZD25(;<1
M;!*2XE126P5--.(50*VD>9!U)8V=\@C$;S5H-0*TJ,DW.W;X)"PXD(O[&-K4
M"XU<:E82H.XX\LBBNJ:BW&J1_-I,%O$^0-;&\/UMH=)P(<%R66!L1.L</I"H
M-Y>>W<M\D*96M;(SK)$MJ>:++@;3=)#;84RI"%-E*$@!)`*0!KXTZE<Z?>+J
M5U=0N)*U%/O$>A>IVI#K:-PQ!8/H7G&Y#MO69(D%%4[D-!1#@Z)KV05!*5$5
MZ_%.L;?0QSC0X>,#-;:PE'EB*F-*U4P^+VVKFW'N<I*BN6XV$-EU2D'MK[*5
M)"5!*V&CMITH:>==9*Z;HDT9T5B%+JTLL17H["GWGT_+)*6T`J?<>6XT'&FP
MXI+2U[5@)3X#K4]-0P'.(:P5)*DJ9,OB%_C[*<TPK*[S9(-\P?!L<S'D!S'E
MOYQ)Q)>?0X=VL%GN;\,LVJ9?5VV[L2IC$!R4W$2ZA!6I[<VBKWS<6;060O;K
ME?3"M*?2O7/EKT)_B^WO;JXE\BTM(:A_EF2KG'0UH`+:>)PJ:X#&F")H*;UC
M>3PL?N3;C,J'<VVT,RX+Z%3ZS$]AU(;.Q<>0V@E-"DE)H:$4UR62VN;'PR4J
MTD]F&7>L]:[;O.S=0#:KV-[9[6XT'PDM<"10M/%IKGWA3JN&7/XD]%N3ULMD
MW\EV7!<!V"ZAN0VRAH".J)(*DR@I3@VH&X[MM00=4&R"*._CFC>YX#P*$US_
M`*%ZY\QG1WO3\NVWC&L#80X$#,MRP[.]/UC_`"//;R6RVD<<7;&V\L,9R*[;
M(K-F?NDE5DNDE,PVV/';V($>W):#B7$EQ+2C]X$'V$:]9T&CE\H%CVQ!V<AI
MAS'XE*;%+;-<MLJ[2%W9UA+32%1I\MZ7);DGYAUQ+"9#CB2.TQ]Y"U)*CMJ"
M%`76V&X`<W6#AR_>FZZ1604YA1JXMD\NYCSKFU[F0LSQGC)=C>5CPOS<AJ"X
M\7K>S$;BP7740RZM++[@<905;/O*]1KN;]NU#IZ`V[@+TMQ'I*HK1VXS7KGS
M5;",`>SDI>M6.[)0-MUC.=2?ZQ:V5*)/0E1#X_EKK(_#=OL5\C./9+^M*0S.
MM;@'B/R9PBH%5!10^!44Z$?SZCD4)')%$HX5FR8;=DZTEP'<UNM<Y(&\@UWH
MG(4!0=*#IHTE2(HB:256W=H5]-IDPKVTZFVRP/F;GC+L@RXK*'`^KOVJY!QV
M3$5V_P`5++NY3=004D@F2=DE\LAM,TV:^->3[?=[)=[;GM^SW%V9CV00TW&]
MV*R7*=<IT>5O2[,M]BC,MXE&<?"V(@`=+_10^60EO22)'O:97NHTX:<$Y"Z2
MW:]K&,DUBAJ,6]K>1[4CO>JB6_[5N:3<8*K;*/"6<LR(3TMBY+:4';*T5+F1
MG'&I(<(J%FBR#Z@#TTU=FL=17WAGB<^*AWS2;0@X$4]BYUOHK6F]XSG6;YRQ
M.@QT&P=BV)A6QIF\,*B7^SJDF3=E)<^:COMN[6VE`]M55=:BA>0NAM6WH(-1
MEW=JSNUSZ]Q+0*::+LGQ?'N.,NB7W%YL3/+AD^8V%QF!#,MJXXRPQ+G2&V+9
M<(3\-[OF^,H^5D*H$MMNA3820H&(8I[N"A+<>9I_2MG<NFBE\H%A@I5P<VM?
M3PHHQYGQ;9..ID:9<.(L$X]N:7F+<Y/LF+6F=,R*WRD,++4MMJ"5J@,JMK:D
M]QII3+K%23UU2.^*$IB:V-A`SRKV)_39MA$L3'-)-,/%]B=WB)G(KK)N-^DW
M._W7'Y4F)!MB[ZVY"7!DMQ[C=)C\=MD1&)+2HT`,[5M[$H)Z5VG5Q9PO:V.=
MQ!?4B@XD"N?;DD%K)&EKO<(/9W)A^*\\YBR_W6<G!./\@2^'8>+D8Q&O30QS
M'V+@T]88Z'[:+FTQ%EOR'6Y:DK0M:W&U;JTUZWNHV1O2]J^P,8W5Q)D!%7`&
MF%:\%CMMN-W.[2QSL(LM/A4WQ-N0*4OX;D@V_>5#=LMR;J3U24L78+*DI^"=
M8E:=;[-V(`2;!F*5)IT-@KM'Z6Y2TD`BE!UZZ0]^@5S0C1N?W-A38,R4:_?%
MA0#4?$&8GP\.OAXZ"^D>NB<$516JW4WA#:B'[!F$9K=^]7CKDAM`\UNIA.R7
M2DU\DDFATT)ZX`4*4"&>'FF$R.T<UF!-<P7D>'ES4JWS+3+Q^3B"(LNRRWDN
M3)F0KN$_(_FI-Z;D%*8=G+<5AYI79:[;;964W+KSRS&PZJ^Q`+H7,J&.B#P7
M`BM:<!R3MV*==I>'28%]L^6VNX6_\E8,O)H-M85<&DS;=&4^R[:EN0%R5.@E
MQL4*34@!)`"F34`#AD!4^SZ42RATGF`4&HFGH."X:N0<7EM^Y_F^^S<,XQM%
MO?Y5Y.N#>0VP79_+;I/<S"[NP!<DR&S$83)=4'9"T$[=FU(ZZVS.FM]=9LD-
MG%Y;FU:]KG:R*YO%=-?1E1>17.Z67QCXG.<)]9PIAZ^Y7)>S'"7[UP0WG#&4
MQ;.NU>Y+ARUPFY%P7`_.7I7(W'[N00(TE[;W94BQK<AQHP*3,?F!`(VG69ZD
MLIH)HXIQIDTMP])6JV#3<6^IAP\VGT*(?U'75R/>9S6IU6YYF;B33BNOJ+>!
M8NGQ\*I(H?'KKU_I%OF[0#E1Q'J6'ZI--YECY%)#V#?]^3V??_Y(\/T_3_&E
MJT_U**;)<C_T953MO_B$/^\"_2DUX`MZH'>].Y,VPX4XI6R1(A9"PRH&A2"[
M:5+56H/D/#QU[-\I8GR_%M8/]K!]+UX;\X6>9-915IKBG%>7A:JXH6.VB9-;
MGS6E2')&]1#R3N6@J0I!*@%)*!M/2M.NO:M4C?X9HO$B8SI+'5HP`^CBBK*N
M,[#DSCH@P#"=#9`"#L#M%4.P*;[;:ECJ5`T&I++U\=#,:L`4*2$R,<ZM!J`]
M!*:NZ>WR[)>:N<",MOY1E+=SD.1S*=5&92KLS^TWN><?AMG:\&^KD<5H5-A*
MG!NK"=`=2,\$MVUB#3-M[!YHQ=Q'I2>OGMNSR8IN:,4B7P$-NQ[UCLV%([K+
M@"@YVR42BE25@I!01TZ&@U)9NUM%X?,#:X]Z@OVQTA,VAK;DGW@*>Q*+%>%^
M<[&\@6VP7B.T:=QNX/06X[B">NY*Y2T.HV4!J"*?;JKW*YZ>W%CFWS&2ZL#7
M+Z%<[;/O%@]LEG(Z.9N-1A51A]XGL7>Y;1)Y'=R;'>/N7K18HL*/9;OD]L1C
MN90;<IQ,.`[%4795BNBNXIMB8TLQ*T#S(&YU/SOUY\CK#J9KMQZ1,\=^"3HH
M=#A6NEIP#0![N=5ZML'S/O+"4MZE>QUN_0W57QBAP<>>.:H9S_%+I`:N&+Y#
M;YUGN]J:OECNMMFL)1*MTM3';>:=3ZDK<0V]O0I)4VZA06A2D*"C\>;C97>P
MWS[;<&/CNH)*.:_W@0<^[B%]#65Y9;HR.ZM96NADII(Q!_;DH<\9<07_``>1
MD\S%,CMMQ3?;S;Y\B#?[+(4RDQ;;'@IV3H$]IZ,^]VJKJP\FIZ#R.=O+R'>K
M[7<-GB=#`YK9&24!#G5J6TQ/;5:J"TN);^W;"TN$9J?L3_QKSG-N^9%^PB2I
M@4"KCC<^'>8R4MA1#@A/J@WE-"H$;(SA`'QUYINNQF[:)+.9CVZOO^&3TDYA
M>A1NDC<2]M!WII,GY/Q1D/)7>H\>2D$"#.*K?-0Z/OM_)S6HSZ5!0H*)\J:>
MV78[YDK8I8GN!.!:-33Z1@%9QW=LU@\V1C6@8XU(]"1,#".8N5))8X[XKY"R
MYI_U,3+;C=RC6LM*VJ+PO=P:AV<,A5*DO4U[9LW3=XV)LL$+FO)H213#N5=<
M]0;5'&0910U"=[#?IC^[#D%+USN,#%,-LD5`>N,F=D<._P`J$7`5(A*9QYV5
M:5W1:>@B_F")'4>D5%=O^AWS[?R*`=I-%YEO5]#/K,/B8./-3AL_`V6^W_#<
M4Q>V89B^2R;-9947+YV2V]?"V5O.F[EQ-R=O%TCS+7<'[E<7UAF)/NR'@R&E
M(2$FB==:6$=M8QVH_B,&)YU[%@IKF2YDJ\/#0.(P]:W[=C6-XQ?+]E$O#.2<
M>O%^F,2<B=MV>7W);"Y<XT,1DTL]XDW&RV]:6%C<U#D165@)(3T20W+'<8M#
MY&Q]CL/4EMF#6AM$K'<QARFC#MV607(CJ-C]HR5BZVAMY*PX`B7'<;RFRR4@
MT%5/L`]?`:BM$\,U?,+@13'-+%U*,(\!]:H8]S=Z[/*_("8D+';>Z<@,-V)B
M42)!QUINT-(MS8LK%O2F,F+)=87)6I->XZ\5&IZZUUA/)#;CRS2H7-NUW;I9
MKEOWJ#T5JH\L7>:VX'`\X!Z0#O56H-=J:'IX_IZ:MQ=/%',P<IL]E!,S0!3%
M*RWYQ=XA*$R'5I!1^&M04GI6H4A50"H=//4V+=)6W+96G0*U=AJK0<E63;+$
M0YP<`>Y+>P<L72PS3<+;+N-BFAQ+J9EBN$RSR6UFH2X%0G6T+6CP`4D@UZUU
MK]N^8>]VD#&V=U(Z%QKIEQ:,:8#T8+(;ET)LVX._XFUAF!&)>VIK^W!6!\*_
M4_\`=9Q')87C/-EYN$="$-(M6;,1LI@=E)0KMI-UC36V$.E(KVVT$4\:]=;Z
MW^:$<C6VN[V4$[3]YCG1O]8P/I!7BO67\K/RMZDC=<2[5#'>.%2^*..-^KB1
M(T!S?156V</?7JO2&6(G-'"=GR2.VV&I-_X[OR84^5(H2N3(L=U$\.AX?L,H
M92*4Z)%1HX^IND-QHV*[-F_#PRDT:>0D8`<#D2WM)7RAU7_(G##*9^E+Z33(
M::)3YM"ZIQ-(S09&I/;53NPGZCOTY><5!B]Y#%XXODAI'<CYS8+AB+T:2L@%
MI%YLRID)]2%*ZJ><;3UJ:`ZW6T;]OUH2=AW!MW#'B=$XF`']9KZ.'<`Z@X\%
M\G=9?R7?,G;72W<^U07MGXO';T#FTP%!6I<>]27MW#/&G(-M7>>+N2+=>;:Z
M$O,R+-=K-F=M4AQ/<;*W+1+$EA*D*'1:RH>8UN[/YK[M;/:S<(F3T&(`\IWK
M((]B^1NH_DON6PW+Y=RL-RVXMJ`9XW%I[0UH-17"M?0D1>/;[R+:5+5!9MU]
M8'IW6Z:AN820%;#"N`CG>//:XK6UM/FETW>!K;AMQ;2\GLJW_.:37U+SRZZ'
MW:$@6CHYSE0$-(=R()-$U5VL.06%3C5^L5VMNPT4J;!D1V1X]4R"WV%)Z>(4
M1\-;*SW?:MR8'6%S;R5X:Q7M!;G7L6<NMKW6R?Y<L,C)&UJ=)(!&8KD>\+5M
MMRD1G&!#ERV.WZFELR'$AM8'I6A*"&ZCRJ.FD;AL6U7M6W5M"[_)[.RF"8M=
MUW&RK)9W$L5.+"6.SQQS!Y$8I19E[D.1^+>-N1<K&8SG;?BF`YEDRF[FM-Q;
MCKL.,W.XQ0RW-[S#*OF8Z=H2A/J(\Z:\OZO^7W2=ILEYN[8?(DCA+AH.D5X=
M_#.O>OI#^7[K7KOJ_P";?3'14ES+<V%SNL32R3\UQ#3J/BDU''D*"N*_/>R>
MY/7.Z2Y,Q9=E2'UR)+ZCN+S[ZB\^I2J]5..*))H.O77YY;K<27FX37<N+W&O
MHRHOZI;*UCL+&*QB%(XFT]*Z0?\`5TWK_'@>]U_'8;$MU%FX70_W4,R.VRF?
MGR]@BO72SJ<+@J0M#Y4"FFPA514-F#R!1/6[))=T:ZE&MM'X_P#K0HN_7=NL
MJX<[\+-38\B)*A\:Y-WVW(TB/#+KN7*7W()DK<5):[2$A3@*D;TE()H=7=U(
M!;-;1=N&U>)^!(%.Y4;=T]EH*5T2RDK-`*$J6LCP\B:_KU0W&8[EU&F-8ID>
M87=R#8KIBMC^6A*ENS<OOPL$!U:7$-M1&)90LKEOE50BFT)22H@#K674CG7!
M#&U-$\^[9$T%X=3LQ2\=X(YS`6]#Q/&\M915:I>+9UAU^2XFG0MQC=/GEGP`
M_#W:CN?*T5$9/I2!?V<I\HN<UQYM-`F^R3"N1[`R'\DXQSJPLA'<^>58)R8)
M:W[5*^:BM?*;">@4333?GDX/:6GOQ[U(C?'2D3V.':0,>Y-\Q=HC;B4.RIL?
M:K:I$EM:.OJ].XM$@].O0Z&2PL]YSL?Q&J</GCWF1_Y'U_4E$U=[2^$A-U:2
MX1M22MKU>-$J"BP>GZ1X==//EC:T%IU'DFWPM>*%KX^T'V(SB!*ZUF10:IV[
M2XO<D"N\K:==4#4@=`0?CI3"][0^C=!_K"OJ3)B>P85+!Q/UK];/Z"@I]'[V
M&#<E=.&2-R-^U7_FQRGJ.XAM?7[4C4.7^(4V5;OIM"&A"&A"&A"&A"&A"&A"
M&A"&A"&A"&A"_,*7=D5ZO`_%/XR@!\25!0.OTZ;"Y_W:=Z^;FW,3CA7U+7%Q
M:6ZBA0HJ>;'W2?%:>M"PH^&I%O:.,[,&^\#ZDB>1KH'@5KI*T<NOPERY$)Q;
M:VK;B,R,&WFWEH;;-WR&2M#BVJ+^6)=45(15?7IY:PO44(=NU_*P-!9'B>.(
M]JUVWN<[;+<`G``GUK8@W%#DF`2&2%JBU5T_:#9K^(V7"#7I4UIXZT^S0/'E
MN%,8VGV<52WTPUN?C0'%%T>X,5-%)5^(M2@5HH/Q.H!*AU'D?'2+.![M(=QE
M%3QH'5-/0E?$Z6ES144XJC?W-61_'>?>2(S[1::FY"J]Q24@)>@WEAFX-/-T
M)"TE3RDUK]Y)U\(_,[;Y-HZTO[1P(8;N0CM!-0?;ZU[)TW<-O-EMI6&I+`#V
M$5S2(L[T1V4SVR%]Q(3M6A*UI*DU4THJ3L5O2"*FH%:>.O-;OP,,IRHO0K1P
M,0T^]DIP<9PE1X4!32$]UE"4QQN)2YVV]JEI"@0VL*IM`/Q.L)/.TSNK56<;
M7MKK4Q<!LOYG.A,KC&6M^8R4*JO>:U+BF"RI"ZE2`?UD'4=]UY$;I&Y@*ZV^
MQ??W3+=E34BM,Z5IAZU(3BI,S!O=+R;B>4RIE\LG*./1D3)4R2^M];ZK.CLQ
MW7GEJ<4N.ADML>K\(MH`H`->>;[>.W"W;)&:W#7ZB3RRSQ*^O?E`V#I_>[CI
M>XU"">TH:"N--8/#&O'-6AW:PV!F3#DR&8%T;EP&)C$J?"8>E)HE/84MQ2=S
M#L<+)53KW"=4-I?71MW,)XD9GDO3OTNQ-P7WL;'2-;I!+6N-`21B17BB4X]:
M<BRS#%WNYW.RXQ^?1%9-=[+"@W2[P+5%=4X]/M]MN"VHTYUA+84&-Z%.I3M0
MH*H=;GY?,MI=W;;7=::"1A7Q#*J\)^?=E+!LK-PLWZ+<2,:Z@QIR[CRXI=9Y
MDDSDOW#6>_<:VRX8]AUB6NW8HS.E7%L6;%[/8OX<L4Z]2H_SJXU[R,/3ICK0
M6%I<>*$J`2"/?+-MMY@GF:/+:<0!F>5.2^--P,TEV!$XXG#&F'H^A3WMS,E5
MID09(4J9$3!M2EUD%A;<2R1(K?97(=<DO*7-7(=6XX=ZR[4]:Z(Y"^6>0`-K
MD!A0<,NQ7`92"CZ%],>*PV]DQK9:VG$G\&W0&TCJ0-D1I/IH:@`UTN.1H;I?
MC3)1QRX51JD50*$=`"5`4\:=.E3TKI4Y(`H2IP:WD%"/W'>UWG;F7D)G+N._
M<7<^+,=;QJT688O!FY?";3<8#LY<NX)&/W2-#<7.$I.XJ1W*HH20!KS_`*DZ
M9ZBW3</C;#<'6]IH:!&*BIIF:?L5E]VV/<MQNGS6MVZVB(`#0*@TS/8F11[$
M?=\AMM$?WG7AKM42%JOG)R'=U4KW53=B$I!Z4H>FLN_HCK+471;O(#PQ=]%5
M5CIGJ1GA9N3BWM!^U2G]J_MG]PG#O(UPRSE7W&7;EK%9&'W6R-XM,O>871AF
M[SIENEQ[VMK(G7(;7R;$1UM*D@NT=('I)UJ.D^G^H=JO'S;]N#KJV+*!M#GZ
M<N]7.R;5N]A=/DW*[\^W,=`TCCSJ<E+/A;)(V16"3VY#;TJ'/N,&7;678\E4
M%B)?[X(96[&><2DRHL@$-E*2VA*?'=TWL`:2<BM'&^D0:#X^-"F@]]VQGVO\
M\O-^7#&7@'Q(WS[(D*HHDT-:>/34.]PC<[@TU/<$Q>_\L[N5`WTA(4>%:;C+
M=<W+>0M#[*@BH8?OV.`+6`=^UU2E`=*=-)OKAT^V1-H/(%2#Q/'%9O9M++YS
MWY&B[/N/X@E6K"\A3!^9B8V_A\FZ%2H-L:B8BYE>2VO++BB=\DY*NS=MW0NZ
MRZLA!=26PE1*CW:[.VN;5D=UJ\]E2VF-37`$\O6M5N<DT<\S(A4R,&GL-/9@
MH=^]OG7^.<G5_!MK5'@V:^7>QV^YVX0'8E_MK,L0K"N(UW)ZX`#+;ZT;T!+@
M<JK;X:L-QV2Q9*UUR\:P`7-K4C#EDJR+<;J*&*TC:^C1B36I=W\4Z'%,2Y1>
M&L>5?52D7B[76^1'&5OP5"'$EQ;-:V6$/P(-O0H*1>E**%)6M+BB-YI75:V2
MV^+8RWK\.TFF%.&=%;0^;Y;G2GQNQS3[7E*571QII);8BON1XC*2KM,1XZE-
MQV6VRHI#;;2`D`4H.FK=I:[Q!<6LRVML*/4[R`:)KUZJ!K15*?I&E+BB)[S^
M/_==G^$8;"]HW)5MXOR^WY;+GY;=;E=C9S=L9797H[%O8DJL.0)<4U=%I=4W
MVVZT!W&E-9OJ*RWR[AB&QRLBG:?$7'`C'L..6*J]YBW6=C?T>1L4M14N%12A
MPIWT4`(7MY^M"PWN5[I<9D(5M4FF;VVJA7U4#W&X(W)^W[=8RXV7YD`M?%>P
M4;F*_N6:=8]>!Q<R\A[*@?8E_@W"OUA;9F&(2\H]QV,73$HF48Y*R:&YDN*2
MU3\<8ND1Z_PTQ%8"Q)D&5;$NMA*5H62KHI)]6G]NV[YAQW;)+N2*2V#VZB#]
MVOBPIG12;*'K:*X:^\FMWPU&JA%=-<0!3E56W91=BQR?AT&UL+CHNMDN$B\2
MFTA"'(%MOM@=MMNFNI6EQ3\Q2W6HR3N*JKKZ=U/3GR-9G6A6S<X.N&`98_4E
MOE+(;LDS<I2B9MG;V]-O^>(&]">G454>M>OGIJ<`PNIQI](3[P"#@,C]!7#!
MR:1*Y1Y.?4*%WD/-W#2G7?D]V-2:=:UU]5;3$]MG%E40MKV^$>M?..Y24NIJ
M$ZM9^E6T^SY5MB^T3#_S1F:\W<?>EQ+'MJ(+L>,I%[;SG!GK3)EE]A\2K=&D
M00I]EL(=<0FB5)/77@/S!)&]ZW>[Y8'IU.7IW26.ST;[_G$U[*-XJ"WU`WC*
M]X'.3F[=2]V%H4\*,X;CC=/]L"#77J/2$>K8HBVE<:K$]2$NWR9_W3^])[V#
M@GWS^SU)-*>Y/AX]#3PS6U=#IOJB-S=DNB:4T%0-O(;?PDY>8%^E1KY\6^59
MGU![JY;KCQ6E#;KJ78N6+*$5VU:=L%"O]D#UT^/7IKW3Y.?\MN1'O!UO_I/7
MA7SA)%[MM/P3_P"BU0.M>;+2$..L$;?O-A)\&Z)ZE15MV@*%!0DZ]?>QS/>X
MKQJKIONM;3EA]27$'/W'P`U"92&UE)4EM)62:4"%*2%*/7XC29;2)T=23C1/
M1M;%$6R"I+N`KQ3CV;+$.;7'&RE:D_=`"5`U(W(60$JV^9KJ$ZV`&E@J*>E3
MXGMC<&USSIQ[%OJ0W:5JNE@<4N&^LOS+.PI*65NOJW/S[,@`]J:I:MST4$(D
M$;V]CNX.UQ]X@@Z1AB,N[L^A,R`B0G@<EORLRVQ$=D]_OH2II:'%.LUVGU)(
M(Z`CJ:>-0JA!&FH]MB+@YYJQ,"X`E\D5U^Q0CYOQJ'R(MMF^MS+=.A/K59[_
M`!6`[*AA94HM/LEQEJ7"4H`]M2TJ2KJA0)-=SM5_)M;`R`-,!X<1RP_:BS>^
M;>VZ?XM0G!PI@#3.I[1ZU6'[M?;M?;UADK)_RM,[)L4MCR[7E5G"WX&6XW&:
M4J5CMX2IMM]B^6R,2_!^82V[1"XZ2ZA;>SP?^8#Y;[9U+L,W5.RQ@=06X_.:
M&@:XB/$Z@'B<&Y$X]J]/^576-_L.Z-VG=2/TB<M8PDX,>30%I[\32BH?]K-V
MN'/7(=SP1.;8SQ=9X%K=O5RRV_6JZ7AAF*U)B6YF)%@6P(DR9TM^2`%//1XZ
M$I6I3@Z`_#^U=%S7L_P[)1'%IJ[5GW8\N(7VY;7XVVT$Y<"TD4<#7,84/)7?
M<;?3WX(N\!BXWSE'*^9TMD?--V+*+5C6/AQ((=95;<5,F_L-_%#UQ#GD>NM7
M!\L=EBF$MT!(WOQ4W]9NKV-IA+)(R<"TUQ[5*S&_:'[<<6CLMXOQ!B=CGQG4
MRF;\S;&;ED[;Z4CUC(LD1?+FZFB?N+<4V#U"0>NMI9[/M6UL;#M\(;'3,_9Q
M46>S^)F$DQ+96UJ!QPXI52^$9<54*;#O";U#;E29*K5E$-R8B[/*-4,R$VB=
M!;_+HO=HXVQ;V@X@#<LT.Z>9&L<&#!4DNSZ'FAJ]QR)P`/''BGEMRL<0VW`D
M7!=MO#"&EK:F6IV!#<E]IV*X\RF.\U.M=J^1>V"-;F&!O2%*<55=6;H:B-6.
M::?MKK8:0`YKOJ19=\)F.,,-6A-HOJ8[L=*T-W86^0S!:<[=VN*8K=IE36;E
M<+:1V8\6(F4X^UM7/:W)=2C3=QD&+203C4\.SM7;/;[25TGZL9Q"V,EGET)+
MZB@.K#32OL3)7_A/#;BY++^,0(\N`U<Y,EVR*.,3H*I+.UE#DJ"^46"[7V.E
M-7'UW2\+=J$H;42!,-,N"HI+6V?4^+43QI7TT`'J4?LT]JEAD=R/`N-P^>99
MMKYMMXL=MO3J(11WH,>*F0NW7^PP+FTI3$J\WR>VX7VQVV:TTDL9G1M>Y-1V
M4(>VE<Q]*H3]^_L:S[BRY7'FNR0H.0<<Y!<U_GS^,,W7Y7$KM)4AD2.Q>77K
MM,QB2ZIMMZYIW1&+DI;2EA"V2JRBNXQ$&RM`(Y`*#*U^W:W3GPNEPTFN>7)5
M<KM+S!HIH%"`I-"#^R`-U54]05Y_9IUI<\^%`O\`S#HH0`E&KC_(C9X5^A1$
MW6#+L5]R60W8Y<:\W&PX[C5VC6*Z7O+K;;%2)F*6Q-SFMML/STL(D)6%(JD@
MEYC])##76I;96NBIC4I'(>I3<M*PI(+2DTJ?40D&AVJH1XUI73AX5X)V'W/2
MM=RYB.PZ^M80AAIQUQQ51VVVDE2UDI/W:)/Z?UZ4'N&-35/:(WBDA('8I89S
M[./=UQ;PG8O<7GG#^28QQ/?!95Q\BD7"R2I]H8R-`.-S,MQNVW65D.(L9`EQ
M'RCEPC1TJ4ZAM10XM"%=@OIF@M-"^IH>SO4=]BUPTN#S'6N.78H]VWD6_P`%
M"$FY&0TE!0J-*2F3'Z[@0XS)0^VHI^--6MMO$]N6N&H%IKX26GT$4(/:F'[)
M:NMGQM:UL3P:@`#TD4^E.]@GN(RK![C'NV-WG(L4N3+02BX87DEWQ:2@U*BZ
M$P)"H1))KZFB*^6MCM/S(ZHVUU(+F22U/W)`R1H/_K`XGAE3UK"[]\L^G=^A
M^'W"VAFAIDYK:>JGM5H'#GUF_=-@(A19?+*,\@-@,+M/+^,P,A6XVV@4#F86
M)=NR1"@G]KJ:=.M.NQVSYH6TOY>[[>R@_P!I;R.C<,ZT9)KC/<6YKY@ZO_DH
M^4G4S7/;M[+"YD))?;ZF.KPXCCRQ5K?#_P!::TYDB.URAP29RI`;C2[OQ-G%
MNR**V5(!"_X+R5VTWQQ*$`J<3WGE$`T)UL+/KGI9VD6UW\,[5[L[`QQJ>,K*
MC4!Q#0"<@`OC_KS_`/%V;IY]Q=]*;H^:4QD1Q3ZL"WW0',+6Z<M1<"XCF5*>
MV>[GV;\H2XC$?*+)@5YF[$*C9[9KIQA,C/N*9;[#Z[R;19914I[<EUN8\#M4
M*UH#ZSL_5US#`7V-^)X@,A*)13LJ2ZG"FD4Y4"^#_F1_*!_,1TE<Z[W8?B-N
M-"Z6U`D`;3Q$QC2\T["2>&:C9]25=CPSV*>X3,,?OL2X6R[XO:<.@7*%<(]R
MB2YN9Y;C=B,:)):#/=*[=-DK5M+GX39/6IHS\R>N;R3H2[M9-#9)HRT/!&!Y
M%H)PPSP6P_D"Z"ZFNOYM-HM=ULI;>';(+J=QD@DA`/E:6?Q!B\&A%#AF#5<.
M4YQ*GU%5/OJ*@":&BJ$5Z&IIKX+EFUB@)U<5_3-4ZV`\UTQ?ZNG:T73%/?"X
M9;L)QC^Y!N,ZTAIRK\A')(0X=Q:E(6Q4J!:=:4.H*J'28&ETH`4J%DAW$Z?=
M^%?_`-Z%#WZZ[LQGW$\2VJ5-1-<@<237$O;)*%EN9G-^[*'ES)L^0^XGY0^M
M3AJ`!0`:MKN1LD8C;74$P^*1\+8A_$+G'T#MYJDAM2E*0%$'T(/3[I5V4*J0
M.G[6J(NU$@YMP7206-'W@,4J\8Q#)\SNBK;C4W&(#L>*Y+D.Y7?(^/P7J+2A
MF+'G2*H7+=J:(I2@J2!IN<3&7S+9M32B[/=6L;!-/K#R:48VOIS"6TGASGZV
M)[K."JOK*5!8EX;E6/9&QN0:]Q";;<7GU$`^2?#[=1G27K0?.C>(N)HHQO-I
M>RID`<?QBE._-$<W+>2\2C/V_(6<]Q@K#27+7>&KG',MI3NS?'BN+2B6TVXJ
MA4A)`)&DB:$M(>UU3QHGK>W@NVE]L87,'$$4J.`-,TBOXRM#LA9FKC.2"2I8
MFQ7&UE8^\'0XT""36O6M=17-L/\`:/IWA3HHI8:T&!_#]:-$7##+NTZ9%JM4
MEY3:3'3%5%1O<2M/<2_1P.A)94JA3U*@`1XZ?;%;M-8SJ)2M%W$=;@=)YFH6
MFK',*?4%?E4F+0@E4:8XDCIU%#5(/7^32S8LE&L&CCR773S::/T^7Q7ZU/T$
M8\2+]'OV%1X)>,1OA<A@R'.Z]M.892H[W*)W$*)\O#4!PTN(!)QS*@O(+O#D
MK>=<24-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%^8$Y`0J6$*;6$[NB5*-0`.E2
MJ,JHKX@C7ZKN`=FOEZ,@$U2CC8_"<6PM*5H7WF?22QT.]-0:P4>'\NNQ,`E9
MH'BU#Z4Z\UB=RTE(O+VX4>9>$L"09*<7+OX+B#5]4S)$O%I@]?FD%***4=IZ
M#R.L!O\``[]3W,-::&)O^B:K8[=-%^FVX:X5-`?6CJV6R%*E12PZG]\ROM)<
MC..(3W`$%0$A*^NT]2D`GPKK2]/3V-W#!):O9(PPM(+37`8$^@J@W)DT=Q)'
M("(P1FB-BSM]H=MP4WK]6U-.BR"`$S#X?JZ^0TBQC>2*`TUE#J,C+78$MP5=
MGU`>.6&I>)<CQ-I=E/*Q*Z[$[:I:B+N%J><.]XE8"'FZD^%!KYF_F)Z>$-S#
MU#$/',\Q.I_5%?6O1_EO>?D2;?)[S3K%>W"@4)<%QB9,GPR@!M+RAZ:]Q2BE
M055":?>V))IU'3PU\B[M=MBA,5,:9KVRR8]L0U`CQ*R;C/$G';;&2VVL$^D&
MB5N(2G8#M1U32AI3HHD^'36%F='JU5%3FKZ.(OX$UR5G'`/$\B).8N<Z$Y%8
M%>R7VZ=_<D4+(*-^U+M:[4T36E::S&]7>EKHFO&@KV_Y7=(SR[O#N5P"UC?N
MD<,,5K>X["LVQGG[C/DC%;+*NN+S)%FMM^-LAN3ELOQ%J;=[S;+1=84II84A
M?0$`@ZSEI\+)9F.1P#R#2I/->O[S#>=/]9VV^6L;S"_#`5%"""./>IXS)Z+C
M)CEQSHU%2V=Z`XHN+!7)2X$DI&W=T'6E/CJMCMVPAS0:U<35>DR[E'([S0WP
MNH1Z>"*;T\Q%C.(6MQEAA(=4\TAEQ8;;;[BW6V7P6%NA(.T+'JK3IK3]'SBU
MW^W?(7-C?(&'2`74=Q`/)>=?-`6VZ]$WUI*T?EQ&7'#%@)7K!\LQ^S0[9#LK
M_($IO(,@@N34C'5MS+G=IKC+,6$S*3.AQ"`TE#3:6^B$450%3E?J>6QM8XW,
M@:2`:@FM3VGMYK\]XKO6]DQ\6`]`_<K-L3RB#F6--Y+!C+A"[WF\/&&YMW1.
MS<7668PV$H4&66TI"DDA0%?/5``6$@8$YK41RQ3Q@BF/!'`0V6&0V4J5$+EO
M>1MH$.Q7W$MCH>N^"IE?7QW_``TIK2<0,$ORH^2UU7.VQ9D:!)EJ9ESGA'81
M\M(,=4TI"DPE3$1U0VYBTD;65.!U7DFNEW$L=!B$L=J\Y;FF)<=6C\ZS6YBQ
MV=+Z&'+D[$FR(K3[H!;1(7"9?["GS79OIO((%:&D.YO&10>9(]K8P1G]&26V
M-[G!K0:DT]:0-@]RG%.3WBZVFS7*X2[=:I#,->4LVQQW'9,AYE#ZOEI22J46
M6DN`%Q;*4%7AT%=9<]<;%'>&VN'^6"0`X^Z#3.N:VD70N]76V'<+%GG:'@%K
M:ZR#C6F6&21'NEYFY%PO@K*<O]O\.#E5T8MEZ,[)F@U.@XE;X-LD2)]WEPI1
M0VN5$:2"A#J"GJ%[5C5X_<&2PZ[$B4$5JT@X<UC-TM;VPK'+&^*89AS2#[5S
M@^TOW3>[#&<B]N<NW\XW!&.\E<V63%\]LL.-9Q_$5GE9VPF;!DR7+.[)F&4[
M,?2YT:H#M0M*0*JA>Z&4>6::L#Q^E9JTG<R?0YU"<PNFGZA;;<3VM>XA27#L
M:X>REMH'TJ.^^V9'0I\*[?`_#4F^-;>0]BM[PCX5QX8*@3Z1]O<>M.1.KEMH
M3(B6J(R7&TH$<KRFPH[ZY.[>IH=T':11.TGST[?PQQ;+`6CQ.8:9X\Z+.;)^
M;>N&8&7>NJFV\QY'B^(6BR1&A'9B2\SQN5*44*3<TQKO"FM7:,XI$Q!A**P`
MV$;5]I*E@E(.K3I>TAEB=/,X2-T>'AI=RPI4]ZTE]>S1`E@U38<!PP3'Y;EV
M67E-O5(OUHCMO.2WUQGH[7S+$8.#:7&(]K>[B=H6O<%%*Z`U]*DZD;E8P,<Q
MPB+PYGBQ<36O$UKZ,E7OO)I:?F-:6FN0^Q2SPPOJPWC^T+2\^'462\KG/AM!
MF2\@RFU[7(Z0$E$=%N@,*-4(ZK^[K,-@ABNBV,T<VO@X@%7UG66T,DAU/H,>
M?JP3QW5KL2K@MPJ*$O2'%AL!3BT[EJ2&P:!3KBR$I'0;B-6L4C61XXNY<^ST
MI+V&OA&"34HWVRH:O,J6Q+M+:6_SJSQ(*67;/&4HA4VW3BZXJZ.0!0R$/-@/
M`$M[*`:/S_?J:.X4R[$DMIG@E-=7[99XCMSN<Z/&MC++;[\UQ1$1MAW;LD%:
M$K4&U;QY$"M?#3OFQAI<7``9KLNB-@<>)`XG$X``"I-2LUHN%KO5M8NEGFL7
M.URD$QIT56^,^E#A94MI>U`4E#B%#P%::>;6OAS]!_<NMC=JHX'#T9+9>N%M
MB1;I):D1K@[9V'Y4R!#DQY-Q1V6E.!E4-IQ;S3SBD!"0L`[C\>FNN?(W`DC#
M]LETF*A+:&BX^?<I]4WW4RO=9F]YLM@M.'?W917;-@&*7W%XKDFTKMMXAW:"
MF^]^XQ)=YGW!^C<E4J.TRVA:FFO2"L44DMP][J&L;:<!A59FXW66*<Z6TIDN
MG+VD\LY[SY[+."N:>5DV5'('(V.VR_Y:WC]M8L]J8N:<[N=M;3#M4>3.CQ$F
MWV]@K2V\XC>"4FAU-B>Z2U+GFIU#_2"OXY7OM/-<?&?L*X[\U7WL^SQP5)=S
M7*W!7Q5OO]R57K\:Z^N]K8XV37`8"%I]`8"?8OG6]U/NY:8NUGZ2KGO9E$OG
M^B3Q8+,U%6W-]X&'"^F4BU**,;9R&U+NJX@N0W?/H<BM=M4:LU%26N@73YU^
M81#MW+&XOTM-.\DCV4*]6Z/%=K%?==*?2*-5;'OM>W>[KGLI%-F9M,=/V?E\
M>LC-"#7J-G7[=>K]'.#=BBJ:+#]25_7)VCW0?M6I[!DE?OG]GRO$CW)<0J'Z
M3FMJJ?AKG5.D[%=ZLO+*@[?I^/AU?W@7Z4NOG,5ICFM\JO?J)S&8ERXI+Q31
M<'+QM6`00'\=!IUJ%$J`!H1UU[M\F0'1;BTY5M_])Z\2^;5JZ>ZL7`T(BGIW
MT;]2KH9O5M20XL,H36M5[$MMI2*H`IM65K_I&H)U[4YK7^]B%XV6-BQ.%4>6
M[,+4PKM-K:4WM#;8]"2A7I`)-5;5T-305/7STB5I\O2T)3)8P34C*B6L3+(P
M;%.VM`4I*4@@@5"NJDN4`K4&GW?T:C"-[345;V\DTT.B8-9T$DT)[\TL;7E+
M+C+C#Y=:#@"6G@%KV..;:)4ENH2/#KUVC].HL\`UUKKKQ'[DZVKF%Y>'M'$<
M.SZUBCW(HG+MGSS[RUJ<>7#^=CP7IT\I+Y$)^9&<BE]U%.XVM31<2>X"2%!2
M)8]`&@?7]"98('R>8VAD_;T(\FY5A=EL4^9=V6+[;XDI+$V-$9;N-RA(4D=;
MQ':;V12ES<@+0YV:@>M)4`&6BZ,PBC(;,?=KD?V[4Y.&2C5-BT?MP4=[YGO!
M4B5-APWLM@M26E=UH6^#(A$K6%;'[9<=_P`VT@@';W2D_IU=OL]],(;<"`P/
M!:X'[P.!&'/+%4L\EF90&O>`""*8M!YU.(*HZY6^F/Q[9.0\AY:]FV;62T7[
M(85T1>."\UDO6&TW^;,F,W4KXTR&?.5$QRXR94?\*UW&4[!4ITI9?CIV,CY_
MZH^2=U;3/WG8=(KJU1`DT+C7PU-2/HX+V/I_YLWK(8MDWG1)MS::9&'\UM,,
ML`?355GW'E:!@N993BTV+F'#GN&Q=QZ)>\:1<9&.92U>6[;/:91?,7N\"WY*
MA<TS$24RHJ5LR%,LN-+4TI2E^3R6$UC*Z*XJ)FFA:10@]R]:@O+QFW'<MF)>
M'MJTL),=*YC^MS![5+[VW^__`)R@1;A;<ORM.5R;6]##47+;9$5/_+Y3"UE+
MZT,6^YJ++["D]Q7J"2`=(6CVWJC<1#YMU(UT@`JT@`5RI6E58;B/OJQ._P`]
M@YI8(S4`PT-=NTQ&I[S,T.#N34/SKC$=8C+2>K`:<4"`4N>(*"QA.HYK06V_
MF68.O(P&88@U%.?>IAX;S3Q'GS,>'CF169YQ*F$,VR\--6Q;<AYU+<-AI-W#
M,=4V0\=K3;:U.NJ!"0>NDN="_P!X@J^CW/;;DGX>2NG/4G`G_,2VR62VZE#I
M1M&VJ7FUJW@J`JVXRXC:4DU"A0BNI&AP8'T\'-2"6OA+XZ%IPJ$R.8VR?,CQ
M+>N7?[&S`>GRK>]CUVE6AR),G#\>Y):2A^"_.0Z@.MNNLN*0Z-W[2@4+.RVC
M7U&FDQXX_P!"9+,[1F-OQ]V6KDI$+&[7(8N/?S5<>U6QF:B0V_.N]^R94F$F
M\7-6Q3D=RX.%J*\`I":`U6QCG8T.FJKY;"Y:?">"J[YG]^WMWP*ZW^)DW,L/
MDNZWV;=+5D=FP"X/\FNRK$^T8[]IDSH+,'#56V[-!*'XLEU\;:H4HT#H?I;]
MBJY-L=<@BZ=Y=2#CQ(]>2HSY`S#C"X7N;>\3QR^8;@DU*G8L?)+O9Y]RCS`M
MSN?*1X349A5K6VI*DQP\_)8-4I"T[$(3'<>6^KG`,5;<;7*R:EI(=0%3K`#2
M.P]O!-^\Y\N)2[-/>;BSH33,Y,1U^*BXVM]QF:S'ND.D=Z5;Y#T9MQ+;Z2TI
M3:30[>EA&^)[1)4$GBG())2P:X^\C$?2E'<.1X&37!V?R9B%OS&7/O.;9+?K
M_9I`Q',<BO628\U;L>BW*[P8TBTQ<7Q.]0F)S,&+;6`]N?;4L!TD.:XB?$YP
M/8`0K.#%F'--UB3MH8RS")&0-M2;)#R_%)>0(6BJ)%DB9!;95W8<;HHJ:=@-
M.)*!Y&G72U(,4@:74.EHJ3R'-==GOJYTQRR>ROG2'?,NL>38WR-QQ<L<Q-PM
M0XYR"Z9/(@3,3196HJ_E+@W;%);F(6@;F6XB7%44@J4U#%(T.?*",<.Y37;F
M]UNV%M'`@$.H*4`RR7&T)`2M"5E(!)+G3[U10;NA`_5IVND5I7L2-3I8B78N
M(6X))=54."BB3Z"?#I6H\E#=\*=/AJ3!*TM-1IQ4;RW\BO9EN-A"FUJ%-P11
M6T)_9/4#I4)KKLLF`T%(T>9PK1'=FRVZV>2S(M\]Z.\V4E/R[KC3@6-WJ.U7
M4I"C3[-/1W#6QZ#I(.)U`.Q](/L34NVQR`OET$4.!`X_7VJ5&$^[_DG%HZ82
M[R;K;B&TNP+D!-BK:`V+:5'D!;*QVS05Z#X4U+CFH?/A(;<<"WPFHR]VBRYZ
M?=$'&#2&8T%`3Z":TKV)\.6_<7AO,OMER_$$X]:<7RZWR++E$5>/M?E#=X58
MI_\`6(MP@6]QBW34FWS)#C?<94I#B0I)1YR+G<]SNH?AKN>5\!X.<2HNV[)M
MVU;F-R=9P#<"QS1*(VAX:[!PU``XJH20:%T^0WDC^EU\:^(Z:I98VM;J:,.*
MW<+8R\:LQDNE_P#U=V5(8PCWL)88O*VY5WX+97.L+<*1.AN,P>1GD5B2NXIY
MAU/1>QIT@'P%2069US!S,0*_0IE!#<ESO"X6KJU[90?HQ4(_KI79J=[LL.9:
M$H"W<-61M:)49^*XE4C,,TD;@V^PR?6C:20"FI(Z4($JX>&N()\5$@!I?&YG
M\/2['OR]:INB`DN5->W\NE/EM!B,*_6**U!B;%4N?[Q*CS,:P@#DE=C>*9EE
M\]RW8=`M\Z2S&5)DIN-\@V%LH2XA#;+$JXR(T5V0Z2=J-V\^0I73,K;AHK$S
M4:\R/:"%$FN;6T'_`!A+0[`$"M#SI0I9/X5SUC".]*XXS9J,TI?]=QU;.01`
M-OJVR+%+E(-&^IH3T(U'-W,'>3(QXIF!CZJG'TKC7;1.V@?$\\7$4KWBE$0R
M,_R6'-MUYR`WN-/QM6V"G*;;.9>A]Q>]!9BW!I1*$.@*!V%(5X]1IP3,T&L3
MBW'WA0^S@IPLH#;FV9I\H@GPX9]U,4J97/B\E(7?OX1R-S:`MZY6BS?,*'0@
M%:X:'E`4IT(Z:CAU@[[K6TYU/TJ"W89X`#`90UW]9V-/[11%/N>$75B4MG`\
M8C3WVPJ%<[:F3'5#D;DK3(8:B2$1R4J'[:5)V@U!TXRVM8SK8`">W]Z7%!-;
MNUNGEDPII<,!_1DDHE3:=H=4Z&^XE"NRR77B5KV48:!2'7E'HD$BIIIUTC88
MC+]QH)]"FR/`MC)(0&AM2>P8E?I%_2/^K+[`/;3]-[VD<%<O\[JQ+DOC7C)6
M/Y?C4K`>0[M)LUT&39!-^2DW#',5NUCD2&XTMLK^7DO(0LE!(6E21AI>IMF#
MSKG`/(5Y]RE6&T;CNUJS<+"$NLY15I%*$=E3]*L5_P#;ZOTO/_QG&/U\8<N_
M_P!B#2#U7L+/]L3Z/W*9_A;?O^F=_P#&,^U?1]=;Z70/J]S;!^P<8<NU_P#D
M%.DGJW8J82'U%'^%]^&/PSO\YI]@*R#ZZ7TO2:_Z3+.WX'C#ET&GG_[`N@]6
M["&U=+I'.B!TMOQ.%LX_Y3?HK5-Q??\`6+OH]8W=S8KS[MV8EU3VZQ$\0<XR
M3^+U0`Y%XV?:)5\-U1JP@W?;YX/B(Y*PUS*;/3V[A_EF+\RF5<?I6W(_UA[Z
M0\)EQ^7[LFFVFFT.N*_NAYO46VW!N27$(XY4M&X'S`TV-ZV]]-#WXY89IS_"
MV_:#)\.[RQF=33]!P6NG_6)?I!.-L/M^[>.IF6GN1G$\1\W%#B?&@5_=U0+`
M/5)HH?#1^M;=727/J,\/W(9TKOLL8E9`?+=D=;*&G>4HV/K\_2BDQD2V/=.P
MY'7OVN#BOF05V$A7I.`!7B.G3KJ/_BC9`_RC(=>62='1O4CAJ;;N+?\`>1K6
MD?ZP3])6&E2I7NL81MH54XIYG<HDD`$AOCU1\=._KNV.]V1U.Y-NZ4Z@CP?;
MFO\`::?H**7O]8F^C^PVTZ[[M8Z4/(6MM7]TG-QWI;-%D!/')/I/EXZZ-ZV\
MY/=ZDT>G=X;[T)'J^U>T?ZQ!](5:P$^[6,K<4!*1Q)S8"2X0$"IX[IU)&AV^
M;8UN+W"F>'[DK_#6\D:A`=//4T^RM4K/_;\WTM/_`,9='_1K^,/^S'EW_HW_
M`,Y?]`_#_@OWW^3KOZSM_P"-WNZLON\^Y'^&=^_Z=W\31F/?_#GFN)!MPFX&
MH30?%*0.E":DMMI(`^T:_2;_`!U=?]-]/VKYB_1+?\4GL^Q.+;RA78KVDDNL
MGHML=-Z2:),]!2HCR^.E6G7TSKZ**6W#8S*T5QXFG-$FSAD+W$N\L1NY<L."
M8&KLOD7,4.D*;0TF(D'H4LF1<SVZ]3LJ\32M*D_$Z]+N[2!WQ3W,:]\[6C'*
MCFTX=ZIK.=_EQ-K0,</IXIM/;U=GF^2<AL,A2BXUWVT@J54*MMS<0`$EQ`(#
M9)`K37S)\I>H?T0WUE*Q\L5O<OBS)(;5Q^OE1>@]1V`NA"8Q35$-1'$X44EH
MS25L,[JBGAZNH&Y5`:OKZ_9TZ^6M[8_,S;!I`AE]\\N:J+K9"9#^8UVEG##E
MG5,;[D^,[AR7@XLUM@7"<6\CMTU"(-MEW%W>Q%DH/X<1#SC2&TN$J-`*4'GK
MP_\`F`Z_VO=]A;8V`<-RAO02T\`]A)K3&HI[<5N_EOLL\6Z":4?\.Z.I]M$S
MG&'MKL%J["+ZU/3/#[25LKW05;0FJ1V'FFWVE@$@CI7]>OA'<]TNYG.$OA'I
M'TKZ@L]FCGB;H'A)IP5FG$7'&/V5$-R)9H;182&U/EGO2"GI50=?+BJ@FM0?
M&O366N;V9L?F1FI'J7J/3/2EL7M8]H<#SIAW*6MIB(M_:4TT"IMP5<43N2A:
MTT*02D;2D=*@=`-9NYNY7DR.-212B]\V/;&V$(T-``-`>/<M3++Z[$C2DC<A
M)6HJ3NVN(*1NWBGH"%I/0T'AI-HW4&M_;BI^^[GY5B0TZ7!N.`/$<\O0D)BN
M61W5N5>WA(<2$U`*E=0M9J*BF[PKU\=37LTNTXT6<VK>H/.+J-I3+A7GGG[$
M?91LO=LN3$90:4NW//!ULK)*T=L-'T$*`6M20:?R:]+^5^TLONI@^4!T,43G
M&O/A1>/_`#SZD?9])RVMH2V:XE:VHK4M&8[C7%+'(;N.'L.XA<F16;C/B63*
M\D_+VGP.QE&00)=IQF[N-%*U]NT=B/+(%5J6U04)-/I.Z#/A26@`TS7QW&XQ
MG+&F2GA[=$,R^$N/Y+*9B4/6M^2XJ877''%N7*<XJ0TMQ.Y##R552FJ@.O6H
MZ8U\;:%]<5K=N:'6T<I]['Z2G1C%;<[,$)%2R[`N30*4[07K"TUOK0J5O<MO
M4>&FVR%HH%943>\X9C;>/N)LJERYT.*Y!MK8MR9BE%!O7SD=R).4E%'"_P#F
M7XZUBB@JJM1;@Q-C+Y213+]Z:ED,=*4Q5,?)/N%SGW'9&BV7*_NOX3#O(F6V
MW!#<:/+DQDN1F+K+CH4M3LI2'5J2"HI1O('QUY-U3OTCJQPD`!U*8T-.)[5K
MNF-MDW"822@4&0'[U)7C7NV1$:Q1D?*0T1G'GGP`7)<IT!2I#I/52AN'C6E-
M>:W!%P\/E<10UJ/WKZ!V&>XVU_EAQ$`;0MH*8XU[\4T3G-6>1K-S;@^71;;`
M<NO&F>62/;H<UR8G(+?>+%<S;9R)#J&6]L-TI[1(4M+S;C9*2=NKKIO=6[3N
M#8[=[C%.:/U$D=XY'V*#UGM]QU%L-U%N#(_U&W9JC<P`.TYAO;SYU53_`+?,
M-R7&LG]D^/Y-9+G8)ZO<AB\UB->;=<[3^9Q)N?PIJ56A,Z-'5<7$1G4K4$(`
M0FIW`4W>Y6=[:7A8;:1KWUQ`X!?(\NU7MI>QOO(IXVRLU-+XRP$'M)-3V+JQ
M^HZM3?M*]QKJ5I"3Q+>4U!J*.Y1:T"HZ^DFM/MU:WO\`R[^Y3MP%+-P[E0?]
M+AI3?&N:2VG.PXS:[>M#R4A2FB<BM*=Z$CQ4G96GF::G[C4[98``$Z'9]Y69
MV)Q;<2$9@*ZODW#;?:KXJVVO([U>YSN3/L.%Z\SDLIB/0XI6&8:-C49,M#C3
MSB2=R%="16HL=@M+F;;FD#31Q]W(X\<U+WF,P70:'N-6@X]J3N/\:_G]\Y$C
MEZ\LP<*X[R_(7Y+E]N#4.+<(=O#5I0Y);D+^2:D375$I11*S2M/#5Q+::15S
MGG'BHD3_`#`XX5:*J8_L^O%MOD[)5V.[W*\6"TW;A_%;:J9+?>;2WCENMEN?
ME18[KBA%-VGVQ^2I(*B=X))UC[@-;N4S0![H%>.:TFT/>ZT:\DT<XBG##*BL
M-N[6Z>&BE16NZ;BD45^&P9#Y]1%1M5&%?B-.R1MBE:UIPH#^U%<'`569$5#[
M4EAY(6V^R^T\D$K4I+K:DE)\:@`^'QIIV60L(TXIH?F8NX)L(<BY9IPW>8L"
MTHN%Z>PV[V2)CMWDN6:/<IKEHN-NM5JGW8M.*MD2]LM-H<DA*U,-.[Z$C3<M
MM');R1NJ6O;C]*>LKVXM)8MQMB&7D,H<QU*Z7-.=#4&HP-1D4N,(M,JRX'A5
MINL)BU7*TXCCUMN%J@7!=V@VJ="L\./-M4.Z+;:7<X=NDH4RU(4A)>0V%T!4
M==MHV-M61QC0P-H`*X>O%/2W$EW.^ZF_BR.<YU,,75)P[TT'"\"&YRUS.\TW
M%;ENS'TREQ[BB6X%*O".V)<9-"PM\-;Z^H)(VD@]-/AI:*5)57;`22NC=[M2
MN*?Z@4.=)^H#[NGE!MDWCD:[6.TEY]I*KA.B2%1WF$H6I2TMMT3ZUA*"-U%=
M#2I;33/_`)/UK*;FT,O',;B`NO7V`P';5].+VCP'DAF3%XQQ)M]I(31A[^*[
MFZZWN02%!M9(KUK]HU+LVA]H0</$/I"T\&&VQNXN:2?0%R/Y"\'<IRE]2E!;
MN17MT$D5*G+K-4HD_&JM?85DX0;:`W(VO'_=+Y\N7%MY(1GK=]:N\]H%OM:O
M:;[8_P`SDSX[\OWK6&78FX4-J6W-OT+^)I$:)<W'I<=4*V.0H<EQ<AL.N(=;
M;2&R%J4GYGZX?KZBQR=&P'T,"]9Z4;HV:$C,XJKSWPOH5[N?<(3Y<DW1H]/-
MB)`954'[6]>L=)D?H,/I6"ZA%=YF?Q)6Q[!E!7OG]GQ;`_[Q_$%:]/\`V-;5
M4Z.JZ'8+G^PH.WM#K^$'+S`OTGM?/*WRJ8^IE$^:NO#VY:FT(@YF=Z*;T+,C
M&ME`5)J%*%".M?LU[K\FSHM]R>,PZW_TGKPOYP.>V]V[22/R[C_1:JO%19!?
M[3SZ4!-2X7-I0_M&T(2112=JD@[5$4KY^.O9XY'/)J,EXK5Q]XDHQ3:7-W>;
M2M,E5%(`-4J)/BE(*5JW5W;>M1TZG3R6QFIP!JC!+LZ`RA#B_FFD)`#Y*@M+
MA4I9"DGU%222-M"HFE`.NH[WN+_+IX3@ILI\S27^ZWU>E;,;E*!84PY4^+)O
M>/SPZW^9V66A`AOI6MEYMYMHI?8EL*14GH$'H`HU4EUE@Z5I<PX)$M]:P,\F
M4:0['#U(UNO+Z;I;56^?9K;G-A;*),:9,DOP+NEEO:(_S,^&&90FQ0TE(6JJ
MEI'CY:9CM([9Q=;U8XY\?I4"[N6Z1X'9_<S]-4W*^1E1YZ)5FQ.#9%;G&Y#*
MI!EQ;@RXA/=:EID;DR`\S5*@H*"A\3I]C6M!)&IY^\<QW43%O,X2AQKIH<'=
MHX]H1Y)NG&ET5_R[A,ZR//CNKN>*W)]3#FZM'56VZJE(:%4_=;="23X#2K=M
MW$:M?YC.`=P]5$W-%9EQ?(7`]E*?0DQ<>!\6S:$\[BF7-W&-O5VXRD_*7JWJ
M4.CCL(NEQ8:H.K94"#T->FI[+^2%U;IC3V4-%73[9Y\!E;_DFN-/0J1/JZ^V
M.1R1P9<97(5F;N7,7`$!O*N->26&%/7C*^(VIC;688%-N38,NZ6RPPG_`,XM
MR7B5V]<*0AO8EYQ.O,?F]TM8[IL#NI]IB:V]@(,A&&IE*$D=],5Z#\H>M=XZ
M=Z@9TON#_P#A[G%PQ(<^HH_')U,*##'*JYBK!G?-&%AIK'<UNEPML525,6?(
MPG)+<VE!20&6+PF4[#"=HH8[C*A3H1KY:F<U@+F8C!?85S^FS`NN8VO=ZJ=U
M*>U2.Q3WSY=8BW&SO#)E3^&NYXI<A(;&T$APX_D9=<*U`=4M7-D>-!Y"*9W.
M%*"BA7.R0F/78SAK'8:2:FO9W\%9/P-[@;?SQQQD2.+9LR\9MBW)'&L*X8TN
M'*LU_9M'(S%\Q&Q7M4*X.2(7R%NS9N-$D2&);S,5=S9+CC8<`5%D>64HFYK/
M<K.S8&QDN;,TU;F1C@ZO`]E$_$SWL7J%RAG-YQ/.I"L>N697Q-JOUJN$AFRW
MA3$QUAR[L34K-IE1K]+8<E-$K]0<345.I,<TC(_+K454:ZW;<;:X,UHYS8:4
M(Y%+SE;ZCW.5DXHN2<;R>RB[S%L1(E^GXY9[G<($=X%#DBW//,OVOYJE-KSS
M+Q23N%#0Z=9(]SP"%*/4UZ^S$)?2<@8T%<U1SRM=.:^>[!EO*'(O*[>1VBQR
MXL5!Y'Y-:7<[I<Y+J/\`D[%,1GS'G9"XP<JI4:,U'0#MW[_0'C%</.J,_ECM
M]:6V]NJ!\GF2'/54>KT*%>=8%R9@LI;>18CDF/2UL_-1VIUID-+7&>0@L2T-
MAM:E1G$.)4E9&TI4DCHH571W(JZBN[2=@=-FIZ>R+ZH^"^SB'WLF^GG[4?<I
MGEN9<_(>2N8&\WDY=;+@DN+B2GXLVYW[%%QX;H;!9BVJ"ZXELU?2H[@`AIQ`
M/>FKK:[:]HYY=HJ,J4[DD/?5]6WW;_41NV..<LVGA7#K%A3JG,,Q[AWAW$\+
M<L4525,IMBLU>CW;D.ZVE#:A_4I%V5;]X"Q'"Q77!=/;)H#1H]*<@VVPM6EL
M#`TN%":UKZU$'%;QE61W"';'H<:7.EN)CMK2_P#)*6ZL[1W"4_+I*B/$[4C[
M-/BX<,2!11;WX:T:'XCNR2BO<A[&KY.Q?(4(L]_MRV6YMLER8;SD=3[+;S*>
M]#D28J^Y'=2L4<)`/4`]-2XKYDU=%,.:?M?+O(Q.PGRB"*<Z\_J6Q.RR\7"#
M#MDR[7"7;K>%"!%ES'I$.&E7WT1&'5J:C-KH"0V`"?$&@U,;</E&@@:4S\*Q
MG@;72,`DR[(425)6DD)5M4K[A5MHDJ"?$)5I5*)>ES&:8\7<*IV;0SQ9DG(&
M,VV!(R;"</N5VP&S755WDQ;[.2W+88B9[??S9EN*W;R]=`7+='^4D(9:D?B+
M`9"7&OSC.``WX:F)XU^C)0YY;^*"21L.LM944R[BEY[JL6X?P3E=5BX.N]VG
MX8<8QZ?+B7F[M9#-LF1RF7T7FTIO;,>*)T8=AJ2V5([K29/;45;0=29F-CE+
M&X@).URON(/.D%''AC]:C<J1M4E;:@5="3XJ'CT/PZ$Z:4HN,CC&[!M?H7M,
ME*2%;B*$*2:T`(\^M0>NG1(]K-+4ET3&M)!Q6TQ?I,5Q:6G2E#@+;J$D4=9<
M04+2?`*2II1!!%-#)GMP./>HQ:T^\$BYQ4$O5H$`[0I!K7UE("NH%:4K]NG+
MN31`2*54RTB;+)C7PXKIB_U=B%%E8+[PISBY;3D?,N'VH\B)+E1'$A%AS5;C
M2C&=;[S;F\;VW`IL@>%=-;(=;'N=@05(O!JN'@\;?ZE`#ZX#SP]XULC-R)4H
M1N',-"E2%H<<(=OF8R"@K2AOI5VH_P!L?+3VX>"0.&9("9B&AL,8]TQU/H52
M$5=7Y'0I];*0DGJ*0(QH?V:!0I\=1GT;$7\05U\8DH24M,9LF:Y3<?RW!;4B
M[S6HSLF8P+Q;K*6VVMB4*;>NDF)&??5N(2C=N4?`=-(-_,T>&/7V!5UQ<V37
M>9,\LX8BH^A+U]_W`X5':C77".4;3;HCDB6TZQ:9]TMC4B2VTT_+1-M/S$=S
M<B.CU;U(!2*#QJT;Z)WOL+9./,)N*/:YB:2,?YG#(_51)N3RI=;O<(&0Y)<7
MKG(QLHB,HR6.^4L=QPO-1Y46XH_$9[IJ`H%&X=?,:6RYMG-\54\[;X39FUBD
M>R.I-6NQQX`_1Q"5KG*F(Y(L+O\`QYQS?%+4%..-V>W0G5A1JM1>M?RCF]8/
M0#SUP"T?_#`PSJJ^/:)FL#+>>YTC/5(7?Z5:>A%%ZC\13X3\FT<?*QV_H07X
M$JT7NZ(A-R@4;"Y;Y$B4PZQ0'<GT@U.D-M;=AU,%''M3\$5]&\_$2N?'2E#3
M/G@$WZAW$%EQ7;!6E27E+VA!!KO"Q4HV$5KU-=./C:Z/RG>Z2`>XD*T(!MB"
M`06Y*Q_C!4A_`<5<DW,WF0Y:][UT+ST@SE?,R*O%]]MMUU5/25*2"2DUZZ^=
M.HF-BWVZAC%(V2D#NH%[-T_''%LMLR)H:P1B@&27>Q7IZ?>K3]73K\-4ZN5]
M!6@D#[>A2#U^()%?+0A%5]N+MLM4RX%2MD-EV2X:T(;8;4XX"JA("D_IIH;&
M9GB)M"7.`]92XR&NU'(`GU`E-%[5^-Y/+DJZ<M9K:T7.VR[I,;LI<87M=?2Z
MXE.QU([;S<1E%"0GIL\=6W4]^S:Y?TRR<=;&C/NQK3BM%T?LK-XM&[I*WPR$
MEO\`9!IQ[05J<Q\>W?"<DN,^!#D7FP7AM:9=O0@ID"-T'X39"MJF$@*Z'J/T
MZB;3NAN@Q@<1(,N7I4O<]EEM)'S01NDA(\312@'"BC/+MLJWP7;C:'7+MBKZ
MRN0RQO3<L=EI%"X(YJYL1_NK9&[ITKK56\D;@YDQ_P"*J1AE3CZ?2L=-;2VK
MW3PASK9]"6FE6$\LL!Q3R89E*SB4,//LNJCOO1TOMD;'VG"'&W0CH4@)4`:]
M4FHU47%I&RZ+@34$%3K:4FW`!:X&N(K3/ZDGK_=TG;W%`>IM#NW:/7O"Q1*@
M32BQXUU,M_=([4S=^&/S!GDFSG2UO,Q6U@'LN3FTA(H2@NIIZ@>JC7QU9-8U
MIPS*HK@'2#VK+!EJ[$)202ZZVQ2JB-JT*6E06E)IMW-4J?'4*Y_AO[BG68Q'
M^S]BEW\S)^`_[JF_Q5^\_H?>_=:E_P#T-6-?_P#**RU05\T5[5"E:`^D*"J>
M!#C76H\M?IT_IO>F"I@>O@CXZR_O`E7!F@/14DO)!D1DD;EJJ.Z@'JFZ':/L
MIIBRVC=(-SA>8)"1,W"A''GDG9[NT?9O:V0$F,_0F=9D)_CW-W$%"UB8VE8J
M?N]R344'@05?SZ]N?NFU[G)):[?.R2[MRT2-&;3QKW<5C!M\S(FNE\,;A@4P
MN,S#C7N9*$J4VW<;@V:45M4W=XQ>J:>??</\FOF.UL9]L^8>\[;;`A\@?*&_
M[RA^I>EW$K)MCMKIF+=8;3^SA6O:I+OY+<[<Q&$%\-JD-/-2`\RU):?C!]"D
MI<:E,J3T=:!!`!Z=*>?CW65Y=;3#8QV+WQ.#'&M"TUJ>!QHM5L\%O>&:8ADD
M.L9C(T^E/!Q/F5Y;O,9*+18I*I+SBTOJB.1I29"$J=6XT_%?96C=M%1U3\!K
MRF[W">[NGW5T2^Y>ZKG<SS6UM1Y$;!"`T-&`&05W?M#S#C;EZ2O#>6,1QE:W
M-D.QR;_9K;D5DDST'8]#G/WB'(F1G7:A+:@X/5YZ:,%E?M;'>PLECU?>Q]![
M%M-IW60NH7O:[*@.'9AVJQJX?3/]NF96TN8S8I7%&4H2MQ,K#;@])L!6Z*!<
MS%+L_*A*C.%53\JY%('@1JDWKY<;%NC#\(9+24_W>#?4O3-A^86\;!<-<]D5
MQ;#[CQCAR/#VJNOGOV0\T\$"7>9=I;S+`FG%;<SQ5E<N+`8"T[%WNT;#<[,H
MCQ6M+L=(\7M>']0=";]T^XNDC,UJ#[[>7`D9Y9E?1'2GS+Z9ZJ>VV9(;6_=_
MLY,._2[`''(9JN7.)`<3<6#ZFE%(W)JHE*1UVD5!%.@\J'4#:H1*UKVGPM[,
M\U6]9;L^)TEM]TFE:X#[5$-Z\R,:NBWWK@E%M$A10774L]K<JNQ:EKVD4-/Y
MM:B&VC?&=8J[$+QMO4DMA<N;K!83CPS4_O9);CS))Y8RN*F:];,-_AC%[3,C
M1A(@295U%PNE[>"G@6'%MB#%0@A)4D(-#177U7H`0[/YL\C&F0L:!JX9Y+SG
MK[<KSJFX8S6\6\5-&D^NO?042N]W^'RW;;:)LN7(F7!O:PTMYI"7FXB%?<2A
MDMI0A!`VDIJ@[O'<=;1^[^>TQG$]GTKS6_LG6\@D<ZN%,L5,'VLN./<&8<U*
M3+0_;S-MJ(\E"VBU&;EOJ8[`<2G=#=*U%*ATWE8\NL-D@>QT8P+0M#MG_(QG
ML/TE*S)LML&#)Y$R?()R(=GL^-VF7/>+<B1Z66[@PXYV6$+=HRW)"E>FB`FI
MIJ/)+%#$^:4D1L;4FA(`X5]*L&$NE$8SS5&GN2YXSKW(WM5HL5ON-MPE$A)4
M\\'(\::VE3:G'Y"/2M##U!L%*E)\M>8[WUA"ZW="W$\P5>6/2VY[G>M?Y5(2
M?>)P'VI9</<.HL,:,N4&9,MM)?#J@VEI0<0`TL5!+"&FW*)!^Z14UUY5=WDE
MV[4?<7N_3W35MMK!$\"233F#0`TSQ4G;(FS6Q;KEQFAR0R5MMM1TH>6E*F]@
M;)2.K:J>(-:ZA?F%^EK21S6VM8K"W?6>5A<>7#^A-QF?)O%>*E^ZWJ(W*O$+
M<J('8#$RZLQOQ#1J-&:6\U'2Y516M80E1J>M=6NW[/N&YR>5;LPYDCZ%6[UU
M;TYT_:NO)@USFF@-*U/X1R/%-O[6.2^#/?%[H>-<;>FY3\[Q'<;WS%C^/Q[/
M!ALJR3C6\1+4U+OU\<DNS(-L5)6E;,>"SOEU4A]U":@^O=&]/NVE@=*]SKIX
M`->5:A?/77'7K.L]R@AM8_*V^WQ:.-2*$U[E:E]2QU2/9Y[BGEE"5KXJ`4$@
M`GYC+;=4TIT!5X#[-;G<!H9Y7%P6!W3_`)>0=H^E4>_2@:4]B3=J84PW)R*\
MXI:(RWRTEM+SN319"%+6^0T&TJB]=Q`ITTK?IC#LUH&"KVL?3O!*SG3;&2W<
MENXT:][<>5%UM9-P3B63"!<&';.BY1[<I;MY5;7I45^>Q+9=EOM,PREQH.QT
MNC:D;@X$)%/)SI_>3;;:V%[WAX..D@9X\5LMVV/XNY$L8HS2`.VG%1UO_%D^
M+Q3S?`M3=KM]UR?$9?S<RW0Y\"1*:MR&W_D:$.H?C3%I)6A5%!82>M3J[NNI
MK30&4E)<:>)P-,,\E3?H]T(9"1&*-^ZT@Y\<4U/T[69<&%>(4MEQ*57S$I"R
MMK8A3L-Z<#0EM*>XMSN&@^'AK-&X;)?/<!@X4'HQJINT`ML&Q.]YKB3Z>"M,
MNP/Y@PM!W*=FK=^[155QIRJ&OCZ?#[-20*D!6*V(`[4@N)`WA#@/4U"EMD!>
MU()405:G11^6"*UJNIHO;]/5>L&DW!QY#\F0Y8!);0^)#D22BQ;'XTA:RHA8
M(2JA2A2=U#7IJ-8OU1EM,:GZ4B-XD;K&`K1/4ME884@BAZ552@VDTI3J2K[?
MMU-3C<U$GA>+*>SKW**L2[3$OSKMRCP9EG4IVY,2W+G<?E79+$N0J.7/F`"4
MJ2E`=3U(2=NC'@H%O&:R/YU%/0N?#._I;\TS.7,E8Y/S+%Y')GN:?EILZ<CG
M3KK<X4F\7R%'FW&=<8$EF(B2Z%"2XAE6X./!H+((`HC#(Z[,;AI)6<FVN5TU
M'$-+\JA=)O%W$-N]NWMFXEX-M%RDWR#Q1B6.X@B^RF$Q95X=MCDB9,NSD4/2
MOE$RIKKJTM=U>Q)":FFK6&$QLAMB02'@5[W56ID/E6I!QI'3V+B%R%TNWJYN
M=:N7&X.$_=-5S'U'H*4/77U?=#3MFK\5M_\`HZ+YQ8W5<B3AYW_PUT#^R^-.
M3[2_:#\G8X=Z;?\`=6])NLF5;U3U8W;F(?)SB<CB/-NM_E4Q$^-&A)E.!2`F
M<MJFYT$?-G6(T[MJX/8P>I@7L/3'_@]O_:?_`-XY4Y^\YWN^[3W%K41UY:RM
M`ZUZ-2PT!4GQ`1U^W7J72?\`X#!W+SO?O_$YO]ZY*#V"5/OD]H%#3_VH_B'[
M:C^-+57^73W4O_@=S_NRH6V_^(0_[P+]*'7@2WJI<^K+E[N,7G@YM*@&Y]NS
MW<G;NJIF3BH;J:'94O4!\B=>Z_)H:H-R9S=;_P"DY>!?.BZ-M>;<[4`#'/AZ
M&JI!CE60ZOMMN!;A2=Z7@%>8"MR2@%7;[9!/7KKVTE>)MNXW>[CZ4<MYID,A
M(D,Q#/A.)"MS$A+;L=P;"IQ+A*0M"2*J2KJFA%#6NA+9=RM?4@N9R_;DMJ#R
M@RRMV/.F;Y8*VGF@I:9=M)H.X26ULRP\VHI<022A-`:$J&GX8M9!KQ3DM_&\
MF`N_)<*$=^:U;G;6I9>G8]?2W:[R1(D6@H0J.B:!ZWFFO!ONN)&X"G44-/`J
M=*&O+:8@JNGGN&Q^3;G5&<J<.Q)R#\U;90BR`L-.H:[J4-J[:U*(4CJ%H[:D
MD=!T\Q]NG[A_G`-&%"EV]P-1PX)9.PW'6>Y%(<+R"-J?6%J`%"$>*>VJE.I/
MV:J_,_,,5,1]2G%KIF:6#$XHCBY3<<>D!FY0E%DJ;2EQ+84I+9(HR4J0JJR`
M/O`DC]>G,1B,U"$D#?RIV.UUI6J=O&%X'G:FDV>\C$<I;*RVXI\Q;?+?`"@E
M\M['+6XM5/50MD^-*UTXR>XC!\0Q4J&UMI&$P/:'`Y8DE>^3.+8',F)2N->1
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MB7`*Z>$-RYOY&D1US`/UE.,V9TX\V"0Q0@X.+CB1R!*Y:??%Q%[1O9'Q_E?+
MGT^..LBX+SW.\D@\=9FKE:Y_WO6C(N'<ABS'LRXPPNUY3/<D8SCV7O6V/_$2
M%JN$R=;A\NW*AMA?=1)#,V@D>#Z%;0W$VW,$LUP9M/`^Z>\*F#CCAK!.3<I@
MQL*X)R_A^]WEN3<6U8=[F[CPS@%R4REPJ9P^V<R8IGTF8%R6MK,")<KLXDJ#
M:4@4U)M[7<GO.BAPXX*Q^-L9(#IMY9;@C"-E"['CPP'V)\52\2Q"9$QO!^0L
MHP;EJU/W"VY1DON(LW'F18%A2I"&V6EN9EA>,0;8958\AR'*^6EWMX`MHAT[
MFM1:V-R(6$T,],17UXY9*DF@MG7(F;&YH:S3I=@X=Z36<<>62YQ[/,S7BZXV
MV)>)ETL7#/(7'M]O5PQZ0U!BQ[I<N<LGMD>WWCF9VWVQ$@2H:#B4&(6%%:'5
M);2&Q\$0D`A!8.(/XN)'8G6Q-(UQC2T<$W$6)RO\JM[!<XM'N*P[*<NM1<QR
M^H;M?,/*<^RL2;=<VGH]JG7S.[9@F.3FE!Q4^YVIOL*[H:#!6[I^:)\3-;1J
M'(9^@<5U[HI121OI^\/[)X)@<J7@>27B':,NP17'64+RZ[V_/[S>V5,8'B`9
M>:2+'C]ML5MNESDS(+:5A!7+>=><6@DH0:EAT%O(W%I!S3F@6H#K:5Y8?NDU
MQYI)7'@QU7R-QPI^/DUHR2]7&U8>W'^7<R#(46]*5N7:-BL.3(R"!:DMJ%'9
M++0(2HGTI4H1W0Z?#I/DI]E_&`&RU\SB:8>M(2"[=,*D3;G%LX%Y@LR$6EU[
MMR8L6]-(48SLJ,Z`EQ+#G4MJJ*CK45&H<T./Y+3HHG8Y(;J81R.'PXQHHY9`
MSD9N$NX9"Q<C.NTF1<Y<^>AQ3D^5-?<>DRS**=KRGWU*)4DTJ:"E*:KG6DC?
M?P5J9[=OAMA^4,AR6G!N]TA'=$F/A%:%!47&2#XIVJ.U((^%-.P74X?H!P`I
MZD^#4!*:/F3Z:"2TVXD^*V5*:6*#R0LJ34G]&G_CI?,T.J0DNBB<"2/S.:/8
MN4P'%H/?<86`'$%P*;6E2#5*PX@':H$5!!K74V*[B:*/P-4S\.>:W4W5IT[T
M/M.5_$71X*.X]5$I2KU_:?$^>I7Q$/XDAT+P/"-2V4W!LE)42E-/4=I\?*@(
M)I_+IVH(!&134D$SVZ=)7AR92J3X&GW-U`GS``H1T_5J0R1GE^7J`>4TRR<'
M!Y83(#FM9<Z.V05N]M/GN(23Y#J55'73;FM::/<T'L-4J6VG>:Z2%H3KK">;
M2E,MHJ6XA2AN!2E*?)0!H*D>6H$\\8`TFIJI-O;&!Q<36H73U_JZKJ?[I?>!
M)2I*">1N+VMWWDIVXEE:Z?H)<\]2-E/FRODRH2$W=87;G<!"#ZE6W]::49'O
M;G-!U2!%XKX[8V^KJIU%YEU(\>OS7Z/Y=3;\:Y&LRI0IQIK:%WXF$^L*JYNH
MDSDD$;)30IT%"(<,J'@?/4%CHIG.$C2=)HFQ_!9W%'3$AUGU-/N-J-"I33BF
MZT'45017;7S^.G5$^&:X_F8A+NQ\B9I8R#:<EO4#MJ0M(CW&2R$J3780&W$C
MIH41]A8/D(,9+Z]BV[SR1=K[>+3D&:/1,B=L[0C,?GR&I45]LO\`?:8FID(6
MW,;#Q*MKNXD]-<<RU+29C1]$Z+-L<1C@!8*&G.IXK>?R/BW(5AV[<7XFXM=2
MY(Q\/69SQ))5^6266DD5\D_X-0?+L>:KVV^Z6V#)7.K^*IRY+0N-CXE^0D3,
M>C9E9+RTE*XD8Y`;A9'WTJ0?EY,67&,KL%E1^Z[6M/'KIYMNV%PDMW/U?UC4
M4[!]"FLN-Q+@+@,$0SHVA/95(I](=26U)5^S0CH04G<D].AVJTMSG27&MWO$
M_4I<LT;P1&TM81@.2L=X>"SQGA:G`DN_DYJI#:&4J'SDL[@TV$-IK7R`U\X]
M22!F^7(I_M2O:-A%=GM_]V$Y(-30"I.J/SQR*MZ(;#N'I.ZG3]'Z*TUWSQR*
M*+3N5N1<K=.M[Z%%J;%DQ5@!).V2PIA1]7V*_FTF*8QW#9VYM<#ZEVE1IYX>
MO!3O]J/&]IPGA;CW#A'84+#:$?-K"$'N/S675R'U>.]PN/U)\>NJW<KM]_N4
M]Z_#S'UIRP`7N?2UE;6>PP6C6^"-M!W''Z2G$S3AG'\C;=<:BM+4V"KN!M#B
MJ%"MM2H&B"10C45LDD?N&A*M9K2W$+C15B<H<`-6HWVY1[<]:KBV\Z._"`:C
MW".$$H;G,K1\O)#E*A2NH/@1K1[/>2NHQ^(!^A>?;QM%KC)&VLA:2H$-MO6_
M\TM^PQ_EIBG'D*3M25N/HW*9VJ*@A?C3KXTKK47;J2-=^*@[L%@F`11D`$`$
MX>E%-ZFH>MCSB5K6MN2PH[C^($`)0>M>N\(IX#2K/_F1W*/=/UVY.6*))<MK
M\LAK6FJN](#NP*J.ZM&Q51U_9\/LU-9_S&CBW%5]P\-L6CFXCV+=L;G=8;VI
M"]HE&@Z%)1(.Q?2@I19.WRKIJ]=0O'XFD_6D;?$7VTD=<F_112Y^;5\%?]T.
MOB/'^GX>/\^I7_T13J'_`/>M%9(N_,K)75@&M0DOD`$>`JEU-!K]N3(\YDE?
MF^S;8@?$X4[UML9?'CK:5\NR5-.-.&DY=#VUI40DK<53<!]NF_.:7AH<"X.!
MI7EV=BZZT@-6,>0^AI_2F_92AG(,AOHF1W47F2)/RR'$%R+U4L-N+2XO<@UI
M6@KKRVQZ(N^F-WO^IH[YCX+E[Y'LTZ`T9G6[E0<>"TK[ANX6L5@]@T,#6U:*
MFIPJ*>TIF$Q9=QY6MO("X3L&#%E6H_(R'$*N+S=I);<6EMKN,L]^A+86I)VT
MW4UX9-\UNE8OF)<]3WKIGQ/C\HMA8W$L\.)=C3E3`K5LZ7W278X]OA>V,`D@
MU!.>![#12:LN/L9FXPQ;LCLMJNK0[3-ER-J5'C7%I2RHF+?+='DL19VY5=CS
M.PCIW*^/C?S*ZKBZWZA^.VR-T.WQPQLC:30X`ZR>533O6LZ?VM^U6'D3'\XF
MIH:@]M>:EEQ5P1GZKA;Q`8QB2>Z0VXSE,8N(<>4RE0`=A#U!*"`#3[QKKSUM
MI.':G`$=ZU<0+F-:,Z*R'A?B?DC$,LDPG<%O]QC]M,B[O8XB+D4,-W"2XZS,
M@2+9(?<>^70GU(V(?2020*ZF1AL0TN;1U>2MMOMI6S"8@:,./)="/#.1HOV)
MVMUJ>F5<+?&3%?6A11/2&%?+(^;CJI*C2UA'[MQ(5U\]6,+B:UK7M6EJ3FI$
M0;JRZR8MR:;6T\A39<<;2IIUMP*04S&BDI3O3T4:;36A`UVX)=&6D!S78&N.
M''-*U.#VR:G![34$$U!["J:_?[],N=R99,FSKV@.XGCG+"EMSKIQO=WT0\5R
MQ.\KN7Y`\AQ,7%\EDL+JRES;;7W3^)V2>YK$7W1&SR7#;JR&C,O8!I#L#EP;
MS[QVJ^N>K]]GVHV.L/N@<'/&HT_M%<O=D]L=_P`PR[,,!]QHSGC++,/EJCW/
M$+A#=Q^0S)2"M"7HJ8W==8?-%-24N*C.M>I"U)(JQ)TSM<#(A:ZZ&,$UQ\53
M7'T!>>LW;=YS(+IS1,"?NX$=_K5LO`_"7..)\(6'&.,+'!Q+CIB7+F,S)=^[
M%PR7)KCMB#(9;S?R\YZ`8$=MIIMU1:0&]R.BJ"7!M6X,>/A0US.(+@.Z@*F0
MSW$\#2*M([:)_P#VY<#L<XV*-F/+*;C._+<GR&U-0T764N).:L=SD6<K==0Z
ML.PW##6M+;9`W*)*E=!K1;?86S8_-F:27$Y&AJ#CCR!]:2;,WP\R:E0:4^M2
MUL/&,&'=!A;L)UB%"4W(@P8SLB+$3;=[GRR&$I=25LA"=JBM2C\375F((&5$
M;:-//$^D\5*BA$+!"S(?TIZKCQUB-EQR3;39H#[-Y:>MT\.1T."1"GM?)3([
MFY"DK2[%?6@E04#7X:Y+$R2VDMG`>3(TAPX'#B.-."EQMT'41XAQ[%S`9G%M
MO#65YG@,R*2YA&4Y)C2TEE26E)MUS<B1%+><HQ^/!:0JH))*QM`ZZ^3KC:I'
M;A/:4?1DA:WM:,B>U>TV^_66W[;%.XM=IC!TD5QYT34W_GG))T867&X\6TJ<
M2A*'6V4(E=AH);2A"MQ6Z4#P4>@I7J=7NV]*-'_,:L17FLCNOS+OIP8]O:UA
M)I6E!3N3P8'Q7S]DO'N8YF^NY0+7BF-7K)&W),02;A>H]HMLB[.1H+94VIYY
M]$8H;!-25#6E@Z4MA&'T.D=G:J:UZCWR*)_GRZFD'#CCRY)^.!/:3#YY]F$3
M,+*W=6>6>39UW:NN09^_)95%8L.2OPULPXD1<EA,5]N$.TZD>M!V@)`(.JM>
MGK>V8V:R`%PX:22,&MSJ&\7=N=%5W6X[INVU_!2D#2_6-0U:G]I/"E$V_P!,
M+V71?;5]0?W06N]S&)V0<:<-X5.@JLKP<@25\V7,7F\&YR7HK4J<]!_+T",%
M$!A"BCU)":6]F'"YHXXMH3ZU0VD3X;A\,U-;0.VF/!6'?5)?4S[,O<*XE/<6
M[QQ:6!N<V;6WLQA[B@[5J4X@)J$]-WQT]>ZW-?(35N-.S[%W=*?!.YU'TJGC
MZ/-M8D(MC+\E%O<8`N-IE/MM.QX]ZMRY,RUR9"7F7PXS%G1TN*3L-=OPZ&5O
M0+]MVX-&-'%W;CCWK-=+1>;N$P=[E/5W+H18]R?)6)39]F6C&;A-OEW8D,7I
M<FU,*D,1I,02[FFV0'78,&XWHO/!U&QMM.Y*PFM=OG&\;O%LS_/E.D.=0`BC
M:]O!>H;>Z\DK:Q-\PL%1C]U?8^;\K\CVB\V:9=+3:7KI*;MTZ5:Y<`PX:65K
M4^$.1X[1[KPCH[X21O!)J``-0[;J>UN.HSLH.J[9!YI;2K0TMU`URK3TUP79
MMOO7;(_<#0:W!N#L.:?#@C';%B]FL=FM;L*1(A9-,5>I,=R$MU^680(+J([R
MW$ML+2$-I6D$)I\3K=[097Q!\S'M>16I'`Y8]HQ',8JI<V...C0`ZM#2F8YT
MR4E7DN.R+>3XH:7+6%5](^6[#?\`Z>J00GQ\#J[::.!.54RMN)L3*ZJ25)`6
MMO>D+#8.W>&^CFPJ\_`T--/2RZJ:"5U-/PC@C>!0,[K(6MS),X<NDU+\AI?9
MNL''+!89S;*QM'RCLFV*=:2?4E"P-%II9'H-`ZJ:@:61Z79U3W)1WF?2I*TD
MA(4DA:5J)/1"TD@E)'ZCJ2\.<TAN:=K3%0E]I'*.!YWR][J<:Q6],7/(..\S
M5:LO81C,RR"%+=R._P`%`CW*1#CLWAANX6B4RXX@G<X@*]0(5IFUG:]^BI+P
M5$M)&OU,%=6HGDM/G1:'_>O[7VEMA78JZEM)&P%5_P`?=)3T!*Z,^0\NA\=,
MR/U7NO&C3BF[JOQL#C[@U5]G!3`Y(<#6'7)WTH"2I042$;@U"G.^)/520GRI
M2NK37&9H*?W[/:Z@]I"D7=#;O(RTGZ"N!Z[%*I+BZD[U.K0LFJE[G%$E:J=3
MU\=?4^\1N9MKB,`V`C#L80?:OFZ"INFMX>=_\-=#_L_@L+]KWL)1)NHMKCON
M8OL^)!^7F/KR5^/BG.!59RN&.U'#,8KGER20P?D=HJXIL:^8NJ"7;U&'8BC<
M_P#=A>V]*L#=D@U@5U2?]XY4E^[9U,GW1^X=T&H/,F?HJ#6I9R&:QXTZ_NM>
MP],P.&PP4`X_4O+M\>U^YSZ?[UR6?L$H/?)[/^I'_M2'$`!'_P`>=JZ'[#I'
M4C2=DN@,Q$5%VW_Q"'_>!?I1Z^?P:Y+>JF?ZKV-P,CNG"C$QY+3K=NSQ,=)-
M"X77\6"NM4D)3M%>H/77O?R5<QD.Y.?E6W_TGKY[^=]LZXN]M#0"=$^?<U4H
MY!Q=>K:MMZW@/!*D]@!2P.PN@(W@K*EJ52I/7X]!77M`7A\ELZ.GEM`KR_<B
M-EUZRN/0IBIEGN!<4AKUG:F4E*%HD)25*;<0P2%%"P0X5)'A73\,9=^90&,'
M'^A);<&&%P&,U?9QQ0GS$7<H-S:89NR4AI<R&4MM7($U#KR*?A.$#K0@*)Z]
M>NI<I9KK%@V@RPX8J`Y['/\`$T!Y[/K1C:[XNW`L]Y:7DH)2TH[-JE(]6P=4
M[5)^ZH>=3XZ9T@FM,4KS?+PJ15*6+=Y,YYLJ`(V(`0I!5Z@K84MN;BNJB>I^
M&G'1N9BY2;?WCW)PK3*+-0=J#X463N2``H4HL-K:&\#=MK4:@.:W63A6JN;.
M[='X-(U<#V?T(_+<:2E8<80MQT;]BMI!<J:U(5]]04*>)'ATIKB[-%"XDM`<
M2,R.*3=QQ.U./EYII,22E04)D847X`[=X+:@4UJ2:`Z4UCG9*+`UMM,U[P`.
MQ'MGS3(;&8\&ZOKO$"&?ZHMYP-SK<TI0!;MLT!:HR%[:]ES>R3X(W>K26DQX
MQ^$]G;@?6,TX9F"42L)#ZXGC12JR'ZAS?$7"[,[)\NQS%['9&T69[D#-[G$L
M<''(;B:6Z!=I-RD"(Q,<W*:BN`D/!`;0O<-NOFSYG]%_HV[,WFRB(L+L%SJ-
MHQCCGE@T=O,KZ3^5>_;5OEH=OW`C]0A<6L$CL9`!G0YTY<*57--[G_K'8+?<
MKN-D]O:1S;G5U?D1Y?*^6.77'^'<:7^)NF+N+S+-]RMN-LJU&@--1GET`D**
MJGS5C2UXC81I)&1PQ7J-W#;V<7G7%"&FH8.-.%.%54WF7)&=7+-KCR'S19YO
MNHNMSL3S+,FX3+KCV+X4N:'EN6K"N/<=DN0<>MD'<AUN4Y&D2G'4)<6\2"DV
M@LH3_%`#^#AX@.=1Q51=W4-[(VVN@V",BH\(!`/-WWOJ2\M')5KY(Q[&L'QG
MG"'G[-M"7<EP/W3V6PV7',*QME45N/:L"Y)GW*_9#<YR0B0V0NUR_E!VG0D)
MW(%J;>+2`YK7#L(;^W<AUE*T-NFNK$'4#V.J<LJC')9$YQ9;):F[%#@W?AZU
MRIK4>P\6<DP(>?>UB]7:&X)C6;Y%FUQN-CL4E<EM+CD.)&M4Z,EYU:$,J#BJ
MR!Y0C$;0&TX9T]*D-%L7!L<GYO!I-"?1[4G[B;-B,>;DMM7G/%%JR)]5N>Y(
MXQN<B]X)SI=I"ES(ENM%ANT7CR%AG'#$B6'*L08;3D*6\D.%2`O4:=SR\`NQ
MH/NZO;P^I-R.F&H-E:P-P+2,3VCF#P1!?H-RNL:=D-QLF%WR-:<0:LE[Y@]O
M;EVQO'N*<4G.PW)F/JM-B8P)KD',8ZWVDSDNW&_,N,S-WW6UK<1'"2X/D<0]
MN1!Q'/%/N=&7ZV9M8V@X$G.J3+]YN=_M%LBXA=L3Y>LUGAM8QQ+PQR+8HZ,M
ML3##):OO(608KB=GL_&L5SMH0ZN;D3B'UM/HDNJ2Z?F5/B,/=D"[F5)TVQ:'
MRTT'[S30!W(D>G!,[-Q;CF!.ODG"LESOBB;CBAA2%2)`OM^Y*R[(0ZI=OM4O
M%7(_&M@LD-]MEJ2A-\<)9<:=0TZ$NOH8-LV25S=3F-'O`XAW]D</0D%K\HWM
MDCX<&GT?MBBZ;:N2;-=\=LF3VNV9WC?%$15QOF(<7+A[+:DON/3EY;D>.6F1
M$7-1(JI]U,R0I\K[D=U:4J<"'QRO/EAFF$9.:/II[4AL5EY1:U_E79=B3E3D
M!]:1L21@^=?E$:/=8UHO]^ODM=PMUV9;M^(X?C84PI/<R.X29]VO-S2IUPEM
MJ(E*ZC8*!0#4<'Q3M#=#B`3B1@I,;9FAS6`NC;Q&+CW\4CLJXAA2+8J_VF&X
MSB4C(KA9+!EA0Y#:R=22RY&3&COO)9<<;86DI4PCMNEP[5N`!0@S6$#VUC-'
MD\,$[:[A,7&``N=G7,`#@3P=V<TPM]XVNUF5Z)#,D)<0AR,H%J:C>VAY"R@%
M;/;4VL4JH*KXC4"6QD8PN:`2!GQ5S')5@,A`>D!(9>CN%I]MQE:30)=24FE2
M!2HH1T\NFJQ[)0?&#5*,K!QJL`.W[M4GXI])I^D4--)U.YE-OF/^S)"R_,2!
M3;(=3_X:C_A/34UMT0T#4[`<RG&W%`*N-:=J]&5)5U5)>4:>)6K_``UKI$D^
MMI!))(3+YI"^K7.T]Y6$K6HU4M2C\5*)_P`).HH>YONDA)\Z7\3O65Y_Q=1^
MGXZ-3N92=;N9]:ZP/]77"F>!?=I*JBCO*W';`JFJE%G"+LL^?5*?F1^BOVZU
M73K'")[SE4IEY_,E+C7\@=JJ_P#K$W!N=[Z\V055,#`N,HE!XI4<=$L)^Q.V
M4*_;J5<SQNGU"N%.')3(V$6C`?[L?0H(X;Q9RAG\;*+W@O'V:YG:<>ND6%?)
MV+XW<K]'MLV7;FGX\:6+?&DNH>>8:*PE*2=E":`C42UBD<Y[F@EI(51+N=C;
MR"WGE:QYK0.-/4M2[0KOCJY=HNUFN6/!UR&X_$OMLF6R>F1$9<;*2BY1XS[=
M77W-P``/0&M-.N<&"KZ@=H4@7$#A6-[7MYM-1ZT5M$J&X*)1TW*0:CPZ=14'
M21(QQH*KI(=&Z6,4(XY(YM\FVPYL1^X0(][C-*0^NWSF^["DK2HE#,MHD=QH
M$`D>>NF-C_>`H5"?+*XZ`YP><`<<"<CZ$MY-PX<NP4JY<66^U25D*7(Q&\WC
M'UI-:K"8J9DJ`-P)_P!R`'D!IB2P@--!]B;9:[NW*['^4W5ZJY(NN-@XS9@O
M7#&+_G5OF,(;=8L=YF6Z\6Z6=P[S#LOM0Y<=(024D(6?\.@0/9[KR?24];37
M\TACN_+,0&%``:CC]*2E%+2%5*?#J*?M=1\000-.L+0=)]]2BUKB8FCQFO#Z
MU9[PI9GI7%.#R`XV`Y9B14$JI\[+'4T3\-?-O4T;G;[<EN7F%>T;%AM%NTYB
M-.A_#KPZ]QD'[$ZHO)D[/6K1TC6YK.,<=(!+S85Y$)\OTUKIUT=6``#4N@UQ
MX+TG''*C=(33S])_V=,LHR0:\AFDF5C30YA6!\-VQTXE;72[V]L6.T"BJ2IM
M+834=:^*?T:@3-;YA(`H5[OTN\R[)`ZI)+<T_L:(A$<I"31]OU("B=Q01UZ=
M0HI/\^F&LI[RTCK6)L;FO>[')(C,,`L.06Z9&EL)[<QI33V_U+!`)0L)()K4
MT5X>.K"WE:QPT5![%0[E9"2+P4`#:5R.2HR]UG"7]UM\CS(?JA9!WMB4I*5)
M,=YI>[J2"5A?VTUHHKD3/9XG''"J\VW+;&Q1"3[Q)]./%01N56DO)*2-E*I4
M*;J*.TD>!!Z:NK/_`)D+'74C&`UP8,^]$P?2[:%)4O<XW.&\T]02M9Z?:$GP
MU/#'-NGD\1]:J3*UUDUIJ3C2J-L>E):3-1O2>TAX)W`=.X2LBGQ2!_+J/N#'
M!P/`MIZ\`I&U2!L,@=75H/U*4_YRC[?^YU7]VG[WQ_1]GAJ73_YMI]/[<5(\
MQG_[V5K80VM\>B/Z`4]$I)*MWII_6*@5&OV^,<8Q."_-&-[G$@DI4B!!D&.W
M+AQ7T*=CA:'&4N(<'=;)"P0OH:>'GIED<9N&BC:%XJ>-*XX]J=?))Y3M)Q#2
M1Z`H\)LD$\BY,7&E)AH1%=:9J&XC15(O)7\J`4J[M$)W)/I^[TZ:^;?YCNK&
M[9:_X?VCS(9+F0"3Q$#RA&<*\=1P[3@O2_EY8.G#=QF%1$./$NR/H6X];6HS
MSI:;":N;4IVI4$))W'>`?@:>/CKXEH*U``)7K:<7!%,P+["N8@)EN1E=QB*R
M%DNOH"J+<2%;>P@J!(IU(^S3\!#7$DTP0K0?;O>;_=)R5.=ZWKE`MN+;_P#6
M.*5`.=B@`$AX`A)KZ1XGRU<636.<7.SX=JD022"0-8KDN-LFE62#%B69KL,I
M#2?FU@-N**4@E?<*J..[R"#3XFO34\Q1EVH@56HA>6!H8<./>I88C?56)?SK
M(=,YUSYR6\M:DN2S(3^,$NM!UE>])J0005@52=-S,.&@>I6S'X>)2/M&8VZX
M)@QW7T19-PJB/,=12WS)`Z_*"2FJ(L]P=4-K*4N*&U)W^C4&=KHV:)`2ZM=7
M#N[TK4#@$1YY;;[:&6LHQM3J;C`.Z7&:*PF;$3ZG%)"3N4\V#57Q3^C47RY:
M>9J'E4R]B<UNTZ."AA[K7.,>9,:X[9S;`VKIEDC,X5I&4QD+@7>!:%1G&9EO
M5=F$A4N.M^2TX(SW=;2$%0"217C-+0V,4ID/I4&]MV3M:2*N!&6&%>Q+;-;3
M8<!XHN4EF*EBV83BDVXPX":)3+F&.(ECBMFB2ZN3,##24CJ5K%.IU*G?Y41<
MV@=7#O4SRXQ$0!BW+]N*,N`N.&N/.)L'Q&3VF+HU9H\BZNE+>YR]7(+NESJD
M_?*ITMROF?'78VMCC:TX`?2<3[4B-@8V@PKCZ4?/Q&W\J7?&FFU"#;F<>C@H
M`^9?^8+[SII7JDN$"GD#KFMVO_T:[I&K5Q1G?HB9\UB*M&]J-M[M.J.YN0I2
M4)Z[BD@@:=!!]U*53_N!]E^,<B\_YGELRBDY7;[5DB(\APF(U(8A0K+>W(S"
M22T_\]';=<*@`KYD*2H^H)Q5WL]I#>ON"T&1YJ3V]R5.R2_+?,>?`*#&@IW)
M)8/[.^`TWU+$N!&RZY<;7^W9"\FSO&*YC-_@1'Y$:/>'&YL5$Z0+9-6]\HO>
ME2-O<1N**N064.,]08A@>0)X*.RVMP_2[,=IX*?-OQJVV:+%:M4=EJ`&FGHO
M80E#;D=Q*7([O@%#N-J!%>M#Y:GM;&&:&TT*P#F#"HHCYMI:QZP5E/0A2BI5
M/(4)K0']6EEQH`,@$B24ZAH(5=O`;"%_4P^H&[1*UL\0^U:.GP)2A5EER%'I
MU'5'2OC75?`1\7)3\(^E5YI\?)7^+I%1Z>2U?JNK<9]E_N"$5&Y]S!\9CL4H
M3N<S%N@23TW>@^/QTJXUEI:[^&33T*'N[B+!VCWJM^E5B_ZOC<\H?OW($?);
M<&F;0;`Q8I$BW);=DQ9C5\>ENHE$%B7VI#(3O;`(`HHG4R6ZE>8;1Q'DQ#PB
M@P!Q./'TJJZ9$39Y71$>93'&JM_YU@W[)O<%F#[%N3;[1B'$R[XNZ-1'8T)U
MRV7%F?(86Y%#*2_+98+*%*)`*@3\-87JSH9W7D/Z,)'P/+M37@8>M>B[!OWZ
M)N#KI\9D:82,JBM<N]2<]J.!7RU\?R[ER);L?9A93>)5^D6N]VI<>XVFVP5W
M(PI!N*9D=EEJ7&F]U;ZB"$('B#4&V]'Q[;=>=,8S*Y@BU8:B&C30NS.';GBB
M3<Y[NT,3_#&75+:`#U<"GL3CN'V;-%93@EMEW.=R$^S\TZP\RSBC#U@L+[,2
M5:DI:0F*T_%>^8D$%:I13W$;J*(U\6RQ[;=SWFN1\UXZ-S@7N+1Y3"Q@8PG2
MP!N!#0`3B:E4+&1B>66'%\GO8URY#AZ$\HB*VMJ7V7)2@R'U1@H1D%M&U#,<
M.%3J8C/4`J)6HDJ/4T$W2[3JIX4H@C`I-6O$,;G9W-Y"@9/?Y]UFXE'P%NRL
M7H/8%_R?>IM]7-@VMN*MA67=]3L=<KOD*8:[6W<#I1BE$8E+2(CD:8+@(.2S
MYQA]DR_%;WA=^NUPL$;*XESM,.^8]+8BYA;)EQBK;5=L4=?A7`1<@M:72XQ)
M2P\&5#<H;:Z7+#&^D;!60\!GER7"]K7:20'<DM+98+?CUBLMNM6YR"PS%ML9
MYYMMJ3*?CI5$E3;F&68H-WDRHJW):RV@K?*U4ZTTECY&`1LX8)8<6.J,T36/
M"\-Q-_(;_CN(8MCMWRB6JYY7=+#C]HM5VR&=',AT3,CN%NAQY-[F-N/NJ#DA
M;J_Q%&M5*JN!D<1UNP>3Q36EK"90/%1<EGN;^I+S[F/U*N/L;X]A6_&<<LW)
M?$O%V%*8MD6?)C1Y_*K%DRO)%IN`6[<;Q?XB.RX&V)#,..AL;&U?C&NDF!N7
MB$@D\L5GGWLT]TUK01I>!EP.?T+JTYP:%LQ+*VT$J;C1\@[1]6Q*6+'?'$%"
M5&I`#?6O4TU?VS=<\#2,3/#Z_,:KR[+6POU8,T2'U1N(]H"X(I@5L13H.U50
M/B:]>GP\=?6.]D?`7#3[K8GT]17S=:D"XC><M;7$^FI/UKH\]H26(_MY^G3%
M7:$W)ZX\UY[)C7`NRT#''(?'_.LE=R0W'I%?=FQM\#;)JV!*W(_%"#KY:ZIJ
MW>V#[P:WU^6%[GTW4;/:-.3G2U[1K<1]-0J)O<Z4R/<9SY(2-N[F+D>H))KL
MRNZ-CJ:']G7NO3$8_0[<.!H8P?21BO)=WPW*?_>N3@^P-"A[Y?9^2D[?](_B
M'KY4.:6K_$=1>J(M&PWCP"`(G)BP<1?P$9^8/K7Z3P\/Y?\`#KYR;[JWZI,^
MKS8KU=+CP9*L<QR+*APL\:JV1ZC(D8HI!4D]%;5,]/@3KW?Y-4\G<@[W-5O_
M`*3U\^_.UUPVZVWX<5?Y=QPK]UJIGB91RWCB1'NT-BZVYP*8*W4J[["5>I*R
MG:D'X[J]"G]6O<8VAQ.I>&17NX6\5+N,:Q]X"H/U!:DV:J\L?./1DJ.YQEM2
MFJK312E;%E0W%RJE&O@233X:L3&V."C,`:*(Y_F.,GXC7UHM8CMJ3ZUJ6`04
M$I2DC:">B02X`*>73RU'1%")"][@?"*@K,(K*PE"]B5A(V.E(46U)'H552AL
M%$T(K6NA-N8UQJ5NP7BRZE*'4$#I5+B4+;7N0?1T3N`W$5-!6NEN>]X\2<CD
M-:1FKDZL4&4AK:MIM;([O=\%K14;-VT5*ZJVJ(-/ATU`?[Y[U8,+VT)P>CR-
M)DH[32^XXLIJEQ--Z%554GH`4MJ617H:=-<JG/BG#PEI)Y\%O%X.A)<!<HPI
M03M4E3:_!7I0:*`H?52IIKK7N;DDN>YY\2TWT!W\-(`*14E+04XI8&T.+VK*
M2DA1_01UT]IAYCUI)P.DX.15-Q+#LWM%^P/DK'8&0X!F-MDX_E-IGQ&9<6XV
MB>$1I;,AF4AQL)22E;:P`XP\EMYM27&P=)O;2#<]NDVFY`DM900`<:%V`(.8
MH<:!2;2^GLIVRVC]%PPZ@1F",<_JXC!<H7N4]MKWMYSSD+CUJ-&N47$;A,:Q
MYUJ*`C(\;E(+]@N,EI2&Z_.VEYHR0E*@'DN)%0!KXUZ@V>;9-UEVQXQ@-!A2
M@%:?TKZ0Z9WA^[VL%](\ND<\>82:^($:NP=V054ECY8Y4XON"V6EJ?L:9+I3
M8I_S$FUQ&%NJ4(]LDEWYZUH;`HA*'=B!XI5JH;>20\"ZJ]GEL]OW6-I)B<^E
M#B*]E.2D+9>8>%N7`U;\XMS>,7]YKL?-/R$0%..+[B5!F_1D-QI))74":E!)
M\`2>MQ:7-G<1D.-)J5]X_0L_<;1N.V.U6-'6O)V&/8W+TYIW+2.8^.HZX_'N
M71.1\)*0IW"<M89N#,N(X`2RU%FO?*.)(3M"HS[(/4A!K0OQN?H`<"Z/L^T*
MMN;RSO'-M=PB,4V56DAP[B,2L5GY1P2!=ERL>=S'VL\EN0W[>]-LKDF9B@[[
MCJUAEB6V+KCB5/.J/<B?+!()]:A74J)[``T#2"<CG[<4\-OW#;V"6P>R[M@W
M".2FL9FNKWCV5*WI4UNRW/'G\@Q&W/K5N5@%^X/NT,L9#E$WOLC*\RBWNV\A
MY/F#MFES4O*8:MSCACH4REU"MBQ-\F,YZQ_9%?6FK>X9)%D;=P#B[7EJ/NAI
M=GQP6";,1E$*XSK[/L7(5N;N27LXY:C2&+%R0Y*AE;L7$<8G\@7IN9`CMLS4
M-K5!@(#K30!BJ<:(*HK=V+X7:XQF3@X=E.0YI8F>&-<&$2S"C:#5&VGO/=7"
MI//*JU[?,R9Q.-6BT28&51X4%ZYX1P1R1;[E/L>&P4=IV)DV0F^0L4P^[7.'
M$[*@Y-A7"-)BO;NXZY2B'6SW2,=5KWO/@;6GK(].:&7#2*W;:0#-\9J3PKH&
M`QX`98I+-1\'^63:57V\\<V2TW49%R)?KU7+^-LURVWJB)E8GB&&87&1@LN,
MIAHA#$JYQNY;B0^\X5(8"7Q,!,8+VR-%234-'93(CM.:G^;I+7-\F9CL&M)`
M?ZA0_6E3#9@)CWC->>^'6>0;/DMJ:MN)2;+D+>)R,.Q%MB$_:KQ:<-L,M,ZS
MA^.1V791N(;CG8(S8`43R`]GGRM<R-H(U,;08YUI[%%-Y#'<"VA,D>XU]WQ:
M1WDJ/>,<>X_RKR*QA/'%PR.XP;;'D7.`UD5XM]MM-H:+D8,!^^W,VIF.PPA;
M:7'E-10Z[Z6A4@:@006\Y+;4ODI7AP';V*=([=+"T;+,U@E>\U#:$FIP.GD>
M:6\^X<?X;'S"5>^(;QG3;EO?QG'\R_BF\1<,Q_+O[-=+I,>L]HVY&_:2I+R6
MFI3+;3E6U!9.Y*)6M:]L38W5KXCC3THM;AEP]S9Y=-]IJ(B`WNJ<Z$8U2.'%
MO'W(,Q%JPCD.QNL6?"I&19?DG*"K)QG9F[K#BN2EV;%FW[O=;G?GY.W8R`TA
M>X^HTZAN2".2IB;5H&-.:L!)+!1LL="[$:22**+=PPEB3ND620E;.]20"5*;
M)02%TW`.('IJ/\GK36?DLF/'Y.!&?%375937A7)(:;:I\!1$B,M"0*]P>ILI
MJ?4%)J`/TTU#DB:T4;BX+G'%%PZBHZ@]01U!'V'3.APQH:+J&DH0T(75[_J^
M,B-"]M?N<==44KE<SXTBBNC93&P%@@U!%54?.MAL#7FR>Y@)!=3TUR55/);P
MW,SIGAI,0S-%3Y]5B\&?[[^:UK7WF8[6`6UM0).UJ-Q_C2A0T!])<-*Z9NBQ
MEP6`^+EVK3VPCEM8W-\0,8R4N?I399$Q_C_FF5,_-'XAY3QMK=:[5<[S+:+V
M&J0B2_$M$67+3#0(A[CP1M;(%?'5UL%P6Q2&$M+2X<`<@5Y/UA8PR;G`^4AH
M#'9FF9"M[;SS`<B0;5>IN*7Q)0'';7D[-N?*([C$>0/F+7D3(E)3\M+;*MS.
MU)70T-::'SK;_;-8\<J#-8PPS,N"VW=(R,B@HYP:.VE:)!93[5?:=G;3JK[P
M!Q^)4DJ6Y=,>MDC$)[0)4-[;^)RK*V%!?6J@:D:8=#MLY($5"[D2`KNPFW6T
M`#+DN#<#4AP/?50!]W/T_?;QQIP/R'RSQR[G6/7_``R';+G#M$O(TY#C=P;F
M9#:;/)A/,W6"N\L;&+J5MN(FJVK0`I*DDZH+RW9`WP`@ZO8MQT_>W5W(8;AP
M?0$X`#Z%2`A2DI73Q)'JZ>']&A\1U\=5DCRVE%K8H@:ZP5N)HH#P-4BHZ4IU
M\M,^:]1Q`6.):TK("2`FO3P\:]/Y?+2-;@[7QJG6^<,&M)/=C^P3MV3WT/<9
M66VX`,%:N?\`"T;\M$]5S4S\U^(Y(#Q:2WZ#_6*4^S7FNZ=%3WNXS739V-#W
MDT*U-KU<RPMVV3HRXQBE1Q[5OJ^I%</]SXWB&GCNN[G^!+.H`^7]Q_U+/8GG
M=;PN]Z)RP+^I'?/V.-[;X]";J^>GZHYUS_`#N-TZO]D+HZYC`PB*TG/J1942
M>WQS9$@_="[G+-/#S[(KUUP?+V,NU27+B./A"CNZV+GFD`T\ZFOJR5G/MP]W
MN?YKC/'5RM&.V.PJF1)[N3-7^8H18\*W3W(L1^WP"MJY2H%T;HIN2ELME84D
M*JFFL;NW3KK&]DA+FNA!\)!KA3CVUX+Z#Z'ZJ^-V2*.(%LS!BVE2.VG(\U;K
MA',..Y#$8;N]IMC,UQMLH=L\M1AJ<KZ%I3,2F6D>'Q&J+X%S2![Q/)>FLW$S
M1`RD-<,ZT"?NRX2G)7_ZS%;B1G(#LV#^*M#LMM#'=<2DJ0D+=*5$I"`3T.KW
M;]C9+&9)000.T46%WKJB\AN?(C\OX6N)%"55)]5'`+=C^+\:7""TTA3UXN;3
MO9<+CJ6#$:=1W?\`PT?JIIORFVQTM(UM."@7,S[IC6O'AI4#OQ]N:H*RMLLO
M*9"5'O!@@GH15032@\CW/YCJ]VYP?(V2HRQ["L#NS-#7M`I4I$05J-JN!ZI0
MR^PXL;:T(D.MU!I4I\!]FK:4GXS3P*J;=C'VI#O>:VO<C*P$B3/2*E+S)<0*
MU*4+[E"H>*14?JTG<6LU,U>Y6GI"<VD!SW1GB34=A^U2&^?=^"/^Z!L_5\/_
M`$>IE(>8_A\U`^*GY_\`VEJR&:N),ITKWC9N--U%*42`:]?6X*?;K]K7W-L\
M4J5^=D,5T21I",(UWDB1&#B$J3WV156T@_B)`K^"H_RG3,=S;BX8T'$R-`[R
M:!//9/%&Y[P-.D_0FPO+:!=KA*2D)>DR5)<6GHI2(ZW0VDJK4A)=41^DZ^'/
MYA]P9>]?2V0=XH8A5O`$-Q7M?040AV*.05)E./90\%C9G-M(J^Q\W104M+KB
MDI5UZ`E"@JAKKY]6\6Y'O=Q:_"A.)@M**5E$4%`I2J1N)4XH^H>)I]FA"F=P
M1S#D.'O1&7D?,0Y/H?D&A>JI1<W44>TH*[:0I1`.T:L;2Y<)&QT&D#ZD];NT
MS!W[9*\3VY<KVO/U)L<*:9=ZBQ8TV?&-$,1VI![304Z$]L5)(2-Q4JA(%-7T
M;R]NHX+163O--#A3%6@8OA\GLLJF=M"MH#>QJI!0FJE%9``V=!X>)TM7">?&
M,58^3GPI3?>0\IN8ZHHKN=<4XV5-^D!"AM0HUK58)^&DO8UXTO%0NM)!P1C?
M\W5QXXTQG$,OX?(0VTK*AZC9I#[B66OSUG;M3;)04E(E5HV\=CE-R%*I+RZ;
M:SB,M!B)Q4Z*)TT+I&^^.'-19YDPM$K-^-;+C[\>\XY=LJ<S)3L-8?\`R>,J
MV..--3"TD=EBYO6Y8BJ/WRTI-*I.NRF*2:.2+`-X=I3.E[<'BA7CF&(O+^1\
M&XY94I&/XBU&SC/"DTCR'+6:XO8Y(Z)4E=P0992:U+*"1XZX\?$.="[`,<#A
MQ2'O+<DYUH;6FV.Y%,.Z3/[B;<PL*`BL_<:[*"24T`'7KJ2]NL4."<&(1(S^
M"X4)6%LVW\52D@*#TUP@T)'FA%2`?CKF@:-'!"RJD-.I=D]XI*%A4@A>TI2J
MI4K<.H2FG376-#,!S0JW/>/[U.&_:GE^&M<EKN,>X<B8S.D6R9;[3.NRW;=C
M-Y#$J,I<,[8_9E7)#A21N45`JKM32@W+^-7M4*;<X;(`ST&K+T*M;"??O[(\
M>Y&S+D&#E?*+R,V>?NF18>JV9;'Q.XSTI2@R)4&!$#]Q6I"U`-+<*=I*35)V
MZJ6,,9.EQT',<*J"-ZL=1=4J1DOZQ?M0+X$BZ7J*7OEBRR[A69Q3LD)?=C.-
MMJLG1AU$=?;*`4+#9"3TU*;*YK=(%5T[Y8\UL,?5\]HZRKN9)=$G?OK_``EF
MZJ!513IC9J0#X:5Y[LZ(_7;&N#EH6WZIGL0M.3WW,8$BW6K,<W8L=HR?*&<#
MS2)?\GBXU'DMX_`O5TCX<94^/9HK[J8R'5%+25$#RT>=$)#*YH;4<$M^_;>\
MZL`_B>)47/?U[]?;=S_[6N9,"X\STOYOD=HQFWX]8W<:R^()J8-_-PN3BKI=
M+#;8#*VV%$A*E()H`"2=-S3:V4`\)<*>O!5U]NME+;N:TG42%$CZ1ON&Q+VL
MV#-,C]PN0.XYC<==I7B=T9L5\O[4FVH7=&KP)LG&K7>)4!,*5(%%2VT="!4@
M=+6>VWEEK%<747_U<P.TD##$XDG/#U*!L=Y8VEQ)1SC*\4H>U6[X]]5SV-7G
MDC(+P_R^T;5=,9_AU$=>/YFTT5RY"$*="Y.'(2':J!3NIUH=06WT,;M4;]+^
M86E_4[-O\1U$ZG(/U'_9-GN*Y#Q[=.:I-@Q9-MDXKEUSM</)(5W1<927+=:[
M2B2O%W%5+=NDO.%`6TX&@%*VFBD/N[5[2'.QY\DJ7>+&1F@/<VO)%7"7O^]A
M'$%N3%5[J;]G#L>&JUV>9R!<+O(38+266HR8%KA1,4ML4N?*,(9+[P>D=D;`
MH)*MW(KJ%@TND+^5:8>I-6VY;?;"@D<X]H3\N?5"]B]]L]P@M<^8W!:N\2=;
M!.C2;FQ(9>F1G6BN*XJT)K*80X7$TKM(J=/B_M]!94$&OM3DFZV,H(#Z.(I7
M@$R'MO\`>5[-N`,<C8_E?O6Q[.K%8+G,>P6WWQ42P0+!'FKFO]B5,,,S[]+A
MN2W%M=]\-,K7N2CHC817T<=`YY?$/NG))M+FS@!$LVLDX:>'>CWEWWF>TO->
M3.+.6<1]\_'7%\C"XUWLTN!<[E8;I9LCQ_(GHKEW1'AW>9`AHN+C$9-'BE02
M$(4#Z>O1N!;<"YM74E'I%$?%;?<S:V7$>H(ZYL^L[[#>%F.++7;N2)W,<6Z9
M4E^Y77BF^83F,FU&0BZLJE9:'LBM"&UW6X3BXEID)"&FAM2!L26V73FO\R7$
MYDIR?=+")[6Z]1.9&7H4PD^^WV?2V'VS[@>)7$NH=]*>0<1:):?2:JVNW=)3
MZ%GITIX4TX;R![PXI<=]9RMUME8&]M:_T*'6-<?_`$J;+S/AON.L.1<=#DSC
M2YY+E&.9`WR[99=MM]TR2%(@W2[7&V.Y"Y;Y"V&I:W8ZG`D1GB'$]4@CA;8^
M=YS2X.Y`8)+7V#)O/#F/=R'!2SYA]QG#>0<=Y:(7)&&*=5B>52VGI&7XRVT^
MX<3OC4*/&5^;K6_(FRI#:6DIJ7%*`352@#=[7(+G<K:.W:][Q<Q&@'#S&XIC
M<KJV-C,ZM/RW^UI;]:XFI844MBGJ[#8HJH(.U/I-?`I\-?6F^P:=NNR\%K]#
M\#GQ7SM%I)`9BT`@>@$?4NE?VC)G-\)?3:B1[PU;H;V8\H3+G9G)CT=_*6F,
M$Y75'C1X;3:V[FFS7!]N:XVM24M(:[@JH`:^4NII#+U"20!1S1_^:8O>=@_\
M+L>X_0N?[W`.=_G7FN1_XQR_R6X00*"N9WF@%.E!KZ)Z>A`V2VQ/\(+R+=__
M`!*?_>N3K^P@5]\/M``Z?^U(</CITZ?QI:O#4+JQH/3=\.4#OI"BV/\`S\/^
M\'UK])0:^90*`#DO0E3_`/5%OUHM5[X4B75T,)FP,X6T\4[PCY>1C&\E-1N"
M>X#Y"E=>[?)P5M=R']:W_P!)Z\(^<9I>[=_8N/\`1:J=+Y>3&A.7,K:D0D3'
M8,)UY!V.1&B47&Y!AX"7*^7D*0V2A)2$M.T)-*>^P6X).)7@-[/,Z,-B:TUS
MJ4SMWRAIB0ZJK;:TBB&T-H924>*264C:'%?I"CO^S4F5I$5,>"JA/$&Z`?S6
MC$=V:;M>=H#X;6EMI5=H#;O['[2E^D"BE'P!H=-"*L>O&JC0[BP..MU-6!'"
MB446_0YB"Z7"5D!0#)*P7!]\;MJ0-R5>0J*_HTS0J5\7:_B^A'+-QCJVNLO(
MW+-$MN+&QP4&Y*CU62H4IT%2?T'10I$5Q#&\/A.IPX%.GBUX$IME#B6W%(*T
MM;J)`'12T)'JZ^0'45'AYF/)%0%PJK1ESYSJD`%V*6KC,Y#3SS24NLJ"2A6Y
M"NJJE2%]:*6$`]32G0^.F:%2&@.<!S*QINT5NC;SC8D!)0@-D)0VX0G:RX54
M-2I2J=""1\*:*%.2^1"0'N()6:;>7&HCTB/&9?F=O\!M;FU*U5VJ4'&QVJ"G
MA0]-*8W4\-.1*C3R>/S<*G!,/EF;<OP&WUVW'[>MGM.%O;-4PIQ*$II4]E:2
M010>1(\M7,-J&O`!."SMWN=PR1[8(7.>#@1D>?L4%>>,?MWN)0FVYC;(V%\I
MV:T&!BV7N.*-MGQ&`_)CXIEU4#O6@RY#@BS0GOV]QPG\2.5-ZPW7ORU;U5MT
MEYMD;1O;:$$UK+IQ+13[W`=IQ5GT=\U9=JW+])N'F*U<'%P=]W\1'[<%2+R+
MPI;W;I=;)D5H=M%_MDF3;+G%<;2EV+/C.*:>8<;*%H6`KJA2*AQLA25%*DD_
M(5U:W-E</MKICHYHWEI:[W@6FA!7UCL^^.<R&?;YQ-:RL#@:_33!0PS_`-NC
MD(OR[2A2`DK42PA;K9VU3M>9"0MLD#K2HKTIJ&^'RIM#'$5;6JW^V=6VUP[3
M/0\*8^M-5C^:\H<42$M6N>^Y;8[H4Y:IR5SK.L]04]AQ:'(:BGP+2FE`^.ID
M=[):M#G&K6\^*O[B+:-T`;Y8J[B,U*+&?<CQIR&RQ9.5+!$MCR@EL.7)*KC9
MU*6"V5Q;PRA%ULJC45W@H%/WE-6XOK&0!\KRV2G"BII]@O+.LNW2/,9&1IGV
M>Q._9>*+AC[J<K]OW)<S&9ERBAOY=VX-R+1/92\9+$6%D,-N2"VF0LJ0'$.;
M5"NX&NGV27H\4'BB.1.?L5;)N!<T6&[VKGM8X$NR(]6&*25QR.7CXM=EY9XQ
MCX5DZLCMMXD^XZU-Y1?<[:E6Z-,2U+M3\')(6/3V9<EY*EL52&G$!:$)HIM4
MN.2WDDI=M;#>`5#]3LN5,JG-2X+:%TSI+:0D$5#'9!OX13CDE_:V;9DERY!D
M<?L6WGC".TMQ.:<S#&<8Y<B"'&CW"1;+$9]_N,9J4])4?EDP6X@=2@(#Y7N0
M=!:P?%0.<6?&1@>+1@X#ZE4[C*\OU?FV<P/A(`+:_P!:O`_6FYN/,\W'L8B8
M!9[SE4S'XTWM0^'<D@SKHS;IG:6A;=N=0M"8O<:D%(2LS:I)H"-=EW"VL;=[
M+?QM<`"P@%[:?5VI0VR[N8&7&Z!C"Q^ILD;CJ<,*$@F@.9P2=C\0Y9E35Q>O
M,-O![`O<]"PNV39;)G/-NJ7&^?JJ5#M?=4K\0HC[A7]T"*BO?;7MY&)1X+5V
M0&1]:DLZ@L;%VEKWR3#[\CM;CZ\!Z,T:.W"#:6,:Q_E;B"-!P'$XLUV.WQ3#
MM^.7/(+I*[3:G,ESF4F\W1Z,ZVDJ6=WS*]W;WH9VI16S111_E7\+XF`^$M-`
M2/=)/;G3)2K>?XB426$[/.D=XB<2`[%S0#ACEV+<<SFT8;AG&N3-<FV'DI-K
MR)]S&?:W>;3FN0X_B,1J-&:MDR_7,-6"SWN[0GEI2W'[<IIQ=`OOTJ$7$GE1
M12RN;(8S5K,G<<,,_2IL-GYT;O/BTO:XDO\`OD`Y'L.>'!)M>,XM(NF5Y?[I
M+'D/$SF41+GE&%P,`PZ!;I$^8XW/:9L*K#\W%M.,0G);25!N4TU+V5*4I;((
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MS/M4VW+V2FBV*D!1K17^U/QIX@]1JDN('6[@U^9%5/\`(;S*+M,*,NAOZ0')
MMRP#V[\QQ(#UNB.7CF6$\EVZ(6N%*3'P.!'5$6M,^U&&M#BVG>\TN4Z$!0,=
M8]0]J^7FR2;KLCI(6X,G-3W%>'?,_JRWV+?([:5U-5CKIS(>&`=V->]5>^_;
M)_XO]W?-%^0M*TR[U8HX';<2E*K?B&/0'6PA]*'`&GF%)!4`2!7SU@NH&"#>
MIF-'NO\`:O:^D[GXGIRTNP:ZX0[UI:^RWW=1/;7%SFV7?"Y^5VG,;U:KJY*L
M]YBVNYVN3:X<F$IMN+.A2(=P8D,R0:%V.I*D?>(/3NR7#+2!\;LM=?6JKJ'8
M&[O/&YLH9.&FC3D:D*TO%OJ,>VC*V@SD<O),/D*"TEK+L0=ND-#;G1Q/YACB
M\B94EQM2@L*;0DUZZNX[JW>ZE2LQ)TCO#1^5Y;SR%<N:D5BW*OMTY#CPX>'<
MD8)-4EX/6^-CV:C$KNPLH0PD1X,.YV"YH/;;2E+2FBD%(]-=*-U'([R(R0[G
M[5";MV[6$CF.@?K!Q(H1Z*HD]X49RV^S;G1A%QR&ZQY./V9]F5?K@]>7FVDY
MABJ>Q&N3C:7U14N-[D[UN$*41N((&H.X.<R,-][%:7I?SSN+S<-<V3R^(`PX
M98+F>#Q](4*4-"5`[J4)/0]:^&JA[B[-;I;B70"0AP*0/2%*W)3U"5*(2H)4
M*'I325U;25$U411(^XKJ-PVTJ:_Y6N+K3I-0H]9?:IS^37EYJV//-N2]R7:U
MW#LM`D"A]/3XZK[J0-E#>-`L]*XND+B.*(1CMZJ0+%+HH`@`*HH`#R">@Z_;
M73,CPRE4A9T8SD2RE*,>G**J!`2ET[NE:)HWU_5IOXB-N+C@E1M+W41L>/,]
M7"-R3@>0*MRSL;GBVSUP]]=H[<@1^RI6[R"JUTZ'MD9J;D0ND:'TX`KH^]NM
MMQ:[8KQ_*ME@WX]&XIQO'TI<BMO7FV*M[,8)C29888>1*>D-/H=0K:`ZL]//
M7E6[^.=['95)JOH?H.V,L\4UD\FW+*\,<,CW%.GQ?D69VCG#'K.S8&H,2%/;
MF0XLARWW27\@S+^6<#[;\9V`W(<BNU92L.H"P2:[=9Y[;2WA;=->XOY&E%OI
M8]PO+D61:"PG.I!'J5S5SS-]$*W.391ASK?&WK"I'S-R=905MLLLK0TS'92J
M*^XDA#+;6Y513IKMMO\`&T&,!OB4JZZ.?.S0QS_.II`H*$JFOZC64C)K!CC2
M">Q&NSSC+16VI3:%Q)`0%J:%-ZPD5ZG57<76N8N:!I*G7%D+2T:R0?GM;I/8
M1@J-,JV2)L!L`!:GFTGH=RDH?:-%*5XT23TUI-L;IA)'%WU+S+>(Q)*6DT"0
M%K`_+KP%(50(!W>G;5=P4$^/4G_!75Q.\B=D@S<506HK%,[DP?2MK#T*_,U=
M!1ZVN!=2*D)D$%M)_P!J21\-)W-Q-OK.<;JCMJE;'^9.9.+A_HI]:'X'_NH=
MKQ'W?_ROMU+\L<__`&37Z>7<J+S'<O\`[2HK9DWD%\M&'*$CY=,@QR\PIQ+*
MG%M)6544UZEMD4J2-?J%#!NSW.;'/(R5HJ0>2^.W[?9L&+A[4>]^1`B6NZR+
M5,8C7%R08$AQ^+1]<!Q*901M;5M+2E#QH#7II&VWEY<[B^SAOP;ZV>WS8\G,
M:YNIKLJ&N1`-1F<%>;CTEN.V;)9;W?6[V;5N4<CK62K2)6PN\N5Q`-8]+_"`
M\`O'B;@D=-=+KSJA4!2UN`*H2"ZHN&JAT53=X^&OCWK::6XZGOY)W%\GG.%3
MG@MGMK&164`9[H8TK2'A_AUB5<L>'Y+:BE6\`CT5)ZCI7X$_IUU,P^^5+7CG
M%+AD,W&,0QN$Y=\US&4S#M5G925=IMT)VRG"UU0RRA2EKK3TIZ^&G8!JF:.*
MFQ1OE>(XQ5YX*Z3'F,#]F7&THSV491F,J#.%R=2M3;DK)I,%<6(RP#M[B+=.
M6E*0!M;":#KJ[EE&WPZ9`7$@G#M[U?VS!81%TK@2:B@S%>]7'^WVYW)[A?C2
MW7V4;EE*L.Q\7*5)<6IY4V3&2\^Z^MPE:UH*J%1J?B=28F%HQX@'UJ_MY`^!
MO8%*BUL(A.N.ON(#2HO4(`"T!+J0`4`FM5I/VT/Z=(EE#QI`.!23FC*]0+1D
M-JE6Z:EB;%F1Y$24Q+82_&DQ932F78\EEX*2ZPI*R%(4**0I0\^D5[&R-+79
M%=:YS':F^\$Q,O&+3@]ZP56.8Y#M]N;@7OCR98(_<9AKO-EA'+<%D*6XIQ04
M_P#E4^,EU1)49-#4=-5DT3;6Y8YONR>&G(\U,;<ODA,;\75J#]28IZ+DCT:\
MRK=!9F9MESZ[A>WI3Q2U;(SH`8BE8)+CH8]#3*:42"30>-C&PLK5,O87)>R(
ME\,6%;8<5Y:H,*-$>40EB.VI*$%UWO/J:;V[B2.M2.NG%TG0W%:T^9CED@N1
M+U=[=#D;5./Q8TD+E%T))[B7P`D$=#7U#0XZ14KGFQTS\7+BH[W[EBVNB5&Q
M-"RTPK:]=I>V4L.!0"'%-RD(AH;+A*:;*D"J?#45[]1J,"D.F%*T.2H0^JCD
M<C+>2^(Q>DP;JECCVZR5_.PVIC\=\YLW';1"=?;6AJ$MAAPN(;2A*EE->@Z^
M[_)>"SNK#=]JW&VM)81`V1KG1A\@>2_4X:L!2@R7B_S,FF&Y6$\#GM!J"&]N
MFE5S>3$3+;[NN*[<79$:*<]X@EF&T\0P6I\W&IZVE-L%IATN-O\`K]-%5Z^.
MOG3JJ=EWN5]\-&QC'3:6Z!0$,;Y>HCA6FJ@RJM=M,)A@@$KAJ;XB3QKCZ^:Z
M7?:#@G!]T]E?">>Y[P'BG+^7W/\`-+3=9;>/6/)LO+<K-LENMMD7YY4>9/A-
MVZ-<NVTW(V+;9:44^E--4$.MFC@\`>Q:B..T^%JZ)DQ<75YT).:?<8'[5I#L
MN.[[*("$L71=M"E<>6E*WEMIW]V*!#272:[=E:;NF[PU.\ZY'$*-\/M_"V<W
MNH%\E\;^S;MH-Q]F4!Q+9DOM_+X)%D$F*TMQ:X:6`P)!;2%!?AL\>HT3SW,H
M`!;@>*/(V_\`Z=_K"->->%_8_P`HW/';-"]GEELDG(+=*N++M^PF+&:BM0T/
MNK^;6S/6"'TQR&W$U0I1I]NF9);D1C$842H[?:I7Z!$\/[>SM15[V_:7P-Q9
M[8,WY`XTXOL6)7W!D0YT6VV-R3;K->+;)>=;O-IND%;DV$J/*BJ4I*PUO0X/
M,$@ZK9.K+G:I&R7$8NK`,<'0O]UP.8'?Q55O^RVD]F9+:L4L9%'#,DY5[`N8
MV]Y9B]UAMPK/Q-@V/RI#S1-XC):DS(3+1$DFWEJ#!##RPSM*R5`-E5!YB5U!
MUYLVY;>;3;MCM+6X>:%],='$"BR%IMEU#)YDUR]]/N_=/?VHT3R$Q,BK8N7%
M_'EZ=DRD3YKTFW/PDS;@AE45$V0F(ZL/2D1U%`6I)4$DCS.F;+KC9;1SW.V*
MQGUD8.&`[>]+DV^[F%'W4K16OA_;)(3,G/SUF*[:\&XYQ1NWKE/O-0[1<[@W
M+8<92@HFH7(:<>["4J+:6PW11KZB*:KM_P"K[3>6Q,M-FLK%L3ZGR01K']:O
M%2+2RDM:ZYY9*\74J.Y*?`I2+CFF%NY3B>"KQ:)+M;7R-M:R1M28H[:%I0B7
M<W4LHF!:BX=H4DJZ]!IQO4.Q7-F[;V[3;PW!T_F-]ZO,_4N16MS#.9?/>^(_
M<=D.9':5/>7PWQ7-Q[!6)F)6^?#N\.>]<0^FY)5=1'PF_P!R8>E(%P5\L\)+
M#;Z2GP=:`K3Q0+&V+0^AH5/54W(V$8_&]C7$?*B[A>)'(.4<\<@8XY`?GNNV
MFT8+9,;:1:FH5O45):ES;RT\ZZX2JJ0E*0`#6CFB\C<)+=G\)@]IQ5A`R`6P
M+!1VI6"_1U]J?MKYEGY7?_<EC4S.,:C\8HSU-H:N=ZM;MJDV/E63AKSS"K)<
M;?(EE]@-':M02VI501XZB2S2RW#8`XM8W##/+@K.S@M/*<^X!T\:*_>/[9?I
M9W-07&XLRU0>M#-];ID'(C!7`?<<::65R,L2D.;&R2%$5`I]XA.I+;6\=_!E
M?Y7>!WI_R]D_"[U%99?M"^ET62XOC/+RA402.W_$V>H+C!2>XD[LG)[C1!&U
M6TK_`&-PH=+^`NOQR?YS?M1HV3A'I[@5JV/VU?2N>NER-LPG+DSX4^-CUP<7
M?N2`PF1/4S(0VW\U>RTME1;0I1`"@4CIT)U:;)O&[=-WCK[:;AT=T6%A+FM>
M-)()P.&8&*C75ET]=L;!.'AI<*8'/%.I[C/I<^V6W<)\IY+@>,Y!B.:8AA&2
M958;DSEM]N\9<W'+:_=OD;C:[O*FQY$"X,0EM+*0AU.\+2H;:'9VWS+ZPN+A
MEO?7,<]L]P#@8F-=0G[KAD:J)?\`2&U6]G+-;-TW#6$M)R_:B*O:8[:Q@/TO
M8,N+*>GR6^;[M:)34QMEBW]C`,I1<S+AJCN+N"9<&YAMHAQH,+)4=P.W5)O[
M_.WXC[^MQ)[=*F[1"3MUDZHH6N7/KS&5R>6^6GC0E[D_D%S<FI0=^7WE5:_K
MZ_;KZ:V2$C:+0U'_`"K/H7C6Y.T[G<$_WI3P^P=.WWR^T%*O_P`9#B+QZ5'\
M9VL5_1JMZNPZ9OA_^KN^I=L36]@/_I!]!7Z20U\O<%Z"FEY)X*XAYAE6B9R=
MQ[C6;R;`Q-C65Z_PC,7;6;DN,Y/:B_B(#:9:X;)7XU[8U9[=O>\;/YGZ5<RV
MXE`#PPD!P&5:9JGW38-FWLM.ZVT4YC]W6*D?N2`'LU]K0Z_W&<>U#"8HW68+
MVQDMJ:#"=SIVM!M1&T=*$_'5G_C7J_\`^Z-S_GN^U5;>A.CVY;=;?YJT%>R+
MVEK1VU>W[C)3?;#6TX^T06QT"2-_4`:[_C7J_P#^Z5U_GN^U,N^7W1;R=6V6
M9!_JXHI=]@OLT?4I;OMOXK6M:0A2CCR`=H%!2C@I0>8ZZ/\`&O5__P!T;K_/
M=]J;/RXZ&+M7Z59U_L+(U["O9RPE*6?;IQ@V$BB0FQ4H/#Q[U:G7/\:=7?\`
MW1NO\]WVI7_N[Z'_`/N59_YG[EM)]C'M$2`![>^,P$_=I8QT%*4KW:TH-'^,
M^JV^YN%T#_;/VI;>@.C!_P#9EH.YM/L1A&]E?M3AJ"XO`_'D=0((+=FVT(.X
M'H]\='^-.KC@[<;DC^V?M3C>@^CFFHVZV_S4;_Z)7MLHI/\`<Q@I"OO#\JH%
M#IT([AZ=!I/^,>J?^ONO\\_:G!T5THW!NWVU/[*+S[-?:V?_`)AG'HZU_P`S
M"M0:@@AU)!!/CKO^,>J?^ONO\\H/1'23O?V^W/\`DK:1[0O;*W3M\)X"C::I
MI9T].E#3\04J-<_QCU3_`-?=?YY1_@GI-WO;?;4_LKVKVC^VE:2E7"V!J210
MI5:`4T-*C;W*4--+;UKU<P^'<;H`?US]J9?T#T8^H=MMJ0>;5SE?7SX'P3B6
MV>UU_A+"K3QV]E%]Y6;S!W#XQMCE\8M,#!7;,BYJ0'>^BWO3Y*FATVJ=5\=4
MN]_-+KS:C$^TW>[CD\6;J\,\5&?\I>@]S\)V>S<X9^&F'+!<YUUP\9*M=RR:
MW2;Y>7XK,63=;DGNSW6X<9N%$"I:6DN+4Q%;0V@JJ0A`%:)%//;CJO=MQNAN
M>X71GNWXO<[,E::QZ`L+*W%KMUJ+>V9@&MK0=R:G)^%@IVSK@VF8PR[(*I"&
M)*ZN(*>B5A6[<`KQIU_GU$DW^Y;XC(,U(;T<'.T^6X%>K5[9L`DNW%O)N+8-
M^,N.KL.OLCYCO+`)6EP*;-5'Q5Y:E;=U1(7.%PX.8W*G#UJ1_AC<H@!;5;IR
MS!]9P2$5['.*7'I8D<36I*W-@:WQRH)64*W%!#Z`2*BM.@.K"/=+::-TCY!J
MJ>_)2I+3>(FZ)'3!P;S!3DX3[:N.^/6G$6G!XUC<EJ2T[\H9;`EI!%0IL2UQ
MRX2/$HJ#U!U4VW46YMNA#!<2>6U4]S#?^0YEQK=$<P<_0K7>-.'?:S@'$]OO
M',G$N.7L9-<(+3:LJCO7IM<-UUE*V5Q7)3C1#B*^GMJ&U0)H=>DP]26T5I#)
MO#=3WN`%>SBLK/"^6?3$7-<UE13/"F'VJSK'?IA?30S#$[1E>->TSA*(B]B,
M]%D1<>F19+K4C:XM*5L79I7;<0[0IZ`5I36WM[FPGB$]I0:A44P')0OU'=(Q
MHDN)-07ODWZ6'L-X^XLY1RG!/:QPYC.2VW`\EG6Z\VK''HMRA2X5JE28S\2:
MNY/.QGVGD`[D4*J4-1TTJY$-M8W-S:`MF\K$GGB4R9IKVX8V\>Z2*K1CGGZJ
M+@0]@6>\B\I^]?A#B?/<WR#)./<NY@L]AR?%;E-[ENO-F;E7&MMDJ:0U)^46
M$>I*'$!72O@-8JPWW=!);0R3RF*1S"6UP/>O0+G8-I%G-_P\50PN!IB",B,/
M6OT(.1/IK>RRSL89^3>VGC4"?E]FMLYA,2Z*2];9!=^93(+MU6J0"/(D_IUO
M[N^F\S00US72::'+$E>=6[6RN\9<#2M6YU1ED?TE?IU0HB+M`]GW#<2ZJN$:
MEPC6*>Q*09#Z$R#'=9NR%1G'0FA4WL4/(C35+5KZMA8'`YC.O,)7QNY#!MQ(
M&IT(_P!,SV-QLN3G2?;%QO(S$6Q^S_Q-<H%TO-X_+9$%RV/1DS[S=[@\A+EO
M<4SO20YVS0*&I`N&`4,;7_VDMD]](-3YY"0DM$^E;].W"4WK([1[1N(;'*7;
M)C=S?L]EN,)<V`Z4OR(+S<>\-MKCR'6TJ*"G;O`52HKIH3,M@9(&-8:8TXI^
M2YO9BV*>>1T1.6&8R/K54W*/$?TQ\?MW)&)M>W#C7%;=>F7Y<-NP6:9%OBK_
M`!.\Q^8O27+BY(2\A1)0D*/IZF@H-9ZXZBB9'+:SL:'OK2GO=_VJ:VQOI)&7
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MH4)`(U<[?\Q-^V>V%OM5\Z"U$GF:6<7'B51[U\M.G.H[@7>_V++R<1B/QYB/
MD.U;<O@+'K_<9&293B<?*;U<W$R;C>+NA]V9<)"64,I<DE$QI"UAEI*:A(Z)
M&J:\ZTNKNZ?<7=R9;F1U7.=F2>[AR6@L.G&;;:,L-N#[>QA;ICC&36C(=Z.K
M)P?Q9&5NG</XXF)OJX(\*05J'@5$*NB0-R1YTKIO_$TG]\U2_P!-NF?CD[^"
MD%B7%WLT`:;R+A!2Y#BFT%<>W1RP@?MGU7A5!_/IK_%$_">3UA)CVJY8XG[4
M_A]M/T_[I8+G.;P7&K/+;BK5"%ZCQF5?,@IV[0FYT2.M/TZ?BZFF+@?B7CTI
MN2WNF$CRW$`YCBI)6+VE>Q>3BEWLC>1X$W;I^.M2WL?.17$6R1)8:$AEB9:$
M7Y,&4XQ,;2M`<:5M<2"`"*ZLH=]NIJZ+EYH*\%`?'-YH+F%IPS4D,`^DK[0<
MCM.-7:+Q-@U_BW%F`M3Z+6\_%DEY*"Y5Q-S22ES=2HH1J4R_O)`SS)"_6X`5
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M$]?T?IT\VTE<P/;C7DF7W;&4JTE.K`^F;[>]J5/\?V-\,D!D"S+9(21XII3K
MTZD'3@V_5A(01RQ2/CF?A/L3FP_I\\*R;%'QF1@]O>LD=Q#D>W_).B,RM2BH
M':$@U!/QT^VR-!'&13]BHTMPUQ)#2:X4[3@/:J+N>,9X\QSGS(;;Q_;8MIP;
M&IEQPF%!MS256R3V)#7SUR>05*JI^ZI=(VBHW"@!\?)M_P![C.]^5#4ACJG+
MNIW\5]J]$=!R;=T39;@:?K+H]3L#EFFC5BC.`9BBZ-JAS+KM=1;WD(0XQ+8?
M)+,\2TIVJBLCK2M0H[?'6>W!NLF88-'!:RWMVW%VV>%I%P6!K@>S&OM2\:?G
M7-EYY=P=<DO+[DF1O!6^:D%JIJ4M=LT2D=$CPU2",Z@_A6JTMT_2T0D>/#V*
MLKWT/-LVVQPV&MJ3,EK.X;5E;45Q'0>)2%+K\#JP?.US:`$5%%D=[/@]"IOO
M#@7=F=Y3MBR)SR2GI5,9@*2E9J:^H#P\]:G;1^0_^LT`?2O(MT%;EI_"ZJ2E
MC3W[)>'B=JD-I4A2O"@E+<;J!3R/Z=65X?\`CF,XD_4J?:SJL9Z?=&GVK6PM
MQ7\1Q"5`H5%D,T%/N)2A837P'K)Z_;J9NPIMSP<P!]*C;)*#N,;.-#]"EC\D
MU\&_^ZMW_P!?Q_1_-ICXMO(_\A1,X?\`[Q4Q4<S8+_>Q*Q!>3V[YA5DA6:-!
M#3O<.5"\SC)@(?\`EQN=1"4V2-W;J30UKK]1[SK/I^QZENK:YG+':8HJ:'4U
MT\0K2F)QKD5\:-V6^GL&7+&-+'5(.H5H!^V"=,.Y"J[W".]&@?P\B+!7:I3$
ME2[@]-5WC<F)L5X)8CL(*6^TXV5*74[J4&JOJ^]^:-G=L'1%ALM[9.<TO-W,
M^!PPH-!@Q=08#4>PX+T_Y:[?\CMRMI(OF_NO4UCY9#H/TZWANF5/A=J9++&6
MT;GI<*C($X+8F(:0X>V5*0"WZG$)2O\`=CN)(2I8HE=0.IJ!77R)U$;]V[W3
M]T9''N#I'&1L9+F-<<VM<<2!P*L+]G3T%W)!TU)//L+7$6\DT8BE?%]QSXQ)
M+I<1F-?H"T@4%:A6B?L'A6A!`_5_/K--8Y^+5#B>U@.I96W`TXD@A;8(-%>D
M5KUJ>G32%(#6C$!7[_2@X?@6/".1O=UG#41#%G<_@O"%W)KNMH#28ZK[(BI6
MIML2Y#;J(S2JF@W=.AU96&B-WF2`$\*K2;+:MCMY-Q>?=)`/$$X&GH1=?;HY
MSQSZG\X6%XY8[NB[36RI1A(AQK@A;,>J30)0E8*B:;CI]@ENKH^>`Z.F5:BB
MA.D9<SX'4T&N/8KRN`YT[,I=LDP4=BR,RX\&$JG:8<AN%34%MPBI1\TMDEOK
MM4D5'GJX`'LIZEH[;4&5!\!R4X\PCM6W";A*5^$Y#@W%Q2FB>\A5K*Y3X4BA
M)(0ROJ*`@>==5KY75\;0&US"DQT+L<J)NN+LX:R*YYAB[\UF=+Q/)W;0'NXE
M+C\";L<@*:)"?FF0U(20X#U0:FATADC)"6LS&:Z]I!)'NI=<F8:QDV/KASU2
MX:)B6F79D%U35QM%[M+O>L][A/)*2B;;Y:`\V35+J06U50M0/+BWCN8@UQTR
M-)((S[EV-XII4,;GS1`XNB/-Y,8<J^F8^DQX<)@7&=<VG%(D)CH;;,B0B4Z@
MJ;K4-MK`J`!IZUHV.D^+_6DRS-:[14ZAFH[Y7S5GF7O.OW&X-X5CJ^HA-K[M
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M;;:96+(M-_@P56R`Y+Q[%,:1+G0+Q-,.W.-19S?;06WB2^A2`*H53QXETKY#
M0F9TA.1KB5LF0/\`+:",*!="OTB?;1R9[<\+YNF<DRY$+,N73BL^';IL5*56
M&ZVJ+DRY8DW>/-F6^YQS<;ZTL*;".E>BMP`1^G7TI\UC#I/H5O8E\+'`'34=
MX]25D;VZ_6RE9K$LF.>Z;BRZXA+BHE.9A*EX1`BVAQQ^4EVVS[/=<9:R%Y]M
M,=(2MF,XU5U'KHE>V,W:=Z\MH+7:Z&OB'/#V)AT>[R/+HI6:*\D[X]K7UG(*
ME;/=WP?+VA)"G+9C$C?50[:?P<#>HXHCJ!UH?MTQ^C]2<VKOD;__`'\'^85.
M'B%'*7&O&5DM/NQY*PR^<KM2[I^>91;G[=8L?EPI=]4W88T>MOL$0.1XLJ/'
M<46&PX^H`%1ZF?\`"W-M;4O6'S<,:5"N+<SBW\NY=JEPQ&7HY#L3?>^J+;,G
M]FG,HMT^W7&#=<3E)CSXSS%QM[K:F+FDOMJCK>C3&&U(Z@*(5M()TQ5NC(Z>
M614'<L8-'W2<1S7"M@6%1%OW:5+O^,7F-#QV[&Y0H6,1K.M$!:&&)+KLYFX2
M%*B_BI;6V6_45CKTU!N&MDCI$'!_::^U9J6,D^`"B\7*R8_>+M"F3K_C,ZW1
M(8A,VV186'WT,(4\&4Q[HN\,*:;C%2?1V55*3U]5`PV.9F+<#WJ/18)N$X<]
M=H\J#=<2@6I+;BY%JD6=+CSP(<+91<T7UM3025)_W$UIXBO1REP1XB2ZF%#0
M#^US-.*<)C\N@]]/KCD2+:VK?%MY3$A1H[C40M!;B&&Q'<4A2$*4XM:$'U`$
MFHZ:[M[M=Z-1KB!CWIKBK3T2'!AG'*S)=?5)PV>\[(<;&Z0Y_=9<I!D/;EU8
M4IUS?3U"JMOVZW36EY$;<^"%3OF=G:N_M!]MN.OW2/:D2>0+H^_<II7\I"_-
MX.0/-OOH"DU#ZF@@4(*B:#6<O!7=)WC*H"G6SV.MJ-()U<%.GZ4/N1S3VN\B
M8#<[SP;><BQC-.-9>$V>=-=NUNM5^MN6\RQ;X,BB386+9'"6BU2H\B,IB0&8
MY["UNOL^D&K,3FSNGBU/<'8M[Z`TYT&*M[&>6!PC<QI#SA6F(XGT#%=._/.2
M_45M/(_(1]L6#>V;/N+K"[!AXDB]S<(;RJ[)%HMC]QA3$W3((';>-W=>4RVX
ME*"UV]@)()A7-MU.;EWPL0%GJ\+G"I+>=,_1FF+EW4HOWFR\C]/&#=8!)[>8
M[E';@CFKZRG.EDN^0Q?:EPQB=F@RTVB0K/\`#+9BEPE3HZ&'41X]IO.01+D_
M;PQ(1VI'9$91W)2K<A0#4\?5$%'V[(YW<M&D>FN:BON>K#[@M7>AK?II56&>
MU^V^\FZY!FS7N_XEX4QC'VX%OF8G<,&M^/2I=PRZ/,>%R1>!$N=ZZ1+71:'7
M4MN(6*!1%0+':F[[*^0;C$UL9HYM!ES%>6.2N-FN-[EFD.ZLAC90:0PM/T9*
M56<VR/?N.N1;9'>8FHNN`9I`WL/LR6%KFX]=XH27&5+0FKBB/&NX'S&K6"0,
MN&5J")&\/ZP5Q<L,MM)&!4ECOH*JQ]H#%Y3AOTW(<)^.S9(V$<ORLCB.R+<W
M.DR48HPBQO1(THBYR(T1^7(,A<7T-!:._P"E3>M-NQ:_J'P\2?\`15#M$@;M
MMJ'?<#J]E:KG.Y*<[O(?(CI*DE[/\U=H4J23W<FNCE%!0!!JK7U3M(;^C69;
ME\.T>D!>(;FX.W*XI_>E/E[#`/\`3B]H)H*_Z2/$(K3K3^-+7TU0=7?^6K[_
M`'#OJ3]C_P`Y!_O&_6OTB1KY=X+T)#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#
M0A<R?^LAWN[63&/:6]:GBRIV_<R!]24I4I26[9QV4"A2KH-YU2;O8V=V^-UV
M`6"H.'`I3;Z:R\41(KR*Y78_*&9*:;[=P20I"T4=:9"B:>.U3(Z@:J)MHV2"
MC6,>1WJ4SJ6^MZAQ<:]JT+CR+G#;ML!=:</=45*0T@A``\]HKU^%-,?INSOP
M$3SZ4^SJ7<7'\K2UW,XI0V'.,XN]P<2JZLP=K1VO/]IML+2.@!=4&T^/6O33
M'Z5M#7FL3PTG$53DO5-XV,MEQ?QIEZ%[N'(&<,7-AF7<42FB4]I;3;9W!*2"
MX-H`5NIT^W5I#LNV"*C(G`G+$*'_`(AGE87XCL1E"Y3OS%P4BZQB\W1783(C
MA#@%3M6DFA!*O,$$#50_9'VDQDH8]67"M%5S[Q+,`'5(7WD'D+)\FMEH:N5S
MERK;!=9$.*XL):C@O-A12!M!-!TK4@#QU(C=</:UMV7/T'PUQH.Q549C;(Z0
M@!Q:16G/@N@#Z=N89QR';(/S\N0<3PV)`AQHSB2$//E20I07052VVA-`">IJ
M=>H=+.ENWZC7X=D?AY$UXC@LYN0C::4'FD\OK5J7N!WHX.Y>*!4CCG+SM%2?
M\R3.H-:4I]FMA?-+-JN=7]T?H*KH!^>ROXV_2%^7+],)-?J-^W'Q]'.=K(`\
M5'YNY@^%3X==>86;VNN+.G]1>O77_)3_`.[/T+]47.6EE6$$@@JS.RA"3T\4
MN&M3X'[::]/NFN=*&M]_S13OJ5Y%9^]_D%+3+&I2H2$H`*$W*&5;JD`!_IM)
MZ$_R:>(#9/%SQ^M,A*%+;ZU[=YH:GQZ_H'7H-.:HOV"4'$9&B]2(SRXLAO8E
M]:V74AM8&UQ10H)0L'HI)/34?,4.2YJ=G4U"XYOJ76;(\9YYO\A['G\<8?#\
ME26NXF-)865($B,I2NR`_51<V[5$^(Z:\MZDAD-^7Q@Z02*K<[)<!UKIF<2_
M"E<55ZW>'$LO.1I.UA2@7&'%*6IM:B5*[)2X`E-:^9.L=?645P1KKYU<</5B
MM=;7\]J2QV5,%]9RZXQ6W6XJFBRM&U:COZ``$A04]U54:JI=IM01YH!-,,*J
MR@W>6A[TW",DOS=_O3K*XQ+BXA<W(744:\`KOI40:5\3IL=/PR0ADF#P58V^
M^W37$M\1IQ*,$7_(Y\@M-18+BDC<7'&EE2M@W;&DF05+4:>&N?X;@(TZC13O
MUXQM\UP_,^LK77R1D#4CY-$2"V8P4'04N$(#=1ZB'Z%5>M--/Z9M.?B2I-[<
MX5>`'D?T+.<[N;H0MEF`XI9(<2VAU)KY527BDZ:;T]:QX2.=4]A*Y!O$E#19
MDYC=(Z0X[#C)=K1"0TXM%01TIN4:D:?9LEL_!KW>T(DW1Q'AI6O-9+ME-VGV
M>4VB(VO<R:H2RZ`GU(*B05DDT&NLV*T$V9,E>(P31W.4BAIZTN46R5/LC=U3
M`E,7"):U%)BM/!MT=LT0LU&\II\*]?/5@RR^&&F$4[0J^XEDGDU5`%*9A=/?
MTJ.7[+DW'=BQ',GORVX6A4)+(N;W9)0WV^K8<INK3IK0[=+&',9/B1EQQ5-?
MLD:T/:1I%:T*X2O<<W:[A]6/DQIF2T[9I7O5+*)6Y*V50G.3;:A3JEE;:>VA
M!/7<D4\]6LN.W2.&6?M3TI:+EA?BS2/H7Z8W(=HXYB<%9/(BY-9RIG$(S7;#
MT+J5-0V?2-R%CJOJ:@#XC3SIVFS`:?NCZE0,<]ES20G!Q^NBDKC^(<?*PZ&T
MK++.A!QIAD@RK>4E/Y6DKZEPTH#T\=/^7`(0/`!IYC!,R/DUFI/8G4XSL7'4
M;'+8M>8V2@@M,G?*MP`0$[4[5%PTZ#Q&IEGY+8!Y3P>\T3#WN'O53V6JS<=(
M2TIV_P!MD-K0AN.XN3!2VYW*!`;7OHY4GT_'3I:#[K:E($K*T)35>ZK,,3X%
M]O?*_(<&7;3?['A=S?QR*_*A(6]=IZ$6JVR$,[VW7FH4J:EY6P]$MGKJOOII
M+:WEN(P!(UA(!PX=JU71^V6F\]2V.VS._+EG;JXB@-?JR7#;D.?<6MSB,JRN
M&].N;TF1)A"Y!,ZX*DK6[)>8:2IR6Z.\HGNCKN'CKYJ=%=W%TZ=C'F9[B2:'
M.O-?IB)]HMHV6PD$<<<36MX`@#.G?5,]BV9_Q5F=[A*NMTN5@LKXBV*3/<.S
MM%H.NQ>ZH)6Z8O0^JOJ4:DGP+FYGD<(7@M=RY]ZHY(+*UN#+;::O:#4#APQ4
MK+<Y%^3;#1"#V$JWBI3XFIJH"IIX'KK@!`H<PJN5Q?(7.-34JL/WU])-@9I5
MUYB:^*)%`E2DLA:U`>1\OMUT`DT&:SFZ#7YC<_#AZE3#>E!$BX.$T5&1<JDJ
M*?5(4RVFA^ZI00E1UM=M:0P,/O&A]"\AW0TF<[@*CTHIQMLHQ:XK0%*^9934
M`T[:6RV/4#_24K4R]<U^Y@L]T9*!MT6C9Y'T`<[,\UHX>D?G=I3N2G<U.'0B
M@<4$)(*OB5_R:D[H)?@7N<?#0?2J[96-%_&ZF-#]"FI^5.?`?]U'9]Y'C\/T
M?S:@?_0T[^G7?X1_XIHS'O\`+N[<DE;?Q3FT_GA><QL;NTK'F.17K@Y=V4(=
MA-V]F:L+F*<2X5!D(!!--?=7673?45OU%=;U+8RG:67C'.DTN<W2,RTTH:<:
M<%\G;3NNVS;=#8A[!*(B`-0J''F/J5@C&31GKGD,)N-=U-V2-$E+DJARA`FH
MD,./ENTO&K4^0P6]KB6^J%&AU[7L75&Q;_<RQ[.]\WD1A[N&8P:`,S7!9>ZL
M)[)D9FJUAP-12O-;MENK.0V.UWQJ++AL7:"U/9ASFE,3HZ'D*V-2V%'<S(33
MU(/@>FOCKJU[I>H[V21I873.-"*$`G(KT2Q!=:1E@JS2*4Y+8'2E"1UI4'J*
MT'^/65<X1X1D4]:GL8TU\S`^I;L&&J9)CL(-5//(:2`*E2UK"1\>E3J*=1<T
M#B<5)QU-#<B?8NA'FC*SP?[4_;O[>K"\B$[,X[A\B7MAEQ+/S5TR:X7PB7+V
M$!;B&[3Z:_=2L].HU.N=,3A`TT'E`TXUJM7,YD.W10QD#PUIQJ<U'SVHX_D>
M:9%)N2KN\WC5ROS5AN5&7%.WBW1W_GKG\M(2MM3"2AEMA+@%25*\133MB)P1
M)&X:2ZAK[57V$#73%Q!T'BNEKA-<5W)+I+ML.-:XDR)8&V;7`93'B18N.1#$
MMJ41T42A:%N+54>&Y735U,]S*:5J88F!ND>Z%-=<:+<[-<H,YEI[YB),J5@%
M:E2HKC3O50/WFUD=>A\]0G-#O>YH::/`X55=''I..<DWCN)(3,D?>;J"XF)1
M#95M]1<9#8`/A3IJ.P".8AN1*DO#"XAN+%9%"4WD%G7'>6%)GPVG&G2"I34A
M"`$N;E=2M"@E74UZ?#4H9*!+JCE'EC`#DN?7ZI?(]V]L63X3R);\$FY$SR3^
M:XI^9LR6(MLQ_*\9C*N+EMN;ZP[*9%ZM#W?C%I!#HCN@FJ-0+Z[?:AI:"0:U
MPKE15VYW)MB):5U$@GA7@N?#F+WD\^Y>IQ`R>+B%N>AL/(@V..CYAKYMEMY+
M3=RN"I$D*0A2:*0EM53TIK.S;C=7`T.(T5K@!Z%3W%S-(RG;7)5SY:XO-[J]
M<LLOE[R>62XEV9D%_NESDJ=)`7\NY-F._+-MN)VCMA!"D&GI\:^65U#5WBY?
MN5>7/#M1/B6G9K#;+*746UA;`E*82_O?>>W!E3O:_>K7LV&0KPI6OV#4$N+W
M`N7'.+C5V:E3[2)XQWDU>;(CPYLS$9$N1!A7&'#GV^1,N[3T#=+A3V),60VQ
M%>6I*5((#FU7[.MK97]S9[)Y5I*Z/7([W30D84Q&-/I3,$0=>%SVU8`,Q@K@
M^-F\5N!9",9<BI<6IU2(^0Y(TRTX^\MY9;9:NJ&6`7'%$!"4CKX:IV2O#M37
M$2\2#CVK38<,E//CS&[$XS'VMY%$"2*_*9AEL>GI`%5(O(J*4Z'ITT^+FYI_
M$?ZRID`#@`>:EKB6"6.26B;SR%'6I24[F.1LT0$@[MM$"]CP"ST\-/PRSO:2
MZ22M?Q%3VL:T4&2?.1Q/CGR2'F,ZY96H`'M+S3(E);ZIJ"MZ^2U``GIZ0.@T
M]JF_O)/\XI5`D7=^-+`XRZ9&3Y^^$A"U?-7J)<!5!W`;;K:[@`I/Q-=19;JX
M>=+W$M;@*XHRR4'_`'=7:'_<]G7&S<5U;%[L4E$":&FFEQ68<:7\PW(8:2&7
MG)"7U*WI":KJ2.NHLA+P2<Z*LW1P;#F-2Y&>-_;M$C6K/GF9<V2S>..;M#;?
M6A@)8,BZV*CL<EI!4[WF0BBA]TJZ5`.H1!&:S\3R\&J;MSVOQ&MI%VNWX>X*
M*V8Q"0HU6K:6PD&HZ'Q!T*(B"Z\!VZ+W7E7:XU4V&U(7'B']W7:O]FIH:_`:
MBNFD:\@'!":OD;D9."7[#[-"NB(2OGP<C+UN=E.IL1A*:0]`=0A:/GT.IWA"
M:5Z`D#4W:[4EYN0:`&OI"XKA_P"(85UXXP>\6N;-D0)?&E_N4!]V(N,Y/89X
MP3V7IC#VUR.H[MP04FI-.@H=;6`M#6RUH^A/HYH*<WVVVCVJY][7O;KA-_\`
M;I8)&3V'"\2O,[E&7(E.Y5<,N;,FY2;E$MK[LRPPXK:9PC-I=C.N*;;W'96F
ML0XTN'S5)>]QKR5[`ZUD9Y+8VL`QJ!2I[U:OPIQGQ!:8T.'88-^ML>.I"F8K
M2<<2TRLK+Q6AIO'&F6@I:S4!-%;E5K4Z?9=31@AA`KV"OK5HVVMY&LYM&%"K
M%<(PO%'8[+,.Z7RW(](3MC6%24J[,^.=H_)2D*#5TD)&W;0.D^.TB4-VW!U&
M>9AED%/A@C;'I%:5/%2BQ7BMFY)2AKD:^P^VA+H3(@V-ZJPQ";2H'\@>`VM0
M&$T-*[!6I))?\V\_OA[$S-9Q&A`<>XHPG\+H826D<CWE;2@#M%@QB4VM86A:
ME+^8L:2=RTU/D?UG2';A>0@EKZG+$`CVIQEA`W%H?JI^(IO8/%MKX^>O5VM]
MRMDQ=SM)M$Z.G&;)CX>MX5-=*7U8_$AB6X9,]Q[>ZDK[IJ5$$C4?XIS@'NTZ
MM0)PID05)T>3$6@&E"./WL/K7*AS?[CLUX9Y0LGML?:M#V/<'\;YSQ;$NL&,
M6KI.E9DU9GIF3VR[+`N5J3.@_(M*BH4&ULH6AS<375FR^DW#>/B!AJ>-(IE6
M@]*Q<TLVWO\`@H\&QBAPSQKAZU%[W'MIC<^<R1PCM)5R'DDD(;2@(2F?.7<$
MI0!1(2$RA2FO=;'K^6TL8[9MJR6*$:=7F4)+30DC@*BG>"L'?[`V:Z?<MET-
MD=6E-1K]2EC].KA<9![E_:MR&C)/E1;?<#QY-_*E6WN%S\FS&VJ4T90DIVJ>
MVUKL(34>.LOO_P`Q+G<;2?:Q:QQLGC+=0?6E>*L;'IH-8+GS2Z2,AU"*9?MD
MOT%1KR\9*X7W74(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+E]_UEF<U$Q;VB-+
MIW7K]S2MGTA1!8M7')54*2H=OUBOZ!JLW)I=&,/#7%0[UP;$,<:KDWMG?GM.
MN?U9)5N"*-[?@0FO;3M6JH(IJK-M"87/8\!S3Q/VJL>]S_>1KAT6XW7.,=L:
MHZ74N2G4N_,>@+W`A*]RFDI[:#UZJITZZL-IL6R7;`'M+'8'$9=_!(EFD#10
MTQ3[\C\`\BXB%S6[,ERT3"Y*9?BN(>[+:E*(2LM)%5);05*Z=`:^&G=WV>>W
M)F\O\LFM:G+@0%UMW&]@A.,W-,JX_+$Z'%DI#;L9)00$>O<4T.XD5]0'2G6N
MF[!T<ML7%PU`D8'E]:E0_P`(^E*1N!+R!U<CYIEMVW-.$(?`;JA)W*VJ*0%*
M5MZ="=1@'7DSF7$F#?=J>>=*YY!1$_,?"W(7$%SR.X66U76'<%QXL.3WMUP@
M/K>"0\E``4FBS44/4)->FK(V0AL73EK7OR&-*=M.-.2CF1]5T6?3ZPW&,4X7
M@L6K(F+Y<[M'AW";'V-]Z"XM+9[1*?6I*$IIN(H::W/39AAM/+A>U[].)H*U
MSRX4R5!?/>^=VK(?8IK<\-E7"7+'[(/'&6=#TJDV29X"G^/5GN4KSM5U_NC]
M:CP?QX_[;?I"_+=^F(?_`/9'[;R*DCGFU)`'B3\Y<Q4>/AKS/;P6W-I44]Q>
MNW7_`"4_^[/T+]53D-C8S@I37U9M8P17<=Y2O=TV`]*?'IKU.Y<6W#"W^_'T
ME>26K2#4C#04O\CA+<A?=61\[$*NG2O>!\-M:?RZ6]P+W%Q%=1^E<C8QS=1[
M?I1NIM<9EUUQ)2TVA3RCM-4MI34FE!T`&@@!NL^[S2O+C.6?>FUM_+>#7"ZS
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MA#D/R+BXZXZXDHH4LM)=920CI4E0J30`G7K_`,L_E'<?,6.6]CNFVVUV[RQ[
MW`:G.ID&G(\5HMFV*;<6.G,GE1C#('&N1Y)VWN`;\.,W>8L9N=NO^*0<C&/0
MS&=DQ,@N$]#:UOOVVT.]YNXQH]%!>QU2]J5';1)U'ZJ^4V][1N[]MZ=:_<FQ
MQASJ-(<!^(AHJ*\`DW>T7/FF"S)G8TT<X#(CD!GBHP3KP8;TLH;47BZKN*D@
M(67"JBPZVK]VX%"A%!37D4S)()I(+AKF7$1(>TBCFD9@C/#M26V5T1IE:XRY
M5H?0BN/GURM*PXS'C`!/3T-N`CS":I4*@T^W4=EY;N]TM'?3ZU)AVRZ`-01W
MA+BR\V7M-$+3;5`'<$.VZ*I2>GB`MDGQTU+?PD>$M::YX))V"3,A_M6QD/->
M1JM4CL_EB$2&RT%"UQ`L%2T)Z+4T`DBA\O#3'ZK$P:3I)''!<_07_P!?VIT8
M'-=ZAXJ\7+A"^8%M*&V$18C;F_L;?$-)-"%5'B.FEC>6!NGPT/=Q[4S)L5T'
M4C82SGJ(/J[$L,2]S&?VM,%42^NP%(:CI"H>V,I.UM-`7&`BBA3XZDV%W%/<
M#21X5%GVBZC;Y9U`.Y]G>N<S)KY/G^X*\92_)==NDOE"3>'99=5WU35Y(B0)
M!=!W=SN@*K]FM8T:K!S#[KL%$GTFAJ-8P]2Z';+[F.39I8Q^1DUR<MTBWK$A
M@2DD."/#+R5*'8!3ZD`BAJ"-9UMU2?RL=0P[,E'?;34+WBD?M1TCWH<RL0G8
M[&<WQ$9F.ZT&Q,H$MI:4D)"0Q]W;J'K+M>IQJ21GV+K(2R@+3I/,)S>.O>?R
M[<WK1"7R+D;$%<JVQ#`:GD/OMN+;0KM-]O[JZTZ'PU-M6M9;`%S@\N:,7'CF
MH-X2S46@4&6'[573;E/.F%8%C_%<_->0Q#CL8O`FQ+;#NT9M"7XD5#CS=]#B
MF^ZIVA"2=@*TI-:#7K$IL;:S@?-0$-%<:&H&%?VQ6`TW4TCG"H;J.-#3-1%O
MW.^3>[ODZ_YCB=PNZ\)Q"R0K?:K=<WW)6&759<0Q</S.&AU^-<(8C/#NHZI"
M3UZ5(JKOR]YNG%@;Y<3`1EI)PH,,#W*V@N[O;HH_(D,<NK47#!P(K0AV8]"F
MYA/L,X:ANR+UC7$/$JY&1XDENY7J\8G`NK+UTFLA33UD5+0\Y`BQG7%`!"DT
MZ$4H-7;-HVYK=;8H?.>W$M``!(ID,NU2[CKGJN[D#+F_N#$'MQU&M`1QY+F!
MR=O&^->6\KXPOTF'C69V[*KU;AC-S2NTW2/*C3Y`99:A2TLNO1YD5.YE2=P<
M10I4H=3\J]5[-N.V[S+\1%0!QTN;BTCF.%.WBOT/Z6WFSONFK.>SD-PWR1J<
M,:.Y$CCV<%)"UE)@1R@J(#5:*)(&Q(]-3X)/V:H@2<3FKSS&/\0(Q597OMDI
M9NUF8('<19G7%T)4-JG5FJ3X?LFM?#2V8O'>J'=G4:Y\1JXC'BJ:LF3V+;(<
M*J.RYC@0``2EI"5'QKN2I2U]1UJ-;;;6N,C"!]U>0[T6MAD>/XI=^V"+8,KY
M3&W&U+4A;D=-4_L@+6I0))](HE(_7J26-??T=P^U06RF+;?+!`:43XF#^9P)
M())6J6`EP>*D.M$.)/CX'H?LU)W1SS:21CW?WJ%L[2+UF!H0:=JG'^;H^"O^
MZAM^[^W\=0=+^7_LBO\`XB'\;?\`QZN8R4M>+*JP^Y`5`3.N:%4J=B1+DU_4
M*?HU^PG6C=?0=X#_`'CO]$K\X>GGE^YQX8U1I9;Q;&W[VR[=H2$66&S,NS:G
M&MUMBN-.24/W!/=4MAM3#96DK2@;02*C7S?\C)HXMQW`S.:V)D;27'@`5Z9U
M6TO@AC8/&Y[@.\X!*:'<(5WM]NNMIELW"W7.(S,@SHZJLRXDA.YF2TJ@W(4B
MA3TZC7D'7<L3^H[R>W<)(I)G$$94*T>UF2"RBMWCQM:`>_BO`0I0](K3QZ@?
MX3K$!39\PE;A"`[D]@;6FK9O%N0H@;CZYC*2`GSZ'2F?Q!WJ7'[[>]6=>Y',
MX_.'NCQW"\?FM3+-CN$8;ANQAS:EU&,62Y7&=&;4:!)5(FJ"Q\`1YZ[<.\[<
M2TX4&GU"M5<RGSI!&<-."GWPSCT#%<1LB(+/R;D-3CKA2AIGN/;PA82E*4C=
M1``-!75M:M\N.@QQ4^U9Y;0VM?$KF/;<PI4://D5[DJ(RVDT!*TD!8W$^8KU
M_3J5)(9"*BE%<-?I4Y8"/0LJ;"0I/9\:`]Q%**4!UZ'^0Z;2#B575DD55DY$
MN80DMO1KF\%`@@EM;Q4"CI2BDJ_0=1O]MZ5(9[H4Y>-)PFV""O=U9>V!((JE
MMP`A)IX)HD:DIJ7/T*`_U8^)[?GOM#YA><A!^X8G:8/*%C<[?<7&N^%OA<UU
MI1(+:I6-S9K2R#ZD*(.H&YQAUHZ0GW?K4&\8R:U+7BH#@?4N!CFF[7>3E%PB
M1K9*<M41]#*50F4NF0S&A,QV&^ZAT;6^XDJ4DI"C0=13K@7S.<V@\/<LXXU<
M2.:CC/N5Y1W7VK)>%NE*NV%E+:>\!5MI6[=2JOMZ:XR*5Y!.+#Q4>2,8OXIZ
M+0HOQH9>=95*,=IV2TP\ASM.]O<Z-R5**D-N@BOAX==/FW%,RHZ?GV_7BQ6>
MX9>;K?;);%JGVJB+E=8$!T`1GWW/1+D,J*0E-20*`=3JY8--I''P!*?M\SW*
MV[BO/<"M_P`@FXYQA<!4E@2HZ9^5V&&N3'0D+5*C)DW!LR&&FO4I:*I2GJ33
MKJ$RGFGTJRCDU$-I3!6&\=<O<.-HCM*Y?XG2ZI`V!?).$H4H[1N.U=\22H:E
M#)6D!TM!4U,5Y&X[BJBNS>0\`@)=<0F.[+SC%XC4ER@)2RN1=FD2%I!J4H)-
M/LTZR4QB@%5.C?K%2I%,9Y@4B&@Q^0>/Y0*"4&)G.*2%&GJ42AJ[J-$U/3QZ
M:<%RP?Q,`G*I,W"^XW,8>;@Y)C<L.)HER-?[,\E8-0-JVIJD*-10`$DTTR]T
M#B2QU7$Y+BKE]TD?YQAPQG$/)7;;TCO1UMRT-'L>AQQ#"E]S8>H3X*%=-JEW
M85`'-427*U#B?BZ1*R.X)O,B/8K':KK>F(K=F9FR;YDD)2[MV'MT>!'2ME2R
MVHA(2F@.H\V8[E3LC$8H#6JBC>N0,1*%):OL9*'U!T*5=+?N<2NFQQMLOM%;
M#R!Z/`*!J*ZBR2>6*T2/(',IJCD-HO,J4Q#O*9`$:1*?(4R\EJ/'4W7:XU*?
M)6ON]$T'AJ&3J=7F5'<-+B%5_P`JW^9FV3+R*\6VWXBB%8K8Y9;;,,X#)HB[
MN;5&F1'%!2795P:[JWE*#$?8RM237:%Z6VC$%OI!KF4ML8<S7575<*\A1,]]
MON-2[;$GV\X[A7*.'28TR.IN`J;BV'6^&V5;+A<75P&V)K*8Z^XI3FU9VI`I
MJ[B=JM3*<VPN]M$TI3>UZW.Q\$XSC-QE[8F'8VV0AM6T4M,4U)":)\?(:Q#)
M2]Q!%%:V^?H5Q?$$*11@B.\M*@@%2&UJ!55-/4$]=OGYC3_!7=O]WN5C.`VV
M:6&#\G+`"4%/]6>H*=%*^YZ=VWQ\]=;[P[U;1"K:=JF-A4.<\E#3<22ZGM(W
M;&':HJ!ZE*2CI4CSU-4A[='%+2X6N<WT$*84$>BL9[P/B!1!H*_9IJ;W/2B/
M%R:K*[?(^4E),=^J6E@@L+4H@`U2H;3MZ_'X:C)R3W?2/I"X=_J,L.P/?ERC
M%<26T.?D<LJ7Z-RY5AQ<I%#10"]A/A2HU:;-_P")V[.#Y6CNH05Y_P!1.,-U
M/.,2TG#N%4QOOV8RS&^?>1LKM&476);;AEF,N2+44PG(R1=\$Q6]#LA^$ZZA
MAU$A50%`C=T->NK>^W":VF8R.F@R/!'.LKE3O;KD=&<-(;_VF!WLJK:OI926
MY7+/!#12*Q.?\0"`D@H2B3=[)+2*5)'4D_'2;R,-N-0/!6]GA:O'8N[#495R
M&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"Y<_]9>C_,X_[/&PI*3^?<V^HA).
MTVKC8$)4HC:2:?IU5;E=&)\<)`+'$DGE10;^,.B#CP*Y/[<@66"_&7(;DI<<
M)0BC:7$$K*]R5$'U@GI\*:CBXLGV[Z@8$*K1_C3S4.\P;M(=*5]M79>96D+:
M=HH*/I2@[3]O0'5=;WL<3',A=22AT]_!)<W4*'!/?>N3<LN=J^1>R*6\AQ@Q
MFTN2=[#+2P`:`A2MRDI"?('KJ!+ONY.@=;7)U..%23AC7!`8QO`:N:CY=1)B
M9"RMZ2A]+FPAQ*0JM`.I);ZGKXC6BVV(266IN#B3ESIFGVR%K=%,"G"@76*[
M&>95'0TI22GO`;0O[U$$A`)-3K,W$=]!=:Q4D)I.S%NEEM>&6N8_<+@^B'/B
MO"S(DJ7!<<#X*DJ8<Z%1)-%`=/"FKR`B&V;,]S@=0KC48YA1FM#G$*WCVT^]
M_';!.QW&6\.LMA1<WXEND28T<L27NYT+SE`"JM0!6E-:G;>J612QVP:QENYP
M#J9T/;WJ/<[:]S'3U.BF=%<9S1D$*;P)R1+#[2?GN+\H>:2IQ.\H<L4PA03X
MU^&MWNK0S;KD-Q88J@]F*H812X:WE(WZ0OR[_IDN;?J0>VU:33_Y?5K-14?=
MF7.H\*^.O.K3_F+/_(7KMT/^#G_W9^@K]4/E*ZB+'P5XI<4I&<6-02V?404.
M5VI\55Z_"NO2KLTE:>4P^DKR2WE-`V@]VB:3EKW?\?8E;K];I=V5!O%L+*_E
M'"VB4M0>VGLH6I`6KX4%:_9JCN=^V^W?(V<GXAI-6CV*RM+"1X:YN+2?K*K7
MS7ZFV2V$WFSV%W\\B3%.-QI$S\-QAF0E0<3L;*C1`5U'CT%*==>?W_5-[(]T
M5DUQ@)QU&A!Y"G"BO[?:8W-U2C2X'A^]56YWS7FXN\^_M7F>W`O3LEZ6L.*:
M2AU]TNK4A8HD4*O#X#6+;LEO)(]\[7C4[5@\X$J__4[G0(_!0=@3`YQSGR-=
M;9;X+M^DNVR(I3C*'7`NBQ]QP-E-"I->GP&K"TLH7UCJ\,;@!J)P&2=_4+N(
M"5CFAU/PCBH]7//;M+CR&VKBM^=(<+KCSK3`+*AM``';`*2H?$"AZZN(MLLC
M%1S7$\]17/UO</Q-_P`T)O+KE>81BTY*N#54I2K:66NT$BNTU2W4U_0=-/VJ
MP80`P_YQ3T>[7\E27C/\(2+S?A#D'DNQVK,L>S>W6QT7!ER_,JC.+<780ZTB
M3'8=;=1&1+CL;U]Q:?30@4ZU^SOEM\N]ZZ4Z,FWG;[O0ZX;YKH<'`M_$VIKJ
M)P7I$&S7MAL@E;,[XF7QN;04`Y#FI3>Z;(V>+\=]N'$MFO:7X&+<-)RJ>WCS
M[<AB5?\`-K],EN17G83C@<FQ[9`93U65H9*B?O==5\H[ZXOKK<=SN\;T2Z3K
M%'$!V0'+Z`G.G6.$#WR$^8<^]07R*U9)*Q65EUM+EQ;MCZXF5M,MI<<MJEH1
M(C75+84Y*3:GV'0'.\E#T9=.X`E05KQWYZ_*:9MW-USM,>NRDQN`W#RB!@:#
M,.S)*?OOC;,>?;O_`.'&+J@8'@/2F1&17+84%25;NH('W16M*"I4#37RP+2#
MDJ^+>[^0&KFX=@6[$O,YPU;4M3E.J-Q2`?$=4@`)Z:;DLH'#+BG+CJ"]8P%[
MF@5_"$?W2X3%6MY<HK2?E:I"2%I"@452?2-E">AKUTS^GVXX*&[J*^#=;2TM
M[@BYW*GFXCZ7"XML0BVDUHI)2B@Z)'AI7Z=;D5HG'[Y?^Z2VA'(<4X>%9!*G
M0@@*2M`90I(4O\3>$UJ!0J!HGKI^UM(XYVZ,*JLGW"5Q&L`T51MX==1R;*>K
M12<N?6KS/<1>$JV^(ZU'CK5-\,!B&(HLVX_F:_ZU5;KQW=Y%RR-"G>U'::M-
MT="RHBFRVJ]2B3^R2?/68\L"8R<14T]!4EUR9QY1``=Q6FU?F&VIC/S*=P0Z
MON!1*5>E0"$^HGK3KJ*V&60-F:/"[$]F.2)IBT:0,FIQN,,T59)+LXVX3I'R
MR4QUI4D)BKW(<1)0HT*%I*.A'^/5@PB.0//B`KAV\#Z%32N\YF@X!3"X%$GG
M[FBP6CEK/IT3!XD>89"+O=YP;*C&<;@1(^UTHH9JVQL%*I_DU*M'13;E"^_+
MG6NL!XU&E,<5#=2SMCY(&NN9%?8NLOV'>S/$^`L/>NCEWG9"G(([IC6JXK[U
MJ9M\I0*0F&I';<6XV`5N4!4.GAKTS9]KM[%I?"YSH7DD`\!4TQS6/OK]]TXB
M1H!YC[%9!$^4@QVHD1I#$9E*4-LMA:4(:3X-I`I1('0#P`U=NT@8"C56D:AI
MYX+E,^I[[<;YA'N.NW*O(61V'-W.8[E=9^#/!1.1XO9+.([,*S/VUULNP(MF
M:<;8C26W"TZ00DA25#7S_P#-?;[FUN!N7G`P2,:&L&;>9=]2^[ODIUI8;UTG
M'T]M]G-$VQ:&/=2H<XU%03F<,5#[',CN$*$8<Q:EKBH[:'5':7@BB=SGD5E/
MWCYG7D$;R:-/+->MW!\AX8!A3CFJ[O>I>E3\C2KN`I8QUC=X+'<6ZZH``>24
MJ/Z]2X1JE:WF537UP?+DP'NJJ/*EJD%H*^YW5(1L!%%+%$D`=?V=;K9W5-/P
MX>Q>3;T\O<.&J33]:([RGY>,U%*E"JTM!!"@%MM,H2%"O6FZOZ]/V0^*N72N
MP('UJ)?M\BV;$,02?H7RR!33MG(_#HB4Z2!0E)4D^']%01IZ_P#X,GI7=J%+
MB'^K0^H*4OS(_P!\;_[J>_\`9\/CX^&NT_\`F:K]?9_]JZOW*3G&?,_&N/X>
MJ%EF;VFQW6\!R[0H=WWPY;\&[/2'8:PAAM^*I(6I36]"MJB@FB>H'ZE[_P!9
M;'+\OYK"]NHXM[>]SC#)^7(&EI`U-=B,?0OB/:]BO8-Z:;6(G;Q3QU%!CR)K
M[$\^,6:*ZJ;.?@6U4F]14)GO-1V#\S$#?;CL27@VI=P1\JY0%:E)`)"0$]->
M.?(VT=+NMW*]C9+-S6M=B*9^VO`C!;#JX4A8P&NDDU'&N5$JHT"%:($*UV^(
MS"M]OBHAQ(<-I+4:+&0"&VF&DT2VTV/`#H->0=>Q,AZJO61-:R'SW!K1D!P_
M>KO;*_I\).?EA>@@;0$*`"^M%?>-/AK#R,+,"KB`U!6_;GUP)<24A12N-(;D
M(4GI13*PXD_:`I(TT30%W`)].=[><QF2>>HEQDS'_G5WY7<>"EDJ;N\14;:2
M`5>H;D^'GJNM'^9.]XR+U/A:7M#1FN@'&;O55ALL@@K99+25D?BOJ;.Y*7=J
M`H+4%#J?(?;K7M>`&LXD!7["'-`'<KM/;S"7$L%MW5HN*PE-0!X-IJ4TJG:2
M?T_;J<ULT50PMQ5HT5C:SBU31@.I#'7TBB4D4_:`*1X$E(VCS^.FY90]NGC5
M(*@=S9;$Q>07Y#-$MR5H4I-0%!2Z'I0E1J:T^%-,*2SW0GVX4N?X+MO<4HGL
MH+0-5$EA8751\34#SII^*1K1I(Q)27M)->Q;_/6,#D7CSE#!GT!]F^87D5B9
MC+`VNB\8]*B!DUZ?C+E_I\*:5<L,EO(P4J8W*+IU-(YM(])XK\SG+L0<D&Z7
M"?=GHS_S,Q,YN9:76)3,R%(>B26E,JE!7[YDA-3U30^>O-'$1-J<>"PSP6.+
M#F"1ZDQPP2)(0X1D$0N.*6M*78*]Z`K<0K8F0K[I54:;^(;R*35*O%\<:P[\
MRODJZL2H;%HEIE%N.XRI"0['E*>"G7:*]$:@3YE7C0:<8\2-.GN1FG;]MN2L
M9>O-<DA2.#(,)S(8D2*O/4)D9$IN#9(]'I;S$QII5L<4^L'J-B4J3UI73Y#V
M1-C>""%*CC+*U5O&#S%-/6>,G)_:>TXQ9E'Y7-X"Q.;66'&B;.!>4!O'E4(7
MZ22S45T1!LCM'EQY9FJGQ1D$..5%+["FI3S"5"3]+N<2TV:7F%);4H@-D)"T
MNS`4U'0@$UTZZ+2?X<6GG4T5G`Z4%K01Y=5.[*V;IE$'&X:1[#.1TL2)+QM7
M.#,N+8[<Z8L1KOXL0K.@Y(=2"VXKL1R&$HZJKM2@L)QCAC<.8)P]:LJO'\-S
M&CM6XQQ0\ZTAQ7MC^D1=7$H=6B3:KV8<RI;=0III:N"GB@.!>U2BL^DGHKPT
MP\-<*/MV$=COWKOFR<6V_K=]B4^3\=/W+A2PX8Y[>?87D*K3=VW6.%U9,(7%
M./1TRKLZ;ICN2KXKE-FY-&7W@R+%&`>EN@.C:2XLQD,QMPUF&((K[2D/;YC:
M.#,>==/HX]RKIY?X+19HA*/9][:L(<<1);+_``[S:[%?=2IE6X!^%QQB"XQ8
M3T3ZP#NJ"-*C@;@\1N`KS&'M5/N(:QK6".,XYBOL5>'-5JOLUZ\V*!>8S+-U
MSRTNQ[.YD,>/(?QZQX-8DO6QB*])#C\9N\293SK;850DNFFZNE39A5;_`!1%
M@]XE0]S7'<PMR7D@6]N7*51U(NT)*WF0&41]Z%FCQ3VME11>P;34"FF57J+5
M[M?()G=B`_\`(F8I;$Z0S<X<-KO376D2%ONI<0E"!2I)4$I2*52$@!DS-::4
M-4)N.3(*,<QS!\+DV]$K*;1/LK-B=NS2X<F!>;5<&&G)\F*VW,9GM1[(_)*(
M[CR6-ZTNE:D)]4NT-29L=)PIW)<K#":.QPK@IS\6Q9,OC#,+/9FY3UUNLCG1
M]N-#AHBQE2<K;B6O'W)%O81MB.N_EB@E1`9;*BJI!!.J;-&;702`7QD"O:H[
M)`_+@GJX?X]?1"PV$YPGF5R<@?)-NN2N8$Q1$4Q#L[#UUE-HS(IE6]:HE6HR
M=X0&5CMI[E%XFX&EM.U75O[WH5E.+\5KO%QE.N^U'*,S0_`B-?F=G]Q#6+1K
MH&WV74P(MO&<6E4"1'6BJWBVT7*%.]0--0ZGA4E7=O$]Y;JCUQTYBA]JE1@W
M!38?B.K^GMRVM"7H]7D>]-M+#*@\V2[(C(YF29$9E0W+0&W=R04[5>&E-UEP
M!:ZE5:QQ,:*-@<TUP`(I[2K"LZXD.11,>1)]D%^Y*3%<N2J\4>YF#Q:_:2^U
M$H[='?XRXL=NR)B$TCI"I89*%&C6ZJIKG"$C3&\5[0?K2;BWD=0R1OJ,J$?:
MFQE<"1V`4I^G#[O(3:V7*N6[W]M.%PJ(/:84CW5H4TXH)Z*JBE#ZA741X9FQ
MD@=VT3,,):271FO8X?:E!R]QN[,P?CM#GM`]SSIML)UIFR\:>ZIJR9AC"&X,
M)KM<H7>+SMC(S26M#24MNF=>CWDNK*ZJ*UHJ[DX!3VP-T:O+?ES;]JY*/?18
M38?>5>+>K#^1L"[V+8?+;Q?E/+49UF4=$Q$)E<FX9.WE&8_F#+[L0AD*N#RF
MTC;1(`&M#TUX]YM(QGYX/M:L#OC1&Y[]):W210D$Y'DC+W]V95ZS2\K]7:GM
M\+W1UQL;RIJ3P)QM(6=@]6X./T4?`"IUH=T87[MX16CY/^]<J=CPR.,GC$U3
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M.K4MK:VDDE;7B`4DBIIHDV=KVD,!(/%(:`YU"0!S7J6[*^<@?-,EA?;*6PZD
M)55*:D^L%70G]%=6]O"VW@\NA`&:ZYH::`@]R^1<OEQ9#\9]M(C*6I)!1ZMP
M-$J"TM]"JOG2OEJFN;$OD+[?(\TR]A?E@EO/D7>;C(<@(6F.TXT^L[2V`E*Q
M585M&\J)H/,Z=?8R&,-D:=.";BP>E_A61YA!O=ENEE;<FR8TZ*N+5M57'6UA
M0352`F@/0]:$:;98.#QY3#YM<,D^U[->B2NCBKD\<D^[GF/BKD=S-)$C$<;M
M?%.3&WK;;E-?,MBT3EM@J[BFU*V=*BM`:4UJV0[Y+%(Z_D++6.`F@XBAIZ53
M@68N@&@G\P<N87$Y],QQ;'U%?;4DJWNL\Z69"U&HWJ3*GI4:U!J37KTU663P
M^XLR.&A>AWKPRRG)_NW?0OU!_<$[DR\=PS^$Q%%_.=6$POFMRV%.(2M:PX@+
M"BE38(Z&OP.O1]R;=2#394\\RBE>535>3688[Q2`E@97#T*BSWR\W93(R5G&
M,NPRP6>[6FX(><N42*AN7<"AU([B'#W`IM2O)55]36FO,^I=XW*"[8R2W9YK
M7T).>'=[%M-KMHFQ&9KI`*5#<*=RB]=[G:>6;#%MN-V9JSY!98ZY=PFAM"#+
MVBOI+*#W>C9))%4CRZZ;COH]SA<&1>5*QE7<B>8XKCVECR2<S5,[D&7VM6'/
MX7.9@2Y@>*4*CLE<T.-[0XA2BVD="D^/4()IJ$#-)`;5X#GN>2".%>:E1W+&
M/#R"0"HKW:^6-P?(RFI:51]^YM#.TI"#LV$'S3\>FH1LKEI,<9;YHPX^E6OQ
M5F\:BU]3CP^U:463@EP:0U\G<.Z%U6N-%0IQ20H;@4D^JO\`@TJE_"W2ZF'>
MCS;-_@#7U/=]J0F3R\41-?C?+W60RVA;R@N+5WY=IE3JE*J"A*&TH)W=`!UU
M;;5LN[;UN=O96Q<YCW5?H%?!V]M5>;7!;W=U'#"QQ?D<L!^(]B;?CSD',EYS
M;N*,6LTR9'Y!NS$.T2!%E2+#:K=.JY=KA-F-!28[%IM0?>4E>S<4`UI4:^]-
MLWI_3/2SMJO07Q0P:&2`5)U8!IKVKU;>Y(K*W%K`U[HFQZ:BF>?-1OS;W`/\
MB<LY!=XA9M6()R.[6K#&([2VD6_'X\@6VT27I4I<B2OO08#=%N&B0=P`\2UT
MBP;=`R882O%7UYG^GBL[L3_*8[171(:D<:J7'&+;=H^2ENY4^B,ZPEB5;V(^
M+W^VW*VN*=>EPWT1HL:X,JGO/*+SKI67:^K<!37L'DB\A_.#)(GMH6GW7`X4
M.&1R*W-I;EM7R:7,(R/'O34<UX?B6$7:+=+':E#%\C^8>B-]@2&K1<6E!4VU
ML2F'7&7(Z$K2XR-Y(02D]$Z_/WYZ?+0='[XS<-HJ=EO'N(9C2%Y(J,O==6HQ
MK@L1U!:66S7+7,<6VLSL`<F'CEP]J:2/E&,,M!*+0RM50"XI@I6!UH1ZJ`#7
MA'PL@.8]JJ'74;A0`T]"W)>4V$6F;_R2VZI39J7&B:@E-`0D_=ZZB.V^X<\E
MLSF@\!P3$L[/+."^W'(,:D6Q3;%BAQRY'4"XMM84G\+;4`$BIK4:=@M)87$O
MD+B1GQ_8),4[1'4@\4K<.R>R0TQ8R<?A%+;86Y*;0X'%E"""?(`]=.0VDSIV
MTG?[$S-<L+/,H:-52-ZD(?Y#G/-H64.99,>2`*T2;H"$D@FA&M<SP6QB.+@,
MU2'%VI6L<=*+\VYN4VEG%+NM*DJ\%"$VCJ#2H5OUGB/$3VH8[2X./!-PR)#B
MGBLE+:&5@K/BGTKZD`@GIY:[]"F->)&$@<TXEHO4*'!A=AF2)"6T(6^E9+3@
M"1X(W4H:^8Z?;I#HHY/?K@HL<9DK2B?.S\@SX]OB1;<PW"4\MD2)K265.GMF
M@<1N27&G$E7B/57K7PUTUI1@)`]@'%5L<#?-?YN+*'Z5UV_2IY%R;)N&X65<
M@\A3+S;+,PFR6)JZ25;^PT4I<4\">\^XEQ7;2M0)*4]=;[I*5\D!<^<FW:/"
MWTXUKVU6'W:C9PUC3HU9JVQG-K?,N:+7"09/X27')"#5MA1*2AIT4JE:D*!I
MX@'6P,K#@W%5C?>'>J-OJRXW=6^6N/,[N$.0]BETPC^&;;,V.+B0+];+C/F2
MX3[FT(CNRV)S;J.M5@*H.FO'/FUL]Y=0V]];C5&PEI`K7$"AY+[&_EHW_;;7
M9;K99PR*]=<N>#44</3BJ<<OOEHMS*FVWF0^E-2E*B1U!IY]36G7QUXW':S0
MFLHI04*]NW>\AN7N\LXZOK56GN2NSUVR"\.+42EF!;VV0J@7TCNDCX$'<3J0
MRFL=ZSD\H:QS36M%7Y<G%KOML9Z*"8JI#B#3;N4]Z20?`@"M#X:U=G$8]O>3
M]Y]?8O/;EX?N0ID!]:3%XDK?N<5M9KT6:^0*EJ4FIK4B@ZZL;$>3;:W8]RK[
M^0/N1&*U)6RB6EJ3!:1L0EB`^5)``(4=@0#4_=V]?AUZ::(^(MI0S`O=A7M*
M?8_R+F$NQH*8=RD=\XS_`$$_]T'^F/#^7QU8?!R?B'\#3Z>:H:__`#]'_%7,
MR\7QK%L<EX!A>41KI.NK$ZX7S'K=<+Q`"YCI2S:U2G!6"H*7VT[>TAP*%:FA
M_03;>L8[S9H]FN-ML9?/\YSIW1!TC&AVEHJ07T;7#-?)]UM4T%_+??$2,BC+
M7",$Z=+A5N`YJQ.PP?R>/%@)=<6W`A,,H<<=+SQ2$)2@O.'U+.TT\/(:F?+_
M`*%W+8>KKEEQ(/*BC!_+P:2["CJ8$BN8PY)O?=S%UM<<I%'.)QXTY)1K.[83
MUW))/_IU!KY\^:T,=OUYN,$7\-MX0.S+!;G8Y(G;3`78G0O&T>F@^Z"!]G_H
M5UYW,QSR-(5D][1_#-`O+BBE'QKT_14=:?R:A2.:UA#N*E#FE/[=K<I_F>R/
ME1")5_QN*5K4E+:2'995N+E&^H`'7SU`VV)_FFHPUX]U5.B)#`1@:*_;B.X2
M<@Y48L[S91(:>6(S*T@;6$/;34#H2E%*D>1UI;<EUZ6NQCKAW<%96#WNGTN)
M+5T7\66\0+%:V&P4[(T=)4JAZ[4DC;X@D@`?"NKF42&GEK05(R4B+:M2DD5H
M?!1I4*)'CM_9Z=//3$ACTT;[U5PJ'GN0M)8NUONC04"_M[JROIO9<"=R!TIN
MW4Z#3$F)9HRXJ2SW1W(QXNN_R%[MZG%%"7E(2L$]%!5&U`T'@$D4\]=&8[UT
MY'N4D\C4[#EI>`H92H3C2C1:%F/O:74'HM%&$DCSKJ>US)*@8C(]Q4-CVN]W
M@OS_`#ZJ?M_O7MT]X_+&"XWAE\N&"9=,9Y/P9Z`TRY%1CN?NR[I)MC"I#S16
M;'D*)T0IHH(;:17Q&LM%T7U!NS))]IMWS1"0C`M`&)X$C)8K>C;[;>:)WZ7.
M!-,:8XUKEZ*JI_*,B:PARVNY/CN6V-N^W-%FLY>LD9Q$^Z2$@-P8RX*'5]Y9
M/I"J`ZB7?1/5&VF-^X6;XV2/+6U+<7``D8./,*!%=6TP)C>TT[4F\VY5Q:QV
M/)K!?V)T2Y14HMLNT7VV2V74S)B?F(L64RRV0MLI2%$`[5-GJ:'5=<[3N-G>
M_"21EDS*:FU'VT."=CD9*P21FK"I5_3ALV-2>$C<;VG$Y=XO&;Y)+>3/;L7S
M;3"$6^&U&[,VKZ(3;<=6U(`:`4:>>I-PUSI*N%8^"DQRTKK*O8XJLF!W'Y%5
MRM>!SWFV4M)<N$'%YKR(HW)6TA4AIUT1U()JD>C:3Y'3#86O-`!56S'L+0`<
M:*?."\7<'7!ML2N.N%[@5;3N?PWCN63T3X=RV.>?PZZ2;2'55[!JYGZCD58V
MI!R(\.:F*QQSQCR"Q:X.<8'QKG4*TJ4[:HV6XEB>3PX#[C:(SK]N8N\"<S#>
M=CMI;6II*"I*0DU``UWR(AAI;0J=2*3$Z2EJ/:O[7I,9*A[9/;V5]I;:G4<-
M<<!92ZDH6@EG'4*V*!(4DU!'EI9M=LA>6.9&'?MQJE.BMS[H;5;]T]L_!]TP
MF-QQ)]O_`!9,X^A37+O;L*/&>,?PM`NQ=DR%W"%9FK2+=&GEZ:ZLK0A*BIU1
MK4ZXZS@>*D`1'(@^KC5.OCC\G(4H%`;W`^TC@3$+5\WCWM_XOQMU:GU..VK`
M;5;$E3,=P-N.*C0VDI["5D`F@`)T@6\,9`C%0.*J+Z-ACHP"K<52AE>3X:N]
MR[U=[K:HLB`JZ-0T2@V'6V'WI#"'TO+9VQVW(H;VJ0YZTHZ@"A*RUIS"HG/:
MW!W%0QY5O^'WJ1WH%_M\M26BE"(\Z2\AQ(=*E+`AHD(64[O#S)TV]E1X0H%5
M&&0XB#)0Y);AI9?<<<C(ER>VM^,#M6XPW)0E3R02`2!Z?`Z8?;,TZY-('.H)
M]0Q]BZFBYWY!N+AXRF_E^/Y$UC^28_8UWR4\A^=C]OGRGH]MM\1V--CO7-7R
MJWV?ZRF0B-&"6Z!.P)E6MLQI<W6:!M0*'[$/<7^\:FE/0K!N`\GC8M9>:<FC
M19-XA62?CD2WVVT+0J5+7(*8,6%!<=4EI*E2IB`JOIH":'3A<YP`<:@9=B=M
MXV4.`4U,`XAPV\WAB[7:U7&9,3<%WD/_`,3Y="CBXRRPIYU$2!?8L01RN*G;
M'#?RZ`#M;3N5NIFZG/(?4CM5NPQ_<SHK#,$]NW$][DO3;MC%Y5)N3,=F6N!R
M+R=:6BAK9VBU'M&8P8T-=4`E;*&UJ_:)ZZ>-O%IU!S@_D,#Z"K.VB;5LCA5O
MK]@4Q<-]H?`2U1G_`.'<]0M#C"FTM<]>X!IH.LNI77LIY0#*DJ6D;D*2I"QT
M(()KUEK(]M6R.$?'4X5[5:LMV/&MC#2O(J;DSVQ<,\B,VX9#C>2P?RDON1#A
M'*?+/&RWE2TM(>,]?'^<XTNZ]M,<!L2B\&25%`3N55R*UC;7RGN[<TI]N/OL
M/J*Q_P"@][?XH7\HSSBT'&PV`GW6>Z!7;"RE7X7=Y<7VG!MZ*3M4.HKU.G9+
M5L;=;W3:2?Q!-_#Q_@/J/V+4S'VM<1WK&+!BZFN4H4+#R^[;KA:.=N;[-D4X
MK;6@C)\G@9\S?\OV`DI-R?DE"NJ:'KJ')"UQ(:^;2>9!'I"=%OX=18='<5R!
M?4]X[M'&?OA@V"PJR55OE\:8%<TOY7EV49O=ENOY)>H+R59#E]TO-[>CH,`;
M6W)"DHZ[0*FMUTQ`YF_6@:=0\]HKVDU`]A6'Z@B\IKAII4$_2DE[N>^[R?"*
M%..-W'AOV^SE1]VUMQ<CA/!&%O!+E$`D,=3YT&MC?%D>YW)R+;B0#L&JM!Z2
M3Z51.PBB_P!TU28^EX_G&->YGV[=A&((M5_YNXGM4QFXW5]%Y_+HV304IGVR
M&$MH=D.-S7$(22I*E)IY:S6X2S27#6M%.->Q3K=QC@+:T<3[%^A)KBXAH0AH
M0AH0AH0AH0AH0AH0AH0AH0AH0AH0N67_`%F>!\[9_9@HJ`1'OO.JEI(^\%6K
MC"E#44H4ZJ=TD`:V&M'.R^M%*C')<FMPFVU+*X*&OEE%!"E@A.[_`"]V\=>A
M^%-9N".X@NC/K>^,9"N!3$D1-/+")H$H660P'T]R"EMU27RK<3X#Q+Q"C50I
MUU82LFG(G<"'_A^M5\X\/I3M8+#P:[L7IVYWYZRSD,%^T24-)=/SB6U[6E(*
MUI<!-/3T)W'KTU:6.Z".-UK?/,1&##0FOJ!IZ5`F+P6F,:AQ'-(#(;U+NMW@
MQYFPO0VW65.-MH27E*V@N=H+])VI%!2HU:B<7#/,^[2E>8YIR*!S65;B#CW=
MBT[>S:6&9@E-RE22]W6NZRZ$J4%`I2E9]`3T-20/&@.AK0UH<T4:?:@BB=NV
M3[;)QRY_-W1%F<88CF)"*$N(D;5I4I)*2$!"RD4`!5NI]NN27#6'1(Y-N;05
M8,4]&39YA[.,X@SCUB<MU]MZHY?N,9Q*4/R`Y7NAD4]*:J)'6I(U$N-QMW-;
M!"'_`!'%P-!S^A-ACJ/,@X8*VOAOW.0V?;=R/#RW)_SVX3N,\GC,0V+?\N]`
M0+)*`:4L)HX?$U7ZB4G[-7UON#?TJ>WE>\ET9`%"16AXT4#X:EPPQ-`;J!/?
M5<-WTX)"6_J&^W.6VM20>=;.[]TI4E+DZ<4`@T-2E?7X:H[!CF.MM6?Y:]$N
MVM=93ZA7\MWT+]);WC<EY9@%IXYRBTB-)LEOS.SR+E#WM(F/G:MM"6"I7I4H
MFAJ!T.MEOT]Y"SXB-S2QD@-&U#JX^OM7E^SLAG:6/P.DBM#ZE2K[J>;^+>:)
M=^N]WL-TL%\8998M<J4ZI0$T*55P)0T0IL.>)-=P/CK'W>ZVF\25N8GQS\#C
M2O.BO8!/`T1ASM`^A0<Q[*X5K%PCB[*$R0A<:.N&M<=;B%#P4I+8"D4)KNU'
MT1PPN$!_-<,^SDGRXG,U3)9#.=MET3,3))DID=Q+I3O65+^_W:-_M`T/CJ!8
MR2A[C4@@!<31W^^LR[I/E%"2\L%#NQ)0G<!510"SM150ZTI74\$A_F#WSQ[U
M8,]T=RTK%/#`4N,5MJ?42H4)6TFE/0HM@]1\!IN:8%K@\\$H5K09HGO\2;(^
M9E6I\EU"5O+0I+KSLQM+3BG8J`A*5*6N@V^()`%-;3Y:=6V?3'4D5Q=M<^*;
M\KL%<<?M6OZ1OF;;N;IKG_:1Z`<]-36HHC7VF9C<,"P+W<\SOVR0[:.+,'B8
M1QRFXMN,BY<D<N3W,>@VLLRD,RDHL-G3<'^X"#V1MZ[`H_4>[[R^YW"QV&!C
M3:74[)7D$4$;34@]G8M[N%\^2[CVYN+2-0(^\**M]&.]H/**4*?><D2I!0V6
MFR](6IQP-(`(;:0I>U"0?2D`>6M?<12'4_3B75X<UQML&#S("17@,%,GV[9+
M(CV=U-YB/!-K>+:Y4AE*T.QR=S+Z5BVSGEU1]Y1H0H>--:;8KV[\KR9-3F@F
ME3DM=M;I768,I)?J.?)23SV9:^0,1NUB=AQ!%FL)=MTUM"0N/=(B5*BS$K0R
MV%*W$I57J4*4GSU2?,7IFVZHZ;N+2X`,WEDQU%2).!'(CFH^]V++^T\IP!>#
M4`_2J]C81;WW4/H!4"IL"O3>VK:H$;0>A!\NFOS1N&/M[A]K)431R.81QJPT
M-?8O)Y"?,="VOFL-"/W_`&+1G@-L/(*!M*=HH-PI5-*]!X5\]-U/I2W0R/AH
M202,T8)MKSL-UTM@,B-UZ=*A(*J;J'H/#3<DK6`U]ZB3%$YC?*KJ<3@3VIS\
M-Q1"T,O.OM]I<:M%+4"G<V2*@`G<:C^35=;[NQER&N`J%HKCH[<FV39#)&'2
M"M*9<E4G<6PUR#,;`]+>5S$=.M=MT/7[2::W`(=`9ON:5B9(GPS^3)[[74*M
M_P"-;.\U'OTM93N<Q::$^GUI[[<5*4D=37]`I366\]CYG%A_+#/^U7[%,N;2
M-KF2--`>'!-O=;?^7O.H=965%APN*;4K82&U#H*U_5\=/,>'"H*C/8\&D>#:
M(^@0H;]JBNH7L<0V@=E0]1&U)"P0?`_H\=*%1FFB)(CRJGCX[Q^7?I:(T..T
M^W&1\TZA3H0ZH)VI;0PW4./..OJ2F@Z=>NNLMW7+PP$5:=6=*TX8Y]RCRNCA
M#O,P<0K^/9#[?^?KK><6>M,BYX5B\Q1<O34M#+C;%I4XVZRM$%<I7=>F)92G
M<E&U*5'J34#7[;;7<CF.B8Z-C\#3`88?4L5>3Q.#C[U,@5T:<?X6Q@UO>C&X
M/W:9)=#LF?*44J>*4)0BB"HI0$H2``/(:VT5L86!HQYJB>]KS4-#1R"-LVPK
M!N2\>G8EG^+VC+,;N02)=JO+")<8K2"&I#-/Q8<MG<=CS*T.H\E#3\]O!<L\
MJX8U\?(BH4JPW&_VVY9=V,OERL[\N0HJHN9?I)^TNYF?D-MR#D_!FFDS)KS<
M/*X=QL\-J)&=E*1&CWNU27G([10>BI!Z"E1K(7_16QW#'O=&6ESB["G?@O3-
MM^:W6<):U[X7-!`H022W[:+CH]W^--X)G[M@ASW+E%O&/0<DB+>2AF?#L\UV
MXM6-N<VPI;8ESK0PS)7M-$EZ@Z4UX_OVPP;5>B.VJYCL0#P''VKWWIWJ6;?]
ML^,D9HD`((YNRIZ57@U*1-OLU3E3(:;98;"`$-A"$$KK0&JMVVA!`\:Z=EBD
M98@,%%6-G$]^XTH6X),./-"\H+X*FR\A@;152@X!1%/$)`30GR&IT,;_`(/3
M3$J!+*QMX'S'PA%EPF!MR0XE6P%I]#(!"MR4/I2D)/A3:C]0U(M[;\D`-&8K
MWIN[N@':@X\V]W"G)/I\^_\`TE?]S?O_`'O/^35_\/\`U1[BS'QC_P`9_C:O
M3S[TZEA=XFM^.Y#:,AR]=LE8C?)]VQJRR9WRSCUT:D4C.NK_`"Q,V:C;<']J
M$.MM*"B=JB`1]<[Q;0[+:1W%O))%?NW>:S?&X$:;1WCUXC,N&$F07S[9/W*]
MO)#<QM=:BR8\/;QD:[1I(%:4;C3FIV85D3E[LUAN;JFW'+O:K=+<4D.-H4'8
MR7-R$.>MI)W>"NNM!\O.J=[9U>+$R.FV^X<62$C4=#,6N#N&0J[BJ_>+6V?M
MA=)A(,:`TQ.>'U)STK2MIM0%#0UZU!H2!0Z\?^;MN6==;@Y_\5UQJ/94<N&%
M%K.GVZMK@IBVE%])/3]'^,Z\T6A\B/M6J^3U3^R!4GX>52?+QU17;Z,&DBNK
M[4Z$X/#\!@RYL[YR.Q,8OUB7$C/E6^4!-2TZ6$H2I3G84X"O;U"=(M*.8X.-
M"2GXY':@S@KXO9+C;]PY`_BB;)=E$HCH:6LK7VE[4MOT#E%!*R?A7IK0;7&U
MKB]U<%>;6QKI2YV:Z2\0:+$&$I"O266TH6$TH4IH*)KZA0>=#J^;(U_N@BG-
M:!S0/=3L6I;X*A0*42=W121Y*JH$JVJ-#]FHTK(P*MSKS3:8#W$]E=NB.DDA
MIQ*U!:3Z!T![=/(^)\M,*2SW0FGQN6TPB'-96"II3#A`Z)0G<"I*%5-`L$?K
M&A=.1[E->3'_`(GQN`^P:RV8[<N.`KHZGMAF5&K4#<I24K"CYC[=+:^2.1K1
M@TYX*`UH9*T#W'9_4J$_K*>PK,/=G9.&,SXN9MS>?<?7/(<6OJ+KD:<7C7'#
M,A:;N<)IZ:\ZTP_)LF10%EIM9)`G.%/AJTM'P1R$W$EQ\'0^".0M;JX&C>.?
M%5746TS[B!);MB<`0*/IZZDA<\6:_11]Z^3-XZT,:P*]1K!>F<@A-R^7,86J
M)=8_;2U*9[]T8=>HEL`H4KMFG4:-TOY7L@BVY]\Z&&1SVMD>US`74K0N.L##
ME6M>"R]MT]=1/>'MB8_L`IEP-:)I.6/H4^_;/A.N2^-L3O%\GW*WO/R$\O\`
M'%MB(88;;AJ<^78N;!*HT&H:25$E0J2?`Y"]NMUO;]]]<QN^(<:9$BGHR5E;
M;%=Q1"./0YHYN`/TIJ\-^@?]1##+\)T_B_&K]$CVV[Q&F8')/'K,IM<R*^W$
M+#B\M;;"4R':JW`U!-*:&QWK<K:M>93TFT7Y_A1M'>\(@D?1`^I_$E6)^+P`
MJ0(TF0Y<Z\F\:2&Y,5\-LEA#+6=I6Z&H852A%%J'PU6R6URYY)CD!KP!^FB<
M_3[LL#',;4?UPG5XU^CK]0#&[O=GLO\`;-?;Q#=:0W9$HO.$2V8K:W5J>[[4
M#DMM,F2A"4);<V`I%2$]=6FSV,3)O,O=8!R#V%X]`IX>]1[RQW,V[8[9@J.(
M=]*=6Y_2B]X\J"PVGVQ\UV68PP`W,Q#*;,U*<4"2&W8ZLNE05-`=0-H(\*ZT
MDD/2MPX&=EQ'IP+F-<!7^P&FO>J8V74L9HQN'?5%]N^F%[_+0XA4?@;W+3F@
ME:?Q"^S++:TI"VU2L>Y#A-J#@%/W%2/LU-,?2Q:(PUSP`3_"<#6F&/'N3WP?
M4QP,;6_Y8/\`0FUL?T[/JR095VAO\-^[JTVY^=.9MLV+=<LF1[?`/YE\M+;C
M1<I5WGFD.,)*=V]11M!\]>973W?$/,$4Q:7F@#74I7@*845M%;;LUC?,!#@,
M?%7'N2-C?3(^KAG-HG8IG^(^Z>P1D+N3OYSDB.4\FMLV,DPXT"`BVV25>9B7
M)D<.*HML--(J%&IIIQ\<M*MC>,,BTUKZDL6M\Z0.DKIKCW*3>5?3S]X=S7%;
MN?`/.%VA6VPX[:+?98."YG'L<(VBT0K<)#")-G9DS9;WR_<4IY)"7%&B12FI
MT-M;:`;KS&O/)I/U*'-:WDKSH:0T<VG[$U.2_3\]SEJM4:UV_P!GW.STIS(X
MMZ=OKF/<FIN<)QI]A:V&7(%O:9_*PTDH$4(2QU*NBNNAK+1[PWR9VBN9U#Z0
MF18WIR'L*D9DOMUYZN[\*5F?M#S:_,VN)*1;S<N%<QN4N`F44]YB"M,)?R\=
M[MIW!/6J0KRKJ8^+8HV$N9+K;Q#7''OI1<?9;@QNLL)'8T_8JG'/IF<D.\=-
M2\KX)]U&*YS.SO+I18L/$V6Y39[;C45JSL6I,BWG%+=(^<N#[CKS3R92MK+?
M;4C>-YK&75))&5:6%M!5NDTIECQ[5*DLWMB:]C'EYSP/V)V(G'_O8XKQ[-L'
MXU]M><PK!(O.,&'?\IX[Y)N%TN%CMEM7^%'MT*P"1;9R9;;9<62I;82H`D^K
M4-LL+11]3W)AK+B/)CL>PIA<)M7U,;"+A(E0_=%`L\2+(07)5KY!:6EX;$Q5
M0(S]L$ITH616B>B"?@:.S_"O8`P$&O%6#(YVXZ75[BGPP#D_WZ0HUX1F?,/O
M7Q941FV)MTG%L8R.XLON.MO/SQ(:NTFR.15QE!M*>SN_:!(\"PV.PJ/BIY(F
M?U&"1Q]%0!CG7@FW2[@QY\MK\*TH".'-2#M'O$Y_QRS6^%-YK^H2J[QF&Q<K
MNY,O\%J7("MSK\>WF:^W#2H4"4A:Z4\22=>M64?R/;MT$=]+N_ZD`/-?I;I<
M[B`T>X.W&F:S4ESU^"^6,CR<0T<:\*]B*;-]0[WHQ;YDL.9[G/>U&L8F-O8K
M=OSJ[QKDBWOLLA=JO%L^44RF3!D)<")*7%&0V05)"AUS[?\`W:127$1=N#[7
M7^3.P@FF-6/B=0U9A1WWZD\%81WO5>D/9+4EHU-.&EPSH:X@\*946].^HG]0
M9)GKL'O,]T,>&+?)$1-\S)]J4)3<&48Q")5J5L4Y.0Q0`UV!0KUUYY<W-JZZ
M=%:N<8`30N.-*X5'`TS'!6]ON&YOBK-(\2)Y/9I[C/JZ^ZCD*W8W;/=ISNQ8
M1&?GY+D.37B>SB%GA,N1F%LW.Y1K,O=)D+DJ+;0475I0HI'I)!&/,<&`C%36
M7.Z34BCE>"<B:TY]R8[FVR>X++?<W>HG(V49?SKG6*SOX&1>(+%YRVX7-C',
M@N$]:+.RF&+BJW-I>=4EOLC8=Y^Z*ZO]E;\!NEM=R$.A;.UQIP+<B>S$JEW-
MUU/"X7&ITHJ,CB.SL3@^]/)4X;RU:(F06J]QE0N'/;[:WVC`6)5NFM<-X0V_
M`N5O>6Q-MTN-)<[;C;K:5(<])`/34K=-S:_<KB2(5A?,YPXG'ZN2C/MV>5%6
MH_+"<'Z<'O/]O]U]W7LVXYA9%?%9;<?<9Q1B\:"]BUV:9-ZGYS"BQXRIO;,=
M#2WS0N$[12IU#+Q*X2$C51=I047Z3.NH0T(0T(0T(0T(0T(0T(0T(0T(0T(0
MT(0T(7*__K.#KK&/>S5U*U,M"_<Y(<>"7-B5+M7&1;0I:4+2E2PA5`?&AIX:
MI]RB$D\1H335EW+HQ(!YKD&D-RGI"7U-*?:*F]Q]12I"5@JK1%:*!\//34'E
M0U::`GFG)6-81I2AN5U5>KK:X5BM`>5\BN*B,AE03)D)!WG[J-@2M()J!U/C
MJ]U0R2B.!I/AKSY*ID8#[^#:I:V[CN\P.W+EEVWN+0AYYM:7DLIW!(4A'@@D
M%-`*JH?MU"W*P:YK9'4!XCB/L4)S*OTLJ>5,5ER/%W(&1V=UF4U(;DLLO*HM
M6]*Q0G>2I"A^FGC45U)A$4;`UIJWO4J.)_EEC@037@I]7J3[?KI[?8L=ZW1K
M;RC;TH2'&TT7.*"153B)"-^Y*=Q*MWP(U/W:[MH]N9)"#YX<`!V'/#/[%6V]
MG=BX,=?RL,3]JK;S#O/O*=;"$1T.QP4AY(JA+@J2D.)%"0.E-9F29TSM3E-D
MB#!1M:U7F^Y9%QA%G?GS([#4NXQ(<-3SB5!4MP_ALCUJ3N53]%=0F?\`-CO^
MI1W,)%'`T3Y73FG,;;Q7F$=B[MPXK>(7]`;;9:2O8[`D)4VIQ"2JBB?CXC4.
M]O[V($,>6C52@P]B=MK:-[AGJ#@N>SV(YC$PGWH\$YI<D%R)9.5[+<Y24?><
M0B2^20$[CZB[4]"::U39X[5D,\K7.8QC30<PM7-&Z2VFAP:71FA.55VW>[CW
M$RN7&<4OL%QV%BQO#*&FVWUE:76DJ[;ST=1"5!*FR$G;4>=*Z:W;>G;JSXB%
MSF`.&`-#Z0L/M]F8:0EIP&)[57]E^>V.]6^7;[Y;(TV:7VHT2[*#;/91W%!*
MU!(\E*W'RJ*"@U6-ORYP8\5D.%:*S?:D-+P<*9<5%_*B+9.#36Y*([JEI=8I
M12'55"MR2JBQ4=>FIL<T0!\VNKA11Q!(\5:0!VI,R7F7ZN.`J<#2EDJ4"2H`
MJ!-2**Z>/QU$FN9&`:0WU)<,7F2!C@:%(J1$97%5(4:/N*6\5%*5=%$@`D)*
MJT'73C)I'`'"M%8-BI)Y9!T#!?8$1#K*>VA06I(`"0$;NGB*>FFH5Q,_66FE
M*?4K:&&D6G2?5BCMNWLQ6^VZVDE?K)*MI!!-1N!ZU'CJ"7<:T/#&A':$[';3
M!PDAP(YI7>Z6V-<6>U[A+CZWQE,7GG/,,F]R.>MI`;>7'1':P?C6`\V$)[3"
MK7;I<UM*J#<Z5^)KKZK^3E_+NLOQ.XO!OX(_+8S.C*C&OWCVA;SIQGFS"9]7
M31LH.XGB%7E;[,MQI:G4)[ZTE2Z4(WJHVTVFIJ0%$#[:$Z^E61QANK,46H-L
M`<G)\N-;@FT!P+99!0I++C3J=R'&T`[/2K<A0`KY;NIHI(K5W;+@B8ZJ`<LE
M=6+=%N&C#$I[5S+?-C*$9L,+4!5M#CA:014E2$J6I+0(/6@&M`Z1DL9>T8C@
M<:^A2'1AYJ5'+)K$I5YEMK;5VUN%]M>Y*0$/DJ(0H>6\G7YG_-K:INF^OMPM
M\!'/.9F89!_O4[*TPX+S7==O^'W&?#P.?4>KZ$WUVL9;CR4I&U(2-RE4W4WI
MVUI4$UUYNR[F<ZAI3N480L,>DUR3@Y-BUNL^"W:^I:G2OD;(Y<#"BNI[S_;:
M2M;;5?25'Q\]#Y)))0#2AH$IEK;-'F.U5;C2O+%*["X+5TQ&V7^V]Q(GV6-,
MCM/$!QO>P#L=&U("DE5#^C3$.V1"^/F$D<*'UK1W?4PDLFAH`+6TQ"I8E(6Y
MR,^R2`M67N(5U_:7>:+H1K>M%+8P_P"STKS>Y<R6\=(2/$:^G@K[\:Q*-#MD
MM3843*L3;!4`L='#'4OU=U05X?9K,"VBCU::X]J<N)'DQMX<?44UG(6(1;9;
M)-R80ON]M25+45J.U;:DD'>ZI(\/(?HT['&UK:#FDC'$I#X4]!7$<1+1O4U&
M2@-+000/31P&J344\CI;JB@.955/.]SRT4+1DGIXRN=RQ_*X$BQ0$7&XE]!M
MK3@!4T]N&US:OTN``TH>OG\-)$GEG6&ZI![N%:.X&G8F;MIEA+R0"!W84R74
M][-LDYQO&36*-GN0M/,2+-$D;[0S'6TS'8;26(4QMI:F6G4I<*24D$A/45\?
M3=G=?R.8ZXDUM(%`WAADZE5A;[R0S7%4:JX$XJX!$]\I"0[T20@@I`Z@```!
M1%/Y]:@@C,*H&=%M]U]`HI:D"A-:C=3J:@%SJ?AI.IO,*9Y$?;ZU#WW9Y(F5
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M6S=//GV*NN7N?<$'(!%TP_-3F8J1VTQ;80\0`$]^2`EK=4#JXX2?CIQM8H"3
M@=8I7CBHTC_.G9&*&,"AIP^Q/U\I+_WI?_<W['C_`+K_`+WX^/\`-JU\_M'N
M*G^&;V_\S3/A^W%3W1@#KUS8N<SB7.Y4AI]#B3+LN'R"V6SZ"'5WP/J0GRW*
M(_1K[,OK[YK]1[E&[<-NN+6T=_$++=NIW:*C$]F'>OG."UZ:LHB89F23`>$/
MD<03W`A.Q'FY"UT9XYY'*B$#8N!B+0-/V:C(33814=::]/Z7V:\V*=SX(]YD
M\X`$26\``[OS`X=@P[53[C=ON8C'2!K<O"XT]`(P]:<6RORI-HCO3K3<K)*+
MKR'+?=T1$3VDH<6E"WDP94R,$O)&Y.UPG:>M#TU\S_.9TSNO+RYG9+')-H);
M(UK7"K:9-+A3D:U/%>A].2&+:(X_"[22*@U&:,3KR9:*.3S`32E$7/J44*%>
MI-*_$5'3^;67G^M.#-.SQ.CN!R/VE*"<CM;K:FBE#B3V7W5-(43N)=['3J!4
M:7"[30IR+^(%T;>S&$Y"A0'E-)<>EB(L.,*":?<70H/0K2HJ!!KU/VZV&W1:
MF:2<L?W+0[9[]%?;ADMH08J7`E36Q`*20E:5;$T'6IJ0?YM69-5H6MTIT(K>
MU27HSB%H!"J+-%@$4(\0%%)\-19(M`U5KBF3FFFYQA(EV!+CP*J;T^`!)4@A
M`K5*:'K\::94AGNA1RQV.?R@)*11"5!5:;PCU`$#PJE77QTZQFINNN1^A=/)
M2TXWORGL(F*2K\:W1WTH7N3N[;[)2V0"JJ5I>;\/MUR27S*84HHSVCS&1G)Q
M^A-CR%8+I#XER6';V9N59%;L,NN16]N\7.2])ON06ZVOWF/`?GN(>=C?.R8R
M6$J0FC>\430:F0-8QC62.HPN%7<!7ZDFZJ8'AHJ]HJT<R.'95<N.0?7*3AHM
MRY/M8OMY7*8N\J6U:N1H33=LAV6%\[/E3W9N.-MLH`';0G=N6Z0D`DZUN]]'
M[GLT,-QJBFAF#S5AKI#6-<">_5CR6$AZG9+(Z'RQK::>\<^(R[TEL)_UC'B_
M+\CM6,,^V7-K1-N]L_-F9=XSZS0XI@I9[ZGFT*L3JWFMA.Q0^_2HH-8G9KH;
MO>BR;2-W%Q/A!K2E>?%3KG>?A8A*87/-*X8CUT3C<B_7WXCXS<;5E'MZY!?*
MTQUI=L^8XY)H)!<#)_K%OBA:2&B?T4IJ[ZBVRZZ<E$5QI>7-U`M/A+3D05VR
MZKAO*4B+*\S]&")\8_UA[@/*X%TN=N]O7+P9M,2/,E,F^X@7EHE//L,I9;[B
M>ZNK*RJI"=OB?+56QTDE@[<0P^0V81D?>J6!U0.(X=V*5)OEN+CR=+A6IJ<L
M$J+=]?WVYR8ZGWN"^:8H;>:8/>E8<XK>MM;@[0%Q0DH0ALUZU!--/V44U[_#
M:6@F@KACECR2_P#$<$((T5:!7`X\\!1.1:?K@^WBYQ9\U'%'+K,:WQV93_7$
MUOEA]8;2MML78;MJR`KU`"NMEO/0/4&PVD5_?&W-M(0#H?J<VHJ*BG+%5]EU
M_LU[X&"07%3X:<NU;\?ZXOM>)_&XZYE:42#N$#%7@5>(J$7]*?2?AJCDV+<8
MP"0UU>1JGH.J]O:3X9/4E0Q];#VN?+KE+PWF-J.';6VMPV''G`A=YE.0X0*6
M\A34*?:(4>NT$'KK,7E_:[?=/MKH%LS`#AB37/!6[-\MWL#V@Z2*I,R?K]>Q
MJVM7]^?'YMBMXWD;N+WAQ.&0G41;VP\B*Y$:#.1*4MGN4"7$=%=?#4,[YMCP
M6@2>>?=JW,#,GN3PW5A&IL;RWF!4)5XQ]=[V19=FC?'%EF\S*S`F4#:G\(0T
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MGB,N_LA=.YP`$I6X1]6KVJ\DP7[GA/)O)%[AQI#<5U].(99&2W(=;2\&MLI:
M'">TK=T%/CUTG]1VKE'_`)H3'ZC;S9X42KQ#ZJ'MCS87=>-\H\@7!=BNTBPW
MA3N$Y_#$"\14@2H+J9T2-WG6J]5-;T#</5K@W';?O&,C^R$_^I6Z<%OZB/`B
M0M;O)>6M("5.*7(QK,T@)0DK<4I1AN@I"03XDZDQW.VREK&!KI'D``-!))-`
M/6D2[G:MB<]YHP`DGD!B?8M)KZG?M&>:29?N`9!``V3;%EPJD^"2';&1X?IZ
M:V;N@^IF@^;MD@-,Q'44IS^E43.K.F)`U[+J.CLJT!*UG?JC^Q2/.C6R9[E^
M/8\Z8@.1K?<[==TR9#274L%;3,K'RI:4R5I17^DH#SUG)-FO=ONV6&X69CO)
M*Z6Z*X"F/IJI\.[]/S,?,V6'RV4J=65:_8LSWU*?8#VVE3/<IP>RIYYQIINY
MQ(C#CKB$EQQE")=A"G'$H]13U(3U\-5$CMIBN'6TGPS+D5J,*X&AKZ5/\W;W
MP?$Q4=`2!7OQ2JM/U`O8C(A(?M_N5X"9@R.U(;7'F6*#'=*ZH;=246UI"C4D
M)6>M21I\.L--!\.6=]$W\5:C(T:G0O?*/MT59LODHN'&K%\7QEF.0HG1L+M\
M*_KL$[&+Q&;OD:\1\;BW9F%-*BA$Q+R4%1H%UTS*;`-(;IK3#2:BO>GIHVB.
MLC<2VH->'!<0.2\17G,.*[#D#+,VXY"W:V[^N[3KA)F7.YR)S;*I2I,F4X\[
M(:6TV'%=U2BXOR\SA+YSXY'.8:4'K6?=&)(FOK2M4TGTZ/;IQ]%^HM[+LOMZ
MKQ%NMI]U_#-VG0'/S!45V]-<BL2"KN/I"4MD@+*4T344'2M"RW%\X`<X.IA2
M@'IJF'PZ!6M<5^J#JZ3*&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"Y8O]9^N
M*V^//:)9FFTK7=<TY9DK4I*#M9MEFP7<@%:%T[CDU-?"H&H=V?+;YPQIP3]O
M$)I--:4Q7(C(N8MK:6"I&QP!*@:$MA2:$"C!_F\SJA,<EV\R,&/%2KB``C'V
M(VP/)&L;RB'*8:C.`I<V"6TF0VDJ-:A*VNM30FNK6"[?;FK1XJ4S5;=6FN,`
MN(QY)[9_,&10')C;L&UW1IY;:F5O1BXA`#G<V@*3M24D>5.G2NI#-SNWZW>'
M2W@6UKEF5&;MCF_FN)\OLP]O!$-YSN1F5UM4U^UVZW.0F1&+=O84REU"`G:I
MP;34C;6OQ)TV^=\_YKZ!P'`4R3[8VL;I;6G::KY>[W\TB,45=<;]`0JI2@)W
M5*B*&HK741TCY/?-:(CC\NN-:IK+[.>D,.*Z(!?:24@+2FH=%3T*:]/MTVH3
MO>/>BW(L<B9-&M\6Z,(F-09L6Z1$AU:5-2XY):=31X4VGX:6)&1-\S0"\<5&
MEDS93!*3*X;R^-<U+E4M_P`)W=()KM_LCO@-ZS4DZS.Z3D$.IFX'VIVR=Y<F
MOM`5!WML=$?G_CE\#=VLWM2RD"OJ^86*"OCX'6NOY?A[`.`KX`[EGP6CNWZX
M'5'!=45\NLBX--QT.NAAJ0B2(W<*4AX#[Z6]ZAY]2`*TUAH;QT(+I36-Q)[J
MXT5$Q^@Z@F2SAAYF&D%YQ.]]M;JB#T!<)'[0W>7GJULYVSGS6^ZU<<[6[5DF
M]$N<TZXRX%O,K"DH<7N*35-3XNFJNGQ&K#X@\DXR(/%:HBN'>3%6EI.V0H]M
M14/Z9V@;N\I/0'3<DFL4I128+8!^JN78C)JVI0TRPZ2Y^&4+2KX[02H%*_!*
M_P"7773/\O2W`BF*D4URD'#%)6;<WK6%,,L(2VT5I"ROU!'3H3U/0Z8#3(X:
MCB59>>:4ID%GQD7?.<QQ#`[&RJ3=\RR2QXO;@W5:OF[]<(UN0[T%=C)D;S\$
MI)TM]@'D'4?4I$,_A.'%'?NYY5M'(7-W(EJMJG)N&X4_;^+<*6D(6AG&N-XC
M>,6R7%(3M!GR(#TLD5JI\^1UJMBWZ_Z8WV+<+5Y,,9&IF0<TT!Q%:4SR*M]M
MOGVMVV5II&#XNT*-%N:8V=MQ*-X(5O%*+`JE!!4HGJ2?+H>FONWI_J*PZ@VF
M&]L36WD:`T]H%2/0O5[8LOHOBHS2-V([BMQQ*V#N9*6U)'04Z*^VJ?`T&KV'
M\N;S,U*8W0W3FCJT7*>X]4+HW45J3T/A2@J.I^-/'5[;W%0?#QYI54F^1,IE
M6:9">91WTO-;7%*:6E"450D'N*;#)JZD@`**B?*FOD+^97IWS9+/?K=OYC&>
M7*>9-3CZ`LCU!'^?YM>-*)OY.72[C%?;;AHJL-!2Z))"5N(!50))Z`:^5G6C
M8QK#B:=G[UF'2$'313*M-N+]FMY?CAQMV*RGM.)*D*0MM/1>Y92I*AXI/32*
M(UUPHCARSF-:[F(\=E"$PE)9:::#;;54G:@(0L)0GKX`$=-.V^,[?2HEZW3`
M>Y<]TEM37)S[9/J1F+B00*>I-Y%:#RI76Q'\,_V5F![[?[2Z&[1"E/6BW(25
MA!CQ%+I3U!#+9"5)W`@$ZSCA5Y[U;2QXE]>7T)#\PMK&(2@V@H6AUL$FAZ%*
MZCJ4D>6E`4%`F`.!R3(8_#<<5#;$-3K+C#*RZ@?O541^&M0(-"H&NF?+>UX>
M]Q=3L44S0^86>6,#S_<K1/;1[7+MSC<H\AE$3CIJTPV'8-U8;6[+N$C>T4?*
MQI2T!2^V2HD'J?CK2[=9_J#FAS?+`.8Q^S-9R]O6P.<TGS`:^$X4^G+)74V+
MD#COV46V]6W+<FOE^S.9;4/VLSK>ME,]/9"&=DAI3C0(*:JVT37IK7M?#L37
MZW/+WCPG31OKJLA-YM\YKH&4:#CCDG,X'^H)Q=FHB67);H_#R23)::CLJ9/9
M?=E.[&FP\HMH!3N]1-:#K73UGOUO<N\N9U'G+BF7VD['#!2]Y'YOM."2[:P^
M!)%SM3\NW*9>[P<D):4XVR2TXH-)(`.XUU)N+AEM0OXE2&LDD>&,%:GU+F.^
MH%[]<VNN#<D<88W*3:\KS&S7C'<MS/YQTN89@4^3V7K5";:<;4Q><J5_5D--
MGO.,]Q:JI2D:\]W+J+R9I(FG$EU#7(UP/H7J'2W3@G#;F<D0!PT@BA<X9T%<
M@>/)4Y\N8O9\0P;$)K-SB-7:\8;`L^&X"(I,G!<$M+,9";K>7TJ6S_&667!M
MZ7-50*2N8I`KM)UD=T<+FV^(!J37TD9GTKT?HQ\K[J:$-_+;,36O(G"BKBGP
MG&,J4DA01*0\E95N^\XPJJ@"D!7J53[=(;(6;?3F5;3QAFY.QQ<*^U)6\-?*
M.O2GO2]\HV!0$'8V?Q>G@2DT%=66W'SHVQY551>,$<KGUKX4C(STE4=99:6]
M.N\E2V03MHRSZ$DDU"6DDG=]FKF5D9<UDI\#,.^BH6OD:XB(>.1_JJ?:I5_D
MUX_YT5_W-=_[7]M^/WOW/^7X_9J5Y]ER;[M%"^$W#\7^VTY<>>>26H][/-X(
M(N6)5!!J<<C^`-?#YG7U>/YC?F4[,V%1SC__`"UXQ_@79N++G_X]GV)2XM[R
M^:KWDN/VB9/Q54.YWJW0)(9Q]AMTL2I333NQP2%=IS8HT-#0ZM=F^>WS`W+=
M8+:9UBP22M!<(@[$GD'$FO=WJ)N/1FPVEC+=.<\:&$T+@X]Q.%3VJR^SSIES
ML=NGSUH<F26RMY;:$MH)#KJ$!*$@!(2VD#7E/S7&[2=5WQWB2.3<&24<Y@+6
MT`!;0'L*NNGS$[;(#""(J"E<T8$436H-4JI3Q'0]/TZ\Y/AMVR<`K^2-SJ:<
M$4NCU=/#I2OCY^/Z]928X>E2&,+C0)R^,G9,=V4]&>2AZ->[/):;61VW5+1)
M8%=W3<WOKUZ4KI;/="G-;I:!Q72][,9[<]=L90R&Q&CQ"NHH0\A*5DI2.AWA
M73IUUN+#Q0:&^\!]2MMK-)*J\7%DQ%0T!#W;6E"04J1Z0H))`"AZ1574?KU(
MC8YE=7%:$.#LDYMN#RTMH[@2:T6$J2IOH`K;1)^'4'79&%[:#-)?DBKDJU*N
M&(S&DJ0IU#56R3UW*23T\16O\VH[H7M&HTHNL>*!O%1"QX/M1E-+JEQMQ033
MIM*5%*PI*J=-WVZ5%(UHTFM:I9"?7B"6V+M<;$_M4Q/;?2ILGTB@#J"D>93M
M)3\.OAJ2`$S)P/%/#*4]#>N+3T=+B8LEB+&24#UQQ%:<6K<H>MMXN?:/+RT$
M->W2YH<PYUX=H[04ECFD@G%IS_;FOSOOJ,\>S_;[SQ[I\%0S%MMFQ/*,ZN=C
MO#[BF8L/&LL#U^Q52T@_NF8-ZC(2=JA44\M;2+=MXDV)D<WYABA>0["FG40-
M7HH,BO)=RVZ"UW5\$50]TE0>_P`6*I-]H.)S9V47?*77HAC6B(BR-H_,H2I_
MS,IUAR2M%M6_\X87RJ"`^$AO=5(-:C6#V.Q)N6W4PHQCW:B*4).(%,SPX*7N
M$_EQ%M'$.RIED`K",[L<6]V:/8S'8DNSW$(8E2UJ0]!C-)!D+6`IHOMK\$@*
MJGK0]=7>Y7,FX0BU>/SZBA)Q8.SOY9*HB:YD@<[W0D'@W!K^(2'YTB_&[0;C
M%<@-,*B*C*EN!U,Q33"Q,<0DMJ2I'K`%55K2HU-V^VD<)-MM")I)-+\.!;[U
M<*#T*3<2"60/K1H'%>\HP2ZY)(MD6PK8M;=LG*>GQKA(4A:W%NMLMQD.0U.]
MS8$[=Y&RGGI,.X[5M&[0C<7A\#)6ZVMKCB*MQIBFS;/N87B(BNDX^A>E7-%K
M,*!<)2&(CWS#JT=LA"YD=3;+ZER$@$,I;>0-CAV'QI45UZ?\S)IK/<K"XD+F
M[))"UPKPK6@H*UPIB51]/,:ZW=&`/-#B*_OS6N[GEML.8VJUJLL&[6N8Q:W5
MNMON+E*^;?4A;S+=5,*6RA*J)4=BJ^JNO#M]W>]#76]C*8VDBAXY\?W+;[-!
M8^=`_=`XV+9`YX8`7$"N`J0#W$I33\G?-QL]B;M*UVW(\GA6DS&&T(,.;:FI
M<^W..-@]AAC>PX%;1N4IU&T`@Z\[OWW\\CI7N;)<OD%7.J"&@X`4!SXK5!W3
MA;,^2&5C!`UL.FA)D'WI*N%`?ZNKN4)IF3?P]:^7;RJP6_)D3?<+EUO2Q<QW
M8,=2Q+CBY+:3N2\[;I#Z'6T&J=X!\M=W*U??&/5*Z)T=#X![W8<L#Q5KT/U5
M'TK>7&XW>WVFY.GV^>V$4Y<(F23-+6W%`*E\).IH%*D"I"?K@U<R[>]'&)$>
MR6F%;;1CF4V3YJTE2Y-TN4;&7YC\J_J4CN-W5],LA(55)9:`02$FG-OLGV]F
MZ`R&20N)J>%4GJOJ>UWV+;;:"RM;1FW;>RU)A:0;@L))N9JD_G2U\0!(%!0E
M6DV]Z_6X<EW*5AMOQAB`>_9+_#D0IDO+V&+2'/SBZ,,QF78TF!(JRVB0I9*$
MU%!TU)@@=<3"!K:.//+!9-LMN7`RM+F#AE7LJDWCN17Z]6"-F+-GC76_MQ&F
MK0[VX3$UV/+G$3;='N+C2I$*(H,I+B4J"5J\B=+DMW15U4H$J2XMW/+HH]$1
M.#<](Y5S3-<_/\V,9LS-XWPB/>[5.PV)9\LD/0S)7W[HE;USLKLA%LG/2(J(
MCC&Y!<0%`U^&F=$1Q<UQ=S%**+(X/=49)><$F=9>*\T?@..6YYBZLM/-QD(A
MNM3$*9CN):1%0PBJ%-%)W5(I3PUR@Y)I*[$LTR^[.9&[_$-S=MT9Z&+4OY^X
M[TF(EVW77N`2$C>Y+95UZA02"FA.B@Y)^WQ<>Y.#/S7);+QSDV3-7R<]/6N%
M8HRY4B1)0R)Y99?EQ67WE,_-J;="CN0M`V>D)JH%R-[HI&R,+VO::@M.EP(R
M(-#3U)^:@B=5K7`BE#D:J,\B\7*VP#)-TE/LLV=$M*)90Z\ZI/<[P944E3CR
MG$[$H!]5!0:]KZ2^:/5]O;W1N=PN9V0V]6,DH_PUTNQP)I48'MQ6,O\`IW:I
M0"((Q5P[*5/#!1DOV6P<EY@L]F:D+9NL?C1V]0A+[;!>E1LVM\Y^+$16KTE=
MMMRUI2*J(0K44=;[CO[I;[>W-DNK8P/B\J(,(;'.QSM7B-:M`!]1P*=_1[.R
MI;P4$,C'!Y=S^[SPS22YVS./CF%6_(UXVY>'GLCD,1(\U#\*1;794*X,N3%`
M-./,*^7B*3U">B_+7D$I$N^W4CP"XN)RXDU*T<,+K:S;"34"E*99):X)(,WB
M_#G3'2E+UAQQ\H2HJVID*8?#2'%T)2$KH/,]#H=I9-6F%4-Q>!VKM%RM^ZPK
MGRX3DL9ZT6GZ<]O;C8<BYR%2K+='4<@IFY))M2FQ%B1<@@P6(K$A*E.2%VYQ
MM24AE),^%I;)+R,32/22MTX4A,CL6-M_IJJ`;]=[K9.+>.HL!Y^'\YB%O4^X
MT!5;9MT1D,]":`F56M/$#6?W2:2+7HIB%G+0#X=M4=>QZ&F)[X_:H^U2J_<5
MP_O!2%J4%\A6)MSUD!>_=4UU!L'!TS33$A,SP/+20108K]%_6L58AH0AH0AH
M0AH0AH0AH0AH0AH0AH0AH0AH0N53_6>[==;EC_LFC6F#,GRI68\RVV-'B1U/
M+>G7.W<91H,5*J!M#\IVJ6PI22HUIX'4.Y]['*GVJ?M\4DLVE@J2*>M<QV0^
MQOW4Q;M:K1+XCOR9EZM;UZMFV=87HDV!$9$ATL3TW)</YDM*!0R5AQS]E)H:
M1!*P9`A6LVU7L-/,&?;52=QCZ4?,[EA>OF672#8,ADV&+<<(L=HC?Q%"N<]X
M$R+3E5S4NW?PW+C*H@]MJ2GQ4"0FBCS64(H:D(&R-#-,SV_$YX$TIZL_0C1S
MZ=O/]OO0M,Z1B"(B\<:NC5Y<E79-J-R62@XZ\38C(B7(+ZAQQL,+0I*DK).T
M5CH0QA>"[S.03GZ;((_):YM`,ZFGT)C^6O;=R%P)>K-`SA&/N.7OYH1G<;O3
M%ZCHE14M+>B27F8T=3#BF'4K35)0H5Z[DJ2)-F^L;F$'4*G'DJ:^LWVS@7%I
M!'#^@)K7&8:$):<C=J05J!76@ZU)'I;37_8U$EEUTT@J(QA?E3!):XVJ(VT^
MM:EH!=0M`*CM4DJ%33:!_+ILSS.HR04:JJ5PC)+N97MF*S\RTA<AK:4A24H*
MRX4@`#K]W[/#4MVID9:YKCAF%!D<'.+ADM?E.[NQ^-\UCLM`-_PQ=$A;8)\8
M2QZC4@*%3Y:SUW:RO`>:`:QGGF$Y:?\`-`<*#Z5SY^WU:4<WX`IRH2<PMA)'
M0@?-+I4GP-/Y];"_H=K=7DM//_`=W+JJM49B3O>7(]2*]I"_O;2FG[)ZGKKS
M*ZF9'^6X&N:S$=?-/+%-ARE:9T6UMO.)>+:I<=3)2%;NWW"-@)(H#JQVF=IK
M2JEM%7`<TUCLTT+#W=;`2-P4D%8J`04C>#3[::U'D/+0X4H0IL3"T4/-:LFW
M/O\`R;;2MY=E).W?4E+:5*41ZU;>M.NHV/$$*='&YA)*WXL:XOS$,K0I+8#@
M)W*V]`-M?7UZCQ^&FY07,`&!J$^QD+"7BNL@^U-/?#<U3);*6UA"7%)(Z'IN
M%5(_'J=6>@B/3AJHDPM+2`<Z_6EQPAD<SCK-IO*D-N(]<.,,4R#)K:9R5K9;
MO]TBC#<:=:2W(;5\]#OF3,RF:'H8Y/[.HKVN8:$JXA`H<%')F+W)EU6A_O.+
M>4ZMQ:]SCKSB2XXXLE>]3JW"5*Z=2=(J7.`XE$WFM9JBH",Z\DA+1?)#E\=M
M,ME*&EJ=4R]N),=Y!%*IW54R]X*`'0^KRU[%\O\`K)_1DFFX<1MLH:'<0TG"
MH!-`*YD<%9=*]5SQW1L[O_E:D"G9EG1+6ZW!,5I#3NUF15`4EP[6DH!ZO.O4
M(2R/&H^\/"M=?8NU74.X6T=Q;'5&]H<#7`UQX$KU@7,;FAS:D$++"OR&8#_R
M$<*MJ-J'[M/#D=R5)6M("+?#`[B6E'H@+.]5>H3K1VV10;E[<(LNU&\6-:<L
MBKQ:[MP+>_<I$,Q+K)C*>=;+$E#CK9_%28\DM!24[%J2L]#XD',]<],VW5G3
M5SL\S-4\C"8SRD`P->ZH4/<(H[RV+78%N/?V!/RCVAXN]9'KU9N19+L9;##[
M*W+*PTEU(>;`24F5N!2:@CR(.OS"W=^X;!N<VS;HUS=Q@>6/:10BF1/#*F55
MA76NH&,X-]JF/CWM_BHB6UEG+&%I3%82"]%8;K^&D%1!E4!KJJ.YL>X.>#[/
MM3?P98*,(HH_YW;;W8+Y=L:MUEE75IP.1471H[&W*IZ+2WW%^('2A%*ZN;.6
M)\K7APH:IRYB+K73A4+F[NS;T/EF6TZPX9$?.W&UQU`[U.MWQ/X*@.M2H4-.
MM=;08VYE^Y3]BL7(9;:;2P5>5TQ89B5\N..6V7+LYMLF5#C?U>,IU:V4]A/;
M("V:[MOC45UEOB(7R^6UP))SX*RTS>15X.NF*<#*/;C_`!7B#T9^YF,X&E2'
M$E]'?6IMAQ8J'(YZII0ZX+R!CM!.(*:;#*YA(!3*L>W#-+';'[C8(DJ\V^QV
M=%ZN\AA"I*[;`;<0VN7*3&C]MN,E:T@J40*J`KIMTK?B?,!J#P&?J4'X>1K3
M([`!6L^QS,<HOF7X38W[W88E@AL1URYL>0T'D"&VE$:.]N[9#[@]*E'[M2!N
M\=>F]/ROE#6^$B@P&?I6`WSRH7E[`XN)^GTJ:'U);!Q1?^-X^67M]JX7VU(=
M@VZ=:)##TN-("!L*^VZ5(;^)HH5%`//6MW>WMY[7S)\2PT`&)!../"BH-MGN
M8WN`]VOI7-;:,GO5JR&"W#N+J9B+@ER)+4HH/X2_P3W$FG1-*G7G]W:"&!QC
MI0FO;DKD2/D\3SBK3\V]T<*7[=\6@_FDR9R?:5.LR9SLQ"I#B5[DE0<+BUK4
MX!1*0E-$T%*Z:;?PRV#+;43<5.&))P4JQC\J\,DA`C(IW*I'(;+,R_+XLO)+
M/':B6V;_`!/<8"BXK\SOSRA\G(O:U*#DD1FZK+1-`K:/*@M>G>@)=TNG;INC
M=-D`"0:ZBT8Y4ICWK57G4SK.P;;VSO,O9W:`?PM&%!3A3,TJH7<F95>>4.<G
ML5Q9F//CVQN2FY/L`!B+;XK11+>=5V]C;+3ZD(:;'WED`4ZZS?46TNW6]DM=
MJB:VVA/@#:D`4XFF?/MYKTS8MSM]AVZ)UZ[3.]OC[:GA6BCCR/9WK"IYU::R
M(;A82HU!0XA2RP5J/7\3;3K\-8NWM9K:Z-M<>\,Q_2M??S1RV#;V*AC<*@\?
MV]*9&]3F[K!:D.H#<AR,]#74$['2XVO;3H#UZ@U\-7%M9?#70@B/Y8RYK.S2
MON;8W$Q:)"/0B7#[#>LHOD+&\7M5PR&_W>4Q9K):+-&<F7"[2MPVPX3+2=[;
M+1J5K]*>A4M02*ZO?@KJ[<8K=I>_/#L69=>6UI&;N=X$<1J>9IR_I"N7_P#;
M;'NR_P#.WC?_`'+:?])(_P#G[_SI_=_SQ_PO]D_X76D_]W>_?^B]_1][WOP^
M[GV++?XOVW_TO\;S.'N_YV:6B.0[`B>N*..<:<F1W"TM;=AQWY-Q5/2IO?`*
M]BJ]=R/'XZ^X^KOF7L&P7\FTV^TVDE[`=+W.@CT'"M11GO>RB^>]LV#<+J-D
MDEU+H(K76<1ZTX;.:0G&0$\=X:V5-^IUBP8ZV\U5!JXTXW9D+0XV.H*5`@^>
MO.K7YKL=O-O)#M5BUYF!.F)H-:UH"&BE?0%?WFPD63XQ.\C13,FH]*Q8Q+3-
ML$5]*0V%2IR0@4H@(FODI`'04"J4UY3\Q=Y;U%U1>;K&TM9<D/TG\1%#Z*C!
M;+8[=UGMD$#G:M+1CV?N1XZ0&T[/O;36G3U$GKU^'^+6"NS''9`9'BM"'-=[
MJ*BG<H**E=*5'0`CK]G0]=8QSB[/).!Q::C`I:81._+;DE]*0M"+C:WEH516
MY*'SXUZ$441^O4EGNA/Q^:2":Z%T[>Q;9)MEMN'1*[B&E[5I`6E*`*-J33[O
MF#UZ:W-@*0!P]Y7NU@>8>2NSM%&HZ%M40E*4=TDJ6*I%#M2G^D:_&GAJ7WK0
M#3]U+JS2@%AUY90DIH%#T$T4-JBD]?#II,FK3^7[R;=JXY)87ER-,M+B`A3A
M*"G>.B-Q:/B.H*O*NN@$QT?GQ0SW@H=L1(*YLII+SC;@?65(>Z;5%Q9H`.HJ
M?C0:X(H\Z);G.K0)5XI*59<QMSS;A[BGAX[4)6E:F]R/4:)!0HCSZ:<P*;<'
M?>R4K\B(6W%4S7YA#2TK20DCLI(+:Z$]":_;I+003R4>,2:SJ]S%<-7^M`<)
M7^T\A8_RS8KBNUV3DCBF$QDK#3DEIJ\7GC6[3(<^'($<EMYV9CUVMU0Y4$,"
MH\-,2WMU;MD;"]S6.;I(K@1@:8K-[Y91G<(IFL'F.875YD85SIDN;;A##H5L
MY1X@G!*6UY?P?.NTER"E;3AD1K@];67'`A"0'^U#0'%=2K;4]2=3=IVQGZK`
MTR:G/;J<*X4.`!X9CO67N9PVUE=([!KR.>-!R4_[H`9Z&NA5&:J#M0DI92H(
M7M<`W[_2`!4)\:ZM;BS'ZO/&_P`,S`*XUS)]"K(G@P->XU)2DM"+$JXW!,F]
MQ(DHQH[B+9)45$+#"UKD1T!>QE+R%IW?;K1[!?6.RS-N;J1CI6OKI-*D>C[?
M0D36UQ/&YHJ*X@X>A:K_`&G;BHN-MJWL0TLJ1Z1M<H`I)0!N"C0_I%=>>[Q<
MMN-QFO6AH!GUMRH`7@CL5K$P6T08S\&/::8^U-7E\!JSO0FVGF9#,@R'"IM"
M5IVE354*W$A=4JKXZ]<^9&]6F[3V5M;L;Y,%NPN(-0XTQ!Q/?@LYLUO):1R:
MG$R.D)[@>";+.?DK1?<+NUMM\5$U-QCK5(2UV4K:B.PW$A]3*FUI0A3I*=I!
M*J:\:Z@@M8G1/MFAH<W$BN/K6GLGO)+":M`%$XTF>U#3UFJCLG)V[DX^F4[%
MCGL0Y$AI2G@\VDNM27$A"Z[DJZ@@GKA'N<9BWAJ5H[S-&-="2ER@8?*LUQN-
MPNV%XULM^9WV!!O$.=,:RJ\QV&&2F"+9%F)7>W703WWUMI[A!*_$:D%X?=M;
M6L9+0GH6#RGOD?1FDT"B5@J.3\IN,%C$,LN,;))<QN.TRY<I%O=<=DI^7:6U
M<64J="UE89*:]4D`';4:]A^6_P`K=^^9N[R[!TRRV;N#+<S:IGEK-+32A`!J
ML!U?U?M_1>U?K6[NG^!$X;^7&'UJ*TJ2*=R>ZX8O[P[7FE]XTC77*<BR6RHN
M#5UM-BRTWE'8@PA,N#E7)+;<F/'B+*G*@"E12M*^I3_RE?."U#9H[2T>\'[M
MRUM,,QJ(K7(#$K'P?._HFXLVWCY;B)CG4&N%S!7D"`ZI[*)MX'+'N-L[*&(%
M\R=,=D#8RS-B.,H"%;T!+2'2TE`5ZA0>.L_>?RS_`#?@#O,V:62AQ\MT;R<<
MQXZD=M`M#:_,OI:XH1=L:VF.H/;3O):!5&2?<A[FXB9+3MXRAU,LAR4/D`H/
MA+*&`5NQ$I65!EM*000:#IJCN?D)\T;".MQL6X-C[(P[_1)5@WKOI:8@,W"V
M!)H!J_<OE@]U_-F(V>?CT"W-L6BXR&YDR&[C3Q#TI+@<[BWG67'TJ+B`310K
MYUU13_*/K6V($VS[BTG+\B0U]0*G-ZFV-V5_:X?^E8/I*/L;]Y_(.,Q'(*,:
MM"(SZ.VX%V^2AU03(7+W56M*JE]Y9ZFIK35/)T#O3'>7-97D;A_Z&3_55A'O
MEG7\N6$G_>,_UDO9/OLO5TQ5W$KCB]M:A/72/=7Y,?O(F=Z/LV,[G)2FPPK;
MU3L_1JGN.F;NUD,4T4K2#]YCAZZ@4]*?&[QS>!CFO)X!S23Z`<46N>[#&9T)
M,"?8[BTD0Y,1+D92''$(E.A\R&]X<HXRYN*3Y;M+M+22P+B<`]A90X"CL\30
M9T/H77/DF%2QP:.PT[TV47/N+Y/(R>0G[W>84R)9X%EL\9^VJ683#$EMZ<MZ
M0WN"_GF'9+1HA)`>!\4UU<]-W=OL4\[IB))'PD:6N8:@8D&IH,0#Z%!O6.N6
MAFLZ,:T_<I"6SD7!,KM$6UV66B\W5-SESG!)MY5#_+T-O/KK\R24O*+_`&TU
M24T)/6E-82_MKB*]?>N+`)23AGXC45X8#DKF"4&V$;C5XIZ@*)WHEH;VP;<T
MEIEEF3"[+,=EIIIH-2&BVRVV$A"&A0)V@"@\*:B-J^05Q)(3C/>'>NM#E:79
M8U[]VH8@36,ALGT]L+9NET7/#UNE6R<KG1=E@1;7\LA=ODP)$.6MYY3SGS`D
MM@(;[1*[-I_XJ1__`+/I`]'`<\ZK9W3G"VD`.'P[?I*H@SU"H^%\;M`T",-M
M0VJ23Z5,VD5"*UZ+%/MUF=XS?W*DM/\`EQWI0^RYQ1]\_M,;3Z:^Y#AY3B4J
MVT']X5O<H:>3A:ZI^`U`L=7FQZ,\/4E3.:V)VHTJ*+]%C6R5(AH0AH0AH0AH
M0AH0AH0AH0AH0AH0AH0AH0JF?JGX-!SNS\.6VXN.IC1[CF$K8TEE15*CG$9=
MO=)=2OM_+3(R5I4FA2NA\M0;U[&-`)I(<NVF:T?3@!G>'8Q@"OI4`8MYQNS0
M;:FZ6Z&[(B);;9D/I+S\5/:4A;3!<W(%5+(\.GE354'LTE]?",UH+AEPR3\F
MH8>W[4\^/9SB^1V]R)\BAL,);`+C:`24FH4.JAU"?+SUSS8CQ5>Z"0NUN;XN
M:<O&[)!R:!/?@695SB0V$(F;$(2TOY5H(;2L*%%K0F@2:@[M2V6UR]@FC:3&
M14'#ZU73W8@?Y,C])K2BH2^I98K?>,DP.V8O:'$W.9=KH$H;:2'4.H8AL%"T
M@;B:U!/4U&FV5;*XR8#33Z4U<1.N+8:!J?5(/A;V!6V58D99RU+D)[Z`Z(`<
M[2$-+`*0H!D.+5UI74)T[H?^6$9KGJKZ$B+;BV,5=1_%$W./LGXXG8M<;CQ!
M='_SBW)W+M)>5*;E%!KV5LNLEYM3BJ@%)!!TITKY"T3-`9J!KPK]*B7.TQR,
M(B(,E5'/%/IT^X3+[`_EHMUHQYJ/`>DV^)=IDAN5.<81N^7;;C07BPX^4@)*
M^E3U.K"[O8((Q&RCJCQ''P?MZ<U!M>G+F9A\^1D=*T&.IWI%0H2\OXS?<9P?
MD*Q9-;I%JOUOQZ[,3($U"FGFW$17-R@2A*5MJ\0H&A'AJGOWA\;7`U!(^E4\
M+#%N!C/W<._%<]_`,?YCF[C^,I0;[V96I!<4:!)^;42HD5IU&KG<'-;M3B[*
MBT4_\!W<NK;$+*N\WN%CEH6W-N\D@-M./+;0YM`!V=MI:W'"H^E*4E1)\->:
MNLY;MV`QX'L5+864]Y.6PAN1Q.6"D/E'LS]Q]TL1NDWB3*TVEH)E,SE)C_E[
ML1@]Q3S3[JT(*5MI)`J#3R!&GXK*YL")"XECCER5Y!LM])*88XP^=K:FA`%.
M8J0H!7;"[XN\W",;4\Q(B2'(S@4@(6V65%M2"*4/A2HUJH=QM1&-<@J.P_8H
M&MH)!-"#3'F%H3L<F6V;!+R'D(C17WW$I<42T24HW+*0?$'IIQFY65Y*UC2-
M(..:F0.+XG.)K48=_%+-BTMQ+0QD05;%0G'3'+/YK&7=.XH%.]5J"S,2TH]=
MZD4IU\-#[O;#*86M(>'4J<L.7U*Q;MFX"V;>.#3;NRIG7]W%1VR"YL?/25,I
M`*770%;B?54D)5122$UU-,D3H](/YI&'U=B(K68R`$$8]BN_XY^F+PKR#PM8
M<AMW(.>M1.5L<P'+I,AJ3:4T6FVR;@Q#-<<?6Q;8]QNCBW607"I;+9W^@5KG
M.)-'&K@M"+*'0!&_'C@<U0KS)Q<OBGEW/<.MSTR;:+9>)[>.761*MTB3=K$P
M_(B0+J^;8\N,TJ:8JE!LAM:4_>0@]-)!;K:>`*Y/%$RVD<]H%&X*,]E84G)5
MKF"KB1)V*6HDU\B0'54Z?8=7&Z^8[;VAG\-[1Z05B=IK)N'Y6+=1KPQ]*.GI
M<"9(;1+,E?RKB5E+3:%$QP0*E2U**>U2E2#T(`/EKZ&^076$DEL[I>]?22(E
MT9<X5+2:Z1V#*A7M6T3/<#$\DN:VM%MW&X/RV($545<"W_.%R*A2:*^6I^))
M>"E$F4XE/3P"0:"FOJZW!#2XY%7'G#[X#$:_,-SD%#[[=H#+:7H*RU<+I<)$
M=M0$>XICV:WRWBE:TE)4M"6R4D!1()U-:--0\'21P!/T5*BW%U"PAN#GYTQ]
M:E'PAF.1Y78<PMT[YYV/;["JX1BI/RK28T&YPV)UU?A+CJ7"7)7.90$&14)4
MG<V'7"!\:_S6]$V<=A9]:;:QD5X971S5\+W@#`@$@D5H:TK@J"X+GRNETD-)
M4Y[<'X]MMS\N*XTQ):28DEP.);E(:"$NAI>T-O!I9HK;6A-#KX=+Y*M::^,5
M':$YY#F1UD&)'9]24D!ME]U+H#85]X$I)`"0=R1N`4134NSDG\YH83I"B.,?
MDN:_WC2BY&<Q4E7N&OR@-H/+4LI(\ZY6D$CI1-`/T:]=B,@V<>9DZ%WI(I]2
MQ<N&X.Y:A3NX^U==^*H0NTVQPJ7L,"WD!20D=8S0JFC`\*:\SC!B-1@\$_6M
M*W%@KE1'=]O-LM'R<>2R^XN\*EPF"RA)0E:8RUJ6Z5(!VD:E06OQ%7@^,&M.
MY,32MA%*T!P]*ESP/QQ-SCCKW#0,:MEVE7!CV[WJYJ;LS+CG<CQ),13RK@VT
MPM9ALE054`450[AYOQ7,%I?1RS`&,,>3GA[H!P[2%`EM+BZC\L&CB:#+$D$T
M]0*H]L&5Y9A#H..9'=;)W%I4M4"4_&5O;45)71LIZ!9/C77H6WDAX(JVK:\1
MC@O*[T:GN#\2'$>HE+&Y9SS)FELF-2+[?[[;EJ6IZ.Z_*EL.*)*BL-D*&X*)
M/CTKY:TC+LLA+7O-'&KNTY#V*J,;(W&2@`XE,%*MF3N7-A`MTE,A#B4M_@/(
M6E:EI30T2H[U'H!U)KKKF-F8`0'-)P',\,,U*9&=`ERBKFGUMUI5AD(7;(9"
M)-^=0%1(+BE.,6HK(V.K.X=RX_JHT#055U'HG0GRVAM)1OV[M<9R^C8\#0<\
MR,%"W7=6,:8K8`L_$/O>OEZ$1QEKN;=PE2"I+L\.MI<0GU;UH6@.)-%**D[Z
M@CPITUZQN%K!\-);Q4$9JVM*5!P]JI+"ZF;=1S5!>RI`=D.:0F(<&8UQU'NL
MK'K:O\^RA3)GSI;KDJ?)"%+<;[CKE5(:2\ZMURE`5*^P:\]VKI:VV;S'PL:^
M1]?6:\RM9N?45UO3HVWGAC816F5!W8J'7NWXV.+6J-<6EE]-V?9:FN+2D$3$
MN+=`;4`D;`!TK4T\SKP[KG8?TO=(]Q]V.1QU#@<3GFO;>B]W_5^G7[=,[\^)
MOA)Y*%W$G"')?/\`E,;C;BVQ.W[)+E)2F4Z26;/CMM6Z$/WB^W10[%OAMHW`
M5JXXHA+:5JZ:K]BVRYWN^8RV#C4^\!]M$SONYVVUV!?<DD"M&@C$KJ9]GOL+
MXB]G>-M72XO1<IY2FV]"<DS>7'8[K"2@+?L^.(<"EVNT)74%*#W7P`75JZ`?
M3O2_0=OLL(GEHZZ<`:G$@DBO8OG[?^IKG=B6LU1V>D^'Z*\:JP#^]K`/Z</_
M`+*OEOWG^Y?['V>'VZU?PLG]Y_\`S!3(?8H'F,Y_^R=JY^,4@6Z1&C2'H$4N
MJ,C>\[$9<<4I$EQ(WK,222$@4'V:T?5]M;R=177F1L)=+J)(QK2GJ55M4KX[
M5K`XZ6MH.[M3HB+:4QW1V("?P5@`1F$FI;(HG_D=M0/P]0_3K*06-JV\;((V
M@M?48<1DK,W#]+JD$:3]";+CV:EVU7B.$)";=DEQBII0@=YJ))105%$_C^0&
MO%=[A8W<9QC1KR!Z":+<;>2ZRB)ST!+*3N$<T-/PZI*?'JLUK]NLCN7_`"Y5
MK![I[TGV9:TK2PZ=P*@`>@IT-#N/GU^&LCCQ4U[6-`+3BE9:7.RIQ7I.\1_`
M^`;>2L@@#Q534@.HP4SP2HI':@S@NEOV(W)Q%AQ24%HD1IC*$)4@J'8(;2RE
M#C:J+(04D;O`CKK<;8_7:@X5J<E>[9[YY*\.R27'FX#/=606P:@[4$^&U?3K
MM'4#QU/*OX^*71EAMV)5UI030!*MW5"17;T`*CN\^NN)9`(H4Z+#J7H)V!--
ME=J>O0H)-0H`43N/77>":`H^BC5+M:6\AN3R2.TX\2E":)6*D>%0=PJ*_KT#
M)=>?$D^[($"_6U]Q815Y.VH.].X[-U:T400.@\=.1M:[$G!)<XE2ZEN)FO6I
M#:Z%^S&0M[J`HHV)"/B%"A_DTW'5S23F'$>BJ2%S[_ZQ-Q79<G]H7'6<S[;\
M[%P#EQNV7MC<E")EBY)QBY6.0V\\M;0#*+I:8:S50ZBJ?52LC;X;.7>((;^G
MPKR-=2`,Z4J<EE^J?,_3BZ*OF!XRS`^Q<9V0<-17KQ@^08/?96*W3`\6E66#
M9HC@_+'K"]<)#ORX?1)%R#[KKVXA06VXDU4H'Q[N<-N+UPVZ5L$K2YHKC4->
MX--:C,4[\PLA;SM@8&2,+BXU-15'MN?OEJL[,?(+@3=07&G9<F6EY;ZWYC[T
M=LN+6L.N.;NV&ZGTCIJ%;&YBA<^Y<3=TQ/-(NHVR.U`4KP&2,&;@^G)1+:3L
M7(M'XBDF@;/S#33I13J*LHZCK0G5%>/%RX.>!K#AE7VXJ0S!H'()U;*HN7*,
MAT%"40D-$JZN`L-O!*U$>G>HMU^-?MU+N1%-"YA#0PLI0=R=CH'BN54Q-UGN
M3H5HWLKCJA/38Q4]L29`1\L"YL;'HV@4VGU`@UU8V]Y*_;HW.IYH%.WTX\E&
MNHF,DK&,"*GO2XM#4!Z%/F3[;!N2[;"8D1&YL9J2VAYL*=HE#H4`%K8&ZG4T
M&H&\2>9'$,/#4>A.V`(<ZHX!-YR;GD#"<&OV86;'8-T1`:GP[?`R2%'N]NCS
MWT6R`9URA):;C2TVQ>^138E'W:BE=9**.-]\^.0T8&U&/$_2K5SW%NDY))Y9
MCF.6_B%E1*,BOEGX\M\ZWM/V]F6'8N8WNZR+SE<:XE"+?;3;);T4H9;[:RT\
M-E4M*2$PLU;A$PUTN)/J."<P^%=W%:'M,L>0W7DNR#%)D2S/3H*F)>0W.S?G
M-GQ6%<9EMAKOEY;$.<W#B0U+J'@A*FU4VK%:Z^^OY+VF+K3=]P##)\-M.#0*
MDZI*$4XX9=J^4_YGW;5+T986FZO#+9^X$_Q3&"61U`)#@#CF.2E,B9FEHY*Y
M,7/A8GD\NRV>\VZ=>C7$+7E%M@7%9^8M$E,>WNW9_)4M^@.5,EI&U14``?T>
MDW*/R(GS6;I7N=0#2X:#3WNRF6."^2OT7;;[;;2#;MS-N&O\ROF^:'D"FBM2
M`.(XUPJI,^W#VU<:<A\08WEN2XS:Y-VOZ\AFJ0_%ELIB16,IND&(TW(BR8BB
MIIB,&NTHG8A"2`*]8YO)9)'-?J;%V&A'&@(_;@N[OO\`N-KN+[2":6L;10&@
MKP-0X4[1@G9F>R?@R:[\LUCK,:0H..!$*\Y,P4-(VT22+N6-WK%`37K6E.NH
M\6[PO&AOQ(&J@!<_/F%`'5F_V[?,>^L7"GEDU[?#DB=SZ?\`PW(^[_$4(FE1
M%R:4=GC4`S(4\"A^TC4HW37'Q&4]Y*3_`([WH^ZZ)W]IC?9DM)_Z<O%TE/\`
M5LHS6*JOIK/LDX`?8V]8V%G^74>:6.5VLL8XY>)C:?Z.:<;\P-RA.HL#SE@7
M#_X23LSZ9.'+;==8Y"R#H/0U(Q7'YQ62:!)49\!-$DU))3T^W4&ZAL+ANBXL
MK&5HS#H8ZN[R6U/K5A'\SMV:T:&N93_TCV@?Y0)</VX*O'W&<'X_P?R*[@!5
M#R4Q[):+PJX/X_;K7(!NR'G4,+C1Y=R0`VVV"%=VI"NJ1J.SI?I'=+>M]M.V
MENHC288R,./NA>E]/]3[SN5@+QEU<1^,BC)Y'-PIQ-/2*44>#B^*R5*WX_;@
MA2@548"":U)IVRBGQ.J+<_E;\K)(9)[O8=M>P12$TB`(`878:2,*@5K7!:VW
MZEZH!#8+^=NIX!\0X\NW[4J>$L'N<Z^WN9:8?<C6RT7.Y/LMA($:VM2;7;E.
MA"NB6D/W-JI50`$GKXZ_%7JX1-W.X$#0V`7,FD#(-UNT@=@%`.Q?8VTNG?#&
M)02\0-J:8DZ14GM)S4W[0TW)O%I:0JBG;O;6*5IZS-824`4J5?\`I=9.-U)!
MSJ%<`D$$?B'TA=4'N%FWMB#[VU/SXCV.6[V7X3!LEO9EV]RXVVYRV>8$Y$]/
MA,`72"S=$_)_+JE4:?#+A8'I<)LR-+KB-N30WU56TO!2.5G`0M'M*HUY/96U
M9L$:"#^'B5E;76I/55O3Z2!0!-!^K69WAS1+I<0`:JCM_"W0/="]>RVY!OW]
M^T>&U%?=0_[C.(ENR4,J5&"F\U05)+A5Z7`IQ-?'H#\=<L;?0&RU%:@`5%:)
MBY<]S--,`>2_1HUI57(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$*NKZ@.(WN
M^VSCN^6U;2;=CPS%J\;U[%)1=(]A^2=;\OPI$#U'R"M56YCPM>`=3:]V*UO2
MTT+3-`\?G2!NGT'&OU*HIS%9F6S6(MO:[TUEQ'SD-M06II[=M>'3HI"G`5)H
M>H(.J8:W,+`#I*U%YY,&DRZ@#7V>A+Y?']ZP:*'9T-YI+[?WMI2!T!'E4D#I
MI.ES<2"`JKXB*4Z&5JI"\2<V3^+L-NT"-9[==F;J)#CBY3*%O@N@+(2ZNH]0
M`!!"@`.G6M=%87S/A?)<#5@I@LUNMLV2Y!:?S2>:J"]P,^%=^9\664H?E6R,
M_<'$G\1+4J:\IWM;EU[BP*5]).JP2-F+C0@$D*RMH'-D;;N_"#ZU)_CJ/?,V
MLWRJ6PZXI"FD,)1M6M.P40W44HGX`5&J][/S"UM2T*7=6QM:!YQ-?8D+D>)P
MN'[G,N5TM;[$RXO)2^F2A2F@C]H[35`(!\?'2G2&@:^@H13@H]O`U\A(J<."
MQ<L9W*9XXC7G`KA-?NZ(@D(CL..(BQJG=M6TFB!M`ZDU\=*+VE^N7+B%(DMZ
M-(CKYG"JJG]W6'8!RGCS=SR/(;W8,IE8-<'<C=L&/,WM#<!U4*W*D26VW8[Z
MWD3[BA*!U'J.XI`)U12S7;Q*+2/7$VA!)QU5Q'=2B0_IO:996W5]/-#=%H`:
MQC2TYFI)(-23CR&*YW^*?9-8\?R:]Y6<KR6X7+`^0G8]IFL6J-;[3<X$-<>3
M;W+A$>4_+AS9C4GU)0ZI*"DBIU.CWVXNX&N\MK8HS1P.)+N-,<N2;W79[?;[
M-S)O,=<O%6EN+-/;AZ\5?][([/97^>K=)RNKWY'9IU]AP&UI4B?)BAG8R5)H
MZM3`=[R$(4-Q0:U%=,7%V]KVZ&M#'=GL]"I^D;:.:>?S"?RV&E#SY\U=U#]V
MO(+V(MX=<)L6YXA.N[C;4=A"6KK;K`G\)Z!-4K>%]Q!.TU!2.A)U;LE@EC9;
MRC'GWJ^CMIW2B\!+:`C##"O%1*YCPW@6)C%YO%LXUC6NYWAJ7<$W1Z[&1,94
M6JI>0T%NJ:4Z[ZMIZ)W4K44%9-9>:\^50`?M5,WVW64[7W4D;?,]@]"I6N>3
M0V,Q39V(4JZ2YL9F)&88<B[#\P^X&6-\CT!Q2AYT`KKQ+J_Y@S]+;LS:K*T=
M/>4;B7@!Q)R`X=B^EODA_*U:_,_Y;7'S$W/?X]MV>TFD8^L+GFC!6N'+B<E-
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M?NF]GMYL^18AFUMSO$[@K*L-MUYOUHNET;L-W#\>.W,G/VZ+)D/OW95Q<GN`
M)8;HAQ-#U4!JK?OT8F="QKJCB0<#VJ>_893;MED<TXXBHQ%,J<U"7G_@:^8Q
MED3(,&X^NUIPQO$6;E>Y+;\^7%MDQ`6Y)DW1^[2WWX3LB-M=*24ME*@4)'4:
MN(=U;\$8;AS?B'@:<<*5KACR6;N=F?%NK9[6![;)K*EW]8X<AQX(Q]KO$.?\
MA8IS+*Q'"W<@4G'EVZ/=7[+"E,M3OR^YO&':+I<(;RH]W2MQE:D1EH>"2GJ*
MIU:]+[Y#LW55EN%R[1;LE;K(-#[PIQ]WGS'%:2S%V=,C``S5C@:FB9K!^->1
M<UGO6ZS<?WJZW&QK^1,:YJ3!L\2X;G$S%762[L^<$5Q%%LH=4=P*=I-:?>-[
M\U^B.F;!DVZ7\;Y)&![1&0\T/,-)(*O/+O+@:H(];1QR_I4S^,_:=R'#<^<O
M$B)`NT]Q+\^2N,)+TI82&_ERM9;@L1(S20AF.AHMH;`%>FO).IOYKG64I;TA
M8^&A`EE.JE12H:"TUXA3;+:I@2UPKAF<U,&V<'X;QGA>1W.].S+E=KW:_P`G
MES9$EU$A_P"8E,/1[?$"%!$=E4]IM>Q`2@J0"10:^>&[OU?\W.K;6TWB]EG@
MDDI1WNQ,=75(UO"@KB:UI1,]57NW=/\`3<]W=L!G;'X:$-J:CGF>P(7[CRW8
M_@.%9M"O,28Y%1.Q2\0T.)269DZ]/WFWJ=87O4'DLNJ;4[T:4@(V]`=9'KCI
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MU)22A2HRTDI)8JFM/$$'5A:/+`2W,X*/<1ME(!R&."L,]D?*<SAS%/=#D<!N
M(]+>]K&2V^&S.9^993(DS8+;3G9/8;=+1<W;%DA7P.K*RL&W%ZYHH0;21M#V
MNCR[12H]:@[C,8HX:$`"X:[_`#6/IZ*G'T+G-DVV7<I#0;2H]QP*WT<4"5#<
MJNULI!)/4>6O5(+!I8UD7W6@5[L,UY/=RDUD=0/<ZM._%2'XUBW^U6FY0K;&
M#[SB.YZFG-Z0K:VH-_A[R2%=*#QUR7;IR3$T5)R`Q)[@,U$.F2/2\@`C'$!$
M\BWHQJ5*OEWFIDW=S?\`*14J*H]N\0M1'1+T\^%3Z6O*IZZ]GZ3Z'@M3'NFY
M,UN+!1KLJ<,,\U17FYEWY%OA$,#W]G8F*R.]/7JX^MT["Z$A!-?25`I)!``(
M\.FO3\!@``.0R5/CQ)*=3!K`9J6I+B'%1X*:(10;79*Z$#Q%`E'4^8KJGO9'
ME_E-%6Y]JG6;&T,CL'<$["L>+2"\\*R%T0WZ05-H-3M2JM0#7J?'441C1J-=
M6*GTU`TQ*A#SM@9YXS.P\(8U=H]M59WVLHY,RU;:I4#`L?VN]@3$@I0N[7!F
M.Z8[!6"0DK71M*B?`?FGOFP6%YMNR[G.(]RW"X+8&:=1<!FZ@Q+1D2,`O=OE
METIU5O>T;OO6Q0:]NVNU$MT]QTMB:30'&@<X\(P=1S`HI9>T@<'XNM[%N"%M
MJQ[$I2T9-=A&<;O&1WQMO9^=WVXK;;>N"I96KL>#+:*I;0D`C7J?0T?3C;5L
M.S^.2,T>7#&O,&@P7C_4KMT^,=+?R>!XU1@5`IV@UQ3F>XSW"NXO;9,2W)5*
MEK_#`"Q1H;#][U5ZU^()U[%9P-N&$/KI'+L(7GUQ<NT/]W(J)W]].5?^)G_N
M[?GO[U7]I_D\-5OP[.W_`,QJ=YLO+_V/DFXL!`M$8"B5;Y-31OJ/FGO0`I=0
M?Y]6G5?_`)BN?[2C6%'V39>91RBF]%%IKO2"*HJ"3_MC0BOEK.Q2UG$=.*FN
MC_*+Z\$B^)7U.2>2D*[92UED$!*-X4EQ=GC;BZ22A2RE*2-OEXZ\'ZD.F]G=
MRF=]*])L?^2A_P!TWZ$\#QW-TIX-D>/CZB:_JUD-R'_"AWX@K.#(I#RUEM^J
M54HH$"GB!T*O\6LH]^H4HI%$J['*$AX(_P"#/<H:`T'I*?/QT1^^$Y%_$"OS
M^G)DDB9BUOB)E;TPKLID,N.J4Y'<>6UO"1^RTH=:#H"?CK:;`/R7=Y5[8N\M
MU<ZFBZ.K`PM,2*2!^##1ZRHE*72R05$CUD5!'PU<%:)F11]$1*DO,K.Q>UU)
M2$_>2%&CI'4A`!32E/#7$XG$B":RE16M;>X%`3OINWBI/7:!T'EY?ITMHU$#
MFF'^\412F(K<I(=5^-(<;!)VIK5=#10J?%/V^.NR,I5O,)*;3E"V-LNP)$%2
M$K!"PZ%#HIE14=U:[14@C[?/78F58&5]U&2=Z[9;'L6&XOD;AHI45,5PE0**
MK25.)2H]%G?7P\M*CP?1!5:/U-F[)[@_8K[DL![(F7"%A#.?V>*%*JY.X\O%
MORUU"%BO;4JV6Z2W7I5*B*BNI`M+:\FBBF;5I>T&F9J0/0JS<HM5G*ZOW%Q(
M6RT6R*Y\SVTEQR`U&4M,I0;8CH[3;,8-$A0"0R"":FM=9_<HFP[A.QA=H$K@
M*FONG3]55AXHO,B$M:5&2\2L3L4MMOYA(<3%>:>92I]*NR^TLK;>2E94H.-.
M*J/A74*229]/'DFJIUN/,;P"?-+%_P#S*!#0E$9B;;7H;ZXF[NN%^8F:&_GE
MO2G`5'>WL;Z"M$@+MK,R!TNK$=G[T9I,P;)<;;DUYC,)?N4.+.GQ6+@MM:8K
MC%979EH(3VE]U3B>J54^%=-..EI=R76C4X-YJ#MQ3FZ[DB*B+?\`Y8293LA*
M;=*6VZ\Z\$BBTQU.!*G$J)VFE"*]-1C<25&@T"D>13BI-655ZCVF018;J],E
MQV$T?CN^A8[U-S/;;<*`D4IX_J.I4[H[AH##B"FF2:"3FFRR)S)[=C.9P;7@
M\C,Y[68*BKQIF%\P\+5?K`!)E&$M:`6([R$A056G<!(UF;H4W`Q?A;7UJ8#5
MH/-)3ER?D..XXU9K7C\RWV>?A.)8C<B]#(BBP(C6*:_"C25#:ERWWJ(B,^6O
MN%P))ZG5C8,\RY8^M/+!]-2NR2TMGLI]TI>^S;!IV:YY=047C^';398G\3?P
M_=A9KJU`N$EU+7R;P>BI>6W)B)7V]P"DH(\=?HA_)#`?U3J*[C($XL[>-O\`
MERGZ`"5\5_S6=2;1LVU[19[H(W&6XE<T/B=(T$,IJH`<N6">Z.SRSAE]Y$LM
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M]X'K3[0-,NEU"A*:D?I%49Q8@J4[9`H15*5KI52?N^H+!Z?R5U"ED-"W"G-*
M::@&GO$#UX*@GWY/*F>YS/4[BK\OM^)6Q*32J4L8U;W2GI3J%237SKJQVZ,/
MM=8/WBO;NB'Z.G8..HN/_:T_550X#>QM?I^ZDE=?3T`)Z]>FHN]S?#=/[A<A
MN+;"X\5<ORGK>64?FWL3*TK-%_WK%)SVB6F9F/)5UPZ)*N=ACYOQYR9ADR1%
M#7=6_><39C8K(0X(KJHT>+FJ($E*^B^^TD;J&FOPAZDEHY\^?B+N^I7WQM32
MZX\FOO,I7U+<XIX\YWQC)\/M>17J]Y;`D9AC:9,G(<;6U.A0';Q;VW^W<X<(
MMJ#;:E$K6KKXU2*ZJV3V_DMA\H><=/CKQ)!RIZ,TGX>Y^*#:_D^8.'`%=5_N
MBG08=E^I3/LMMOEXR*W^U_ABW72VQ41WT7;O67D.38+;CD>,A<U<UV+=7/F$
MO;MSJD%OTUT^?RY[J7L;@MK>&OGCE&T+F4Y']VV?7)=L8;]I_.L%JT6B+;&9
M,B`^Q&>5%4TZEU2S8EQ:*3'HI"G#4'H:TU1W5M!>/U3NTTRXK/Q2/CKK;2O:
MG>^G5S3DU^]^?L_:F<'<QV8W7W,<019-QN=LM[UGLZ9V:VMI^=.E!J*ZB*PA
MPE:PVE02":5U&@MX8;ECHWZM+LJ4P]:5-<4C.&>&:_3?UH@**J0UU"&A"&A"
M&A"&A"&A"&A"&A"&A"&A"&A"A;[YG9S/#=U>M[;;LEJ'<BE#NXMJ0MJ,A87M
M]5-I\NNH6X&EL2M%TNP/W5C":!W'E3%5]>U7`)%J,'([Y1\S8<9P]T!STT#C
M=7%I)<*$.!(*O5M2-5UDVD>NOO+2=17K)*Q,Q#*BO?\`T*:?)EFQN_V;88C>
MYM*B@AML$*V^F@">IZZEW-MKB`U4QKDLM#.\N\&!HHJX7Q[9DVV_PKC:!<'G
M7'D1U/I=HTTHDI0P&U(4A81]T@T"JUZ4&E6S(X8RRE7D9J)>/>Y_FUI(WBJP
M.:O:_P`F7#F7&+S:F6DV=V<RW/=60'FHB5E!``.Q2PV?AXC58,=0_K%6L%R]
MCVSNQ=I'L5FUGX'MMCLF.+Q2:8=XC".[+6D@%QS8CNH)VE-%FM>NN1QZ,*I-
M]>R3O\QXYIO>9.([KD;H<OLIN2WV$M(0EM+I<<-$**O224@`G46:/XJ4$FFG
MTY)VUO6V[:0FK_5WJ0_"OMUX>L7&%SL]VA19DZ]1G"Z[(0ETQWGV:+2@+J4H
M!5T`U9&!K[:C1^:1FFI-PF-QJ+J"HQ5#G./M-G8IR1RO%E6RV77&[[B4NTXP
MM3]U#"T3,NQFYF%?4-NM)$%NV6A\H,9:'$OEJIV[P<K+,W;V/\[W]1-,EII[
M=^^>0+(,#XQB"<2>=%51DO$.0X%?;_Q[(=Q6WNWR:;[:B;@%LHM\]Q"$*;CJ
M0]>'4-+01525.``TJ`2//61W$NX>:9'"T=+K+1AIQR)X^I;N?RQLGZ>^)K;\
M1:*G&N&8&%.ZJD'[9/;AR;-YTQBV6A^SWYG\O3=[K=\>DSTIML6.\E"X@<F1
MH,EFX.(4G:C;VW&U*!)Z@>@>?'>!EO`:N:XD<<*_5[5Y?MNQ76PF6YNG,=%)
MA48$'AAC^Y7(P_:+?HF*7/)U-7MRYIEOLILZD,--!M*E`.I*4!2PHI"AX"AU
MH#8ED.MYHX#*B9;NSO,\E@K'6F?[E#/E;B[-7L1O,9^!VIZ(;X6AONF0(4<%
MP@)*"0XBA)'0'RTQ$?+?KSP4Q\GQ%K+&136W3W*J2Q>V*3D,VW99$O=\5,=1
M*N5SMBX$-<=I*-[%F@6V0Y<4/)>E71;32^^TC;O*A6@!\@ZKZ/LM^WN/=`--
MQ%3A6M#WA?0?RV^;_5'0WRUN/EY9OC/3]]`\$$4<TR``FN-:`=E5,SC_`(ZY
M#BX"RG);+?[)8\%RRV2TLAZW/6!#LUV(U+EW-,BY,RK@T_+90@M0VW>RZLKZ
M-E5-%!,^.U$<K-,<4M:Z*5QP&K]JKS2=NN\ULJ[6P4I)C@,Z4]G!-7DO$TN9
MQ.UAEGM/R66)SCDG*ILJ?=+;`5/C9/A/&MGQ"V(0AQX/H1=K//4M2E=M*U`5
M"B:V%M)9^6V0^)_FO?WZFZ:>C.JHKFSW:[O)6!TCHS&QM"XD$!VO$>SVJ\#A
M7V5<`W[VTXS<LRQ>RKO:^.\7@7=Z!.R$K%Q1C2OS-#[;#JF77%+2I06Q1/K)
M3T(!V=A8P&`24]['N6?N[VZCE^'>36/"G+L555YXLF/\GV6_9]:\JA(X_F6E
M_'[E=D1EHN<%;DB?$1'@R!+4Y9H32&&_2X%4+FX"@2G#;D8VRSAC:%TA&?8M
MKM_F76F1SO=`J*9.Y)L/>9\OSW;EVNU69\N6+`LG4FWPIEMC(?ND^W2!&7+=
MCNI4A-OD0$]EEQ#ID(<VC96IBV;;..C[I^HM;AA[N&`S7-V?<S5;::BQOO`"
MIJ$V7T[<^O'%^!\G6&Q6EV]+GYU;%3;:XW)0WCN^U,VZ5>Y*VD+1%MR'NPE]
MQ24I2H#<H$HK$,[;N5_G"3`<!6K>&*YL]V]UNV(`EY>1XO#C7EBCK@^WL\:9
M/EO%62YKC&89>Q>;AF4A-F4I:[;`R>:N2_"E]YQ3CKT:Z+65+%`0Z#0`C3NZ
M6&\6\;-RDCD9MLE&L<_GP`[UZ!TI?;9*9=I\QK]PB.HM!K1O$GN*F>B+"?C-
M/L]DJ0=ZDJ"4I``45JKU_9&HL#I9GB-YK4CUDT"T=Q!##$9O=C:"7'D`*J&'
M*F7MY=D*K-;Y+:K/CDA6Y25T9E79`*2NJ2-Z8Z>B*@C<:^6OM+Y-]##IW;#N
M]ZW_`.MK@`$$8L9F-)KD>5!FOBOYL=9NZFW4V5N[_P"J[9M&T.#G5H=0YIOK
MFPN[V&?BMXDR&+9=T[%NI4E:XB@HJ:E);4HLO%"^A2H=02*CQUONM>C=MZUV
MGX"\8!=LJ8G\0[@#S%:+S[ISJ'<.G;_XBS?2"3PR,.3F_40..*2]ZX1C6V%@
MTFV1+_G#4%Q=POC-I8MUH@OV^V1D]RWRIKUV;,*ZW-AQ3,<-H"5':-X4/3\/
M]0[>[IS<I-GW.(LN8I`:\'`9$8<?8OIK99I-UV\WEC)J@E92M,B<^.-%SF>Y
MMCM>\W,Y4?%KEA]MNO*-KN=CQJZ?..2;79)D^UKMUO3+N!7*N;,-E'92^I2R
M\&]Q-:ZT]M-%/LXE8<7-)IRIVK.;G!+%N3!(,`VE>U=66(R&7;=;0E?K-NBH
M4V6U="W';"@IP@IJ/YM>?O\`?/>IZ7\O:;5,!`2$1)"2OMF@JPN@J`>IKT^(
MTY%-H\-*XKO<D/F><\C8/Q[.B\>VZ1<?XOQU&-Y.F)$<N,C\B=<8DNM-Q6`I
M\J<=9!)2E50DU!&MOTRZT?N.JZ.F@H..>?JHJ+?A(8&AC:Y_4HX\1V2W9'=+
M5"?:"ERW$(0CP4E6Y*!Z>UZ%5/4?$4UZMMX@B+F2&L(!->P<5Y+O+)GBD6$N
M']"M']U7L[R/VK^W3C_E]YQ:O[VKRU86$1H+@%GA&T2;Q69+#?;C.W-+(0T"
M4K4&W-M0#K>]!V^V;QO$TC&A[+6%K@:YZG$'NTG/G55^^65QLUG"+F35-,*%
MM*:2<:5J:X$'(9JDS,;VN0\X%.+66QM2G?3X%2E>)\?#7L;XPX"F#0*`++_$
M=B05GBNS)H6I&Y3B]J!U62H4ZT`H"?#IJ(XZ6%_)/U\;6_B*G9@>-&):(C;[
M0;6$&0\BE"75)"E*I2HHD#]0U6VA\][I,J$X9J>[4QH#!J-0%&3E/W(LHSBV
M<'<#P8_(O.6471%EA0V2J1B^'*>)1)O&57*(7`EJSL`OO,MU+:&_Q%)^Z?./
MF9\RNF/EGTK?=7]63"#:+.-Q<:^)SPW4UC!Q<[``=J]0^67RYZE^8?5=GTOT
MY"9=TO9&@`"K8V%VETDI^ZQN)J<$\@XUPSVR<0W>S7Q<C*\GRF+<KSRGF[0#
M5PS?++ZA%ON;T9N6I*H<&$Q*+-O;4H)9CM[=H)-?S"^1'S@L/GY\_=P^8W4]
MG=O?MUI*;1@?6W@C<=+7:--&N=[Q',YX+]0_GM\I]R^0G\MUKT-TU>6D'ZC>
M1,NBY@\ZX>T!Y_-UU('N#`T`[4B>(K-C'#G%C]ZMUN=LSN4!=XD)G_+MS!'*
M"F!\R([BVU.*C$+(W$@N>5*:_6#Y=;!906+;VTBD:+BCJ/P([*?6OR$ZNW>[
MO-P,%SI+8#I%!2O;^Y05SCD*X\AY<[$A.%<9,O8EPI64.[5&IH3]Q(34DZ]K
M$4=K:N(;1^'HQ"\]D9YSWMRK4J4?\/6__?C_`-USY?[H_M/^^?<^[_D^&L;Y
MYY?_`,Q\UI:?_,J)J;(M0M<?:ZVVD?,$H+W4'YEZO_K>SU)']`:L^KGAG4-R
M7?C439Z?I[:\T:!]545?;J%)"0'`5>(-$TG*J3^@G658:S:AS4Z7^&6CCAZT
MF^*&U(9SUU6\?,98V4`J2449M%O2>T`2I("E]=W4JK2HUX?O8+[V=O$3../*
MJ]#LQ2TB:<VQ@>I.NIP]MM-!U:4"?,^HTJ:ZR6Y?\O16,&12+N*-CBE$@GJ!
M0U``%3Y#K762.:DKW9IICSXH42$+>2A9'EO4$I_\$$]=+C]\)R+^(%;+[`L]
M_AO/8]A5(6VEZX1I;8!.Q];;J-P4FH]0;\/'I76BV67RKHAQ.DA6UH]L<X+J
MT)`]*ZW,4R1J9:SO2@$;4)<2"=U64N))0/NH!)'VT\M:Z0AU-*T[#IS7BS99
M.;D!AY#>SNN=LA)`0K>2A`<%*;P0*DD==(7"2G88O$^>(P>"$DI(!`4L`D=*
M=0=Y)\QX#7.*7]ST+7O;7:;ARI3A*D20@.=4]!3Q4DTZ)43X>6NXU"2"`,<T
M5W^"W-VI4\E3B64.)"DE8*@DJ0@^6U234BG4$:E.<UF:;1A*P^1F?'UFL+!:
M*H>1I="$[E(1&<CR0NH)&U+:R"/(:8<TM->!7'/#!4Y)CO>M"QKA#V*>Z.[L
M,L"9_<AG%J5,=2E3[TN^V9ZPQTI4H*VMKE7!*0!XD_$ZE;?&^:\CT'W7M)QY
M$%5NYW+6;=.]OO>6X"N52*"OK7%8U9_;P_P5"RE?(O)3_.$AJ%8VN,V\6L\;
M`;='MT:'"@W%[)%P7+@^740G),@(DJ4I<E"`$[548BZ+W>_WN6629K+)[WO%
M"3[SB16HP-*8+&R7FVP;8R9I>;IK6M(IA4-%2,<JUQ3(M%*WFT*HGN51N((2
MD$HZU4D$]-:%_P`N[J.#XEURWRZ@8#''T*ECWJ-_N1!OMJE@Y&8D6Y:8Z;4W
M(7%3;YD=YM$)+KT;MN-W"/*DO/#OS&R@24]QM&\52FAH,;-LL^T[Q);7DLDL
M30',+6G`',$-SIP-/4K)EQ%<0ZVBG?@MO)U,6VRH,*:MUV4S)<D,K=A.&`T+
M@M$%*%0`(P#T1*5E'WDJJ31*T@<VK:8[]LPE+V-$X#"00=+L\#0U!R')-7,[
M+6-DL8U.KXN5.PI*1+N2ZCMJ)+:TA1[A^!!40E1-`-;R+Y6AV$EZ8S2H\((.
M',\57CJ-@)8R`8'&I2D1?'T/OJ2TE9,44+JU@U2HG<#U-?3^H:S-MTA%-<.M
MW7#P\"N#0I7ZD?PA-+BF02K5R;E=Z"=JW+LZVXPE2D)<;DV"SN-%3@5OH@H/
M3[=8B^L!%OTEF'F@HP.I4GPZP2.T#'D5;6\SA:NF`&HD9]J9GW2Y/,?Q#!;6
ME2$"LQ+X"E%4B/-N3%Q<2X@G8W1^`A7Q)3J8+!ML(9V.+I)H7''#`Y8<P%'D
MN1*U\9%)-/HR19[0[%:[UD^2&\W6VVJ%#MT=Q*[O%GS+?*?89N3P9D,6]YEY
M:66E*=W$]ML-[E`@:_2G^1>$6VQ;YNSM-'7%M&*\>-#]2^'OYMMPO+5VU[=8
MQS2W#V2APC+10/P#AJ!Q!XX4"L']B=IQ*X\E\E,S843*<M3;;C_#\M],J1'M
MV-P[@Q&N#T9FY0KE9IT.\B2R&DO*+["8XV`[R1]@]6/F:&3F<NM_-(P%*FA(
M(((-`?6OGS>Y]R@MK6V-O\/9"+4TM>WWS@00UV#B*DX#O5E=SP+"+D9<#+>.
M<?NT=]*%N,OVG&U-H4GKME,HM1#[A`%"I`*:?&FLM%<ROIY,QCKGB7:N^I%%
MFA-.QWF1O<V3GFFU7[<^#+A<''8O$>,LP4%)6+-878=P;<#9]7S5K?@,%*G"
M#3M`A(Z'4T7CXVZ#,QT_];#NX'Z5(;NE\T:7SS%W^3I](+22.>*P'@/A1LJ_
M*[-G=M2A>PR,?O.=-,(=2JBFMULRAI+3K)-5)*!M^!\-.?'[A&?&8:GM'UM2
MV7UX_P![RCWM`]5!BE);.$L.HRY:.3N7[1T-6W<TRQ!202E.^/=)5P6V`?BG
MJ/'34F[;@22ZWMY3Z/W*ODE?(-+PVE>`_<EM!XDN#=!`YZSM)W)HB;<[3.'I
MH`FLW$WE*/Z5]::B/WUT9_XG:[=S!Q&JOII(T*KG`>XM)(;7APIDF^R/V$<?
M\@Y%,RS++W9LKOMU=C2+O<KE#C,3[FJ-'8BH1(D6N38@THQHZ&]R$)(`J.OB
MW_CFWM(S;P[86@UH6ZJ-)PJ`7.K3//')/6V[]4V0;#:[BYEJTX-\MN5:D9JM
M+Z@/MMX^]OLOCN#A-FBVR1EMORFXW%,2ZW.YLKC6Z3:XL%*1<;K="TI"I+@]
M*DE0%55J*4^^]1R7GRRZEW$U!AVV6,5&DZGL.-*###$\,E[O\I[_`'7=^H[9
MNX3></BXM-12@)-0:5KC3NHFI]I'+./\*9SD5PN]LN%RE7WC^1;[4W`5&08C
MT/);!<ES'C)4V%,,*@-DI3ZC\-?D'LW2.X=9BXBL7,:^*R\YU<R`*D-%#4T!
M]B_2`;U;;(Z,W;"\RN+13(&N9-:C)6A93[Q9-GYJ:X?3Q^V^Q,SK'\;BY`C)
MG$H<MF13[6JVWENVFTJ^_`N;;@:+Q'EN.FW='6[-FMMR@N/,;-&79<B13LH1
MZPIDF^5W`VIA#6"1@)!).-"*<\U:OS]F=]XTL'O^Y#F6RWW&VX9QWPB_B\9I
MVWP)5W98LC[=U:N=Q@-2+HDIO5T6F.9B5.-L@=D=DIUD;%KY9RR6E'&@XX9"
MO:MIN$H@%T]U2&M;]JH:G?4;O,QE<.3Q'8Y41S<EQB7EET?;6A7]-`MB$J/7
M[*:NF]*M?_MSA_5"Q9Z@A=G!_P!HIU_9'[K8&6>]OVF6-CAW&+*;Y[B.*+6F
M=&R"\2'(*KAF-MC_`#C49QAMIQV.'=R4J--PU%N.F;:&%\P/BC!=7*M/M3+=
MUCGD\L1Z*G,&J_1%U3*6AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0HC^\Y^#
M&X9RB5/4`U%L%\D)17UNNHCL*::0`:[EN)`%//4#<7-%L:D56BZ7!?NC6M/B
MJWVGZ%$/VX3FKUQMC4MU"BZ;5!)2NNY(+#>T.)-""`.M>NH\#VO@;IP5AU&T
MQ[@Z/B":I_ID5AQHEQ-0.A!/2A^`\*C4^;^&%GA@<%BM%CB?B+0$IW[E5'WO
M&GJ(I3PIJ,NG'-$.38=%E44-A4-RPH@E8\JI5T\#J),/%A0&B*GF5@M^-*CH
M;#;ZB`E*3U-$T'CX5)U&B8]E=17,>*U;UC;4M)#KA4K[@/4T\0?+PTY0+@P-
M1FC.U8@EB`AE#YHL'H-Q40?*O3P'AJ=!D"I+)&!H#A4J`WO?C1<5QJ"X9UMA
MNW"X18"';I<;7:65*D+HE!FWB=;X@HH"M7*A-3Y:R&]6YG<X`M!YN^W%:/8+
MZ*UG$SFR.QI1C'./L%/:J@5\=8%R%.G7_(T6PW>)>[5$[KKR/G&&X;J8MM99
M=0\EX1+DIYSME.YMU)W(40>F$9$Z&X;&X@FN-#5>NZ8KBV,\H/B:",,17@>1
M]*L>]HV*8OQOS-&L4*2\M>46`NIB3E1W9,80]KQ>:<HB4IEU3A^]N`J`#2FM
M=M<L;;QM!0@'@L#U!'_PI<WW`5<)(:@&/V7**94W79UV$[:'=T%.NMZ2'BO`
MA>:MPRYIHI>%8FJ/=''8$-SYD/\`=W1VW"I*DD*2E2D'HH:BSM%<`,E(CF+!
M0ERIXY(LO$%QN=ULME>AX_E#UXDQ%N6EQ^/)C#'Y<.^S(MPAM;(B8B506%'N
MBE""DU.O/-X);-X,#7A@O4MAA/PD9D+::=6/(I&9;R-8F>$;G@3\]M5XN&1-
MQ(S2;DRJ5.$>]PU3):HJT>LP^X`L%844$54?#3,]Q%+L@MVO#IFOQ&).?U*6
MZUDBW@W1;IMG-P/#]BFFXNXRLF58ODTRXA%X=FS7H$68'9##UJ#`:>!84V"4
MN.HD`E5?3^S0]=55O&]L#Y#@,AS!*M+BYB=<1MBK6E<,,!@5+V![N,1XSX.O
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MM3]J?N/R&U(MEPY2Y3S6V6+`V[I#:DLVIJY6]Y%[N#_XB'IJ++&6AU#9':<D
MEI2@0*:],^5O1)ZDW9T.XM)VAD9<\@D5-*AH(''(\EY;U3OTFR6!%I)IW"5Y
M+#GIIQ-?73BJ?^+^;LHQ+FZW\EY!DKMPGWB_2DY=>;M)6EJ;!O+A3<'I<A95
MVTI>"'4J5Z4+0/``Z]_^872\.Y='3;?:05D@C#HHV`$^`4%":8E8SH+J:?:^
ML[>^NI@V"9VB21U0#JQ)=2N`X9J[N1S3>LNQIV!A;Q?EW!IB&F?';>7`9;F-
MJ4IZ-.4AMF2MMFAJUO0-P]7EKQ+Y.]#OW[>SN>Y1EEA9NQ#AB9`1AIH00!7,
MYKV;YO\`7;-KV<;/M4A=?78K4'P^5C4U!K4FE,,N*:Z=QSF=D8:>M:UW264]
MR4PTM":J752U*6Y3N/;B>GGK[2BCJ"YE`QN'HX+Y!DD!!::ZZX]Z/;%%DS7A
M`G6RZN7-M(2XE]IU;+3I'I4I20ELH`/IH?/3[8R\=BCTKGDGD<G,X/CDBS9#
M+LMNAY*MMFWS)BE1Y<4PD&3.:#DE"FTV\QUA2PLA`6$J!!K7PGY[]#G?K"/J
M#;F-.Y0-+7"E`685.`-2*<?6O6_E+UA^BW3MBW5NJPG-6'5[KA72,:4K7&G)
M<QWORN,]'O9'Y@'&G;..,6V&GE,E*(BF[?=(ZT!A;K`:D,3$K!25`UKKP/8H
M3#L;XWTU"J]&WRYCNMS;)%4,Y%=*>$\DQS@R4W)IJ0IEZ)-C.,J0TZMA$1D?
M)J+;G0`$^HCK7Q\=4;(VNPH*]R>&2>:=DCL/BZRW>YQHL/&LWA9!(L!:N$21
M,>NEJ+\63(F16G7)D1MLLE+:7@A+FTD=*5&1M>1I:,21ER%5'D:YQ+FFC6@5
M])6;A+GN9PU:L8SW%9C$W.7_`)VR!R7&:?B0[9-*HDE+\.15I?S$%1;!!"DA
M1.I=D7PW+;F.FIG`J%>V9G@+)7$-&(H>(R]'-1CL4F';>;K[(NC;5D5_$S]Z
M>8;4GL%V?)5+>#)25(9:6^Z5%`Z)!H*:]+NY9Y-L^(@!+R&U`[1C2G:L7MS-
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MNENFW*,^O>X^-I,ET((%`->$=?\`RVV?YD.;9=66L-WM$0JV.1CW-+^<C0\-
M=3@:5`P7L/RY^;W4?RO,EQTA<36>XSG\R9ACUD#)K"YA+!2E16A.-$YL/E:Y
M\\2+)CCDYJYV%.3JB7MN6Q?+=?8";1";O#J9UIN[LU4:"_'=2A*TO;5NJ*?$
M:K.BOD5TIT8Z2TZ,L+"PMIW#S7,A>'N%!@07FN6%33L4OKCY[=9_,!S+GK3<
M=QW&XB!,;))6>6UU3B`&`#OTUX56C[B\_0N.Y9VW@Q`C-=A#32PD)0T4H2TD
M4HD>D"E2.@&OL78;5EM;-&6G,G*B^:;U[KF4R@DDGB<?K1[[4?9OF.8JBY[R
M`VO#,*F5D6^'<&S'R"]0UE+C:HT1Y(-NAR4'<7WO6H$;4?M:<W'=WND<RV`(
M!ICD<0*IEEO(QIE=33I/'F%<1_<'PI_YU;?_`-@WY%_:I7^;?_&_WW]M_P"'
M^]K'>6_G_P#S%7CFKW#_`/9%SM6?D2'9<L1AE_?F6Y%Z95.QFX2PJ-;)#X><
M;EV>+,3/8ADU1W4!PH="U*24TV%4[J_</+ZNO+&9M7>9X"<*BF0_>C:[.0;5
M%=QU,9%'-&-#S/%.[WV_WB7"Y^U7YI"@10UJ1=U'J/@"?LU30RQN>'5`&?<E
M2$.80WWN'>M3BXI7:,A<"4@O9+<%E2>I7VXEM;25*KZR$HI4=*#XZ\/WI[V[
MG.*^`O)]!7H-B0;.,_>T"O?Q3CNU#;1_R#_[EK+;@YKX=+<7*S@R*25PZE73
MP43N_P`E0^'Z=90M<,U)1&XM;:DK;Z[3N^'44*>OB/5KL?OA=!+<1FIG>W:^
MOV_DG"KG%F?+NO3X;L=TJVMMR5J2DAVIVJ2-Q&T]#JWLI&QR-=6CM0KW5"DP
MRX@D^.N'U+KZXESUB[8ZT[)=^7?2P&)(WE*1+8;2"I(`]0<356WRJ?+6ZB=&
M\:LVE:V"3S(Q4U>,TZD"\MN+)9WN.)4"-K:5)J-E*^JA"P1UZ==-!['&C3BG
MTXN.Y(Y^8Q6'724I=2-BNBVR:%(6T0"D"OCX5TI*J:4X)U\FI-LLH)H"TZT\
M#4)VJ;!41U!(.Q7C0ZZ,UQ)5IE+D-IQ:UNA:2H[]RS1A!ZA0/@0>G4?H&I1:
M#FDIV>.DEB`^:T2I]LI4HC:E)WI"B02$@[NIII$[27`1^Y3VIJ?W/2JJ_KI<
MC2L/]A/)UMA,O3)&0SL(L3[$1*W%NLW/.L=;<0`R"M3:&@XZ:#]VV=2]OE=;
M7#/RG2.>"?#F``<0%0;]I_2GL+@W6-->VN2XR+=;KLBV0[@]#K`;2ED2V'$.
MQDN!UH+0ET':I:3T6`2I)'4#6VV#JC9+S1MK7!MVZI(=75JY8"B\UN+&6U8)
M7`^61GP65,A*7T%O<`VOJ3X4`JL!0)-0->A,LI+JQ\K++UJF#_+XTJE=*<;_
M`"YY:25!*WB2H]2#%CFOB?&GV:\NW1D\74&B2HN?A"3P/OD`U'8`KN%\C[.@
M.!<%JW8C\I2ST#G80=BO20E2P*D="*E6JVVD#V!I=5YG:1C4FAYY^M2+ES61
MF-^`:WMPXI/))!5V^@W443N'4&H'[XGQ_1KU>[87M$1Q`8*BO9ZUFHFESW$`
MT+D:-K4$2]I)<$;=12MVU1)2DU)4#2E=>>[;I_5SK]S2:^G)7,I(`HFZ<CNM
M99<I*1T?:9D.D$%*7&;.F/57W4]=B:?'7F?4T`M^K2&-TM,1<?[086@^K!:"
MQD+K,`FK-;0?6F$]RK(<_A]0<!9MK-LAI1N20I^7%N<DU%2GTMM;O$==.7,9
M#(WM'Y<,3&`?VAGZ*IA[F-N7FOY>H@]P3R^R*/E\.-RCD6'61R^.VO%\H1?P
MS=K-:'(>*KL,6!>[@EV^1)C#Z66+GM+32.^O?1)'6OZ6?R8VNUQ?+*[EO'`M
MNM\`CP=B^)O@:--,CQ.'.J^)?YGS?S]6[=:02-C#;!KY"8W/-'.KIJTC3JSY
M]JLC^FUBL)4?-L@>A7EAHKDV=^\)BI-IDK*+6MBTQ9!65+G1HZ^ZXE21M0]4
M+Z[=?2/7I8+B`0O/ZEH\<9P8UN/B%,*DX=R^;]]O]R-W^GN;`-H;%%)&X"DI
M>YI#M6%-!SISX*R^X0<9&X/RYRR`$JKO;ZI24)64H9(WA!/4?#62MX+^2AT,
MQ'`_O5#YH+M-?$DB^[9HZE)AWZ5$3O"PVE92VDIV;5;%-(47#VO4*D*KUZ:N
MH;"[+*NCKWT)2M3JT#"3S7K%KHAR$_(8"DHD7.:M([99*@@-,[U-U3LW]LD_
M'QTN[M6^<0!X0T<>/%!!.:<>TSFY:0KHIM*U-J"NH"T*VK0=U2"%`U^.J"YB
M%/#G51'/F;B:T3BVV'$>V[XL=TCH`MAE5:]37<@U`KX:S5X][6D-)'I*:+BX
MU*6S%BLRTH#EKM_121TB,IK]OH2FE/#5!+<W`KI>_+F4"@..2H5^KZ]%9Y8X
MKM$-#;#-LX\DSG&&4J&UZZ9)(0I5%&GK;@CPZ&FI75%V++Y`=4;A-4O=&YC7
M'@'%C`?6XCTKWOY!,$_5E@V0:F.O/6UC7D>HT54K($>8J]CPL;N.-J5U"E0+
M[-N5IGMJ(-2GMS4.4^+0^&O@[Y/0/M3=;D]I:(7VT6K^HX/9(PCB"'`&H/85
M]Z]221RF*$GPEA(["'`U_;FK#+BA62<S^S?/=CA3GC/$5IN;]2L/Y)QSF$/`
M[N"LHZ."):83BA0T2X#4UUG]P:-OM[O89:-.WWMPP#\,;ZR0CNHYU#B<,5HX
M0VYN;7<G>[=,!I_6B(8?4&@^E7?>\%5H:X/^J?<84F6]/E,<#VN_L/Q&&8L*
M>UB'&[<*-:)#,E]R=$<LMSC.NK=0RXW(<<;"2A*5*\KVQC?BVQ/'YM<N/XOH
M(/I6_P!Y<XV%R^OC-,?0%RD*"AN!%"-U*_#R_FUOPT-R"\P(HI?_`$[B3[^O
M9;7K_P"U/<,#R_\`/S:-0]P:T;?.0,?*/U)^U_CM[U^H5KS9:5#0A#0A#0A#
M0A#0A#0A#0A#0A#0A#0A#0A4@_6MO64VG!>$8^/WRY6J%=\IO<&^Q(#ZF$W.
M)^884I++ZDK14);+J17I1P]=9?J*7RWP-!IJ<:]N2]D^4%O:37-^^X8USV6U
M6DC(T=B%G]L^>VEO'$6MY)BJCDLE!I1"4J!0E)J`K:A0'3IJ792,=$U@/B*R
M_4<7F7TKFBKZX*7C]SM3T;<'RD+22D*4C:5"I'6M?#RU,?(:4<<%F8F@NHX<
M$AK=R7`@S'X+J$+[:RCN;@$D5Z$`&A%=1=;W/TL*Y(PM)-/`D%RAS]9,5,5A
M#C;\B73MMME"G*+`Z)34D44=1);AP=ITU//DI$=NYS/$TU*4W$'(D3.8RENN
M".X7%`-.*2%4`-*"OCKL!DDKQHFY+5\0U5U-X]BT>9>4[!QW#4J3*!=#B4J0
ME22YN<.Y`2DTZ+3_`"Z[/)\.*N%3R2K"V==`AW/`HE>]S^*VWCF3E,2V.3I\
M-"?ZD@'O2"4@)+8)22"=2(+N'0USR&]G)3#8%LWP[AXOV*K$]U.>Q?<%BMUG
M7B/;X2[#;9DBW6R[QHLF&W=7&PF$9"9C$B*T=U0%50L%0VK&L?U1#=/M72V[
MF!H-3KRISPQKR6ZZ$?966Z>3>F3R#^`GWN1%:4RKADH6\2</7?EQ]QZ=>H./
MW)$3'KI%4GY*?.O$9]FX1Q2Y&6VV;>W+B*4@I<'RQ0`D!2R306&W,NZ2!VB<
M@&O$@Y'DK_<]T=;7$D(<=!E<:4X>I31P/C#(N*>;\>SG^)$Y4&;$ZPZEQIYF
M0ZUV+8A(96X^\I,)F/&"4IJ-IKTU>-LWV=TQX=A3'[5F]PO(9K,ZV5C+@.X\
M%:-_I#8-%QN0[=X<AF8B,M>U#JE`40:DT62!N_FUJH[IKF@>92O']@L2=OD;
M)Y;6EW[5409OO3M$?'YLU&*W*5'>D7%J'+;D-I8^6BJ6@NK3W-XW$5%14Z>G
M!@E;!,ZLSQX1Q/8E6FW"XU3G_EF#Q'A]JC"YB6#^X#B2WO0ID?%<MO\`=;C=
M'K_#AO2KPHV]_OW*`\\X_:&5QK@SM94`^=S8%-Y3369W6PCH1,`R9O[<%L=O
MNWQ-:X`R6S6@!O"CL`>>"@#;N"IMQO-GC/W%V:ZY<LNG-1Y3;J4JFQ7I*_DE
M)<<>W,NJB(4HT2?4!X`'6<M6PA_E-H2:U[>U76X124:^.I``XGZ%)'!.$<A1
M9[W9+#,FLXS?+ACZ)YM2;G&CV]ZZWR-*<MBTS5QC(7:8;Y=0X$ALK&P$IKJ2
M;<O+M+:P!PU?551F3M@C:Z4TGH=(XD5Q43N9L)3CG&.8MJE2IR+5>K_`A_AM
MI<D?EQ[(*PEW87768ZU!(&VI53QU>;*(FWK6G(`J-U/+//&Z@(-&T&&.&:?O
MVP<88]<;S;OXQ6Z[%39[-/8BIGKMTF,[%@N(E!<AIU+FQ#TUPBN]L%7J%::J
MPR&;=@)*&-M2>RN">>9(]J\-0\T`[QBF,]WU@M-F@_G3\P76T\7\GXM@G'>(
M762M^P)Q"58TY/<,;EJA_)R[NS(<M@[RUO[^V5)H#2C+H;8RMBH-+7`4QP:#
MC[%"O1=LMC<6U=;FU)PQ<>P]JIF]SF&8?>[8QE&,7!+N.0\@R:U0(S`?;A0Y
M!=;O##,..M:TA"8$@,A9JX$L)"B137UC\DYK2?8KRP@:TNCG:XD9Z2:CMHO!
M^O8KF/<;6[G<ZCV4+3P(S.&"JBS!2HCLR.5J"$*4KME5"K<"`*`DD;1X"HJ=
M>B[H!YOEC!G+]ZRL1>3JBQ(]/TJYW@[/<<P;"<(PV]P.09-RM^.6=A5W7C$J
M5\]-DQ&GE`*MTV4\PEA+O:3N!VMMCJ>NGNG]FCVBP>(6-C$LFIP'$T.)S^Q*
MW;=+C=;EDMT7/?''H:3P;AX12G+EZ5)8^X/B;&0VJ_YK<\8=((1%N^.96A4A
M"#M!9+UB>:DK!200%G:13SUIHFEC-3L(CFJ%X)D(&=4]=BY9X^?L;63.S9\7
M'G]@AY/DF.7C&+1-4L@)>;D7B)"6(06H#OK2A@DU2JG73XN(6,+6MKV_MR1Y
M<@X*!ONFY(NJN2K1(D%2[`_#<@XBY%6?RM*[>XTN>ZXD**5/O/.=[ODJ2ZWM
M10`#<P/*N(WPST?$]ND@Y$',>GUKK&R!S9&5#V.#FG*A&15=ON`]MUUYXN&(
M\T<;W<.WF"S;K/>,3RQT6UR_HLUS+C<K"[V^HM3F6FE+2U'FK:6IH)0TX0$(
MU\\;_P#*R\L/BIMD>'64A+FL-:MSJT=G?BO3K#KF&Y\B'<(]%RP:7O\`NNQ%
M''D>X45N6#L7['H]F?#P8=%IC,2F8_4(6_"^7>2DJ=)[B4**3T!\=?.;Q<VT
MSK>4%MPPFHIEC3BO78C;R0!["UWA!K7FG1R7/KM<^,[!@MU:MB8.'*OB[#*+
M;<*4TS=UR94L2Y!=0VI3S\E6YQ2@5)2@&NQ)U.VRRO\`<KAEGM\;Y;QSCI:!
M7$T%>[G50KNXM;*%]S<N#;8`:C7@#AV^I-!!S[CRVVV):+CGN.1)41Y"PU^8
M]\-K`2'&U*:=4A53\"1KT^Q^4'6[XR^X$$+S]TU6/NNN=A+R(?,?&>0_H18[
M/Q&[W\WQS/K)>%*3LAVBTF0IR6^3L;8D+2$CM("0=J2=QZ$@`U]-Z=^7^X6C
M&MW>:/0"!3G3NX+![KN=E.\RV<4@>#J!/#V]J1>>O29SBF2XGJ-[IVT^\?N@
M=$DBOZ`->[;=;LMHO+C%(@`!3+!>?SS22R.<ZN)R3$Y7EUEXYMJ+A)8%YO$H
MG\AQ_>$_F<IK:#)N2T*"HUEAN_OEU!>4.VC]HI?G89!0C2VGO_5^W-*@:TC4
M1X@5&]''7-WN2S"%=KO#O&43[J^8-NEO1GXF(V.*DD&+!<+:;9;+7!;0=P;J
MH[:'<HZI9?):QK(::0K-FLO+Y/>*N-X/X#X\]N^(F.&[?D.972.VU>KPJ,R^
MJ6^$57%90H$Q;1#)VM-?MJ]:ZJ\*UL,TDNF.HJ3CV)PR"+QN-`C[-L\D6Z$Z
M]!ARIKS32C\I'BEYT(*0E(5&;2M1`_1TU9"QC9X&M![5#DN`^3PNJF#M`OM^
MCR;I;L5<1FF5.KA0[3!MC4:Y_(-+*&G[@0AMR.AYQ96I;I"6V^I/778(XF7&
MJ@``Q7'R/$)T'QU3^<6>U3&L4G,9GR0U#S#.%+3,AV];9F8]CCQ.Y/R[#J>S
M<[DR33YAQ.U!_=I'WC:RWMP^+R(JMM^VFH]_9W*!'&QA)D>'<E):Y-7.8E-.
MZV@@!+=:`H\4@)`24_HZ].@U#\MK820/'IP[ZBB'/)#F@^#2:)7?EUQ_WP_]
MB^SQ5]__`'K_`&O_`*%-5GC[?_'/^W]JM</_`-C7._,L-HS+'%8_?846?#<6
M^XVB4@NIBRT.N%J7'"IK*$OL*/0!*:CH>FI?7UJR\W^\A<QNIKJAWWAW&O'B
MFMEN)XK.*6-[FZF5(^[GR3:62'D&.2Y6.VZZQ+#.@++SEJNS\IZU7NQE);7<
MK%=DW()=W,^I+#R%28[Z>VMU::$X"!S[>=K'>`^Z&G[P(I5OHQQJKB>0RLUN
M`UD@D^E/GQ`4JL$I*5A8-_NR2X*A+I5&A+[@W*6:K/VG7F/4.&[/C^Z0[V9+
M7;=C:-YXIT'5DMH2H"H24]/"I4:]2?*H_7K)W`((5M;Y%)JXI*"$FAK05%>H
M-3U^WTZH)LO2I`1$]2BO+P_Q:8!+349I;0'.`.2<_CV^/0$QGFUGYBSSVGVC
M4@ALK#Z#6M=J%A0KTU*B<31W$%=<`R0:>%"NM'VQY);\QX]Q_*'5[_S"V6R=
M-^7=)0I]R$TA[JH$)7O0JO04/2HUZ!:T-JQP.)"UM@08M9(U%2YQ^6I-W[+Z
MTN0G`7(LI"^TJ0$$)((2H(<#50%I^\E0^VNE-C:QVH5JIR=."0N[L*(2ZZ7M
MR=G[1\C1-*`CJ#3IIQ=3_J1+F6I:5PW^Z&R'@65*:>0VE02M)V@**D>))K4>
M.G6,:14E<Q6Y:;>U*L;#Z"VTJG;>J0DI01M7N0LT3ZP!4=.NG'O+<J%`!*5>
M-M)C1I-O;'I?C.+:74]L*3N*>G4_>Z_`_P`NDLD)=0T27L#A0JAKZ]=YDQ?:
MC:8P=(,WDW$V9&W:I:HL*!>I@2E"P4*0AYA*J*(/2O3IK7=+LEGN9C:AOQ,5
MNX@N%0">7H*R'5[FQ[:R,@%KI0"#QX]BYB[AS'F>2<781@-_-L<Q_%PPNUOL
M1&XTIL.E:RPIUI2=[14ZOH6R0`!NZ#3NP=-V-M?LOF1R1;C4N(<6ECR2:N%`
M".ZO!8:^W*YN;)L4FG2S`4X#EFD)\W'92J2XZ@,)<.]PJ2$IW^BI`%"2I8%!
MUKKV6WN+6UVY]W=O$<$;02[@WM/8LS*)'O9#"`9'D@)15);=05%-.Q5"ZI"N
MFU5002?$:\?ZIW+;[W>1<[=/%-$;-K2YN%*R.PQ.:TUG;W45N&S#)P!H"D-*
M=?\`S[($2)KSI_+[@M`<<7L2M&PH4A.[8CU=4T`UYCM=[,VZG9KH0QY::X@@
MD"E>)S5[-&W0TZ0XNH#Q3'<<W.Z2,ZAPYESN;S.Q]Q<9ZX2UQUAN.I3=6G)'
M:6*FO4==+Z"WG=[[JJVAOKF66-KW8..!&(H>Q-;K;00[>#$P-<XXD#)2<9FQ
MDK4R7VP\\AI(84XWW5)*W%TV!PJK1%0/AK>1W<=ON)U$8]O:J;RO,8YQK@*A
M")$:D+R>12KD?\H:0I0'I^;ARSM-5(^\(Y\/AK%]4N^)ZBN;J+W(;$N':ZF7
M:,<LU;;<W_@6#\<HKZ#4441/<T\5OVB`RI%9-V;6ZXVK<$BVV01R"L+71Q#L
MPBG7KIN>0%CHZC1^4*\::15#XHQ(]SJD!SOK4OO8UBM\NG"G)LNW7;$K:W;'
M<BO,T91C$>_N9!'AVV(TNQQGW'67H[4E$)7<:!6VX:%2/2-?J!_*B8MK^3>V
MRSVTLYNMVN`TQN#1%XPWS7@@Z@,L*'D5^>_\R<-ENOS'=\3>26YBV^`,:)-&
MHT)RJ*\E8M[`(U\N>%9>J+9Q9V'KJB<F7:IJDKGIE2YJI:Q97F1"@QHQ0S'9
M=0I:G4,[:`(!/T#UY<645W;O<`7^614UJ3A3ZUX#<LE&Y2F6Z$[2Q@IAX-`H
M.ZH.(*F==;9>8\I"'79SJ'66E.=^WI*$N..K:5^*TAH[T"AH5CS\M9JQW"%Q
M+@*%N0K^Q7#Y>G[M4AKY8IS+KCK5RC*90"3',-25*`0H$I?#RBA170BH(`J-
M:"#<)',#F!M*]O[DY"Z`T8XG43Z%]Q><6K5&2\@MO+=DK6V%)40I4QT+`4FJ
M/24>/6ND.;-,XO8!VIN4AKRT>Z$[5KFI64[#Z:BH2`D!02:?S>.J.:`!IYJ`
MZ1S\",$[%FF`AK:H$`BOCO\`@*C=YZR%]``"#7%-9!.5;W@O:22:44?,4/A2
MI/AK*70TN(&=$+G6^K/=_G/<:Q$4=R;5QUA\1)Z%23*N5WG+'2A35+P-/MTW
M\TI66'\LF\//O7$K6'N,S2:?UO"/17!?1W\MUNV?JRPU:J-ED=A_8=V9*ME#
M:W\:SWLC<MN#;G&1]Y6ZVQ7;KL%"2?4G^?IKXW^64;7=,[K*VN%Q&X=[37^E
M?;/4-!?VL-?"8S7]N"L<X&?9RG&O;=)2ZEQ6">\7%XD=U11M38^2[=8;ZD!X
MGTLIN>%K6.NVKBC\=9'YBVSK;KBYF)'DWFUQ2T!PUG4">\##L6FZ;E=)L\`D
MI6*\<&]@=2H[L*A7(>Y;,,4Y$]F'U'\_PZ_XW>K/)Y4XZPE,BQQVHT]V1BCW
M$^.3WLA"%E5SF/WB++:ASBD)D6UAE**AO7G_`,OXV;AU9;"X:'-E+@1P\+0T
M4]`Q6\ZEF,/3][<14+VZ:<<Z#@N8"5$;"U*34`4J-WEM'A4'7TO/T=M=Q3R6
M&.F="!7U@KQ2WW"<$UTGOK]JEA]/*-L]_'LO6%=![GN&#3[/XYM'^#7G75W1
MDVV[1>7D,K7L;"YU.-*\^Q6NW[H9KZ*``5+Z'/V+]0#7SR,17BM\AKJ$-"$-
M"$-"$-"$-"$-"$-"$-"$-"$-"%1_]:R4S'PW@1#^WMO9G=D5*@@E1N&%T1N(
M](4`>OQI\=93J6-KY+8DXZG#Z%[-\GQ6XW#D;<`]QU)@L)4BWXO"N=L*>^XA
MAYRA-2EYM"PGRZD>9\#INWD="06TJU46YL\R^DU5P>0.X)Z)6:7!NP1Y*I2T
M%+2PO>X%#<A)VA`KT'7KX5U9/D+QC19J:W;!,0VN7%-YBLBZY*BYW%%P4EI+
MB@VI5-R:*K4^(^^=-EYA'F#WAS2C`R2/Q5Q49LW?5=.5K';')KS@BE+3J5'T
M&GB:>(`)TY;%KX7%P&HD_0I&3*<@I=8HE^W2VFK.XIH!HU4V=@*P-NXE`!`.
MFHOR:Z>*BO<^1A81@4QON%CRKPW!CW62MR2_<&DI.\U0A&U+6T'J0`:=>NGZ
M-G?JDQ(;DG(H1"P-:2,:^E&EMNUJL>)?D[MC,E]M,<,S'6=R"=M`%O*5M&T]
M:?'55*^$APH1)V9*QC;*Z07!(/[L%"CF')I+6.9_'C6@);7:I+[CJ"HH4L3;
M6EH=I`*5J'S1-?$!-!X](&_4=MTL;LO)%.9-3@M!L,3!=>;J(?J'<,L4R_!U
MUY4P/BZ-F$*PW5Z%;+;<8EC<>FF,T_99-R_J;C0AM+FHCMSW=B4NBJ4E?@*'
M6:VV:>*VBN!$6OTZ<<00.[OQ5_N%C;S[DYLER96UY@4]G%2%P3F?-<PY)BHN
MUJ?AP(EBND1VANDA!DQ4Q&5I6].82VE2'$K35*CNI6I.K-NX.O)]#VT>`>!&
M2B7=A;00>6TU;Y@S(/-'\QG/L@XGS6^6F%*;;C/75SYR2^Z'E1V%+2KY>J#5
MLH%`"::OMJ;YMRR-P\(<%1[S+!;L?'$/S=&?+!)'#^&^8LO]OL&3C%I:WW*)
M+>3+DR'-SC;A45*2E#"SN(.K7<H-.\^?+J^'8:BG.F662IK.]B9M`M\!<2`@
M]U?I48.-.7\\X;N,:RKC19DBP6C++;(@W!,U;#5UD3+9:774=IU*2II40E`"
M04E:JTUAMQW'SK^6,'"G%;VWV^!UK&QNH`Q-R[#7DI!X?F-VNN=8M.;C8Z]C
MURR[,EVTMA\72W6B'CMWD3&Y:GTLQ9+]QO#32DJ:#W;930E"R4BJC,<!;.:F
MKG`_4ITD3IXI(V^\TMIV\TM;?[DK-B$?/K=$N0F7&%=8MM@]BWY)V$W!MEN1
M%;4RM;*4I10*WH26J=.H/2QM[^!T4K&G%U#GQ`P59=;9,1'(_-M1AR)Q4'^;
M\IOU[X9OS;EH6I[\Z_.)KP8NC,<O71VV!]U:4K"EI><NRDMD+*D=2:@'4_9W
MN-\"_#`]GTIK?&QN<0'5(``Q&."7TC)[[98MW3AT>XVVYVR*]%B?)3!<IT9[
M^&KA.<")+,)QH-*D,I;V["3M%:ZJ:-;`7AWC$I%:XD43Y<YTX:6^$Q!U.`-:
M?0F!$C/>6[7F/'^9XX[=G,^C8W?<5N:[!/O&3V;,<2QI4IG(+$[&:CN1%W:!
M:I4>XK+:VG&-XVHH5:<L/*DOO*G)T>74$''41A4G"E<U3[[YS8(Y[?WP^A;P
MTC.HSK3+MX)J,=X?LO.V(R+7C'$4O&K#DKV/Q46!J5,D.P^2\3QV+B&=7G'7
M[PRB=">R.Y-,W21%#BXT<S5M@+:0D':]&]9R]%[\V\L0Z2TF(CN`#E0TK3D!
MZ>U9O=.FW=1;7+%.W3/'1['9&A%0,?;3%4U<Y>R#D^UY??+/%NN+P)%ON4V$
M]&R&?=+#<XSD5UQ"&Y41RS/-,2D'[X2XI"5>!(H=?5\N\6>[1QWFWDF-S`37
M&A/<O"X[2>S<^&X%)`\@X&F"?+$>0N>+#&PU_E'*;!,7BJH3!L>*1ER'KZY9
MT!FWS;[D3;,**(9++3JV8Y=6_3:O956K*UW-YA8QF)U<:Y*++;1L&H$U)3L9
M;[Q\X?C*CQ)$>(^X@]MUIAE3P<H25T6UM;-104`UH8R7@5)H1EP5<Z)K9"X5
MS4/N0^2\^Y+MMZM^3YI?WH\^(\P]&7-6U!4TZE:9$(=JID/.HJE9Z(:23XJ\
M'@S4-`XX>M=+BT:AF$F>+!GG):EX!F5ZND^Q6VXV>=9T_-*DBSV6WP5VY-IB
MS7GG)BHUQVM]S>I2EI0=Q/0:IS#-;W/D%Q+3QXIV237;":@$G(*QA&/1I>28
M!CT="!:\>MKUQDLMH"$%*"VQ&0I`Z;J5Z#I0:O+:1S9FT_I'(JDN071T!().
M8]:0_/\`Q7[B,DY/A?W%<PXSA-KR'$W+FSC&5P;HXRO(,?*6;NN'<K=#GMPF
M)D63&<VK2K:X5D#;X>7]:?+%VZ[P_<MM;$6R,Q8!1Q?RKE3BMOL_5IM-O$=V
M]Y?JTBF=!CCVJ//M>R7EO,>2.5>%O<O<#=)[-E@IQ]<=2'K%,DQI<DW%RWWJ
M"E,22ZMHLJ"%*0[1*O0"E0%-\MK)G3G4USM>XP^5N?D@L<!QJ:T)!%",O3BI
MW53KR]VJ+<;25WZ:78"M2>8=3[`L_)_MM9MURE-V*4XHH"G#%=4X\6T[Z&A4
M`LA((I4]->WWGQ4D6MIU$95_=18>*2*.OF5]"U?;QPI>+7RG'OUW<`MEAMLZ
M6TTE3S:'I\A'RD3N-E9;6EIMUQ8J#12?(C5%#)+/,(Y10`UP!S'K4Z:7RX=3
M:4.&/)2KRA\R[BF(A0<[[H:"$5!!4H)!)Z$$*)KK7L_+A%,@%GI/?-$U$/@7
M)<_S.3,N32@[.=;A0(J#40;9%)1&:[@.Q*2A*G'">@*B3IK<KR*VMM&9<*_4
MI%NUU,CFIFXW9(^'6R!BEJ(7'LL=4-QUIPH0XZVI3KZDD="I3RU$^?QU668U
M1ZWC$A%W*\R>6,FE$]YO*8LA;;R.R7E`(475'<%[J*)_9(/CY:EF@II`J2HA
M+C[U:+UQ_A5ZS*^N1;>ZB%%2E4BY7N:^H-1(BU$-)'BY(DO4.QM/4T))`ZZ+
MJ:*W>V-E3(3Z%(MXVO)<?NBH4_,6PZU6**(V/14*<D-):F7I:4.3)B@FGXBP
M"6F5=2E""!3QZ]=1V1M<2XYDKLLCFF@R*<NV8LI+2%SG6RI`JE#A"5FGJ"J`
MDD"FI."B8HT?M]D82=[K6\4%/(5^]N4?#^33DL;6PZP<</I"4/==_9*5G=Q_
M_@?^RK;XI_<_'[GA_/JG_P#]A5S_`/0URZVJ6&FDI"U)*5O]2\4;2I]9-$?/
MQJ>-:T%?Y]2>M_\`S1=?VU$VC_PZ#_=_6MJ[1;=>8["9NV0Y"=^:BN%_:]'?
M"=KG:<_.%J#<AJJ'444AQLE*DG6.?;FXF8][O$TC3V#DK9SZL#>T?2COB<I1
M9;N0`GM9/(*0!0)"XD0F@\`/LUY/U.W1N#9<QKDP[BMOL_\`R[NX_0G+GDI6
M$I5Z2M2A0>!("@:GKY:Q=_<`.;AP*M+<^$HOD)[R000%GT`$5`!!)-3X5/Z]
M4,V7I4@))RDE!<!K7T@=/&A\?UZCKJ-<6F?*75ILKVMS$JBJ"NH*U4+(%:BJ
MG$T_7I^"7RG'"NH43L<6KQ`\5T(?3OYGM1XZG85<I\EBYV*3T0I&]DP7G#V"
M%J.W<VJOIZ``ZUNR3>8#!2A%,?6K>U=H#NVBM6Q[-(;L=F`I_P";:W)07&2@
MK:?/1FX,!1)5M4HH<I4K;6*^`U>]BO8I?,.D#@CZU9Z;5DUO2M]TMO/(AHH"
ME;:G5J0"VH%-0A:3NKU370GP:&JFV[GUVM]I94V.^82&W7&2>C\=12AQ!)`"
M0`=PKXU.DD)UIJ*I2XA<(V4VJ:V%.LH=;7^"D;E=^A=V;C6JPL`5H!I+O,_V
M;M*6$?0YKF/2+9<'7'G(?S$:-("6G''FF9"@R26DCU(0LC=M!Z5)UQS==*G(
MU3;_`'5SV?ZR)<<IMOMIP6U83"7<LAOO/.(X]#M+,=4M<U,ZQYDN3';:03M`
MC-A:G.FQL%50$DZF3;O=[-$VXM'Z#)4.[64II])XK*;]:17D8AE%7:PYIY8>
MU<K3]VDV.?<,7N]7[I8IHC/*8"51T)=1")#:Z(:1\M**T4]1JDU5Y:LMHZUM
M[;:H7[H7.O@\G0/PG`8]]3DL'-M;B\MA]T8>E*NT7SNKMC0^7[CLMV.AA+S2
MI*4MMN.]U09HHBB30J'P%=2>H^OX;OIVXV>.(L;<1Z2[4","#EIQRYIJTV2:
M.Z9</>`(S6E,Z]M>Q(7D[&>3\BNUOG8;E[N/V&-:Y[=]9C7!R-/<E(6N3&>;
M;<CN1DMH2UL6O<%[5TI37DD,]6.;%X23JKV<EJ'.J2>96SBET6[)Q=R[R'+C
M>8E@-LGS7G5N+E3#*@I<>=75MN0ZM+`45%-*^%-1VSGS//?B0?HP78_X@[TU
M/N0Y91Q%R1;LBBVAN[OR;:U"C0$/(@1G`F/N=<>>9:<=;#;;VY.Q&[?2II74
MSIZZDL=RCO(O?C)/>#P1N,9N(/AP:$XU_<HK->YF!(Y":SY^Q3K8/S"WW"3:
M8L@3H[WR5M_+WF427"VXT'U5=KVZ!51YUUI'7H=?B]TT`X5^NBA,M2R#R=7I
MHK-^,,MC<B8AF]RM[<VWMVY[`_FP]M4\[)=A279\=+J4KHVPJ[MLN*`J'4*2
M/CKK[D;ANTD43M$DD->=,*D<.25';FVM@XG525@Y9FB8#W406K;R1^1MI[34
M03+JTV$!`2BY)@I!`(%251UU/B=1X98GM8UK*,\IKB*\Q4^M-2-I*\<2X^U3
MO]FV+YF[[9LAFXE<I<63?7[XFV0H%RML9B>I%WN4&ZJN[=P25D-0T%#`1ZE[
MC0@TK^NW\KH%M\G-A:V%IA?<7$A<0?#KEP;VTICP7Y>?S'[OTK)\UKK];CG-
MQ9QPLCI&7!SPW,'A7N*G3[,<PQ+B?BF[7+*^5,=L4W(;TTPU:LKO$=-NLUNB
M?/QX42T-IEK,=<]X*>?WA"0H)&WS/J77%A<[ANL;OAIGVD;:![.+NW#`47E<
M4EK>W<[;>,.=J#G:6.!)(S-6CN4AIW-V-71*A:N6>)[MO)*6V<DLP*FZ*]02
M)[2U.`T^`(\M55MMH8`YL4S#_6!]IHI8LA7Q0R4[&D^Q("X9Y.GF2TF?B[X6
ME2&'[7.:G!5=P2LB/-4$*-`:>H&NKB&V>P#4<05/@L&:-8BET@\6$9),0+CD
MD(@)N27V=RBED1VVFVU.+[AV*;8<<`*JJ(.I[(R_')+G9:.C\M['M)_JIR;)
ME5^!35+;H10*KL2*@GQ)::*J_J/Q&NR6,$C:$%5);IXX)Z+)EUT;2VMV`A0/
MB0IJH(I7;ME-DUUE+_9X7R$-)!'I4=T!>XNJ,4[ELS66AM.ZW*5Z-U`ET'K3
MS;#M3X>!Z:Q=WLD8E(#Z'N_>D?#G*JYU/J4WEV[>YG,Y+S2FDQX'']O0TYW`
MX$IQZ-,VH"P@]?F"02!6M=8/^8QXLOY=6V;7@:MT8=7"NH\/2OJ3^6:`GJ&%
ME<H)SZJ8*)F##N6R\NK0BDB]*:+9%4EIB!":V]2:I42JM=?,ORD@B_PC<8>&
M6_D#NT:17UFA7U=U,:;HT\F#ZD^V)7&Y\><%VRU-R>U)NG-+M^QR0E='TX[@
M.+RX=MDK<%%-OQ)^6F,/_I<*'4Z\IZ^;([JF^<[2^/;]L;'6M#61U0*8TH#Z
M<UKME?7:(6_WMQJ[J`BG;DG#X*S')O[E?>%A4.ZR48W?N/,;RJ_6U2>ZQ<;A
MB/-7&C5MDU*OP)$5-]>HX`2M"U)/0],=\H33JFUGX"4MI_;#OHIZ5<;W<2#9
MKF)AHUT;1ZB?I47WUA06?#<.@/V`:^P+C(+RE2P^GL0??O[+T;=W_M3G#"CU
MIT&<VG_&-8SK?_REN'_R=RL]F_\`%(/[:_3YU\<KU,(:%U#0A#0A#0A#0A#0
MA#0A#0A#0A#0A#0A4'_7.M<RYX_[<^RZZW&@Y!F<YY#:DI#DIJ=QW\B'=Q]3
M(45E0'7IY:RG4D>J:U=7)Y^I>R_*2Y%LW<R03KA8W/F7*/\`QBW=).)QX^V2
MK>U'15I(<%&F-GHIOV``5Z^>H[0]U=`J%7[SH;N1>]U*5]*=&Z8G=',:;9BL
MS%;DU=+X7N7L!.T4%`4U\A4ZL0V0:7/;0#%9VZG8Y_F.\+<D9\589E;5KD1X
MEN6I+SZBZ9'=24)-*D`TI4>'0^.I$D,LX+FC!RAONH&MU%R2[W`E^G\P0YAM
M*TH7U7)4E7;!VU4G[H)ZFM=.06#Q'XS0UY)GX^WX9J<=D]OLR+'#H92'%HHL
MT77J`:@I'3KIWX$G[WL46YOY,/+!:D-R%[:+=<8K=RO:777X*R^R6UK2`4D$
M>FH4HC:/$ZDFWC$9T8.IFFH;V5[PQ^(*CWR3CT''^/94:.[20]<66DM.M+6^
M6RL)4E+B4D)/7I7IK,7$?EBE:ZC]:T-DVLP;Q:?J4<G.9&_;_'5<48\+C:)S
MT%-UE/L79T0UR^\VTZI5MF,J]':)V[5U`W4HDD2H]SL8@V*\M_-C&>%=(X&M
M.)X+DFS7VZN<+&X^'>"<:Y^BH3R<.^YJW<B9+F\V]9$_"LS_`/"5MQ/&HC;K
MMIC7R.B8U>HUCB+BRUO,RXTE,JYR)SZPVXVAEMM-5*U86=[LMZR2,Q-B+0/+
MIVUKPQX*'=[#O-E%%)Y\DCFDZG"HY4XGM4S)^(VC)&F6'+%;H[;D3LN+8@J;
M#J7`H%P.%]1W$J5Y5Z^/AIM]O$]NDM93F!0^M5D!DMY_B!+,Y]34.=5N/9]"
MRV_V^V(X9<,;8BG\MF1Y,1]M]YQ:DL20K>$[W#L02?`4^S4BVM(K8&>/W^'8
M4Y=;A-<7)K@TT%/0%ZP[`(/&6`1\=MD>-\C9H\MB$V4..]MJBP-QJL=$FHJ2
M=29C)-9N>\U(-/8F6>*81\U0[E?&/\29/F-]MSMGD"Z7K+)41IIYI^2VJWWQ
MZ?<&W830+\,N-.)6GN)'<V]*TUXEN['MO-4@HY^#1S*]SVZ9K;*(,\361`D\
MA5.;B^+0D0H-CCV>V#)K5^8S(MS$=:;BVJ5#VOVV,ZVA0;E.Q@&U*2VDN*<H
MHT4=(\B1S/+TN#Z<1AZTHW4<9\^K2ROXA7'L2)R#BE%GRT?-QHR#=9EKG3$Q
M6$+6M4J.6HZEH+@(/80D]4U)4!34-MHZW&AQQ!KES*F?'-NQYC!0$4SY"BB!
MPQR=RM<^%<J@W+/\I<ML7W/YEB$"'+O3SO:QJ%?;?;H=G"'2MV/:XZ0M#;%:
M(2K:`!0:T>ZRR,F:&&@+!]"J-AB@>298V/.HT)%:8\%.Z?A#C]YB0L65%L\Y
MF?<7)<FU3%V^XRU66TO]]V8Z5[78Q;=2`=RJ54/AJL@CUAMN#0U)K^Y<EG9`
M]]R_+`4]*6>#8ZQB-P<RUKYJ18)%DFNW65'C-7%BS)LT:1+NUWD2&@]+2RS#
M2X7E!"E?A**O34'C&RLI(&DMR]>":,EHYDH!H_6,?2CNTXO\OE%TO5GM*[M=
M&;O8561MIGY5Y:;D[&4X_$?B-M.L1W&G5!1"$HJ"5=`*3K.PD@E\UV+B?=I[
M*IB^O(9XO(::.HH`_41X;D9JR><+'CRV1*0[;LAG6]#LB%<W+'#AA^]-/AJA
M-N2ZVU-!/>2E;3BO3N5KW'H7JH0WHVB9WY#P-%31I<,"VO`KRSJO8#\";V$_
M\0VOF1TJZAQ#AS%.STJB6ZQX[#R_F76P#4E"U(*76U*\`34$A0Z'7T#')HQ(
MX+R6X]T=Z87((^Z\OMP/3!;6G8^ZE+>^H"G=J5;7`V0>C@H?AK1[?-YL8`%*
M!0)?<*+OP;M+BV`I9[EPD-PH7<*6/FY`34,JD%)5VTA.Y9_H_JU8%^DJ*I.<
M3\>P\/0ZZVONS9#Q<F3G$[$./``(3'%5]N*R$[&TU/I`KU)U&#*7'G\.2ZGU
MM4MEG*+C=9+R6FV++'86M2TI0"VZXX2@@B@5N-?'QKJ7:'S'>;E0Y*INSI?Y
M?I3MV&<W?G+9.0C>_'M=_DPY*1ZV$RH*(:U(*JT#X<`(!H:?HU;L=KN`[G]B
MCQ?Q`H7VV9-7Q8)*9J+;-.5Y9?8-R)*'(\J)DTUMI]#^X]F3+<BT2HGH@)3X
M$@TMY!#(YSRQGG#[]/%08@5Y=G:K>WF<PZ"YYC)]VO@J>-.?:G9MN1IS(+DN
MH8&46RU6YW((#2047>TSXI>M666E-"IV-*H4R6DU[;R%I/5/659RRR6[?,-:
M*'<'R)W5QJC_`!=IV+9Y]R>C-MO2Y+D=OME"RXPQZ6EI4@"I<-37RTF)M)2>
M]=N)0^`"E,0ON)XA(S+*&H$9:H]2Z^N0([DDLK15+24MM4W%U9V@]/,^`IJ;
M<S0P6?C<*D>K%,6T3I7$M]X<.:F);,)M>"V5UD27)EU,1U4^<YM+C#.Q1^5:
MZK2V5K^\4DD`=-9X@W3]4@I#D!S_`*W[NQ74+A"S2#J/'L/),;<OD[CZ*K0V
MEU;W=9<6VMQ2QZRHI4"O<K5[&WRXPPXT55*_1(9/Q)&7B[QDQ`W(AA^Y,)4Q
M#EH6X'*5)90\D*4E91]HTH8U[`F7R^8W12A)1-"Y)3@\4VUN41,?69UU65$]
MZ6XG:II2JU;;CMI"$I'W>OQU4RR.>2Z,4?P]"L&6Q:P"OL2AC^[V984@,S26
MTD5:)67:@#H#N5NJ1TT0&8M/G^]5*\@\U,?VZ>X2Q<R&9:ILE<6[QV0XA*EJ
M22T/%::T`^T$4ZZD12C6&TS42[CT-;C6I3N9/`:B]YS\YVI`)4DN!7>'[-:K
MZ)/P/0_'4F<^7$Y^>D5]1"B,;JU-_JE:?YRQ_P"/L_\`8_V/%7WOZ?W]4GQ0
M_"?_`!W7GPY*^\@\_P#V/DN>B$U&+.]V5,2LN/@H9WAI([RZ;=I!_3JRZX8'
M]4W3)"YI#JTX^Q5^SL<=OB`%-+:&O.JW'"VVVL-+GNU0?&0XBE!XE/<]0Z^!
M&LNWS&X0@EV0K]*LJ8T-,TH>*4MIM%]:2I:C^?*>*7*;@5QT)H*="C\+].O+
M>LK1]O=P,.&ICW8^LK:;)-&^"0-QTC'TC!.9(]32#2I'2M.OGU/GYZ\XO8W/
M<W3P!5Q;Y'O12ISMD@DD#J?$J2KQ"3X`=/#5/+[M.U20M&?&0^A*V^BJ56-U
M#M2.A2.H\^HU'74G$J4TX%H-%LN!2#UZ+;(4D@C[1KH(!!.2<:UY;5IP5@_M
M-Y/.%<C8Y=7IB8=HOO:C7%:D)6TE1`;474+])0EZH-?AJ[L;E]I*TC)^/J_I
M4BRDTR:GDE@S72'@MTL=[<@W:*(3RUALN/PVTI8>3]U06RD[5I<30[2`H$5!
M.MJT%T0E!%"KYL@<?!451UD<10NS+L:BQ'EF0JB@@MH4I"B"E1WT(&X'XZ`"
M309IT%[C0$U[U-21+'Y354D%J9!2VI;B4;D]V,-BD+"`:I6JH/EIF:*75ARY
MJV;(S2.=$8\(96U\RJ.I39<>0JE7`O>I"R"7$@%524GKX#ST]&QQC#?O#-<,
MC4]W(<E%OM;RXBFT_,.PY3`^"2\E:V@JO3UI5Y]=+B'CH5R3W51W]?*R9$_[
M>\`Y1Q?(/R@8#R[@E[DJCO(;NKQRW"L]Q6,Y;T@.;4LRY"DN&@';*J'<-7&T
M;?9[KN\-G>T-M''+(0<G&@#&^L$TX9K*=5":/:_.A_B:Q2F!7&QEZ7;;'E7R
M*O\`!?=;3/[@6XXB29H<,I;Q)6I$BOJW>"_.AU0]5;`RV!W*S`;J^Z'5`H2,
M!RIR62VV],_Y,@<)LZD8>OFD-8L@2JZ17Y<XLP3.0'W3+4T&$;PZ%+6VI+K0
M+E//:L=#45&O/)'U%)"2/6K3-2\M-^@S80C-NLOPW&G9/=2IM[NJD-I4Y3MK
M+00X4#Q25=*5H::5)=ZX1&P!M*8@4."ZF(CMS/XNMR^^&XR)[R%1U,>IU"Y4
M,H<#H6E+=$)-1M5NW>(IIB-KB0?NKK2`X$\%"/WI7IZ7S/=;;5'8AV;&%M!+
M:DNH<7:@IQ*E;B-JDN`]`*]-2]N_Y9KOO5./I2I7AYJ.2BBA(>VH30=U26Q4
M=!O5LZCX5.K6*323K)HFU=_[0(Y;X[SJ&KPF1N5GJT%''\.S_`3'4"IMQ7=3
M"N:PF@-17RU(V2C^H13WB`!Z05R]!;M,Y&#@T.'90@UKS1;[M\.ON1\C#)[(
MNP!EC"+,_)C7J\,6I^:^6X`^5M;+L=QNX2G%S=U`I*@E"E*I35B(J0VCF@#4
MQS?\UQ&/8%%NOS)Y2S(8^RJC(GE#E?C&UQFFV<D@6LR5LM,8Q=(-YAM*6%ON
MJ=@VJ:\Y#96HE6]QE"%+/B2=;+:NNNNNFX&6>R;UN5G:,J61Q3N\EO.D1.D$
M_P!4!8Z^Z.Z5WZ<W&\[;M]Q,2"9)80^2HR\5*FG::\DNHG).6O;77T0)R9"2
MH]^)9WG5U"%E*^['2X#ZNM2*^5=;:P_F&^=&WM:RWZ@O:--:O#)*]E'`T[U4
MW'RKZ`N927;7;M9V/E!)[:.1LO,S)VIE8_;R[UW[8BF*'QW;X3R4]!XZTEO_
M`#6_.R&K9=R9<,<:D2PQEOJ:`[NH1CG@H$GR:^7KJNBM)8Y.;974'<":T[TZ
M.+63@"_VBWOY-RU<N/LIDN2#,LPP?*KQ:HE)*VHBF;W9[R^_([T<!U=(E4;B
MD`TZW5E_-C\TV@NO&;9<#A^6]E/:FA\F.CC@Q]U&WE5KV]YU#4>T5[DI?X#M
M$"8ZUC7N%B1XPDN-09,S*LOPIV8RD@-S6HF1XU!#,9ZM4`O*('16VAUI['^<
M#JF*GQVSVDCAF8Y7M![VNK[%377R)Z=?)JAG);VQ-6O9.1<^L\IZ-:?<#R/%
M^6>=C[Q<WKG"<++I:#L99N2&Y$5PBJ%@`+2H*`ZZUEG_`#EPEH_4-@<UU:'R
M[CAS\0(]6*RM]_+YLTSCY$EJ!_NGCZ')XK)[@_<%;2A4#W&/OI;*1V[_`(W`
MFA/AM"P]&GFE!U\=:FQ_FV^7ER_3N&U7\=>3VN'I+:$^M9.Z_EP?J!MW6A`X
M@O:3Z"2/6G-9]V_N<:<:?/*_&UT1'[*=LS%XT)#A945-J/9L;8*MRR#U`(-#
M76ELOYCOD7?UBNAN%L0"2#&YWIU:^S+APS68NOY;]]:YPBACD!&!;-[`*4J%
M$[G6ZYER1DDOD++9%AN-UO-SMZ[NK&W4_*MF'!:@L/HMJDI5&C):92"15`4:
M4'@/)?YCOF]\M^LOEU8].=#W@GD&Y1R2,<'!X8&D8AW$DUIQI4Y+U/Y-?+C?
M^B-[EDW:V\FW?:NCC)+2=9<TFE*Z<`:GT)*8DCL6J<VVG>7KS=%-I2`2IP/I
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MO4K_`*>JB??U[+^M"/<]PPD4KU'\<VGQUA>MWM=TKN`'_3O5MM$;AN4#CD7C
MZ%^H!KX[7J`0T+J&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"YP_]8-Y;Q+CB%[1
MK+DEP<M\G+\FY1>MI;94XEZ-C0XTDW9+ZP:(90BXLFA^^JE/#5#O=G-<^2^*
MFECC6IIG3)>H?+6]@M3N$<Q(=)`-.%?=U$]W8GR]G]IQ[..+\<ND%?S4:[0D
M2HTE3:FW%-%0;"@E75.XH/Q'34FQM`7L9)@[LX]ZH][O7>9)(SQ5/'-3?F<5
MPD6D-%`V[:(*E]13Q4.@"33P--71LF-]W$\CDL<Z21_O.)'>4;XEBUIM-ID,
M([27Q^V1NH:].IZ4H#J5'&&,#:#!)X8I(9'!,"6W-BT=D`]"@"H-0#0@`4_F
M.HT^#\.2Y3'#-*FSWB^+:05A]/I)'6@(H/T_#2K<`UJ$M[7MIK1+F\Z[+MB@
MI*E)4%!8*R!M)!430'J0.FF;M[/*TLP.KN3D'OU[$RERP?',MB-Q9T(R5[VW
M2E;3J4)>1ZP04J2:[C^C[-5QL8IV5=[Q4ME[<13:6']Z@3[K\85A]F3(QU%N
MC3\?O%FR:(S=(WS=NER+3,0ZF-+BN]QJ9"6DJ[C2^CB*CSU"AEALKET)#3;R
M,TOJ`:9T(![5H=LEEN.?FZLQR[TQGM#L]JRVZVZYV\*4$WB7DDAIN/LCMW&\
MLW9R>TD[ULH@_P!:26$CJ&T`5)IK-VUI!'NXC)=@>&7H6FW:[DBV_P`IM3(X
M&M>SM5U%IC/2X$#8^VEMMD(W!U*7P$=-J@#NK^G6VD,=-+<P>2\WQ)J<TX$5
M$R%%&X*=WM[2A2E=?30*-5453KI8_P"7]"BG_F/2F#RO.)EMM5TA[$(V*F)(
M.Q84G8JI5N0OS/3X:CO>/AW1UH2:YJ4RK9VOH2VG#O57=ER/C?"9V27C(L4=
MF)5<'KHB\"'9F5;Y#C*JMOOW:,5N(=^Z-Q)!\!10'G,SK)\CA>,+WAY+3R!Y
M'ZEZS&R=]G$;9_EC0&N%,Z<".2<"!SG'&23I%UQR^IAO6E+2G&1CRTKML![:
MQ\VL76.&5,F*VVV@*426TTK456-P:WPEKO)`H,*GL[^]1)-O#`'AP\RHK4T&
M.:3-KY?XTE7O(YN5XG-7O"7(L5RW6@25VRV$+@1P%WAD.24!LE`!4JI%/$:C
MPRVKB[XAOO88MQ'KR4NX@N=#8[=P;3DZ@Q[DR/$OL=EP?;C!N4]VY1LANO*=
M^]Q-YQZ.WWH4.\WN^NY`SAQG+FOMRGX-IV-.K+E#)*MI2D4U/DVQES!J!/83
M]JKMMOGV=^^,NPT$9_>KGZN*?*T\K\12\L>?@XJLQ'H"T0EQ[;:`M3A5(:FJ
M>)NK:D59<2BJUG=O^W52V:QBG,D8=2E/=4B2TO)+<1R2M>[56AP]O%;EOSG'
MLNCN8W@]EN^.P;Z]+I?8<6VVYF,QV!'=#[8FR97<?*2V'6T+\?$$UU*U178%
MO`UT;W4H[@/1V^Q0I8YK+\R9S9&4J6#CZ>8]J,;9-Q*/?6\4N;4BX2&+A&EW
M;Y-<Y;UTCLMI=$*3):>7.DS),I:N\D.);VIVI%2I09M&Q0[@1=222"-PU9@8
M9@8^U$PNKC;Q/;0:-0-#Q]>:7_(LS#AC,Y_%+=<X]Q5<W#.PN[[H^.O-W2UN
M09[4K'N\6OEI3$9D(DQAN-76G@4E!3975S'$[XG;'5#35K<M)/+F>U1[-MQ(
M?+O6`.<*%QQ-.6K.G8N8WW:>W*\<07J7E$7&Y$?CW(+D^B)\GNF0\3NK[JW!
MCDI\[S'8(W&$5J(<;24UW)(U]%_+WK)G4=FRPW!PCWJ-M'-=A7D0>*\NZQZ8
MCVBZ%S8UEL9!@1B`<SW%5;\HPWK3!?NEN;4M56&]KBDI0RT[*;9>?*FZJ6II
MM94!T!V^-->K6UP8Z!E=0]2\[>6N<:#PDI;8SBEGQ>-+<FH7=+E/2AB1)F44
MKL[P0B+50[&P@*24T*5)"AU%=7=K*Z=M'>^/H426C7=E$Y%GN\VV!FWW!:9+
M;K;CEMGJVM(EQJ?NWD"@1/CIH'$THKHM-0>DD@MS44DR_P`,Y>A(5;UVSW/G
M,?CW,6RP6IJ.Y>7DJVJD*<4LLQ`XH@%':;433[I(\M2[=S(H])'BJHQ`)\6)
M4Z\*?M$*,F0S)2BW1XC5AMRJT2ZA"DJG+36A)+A2D'X@ZZ)*2:@32J6V$GQ-
M`428,`8Y9T<?S@W(,.5DL9X.I[B7VIEYG2VW%5-:J:E)-?'KI<C-3?.'\/(_
MT)@3-#P,:U6HJWWJTX]Q=FN(M/KR3`\HDXE<XD9I3R;WA,NY(:N]EET-1\K%
M?1+C+57MNM#R43JN9'+\.YT9(D9)J`K0:>7LR5A)Y=:R`&O952H3:9-Q^1LM
MKC=Z3+>[,>*R*5+RRH**#Z4(2%$J/[(!)U)?.8P9\.:ATU.#0*U."DO@V'VS
MC2V2UKD,RK[)2E=SN*``TQ0%*($.M2$-U.Y712U$]!TU3NN#N)\QU0ROA'/A
MB%:"WBLVZ6G_`(DCQ4R'*A[DUO(F=OH;FQ(SVT/K"5*!.Y25)]216IJH#]>I
MT$;PVCN!YJ.Y[&8$8E,8G(TQXJF3M4ZM*BDN5J-U0I0ZT3ZCTU,U.YE0B`<\
M4E)%[9A1)MTF.)4W`8=DT)ZEQNH;!K6H+JAXBA'AIQT@+*"M4FWB(FJ0"W%0
MDRWDT/RYKLB6$N.J5U"@FNXDD5(IYU(KKD<>(?X0*J:^0"K<=5%YX^P7DCE.
MX(5CF,7ZY0BH!5Q$%^-:FP3U<=NLM+$$(2D]3O)KIU\D3#1U#APQ4?4[F59K
MP[@<?A-3$^X7-F9E$B,&GHMM5WV(:%`*6ER0*=YQ*O'8"-0&$--2GI*3`!N-
M.:<O.>3I"XSG]8<#BT$%%:(0=M!UKT)!KTII%W-2UD))]WZPF!'[P`&K24E_
MXVF_[\Y_V$_.?^'_`$OO?S:S'G]I_P#%U=^4_P#_`&-5F(N&*M@%5]MB`DUV
MB6P//<2=BR*D]:^>O=CT#T,^9]Q<[T7S/S<Y[7$GUE8N+>MXCC$,5K^6,:4*
MTYUYP]:V2[DL-A"%D)2B:T$NN.;0TH@)*UK;4/0/NU5U'AJ0WI/Y?P^$;N*M
M%.'V+KMRWJ04-I4'O3@<9RK"^W?6K+=6[F69<-4\-KWEA]UEU2`L]M`!6V00
M/AKYT^>EAT]97>W'8+PW9#)?,I2C>6(H:]B]#Z,?>R6T\=Y;OA=4$$Y'N3F*
M/I4*]32H_0:C7SXYSG>\MK"TM!J*(BE!:5D*Z!2E*'F.E$@UIYCRU339>E/!
M%JU*:7OHE25?L^)-.A-?O)/JU'747/I[JE+IM)-?#RZ]*"@\?/0EM<X>'[I*
M<+C^[*;<<MCCA0\ROYZ`:GH4E!>;3U^\%`+`'E74J%[WN`K5XR4MK&MR"N2]
MK7-%Y=LQM\6Y(1,M@:7)ARY"XS*P5$)4VZZ"TXY45IN%#Y>&M+MEU*Z,M+JF
MJE13.#L3A13@C<[9!.N\-RYV?>E=#(4T`XZ$`=HO-J50+0?$TK\=6T5R\R!F
MD]ZDBX(-6N&I6&2,K>.$6*;%D.!N1#B):2X5N=I*HZ%H+J_6@`[B$FE.FK)I
M:X5?[RNFDZ`>-$GN*LDDC/#'2IC8M1(#!4C>'J.4H-VTI4%#TT'QT\&AN2:A
M>Y\K6NQ:5+WD:<A['X[[I?(AOM%U30"E(:6K[RMZTH4$.(!*1720QK349J4\
MFI;PJJN/K5/BY^P+%KHPB+(:D<S\9V&>_P"#S3$:%EUQB(3L2$OK,ENE"=K8
M6JG4G5'OUQ/:6HFMG%DNNE1G2B@;I&R2T:'"H!KZ5QS<@67*9]I93AMPM$:4
MU-9=GHN0AAM4);<AL-)1+A36W5&86]R2D=*]=8L7,SX]$LKRT<"X_:LI)&:@
M,;X>Y.`QP6;3B/&TK+)V)7_+,QL\:\RK):;2Q(7&@-_-I7(NLI4.&Q\VN7'H
MVPTRM"VB5]P;=FDDQNS(37ER<BD]/XPLL>*%MV&-9DMI4ZJ?;KFF$V4O%2-R
MH_SO80II7124H&TCJ!IMK*NQ'A7#AAQ3'WI7]W\M4R'?8%T[K4M<6/.EAU;"
MXK3D]M3#J6WF"2Y&]96"`WNK4=-28@-8'"J2JM<GFY)D=ZN>0WNY.W^[39#D
MJ?-9=<GAM#RUJ;]:$=J+";!V,H2$MMI`2D`"FI[8!;L#&M+6YA=S2?A)?<=2
MAEIU]:"'$M,M+=</;4%*(0VE2U`>?32Z$FG%<+@W,T5QW`.:N81A]VAKMT]R
MYW*[\ZP6X2DML)-NSRW8<_C-[+DJC+\&+>[8ZMQM/XA0V13U).G;.#<H;QMW
M`',?@0Z@(H,L\$^^:T-LZ.<AT;FT(J16O=BLG(=^RK.KC:KE+EHBNQ;+`M<0
M6&V$6QI,*)$@J5,<N"G9$FX*3#WJ.T,DFB4I'A=N#FM9!(:Z*T[-6)]9*IS.
MQ[G/!IJS[LOH17'MM^BQYMOFW=]GNVZ0V[*3;(K3U)\9WMMM*89:^3F--.H2
MVI87W'2%[4M^)H<.!7(VMI^7DF4:X*RAMJULP^5L@C_,+5\TNXVBUOQXI:16
M,VFJF7'75D`#<4H6`5]$IJ>Z7<B@SQ.P:-)1A;>(>7X\9M^/R'CLU0GB).;F
MXTZO\OBE;33-P6[%>9+C$@J4:!(4E"=QZ%))I=R*/,9S".V>+.>$2EMNN\=3
M/EE]PR7%WV"510`6;BSV8LPN0UH]9":N)0"I2`*:E0D-90X&J/,9D"*HQNUB
M]PTR3!E7K#+9FM&S%M;T7.9,UYV.TE;ZU0F,@B,O-Q&VRI:@`GMU]0373[1J
M]W%*+FMS(66`.3HZ)CMQX:O3+-MEIAS)L:]8S+9CR5I0I#*%&>QWZ]Q->V2.
MJ:TJ-*\MW(IG3;]GK2YOEZA8U!D"Y\<<O0[G!1'=DM+Q*UW>UP>Z4?B729:I
MR9L1I;.XH4&5@F@\.H;-`:'-`9`304KWITN'N#)ON?A727B_,$?A)S%YD>W.
M0,MLN.PW+[)GLIF%U=MR[+<1G)C04EM+;D=,@++A22"GK)M;-UR26D!E*"N&
M/?FI,<-N1XL^53]%5(Q_Z8WN%M-EN^71_<3Q7FF,X_:;I>[^Q9H%N3D*;1:8
MC\^Y/04,7Z\V>3(8@QENI:7(25TVA0)!TF[L+^S@DE/D2R-C)`K5U1R.?M4M
MEBQP(B#6\\`HYX':K5;LC1%BW(WZP62_9'>&KN_&;A*O5ELL^Y7&+<%Q$..M
M,?FL2*VX&TJ(`=VC7N#)Y]K^4%GMY8]NYWT4<8-"")99"7@5PKY0.'+$8KSZ
M$1S]5/NJA\,!UGD0SAZ'4/H3>7RZNW6X7*\2W=TJXNRYTA:CN)>G2B\X?,FB
MG#3[-4GS4@CV[;?@8"/+AVU@%.%'-;]'VI[8)OB+DR5JYUV]_H.K'VI]O:+(
M3*M'N+92KN?.>W[W`-FO0J^1*+J/3XT1^5"@\@G7E/RO<V/=XW`TCCNX<>6K
M4/:M3O#7&UDH,#;2U]!8F)=>4#L!H$E5.@\":CR^&OL"=S74H5Y:I>?3R-??
MO[+SYGW/<+D_]>K/76%ZT-.EMPKE\.]6^SF3]2@#O<UCZ%^H%KY"7J`0T(0T
M(0T(0T(0T(0T(0T(0T(0T(0T(0T(7.[]>/B/VX\EWWV9W3GZZ?).XC?N7AAL
M-5YR6UM7(7UGC,Y%'>CX_:KHFX-K%E@I*7P@("CM/K52JW,WH+!;M:8C75SJ
M!A^Y0I_FCT+\M[E@ZQFFAFOFED.@5J6^\*4(XXJ3_M0B8XQQ_9481&@LV-B(
MRW;6;<U*C1&(@H6F8[,B)#<0TW7IZ!J9M+7/>UT_OJWDWRPWR!FX;2][K&85
M&H`&G!2_N2KP[&4.V1L31/J4D4ZFIZ]:DZNIVR-%6`YJ('M.`()6K9K-,DQ7
M5.N*"RHE02HA(ZCT^5?&NF6&8N`?73W+J*\@@/1^PF,I+KE:'J%5'BH>-*]/
MAIJ?W_0E!KCBT%'UK5<$L,H$=M=4IK0)]5$U*O#H!7KKMNYK:U-,DIY><7K7
MRMI]VU/(6TVEPUVD`;0D@U\O$G_!I-P("RN%:\TJ'W\.21=NA/,1T%J"%.%/
M5U)/I)'4^GJ?CIEA:UM1[J[_`+?TJ+_->&X!?I9&=S;O%0\4PC'A(=<CR!(J
MI*)"D,ON)`+1*:`4(\2*C64W&#5.97`Z>:TNUWEW;M+;9C'&M:G--'AEO]LV
M#NO#$;K<(#[UUCO%ABWS(T1BY0K<ZR&PVBVL1FFDL#<H5`WT/33%NZW#Q(\M
M#FY&O[>U6=S-N%Z!&8H^ZI3A+SVU6V_H;<OT5M"0@QFC+IO#@]&Z@*@X=IJ-
M70W"TD&D$:^)KZU2/VVXB+I)6G2,Q3`>GL3C+Y;;9@*6UD4%M:$EW>Y(2K:P
MD;E$^D[4T\>IT^RYC<`S4"PJ%-8R!VL,+:TH5`[F#.UW_%N0;S9[S)=1#IMD
M19"D(4>\GN=M8'A4=2!XC54]QDOC`\XAN62O8;06]J'.H9"X&OJ28QGC^S9K
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MXB[-5UXS@^%8[RMD_"&;8UCDC-&\9;SG`W+K94F;E.$.7%=JGSW;A%<2B==;
M+<@VU/7%2E89DQG'$`DJ-#:V4,\;@V,F6)VA^!][.O8KVYNY8V`M?0U2NSW%
M;1B6&WU.+X]!M#UM5;I;3-O;V@%Y;*I41+[S7SK:'TD^L.A39J0*Z+F-EM$3
M&W3*TBF&1]*8AE?<3#X@DL(^I,3A$9^W7:#<X2+=<9;=P3+GOJ,BY_/R6G&E
MK2G:@.K#:*E1`K51Z5U0[<R=]_Y\[2075=AGCBKF^FF?;F![RTB.C1E04PR3
MQ<[75C*VK%<V;="LV1LJ5'7*M@>:[\1M"U-NO,O);+*$*24[UT4$J(/PU=[P
MZ`!L]LP,>T'AZ<LCZE5[,V2(/BNGET3B#B?K&/J4>,0L&'>X7C*XXIF^.K=Q
MV5?[ZW?6V7XSDZ\1(L^79;?(*)*%OM2E_*EUI;*/ZN=JDD*T;1)\+=B^LG%M
MTUX.L$FCN-:U&5<#AV)W=6>9&;62@A+-(!R%>/[\US?>_3VB7CV\Y??\98,V
M\<=Y`S.DX!E\B*ELSK6XTL_E=V[>YF-DMF*MDAH$!Q(2\@;%@)^I>D^I[7J"
M'2P`7D9\0KC2E*T[2O$M]V.3;)7/:"Z%QJ'#(!0UQ.Y#)[5C=Z;!2'+:VF>R
M:%;-XMKB[9=83E:[%,7"&Y4>/4'X:V>W7<K)W,D<!0T(P5!=0,H)&#\HM&/`
ME*B__(RHPCSW%16RE"VW$#MKA24[BQ,97XEQ@^`(HM)*55!(UHP[S!J::A5C
M6M;[J:BPW-R9<[IC=A0]<L@G2T.3[E;FR+>W!CH"$S79))$9IP(.Y*R"V:A7
MAIYSFL87.-!3VJ(8WUR*DO$S'&KO:X]DQ#)8-[./QFK9)%NEMR5&>A.Z6^I+
M2B5%4LK]0\M,,G:8@7.'F43T;9A2H/EI"W2?$N5X;^?D&!D$=AQA)65!N:D4
M#*RI0&V2V4TJ3U2/LU)BGUQ^67`L+E&FBB9)X1XOK1;P;D&91^0LFPF4_'D6
M:9NODIN4QW7(_:0F,E^WN[@6''G2VERN[>G3<A='/H9_R[L_JQS4XL:^VJ[^
M/^W!60XBQ;L6M2LBE+0;Q<&ELP4_>5;XI_;65$+3(F4ZT^Z@`>>JZZG\Z3RM
M)$`QKPJ,!BEV<1:S7(*2=J+,RR[Y:SHF2I/:+JPJ.RE9(>*%$=S;TJ*DDGQZ
M>&N6H$CPZ/&,'@B?PEQ&845LGRQ4R>M?WNX!T'4+!37>.M.NK8`#`*O<XN-3
MFBFQXWD.7N/.PE1H4%A80]=KBXN/$00*J::2`IR2ZA/B$@T-*D5TU)-H%0"[
MN2O+?R*=4\6\>R;6Y;LDR*\7AJ0VW\XBU+3:VG`VH'LH=4E^26U]0>H(`Z:;
M-PT\0.SDG88WZ\BMO'L(X5PL-O8KQAC:Y=4G\SO,4Y!<2NO1?S5X,Q:5D^KT
M[0-(+V$U+L>]/.B;7Q#%+QW,[U<D"(RI,6&A.Q+,1*8[`2/2$);92VE*?L\A
MH$C!Q23%&!DD^MF0QWI#RR'554%K65%L=>I*JD@^9\CX@Z6YS6^\:*.POKX,
MTT.27-Z:ZM@N%U`<V_#<JO44'B"?Y=5E[,7,>QAK'H-5(#!H+J>+2:I??('^
M@C_N[4\3_)_Z+5%__%U=?_0U3$$[B>@/3S'E\/#4]S=>!H/[(#3Z:9IELLK3
M4'V#[$G+VE:7(W@!\TP>A\`EQ-`/"@57J/AIV`!DC=%0XX5J:XX)+RV44<!J
M)&/%2Y]O$9J-;LT=2C\:X9'"2%5).V%CML<*2.H229)-!TH/MUY%UR]\VXMA
M<XZ(]=.WO6QVT>3$*<5(4$+22!ZBG]0-*=/,==8!6<DA8:!:;[8>`;IZTT5N
MJ/"A&WJ*^)U5O9JSYIP(A?WLK*'&@:?=41T(^RM=1G"A(X)2T715*E#[P'ZO
M,G[>@TE=!H:K0B3WH,^),CD]Z,\'!6M%TIN0K^DA::@CX'3D3S$_6,2$]YSN
M05AO`7(D7%TRLE>L$+)K"\FW1[];GU*1)AQWG"(-R96E03L1*W1700H`[/#<
M-6EG="U?0CPN^O%216E59WB'*/%=_<M*+8N7:G"\@IML]U+T1MJ0@I6&U.#>
ME+2R/351IU`UI67,&!83KX)3*ZQWJU2VQ8URXSB_)SF.W'ML/\)MTI;0&VBE
MA2`I*DN!24BI\JZNF1@@.XK3L/Y0[DG>(;9(=Y"L;O=JLOJBJZ`I;=2AQYI&
M]NJ2EY))!)`Z>/3J^F;?^.U60-P$R5H@W5$63&E)5'E1D)30(*5`[FU"E%)\
MA0U.A3'>\>]5-?7&L=_QOZ6O.%XM##"YO%V<<39U;.ZVMUE4&+FD/'9*W4L.
M-U;1"R.JO4""#Y:H]]@;-8^(D4D'T*)N7_*`]A7Y\4;W6<@2XE\=?A61)A"V
M=@QX]T2A3TB845?4F[`);HW4``U5_-CQ8QGB[V+*22EAH*9+#)]X?+-P4B.Y
M^2;6H\>&E+D&9,,>&SN3VHZI-Q>+324I31*:!-/#1\#'S=[$CSW<@DUDG,_)
M\ER+96;C\E/F,-NK$"%'>60X$.H'=_K);0EHDDBNTFAH1J1':,=@2:`)DXFJ
M>_!KI:GK2TYE;<Z_R;:S>EY.U.FW&*N[Q%V23.>A6V.E@O6)AJ&A3?S3`4Z5
M+W]"$@PM+G>%OO')#3I<"0#3U*(.0S>/9&5+O>`R%X79Y$B&8N*2[CDMVCML
MI[8<CR+])#5SE,2*G=O2*5Z#4^,S%H;.<1@.Y*DD#S4-`[E+3CQ7"N.1XK0O
M&._G3`>0NY7!I4.3&+[RWY<2++=BM/(A,ON*2C>XIS8`"HZT5A:PQ1^4?'3B
M<_8H#WNDP(3]6Q[!;O06_(L;E*704BY39TN*43X)0_/2LDD_#5G@!09*!+(X
MU93"J6K'&\V>`NWQ;G*0JBTFVRHLT'I0*28;CU10]-/QPN($FEI;7,YIFAID
MCNW<7Y4N5#MXCY)&$^=$@*DW&%<6+9%,V0F*P[<Y(0>S#2IVJU!"U);"B$D"
MFI!E@;A(T5[%PZN#B$H+1CN0V*X?,9!`R.3;'KU,Q"%<;+(L5P;N=PMJFBHM
MP[PMN[(M)2^TIF2J'VW0H("PH*2']$?X0N2-FB&I]*']N:?3->-I/'&6W+C[
M.\6R.UY9:L?B9-?K*<+Q#)W++9)\"-=$S;_+Q1,Z/;FV(#[2Y*'G$N1"=CP;
M<!2.:8SB&A`-0$4WJV6JVV>S7FU0&)CUT@2'\=<_A^XV'OP$37HDBXQ)+M^C
M0S"1<H[C14VTM"I#*T4)0JG0R.M-(7=6GQ#@DS'F37!;!*QMOLP'792F8MU6
MU\U,<#93,WMK?7">2\WW"ED!I:CZD^&GC;1'W<.Y)?</?F!@E'%ELJ3<4W'&
M;BZF[SVWIB691#*;>E:EJ8999A-M_/I!],DD)*@%*:4H`@^%9S*;\T]B<"V3
ML&><9?ND7(8UQ=;DVM<I^)%F)-C<8<##=VB)[+602(SS30W;(A63W/2I'KDC
M;=47F-#34<5)CFMV@.<3KX\EBO-RP/'K)=9+=P3<X<93T.Q8NNUR[0_<@X[+
M=[^079];@%F+B6G#`BR%.H0_3:HI(TQ)9Q0,,ETT!E#2A(-?6GOB&N/Y?NJ#
M69\C7B\S)CL9V*TIY!@+3;H3%MM=MAO)(^2@P88VQ6BA&TK=4N0XGH5H!V:Q
M=[N8#G16]`TM(.).?I4Z!K\?&Y/5AJ(S.-V28TQ$D_/V!I"7TLM*3+#\9IIU
MI94D]UI:"H*3U!IUKJYFZKW>6WV^U%U.Z.)X(:YQ<T%H(!`.`(K@HD%A;ME>
MX"A<"#VU-2D=RA"BBT&Y1;3:K:Y#BOQGC"AMP4OI>?BEEU2&@&G9,=0.WI7:
MI7C33.\;]=[GM=R+Z5TESHTU.=-0P[EUNWV]K-$Z`:2'<..!S2I]C;,J3<^5
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M*AGZVW)-AXZ7[8'[M8X-XFW2Z\GL6E<R`F:8*V8^"_-.,E05VEN!]OR-2D?#
M4><5>P')VKV"J^9?YB-SM+"39HKEC72332".HKB`VO=443Q>RB]RK[QK9IXB
MICIDQFW0VEH("$%22D!%*)]/6GEJ1MP\1DX@A>W]%2>9T];&@:/)9@,LE.RX
MJDMPR4MGJ2#5%1T'C7[1JZE-6@]JT4/\0]R+[2M#T9YMR0AEU6[<@N)10>-0
MDJ'C35>^9S7$`"@4I,QR+.=L+3TZ%):D.1ZN;`XE;@/0^E(52IU`N;A^NM!D
MI5N*L]*::P<\W9(67VBANBTI0:%5&_3T">J22.NH(W`-_B@!2GV3Y?X9R3!<
MK>\6]V_,K%AD&$76[NZ&EO@@)1ZD@[JDD;`JOEJ>T">V,IPQ1'8OC=JD]VB?
MNTYQ*<CMLR9X94MM#I>#Z0&ZH"B.CHI2OB:#4:&0R-$9I0U3$L08\R-J2%&[
MEZSY%R9-1&L>8,0$0I2'IJRVY*:D):-$[?E%U1(30[2H@"M=9??7R`Z&$BF"
MUVP:6-JYH)..*9ZX<+9+;X:YEGOT&1-2[)F!B3#>8;N,I5IF0/EY$P.2%-LN
MOR$+2KMA25@FM-9;X:^'$K36\]N)V^8T#N4*7><6\AYC3QQ>,+NMCOMIMD.=
M.D2YRGY$=V-/G1U07&X\5D1UNEH+22M8<;4*$BAT]!')Y[V%SO"![<U9;Q?Q
M3;9)"&MH!RIEVIX<RO\`&L6*W>ZRTR&PNUNE2G"\*,J31)9"G!M)W>>M3T_8
M27]X+<.=J!%!ACWK.WL<;[%CM(!T#Z$W,_,;=9^!N/9-H3;EHSF[FV7U$EH/
MR'K<JX-J4M]TR"MI*$*4"J@Z'QUL-HZ<M]QW?<)9VDRVK,.^F1[%!T^;MS93
M4/(X=BL0N/%>,9*S:%XC>&K%!AXY;X4J)C,AV3#4ZM`>K(98N0:;?H.@4*$$
M^.O.MPLFB8EKG#U?8INV7$T46NM7D8DXJFCW;>[SB;VZYU=^)\%R7*>4^2,<
M7*1DT=I3%FQ3`[B^TRW,@W*]2)+CD^[M(0DKC,-J0VM.Q3@*5)'M'R^_E^W7
MK+;F;[N]Z++997$,&G7*\<"T#@<^Q:FRMS<M\V8-#3Q'[U'3`/JW<@\9VQRT
M\>8[QW;F7W&ITY",8G7R[W>Z)0TA=[O=P1<#+O%S=#0'<=!1M`2E(2`!]![;
M_+)T!M\38I+C<9Y:5+R_RZUQ]P"@`X'B,5,DZ>VZZ\4X<X'A7!26Q7ZP_N_N
MC;DTP\.3!F,A!_-\!AV]M""X':QVTS(\]-0*5I3;YZT;OY?^@'M:T-O!I%*B
M9V/:>U0Y.C-DD(.ES:<BBG/OJ.\M9Z[C=VN^-8!!S/$9#CF,\@6&'=[;DEC8
MG(0Q=K5"D*NLEI5MO3#:426"E33J4BJ24I(HY_Y8NCS,Z>.\W&$O.(\X4)Y^
M[6J5:],6T;B9]3FTPK3[$01O?GS@O(FLEO$NS7QT-1HL^)/9D5N4".LJ1$?=
M2^6T)5454&R32BJCIJ+=_P`J_1\]J1;7>X-NW4I)K\P5KB2PBAK[,U/=L-EY
M>F.C7<R,O4I&X3]0_`X<MB7>^,<NQ^8CNJ<G8ADEIG16W'Z=YUFUW&VV]M)5
M_1"Z4`^&O/[W^4[>8)C+LF[PR/X"1IC.&0[#VG#C15K^GI2TQB2*1A!SK4UX
M?8I'6[W>>U;DJ*AC(N4,PQE]:F7%L938S;'`IA+B6T.W.SVR>Q+9*7E[D*>V
M*-%*3N"2/-.H/D-\U+(N9)9&[MVU\<4C'`>H"E>U1(>G)K"02VT3!)SQ-/15
M/%Q3-]O[-OGP>-^:<>N4.X7>1<OE)&18Z7H3]R?^8>@PHTM%NN*(C\M:G$-+
M"MBW%!)H::\_EZ*ZSV+6V]VN_8TG47&!Q`]159N%A+*=<]1CP"WN:/;'Q_SY
M@.18#F%R4]:L@0W*C7*'%@OW"R7B(RM%JOEMD*D/K0]"<<ZA*@AUI:T'TKU7
M6&^;MLE\+ZS+XY(Z:@6N;4#WJM.(-*X55/<[3;W5NZWD!<2T@5X+B<Y7P#,_
M95[O,U]L_+,9$2VYI.1EG'=_5N;LMTFS4I8?D664\$I7:LOCQ6W4)W;F)R5-
M*&]2]?4.Q;_9;UM\>\;>VD4C/$,?>IXCS7BNZ[3+M\AL;FH#<6]K3DLV<6'(
M<MN]OQ?'DR(JIR%JN5P"%*^2AM@MN!LA)_%/E6FO2MMDCFM&O96IS6,N"89"
MQN(2'Y4R[%_;;QM+P_$)XA9/DJ7/GWVRA^]2EK92T9$J2H.+2ZI*B.H``-`*
M5T7\T;CYTGA:!2@R[TZR-\N#,Z*"'%M_RQ,IZ59Y+9N<J>XZ[+F`F0E:U56I
M$QI<>4T5I/7:XD?#RU4LN#(P/:/"5)T$,\MV:6'(ON`5:+@+(M=Q<DPV$&ZS
MX]Q;G$NH2*MQQ<V),E"%N*Z@R%'[=0+K=8+631*YP=2M!^V>"=AL3,`0`6UI
M7BIN>PG([CRC%S;D"Z6P041)ENPZRS7ZB9<(<9D7"8N:$+5'#K;TIH)*/%(Z
M^&I^Q[E)ND;YGM<R(:M->-/VQ2+VV9:R!C"3GFIT9!DC,F[1K3#>"V(SB&W]
MA`2K90K-3Y!-0?T:?E?^63^+ZT#()D.5,^<$XCN?@1FF(;+`(JE&U8[J$@'I
M4FI\OCJ78-$$`TXUY]ZB2C4XM.2*.+\?E\E939<48=#+UP==>*E[5+:MT5I<
MF4X"KQ5V6R$`=:J!U.#R>2@O9H=052KY4N&2\>3SCDQIMFQQ"J/;WHS?99"`
MK:-ZSU+JZ5*E$J4=*-O(S%^78GXY'/)!&2;6-GLD,HH\M8W#[BJJH">HZFNT
M'5?-"X5,>+Z\4^UQ::C-.'CO(,!UUE#K_H6I*3W%45U]*@14T.HU'`>/!Z<+
M0]ID/O*2-A-DN$1+[)4GM-A0<^\ASP/1*3\?'3T4;7BI-""F:<T@\TOAVK8;
M=[:`E24@*\0#054*D*I_+YZ<N#@.](;&&8A,RVX!O4HJ54U*U"I/6I4HBM/C
M\-54GN2?V2EG$:>!P]:>G\P9_P!_5_W>MOWE>'Q_3JL__BRN-(__`#&CT<U3
MZFT)02>\36G@`/#^77N=O\EVEQUW;@*<6G[5@G];N8*_#1GU(DO%A;7\NOOK
M%)+2R``:CN(J*GP.KRV^2]E&^.5UVXT<"<#C[>*@GKN4E[66T;7%KL>6"E!Q
M/LM5J=<0E:&E9(X5`FB2A5GLS*MM.J@0">O7<#Y:^3?G?96>R];NL;*,,@\E
MN`P\1;B[TG%>K]%32WNR12RN)?4FIQPKEW#@GW-$/%LFE=R@3^UX5IU\JZ\:
M6NDC+Z8K5>.TJ6E)!/BH^!']&GZAJ/<>X.].\$7.`OT0XWM36NX>(/EU-:#X
MZKGO%"U`"+OEB@T)V[B#0BH(%>M?.E?T:975B_+@'"XE:2D=:`@"M#7IX^>@
MJ1!Q]"?W@+*;;B^7PHF1QG)V*WGN6R_P4.=IQ^T7'^KW`,ON'8W+8&V2PHT"
M7FDGXZG6TH,@;3/!2FRB)P-*UP4Y,[XCR/CEVXM0W+G/MD1Z-*LM^900S*M,
MAEN?;[BE3"G([B)]M>:=!2HD;J>6K1\4L9);A3BI/E'S==59I[4N9+S=L%8Q
M^2XFY[+/\HXQ,*WDNMMH6#WD*7O[:O$$`E).M+MMVZ6$L>/$*X^A2H9`7^33
M&E:J0?MHN*I6=9:[%N2A!A2(EP8B25EQ-NEMO%EQE$A2E%3986JGI'I\JC4R
MV?KKA3)6$`I56;Q9[DNXMR1/_$9^7+\9A:EM]S8"I27U`54=OQ(U*5D,AW*#
M'UJ<D@V?Z7/NT=N^QUF^X%9\9C0%=MQ<NX7S-<7AP2DN)4&9<=Q?>2YM4$J0
M"#4:I][!^!=)PU:?K4/<7Z+5S<]35^:SA'&Z,HE7FV,+B61$A,)2'+UD,6'%
M469"CL+AA#>I.\*V@>`Z:R4#YFL/ENHVO)8JX]\=R-L@X3DXDX77,EPF7'2E
M277HEY<N*1O0O85`0V0HI4!Z0-+CD$E<*43"193;&KTY=)F:VF,&834;M,6^
M;/5,6E>]3(4VPRW$:!Z)"=PITTXPN9$YC07.+JX(1Y$Y5L]G+K[<RX3Y1M]Q
MB`1H9BQUJN4-ZW/E:WW7G>V8BP%!(0I5*;@#IGRG&02.P/)"5?$6;WRZ-R;3
M$GR#!1/M,&%`EPK?+AP&):I!D35N/0Y!CMM=E*$H#E%E=`*Z:N/>'<A+O*O:
M[=[I,FR\>NN,+9D2)#T7YN1-MTE/?<+H:?0W$>BK<0HT)"@GITU)@N7U/EX&
MB$R>2>VGES&RF1.Q*XS[2HJVWC'H\J_V]Q;;3#TA)>M4-Y3!:3(3N#B4[:BI
MU8#<)P`*Y(2+&)W2S(WRYEVL"T!S:N3$O%J"%`?<[C\>+MVIZ^/AUUW]0GYK
MA%01S7F%R7R!8'DMV/DG*HY:ZI,/(+H6:#P*=T@M@?H'34J#<)R#CQ3`MHS_
M`!,2GLM_NJYKM6/6ZW6_,LE_/HUTN$J9D<G([K.1=+/*BP&K=9G+*X\;;"-M
MELON_,-_C/B3M7T;35$6YW[IW2"5Q!;2CL>*[\+;_A2Q3[X>;K=%M#<*Z*?F
M-PG49"[?8-KN\6XW'\QDOQY%O:<M#3T.$BWJ8;4R\[)4I]+C@<`6$)GVN[W<
M3G.NGAS:X4PH.21/:12`:/"YH1S&]_W+R$,MW/%>,;PTSO"?G<.C,+HXXIYT
M)7;7[<XC>ZHJ(!ZDDZG-Z@!(:0QPKQ%2H_P#OQ#U)P<?^H4MDI_/^`L"NR21
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M%+[;>YQ))`U8R-NRUI<-3`0:474PG)N+3Y6+W"$Y%2U+CR(DMALI4#W84E+F
MTD`*4AUL*21_E>&E2DRUJ-)/`\$)?>S#!WK;RLON2#V)G&G.K*U.KH'8D[@_
MD0-(*W"4I[GS#1`)I_-I,+"R@K7%+CB,I+*TP1"U$0IILE2`2A!`WTK5(K4$
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M:_HI>==0L@]VGM<-*>XGA,UZ"G)V'>/_`,&-"%F3[K/;&O[GN$X75X_=Y+P\
M^!H?"[Z$+.GW1^VQ71//G#JOT<C8D?\`X:Z$+83[F/;LH!2><^)2D@$*_O!Q
M:A!\"#^:4*3Y'PT(65/N0]OBQ5'-_%"AXU&?XN>GQZ7/0A9T^XC@10JGFCBU
M0%#TSO&3X^'A<NM="%SC_P"L%\C8IE4;V?WO`\MQS+[?8<MY/AWZ1C-ZMM[;
MM4B[0\!>M"+@NWOR!#_,!:Y/9WE/<+2J5VZK=Q-'P<]3C[`OC_\`FLCFC/3]
M^UI=!'=R!W9J#`"I8^Q[E<6KA:Q/MPD.F/;6$J5VS7T(05D=4]2-2K&ZC8':
M\,0OHOH6Z#^D[5]#1L+?3@I477W6V=RTS%-L$/PUN-.I[1-%H3\0H@$ZDS7D
M;F4;B:K<0-\^/S!@%$U'N2R3*;O<%VYMV-$B!PI>15.\>H"J`M121\:==53[
MY\=PUAQ8X^I3[:%LY,+LF^U-Q@/+N6<@YOD-JFRN[$A(4GMJ.XE7W>GB"334
MJ\_Y<=JYI8QU&#`%.'E%XFXM#,H0VREQ#J3N14[R%5\!XG;Y:I)(]>1I12XY
M0^01TS4+KWET*Z\D65*X0%V<"WFRH`J`"@-J$FI'J\ZC6E-N8MJUDUQ'M"DS
M3B*06Y!)=A5.E/O>3/V+)9CJ)S)A,O&.M+JD[DH;50)(53<0!JCVR1AOXHY!
MX->*5M/\*4?BJ/44J_:2]<;WB=RN%Q,TOR;BM(,MTO**.AJ"%J"14GI4:YU`
M(6[K((?<P]:M+64>613)WV*:$BS1U1.R4&G:`2L)IZD@%1Z=:E0U1/A,M`#2
MBE>8#P4)>=.#\?F9);.3[1;F86;PXK%HF72.V$F]6=IW<Q#NB!0/.0EN$L.G
MUH"E)ZI-`AD18ZI*YN%^^6S^'(\)("+.2K=@L3"'K7FEK=D2;EBKS=L7'.Q"
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MV=B?%]C;G26EI5<W&7$M,V\J;"DN7J^2RIM+RVZ$-J6MT@^E%-?5FV73`[R6
M:G-T@`DXT_<M=9RM</*;B&C-27L,ZZL1N]E-XBR)CJ0$0;:I?RD=52-@?<*'
MI;BCT^XA%/+6EM_=/>I:WTS5N2A)D.;0".TW4JV!1*$$)2:!2_\`U$:1</&K
MR^(Q7<4?"\%:U)"@6VO13J-Q'0]:]:'KUU(C]P=RXME-TKM0E0`2`M6U2MH*
MCT!(--R0/Y]*)H*\EU;";MM4/Q`OI7<34I^]4>HT-=1_X^(PHG8Y-`-159$7
MGN%*VE)4K<`BB@'$*5T`%#N!/QTY=MBC'DAC7:ACJRIV=J2R-DQ+7Y)7Q<KR
MB-VS#O\`>X9#9;4(MSN$<!L`$-@HD)&P4Z`4%=9Z79MC<VLMG:O+B`=4,;JD
MFF)(J>\IX6UN,',BIS(-?2E?C'&,#W(7:+=^5(@RW#\+<=M5HNF0(:O-T>NK
M*@\]:,>NUV;F2[3;;<\L+DO1R%&0=C920M8\7ZIW39XM\=TATQ;V;+^/QW4C
M(QH8TUTMHS`/P/;6E5YA\T-VVGIS:H;JZLX)MQG<YD((KI(^_ISI4U]"D_#]
MNG$,-+J8.*(CNO,]ER7'N%P$Y2%(H299E%T.%/[0IIN*`QL#*UHODV^O3<SF
MYD:!(_,-P;Z`HF<@_2L]K'(-VD7ZX,<D6V[R5K<>F0\]GR_6LE1HQ>F+HTA"
M3X)2``-5UUMCY9?-#P!W%)?=.C:"S`IL4_2$XCMC3C>(<E\D6:2H.%M^Z-8_
M>V>O@2VF!;7%#KTVK%!KC=NE#=#"'/I@,J^E*9<:FA\F',J(.<_1!S%V3=[G
MBO-&+9"[63-<CY#CUULSJ!Z=OS,J+*ND5M.]8!40$IK7[-4UQTY/(X^:&!Q'
M,)]MZZ,4A-6_6G_X2]IO)'MWX:M^`W/^%WL]N%SOUV%HMM\+Z[@T[*2#<H<@
MQ&4JBML%EK<YVP%]-3[&S?:VSK-C"7"E7<#W'BHCY#+.)YW@.'W:8CO*D%Q7
MP59&K\+5GJ9-PO\`.M`N4Q<28\PS:'7E!*H$-31'><CA5%NDJ"E5H`-63[!X
M<R*8>'`U]"3)=%X(B\)&-4N,A]F'!=RF&Y7.U7MXM`5>DY/=&D*""5J!;C.M
M(4GKX4U=_#6\;:%N052;JXDD][$E('+_`&SVK%;<]G7!!GVGD''V7)>.-W"^
M/NV>ZS$((%NN"9O=,:#*0=BW*C:#6G2FHLC&'^&*"BEQ3/8/S/$<TV_,4E>4
M62TVW/8=L<OR+!$3D=QLS93"3?E-J7.7;UN-(4]'C/*V(6I*2X$;J"M-6ME;
M226XU>&G-5TUXYDAECJ-2@></O./3W&F5JFV\J[L23512]$>.]H]4^E13T/P
M4-1KRS\@^[B<:J?%>AX`(-:<TJH>'7"\+;^1:D-O+ZJ(W`;J@=*@GP_4=4<T
M,OFG2TD*;'(#1YP"DIQR+KC=JN5MO1>2XR$J94]596A235*R0#M`/EU&F'-<
MT^,4*<D>R0@L-0D)D=V$R8ZV:A(4L^DFA70TZ5IL`\_,:3=2B1H`%*%("2DR
M=V(I-2@)&TJJ3N-/`@4]/3IJ,]]8'LXZ#]22\Z&E_+%+G\S?_P`C_NY[_N^7
M]/\`1JK_`/XNK/XD<C_R^O/V*MI4QE-0K<#3I4@I!\JFGAK[N9<6S#^:YH':
MO`9/,<*-U>U$]RD[FTK2GN!"TK(25&NQ051/H/C33S[FVT`ME92HX\*I$<4N
MLX&I:?:$_?&\I,S%KF\A"FVT9`M*4K2I!*C9[0%J*3^T'$J%?LU^>W\RT9CZ
M[\UE-$EFQS2TX'Q@''G3#V+Z)^7<C7;!Y8KK8X#NQQ_;BG\C/&9;X4I(W*+:
M&U)Z%0<9';76E*$A/7[->''^$P\:+?+(]7MCIUJ*CR\#_-746X]T=Z%H*4M-
M"HIV]=P`ZI^'7Q-3JJ?[Q75X4XR0:T4JB@!^T.I%?C2HTA"Q(:[P4/74$`*0
M"2FG6GQ`-="Z"1D5G;4\PIM33BT.LJ2X@D]*MJ"DKJ/4!N'5->O77*N#@6DB
MA4T`$"JN%]K_`#QBN3X=8K3R2]<)+$!G^`+F\PM@&W6EU2I>(S933R2U*:CO
M.2X16=KB4".D*I0:TUE=12-\J9SJ.%!F5-CD!`::ERL2P7@OCW%50K]CF;L3
M[)(2XY%CP5-M28BE+4\F/-4XIR0P4DD42GRZ&FM)9V<,=7ZSH(X?8ID0:!JP
M#O:I"<*V^SX]D&538+1";J5*-7@ZTZ4M%(64DIKO6JI'Q^VNI=O&R.N@DUIF
MIT'%3%X]RYJZPDJ7$3&D`EIXI5Z&W4**%J>416NZH'EJ2K!KP<!FGSRG@G$/
M=!QCRKPMR)%C3<+S_B+*L)O*%-I?#3V6,"!:[M%44EM$['YD5,UARFYM]I"A
MU&J?>8S-;B`$@./['O51NCGDM:WGE]*_-LY%]K>'^W;E7,^*^4^(/>M"ROCS
M)KIC&2/XUC>!7BS3)=KDK;;N=BN*\6=@SK3<HW;D1W4K<0XRZE0/6FL:_P`V
M-VA]&$8#M'-5%Q$=8I&7"G`5]O-([++1[67X+[#W'7OG5)30Q$7^)QK:HK8+
M*`>^Q;^.9$APAP*/I<11)`\:G22YPSD8>X:?Z5%$)'NV\K>_Q?T*-\RQ^VUI
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M4:,N9(9B&$.#:$T.00JX.8.-,0XX1Q;<;^9<N=R1QQ#Y!O,3&51;`Q9GLEN,
MI5FAVZ+*BW*(N-%M$%+JTA#0<<DD#8$TU(+9(P#D'#@4)H463CF:CO1,WO-G
MHM2&H]]Q1$U::#H7)5@O,A02*]%?+#=UH!I`)&1HA;`P^RAI4B)RI@DI+55J
MA.2LHLEQ>;2"HML,7#'FV5/N`$('=^]TKKI<XBA)(0B:+8,IO>46_&L<BW2Z
M3[U=;9:;%":!?=G7"\.1HUNA)6H);4Y(DRT(!)`W'Q`UQC-3@UN9*$Z]MXXS
M#"<KR/"+W+_),JQFZW6SWVW+@0;U':N%IFNV^5'0ZXX&W.U-C/(4M"MI*.A(
MZZC2W#V?P\<2#WA<3KX3P-SEFLW\XM-\X29;8<`VWSGWC7%X<A`4MIH.V*X9
M]#9-`GU(#-4D^%=."<?UO4G/AC2M`GZE\><OXNBU0+Y']JM[DWN:S:6H]AY8
MP3(I,%E[N!V[W55@F7W\KL\-#2N[+<6D)44I2%K4E)<#R14$KIB<UO8%JW'A
MK+#'D6Z=RSQ-:8JEI:"<<N>5Y&&X8`WICIM^--MR))-$AQ;Y"1]T(K74&X(;
M)2AH1C0)L"I2WP#AJRX\_;+DS)RO,VT7"/#,RW8L_9,<1)6^PA*9MUE&Y/=I
M"WTE?I96`1U373`=#'*RFLM)IB./!.^2_L]:Z0[<W;H\&-;WK,M8ML")$]#B
M-NV*VU$^ZIL5KL^/76\:^'0&D<!P2&L<XZ1FF_SCBKC_`#"$[OMERM4\J042
MHHCK3O"BH;VE.)!22*FFHDUO`]QD;[QX4P2_)D[$B./>)6^$9:>6LK-NC\?X
MY;LSB&\W&Y6*#^<JGX/E%MMEIMUDN=R9GW:;<)TE,!#;#+Z52$E)H$J*:6\D
MBMI`V0Z<*]G]*F6EO(UQE=0,`/'LR35?Z4G#S"$)B\7SRI/G^48K%-`.@(2I
MSJ#J+\<S\3O:HQ="[W@/4I&^S/W/85?_`'>^V''K=QN_;WKUSSQA:XTYQ=C0
M(CLW*[<PB26XT+N'LJ7N]*PKIXC7?U`2$1N'AYI,AC+:,S7>EI],KE@_UD:S
MRWKU[0[Q':JAF#S/;U.$#;W''>.)26S44KM:)U!NC&'C6,:*3;R:28P3J*YF
MXKEP85U:6$T/@WU-:UJ!XZ@R%AII">T,Y!*F!=+@E;82TZM;FUM(+:P25$)3
M3T]:D]3X#35`C0SD$MH]ZE-++>U0#9`42A/J4DT6I-14@J!IY4U-A<X1@`FB
M[H;R"4$;))`(2HK``KTH*BE`2!33NM_,^M&AG(>I*N#D;JZ)2NI)Z=10=?$D
M^&C6_F?6C0SD/4E[;LC4$A.]/1)'10I7[P/3PZ#7-;^9]::F:W1@,:\`I8\4
M8++N5NC9OEC3\;&75*_(;24%F9E;[:O4ZC=1;-B970./?[J1M1YG7/,<!4DT
M"<9`6@-<`7'TYJQ*U0K?.L%F?E0("@_:[>I;28;#K"%*8:;[;3?:=VMMJ.T`
M=`!U\]2X@[3J=D<DG2PD@`5!Y+7?Q3'7@HN6*TD$[21`C(545I0H;24GIIU=
MTMY!(I'#W'$:[R[]%QB/#NT])1+EQ9MT:#R*@D&+\Z82"2!U2V#H7-#>02T;
M]J&#<]<=9[A5]7)M]O3-Q.XMW%M29,JW2HLFZN,2(2GTE++I*.M:[@`/#51N
MD,\CHI(_=:'#/B<EC>N.A]AZ]VH;+O`+0)&N;(,V$&HT\J\:*<7!G`UAXOPE
M&'6FY2+Q#8A]E,R>RPV\M`:V$J2R-A))^`TTR&01M#J:N*OMHZ?L^G[!FUVC
MO-M8V-:"<S04-4T6;X39[2U?VH6WNK?=6Z34^L@`BE`*;0/UZAQ.<)#B5I6V
MD4#0YF7+@D!Q]@L"/9+M.5V0^XEXFB0"JJ?3Y`JI]OAKEP_5(RAQ:<4[%!'&
M[X@&E>'L3>>W2UV]KD+,G&*=Y4MQL@%2A]Y1K154IH1Y:NR2YK0[$4&:KWM+
M7&O$U4MN0<4$W'52ENM[8[CAVE-2K[_0T'W3J!(PMD+C[AR3D`_-#_NA5;2;
M&]_I"XR77U)9<9>0$I11(/?V^GH.H'A\=7KI"_8WQ5)F)%/Z>"E7%#=U_JU'
ML4VL_P`.F6OB?,6X4L.K7`?E-+4TGN)4ME5$E7CY_'5!M>C]3AU4TZQ7U8^U
M2K8"-CJ8`Y46M[#L:NBN*%2+H''W1/=+I=J-M%="@=`"1X'4[?+?S=SD=`&Z
M*TY8I+IV0G2203C@K!F+*'(J9#C!::`]*G5MI*P!ZE)3U-`01JG-M*S,#UKO
MQ3=0:'$DILN1L6M4W'Y'S3J83:R:/E.Y/J(4E6T;!4&GGIAS:885JI-PYLD8
M8TU<'"OH4)?<)@3N48=WK%),DXWCTYY]:(KZD.)0R3W`M.X)4$BM03K1].3?
M"3ASM1;(0.8'<EOGB$9!-#1+'@_VZW;*?;'Q=(ELPEF+*M^2,NEQQ:PQ'D&0
MXA:45"UN@TIU!\](WR.N[R7+@#$*#M]2I+Y[9A&(S72^I[E*V`^Q=K[=FH$P
MID0K%:X[3CT%+;49ZLUN,B3';6E]P,/M>IMS9N34#XZK9=%/S&E[:9#`G$<>
M&%<5?61`(?\`[+]N"X9_J`>R;W+\&Y]'OO/.<X"XGE3.LNR-VY8]ECE^S+.H
ML>?^87*\MV1<%ES'K'OGL,;I3G<0M?:0A>TD?9/1?6NT=16L6V[)!.RSM6M9
MBTAC#0-TCA4D4J%M;&_%Y'Y$`_+:0#PR4(&\PCV><S@_'-M:7>`%SGH4':S"
MMK,AVC]WR2Y;5EE<I0/5?<D/K%$I(!IZY;WUM#)Y3"!<,.(XCO[^"T#+D%QM
MK8-U4S%!GVJ1>$,,VII$_(<B_.[JXV$NJHAB#!77<ZS;X]"O854!<<)6H#H$
M@D:VMM,^YA$C:!HS-:"O:K,.#6-:XU=3O2R5D,&5O>COMAOYF@HXVHN=HJ`)
M3U)37H-=)!-217O7?,;VK(Q?$L(:2M]E2GE]\T4@&A2HE"JGR`'CJ?'3RQB,
MDL&HKP6Z,CA-(<WNI'XAJ$.`UV@BE$D]"!_*=*PYA=2>N>61V8[I0\GU)`HI
M0!`6:'Q/0@5_1IMTD45*\>23(YHB+?OG);T>Y%_Y>3%>9F+[*%&.VD+<3WD)
M\>T\LD))\#0D:A32B>:K'84XE.6DK&LH_P#B?MQ6S:,ID7*Z*QZ'<WSE$N7;
M[*U;6%2#%B.W5UQAI]U#R`%&,T"X4UK0"AUD^L.HX>E>G;O>Y\3#&[2*YOR;
MZ-1!JGH6&\NA;-)\3OHQ5A7)-V5P;BG',*QOJ:L5OM1M4]DA(0F>M?SAG+/7
M>],=6X7"HU4?MU\.?)+J^ZWG>-VBOBW]2O9S,>>)Q;JS(:!@O(OYB.F)H6;?
MU!&28(V^6:'W2<,NVN)6/#O<7"O#:4NRXZ7&BEM="FNT>8":`D[O/P`U])'6
MW,KY8?'3W@$]+'(,>;&0XR^RZ5(#M6U`@H!I5:DG:G=7P\>FNN<".U)H#GDL
M-KY/LJIS]LN,QB*^XW6$X\\&PM214@++B4"OZ1TUV$`R@')<.D-.H>&B5*^1
M[-AT:;D2E6:_2+=;I"46M41B^JN29#C6V`Q:GP]&DS'Y00A"E`[2K<2$UTSN
M6V6E\0V34TT]YCB/0:*-9W<]I(1Y;'15KC0XJ&%KO&16@S<FS20FY\D97)+L
M>U,%!@XI;%N+-ML<%EH%J+!L\5P)2@5JNJE$J)U.M(Q#`+<$NC9E7M_H46]F
M=--YY`:YV8&2U6<LFXYFD"6^X7Y"[<KYDI.ZNYX+*>OW2D`G3.Y321R,<W&E
M,^2D66,9U8FJ?"=R%!OD5D?NPH52VI>TA>T4.T%-2==^(\T:S7%<D8T2$@`+
M)8Y2[@V\TI7?0$J"14[:$$4H#MH*U/QUUI!Q"33%1QY(Q=%^R7Y9+`5'^XXT
MA!ZCNT52E"0.NM5`3\.VJIKO^.1P1'E?'UO:M\3;%;1\LTAI'I``0A%0.HZ5
M!TW>-,L5#B01FNVLFF6KB=-"BS%[/!LZ)$\M,[MBD-(<'X6X`[2`0=M3Y_'6
M<D.)TY*X8XO%&DZ2FDY`S-]4]QM:6F4@;%I9H&BD]*J51)%`/U:J;EQ+P37)
M2XF%@H>:8R5>$R'5N-&@W*)6$CJ?!7A0Z@2.#@*)X(AF7!;J]OJ4W3J%TI4>
M0'B*_'3;F'R7NX:"DNH6EO$BB=[<W_OC?_=IK]X?>_\`U>JW_P#BZMO*;R'_
M`"VGT_8H2?+1?`1HX/V,HJ/_`%$Z^R_)8<P#WE>.^I9$1VDBB66NO_!-G^8I
MUTB.F@M;3N3S3&VAPU43C8A1=HN\0(2@L2HLL!*=O[UIQE9H*`_NDZ^2/YG-
ML:)MJOVMTLD9*PFE`=!UAH[<*\Z+U?Y>SB2&>`$$@@@#/M*7N*S"H2H2JC:?
MF&?\H>EMT`>%?2#KY<@D=(!&34C(=B]"D+P1H2A4=BRD_NE@FF[P-4^(K4:3
M<>Z.].\%IR6BKU('I2>E"#4&@IUJ3U^&JM[3J)X+J*&V7'7@A((45'QZ4I^G
MSTVNC/')*#:(S24@E2C]Y9->M`?B>NA.O8TG\O$(GE*>6H!HJ0`FGV'U'K_)
MH2HGN<ZARHG#XIS%>(WV4S/<6JRY#;Y-LN<=UX--A02F1"EH6LA#<B'.CM.H
M4HTW(`\]/0O\;6N-&54D.+349JRK!O<-AUAML,/Y5&C]N.W\XH75@!E20#M7
M_7BAL)2144*#3PU?1;K!"S2]X+AVJ3&WS1K?[U5/SA3WX>V.TEN-?N1L8L[J
MDH3(D2;NQ*94LE)4HJ2MUY@*(/P%*]*:O+;J#:&L'FR1AYYNHK2U=.9@P1N>
M#B:#@%.:\^Z'VFXA8&LF_ODQR\P,D;7,M-OQ:=*NMQ>>=ZJ;1;K0PM]I2'E^
ME;Q0DUJ*ZF3[G:QQ"2-['5I@#7`J8ZZB@=XJ5Y<4K.#OJ%Y=^2WN-A/$%SOU
MD[KJXW(^6LW*TV6#;8P+:&WH%O8GW2\!AP$I2U\N@DDN.MI!4*B;<3<CS:$P
ML.8R'I3,PANM,KB0*X4X^PJ#^2?6.]J5^RF[3<E]P<6P7],E=ON]MLUDSBWV
M*-,M*UVUP06NS/;0Q6-TH^ZGI4*4.IF?JVV.C87^4ZK<":&H[^]5LET87EC@
M[`]HP1Y`^J;[4KO`7=(/N.@2[?MD%<Q^-E"8R4PDJ,ONNRK4$H3%34J)-!32
M?C-KN3H;'$YPX`#CW)K]29_6]92)O?U+O;!>HS@MW/F`W5M:4E!DMH6E8ZTH
M+A9TC:#\>O36I@Z6W2ZMVS6FW3/C(%"V)Q&(PQ`5;==3[3;'RYI86S<G.%>W
MBHO9M[M>#LSDF/!S/B*\RI!=6S'%KQ"1)?0WZJMM/VD//40*F@-//35QTOO5
MN_R)=OG9<.:7!IA(<0.(%*J`[?[*?\R.:'RSR(^E1^O/)_'\MYIA^_<>P^^I
M28L9;>+PB[XU3%C_`"[)<H`?N)/35!=VL^WNT7T9A>16CVZ3[5R.XCNAKB>U
M[1A48K[#R?`2#V[GQ\]50V@M8NY_(7&:T)TPV5C<06^Q.AKS[H)2LMV38>&@
MVB1@BD+2\VIA+6.!*V7BE3J`V@!&UPI!5TZTKIR%\1DJ[0:USHN4(-.*B_[K
M+)Q_R4WB5CN>'8;DD2W-2ICBV++:I89%6XL*(94="U--M(0M0;24@;JD&NJG
M>R"YGPVD25&K108=M,Q1"K$Y:P*ZQY]CCY)P/_>]B>-6IVQXG>++(2UD5@Q8
M39$^'C5UL\IAQ$UFQO2G6X<IE32_EB&UJ(2D)@"Z;I#;HOJ,J-&2*IF7;5[=
MTNJ&0>W#DO&@E!"RK#+@^$+*?4"Y#S&)N3NZ;@WU'EI(?:R8,G<".;0A98F+
M^R*>M#,R#=,9<752A>K)R9;4H-0-F^WLWT"BOM/AI8C+C1DS3RRJA.Y@-M]O
MO&^:8OR!Q%;[QR;G>,7$7O"<8LXS:189&508RAC\[)YF5VRT1V;+9+@&YKK,
M=N0_(,=+=&T*6X.EQM3K>X.=P`X'@4)2<;<"XAE#5_Y`Y,R>^2;D_:YMQOKK
M+D=B.S<KI-4U<'H\F)"=NSKTF7,64^I94ZH%*?`:KM6OC7$GTE/PL:\'4G&P
M_P"G?[?\_6W`Q_$\[QBWR76N[F629/-CRNWN0I7\.8:]'-QGR'6]VU^Y*@L(
M/J[;XZ&QA?=2'34-%.("5$]SG%KL@%:)QU]%+V/9?%A)N<7FV,$-A"3:^1K<
MR/N)2I>R1ATE&]P]2HU)/V4`LX]K?*1YDCP\Y^`4"M(K>*4`.%0>U/,]_J_G
ML2<;K$S+W,6LAL42C.L,E!(ZE5._@22"/"AUU^S:7@?$.I_8">&WVN>D^LI6
M<??1%]JG'&1V>^67F7W23K99[K#O#N)7?*\45C5XDV]]$J,U>(=NLEM7+C)?
M;05)J@N!`!)'33K=D#I6:)@YH-34`4(R3GPD/X?:58(GVQ\=;G%HRC-MKS:D
MD*MV/N)2%+#@6DI>:JI"A^L:LC9OJ?&%#9:0->?+UEV.8H/6O!]JN!2%H0G.
M,N:"UI3UQVR/+"J@;C_RLT=M#U\-(?:/:TG6$Z;0D4:"#S4=_K#^TO%_;/[,
M,4RW&,]R;)KCE/(F$0+@U>X42VQH;##E\NC$NVP84B2W%`>NKC;NY;A=WI)5
MZ::[M,EA;;F#O$3)K5S'`UR`H:&N%#CFJS=+>\^",$;M+@_57.HPPR[%S>17
M%O1(SSJ=KKK#;CB0-IW*0"?3TH3X_KU@[UD#;J0VI'PNLA@K6@&6.9JH$9<6
M`O\`?XJ7GL#.[WS>SX!*NGN2X@\4D>&:6K^74>/^(WO2U^E+J\7%2]]9+VT9
MY[C<)X1C\;XRG*L@P_*LLER[<FX6JWOM6:\V6`P]*;7=9<)IX)FP&4%*%%7K
M!I3J(EQ%K(-"2GK:-KIM3G!H`XKGDN/TZ?=#;"KYG@G,5I0:*7":M%Q3X>(_
M+[I*40?+IUU#?`X4T-*L?AQ_>L]B3H]F_-%C47[CPUR/#6V@]LJPZ].(+J@4
M$E3,1U'H!)%*Z:\B?\#O4GFVX.`%3V)/2O;ME]NZS<.RV!M-?ZYC5X8(H>M5
M/0D>>I4<4@8`6FJ:?"]KJ`&B(Y'$LZ+5#L66PKQ_'C/,%/4`BBTITORW\BD>
M6_D5]C\?R6*`[55-!N2FGC\"`2!\-<+7#,42%,/VT^V&RYH]=,VSE3$C&L5E
M0V8^)1G5L3\KN[[2I3#-R6W0V_&&&D[Y#E>[(J&FQZBH<`)-!BG28V1Z@1J2
MG]RO-3&`Y%8\.M<%%SS>_IMCEMA(BJC8_BV,+N*;.S<'VVU-(3#CJ9<9@P8Y
MW.K:)64(25*=9;.D=B?#Q'8H`G$<@C8"17/,8J=6!6YZ/A./-NA`6W;D@EM/
M;0`J2^H4;!-"4J&[XFIZ:>@+_)`?@X$^JN"?H*DC,H_<BFNU(]7B3U\/UG3J
M%J.Q2003ZAX4\14BOV:$*5_MCMT*99^4HTIX1W7(N+*B[T@APM.7TN)*E5V]
M5)TB1K7LH[@H-V7AP\O.HKW52PQNY7>TS[C:IJ4(]3B82D.%8+"CM1X&@-3U
MU!"D6_%,KR+#D1V[Q(>6H_,**@DD4ZC:/Y#YZK_+:UQ<,U/\^9XTUJ.Y(O#8
MI&-3'UK*4.-.I""JB22CIY]`3IJ1C:%W&H^E26.D+`PYIGN!H$JU\B9<X\6P
MEZ2^ZWM4E0(22#4GX$:M'.`:!7'2H]PQS7:B"&T4X)EDN>4X])8MX86M;B_%
MQ*=Q]71-:@FAU&<)'>\#@F6N<WW5$+,.%,FA9QBN0&%%#-N>2J6X2>^D*>*S
MM.VBA3[=2()I'6SHGGG@I/GQR/!(I)2E?J3WY.S,G8M?&'6&Q;T0CWG0/2@%
M'J"OV2%4Z_#5;9,<9]5#J#O"I`<\>%*CVGF`W@TR/;'&$QDS-E&R@`$(&ZOA
M0E5=6K@0]SI/?<:FJBW.LO\`%R3UY=+C1G([4V],VQAYIQCOJ?:"&G)%4(7Z
ME4JE77].F)G1AE'$:^':F[6!WG`QM)`SS4+,LX[LO`>4+R[,N3>0.3I&4,1&
MXMKO4F,+/9XK)?D,-V^VP4I8%?F#O=(WN`)"B:"F8^'GLY]=U("UY)Y4!R'>
M%L[B[_4(Q:P0QQ!K14C%Q+12OIS*FEP_RIQ_=\!O<`X<9;DZS2VHS?R067TE
MA8[*P4DT)7X#KK;6;F,MV.CII&-?2L3<QR&<P/=^;6G).Y[2+OCG(7!#MCA6
M:/8IECN%[Q^=:@TAN1;70^XY!<4@C<QN;(*4^`"=.S-CNW.?+XBXXT_<H<D<
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M#>[2*9Q-"6NH1V@-H#R4T]9,&4%3_6)"2TGZ"7U"MJE1\F]N<M3=2E*<_P`U
MC%P^'0/<=$`;37K2E-;&+^8O8<`^TO!AG5A;Z@-7=CWI0ZXC&!CH>68]:)'/
MH/?4?'<#3GMZ>2V$J[IY7OS*5%5:MI#N``U"O,T%-2?_`.XKIS_I[GU)0ZXA
MJ*QFG<DQ?/H,_4V=C+<A1O;NXXEHGLN<O7>BU="&PZ,#"`2KH233XZ!_,7TY
M_P!/<?YJ[+UM;DBD94<LE^B5]8>Q3')UHX7XIOR(3:'4?PWSIC)5/2D[514,
M7"-:G"[L)(4KM#I\=5G_`+^]CUCRXYVU.-6\%7,ZROFN)=$P-[TS+?LQ^II[
M>\NE<D\@^S#E.)9,5N,7(KM=+//Q7,K0N+96%,37W9EDOLM]+$B"M00LMU2[
M2@->E=U5U_TQ\Q]BN.EW7$MO?2LI%A@75!!<>1IAVJVVSKN"WN1/=1D.:<VX
MYX8<\U++D'W$<9<Q\82K3EUMSGC]Z;!BNK=R7$K]89=ED,J:<"W3,@H8;6R4
M'<=Y01YT.OG+HWI'J;H?JRWW*2,R,8[RW%M?$'.I6F50#5:GKG?]FZPZ*N]N
M@(%V6-<PNP(+`20!VJO#DJP<D<)/67,\;R"V<B<;9"TF98\IQ^2N1#ELK3O7
M'<*"I,>>T!ZFU?>I5/3P^PV^:Z$7$N##Z*=Z^&I*-N76D@I,SGA6J>#A;W7V
MF9*98N,D-A82F3'=4I*F:>E;12HU*NOAX]-0GW1B&IV+:H?#A1@)<ID77E/C
MZ^0`\Q:6GG4H2ZJY/1W)K-O:2E7<F+B1EH?D!M1^ZFO7RIKDUW_P;IH3^;2H
M`SSRIW)ML!D>(Y/"TYD\%@F9_A]XL&(*QV-+CWQ,U5ON<]1>81<F69,J4U=6
MXCS;"XH=::;9HA*4JIOZ;J%K8[J\FCE=?FCB:QM(`+0:>'M.!SYKNY06D8;\
M&VA#17$FIXG%;\1U;<V3=5MH?EI`0TIY5:)'K!&^N]0[9UH&N+<E3.8U]`[@
MFXR6Y*7?C*>V%SLI;4E'@%$!5*CP.[XZB[D\.<T5QHIUI&!`2T&NI:",C7%)
MWN%)2-HW.;]I'Q2>H-/M.H,4KFD-)\*)(QB:>-.+@?*D.W7)F-/E)2Q,<#6_
M<12J@":5HD$4.I@F:,`X*,6/`K0J2\?%85R?3=83C4IMW:ZVZVM#@"7!O`)!
M-5>KP\0=:>VE>;=M#54=R02'_>*;WE&V+@VER0I`JE3;0&T`A;BP@))`\:J/
M34N4TA+G88)J/5K&G-1<S3((UBMYBK64D-44EL@N*70JH$J))`K0ZQ\TAHXM
M/-:B&%C6##%0KR/(%W*<M9=<(+E0"LJ2D4("B2:>'358]SGXNS3Z3DBXT;#3
M*JE0H0NH34D5*0*J'7I^O4=C*GQ#!=)0CN**-Q65*-4U-#0"H(\_/2I<+=]/
MP'ZDW(2V,N&8%4^_;7_1/_=JU3__`,74_P`^3G_[+J]*I'7S;R4ZK;^?H0`F
MH#5KMPJ:TZ_U51K_`":D2?.?KF84BO+0D'[MNSZPK4]);"/]C[2M0\L\G.@[
M<FNE>H/9A04'U?`IA@"@U&D^:'7T[?!<R^8['PL:!Z!3`<@I#.F>G6M`D@C:
MT<22I)^V#,LUO6:7^T9)<[E<84[$Y4F*9Y9#34RW3H3I[:6VVU!U<5YP>!%!
MK`]==1=5=1;7&-^DFGAMYM3`YK0&ES=)Q&-.*L]KL-IV^X>+`!M6_=R]9Q4Q
M[5+_`"Z[,.K/X)66W*]?P724J_10FOZM>3Q2&&02`5(5TG03\H5*2LI*Q0)4
M:]=U:'KXI'31)*9,QQ0L#D$%6_<G8K[I0*$JH:]10T`&F2-0H4+0<+41*BZE
M:U)-`=W0]0:G[0#J.]NDT"4M==VCFJ0G<1]HJ#Y%/VZ;*D0<?0L'S:'U!*4G
M=6H)^">I%?@==337%CJA91'0^XD(6A2DJ2&Q5)*E+H"*'SJ*:ZUH<X`IYDI<
MX-(1O=<;;,%^.AQLR'(SPD)"0HC\,J`7TH2/TZ:N(6ZJU.2LK?!OI3.7"RM0
MXK4%AI)N$QQLM-)ZGMIJMV2?%9Z#:*=.M!X'68WAVFV\MAI<.]U:O9(I)+DN
MC%<*>M.WAN:9KQQ>X4:RST7BQV"S,7"^6:X,F5;F986]-7$->W,A."/V@H-.
MH`4L`BO355MF\;A9TB+RZ`8N:>8XUS]"TUWLEI.&BE)<!A3-6HY;]0'DR_<2
MXC$OEFM^`8BQ8B;C8<2=FW&?>(Z(R4[+K/?$<QV)\QU(1%:;&[[JUJ&X&ZW#
MJ3<NI61[+M5(K<O&K36KN)!/`+5;%M^R]%M=OV^>(-@=H:X`M!-0'=^/<N;#
M.\6^;G7J_7"?-9?N-QN\Y,-99[J%3Y;TM+#_`&GP\V(ZGCXH]5*#6KBV^6.)
MK&M#2&XBI./I7SS>7HNKI\PI5[W$^DFGLHEO8[N;-PK;7)S+5U;N-^N\!,..
MTH3+@T9E'$EA3C++K#3+8+I*DT/7Q.M;M#3;PM?)&TOY\^]4MT7-D\MCJ4]J
M2E]RAK#L1&3JQ>Z1K0)3,5R,J9CS<J1(DN%N,AE08NDMJNTE1J%;1\>NO0K3
MK;JC8[:FW7U[;VYIX0X%F/`5Q`Y<@J9VQ;7=RE]Q$'2&IK4U[4H^,\RD93;X
M&8V-MO%UE^X6]7R,$76\,/1QVWD.W>[.RHRDN-.A54Q4_>Z`'5[M'7W5=Y,&
MMO9`7>$O(:YY!S&IPJ.PC+)1;O9MNLJ201T(R%30)YD3X$*#<<BN++MQG6VV
MSYS]VNDA4RZN-18[LIQE,R028C+G:`[326VD^2=0.I[.#<J7.X%\UP&TU/>2
M<R?1W)=E.]K_`"8_"TXX>I-1P9SK(Y7N&0V^ZXY;+.]:XD2X01;I,EWO19#Z
MV'6I`D5_%CJV>I-`K=X#S\XLK3;;QSFB.A:*YE7<SI;8`M>XUYJ3;!C`I5V:
M`BI2E2@>HZ==3)=GL`RK6D'O*9^/DIB`3Z5OMN1$`[4OMUZT0^JI(\"4UH/#
MQU&&S6#G#4TD]Y1\?)^%OM7AUQ86W-@ORT28Q2"TJ2[VY3/WEL*H2$$D520.
MA\B*@HNNGH1'YMMJ:!F,ZKOQTGX6^U9[==7HOS<N/=+L]&4E]]VW2I4@OP)"
MPM;J$*+JB6''%;DH/W#7:K:4I$=^TV4ML;FW>[2".`3LET]C00!5,]SOFF/8
M=9L=O-YA7S*)ESO:+1:+-!^3=^<E".ZZ^B2J8AQ:&VZA-`DK+A2!2M=-7>S6
MEJ`7O>YASR'T(AN99I!&UHJ>],KQ1[F>*,$YF9S.[6[+K+86\#O6/RHT2UID
MOQ,GN'SVY;ML%Q9!:CE++!<;&[JHD4%#52VL`JVW)T4X\U.TO;@\4<GLXE]W
M_&5KM"+)#O5^@Y1<G(46"\W:9,%E"S+??>2JZK4$1E/MT;30*W%="4BIU'MK
M5[9`)_#`<R,PG&2%F`%:J2F"^XB9D3$9-HY/N]FNDD)DMVR?='H5T7O&VD4R
M"VBXLI4FH<CEU"O$*ZZWFU]&V>Y0B>'=&,GKA&^-S">XG`^A4]SNT]A)62!Q
M8>*>D^XOF_%(<R?&YKSVVQ+;"DSI+C-YDH#<>$TN2^X@;JK"&FB0/`ZM9>@=
MSB8Z:2_:UC6EQ:(GN(`%30C`X8X*/'U)(^4-CC>UQ.%<DB.+?J5\U<L1[XK#
MN?.6F%6`14S$WMZ(R^$7'OHB2V$J$UI]LJ84:*H4J`!'75#8;)N&Y0R2;9N+
M"&`$!["PG'D<>&"MI-ZDAHU[7EQ%:C)8L3^HO[Q)N/XZ[=N>LP$Q_.86%7HO
MLV%:GI-G<N<2^K(79_P$7!^W;QMV[0X"F@U76T.].#G/NXPP2E@P&;6N)]H`
M3[]SDU:8G$^$''M4@,:]]_NW?@1G9'.%P95(+JD&=9,;<0B.XZOY=)I85DCL
MTZD5\]3[/;>H[C;V7LMS$W6":`>K--G<FQ3:0\U+:HYS+ZA/O(PBU-7.#S#9
MKJL?(O-/_P`*XM.2$N2'(ZHRFW+''*7VE-@JJ/ND$'RU37EUO5CB^4.`SP%/
M0I3+R5X#FN.DKUD'OD]SOO9]M')P]R/(;.?6WCZ3Q/<\1M`QS'+$Q9YEQS.%
M!GS4IL5L@+E]R,\PU5];@0!Z0*DFO?->W,!O9#^54MPPQS^M2!</EMI&OQ+:
M'OKA10I^:(`VL@$^("@!T\.M/AJF4%2V]@DE:O?-[/$E``5[D^'P37PKFEJZ
M4\]+C_B#O0OTHM7BXHV<_3Q"D8N-R4]QJ['K3<=BX'@3X`;M"Z,U'LWRH/K'
M44KO1_LZXIRU5W11(*7R!Y_B`5/V;3TT539CU8.<=/)%4ZX**"%.J<3M(*.X
MI:>@)H14C0CRR!1KB&INKO'A2D+#\2+(^^?QXS#HH:]/Q&U:*KNEWXBFBOV*
M8Q,KW\:QYTD!2BY9+6L_>%3540DGKI#V!XQ7(Y"XD%,#GN4GC]B/A6+6+'[0
MOD6XQ(CV1,0([5PLRT0+XN3-@1FTIBO3C"MP9CK>0I##CH<HO8&U,1BDU.`J
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M4R%@JJ0=V^NTI(53P`K7]&H)S*D0^]Z$G,/?><P%U2=[KP;=!"1TJE)]12.G
M0TTU,2V,N&>'TIYLI;+2@HH\<7/WK^\'(DGYA3KJG4,LH2M1HMTI%`FM*UU)
MU%Y:2.`4F5HN(:.-*8J<D1>76MBQVZ&EXF0YW9"&D+4X*T)"PD*!'7SU+^A5
MB5>5W2<'(\.6RZAPI:ZNI*:J"?425#K0^(U`?(Z&I`J3AQ2HFASQ4TIBG,M'
M&<J[X'<V/E9,A4^$O>4-[FW=S9*1U!])W>6EP1GRFR`D.Q/M4IUP&S5=0-!^
MI0`P6T2N,LAO&/7EV\6F)-N3R(\!*U("BZLA+S)*@D&AZ`4VC5=--/-+B2#6
MBN',M_A_/;XN]+SD3BV=DC^.]F^7Q5E;FIE7.#(<!$Q"4*4RD.MJ[J0%[2*4
M&ID4$D#P^<:N0*A-W&VC]P4JGP<Q5G,YV/P+C;%S_E(<2'&:>075!#2$M"BE
M@E14E.N36[+J4.D!`KEP3IN'1,,\>9'TJQ_BSB^PX;98BD6B&S-=CMUJPV5,
MMJ0*H-4TW'[!J_9"R.(1,]RBRLDKY93*[WRFWR/'4\0<JL\E6"+\OB>8L-6?
M.K?%&R.U,2X!!OJ64I#:'6B:+5YITJ.,`>7'4RDUH<J)))=B2ECROCD:^P;=
MD5L`5.AH3)BS(HJ9#)HXE*EI%5ME)Z]=-7.0HFXF20/UN`P2(L$L7N`W)[;R
M)36YF4P$D]MY!*25`"E%4Z:IW5UGO6BBD)`DIB1]*-DVAY=5&.XI(K3>V2$F
ME*T2GR^WIKE2GO//(+XFV]H=$%2BFA\$D>70"E>NBI1YYY!!-NV[34E?B4E1
M*?/I3S_7HQ*2^0O&-`ML6]T(W!!H1U"&U*\>E#M'VZY0INH6`6]2B=\9T_:A
MM8K0^FJ2/+10H69,!XT"&G=G4&K2CMZ=`:CU5T4*%I2H?RK,AY[NL-,M+<>?
M?)9980T"MQUQ:MJ&FFVQ4DD`#3T49D=ITO=E[N=20!GP3CI"\`*A+WP^Z>3R
MA>U\8<>7!7]W]AGI_.KE'6H#+KM%7U3Z=J_R6"\#VT_[HL;U"E`/J#Y>?+B#
M:+#]4WP1G=)F^&,TJQA&!''5[%7NOHFRF$Y@_0JX<[EXI:,4R#(LW,.!AN,V
M:1=LLGR4LK:1;F&U;X3;;_I7+F.`--M^*G%CH0#K63LL[*,ZB'$5P(;GSKG5
M-[CNDTL!;"XQQM:22,S08A<YW%WOFQ[DWW!<J<:Y%8K+C_"O(%R0Q@>,0&(L
M2!BB[4PB$P["0R@--393+:7G%IHIQX*4:E1UCMFZHBNM[EVNX/Y8%6C&AI6M
M?9DO-=XLI'6QW"$5>X8'BBSFSA&XX+?9=TQM2BA*Q+CKCDJ:ND%RJV)*-H2.
MYL)W@'TGIK2;A`YM&NH(SC^Y4]I=2.?0MQT]O8O/&W,S*&3;;O=X]JD0T@N1
M;FETPY7;\4+6TI+C;@/J"@>OA0^&JQL@:\1"E%8.9K9YIKJ*EUAO,/&UVE6:
M#:,@1<;RFYQ!,;35F%$BJ;>;<+2WCW'MLEQ"17P"M6%F0)ZU&2KI@<<."FD#
M':A&4^XCMI94ZAQ"DGHI!V$J'0J.\ZT7A\MKZBKNT*KH5&C+LOMD5R4$7&(7
M4N*6H=]LN'X>>Y12/Y-4MU/J?JPJ,%9VH+&Z!6AQ4?,BY6C,]P(GQU[]P4`^
M@!)/AXGHNGEJ,V74X#!/.BU.J:U3,7;F%*7.W'N3;;@65-J^92D@I*?`[@FH
M\=/8<PCX<9&J>3BOWT91@#B8-UEHN,!M6S:\\EP]N@2DI(/P'Z"=28;]UK&&
M.>:<%#FL8*#PJ2M_^H=QGE6.2K9<+#,-R<2T[&>BNQTMB0RM+B`XE9KL]/7S
MU9?K#',TN=4$*$W:XVOUAS^Z@4+\LYM.8S'7V%-QT.K_``PIQ/I0"00:*/6G
MAUZ:JY9VZ7>70LHK5L8\NN-0/H2+<OJ'$=7&EJ52I24;:^9J>A"2?#41C]0Q
MHFB"%JMWAKNI)?:6Z:I2HJ14#Q('7_#TTNHYCUHH4HH=XA1V5K>?C^!6$EQ%
M5?I56A)^.N.#7QO:3]PI$H/E.P/NE/+_`!K:?^<(G_=JK_:/+^755Y3>?_VO
MV*73L_\`8U1(EU:11)V#X)`3_/XZ/@K;A&QO]D+78KV94DIV]YS;TZ;^GQ'2
MNFS"]ITL:=(R0GQ]MUY=M_,V%MN/+^7NLB?8WD%9VD76VRF&Q2M*F2&Z?;J@
MZIMIKC8)F`:=&))[JI</\5O]H?2K);E'4V^[5*D[%&NX>":D`$CI6NOGY[PQ
MY8<PKZB5=L=7.@@`UD16PV>IW.,THVL?$M@;3]E#I2XMR#=W&%B+).Y*O-8/
M0CH"?A7_`!:1K!=IXKM$?/1H]S:6$*0%(3U22G=ZCZ5IW&I34'[.FN/87&J*
MI&RH;\9>U75()JH`GSH*GP23333F%N:ZM<BO@5`^>TD5`^-.I`TA.O>'-#>2
M.K.R524.+"^VS^(.WLWA:2-E$J!%:]?.E-<3\?N!.#;;.%D.NOS@9/<VLA2E
MJ4%!1WR#0T2H&E!T.G&L)&H<$Y2H7N!AD6X.(GJCMMSVXX#<\IWJ;+*"ILK)
M)0EL+ZF@KJJN]G@O=4K/#='B<E<[;O=WM]&,QB&0XJ4OM<]AUW]R>0,6^9R-
M;,6Q9$XO7!;%CN-RNDV4X^5J+[3TUEF<H.'<D.R6VQ7<4D@:?VWHN?='"*>4
M,C`J2`:FG+O6H_Q,QS0;<.%QF:T]/M3]_5N]I'%'M6]N_`37&S-ZG7VY<NR+
M;EN7WZYR9EWO<=C"YKL.$J,RIFT6VTM3&''&HK#(HOJIQPBNMW;=);1LK(X+
M77YDV#W85XY++]4[Q?WUHSS9'>7&,&\,U0/F%M5/M1-DM%BDWKO,N!=V:<=;
M=9`VOA:1(;;2Z4T((2.M=6MYM5MY8;;%WG@>\[ERP7G_`,;,<#2B;9UV[?)V
MJ!<6+;&D6_YI"(EK:4W;XZI,DNNJ9;=6\0Z\2"M6[J0!X`:9MS\,#"[%PY+L
ML9DI0HIY.P>3D.%*D.R+I-<AW>%+AV]A=&8D=R,(4I+,=I!^82XM`=)6"4*)
MH0#I>XZGVE&@G$)4$S6OTT-0$I.%;/.P_$4Q&V9#:9EVG3RS.25+;"VX["2$
M%"2A+O8K3SU9].C2QNK#'ZTQ?R"7!HR3S7<7"^PEP^_":@/VV\P[E:C!84W=
MTSX#D6&AUY9[D=J*\HKHD@.5HKH-6^\$&+PFN"BVA\N36<0F<X4X]EX;=;Y=
MIUE:LSLFWQ[>SV%!/=3\SWWRA*'5I#8#2/'S\//6-VV!\3WEPH"!]*M+DB<`
M-PH5)R.\HH"MZJT&WU>JA'Q\=6KW:!4JN+:.+>2,FWCZBE3@(36A<-3]@Z_9
MH:X.%0N9+V)"UD))<Z_$DCI4]0333T<@8*$(JOBV6W5K6M3J%.,O,N.LT#BD
M.M*;HOJD+"2JHJ>AU"NK%MX2^-SHYR,2.(Y*5;W<C''S<13"G[U%7FWF/#<?
M9R3`(<O(965IMP91-@1;6JWVJY24`HB39DUV0\P\VTM*W%1F@\CH$K0JI3E+
MG;I;63RWOUD<<<5:L<'M#QQ%57_.=<=:E.ONK=>=*G'775%:W77'`MQ:UJ)4
MXMQ9))))))TZ]P<01R2UFPVJ\ELR.E!.8('D=J]QK_MJ4)\=1KC^`Y"M`XTL
M+UZXWL5HOUD?7:VH[HB6VWW"VFTP6#+?6Q\B;JU*NK3G;(4I2E@[B2D@4&M]
MLFUR[ELL!GEO'.#"&4<P4;RQSQ]BH;V=L%QJ:(:D4XHYR'&LBM^+W^UV+)LD
M599MEND&;CU[5&NO]2DPW6I#5IO;+[T^WOJ844M%3;S:2>J0-39+'>MNLWQ6
M5Y*YC8R-$IK3`X#2F8+BSN)F_$Q,U@X.;P]:93V\VS%<.N>0-VJ[79FXWNUP
M(Z[/?EQ8\AP1)+CX<BL-QF1+V!?12%*!235(.J7I+<)6226DQ`G<QIQPKB:T
M)Y#@K3>#));![!YE`!0<`$X-BC)N=]SR-,=D(M%DY)M.9N&+5M27KE8K8MII
M"4@G;+NIJL`=4K4?"NJF\O&7;1;092W;FN_LU\13T8=$/.>*`QLP]!4B'+G+
M9HTAUI#;:$H2*^E*4]`$C[VQ(%->E/8V.W$;/<:T`=P%`LV_Q2:A^*J1&77V
M;*M\>W2'8J8\AYY25[G&W>]'84ZVE#8WEQ*D!:U#Q`14:\OW_P"\KZR/FM#Q
M@`I'^TV(B7Q![@\;?E1B!@6!W)<@N!IDKM/+7'T13VZ2EHI:6J6H)*@"=PZ:
MI+?QV9CXZR?8KFW.AD[SB-`'M*/4X=!)%;A!4*_L2&G*_HV$ZBO;JR492Q]B
M.+VZ)[V_:1(1);<6S[BN)'$A"75U6C,K6H)JEM21X>9`ZZ=M6%LM3R0OT8M6
M*%#GW4RA&F8/5PH2MB_U`-*E*[53[?/0NC-1:;N9<!'<6"D5)W'KUZ4!UQ3E
ME^=52O>6?T$D_P`@-="%A?F`!.XT)/0)H?Y>IIH0B.9**@KJ!0T%:=?6.NA"
M1UR<2HFBD^M))ZC[P\//0A1UY[2TG$,6D$([T;EG"%%T!/<0S,MF6VQ397]X
M-N+FIJ/`G70H=S_&;_93.YI/;MW(W'DQT(4N5PS?&6P2-JE6W+,8<`44DTVI
MN1IY]=$?@>YQR<VBXSWQWJ??&F6VB!B<)N:PM;DIE$E"HZ=U0\4E*"M9`2E`
M\^IZ:XIJ7EPS;%5H72"N8H!0;0N*T$[B/!3JSZTT\QH0FU?FVE]YQYJ$S'2X
MK<6T)51'0"G7]&A"2.6JM[F-Y&TVQZG<?O*4[4J-%*M\D;Q0U!37Q'4:2]NI
MA',)!D#7:<5'+VZ[I/%-F<4XZMP2[H@NJ6M;@"9:MJ5+4HJV@=`"=(MW!]LU
MXRJ1ZDX4AN-&Y0]RG.L-]^4_%(M;K$=Y]YZ.RERT6%P]EE2U--`DDG:!XZB1
M?^)3^A$/_+'^VIH8U:K;)N"8EQEF!!6RZ5K:4&D[P`4C^B-Q^SKJV;`7-U5&
M*XEI)M/'EK#JHTN;+E$$UA(:0M2Z"@,I++8`!'VZ5\,[F$AT@:[3Q6+#G]N8
MV1QM;Z&Q)D$)7(<=`!BR``5*("J)/F/'3L,9CK6F*1/P]*?2YJ2^7%.%+E5'
M:7`E>TFO@55Z]-2&MU&@4>M$E)#TI*BEJ5+:2!3:W*D-H!(K7:AQ*>H/PUQS
M=)HEQ^^$1R;#9+HI*KM:+7="DUW7*#%G+!_I)7*:=4.IU'DB+W5%,E,+YAA&
M:-1S$XNXPG-+:GX5CSK4D;7PU'7#4M/;6W]^"_'6D['E`%-"*Z;^'=S"<BED
M:3YIJ$$^SGVS7A&]>%7:VK4@=;)GV>6Q2/+<REO(7&6RG_:4U*:`&@<DN69K
MV:0T'OR2-R'Z?'`\YIURW9CSACY`)2W#Y-N,M#=?\FZ1I:R*?Y6B@4?RX#BY
MM'<FY>A1FS#Z?F.QTNBT<Z\I);%2AF^R3=6@DB@"BQ<8!4:_9HP&2/*MN3E&
MS+/:?G>.)V6WERY7!EEKMMHE2LD@!03Y[6+Q);0%$^0T+JCS>>/^2+"M;:LH
MN:DI-"Y"R2\M!5`2:A;S:E$?;J.6^4XRG$<N](>TN;1$\>X<S80U#R"V9MGE
MD;F+_JLZVYC>(RW7&U.I`*8US#E:L*IN3U`TZ")(\,*I@Q.#2:Y)V<>][WO'
MQ0):M7.>:26D'TLWU5LR-`"?V5?GELN"RGI_2TS\.[F$SBCVZ>^KWKY.%LRN
M;,GBM.#;LL%HQZQ$)53TI>M-DCR*4\]^G&1:#5Q!"5'$231[SWT^I,SD6>\^
M9<2YD?)G)-Y4[7<;CEM_6C^E^Y5<&FD]*^"133N"=^&8/$*ZTA/RGDR4?ZK>
M\U?=ZGM,77(Y3B@>NX)CRG?O$"FA/L:6-HO(XIY[OB%LQ+9RM(9D;@YN>RME
ME85THIR2^PS10/Q\]%`E(U9]M_N1FH*%IRJ&RL%I;=US@QD;*>I+C2[V\XI&
MTT(*#]HT(62/[,N3WJ&X7RR6Y-:J)O%PFN)*NIW)APU)5U\?5IXW%UHT-FE:
M*84.`30BI)K[5L77V6246R8N^YTS+C):0MZWHL\J7$D%*P`'1<)P;6$DU%6S
MU\-,^=>L\8GD)&..6"<(:X4(P*B1E'MOPW'>1L">BQ(:V\EBY;AJEHQZS(W9
M'%C,95C#;++45*TKG1K)<V@K<5E:DI'CJZL[ATG3=P(!_P`7:W+)JCWO+>',
MET_Y3FDUPH%1W,+(=QM@<+642,=_:IJ;ZP"I1+]B'+XDJAIXSN]Y4PP'$N1[
M=$E1G67&TN)^5?<<#+P4D]$!6ZM00"*:HW2WK11L\KAW^U6;;-FD&W;XJ<2,
MD59!P-?\*BML9+Q'.L"$-?+MR+SA+,-I:VT;0!+D0`PXM:AT(6:ZJ9CN+I7.
M$LV)4AC(X!K>T^8T8Y475Y[)N+>/4^TOV[N3./<*5<#Q/B'S3[V)6`RER!:V
M>ZM]U5O+BW5+%5*)))ZFIT]$^Z:P!\DFKC4J$:$DTP*E=_`&#4VG"\1*:4I_
M#=FI3X$&$133OG7']X_UIMT4+LVCU!:IXQXX6:KX_P`'6?BK$["I7\IM_AKG
MFS_WC_6E!L;?=`!6,\5\8JZJXYP-1^W#\>/^&W:YYD_]X_UKJQJXEXL4:GC7
M`"1X5PS&S_.;83H\V?\`O'^M"\?W1\6?^RTX^_ZEXW_Z[-=\V;^\?ZUS1%^$
M>H+Z.).+1_\`,UX_'Z,,QL?_``LT>;/_`'C_`%H#6#%H`*R?W4\8#PXWP$?#
M_P`QV._^N[1YL_\`>/\`6C2PY@57W^ZOC/\`]EU@7_4_'O\`UW:/-G_O'^M<
MT1\AZ@A_=7QE_P"RZP/_`*H8]_Z[='FS_P!X_P!:1Y$'X6^H?8OO]U?&1^]Q
MS@9'E_YD,>/^&W:/-GX2/]:<#(V^Z`/0A_=7QC_[+G`_W79_Z(8]^Y_WK_-W
M[O\`R?#7/-N/[Q_K7<%^($B$5`DLD#RHG_%KZG^'=^%9%TND5+O:L@MYH2$=
M!X@CU&OA0?9J487"$4;XJ!)^(;^)*G"C(L^98I<HS:OF(.1V.4UT`)4U<HRZ
M`_%201JKW*W,FW3LE:#&8G5!XT!X)V"=OFM)/AU#Z5<!D$*DE]70)4Z:C:0:
M$^'7HKKKY/NXZS.+1]]WTX>I:L.!%1D45VV9\A+;/4H1Y>1"J[@1X4VC49CZ
M'Q%"6CUMB3E-K'1#X26'0>J5JKZ"0*$@C4IL+GC6T9H7E=AN\)Q*XZEK"0`D
MA)!I0UJ2#XTZ4TKR9.7M0C2.)CU43[>ZZ4[0MP,@U`Z!-!6M$CQ'4UTA\9;[
MX0G7LW&$*_VZ)<(T?8U(4H*24K#B'4#J@I("MOZ1IR.R,QTTH*50G.QS@Q"D
MMNAE*25>A)0L$J*B`%(ZU!I4:F,L``&!H)[:)^-LF!'N=Z>&R^UR\W6?&=93
M(0R^MO>EEEU1ZFG@D;P.M.FDR;<[53W>P9>Q36QO<*@8)?8C[.;]/^1;4I8A
MI>=1+2EM57BAQ;10O<=P#9'ATT]!LKS7-=\F3E[5:K[<.';-PE$!9J'26Y#Z
MR`5E8]6T`DDUJ.G36KVVT_3VZ7$N#N)X5X*PAA#"':0#10?_`-8/RV3!]E&(
M9A:F8KDJ%S[B#,3YYCN,,LRL0S!I92A"V>JR@5"30$BO72M]>^!D$@P?7#VJ
M/N;!*QL;LG8+F"XZNQS?"K'DTAN(Q-N,=\2VHRW>RW*B2I$-Y+27%N.(0I3&
MZA42-VE1N?,P/<!6G,+$26YCD+6&K:K6GVM+,_U-JZ*220"$BA!!'PU37!(G
M=122E([=+19XL8WB\VNTHE+#<<7*X181E*%$@,B0ZWW2G<*TK2O73@G&D-<3
MDDAK0:@8HY#(5L+)2II80MMQ*PM"T+&Y+B%))"D+!J".A!J-66W25+L?`HT\
M;G5<,J(\CPU;*D@D``T)"J#I0'IT"M2+J9@(97PT3,,3RW`<4:,QD-NE*J.+
M0A+A0*BJ5*4$]5`)!)0?T4U6>8\_>*D:9^?M2ZM*[/1"9K"FQ04<Z+2!XTH*
M'PZ::=/P<2G@QM/$!J3GVR)A+J$5<86:#<D!*#0]37=504!]FEQRY$$Z*KNA
MG()4-X]@[R"=A(Z5V*W`>="H4H=3FR,=D0CRV<@H_>Y+-\%X9X]GWN`M$K++
ML56S#;4IQ*N]='$#NW"0V:E5NLS*^\[_`$E[$?MZ9N;ED$1.JCC@*?N2FPM>
M:-:%1T](D3)3\R8^[*F2WWI4N4\HK>DRGUJ=?D.K/53KKJBHGXG69ED?*\N>
M2X]JGL&E@;R"R2%%41P[0>@K7R`6GU=?,:;2DH.-8QD9MCC)`(>N<1":BI]3
MR$DBE:4"M1[D.T5^YQ0K>K!`=MT!J$S1++"$H;0$DH2@"E!3J*^/V:W>U[SY
M5FV.M(@,!7`=RSU[9LFEU$4;V#BCAR)(?2H)4*4H`JH%#X^/0@TU.?O;7,(!
M%3VIN/;6`@DD-3?Y7A42^Q$VY]4=E\/H=@SH;`1<+5,2?PY<1;/;6EUL@>DJ
M`6.FLQN]W"+9GP[&B=KC0M&(KQ!5U9QNB<0YQ=#V^T43[\&<'0W;#G$/*[W&
MO-YR*1"DV>Y,M2+4U$>MMBM]HMHO+8?>+KS8BEQ6P*3O>*@*FFL[8Q7$;SPD
M)J,>)S/>>/-6$SF2`-&(`IZ.`3PY[P4U;V53+2^%ME.X-LO2)#@%!7JZPT@G
M<32J@/CK0NWW>8QHDHZ,84&!P[5`?M]J1X<^Y1&RRPR8#<;YIA87$N##KJ%U
M(#*BN+(/PI\J^OJ.@IJGOYWW31([!W$(BA,+M+/X:FC[)+%)6_SC;41(\U]W
MA60I$24ZF(PM=MY.XR><+KRF7TMA"(N\':>OZ:Z@1LDT_E^ZK.THX3M.(T#Z
M2I.(Q3(DG:FT8PR`?]TO4IPI'4T2EFU`$FOQ\='DR<DUY4G)26]G&.W^/[M_
M;(Z^WCC;+7.O&+KJ8[US=?[:,KMI6IDKCL,ER@Z;NE=.PQO8^IRHDF-S15V2
M[N-24E0/]YMVBVV?QXB1*CQR]&R52`^\RSO#;EE"BGNJ3NV[NM/#0@*'\3(;
M<^%*;G17`T-SC@DM+0R*_><6E1"`>G4T&N*7YK.:W_SR$:'YZ*H*I0)EL**B
M2-NQ*7"37R\]=339/&22=*QOWN&E!3\PR3U&U3[8*5$>!3OW!0.N*0'-+=5<
M$4O7ELT`=3U'0[T*\Z^G<:$:$CS6<TG)EV0OH@MJ)'WJMG:KR%0:=?Y=)<YK
M,7(\UG-,'SL]7CIYY2JF)GG&$U3FX#;_`.;&#`^\?`4N)'Z-<;*QQH#BHDC@
M7:G'N3`<BR`,HX3<"@._QYRK`(2I*D[HMXXZDH*MQJ2`A1^S3BZZK,3RJIK8
M,X)6&V%Q#P2I=N;`<3MW)*4CJ$K!!VD]`00=<H:X`GT)^-]&ZGDT.2C+[L??
M3[>?9I:+'=^;,FN]M8R"XKM<1&.XY<LG-NE!KN-'(W+:E3&.LRB0&52E)6]U
M*$*"5$1OBX'.=%"YKYPVH`QK3MR4@Q2N:UY#FP%U"ZAIZ.957>1_6IP[.I<B
MS<-7C#K7(D.IBP+KE[;[\!#CY;2QWW)<['(;RWDDG8R^H`>*DGH<5?;WO3Y*
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M%ELK+S,F*YM?CR6)+*VW$D4"DFA4*$Z6WG@GO97Q$4<`17#ES^A9HPRV]N1*
M,=7#$<>2GJEJE-O[/4]!ZC0T)_VNKIDK&L`.:88X/`<W(K94QL#2E4(=:0\@
M@@@H74IKTJ*T\#UU)((I7B%W2":D"J4>*T:OUL=/I*7U[2=M*&.X"H>-.I(T
M!,3\$\<J8A8"2JG3=NK1)/4?9U_FU(#XQWJ/BB!V0DJ-%;C3RJ0KH*=0*=-,
MO())&27'[X7II:3ZO+P/CX]#3PTA34H8,PHHD)455J`FI(^P"G6H'AI36EV2
M2Y[6>\H;>X[ZEO"'MH3+LJ)CG)&?M!3:<1Q64PZW`=2*`7V\H$B);!O^\@!;
MGE0'2'D,%7)@W(=X8?%)R.'TJEKEOZZON@DO39.,V;C7C>P-*6I'S-E_/I3#
M5?3\U=\@G.17'0CH2AA`)\$ZB/D)=5I.E-F26OCP=R!4=L8_U@WD"R7-0Y"=
MF<IM%"DMV[%,8Q/'(RI!-$MKO<V`QVF2H]5MQWR`.@.G(I0`=9QJC6_F5<?[
M1_=E>?>5Q3?>3[IA-LP1N-D@LMLLD.\RK\X(2;>S*,JX7"1#M[3LQQQP]&8[
M3:4]*'QU)3T)<2:G@E+F%F+Y=W44!4"GP%1X?;IF?^&4^EMA/!%MY2Q^PVRY
MRY$"-#A2+ENBL-N.NJ:FOMENKJDI;3MD>-">GAHA_AA&8IP3H8S[->+:O.3F
MKU<W&9*VDI<N"8K2DI2#1:8L1+G7K^T#IU)T,Y!/99?;7P_9FT"-A=M?VFE9
MKLZ6KPI50?F*0>OV:4UI=@%T-:,@`EY$XSP:V@&%B.-Q0FG[NRVU2B?`$+<C
M.+!^-3KIC<T5.24MF38(++:A&CLQ04A/X#:&:`FGI2TE"!_)I"XD+<K,R=[8
M!_VRE;N@!`^WH="$WMSM;22JJ>O4BA'1--I(_P#"T(2&GVI!!%?`J\2?`)Z^
M`^P:$)KLS@*:LDY1"`D]E(\5%05(:%.HKZB:4TQ*)":M]VB%6I[@?S"V<:Y%
MEUB6\SD7'4BU\G8^_&I\RU<L"ND3)'4QS0T<FVF%*C'R*7R#XZN>E':MW%D1
M6*ZB?"X'(A[?"#S\=".1%55;W"^7;)98OXUOIF;PQ8X:L?[)([02$ZEMY\Y4
MG6^/)MO).6FU72(U<H?:O4E+;T2Y-MS6'$T-4H>:>2J@('7IJN8#$71"NJ-Q
M8>]IH?:$_J,L3)C3RI&ZFT.%#]%*HW@Y^;K16>)RK-0%I<$>=FURBQ5$'TA;
M`CRNB.M"%CQU(CD@;1TX):,Z9GTI#B_06M)HNJ'VKR8,OVX\+RK9;46:WO\`
M'N.NP[4W)>F(@1E0D%J*F4^`]([2*#>KJHZJ97,=(YT8(83A7-<9J#?%[R?[
M3:4AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OQ/&L+DD`DQJU)J`I0]/7P&VE?M
MU]P_ITO9ZEXV[<M?O`K.G"G"%=U]EO<01^&*$?K<J*:0-JD#M7'N2/CV\CZT
M?XKQZ'\KQ;NOH6E.0VA2@EO:"A-P9=()#GF4TKJBZEL9+?9KJZ!`TP/)PP%&
ME6VV7^N:*W#22YX[3B59C,:3<&MZ?O%))2:[5*0"#0GQJH:^.+MGYI\L$@DG
MGB5Z9%JTT=D,DA5MJ2LIIU'C3RZ^?PIJG.:>2VLTD.1^PHU[9!;VK'0CJD@>
M1!U8VSWD!OW`%Q2(P^)$OEF,A[:9$5P1W4*3T*J="">B*BGCT.IJ$N8N,P5;
M>S'!6H'J0-N[H"D=>IZ=-<?`7^\UV"$Y*(B+5#98A*#1:1O2E&W:I8IU50T[
MBEBE#UZ:EEGE-!C!U>M=3_\`"=SNL^XP[+=K2Q(B%UQTS0-DN.EM.\%:7$A+
MK1(H:'=3RIJ;:M<][=8.*DP%Q>UKOX?[<58-B-GB3;W:(+2EQ8SLF(7&HH,=
MQ]M;BBXXJ2E:%,,(0*E(IOKU(&K=L;&Y!6D&DS>6/<I52#QBSVZ`S<HK3#"#
M'N]T0TI24E:&Q-D%**J'J`2/,?;J2P"3WN')3/+849O0VWW4A(4RVD[E"JBE
MS;U!4*T.Y7ZM/D-(`.54C6^M`H,?6-PJ+R#[2L6QY<:.N$UR=AD]MN4RE]IP
MQK+D8>6MI;;B>X>\*5'0:JNI&R36$;J$O:^@H,AFHFX.<(VN^\/WKF.@\42L
M:@-6^`B,Q%C[]C,>&MINKSBG5%#;32$#JKR'76;@N;IC0UU10\0L\YD=27>\
M427C$IS;#JOD'''$E/;<1'D$5*CU`+8-2/+4BZEF+3(S&0]GU)F%@D)U<%$O
MF3A/D+/KO:9-H8MZ8ELMCL1#=Q<F1G>](DK?D+2D07D[%("$^/BG5:V\N6BL
M@)]'%.^1'7BGTPVPY#8L4QVT7:.'+C:K1"M\AV,W(5'4[#92PE32W66EK2&T
M)'5(\-=;?737%\50'=B#!&13&G>G'LL.2XTZXZE:%!91^[-*"GWNG0ZE0WEV
M\>,XUY)AT+8\&`T1^8FVA]0H:UH?+KU!%-2Y+B4`:"*]R10C-9`FE!XD?S_J
MU%,TE=3OH7=!.-"LR4.DU0A1(ZU%12GG7II0NY&"N&D+NAW(J!?N.@\O2N0I
M=^Q^+E,?&<:LMK<BW&%=78MLB+AL.7"YW!0;GLH95W72E2E)"E!`'44T@WKI
ML65`"=CBU#Q@J.7*W)]YY7RI60W13C$*-$CVZQVM;JG$6^$A`4Z1NH%2ITD*
M>>4!ZE*`\$C2'/<X4<:A/-C:PU:D#$AOS76F(K+LF1(>3'BQF$*<?DR%=>TR
MV@%2U!/4@=>H^.FW.:T5<0`EKT^WMAOA0-0I)Z#[J@0"%5\"D^.E4/K0G(X+
MMZ[ORI@UNCH[KDO(+9';:K52G'93;;:1]I6>@\SIBX;)ITD'0<\%T-<<A56A
M>Y7"^7,'P1I["+!FS=\G7N%$<EV"RS;@]$M@;E.S5J^4B2OENZMIMO<:&BJ`
MZ<9&8HPT:@U);#I-0TU1E[=L-Y7S#`)#^86;*E76#D-PMS<J]VN;;94BW!F*
M_$(:DQH[CZ&PZH!P@DD4*B1IQH>_W-1[EPP5-2TU4F;-Q%=H#S;GY!-4\.JG
MWV-YK2M1O!H?T:4V*5CB_2XFG$52FQEHHT&B?[CG#9D.6!(MKR0[.*5J6V:!
M3+;*TDIIX>G^;3ELUWG`T-$K0_D5.2UX9#GP1&EP$+0ZVG<'&@"E)\:#[2-:
M<QQ/:=0&5?2N:7\BHO\`-OM,.0PG9N+-(5+6W)2812EMQ9=0M!">AWJ]8IK-
MW]I)I\R/$G,`8^I=TOY%-O[.[7/L>3\DL3XLB#/?X7R2)*9?84VYWXV98/&G
MM!"@'*LW".0H@?>!U70C2/+=@\DT''T*59-<!,\@Z"P"O"H.7>I4.J"!W'7&
MFZ]3O<;10#H"=RA3H/U:<'B]W%*U-YA/G[2KM:4^ZWVV,*NMK#[W./&K33)N
M,+O.NJRFWI2VVUW^XXXI70)`))TL,<<@<`FI2"S#FNX'7%&51OU0YCT*7PRZ
MUO\`6QF[:MB5J/W\94*[/`:2YS6YD50J]<`OS[\7*XJBYM<QR4ZG>VM-?EB%
M&FY(!(!^.FH9'/)U4P0DS9\KDIN5N4I2U(1.B$DH]71Y%*[J`$?R:?0CK.[Z
M[%RZ^-)!`$M*QZ3X.,-.>2@#][7"YM:5%4DL!=JQJL>47YQ6*87+[B4]QFYQ
MS0*2HEF56A(/0]?,Z8FD<QP#<J)2)[7=').%YDEM:U.LN65]L!:PI)^9<;41
MM]0])\M,/D<_WLETM<,P0F#Y"N,AGC/DYUQV0HQ;=A5Q%775!*K=R9AK^\;S
M1*DHKU'6FE0?Q`N74$;[6IK7#CVI%<DW"4_8?;[.[RVR'>7;.75*4A00];;?
M-2"O]G_-@/7R%=3HM+IC&\@"F'>F!4P$`XT(Q4;?>3]2.\>WOBVP<+\5SV6^
M3/X5;EY=E;#K4IW$;:[&CHCVVSJ<JV<BN0(4IU5?EFE%2`7""GSK?>H[J2X&
MU[:_23)1Q&/MX+=[+LC76HN;VGPXC[JNX4/U+E)YHYQSGW!Y);,7RC(ILR-)
MN)7<I\N4_,2N4_([C\QQQYY;CST;>I*2HDEQ2U'[W2_VN`;;'\0YH,P&&&-3
MSYA0-RN&W%Z(H=7PPX`^$=H&0*?"/CO"EAXW_AIB[8M-C.)>)8=Q>8[DMUNC
M=0NN1HGORF&I3R*-N[4LLH3N4SM.U30EFEG+W@Z"2:4P]2G/:R.S+(_<(';Q
M46&[WD.+I<C8Q=+WCV/JEO[;-)D(D-/.I*`XN--CI9CR&R"/40PE7]`^)<EM
M8;D#S(F.IQTX^M0&ROCIH-`,<$8PL_NS-7"'YC3H<1,@NAMV$\E:OQ"AG:XT
MS(5XE/1M?F*]=1G[9'4&(:'<^/H/!3&;I+0B4ZV\N'I'%3%]J7N!S;A;,(.3
M<1Y'=\7GMK6ZY9;=-"+9<6:CYIAJTNN_E\IU"5'N1Z-N+%%`+%$BO(O8'"1Y
M\+3@:?3S5PWX6\;Y);B0NM[V8?4?P_GVV1,;SOY;&N06XJ]O;(%KORXJ2'UV
M_<$+:G)V[G8J@EUHDU2!36EV_=1=`-F+?-/'`*@W':OAB3`#H'#,A6;8U>&[
MW&+K$4M-M;&&GO6I3_;0`^XHE(0E/=Z)`KT&M8Y["&BH]T*F2O8?7;TNS4T[
MD:-)DH!3N`6Q'><3N2:;AN`J-"8N*>47#WQDF]L_,%VNK%W7(3!"K=9W[B@M
MQU("G&78[:4.?BGTD/'I\?/3K@P-!;FH#'2FNH<.7%"+RI/D6>ZW1;4(K@OV
MUD(V.I0OYU;Z#W*/%50&AM\!IHIIDMR*.H:]R\3>:5V/'8^13(MM:B*?NJ);
MC[SS$:-&M<>-(>E./;E[$AMTDUZ4'QUPEHS-%-CGF<VK\^Y5Z\B^[/E?W1W.
M=Q3P0Z..L*$5YS..07IHM\Q=D90KY]\7F2IA&.61QM*EK65-N=D`N+2%%.@3
M,C^\T5[5U[R_WE2A[H>?/:[P@F=A?#UU;]P_(S7=9O.7QGG8_%]IN(J'=M^%
M+AG4QEZNY,#9"J/[8O[FJVXO6O!8P'57/@E>9(!6E!W*D#/<^ROD&\O7+)[H
MN6H/*5%@L(3#M-O03Z68-M8I&80@*I6BED?>4==@#I`"03SHFGN<02/>^O@L
M]KXNS6XX!D7,:+,J/QGA]^LF,7;*[A*C6^#*RF]+_P"3\8Q],IQM_)+_`/+(
M5)>C0TNKBQ4EUXH24[O4]O\`E9N]]TC?=8RS6]KMEE#YOYWF!\S:@4B`%'9Y
MC$FHR"\]N_F?TA8=;V/RXEN1/UC?P23LMH6O?)'#%G+<O;6*VAD=5D<DI:7/
M:6LKDNO7Z0N4V6W^RUB1)2XS*>SG(I,YUMHN;HC35EM\!!HLE2FMRN@%1N)Z
MZ\])`SP7HC9A%B037DI\W?+<7?<AM&=M?N@2N$VY&D[GN[)<AI`(:*6ZR&U)
M]1`U"DD<ZK?NU4ILC7-!K2JD-[:.6N-[WR1E_"%HNSLCDCC+`,8R?,K&Y:Y[
M#-MLO(4ZX+QB6Q=76$6VXF8+2]W$,N+6Q0;P-VI,`_+"27NUT;[BF?9(@_K1
M"`FLV1\4U^[YFGA34J-C7`U3]$ID,(2G:?C7H3IYK&M-0A876TCI4$$TH#U%
M.HK]IUUP:11V2$GI:0`M(\"#_C_V-17AH=1N2XD!<6P=X\P%4ZG[Q/4?S>&D
M(2!N;/0J(ZA)"?'Q417]/70A(B8R3NZCH"//RIH0FFY";2FPR4D]"\Q\2/PW
M.YU^PE/\VN.]T]R%!'*K6S<[--M<MI+L6[H%KDM+2%)<BW!IR-(;<2JF]IUE
M1!'AI.VW3[*[BO6>];RQRCMTO`([?"3AZ4S<1.FMI+=IH96&/NU<?0H7\%W.
M<GB'CP7!2UOVZRIQAXEY\NKD8K<9V++4JCA"E+-G!5TZ>.M%U3`+7J.[@93R
M_.+@!P:\->VO?J-#QHJ79&R#9K>-QU2,UM=V%KJ#NJ!AS4AK7=;6I24O1YKC
MB4G>(\]M!.X$I.QZ$[Z:I\S^C5"',D=Y+FG'CCWJR+7#,&BZY?:`M+GM>X'<
M0%I0OC+%UI2X4J6E*K>V0%%*4I)%?$`:KG`!Q`RJDJ1^N(0T(0T(0T(0T(0T
M(0T(0T(0T(0T(0T(7XRB&MS975(Z=!0U->@%?#J=?>_GNY!>$46JZZEDA*DF
MHJ*"G0CR_FU(::M!YI.26N`-!_,\;"DDA-VB+I3H"$J?0HT\J-G]>LGUS(8N
MD-S>!4BVK_G'1[*U5UL7_BUOWGZ5-NT.)4PA1%.S(>0HGKX.E0(IU\%C7Q6,
MEZ^BO([9\F^F8@59FI*PL"@2L@>E7@$E5>GZ-5%Q$(9-`-5U:=B5M=6BHW!M
M2C4T(*?4*?&E-2K1VGP\'+BD1Q"X[)D7>.E!4AV.PXL`$H#J'"D$C_:'R!ZZ
ML&^\.]"E=8[1%,0NK4D_+H=4Y6@VJ"=X%#6BP/#SZC5BNK>Q>5C-YO<*"9)F
MW:6ZVQ&@;24K53<I!!!+CB*'Q_DUUABD=I:34+E5-S"L2=#0D*C+:CJH$!D[
M*M@G<VM"V^J$E/5/VU&K.&(-:UU5,C/Y84@>'GIPY2:*@MM$=IMMEEQM3<)3
M`9+9^74X#WE-]0M!]5%5%1J4%.L?^8]"DM#>2NX7=#Z$E:;O<UJ=8JPH%4IX
MIK_N:MR5?#J/+4QC`RN*L7.T!*%\-A*`C=0%(27%#U%*>J4KZ`@;P#]HUUS=
M0'8:H:RAU*)'U`H'\1>WO%XCDEV$A.;6)\*['>JIBW7QDA3:G&:[EN'U!7\V
MHFZ2EUG2G^U'T*!N?\-JI&=XN3(/^>4?$)7!70'P_9E&G0TUFWQA[@XG)9]\
M8>:DT6PCB+<!OOL9%*':J'**:^)!*%J(^P@:6B.(1UH:U1BQP\P4DF_6\KW!
M*0J-/'0@>`#"ZZ4RU8':W$FO!+2CB\,LK"?^6+15=?4MNX(Z`GK_`&$^`\M/
MMMX'.#2W-"5-OX882E*/S;'S4_>(FH*B1TJ56TFOZ=366D#!32NI2Q>%V5.)
M1W\7=&Q2B^MY/:&RA*'5/PTA*UC[HZ[OU:7\-!^%(>S6*%-!RE)QOC6:Y9&\
M>LF2W]41J5MCMP19H:7@HMF5+$?NO/=*]M"1T\5#5;N4EK;1T8T.>:89)0%!
M3DH79%<IMVN"Y]W3:HJBK\.-;V(=OB1FBJH::9CI0"D?TE%2SYG6??<"9VD-
M#0<,ZH5:OO#Y4AOST<7XS,W!"8\S-I49X+;7(0`_;K`A;9VE+*5!Z4*_?+:#
MU2H:7'&(Q2M5U010@ONI;;()-2=P4$,H0"IQY1`-$-)!)^S3B$Y_&>+.9;D4
M5?\`66K39W&>Z\P769,B2MTF%`CNL*2XB=.>05K*%;D-H-.NRK4SFLC)<*C#
M!*8W6[2KV<7^C!+S7CZPSYS.>8?FMV";M.BFTR+]:F+?-:0]!MCL(.PIT>X-
MH(6\ZE]02I?;V$IKIZ&TO!&/,'C.([!P3_PLKB-`JTJ2/MU^C5$XCSNS\AY/
M%S/,YN.3(MSQ^W0\3OMHMS-WAOI?C2KFZ[)GOSFXKB`L,I#:5*`W$IZ&5;V<
MOFB2X<XM;]TY%2H[*X8,E;*CCG*V=RW,/R,+57>LXW=0HU\35,$`5Z^'34_R
M(S[V(Y)?PMS^%;C6#WCME3^(WP;G7%[G\?N/0N$FGXD/^E4Z?C\N)CF-:*GB
MN_"W'X5Y<PYT(47\<G#:1T599*!TZ#HJ*.H\]<P]"[Y#PTZ\'\EKMXH(_;4J
MSN,$J><456YQ!)4VH&I4P!T!^/70=`]QH"1%%(X'S!I1\W!V-M[F0T4C;ZF>
MVI9-`*@I'B$ZDQ2%YTTX(DB#&ZJ\5F?L9N;ULAVV(Y+N$Q8BL1(S57I,QU80
MRTVW3<M;BNE!XZ9D_B']N"Z(=48-:%5??5VO?*O`D_B/@V";WQE;,OXPO&6\
MD8DS;[7:IV17>[\DW.\1;G<+Q%C*OBXTD1&'`TW+0RM3*0M![8I+VC;[:3SI
M)0'2``M/X:FAHHO4%W\,UD=N`&Z!6AS-2">]44S;I>IJ%!Z[7:02#U<N,UTU
M(/FMY7WM3Y=IM&@:1191MW.XYJ3'TY;:XY]1WV'/2')*G&O=IP2Z=SCBT43R
M#9%'?O)!J!UU3W<$44+]`H0"%)@NI?-`<:@X+]9;6:5LJK/J0CEU=TXB;XMQ
M!.5),+,_SG=;9L[Y-9?QL0`%Q'6^UWP':A7CM^S7/A)+@ZF<,%%GO+:V<&SN
M()%56VQ`]X"D;6N'6]RDJ!'Y)=QN%3Z2?F3T/ZM2V;-?1UH`5!_7=L=_#>2C
M!G'/>6\*M<+1S7U$JL]T0/A7U2O&NG3MMU2@`UKOZ_M(P,AJM]O#?>@M:B[P
MK`42.I7;YP5\*DKE*\!_-IG]'OG/\R@31ZCV@/T^849-<=^\1]"-_#MF0@G<
M0ZU)2EM2Z%54JDT22?AXG79-FOGFND(?U'M#2!YA17D7"7NFRBPW''KUQ/:6
M[;=&VVI:85RN=IEE+$EJ6T6;A;Y\>9'4EYA)JA8JFJ35)(+,FSW<8J\8*3)U
M)M#P`9%#3D_%<GQ*/GG'KV+N,9[>>$<GSN-;$WC([G&@P,-S3%K3+@72+<9*
M8#-V;NCT<A#27`6G`L.5J!'-N^&9K&8O(R2V[O;W=M*8<88M./'$I!^X>1R#
MQIP;A.?YQ9XMD<P3+,\FW9$N.XAEBT.87DKP*:K"D;EQTI!-=Q(%#75?U`9M
MMMI)R*/(`;WN&'J5ALKH[RZAC.,3CCZ#DN3#GG.)V3QLRS2XE]VX7>;`N,A<
MAQ3CSTFX"+<%LJ[@W,*2Y-;:2@4#:6@FG0Z\SV:V<W<`;@:I"2:]Z]=OVBVV
MGRXQX,*#DH%6C>BXR9*"MHQV4/E0(5VM[G<]*R``IUPI`/C]O3IZ&^36VE,%
MYU#[Q1\]<IJ$..L.N-1FF=O<.Y*U.OI":L*)"JEL*H1X"G726-U.TJ0Z1[64
MJ2WDDLJ_2BVIEYYY:-[BVF5'<V$;6^YO"ZD$I"13[!\-2V,#!11S,2*4S6U9
M[N(SA!5V5*">B%%*]H6%!T$C8MULC=MJ"JE`0=,S\%V'BG-@7HP%-7"`KLS6
M%M27^PI2`^MHJ7'G12FA:D,J'2E`L$A2>A!CO:U[2UXJ"K7S7PTD8<5);$>;
M[K9W[9EMCF/V^\17HKMW3#D.MI?D1W&S'O+"&R4K<0E%0X"E:/N*40:"J^!?
M"_S&81@X%6;;H3M$T@!;3Q]G+OX+M7^FM[I&^?N",1?F/N2;S%:D6Y]YY1[J
MG83A*P^\MM`?2\DDM*2`KTE*A4:U6W2NEA!?F'4^A9J_B\JX(I0$5'I5EMQ;
MNAM$]5GLKN1WA<5Y-OQ^.5?,75]2"CY%HI0M6]])(Z`G[-7OC<\11`&1V554
MWCV0P&XD-(V9IF8MCY1@HDH9]JV1,";&5$DI9>GI[L5U2%*:.Z`JB5*0/`@]
M-2/AKH9MQ5$-_P!H(_C!O?DM.3"S^V6NXM3/:_EL6V+2S(N#;,J>0L1"M;+B
MDIAJ>JSW"0$^-='D3Y>6_OIX?6N_KVS_`/41^M1,]]-_R[!_:MR)<IG!.58M
M;;"]9UB]S+K)784FXWVTPY+*Y[#1;D,7$!"$^M2%&@'0G42ZM;AK/.TY<$];
M[KMUW)Y-O/&Z7E5<BW/_`+@^2\HA(P=O(IUBP6:^)%QQ&Q/O6ZUWMY#RE-KR
M%3*Q)OP95U0W)4ME*O4&PJA%+))Y@&%**Z^'',J,<U]2VAT``;&W:*4````_
M5IDFE.]=F%(P.2Q<>8?!S?+T0;]>/X7PVT0[AE'(67=@R4XG@M@:3*R&\MQZ
M4EW);)3%MT?H9=SDQV!U<U[+\I>BF]6;Z8KQPBV2RC^)NY74$;80:-;6O\21
MX(I^$5&*\T^9G6$_1G2SKO:;87_5-[*+2PL]09\1>3CRX&E[O"R)DCA-<O)!
MCM62R-.MH2&YG]QEWYPS3%;':K>O">$N-&)5AX8XHAR$NVS$;`ZLJD7F\+9*
M6L@Y&RUU/SE]O#@6_*E+4VV41VD(%Y\T?F&_J:?X#:VF#IJW=IAB%6>YX"Z1
MHP<'4JUIP`H<225EOE5\JK7Y<VUSO&XSG<_F-O4GQ.[;E,P^=<W#@&NCB#P'
M064&GRK2W8!&R%K7#4Y[G'KW^DIB\N]>R.U.LXOR7=$7++\IB+N6)X5=<AL[
M28$JSR0TB=!C/-F:%@!ULFJ$E/QUX]*Q\@`8USCV!>Q"[M!X9I&LE&8*E_G,
M=C#\CQ&'=3=;&[%@P'K?;\RQ^_XU>+BA.0/J=?9ARK42[#[TEMA"T;M\A7;Z
M$IK'FBEA+0YCPTC,C#N4F`P7+2^!^IH-"?L5@'"63W&)R;8<55CD",U=^.EW
M.;>)%ME1+^"W+E/0(4N08PCK:2PH+;:<>[S(6K\,!6[3$#I)+KR@XA@(4S3Y
M4;*8AQ^M35LB/PI"CX?-R-OAUZI_6.FK]C-"6CX;0!50J!X$@5H3XU^.EH1;
M(*45"7`5$D^(Z4(_:\/`Z;E]Q"3LE1(</B1N(KYCK_)J(N)#3CO[A\ZK/Z_#
M_#H0D9/%4G<*T36A^-5?X330A-W<7'V94>(F(IQ$H2G'96X;(R6&TK0@@*IO
MD.+`%:]$G74T)#YFBF":CDA.VP/$]-RG%'KX;6)"T#I]J=)=[I[DZH,9POY:
MTH7U2H25@4-#5JV7%Y(!^([?\O7RU&M\6N"!FH`<8?-N6;*+5;7%1W[!RGRA
MCRRI"5KCL_Q+.O;*FT*4E*4?*WMI5:@FNM;U3^9NC;TX&>UMG?VM4#7$G^R3
MI',8JEV'PV\\?!ET]M>>G&O_`&O8G[Q:,+>5RY,F5)DK2W&4[,7W*J0"EQ?:
M;!9902#2A5M'B:G6>:=+JJWD]PKL3]GM?]%O@:O0_P!V6+U_^![>J^3!Y[U"
M4D=(0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OQEVUG91-/351KX;1Y#J>NOL5
M]_</&!HO*G1Z1C1)^Z*.]"_BM-0*UK6E:?#KJ7;7DKWM9(1IHD$`BE!DG4XP
M0!F5L-`M+'=>`%2=S-L?437X`^?EJA^9>YAW1]W%&:!S8V>G6'>JF'>I'3UN
MYF\QUI@UQ4O[6H-N/H-0FC;XK_07Z%&I(\2!KY#N,PO4$OTP47['Y4-(*Y$4
M*<:64@K`IN04GPH0#_)IY\1E9A3PBN*$TUH*F;FAM0"#N6RYOJ"DFJ#T/VZA
M0O!F#1FA34X`L82Q=;G+CK=;?=;9:+1+;J#&J5.QUGT.A*U#>A0*2/-)U>P>
MYZ4*3,Z2(L521%:6EQ*F2X60WW-R`KY=\!"5-2$D?=45`^(40=/KJ8]^:[C>
M;8OE=A4N!<K==F'E-.IV]B4TL;%!:>A2H"E:_=-.NH$<[K>8/;F742HW!KJG
M$*QK^^N[7B+%N`@,1[@&RB0TE1#*G'D)<2XD!+9*'`#0GQIK1NNSI\RGCIZ$
M^V9KG4`*>?VZY7D&09:\;K%82P['>6RZVX*(="J-K(4:M^D442>@)--<MKDS
M7'C]XMHK&R-)_0I7LO)-RN'J2'$7.8"(ZU&/*++J@IQIQ:NA/]&G7]>K'RG\
MPIWF#DCYIQR0:;BH)62$;#L&T@T%1NZ4U(&2[YHY%0L^HYD5YLOMCA7.QN[)
M,#/\:8<+K#4IMN,\N\-.)#*SX_=Z^(&J7J1[H]L:]GO"4*#?_F15&30J*;5R
MMF\HD(GP7'`DE25V,>E6[:4E56TI4/@37SUBH]RN6C$4=54F:/T<K9^A1:<B
M0'4#=M>-LCE"@%&B@&[DAY)6!X%(II+M[O?]LP^A2/AQ_>,]OV)L^5?<_P`F
M<98W%R:#B^*W5I=_L5GF0KS'GPI`CWFZQ+6)<-R#=)#:ELO2TT0H>JOV:E0;
MQ=O-'TT4RX]R:EB,1TD@UY)@N2/JB9]QKE:L95Q9AUW$>W09ZI"KO>X2P)B7
M5!!;1WT40&_TG5A#N%PX"1P+<<CFFTGXOUD<F1L$C@W''"/$1\NNR*II3H%6
MQPA7Z3J5^I3(2HB_6B=CI2AW@6(Y125*+.;R/UTWV,U.G&;K*TDG%"9G,_J9
MV3,KS<K[+XFO461.4%)CL9;;WF60E`;0A'=M"'2A('@?#53<DSN<[BYU?:A,
M9D?O8:O$.?\`D^%7&UW%45]%M?F7:),AQYKB=K#LAMF*RMQ#*CNVC[Q'PU!%
MJ_S0^HH"$*!]PER9LAZ7,?<E39CSTN;*>47'9,E]Q3KSKBSU4M;BB5=/'4Y"
MW[=;9<V5$L=N;[EWO#S+"JG8EEEVCC;#KBJ!II+8[\A7@E"0#]U0TA[PP5*%
M<)]/'!./;#G=IY#Y"A3;M@&`RE.XQ#BQH#B<RSUAUE;E\GLW"9$;=M%K<V.-
M(]=5(8;4/2Y6&RXM!<5N]0MZX_5[5.A\<=1]T+I(LGO1XGA!*G[9G:'`:DBU
M6U^M2*J*D7E.XD5^&M)'U!M98`'X##+DI4<H8W2:YISX7OTX60V@'^/&A11<
M!QI%$JH*).RZK"NO3II7Z]MGX_8I#+IC<P:I0-^_7A,EM2;MFS*3M)2K'IP"
M*&M26I2R?A31^O;7^/V)7QK.3D=L^_'@O[RLSREA)!![F-9"2GP)("6ED4.E
MLWS:WN#?,`KQ(1\;'R<C.-[[_;ZX4MJY+N[73IWK!EB:5H:J*8"P/U:?_5-L
M)PF97T_8CXN,FE"E1&][G`[E!_>FI`IM_K%HRI)6/2:T-H4:))TIVY6+?>D:
M$\9F#WJ^JJ,3[S/;Z&G)$GF"SQF6@5.NS(5\;0AI`)6MQ3UH(2A"4FII44TK
M]0LOQM3;+F"1VFM#VA23]MON7X9O%UQGF7'N2\8OW%=ND7UZX\AVUE=QQ:%%
MQ]KM9&\_<T6YQME%C+R1*73\&H)/GH^(MIXWC4-`&:?<QDC"#BPC@J4/]8@S
MG!>7O=_Q9=\2EV_(K/:?;SC\/\WCQY+;4IZ5FN:3G`/F&([C@9;=0`2F@KTT
MK9Y);5KBSW"X_0LAN,)C_)<*.=CZ*D?4J`_R""XHAN+%;;H*@-(*B3\"!N3U
MU8/FEEIYAR5;'&65K13%^GGCMO9]^GLP>3"8+C/N=X8<2YM)4E2,YLZ@L$#T
MD$5'P.H5W_R[NY2X??\`0OT^M952TUG(DP19-JJK:5LR_B*[5L#Q'7INUI-@
M;7S"<FBJPO5['.GMR#3$I(1[J@,]5%1"Z$55Y^8/B=7AAJ:FBQ4]6@46S^:)
M4GHYMK3J%*J*^1%-)\D-Q-$VZ4.9I&:\/3'2BJ6W*`$A6UW:>A'B$T\=<`(.
M`P[Q_2D!KW'`&G-%B[I5'WE%-!52=RNM?V?*E=*[0I<4;6@A[@#7BDS.N@7N
M0$JZ`U]*S6G@?#HG[=``/O$#O3A:W[I![E1C[DK^^_[T\PQR;&0TW$]G_N4F
M0'0E0==;%XX0R'MJ4LA"PPY*6H`>`5768OF@WX%12IQ6FV$.DV^]T#+R_P#2
M"JM^NOS]>+#[=+/QC!?@IA<D9)C<=;J"4W4*E&:Y=&BXEVB(J;4RX%)VA1#G
M4TUD>M)WNO[:P)!MA&9#3B6XA>@?+VW9X[F4'SFO+6]@<<:KDKS?(G+CA]R9
M^Z'\B!6BM`6F`P5)5\=I>2*UZ4Z>>LS9VSX]RUN(H!7UKT7<IP[;'.QI7Z,$
MP4.4A+5P9HE0?GQVG2.B@PTS4IZ5-%J("AY:T)A=S"R['M?@.2.9BTJMZDME
M*4KD(351^ZE`"E)2%&H0AM*0.E=<C%):+LON%(\1@^7G-BB2E#22?2G:^ZA1
M57Q)*4@4\P=2U$1?(;(=*0D(9WJ2TH`[Z-G8A39%3NJD:XA*"RWQR*]\LNKB
M-A#B*;RZPNH66ZB@<;)W)Z]%#[=(D9K;0)QC]+JNK1.7CCS+3Z2TXI2'%T46
MUJ6TK?M40ML`J0EQ`ZI4GJ3TKX:C`4?I*F1'401D5T[_`$7.58=JNEXPU]<Y
MB$Q.CM*<+S08C/7Q/]32ZVM*5Q6Y,J-VFU@[@ZI`4:*5KNU2!LCVFN94W<8S
M<VXE90!N&/8NMOC";)M^9X>^^\J?"-V@/MR2A+,F*ARB4=TI46WV4E83N`2L
M$BH/76IV_&Z:SB5A.HV.FV:>)F#BROJ5A3EV0XOH]XHW#U*5TJ?`=/CK;LC#
M>`7A`A<6C$(N<N047CW!M"4A)()K4IKT/3I33E`CR#V*JKZS]P;?^F_S_'"C
MZ9''BS3TIHUR!8%=!6GB-5>]`?ISY/P_71:GI%FG>80:9GZ%^=#RDL+O+%*^
MFGC2@!4I77KXZ\[7MB13[@5'4E)3T;%:*J:@=3]FEQN#'5.29G]STIHN0<T<
ML^+7'$+;)<:?RZXPI&2EI"T=VP8^I,NT6I<D+2%QYM]?,EYI-0I4%@JI0$>V
M6?5>R;'\F/\`#>TS!W56][Q))>X&L5G:1-^&@KRFF<Z5],*LC`K5U,/==/G<
MNK[;?]PB+K/;K5[;4.H6?$7!TSW''Q,A`ABP_P!K-6GAJQ5FG):NT17[*5>J
MJCTH.B31`K2@IX)\/@D#R62:24ZI#4K6U)=5QJ</8N[GZ/?O2XH]N_L*P^+>
MN8^7;)G,#.<ZOT+CK&<:M=]X_N;<I^TNQ4WT2[4W(6+XTRII];5Q;=C#:X@)
M*:*OK.Z@B@!D&9SP6%W[9MQW'<GOM&ES`/1BGB]Z7U&>#.<^1H6:X?:,_B3+
M#Q9!Q3&YF06>PMN6O+8'(S&=Q[N(RKW<6G[=&,".*+]3CB"E2-IKJ'?7L,[V
M",$-:YQ.6-0!]2O.G+"ZVF!T5WBYW*N'?5,+[6OJ9WCC!]O)O<5<\NYZY'2+
MQ$-]L;.-X-9T0K@N*U$9-GCA4)]R)#BA"7!':4@J4:K*B=5S/($SIW`ZR!2G
M8%=L=.T:*CRZ^E3LLOUN>)&$N,/\(YV$J>6[W6\IQIZ@<(]/;7%9)(`ZT534
MMEW&W,%**<2V_6;]ODT($SC/E.W!=`2TO$IP2.NY5!>8I(_D.G673)#0`HQ3
MQ8O]3OVKY91MV?F^.+<4E(_/,32^P"5"FYVR7.[*'3K]S2WR!S:"J,5(7'O<
M!PQG@;7BW(^,35J0-L9^6JSR5%9.UL1;PU`>4Y3R`.F:5-%+A]STI7RWH[R`
M\@H=2NE7&5H6VXD"H4E:%E*A]H.E.86G%*>\,-"DC*"%;JH04D?=J=U`20?T
M:0N/:7C!)"XH0E*MGCU">M4U-"*?$"FNKC'`'R_O)E>34%5D#?AW'9`/CN`^
M5>`4!YT4=)(J".Q.J"7+$=<:T6U._=W;C(%"GP";5.0=P\ZEX#]>FXHRRH=Q
M0H(\:!VW\G<_8PI+8+>7XQG<($E-;=GF$V=AQT`="/SK$YB2/Z0UI]\_/L-L
MW$XR26GEN(R#XG4+3V@%OH5)85CW:\B?@YPCD`YM<"*CU8J25LLC$IT./T=V
M!90T$E`_$2D*"BDEQ050&E:=!J@:W4:!6DD@H6<5UV^T))1[8."4GQ3QIBX_
M_E[>JZ0U>3VJ,I&Z0A#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A?C%-/A)2:U;-
M4$`&BB1^R:5*3Y>6OKVL:\I+G'-%DRKK].I0"D)Z=155!T'4G7=3<EP`DT&:
M>_@^V.3[[D$P)"W;;:PAD[2"IR4\TR:?!9CMK_EUYA\S[U\>V164?N2OU./]
M@X+1].VX-T97-&L--#R4G8AVS&A2JRS\M3J"E:FPM%0>GBCK\->!S/:\C3R6
MT3AXC-$2YQ#(52.\KY:1U%-CO1"^M!1"CY_'3L$CR2TDTHA([+[0]9,VDQU-
MEIM^4S):(KM6V]0DHK^QN!U$>Q\4^H8`DT]2%8A[3[KC=PLEUQ.YW%N'<A=3
M*:AR%41+BR4!*7HIW#:XTX-J@#N\#X:T&VELL6@XR:C^Y<Q4P9/$3$]N4R'T
M+9<4VCYI)WC:LT;:GHZI70FB7!0=1U!Z:M763C[U&^WZ%(A:#75BF!Y/]O>3
MQHIFVEOY\VX)DO,()+Y8*BI+S"$I2I[M[*U%3^C59/M[XV^8,:']BD&)]<!@
MCS%KZ_*P1IN:D-W&)/3"?W`F0R64!#16DI#J4+;JJA'B"*Z<;*WX8%YQI]:&
M`ME`.:F_[7+:N.S,E2W.\GTH*J*;#S:E%)*"DK6"I)\:]-65DP"/S*>.N!5M
M:5$A>?=I12@A/)%POA#;8CIN\WM(:D*=V46-H0[59.Q:3UJ37SU:PN)K4U4@
M+=9NB^\4I6H/44K<HA*U))_#]`/1=%'PTOS&#BNJ%'U.TW*5[,<NB665\OD3
MU^M[=DEMH3M1>_EKLNW%Q:JI:::?\5D[4*]1Z:INHG@;8QXR\T)J6AC<#E1<
MD?L@P3E]?*MPNUY1DUMQ%$2YQ<R-X=GO-W6>\RX;<]%$M;K,YY%T2#\PTI7;
M2%5(2K6-F,,I:8J&C0#AQ5-,`UV&`HK?D8)!5M!NDE&XT(*637]!%03I7PSI
M/?-*=J9HHR>[K$+;:N*[:_\`/N27)G)/%UL::>+3049V=V3<V@MU4MU;#*R!
MY!*CY:0RV:'_`)3JR#'EEWI;GN=[QK15G<T<#9=GN?7*^VV^8XP@QH]M5%F*
MF,.M&`IYE*=T>+(;=2M"@JM4D$D$=*GCMR$<NB;Q.&9_H71&\BH&"C_E'`.6
M8=;WKE>+YB#,9E)4IQ-SF=PFH"&FFS;0IQYY1`0C[RR0!4Z<9NMN]_EM:-1[
M_P"A=$4G)-G>\,R#&K;:+E?[:_:V+VJ5^6B4`W*DMQ$L*<>7$/X\9LB2G;W`
ME2J^'34ICVR-+F&K0:>E)<QS?>1'`MDRZ//LP6N\J/#ESW:J2VEN)!95(DO*
M4LI2E+;:?,]30>)&E)*U5*[?H'DH*->AJ/(C[-"%M,*2C^NNI24L+"6&B"4O
MR2G>`KR++*3O<^/1/[6A"D3PWQCDN63)L*SP7I=_GXU>\LO$I?H_ASCVRVY^
M[W6X2GE!0BR;ZTP$I*AN4RMM`']8H(TSFO`#3B"I$<1!\8PHK^OI2X]8^:^#
MLFNN:6&VKC8GF:<;L3%F@I>5%LS6/VRY.[H\`I>NDL3)CCKKA"I"AN40:&K,
M4$<SCJII&94V"-KG>6#I!5L;?MHXI+A2;.7/5M!0^M*".A*J`[DD=01XBFG'
M6S6/TQ@&/N"E?#LC\)HX\UOH]KO$BS3\I>*%]2$S)%#T\17IY:?^'A?F0WN"
M/+CY!)/).".#,6NN&66Y1;FS,SO(CC./I:=N#_S%T3;Y5S6VX8S,A,=IN)$4
MI3CI;;'0%0KT;E;:VVDO=74=(\)S]2YY;.02G=]IG%+XV(B7)*U#8*3W@"I7
MA0&M*UIUTM]NP@LH`>:[Y<?(*FKD3W+^US`_<7EG$R\>S61C6#WYW&+[EC&1
M,I7-O]NE-Q+XS8+&J`M3L"U/EQ)=>?2J0IE6P`4)A&.-@J<8ZT)^I1WAK9`!
ME@KD$^T3AVXL1Y)3<Y33T=B1%>,U=5,2&DOLNH^Y3NMK"B/(GP&I#]LLIFA\
MC0&\,U8,FDCKY9(JL4GVA<20V7IJ$7@.,-ESI.=4HI0I!*%!1V`.)J"1U`\]
M=-A:L:2WQ898I$CW3-TRG4VM5]]F=ILV.?3`ORH%J7+MTV'[OI)LS3SK"ID>
M3RUE>/LVUE]E#C["E0K4VC>D$IZT\-<M64M7MI[PP]:G1,C9:`T`P^M07^JF
ME+?N-QNWD[D6[A[$8^T4&T*NV2.;.E00G6HL;B%EN&N-"/L67WF-YNZ`8AH!
M]JK22EJE4I&T^-!0FE1\*ZF_%6_XOI53Y4G)3!^GS0^^SV<`)5M'N5X>)&SH
M",TM)W=!T36GCJ'=7ML^%T;75>>PIR*-S75(7Z8NJ!2%5G]1WE"S\<W#BA-W
M]P.7\(HNT/+U-L8N]BS"<C^2>Q_>[+7D6%9:]NMGS(".PJ/0/'<%^G;)M]PD
MLJMCK5V=`H-WM5CN+FONVU+,OS',IZ`#7O56\SW:\7Q01+]^_-0_:JWEV&1"
MJGC_`&;C",`*?"FI?ZQ>'\7J_<H;NE]C=[T8/_KW_P"JH2>_#ZAW]V7M?Y,R
MOV[>]+FG(>88$2U1,;C3.2(;[$9JY7F#;[I=$VV-B\)F?+@VZ0XIII12G?15
M?30PI]UW!P(J]@KGE]2CR]-;0'1MAA8"96@GS7/J*X^$@`U]BY<+I[Y?<^J:
MW>KE[F?<8YE4E;$L9*US#FZ'OG&5(+3KC#.01FPA"V?31O9U/0U(U'9>3O>'
MOD<9ZYU]78KP[!M#6&%L$>C$8"A]%5TB_3B^H)_?+[<(=Z]SO,_N:O?)MIS/
M),:<O./\F\K]C*K%;S"D6J[3+?BUTAVR'<VDSEQ'4L-(0Y\NE>T*4JLZ*\W&
M:ODOE<&FAH,CZDU>=.['`R)WP[`'L)J[,T-,,<E/H\^>WZ>-PN7O*OQ4*C9E
MGN>F!=>B:?(W^A!K3II;I-T<*.\X^@_8HD.U].L))CMO6/M3*Y=R#P%>K]E5
MKXFXPYP>]P>4\;Y+AK62YY9><[U<+/@F5)LT/)9-QN&<RKDU8;"^W&@A<U26
MT(<;8&_P!@SBYD#B[47LI6N8JI]M;;0QCXK'RH]?O:2!6A[3BN7?ZB47D/!X
M?$7&'(]P:F91:95VS7(7&KT]?@JXR8UIL$53]QDI2X_(#49\CPHFI\=8F^E?
M=;JX2.+S'&*5X`C$#OXK7[3:P;=9![`T$N)+AQQPRY*KRY3%2,4G^H$O?.S2
M2?4LNHB.$I-?)QD>'@-.6X/Q(<<R/HR4VZ=KLRT&L9X)I8;NU:W22:K6\L$F
MA_#90V:_9U/F=7ZSH):?"CT25EN*P[7=VB0*T("F44+@KX[T5^T'2=+:UIBN
ME[B*$FB^IDM($9M/0]EHJ\ZG8`M1I^V0.E.@!Z:Z:TPS25I/;'RD(('8CI)&
MT^I;C@H02!38D_S:1&'BNM"+5(<:0723^$G>%!*Z`&@H%)%?4"#4=-.)N4/+
M?!G5./A3;T^8S\OWD%)2I[M-AQ!:J%*=]9*FE`CQ\ST'CJ/.Z.)NI^!*E[<V
M=[R'U("Z;OHH<:/Y%`Y9R)422E;\&\LV^61L4EW%Y.(/IV;BL[W%75THW44%
MLU\*T<VV.-\CGQ@$*9?ROAA$52*G)=+W-V?WSCOVF\L<H8]<9MLR+">#LLS*
MS7*V;6+A;[K8\:D75N7#6YO;$A,ABJ=X*4J'F-6OF/BAEFB);*V,D$9@\PJD
MPPS@13-#HW/`(.1!S!["N=7VI?72Y*:SN)#]T>2<MY?Q[D.V#&O>.<B7_',A
MQAZJA&N*8UDFVFU7.*J0KMS6'4AP)*'&5U"FU9JPZOWNUN--W+YUO0`DY@NI
M3V*7>?+_`*=DA,MI;M9./N\",<L5T0Q^<9MRCQ9<3B'WL28UR9C28,A7).11
MH\YB6VV[!>CNR<]8"VY;3B5-']H*%/'7H8O;YP'B`:0#74WB*\UY^;;I.$F*
MXBB;<M)!!-`".S-0C^HWR-<KY[.N8K1,XR]QN-(?8QM3EWY&Y1.18S%,?*;0
MZ&Y]A<SN]+D2'UH[;),19:>(42FFX,WL]P^S<R20%I.(U#%3;"#8A.V;;V1>
M:TX.:#AZ5QE\E.;[NGK7HCK3X.%/@?#QUE5JTA75$)4D=*H)K^BG30F9_P"'
MZ5%#-IXFY)<UUJW&=3$30U2E,="$N!(-`/74J\1YFM0DSX7$14&1%#Z"2/:H
M@)`H":%(M#I;D-K_`&>Y7=ZA0G=0@>()KYU\_.NEG)<5[?M`SQ$?V\62,XL*
M=:OV0H2E:@4I0'(J4BM:UJ#J3;`26S=>(J4H.<!0'!.9<\F^<<!^8\=V_MJ'
MI^P&HI72WQ-T^`#4NE[R*$X(O9F+404E04"#2O3Q^'AUU$<TM-#FD(^C2UH&
MY2U;C0BE=O5/7PZ^>N(1BW=GFB*.JVCH`"2I(\"1N((33R'CKK7%N+30ISRI
M.25UJS:5"(4V^3MH4U)&PBE$T!Z]-2FS,TC4?%12&QLTBH%4]>.^Y16$19%T
MO-W9MMJMC1ES9LI12Q&:0FFXFJE+<4KHA"0I2U$)2"2!IUK@X:FY(,D<0[L4
M['L.^HGR][BOJ#\%\5V*[7+%N#E?WANW+&DNENX9\]:^-LKF0+CE="I#-NAS
MF&WXEO:HEMQ"7'5..!(;:N9'U9I)]_'^SQ4"YNO.?$UE`XR`8<0NI^7NJ2DI
M%$^!!KM]1\:4T^K$.:3I&822GA1\"D)0FM.M:JZ5\*5&N(TMK6F*9KD]81;(
MY4>H+O6GC7M(-?A7?H)H*G)*4#^9W=S>.L)5T5-N#RQ\4(:A-?\`T?26N:_W
M2A0%Y`2K$.;>/,Z>@2&\=S>%%X8RBY)VF/&O4ZZ+R+C6YN#N)]*;PF;:M[@`
M2]<VJ$D4.DL=6Y=/7%A)_P`_:2/NXP,`\2`"=M.;-+#V_=KBJ._#K?<[?</N
MR-\A_P#5;[S3Z*4'>I:6]$MMU?R[!;0?0XXOMTWDU"T5<WE":>('4GPU31F(
MAI;B2T'UMK]:E?\`$:_$S\OG49<"NMCVB$GVP\%$^)XUQBO_`.X-ZIW^^>]*
M4C-)0AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OQAV6':*0$G<A1!%!05^Z4DD;
MNFOK&29H`TD5[UYB(FKX]%<44)(*5!8]=/NTH3N`K6HZ#[=,FZTXFA'8E-B`
M.%:K4MO+MTXBO<*XPV$7&W7&8XQD%LZ(7,M\5M.QV*^4K^7FQ%OE;9(VJ/I5
MZ34>6?,JX$S+8#(AV'%:;IYKFR/+@0VA[L58#9+M9,RM]NR?&+A'GVNXEE^/
M)84"A82D!;+R4DEB6RXLI=;5125`@Z\9F:R,@`TKVK3)2I6692VE?=6/V>AV
MTZ%)-*`?'R.F8I)&.-<#3B$)\V\''-V,Q4V*5'8Y"Q>-VEPGCVUWFWM@AAQI
M70+=](Z"I"_L.K)\+;N%KHC2=HQ%<SV!";=MG-,(N#?YQ:KQCMW@O)2E\,/H
M:6MHT):D(';6%=//U#4>..XM903JU8<,*+BG#P5[H,CBY-9+#DX<N%MN<AFV
M?..;EEI3_I0B2%)HIK=TZFHKK06-\?,T3X@IQKW,R5GE]4'+<Q(94T]%?9"X
MSA"2_'=H"65N??"-AH-QHM.M`\,:VK<:^E3`<*J.F31($E^2H14MN)D-,OJC
MH2AU#K=%@NJ0E"CN`J$FOI.J:6WC<XLQI5<\MNK7Q4ON%(:;;;&D=O:'RV%E
M9V;65JJH((KM)!-?YM3H!ICT\E.@]STI?,+6F?D;;.YDR+M,4C8@]QULNJ4A
M8*T)'W>@\0-38,RG@M6`TMZ6A^9)<"PKT)"U)(6V=J"%`#[M*BM!72&M#I"#
MEBCBH*_5?OL^U>U7&8D%#;BKSS%B\2X?,/W.+6U,VC*YLU34BTW"VR6WUB.@
M)!<+94H[DJZ:H^J7NCVP,&`\RHJFY?X9[ESS6G,9=D24P/S-A&U(V1LWSV$D
M!`(V)$7)FT[>I/4&A.L'#>%C"'1ZS7/5I]BJ)@2\8')')YGOT)<2C^7;'933
M2^SR;G+12%!Q2B#)N<X4#:>A*30^.N17H=7S6.8.'BK5.>2SM6KD6<V?*T6R
M5F&.WC.T8U<VKW8V,HY#RF>Q8;O&=2Y`NWY6WV&'GXCB*(>47``2GTA1JZ[<
M8(VU`<2<,.U'DQ]J9F?=X2E.OKC,KE.O..K):2%K<<6I2W"LI"CN4HG=4D:K
MB'.=08N/I3C6AHTC),]`R-R_2[I?9#$/^&X[B[;88LAJ-VY;UO>6B=?WWU,J
MD%'S*5,14)6!L0I9J5"C]RUD;6QQ\14\P?J[EU,#SM?$WF5CH1&:8:C(N)26
ME/J4]W%Q4J4H/+)30MT'05_5JRV@.$+M5?$:X\U'F((%*9IB$++/<VJ<2EU'
M;5VU$':34MNT(!%?V345&K=1UX0E#BR!N%034^5`5*6KKX)`KH0E?C<&-)==
MN<]E;]BLI;"81&Q=YN;Y6NWV9N@4HJGOH+DA0!*(S:A6I140K'_;5R/A7&^+
MY''R#+0;SRY!:BYNP[@-UGO1()N7R#=KMN16;(H[QQYQ4I#4ADQ5([J5((`;
MIJFN!5N)(H58!P.1!5L?!_N<XNX8Q!JP<?IX;QNQ//,3IXB8UR/;1<[DW'9B
M"Z7%R"FYMO7!R,RD*7M%*=`--PW3H6Z8W-H>>*6P`NH<`GRM_P!1K%7W7&&+
MSQV^6Q1:V+=SBEH$5HE#L;BJ],.`C]H%0IYZ=^/EX%JE-+6-H#AVE*.V?44P
MZXRIENBWOB5V=;FX[DV&_E?*EHEM-2&E/-+^7N?`S*W$]I"CZ=U"*'KH=?RM
M]XM"Z)&G(A*N3[]+/;;,O(9R..8MGCLJE.3WN1LIBAN.I'[S9<.%XDAON(\D
M@J*3X4KIYES,360#3PJ%W6WF$=S_`'OQ;99KG=)MFQ&-$@VUR>_<$\IP@U#C
MAJJ)3B)^&VQP);*@:=%'IYZ<=<RAM6T)[D>8RM-3:]ZK?X^]K&(YMSI=^<.5
M./7LOD3KU(R/^'K7R!A%MM^27J9),QNY7V//NK?S#("TK6&5,*>='KZ5K%:V
MYD;04\O54BE#7CBD-$<DY\P@-`YTQQ5Q,GW"7K'K<9MWXKOL*WQ4`R)TC/\`
MA];++0(`W..9[#VMIW!*0$U\`!X:LO.N0T,,30T9>,)W6T\0DM-]W.-RH=TM
MK<&T6:\+BO"$,HY%XLAVI$UI*G&&+E)M6<7J=&C/OH2VI;<5Y24J)"333+[E
MX;1S6-!XZ@5PO:.(]:>#V\X?D7'OTS;+9<BO5FM-]DX=R+=OXDL5V:N%BV9Y
MSAE]QBW2T7BS.7!#T*X"X=IE:"I=7`%`&M'X-/DC3B*?6K,?\F/1_I!5]_4N
M^1=]T,YI^(X\8>`87'[?8WI:3V[E(#22FOK'S'AX#3,Y(>*$Y+/;O_S[_0H!
MICP-P+-D=70^E0;2*G^7X]/'3&IW,^M5JE[["HZD^]WVB*%F<:3_`*1O$1+Q
MV`M?^;*U'<1N5T2/+3EN#YE22<$+]'G4Y"K*^H+F&#8G=^*59;P+9.:9<R'E
MAM3]WL6*7@XXB,_8?FT,.Y+:;HY$3<U/ME78VA?8&ZNU-+3;GAK7#RS(:CA5
M4FZVMU/(U\#PU@%#4TQJH%1><,*C*_Y%]DV$13M&S_D+!H@K4CPAX*X0%>/0
MZM_BI?\`I/:J23;;B4`27364Y&M?:F[Y\Y*F\J<'<J<6W'VIX9:L<Y&PV[X7
M>IC7RL9RW6S(FDVQZYL+M^%1EHDVQ$CYAHA:2'&TZAW[I;NQFMA:EKWQD--:
M4=P*D6%JRPW"">6X?)$)6AP-<6DXD?4N?GBK_5P\RSW!+?F.1Y?DL6;<42S#
M9?G8SB\N?$:DO,PY$6S7:4_=$0YC:`I)=0TI8`4`$J&O/O)ZG;*QL;;0Z6M&
MDN<'F@I_9J>&/>OH!ME\MX8S\9>7QE>"06,!8TN%14^]0<<%;_\`3UXH]PWT
M_N(,I]NV)X6F18[;R-><@:GYM`G-7J5<[G!MS%TDLNV:XL0[E:9`ALJC/CTJ
M&X))`KK7]/?K%O9%T[!\1(ZK@TT#2,*?O7FOS$GV2YOK2#;9W"Q@LVM#J&KB
MXESJ]H)I3ADIZKYG]U4L*2_:\0@D@50W;+HLH/P/S.0UKJV^)WL\AW'4O.38
M[8#0RFO<4UN&YID.4\R<C,<E6N#9N2+/Q;(MD;,+5,=B0KY@>12;9<)]N>L;
MSLEB(_:TV=MI3ZGG-P25T0"1I,$DCK>Z?<@?$:36HI@.-/KR5YM5G9T%`"-0
MH>>/UKAY^J)DK^6>XB=<D+=5!N%NC7*.VXI!=;MKDB[W&U)5M2A"5*M,N(M8
M2`*N?'7C&VN?)N%TZ;WA(&\L^'>O6[F,?!,8QM`&Y`>WTJL8K2_C;H8(-(;^
MY("B*?EZ%!9J*C>XR:_;Y:O6M#+E@')0`\R6C^+6_1Q2%M>URW.+2/6E2T*I
MU4$N!LA)\^G;)&K<D#-4X%<ED6EQVXJ:!)#3#;163YNMH;%22-Q-=&:,EY*@
MA]002$I<[*#TZI"4>?44*5>6A"SQU=N2IFE.XTA()\4=0"2#\"H^.N:F\PD@
M_FM!]PYIT<3P*XYM(G0+6O<U`MZ77GE)"FT,LN)0TPVW6A7)FND^/0)/PU"E
MO!!C(12JN[':I+^1S(0:-&?#NKS4AN,N.+SA<"1<;]CKQMUPW,,WF,R;@+5V
MDE:I$J&AON]JJ22M.X(2*D:A7E['<,8R/!YX\%H;/;YMN#OBHP81DX''TA=B
MWT9.-K-9/;1=+TT8\>VF[Y:;;>&C%G/7B+,LN.7"[7%Q+$A+C/S$AU+;8="5
M>D]`!36OZ8VUS[9TEPX-?J<,Z84'->>]:[_%9W@9%%JC#&U.K)U34'M&&"=_
MZFG*W('"?M,R#%,9Q/%,QMG*?%.581-E7>XW:TW:TKO5E7:[L];8L-F5"E3+
M<U=4.L,O+;#VW:*]0(75$TFR6C70M#V2M<"2<`!3CVU4[HUC>J7N;&XL?$6N
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M*G5[:>'W:]*>!\*JJH3812,`J&B(O&@"?(4)Z=?UBH(_1IQ"F1P1S3<L1LB<
M8?'<M0F/RXZ*E/:<F!OO))IZTN*0%?9J1;.#&^74!H0IK8QG[-Y2E8VI"Z'<
M"2*^%*4)*E?S:EC')=3X664T^&W*E1-"!0@]:#K7X'33XV%U7>\N)>,M#8=M
M`HTK4D5Z5)\R=)$,9R^E"Q/,=NI"-Y*A7H5#P/Z-1"TC.H3OG/[$G[I.CVN+
M,N,V0W!@P&')4R2\>VU'8:3N<=6?@!T'B5$@"I(&N`$F@3KI*1ZJC4H(\C\D
M7//[EVFG'XV-0WC^66U14@R5@E*;G<FP2%R5I/X:#4,(-!ZBHF;""(Z*LGN"
M7D5;0A3<^DI>%XS[_.#KNW(1$7&C\AI4\XA#C:4O\<Y0P4E#B2D[^Y0>!J>F
MGHX63S-9)6B;MV-DGBXTD"[?[3GR[@A.YN--W#<XY&48[B1M)KVW5K02?A4:
MGRV0TTA]ZO'DKSRPQQ-#FM^;DMD#UK@R+E#@W*^.28UFMTZ5'BS;P];XKD^>
MS:([KP7='8$)I3SR6`X6FDE:P$BNHTD/EM\7O+IHVFK#5EV]W--1RLL_(PVP
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M!CNT'W'@?A(%`<B0:%=BWM"K_HP<$U\?[M,8K^G\O;UG'^^>]=4C=)0AH0AH
M0AH0AH0AH0AH0AH0AH0AH0AH0OQ?4O2.I2XKH#6A`]/B?M\O+7TA\0>2\^^'
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MK5;<SL<*^]C:H278K:W4]:DA:P5`$TK0U^&KFWO[?RJ7`K(2>/#U+JPV_)\0
MR2\$V>TMV^1&*Y26VD!"`XE9(=2$C?N"O`TZ@:3Y\&MKX!EFA2RP#G:X"(JT
MW..F6PUMC(D+(4V5MT2WN"O6@N>!J"!J[CO6G&0:13O3_G'DG1M,^RY9.$NV
MLAE+R%L2&U44VF0V2E48KIT4DGTA5"DFFEL<U\H>WW25(:=3`Y2BPA\HCM)B
M(+@`;:6E#B$E(3Z"H%2MM0!YD5I34Q3+?W/2E@5H:"U1WGWWI"G122SL5&/<
M4AUN/2BELKVU!J>E.IT_!Q3X6:6ER-\LM3;8;D*"J+4>XXH4!44FA30I%*5U
MR/\`BGTH57'UA<KCQ.$.(<<#[9E3^1)5R*$DGN(M6,S$N%7@H]I5W;K]J^NL
MUUD\BUA;3#]ZC2RXEE%SUMW-)(W5)I]U.T#RZU)Z&OZ]>=*,M-^Y-.3$(*5;
M(S;A6/+O/@-MU/6NQK>2!_2&NIN1^BF"^"]HM[J)`2X6VZI2`:K"5U#J7&Z_
MCLN(]*DCJ$FE"/#B6#452-S[_E'&YDK$G2X[=5(M392JGY'(FBDI$A205H[4
M3>N,=I[AH/%*M.0R-BE;([W0:E=3)R;_`(S:T(LSEWB-N6EE$%N(SWGHL;Y9
M`2F,_(2E3/S`2D%=5;BHFH!)&GC!/.\RM;X"<.U-22:#2B8+D&2],R0A9/:3
M%AHCM`U0VTXC=4(\$N.5J1_+J_LX]%N,:J(D=*>4ZX=RW'%]0ZZXO>MU:30+
M4>IJ$@"E3X:E(6U#A2)C\:VPF^[/G.);H31*&U#N>LT':;;;27'5'HA`Z]`=
M"$J\@E1[8U"M-L6H08(<^7?H4KDS'T`3KRO::H=G+;HPGH6HZ$`]170A&V(9
M0C&[U8;U.ERI-I%P7(D1NZIZ9$0EQ/S,A38/;=1\\M#Y2*+7V03ZCU@SVCWQ
M.#,31+8_0:JQ>Q1K3,CQY[4.`\B0RW);E(89=2^T\@+9>2L(VE#B%A0(\CK-
MEAC.@YA3&G4`[FE0YR,]9Y:,;L5DN.3WUN*V\NW6SY:%;;:RM6UI=XO,ILQ8
MCCP)*66TO/E/78$D'4F%D.D/D>0X'("N7I014423G-\DN<CXS>KYCN"L_P`8
MVAVT-6"5DES>B/W'%OF;Q;$W"[Q\?6J-<3"G/]E#3?:<#1"U=$@S!';7.+0X
MT_$*>I)9'H3EW)J[KQO);#*XBOL>X7BP72SV^=C=]M68VEJ1/A/QHJ@J3/MM
MUML8274E2ODZ(1U/AKA;;?[$N+NTU79'Z!7/%/!R?:[A=>)V\7:=+%VSR[XE
MA:%M`.!"`MJZ7M;5:;DM6VP2E5KU&I4?N#N2&1@N$M<3P5I?$MJ3(L5BGMH`
M3*M%JEI4E:25(DP6'DG<:;D[5BA\]38?<]*=**N=KN74QL5BNI4PVTC([\"2
MM+=L@2BFTPE==H=NUZC`I!\68CWV:3/F%T*L+*9_S%TN;I*2EQ6X`IKU*C4@
MCSK36=EDU$MIDY1G2:G!M*>)=+?'!8<^FMQ$R_:U71AWB/B:W*@LNNQEO"Z<
MSS60ZIYA*G@(*I(D*H**2T0J@).M!9FEFP_MB5K/_8QW#Z0JY?J`/)D^Z/-T
MK(<$:T8I'!*0*$6)AU7H%0/4]6GVZ[=#3.YGX<%G=W_Y]_H4+NVA(10)^*2E
M*2#U\*I'0_I.HRK%*GV-T'O5]I?W4[O<-Q/3JGH3F%LH.A\?*FGX/?\`0NK]
M$/4Q"A3[MG0U-P0[4$F/D`!6D+H.Y::]"#\=:/I_^(_]N!6?WV1[6-:TT'[U
M$J`)MRFQ8,)EM<J6\W&CHHAL*<<.U`4M6U#:!YJ/0#KJZ>_13"M55Q0OF>&,
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MBIN,]Q21*?D%#=&T*2A(";"WG>^9L3&U>\T"RVZ[92,W4`]W%W8%6E[D^=$X
M9R=R&NRXPZ;E(]NV0Q;I>;7<TR[?CAF63.&K.+B9LE+TY^Z28K348PD+2'$K
M[NW:FM5U)Y^U6]W-<C1KA+&]IX^I1^EXW7MWY9>0P.8<JYGZEQ;>Y[+#G_*=
MXO"6!'B"&BRV]@N%P,1;5'=A1&^Z-Q<>=8CLI))JHH/E0#Q;:I97OFGF'CEE
M\RG+*@_>O=Y6:08JUTMIZ@HC62,5XK<92SUC?FD';X)4$Q'7*@F@"BEL]"?$
MZU)/_&M9R;]*HK:#R]IEEK6I<WUG-)#&&FW(=S=I5EE38!4?2'`S2BJT)2%+
M-?+[=6-T-#M'I55:#7$Z7*@R7Q)K=GTI*:*DLE*00D42D('B>E`?/QTJ/W!W
M)G5J\7-:*T%+>Q1`<3(=1N\0%)4*4IY;'!_)KKO=/<A'J$)DH;EA%76DN,O@
M4HE01N0=H!(W+0>M?VAJ$EQQZZXJ??LWLC,R%F+CK(65SHC##A"C5D+=E422
M@GPD#_8U4;LS6\#+)>D=*1Z8)R#]\?0K,<$XXAY].L?'S=WM^+#(5(M"<CFI
M0;?853=J$W*X*=*&TQF72"^LFB(Z7"?+3&WV_GW<5MG5X^FJM=X<^VVVXNXA
MJECB<X"E:EHJK)>2\0L7$%^P+,?9AD]SQ_/^2,DQ7!T8W@$A_(,9Y)G/QWW'
M'[S%9CMXQD6-8_C<%2[G.CKCR8T4M/+>7WVV5>D[B\6%PRW!_.D?1L8Q)`I5
MQ[*?0O&+1TN[B<[G$T01,UOD>T#WFU%.W@%?"W9F>3>*(N(<V8UC]S&38E!A
M<AXO'8,NQ_.&(RY>&K8)A>=0U"N"%.1'5$.(*$*]*A06VX6EK>[8;>\8)+9T
M;FD98FE'`\*>U8W;)KFRWYEWL\CV-!PTF@(X@CC7V*J/BCZ>'`_&G-%SY<M=
MHA7*_6^?(8X\0Y8+=;H.'1^^]NR%B"EI8D9Q<!)4E<W<0T"=@2:G7G6S[';;
M7<R/C<]X.0)RI@%ZON745WN$88YK(W85(S.&(.`SXJ_+C?EF%;\"@<;7&SL7
M2QMH2E^2^4%V.2`'I5L5L+C<N&*N(65>HI-?$ZW-M<Z-$TF+F\5E)[&*[%'B
MKON]A52WU?>1X5A]GG,?',A?S4G)?X?:M+["TU>C6?)K->5W)::?V);+*4=*
M4<=`%>NINZ74#[<'5B0LG86<L&Z![&4#''#G7!<-68CO2WC7<4)J3\!W%4/6
MGPUC%N4V<IP(ARUD]41GUCRVT:53RZTT[![_`*$S/[GI407TK"U[ZT4M0551
M5N77HH&O5)'GY_8!0S%#6K&BN3)08:34K6H$@?=36A-?`$5Z:$*0N&XN\E#*
M-JE=$T'](BFX_81H0IK\;8[(_JZ"VXELJ1X`T`)JHU(_D^&K2WR;W(.2F+8+
M(&$_=HFFW<JM2".E*BF[5Q:V<5T#4>-<2O1&6E=0D[4FB0/42*4ZD>!T_+LC
MQ$96X4PI1=6PF,X\I+2&RXM:DI0D"M5*(2!4=.I.L_<VTC'^6\4'-"@1SOR@
MSE-Y7B&/R`[C=FF%%SEQU;F<@O,512H(6CH_:;6\DI9_9>=!=H0&R(48TS4Y
M534W\,IDV6*$J\/@H4K7H:>.IBJ)O?\`0I*^TC*G<%]P6"Y0APMKMQOX2X#M
M/]:QZYQ.I'4"CU/UZ7&_RY!)F0INV?Q@KIN8_JRX_P"W7#0U:!_&O*]T@K..
MX4)*F;?;RM!0U>\NG-_UB'96UJJEENLF81M;VIW.HL'WL=/!BY:&><Z0*<5$
MCZ37N"YG]UGU5,2Y/YSS:Z9I?X/%',TFUQWW51L>Q2V+QM,%NRXCC[*C;L=M
M#2KB!L91W'E>MY;CA*S474\C[J,$^`UP]"J9=<EY!5U&->XT[VE=87*3B5H@
MA1*=P)``KU[CB@KK0"O:I^K2U:*K'WH6?D+);1;[!QODL[#+S-MKS3V86H,+
MO%AC./.]QRSMR8\IA-P=H$AQ;:TI1N%`H@AJ60QTPK5"AAQGB_N/PJ='DWCF
MB_<CH9@.6XP,WQNQRK:XXIQ#@N#J+-`L<YZ>VA&U)5(*0%&J22"'AE50#F44
MY(_S-@7-N,Y@<Q5;[;S?+BX#D$BWXO`C6^#F6.6V[W/C-A$:2X\E$6YVUVZ6
MU*G%J<6\F*VI2Z-A-[%2[VHLD_C6SM3?]V<*=F)4&]E^#GAW#_8/:893Z:Q.
M_P`@G2!QU$U%%WB>Q-BX1O9Q[;&+M<)MVN;7$6'IG7*X[/GILG\M;+LB5VP$
M!Y:CUH*:R3_>/>IQ!:=)S"EAI*XAH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OQB
MDQ'B3O04J6-I`0K:D'I6O77OK6/<>2\_\]G:O7Y8L$@J*>@4"4J(4DTZ@@4%
M/M\M."%Q(%0*FB<+P&:^&'M4?.5-PR!N&22(]O802>FU;RU/J345\4+!UY5U
M;,T[NZ*I)8&CLRQHM9MC=-H.=2F@74$@TZ$@$>!_0?/68E>UY&D45@CW&<KR
M7#+JU>\3O5QL5T8*")-ODN,!]"'`YV)C2269D51'J;<2I!'B--(5C/$?N^LN
M3R6[!R8W:L7N3Q8;@WR(90L<^2ZL,_+S&W`^;2ZHKW!U2RP>H)1TU%?`YSB1
M2A0K!^/+1-O]\1;K6TB8N7!FJ2I;T?M%#3"UI>2M3J&WFT[*^@DE/4:5!`[S
M7-P]Q"<OC"R3V,GO9<BRBM.,-W**VE/J>;F--+82VJJ"%%Y]*1_@U+L8C&':
MJ<$!2(Q;';O*QO'[@ZI;2[W"N<F&J8XVP\\]:G'6I\`M("2[.B*;5N0H=T$=
M/#5BUKG&E*=Z*J27$K\2Q1WHTIAUYHRE-OOJ;*4N2U*2`&XZ@'']JA12A17G
MJ=`-+FA3X"&M:3D%,C'S#1M<1;928R7FW)%T;6VTU&?<71#<AGHX\M;AH`D*
M43]NK1CVAI!&*FMF!]UKDYMMLMRN3R4;'#%:AH67W6%QFX\]E#;CD.2YVT%+
MIWFB5"IJG].B-X96JD,8YV8IWIPW\!#UL:DW2YM17A+AO-K@M(N+D:&Z0@N3
M5*4AA2"CJG:0`?&HTE]Q$X:6'Q>@)P1L'\4T8J!?K=<N\329W!?"6`W^%DU\
MPF)?\TSJ[P9T"X&%<LD;C6JVV.XN6U;S,>[-1K>X\N.E9[#2FPH!1.L/U7<-
MD=%"VI<PX\0/:H-Z^(4;'72WCS5"!NT5D%0?0IRM$LI71U6Z@!*3U2D$]5>`
MUD57F9O(KXW/C)31<MA3BE%;B@\U]Y7D/4/2D=!]@T)J-X;[U5@?ND5OI\Q%
M4>A']:9K0BM:;JB@\?AHQ.`%2EXL_,/N_:F9/*T6TY'.O;3JI+)B+L=FL8DL
MM0KNRA\+NEYNR7EMQ6H3TAH-1G'2%;4*4W]ZNK06Q=$R%WA9[SB!5U>%*]G-
M*\]G:DE=TV2]VN([BD:-=41+BY?+WAR)Z95ZM;CCKC\G\JF!I#>1VE;[I<50
M&2RGTJ"D@$287/8U[)6:(2S2'\*_UN(/<"D.'G>)N`'-,G.ELS[E.EL-.LQT
MAV0EEY6YUM0&WMBGW4H>7Z4?L^%>FK&W86VS2<JIA%!64+0H)20FBDA:=P/G
MZ@>BC\=.(3F6..W8+'-O%P2I-PNL<)&[T/,VJ2>ZW%;2>J9%\712S0%$5('@
MXK39D&L1@$N*Z!4T&:)19[[/@2ILU,*VVF9(:F*GW9Q,4%UA+K;:;7'&Z;(2
MIM904MME)`3U'CKCIHVG2#5PS`X'D?W)WR'<PLN-7C'+!+=5.LJ+XTZN.PN7
M<S)2S#8[KR)\EJS1WXBY+LF&XE+;;KPVJ34GPHF>.25H$3RP]G'L28WM8279
M44VN/,VQR1AD=_?9VY-GM$R=.L$5M49=MAQ/F9$>.($A9=2PW#0@%:0IM1Z@
MZHW6;7SN8_67U-7<#3BG_/9R*>/C^X2V<5LBKK(<DW*9!:N<XKHD-R+FK\P7
M$0A"0E+,),E++:1X(;'GJ$]K&/HRM`E:@YA<*Y(VSQB3<<6D72SH+E[Q.1%R
MZS)2FJUS;"HRWHS:OA/MO?CD>?=IJ5:ESWZ`3J*AU/-2&PI;&16VU7:VK[L.
M[V^'<HBTDJK'G1VY#1Z^!"'!YU!U):RI(%*H)3LV;&S?>8^,\;<;4Y#Q3'\J
MY$NR$H51M^XL(P3&TN5])4[^:7):!][\$ZE-%&@*='_#'<II<99&SCN+VK%D
M1Y-ZSVQQAC7\%6Y*_P`U<E68KMT.9<7%H[-CQV5`99E&XR5(C_+.A39<64MJ
MF1@B'4,22109CM[DHYI)<L0IF.X[=)5VE,7/([R^;CD-S;;6S%<D)9,>+;K7
M'<JN-8[-%`8B-GUJ2%.N5==<)9=&YC2XG`)#Y&LS!57=YN:ERI:E**4=QQ21
MX[A7:$U\22-9MQJXGM*9,C7$`9U"ZGN(U.N?3FX!1&NR[.]+QSVYV[YM+C[2
MEMRN9FUR+6E<9#CH7>6'7(@30(6)&U:@@J(TMI3X./T?Z2UM/^%8WBX"GK52
MWO[NTE7NQY30TM2$,KQ:.D;R"D-XG9213U4H5Z?NXW.N9'"E`[Z@LYNYK?R#
MD:*&(GS]Y2'W`FM>AIN!)H*^&[IJ"JQ2O]ATN4KWP^T-+CKBJ^Y#B$=35.TY
MI:AM5Y;M/P>_Z$+](+4Q=4&_>$^TS/X_#BPC='R.A/@?79P>OV:U'3<9>)Z4
M]T?2J'>GM:P!V?[U#&ZY.WB<)G("\RVTU*8;#JY"&"A3Y*&U)"P5.DJZ;$C<
M:_IU+W3_`(>(M=GV)O;!YES1J\6KFFV7YRDQZ6Y'"@TRN(TY*E3GT@$Q8L1I
M"WG7TME*E!*:-A0WE-=9^)]*.-:46R&&!3M0KVR[%=>?L5_@-AI+C*KLU!:<
M4UO22OL1ILA]L!)_W1"*:?\`.;R*[5,QFV:VI"'6(CCX>65I3WH<IIL*/3H\
MN(TROKYA1Z::D<'FHY)M\C6&AJH39]R5?\6FMKN2*0I<EH,NJVJ;><[J0PP'
M&_-:*D]>A3U%"08[)7%[7PDB1C@17L*CR.CE\#@?+((=W$*N'WN3+$]<L^R'
M'W\@M=TS[C*W0'8,S,7KAC=HBV62J0N/8K+)BM"U=RX=UU?XJ@'7GJ#8X=/=
M>[J[>ME$<,09*P>,C'63][LQQ*SW36VMVS>9GNJ&5&GM!."Y.L_@25Y:U`D-
MJ:>3?)BW#(3L6E$*65NK=-.JOO!'D=VO$MO.F"2,^^P!I[SDO=KN,O,36T!+
M`[T`8^E1COUWC6/%;E8Z-ID3+C)D1EJ45+4I0+-/0:)`:<<'G4T&MG91.GO(
M[AM-`8`:YY+(WT[(+%UJZNO4<LL4B<9G!J$]#4H!,U_:]4=`%I*$+!Z>50?A
MXZL;PA\FL99*JM1ICT'/->)>ZW7)U+O0/!L(430`MGH214D.`U!^&NL:9("6
M\$B;P2:3][)&$H)DH?<;V@J;$H!/2G;!#HI]OI\*^&DM=H\#LTA&>$/,39;\
M"3T;G1T!)/78M3[:$.#QW*:*R?M%/AJ-?-(:'C(9JPVYP=.;5WN2,(]/!69^
MS9<9FW7:S%*6KI"N)CR_553K;<8AAU*!6I4AA()\-4%Y7S6.X/94+?=-D0V[
MXW>\QU"./?\`TJUO@+CU_D+D_&^/H>/97G%TO_Y@B'A>`KAMYMDRHMLDJ_++
M$N>IB##[CFU+DF0I$=E!)<4*BMAL(;^IQR%[FAI-=)H[W3[I((KWJUWF6X9L
MMS<V?E&1C!_$Q8`7!I+@,2`"<JIY./[!]1&^^X/D[$_:KR%[5U7/#)=_QV#+
MYWY!P:W<HXEBEB?F=RT)M]_OV1VQRU8TQ"49C]A0+;(^7W+`#>U'T'+\OKKI
MZ"#?]SL;UPNH`YDLGYCFZJT::9$9AO&O%>4[WMNZG:XQ>Q3BSD8'-?;$,MY:
MUH=+O&23@:@84P"MS]I;/N7XVQ;D>+[UO=;[?N<>:+[<($'$..^![MQW.L&`
M8M#AKG7";,FXQ'@WB[91D,E](6A;:HT2'&&Q2G'5[<IN.T;Y;6[KJYM[P6;L
MGOB=&W#.FJA[\%GK+9[NV(N3!)'",RX4`]2=*ZV"3F+<>YL9A>L47;E/264V
M20PRY.(`*&YG?8?"F`MM7W0@^HFNO,M^V6XW012VM_=64L9Q$.D!XK727'[I
MXX56[Z8ZBM=A,S;K;[*_9*'4-PTOT:FN`<P`BCVD^%U2`*X$I]L7G"U6>)=;
MG(;C1(5K1-E29!2W':89B=^=.>42`&6(J%J)KT\>NM);.+M`<7.HT"KC4F@I
M4F@K7N66>7/&`HXCG6G<<,.78J!?J&\P+Y>XTY>R,/`VR/9X=MQR*$I"H]C@
MWF/\CW*4*GI'<4ZLGJ-X3X)&GKPZH_+'O9^A0W,T.X57,M>%%Q<HJH3VR?U[
MZ_I\]5"GII[NL-VZYK\0F'+/3KX-+^T:ZUI<:-S3,_N>E1/G>!ZTZ4_]0`'A
MUK_CU-C:6L#3FH:=[CW!I$A+,B0TONOE#A&P!2$']VBII^R:G_*TM"F=AO'X
M93&+L<DJ"0">IZT'JVU'G_)H0I@85BS41`44!*0`A?AX)ZI2$^7AX^>IT$S=
M0;C4!"=]#;;82E":(2``@^%/@/.FKBWNF`AF()*%E)Z]"H_&M`2:=30&FM(+
M^$,#23@$S(QSR"TT3$^X[E!KCW%FL.LTDHS?-K>IQ]YI='L6P^5W(SL\%-"S
M=\G"'(\4_>9B)>>Z*6PK62WJYCFD#8SB#]2>"KWMR$H14;0E(2A(Z`C:.E!0
M`"FH,8\(/&BK+DGQ=Z.5.T&VJ-Q\QU!!^%//^;4EKVAA:<U"&)IQ*Q)Y`5Q]
M-C7B%'1-N[4::W;V'">TQ)EQG(D>?);2VXI]B*X]O+0V=RE"I(J=,J9;M,,F
MMV78F`G76YWZZ3;S?)DBYW2X25RY<Z2M3LEV2X0A\E:T-N(8!;&U/@$T"0E(
M`T*5+,'B@KFI4>SGW;9?[)^9V.<\(M&-WV]Q,6R'$_RO*UR&[/*@Y+\BF4VX
MN)22AY9@I2@MJ0L$FBO(I<0T:CP2?,=J8]GO,!./<5WEVG-YG)G%_$>?W2!&
MM-RSKC+!,XGVB$Z\_#M<[*L<C7V5`B/R/QW8D1Z>6VU.>LI2"KKUTPZ=A!&.
M(5K;2NFA$K\W?0F4SB$Q.O">\`0U!8;`H#]Y3JS7_P!.&N6^(-<4^D7%QJ`E
MW=VT4`4?`U^`_P`.I**!(GEGB2V\E\>9+AZ9@M-RF1XESQB^I0"[C6:8[.C7
M[#,D9^\4FRY+;XSZP/OLI6@]%D&RL+MEM.Q[@2W(]SJCU"M5&O(([BU?!(/"
MX>W,>T!=6WL0O%WR#V:^VJ\9!9'L;O\`.X@PUV_6%^E;5?$VMIJ\0V5`D.0V
MKDV[V%_ML;%>>J6]B;!>2Q,(,;7D`CEP4.`3-A:+@@S`8D95]*EGJ,G4-"$-
M"$-"$-"$-"$-"$-"$-"$-"$-"%^-M&;[RT-!))312U@$]*>?@!6E=>[7FYO;
M+II1JP@A:[()1/05%CN5*2VE2Z"@)"4]?"O1:.E3\=07;L"0TBOB"?,3=`:!
MR4)>2G2_E=X>34MH>2D5Z&C;33?7J>H`\M>3;K<&YW&:4_C(]2U=HS1`UM*)
MJEGK2M:>5*4KX?IU`4E8RM*205`&G7]!T(7DJ2H%(HLGIMK2OQ\?LT(4P?:S
MSSRKQ?>TIQ"\VN7;XJGE-6'+8LB[V4_,Q7FY;+"&I,6=`[R%>HL.I36A*2=,
M27#K1WG:=;"*'L'$H5OO`'OWM5@9R.S\BX!-MIO&/6^S)EX_.CWZT!5ND?-,
MN!BZ.VNZ,H+S:%(2EY:DI%`333]KO&TLU>:).%$*Q.R^\3VBW#$942[9M:\5
MEB/C%UML:^63*L=A-9#`3)_,9YD(LTVRID352E)>6ET)>\2HDDF\CW;:Y_`V
M5N`R-1]("D?D]BD?BON(]C2[A$6_S?PHBVW)3%XFK7R7:K8JVN!M;K[6]11(
MCM=QY20E"`KT)'4]=2!=6`&L21T[U80&WT-U4IZ4L4_4A]@O&JIEQ;Y2Q7,;
MO!:G,6JV<;6/(\WO4M*U%<9$1ANV0[+'D[CM[S\A">I-0FNF9=ZVN$T?*W52
MM!4U](%,5,;=V\`TL:"W-0XYM^LKF_(5CF6/A'CU_CE]Q:(\;,^1(=COER%M
M:CAEQVWX/;T+LD.9+7Z@]-D22T`*-;O4,Y>]42&OZ>VG]OZJ>U1[G==5/+`X
MU5=F?\T\Y<X0847E;EG/,NA1'4O0[4W<1C6.,JV=H(;QO%V[5:'@$&@4ZVXN
MA/7J=4#[R\O!J>]P=Q:#QY_L55R7,\N#W$MK6BA#R;`4UF4I@)DQ5P(%MA*;
MB..LH!3%2[VW&V?PR4=[I7U"OCIFEP00:T.>*:UO(H3@D0RR&`0A"]R@.XX\
M"ZZX4^&]YX*<53R!.F2US31V:0BF]Y)9[&VE5XG1(ZG?2Q'V%Z9*61T;CPF$
M/2Y2ETH`E!TKRI>2=CT5.M-!EUSOF2-1K3#M7Y)'OKJF8%OF,H9R"\-,A)DR
MYS36]S'\=BM$*>4I7S#]4MC9N.K""**!PE)U.IEW_8DN<3A7PIL_X?39LHO-
MG4U<I#<<1G#.M<"W2+[*0Y%C]8J)KE8MJ[F\(5&;4I--JB*#5LV1DC/.``EX
M5[.P)"*\JLZ;;&C3;;:)>/\`]>9^6GW>XJ3D$M\KVAV-&1(48C#1];CBBDD4
MH!I<,KC)2X+?+ID`0/41FE-<YN`."1-SFRISUQFS74RI3QB179:$M(,I3*BE
MQQ?:0VEQ3PC`J<(W.%534]=/#!N@>Z."2O5D@,2)B9<_M(ML#LJ>0\H!J2^L
M%3$$D_>0[L*G:>#23X$C3<FK3X/>0G9METQ"5*7=L@R6.PI#ZF[?"3!,MU,A
MQ.^5>7XSD9]AI!%&F#0]ML5%*BE==PW,D?Y8)><\1DGXS$`"ZFM-[D^2B3D$
MURSR%3H+:PU&G3FVG),M+8]<A+G;;6RTX:]M(H4II7KJ7!"&Q@/'B1)+CX#@
MDS)N3L]:52&XZ7TR5OE]"%AUP.(;;7'6HN*W,_A`BOJ!)H>NI*82O;R&+<%(
MMBK?#ML>6AN.TEM]YJ';GE2&U2I\67*??FVM+D%*VUM-.&.XI0*FSIE\1:62
MM.KQ.U-[*8>H]J%.W%[O/LS=E-\NZ;SA]\^1BV+.8_R@1`E3`VB%9LH3'0(J
M.\X0TS/;"6U.T0\E"R":.2&.0ND]Q]3X?VYI0<X"@."E#8K,XEU"''EK0@CN
M)4AI04*BK:TEL"A!/CI$#71DN.#EQ.![;(CT*P3L<65+3AN;97B4*D="Z6^%
M<US+0WN50DMVVXM-_9MZ:FQM<'$D*1)%5HT#%2^]M\MF^Y)R%R4\LKBY)D$7
M$,6<^2"VG,-X[3*M;3[5%T[5TRF5<Y`4/OIV'X:DQ@%X!R3S`6Q@'.BL7Q[(
M+6&"@NMMU1L456R0#M`].Y33XW)"B:`U\?+5G"(8VEPH)#5=44O<O&8FV:0[
M#ND!L=I=&3!FA:J@CTJ4O:D`@FA'Z]19OX#JIF5CG4TBJIRGP;@95Q4N0P_%
M9>+;/:#C14XE/XY6E;B@%!:P$T'W?MUDR<4H1L%#3%=9_!C3;GT_O:I'EV\R
MVY]Q]N=K;*G7F6TRV\_;N4:6RY'<2MU=L=82Z4*]"E)VK!!.M/8T-FSN^M:F
MWJZUBUXNX>@JE_WPR/F?==S.KK^%D%KC=1M_LV,6)LI`/AM((^W5A)H^&,K_
M`.(7&IYX!9G=<;^1PR)P44@21U%#\*U_GU3JO4LO82"KWP>T,$4I[C^(J=:]
M!F=JHK3\'\3T(7Z0VIBZJ;OJI9][O<:R'@K%O:U[5\F]P;>8L9A"S3*K/%@O
MVKBU/YCB<2V7&]*G2(@")D>;+D)0AP+<1!6!UIKV?Y4;!T9NMGNFX=6]06NT
M"T9$YEN]CG2W@J][F0$"@=^6(W:B!26HRJ,;U2=U,T,6W0/F8[WR*>`5S45.
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MLX*`]1JP_P")"7#TT>;'S7'.B=B:$J$^?^Z;AKF*1;K)Q)RKQQR7.M&1P[K<
M;9B&80;D[;+3%CR0[=G8;TDW*1":>>0E2MI"7"-^T#3,CV,;JBPYJ(D5[A>7
M^(,"X/NU_P`P5>,FY-GM7:T8+AUJ-CCV(0Y46.U+N667ZY0+B]#M^YU2DMQ5
M)<6E-.A4",OOO6%AM-J^V#'2WTC2&\14X5%,J=JOMHV"[W:Y9/J+(FC/#$#)
M<I?)^23IV17+)[JA`.QZ7,F-0S;;2A]R2XL,V]MQ"2F(E3VU`ZE2$5]142,%
MM,#YM(,GYDK@7#O.`)RP[UO=Q(MF&0.JV.*@/<,1S4&[O(_,YR9#X[;LQU#<
M&,JJ>W%#BD1RY4=0L]:#J3UUZ5#;BUB#VD89GDO.IKDW<I:0:$X#GVI4)QY,
M1+4;>@RE`K?*2H(90M*-O<4`4MJ4V%[1XTZZA27;9<"*8JQDL_A\!B\\.Q)Z
M[L%V`RCUKE0U.%QP@@F.E025&HZT4V*>(ZZDVLOB#:_E'/DJNYCD)+Z>(9=B
MTK)/2[2"Z*.U4N.X1U*O%;2^H!#J*C[#2FEW`'FZV>X`$6@J2)L21A7GP]J.
M+6A<.[Q@@*!;E*9IX*")-'&Q04-$JI3]&FY]#X#Q)R3UL71W;:8/"L`]N%^7
M&Y/@*MS3DAV_08:5PV`5K>NL5T1DLL,A(+CD@A2$I'52EBOAK,W37N,=`2_5
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M\5+F_P!FN5597G5NY;AMYVVZ8QL)'B+0`YW=W*PW(\[PFW6P-Y+B#[U83:@W
M/Q^3#82UM2EU$B6Y'C]@-@JWHK7RZ>.O"H[ACSY+Q@!GW8+->66-%*Z>%?95
M5K>]OW#X]A7'#/'W'%R<+7(X7#*52C+_`"3%+8J,NY18+JR7V&9KZ68H"G%*
M#*G4FHH=3&$``LRX+BH_YOR]V7PSGL);FX/65`*O+<B9%<%:J\21]NE.<YP)
M<>"C2^^%4!-<[GS!)H=@"AX^(4H5-!]Z@U6-<UWNE2TT60N=NT745H?D97J^
M'X2NE*>8T_!_$]"C3/:YM`<:IGL%Q)[*+P'.TIR#`=2IP]0EZ12J&:4.Y"*U
M5]H`U+)`%3DHRL"P7`6X[#2W6=IH%*30[J4\O33[Q`^&D>;'S2FL<X5:*A2.
MQNQ-,H9!"1VSXCQ`'4`4KH\V/FGHXCCK">.W1TM-T2E*$I-4C]I5>@/3IT!T
MXUY'B:4YY;.2.T)W^'3QJ?&GCY=*UTZR5^H5)I5<<QH:2!C1%>2918\!QJ[Y
MID0[ULL;:7$0=W9=O5T>*D6NPQEE0(?N<I.U:A7M1TNN>"#J5Y[/Q?2HBJ+R
M?+KWG&2WK+,CD_-WJ_3G+A.=2-K+14$ML0H;/41K?;XK:&([2?2TPTA`Z#4`
MC4XO/O)J5Q:!1!AX)1T&X$)/PIU!/D?$"FI\?N#N4"4%S3S*U[C=6845Z9(4
M$(9!7]^FX@':@&@'7^8#2TB.,``N'B3%W2Z/726]*D';N4XV4*V+4V@T96TD
M@+(06'4+`_:'3Q)UQ.K98"F=^X[RHD_="""K:5$A-05%8)/AXZ$+=C6^Q7QZ
M-:\EOL_'+8]*B+7<[=8$Y+*#K$A#K;2+:J[64J#FTDE+Q4:;0DE72-?2B)C=
M.)(RYJ;%$QS<<*M./H7>Q[4_<EQ+SSQ)A%FXZN5U1<N-,"PG#+SC^56A_&LG
M0SCF+VFRM7T6.91XV:YOQ%J:=;+K:*A*UA1`,.)[I>%'#AV*;;1B.W8P&M!C
MWI;92M2KS,(6!VT1VR`D$@H934%1KYG3\?F8^6I"(&5DAQ14OH@^"@.J@14$
M)%*'KJ<,L<T+7E)2EE3E5K/Q4XXJM01^THZ4RFKQ9+CM-/%[JZEO:"0KVO\`
M!)'@>-,8IY_^L#?GJN>*/(4)]-1TY*1VDI*&A"&A"&A"&A"&A"&A"&A"&A"&
MA"&A"_'*MZ$-K]'3N*W'J2/T>-:$_P`VO6+V=YN'UIX74'<LI!$TQ:S762E`
MZH"/LH5%22*T\`KI0FIJD#P%-5S7ETN/-.F,#$5K4*".>)4G)[UN3^&F=)'E
MU*5^%/T#7GMS_P`W-_O7?2M''@P=R:UVG<50$=:]104(J`/T`Z:2UK.JIT":
MGXD5%#7P^W0A?$-"@))J?+PI^NO6NA"=K`UH@JBO-E+96]M4XM12E3:UJ8<J
MM-2!U%=0[\CX<@9H4M,;<,U*6Y`#JG`$)=)!_#;*=JNH`6*>!\Z?'6:0GMLZ
MI\1GY5$<RH)*/O`)CAI0-?2Y]Q-:]$_9HPX@$=J$JW[5CDQ#JY\*W*;0@-*3
M<(L1^B%MT+8<2%J2!NH"H)-14:YH;75IP]-$ZV5[104H%BMUIQ6ULENU-V^W
M)4=P$1I*0=Y^ZMQ-7%T/Q.NX<``.Q=,SSA@E)"3!;7N[A>45)KL)J0GQIU\Q
M\="92ZM,_>ZRI,<MH:4BM5>FHI0JJ#^O2F/+#49KJ)+KB^/WBZ7"Y28[IDSI
M"G'W$R'$[E?<!"`0D42D#IY:G1N+F!QS0B]6`XT139-'Z)!IT\``K<*:XZ-K
MS4UJA8SQGC#I2O\`K:5@^E>]I3B2.@(445Z:6A8%\18W(675/R`O:IL.*1'+
MH;)W;>[V@X$E74CP)T(2-N_MBP#(4);NKDV26Q2.\X6B]&%2=L>0@(>:22>H
M"A7ST#4UXD:YP<"A%,+V@\>6YQ;T)U]+RVUL]Z6V+BLL.=%M`S''MC:DGJ!T
MTJ5\L[@Z1[B1VHHHW\P>UB+C^1V=NSW5EFS7>"_,;BMVNXO/W"\VIQME>-VV
M#9HTEP3[NS+:+!HEM(#BUJ2$DE^WF>TFIKAQ4H0QG`$I0XU['\E?AQI%]O\`
M9+&N2TF0Y;`P_>9T%;HWB,\\"S#3+C(*4*6A:P2GQT^^Z>UM1IJCR8^?M2\5
M[,[HU#C18.<6I+44CLIEXU;Y1+M5J[RA(CO*"JK/BHC]6HIN)72"3CRR!7/)
MCY^U-Q</81FS\A^3'SS&7G'WG'SW;5+A@K=4I:@&XZU--)W*Z!(``\`-/?J$
MS,'PDGL<%WR8^:34CV%<KH!$?(<,D55M']8GL*('6OKBJ`((U(%\P^_&Y@[P
M4W+&U@!;5:C7L5YC1*8K+PYU#3@7O-T<=20D@[78[\':L**?`@A7@1I+[^-K
M26-+G<LDIL+2T$UJI"8AP)RM@F*7/%7,0P;-+%>&EBZ6RWW^1C\Q;DB`Q#FN
MLL79B;;'7Y"F0X5I=CU>]:4H-`*XN,AUAI:.1Q]J5Y+.U.QC$WD&Q6Z!9D\/
M\ESY\&+'A-KGO8O);EF*VEIA<_(VK\F#N4$#N/%`)%5;2>AYB,T>2SM4C.+.
M/L_MV)9!;YB(5LRG-9^27RY7.V/H?18KODR%,H3:E2J(D&PQ$LM,NK1M<6T5
MD4--31DGADIN\18-D&,XYC>,0K):8MLL%HMUIA(3<V]R6(4=MCN.+6Z0N0^I
M)<=6JA4M15XG3L0.L+N>6:EM9L6O[S*4"#%25!(-+C;S4]022J2*`TK4ZF43
MK(@YA)KJQ2"Y(]N^7YQ`=CQY8B;T%(,?\JF*&[=0C_E9DFFAT+Y6EK2`WC7Z
MDF.UN'`ZJ*!6;>R_,<)MER:3)<O%V?[U[MT9=N8A.RV6>TQ,A,!FXW!#TA9=
M0M%2@*Z@5U22[6^/&N1Q'8FZ4-#FK;7;M=X'TO..+589ETQW*\0P+%\WMLNU
M/2H=UM>0XY>W)C<MA8+;C,YI*7$F@Z5IXUU<P,C9M[9(ZBC>/?Q5F^=[=O&F
MFIC</6J/;Y<LIS&]7#(\AEWC(<@NSXD7.[7'YB9<KA(2TVR'Y<A2"MYP,M)3
MN)\$@>6HS[A[X_+---:K..+W.)?745HFV)C];E.BV\$5#55S9Y\?NVZ$'I-3
M_EA`^)&F%P@C-2F]ADJRI][_`+16FXF3O/J]Q_$:&I+D2V08:5',[5L=<9<F
M/S`R/VA0*IX:?@_B>A<7Z/FIBZJG/J8<W\U<1W+B"%Q)>H]F9R2%FB[^Z]+N
MD93BK8]C:;=L%MDQ>YL$YZN]72O3Q.HTSBUV&G$8U`->S$9)Z*/6*U(H>%/L
M5-^9<V>YO/&S'R7DM,AA!W)8#%XG,[U=2LMW*\2&E+34[24]--.ED<,2GG10
MR.:2!4'!4^?5\YLY]]O7MP]MF-8%R!>L(/,N7<MWK-[SBE,=N]P@6)6/-X[;
MVYD%#;]L8E_.R'W%,+;=D!M&Y12-3&^Z*YD)FY>[XD0FC6>0'4&%7:R/HH?:
MN9I-]Y6Y0OS-L.09_GE^NCJBW#E7^_WZ;*74*=><^;G/G8V#N6M9"$I%5$`:
M4F4[7(WLW]QG&>/R,KS7C9^%98=M<N]SDLWFSW>3:[2RMAI5TFQX<MY[\M6Z
M^$I>:[K9*5]1MT`@Y(.&>"WO9E=+KCON#XUS6PJE0'L#R*'?ILZ.XTF/^5!8
MAW6WS$+2#)B7"VRWD/L54EYHJ24G<2*O=]RBVVT=+)F<!WJUVFT==SF,-J*<
MOH5K5TY.NON2YVON"X&[C^(8TAC);J_D-]8C-V["<-L$"7<ITQ+3KBUR[C);
MCB/!C@H7(FNMM)HGU#REMA<[Q?\`FN<6!VIPX$"E:8\\J+TFTGCVBTHP`MH`
M>)J<,*<%6ES/P1FICY/FF17:\R,3E7^WVO#&[RF(;M>KC=KBN);W[\Q;FF8D
M-BWQ&G'W&0"XYL%"$$DZ7;88[2'\MNDU(]/-4MXYUPZDA\.=`I*X)PSC>`<5
MQ&)&#8Y><OS)R&NWR,CL5OFW""FX!%ML4:*Y/CR)%MW1S\U)4BA:3\RXFJT(
MI9F>4L,9)TE0FV\+7AX'B"B)S=Q!9\$O$#&K7,<=DRH;UUNJ9%`R@H;7',U)
MH7&$3W.YL;*E);"`@>!)1J*=+`Z/RSD#6O'U\E$B\6^0]$>5$1N,U:XNX#<E
M#++J0HBG4)JK[WF13]-I:D>$]BI+INESAC2N"1=MLSLN\PVHB5=V3.CQ8J$I
M^^MQ3;""E/C4N+'Z]3)"/+=B/=/T*)&#YC:#&H2Z5;B9+TAM!0XFWLS%.T'X
M+T)]AA<@$GKVUOBOZ-0(Y7R,`=D,E,?$V.83-KK4I?:CE<3"N>\&O60&X1K#
M#RF18K\];51OS*V0\GARK6W<8*Y0,9B3;9%P0^TM5`G;6HI455Y(;>(S$O`:
M<VY_059VS/.E#"-1=ZL5VD^VKW466V8O:+_EJN9<_O-OQ.)9(MIR#(\>D8Z]
M+B/,PGT1VFK>IVV?)M,.*[S@D*<"@D@&AUDX?F)8[3,^4NN9Y'"@C+Q3E^$4
M/'%7%ST/N-WID:RWB:W$.:TU]../).1A/O7Y'Q.)*B8I#R:S;+W($:W\@\H.
M<MV>9:H\A:K>IR'D^(6V?:W'&EJ'9A2VVV4A*4K5M!U`N?F.ZV>Z3:([ACGB
MOYCQ*S4<P&M#2.'%6MIT5'(X/W5T+R!2C&%K@/Q:B2/8KWN+<UON<\4\:91<
MHMO@S,DP^Q7^\0K?'=,--PN5O1(D,PC*7(DLPFG'E=MLN*V@^)\=>N;7<W%U
MM5O>RC\Z5@+L#2O8.'K7FUY$V&_FMHJF*-Y`XFG:4KGDV:A;E-VU*7%!+B9*
M6$H45>*7`]Z#4GK72(W-\TXBN/TILN>6T(P"XLOJ*<PV3F/W<\L7G$XEIAX=
MB%R;XXQ86:!$M\*?$PU3UONUZ+<)IEJ0_><E5->[U"IQDMBM$BEA&]^#1[J:
MP.*K6YADK'&68U/H-J"=GE4RHX!H3]NERR.:=(R(4:4$R"G[8JM3NEQ,O<0?
M0@U'D*.&A-3\?Y=0V,#,E+&:;*[PY=VC/VF`R7Y]T/Y9!90*J=D2U=INO7[B
M`2I9\$H23IQKRQU1FJ]U2\TYE2PXLX;BXA9HD>6VAR5M"I#BAM6I]0"G%&OB
M"NIIY:69GN;I-$^R%KF`NK5/Y;[8E"D-,M>"AU!`'ZA4T1\*^.FD\Q@8*!.!
M9[*[T4*@^*@0/Z/@!KM"<DM.-#M2]J0.@-*U`ZJ4/TD4U.9[@KR2#1*%BV-H
M%!M)_0?$GH`:U%3]FE98KAHYIY*L3W5<LIRW*&\3LTFN)XA(?900O\*Y9`I)
M9N=Q6E/[QN-M^68)K1*5J'[PZ`0<E%D:UI\*AO*R%N$%*!*ED'I4CS\P0?/7
M4RY@?FOF.YF_<I;S#K80RRD[5I-*CXKZ?IT\V9P%!2BAN91Q`!HMV3(C7UJD
M^9(@MQ76RX]':0Y#2J05KCHDET)0%O,M*`074J6E)(U/M;'>+Z&2YL+6XGMX
MO??'#)(UF%?&YC2&X8^(C#%<U6K'".:1C9G9-+@":<@<3Z%A:PAN30PLAA2V
MST0VXQ,0H=%AI1=CO3F^B'"":#R/EJO-PYK_`"W4$@X'`^D9J2(&&A%2#EV]
MRVA@5^(I&>LDDUV!M%ZB,.T`_P![GKAE/ATKUU,%#EF!4]BZ;=C31U0>U%$_
M'N0<>=BRHV%WJX)<=#+SD>T*O$=#+@'XK2XWS$0N;D[4J6K94ZB7=O'=15J3
M3BT_TIP#2`W@NN7B2W3,,X@MF1XMRCG',-YX(Q>T\L8<]R%CSV'\A\<X9;+@
MFR\X>W/.<6?ESI]M6U8G#+99?=[+BD17F6TH:9<<C6EK+"]S6'!S3I+NS%U?
MJ^M6%N&:&-<:.?JICEI%<>_AS5B-QEP[U)=NL!Y,B!<`U.@/I5TD09<9A^(Z
MBE0I+C"TJ'Z?AJ9;9%<#AS")SN:*D]/4DC]1/ZNO34A*J!FBZ<XI#0IU!)%#
M7X=/,?'0FY,8RNJ+V??]US@?_P#!GC'_`-0-ZA2_Q#WJ(5)'3:XAH0AH0AH0
MAH0AH0AH0AH0AH0AH0AH0OQRTJV*"2L)4"A">VIM2#T!%2FJ5`#PH:UUZEN#
M=4_H66BS*,OFO2I.]I)I0=3N)IY^A0K74%F$@':I+?>'>H3<D-*:R:^+)KNE
MO*":FJMY24D#J`**(K]NL#<?\U-_O7+0<!W)J'R2OJ-I\=OC3P\_MTRA:REA
M)(Z;AY?;2H'Z]"%\1N4KJL#^DFE`GH:"O4Z$)S+)V&[=:.WOWK[I(5U2HB0]
MW`H]`E/^'X:@W(JXCFU"E7@DM+;$<,)0C9M/;6D^E/0A(*U*HG=Y_;K..&EY
M9R75("W./2$H7(=(0I1HVXY5*""?2H`@%*@>E.E="XES"4A*7&EJ4METN(*%
M=Y:$T2VFA3(`0U4C]@;?/J3IWS?R_+HNHHN-K3'J['IVP`I*4GP2#XT2FM:_
M#X::7%N6=:G74*#@"`2DU2/%0&ZI])J/#].A"=2+V([7<J-J$%3A*CZMJ-P(
MH.IJ/#2XV>8[36F"ZM1AY).Y*MP/B:^!J:*J>IH=2&/#"(O:A;Z'D*.VIK2M
M0*C_`!:?0MALBNZOAU`_I$>7V:$+<2H*`(_7]AIX?JT(6VAU/A0(`\.M?\6A
M"VD/GR.Y(%*=!^CK30A;+;HV@J4-PKU\"*[@:4'2H/\`)KA3\&96=*CT-:BG
M3]'EUT)P1T?KJLH5ZA3RZU^T'[="#'5^NJV>Z2*U^Z.J>GJK05K3IUUT)N?,
M=RR]U%00H5'7]>A)?)K%*+(AX%85]X]:T\*T/B?+7$Y')6C*(R9<:44I--WB
M#XFOPI]FGHY*#33BE/ET&E$K;2PVM:4J6E20JM`D5)Z>!-:4.G'LUD8KL<GF
M5PI1/QAMN8<>:*B4D]/N@T2""#X#X:?8S6=/8G,E*K%X<9I#24`>1*Z#Q^/4
M4\-3&C2`$N+^*"GC@".TA(64F@!4*>-1X&AH?\5-+4Y>ERF&R5CMH3M65!.U
ML)H:[U4Z=$_$Z$*&>,<D,Y[[@.08$8I<MEIQN#:;=0U"S:)BC-DI30"LB1*-
M:?LI&HK;CS[@X4HVF=<E7.S/>IX7Z$)_"UQL2W74-W3%Y-K:`<6.TY<("FF.
MT"K\.CSP4"/NGJ!JU$9EM_+K2H4D?\O7L^M<^Z8CC05'FW"\W%;=6UB?=[@^
MUO;.QQ+B%R`A?K2>FVFJ-PTN(Y%5<_\`$!/(+99JW4,]J,FB2D-(0D53T`V@
M#J?TFNN),DOF4PI12X]B#KBO>Y[1=VTU]QG$?4MHW?\`3.U_M4!T]![_`*$T
MOT;-3%U<I/\`K*_/?,7"M\]HT?BK*F<91DUHYG5>U+L=EN[TA5KE\;)@%AR[
MPIORG:$]VNP#?45\!J)<>\.Y.LDT`BE:KEXQ7GGW@\T9MC&"1^<\QBS<MO<&
MR,.6U=ML[4<SG0AYY3=FMT)91':W+H"":4TW&SS'AF540-.O4."MB^KS[2Y/
M)'T\./Y6*9)>LXY4]N#^(7N=:KG&>G9#F-F_(%8WEUPM+S8<>FSW83C=P<9`
M*E&.M(!5MK:S0TTOK[K:)K<)?,N6W+!5@\)["<%QT85R'EO%.2)RO#;LY8,E
M@1;A;P\Y'9<6EB<RJ/.@RX$YM3;C;[8VN-K17IY:CN&II'-+9[X[U>7]3CD3
MD'-O;=P[?VYK46U7J_XW;(Z<7"4N93C&5<4VC(5MWMF*N0\XXQE3,UKM)#2%
M(;;]!'J/(F:!3/%%VS6\&M*!5>8;A^0X+B-I=O-NO&,WCD*8MBT(ND&;:9(Q
M*`HKO601XTIEA]^+(DM?+,NA!:*HSIK5)UA>H[AMS>_!.;X(\3CGP'=0XK:;
M!`Z&V,S'>-PH.SGWU&"G-[/>+).8RI%Q@PU+3+NJ&&0H;W4LAMS>I;9"NZ(5
MK4G;4$ETJ7T(ZPMOB+CJ<ZKFBG>KVZ#8FC2/"X5[E*WWPXUAF/8/Q%;I2[K;
M+?:^9\,1D:E6&]H;=LBV)S4B2M:+>IF6E3RDLH2@K><#E&T*H=65P`WRF$X.
M)->6E5FKS)'-RH*IDN<N:[5(O%BO>(6*1&AVUFYS9-PS>'*Q2SP)$/'+@PVX
MW#E):OER[")TA3+"(S/?Z)#B36C<DS&TT>*J&LU*H3D;DJY9E>I\MZXR9]YO
M,A1NES?2A+<*V%2T0+3'99/:CCMK4I3;=$ME80"2E2C)C9)Y0E>*`FB@W$HU
M^3"_Q#$K<.%W&!A,V[3V'X<I"4V_Y9U*4NQFZL2!W4&JD/R%71"R"$E/I'3J
M-2+=VDEOXE&GU/:"[WFCUK8]K\/&7?<CP>G*RTG&8G(>&3+R7BVEA,*-D,9)
M7+4XDM",F4MHO$@IV5)Z:D/%8R.PJ+`:7+C_`%?M2BP%NPY7[DUVNZIAKQ?/
M[[RE8GR&6EQ8L'-;?E,*R2V$T2S&1"E2V)3+J0.R&@L`4TF%^J,-_"G'.UO=
MA3\ER5/L>L5ASGW)\:87R?%?F8[RC?9_&UW=$P,26+OE-@N&)V"6F4IUEIF1
M:[],C.(WJ2E/;3NZ'4>\B=<O;9-%0XX]U.2L=ND+6MG;F!A]J[%/IOX%BV9^
MV;$+_>N(\9O^3V^Z9-C.276]WEYQMV_8Y=EVJX%,*2[=D)2IY@K/X20HK/34
M.SZ4L+FW\XVT==9;B*DTXDIR_P!YW!DQ9YT@U-U8.H!PH`K%(>(72R+*,6X\
MX;L+82FC_P"6-N/ME5>B4Q,6ANJVA/CWDUKY:L8^E;&"FF*)A!K31[<U6G>K
MPBCY)2?[26'SG,LMIJ/,Y!M4"*RTEAB):[)=Y#,=E`HAMD3\C$="4)Z)`:"0
M/+RU:,VX`4=(^G`-P`[@J_SFZS)3\QV9YID/<#?\BXKX6Y.Y*N?)>2//XKB5
MTFVUB'!QVVHD7Z6@6RP1PY^5RY(#MYG,`@.`[:T-=3AMT$(#\S1)EN@(R-.>
M&:Y5TSW''2M]U3SKJRX^XI16MUUPE;KBBJJBMQ:B2:U).N![6N\IHH%'C'Y8
M3<<RO_\`RL<P(-/Z@W15!T!FQ:"E--3GQCN7'2Z'::5JJU(KP^4N+BR$[8[;
MA42!0;C7QH/,Z3&S7QHG2:*0_`7%CBHZ,]O\52'):7!C,*0V:LV]WHJZN)4F
MJ7IP3^%^T&:'IOT@BAHFF1%K]=5*INR`E-:#::I%!UZ]1]WSTX(_!KJG:XH]
MA69EL[U)HK:*&B2*^?PH=-KJ4\=#;=:[1YU`IU_5]FI<<>BN*235';,I#;=5
M=$C;U!J3TH"!0>.G4A[=3:)H^=N3?X#P&X+A/=J_WT+M%G+:@'&EO(I,GH!)
M4/DHR^BAX.+1KCAJ!',));IB+>Q4X7^65.$*-?2O<2:G=0FI)34DD_SZ3&SR
MQ2M5$34W5_=NJHU2*I34DCJ"GK3P(\M.(6?&7#$:E/$@N2'$QF:]`5NG:#05
MJ!NK^A.CB!S*4QNIP;Q.7>K[/IR<%7S)_;IEF:#@FT\GV;*.3[_%:F.9'9K7
MD#K6+6FPV9,2#"NWRB_R^--7*(6U(25.J7TJ!K]+OY1[&#8_EU\5)OYV;>]T
MNS<"-T!EB\J*K&ESVCP%P\0P/<OF/YH[T9NKA:11NFCM8`"&NT.!>#K`=]XT
MX5'>$XW)7M:]NLQMZZ<F\$<S\02(Q<9=NEFQN[+MS<=H*)?<FV>'E<&4%R'*
MH=HHEM'4UK3ZQFZ+W#JEKH9(/E_U>V4U\NXM+*.X/89'1P2$NS\4CB.869V[
MJB>PD;%";J".@H"7.K_VG99')1^'L5]N><;$<2^[VRP;E)J&L;S:397;G'7N
MH&7H[MSL\U*Q\/E%?:->3=3?RO\`RRF;YO5ORRWK9I`:^9M=W>>4PX^-L<_Q
M41&9`;)RH-*U]C\RM\L/"V5DK`:_F-U'UU28R#Z8ONCQX+EX1D.`9S&2DJ9D
M6N_.V26\CQ!29T:UQ"5=/"0M-?/7C.Z?RG_)#<9"S8.INH]EO7$_E[AM4-P'
M$?CE@,4YI^)K:Y:A2JU5K\WI])=?PMEU?A\)'<*%,W-XR]_O"J[@IG#.:[.R
M_%<MUTEX=-N5^MEPMBVE1WHDIRPOW:/+M[L=12IMU12I'0BG36"W/^23K&8.
M'1/4W2N].I7R_/FLYZ<C'<Q-`<>`UD$X56FL_F1T_=D!VMCCG45I]",<<^I+
M[Q.*F8./2<[O<6%9F&8$.R9QAMME-PHL)IN/'@)$Z`F:VU'::"$-A2=B``*4
MUY+OO\K?SZZ4CDGW#IVZGM&_[2U?%<,PY^6\N[J--<5I[?J'9KK3\-.QP.=3
M2GVJ2&*_6HYDCI:1EF$<8Y6D!(<<A?FN,3%[1\&YS[#945?[R>OEKQO=-AZ@
MV-QCWFPO;64<)()AZ`?+./?0=JN#>0RC0Q\=?[04E<9^LQQ?<VV4YGQ/F=C6
M:!V1CUZM6016ED54I#,QJTO.`>0WUH-4XE#H_,`<.QV#AWC&B>\RL6D4/:#4
M+]!KZ>^>6/E#V0^UKD3&A-%@S/A;"<ALXN,=$6>(%RM33\?YN.VZ^AE_MJ&Y
M(6H`^9U$<=3B[FFU,724(:$(:$(:$(:$(:$(:$(:$(:$(:$(:$+\<`1GE.@I
M](6HD*4`6P2#7=4C:#X5UZ1=EQN#B<EEHO>/<MY,1T)^Z"6PHJ(6D;O.J05G
M<!Y'H-0V,D,P-<-7-.OP`(YA1%Y894C(;@XE)_$#>ZM*]&TA2A3I44&L9>.:
MZ\E+<O,*T,9JP$\DRJZUJ:>=/C^O49+6LX5`D@)HH^)'6I'_`*+0A>VD4\_4
MJE:FHZ`^'3X:$)Q+:0W;+=VRH.!+NU2DT""7G"2GS^ROF-0YS22IRHCBI`8)
M/2IMMON+[@!#B1YKJ%)ZT(%!^L:HKH#S2\9%=4G[!N6RSZ^H)J'$E:BE0J%5
M/3QU'7$X4>$'(S1*]_12MK+H6%DO*]0=VH45(``*14#PKH0E!'M!>:27`ZAE
M05VPI9"@XG<-H34*2*_'XZ$)-P08=Q=8))0'"-JD4-2H%-?#^EH0L7*65R<8
MPM4V/<C:I,ZZ6VWQY;;<=YX)[CDN1'89D(<;W/QHA0I92K:E9(ZTU<;19,N9
M]4YTP@'OJD/E,(UM%3DF(;YFO]4]B[A0KTW18NX_8L=JE/A]FM7<;=LGEN(:
M2^F8-"HQNIW&H:`MQOFK)VB`F8PNH*MZX#"DGJ*@K"``23T&JKX*P;_"#VM[
M37Z4Y',2/S,'5X(U9YTRM%0!;E?M$K@HI^H!T&@U'^"A[5(6^SSOE77=$LY'
MB%&,\DJ5^AN3T!_1H^!A[4T96`TQJC%KG^_@D*M5E<410!)FI`/D?WO3IH^!
MA[4><SM1K%]P-VJ4JQ^V.44-ROFI3?Z=M`L=/M\==^!A[4><P\T7Y;[H_P"$
M+!(ODO%(\PMO,QXT1BZNLJEOO+H&TN+AN;-C:5+)VGHG21:-=_$I3L2F2!WN
MU6"1[M9<"79(,KC=Y3M[M,6=$[>1,MI,V2VX6[27'[<$AY;K8:2X?3W7$`@;
MJ@-G&W%GO)S4[F4XUC]Q%JOMJBW>%CD\QY;16VDS&$+9=0I3;L24E;84S(CO
MH4VX".BTGRTDVSR"`!5&IW,HL'NIQ.#+5`RG&L@Q225E#"[LN$NU345HEV+>
MHKKEN4E9(]+BVG$^:1IGX.;L]:Z23FEI$YYQ2:G>Q;[D^R0-C\*3:)K:AYFK
M$Y6[X]*G1\'-_5]:Y5>YON%XZM&U=Q>ND,4JI+S,5)22DD[DJEI4D`"M:4II
M+K65@J:4[T5IB%@M?NOX6F2T184_(+H\5[%KMN.7"?&9)`J79D4+B(`!_I^.
MN-@?375M!VXX+H/B!*>6R^Y/A=I38E7*]1Q0%05CMR6OQ`J`VA7G^G2FR!SP
MQH)<5*$T0RP]"D+AWNHX"!;'\17?N$(33^&;U0#K4U^4`IM'6AU/MK>X>\AD
M;R:<NU(?=1-%352#L_NQ]NK`07\X=CI'3\2PWD4H!4`)A*I2G6M=3C978;J,
M;J)L7L`-22!S3@1?=W[:5I_[48#9<!HE^U7MD;2.A.ZVGKTT@6\OWAI/:IUO
M>0.CU!U14IO^2O>!P&UBEV9QGEC%Y-WD1GX\9GORH;Z%A)0ZH_-Q(X2&MW4U
MH-,2RLC:^(U\Q)DNXW4TZ@HD>SW.L<R#G)IJP9/9;^Y>[1=VE_E%UAW-3SCZ
M0^FJ8SKB]Q6V=0;-PAN],H.+33#F0N#Q4[5>]D<5^!C=JAQF$/.&998CB'&T
MNC9VD?,42L@)6G;T4.HUH'-)86MP/!6+6%C-#J5`_>J#<[L)LN:YE9E)*%6W
M*;[#2D@`):;N4@M$)ITHTH4U4.DB#B",1V*@>:O/>DVEA('4D$^-"/\`8\],
MRO8ZFE(4KO8@R?\`3<]HNW[H]QG$BB2>M?XRM(IX=0*#78/?]"%^C1J8NKCX
M_P!:GCNMW/V57/T)CIA<ZPEK<(2`ZMWBZ0A()(!4I#:NGV:BW'O#N7(WM;<!
MKLM*Y-,3Y,N_'&4V',\:66KYB=W@7VWS6PEQMB7#=0XWO"CL6TXDE#@/0H4>
MHTW"X,E#W9`J3;YE7'YQ]6S'9N`XNO-N,;Q)=R%MB+"NV'7"%.:E2(JFI;O:
MM5Q?MSK,Z$E*VRUW%;D@[23TUJ-QLBRTBO62A\,C1@!D>1/,*''>M?=/M'MH
M&FIJ,^1[>]1'Y$]ZWL:SB9+O.;\=7=F[/5[TN[</A5S>4:)4I<C\N?2\^D#J
M2LU\:ZI"0T$G()]QU/\`#Q4I^`,*<]PETX2:XL_.[[B?+^68W;<0C76*XVUA
M6)?*33=\AFVIQN0Q9H6)V:S2GG`4I"4H#0.Y:$F;!:MECUN-.2DV["+AHDQ]
MJ0_ULN"CAGO$QA['K8]'XT8]M>/XCQZAI#CZP_C,*]P9T9P-H_#FR[VX9DM1
M-7%S%+/WM>7]2`Q;W)(01&_0YIX4#-)'?JQIZ5L]@(N+>7RR,)#AQ'HX!/?]
M+/BZ'>,5N5TEVMRVMPU0[A&4XA7J_B&!&6Y(;6XC:\VX;.4"GW:J!H3JRZ>8
M+ADKPWPZL*CAV)>_R>5Y8U4(:,BGO]\O"$_DS$'<'QK$YM\>FOUM[,0SD/"Z
MD`Q)T9$>#V&Y4-\I<:><E,I;V=32M7]VM;B9S(;5H,[2*<`:\*]O%5UA=PQ@
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M5'6M`;[[<58=(0N%+0A]82H4*>TZTA:5>`U8SRQ/#8FX/J.%$BV8?B/---!`
M"E)S'Q$]PE<^"W[)=83U]SCCN!=KM=VYG=AQK].NDMEV6VVLH+-M%BR%IAEU
M.T%43N#J30='HY8\EQT;G7WA]W+L(2XQ5,GCH<+,M1X[60X%[AY:F;KL$>9<
M1"R+"+G$N*W5.+6B,Y)9>IO'I2YUKYP;AQ9<Z@2#17+`W1J8`&5HNU7Z9*4N
M^UR+?&FG&8^3<J\S7Z*A0(0N--Y%OO8=8'@8SC3:=AJ=PZ^>K_;O,;;`DG2[
M$8JAW.1OQ?\`ZNGIK53^<=*5TZ>H)4:UZ=5#IU\-3"2<U7+PIQ25%2:$+I2O
ME0?`'I6NA"JC^KARG&Q#@?#<)=G"(]R%GS#TE"5*WOVC#H+ER>;+2$../MKN
M\Z$=J16J*^6FYW.\O,YJ$\DN/>N=5.70RI(8B7>4JOWFX*H[7P!WW!Z$:?H!
MU"J:UXKK'EKA4G2DGR;>U73C?-8*(,V/)18EW`-2#&<*XT>7$[[B#$E20"S^
MTDD&AJ*]:!))J5V1[7/#AD%$'AO`F\VN*)]\>8A85&>:1)?F.IC)R.=%)>%A
MMRW5H#[*%("IKB"4I:_#KN6=KC&N=72I39&/RJK)HS++;+24(0&TM(#8:2D-
MH0$@)2T$@(2V$CI3H!I!P-#FG%O(*:5'7]-/M\-/ME8&AI31>W7HXKZ:>6FY
M'-<:M3@0TG4[F5U?14D"I->@Z_'IY]!HU.YE"K0]P6>?Q;F$P1W^[9[`7+/:
MMJB6WNRL_/3$#P2J5*!H>M6T)TICG:P*G-,22-`+/O44/KT_O6YU/JZ"A-`#
M4]37QZ:G*(FXNKGH7U-13P/C7X=>M-"%MV)]*)<!I;@[4-F3<Y!K4)44*0V%
M?:AM14/A77>!`S(IZ3@G(J"9A.0<#ZL5VT>R'&)_$7L6]O.-QK>RQ?KOAEKR
M>XJEU:CM7CD2[2LPD+N!1_6$H$2[I0I831(2*D#7ZE=%[:_:NE=OVZ.C9(K.
M*HK0%VG50<Z5P7QINMR[=NH]PO'T,+[F33_8!T@^PJ5F/9!DMPN#5NGVJ.S&
M<>DQ'+O:KM\Q"4[&AKEN!#$AHO!'HV^)%3\-:4,?)7XIC:GL!JJR2&*`CR<*
M^A><RX4XLY#96SGG&V!YDAP4<7D&)V:XR"!_1G.152T&OFE23K7;3U3U'L]&
M['N5_9AM#2*5[6FG`LU:2.RBCN>UF)^A1WN7L']OR75SL'MO(/$5Q%2B5Q'R
M;EV)L-J/4+%G<N4^R.)017:8M#YBFM]#\V>MYK5UKOLFW[O:OIX+RSADJ*UH
MYX:)*]K7#@@7KP:``,[,"FPN'MI]TV(JDN8#[G[MD$=OL?EUKY7P_$\T2H44
MEUJ5=V8V%7AA#*MFU27WEJ236A3ZNOZDZ#WE@CW_`*3LXJU#GV$\D!->/ER>
M:P=H4_\`4+0D:@_32AI@>WO25RG!_>A&@JC9EP1[:/<7:R%"0K&,LG8C>)#7
M4>FP\DV:]V7ONIZ[$2@DDTK3KJ;:L^7=O1VS;SO>S.&#62M$C&]K9("T@<ZM
MY*1%=61_@SRQ`=E0?;@H:<@\8^VQY+R><_IX<S\3.KWJE9-A^!R,@LS#A^^Z
M+UP_?5M]M%/O*A@$?LUU:?I>^;E$Z/;]_P!JW2%P_AW(8V20<JS,Q)_"3CF5
MH+#<=X8-6W7D4K*4H2`_U.IW9J-$KVG?3?Y`E&'Q_P"Y2\<:7QXE`L>47V-:
MY+#RB:,OVCD"PXW<PXE5$E'SE:^9.O.^H/DGM5_$Z3JKH3:KN$BH?;,,<C@<
MSJMCIJ<JEK<.U7EOU?UCMNHRP.<&X#B,>QI<.-<*K]*GZ76%0>./IW^SC`K9
MD+.6V[$>`L`L,')H_8[%\BV^SM,LW)HQID^.I,EL!54/.(/DHC7X[_,;;K#:
M/F'OVU;7;"RVVWWB[CBMZO/D,;,_3$2_Q'1E7E2B]\V:Y?>;3;W4O\5\32<Q
MB<\P"IZ:QJLT-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%^.NP6UH2IW?123Y[4I
M-*[0D`FG7XZ].W!C6S^$<%EXO>/<C!90TE?12_2H)6$*H?3T"2NA(H/+41A`
M-3A0'Z$X_(=X4-N6#NO<Q))HMQ+@)&U(0M"10T/3TC]6L#=%K;EX.#RXGUK0
M1?PQW)C':=Q02*`&GC7P\Z_;II.+`L)(HKPKT_3UIH0MN(SWGV([;>Y;BTH3
MU/F0*UH2!4ZX7-:-3C1J$Z$VW",S"96D]M`!HA?4H<--@)!HD;>GZ=5A<Z2I
M)KB0$<4\&%!EEIM,9"TH`3ZEH"MJ54Z%814I"O/R%-5=S@X`YA=4H<=?:<8B
M.;W4K;&U:``04'=^P`2L_J)IJ,N)ROXG;LMN^8,1J6XS&*FUNEP.I2:*4HH4
MD4^]T)2/"FGJ1>57#71=6Q:,K9O*FW25I4NBEH15*4G[O@5=%?ITPA"9'>^?
M:DM`EEP[5N+Z+)!%2D?=.VOEKJXHZ>YF\)^>X_QI.][8BZWR0V@>D*D]BVQ%
MK254)2&G2/L)U?;<R4QMT@XGV([4PSB?ER4!+5$"@(04U.T5\%4\=:1VW2GQ
M"K6J#(X.>7-Q"$-S<I8*^V5$N&JMHJ0D4%:BHV_R:X+33@[&O%(J1DMYB1M?
M;#JEJ0I>W?NH/40DJ36FX4_4=+EM(X@,0ZO).>;)S2[9BMJ`4VI8*0H^M!`!
M13:`:]=P-=,F.)HQ%`FZDFO%9$QZ%(6&2D[DE55%P+"A3;Z=A3M)J=P(H*:3
M2#L1BMM#+((!71(!31)"=Q(%`L==^T"H\QUT4A[$8I&\B655VMEN:+J1%3*G
M,+<>*4QX\ZY6B;"L\E]?0-M(N3R$;R:)4X#TI72&,#3^:*#@I,&9[DGK[,_B
MLXI`M\:7_$<,.1+K#<C/-2,><:_+GB]<G7&PVS&9N,!#C3FXAU*:IK72&^7Y
ME#30E@O\S'W$OL)D(=7E[\)8_*G\SN[EM4C]PXDLPA<'(Y!+;C"KHEZA%1NJ
M1I,FC5X,D'S/,PKH2ENU^BP&4QW6VYSTU*D,VW:VZJ8H`CU)6E3:(]2=ZB*`
M5TT7-;[QHG4B3@>.W&0)ETLMDCOD$_*V(?D["-YJ0MV+V5/N[:#=4"O4:C@3
MO--1;Z`A;)Q+CJ$ZPN-B=I<D;1W%NG\U<JD[@M:I#\DHJD#Q`KI<OAA\9J13
M%"=ZS3[&S"+:;8Q'::2C:U'80TT$H*5)4AMM*$#H3Y:JY#5U0<*("/;=/P]4
MSOR8='`H>NJDK%/.I/I%#T\M3+!S6N)%/,X+J<%FZX&\RD.B0A/BD!STCR&T
M@=#]NM/\3.134?10?0JUL9U'14E>)$O!%()1*>;%>@^9HHBGB0#6FZGVZB3N
MD-7&4UY53T<;M8U-P[4WU]GVEHA=JE/+]6W8X5*"A3R4*D;?CYUU&;)(,B?3
MC]*D&-A-:"O9@HL<N91.METLEV;:$BV!M33C:6U@M3VW-Q:>4EUD):N$8[=R
M@L)+705.F7VXG<7EP:[C7BG`TNR%5(OZ6F5(QWW/<<;_`,)FZY@Q!;`2I:6V
MY4.8AQ@J"@E*5+V$`UJ4Z9>^M[$'$&+50E6#/>;WA=H][;3.DVHG:ME%]D.-
M@)JTI*(,M*:@=/0ENOV$:NJ.&#L'?M3V*W=3S?%E^Y4F^YG'?RGG'/F4A(;F
M7&-=6MM!5J=`C.*(\`270K5->1L9-1HI455,Z!H>=0XJ/BV"BM%A5.G1-*GX
M>/CJ)1<\J/DI4>Q`'_3:]I)IT'N*XF!_2,QM?3^73UO_`!/05$<QS221X5^C
M!J8D+D*_UN*^6_">`/:]G\ZTRKNFQ\D9;9`Q$<996W_$]C@;7'77@0A@.69-
M:`DJH//46?WP!G3ZTP<+AI.1;0=IKDN('"N9+/>;-.OES?L>(VQYYVWQ(=WO
M"9-YGN-I2M2H\%B/M>8*B$JKM">A"CX"/+%.UVAK7:QF*5^A6D7E"(4(\RN.
M*?SB^[85R7CM]Q.\VT7/$ES$28STIJ2RU:+NNK*9EM>84U*MT=*EC\9!`0M5
M#T)UO>C[!UY#-MM^T_#X/:UV&)QJ./HK14V[RM8\749`D(TZAV84Y8)N)?!F
M'1N1;;B]]O>4KL%_8>C6Z5;\D[C4&[E:3"B2G90DDHGH0M*$@%044DG4;J/9
M181Z[4$#[VJM*?U>94?;]P\UQC>=4O`KL#^B5QG:,#X'?OS5QOMV>Q*Y7GBC
M''+VJW+6Q%7)C93>9<%4*(P_O=1=XD/<I9)2VZ*"NJV%SFP-`XM6G+#'HDI2
M33FIQ^[/@S#>9WK,;Q:V[C/M[@7"F/MH=?MSCVQJ<PT[MW"-,B*6A:?.M?$:
MS]]MMON`:+@`EF`S&'+!/V%X_;I'RP5#I,^WUK3X<X'Q;A_`K5AF+VTM1(4-
MJ*9#J$?,NEMUY\+6XE(W;"^4@>%/UZDVUBRVC:R%E&@4PXI%S<S7DGFS$EW#
ML]255PQ1`E(E,L(4I!!)>'J0:42:CPJ?&GQU);"[6'%N(*C$`X%'3*RAI#,I
MAHI6G:DI150%05$CQIJ88VGWL>_%<$<8X#Z4E+KB\=^29D9!0550XBA"'6UA
M6YMQ)H'&RFH(/QUP11CA7OQ^FJ!&QN2HB^HU]-&Y9[<9F>\:75RP2[LW(N)B
M)B-&UJG/,J9N<?NQF3,AIE(.Y:#O8<2LDIJ-55]M0E?Y]MX'<0./</L3GQH@
M'E%NNN1_#V%<M'+W`G(_$>2LX5R/C\_&7I,Y,:U7I3;YL&1)<1LBQXMY0ER"
M4EY*0I&]"JJZIH*ZJ);-\;M,@)?12(KQKF4<0VO!'E_NMDN?!!M%RM\N#S-Q
MUG=B^>N<Z5,F3[G@\NWRK-:(4!V6M1CV.R+6R@QT)"$.;7.F\C20SR\P15/F
M9]&>6<6O`[FG-/\`G%+]RGR#@G%N&0)#V;99D0;9A10)9M<R3*5;94D/-J(5
M!MUOMB9SKG4I2@@$^G4&X(?=!K<<%>VSHW6QH0<2N]SV\\;0>&>$^,^+H+9:
MCX;BEMM2@HU5\TEM3\Q3BJ`K<7*=54GJ3K40-#(6L&``68NG&2<N=B0<$[SB
MPI?3X#S\:*53_#IX"N2CES0:$XK7D/L0VE/S'V(;"!N6_+>:BL)2.I*GGUMM
M`?KTORI.17/,9S"YN_K`Y\G,.:N-;!C\QF^8W@/&C]RESK+)9NEO;OF69+/1
M,0Y(@N/M%V'`QZ.':$AL.IW4W`::N(Y`S$'-0W9GO5-LG*)S^08_A.*PX5VS
M7)Y34:VQ)\]JV6>`VXI0-ROMT>(9MUN8;25K6H@)0DDGP!@4.K33Q)*EM;>'
MK9AMJFW+F_(WL4NK=EGMKR*%&C-<;M6N2N,\[)<N<I<Y$^.RXPE*'P\E"RNA
M;JH#4V"&W+*W&L25PH,%U5;95[D[7@>57.)AN5?W@6JW.RK7;9,*U(AXW-M*
M7DE*([$R'"#<9PMIZ-1P%4J*C2VL:WW11*:XM]U/;Q+S8<XB*'9C8CD"=LE5
MNA%Z78IK4@*6RER%(6A4=[L!'<+"VE;B2"1Z=0'D!Q)P%5-8]K@!7Q44C[5E
M3<E;<&<A,"XJ2I3;0<#D.:E-2IVW2EH;[P`%5-J2EYO]I-**/`0149+NAI=J
MIXDK$2T%(4.IH*T*2:D=>G0:ZE+W\XGKU\.I^Z33]&A";7EK-SB.#W6;%<*+
MG<4&T6DF@4B3-;4EZ4D`A7]3B;W`1X+"="X2&BIP"JOODDA"A51KN%":J(KX
MJ4>I)^WKJ1$(J`GWU"E(+R1DFANKNY>T=-QH0:>H4/7[/'4E-I!7-2:A'D-Q
MW?8#_BT(2TXMQ:7G&76/$H*2N?FN4XO@\'8DJ/<R:\PK*BA359`$T'[`-:3H
M_:_UKJO;MKTES9KR($<VZ@2/2`JS>[YNV[+=WSO]E;2$'D=)H?05WWSL2C+M
M>-XM;4+_`"O$84.VQXS,R1:7%QK1;&+/:A'E,M]I;;++9JD$)\JBFOTXF;KD
M=%'7R(WEK:88-H!0^A?&]DX0VX<_"8Z20<_$:N'M1Q@>)R;7-DR)KMR=_J/;
M"+D($A#4AZ2I1$29&+C[R6V&@E96NAW#S)U(MFRL!IJSXFOTIRZECD+3$*`!
M.H(:DI]'0"OC0`)ZE1!->HU<V_O'N45S6NP=DOAC$#[Q\/VD@CKX?#S.K&-Y
MU!O!,2"(-(%-2UE1TKJ2@D5)!236M2?#^CUU,9(YN`-`HZU51$;E':$GI6B0
M%?\`IR:+/C\=/>8WB?;]62XYC7^\M`Q5[BIN0^U0D`-N&H\/V5!1/73I:S30
M@:<\O:E8<0#Z`?JS[<TV6<<:\79M'<@<B8-Q]F;;C:FWFLNQ.QWQ]3;@\%O3
MX4R0W6OD4U^S4VTW;<-M:7;;=W,#@/\`9S/9ZPUP!](*D1NO8F:XGS,8!4$/
M<*=V."ZG_9!CF.8A[1?;QC&(6BW6#%[%Q9B]ML5DM#08MEKML:$$1H4!A/I9
MBL(&U"!T2!0:_([YL7,]Y\S^H+JZ>Z2XDWBZ+G.Q))F=B3S7V/TI))+TW922
MDND-NVI)J3@I3Z\^6@0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(7X\<.*M:$[`H
MBA221442?30"AK7_``Z]0W(CSUEXLSW(W5;RXS0BKBDDUHI*@-I->AJ5:KC0
MBB><*BA4,^;8"X%[4E2%(+\-IU`6*;NA22!XGJ@ZQ>Z6S&7YH3D"KNV>7PAQ
MSR4>2*&FHB?7D@'QZCX'KU\CU\*?9H0EWBL!IL.7&3^RPIYD'PVA2D;QY;JI
M('PU#O'EH$8Q#J51BMZ+<5SXDIU>Y;AG*"/.B5(1VD"GW$U20/L&D&(1.:T5
MI@<4<4^V!-E=J0E;J6GVR1U!Z,[=R$+23^(D%1!\JGPU2W?\=R$]MEN"%I3'
M3VU+VD!7I!2!N2X4[W&TJ`(\#3IUU'0G3EL(5A#'>93N[B6D/H0A`*0VVHM@
M-^FGJ-`.@UQ=2$QYV3'G]N.M22I6\>G>`*'J1TJ:BF@(2_:OKZ9;+$QU2JN#
MTFB`36@(3X`?;]FNKBCUR['-ZY*N$_NA;%DMUILS"$I40E7RJI3R:U`],B2L
MU\CTUHMNN1"0V3W*5]."[A1-E):4"I"VW*I/AN/K`%!0@@DGS\1YZT)WJ(MT
MG*G:HXMV`4J5JF(544EM2!2O4%0ZCS!/CI@[I!1'D-YE!#*@L.;$+HM-#VU*
M55-#UJKIX>6J]NXQMS=5'P[>92K:N04R$*A*]*5)6H.*;0M*J@$#U$'RZ:Z[
M<87BAR7?AV\RL8G2TC8EMY+211M!7O`\`*[]RAT'7KIDW-<64+4>2WM6)4NY
M+`.U20GR\>I/B.O3J=<^)=R"YY+>97PRIK[$B+,K(BR6RT['?2'&76U)V+;6
MW]U22G[-,Q74I)U&O>EMC#,17%$"L7B.-H95<,F$$@!5N;OTY,`MTZQU)4M4
MCY<@TV=S;0T\-<-Y(#2C?:G:)4-3ORYANW6F(MMF(TVS#BQ1VXD2@]*5@FB$
M;JFJ>OF?CH^-DY-11;]HB+8=,V<I^5='TE#CQ"5)0UXH8CAP*4E(\*]"=-/N
M7O-2`BB5K6YU``:`%=OXH5N)\.NTCJ=._J`=A'0E"S"P/3UM]L1V2"?W31"J
M@;1W%$U4J@`!^`TW)=/D86$"A2F-#G4*7-KPJYOQ^RF0T%+VBNP@4`(!)!W'
M]%=1EU[0UU!B$<Q^*+\I>]EZ*M54KJ0MNA'J2:_I^W3D4AB?K:*E(1Y_=-E3
M]#WHNY5%%9<4"1X4-/.I\]3)=PGD;IH&]U?M3;8FL<7`G%>'N&\N0`K=%4!N
M-2[X`4\"!7KIL7DH%"`3Z4XD[<./[M;166TDT/52%`BA\:45T/2NF9;F5QU`
MTPX(`J:)H<HPVWWF:A$QI$J,PD!IC;O;6^%'O+>VJ*24]`#UZ:@_'7'-3&,#
M,E([VZ6*#C&:\6S[);H\>7;>2,<>9;B,(:4Z[(FHBA-4#<M2NY2IKX]-<@GE
M-PPDU\03C??;_:789-CR7'8"HT1Q*6I3CSS2J^CN0Y`65CHI3BG7Z=`3]FO0
MBPR^(>^0/H5I(?&?1]"JA][../V_E.T7LL%IC(<9;V+("0J1:YKS$@`?>HE$
MA'\NJ/<6/CG`?GI'UJ%/[_H4+WXR4"A3N*E))4G<-OWNOC3KJ`F5*#V*L)'O
M5]I90.O^D1Q,KJ?_`(L+6:_I^WQT[![_`*$S/[GI7Z)^IBAKE2_UJO!8W(WM
M0PC'Y:G6V+5?K5EBGF%!+S+<#D+`+#+6VK:O:?D\E6":4`.G+6V9=W\,$A(:
M]U#3/#'BHE\XQ0"Y;B]CL!PQ"XP\!X>PG"4E=MM3:ICC`:7/DK5+FJ;0/N_,
M/`K0%D=0C;77K%EM]E85^'B;J<,214FG>LM<3R70#92:-/"H6"RF38\JOHMS
MCT1*)ST52@M2ENQ7H\=9;7O*@M`6`H`^!`/EK`;QN%WMV^R7%D\QN#1@,CS"
MT>U0,N=J9%-C21U#QPX)E><L]RV;<WF[6_$LLRRR`N*N!)&^Z*BO1WX<Y]"V
MEKMST-*`E>TI0ZX"?,C6<W#JK>-]E=%,X!K!X@!@13MYJWCVRULXVW&)+S1N
M68-%V?\`TA;Y,R'V0<9Y5*CN6R3F=\SW)[C#4MM:1*C7]>+/KCOLG8]#ER,9
M6XRZGHIM:?/4J.9XC:*#)65T:2^6/=8!0]^*M$CH^<<)E'>XC;MVCJ'B34;O
MVNIII[X=G,J.E/\`E[;#!0M02G95*U#U-FE5)H?\K^33S1I``X(2-F1V'"6D
M`@+22%5(^[Y*%>H4-=0B15F=^_&>8;(551?W;:C;TZ5(30^)T(19<K[;K>6X
MUQ?C=\.`*+=3VO(@@`G:3^@5I70A9C)PS)K-,L]SFQ4J4%2(#CP!*7T"@`3X
M@I4NAZ]4G7:IHPM<:U-2J^?<'[6.%N6,=N&/Y$K&Y$6^,OH7;[TV!:I;H]#B
MH\D`&W3F%FH<:4'$*&[I2NE>1%,TEP%3@H[QY;\."H5]S'TQ1;TM7*SVBZSY
M-CMZX%LD*F,SV\AM;1)8MTZ\!(9O.U024K4X)(4D$[C6M7>;4!'KB+B1SHI=
MM=L$FB7`'DI"_3&]JUT]OO+F'<M\TVB)(NN3W)_'8[DU29CV(-7>*ZJPW-US
M;V8S,^^.I;*D]&R@%1\-4D>U7MI<B[NFM\MV`I7CC]`6ADO+2:U-M;$AXQ)X
M\ET$>YSG*![<N$<PY9DQ8DYVP?E,"S6N:ZZS%N%YOEWAVF%&<6RI+W:9$ER0
MM*/4IME0!'CJ\=35A@%EO-<WPYT5+%]^IARMEV<IPIK,X>*0WXZ%)NN,P8%K
MA_.OHMLQJT(D."1=W)LBU7#YJ,%2VA+0VXEH[DJH]%&UPU$XU3;G%YJ4HLEQ
M?E+.L9FY/#Y+&<.R0IM,BV2I5RNEB6I+C@>GV[+_`)I*)?H*1'?:0E2R$L]\
MD[9;GLC_`(E<5Q0,Y0QV\N6AI5PO-WO5_LKLH(NEQC6^UW!%70M^"J/9;99H
MK#3+B*=OLA0IZB3UU-AMXWGQUTD544SN!I0448L0BXZ+Q<,O98M$F\3$/6U5
MUA*B/N+0'4&>E<R,5MJ<4\T$+%=R0C:0-4^XOA@DI$&&ISKC[$\QX<T'"I4$
M/>OSG>LBOL/AZS7VXC"\4$>Y9#9V+C(_*;EE\EH/,F5!2Z(ZS8H#B`@*!VOO
M+/BE)$2)Y>VIYI:@G&/=>997]U;B0M1/4(!W+-3_`$4`Z<0GNP[/&L5N#4Y9
M>6?O+99VA:05E24^LI2D`=`/AJ'/`TM)J:U2F.+':@IO<?\`*5DY`A/10ZXI
M^$&U/PY*BQ/C*J"S+CNM+"D*0YU0ZVJJ5?#PTPUNEM%-8[4P$YI[['EBVG6;
M3=7TK??W?EMQ4$I_,DMHW+COA*0TS=&D#<I(`2^V-[8Z+2A26EVW<`K_`';U
M?T:"E:_LU'CH0H=>X#*W+KDT>QM.UAX_%VNA)^]<I@0[)4JG0EJ.&D?80H:X
MFIOX?I41[Z]T6K<L))(%22>BJD]/L.I$40(#ZFM5"35SUDK4JII16TFM022!
M^CQU*0D)=%D.!->@*_"M:5\/'PZZ$*PSZ7/'\C//>)PE%:B(G,8O<\@Y1E1W
M-H9K@N/W&X68RB3Z&5Y(J`FIZ5/QIKVW^7_:#N/S"AW"05MK"WEG=_:Q9'Z-
M1%>W(KSCYJ7HMNC980:.NKF.`<Z&CGD>@$<J9KM=MJU/A#BU-N*+$="U,T4Q
MW4H2M\L*JH%`==-/L\=?=MN^5D;6O`J<?625\US`><_O^H)7P6O2"DJJ2>E:
M`[:GKTZC5M#D4UP1^A)-.@^!'\YH-26/+#4(6<IJ#45!%""*^7P/PU-:ZH#L
MBH+_`.(>]:ZVFT!2W%(0VELJ4M:@A*$CQ4MPD)2@#X]-.>80N-#G&C02[D$E
M9$^2Y(C-6*U*O#+WS/S5V7+3!MD-3:$*C[7ELN/W,/N**3\JA:4;?4KKI;9G
M./`!3F6L3(G27+Z2"E(V^]VUX+2=L,B:TZ+I/?<2XE:%PK=W+=!+;@V+;4XT
MX;D^"D]"I](KUVC4HR/(I7]OVY)GXEX_A@,//C3D:K39LELMD9J'!@QHT>.R
MW'92&PZL-,-H9;2X\_W7GBEM(&Y:E*/B23UU):&^56@U)LR2/)+R22#]"Z>_
M:<-OMKX331*:<>X^*)`"1_5$^`'0:_)GYG__`(1]^_\`OM=?]ZY?9'2/_EBQ
M_P#D[/H4A=85:-#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A?D'0"Q5+9*$T4"D=
M$]!U^\"*Z]"W'^,L[P2D:5%4`G>E5.A2*%5:=:*544U5"X$;\B:)]L!(!KFH
MA^YVW-L/V"X-A*&WH\J*I=0:JCNEQ"%*'2M)'35#N4@ENR\"@TA6=LTLA#3S
M*A>H`*W*H-I-.M``>GF?$Z@*0OA/50H2`#17DK]'Z="$N+6^M%C4"0I"!)Z*
MKT1LKVTJKT_$5X?'4-P+IBWM3QD'E^6!BL6.K48\IM(2I2WXY!!-45[B"J@/
M@G=YZ[>.UR5_J`?2F5('$'GK>XE*F5O,..(#FTESMH/1050$TJ*_S:HKC,>E
M=3YMN0F$]V/'.T,/%M)2:*46RDA("2I`ZD^!(!\]1EQ/0P&KC@;;S.YLL2&4
M+8&TA+@0X`H!"4"BDTZ[4@_#7#DNIN+3M9<D.K24+9<^[U/4FM2#X[A\.F@9
M(6>%)1<<AB[5#8A0K5.X4W^0\U!-=#1YCPP8$H21O=DE7.XW28M+A1/F//J(
MH#^\7V12FZB&SJS`TBG)"*I.,-!M*W!0H2-J_':=NVJJUK]ZFG6MH-?!<[$5
M*L+9%5E"0=IVBAVD#RZ5/GI+W:C5=&"WX^.(=6`EK>04D`>KP/7H-O3II%$X
M^0/`H$J(V%;C78E"`-RAXGU4VB@I0@=#_+H7&.T.JCEK!0JFU-"GK3;N/CYU
M%"-"'NU.U+;_`(!``*HYJKU52BH-?.B4T!UPIZ'W2@YQ]M;4I,8E8!HGM!/7
MR)-.@UVJ3Y!YK2_N^4%I"BHLJ15XK01M6`-Q00/2%>`^%-<4AHH`%OL\=MMI
M(892$%0]6T562*E2U$$J\>M==4605EISHMM&`NMU46CL(\$A/CT`(%/*OEKB
M?C9H%*U1BQA2T&JFE*4!T"$U\"*$@BOEKJCOC+!4E'UOQ):**#*DDGKZ34A/
M7S%.IT)M.+;+$M(HI)001M%$I*>A()Z5(\M<4EG\(^E+F#`<;`JE2NE$D^*:
M#H*`54`-2;<Z'Z^`44I51(A('I*E;:]4$D#T^7E33IQ)*5&S6=/8MQUH-I*2
MCU[.I-:`FHZI)T)QT):TNKDF8SQ;;*"%AO=L6:E*:;4J!VT^!IJ/(0U^K@,4
MTW,=ZC`&2')*P`!N?%?*KJE;>@^ZE-1^K59/)YTA>,*J>I%^WF*AS/N.T>EM
M4;D3`GE`DJWI&2P&W%@&JMIZFHI]FG++_FF?VDN-I<\4X8KKG7*+CRW2H$+<
M=70#K]XE/0T-33PUZ2[/T#Z%8/.IU56K[[&D2LEXW%%A8L>0%2CZD@&YP-M$
M[@$D)Z*-$DT\QJCW&,OF#J_=^U0YSX_0H(R;8V$C:I9(^"FP!7</!1)(/QJ-
M52:4D_8W':1[S_:@3L)3[A.*`"A.TE0S"UT)45JW"OC3QT[![_H3,_N>E?H8
MZF*&N<S_`%A>R?Q'PQ;[(E)6Y,X<YNFL)`W'YG&7\!RV,H)\"I#MA!!\1KL,
M@COK<D5_-`^A,7L1FL)`#33BN)NWO-NMQWTJ_#=90M)\!1Q`4!_/KVN2(LXU
MJL2]^CMJFX3;;U>\HRRWXM;'+[?6U2;DS:XS@"Q'A6Z+(ESI:@JL:VPVZN/O
M*HE"`?,@'R7J-NO>)6\=+5K=I.O;(W\GN2PQGVRXEC=[NF89Q?;YR=E;BG)T
MFQ<6<:Y+F5@MW:`=4F5?9]EF6C='#@/X3,A2.A616FJ/RBSQUR5Q%)0!E,5U
M\^RE=@3[:>%48IC<;#;$O#80@X[`E76<W;XZIURF3G%2KV\_<5R[G+<7)D)6
M4MH?>6AIMII+;:+"-_EL!..K%2%-VS*WMQ7^BDJ>6]M2-PVHZA1J>M#^K4M"
M^W6^]U26FE$G<=H)/1*#UJ0:&IZ4T(1,&I,D!$1MQ\NFJBD[0C97IN5^RK].
MA"\24=O?$8>+LMMD)E!M2G4,=RI"304W4\_+QT(3&\CY38..8;3DFW2,ER6Z
MNI;B6ME1/9;6M($F1M)+<9!6-RE42!^G2)'^6*D54<GSO",*)OG;O=(,BW7C
M,W,>QN+(:DO*M4:6NY7#LMMDL./_`"ZA&:0\30*0XM0'6FF'S!["VAQ2F/H1
M'Q'%-GBLW%\GF7:=;<@CR;;/EN)O^+SFW9+:7T5294-0<[L>6VH;FG&VOQ4$
MI.XBBB*<1@`C"J'Q%[J@\$595BMXQ1U;%BG)EV*\-NR+2EPB;9[AL05NPPW(
M!9;D-`44VI(<33J.NK=I8Y@>PU!3$D9CI4UJFVL.26G(]]@N41NUW>)W(L=A
M*B(LPI)[L-G?1<9U1`4V*G8L!2.HIH<-32WF%R-X8ZI1Y[HN`.=_??P5A'#?
M#,_`8>4XSR);KWG?]XV:C#A<\=LUFN5OQ^[6NEMN2KNI<ZYCYQM*`XRZS6AW
M()IS;R-?HX#BG'-U#S1D4UEM_P!7BR"X6;'$<V^ZWC#C/,D6[\N8F<>V3)\D
MNIB-.+<;AR'[VO&+/D,",5`AJ9#>:0HU;*222KR'`U!%5QD1>*UHDGS-]$GW
MD<%8$U<_;![TH7.-VNETB8O(P-WC:X8M>Q8;RU(CRKK%<_C;,K).M]O2E'S$
M5,>`@H=*PM"4$&4SS'.:V5PH7`5_"#F3V!*$)UAM<2J]YGM-S3A2Z7"Q^ZB]
M\@9KR@T6Y$G';U,O6'XM#AOI<7#8C8[;+F&[Q;I`]1DNRI++ZDD("4A23]@_
M+KY.="76QQ[U=RNW:\E.O!Y;%&6_=$8\31CXFO):\XY!>N=,]![*^P^.NG_$
M&M2*BE3C0CV*H3G[W1M<7\@3>,N/\`Q+&+1ALU$6Z0F+8S##Q(^<6PPE@,JC
M]Y,L+*FP"K=NH=8?YK[IT/9[L[IR/9K..Y8T"21D;8W#`$%E!IK2E:9XUQ*S
MO4]SLEM?R;;9V$+(VM&LC`@4'N\S^]5P9)=%9'D=ZR"3,?EO7Z[3[LZ^ID!9
M5.?<?4E6YQ`_!*]@I442*=.FOFZ]BABN7-MWA]N35I'+DO/W4+B6X-KAW(I:
M<CQGTN!+SZ$_=/<;96H*311HA+X;4`H@#KJ*N(ZC7"([Z"B:S51_$26)9ZC[
MY9*8BUTIUVJ)^S0A./Q]D#V)Y=CMX:D)>@2Y?R$B5'4HQI$24I+$EI:2E*DO
M15.H<4VL!:"D&E*$HD_AGN76G2X.Y*?9O,::R8[KU$*H$J0X4N-.H.]E]ASJ
M69+"P%(6.J5#S%08"7)('N!I2B6MISCL6^8Y>'DK?L\%4IQY"0ENY16T.EFX
M--H_=/O+:+;K-:(=!I5!02*3'*)*X4HH97JY2;A)FW.2LKDSI,B7())42[(6
MIU0JJI]!53]`UU*>[0W4FJOC]2NAJ`GJ.G7XGPKJ9#_#"A/=K=J3>35G8X1T
M*4D?'QZ^8^&G4E-W,.]X^(!70?&A\:?'0A="WT)..3.Y)YLY,>:JSB6!XW@D
M!]2/NW',;LY>I^Q1%=R;=BR$J`\G>NOK3^6?:O+M]UWU^+GNCMV'DRGFO;VD
MO`*\'^<5Z9+BQVNON!\U.6.CVEU5TS6U(;2E0HC<7'O2-O1;A(W`=*["*Z^L
M(!5H',KQ<YI8P5T0%4"B*JZCR)V]"#45KJ=&PL%$(X,EB,T9,Q]J,PPA3S\E
M]26F&FT)*EK<<60AM"4`U)(`T\T50;>:X\,(U.&.=,%C_,G9U4VF/\PT1_G"
M45QX%#4;F1M,J;M(_82E!\-XTMH<QV-:^O\`H33H&1&D[J.:<6MS[@<N_L6"
M+8@HEZ]3'+W(^9?>8#T=J)`B-*=6J.Q'MK*E,."(D[0Z\7754W%0.EEY!T\$
MNXO3*=,#1%%IIX?>/.IY%&[R1X`_93^B!2@\>@II]AP4`HM?20GP"O56BATH
MGJ2/T:DQN!=1=K5$TNFQ9(VUH%%/6O@*@&OW=/G(]RZ/J/T+I:]J/_=NX6__
M``?V#_ZE&ORA^9G_`.$;??\`[[77_>N7V9TC_P"6+'_Y,SZ%(/6(6C0T(0T(
M0T(0T(0T(0T(0T(0T(0T(0T(7X[[5S0E22II:E5'^Z(!()^Z2$J4$GP\=;3<
MGN\[,J@:POP"4L6[-!"5"&$D`>HO'TFE#ZJ@T.JLXFI4UHHT`YT3'>XI9GXE
M:Y"4(4W'NSG<`HH-]V*0A522?46R!JJW'`M(P)<%-A_ACO4$G*G<-H54^9Z=
M#YBG741.KPIQ*>AZ&GA3H-"$>1IBD6EQDJV]Q+JDC=MV@NH!4/-6XII]FN:6
MUK050C[#]JI*2@HI3:I5$E/5;=:UZ=.X*ZB7U!`7#WD*2=M_!%$!*-P;;6M`
M[>Y03ZD^CH=]/"M-9LN+LR2A*^,_*?C.?@R?EVDJ'=;"E(24)5U6H)71(%?`
M$5'AKB%)+`'DW+'KS;@0)#2'7"VJI4IV(\M84*A)J6723TK0>&N+J;R^.?)D
MD)&Y2E"GAN<%04[3Z3T'3ST(63CZVNWF^J#(<I&;<E.A.ZM0V4)'IZFJC7X:
M7;M<Z=NE<*=F5B+S*=O8<).Y02EM?0#P"J)-*C^;5J8WU7:I.2\7DJZ"&YM/
M])*MBNB?"OP.FGB726MK5<P2>D8DLN$_+J:76@316USH-R21X54#0^1U"<)V
MFAU)Z-S`*/S[D?6K&>W1PMFI-*J!H*J((!^(IX:?MVRN)!KZ4YKAY#U)SK;B
MY#0?#*EM`I:<<*":$C=UZ&JJ>'QIJ2(GKCM$@TQ@:O4E.SC\45JVI9`^\34#
MK_1`KKOEO3.DAV@^\C)O'V@DI2V#0CQ'AT'@DBIZ?JUPQ/3S2(O"_,K,K'&4
M=-B*^)!1UI]@/6IT>4]2%D_(6%T0$;:4HHHVI]/7U5'4]/Y==\EZ0\.+?#FL
MJ<=C(2$`(4DD[CMVI`4:DD'Q\=."/P4(&I<8S"KQXUF&.1TK2E*$`%/2J:$=
M#44\M->4].47U-ACI5TVUKY)/7KX$"AZGQ\=.R,J/`!5!:#F%MMVI"3L:22=
MNXA(*D4/DH5H2:UTRVC7>/().AG((V8M?0E)92H[0JK2>A`/6M/3^CPU(`8X
M5`%$H!M*`8(V8M[_`([6DAL>/92`13;4DZ6`!DN:&<@CEJ/+;H/EXRE4VUVJ
M"R"?&B3XU\]"Z&M&0`*Q2[1*>JI+:4G::]":]*CJ?4:?;H29&ES"T9IBL]Q^
M8\A7]7<71!`(;4:'<.E:U(_PZBSYGN3<<>EOB`U*/#ME=C/NMOU;(6K<A2#1
M)ZB@%*>(U4)U37X1XEO$2Z\&<GG&[BY8<@R[&+0YES%NG.69`L^4.17[7<KN
MVT;?#D1'88=+;BTKV.)6*@FEO;PEKHY0`&Z@*IR,.UC3S72"Q)`=55X(W+Z)
M*NH25*'0UVJ&T]"//6\<6U]YN0X]BGOH75;[JKC]\-P2_GV#0$+3_4L4F..(
M!J09E[E*37J:[D,`]?AJIO:&3"A\/VJJO'.;,*$TH/I4*I/J`<!V@)(!'BK[
M%>?CJNBBH3K`3,DM::"5([V,BGO5]I_F/](7BD*'D%'+;:H`?$#1'&YLA<?=
MQ3!<XX$DA?H<Z?7%0)]<"5(^6X?M$7&FKX_?L)YKLR9DNZNP(%K1=[9C=I?7
M)8:1267F9YV[EI2G:>AKTCR$MF8X8:2#W8YI3F.EM98V^^YM`N"S'IE]:MML
M@O8OE'SD..W"F-FUI99:D0D_+O;94N0RR\@NM&BD$I(ZZ]=;U-LXAC=+(X^"
MA\)/BX_TK(';+J25Q#1HX5(6U9^.;Q.MO/=\5$EP;KDE@Q"UVWMD(F?E*LA@
MM7R`^Y&6XDIG,H;"T)604"AK77FV_7,5WN,EW;$^2Z@!I0^I:/;+>6&R;;/`
M$H>XTKA3O6QQOC_.V$)KB')_(''\78MEMC&\PR2R%MI:-JFPS;;DPA"'*`*`
M`W4ZZHBYY%"316#89`X$CBNOKV47RWW'@KBE,%BZM)B<=V&+--]ERYUVGWV%
M!%NRF\RY<QUY]]5^OT:5,0HJ([<A(31(`%CYC'L;I^Z*%3IRQTI='[AI3AWJ
M9(N!M\,J2JB$1$M-CQHY*<40E/\`1_!;'3IXZG,D:_`9IM%DUYUAV(RT@EV0
M`L)*@HE"S1*CX[0:U\NNEH2_MUO?*&6(H6J4ZVEQU;50PRVKKN=4"$A`'6FA
M"0V=9"NR6Z1$LTEN.E#R$3[N6VW%AQW>"IA"BW\Z\VA)44`T0D>KU424.D:S
MWD*O'GGE=J$T_B-B;6F<^&W<@NLEU,N7<'BE"HJE2W4(>[-`'$L@(;:5X)!!
MU"<YSLR2$VTL)\.:8!_-9OY#%?F[ITE=K>MX=?6M99D**T%ULE5`=HKT%`=<
M49YI(2.::*/>I5IDL7.&\ZTM]=)/96MM1*5[PNJ2*+KU'VC7"`<\D->[4,3F
MGVLW*MTB09$9UQ<NSSWV+A>6@>Z7#$HIR=!0O<8%VC,%;V]K;O+9!J%$&1!*
M(VEI)`X)V?,(BY)BKAWR+DL185#NQ89F2HPV-L7-#;;T*<RM'1+5TAJ0ZV?#
M<"!UU=2O8^W$D60(KPX*.GZX8Y3ND*Y6Z\P9BHV4X^ZTZF0CMK3<(S924.K8
M51M]2MH0^VKTNI)KXZ8C:VZA,@<X/8,`*X]Z6Q]"`[W%,7*?<0_R5EC7S=N8
MMRE6N(NWJ8?==47GFM\E2"YM_J[TAM:$M[=S92`23J"Z5@JTU#NY2V%I%69(
MQMG..0P+?<6K<U%0Y'A2%M2I<MR,]&7$_$JVM1[3.\-D'<1T/AJ('OR)-%W(
MU&85+/U5_==9\OXCL?(=FBHD7[`LBMT1%SDMI;4O&\G6Y"NEG><712XT:[(C
MR6JG:A0<I3>:^V?(KKV3I/>+C;9*FRN[<%P+J-$K'9FN'NGWO0MATEOPV:XE
M9,"ZTE;6@-`UPID.W$E<QV8>Y/`^7[\6,EX5P7D&_L0S%3<A9T-W[M1AN9";
MS&7%ERD,@42WWC4>E/CKU3>OF?\`*G>KQ[NHMIMKV9I+=;0`X\#60#4>50>"
MMMVZEZ4OY:7]BV21F%0"QW^4]OB/H*9*_2N&LUD,XY;<!>XHR1QURLUB'G5T
M@V^/'0MUQN1CH%\N-P=G5#+"&&VNVL;U.A%=>3=9W7RAO]G)Z3V^XLMZ8^K0
M'O=$6\B'9'/L60W:XZ9N8:;5;OMY_P"V][3_`)V-?8DU-POAZS-+9D9'EV27
M9H,D04.8-Q_;FU%]HK3--ZOF27^*AR.%@?U1#]:$H%*'Q=9E:\88TRX\;!@-
MDF-J0XA!6WE.>3&E$+#+B9ER1C^*E85M"UAM:!U(\AH0M.P\?7-Z/(;EW*VV
M-EQ^WK=BO=Z==%%J0M2'HD>)'B6QJ9#:)WJ4[U2L)W+!-`@'`Y(4B7;7D=O2
MJ3;)`R.`RC>9D!#B9C*-O0SK2LKEL*2$G<M'>8'^^:C21$N\`%*)Z)T8%'YU
MY+3=R.3(M=P82X?ZTB%"(4KKV6EKFR*=:U<4M`(^S3+F.9BY2@&CW0`D'<'@
MAH]3T*@1UH213K\=(3$TC2TM&=4V%U>+JE[2*"M2":'K4C[>@U-A_AA1DA[F
MHAM="1U/@2/!/33J$AF4%^:TDDE)=2:*-1M!"C4'XA--*:QS_=0NPKZ,7&J<
M6]F4S,YT/M3N5^2,KR%#CB=JI-DQQ$3$+"H*&USL)E6N6MLCIZZCQU^@GR)V
M#],^75G.X?F74DDKAS+CX">=&5`/`8+Y3^9>X.O.M[FI_)@BCB;Z!XQV>*A(
MXD55KZY[<(QVE_-$R`ZAGL0YDPK+':"D.*C,/-L*4'!M[A3OH:5H:>VQ1!K0
MV@U56&TO?^8#2/OQPSP1TW<KLOLMP83$9E;VR3*NKA+R(R6G3W(4"(7"XZI\
M(&UYQH;2H^(`,CX9SLS3TIM\UM%@XO?7D2*(^:@6^4I9NBDW@J;2A35P2AV'
MZ@0I*+=0PP"#3JA1^TG4P6KFY9?MQ3;[_6*-\/=@4HOF&O@/L'G^H4TYY3Q@
M`FZE_B)J3Q6XV_U24JJ0GJE74"O7P/EZM-.C!S&*,0OCKI\=HJ:UV^G=X>/E
MH#0$+5<4E5">@VD=2!0GQI\:@?S:>8UP*Z`B68D%%$U(/3H/42:'H/U'4DUT
MFO(KH^H_0NE?VI?]W#A>G@./[`!^J*-?E#\S/_PB[[_]]KK_`+UR^S.D/_+%
MC_\`)V?0I!:Q"T:&A"&A"&A"&A"&A"&A"&A"&A"&A"&A"_&M9F.@A*PV"?@H
M&H`K1/GN*1_+K7W[V/EJP@CL5-"US2:@A'L:6XE(ZC9TJ//PZ5\CUU6O):VH
MS4A-#S/D:!;8V,)0EYZ;6YR%%6TQ6HJ'!&V^7>D.%73^@D_$:KKLLD8TDC6"
MID/\/TJ'CQ(6M6TD$U33J5`GQ`^&H:=6OVT>*O22>E5"E3UT(7IUZA"4D*HE
M(!%"!U)/AX^.A"<'%(W:C1722E<A;CQ6D;E);+K81M`\=R60:>5=0KHZ@8W>
M[1"D=98$BZ-M)0A8:;H2M(JIQ2A4E()!(I0^.J&9C64T\5U.1;;6S&0ONJ0\
MM^.GN,L*<`0Z1V>Z4!24I4Z@]4C]KJ=,KB=;!YJ;?<PE!VT66G4D='67%4V5
M!-3V%T/V=-"$3<CQEVV<XA*E]KN%;:]IJM"J%%"!3U)4/#22:+J=?VX6@OR;
M[(4`MY$-HFM"0)+R=B=PZG8A)Z?:=6NUP->YTCP:BE#ZT*6GY*5#HVD@IHI*
M0%*J?&I/D-6_EPN-!GWKB\'&VU'<ML%/[/I2!]M3YU.GFAK6Z0,%W2:5H:+T
MC$X[E#\NT>M2%-I4HCSI4'H:ZXYC'9@+B,&L0C-DK^4;4$I!4@,H(*6Z`'J/
MOT5^L#XZ088SP0E#'QF(E"4&,RMDA*^V&T!!W"J"I-`#7I2NN>3'P'M3T0+7
M:C@*+?;Q:V&J#!C&H`51I'I)\030I!'QUWR8^2'ZC)K:*K?3B=H4A6ZW1B$[
M:A(557Z>T0/*OEKAACY%.!IDQD'B"::ZPVD7":VVD-LLREM)`J4I2DT"1UJ2
M/M.H:7*YX`T9HN1&*.I55*A0^`)\"*#J1UUU+;4M!.=%L:$I>`A.[=TW5\C7
MRIUZ^G^30A9`E2NB4U/D:=?UGX5UPD#-"R(;(IW=B/C0@;C3QZ4Z^&D>6QWB
MYKBR):<"@XA9!2"4I`%%`^(4?&AUT:6>%=1I'67$A5%I5U2K<"?@:U5X@TTM
M"-X9#:@O>@+J`"M5!MJ-P`K3<=<0CGYEHMKW.)!2**ZBO7X`CKT_3KJ$VN0L
M.W&4Q;[<E$J;,?1'B1@^RVI]QQ6U([CSC;380DDDK4D4&FGL8XT.:C32.:Z@
MRHHB\M7-["95J9GLQH[M_FJBQ'WYD/Y-C:U)<$R3)^8$9<5+S!;4K>4I60%=
M#J#);,BH)`6UYX)<!?-4"KL*X#AQ*GS[5+-?!PW(N&*\PR!NO%LNMZQ5%OGW
MFPXE<[[!CWN/:Q9KTZ,;ELW&TW.).+K$-J0A+R4!=0K5FV%_P\8#@YA!)`S!
MX=V">:XM-1FILOXARI;<6_.KAGEG:LI@2GYEPQ_$(;$QIII*I+B'I%\7=($.
MA-:H8*D]`DC73:3!['0O.JE2*UH,JD<D\Y\[6^8X$,YTP4-+I>)U]N\B\7*7
M)GRY;E5R)"FU.K:31+2=K+4>.V$M)'1MMM%:T2/#5H8G-`QU89CZ%77#S(\.
MJ#@LCK9?0II"2M9(`2G[V[R\>GGX>>FTR`3DIY^P;AR=/]T?MKRB3/<B)L_-
MO&UT3'$4.I?,+)X#Y:+H=3VTK**$T-*]*^&E-AEIK!#F=G#^A2_A_P`LNTFN
ME=Y0TE0AEBN:[Z^_MRQ'G7+?:E<LLNV316<0MG+K<>U6:[2X-KN@O+^`I?\`
MS>$RXF//+*(5&^ZE6P+5MH3J-,TN<*`D44NW/A*HI8]NN(VU*842QNRFXQ4P
MPMXN.?AM^AJFZJ5$)`Z_'3[&AC=`KI',I$SFD"E%'3W1<6\[8Y@*5>W?!K1>
M\HN4^/;Y[$W\M#D&T;%RDW")'N4R#"DOQY\=I*@XI82VI1"%>3<_\/TIN,N#
MO#FL&.\?9<+%:Y>66>#C]^:M$)W((SLF.J+&N"832[HZVZRI;"8290<*:KHE
M`\:"NH3JZ21FK&32W+*@5T?L!SC'LOX<PBZ8K?K7DEG:BY?8/S6UR"]`=G6+
M(9D*2RRZ0"KY5US:?(^500=3V,T1@T()%4V0:`\"IX7*4N2_#M[5%)=N+"=P
M50;&T-)Z*'0@$GIIYA>#X%Q.'8X+,R^2I\DH1#M3*`7GO2AOM@E:G%&@#;+:
M:FII34MLC:#41JXKJC;E/NE1?,VN6#X.&(F&V*/)F9#D)*A-O#D$A#@;?24?
M+0%OJ":)]2T@T(Z:9DF<'4:<$*+U]YDFYIE<>7-D/1L;L<A3MNM:%J2V^^E*
M0N3(0C94R>VG:WU"!X=:G0PMDQE(J/0A1"S?('K]E5UN3FU)DSG5;0K<A*=U
M$-H!^ZEL"@\Z:84$.+35JTI+ZW;`D&@#<DA!\0>[NW4\O'0N$DFIS*2N[>AQ
ME>Y0%0!YUH13QKT/EH7`:&J-\8NCC2_EEE)V56VE0Z!=:@J2>E*>(/0BHUS)
M2&?FUU\$\EL@&[81.L*W.Y&"7;;;BXYO4RUO5,Q]NI]7S%FN`,4'Q5'4T:]2
M-7=N0^%T?^ST^U1RF_PO)'K/=K;<"HH6PZEB6V30[%'8\DG]K:H>?PURR?\`
M#O`P#>-?WH3_`&=WA^SR;'D4!P&%(:2TVMO<E`>2ZY*;0I2""`\'%$&M:I(U
M&W9@8X2,&)IW<4XQ[FT:,JIK.4?<*F%A.1W2XR;7C]HL-AN5SN-UER>PRHPH
MCRV427]S:`T[)VHV@;W%$)'4C5/))2F@A30.:Y`N??<+RSS.RNR9OEL^1C!D
ML7).*6Y+5MQXRV"I<=;L.,E#LQ453A[9?<=*3U\=,,EDC<7,)#B*8<BHCY)1
MG4!3E^D)[)N._>CR9REA7*;\^R\:<?<5O9=<KO:EV.)+@Y7>LELN,X:5W&_6
MZ>TU#5)ER5N-(7'<>[02EU)\9ULUK@T:6@'D*)JI<:G.E?1E534]Y?TKN*_:
M/A5IS;*\ZN^3<?W'+;;A<!U&4YK!6Y=K[:+K?;8Y.Q1Z9<&;C8Q;K,^795MN
MLEA"T^J,$J!U8.#(&N:_"F=>=,DK0[D54M?$\9P`U#Q*SVV'"AM)8:=MV-EE
MV2&R:2I#LQ"'GWWOO%1V^5$IU4/O;<4T-*YH?R*1$K*+5%W[HEQD^)2"B-%0
M.E2G]\_L%1X;?'37GO.(."=DC:V,.'O8)M+QG:$.J^0LC+&PG:N5*<>(_:J&
MV&HR3U_RCIYLE8ZU'F)A(R7R3EX=WPKF+:ZW7LJ@,H9=2KJ`M+CG><2JGF"-
M=8\T_,P=ZD)>62ZW&\V]VZ764[-G2I<AQR8^I)=E."C:WW0D)1W'%HZD`5IJ
M*Y[W>\G1+*?=Q]"+KS,#:%()H>I/A0FE?'RTJ)H>ZAR2GAFBO^TX_6F]D+*^
MX:]""?+^CJ8`UC:#()A(B]^"OA2OZRDUUT.#LC5"2UN"C+6\$+5V4N+2E*2M
M:U4VH2A`!WJ6>@'6ITY%#)-*QD+@V8O:&UYN<`!3B36@"-3&?F/]QM2>X`U7
M==[11:^+_;-PGQJIEIQO$N,\4;N+MGD-SW4W6XQ!>;LN1&BUE(D"[3W2[T4$
MJW`DE"J?K!L^V0[#L]KL\8TQ6UO''3E1HQ-<<2<SGS7PYN%S<;EN%QNLSJF>
MXDD(X@N<13L`%,,E*>)=XLT(-LF1I[:7/Q4=]E#[&RNY2BD;EJ0N@*2BHJ.O
MQO8HVEH<?>JJN5\C7>&NFB47SR$I!>2ME7C50!;(K0'NH*D)I_E4U/B8UP-5
M'+R_/%;3;XVI<2H`'U)-00:'Q21XCIY:D(6TW.<20=R5GI2I\.E#0'KIQC*N
M%0=*6)7M%`4=,3]J3O-`?`)Z@&@ZTZD5TB6WJ[`$H\Y_%;Z)(64I"AUK7P!/
M3X>(IIAT(:*D)V.2OO$+"ZL>K<:$52*B@(ZT(/AUTMHH,$[K9S"+O(]:>/4&
MA_ETX]H\HGC11WS.:XT(TT/T+I?]J?\`W<.%_P#XP+!_+\J*_P`^OR=^9?\`
M^$7??_OM=?\`>N7VQTC3_#%C3+X9GT*0.L2M$AH0AH0AH0AH0AH0AH0AH0AH
M0AH0AH0OQ\'^/+G$=5W+0EM26^X(LC((CKC8K3=W8D8=2GP"MM:^=::T;F@#
MW7C^T`%7HMDX])@.%U4:"R@`;V7KDU*<0M5-X#C*V/Z0H""4^9.N_"S2LP'A
M(JDN-!7M4%N1+W)&?90AW\1J//<@M-E046DQX[<4%I844]*%0\1UU32PNJ72
M8.'#N5@QH8P`)NWDA8+R"2D%*5`II3<#MZCIY:B)2+%.UJ"D$5/CU^ROZ="%
MB2G>H(KMW';N/@*]*G[!H0EVW>Q&?:9;:0IB/L9%""*-I"*I*2"*TK^O3,L/
MF5-<:(3MXIFZ8TAAKYE?RY<"2C=1U*13H@CQ"1X:II[5XIYF!75(^$(*&$R2
M\`AT>D`E2U(=<0M%27&]ZMM:4(^S5:<T)16VZMHE(DLNM[PX4N,UVA38(2EQ
M'4J"P!X'R\]"XG6R>SIRS#V;G'!<N%G2`L-C>5LI23'6I":AP)\/'I0:215=
M4@/;QA3]@P1FXS0#=\A6+B\%5"VH`JB`RL*IL<6A1=4#Y+&M'MT>B`8UJN*0
MJ(Z@1N"104W)H3_.-2VQ!KM54+;:9]2MQW*&TT(\?'I1`H21]FG4X)#HT4P1
MBU&_$%#Z5#<$A2JM^%1U2.@/B-";1JW#'B&RHGJ`HJ'@>A*5=`*Z`G9(PP#%
M&#,/:DA:0I)4%`=3M6KJ0>FT@4H/AKB?TZHPWL".8\$50"A24J4=ZU5IX^"J
MCH2?@3H76MTMTI.Y+=T6N,6VMHD/)6A!13:%BJ4K4W0;-J3Y5K_+IF20L-`.
M"6!5,RX`ZXIUQ(4Z5%>ZFTE:NJB0>GJ/QU%2EY*$$[MJ-P^Z2>H^/0"IKH0O
MI;3MZ`J"OV5`JH.H-*#]K[="$`TR/4$@*`%!M`*>E#Y5ZC0A`,MN;2!U)2:I
M])4BOD0*D?H\](>S6*(60,HW$4H4FE/`_`;OCX>>NM%!1"]&.RHIJBB016A^
M!/44\ZC23&"[4A;C<..X4C::4)!!(H/L\//3B$;-6MFE*$`D$I"NH``%0>H]
M7GX'IH0MERPL.BJ7%AM6ZFTI4L4`Z%-$FJB/,>>A"93*&(!F*9!ND&0RO\.0
MJ*M*4E*@0XAU*Q10IY:CR5,@]"B2BLE.Y5Y\BX2U<>7G<6>GOMVJZ,IO2G`L
M-?,3KO'##CL=:]W86]*;0V5"O;0E930T(CS!\]R()'8#BM;M]S\#T_+?PL;Y
MKG>7CPSQ':K@\3R#`N+\*G8_B\A5NLU[O9O5YD764M"T3[2U`MMPG29$Q+;<
M.UH8M32&-SBBAIKJ?#5RUOPT(:W%902RR/#6M!<3BE]EON"'*."8UC^*RG%X
M4P9$]5Q2MQHY.^MT--/=DI;6BT1^P5,A8J^3W"``@`AF(+F@>)YSX@?A[N*D
MW7FB/RG&@8,DT+:PE84/$&A-2!\:%(\0-6D&,9':JU.IQ]C[^3WR%$2UO&]!
M&U(*545N5NKX;1U^VNFS`-;65P*D0<5=_P"SW"T6'F/@I3D5;+@Y)PHM!0(2
M0F^1%DMK-2H434IZ*3J\DB9!9.8P"M,U<R,I;DU^[]2ZP]9M9Y4O_5E2VJZ\
M'E;/>4F!GH2*>`4_BN[KX=:#3,DA80`%)@%6GO5+-QAO?./I2.VV:+0C:?!2
M>M5)Z=3KL<I?7"B/AP.*+7<?5++0<`4"M(I0J`#GI/ZQ77)CX/2ELB#75!22
MR+BJT9-9[K8KVS\Q;KU;)UHN+":(+\&XQGH<ID*ZN([D=Y2:BA%:C4-..&II
M;S3P>RS@K"O;5Q;:.+..DWE.,6N9FEXBIOER5=K@)F176#,EI5-=:CE4</*H
MA.VB!YGQU/;*9&`$4TBB43X6MY!3MMCR7;M">30]5E*"H&BTJ4A8/]&A36OP
M&G8Y#&:@524@O<;R>,`XS7CUKDKCW[+"]\PIIQ)>8@N*"5&A%4AP43T\JZ2X
MZB3S7%77@TY,*RYY+%%=QBV6VO4.+*EORY!H0`2L[2JGB!KB$2VJ?!>3(6UW
M%KCMNO.%'J;;*05544C:D`"G7J>NA-R2%A&"9&7-#TQ922H/NNJ"MWJ'J)W$
M@TK4^7775$2H?>ER+4Q$2VVW%8_$2JA[CA3U)WDU/^#0A)%E_=)<!J-YW(%2
M>A-2JHZ5T(69UIR#(B3T`I:=512D$4W)Z+04UI7;UIYZE"V!C:^IJ4XR31D$
MZUDN3S;+S;*U;I;2W8J!X"=%"7F*5IM+P3L/V[?AIZSD.,-,,ZILI!7)26+_
M`'5*4)9:EK:N<=((&U%P;^94E(`K1#RU"GB*:<D%7%"=-%SGY!QM?;-#;:G7
M:%:;D_:&9"EAIR[PHCTRT-N+:/>0T_*92TO;0[5GKJ>[1<63@]H!:'8]P0#0
MU7-+[@>>>5N4F7+1EMP;M]AC3%.?PI9XZK?:V9;+A2DW!M;KLRX2(K@(29#B
MPVH52E)UB@IL4GF5J*44'KM;VG5U*/,I"@`!TI^CK70E2,\P4K177_1W]NUQ
MN%UROW'2<DOC>+XVO(.+3A>$9#F.)9Q<KO<[9C=RB91"O&.R[=;+A;+(;IV5
MV^<^A+CCG<V.I04:=9;&YC>USW!@&0^WVJ5M&[S;%>_$116]Q'32Z.>,2QO:
M<VN:<P1AV&A&(1E]6/GOW(7SDNQ>V+E6+<X_$W&5T7G/"]VR+';/8,OS'&+]
MC5MQ]%XO<K&A"QZ\P+/-@W"%"=:@1)"07`_O7UTN22<6XMIGF1P'O$4)Y`T^
ME*O;JSO;N2YV^U996;CX8&.<]D?,,+L0VN('!5R\4X`WR;R;@?'KLQZUM9?D
M<*QN3XL=N5(BHE!=768KDF&W)=0E'I0IYI*CT*TBIU6QL#ZU45656OZ7O']R
MFQ6<DR;E:S6M^++D/W-;7']M4T\VVPN+#5!1<,HEI7-6Z4;R$ANA*O-*7H7^
M89&Z'@1D"I&!K^V"F[A8VUO;6CH[J*:>YA,CXV->'04<6@2%PT^("K:9\$N;
M9]+[VHV]87<&<^S!>ZA-USER&RM(4$+_`*OC4*RU0%BAHH]32NID48P?557D
M`',KG=YPLUDQOFGDO',9@IM^/6#/\GL]E@)??D"%:[1>9<2%'^8E.O29!98C
MI!6XM2U'JHDU.G)(]9U$Y!,O9H=1*"UT@XW:FE40LPF)"P0KJN2#(VFHJJJ7
M!J&I4<0C)(-:I%W>XET[205%0H`%`4IUKY>&G8?XGK41_OGO10D]QL]*$A0Z
M:>>\E_E<#]:2DC=Q50"A\`1XCP.EQL$8HA)JW7$VN4U*;[B'F7VI#+[6W>P]
M'<#K"TI-=ZT.H"D^0(\]/QR20R,FA.F9CVN:<Z.::@T3<T3)X7028QO%#PP.
M8KVJU7A#ZG7)^)*A1N0;59^2+<PMK?>H#W\$Y^TA%077;W9H_P"6WQQH'H+E
M!E!7A45KKZZZ0_FSWJP@;:]=6L=_:,HUKX]+)FMI04:X>6ZG$^%Y'WG'!>1[
MS\GMHN6.=L,AM)#CH=1S'<<7'$=E%;CPQ]0+ACD]$2(QG$>V7]:'NS8.37&L
M-R*-(D.-GMVG,H<A>*W4!2-J4N2K.E0*:M]`-?2_1_S2^5_73A#LNY,M]Q(J
M;>9KHW@_^M\L.KP\DS5XAB\>WKH;J/8?S+RW=/;:L7P^)H'$FN5!FK%\?Y.3
M.3&"KA'M,N2E#<"RY7)#"+L2G>AZQ9/VS:[XF4%!($5;R4D$@D$:]';M]_%X
M1'YA.-68BG`BO,+&2,9)(6M#6Z>`S_RN13CHRIBW15BXVN79WFMH:'>;;C.N
MK;4M+3<T*7&""E!]3P"$FE:5&F\0H[&:W$941G;\YM:I3#+SZHI=I55V2W;6
MFRI/X0:N7<=M$XNJ-`&72H=*CKUFQ_PQW)3X0UI=5.$U-82$AP_+[O4DO$)0
M:^!2\DEA0/B**\"-*KS4=&R'13U&G044*G<#UK45Z::?'JQ"Z"O2GQM]))ZC
MTK%>E#4CR_QZ2(#7$X(JO`<)!)`VBFXU\/U>>B5@;$17@D2>X>Y=,WM2I_HW
M\+TZC^[^P$'],4:_)?YE_P#X1=]_^^UU_P!ZY?;_`$;_`.5;#_Y*SZ%(+6(6
ME0T(0T(0T(0T(0T(0T(0T(0T(0T(0T(7Y#D*T8W,46V$,L?*J%&US60%E>U7
M:0@ML`"J=U0I>U-!Y]-@V!\6+R#7]N*JV2!YH*H^FVVSS6&V(L>T0W@A"`XB
M6M*"XG87%I:6EL.E:DTW`^BE0-<<QC07M#C)1=?EZ1]*J7S1Z4,IR=J5$##R
M;]=FW6WD;5MD37MJ:[>O2A!!((ZC65F),AJ"#56?`=R2BWEH:6A*4I2L!*@*
M]14$$CS-=-(6HI>Y`!!J%>-.G0'I7X]="$H,-L;F3958+`VHH-UN3$9;@`):
M9J7)#H!Z?AL-J/7ITTU.]T<1>W,?:A2;N/MDDM/.&%D]O#%%%/Y@\PPM*:BG
M=]::*/7R\M18]QF8*8(HB!SA-BPK(NF512\-JVF+8XU([]?)Q]+FUA`KU/4Z
M1+N%P^A#=5$):S+O;8%OB6N(^XM-MB*(6'$ON+6D!EE1=2M124K4318KT.J-
MK7R/-01F<>]=159,P4RVKYA]*5@IZJKN4`#55:>)TES=)TG,+BE-PQR%'?GM
M6MV0VXS,"([J%J20H.^D#:?Z)I0?IT_#(UM&D8U75878)8CJBQT?A1E--M%)
MZ-M@I0EL@)(-$T'IJ`1J\BD$=:@I*<MI`W4*PY3P(VI'C2H304KXTJ?'4P&H
MJGVM\OQG$(Z8;2"-J.Z":G;7U*\$T)'3PIHHG!*UQH`C%IA*P0M-$E5=M-VW
MPHE7A6A\?#0G:!&K$4`$**3M3N&WTE)4H&M31*>GCU\="$<QX3-1LVK6I2MN
M]0V]3T4LFA30#[:Z$(\8AC<F@2I(W'<24]*"J-J=P4*I\30C3@B<6:\*(6&5
MB%DO5$S(3+K@)4%(*FE-`K(+B5IZ;5'])!J-#+>*8:GUJ%T(DF<+6B02J)/F
M0P2I(;HB0`%"H74E*PGSI4DZ8^`E_$WVKM41O<#WGMER%=H3^PD%#S#["D_#
M;0.`E8-?'H-<=8R@5!!]:4P:W:1FB1_A/.F=R8\&-+1X[F9;6Y02@E2]CA"T
MI'ATU'=#*TT+2G?(=S"3ESXWS.UMN/S[')990/6Z"VI"0D;B24J5TI_.=(+7
M-]X$=Z;>PL-"DM%M%SF*WPK;-E*0%)*H\=YU(K]Y*MH**@#S\/+0&N=[H)*2
MO#\";&7MD0Y<<IH5*=COIJ?&A"FP:].M/CI)#P:%I"0'DNTT/>L)0I`2H$I4
MJA!'0$$]4]>@IXZZEK9;4M/J*DJ4*]:=-I(\:4^%*Z$(YB.$^I(0KQ24KKZ#
M^R?U^6A".HZMI4I("3\*U'6G6AZUJ/'0A?+G:(M\B/Q)+@0AQG:7$I!<0HIK
M5"@FHHH5I7P&N$5%$*!O//MUR.^&WR<3N,*;D<%:?EEJE/6B0JVN/%Q2);WR
MTIM+C"_6P1TJI0(VJ.H$D+FRL>2*"OU*SV^_9:1RVTX+K29M'`4K7&E*X<4F
MKCQK[@.0X6.XER=ECK&#VWM(NL1$^W2)LV.)2YCT='Y;!84XQ*DDK(<*6U.J
M+CB5J.N/ENY/`<&5]B>@EVS;H#);1"2Z^YKR:?Q8<0,/2IHV7'VK1`MMFM\;
MY"!%A-,P6!3:U%C-EMH)`ZGHS3[3U^W5A:-:P,:SW0J6YD?,'2R8O=B>]&<"
M-(G2V8T5)<=>=#8`^*C0]14)/75ECDJ\9JU/VQ<'.M,-76:P%N!A+[O>IZ"C
M;UJM2:J2%^(H=7^UV;P?.)!;R6CL+<N89,*%6I\%6;Y?FSB4H;"6(_(F(!"-
MK:@XI%WB*#IV=4=H)-#TZ^774N]_Y:3M!"G7XI8R=C%T:#_&?\.LJL:J<?JJ
MM=R[<)UI00,[^(-3(Q;^:@U%G]X=RE6_NGO50-Q@.J>;<VD)6V!6E0"V5#U5
MZ@;::1&\,)JGSBL#<,@!20"H>:02I)!Z$>%.HZ:0XU)*ZC)5O1('<0%I0XD*
MVE'4%0]?A7P57]6N(3G8"T8:V&J*(V7"OFHH6N`M6Y/2B3M.I,'NGO22G=L#
MBQ=''$D!F-#FR*BI"5%U0'4=!2OQT^N*O7W%9K*RC-W&R[W(UO3V&DU)0CLG
MM@)!%**IN_2="$T-DF!.*Y!%+RFW95T:6%)-'2P(P13J*("O"IT(1M%$6R\6
MS9G;#,S(+D[`AIZ=Y33:4B2_6@4$;.F[P)--"$QK;4=N2**2A*%TI]X(2/,`
M554$_HT(H$I)%T2(2V6FDJJ*%PJ57::`;>E!^K70HTD9J7\$D0H)?"B0*)!\
M>GETZ^/30F4NL?7"D]^U7%OO1Y:-\9231;,M*5%"FU@&A='I(\"::FV<@:XQ
MFM7(6K9KF4H04J4DQ9!2THDJ44(6=JE&E/`=?M&E2BA%/QKJULV<V7J%)2$A
M+L8-=2D`)2X)""2D]*)E$`?`:>F.B0`_>^Q<2QX_N(8FR&R?OQU/(37TJ<;3
MN`\Q0BO74JTE#"\4QT'Z"E-Q<!VA0Y]^OTYIN-QE<EXHXBZXM?T-2VLLM<2C
M,*X3VFY3MASBU('>M%S8=<*&I5.V\FB@55IKS=MVYSG^9_>.R5C):/?320*=
MZH`R_#;SBMS?MMZA+B/H<4$JW=QA]('I7'>0-CB"!7R/Q`.K5KFEHH031,&3
M1@X&@PJI.>UCWS\U^TF/,LF`C&K[AETOG\0W7$LFMBEM/71QB#$DR[??(#L:
M[6N1)B6]IM1J\VG8%!L*%3-M;AL&K4":I6L%GF4P1K[L_=5)]Y/+EDY.D8I+
MP]S'^-;%@R[-(O[N3-"9!OF07F=.AW)Z+%D"'+=O02AMQ'<0&^II0!B[N622
M5`(\/VH8\/;49+W[29=FLON6X:N^2W.!9;#:<SBW*[W6Z2$PX%OAPXDQQR1*
ME.%*8S8)`WU%">G74&-X96J6KV.1?=M[0+##D-N<KV&>MM`:2U97[Q=T*[2T
MN;BN-`G.N%.P#QHHCXT.I0-1V+O:H*9M]2GV\8TE<?%H^6Y`I#W=6]:<<<MC
MD@!=5!ZX7B\0)*BX:DK[?C3TZ<C]\=ZZ'B,ZSD%SM<F7YO+N0LTRV(TZQ%RO
M*<GR!AE\[WF6[U/G7!EAU8Z*<93("%$=%$=-32JYQU/+N!2@OT\1DMQ15*8[
M+#*`"0`6FD-^)!'[/QU7)<LH>`!7!-E<KAM43O\`Q$T`/<!%/`^/4'4F*)S2
M'U%*)I&%FF(D-*`4-P(3M\*D`FJ:GKT\?/4AQ#1J/!"+[O%)"ET/1*Z$@T-$
M*H1TZ@UTECP\5"$B$6V8XH(2RJII2OIJ3X4KUT/>(Q4H1_!P^\25#Y9MU;E4
MA(CI75)\O6E/Q_4-`?$X5)"*$F@Q*<NQ\>Y<M2$OI=03T20EQU[K0^I3)%#T
MH0?+3<URP#275(Q&)&(R(.)!'`@5'!/-@<YOBP;R4JN.>3O=[P9"<D8;/R>Y
M8>C\6?8'H[>68N^RV*G\QQ*Y-3XI:H>JTQ=P_P!\2>NO8>B?GU\Q.B0V#:=P
M=/MT=-,%U^?&W#$!PT3@=C)F`YD$K)[YT)TUO3#Y]G&+D_[1N#O32@5F7!'U
M#\^O6'-9->L"NEDLMMNLRR9'<,$+N8V.&_&BPW')%YXIO$]^^8[:G')Z0B1:
MY4=A:TK;#22FFOK'I+^;+I7?V?"=:V#[+>'M`%S'KFM@:C!P%9(VD5.MP(!P
M+L5X]OOR=O(W&?:[AURP?=?@\#T"G8K#N*_=3QIR=#95;G[;.+19[CO'LH3E
MM%QTK4S>>.KJQ&R:$WW`5K0U'G;=U4N`G7T=M&\]+=2V$=[TO>VD\+C0AD@+
M>XD5T.)^X\-.6-2O)=TZ<W3:I'LO8GQ%IH`03J[B`1ZU+_&L_-S993CESLF:
MPHZ#'N#420S;+S;D-MA($FRO):7%=#B=BF7DL%`(H#X"R?;7,53*QS`#3Q#,
M]E"<.15$^WG:*/802/8EO;<GLI>1%>?E66?/WR&K9<BF.X$,J#3R([#B5-*;
M)]6T]:44/2=-%AS(+2F(HW-!J:I<-NNE.\=J2UM*NXTL-K``"JA!4MISI\%C
M]&N5(S3B,8#\>:VP6G4T>'I"P6U'J11(4!O55)'IK0ZA7,S61O<0<`DR?PSW
M+II]JX"?;IPTD`C;@-A'7[(HU^3GS).KYA[ZX9'=KK_O7+[>Z-_\J[?_`/)F
M?0G^UBEI4-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%^-D\Y=;3.>4H*0R7*M+:2
M4^*=I)7L[C:E?:>NMF7.())P"HQ',W%J4;=^DR@"[.?JA*&J+?*UA`ZC<I"&
M]PKU`(J--VKR^Y`K5AK]">?J$6/O"BB_SG8H!?BY)&WF9+<$*X%-"T\IEI:H
MKZZA*DO[$E*E5(*4CS'6MWRT9"\73/OT&GARKZ5,L)=>H2&IIQ]BC@M-04GI
MX?XCJB4I:VY*?0$[^O0GIU/3PIY:$)W>"F&'>1K>S(G"VNN0;E'B3*)4IB9)
M8$=E:$J.TJ`</GJ+N.HVX\G.F/K0I%9CQ!RZS)>5!O\`!OD)\;FR\IV));!V
M_OD)0MBM1XI(KXTU50W%O"S1<L>Z2M:@C+@C%$5HX%R%Y(D9CD"MQ6%JM=ND
M[4%->@6]M!&X'K1/B-+??PMC(MHRU_:?H0G2LW'-IMK#D1$&,6E!*5LJ2U)W
MBBU!5!&0XMRC@).Y5.G0:KO.E.;BNY):6SB^S.@*-K@1X^TU>E!+-"5&J2T$
ME9W#P).CRW.\3S1IXKB+;A_=5ADF1=TN"1.QI#-UN+MH;'=@QDS8D52]J%MI
MDO%R0@)94L*<%:==.0VHDD`8\D@A*#'.%1DIQ<9\D8AR#;4WO![PF\V^V2FX
M$QQ4:3#?BRT-I<,>7&F--+:=4W10\00>AU=F&7DDJ4,+;*1'=;21W64N"@`!
MJ*[0KS'\^IH%`!V)1<XBA."/8T<D`@[/4`$&H"A6OE4BG4UTYH=IU4\*X"0:
MA*"+#2J@*O/KT!`"4UIU/@33PH=-J3"2YN/-'C$0$)*&2M)"5%0!&XDDCIU"
MDHIUJ?+3GDR<DZCIB'NJO[VU(^XG>`2FHVJ3XD5\!73D<3M7C'A74<-P5K)<
M2GIM02NBJ@+H*;2!0@FE:C4G2*::>%"-XD5S<$;=Y"=R206RD;U%(%?PRI(Z
M]*$`C0&M;[HHA'L6"ZE2:52@[R-P<.X@U3L)%:)*JFGB*4\"#U"/HMO4D[0E
M)8#:5`H"5EM(*J[0@)(2`/+2FZJ^'-*8'%W@S2BC6\I2I6Y04X`4D`-(5XK`
MKL(24@>="/MTYHD.)4MCZ`,>?&L\_&(=VBNP;@WWF7JI+"5+0I:""!1T(]84
MFAZ].NF9+,3D.>:$)PAKLP$W#?M_>M[ZIN$YI?,:<<4I2XP0F5%2H+4E25-E
MP'97IU!\0=-&REA\5J6:SG4<$V88WBE=*-AQ_P`YL-H2WD.#93';*"(]\L:&
MG'D>H&KG;&XG:?TC0;;<7#QQ1/8>5`3ZRDLMWA]"\NCY+`]B?)B&P;YP)@&0
MMJ%5KM#S$1U:01ZFVP$A)Z4H?`BFH[X9(WZ)8`.=",NQ/^13$,!*3$_',-;*
MF\F]N.=6/<H;I&/NKD-I*T_>;"2IL]34=/C\*:'Q;<W^*V=O=4_0"D:9?[EO
ML^U(ZZ85P=*:<3;+;S+:)Q0%1X3V+OS"'55]'=#:$J0I5.M2#7[--F#;VM);
M*YSJ9%KL/8F'L93\ML@=VFH]"PX=[;.4,WD$XY9;C!M()2B9DL1RVO[:E*%2
M&PDEG<I0`K6M0-1X[*XDC,C!6,<20/IHG8[&>0`THP\:A.A.]DO/L!?98LEG
MGJ/;-43VV"DO)!1O;D!+M5)(IT)57I6NG&[=>/;YC&5:.1:<O2GOTN2E0XU3
M"Y5[9N>;#>7P_@=^E)6IM(F6^$X\RI"D[2&4)VN[4=L@':*[:^&HKK:7[['>
MD%,_`W7X/:/M3<Y!Q7R':T)$S",ECOD4<[MEN`"D`D'>I3!J%;:U^[ILU(TN
M!IW%,FVE!P8:]F*+(M@O31CA=@NZ7"E*=AMTU"@LHVJ4*,C]H$'R\=)A$@G%
M`=%5PVTQ%"TT[5.3VP^V2YY+=HMZNMME-,,J#Q;E,+0`E)W#<'`D$A()^ROP
MUH[&V=*_S'-K$#3%2;3;-;]<HHSDKEL<PBUV"U,VR(TV@-(VI<IZUJ[6URKB
M4K`(2H%/0TI\136A;2,:8\&]BT44,<8TM:`$]7#-B^6Y3XV)0JK.;8RH!*4+
M#:T7-E6Y*RC<E*J$E8H"?#4>[-;63B=/M4?<-!L9@,Q&5>>/`?H&LNL*W%H[
ME4-]41@/77A@E(5M@9R*&G^_XM\2-19_>'<I=O[I[U5%-B([:%"OI50]1T"O
MA\#4:84A:*(E?50*2.E%4KU^WPTHL<!J(P15;\6*$,D'H65K6DA/BFNY*:GI
MTK]OAIUK6^56@KBN<4IK`ZX))))44LR@.I'1SY5*4CX4VZ5![I[UPIRWIS%@
MM&47AU*NQ!L+S@;005K44NK2A)4-H4XN@T^$S,2T"G-5*9!/FW:;-NSX0VN2
M^X[M*BL-I4HJ2GP-33IH3C:EH)SHD[;YA^>A1J%8N+Z(B60D`KE=T)9;0D]"
MI9-`?#KH74L>1)S3<J+:6E)^6L4<P`AH@M*F%17-4WUHH(DJ*0JE2$C0A-"A
MI:E*=VGU$]*I^(/C7QT(69X[&T;N@`-?/S3\*UT+CJ4\62*BJJJDU%?YJZZH
MC])=X,DH8+JT!M]HT6VM*D*Z]%-D*2KR/0ZZ'%IU--'+C6.=[JWIC8AW+<T-
ML*[L_F,2@HAEQ:BF;$0?`F-+W43_`$%)U8T!H3GFN(ES>653+230I-L86*'I
M4N*;4:@'<:M4_5KD[J.8YW)<1OB4M0FPU))_%+C%-WCN;4$]5;=#7U:3&:$@
MBJZ,P1G53QQWE:-FV'PVY/RZ4WRS(B):G14*M.20"@L&!=[:^I4;YD%)!;(&
MY0W-*2JJ=82[M3;R.+35E:G]NU:."2(Q`.Q>,U39[I?9<QFEVN+N"V809$CO
M26[.VHO0PX2:FR2%#>VT5TJTLU;Z)/0C41DTL3A)'CC[$B2(.'C`+*JECE#@
MO/\`C*Y/V_)<>N4!32U>J1#>:4A%:)66E)!4V1^VC<DZMF7[)'AFD`%09XB&
MD,'A2,Q1J#"C7"1.?B,[I#24%V2TV5(0WZE@%8Z!P_IKIR2CG5%*)B)I:VAS
MJMB[91C<)MU]ZX-+:;!4X8K,B9M2F@)4F*T\:`CQTAK'/]U.I"?QM8KVI]FQ
MQ[E<EH2E3BV+8^Q'2%4#:2_*2PVI2J5IX_9I]HD9B_W>]($C2[2,T7OV&]7<
MTBV%]O<H*2I]PJ*0:&A;::6*GX%6E&5C`7DX!-O9,]Y:RI:5A_N&Y+OY2FSV
M60^DK2I#<:UR)*U$*J*K2%4"O/H#33?ZA'^,^W[$CX6?\/M'VK>G\*<NJF)7
M>\(E.0426A<?D(MP8N#,4.),M;#$E"VQ(;9"MF[T@^/32([RWE>8XW$O:,<#
M]B:$;SD$P=]QI+%TN;4A]JSP(XN+MN7<0^^_<78"RG\I,F$EV`S=W-I"DDA*
M%"E#4`W,9JP'L"210T22[,E2&$L.FUL71*WVOF7"Q&4Q`>VF1\P_0RMLAHT[
M*5JK4)3T-%YBAR0E)9KW&1-M_P#$,1\QKA*AAHJ"FFS`<2ZW+N+,R0X&W]C[
M1*4!("BE210[1IJ1I$1$(H_L0K,_;Q[;.*N<H4&3A^9VB\7=^&_/>Q5U:8N5
MPH\24N%->?LKZS)>BQI+9!>9#S.TI7N"5I)HI7[A;MU3:G`FF)!^A6%NV![B
M"`<%)#)O;+C7%$"5=+O9)*+9:HSLRX7"<40;7#CL-J6](EOJ"&D,H2*E1_1Y
MZC-,]Q)I976[&E5.;%$SQM:`4P%EYU]NRW`W`R2P6T-J*4.3+1>(R#L4I)<1
M(=M24*15)HHFA%-/_`7;G5<VN/,?:F3<6KCB1J[BO>9<W80;<Y%PO/,8D7*4
MTI+$QBYQFX\%*AM[RR\ME0<J>@II_P"&?%FVE5U\T$<1:T@2'+!0>N\K*[1>
M'L@LF3#\S<[W>O5FNC9ES4/*!DIEN1GE)EQ))'K:="VU)`"DG5E'*0"Q[G:"
M*$5-#V&F?<JU[V4!CP=5*2Z\?<FV2WP^43D9L^3WZ9)OS\%A4FTW*([-=,AN
M>B3$[4:/(FA7<4VE+);*OO5Z#0;5O&\[+=#=MFN[FSO:4$L#BQ]/N@T+=30?
MNNJT9TJH5S;V]XTLNXV2,.8<`4_G&GU&.<\"D0(/(<>%R;`MR418TS)5S(F8
MP6`0"FT<AV=^)E,-2&QZ:R)""0*I\=?2/1O\UO76PF.#J**#=K-NG4YU()W&
MHU/+FM>R1Q`P$C=)/O8+S7>/E7L%^TG;/,M;AQ)))JPU[!7#L5L?"GU0N*\]
M:CV:^91^22'NRRO&^:8J9]L4X*!U,'DS&X"W6"M)HA5XM;BCXJ=\]?6G1O\`
M,#\K>N-,+[DV&[D"L5P!$*FN3Z^2ZG'0&`88%>/[U\KNH=L>7AK)[6IH8J`T
M[6UU'LH%9YAW/''KENM+DI]S$8-S.VTW9=WB7K$;F15[MP,YLLRZ6!]OMJ*D
MHFN1G4(H.VD"@]?_`$]LML;F"IA)%".-1AI&9!%*4K48CFO-Y]NNH:CQMD!-
M0_PG#^U2JDQ;;]'<A-7%$V!<[:XV9'SS;S)9<C"KBY")+1=M\II+8)W)+::=
M?#6?O[*8P/C`<'D884=CEAG51-+S$6D'66D#OH:>U=)7L,S=CDGV;^W+/(D9
M,2%E7%V/7BWL)\$VZ4RLVY1H2`IV"&UD5-"HC7Y6?.#;G;1\U>H]KD-9[?>;
MJ-^-?&V5P<*C`T-148%?<W3`C;T[8MB%&"UC%,ONBOMJI;Z\Y5ZAH0AH0AH0
MAH0AH0AH0AH0AH0AH0AH0OR.+SA:9"G1V5J2*;@EOH4D'Q34]0=:<SR!I#J`
M$<E7T)R36W#"W(Q4N,RML@*&U).T':=I4E0!)^.FMNF_X@ZB`UM:=WUI+FAP
MTN4<.5[=.1C5R#R4M".N.^E927.Z6GNK212J7'0HA)ZTU9[F]EQMKFC3YL9K
M7F#G3F4B$OBFTQ^Z:5PJHC+=*MX((K3;TI2AZUZ_9K%T*M@"<EA`)(`!/V#Q
MUQ<2RQ*W33<A<8RG&56](D-.(7M<#I6-G4=:>DUU&NBWR7"O+Z4*>N.\US(E
MM0FZLM2%MM)0E:R.\L@!"*D))"B?/[#K/RM+I*T.E=3@6SD?&KZA;OR[06T`
M7MP*U)66PI.]13M-`3]@II$K6-IH0L5XS26B,A6'X\S?K@\ZXTN5,N+$.QVH
MMI0"_<'TM]X@)(VM-)4I7Q`UR+RM7YU=-.'-";]<?-<E)7D^5[V%;DN1+)&7
M;;5'KN`3&3O5,D(254+CBZ4\AIN6Z:YQMX!V`D5[<4[I9Y>JOB3+\NWB/$MC
M&"X_;7X=I>=1*NUW>:4P+Q,C>MJ''DJ`#S$5P!Q9J4J<I3HGK>6%M'&P2.<#
M*>1%$ALCFC2*43585G>:<<7R)<L3OD^T+;,4K8COJ$&<RV\I3[=QA+"V)K:U
M'IW$J":JI35J2!G@D*8N.?4&Y?L\Z/\`FJ,8O5N2RA#]OF8\W!$<LE(28LNU
MOQ7PA](]9.^AJ0/+1XONMU'E6GM0E?=_J+<Q3)R!CN*859X3A`:2Y;)UVDFB
M"I04N;.0`VYX@A`*DFNE?%QL9Y4K7!W$`U]J4P!S@TY54TO:U[PSRS?HN!\B
MV:U6+*KF%G'[I:"ZU:[R^A`4JVR8DAYY=MGJ2"6E!:FGB-M$JVU1')'/,(HJ
MM)%:G+N[U,:P,%!DK&HL9-2WM1NH>I42:`5J#T#=*GJH^'Z=624CQB,K=Z$I
M2"GH$D^HJ4D)40D[@"?%7PT(1ZQ!0@$J2[N3V^XVVH]PE2Z%?;"P/AU^S74(
M_;A%+I*`%;$*/:119-"$(<"@L@=Q2B/$@]:TT['&'`ZJI0!*.XD1QRCWRZ>Y
M5*NJJ!2$MH#E&^J6JE)`Z^(\^ITYY+.U<HE!#@G<GQHZ[]UA5$M)4BJ]I4?6
M=QKX>73Q.NB-K349J5&Q@HX>]1*F%:^XHJ+9<VN$54D*0%)\":FH)I2J1Y]:
M==.4=F`4LQM+M7%**-:TK5N[*A7\1.[=M0$`A*=BBDII7PJ">E*Z>BB#@2^H
M*6E/;[6`SV4-!:PLJ"0A24I24@E!6`25N5Z>/7H>NG?(C[5VE<DHXT1M;V[M
MG8"F@3L2-P2JCC+BJD%%%>D`$=:]#IT`-&D9)]K`*'BE="M27>V$H4#1E6YP
M'8XVA92H!?J%3N"JFE/#06L.)`)3O8E)!MBT(<)6MEE*@$)VN-N+<>65)2C:
MOM^(!`I4]?#0&@>Z*=R[I?R->Y+6#9T$4V!3C2%J4X$I"E[4#U;O7N[@%!4=
M"/#X\\F/BQOJ4X1LID%LR,1M5Y^79NL(2F$3%SH[8ERHR53&DE2%+4S(82ZE
ML>+3@<;/]`UZ-RVL,P#7CPC@,`>]*``R3E0X"77/#\55%O.H=]3V^BBZLJ!*
M72L#<H@[JT!&E0PQP,T0C2VM<.:ZCM5E#H#J4E+C)2I-&OQ7'@%;@%;PKJ$T
M&TCQ^!)+M:>]XN_%*8T&M5NBWN2"@27`A&YU+CKS=`I!IL15:2XCM$$$@T3U
M'4==-F.+/2VO<G&N<"=/A[1FMY>-VMR1&2JVV1QQQ`;49%OB(2YW"2I$8K92
M7WU-`'H5'Q/7QTDQ1$4+6^I+)KBX`NYG-9V;*TPYL0U';V%QM0B)89:1N0=H
M*6DH-4DU`*21U\0:Z5&QL8TL%&U2"T$UI1&ZK?N;;<:88)4.TXG>MI0<"`D[
M2$4[#BDFH'J*>H&I7EQ\_:E)P>,(1_O#X\6EE'HS#'05H;Z!;=R94[O(35:D
MA--]$F@Z_957,#(XWO:75H>*9W!VO;YFN`IY15Q0\-9Q>>@`"@R52?U.6]]T
MX;5YIA9N/'R+^,?9]NHLX)>*943C'O;[N2JL?:JSU%2E0/3PZG[?'II?DL[5
M,JM5ML$[2D@4\A32RP.;I.2%M+9+?5`)"FNB>IH4^&X4H"=VF'N+/RQ[J[VK
M=@E39*Z;5!)!Z=`*)4K]=4:7![I[UPH^Y&E*8P')$@DAZ%'0JAZE*E`FI\TT
MT^D.8'X%5875\1V'5+4H-!:]PZ'S(!'@::$H"@H%CXQ95=Y-[RY;1_+<,E+C
MVI2T`-S,FEQZMJ34E*D6B*KOJZ&CJFOMT(6-^(JXO.NNE:DMJ6M:E>*EKJ5%
M1K4J4K0A)^;L8*DMI`"3MZ>%*'[?'0D2.<T5:B!UTK\30>0)I\/M^S0DO),5
M3FB\J*E5)\_(]*5_V-"::UA:23BE#;7`4*37H%&M?T?L]?LT%+@R*5"F!<K:
MY`%5RHJE3[8JH)+K;9^;B#J/[7'35/Q<0D>>I<,CGNH:4HF#FF_REU$F/9I2
M?26TRH[B2?)#C4AM('E^]6>NG+NI#.=%Q'&*.`R82P/N/M*`/3U)54>%?'28
M01&:YKK<".]2HL5B3:<0LUL2X)26H:U(<*.V%!^2_*2DH"E;%-!_;T5XIKTU
M1RT$CV/`H:9^E6;'N96BQ6B^OMWF+;)RUNNU??MUP(2IZ.J$RI]Q$M2AL]+"
M#1P@A8&Q8-:FDG@#&DM!S5@R1L@#7D`44J8/&O!ON-L@P7E#$K+)OKC*T0E2
M&Q'<F;4JK(Q^Y)4)4*X-CU*C[S7Q1W$U"8VBG,%<?&'5`Q:57GS+]#JSW"\/
MW'CK++4FSOK6M-MR&V=J\PJGHTFX0DIBW%E(Z!2D-+^-?'7#J!J"4P8&#FF`
M1]%^3:G/^5KDZ]M-%?(06T-FA\4K=6M6T^733AGF/&G<N>2SM2WM'TGL"A*8
M_,8=TE+0L;ZN-M(/4D^EF.GQ/Z_MT@R2.%'.-$XV&)WA<*!2`Q7Z=O%UD6@H
MQ*$MP#[TIA4@U3^THNU3_)I'BKF:(\B-LH`K2JD39/:=BMEBT@X_`9V^H(:B
M--)H0#0!`!(ZUZ>>BF*>>P!WAQ"Y>?JE<K^Y*%[A^0/;W9%W+"L'L-]QS&L2
MQ["UF*,R;ELV^]VC(<DN/R[=R7<KPY+24QD*$-+3*6TA9+BUZFPAMV1#RZ&0
MYY$JKO+B7S-(`#`<#3ZU2]DEJ18+S=K4B\,Y-;;4\%W"\6^+,9M\R^JBI^=B
MQX5V5`D.+@7)QV*^\ILC<VI83M4D&>01F"`J\DDU14EQ21*`>:CKEPWQ=IC3
M;,N.F#-0U(B6:&RS$DHA/+6R6R=Y()2*-A"J\7%[><[KBDNI2P]<WK>AR(L-
MON0K"RCUE-TNLJ:_!=71M2@M#@0/O*`26R(1WB&29%BN2VS)N.KW=<4R)/YK
M;[2_:[O=8;T"U28:[;=RY?D.0TLPYL<J[E%N,):60LIV@:2YC7BCL0C'@:*=
MK'U&N2\LX!SOV[\X1(&<V>^\8S,>Q_/YK8&<1LPM^01+E:)\^\LJ>C9+:FX;
M"HKI6@RMK+*PY4N;H[+.&.;SVUUX\<,5,BNI`/+---"%'SBKVQ\W\T-7-KB/
MC2Z<GSK%;(%ZO5JQ";9[G?[5:+N4FWW&981<FKPB`\^YV>\&"A,A*FE$.#;I
M4UU%`?S*@<^'K4.-LLU0UKB['($X<\%\ROVR\^X*EPYK[?.6\?;;J5KN.!9"
M&*)/WN^S;G6"D?'?0:7#N5H!5U*'++ZTIMO*W[K_`$@_8E9[:>!6N3\XN+C^
M./)7@C,&\R,?N[2[5-N\N1(=1"88C31&,UJ&]&4Z^S4%0"4T4"1IW]1L^0]B
M`UQP`)]"E1S'`G**[?=XLB&N-1#L68PY'D)'J*BIEY*%``]`14:E.D9+;ZV4
MTD8+E"#3BH3\AO63$[=)+B(ZKK>4F-:XK_;+)V$=V:\%H=;;:BH54*4G:72D
M'I745<((S4>&G7;<-EUA7-MEU"W;=>8[2%)=V@KV.H2]\I)2GP+C#R%)\2DZ
MX33B`?1]82FO+#5M-7/B.Y2:XAY]S'$YJ9G'MWS3`G+-Q^ZB-:</4[ET;+L^
MM;"D-77)+'?KA\M`M>3M/K$_Y)I[Y5M`++)"G`/1^C?FQ\PNA96,Z<W.X9::
MOX$CS)"[L<)"2`?ZKF@<**CW3IC9]YB(W"WC<,RZE'\O">>-<BK'N/??YR6J
M#RW9)F.(RVT8CQP[?<SY'X'F3,4M]LLESMT.T/W6^XGD3,6USF(5[R!FWS'$
M6]J5'DMK<;!;3OU]:=&?SH[';2VS>O=N,=Z)6EKX298W/C/F:7-<=3`[330Q
MTA(-*T.'E&Z_*2&"Y9^D7(($C7%CQJ-*AQ&O`5T\?0OT;OHR3'KA]*7V`3Y!
M*GYOM>XLE.DDJ.]^P,.D554G;NI^K7PYU#O%QU%U#N'4%T29KZ_N+@DYTFF?
M(VO;I<*]J]MAC9#"R*,:6-:`!RH%9GJH3B&A"&A"&A"&A"&A"&A"&A"&A"&A
M"&A"_+1-K9=!/:!14*H$I`4H&H)K]X5_5K5W3-<#@HT&9[D2S<1C2DK/8'B=
MQ">I)Z"I^ROE751;BA:.Q$D5*OJFDS7BBVW.#(AR8;+J'Z=U"DCHA*MP)%*"
MM!TKTU'W261D8:TT;5=@8`3)7/!0OS/@W'K47G$PNS51JIM13V:^!0FBJI`\
MJFNLZ^:9I'B4V.317!1VO>$+L;I"HSAB$E34T-+4A2=U$AP@40NAZBO2FI$=
MX7&FGAS3GD5QJBQI#T9EQ,1_Y4J*5*="*`)3N3ZZ56E`[@-16A`KTZZX7-+R
MYPJ.22^'0W56J5MFM#+_`,N]=;X_-*@'/E(BE)0IP`[>[(4I04/4>B?'PU"N
MKD,<8VMHTMY\TQFG5C.)BL*3;8*R@T0MIELK4I"RI24N.%6Y1)2?O':/YM5*
M$?1,A@8W9W9V079NW075JD(AN.HWO[BA*T(CH)D2GT52G8T@U'V:=9;74SPR
M-E:H2.L'N0LL',(,RX8P[=,3M\E"G+>ZXJ/+NJ$+2HEZA+46,0C]WZU4(KUZ
M"^M-LCM'ZKANI_$9?:@I\^0/<AP'SI?G&KS@CW&5@BQ:6F!8VE75$=;3':03
M(=V+*G$I)<6M1`4KTMZERPQ/=6$:&TRSQY\$)EOX*X>OP=D6/D:U6H(2HMQ;
MRU*;DN(*RE#'="4H2XVGJ*`?'4:2*?"AU^RB$C7^/L9AEIT9IC*I#87'<CK,
MQ<EUM*J%QO9&6P@E!]/J!.EB9]-+6U<.U"T'Y%2;?9&X;DA"0W(N;2>XXZA"
M6QO+CQ*(D=`2:J6`>M!4]-,2%U2]PH[DI$464E5.WV,<3.7'EW'<GNS,HP[!
M-_,&)YC.@S;W%9=>@0H@>*'?E4*3W'GEI`[>T!("AKML_P`V5@RT.KWUP4E7
MPPVV^Z$AQ+E1Z]NU!!W%6X';MJ!4!-"?C0ZT*XE&PTV7&DEDK<2"H*4G;T-2
M"JH=H-R.BB.OV:$)418B`6SU!":!M:DJ0H`I)%0DJ"*KZDCJ#72F>^.]"/X<
M9871II'11)!0HALFE:>+:@DD=4TJ#0ZFIYDF@4HE*Q#;<HWZ*J2$J*"G>5*)
M&VE2E%.M"?CX:Y5<8S7A6B4<2%O6$HJ%!:=OI6$J`'1M:>FYPA0I0T%/L.A/
M-BT.U52K@P?2"VMM!23N43U36NV@.WJNAZ_'RKJ;!_#"?1_&@E(55S<A*PHJ
M[90E2BH=6]J=NX%`"NH3YFA-2ZA*.#$=I6K9VJ05]G:IQ"5*)3W`ENJ'.J:4
MZ4'B?'0I#6:4JXUM!4%*1N!(0K]TEDI`205$BA2"H;:`J)!Z].@EI70HCJ@I
M:VG`4J0VP0YZ76`&UI=4A2T[RK<KHJOAUI31C3#-2(HM0#ZY%*J/;ZI[GRH0
M=KPW*25]VF];04C:#M6M0ZUW(^W7&F3_`&C=*EI50(H0@,K6\K8K8XKJI2BI
M!*BR4^E'0=$I2-P\^NGG/U"BXE+"C)0X@$ETN$H5N:;"32K:'*I`_&4IJH"1
M3;]OBVNI66JUORI"8D>,MQU]SM):<+49*B%(I]\MLQV@JM%`H"C^U2FDN=HJ
MY^$=,#S/)+#:BM:)0?*/(<V!M+;B`H!+P`75#BFEI:7%*D**6PHIVDI6:$&A
MIH!U,:_F$L-TKW'A+1N"^J9#OI55QI?8;7^&IQ!(>;=<W@5*=BJ=//0E([8M
MZTAQI;8D("DKCH?:WML+;[B"K<4*<;<>0"$4VE`)'GU$+=;MP84A&]QK<I"5
M`!QQX`*;00XXX7]RJD#R`IY=-.LCUBM:(HMA<=LJ=22H*;<51:AN1N)0!VU5
M"5!*U;2145\ZU&DOCT411+GC5G;GN#K7U>3E=@<!:2`TE+LI(JTIQI`6%)6*
MJ10[3U`TQ>1Z;1[ZY-JH>X_^'S?[LJU\>`_0/\&LFL$WW1W*I?ZFW^<N'NG_
M`*Q9J*_^]\9T)Z.31A3-5;*;;*2$J*C5.T$*)\:GKTKX:XI2^MQ%+'6E?$#K
M6GZ!X4T(6\_';#&T`DA:22`04@@IJH]:@E6H<WOE*&2U66RA8;4=H6M32CT/
MI+:P".IZU&G8/=/>N%;?):"YB=YA4`5)A`,]>I[3.\#_`&Q*?UZ?7%4MFDF1
M\DZS&.T(#RG5E([@*4JH$#=\1\:Z$)YL>L+V)</8K:)@[,R9&DWN<V0$O+FW
M9_YI2G@""5AA2$=:D)2!H0DU\L(]EDS"D[G7$I155-HJ=Q":5Z@:$)L9[W18
M/[0)K6NY74^0Z5IH2'OT"N:3:UE?4^'D/A_Z%-""/,9RJ@JFT$(H*@;JUKT\
M*>.NJ,]NAU%OP7]AV[>@(\_-04/AYG0NL?HKAFE;#DJ8<9?;<*%(4EQ)%:I<
M2KI0T/A3QT_![_H2,S5)?DMINWF!)8`1%NCC\UA*4^AEW:PW,8(\4]MY51Y;
M%)U+>-9:<M*$,1*JV\K5M4MT.=*'TMC<2?@*D#XZZNC,=ZFQC\ABX6-IMM04
MF(AI@I``4G?&9DMD]32J7Z?JUFMP_P"8/>IZ32(!3E%J4D%25LWQ(JG=4&R7
M!6VA2`?N:06ZV`574DK;R)+QK);Q;[N_(<L[607),68DK^=LQC7%WY<M+:*7
ME0F*`I"?Q&2`4$@4%;/#I<YU5-M[CW8:>FJLOX:]R$"["#C7(5PC?UA+#5BS
M<NMF#<$.4$:/?WTU:8<<J`B:#VW#^_VJ]:HHQ-%,>S5CV*7<RQH6`E24J%*@
ME(4%I("DE*@D@I-:@@D$:<D9Y=,<U&!JDE-QN,E2E?+-@=178#]TG=^P=,%O
M%%$2N6:(T3M9HK::$I`K4>'44TH"@HA%JXB4;AVT@`TKZ33K0=`="<8_2*45
M?/OM]AG$WN^P*_(NN)V=GER#9'V\"SY$B58KE;[M$2IZU0;S=K2!*GV1+_I"
M'DO?+%>]K9Z@IV*=]N\2,S4>ZMO,:T:J8\EQC\[^W7DO@G++/Q9[C\"R"!9,
M7@S(UF3;;9:XMXD1E+;$"[V_((L9JW\CXU;$)6IMEEYM^KI+PW)`&HM=U@N(
MQYHQPKCQ]2J)81'7&M"HOYGPO*M=M.5X;<XV:82Z\AU=PM'>+<*2@GMP<GM-
M&YECG-#H6Y#:`NGI*D^-B^&-[M41HPA,)G6U-KW1GW?RUV>^^[=WGU-1K48[
M9;?A18_9C2)B'$O-J^-`4T#8W$QY(_+(%:U0MOY67),,MVT)>N[,EJP6ZXMO
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M>O:%G&+0I;#L"'RGAS`5V(&3-)1D<%D))'Y7DL-+;W>0D&A5L4H_>5IZWOWP
MAK'?PA@D.L8GN+_OG&JY=/<1CUX@\N9E`FV*]6:'`NKT2PVFYJ#C\&Q(=*+<
MTMW[BT.I)6I[KW%D]200+]CVR,#V&K2J*;^(1R7SC.%?;5.9>CLVF3:I!#4Z
MS7*5/7#<;<(0J<(K4)^.J5"!WIH@J6`4D*!H%BV^(XTIV<TTGRY!X@OV#,6_
M*;KQLQ<,:N;[4^T<D\)W=25,J6VER,Y<;+/@!#;R4FH0EF'ZP:*"P0(&F5[B
MPN;0<\`I;F2.:`\:6\UAMT[BG-G&CD-_CR9CT1VW7FYWK\VP?)+IM6VXVS<+
MY;5S\<NA6&PEWYUU]14E*Q2FP."30T0N:QS6NU#C1U*:FGAAAZUP6\9&7CYK
M]83Z0UOM=I^F#[$[;9#)-HA>VGC&/;?G+A;[M*^3;L+`8#USM26[;<%ANGXS
M*4MN>(`K34ECM30Y1WMTN+58UI22AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OR
M[FVSO(%5!0^/7PZU-.E1YZT#B6O,;LPFF/:[!J-FD()75=$I:JBM05$4*N@!
M!%1_)J--(QK".7)3K6%U':J'5B.Y)Z:VF6M>]DH%2FJ2/NU-3U56A-/(>&JJ
M9WFDTKEQ3,A:7'3DFOR7C*'D+3P[KC3KI&TIH$HJ#X@T`-:=>O74#X=_8D)C
M+SP%D;8>;CB-/C."A9D462DJ\"%>A77P!&H)C>W+'N7=1YE0%Y`P+D+#)LYV
MY8O<X$02I"FEHB.OP/E2XI2$KDLI6EML-I'BI)'2G74Z"XMZ-@<1YO(YU3@C
M>YM>!390LQ,1:BFW1W'ZK]*KA*0T"JH!"$`*!Z^9U(=8,N/S=-1V4X)+F.::
M46^YG65RZ!B2Q;6$=I/]0C)6XE**;"E^2MY7<J/$`=?TZ8-C;M]\:>])H_D5
MHI97/+DF[JOEPGK=4XJ1\\TD%DI)5Z'K=(6A1-#0*"?LU)#X8\2]K1E7).^2
M_L03CUTD2`F#!NCR$D]E#4/YM[U`$!PM1`ESJ/Z(Z>'GI+KFWKC(T]M2?J1Y
M#^Q'D/`N0'7DN,8CD,A:B.VB-C=P="VU`J55MN,!W"?#SUSXFV_O&^W[$"%X
M/!.39>#>6+RMI$7CSD"4AVAV1<)FMIW]=J%N28*FR4U^T5U'GN8*"CQQRJI0
M:.2?C&/9)S-D[P".-;M9^X$!<O-LAB0$);/0*5'8?@%*:IIM$9Q7D`=(C?.7
M5@8YSZ>SF@AM,@IB\8?3H<@)C2,_S6!!CMJ#CUJPV&N0\NA!2V+W=$,,15$]
M%*;BK7X47YZ>%C<SO\R8!H.8)Q1EDK,.->,<,XWM\>U8G:&84>,@M=]YWYV<
M\MQ16XN1.6I3A6XOJX:@K)J?LL[:V9;L+0!4FJ$]46.2L!;+1(!(`*@*DG:$
MUJ``$D^-1^O4E"/XT8"B-A0D(]2BK84J*NOXB0G<D#P`ZT\=.Q>_CR74I8[2
M7$TWIV-+V.*I4J6E!`J$A(W)*:$4'0CIJ30+H!<:#-*2"C</0FBR*4!2G[H4
MH.4J003U'C4>5-%<5*C9I!U4JE-!9;)W[4-ET(5OJ"2I?K.W:W3<2.GQZ]-3
M6/9)@!EV)V@2C::6`MWMN/IH"H)]040HI`/J"TR4[B4';U344%00YI;R"$J(
M:6PRV_'[:O6A/=JL[A0!2EU:!;HD4H!M"SX]-=R74JV8^]"D!3/5QHI)2V2E
M56QM/I2IU0/@D[:D^(KH2FL+LDHK='4I9[C;:-K8W-@[%*3N`2YNWIV)HCHJ
MA`'2GGI\TD%&9A2DJH493H0V#L3^R%.;@TDMJ+2G-C@#C832B0JI'EI#HW-%
M32BY1*R*V[V4*5W$I""ES>`X3U#>](0''5E5?2!15/$?!`J3@GHVN(U@^$%+
M"%&<4-J3V#N[30VI6EQ"T!22I"UE:B=U20:T3UKJ2QA;[V*DM>U_NI316$U6
MM&Y1;6VI31^8+27$I0S1*2EG\)/;%>I2M9/2HUUQ:T5(2D?1D.K>0TA5$IW(
M?#(2:*!*E!=`0VV6SU%#]GAIBFIV'%=2B1&2?6I#@*6T);;2$EM39V[31=$.
M*%2*'=0=?A3CFT\+L5VO)*>)\NMAM3GK2&JH6A3J_0XFB4)6BJP$JH=W4`[:
MGK72#[$XSBCF*MN.XEIT;BM*G&1Z5&J2A&]+5.VVK<M*-U0DGK2IZ]:TN-`E
MD@"I2M8CM!KTN+DASM%NB2@J=0*.)ZI*>H434';7IY:7Y+^Q=&(JM$1$+F3G
M`IM+;!&Y4CM-+?<:2*=DH*E.*!4?O!*?21UIU>C:6MH5W(+"AIUJ0D/*2IA;
M*UEPJ#3Q*5H6VI2DT00I3U/*@%3][HO/-):X.R2WX^;/\=845EPH1D]C)]1<
M0I:[@S12700"$[:5'0@TI343<,+&7^RHNX_^'S?[LJT8>`_0/\&L8L"WW1W*
MI3ZG*]MRX<`!J8>;U-.E`_C'G\:Z$H9JK="D]%A)`"A7U'>?/[WA3]6N*<C-
M#BU%#B&]QIT"5#U5\CX$GKH0O:V)"Z[DJ0E0VK"33I]HJ2.NHTL9)+^"4"M(
M.!*HP5][YEE2C3RJ4GJ3_2.E09'O7"BCD2^.(BRV5?B-L%`"@.M$M)24BOD5
M:?7%6ME*8[LZZLEE"$NN/+:*>JFW%FH(!J"$*\!TI30A+FVY^SGEE$6YI9AW
MVQ-HB36$*"6I<?TI8N$9!!*&W-A2I%3VU#QH1H0D_DUP1\LS#CJ`;;I5(/11
M(ZD#S\?YM"$V,U'I(!``0I2B?&OC0&E/`:$4KFB+_9'\^A","R&X]:U5M)/4
M%-2#]FA)<!I/<BY"MJ@?MZ_H_P#1:ZH25$1P;0D*)%*CKY&G4GX]=%2,D+=R
M"VIRK&9-N2$BYVQS\SM*ZT4XII(^>A>)JF7%!('^^-IU/C_AA=27L2]EQ@MH
M55#*2T0*A)*D56NG0[B>GZM.C`@]JZ,QWJ6O&TU#S-V8'0--V@+/[/<3'E,)
M%?V2M+(`KX[?CJEOG-=<&@R4]+JUM(<R6RA0"B'+RA)57H#CUW/3]%-0U)E'
MY8HHV<@6\M9'E*T)51.27NG4`4$QP]`?,%6H\K#4N^ZHV6(2/QO.9^)N)C.I
M<G6-Y:C)MM078ZED]R3;PHA*'*FJVR0AS_)5ZM-BWBD;K=[RD12AHHXG-65>
MWWW7G%HUMLV2S)63<=/[6H%P;*I%ZQ1(VH+;+:MSTRUL*Z.0ET>8\6C_`+FJ
M$TF/^(#BK![1)300K,H-QM&06N)>['<(5XL]S9$B#<8+Z9$26RL_?:<1X%)!
M"DFBT*!2H`@C3Y+6MU$8*('U<64.'J1%<+>*A3:0`4E-.I430GKY#].HCR'.
M)&2<"23T1P%70"I-=W552?)(Z"GZ=(744.QU'<2:BA/J'4].H)%/'0C/-,=S
M5P-Q=SSA\_".6<+LV88[."BB/<XX,JW2"*-W"RW-LIN%FN3*J%#S"T*!\:CI
MI30RM'5#>SFDF..0:9/=7,;[NOI"\Q\!7>Y<I^UJ[7W-<58;D/3K+'CQY>>V
M>V`EQVW7RQK;_*>3\>0V#N'93,V@E3:CU-K8[K+`ZDONJNN+0M<7Q?PP/3VJ
MF?+,;XHS.)=%Y@S#X3SZW,3WY,Q$.Y2N+LIEPVWGY,%MA$=^]X'DKW9*40)#
M;L9;Q"4+;J$ZT\%PVYIJ+:D8=R@8\5&S+..<VP6SLWO-+!.L<6_6^W/8P<B8
M6\ZJTW%"Y+3\=T3%-V^7,C.(6VPA+CIWD*4V008YC=H\S#231(<\,Q*326TA
MM$F2Q-7:K':&Y-IB7:3'L#KDJ2I"VY<2(TE#TYAUYI:OPBE*EH];JU)(5T0O
M(!-!7*O%=!J*C)9[;9)N2=NSVFW_`,5Y+D#?SLQR'"N5RN5AM4=I#KO8`6PT
MOMLA2W-@:)4G8"I*AI)8X.T'-=2AM+$2=>[DW=K/>,UQBUP$6;Y9QQC'KI;)
M1+*GY5O@1T**IT9"2I*5MA`W'>EQ5=SS:0X28U]*Y0'-+?BSD"\\,<J8WG7"
MO*V:XEE=A9NAQ=^W2W8-ZLL::VAFZ6JY.=L09,2X,@MOPGV%,2$I_$;(VZ9\
MIMSX)22T8IR.62%P='Z5?!Q/]9OE&[8VY8.5^$[?RK>H$-R7)S'`I$S&UR+5
M&VM29V38S&L616YGL%7XLJ*8D<J4`64$]:^?889'.>PG43EP5HW=':_'_#[%
M&CWIW_V^>[_B^/RMQ)=X'&O,>!MS9E[P_*7$QF,PP]QI4RZVVP7J`R]:KE=K
M1.83)B)=^6=<0IULM`K2==M;:\L)/+:POM^8Q`KGGR2+KX6ZC\QATR#T9=RJ
MOQ#+<1MK;`N-T#<AL!#JD0)I274[0MQ`2T1VU*2?`'5OY\8R!]2JU/WVO\I8
M?EF8V_B*W9HI,[/7';?8;;=+++NN.3+PW&DRORJZVF<VPA$>Z-L*"'X[S+K;
MP3][?TA;I%`]HD@.-14>A6EI<,\P!]3A3TIS^>_9=?##>FQL%3;9+0<[5]Q%
M:I;(2LK4IKO*;1+?MSG57R5S9DA'@W)1XZH3=.BD\EP\`-%-N+)L@<Z,TE(J
M.`_:B_2!^D19)&-_3#]BM@ET^9L_MKXRMS](RX8+L6PL-*/RKBE+CU*?N$G;
MX5U=P_P@J![2QQ:[,*QC3J2AH0AH0AH0AH0AH0AH0AH0AH0AH0AH0OR^$IHJ
MJ24?TD&BB0/#KY5Z:T!\3M9]XJ%XV8Y(T178V*G[IJ%(`*DJK2BOZ(H::;=%
M&X'4%.BFE#00>")G8Z^^X0E)`J=J_#QJ""#6M1JED:8W$.PI]"YVKUVE@**A
MUZ$)H%*.[SINH!6OV]*Z9\V/F$+9;C]S:5FH-*F@(4.J=E`:&A^.E-8UIJT(
M64VZ,_1+[3;Z:!!0\TVZ"%^D@[DDD#270Q/KJ:*GU^M+$CP*`X)'W3ASBZ^N
MN+NO'N(W)TU'S#^/VTO.'H3N=$8+5UK]M/LT@VT1:6BHKVG[4L7$S10'V#[%
MH1_;APHP]W6N-<1;4E(3_F"W%!(ZU""QL^RM#^K345C%'755U>9/VKOQ,_XO
M8/L3CV7B[C^Q.-OV7"<5MKS*1VI$6Q6E$D]"5T<^6#R$@'IM(TZ+:`?='IJ?
MI2/-DYIQXD2.TH=EAI"PT`"B.TFJ2$]`MO80$A72OA]NG0QC10-;0=@1YK^:
M/FTN-GN)*JI2JI[I)4"D!8232AIUZ=>GVZ[1O)OJ'V(\V3FE)%9?=`4T5K0T
MEM14G<H>H`BFVH!W&I!\M.,:370UOJ'V(\V3FE+'BNE))<2>B5*IMW="?Q$'
MHI!\*]:5^%=.QL>'U<*#U?0I37AV`/B1O&CH2&QL#G<)6'4IW$=*E:Q1)W4-
M.O44U)`H*)25L:*$A'0@+)#R&2.VNJ2$*W=0T"`">H%1TK72@USA4#!"4T)!
M0&P$!9W[@/5T;3X&H42#M%"?.OZM*CT8ZT)11T!:5`(`--NQPD+4FM4GQJ0H
M5\Q0GKJ0UK!XFA=2E80-K>QH]G;522>AVK2DH"U#:I1*>A-#\?'3@!)H,UT&
MAJ,TI8C16!N2$+))*44*$%/6GJ*=_P!T]$]"#\-/QQ"GC&*5YLE<TJ(;1*NB
MU`(_%2*_C.+4E23L2NH`(Z]*;2*=:Z?:QK<6BA4Y*J(RT@LN.G<X:)2:]5`D
M44$M!+@W;=NX@_#2P"309H1Y!94M]Q3-`PXIXE+22C:Z5)"E,NC>@(=!(='W
ME;=PHJM5%CQB0NC/')*N(RZ075=H*J"4,A2G:@CMH2OU,-J<0E217P^RI.N-
M:YWNA/@L&24UL8)(4A@,*>**H<=<6X'"$)4DD+<W`()!W'U$$^%#IR'WCW)P
M):0XH_\`6A*0@J%206W%*&T)!(].U0/50!Z^!H-2"`10Y(2AA1'`=B$AJBE(
M#0Z%*=I"=X"J-E2E=#T&WJ*TII.AHR"<:]P\-?"E5'C!;E"&%2$)WM)6Z'`%
M)*U/5#B2X4#8@A037RTI26:/N9(_AL.+<[BEA*QZB\X7`VEM#W9V.CHM14A7
M2H%:CK322`<"EI2)0RB4PX70I-03N4I*0E8(#BP%^H$"B4U\/CK@:T&H&*$>
M0_Q/P$O;5T!*&TI4MI-$&O=!0M"DJ7N4`G[M!H<T'&F*$<0'%,JW(7VBA3I2
MTXW53C(3M#RD-*[OI50J5]TU-4TU&+'\DZQP&:5=G4MQZ,H/EQ*O4MBK3;:U
M+&Y)"]Y)<]1]`)"@37KTTXP:#5V"ZTAQH<0E0AY*DLE37RT5QP=YUXN,K;6W
MW0-[;2DA`4D>HE5#T!%55'=3M6H_PUTN#11N:U)3+3KKR5M,;'WEH7^&`X5$
M!(="B$@]0HD4J=WGI\@C--:W\UZ9B?+[:/\`92X'5]0G>$)4K:I*FF_6KK4*
MH*;J#PUQ<#BW)+/C^,\WG&%@[`EO)[,I*C^(J4#-;;6M+J:*/HV'<4@DD@GQ
M`A[C_P`C+_943<)'_`RBN;59Z/#6-6+I3`*IWZF+8<N7#H*=W]3S;_\`38R?
MYJ:$#-5B1X;I)+;2=H^]U!Z>)K4&GQUP*1))EH*/H\1PI*$N`4\!2@`(J0%`
MUZZ[1->8_FM><VMMRGK*0C>$TZ]*U->@4?LUPBHH<D_&\$`$^))5]'K"Z%($
MR,=JO(*DM_$]!ZJ_#26M#11J>3?\BRRMNYLI``4V^H$'J7&U5`\.I"1_-I2X
MJ^+T[WKA(65;B5J!\NH403T`\="$@&7?R[++;(2YVF9;CD-U0\VY:2T@$`!*
MMCY21^C0A+%]Y;KB]X4"E=#N-:E(V].G2A!T(1-/_H^2DU/ZJ]-"$05H0/C_
M`#4'\]="$;;280('0(-3^HZ%QWNGN10>G73\7EX^8H*,X4C;5)5UW5'@*IH!
MM\/,^>B)K7/(.(0E;9RXJ0VZV0@I6%$5!)V$=`#XUKJ8``*#)=20BH1"RVX1
M0*M,RGUMC?X)-7$CP\D*\/"FE"E17*JZ,QWJ2/#CG<9R=PC>%/0&E)50A2$)
MG*"2*TH-]1\#]NJ>^9IEU`8'BIX3M60J&66!'J4@R;L`Z>O[S'+SZ'/)*P2*
M'H%^76HU!2RYQ%#DF=SQA*\ARX4!"<FO:?`$A7S"5E()\#ZAH(!%#DDJ.UYB
MEA\G:0DDG<34`*)-#3P_PZ``T4&2%&/CSW(JL>8YC9VYCLF/8<BN%KO=OF("
M#%1&E*8:EN);3_6;,XF@;F-`OPE'8\E3?73,\'Q%`32B>MW"(FAI56D\)^Y6
M_P"*!FY83?):[!*DQI&18BY)97'?[FWOK;2\S*CP9\B.FC4QA.QT!)5O`HFG
MN8KAS=#7E@:X8TS`X9<5<02P5_,:)&EN66/`X4R5T''7(>%\J8PSD6'W/Y^(
MG8S<H<I247BRSU)*EV^\Q0HJCR*UV+%67DC<TI2>NI+(VN8"0HKHGZCI!T^S
MUI3R8#2QZ0E(K6H3X$GX[@34=-!9$W`CZ4GRY.7T)+R(@%4E%%(J2"*'P\*$
M]-(F8UH%`NB-_+Z$4.PQU)0#NZA)'CU^T^6F$%CFBIR1++@(4%(<;J2.BNB3
MNH:>KJ00/,:X144.2ZQA=0T\*J\]Y?TP>#_=)&NN0LVZ-Q[RA(86!G&/6^,8
MUZ<"*(CYK8`EN'D459H%/41,0.J7"133T<TT1!C<11-SV+9W`B@H.Q<M/N!]
MHO-_L\S6QP^8\"')'&%D_.H.*6^ZW6]W+C"2U>PVW.NF#7KN*3AF6]EE/98G
MM*["B:((-=75EN3KAC8I#32:FN&"I[BU<&CP$8]JA%G]ZQK)I4_D#,\EF7S+
M9K%RM$'C2_6O(G9/'M@L[(MF)(;R2$W9K1=+G;[3#96PM@&$@T"F2-VKHRB2
M9KG&K&"C3R%.Q1::?#R2:3>;W>X,+([]-<_/(;91%NEL?6QE%IM4%AE<%R:^
MVPS;;G&#-4*9:4I3>SU,T.[3A=`7:B1J0DQ/RF?E+Z8]OC6Z3=XY;;5FT%,R
MU*1%HI2VY+#=$2WP*`(JIJIJ$IIT1+^8068@(1*&K=C35W,^!?94M^'2W7ZW
MW)AEYVZ*>;<0;BIZ-(2F"IP44ST40*A1\"U22+Q950EYBG*G)'&EYE9+CV7W
MBYYS?[3%F1;EAF3WB([;F6%1WWHN10;>RTBZ6EL1DJDQ'DK8?<:"E5`"E+9*
M[4-9\*$\7(',UESU_&I<>VXG;^3%PE7/+LMP5J=8;?E'X+3:!=L5^5C8_!R)
MF2779<B`&V)B5I!CL=L)+Y=$XYX]Y11.I[8)7L@N.67.%[RN.<YGV2_RX!MG
M(/%^1W2S(Q4MH=9N*LBQ"R%MR[P);A0X9$(+ELJ2K\!T$;:^^BDJWR'%@QK3
MCESJI5O':/J;E[FD94X\UT/^UWZ;'TH^0LSQGDGVW9WEN3Y7@%\MF76:)`Y9
MO$L]ZV&'-BW!5AO=H@W2[6`&4VV^XTGLA:BRM855.J=\&X6[M5RUP8<C@0:Y
M954J.QA<X2VUQJH<@.'+)6@Y3[<(R&GGK8PE32`0&PHDE)KT(!W?I!J-,NA#
MSYCAB3FKYK7/\31P^I=*/M"M1L?M@X*LY;#)MO&V-0^TD!*4=B"A&T)2$@`4
M^`U?,`:P`9463N`6SN!SJI&Z4F4-"$-"$-"$-"$-"$-"$-"$-"$-"$-"%^7V
MC[Q\/NCQ\?%?\WP^W5^%'G]T=Z,VOW?G]U'_`+M][[/Z/Z]"<9[@[EK/>?A^
M\/W_`+_BO^;X:I[_`/B._L_4G%C'@]]WP;_]6>'_`+C\/UZI5Q;`_=H\/']G
M])\/MU9\%U;3?W5?^K4_[;P1X?9_CT(1JW^Z7X?M?>_<_O$^/VZ$(P:^ZC][
M^Q^\\/V?O_Y7^.NA"-6O_"_>_M_[;_<_L_H_9H0MMC[W[7[L?=\?%OQ^SX?Y
M.A"5MI_M#?[C]\Q^_P#W?WE_>^W0A*AG[J_WWBK_`-5?>7X?\'_1^S;J3;\?
M0A&$;_WG]QSQ_P#5GE]G^/4DIZ'W_0E%$^ZG[OWT?NOWG[P^'_`_^ZZXI24<
M/[SGA]T>'W/V/Y_CJ3%[A[UT)5QOWC/W_!/[KP_9^]_DZC+B4?\`XO\`=_>C
M[O[_`,5?^A_M=36^Z.Y=1W$_>)\?O/?>_L_W5?S_`.+3L?OCO0<DH;?^X=_V
MA^]]S[X_L_V_X]34D9I90OO.>/[L_O/O?=/[S[?Z7ZM=5FE*QX_[E_96/#[O
MWO+_`('_`'O_`"JZ<B_B!"/+?]R3^_\`[0?[-]W]VC[_`-G^*FI+_</<NI3P
M_%W]]XQ_WG]D_>K\/_*/C]FFH?=*X,TL;7_:/]T^_P#_`$%O[OV_T/LKKD/O
M'N4P)26S]\K^T_NG/O?NOWJ/W/\`P/Q_RJZD(2SA_P!G'WO]P^_X?VEW]U_P
M?P^VNA"5$3^UI^_]QWQ_>?V3_=/M^'^537"I,&1[T<V[]S#^Y^Q]S^U_O$_O
M?\G^E_EZXGT?I_=0_']Z/W'W/OG]]_Y-_P"[;M"$J$>"OWG[L_N?'[K/[K_%
M_D;M=0C*+_9%?NOOK\/'[B/WG_`?[Y^O7$)86;]ZWX>#GW/W7BG][]O]'[*Z
M:F]STI<?O>A*AK]P/W?]E<\/W7WSX?\`D_\`2_\`"TG_`&'[<UQ_O%%4'[KO
M[_S\?O>"_N?\%\/^#IJ4[)O]E)6DO[L#]U]QKQ\/WG^Y?XO^$TA"<+`O^T'"
MOWG_`$AM'W?W7^<6O[3_`)/^]_Y=-0MQ_P"1E_LJ'N'_`"4G]E6?#_9_PZQR
MQQ57WU$?\[<3?]&_[%F'_2'_`-6X_P#V/[?]\_\`!T+BKQA^"_\`L]^X?N?N
M_/\`>?9H0C"-^\_^9_X'[OW?#_!\-"%BNG[M'_9Y^\'C][[I\?\`)^/V:$IG
MO#O24G_=<_[-?WD#[_[S^T,_=_R?AKBF\.*:3-OW[_\`V7_O)7]J\?%?_J7Q
MT(4&KQ_G.9_V*?OE^/\`MC_/H0FUR7[T3_L0_?,>'WOWZ/W?^5\/\JFA"<JZ
M?OS_`-B7[U?A][[JOWG^7\?MT(1!-^XG_L/\?V_'P/\`ZC\="$G%_OS_`-B'
MWC_M/#R_]#QUQ=1\G^PG_L1_5]WP'\VNI+O=/<B5?WC_`-AOWO+P\?+_`-#Q
MUU05F9\/_F'_`'O+[W[/\VGH/?\`0A*NP?VUO_L7\%_=_P`?VZFKJ3ES_P"F
M%S_[#OWKOW?O?V1/WO\`+UP+K?>'>G]X=_L%]_['_P!]$_L?W/NO??\`\OX?
M9JMW#[GI4\)T4?VM/_9C]Y']A_M?[U/]G_X?^A_E4U7+J;O,_P#/N6_]D/\`
MTIO']I_?>+'[_P#X;^G]NA"8R_\`[MW_`+$O!/WO'R^[_E:%PJ"EP_Z17G_N
ML?\`2&Z?YG_SG_:WO\\_^7_^-:$>M/#[?O[;;O\`L;_>7O\`S%_8?OJ_=_\`
MQ/?T?^&TN7^']S,)$7\0^_Q5MGLV_P"V!W_HE_T>N/\`T,_L7B/^F'_OJ_\`
M%O\`RS;J`_WN'H6A9_X:?XWNGNS5K2_NG_HQXC[_`(>(TIGN_=].:IO\]$T[
M]XO_`*)?^%][[H^]KC./N^E=_P#C$0O>/_L(?>/C^CR^S2__`(M+9[WW\D4.
M?_<;_P"]-'_Q:'^]]Y%C_C_[`WCY_=\O'[==_P#BT@?^L41?=Q_V(<D_]V3_
M`#!)_P"VK_H!^[<_SQ_E_P"\?\+358__`-7FI=][C?XF?WLLOI7#/FG_`$O<
M_P"YY]]?^;_\U_>=_L__`)+_`$?\C6DM?^6C_LC]@J"3WSWIC<A_S9<?^Z'_
M`&H?V/\`S=^]_P!T_P""^'^5I](2OQO_`#-!_P"YM^Y;_P`W>'@/WW_E/]+[
M=2K?(H1F_P#N'O\`N>_=/]J_LWE^^_R==N/='>NK'P1_VFR/^[#_`)DN_P#V
M??YQ_L<W]Q_Y!\?LU$7$W.'_`.?KQ_W1_P"TH_>?YY_M_P#N_P!G^_\`^572
MF>\.]">_E?\`SID7_=+_`,SVO^P?NO[*?[-_P_\`O_V4T_<YCTH4MO8]_P!J
M/$?_`$D_['>>?^[?_P!,O\RV[_H;_P#$K_SO]GR^F!_X?Q_B<?=R/M_>K+9N
M/O\`'W>]=P.&_P#0_&O\V_\`1NS?],?^EG^;6/\`I1_[_/\`QO\`X;=JKFXY
M9CNS"N7>\?XO[<U=WP1_V.<;_P!D_P"B=J_L']B_<#^R?^3_`-'[-6+?='<L
EU/\`QG9Y\<T[.NIE#0A#0A#0A#0A#0A#0A#0A#0A#0A#0A?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>5
<FILENAME>v220305_ex1-1.htm
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">PLACEMENT AGENCY AGREEMENT</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 180pt"></font><font style="DISPLAY: inline; FONT-WEIGHT: bold">___</font>__, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ladenburg Thalmann &amp; Co., Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4400 Biscayne Blvd</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14th Floor</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Miami, Florida 33137</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ladies and Gentlemen:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Introduction</font>.&#160;&#160;Subject to the terms and conditions herein (this &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Agreement</font>&#8221;), Bioanalytical Systems, Inc., an Indiana corporation (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>&#8221;), hereby agrees to sell up to an aggregate of $5,000,000 of registered securities (the &#8220;Securities&#8221;) of the Company, including, but not limited to, series A convertible preferred shares (the &#8220;Shares&#8221;), convertible into common shares, no par value per share (the "<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock</font>&#8221;), and common share purchase warrants (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrants</font>&#8221; and, together with the Shares, and the shares of Common Stock underlying the Shares and Warrants, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities</font>&#8221;) directly to various investors (each, an &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Investor</font>&#8221; and, collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Investors</font>&#8221;) through Ladenburg Thalmann &amp; Co., Inc., as placement agent (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Ladenburg</font>&#8221; or the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Placement Agent</font>&#8221;).&#160;&#160;&#160;The Placement Agent may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Offering (as defined below).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company hereby confirms its agreement with the Placement Agent as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="DISPLAY: inline; FONT-WEIGHT: bold">Agreement to Act as Placement Agent</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the basis of the representations, warranties and agreements of the Company herein contained, and subject to all the terms and conditions of this Agreement, the Placement Agent shall be the exclusive Placement Agent in connection with the offering and sale by the Company of the Securities pursuant to the Company's Registration Statement (as defined below), with the terms of such offering (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Offering</font>&#8221;) to be subject to market conditions and negotiations between the Company, the Placement Agent and the prospective Investors.&#160;&#160;The Placement Agent will act on a reasonable best efforts basis and the Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion thereof, in the prospective Offering.&#160;&#160;Under no circumstances will the Placement Agent or any of its &#8220;Affiliates&#8221; (as defined below) be obligated to underwrite or purchase any of the Shares for its own account or otherwise provide any financing.&#160;&#160;The Placement Agent shall act solely as the Company&#8217;s agent and not as principal.&#160;&#160;The Placement Agent shall have no authority to bind the Company with respect to any prospective offer to purchase Shares and the Company shall have the sole right to accept offers to purchase Shares and may reject any such offer, in whole or in part.&#160;&#160;Subject to the terms and conditions hereof, payment of the purchase price for, and delivery of, the Securities shall be made at one or more closings (each a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing</font>&#8221; and the date on which each Closing occurs, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing Date</font>&#8221;).&#160;&#160;As compensation for services rendered, on each Closing Date, the Company shall pay to the Placement Agent the fees and expenses set forth below:</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A cash fee equal to 8.25% of the gross proceeds received by the Company from the sale of the Securities at the Closing.<a name="Page2"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company also agrees to reimburse Ladenburg&#8217;s expenses equal to 1.2% of the aggregate gross proceeds raised in the Offering, but in no event more than $60,000 with the Company&#8217;s consent (provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions of this Agreement).&#160;&#160;Such reimbursement shall be payable immediately upon (but only in the event of) a Closing of the Offering.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The term of the Placement Agent's exclusive engagement will be until the earlier of (i) 12 months from the date hereof or (ii) completion of the Offering (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exclusive Term</font>&#8221;);&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">however</font>, that a party hereto may terminate the engagement with respect to itself at any time upon 10 days written notice to the other parties.&#160;&#160;&#160;Notwithstanding anything to the contrary contained herein, the provisions concerning confidentiality, indemnification and contribution contained herein and the Company&#8217;s obligations contained in the indemnification provisions will survive any expiration or termination of this Agreement, and the Company&#8217;s obligation to pay fees actually earned and payable and to reimburse expenses actually incurred and reimbursable pursuant to Section 1 hereof and which are permitted to be reimbursed under FINRA Rule 5110(f)(2)(D), will survive any expiration or termination of this Agreement.&#160;&#160;Nothing in this Agreement shall be construed to limit the ability of the Placement Agent or its Affiliates to pursue, investigate, analyze, invest in, or engage in investment banking, financial advisory or any other business relationship with Persons (as defined below) other than the Company. As used herein (i) &#8220;Persons&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind and (ii) &#8220;Affiliate&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If during the Exclusive Term, or within twelve months after the date of termination or expiration of this Agreement, securities are sold by the Company to investors identified to the Company or contacted by Ladenburg on behalf of the Company, then the Company shall pay to Ladenburg, at the time of each such sale, the fees set forth in this Section 1 with respect to any such sale.&#160;&#160;Upon termination of this Agreement and at the request of the Company, Ladenburg will provide the Company with a list of investors identified and/or contacted by Ladenburg in its capacity as placement agent hereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Representations, Warranties and Covenants of the Company</font>.&#160;&#160;The Company hereby represents, warrants and covenants to the Placement Agent as of the date hereof, and as of each Closing Date, as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Law Filings</font>.&#160;&#160;The Company has filed with the Securities and Exchange Commission (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Commission</font>&#8221;) a registration statement on Form S-1 (Registration File No. 333-172508) under the Securities Act and the rules and regulations (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rules and Regulations</font>&#8221;) of the Commission promulgated thereunder.&#160;&#160;At the time of such filing, the Company met the requirements of Form S-1 under the Securities Act.&#160;&#160;The Company will file with the Commission pursuant to Rules 430A and 424(b) under the Securities Act, a final prospectus included in such registration statement relating to the offering of the Shares and the plan of distribution thereof and has advised the Placement Agent of all further information (financial and other) with respect to the Company required to be set forth therein. Such registration statement, including the exhibits thereto, as amended at the date of this Agreement, is hereinafter called the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement</font>&#8221;; such prospectus in the form in which it appears in the Registration Statement is hereinafter called the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Base Prospectus</font>&#8221;; and the amended or supplemented form of prospectus, in the form in which it will be filed with the Commission pursuant to Rules 430A and 424(b) (including the Base Prospectus as so amended or supplemented) is hereinafter called the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prospectus Supplement</font>.&#8221;&#160;&#160;All references in this Agreement to financial statements and schedules and other information that is &#8220;contained,&#8221; &#8220;included,&#8221; &#8220;described,&#8221; &#8220;referenced,&#8221; &#8220;set forth&#8221; or &#8220;stated&#8221; in the Registration Statement, the Base Prospectus or the Prospectus Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is or is deemed to be incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus Supplement, as the case may be.&#160;&#160;Following FINRA approval of the compensation arrangements set forth in Section 1, the Company has no reason to believe that the Registration Statement will not be declared effective by the Commission.<a name="Page3"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Assurances</font>.&#160;&#160;The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required by the Securities Act.&#160;&#160;Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.&#160;&#160;The Base Prospectus, and the Prospectus Supplement, each as of its respective date, comply in all material respects with the Securities Act and the applicable Rules and Regulations.&#160;&#160;Each of the Base Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.&#160;&#160;No post-effective amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission.&#160;&#160;There are no documents required to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period.&#160;&#160;There are no contracts or other documents required to be described in the Base Prospectus, or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, that have not been described or filed as required.&#160;&#160;The Company is eligible to use free writing prospectuses in connection with the Offering pursuant to Rules 164 and 433 under the Securities Act.&#160;&#160;Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable Rules and Regulations.&#160;&#160;Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or behalf of or used by the Company complies or will comply in all material respects with the requirements of the Securities Act and the applicable Rules and Regulations.&#160;&#160;The Company will not, without the prior consent of the Placement Agent, prepare, use or refer to, any free writing prospectus.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Offering Materials</font>.&#160;&#160;The Company has delivered, or will as promptly as practicable deliver, to the Placement Agent complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration Statement (without exhibits), the Base Prospectus, and the Prospectus Supplement, as amended or supplemented, in such quantities and at such places as the Placement Agent reasonably requests.&#160;&#160;Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Shares other than the Base Prospectus, the Prospectus Supplement, the Registration Statement, and any other materials permitted by the Securities Act.<a name="Page4"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsidiaries</font>.&#160;&#160;All of the direct and indirect subsidiaries of the Company (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsidiaries</font>&#8221;) are set forth in the exhibits to the Registration Statement.&#160;&#160;Except as described in the Base Prospectus and Prospectus Supplement, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any liens, charges, security interests, encumbrances, rights of first refusal, preemptive rights or other restrictions (collectively, &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Liens</font>&#8221;), and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Organization and Qualification</font>.&#160;&#160;The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing (where applicable) under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.&#160;&#160;Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.&#160;&#160;Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of this Agreement or any other agreement entered into between the Company and the Investors, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under this Agreement or the transactions contemplated under the Prospectus Supplement (any of (i), (ii) or (iii), a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Adverse Effect</font>&#8221;) and no action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Proceeding</font>&#8221;) has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Authorization; Enforcement</font>.&#160;&#160;The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and the Prospectus Supplement and otherwise to carry out its obligations hereunder and thereunder.&#160;&#160;The execution and delivery of each of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby and under the Prospectus Supplement have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Company&#8217;s Board of Directors (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Board of Directors</font>&#8221;) or the Company&#8217;s shareholders in connection therewith other than in connection with the Required Approvals (as defined below).&#160;&#160;This Agreement has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.<a name="Page5"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Conflicts</font>.&#160;&#160;The execution, delivery and performance by the Company of this Agreement and the transactions contemplated pursuant to the Prospectus Supplement, the issuance and sale of the Securities and the consummation by the Company of the transactions contemplated hereby and thereby to which it is a party do not and will not (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not reasonably be expected to result in a Material Adverse Effect.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Filings, Consents and Approvals</font>.&#160;&#160;The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of this Agreement and the transactions contemplated pursuant to the Prospectus Supplement, other than: (i) the filing with the Commission of the Prospectus Supplement, (ii) application(s) to the NASDAQ Capital Market (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Trading Market</font>&#8221;) for the listing of the Securities for trading thereon in the time and manner required thereby and (iii) such filings as are required to be made under applicable state securities laws (collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Required Approvals</font>&#8221;).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuance of the Securities; Registration</font>.&#160;&#160;The Securities are duly authorized and, when issued and paid for in accordance with the Prospectus Supplement, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.&#160;&#160;The shares underlying the Warrants (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant Shares</font>&#8221;), when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.&#160;&#160;The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to the Prospectus Supplement.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page6"><!--EFPlaceholder--></a>(j)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Capitalization</font>.&#160;&#160;The capitalization of the Company is as set forth in the Prospectus Supplement.&#160;&#160;The Company has not issued any capital stock since its most recently filed periodic report under the Securities Exchange Act of 1934, as amended (the "<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange Act</font>"), other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time any Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock Equivalents</font>&#8221;) outstanding as of the date of the most recently filed periodic report under the Exchange Act.&#160;&#160;No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by this Agreement and the transactions contemplated pursuant to the Prospectus Supplement.&#160;&#160;Except as a result of the purchase and sale of the Securities and except for stock options issued pursuant to the Company's stock option plans, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents.&#160;&#160;The issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Investors) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital stock of the Company are validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.&#160;&#160;No further approval or authorization of any shareholder, the Board of Directors or others is required for the issuance and sale of the Securities.&#160;&#160;There are no shareholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s shareholders.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">SEC Reports; Financial Statements</font>.&#160;&#160;The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">SEC Reports</font>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.&#160;&#160;As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.&#160;&#160;Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">GAAP</font>&#8221;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page7"><!--EFPlaceholder--></a>(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Changes; Undisclosed Events, Liabilities or Developments</font>.&#160;&#160;Since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans.&#160;&#160;The Company does not have pending before the Commission any request for confidential treatment of information.&#160;&#160;Except for the issuance of the Securities contemplated by the Prospectus Supplement or disclosed in the Prospectus Supplement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective business, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Litigation</font>.&#160;&#160;There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Action</font>&#8221;) which (i) adversely affects or challenges the legality, validity or enforceability of any of this Agreement and the transactions contemplated pursuant to the Prospectus Supplement or the Securities or (ii) could, if there were an unfavorable decision, reasonably be expected to result in a Material Adverse Effect.&#160;&#160;Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.&#160;&#160;There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company.&#160;&#160;The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Labor Relations</font>.&#160;&#160;No material labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect.&#160;&#160;None of the Company&#8217;s or its Subsidiaries&#8217; employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good.&#160;&#160;No executive officer, to the knowledge of the Company, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters.&#160;&#160;The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page8"><!--EFPlaceholder--></a>(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compliance</font>.&#160;&#160;Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or governmental body or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not reasonably be expected to result in a Material Adverse Effect.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulatory Permits</font>.&#160;&#160;The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Permits</font>&#8221;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Title to Assets</font>.&#160;&#160;The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for Liens disclosed in the Prospectus Supplement, Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties.&#160;&#160;Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(r)&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Patents and Trademarks</font>.&#160;&#160;The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or material for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Intellectual Property Rights</font>&#8221;).&#160;&#160;None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.&#160;&#160;Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a notice (written or otherwise) of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have a Material Adverse Effect.&#160;&#160;To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.&#160;&#160;The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page9"><!--EFPlaceholder--></a>(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Insurance</font>.&#160;&#160;The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage.&#160;&#160;Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(t)&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transactions With Affiliates and Employees</font>.&#160;&#160;Except as set forth in the SEC Reports, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Sarbanes-Oxley; Internal Accounting Controls</font>.&#160;&#160;The Company is in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of each Closing Date.&#160;&#160;The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company has established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms.&#160;&#160;The Company&#8217;s certifying officers have evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by the Company&#8217;s most recently filed periodic report under the Exchange Act (such date, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Evaluation Date</font>&#8221;).&#160;&#160;The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.&#160;&#160;Since the Evaluation Date, there have been no changes in the Company&#8217;s internal control over financial reporting (as such term is defined in the Exchange Act) that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Certain Fees</font>.&#160;&#160;Except as set forth in the Prospectus Supplement, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by this Agreement and the transactions contemplated pursuant to the Prospectus Supplement.&#160;&#160;The Investors shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by this Agreement and the transactions contemplated pursuant to the Prospectus Supplement.<a name="Page10"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Investment Company</font>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.&#160;&#160;The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company Act of 1940, as amended.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Rights</font>.&#160;&#160;No Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Listing and Maintenance Requirements</font>.&#160;&#160;The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.&#160;&#160;The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance in all material respects with all such listing and maintenance requirements.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Application of Takeover Protections</font>.&#160;&#160;The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Investors as a result of the Investors and the Company fulfilling their obligations or exercising their rights under this Agreement and the transactions contemplated pursuant to the Prospectus Supplement, including without limitation as a result of the Company&#8217;s issuance of the Securities and the Investors&#8217; ownership of the Securities.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disclosure</font>.&#160;&#160;Except with respect to the material terms and conditions of the transactions contemplated by this Agreement and the transactions contemplated pursuant to the Prospectus Supplement, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Investors or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement or any free writing prospectus.&#160;&#160;&#160;The Company understands and confirms that the Investors will rely on the foregoing representation in effecting transactions in securities of the Company.&#160;&#160;All of the disclosure furnished by or on behalf of the Company to the Investors regarding the Company, its business and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.&#160;&#160;The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.<a name="Page11"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Integrated Offering</font>.&#160;&#160;Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Solvency</font>.&#160;&#160;Based on the consolidated financial condition of the Company as of each Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&#8217;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid.&#160;&#160;The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).&#160;&#160;The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from each Closing Date.&#160;&#160;The Base Prospectus sets forth as of December 31, 2010 all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.&#160;&#160;For the purposes of this Agreement, &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Indebtedness</font>&#8221; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#8217;s balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.&#160;&#160;Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Tax Status</font>.&#160;&#160;Except for matters that would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, the Company and each Subsidiary (i) has made or filed all United States federal and state income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.&#160;&#160;There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Foreign Corrupt Practices</font>.&#160;&#160;Neither the Company, nor to the knowledge of the Company, any agent or other person acting on behalf of the Company, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.<a name="Page12"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Accountants</font>.&#160;&#160;The Company&#8217;s accounting firm is set forth in the Base Prospectus.&#160;&#160;To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&#8217;s Annual Report for the year ending September 30, 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulation M Compliance</font>.&#160; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&#8217;s placement agent in connection with the placement of the Securities.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Office of Foreign Assets Control</font>.&#160;&#160;Neither the Company nor, to the Company's knowledge, any director, officer, agent, employee or affiliate of the Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">OFAC</font>&#8221;).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">U.S. Real Property Holding Corporation</font>.&#160;&#160;The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Investor&#8217;s request.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Bank Holding Company Act</font>.&#160;&#160;Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">BHCA</font>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Federal Reserve</font>&#8221;).&#160;&#160;Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.&#160;&#160;Neither the Company nor any of its Subsidiaries exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Money Laundering</font>.&#160;&#160;The operations of the Company are and have been conducted at all times in compliance in all material respects with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Money Laundering Laws</font>&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Certificates</font>.&#160;&#160;Any certificate signed by an officer of the Company and delivered to the&#160;Placement Agent or to counsel for the&#160;Placement Agent shall be deemed to be a representation and warranty by the Company to&#160;the Placement Agent as to the matters set forth therein.<a name="Page13"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(mm)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Reliance</font>.&#160;&#160;The Company acknowledges that the&#160;Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations and warranties and hereby consents to such reliance.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(nn)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forward-Looking Statements</font>.&#160;&#160;&#160;No forward-looking statements (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in either the Registration Statement, the Base Prospectus or the Prospectus Supplement has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(oo)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Statistical or Market-Related Data</font>.&#160;&#160;Any statistical, industry-related and market-related data included or incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus Supplement, are based on or derived from sources that the Company reasonably and in good faith believes to be reliable and accurate, and such data agree with the sources from which they are derived.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(pp)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FINRA Affiliations</font>.&#160;&#160;Except as set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 2(pp)</font>, there are no affiliations with any FINRA member firm among the Company&#8217;s officers, directors or, to the knowledge of the Company, except as set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 2.pp</font>, any five percent (5%) or greater shareholder of the Company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(qq)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Incorporation by Reference</font>.&#160;&#160;No documents are incorporated reference in the Base Prospectus or the Prospectus Supplement pursuant to Item 12 of Form S-1 which were filed under the Securities Exchange Act of 1934, as amended (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange Act</font>&#8221;).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Delivery and Payment</font>.&#160;&#160;Each Closing shall occur at the offices of the Placement Agent (or at such other place as shall be agreed upon by the Placement Agent and the Company).&#160;&#160;Subject to the terms and conditions hereof, at each Closing payment of the purchase price for the Securities sold on such Closing Date shall be made by Federal Funds wire transfer, against delivery of such Securities, and such Securities shall be registered in such name or names and shall be in such denominations, as the Placement Agent may request at least one business day before the time of purchase (as defined below).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Deliveries of the documents with respect to the purchase of the Securities, if any, shall be made at the offices of Placement Agent.&#160;&#160;&#160;All actions taken at a Closing shall be deemed to have occurred simultaneously.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Covenants and Agreements of the Company</font>.&#160;&#160;The Company further covenants and agrees with the Placement Agent as follows:</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page14"><!--EFPlaceholder--></a>(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement Matters</font>.&#160;&#160;The Company will advise the Placement Agent promptly after it receives notice thereof of the time when any amendment to the Registration Statement has been filed or becomes effective or any supplement to any Prospectus Supplement or any amended Prospectus Supplement has been filed and will furnish the Placement Agent with copies thereof.&#160;&#160;The Company will file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange Act subsequent to the date of any Prospectus Supplement and for so long as the delivery of a prospectus is required in connection with the Offering.&#160;&#160;The Company will advise the Placement Agent, promptly after it receives notice thereof (i) of any request by the Commission to amend the Registration Statement or to amend or supplement any Prospectus Supplement or for additional information, and (ii) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or any order preventing or suspending the use of the Base Prospectus or any Prospectus Supplement or any amendment or supplement thereto or any post-effective amendment to the Registration Statement, of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, of the institution or threatened institution of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration Statement or a Prospectus Supplement or for additional information. The Company shall use its best efforts to prevent the issuance of any such stop order or prevention or suspension of such use.&#160; If the Commission shall enter any such stop order or order or notice of prevention or suspension at any time, the Company will use its best efforts to obtain the lifting of such order at the earliest possible moment, or will file a new registration statement and use its best efforts to have such new registration statement declared effective as soon as practicable.&#160; Additionally, the Company agrees that it shall comply with the provisions of Rules&#160;424(b), 430A, 430B and 430C, as applicable, under the Securities Act, including with respect to the timely filing of documents thereunder, and will use its reasonable efforts to confirm that any filings made by the Company under such Rule&#160;424(b)&#160;are received in a timely manner by the Commission.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Blue Sky Compliance</font>.&#160;&#160;The Company will cooperate with the Placement Agent and the Investors in endeavoring to qualify the Securities for sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agent and the Investors may reasonably request and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose, provided the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction where it is not now so qualified or required to file such a consent, and provided further that the Company shall not be required to produce any new disclosure document other than a Prospectus Supplement.&#160;&#160;The Company will, from time to time, prepare and file such statements, reports and other documents as are or may be required to continue such qualifications in effect for so long a period as the Placement Agent may reasonably request for distribution of the Securities.&#160;&#160;The Company will advise the Placement Agent promptly of the suspension of the qualification or registration of (or any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Amendments and Supplements to a Prospectus Supplement and Other Matters</font>.&#160;&#160;The Company will comply with the Securities Act and the Exchange Act, and the rules and regulations of the Commission thereunder, so as to permit the completion of the distribution of the Securities as contemplated in this Agreement and any Prospectus Supplement.&#160;&#160;If during the period in which a prospectus is required by law to be delivered in connection with the distribution of Securities contemplated by any Prospectus Supplement (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prospectus Delivery Period</font>&#8221;), any event shall occur as a result of which, in the judgment of the Company or in the opinion of the Placement Agent or counsel for the Placement Agent, it becomes necessary to amend or supplement any Prospectus Supplement in order to make the statements therein, in the light of the circumstances under which they were made, as the case may be, not misleading, or if it is necessary at any time to amend or supplement any Prospectus Supplement to comply with any law, the Company will promptly prepare and file with the Commission, and furnish at its own expense to the Placement Agent and to dealers, an appropriate amendment to the Registration Statement or supplement to the Registration Statement or any Prospectus Supplement that is necessary in order to make the statements in any Prospectus Supplement as so amended or supplemented, in the light of the circumstances under which they were made, as the case may be, not misleading, or so that the Registration Statement or any Prospectus Supplement, as so amended or supplemented, will comply with law.&#160;&#160;Before amending the Registration Statement or supplementing any Prospectus Supplement in connection with the Offering, the Company will furnish the Placement Agent with a copy of such proposed amendment or supplement and will not file any such amendment or supplement to which the Placement Agent reasonably objects.<a name="Page15"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Copies of any Amendments and Supplements to a Prospectus Supplement</font>.&#160;&#160;The Company will furnish the Placement Agent, without charge, during the period beginning on the date hereof and ending on the later of the last Closing Date of the Offering, as many copies of any Prospectus Supplement and any amendments and supplements thereto as the Placement Agent may reasonably request.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Free Writing Prospectus</font>.&#160;&#160;The Company covenants that it will not, unless it obtains the prior written consent of the Placement Agent, make any offer relating to the Securities that would constitute a Company Free Writing Prospectus or that would otherwise constitute a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">free writing prospectus</font>&#8221; (as defined in Rule 405 of the Securities Act) required to be filed by the Company with the Commission or retained by the Company under Rule 433 of the Securities Act.&#160;&#160;In the event that the Placement Agent expressly consents in writing to any such free writing prospectus (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Permitted Free Writing Prospectus</font>&#8221;), the Company covenants that it shall (i) treat each Permitted Free Writing Prospectus as an Company Free Writing Prospectus, and (ii) comply with the requirements of Rule 164 and 433 of the Securities Act applicable to such Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transfer Agent</font>.&#160;&#160;The Company will maintain, at its expense, a registrar and transfer agent for the Common Stock.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Earnings Statement</font>.&#160;&#160;As soon as practicable and in accordance with applicable requirements under the Securities Act, but in any event not later than 18 months after the last Closing Date, the Company will make generally available to its security holders and to the Placement Agent an earnings statement, covering a period of at least 12 consecutive months beginning after the last Closing Date, that satisfies the provisions of Section 11(a) and Rule 158 under the Securities Act.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Periodic Reporting Obligations</font>.&#160;&#160;During the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission and the Trading Market all reports and documents required to be filed under the Exchange Act within the time periods and in the manner required by the Exchange Act.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Additional Documents</font><font style="DISPLAY: inline; FONT-STYLE: italic">.</font>&#160;&#160;The Company will enter into any subscription, purchase or other customary agreements as the Placement Agent or the Investors deem necessary or appropriate to consummate the Offering, all of which will be in form and substance reasonably acceptable to the Company, the Placement Agent and the Investors.&#160;&#160;The Company agrees that the Placement Agent may rely upon, and each is a third party beneficiary of, the representations and warranties, and applicable covenants, set forth in any such purchase, subscription or other agreement with Investors in the Offering.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Manipulation of Price</font><font style="DISPLAY: inline; FONT-STYLE: italic">.&#160; </font>The Company will not take, directly or indirectly, any action designed to cause or result in, or that has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any securities of the Company.<a name="Page16"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Acknowledgment</font>.&#160;&#160;The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board of Directors of the Company and may not be used, reproduced, disseminated, quoted or referred to, without the Placement Agent's prior written consent.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Conditions of the Obligations of the Placement Agent</font>.&#160;&#160;The obligations of the Placement Agent hereunder shall be subject to the accuracy of the representations and warranties on the part of the Company set forth in Section 2 hereof, in each case as of the date hereof and as of each Closing Date as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder on and as of such dates, and to each of the following additional conditions:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Accountants&#8217; Comfort Letter</font>.&#160;&#160;On the date hereof, the Placement Agent shall have received, and the Company shall have caused to be delivered to the Placement Agent, a letter from Crowe Horwath LLP (the independent registered public accounting firm of the Company), addressed to the Placement Agent, dated as of the date hereof, in form and substance satisfactory to the Placement Agent.&#160;&#160;The letter shall not disclose any change in the condition (financial or other), earnings, operations, business or prospects of the Company from that set forth in the Base Prospectus or the applicable Prospectus Supplement, which, in the Placement Agent's sole judgment, is material and adverse and that makes it, in the Placement Agent's sole judgment, impracticable or inadvisable to proceed with the Offering of the Securities as contemplated by such Prospectus Supplement.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compliance with Registration Requirements; No Stop Order; No Objection from the FINRA.</font>&#160;&#160;Each Prospectus Supplement (in accordance with Rule 424(b)) and &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">free writing prospectus</font>&#8221; (as defined in Rule 405 of the Securities Act), if any, shall have been duly filed with the Commission, as appropriate; no stop order suspending the effectiveness of the Registration Statement or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no order preventing or suspending the use of any Prospectus Supplement shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission; no order having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company shall have been issued by any securities commission, securities regulatory authority or stock exchange and no proceedings for that purpose shall have been instituted or shall be pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory authority or stock exchange; all requests for additional information on the part of the Commission shall have been complied with; and the FINRA shall have raised no objection to the fairness and reasonableness of the placement terms and arrangements.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Corporate Proceedings</font>.&#160;&#160;All corporate proceedings and other legal matters in connection with this Agreement, the Registration Statement and each Prospectus Supplement, and the registration, sale and delivery of the Securities, shall have been completed or resolved in a manner reasonably satisfactory to the Placement Agent's counsel, and such counsel shall have been furnished with such papers and information as it may reasonably have requested to enable such counsel to pass upon the matters referred to in this Section&#160;5.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Material Adverse Change</font>.&#160;&#160;Subsequent to the execution and delivery of this Agreement and prior to each Closing Date, in the Placement Agent's sole judgment after consultation with the Company, there shall not have occurred any Material Adverse Effect.<a name="Page17"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Opinion of Counsel for the Company</font>.&#160;&#160;The Placement Agent shall have received on each Closing Date the favorable opinion of legal counsel to the Company, dated as of such Closing Date, including, without limitation, a negative assurance letter, addressed to the Placement Agent in form and substance satisfactory to the Placement Agent.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Officers&#8217; Certificate</font>.&#160;&#160;The Placement Agent shall have received on each Closing Date a certificate of the Company, dated as of such Closing Date, signed by the Chief Executive Officer and Chief Financial Officer of the Company, to the effect that, and the Placement Agent shall be satisfied that, the signers of such certificate have reviewed the Registration Statement, the Base Prospectus, any Prospectus Supplement, and this Agreement and to the further effect that:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The representations and warranties of the Company in this Agreement are true and correct, as if made on and as of such Closing Date, and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to such Closing Date;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No stop order suspending the effectiveness of the Registration Statement or the use of the Base Prospectus or any Prospectus Supplement has been issued and no proceedings for that purpose have been instituted or are pending or, to the Company&#8217;s knowledge, threatened under the Securities Act; no order having the effect of ceasing or suspending the distribution of the Securities or any other securities of the Company has been issued by any securities commission, securities regulatory authority or stock exchange in the United States and no proceedings for that purpose have been instituted or are pending or, to the knowledge of the Company, contemplated by any securities commission, securities regulatory authority or stock exchange in the United States;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;When the Registration Statement became effective, at the time of sale, and at all times subsequent thereto up to the delivery of such certificate, the Registration Statement, when it became effective, contained all material information required to be included therein by the Securities Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and in all material respects conformed to the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder, as the case may be, and the Registration Statement, did not and does not include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading (provided, however, that the preceding representations and warranties contained in this paragraph (iii) shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by the Placement Agent expressly for use therein) and, since the effective date of the Registration Statement, there has occurred no event required by the Securities Act and the rules and regulations of the Commission thereunder to be set forth in the Registration Statement which has not been so set forth; and</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent to the respective dates as of which information is given in the Registration Statement and any Prospectus Supplement, there has not been:&#160;&#160;(a) any Material Adverse Effect; (b) any transaction that is material to the Company and the Subsidiaries taken as a whole, except transactions entered into in the ordinary course of business; (c) any obligation, direct or contingent, that is material to the Company and the Subsidiaries taken as a whole, incurred by the Company or any Subsidiary, except obligations incurred in the ordinary course of business; (d) any material change in the capital stock (except changes thereto resulting from the exercise of outstanding stock options or warrants) or outstanding indebtedness of the Company or any Subsidiary; (e) any dividend or distribution of any kind declared, paid or made on the capital stock of the Company; or (f) any loss or damage (whether or not insured) to the property of the Company or any Subsidiary which has been sustained or will have been sustained which has a Material Adverse Effect.<a name="Page18"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Bring-down Comfort Letter</font><font style="DISPLAY: inline; FONT-STYLE: italic">.&#160; </font>On each Closing Date, the&#160;Placement Agent shall have received from Crow Horwath LLP, or such other independent&#160;registered public accounting firm of the Company, a letter dated as of such Closing Date, in form and substance satisfactory to the&#160;Placement Agent, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection&#160;(a)&#160;of this Section&#160;5, except that the specified date referred to therein for the carrying out of procedures shall be no more than three business days prior to&#160;such Closing Date.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Exchange Listing</font>.&#160;&#160;The Common Stock shall be registered under the Exchange Act and shall be listed on the principal Trading Market, and the Company shall not have taken any action designed to terminate, or likely to have the effect of terminating,&#160;the registration of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the principal Trading Market, nor shall the Company have received any information suggesting that the Commission or the principal Trading Market is contemplating terminating such registration or listing.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Additional Documents</font>.&#160;&#160;On or before each Closing Date, the Placement Agent and counsel for the Placement Agent shall have received such information and documents as they may reasonably require for the purposes of enabling them to pass upon the issuance and sale of the Securities as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein contained.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If any condition specified in this Section 5 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement Agent by notice to the Company at any time on or prior to a Closing Date, which termination shall be without liability on the part of any party to any other party, except that Section 6 (Payment of Expenses), Section 7 (Indemnification and Contribution) and Section 8 (Representations and Indemnities to Survive Delivery) shall at all times be effective and shall survive such termination.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Payment of Expenses</font>.&#160;&#160;The Company agrees to pay all costs, fees and expenses incurred by the Company in connection with the performance of its obligations hereunder and in connection with the transactions contemplated hereby, including, without limitation:&#160;&#160;(i) all expenses incident to the issuance, delivery and qualification of the Securities (including all printing and engraving costs); (ii) all fees and expenses of the registrar and transfer agent of the Common Stock; (iii) all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of the Securities; (iv)&#160;all fees and expenses of the Company&#8217;s counsel, independent public or certified public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Base Prospectus and each Prospectus Supplement, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&#8217; fees and expenses incurred by the Company or the Placement Agent in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Securities for offer and sale under the state securities or blue sky laws or the securities laws of any other country, and, if requested by the Placement Agent, preparing and printing a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Blue Sky Survey</font>,&#8221; an &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">International Blue Sky Survey</font>&#8221; or other memorandum, and any supplements thereto, advising the Placement Agent of such qualifications, registrations and exemptions; (vii) if applicable, the filing fees incident to the review and approval by the FINRA of the Placement Agent's participation in the offering and distribution of the Securities; (viii) the fees and expenses associated with including the Securities on the Trading Market; (ix) all costs and expenses incident to the travel and accommodation of the Company&#8217;s and the Placement Agent's employees on the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">roadshow</font>,&#8221; if any; <font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">however</font>, that the Placement Agent shall only be reimbursed for any such costs and expenses of the Company&#8217;s and Placement Agent&#8217;s employees on the &#8220;roadshow&#8221; that do not exceed the $60,000 expense allowance available to the Placement Agent pursuant to Section 1(a)(iv)of this Agreement; and (x) all other fees, costs and expenses referred to in Part II of the Registration Statement.<a name="Page19"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Indemnification and Contribution</font>.&#160;&#160;The Company agrees to indemnify the Placement Agent in accordance with the provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule A</font> hereto, which is incorporated by reference herein and made a part hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Representations and Indemnities to Survive Delivery</font>.&#160;&#160;The respective indemnities, agreements, representations, warranties and other statements of the Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent, the Company, or any of its or their partners, officers or directors or any controlling person, as the case may be, and will survive delivery of and payment for the Securities sold hereunder and any termination of this Agreement.&#160;&#160;A successor to a Placement Agent, or to the Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution and reimbursement agreements contained in this Agreement.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Notices</font>.&#160;&#160;All communications hereunder shall be in writing and shall be mailed, hand delivered or telecopied and confirmed to the parties hereto as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If to the Placement Agent to the address set forth above, attn: General Counsel, Facsimile: 305.572.4220.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">With a copy to:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Weinstein Smith LLP</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">420 Lexington Avenue</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">New York, New York 10170</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile: (201) 401-4741</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:&#160;&#160;Joseph Smith</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If to the Company:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701 Kent Avenue</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West Lafayette, IN 47906</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile: _______________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:&#160;&#160;_______________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">With a copy to:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ice Miller LLP</font><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">One American Square</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite 2900</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indianapolis, IN&#160;&#160;46282</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile: (317) 592-4666</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Attention:&#160;&#160;Stephen J. Hackman</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Any party hereto may change the address for receipt of communications by giving written notice to the others.<a name="Page21"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Successors</font>.&#160;&#160;This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and directors and controlling persons referred to in Section 7 hereof, and to their respective successors, and personal representative, and no other person will have any right or obligation hereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Partial Unenforceability</font>.&#160;&#160;The invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other section, paragraph or provision hereof.&#160;&#160;If any Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Governing Law Provisions</font>.&#160;&#160;This Agreement shall be deemed to have been made and delivered in New York City and both this Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of New York, without regard to the conflict of laws principles thereof.&#160;&#160;Each of the Placement Agent and the Company: (i) agrees that any legal suit, action or proceeding arising out of or relating to this Agreement and/or the transactions contemplated hereby shall be instituted exclusively in New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York, (ii) waives any objection which it may now or hereafter have to the venue of any such suit, action or proceeding, and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New York, and the United States District Court for the Southern District of New York in any such suit, action or proceeding.&#160;&#160;Each of the Placement Agent and the Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York and agrees that service of process upon the Company mailed by certified mail to the Company&#8217;s address shall be deemed in every respect effective service of process upon the Company, in any such suit, action or proceeding, and service of process upon the Placement Agent mailed by certified mail to the Placement Agent&#8217;s address shall be deemed in every respect effective service process upon the Placement Agent, in any such suit, action or proceeding.&#160;&#160;Notwithstanding any provision of this Agreement to the contrary, the Company agrees that neither the Placement Agent nor its affiliates, and the respective officers, directors, employees, agents and representatives of the Placement Agent, its affiliates and each other person, if any, controlling the Placement Agent or any of its affiliates, shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the transactions described herein except for any such liability for losses, claims, damages or liabilities incurred by such persons that are finally judicially determined to have resulted from the bad faith or gross negligence of such individuals or entities.&#160;&#160;If either party shall commence an action or proceeding to enforce any provision of this Agreement, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its reasonable attorney&#8217;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Section 13.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">General Provisions</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof.&#160;&#160;This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.&#160;&#160;This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit.&#160;&#160;Section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.<a name="Page22"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">21</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company acknowledges that in connection with the offering of the Securities: (i) the Placement Agent has acted at arms length, are not agents of, and owe no fiduciary duties to the Company or any other person, (ii) the Placement Agent owes the Company only those duties and obligations set forth in this Agreement and (iii) the Placement Agent may have interests that differ from those of the Company.&#160;&#160;The Company waives to the full extent permitted by applicable law any claims it may have against the Placement Agent arising from an alleged breach of fiduciary duty in connection with the offering of the Securities</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[<font style="DISPLAY: inline; FONT-STYLE: italic">The remainder of this page has been intentionally left blank.</font>]</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">22</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If the foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all counterparts hereof, shall become a binding agreement in accordance with its terms.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Very truly yours,</font></div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">BIOANALYTICAL SYSTEMS, INC.</font>,</font></div>
</td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">an Indiana corporation</font></div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="46%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="46%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The foregoing Placement Agency Agreement is hereby confirmed and accepted as of the date first above written.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="40%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" colspan="2" nowrap valign="top" width="40%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">LADENBURG THALMANN &amp; CO. INC.</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="36%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td align="left" valign="top" width="36%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="36%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="36%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">23</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">SCHEDULE A &#8211; INDEMNIFICATION</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company hereby agrees to indemnify and hold Ladenburg, its officers, directors, principals, employees, affiliates, and shareholders, and their successors and assigns, harmless from and against any and all loss, claim, damage, liability, deficiencies, actions, suits, proceedings, costs and legal expenses or expense whatsoever (including, but not limited to, reasonable legal fees and other expenses and reasonable disbursements incurred in connection with investigating, preparing to defend or defending any action, suit or proceeding, including any inquiry or investigation, commenced or threatened, or any claim whatsoever, or in appearing or preparing for appearance as witness in any proceeding, including any pretrial proceeding such as a deposition) (collectively, "Losses") arising out of, based upon, or in any way related or attributed to, (i) any breach of a representation, warranty or covenant by the Company contained in this Agreement or (ii) any activities or services performed hereunder by Ladenburg, unless it is finally judicially determined in a court of competent jurisdiction that such Losses were the primary and direct result of the intentional misconduct or gross negligence of Ladenburg in performing the services hereunder.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If Ladenburg receives written notice of the commencement of any legal action, suit or proceeding with respect to which the Company is or may be obligated to provide indemnification pursuant to this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule A</font>, Ladenburg shall, within thirty (30) days of the receipt of such written notice, give the Company written notice thereof (a "Claim Notice").&#160;&#160;Failure to give such Claim Notice within such thirty (30) day period shall not constitute a waiver by Ladenburg of its right to indemnity hereunder with respect to such action, suit or proceeding. Upon receipt by the Company of a Claim Notice from Ladenburg with respect to any claim for indemnification which is based upon a claim made by a third party ("Third Party Claim"), the Company may assume the defense of the Third Party Claim with counsel of its own choosing, as described below.&#160;&#160;Ladenburg shall cooperate in the defense of the Third Party Claim and shall furnish such records, information and testimony and attend all such conferences, discovery proceedings, hearings, trial and appeals as may be reasonably required in connection therewith.&#160;&#160;Ladenburg shall have the right to employ its own counsel in any such action, which shall be at the Company's expense if (i) the Company and Ladenburg shall have mutually agreed in writing to the retention of such counsel, (ii) the Company shall have failed in a timely manner to assume the defense and employ counsel or experts reasonably satisfactory to Ladenburg in such litigation or proceeding or (iii) the named parties to any such litigation or proceeding (including any impleaded parties) include the Company and Ladenburg and representation of the Company and Ladenburg by the same counsel or experts would, in the reasonable opinion of Ladenburg, be inappropriate due to actual or potential differing interests between the Company and Ladenburg.&#160;&#160;The Company shall not satisfy or settle any Third Party Claim for which indemnification has been sought and is available hereunder, without the prior written consent of Ladenburg, which consent shall not be delayed and which shall not be required if Ladenburg is granted a release in connection therewith.&#160;&#160;&#160;The indemnification provisions hereunder shall survive the termination or expiration of this Agreement.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The Company further agrees, upon demand by Ladenburg, to promptly reimburse Ladenburg for, or pay, any fees, expenses or disbursements as to which Ladenburg has been indemnified herein with such reimbursement to be made currently as any such fees, expenses or disbursements are incurred by Ladenburg. Notwithstanding the provisions of the aforementioned indemnification, any such reimbursement or payment by the Company of fees, expenses, or disbursements incurred by Ladenburg shall be repaid by Ladenburg in the event of any proceeding in which a final judgment (after all appeals or the expiration of time to appeal) is entered in a court of competent jurisdiction against Ladenburg based solely upon its gross negligence or intentional misconduct in the performance of its duties hereunder, and provided further, that the Company shall not be required to make reimbursement or payment for any settlement effected without the Company&#8217;s prior written consent (which consent shall not be unreasonably withheld or delayed).<a name="Page25"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">24</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If for any reason the foregoing indemnification is unavailable or is insufficient to hold Ladenburg harmless, the Company agrees to contribute the amount paid or payable by Ladenburg in such proportion as to reflect not only the relative benefits received by the Company, on the one hand, and Ladenburg, on the other hand, but also the relative fault of the Company and Ladenburg as well as any relevant equitable considerations.&#160;&#160;In no event shall Ladenburg contribute in excess of the fees actually received by it pursuant to the terms of this Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For purposes of this Agreement, each officer, director, shareholder, and employee or affiliate of Ladenburg and each person, if any, who controls Ladenburg (or any affiliate) within the meaning of either Section 15 of the Securities Act of 1933, as amended, or Section 20 of the Securities Exchange Act of 1934, as amended, shall have the same rights as Ladenburg with respect to matters of indemnification by the Company hereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding any provision of this Agreement to the contrary, the Company agrees that neither the Placement Agent nor its Affiliates, and the respective officers, directors, employees, agents and representatives of the Placement Agent, its Affiliates and each other person, if any, controlling the Placement Agent or any of its affiliates, shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection with the engagement and transaction described herein except for any such liability for losses, claims, damages or liabilities incurred by us that are finally judicially determined to have resulted from the bad faith or gross negligence of such individuals or entities.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">25</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>6
<FILENAME>v220305_ex4-2.htm
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT C</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CLASS __ COMMON STOCK PURCHASE WARRANT</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div>
<hr style="COLOR: black" align="center" noshade size="1" width="10%">
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="57%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Warrant Shares: _______</font></div>
</td>
<td align="left" valign="top" width="43%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Initial Exercise Date: _______, 2011</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THIS CLASS __ COMMON STOCK PURCHASE WARRANT (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant</font>&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Holder</font>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Initial Exercise Date</font>&#8221;) and on or prior to the close of business on the _____ year anniversary of the Initial Exercise Date (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination Date</font>&#8221;) but not thereafter, to subscribe for and purchase from Bioanalytical Systems, Inc., an Indiana corporation (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>&#8221;), up to ______ shares (as subject to adjustment hereunder, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant Shares</font>&#8221;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 1</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Definitions</font>.&#160;&#160;Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchase Agreement</font>&#8221;), dated __________, 2011, among the Company and the purchasers signatory thereto.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 2</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exercise</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy of the Notice of Exercise Form annexed hereto. Within three (3) Trading Days following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160;&#160;The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. In the event of any dispute or discrepancy, the records of the Company shall be controlling and determinative in the absence of manifest error. The Company shall deliver any objection to any Notice of Exercise Form within one (1) Business Day of receipt of such notice.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font><a name="Page2"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exercise Price</font>.&#160;&#160;The exercise price per share of the Common Stock under this Warrant shall be <font style="DISPLAY: inline; FONT-WEIGHT: bold">$</font>_____, subject to adjustment hereunder (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exercise Price</font>&#8221;).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Cashless Exercise</font>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may only be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a certificate for the number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="TEXT-ALIGN: justify">
<div style="MARGIN-LEFT: 27pt; TEXT-INDENT: -27pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(A) = the VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a &#8220;cashless exercise,&#8221; as set forth in the applicable Notice of Exercise;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(B) = the Exercise Price of this Warrant, as adjusted hereunder; and</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 99pt; TEXT-INDENT: -27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">VWAP</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if the OTC Bulletin Board is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported in the &#8220;Pink Sheets&#8221; published by Pink OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.<a name="Page3"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the event the&#160;Company does not have an effective registration statement registering, or the prospectus contained therein is not available for the issuance of, the Warrant Shares, there is no circumstance that would require the&#160;Company to net cash settle this&#160;Warrant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Mechanics of Exercise</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Delivery of Certificates Upon Exercise</font>.&#160;&#160;Certificates for shares purchased hereunder shall be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">DWAC</font>&#8221;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is three (3) Trading Days after the latest of (A) the delivery to the Company of the Notice of Exercise, (B) surrender of this Warrant (if required) and (C) payment of the aggregate Exercise Price as set forth above (including by cashless exercise, if permitted) (such date, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant Share Delivery Date</font>&#8221;).&#160;&#160;&#160;The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder certificates evidencing the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such certificates are delivered or Holder rescinds such exercise.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii.&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Delivery of New Warrants Upon Exercise</font>.&#160;&#160;If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the certificate or certificates representing Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.<a name="Page4"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iii.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rescission Rights</font>.&#160;&#160;If the Company fails to cause the Transfer Agent to transmit to the Holder a certificate or the certificates representing the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however, that the Holder shall return any Warrant Shares subject to any such rescission concurrently with the return to the Holder of the aggregate Exercise Price paid for such Warrant Shares and the restoration of the Holder&#8217;s right to acquire such Warrant Shares pursuant to the Warrant (including issuance of a replacement Warrant certificate evidencing such restored right).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iv.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Exercise</font>.&#160;&#160;In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder a certificate or the certificates representing the Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Buy-In</font>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160;&#160;For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.&#160;&#160;Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.<a name="Page5"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">v.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Fractional Shares or Scrip</font>.&#160;&#160;No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.&#160;&#160;As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">vi.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Charges, Taxes and Expenses</font>.&#160;&#160;Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">however</font>, that in the event certificates for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">vii.&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing of Books</font>.&#160;&#160;The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page6"><!--EFPlaceholder--></a>e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Holder&#8217;s Exercise Limitations</font>.&#160;&#160;The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&#160;&#160;Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160;&#160;&#160;To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160;&#160;In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160;&#160;For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported.&#160;&#160;The &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Beneficial Ownership Limitation</font>&#8221; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.&#160;&#160;The Holder, upon not less than 61 days&#8217; prior notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply.&#160;&#160;Any such increase or decrease will not be effective until the 61<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font> day after such notice is delivered to the Company.&#160;&#160;The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 3</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Certain Adjustments</font>.<a name="Page7"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Dividends and Splits</font>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities (other than its Preferred Stock) payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.&#160;&#160;Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">[RESERVED]</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsequent Rights Offerings</font>. In addition to any adjustments pursuant to this Section, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchase Rights</font>&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise thereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until the earlier of (i) the first day on which such Holder no longer holds any Warrants and (ii) such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page8"><!--EFPlaceholder--></a>d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Pro Rata Distributions</font>.&#160;&#160;If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Common Stock (and not to the Holder) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe for or purchase any security, then in each such case the Exercise Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders entitled to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the record date mentioned above, and of which the numerator shall be such VWAP on such record date less the then per share fair market value at such record date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors in good faith.&#160;&#160;In either case the adjustments shall be described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one share of Common Stock.&#160;&#160;Such adjustment shall be made whenever any such distribution is made and shall become effective immediately after the record date mentioned above.</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page9"><!--EFPlaceholder--></a>e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fundamental Transaction</font>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fundamental Transaction</font>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Alternate Consideration</font>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160;&#160;For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.&#160;&#160;If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&#160;&#160;Notwithstanding anything to the contrary, in the event of a Fundamental Transaction that is (1) an all cash transaction, (2) a &#8220;Rule 13e-3 transaction&#8221; as defined in Rule 13e-3 under the Exchange Act, or (3) a Fundamental Transaction involving a person or entity not traded on a national securities exchange, including, but not limited to, the Nasdaq Global Select Market, the Nasdaq Global Market, or the Nasdaq Capital Market, the Company or any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction, purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction.&#160;&#160;&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Black Scholes Value</font>&#8221; means the value of this Warrant based on the Black and Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg, L.P. (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Bloomberg</font>&#8221;) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date.&#160;&#160;The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Successor Entity</font>&#8221;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.<a name="Page10"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Calculations</font>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice to Holder</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Adjustment to Exercise Price</font>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii.&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice to Allow Exercise by Holder</font>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160;&#160;To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.&#160;&#160;The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.<a name="Page11"><!--EFPlaceholder--></a></font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 4</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transfer of Warrant</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transferability</font>.&#160;&#160;This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160;&#160;Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160;&#160;The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">New Warrants</font>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160;&#160;Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant Register</font>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant Register</font>&#8221;), in the name of the record Holder hereof from time to time.&#160;&#160;The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.<a name="Page12"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 5</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Miscellaneous</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Rights as Stockholder Until Exercise</font>.&#160;&#160;This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Loss, Theft, Destruction or Mutilation of Warrant</font>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Saturdays, Sundays, Holidays, etc</font>.&#160;&#160;If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Authorized Shares</font>.&#160;&#160;The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160;&#160;The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160;&#160;The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.&#160;&#160;The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</font></div>
<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a name="Page13"><!--EFPlaceholder--></a>Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160;&#160;Without limiting the generality of the foregoing, the Company will (i) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (ii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Jurisdiction</font>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Restrictions</font>.&#160;&#160;The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Nonwaiver and Expenses</font>.&#160;&#160;No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.&#160;&#160;Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notices</font>.&#160;&#160;Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company, or to the Company by the Holder, shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Limitation of Liability</font>.&#160;&#160;No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.<a name="Page14"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Remedies</font>.&#160;&#160;The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant.&#160;&#160;The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Successors and Assigns</font>.&#160;&#160;Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160;&#160;The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Amendment</font>.&#160;&#160;This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the holders of at least a majority of the then outstanding Warrants (based on the number of Warrant Shares then issuable upon exercise of all outstanding Warrants (ignoring, for such purpose, any exercise limitations therein).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Severability</font>.&#160;&#160;Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Headings</font>.&#160;&#160;The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">********************</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(Signature Page Follows)</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">BIOANALYTICAL SYSTEMS, INC.</font></div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="4%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td align="left" valign="top" width="46%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="46%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
</td>
</tr><tr>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="46%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
</td>
</tr></table>
</div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTICE OF EXERCISE</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)&#160;&#160;&#160;&#160;&#160;&#160;Payment shall take the form of (check applicable box):</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font> in lawful money of the United States; or</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings">o</font> [if permitted] the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)&#160;&#160;&#160;&#160;&#160;&#160;Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 108pt"></font>_______________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 108pt"></font>_______________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 108pt"></font>_______________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 108pt"></font>_______________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[SIGNATURE OF HOLDER]</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name of Investing Entity: ________________________________________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Signature of Authorized Signatory of Investing Entity</font>: _________________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name of Authorized Signatory: ___________________________________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title of Authorized Signatory: ____________________________________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date: ________________________________________________________________________________________</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ASSIGNMENT FORM</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(To assign the foregoing warrant, execute</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">this form and supply required information.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Do not use this form to exercise the warrant.)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FOR VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_______________________________________________ whose address is</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_______________________________________________________________.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">_______________________________________________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 252pt"></font>Dated:&#160;&#160;______________, _______</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 108pt"></font>Holder&#8217;s Signature:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_____________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 108pt"></font>Holder&#8217;s Address:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; _____________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 108pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; _____________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Signature Guaranteed:&#160;&#160;___________________________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE:&#160;&#160;The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company.&#160;&#160;Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>7
<FILENAME>v220305_ex4-3.htm
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT A</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">BIOANALYTICAL SYSTEMS, INC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CERTIFICATE OF DESIGNATION OF PREFERENCES,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">RIGHTS AND LIMITATIONS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OF</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6% SERIES A<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#160;</font>CONVERTIBLE PREFERRED SHARES</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PURSUANT TO SECTION 23-1-25-2 OF THE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">INDIANA BUSINESS CORPORATION LAW</font><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Board of Directors of Bioanalytical Systems, Inc., an Indiana corporation (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Corporation</font>&#8221;)does hereby provide for the issuance of a series of Preferred Shares for cash or exchange of other securities, rights or property and does hereby fix and determine the preferences, limitations, restrictions and relative voting and other rights relating to such series of Preferred Shares as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">TERMS OF PREFERRED SHARES</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 1</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Definitions</font>. For the purposes hereof, the following terms shall have the following meanings:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Affiliate</font>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Alternate Consideration</font>&#8221; shall have the meaning set forth in Section 7(e).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Beneficial Ownership Limitation</font>&#8221; shall have the meaning set forth in Section 6(d).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Business Day</font>&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Buy-In</font>&#8221; shall have the meaning set forth in Section 6(c)(iv).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Change of Control Transaction</font>&#8221; means the occurrence after the date hereof of any of (a) an acquisition after the date hereof by an individual or legal entity or &#8220;group&#8221; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective control (whether through legal or beneficial ownership of capital stock of the Corporation, by contract or otherwise) of in excess of 33% of the voting securities of the Corporation (other than by means of conversion or exercise of Preferred Stock and the Securities issued together with the Preferred Stock), (b) the Corporation merges into or consolidates with any other Person, or any Person merges into or consolidates with the Corporation and, after giving effect to such transaction, the stockholders of the Corporation immediately prior to such transaction own less than 66% of the aggregate voting power of the Corporation or the successor entity of such transaction, (c) the Corporation sells or transfers all or substantially all of its assets to another Person and the stockholders of the Corporation immediately prior to such transaction own less than 66% of the aggregate voting power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a one year period of more than one-half of the members of the Board of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors was approved by a majority of the members of the Board of Directors who are members on the Original Issue Date), or (e) the execution by the Corporation of an agreement to which the Corporation&#160;&#160;is a party or by which it is bound, providing for any of the events set forth in clauses (a) through (d) above.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Class A Warrants</font>&#8221; means, collectively, the Common Stock purchase warrants delivered to the Holder at the Closing in accordance with Section 2.2(a) of the Purchase Agreement, which Class A Warrants shall be exercisable immediately and have a term of exercise equal to five years, in the form of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit&#160;C</font> attached to the Purchase Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Class B Warrants</font>&#8221; means, collectively, the Common Stock purchase warrants delivered to the Holder at the Closing in accordance with Section 2.2(a) of the Purchase Agreement, which Class B Warrants shall be exercisable immediately and have a term of exercise equal to one year, in the form of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit&#160;C</font> attached to the Purchase Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing</font>&#8221; means the closing of the purchase and sale of the Securities pursuant to Section 2.1 of the Purchase Agreement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing Date</font>&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto and all conditions precedent to (i) each Holder&#8217;s obligations to pay the Subscription Amount and (ii) the Corporation&#8217;s obligations to deliver the Securities have been satisfied or waived.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Commission</font>&#8221; means the United States Securities and Exchange Commission.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock</font>&#8221; means the Corporation&#8217;s common stock, no par value per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock Equivalents</font>&#8221; means any securities of the Corporation or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Amount</font>&#8221; means the sum of the Stated Value at issue.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Date</font>&#8221; shall have the meaning set forth in Section 6(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Price</font>&#8221; shall have the meaning set forth in Section 6(b).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Shares</font>&#8221; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Notice Period</font>&#8221; shall have the meaning set forth in Section 3(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Payment Date</font>&#8221; shall have the meaning set forth in Section 3(a).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Share Amount</font>&#8221; shall have the meaning set forth in Section 3(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Equity Conditions</font>&#8221; means, during the period in question, (a) the Corporation shall have duly honored all conversions scheduled to occur or occurring by virtue of one or more Notices of Conversion of the applicable Holder on or prior to the dates so requested or required, if any, (b) the Corporation shall have paid all liquidated damages and other amounts owing to the applicable Holder in respect of the Preferred Stock, (c)(i) there is an effective registration statement pursuant to which the Corporation may issue Conversion Shares (and, as applicable, shares of Common Stock in satisfaction of the Make-Whole Payment and in lieu of cash payment of dividends) or (ii), with respect to conversions that occur after May ____, 2014, all of the Conversion Shares may be issued to the Holder pursuant to Section 3(a)(9) of the Securities Act and immediately resold without restriction, (d) the Common Stock is trading on a Trading Market and all of the shares issuable pursuant to the Transaction Documents are listed or quoted for trading on such Trading Market (and the Corporation believes, in good faith, that trading of the Common Stock on a Trading Market will continue uninterrupted for the foreseeable future), (e) there is a sufficient number of authorized, but unissued and otherwise unreserved, shares of Common Stock for the issuance of all of the shares then issuable pursuant to the Transaction Documents, (f) the issuance of the shares in question to the applicable Holder would not violate the limitations set forth in Section 6(d) herein, (g) there has been no public announcement of a pending or proposed Fundamental Transaction or Change of Control Transaction that has not been consummated, (h) the applicable Holder is not in possession of any information provided by the Corporation that constitutes, or may constitute, material non-public information, and (i) the average daily trading volume for a period of 20 consecutive Trading Days prior to the applicable date in question, exceeds 20,000 shares per Trading Day (subject to adjustment for forward and reverse stock splits, stock dividends and the like); provided, however, that paragraph (g) shall not apply after May __, 2014.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion Amount</font>&#8221; means the sum of (a) 100% of the aggregate Stated Value then outstanding, (b) accrued but unpaid dividends and (c) all liquidated damages and other amounts due in respect of the Preferred Stock.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion Date</font>&#8221; shall have the meaning set forth in Section 8(c).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion Notice</font>&#8221; shall have the meaning set forth in Section 8(c).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion Notice Date</font>&#8221; shall have the meaning set forth in Section 8(c).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fundamental Transaction</font>&#8221; shall have the meaning set forth in Section 7(e).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">GAAP</font>&#8221; means United States generally accepted accounting principles.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Holder</font>&#8221; means the Person in whose name a security is registered on the books of the Corporation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Junior Securities</font>&#8221; means the Common Stock and all other Common Stock Equivalents of the Corporation other than those securities which are explicitly senior or <font style="DISPLAY: inline; TEXT-DECORATION: underline">pari</font> <font style="DISPLAY: inline; TEXT-DECORATION: underline">passu</font> to the Preferred Stock in dividend rights or liquidation preference.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Liens</font>&#8221; means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Liquidation</font>&#8221; shall have the meaning set forth in Section 5.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Make-Whole Payment</font>&#8221; shall have the meaning set forth in Section 3(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">New York Courts</font>&#8221; shall have the meaning set forth in Section 9(d).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice of Conversion</font>&#8221; shall have the meaning set forth in Section 6(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption</font>&#8221; shall have the meaning set forth in Section 8(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption Amount</font>&#8221; means the sum of (a) 120% of the aggregate Stated Value then outstanding, (b) accrued but unpaid dividends and (c) all liquidated damages and other amounts due in respect of the Preferred Stock.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption Date</font>&#8221; shall have the meaning set forth in Section 8(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption Notice</font>&#8221; shall have the meaning set forth in Section 8(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption Notice Date</font>&#8221; shall have the meaning set forth in Section 8(a).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Original Issue Date</font>&#8221; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Person</font>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Preferred Stock</font>&#8221; shall have the meaning set forth in Section 2.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchase Agreement</font>&#8221; means the Securities Purchase Agreement, dated as of ________, 2011, among the Corporation and the original Holders, as amended, modified or supplemented from time to time in accordance with its terms.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities</font>&#8221; means the Preferred Stock, the Warrants, the Warrant Shares and the Underlying Shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Act</font>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Share Delivery Date</font>&#8221; shall have the meaning set forth in Section 6(c).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stated Value</font>&#8221; shall have the meaning set forth in Section 2.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subscription Amount</font>&#8221; shall mean, as to each Holder, the aggregate amount to be paid for the Preferred Stock purchased pursuant to the Purchase Agreement as specified below such Holder&#8217;s name on the signature page of the Purchase Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in immediately available funds.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsidiary</font>&#8221; means any subsidiary of the Corporation as set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3.1(a)</font> of the Purchase Agreement and shall, where applicable, also include any direct or indirect subsidiary of the Corporation formed or acquired after the date of the Purchase Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Successor Entity</font>&#8221; shall have the meaning set forth in Section 7(e).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Threshold Period</font>&#8221; shall have the meaning set forth in Section 8(c).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Trading Day</font>&#8221; means a day on which the New York Stock Exchange is open for business.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Trading Market</font>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE AMEX, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transaction Documents</font>&#8221; shall have the meaning set forth in the Purchase Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transfer Agent</font>&#8221; means Computershare, the current transfer agent of the Company, with a mailing address of 250 Royall Street, Canton, MA 02021 and a facsimile number of (781) 575-3602, and any successor transfer agent of the Company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Underlying Shares</font>&#8221; means the shares of Common Stock issued and issuable upon conversion of the Preferred Stock, upon exercise of the Warrants.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">VWAP</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160;&#160;if the OTC Bulletin Board is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported in the &#8220;Pink Sheets&#8221; published by Pink OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Corporation, the fees and expenses of which shall be paid by the Corporation.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrants</font>&#8221; means, collectively, the Class A Warrants and the Class B Warrants.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant Shares</font>&#8221; means the shares of Common Stock issuable upon exercise of the Warrants.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 2</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Designation, Amount and Par Value</font>. The series of Preferred Shares shall be designated as its 6% Series A Convertible Preferred Shares (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Preferred Stock</font>&#8221;) and the number of shares so designated shall be up to 5,000 (which shall not be subject to increase without the written consent of the Holders of a majority of the outstanding shares of the Preferred Stock. Each share of Preferred Stock shall have a stated value equal to $1,000 (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stated Value</font>&#8221;).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 3</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividends and Make-Whole Payment</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividends in Cash or in Kind</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(A) From the Original Issue Date until May ___, 2014, the Holders shall be entitled to receive, and the Corporation shall pay, cumulative dividends at the rate per share (as a percentage of the Stated Value per share) of 6% per annum<font style="DISPLAY: inline; FONT-WEIGHT: bold">,</font> payable quarterly on January 1, April 1, July 1 and October 1, beginning on the first such date after the Original Issue Date and on each Conversion Date (with respect only to Preferred Stock being converted) (each such date, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Payment Date</font>&#8221;) (if any Dividend Payment Date is not a Trading Day, the applicable payment shall be due on the next succeeding Trading Day)&#160;&#160;in cash, or at the Corporation&#8217;s option, in duly authorized, validly issued, fully paid and non-assessable shares of Common Stock as set forth in this Section 3(a), or a combination thereof (the amount to be paid in shares of Common Stock, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Share Amount</font>&#8221;).&#160;&#160;In addition, upon the conversion of Preferred Stock (voluntary or via a Forced Conversion) prior to May __, 2014, the Corporation shall also pay to the Holders of the Preferred Stock so converted cash, or at the Corporation&#8217;s option, subject to Equity Conditions, in duly authorized, validly issued, fully paid and non-assessable shares of Common Stock as set forth in this Section 3(a), or a combination thereof, with respect to the Preferred Stock so converted an amount equal to $180 per $1,000 of Stated Value of the Preferred Stock, less the amount of any quarterly dividend paid on such Preferred Stock in cash or in shares of Common Stock on or before the relevant Conversion Date (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Make-Whole Payment</font>&#8221;).&#160;&#160;The form of dividend payments and Make-Whole Payments to each Holder shall be determined in the following order of priority: (i) if the Equity Conditions have not been met during the 20 consecutive Trading Days immediately prior to the applicable Dividend Payment Date or Conversion Date (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Notice Period</font>&#8221;), in cash only, (ii) if the payment of dividends or the Make-Whole Payment, as applicable, is not limited by IC 23-1-28-3 and the Equity Conditions have been met during the Dividend Notice Period, at the election of the Corporation, in cash or shares of Common Stock which shall be valued solely for such purpose at 90% of the average of the VWAPs for the 20 consecutive Trading Days ending on the Trading Day that is immediately prior to the applicable Dividend Payment Date or Conversion Date, (iii) if the payment of dividends or the Make-Whole Payment, as applicable, is limited by IC 23-1-28-3 and the Equity Conditions have been met during the Dividend Notice Period, in shares of Common Stock which shall be valued solely for such purpose at 90% of the average of the VWAPs for the 20 consecutive Trading Days ending on the Trading Day that is immediately prior to the applicable Dividend Payment Date or Conversion Date, or (iv) if the payment of dividends or the Make-Whole Payment, as applicable, is limited by IC 23-1-28-3 and the Equity Conditions have not been met during the applicable Dividend Notice Period, then such dividends shall accrue to the next applicable Dividend Payment Date or Conversion Date, as applicable.&#160;&#160;The Holders shall have the same rights and remedies with respect to the delivery of any such shares as if such shares were being issued pursuant to Section 6.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(B)&#160;&#160;From and after May ___, 2014, Holders shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends (other than dividends in the form of Common Stock) actually paid on shares of the Common Stock when, as and if such dividends (other than dividends in the form of Common Stock) are paid on shares of the Common Stock.&#160;&#160;Other than as set forth in the previous sentence, no other dividends shall be paid on shares of Preferred Stock; and the Corporation shall pay no dividends (other than dividends in the form of Common Stock) on shares of the Common Stock unless it simultaneously complies with the previous sentence.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Corporation&#8217;s Ability to Pay Dividends and Make-Whole Payments in Cash or Kind</font>.&#160;&#160;On the Closing Date, the Corporation shall have notified the Holders whether or not the payment of cash dividends on the Preferred Stock is limited by IC 23-1-28-3 as of the Closing Date.&#160;&#160;The Corporation shall promptly notify the Holders at any time the Corporation shall become able or unable, as the case may be, to pay cash dividends or cash Make-Whole Payments. If at any time the Corporation has the right to pay dividends in cash or shares of Common Stock, the Corporation must provide the Holders with at least 20 Trading Days&#8217; notice of its election to pay a regularly scheduled dividend in shares of Common Stock (the Corporation may indicate in such notice that the election contained in such notice shall continue for later periods until revised by a subsequent notice), and with respect to a Make-Whole Payment, the Corporation shall notify a Holder on either (i) the date it receives the applicable Notice of Conversion, if such Notice of Conversion is received by 12:00 PM Eastern Time on such date, or (ii) on the Business Day immediately following the date it receives the applicable Notice of Conversion, if such Notice of Conversion is received after 12:00 PM Eastern Time on such date, whether it elects to make such payment in cash or through the issuance of shares of Common Stock the Corporation may indicate in such notice that the election contained in such notice shall continue for later periods until revised by a subsequent notice).&#160;&#160;The aggregate number of shares of Common Stock otherwise issuable to the Holder on a Dividend Payment Date shall be reduced by the number of shares of Common Stock previously issued to the Holder in connection with such Dividend Payment Date.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Dividend Calculations</font>. Dividends on the Preferred Stock shall be calculated on the basis of a 360-day year, consisting of twelve 30 calendar day periods, and shall accrue daily commencing on the Original Issue Date, and shall be deemed to accrue from such date whether or not earned or declared.&#160;&#160;&#160;Payment of dividends in shares of Common Stock shall otherwise occur pursuant to Section 6(c)(i) herein and, solely for purposes of the payment of dividends in shares, the Dividend Payment Date shall be deemed the Conversion Date.&#160;&#160;Dividends shall cease to accrue with respect to any Preferred Stock converted, provided that, the Corporation actually delivers the Conversion Shares within the time period required by Section 6(c)(i) herein.&#160;&#160;Except as otherwise provided herein, if at any time the Corporation pays dividends partially in cash and partially in shares, then such payment shall be distributed ratably among the Holders based upon the number of shares of Preferred Stock held by each Holder on such Dividend Payment Date.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Late Fees</font>. Unless the Corporation is required to defer such dividend payment as described in clause (iv) of Section 3(a)(A) above, any dividends or Make-Whole Payments, whether paid in cash or shares of Common Stock, that are not paid within three Trading Days following a Dividend Payment Date or Conversion Date, as applicable, shall continue to accrue and shall entail a late fee, which must be paid in cash, at the rate of 18% per annum or the lesser rate permitted by applicable law which shall accrue daily from the Dividend Payment Date or Conversion Date, as applicable through and including the date of actual payment in full.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Securities</font>. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall redeem, purchase or otherwise acquire directly or indirectly any Junior Securities. So long as any Preferred Stock shall remain outstanding, neither the Corporation nor any Subsidiary thereof shall directly or indirectly pay or declare any dividend or make any distribution upon (other than a dividend or distribution described in Section 6 or dividends due and paid in the ordinary course on preferred stock of the Corporation at such times when the Corporation is in compliance with its payment and other obligations hereunder), nor shall any distribution be made in respect of, any Junior Securities as long as any dividends due on the Preferred Stock remain unpaid, nor shall any monies be set aside for or applied to the purchase or redemption (through a sinking fund or otherwise) of any Junior Securities or shares <font style="DISPLAY: inline; TEXT-DECORATION: underline">pari</font> <font style="DISPLAY: inline; TEXT-DECORATION: underline">passu</font> with the Preferred Stock.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 4</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Voting Rights</font>. Except as otherwise provided herein or as otherwise required by law, the Preferred Stock shall have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise <font style="DISPLAY: inline; TEXT-DECORATION: underline">pari</font> <font style="DISPLAY: inline; TEXT-DECORATION: underline">passu</font> with, the Preferred Stock, (c) amend its articles of incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing.&#160;&#160;In addition, any matters requiring class voting by the shareholders of the Corporation under the Indiana Business Corporation Law shall require the affirmative vote of the Holders of a majority of the then outstanding shares of Preferred Stock.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 5</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Liquidation</font>. Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Liquidation</font>&#8221;), the Holders shall be entitled to receive out of the assets of the Corporation available for distribution to the shareholders of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.&#160;&#160;A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation. The Corporation shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to each Holder.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 6</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversions at Option of Holder</font>. Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to the limitations set forth in Section 6(d)) determined by dividing the Stated Value of such share of Preferred Stock by the Conversion Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as <font style="DISPLAY: inline; TEXT-DECORATION: underline">Annex A</font> (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice of Conversion</font>&#8221;). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile such Notice of Conversion to the Corporation (such date, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Date</font>&#8221;). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error.&#160;&#160;To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue.&#160;&#160;Each such Holder and the Corporation shall maintain records showing the number of Conversion Shares issued upon conversion of the Preferred Stock held by it and the date of such conversions. In the event of any dispute or discrepancy, with respect to such conversions, the records of the Corporation shall be controlling and determinative in the absence of manifest error. The Corporation shall deliver any objection to any Notice of Conversion within one (1) Business Day of receipt of such notice.&#160;&#160;Shares of Preferred Stock converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Price</font>.&#160;&#160;The conversion price for the Preferred Stock shall equal <font style="DISPLAY: inline; FONT-WEIGHT: bold">$_____</font>, subject to adjustment as set forth herein (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Price</font>&#8221;).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Mechanics of Conversion</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Delivery of Certificate Upon Conversion</font>. Not later than three (3) Trading Days after each Conversion Date (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Share Delivery Date</font>&#8221;), the Corporation shall deliver, or cause to be delivered, to the converting Holder (A) a certificate or certificates which shall be free of restrictive legends and trading restrictions, representing the number of Conversion Shares being acquired upon the conversion of the Preferred Stock (including, (x) if the Corporation has given continuous notice pursuant to Section 3(b) for payment of dividends in shares of Common Stock at least 20 Trading Days prior to the date on which the Notice of Conversion is delivered to the Corporation, shares of Common Stock representing the payment of accrued dividends otherwise determined pursuant to Section 3(a) but assuming that the Dividend Notice Period is the 20 Trading Days period immediately prior to the date on which the Notice of Conversion is delivered to the Corporation and excluding for such issuance the condition that the Corporation deliver the Dividend Share Amount as to such dividend payment and (y) shares of Common Stock in lieu of Make-Whole Payments, if applicable), and (B) a bank check in the amount of accrued and unpaid dividends and the Make-Whole Payment (if the Corporation has elected or is required to pay the Make-Whole Payment and accrued dividends in cash). The Corporation shall use its best efforts to deliver any certificate or certificates representing the Conversion Shares required to be delivered by the Corporation under this Section 6 electronically through the Depository Trust Company or another established clearing corporation performing similar functions.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Failure to Deliver Certificates</font>.&#160;&#160;If, in the case of any Notice of Conversion, such certificate or certificates are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation at any time on or before its receipt of such certificate or certificates, to rescind such Notice of Conversion, in which event the Corporation shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation, and the Holder shall promptly return to the Corporation the Common Stock certificates and cash issued or paid to such Holder pursuant to the rescinded Notice of Conversion.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Obligation Absolute; Partial Liquidated Damages</font>.&#160;&#160;The Corporation&#8217;s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares; <font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">however</font>, that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder.&#160;&#160;In the event a Holder shall elect to convert any or all of the Stated Value of its Preferred Stock, the Corporation may not refuse conversion based on any claim that such Holder or any one associated or affiliated with such Holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to Holder, restraining and/or enjoining conversion of all or part of the Preferred Stock of such Holder shall have been sought and obtained, and the Corporation posts a surety bond for the benefit of such Holder in the amount of 150% of the Stated Value of Preferred Stock which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to such Holder to the extent it obtains judgment.&#160;&#160;In the absence of such injunction, the Corporation shall issue Conversion Shares and, if applicable, cash, upon a properly noticed conversion. If the Corporation fails to deliver to a Holder such certificate or certificates representing the Conversion Shares pursuant to Section 6(c)(i) on the second Trading Day after the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $5,000 of Stated Value of Preferred Stock being converted, $50 per Trading Day (increasing to $100 per Trading Day on the third Trading Day and increasing to $200 per Trading Day on the sixth Trading Day after such damages begin to accrue) for each Trading Day after such second Trading Day after the Share Delivery Date until such certificates are delivered or Holder rescinds such conversion.&#160;&#160;Nothing herein shall limit a Holder&#8217;s right to pursue actual damages or declare a Triggering Event pursuant to Section 10 hereof for the Corporation&#8217;s failure to deliver Conversion Shares within the period specified herein and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.&#160;&#160;The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Conversion</font>. In addition to any other rights available to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable certificate or certificates representing the Conversion Shares by the Share Delivery Date pursuant to Section 6(c)(i), and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Buy-In</font>&#8221;), then the Corporation shall (A) pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x) such Holder&#8217;s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under Section 6(c)(i). For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation&#8217;s failure to timely deliver certificates representing shares of Common Stock upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Reservation of Shares Issuable Upon Conversion</font>. The Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock and payment of dividends on the Preferred Stock, each as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable (taking into account the adjustments and restrictions of Section 7) upon the conversion of the then outstanding shares of Preferred Stock and payment of dividends hereunder.&#160;&#160;The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fractional Shares</font>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred Stock.&#160;&#160;&#160;As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Corporation shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price or round up to the next whole share.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">vii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transfer Taxes</font>.&#160;&#160;The issuance of certificates for shares of the Common Stock on conversion of this Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificates, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such certificates unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Beneficial Ownership Limitation</font>.<font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>The Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&#8217;s Affiliates, and any Persons acting as a group together with such Holder or any of such Holder&#8217;s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i) conversion of the remaining, unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates and (ii) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation&#160;&#160;subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred Stock or the Warrants) beneficially owned by such Holder or any of its Affiliates.&#160; Except as set forth in the preceding sentence, for purposes of this Section 6(d), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160;&#160;To the extent that the limitation contained in this Section 6(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned by such Holder together with any Affiliates) and of how many shares of Preferred Stock are convertible shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&#8217;s determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates) and how many shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Corporation shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160;In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160;&#160;For purposes of this Section 6(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (i) the Corporation&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more recent written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&#160; Upon the written or oral request of a Holder, the Corporation shall within two Trading Days confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding.&#160; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Beneficial Ownership Limitation</font>&#8221; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of Preferred Stock held by the applicable Holder.&#160;&#160;A Holder, upon not less than 61 days&#8217; prior notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 6(d) applicable to its Preferred Stock provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of this Preferred Stock held by the Holder and the provisions of this Section 6(d) shall continue to apply.&#160;&#160;Any such increase or decrease will not be effective until the 61<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">st</font> day after such notice is delivered to the Corporation and shall only apply to such Holder and no other Holder.&#160;&#160;The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 6(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation.&#160;The limitations contained in this paragraph shall apply to a successor holder of Preferred Stock.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Certain Adjustments</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Dividends and Stock Splits</font>.&#160;&#160;If the Corporation, at any time while the Preferred Stock is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend or a Make-Whole Payment on, the Preferred Stock), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event.&#160;&#160;Any adjustment made pursuant to this Section 7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</font></div>
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">[RESERVED]</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsequent Rights Offerings</font>.&#160;&#160;In addition to any adjustments pursuant to the other subsections of this Section 7, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchase Rights</font>&#8221;), then each Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&#8217;s Preferred Stock (without regard to any limitations on exercise thereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that a Holder&#8217;s right to participate in any such Purchase Right would result in such Holder exceeding the Beneficial Ownership Limitation, then such Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for such Holder until the earlier of (i) the first date on which such Holder no longer holds any shares of Preferred Stock and (ii) such time, if ever, as its right thereto would not result in such Holder exceeding the Beneficial Ownership Limitation).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Pro Rata Distributions</font>. If the Corporation, at any time while the Preferred Stock is outstanding, distributes to all holders of Common Stock (and not to the Holders) evidences of its indebtedness or assets (including cash and cash dividends) or rights or warrants to subscribe for or purchase any security, then in each such case the Conversion Price shall be adjusted by multiplying such Conversion Price in effect immediately prior to the record date fixed for determination of stockholders entitled to receive such distribution by a fraction of which the denominator shall be the VWAP determined as of the record date mentioned above, and of which the numerator shall be such VWAP on such record date less the then fair market value at such record date of the portion of such assets or evidence of indebtedness or rights or warrants so distributed applicable to one outstanding share of the Common Stock as determined by the Board of Directors of the Corporation in good faith.&#160;&#160;In either case the adjustments shall be described in a statement delivered to the Holders describing the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one share of Common Stock.&#160;&#160;Such adjustment shall be made whenever any such distribution is made and shall become effective immediately after the record date mentioned above.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fundamental Transaction</font>.&#160;&#160;If, at any time while the Preferred Stock is outstanding, (i) the Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii) the Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, (v) the Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fundamental Transaction</font>&#8221;), then, upon any subsequent conversion of this Preferred Stock, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion of this Preferred Stock), the number of shares of Common Stock of the successor or acquiring corporation or of the Corporation, if it is the surviving corporation, and any additional consideration (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Alternate Consideration</font>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in Section 6(d) on the conversion of this Preferred Stock).&#160;&#160;For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Corporation shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.&#160;&#160;If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this Preferred Stock following such Fundamental Transaction.&#160;&#160;To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designation with the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the Holders&#8217; right to convert such preferred stock into Alternate Consideration.&#160;&#160;The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Successor Entity</font>&#8221;) to assume in writing all of the obligations of the Corporation under this Certificate of Designation and the other Transaction Documents (as defined in the Purchase Agreement) in accordance with the provisions of this Section 7(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the holder of this Preferred Stock, deliver to the Holder in exchange for this Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of this Preferred Stock (without regard to any limitations on the conversion of this Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of this Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designation and the other Transaction Documents referring to the &#8220;Corporation&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designation and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Corporation herein.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Calculations</font>.&#160;&#160;All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.&#160;&#160;For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice to the Holders</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Adjustment to Conversion Price</font>.&#160;&#160;Whenever the Conversion Price is adjusted pursuant to any provision of this Section 7, the Corporation shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.</font></div>

<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice to Allow Conversion by Holder</font>.&#160;&#160;If (A) the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E) the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of the Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160;&#160;To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.&#160;&#160;The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 20-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 8</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption and Forced Conversion.</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption at Election of Corporation</font>.&#160;&#160;Notwithstanding anything herein to the contrary, subject to the provisions of this Section 8, if after Original Issue Date the VWAP for each of any 20 consecutive Trading Day period, which 20 consecutive Trading Day period shall have commenced only after the Original Issue Date, exceeds 200% of the then effective Conversion Price, the Corporation may deliver a notice to the Holders (an &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption Notice</font>&#8221; and the date such notice is deemed delivered hereunder, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption Notice Date</font>&#8221;) of its irrevocable election to redeem all of the then outstanding Preferred Stock, for cash in an amount equal to the Optional Redemption Amount on the 20<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font> Trading Day following the Optional Redemption Notice Date (such date, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption Date</font>&#8221; and such redemption, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Optional Redemption</font>&#8221;).&#160;&#160;The Optional Redemption Amount is payable in full on the Optional Redemption Date.&#160;&#160;Prior to the three-year anniversary of the Original Issue Date, the Corporation may only effect an Optional Redemption if each of the Equity Conditions shall have been met on each Trading Day occurring during the 20 Trading Day period commencing on the Optional Redemption Notice Date through to the Optional Redemption Date and through and including the date payment of the Optional Redemption Amount is actually made.&#160;&#160;Prior to the three-year anniversary of the Original Issue Date, if any of the Equity Conditions shall cease to be satisfied at any time during the 20 Trading Day period commencing on the Optional Redemption Notice Date, then a Holder may elect to nullify the Optional Redemption Notice as to such Holder by notice to the Corporation within 3 Trading Days after the first day on which any such Equity Condition has not been met (provided that if, by a provision of the Transaction Documents, the Corporation is obligated to notify the Holders of the non-existence of an Equity Condition, such notice period shall be extended to the third Trading Day after proper notice from the Corporation) in which case the Optional Redemption Notice shall be null and void, <font style="DISPLAY: inline; TEXT-DECORATION: underline">ab</font><font style="DISPLAY: inline">&#160;</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">initio</font>.&#160;&#160;From and after the three-year anniversary of the Original Issue Date, the Corporation may exercise an Optional Redemption regardless of whether or not it then satisfies the Equity Conditions, but otherwise in accordance with the terms hereof.&#160;&#160;The Corporation covenants and agrees that it will honor all Notices of Conversion tendered from the time of delivery of the Optional Redemption Notice through the date the Optional Redemption Amount is paid in full.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Redemption Procedure</font>.&#160;&#160;The payment of cash pursuant to an Optional Redemption shall be made on the Optional Redemption Date.&#160;&#160;If any portion of the cash payment for an Optional Redemption has not been paid by the Corporation on the Optional Redemption Date, interest shall accrue thereon until such amount is paid in full at a rate equal to the lesser of 18% per annum or the maximum rate permitted by applicable law.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion</font>.&#160;&#160;Notwithstanding anything herein to the contrary, if the VWAP for 20 Trading Days during any consecutive 30 Trading Day period (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Threshold Period</font>&#8221;), which Threshold Period shall have commenced only after the Original Issue Date, exceeds 200% of the then effective Conversion Price, the Corporation may, within 1 Trading Day after the end of any such Threshold Period, deliver a written notice to all Holders (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion Notice</font>&#8221; and the date such notice is delivered to all Holders, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion Notice Date</font>&#8221;) to cause each Holder to convert all or part of such Holder&#8217;s Preferred Stock (as specified in such Forced Conversion Notice) plus all accrued but unpaid dividends thereon and all liquidated damages and other amounts due in respect of the Preferred Stock pursuant to Section 6, it being agreed that the &#8220;Conversion Date&#8221; for purposes of Section 6 shall be deemed to occur on the third Trading Day following the Forced Conversion Notice Date (such third Trading Day, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forced Conversion Date</font>&#8221;).&#160;&#160;The Corporation may not deliver a Forced Conversion Notice, and any Forced Conversion Notice delivered by the Corporation shall not be effective, unless all of the Equity Conditions have been met on each of at least 20 Trading Days during the applicable Threshold Period and through the Trading Day after the date that the Conversion Shares issuable pursuant to such Forced Conversion are actually delivered to the Holders pursuant to the Forced Conversion Notice.&#160;&#160;&#160;Any Forced Conversion Notices shall be applied ratably to all of the Holders based on each Holder&#8217;s initial purchases of Preferred Stock hereunder, provided that any voluntary conversions by a Holder shall be applied against such Holder&#8217;s <font style="DISPLAY: inline; TEXT-DECORATION: underline">pro</font> <font style="DISPLAY: inline; TEXT-DECORATION: underline">rata</font> allocation, thereby decreasing the aggregate amount forcibly converted hereunder if less than all shares of the Preferred Stock are forcibly converted.&#160;&#160;For purposes of clarification, a Forced Conversion shall be subject to all of the provisions of Section 6, including, without limitation, the provisions requiring payment of liquidated damages and limitations on conversions.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 9</font>.&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Miscellaneous</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notices</font>.&#160;&#160;Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by electronic mail, facsimile, or sent by a nationally recognized overnight courier service, addressed to the Corporation, at 2701 Kent Avenue, West Lafayette, IN 47906, <font style="DISPLAY: inline; FONT-WEIGHT: bold">Attention: </font>Chief Financial Officer, email address: mcox@basinc.com, facsimile number (781) 575-3602, or such other facsimile number, e-mail address or address as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this Section 9.&#160;&#160;Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e-mail address or address of such Holder appearing on the books of the Corporation, or if no such facsimile number, email address or address appears on the books of the Corporation, at the principal place of business of such Holder, as set forth in the Purchase Agreement.&#160;&#160;Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile or e-mail at the facsimile number or e-mail address, as applicable, set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or e-mail at the facsimile number or e-mail address, as applicable, set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given.</font></div>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">21</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Absolute Obligation</font>. Except as expressly provided herein, no provision of this Certificate of Designation shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages, accrued dividends and accrued interest, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Lost or Mutilated Preferred Stock Certificate</font>.&#160;&#160;If a Holder&#8217;s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership thereof reasonably satisfactory to the Corporation.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Governing Law</font>.&#160;&#160;All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designation shall be governed by and construed and enforced in accordance with the internal laws of the State of Indiana, without regard to the principles of conflict of laws thereof.&#160;&#160;Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">New York Courts</font>&#8221;).&#160;&#160;Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient venue for such proceeding.&#160;&#160;Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof.&#160;&#160;Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designation or the transactions contemplated hereby.&#160;&#160;If any party shall commence an action or proceeding to enforce any provisions of this Certificate of Designation, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&#8217; fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</font></div>
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">22</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Waiver</font>.&#160;&#160;Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver by any other Holders.&#160;&#160;The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designation on any other occasion.&#160;&#160;Any waiver by the Corporation or a Holder must be in writing.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Severability</font>.&#160;&#160;If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances.&#160;&#160;If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Next Business Day</font>.&#160;&#160;Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Headings</font>.&#160;&#160;The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed to limit or affect any of the provisions hereof.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Status of Converted or Redeemed Preferred Stock</font>.&#160;&#160;Shares of Preferred Stock may only be issued pursuant to the Purchase Agreement.&#160;&#160;If any shares of Preferred Stock shall be converted, redeemed or reacquired by the Corporation, such shares shall resume the status of authorized but unissued Preferred Shares and shall no longer be designated as Series A 6% Convertible Preferred Shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">*********************</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">23</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ANNEX A</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTICE OF CONVERSION</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(TO BE EXECUTED BY THE REGISTERED HOLDER IN ORDER TO CONVERT SHARES OF PREFERRED STOCK)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The undersigned hereby elects to convert the number of shares of 6% Series A Convertible Preferred Shares (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Preferred Stock</font>&#8221;) indicated below into Common Shares (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock</font>&#8221;), of Bioanalytical Systems, Inc., an Indiana corporation (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Corporation</font>&#8221;), according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a Person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as may be required by the Corporation in accordance with the Purchase Agreement. No fee will be charged to the Holders for any conversion, except for any such transfer taxes. Capitalized terms used in this Notice Conversion have the meanings specified in the Certificate of Designation for the Preferred Stock.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Conversion calculations:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Date to Effect Conversion: _____________________________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number of shares of Preferred Stock owned prior to Conversion: _______________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number of shares of Preferred Stock to be Converted: ________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Stated Value of shares of Preferred Stock to be Converted: ____________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Applicable Conversion Price: ____________________________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number of shares of Common Stock to be Issued: ___________________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Number of shares of Preferred Stock subsequent to Conversion: ________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Address for Delivery: ______________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">or</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DWAC Instructions:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Broker no: _________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Account no: ___________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">[HOLDER]</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="3%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td valign="top" width="47%" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">24</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>8
<FILENAME>v220305_ex5-1.htm
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman Bold, Times New Roman, serif">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EXHIBIT 5.1</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ICE MILLER LLP</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ONE AMERICAN SQUARE, SUITE 2900</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indianapolis, Indiana 46282</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">May 2, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2701 Kent Avenue</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">West Lafayette, Indiana 47906</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Re:</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Registration Statement on Form S-1</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Ladies and Gentlemen:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have acted as counsel to Bioanalytical Systems, Inc., an Indiana corporation (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Company</font>"), in connection with the registration under the Securities Act of 1933, as amended (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Securities Act</font>"), of the offer and sale of up to 5,000 units (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Units</font>") with each Unit consisting of (i) one 6% Series A convertible preferred share (collectively, the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Series A Shares</font>") which is convertible into common shares, (ii) a Class A Warrant to purchase 0.5 common shares for every common share underlying the Series A Shares (collectively, the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Class A Warrants</font>"), (iii)&#160;a Class B Warrant to purchase 0.5 common shares for every common share underlying the Series A Shares (collectively, the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Class B Warrants</font>" and together with the Class A Warrants, the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Warrants</font>"), (iv) common shares that are issuable upon conversion of the Series A Shares and exercise of the Warrants (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Underlying Shares</font>"), and (v) common shares that may be issued by the Company as payment of dividends or make-whole payments on the Series A Shares pursuant to the terms thereof (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Dividend Shares</font>" and together with the Series A Shares, the Warrants and the Underlying Shares, the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Securities</font>").&#160;&#160;The Securities are being offered and sold pursuant to a registration statement on Form S-1 under the Securities Act originally filed with the Securities and Exchange Commission (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Commission</font>") on February 28, 2011 (File No. 333-172508) (such registration statement as amended and supplemented, the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Registration Statement</font>").&#160;&#160;Capitalized terms used in this opinion letter that are not specifically defined herein shall have the meanings assigned to them in the Registration Statement.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection therewith, we have investigated those questions of law as we have deemed necessary or appropriate for purposes of this opinion.&#160;&#160;We have also examined originals or copies, certified or otherwise identified to our satisfaction, of those documents, corporate or other records, certificates and other papers that we deemed necessary to examine for the purpose of this opinion, including, among others, (a) the Registration Statement; (b) the Second Amended and Restated Articles of Incorporation of the Company, certified by the Secretary of State of the State of Indiana on April 27, 2011, to be a true and correct copy thereof; (c) the Company's Amended and Restated Bylaws, as amended to date and currently in effect; (d) the form of Certificate of Designation of Preferences, Rights, and Limitations of Convertible Preferred Shares (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Certificate of Designation</font>"); and (e) resolutions of the Company authorizing the filing of the Registration Statement and the Certificate of Designation and the transactions contemplated thereby.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">May 2, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Page 2</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In rendering this opinion letter, we have also examined such certificates of public officials, organizational documents and records and other certificates and instruments as we have deemed necessary for the purposes of the opinions herein expressed and, with your permission, have relied upon and assumed the accuracy of such certificates, documents, records and instruments.&#160;&#160;The opinions set forth herein are limited to the law of the State of Indiana and the Federal law of the United States of America.&#160;&#160;We do not express any opinion as to any other law.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We have also relied, without investigation as to the accuracy thereof, on other certificates of, and oral and written communications from, public officials and officers of the Company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In rendering this opinion letter to you, we have assumed, with your permission:&#160;&#160;(a) the genuineness of all signatures (other than those on behalf of the Company), the authenticity and completeness of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photostatic copies, the authenticity of originals of such copies, and the legal competence of each individual executing a document; and (b) the documents that will be executed and delivered in consummation of the transactions contemplated by the Registration Statement will be identical in all material and relevant respects with the copies of the documents we have examined and on which this opinion is based.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Based on the foregoing and upon such investigation as we have deemed necessary, and subject to the assumptions, qualifications, exceptions and limitations set forth herein, we are of the opinion that when (i) the Company's Board of Directors (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Board</font>"), or a duly authorized committee of the Board, has taken all necessary corporate action to approve the issuance and establish the terms of offering of the Securities, (ii) the Registration Statement becomes effective under the Securities Act, (iii) the securities purchase agreement pursuant to which the Securities will be sold to purchasers in the offering (the "<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-DECORATION: underline">Securities Purchase Agreement</font>") is executed and delivered by the parties thereto, and (iv) the Certificate of Designation has been filed with the Secretary of State of Indiana as an amendment to the Company's Articles of Incorporation as required by applicable law:</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Series A Shares will be duly authorized for issuance by the Company, and when issued and paid for in accordance with the Securities Purchase Agreement, will be validly issued, fully paid, and non-assessable.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Warrants, when duly executed, issued and delivered by the Company against payment therefor in accordance with the terms of the Securities Purchase Agreement, will constitute valid and binding obligations of the Company, subject to applicable bankruptcy and insolvency laws and laws affecting the rights of creditors generally and general equitable principles.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">May 2, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Page 3</font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Underlying Shares issuable upon conversion of the Series A Shares, will be duly authorized for issuance by the Company, and when issued upon conversion of the Series A shares in accordance with the terms of the Certificate of Designation, will be validly issued, fully paid and non-assessable.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Underlying Shares issuable upon exercise of the Warrants, will be duly authorized for issuance by the Company, and when issued, paid for and delivered upon exercise of the Warrants in accordance with the terms of the Warrants, will be validly issued, fully paid and non-assessable.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Dividend Shares issuable in accordance with the terms of the Certificate of Designation will be duly authorized for issuance by the Company, and when so issued, will be validly issued, fully paid and non-assessable.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The opinions expressed herein are matters of professional judgment and are not a guarantee of result.&#160;&#160;We express no opinion other than as hereinbefore expressly set forth.&#160;&#160;No expansion of the opinions expressed herein may or should be made by implication or otherwise.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our firm in the Registration Statement under the caption "Legal Matters".&#160;&#160;In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 360pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Very truly yours,</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 360pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 360pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">/s/ Ice Miller LLP</div>

<div style="DISPLAY: block; MARGIN-LEFT: 360pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 360pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 360pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 360pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font>

<div>
<hr style="COLOR: black" align="left" noshade size="2" width="100%">
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>9
<FILENAME>v220305_ex10-27.htm
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES PURCHASE AGREEMENT</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Securities Purchase Agreement (this &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Agreement</font>&#8221;) is dated as of ___, 2011, between Bioanalytical Systems, Inc., an Indiana corporation (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchaser</font>&#8221; and collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchasers</font>&#8221;).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant an effective registration statement under the Securities Act of 1933, as amended (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Act</font>&#8221;), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE I.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">DEFINITIONS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Definitions</font>.&#160;&#160;In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Certificate of Designation (as defined herein), and (b) the following terms have the meanings set forth in this Section 1.1:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Acquiring Person</font>&#8221; shall have the meaning ascribed to such term in Section 4.7.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Action</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(j).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Affiliate</font>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Board of Directors</font>&#8221; means the board of directors of the Company.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Business Day</font>&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Certificate of Designation</font>&#8221; means the Certificate of Designation to be filed prior to the Closing by the Company with the Secretary of State of Indiana, in the form of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit A</font> attached hereto.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Class A Warrants</font>&#8221; means, collectively, the Common Stock purchase warrants in the form of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit C</font> attached hereto delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which warrants shall be exercisable immediately and have a term of exercise equal to five years.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Class B Warrants</font>&#8221; means, collectively, the Common Stock purchase warrants in the form of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit C</font> attached hereto delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which warrants shall be exercisable immediately and have a term of exercise equal to one year.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing</font>&#8221; means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing Date</font>&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the third Trading Day following the date hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Commission</font>&#8221; means the United States Securities and Exchange Commission.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock</font>&#8221; means the Common Shares of the Company and any other class of securities into which such securities may hereafter be reclassified or changed.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock Equivalents</font>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company Counsel</font>&#8221; means Ice Miller, LLP, with offices located at One American Square, Suite 2900, Indianapolis, IN 46282.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion Price</font>&#8221; shall have the meaning ascribed to such term in the Certificate of Designation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disclosure Schedules</font>&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Escrow Agent</font>&#8221; means Signature Bank, a New York State chartered bank, with offices at 261 Madison Avenue, New York, New York 10016.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Escrow Agreement</font>&#8221; means the escrow agreement entered into on or prior to the date hereof, by and among the Company, the Escrow Agent and the placement agent pursuant to which the Purchasers shall deposit Subscription Amounts with the Escrow Agent to be applied to the transactions contemplated hereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Evaluation Date</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(r).<a name="Page3"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exempt Issuance</font>&#8221; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FCPA</font>&#8221; means the Foreign Corrupt Practices Act of 1977, as amended.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FDA</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(gg).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FDCA</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(gg).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Final Prospectus</font>&#8221; means the form of prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission and delivered by the Company to each Purchaser at the Closing.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">GAAP</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Indebtedness</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(aa).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Intellectual Property Rights</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(o).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Liens</font>&#8221; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Adverse Effect</font>&#8221; shall have the meaning assigned to such term in Section 3.1(b).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Permits</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(m).<a name="Page4"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Maximum Rate</font>&#8221; shall have the meaning ascribed to such term in Section 5.17.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Person</font>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Pharmaceutical Product</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(gg).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Preferred Stock</font>&#8221; means the up to 5,000 shares of the Company&#8217;s 6% Series A Convertible Preferred Shares issued hereunder having the rights, preferences and privileges set forth in the Certificate of Designation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Proceeding</font>&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prospectus</font>&#8221; means the final prospectus that is part of the Registration Statement at the time it becomes effective.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prospectus Supplement</font>&#8221; means the amended or supplemented form of prospectus, in the form in which it will be filed with the Commission pursuant to Rules 430A and 424(b) (including the Prospectus as so amended or supplemented).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchaser Party</font>&#8221; shall have the meaning ascribed to such term in Section 4.10.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement</font>&#8221; means the effective registration statement with the Commission file No. 333-172508 which registers the sale of the Preferred Stock, Warrants and Underlying Shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Required Approvals</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Required Minimum</font>&#8221; means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially issuable in the future pursuant to the Transaction Documents, including any Underlying Shares issuable upon exercise in full of all Warrants or conversion in full of all shares of Preferred Stock, ignoring any conversion or exercise limits set forth therein.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 144</font>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 424</font>&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.<a name="Page5"><!--EFPlaceholder--></a></font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 430A</font>&#8221; means Rule 430A promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">SEC Reports</font>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities</font>&#8221; means the Preferred Stock, the Warrants, the Warrant Shares and the Underlying Shares.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Act</font>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Short Sales</font>&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stated Value</font>&#8221; means $1,000 per share of Preferred Stock.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subscription Amount</font>&#8221; means, as to each Purchaser, the aggregate amount to be paid for the Preferred Stock and Warrants purchased hereunder as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in immediately available funds.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsidiary</font>&#8221; means any subsidiary of the Company as set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3.1(a)</font> and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Trading Day</font>&#8221; means a day on which the principal Trading Market is open for trading.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Trading Market</font>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE AMEX, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the OTC Bulletin Board (or any successors to any of the foregoing).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transaction Documents</font>&#8221; means this Agreement, the Certificate of Designation, the Warrants, the Escrow Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transfer Agent</font>&#8221; means Computershare Ltd., the current transfer agent of the Company, with a mailing address of 250 Royall Street, Canton, MA 02021 and a facsimile number of (781) 575-3602, and any successor transfer agent of the Company.<a name="Page6"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Underlying Shares</font>&#8221; means the shares of Common Stock issued and issuable upon conversion or redemption of the Preferred Stock, upon exercise of the Warrants and issued and issuable in lieu of the cash payment of dividends and Make-Whole Payments (as defined in the Certificate of Designation) on the Preferred Stock in accordance with the terms of the Certificate of Designation.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">VWAP</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if the OTC Bulletin Board is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board, (c) if the Common Stock is not then listed or quoted for trading on the OTC Bulletin Board and if prices for the Common Stock are then reported in the &#8220;Pink Sheets&#8221; published by Pink OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)&#160;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrants</font>&#8221; means, collectively, the Class A Warrants and the Class B Warrants.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Warrant Shares</font>&#8221; means the shares of Common Stock issuable upon exercise of the Warrants.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">WS</font>&#8221; means Weinstein Smith LLP with offices located at 420 Lexington Avenue, Suite 2620, New York, New York 10170-0002.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE II.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PURCHASE AND SALE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing</font>.&#160;&#160;On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $5,000,000 of shares of Preferred Stock with an aggregate Stated Value for each Purchaser equal to such Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser, and Warrants as determined pursuant to Section 2.2(a).&#160;&#160;The aggregate number of shares of Preferred Stock sold hereunder shall be up to 5,000.&#160;&#160;Each Purchaser shall deliver to the Escrow Agent, via wire transfer or a certified check, immediately available funds equal to its Subscription Amount, and the Company shall deliver to each Purchaser its respective shares of Preferred Stock and Warrants, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing.&#160;&#160;Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of WS or such other location as the parties shall mutually agree.<a name="Page7"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Deliveries</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">this Agreement duly executed by the Company;</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a legal opinion of Company Counsel, in the form to be supplementally delivered;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a certificate evidencing a number of shares of Preferred Stock equal to such Purchaser&#8217;s Subscription Amount divided by the Stated Value, registered in the name of such Purchaser and evidence of the filing and acceptance of the Certificate of Designation from the Secretary of State of Indiana (such certificate may be delivered within three Trading Days of the Closing Date);</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a Class A Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to ___% of such Purchaser&#8217;s Shares, with an exercise price equal to $_____<font style="DISPLAY: inline; FONT-SIZE: 10pt">,</font> subject to adjustment as set forth therein (such Class A Warrant may be delivered within three Trading Days of the Closing Date);</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a Class B Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to ___% of such Purchaser&#8217;s Shares, with an exercise price equal to $_____<font style="DISPLAY: inline; FONT-SIZE: 10pt">,</font> subject to adjustment as set forth therein (such Class B Warrant may be delivered within three Trading Days of the Closing Date); and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable, the following:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">this Agreement duly executed by such Purchaser; and</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to Escrow Agent, such Purchaser&#8217;s Subscription Amount by wire transfer to the account specified in the Escrow Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Closing Conditions</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:<a name="Page8"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the accuracy in all material respects on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the accuracy in all material respects when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein);</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 72pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission&#160;&#160;or the Company&#8217;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE III.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPRESENTATIONS AND WARRANTIES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representations and Warranties of the Company</font>.&#160;&#160;Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or warranty otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:<a name="Page9"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsidiaries</font>.&#160;&#160;All of the direct and indirect subsidiaries of the Company are set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3.1(a)</font>.&#160;&#160;Except as disclosed in the Prospectus, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Organization and Qualification</font>.&#160;&#160;The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing (where applicable) under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.&#160;&#160;Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.&#160;&#160;Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Adverse Effect</font>&#8221;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Authorization; Enforcement</font>.&#160;&#160;The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.&#160;&#160;The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with the Required Approvals.&#160;&#160;This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.<a name="Page10"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Conflicts</font>.&#160;&#160;The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents, the issuance and sale of the Securities and the consummation by the Company of the transactions contemplated hereby and thereby to which it is a party do not and will not: (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Filings, Consents and Approvals</font>.&#160;&#160;The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.6 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, and (iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Shares and Warrant Shares and the listing of the Underlying Shares for trading thereon in the time and manner required thereby (collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Required Approvals</font>&#8221;).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">10</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuance of the Securities; Registration</font>.&#160;&#160;The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.&#160;&#160;The Underlying Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.&#160;&#160;The Company has reserved from its duly authorized capital stock a number of shares of Common Stock for issuance of the Underlying Shares at least equal to the Required Minimum on the date hereof.&#160;&#160;The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on&#160;_______, 2011 (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Effective Date</font>&#8221;), including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement.&#160;&#160;The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission.&#160;&#160;The Company, if required by the rules and regulations of the Commission, proposes to file the Prospectus Supplement, with the Commission pursuant to Rule 424(b).&#160;&#160;At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Capitalization</font>.&#160;&#160;The capitalization of the Company as of December 31, 2010 is as set forth in the Prospectus. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.&#160;&#160;No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.&#160;&#160;Except as a result of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the Securities will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.&#160;&#160;No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities.&#160;&#160;There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders.<a name="Page12"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">11</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">SEC Reports; Financial Statements</font>.&#160;&#160;The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">SEC Reports</font>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.&#160;&#160;As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160;&#160;The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.&#160;&#160;Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">GAAP</font>&#8221;), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Changes; Undisclosed Events, Liabilities or Developments</font>.&#160;&#160;Since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof: (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information.&#160;&#160;Except for the issuance of the Securities contemplated by this Agreement or as set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3.1(i)</font>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.<a name="Page13"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">12</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Litigation</font>.&#160;&#160;There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Action</font>&#8221;) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect.&#160;&#160;Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.&#160;&#160;There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company.&#160;&#160;The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Labor Relations</font>.&#160;&#160;No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect.&#160;&#160;None of the Company&#8217;s or its Subsidiaries&#8217; employees is a member of a union that relates to such employee&#8217;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good.&#160;&#160;To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters.&#160;&#160;The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.<a name="Page14"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">13</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compliance</font>.&#160;&#160;Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulatory Permits</font>.&#160;&#160;The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Permits</font>&#8221;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Title to Assets</font>.&#160;&#160;The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens disclosed in the Prospectus Supplement, (ii) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (iii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties.&#160;&#160;Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Intellectual Property</font>.&#160;&#160;The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as described in the SEC Reports as necessary or required for use in connection with their respective businesses and which the failure to so have could have a Material Adverse Effect (collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Intellectual Property Rights</font>&#8221;).&#160;&#160;None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.&#160;&#160;Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to result in a Material Adverse Effect.&#160;&#160;To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights.&#160;&#160;The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.<a name="Page15"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">14</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Insurance</font>.&#160;&#160;The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount.&#160;&#160;Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transactions With Affiliates and Employees</font>.&#160;&#160;Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">15</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Sarbanes-Oxley; Internal Accounting Controls</font>.&#160;&#160;The Company and the Subsidiaries are in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date.&#160;&#160;The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms.&#160;&#160;The Company&#8217;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Evaluation Date</font>&#8221;).&#160;&#160;The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.&#160;&#160;Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the&#160;&#160;internal control over financial reporting of the Company and its Subsidiaries.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Certain Fees</font>.&#160;&#160;Except as set forth in the Prospectus Supplement, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents.&#160;&#160;The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Investment Company</font>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.&#160;&#160;The Company shall conduct its business in a manner so that it will not become an &#8220;investment company&#8221; subject to registration under the Investment Company Act of 1940, as amended.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Rights</font>.&#160;&#160;No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Listing and Maintenance Requirements</font>.&#160;&#160;The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.&#160;&#160;The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance in all material respects with all such listing and maintenance requirements.<a name="Page17"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">16</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Application of Takeover Protections</font>.&#160;&#160;The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&#8217;s issuance of the Securities and the Purchasers&#8217; ownership of the Securities.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disclosure</font>.&#160;&#160;Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.&#160;&#160;The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company.&#160;&#160;All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.&#160;&#160;&#160;The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.&#160;&#160;The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Integrated Offering</font>. Assuming the accuracy of the Purchasers&#8217; representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.<a name="Page18"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">17</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Solvency</font>.&#160;&#160;Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder: (i) the fair saleable value of the Company&#8217;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid.&#160;&#160;The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).&#160;&#160;The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date.&#160;&#160;The Prospectus sets forth as of December 31, 2010 all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments.&#160;&#160;For the purposes of this Agreement, &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Indebtedness</font>&#8221; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#8217;s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.&#160;&#160;Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Tax Status</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.&#160;&#160;There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">18</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Foreign Corrupt Practices</font>.&#160;&#160;Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is&#160;&#160;in violation of law or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Accountants</font>.&#160;&#160;The Company&#8217;s accounting firm is Crowe Horwath LLP.&#160;&#160;To the knowledge and belief of the Company, such accounting firm: (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&#8217;s Annual Report for the fiscal year ending September 30, 2011.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Acknowledgment Regarding Purchasers&#8217; Purchase of Securities</font>.&#160;&#160;The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm&#8217;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.&#160;&#160;The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers&#8217; purchase of the Securities.&#160;&#160;The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Acknowledgment Regarding Purchaser&#8217;s Trading Activity</font>.&#160;&#160;Anything in this Agreement or elsewhere herein to the contrary notwithstanding, it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#8220;derivative&#8221; securities based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &#8220;derivative&#8221; transactions, before or after the closing of this or future transactions, may negatively impact the market price of the Company&#8217;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &#8220;derivative&#8221; transactions to which any such Purchaser is a party, directly or indirectly, may presently have a &#8220;short&#8221; position in the Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221; transaction.&#160;&#160;The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Underlying Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders' equity interests in the Company at and after the time that the hedging activities are being conducted.&#160; The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.<a name="Page20"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">19</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulation M Compliance</font>.&#160; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&#8217;s placement agent in connection with the placement of the Securities.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FDA</font>.&#160;&#160;As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FDA</font>&#8221;) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FDCA</font>&#8221;) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Pharmaceutical Product</font>&#8221;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect.&#160;&#160;There is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree or permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect.&#160;&#160;The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA.&#160; The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.<a name="Page21"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">20</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Option Plans</font>. Each stock option granted by the Company under the Company&#8217;s stock option plan was granted (i) in accordance with the terms of the Company&#8217;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&#8217;s stock option plan has been backdated.&#160;&#160;The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Office of Foreign Assets Control</font>.&#160;&#160;Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee or affiliate of the Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">OFAC</font>&#8221;).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">U.S. Real Property Holding Corporation</font>.&#160;&#160;The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&#8217;s request.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Bank Holding Company Act</font>.&#160;&#160;Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">BHCA</font>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Federal Reserve</font>&#8221;).&#160;&#160;Neither the Company nor any of its Subsidiaries owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.&#160;&#160;Neither the Company nor any of its Subsidiaries exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Money Laundering</font>.&#160;&#160;The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Money Laundering Laws</font>&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.<a name="Page22"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">21</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representations and Warranties of the Purchasers</font>.&#160;&#160;&#160;&#160;Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein):</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Organization; Authority</font>.&#160;&#160;Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser.&#160;&#160;Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Understandings or Arrangements</font>.&#160;&#160;Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws).&#160;&#160;Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Experience of Such Purchaser</font>.&#160;&#160;Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment.&#160;&#160;Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company acknowledges and agrees that the representations contained in Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transaction contemplated hereby.</font></div>

<br>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">22</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE IV.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">OTHER AGREEMENTS OF THE PARTIES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Underlying Shares</font>.&#160;&#160;The shares of Common Stock underlying the shares of Preferred Stock shall be issued free of legends.&#160;&#160;If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise shall be issued free of all legends.&#160;&#160;If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale or resale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale or resale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws).&#160;&#160;The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance or resale of the Warrant Shares effective during the term of the Warrants.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Acknowledgment of Dilution</font>.&#160;&#160;The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions.&#160;&#160;The Company further acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Underlying Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Furnishing of Information; Public Information</font>.&#160;&#160;Until the earliest of the time that no Purchaser owns Securities, the Company covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt">4.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline">Integration</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">.&#160;&#160;The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">23</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conversion and Exercise Procedures</font>.&#160;&#160;Each of the form of Notice of Exercise included in the Warrants and the form of Notice of Conversion included in the Certificate of Designation set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants or convert the Preferred Stock.&#160;&#160;No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants or convert their Preferred Stock.&#160;&#160;The Company shall honor exercises of the Warrants and conversions of the Preferred Stock and shall deliver Underlying Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Laws Disclosure; Publicity</font>.&#160;&#160;The Company shall, by 9:00 a.m. (New York City time) on the Trading Day immediately following the date hereof, file a Current Report on Form 8-K and press release disclosing the material terms of the transactions contemplated hereby, including the Transaction Documents as exhibits thereto.&#160;&#160;From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.&#160;&#160;Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except: (a) as required by federal securities law in connection with the filing of final Transaction Documents (including signature pages thereto) with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Shareholder Rights Plan</font>.&#160;&#160;No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an &#8220;Acquiring Person&#8221; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Non-Public Information</font>.&#160;&#160;Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company covenants and agrees that neither it, nor any other Person acting on its behalf, will provide any Purchaser or its agents or counsel with any information that the Company believes constitutes material non-public information, unless prior thereto such Purchaser shall have entered into a written agreement with the Company regarding the confidentiality and use of such information.&#160;&#160;The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.<a name="Page25"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">24</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Proceeds</font>.&#160;&#160;Except as set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 4.9</font> attached hereto, the Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&#8217;s debt (other than payment of trade payables in the ordinary course of the Company&#8217;s business and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Indemnification of Purchasers</font>.&#160;&#160;&#160;Subject to the provisions of this Section 4.10, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Purchaser Party</font>&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such&#160;&#160;Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence, willful misconduct or malfeasance).&#160;&#160;If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party.&#160;&#160;Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel.&#160;&#160;The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.10 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred; provided that each Purchaser Party who receives such payments shall promptly return all such payments to the Company if it is judicially determined that such Purchaser Party is not entitled to indemnification hereunder. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.<a name="Page26"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">25</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.11&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Reservation and Listing of Securities</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum on such date, then the Board of Directors shall use commercially reasonable efforts to amend the Company&#8217;s certificate or articles of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at such time, as soon as possible and in any event not later than the 75th day after such date.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall, if applicable: (i) in the time and manner required by the principal Trading Market, prepare and file with such Trading Market an additional shares listing application covering a number of shares of Common Stock at least equal to the Required Minimum on the date of such application, (ii) take all steps necessary to cause such shares of Common Stock to be approved for listing or quotation on such Trading Market as soon as possible thereafter, (iii) provide to the Purchasers evidence of such listing or quotation and (iv) maintain the listing or quotation of such Common Stock on any date at least equal to the Required Minimum on such date on such Trading Market or another Trading Market.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.12&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsequent Equity Sales</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;From the date hereof until 90 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.&#160;&#160;In addition, from the date hereof until the three year anniversary of the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents at an effective price per share of less than $_______.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">26</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;From the date hereof until such time as no Purchaser holds any of the Warrants, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration (or a combination of units thereof) involving a Variable Rate Transaction. &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Variable Rate Transaction</font>&#8221; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into any agreement, including, but not limited to, an equity line of credit, whereby the Company may sell securities at a future determined price.&#160;&#160;&#160;Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">4.13&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Equal Treatment of Purchasers</font>.&#160;&#160;No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ARTICLE V.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MISCELLANEOUS</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination</font>.&#160; This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before _______ ___, 2011; <font style="DISPLAY: inline; TEXT-DECORATION: underline">provided</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">however</font>, that such termination will not affect the right of any party to sue for any breach by any other party (or parties).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Fees and Expenses</font>.&#160;&#160;Except as expressly set forth in the Transaction Documents to the contrary, (a) each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement and (b) the Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.<a name="Page28"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">27</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Entire Agreement</font>.&#160;&#160;The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notices</font>.&#160;&#160;Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via facsimile or electronic mail at the facsimile number or e-mail address, as applicable, set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or e-mail at the facsimile number or e-mail address, as applicable, set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">nd</font>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given.&#160;&#160;The address for such notices and communications shall be as set forth on the signature pages attached hereto.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Amendments; Waivers</font>.&#160;&#160;No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Purchasers holding a majority in interest of the Securities then outstanding or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought.&#160;&#160;No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Headings</font>.&#160;&#160;The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Successors and Assigns</font>.&#160;&#160;This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.&#160;&#160;The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).&#160;&#160;Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Third-Party Beneficiaries</font>.&#160;&#160;This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.10.<a name="Page29"><!--EFPlaceholder--></a></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">28</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Governing Law</font>.&#160;&#160;All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents (other than the Certificate of Designation which shall be governed by and construed and enforced in accordance with Indiana Law) shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.&#160;&#160;Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.&#160;&#160;Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any action, suit or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.&#160;&#160;Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.&#160;&#160;Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.&#160;&#160;&#160;If either party shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.10, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Survival</font>.&#160;&#160;The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.11&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Execution</font>.&#160;&#160;This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective as to the Company, when a counterpart has been signed by or on behalf of the Company and delivered to one or more Purchasers (but only as to the Purchasers to which such signed counterpart is so delivered) and as to each Purchaser when a counterpart has been signed by or on behalf of such Purchaser and delivered to the Company, it being understood that the parties need not sign the same counterpart.&#160;&#160;In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page were an original thereof.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">29</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.12&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Severability</font>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.13&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Reserved</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.14&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Reserved</font>.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.15&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Remedies</font>.&#160;&#160;In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents.&#160;&#160;The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.16&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Payment Set Aside</font>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.17&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Usury</font>.&#160;&#160;To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any claim, action or proceeding that may be brought by any Purchaser in order to enforce any right or remedy under any Transaction Document.&#160;&#160;Notwithstanding any provision to the contrary contained in any Transaction Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Maximum Rate</font>&#8221;), and, without limiting the foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate.&#160;&#160;It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the Closing Date thereof forward, unless such application is precluded by applicable law.&#160;&#160;If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Purchaser to the unpaid principal balance of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Purchaser&#8217;s election.<a name="Page31"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">30</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.18&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Independent Nature of Purchasers&#8217; Obligations and Rights</font>.&#160;&#160;The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document.&#160;&#160;Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents.&#160;&#160;Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose.&#160;&#160;Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents.&#160;&#160;For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through WS.&#160;&#160;WS does not represent any of the Purchasers and only represents the placement agent.&#160;&#160;The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers.&#160;&#160;It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.19&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Liquidated Damages</font>.&#160;&#160;The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.20&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Saturdays, Sundays, Holidays, etc</font>.&#160;&#160;&#160;If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.21&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Construction</font>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.<a name="Page32"><!--EFPlaceholder--></a></font></div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">31</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">5.22&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">WAIVER OF JURY TRIAL</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">.&#160;&#160;IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">(Signature Pages Follow)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">32</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">BIOANALYTICAL SYSTEMS, INC.</font></div>
</td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Address for Notice:</font></font></div>
</td>
</tr><tr>
<td colspan="2" valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="3%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By:</font></div>
</td>
<td valign="top" width="47%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="45%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Fax:</font></font></div>
</td>
</tr><tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name:</font></div>
</td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="47%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title:</font></div>
</td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">With a copy to (which shall not constitute notice):</font></div>
</td>
<td valign="top" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="45%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">33</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[PURCHASER SIGNATURE PAGES TO BASI SECURITIES PURCHASE AGREEMENT]</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name of Purchaser: ________________________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-STYLE: italic">Signature of Authorized Signatory of Purchaser</font>: __________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Name of Authorized Signatory: ____________________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Title of Authorized Signatory: _____________________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Email Address of Authorized Signatory: _____________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Facsimile Number of Authorized Signatory: __________________________________________</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Address for Notice to Purchaser:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Address for Delivery of Securities to Purchaser (if not same as address for notice):</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Subscription Amount: _____________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares of Preferred Stock: ____________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Warrant Shares: _________________</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">EIN Number: <font style="DISPLAY: inline; FONT-SIZE: 10pt">_______________________</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline;" face="Wingdings"><font style="DISPLAY: inline;" face="Wingdings">o</font></font>&#160;&#160;Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur on the third (3<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font>) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</font></div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">[SIGNATURE PAGES CONTINUE]</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: center">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">34</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">&#160;</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>10
<FILENAME>v220305_ex23-1.htm
<TEXT>
<html>
<head>
    <title>Unassociated Document</title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 2%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 2%; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Exhibit 23.1</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We consent to the use in this Registration Statement of Bioanalytical Systems, Inc. on Amendment No.3 to Form S-1 (No. 333-172508) of our report dated January 12, 2011 on the consolidated financial statements of Bioanalytical Systems, Inc. and to the reference to us under the heading "Experts" in the prospectus.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Crowe Horwath LLP</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fort Wayne, Indiana</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">May 2, 2011</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>11
<FILENAME>filename11.htm
<TEXT>
<html>
<head>
    <title></title>
    <!--Licensed to: Vintage Filings-->
    <!--Document Created using EDGARizerAgent 5.3.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ICE MILLER LLP</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">One American Square, Suite 2900</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indianapolis, Indiana 46282</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">May 2, 2011</font></div>
</td>
<td align="right" valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-VARIANT: small-caps">Writer's Direct Number:</font> (317) 236-2289</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-VARIANT: small-caps">Direct Fax: (317) 592-4666</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-VARIANT: small-caps">Internet:</font> Stephen.Hackman@icemiller.com</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">BY EDGAR, FEDEX AND FACSIMILE</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mr.&#160;John L. Krug</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Division of Corporation Finance</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">U.S. Securities and Exchange Commission</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">100 F Street, NE</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mail Stop 4720</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington, DC 20549</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">&#160;</td>
<td style="WIDTH: 36pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Re:</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Bioanalytical Systems, Inc.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Registration Statement on Form S-1 filed on February 28, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amendment No.&#160;1 filed on March&#160;14, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amendment No. 2 filed on April 20, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amendment No. 3 filed on May 2, 2011</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">File No.&#160;333-172508</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear Mr.&#160;Krug:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On behalf of Bioanalytical Systems, Inc. (the "<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>"), enclosed for your review is Amendment No.&#160;3 to the Company&#8217;s Registration Statement on Form S-1 (Registration No.&#160;333-172508) (the "<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement</font>"), filed with the Securities and Exchange Commission (the "<font style="DISPLAY: inline; TEXT-DECORATION: underline">Commission</font>") on April 20, 2011 and amended by Amendment No. 1 filed on March 14, 2011 and by Amendment No. 2 filed on April 20, 2011.&#160;&#160;An electronic version of Amendment No.&#160;3 has been filed concurrently with the Commission through its EDGAR system.&#160;&#160;The enclosed copy of Amendment No.&#160;3 has been marked to reflect changes made to Amendment No. 2 to the Registration Statement.&#160;&#160;In addition, a copy of this letter together with the marked pages of Amendment No. 3 are being provided to you contemporaneously by facsimile.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If you have any questions regarding the disclosure in Amendment No. 3, please call me at the direct-dial number above.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Very truly yours,</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ICE MILLER LLP</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">/s/ Stephen J. Hackman</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="top" width="50%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stephen J. Hackman</font></div>
</td>
</tr></table>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>

<div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
